PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Finch, TM; Zhao, N; Korkin, D; Frederick, KH; Eggert, LS				Finch, Tabitha M.; Zhao, Nan; Korkin, Dmitry; Frederick, Katy H.; Eggert, Lori S.			Evidence of Positive Selection in Mitochondrial Complexes I and V of the African Elephant	PLOS ONE			English	Article							ADAPTIVE EVOLUTION; DNA; REVEAL; PERFORMANCE; METABOLISM; INFERENCE; MUTATION; RESERVE; GENE; SIZE	As species evolve, they become adapted to their local environments. Detecting the genetic signature of selection and connecting that to the phenotype of the organism, however, is challenging. Here we report using an integrative approach that combines DNA sequencing with structural biology analyses to assess the effect of selection on residues in the mitochondrial DNA of the two species of African elephants. We detected evidence of positive selection acting on residues in complexes I and V, and we used homology protein structure modeling to assess the effect of the biochemical properties of the selected residues on the enzyme structure. Given the role these enzymes play in oxidative phosphorylation, we propose that the selected residues may contribute to the metabolic adaptation of forest and savanna elephants to their unique habitats.	[Finch, Tabitha M.; Frederick, Katy H.; Eggert, Lori S.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Zhao, Nan] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA; [Korkin, Dmitry] Univ Missouri, Inst Informat, Columbia, MO USA; [Korkin, Dmitry] Univ Missouri, Dept Comp Sci, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; Mississippi State University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Finch, TM (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	tabitha.finch@mail.missouri.edu; eggertl@missouri.edu	Zhao, Nan/K-4015-2015	Zhao, Nan/0000-0002-7897-2374	National Science Foundation [DBI-0845196, IOS-1126992]; University of Missouri's Life Sciences Fellowship; Div Of Biological Infrastructure [0845196] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Missouri's Life Sciences Fellowship; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (DBI-0845196, IOS-1126992 to DK). Funding for TMF was provided by the University of Missouri's Life Sciences Fellowship, and NZ is supported by the National Science Foundation (IOS-1126992 to DK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; AMOS W, 1992, MAR MAMMAL SCI, V8, P275, DOI 10.1111/j.1748-7692.1992.tb00409.x; Archie EA, 2006, P ROY SOC B-BIOL SCI, V273, P513, DOI 10.1098/rspb.2005.3361; Arsenieva D, 2010, J BIOL CHEM, V285, P36561, DOI 10.1074/jbc.M110.174383; Ballard JWO, 2007, EVOLUTION, V61, P1735, DOI 10.1111/j.1558-5646.2007.00133.x; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brandt AL, 2012, MOL ECOL, V21, P1175, DOI 10.1111/j.1365-294X.2012.05461.x; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Codron J, 2011, OECOLOGIA, V165, P89, DOI 10.1007/s00442-010-1835-6; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; Dalziel AC, 2009, MOL ECOL, V18, P4997, DOI 10.1111/j.1365-294X.2009.04427.x; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Eggert LS, 2005, METHOD ENZYMOL, V395, P73, DOI 10.1016/S0076-6879(05)95006-4; Eggert LS, 2002, P ROY SOC B-BIOL SCI, V269, P1993, DOI 10.1098/rspb.2002.2070; Foote AD, 2010, BIOL LETT; Garvin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024127; Goodman M, 2009, P NATL ACAD SCI USA, V106, P20824, DOI 10.1073/pnas.0911239106; Greenwood AD, 1999, MOL ECOL, V8, P133, DOI 10.1046/j.1365-294X.1999.00507.x; Grossman LI, 2001, MOL PHYLOGENET EVOL, V18, P26, DOI 10.1006/mpev.2000.0890; Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hubbard S.J, 1993, NACCESS, V2; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Johnson MB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-244; Krause J, 2006, NATURE, V439, P724, DOI 10.1038/nature04432; Lister Adrian M, 2013, Nature, V500, P331, DOI 10.1038/nature12275; MCNAB BK, 1983, J ZOOL, V199, P1; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Morgan BJ, 2003, J ZOOL, V259, P337, DOI 10.1017/S0952836902003291; Murata Y, 2009, GENE, V441, P176, DOI 10.1016/j.gene.2009.01.014; Ning T, 2010, GENET MOL RES, V9, P144, DOI 10.4238/vol9-1gmr705; Owen- Smith RN., 1988, MEGAHERBIVORES; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piccoli C, 2008, LEUKEMIA, V22, P1938, DOI 10.1038/leu.2008.69; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Radermacher M, 2006, J STRUCT BIOL, V154, P269, DOI 10.1016/j.jsb.2006.02.011; Rand DM, 1998, GENETICA, V102-3, P393, DOI 10.1023/A:1017006118852; Rankinen T, 2006, MED SCI SPORT EXER, V38, P1863, DOI 10.1249/01.mss.0000233789.01164.4f; Roca AL, 2001, SCIENCE, V293, P1473, DOI 10.1126/science.1059936; Roca AL, 2005, CURR OPIN GENET DEV, V15, P652, DOI 10.1016/j.gde.2005.09.014; Rohland N, 2007, PLOS BIOL, V5, P1663, DOI 10.1371/journal.pbio.0050207; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Sali A, 1994, PROTEIN STRUCTURE DI, V64, pC86; Sanchez R, 2000, METH MOL B, V143, P97; Schuttler SG, 2012, SECRET LIVES AFRICAN; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sikes S.K, 1971, NATURAL HIST AFRICAN; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Tao N, 2005, FINDMODEL TOOL SELEC; TAYLOR WR, 1986, J THEOR BIOL, V119, P205, DOI 10.1016/S0022-5193(86)80075-3; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; WHITE LJT, 1993, AFR J ECOL, V31, P181, DOI 10.1111/j.1365-2028.1993.tb00532.x; WILLIAMS TM, 1990, J ZOOL, V222, P235, DOI 10.1111/j.1469-7998.1990.tb05674.x; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; Xu Shuqing, 2007, Journal of Genetics and Genomics, V34, P720, DOI 10.1016/S1673-8527(07)60081-2; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	69	30	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92587	10.1371/journal.pone.0092587	http://dx.doi.org/10.1371/journal.pone.0092587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695069	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000022
J	Davis, SL; Dudle, DA; Nawrocki, JR; Freestone, LM; Konieczny, P; Tobin, MB; Britton, MM				Davis, Sandra L.; Dudle, Dana A.; Nawrocki, Jenna R.; Freestone, Leah M.; Konieczny, Peter; Tobin, Michael B.; Britton, Michael M.			Sexual Dimorphism of Staminate- and Pistillate-Phase Flowers of Saponaria officinalis (Bouncing Bet) Affects Pollinator Behavior and Seed Set	PLOS ONE			English	Article							FLORAL COLOR-CHANGE; ANTHOCYANIN BIOSYNTHETIC GENES; BIASED NECTAR PRODUCTION; SELECTION; EVOLUTION; DICHOGAMY; FEMALE; INTERFERENCE; EXPRESSION; DISPLAY	The sequential separation of male and female function in flowers of dichogamous species allows for the evolution of differing morphologies that maximize fitness through seed siring and seed set. We examined staminate- and pistillate-phase flowers of protandrous Saponaria officinalis for dimorphism in floral traits and their effects on pollinator attraction and seed set. Pistillate-phase flowers have larger petals, greater mass, and are pinker in color, but due to a shape change, pistillate-phase flowers have smaller corolla diameters than staminate-phase flowers. There was no difference in nectar volume or sugar content one day after anthesis, and minimal evidence for UV nectar guide patterns in staminate- and pistillate-phase flowers. When presented with choice arrays, pollinators discriminated against pistillate-phase flowers based on their pink color. Finally, in an experimental garden, in 2012 there was a negative correlation between seed set of an open-pollinated, emasculated flower and pinkness (as measured by reflectance spectrometry) of a pistillate-phase flower on the same plant in plots covered with shade cloth. In 2013, clones of genotypes chosen from the 2012 plants that produced pinker flowers had lower seed set than those from genotypes with paler flowers. Lower seed set of pink genotypes was found in open-pollinated and hand-pollinated flowers, indicating the lower seed set might be due to other differences between pink and pale genotypes in addition to pollinator discrimination against pink flowers. In conclusion, staminate- and pistillate-phase flowers of S. officinalis are dimorphic in shape and color. Pollinators discriminate among flowers based on these differences, and individuals whose pistillate-phase flowers are most different in color from their staminate-phase flowers make fewer seeds. We suggest morphological studies of the two sex phases in dichogamous, hermaphroditic species can contribute to understanding the evolution of sexual dimorphism in plants without the confounding effects of genetic differences between separate male and female individuals.	[Davis, Sandra L.; Nawrocki, Jenna R.] Univ Indianapolis, Dept Biol, Indianapolis, IN 46227 USA; [Dudle, Dana A.; Freestone, Leah M.; Konieczny, Peter; Tobin, Michael B.; Britton, Michael M.] Depauw Univ, Dept Biol, Greencastle, IN 46135 USA	DePauw University	Davis, SL (corresponding author), Univ Indianapolis, Dept Biol, Indianapolis, IN 46227 USA.	sdavis@uindy.edu			Indiana Academy of Sciences; University of Indianapolis; DePauw University	Indiana Academy of Sciences; University of Indianapolis; DePauw University	This project was funded by a Senior Research Grant from the Indiana Academy of Sciences (http://www.indianaacademyofscience.org) to S. L. D. and D. A. D., a summer research grant to S. L. D. from the University of Indianapolis (www.uindy.edu), the DePauw University student/faculty summer research program and DePauw University Science Research Fellows program (www.depauw.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster WS, 2002, J EVOLUTION BIOL, V15, P468, DOI 10.1046/j.1420-9101.2002.00399.x; Ashman TL, 2000, OIKOS, V90, P347, DOI 10.1034/j.1600-0706.2000.900216.x; Ashman TL, 2000, ECOLOGY, V81, P2577, DOI 10.1890/0012-9658(2000)081[2577:PSAIIF]2.0.CO;2; Barrett SCH, 2013, J EXP BOT, V64, P67, DOI 10.1093/jxb/ers308; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BERTIN RI, 1993, BOT REV, V59, P112, DOI 10.1007/BF02856676; BEST LS, 1982, EVOLUTION, V36, P70, DOI 10.1111/j.1558-5646.1982.tb05011.x; Brunet J, 1998, FUNCT ECOL, V12, P596, DOI 10.1046/j.1365-2435.1998.00231.x; Campbell DR, 2012, J EVOLUTION BIOL, V25, P352, DOI 10.1111/j.1420-9101.2011.02430.x; CAMPBELL DR, 1989, EVOLUTION, V43, P318, DOI 10.1111/j.1558-5646.1989.tb04230.x; Carlson JE, 2007, AM J BOT, V94, P674, DOI 10.3732/ajb.94.4.674; Carlson JE, 2006, BOT REV, V72, P179, DOI 10.1663/0006-8101(2006)72[179:TEOGNP]2.0.CO;2; Cynthia AD., 2011, PLOS ONE, V16, P1; Dai C, 2011, FUNCT ECOL, V25, P271, DOI 10.1111/j.1365-2435.2010.01795.x; DELPH LF, 1989, EVOLUTION, V43, P1252, DOI [10.1111/j.1558-5646.1989.tb02572.x, 10.2307/2409360]; Delph LF, 2006, INTEGR COMP BIOL, V46, P465, DOI 10.1093/icb/icj038; Delph LF, 2012, EVOLUTION, V66, P1154, DOI 10.1111/j.1558-5646.2011.01510.x; Delph LF, 2010, EVOLUTION, V64, P2873, DOI 10.1111/j.1558-5646.2010.01048.x; Eckhart V.M., 1999, GENDER SEXUAL DIMORP, P123, DOI [DOI 10.1007/978-3-662-03908-3_5, 10.1007/978-3-662-03908-3_5]; Faegri K., 1979, PRINCIPLES POLLINATI; Farzad M, 2003, PLANT SCI, V165, P1333, DOI 10.1016/j.plantsci.2003.08.001; Frey FM, 2007, AM J BOT, V94, P437, DOI 10.3732/ajb.94.3.437; Frey FM, 2011, PLANT SPEC BIOL, V26, P235, DOI 10.1111/j.1442-1984.2011.00325.x; Galloway LF, 2002, INT J PLANT SCI, V163, P133, DOI 10.1086/324556; GEBER MA, 1995, TRENDS ECOL EVOL, V10, P222, DOI 10.1016/S0169-5347(00)89068-0; Gould KS, 2010, J EXP BOT, V61, P2707, DOI 10.1093/jxb/erq106; Gould KS, 2000, J EXP BOT, V51, P1107, DOI 10.1093/jexbot/51.347.1107; Harder LD, 2009, NEW PHYTOL, V183, P530, DOI 10.1111/j.1469-8137.2009.02914.x; He QL, 2011, PLOS ONE, V6, P1; Huang SQ, 2006, NEW PHYTOL, V171, P417, DOI 10.1111/j.1469-8137.2006.01766.x; Ishii HS, 2012, J ECOL, V100, P1029, DOI 10.1111/j.1365-2745.2012.01976.x; Jabbari SG, 2013, PLANT SPEC BIOL, V28, P21, DOI 10.1111/j.1442-1984.2011.00352.x; JACKSON D, 1992, PLANT J, V2, P425, DOI 10.1111/j.1365-313X.1992.00425.x; JOHNSON SG, 1995, OECOLOGIA, V102, P174, DOI 10.1007/BF00333249; Kudo G, 2007, OECOLOGIA, V154, P119, DOI 10.1007/s00442-007-0820-1; Kulbaba MW, 2012, EVOLUTION, V66, P1344, DOI 10.1111/j.1558-5646.2011.01536.x; LLOYD DG, 1986, NEW ZEAL J BOT, V24, P135, DOI 10.1080/0028825X.1986.10409725; Lowry DB, 2012, AM J BOT, V99, P82, DOI 10.3732/ajb.1100285; Mallick SA, 2001, OIKOS, V95, P533, DOI 10.1034/j.1600-0706.2001.950318.x; Moore JC, 2011, CURR BIOL, V21, pR176, DOI 10.1016/j.cub.2010.12.035; PRIMACK R B, 1982, Arnoldia (Jamaica Plain), V42, P139; Sahli HF, 2011, EVOLUTION, V65, P1457, DOI 10.1111/j.1558-5646.2011.01229.x; Sargent RD, 2006, EVOLUTION, V60, P934, DOI 10.1111/j.0014-3820.2006.tb01172.x; Schlessman MA, 2002, INT J PLANT SCI, V163, P409, DOI 10.1086/339513; Streisfeld MA, 2009, NEW PHYTOL, V183, P751, DOI 10.1111/j.1469-8137.2009.02929.x; Varga S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062575; Weiss MR, 1997, ISR J PLANT SCI, V45, P185, DOI 10.1080/07929978.1997.10676683; WEISS MR, 1995, AM J BOT, V82, P167, DOI 10.2307/2445525; WILLSON MF, 1979, AM NAT, V113, P777, DOI 10.1086/283437; Willson MF., 1983, MATE CHOICE PLANTS; Wolff D, 2006, FLORA, V201, P353, DOI 10.1016/j.flora.2005.07.010; Yakimowski SB, 2011, ANN BOT-LONDON, V108, P765, DOI 10.1093/aob/mcr025	52	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93615	10.1371/journal.pone.0093615	http://dx.doi.org/10.1371/journal.pone.0093615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690875	gold, Green Published, Green Submitted			2022-12-27	WOS:000334101100111
J	Vonk, WIM; Kakkar, V; Bartuzi, P; Jaarsma, D; Berger, R; Hofker, MH; Klomp, LWJ; Wijmenga, C; Kampinga, HH; van de Sluis, B				Vonk, Willianne I. M.; Kakkar, Vaishali; Bartuzi, Paulina; Jaarsma, Dick; Berger, Ruud; Hofker, Marten H.; Klomp, Leo W. J.; Wijmenga, Cisca; Kampinga, Harm H.; van de Sluis, Bart			The Copper Metabolism MURR1 Domain Protein 1 (COMMD1) Modulates the Aggregation of Misfolded Protein Species in a Client-Specific Manner	PLOS ONE			English	Article							MOTOR-NEURON DISEASE; SUPEROXIDE-DISMUTASE SOD1; CU,ZN-SUPEROXIDE DISMUTASE; MUTANT; DEGENERATION; INHIBITION; MUTATIONS; TOXICITY; PROMOTES; DEATH	The Copper Metabolism MURR1 domain protein 1 (COMMD1) is a protein involved in multiple cellular pathways, including copper homeostasis, NF-kappa B and hypoxia signalling. Acting as a scaffold protein, COMMD1 mediates the levels, stability and proteolysis of its substrates (e.g. the copper-transporters ATP7B and ATP7A, RELA and HIF-1 alpha). Recently, we established an interaction between the Cu/Zn superoxide dismutase 1 (SOD1) and COMMD1, resulting in a decreased maturation and activation of SOD1. Mutations in SOD1, associated with the progressive neurodegenerative disorder Amyotrophic Lateral Sclerosis (ALS), cause misfolding and aggregation of the mutant SOD1 (mSOD1) protein. Here, we identify COMMD1 as a novel regulator of misfolded protein aggregation as it enhances the formation of mSOD1 aggregates upon binding. Interestingly, COMMD1 co-localizes to the sites of mSOD1 inclusions and forms high molecular weight complexes in the presence of mSOD1. The effect of COMMD1 on protein aggregation is client-specific as, in contrast to mSOD1, COMMD1 decreases the abundance of mutant Parkin inclusions, associated with Parkinson's disease. Aggregation of a polyglutamine-expanded Huntingtin, causative of Huntington's disease, appears unaltered by COMMD1. Altogether, this study offers new research directions to expand our current knowledge on the mechanisms underlying aggregation disease pathologies.	[Vonk, Willianne I. M.; Berger, Ruud; Klomp, Leo W. J.] Univ Med Ctr Utrecht, Dept Metab & Endocrine Dis, Utrecht, Netherlands; [Vonk, Willianne I. M.; Berger, Ruud; Klomp, Leo W. J.] Univ Med Ctr Utrecht, Netherlands Metabol Ctr, Utrecht, Netherlands; [Vonk, Willianne I. M.; Wijmenga, Cisca] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Kakkar, Vaishali; Kampinga, Harm H.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands; [Bartuzi, Paulina; Hofker, Marten H.; van de Sluis, Bart] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Jaarsma, Dick] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen; Erasmus University Rotterdam; Erasmus MC; University of Groningen	van de Sluis, B (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands.	a.j.a.van.de.sluis@umcg.nl	Wijmenga, Cisca/AAE-7719-2019; Wijmenga, Cisca/D-2173-2009	Wijmenga, Cisca/0000-0002-5635-1614; Vonk, Willianne/0000-0002-5906-3933; Kampinga, Harm/0000-0002-8966-8466; van de Sluis, Bart (A.J.A.)/0000-0003-3039-4365	Netherlands Organization for Scientific Research (NWO) [40-00812-98-03106]; Marie Curie International Outgoing Fellowship Programme [303096 FOLDEG]; IOP Genomics Programme (Kampinga lab, IGE) [IGE07004]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Marie Curie International Outgoing Fellowship Programme; IOP Genomics Programme (Kampinga lab, IGE)	This work was supported by the Netherlands Organization for Scientific Research (NWO, grant number 40-00812-98-03106), and partially supported by the Marie Curie International Outgoing Fellowship Programme (WV, FP7-PEOPLE-2011-IOF; contract number 303096 FOLDEG) and the IOP Genomics Programme (Kampinga lab, IGE grant number IGE07004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardley HC, 2003, MOL BIOL CELL, V14, P4541, DOI 10.1091/mbc.E03-02-0078; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Biasio W, 2004, J BIOL CHEM, V279, P5429, DOI 10.1074/jbc.M311155200; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Burkhead JL, 2009, J BIOL CHEM, V284, P696, DOI 10.1074/jbc.M804766200; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Cao XH, 2008, J BIOL CHEM, V283, P16169, DOI 10.1074/jbc.M801522200; Chen XP, 2012, NEUROCHEM RES, V37, P835, DOI 10.1007/s11064-011-0679-8; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; da Costa CA, 2012, NEURODEGENER DIS, V10, P49, DOI 10.1159/000332803; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; de Bie P, 2006, BIOCHEM J, V398, P63, DOI 10.1042/BJ20051664; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Drevillon L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018334; Finkbemer S, 2011, COLD SPRING HARBOR P, V3; Fukada K, 2001, EUR J NEUROSCI, V14, P2032, DOI 10.1046/j.0953-816x.2001.01828.x; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Gu WJ, 2003, NEUROBIOL DIS, V14, P357, DOI 10.1016/j.nbd.2003.08.011; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Jaarsma D, 2000, NEUROBIOL DIS, V7, P623, DOI 10.1006/nbdi.2000.0299; Jonsson PA, 2006, J NEUROPATH EXP NEUR, V65, P1126, DOI 10.1097/01.jnen.0000248545.36046.3c; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Ke Y, 2010, AM J PHYSIOL-RENAL, V298, pF1445, DOI 10.1152/ajprenal.00257.2009; Khare SD, 2004, P NATL ACAD SCI USA, V101, P15094, DOI 10.1073/pnas.0406650101; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; Kumar KR, 2011, SEMIN NEUROL, V31, P433, DOI 10.1055/s-0031-1299782; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Mao XC, 2011, J BIOL CHEM, V286, P32355, DOI 10.1074/jbc.M111.278408; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Miyayama T, 2010, BIOCHEM J, V429, P53, DOI 10.1042/BJ20100223; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Munch C, 2010, J MOL BIOL, V399, P512, DOI 10.1016/j.jmb.2010.04.019; Narindrasorasak S, 2007, BIOCHEMISTRY-US, V46, P3116, DOI 10.1021/bi0620656; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Prudencio M, 2012, J NEUROCHEM, V121, P475, DOI 10.1111/j.1471-4159.2012.07690.x; Prudencio M, 2009, J NEUROCHEM, V108, P1009, DOI 10.1111/j.1471-4159.2008.05839.x; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Redler RL, 2012, COMPLEX MOL BIOL AMY, P1; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Seetharaman SV, 2009, EXP BIOL MED, V234, P1140, DOI 10.3181/0903-MR-104; Shipp EL, 2003, BIOCHEMISTRY-US, V42, P1890, DOI 10.1021/bi026704y; Sommerhalter M, 2007, J MOL BIOL, V365, P715, DOI 10.1016/j.jmb.2006.10.030; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Tiwari A, 2005, J BIOL CHEM, V280, P29771, DOI 10.1074/jbc.M504039200; Toichi K, 2013, J BIOL CHEM, V288, P4970, DOI 10.1074/jbc.M112.414235; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; van de Sluis B, 2007, MOL CELL BIOL, V27, P4142, DOI 10.1128/MCB.01932-06; van de Sluis B, 2010, J CLIN INVEST, V120, P2119, DOI 10.1172/JCI40583; van de Sluis B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007332; van Ham TJ, 2009, EMBO MOL MED, V1, P360, DOI 10.1002/emmm.200900051; Vonk WIM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029183; Vonk WIM, 2012, CELL MOL LIFE SCI, V69, P149, DOI 10.1007/s00018-011-0743-1; Vonk WIM, 2010, J BIOL CHEM, V285, P28991, DOI 10.1074/jbc.M110.101477; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898	64	31	31	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92408	10.1371/journal.pone.0092408	http://dx.doi.org/10.1371/journal.pone.0092408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691167	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100021
J	Meyre, D; Froguel, P; Horber, FF; Kral, JG				Meyre, David; Froguel, Philippe; Horber, Fritz F.; Kral, John G.			Comment On: Valette et al. Melanocortin-4 Receptor Mutations and Polymorphisms Do Not Affect Weight Loss after Bariatric Surgery. PLOS ONE 2012; 7(11):E48221	PLOS ONE			English	Editorial Material							OBESITY		[Meyre, David] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Froguel, Philippe] Lille Pasteur Inst, CNRS, UMR 8199, Lille, Nord, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, London, England; [Horber, Fritz F.] Landesspital, Dept Internal Med, Vaduz, Liechtenstein; [Horber, Fritz F.] Univ Bern, Bern, Switzerland; [Kral, John G.] Suny Downstate Med Ctr, Dept Surg, Brooklyn, NY 11203 USA	McMaster University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Imperial College London; University of Bern; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Meyre, D (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	meyred@mcmaster.ca	Meyre, David/D-7315-2011; horber, Fritz/AAL-5419-2020; FROGUEL, Philippe/O-6799-2017	Meyre, David/0000-0003-4850-7444; FROGUEL, Philippe/0000-0003-2972-0784				Kral JG, 2006, BRIT MED J, V333, P900, DOI 10.1136/bmj.333.7574.900; Li A, 2013, INT J OBESITY, V37, P559, DOI 10.1038/ijo.2012.82; Potoczna N, 2004, J GASTROINTEST SURG, V8, P971, DOI 10.1016/j.gassur.2004.09.032; Sarzynski MA, 2011, INT J OBESITY, V35, P676, DOI 10.1038/ijo.2010.166; Stutzmann F, 2009, INT J OBESITY, V33, P373, DOI 10.1038/ijo.2008.279; Valette M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048221	6	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93324	10.1371/journal.pone.0093324	http://dx.doi.org/10.1371/journal.pone.0093324			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686325	Green Published, Green Submitted, gold			2022-12-27	WOS:000340842300009
J	Chan, KKW; Sit, RWS; Wu, RWK; Ngai, AHY				Chan, Keith K. W.; Sit, Regina W. S.; Wu, Ricky W. K.; Ngai, Allen H. Y.			Clinical, Radiological and Ultrasonographic Findings Related to Knee Pain in Osteoarthritis	PLOS ONE			English	Article							EULAR REPORT; PART 1; ULTRASOUND; PREVALENCE; INFLAMMATION; RELIABILITY; DISABILITY; FEATURES	Background: Pain is the predominant symptom of knee osteoarthritis (OA) and the main reason of disability. Ultrasound is now one of the new imaging modality in Musculoskeletal medicine and its role in assessing the pain severity in the knee osteoarthritis is evaluated in this study. Objectives: (1) To study the correlation between ultrasonographic (US) findings and pain score and (2) whether ultrasonographic findings show a better association of pain level than conventional X-rays in patients suffering from primary knee osteoarthritis. Methods: In this multi-center study, 193 patients with primary knee OA were asked to score their average knee pain using the Western Ontario and McMaster Universities Arthritis (WOMAC) questionnaire; patients would then go for a radiological and an US evaluation of their painful knee. Findings from both imaging modalities will be studied with the associated pain score. Results: Ultrasound showed that knee effusion has positive correlation with pain score upon walking (r = 0.217) and stair climbing (r = 0.194). Presence of suprapatellar synovitis had higher pain score on sitting (Spearman's Rank correlation = 0.355). The medial(r = 0.170) and lateral meniscus protrusion (r = 0.201) were associated with pain score upon stair climbing. Conclusions: Our study found that both imaging modalities shown some significant association with the aspect of pain; neither one is clearly better but rather complementary to each other. A trend is found in both modalities: walking pain is related to pathologies of the either the lateral or medial tibiofemoral joint(TFJ) while stair climbing pain is related to both tibiofemoral joint pathologies and also to the patellofemoral joint (PFJ) pathology. This suggested that biomechanical derangement is an important aspect in OA knee pain.	[Chan, Keith K. W.] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Sit, Regina W. S.] Chinese Univ Hong Kong, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Wu, Ricky W. K.; Ngai, Allen H. Y.] Hong Kong Inst Musculoskeletal Med, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, KKW (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	drkeithchan@gmail.com	Sit, Regina Wing Shan/V-9982-2017	Sit, Regina Wing Shan/0000-0002-4717-7773	Hong Kong Institute of Musculoskeletal Medicine (HKIMM)	Hong Kong Institute of Musculoskeletal Medicine (HKIMM)	The authors are grateful to the Hong Kong Institute of Musculoskeletal Medicine (HKIMM) for sponsoring the X-ray films and for providing statistical support for the study. We also have to thank Esoate China Limited for providing the US machines for all the five centers during the study period. Last but not list to the team of musculoskeletal physicians and radiologists who had scarified many working hours to get US and X-rays done.; US Team:; Dr. Keith KW Chan; Dr. Ricky WK Wu; Dr. Andrew KK Ip; Dr. Stanley KW Lam; Dr. Allen HY Ngai; Dr. Mark WW Lai; Dr. Paco WY Lee; X-ray team:; Dr. CH Tang; Dr. KS Lam; Dr. John Lo	Abraham AM, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-70; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Bedson J, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-116; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Chan KKW, 2011, RHEUMATOL REP, V3, P9, DOI 10.4081/rr.2011.e3; CHHEM RK, 1999, GUIDELINES GAMUTS MU; CLAESSENS AAMC, 1990, ANN RHEUM DIS, V49, P771, DOI 10.1136/ard.49.10.771; Conaghan P, 2005, ANN RHEUM DIS, V64, P1710, DOI 10.1136/ard.2005.038026; D'Agostino MA, 2005, ANN RHEUM DIS, V64, P1703, DOI 10.1136/ard.2005.037994; DAVIS MA, 1991, J RHEUMATOL, V18, P591; DAVIS MA, 1992, J RHEUMATOL, V19, P1943; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Gale DR, 1999, OSTEOARTHR CARTILAGE, V7, P526, DOI 10.1053/joca.1999.0256; Gibbon WW, 2004, SEMIN MUSCULOSKEL R, V8, P313, DOI 10.1055/s-2004-861578; Grassi W, 2004, BEST PRACT RES CL RH, V18, P813, DOI 10.1016/j.berh.2004.05.001; Grassi W, 1999, SEMIN ARTHRITIS RHEU, V28, P398, DOI 10.1016/S0049-0172(99)80005-5; Guermazi A, 2008, RHEUM DIS CLIN N AM, V34, P645, DOI 10.1016/j.rdc.2008.04.006; HART DJ, 1991, ANN RHEUM DIS, V50, P467, DOI 10.1136/ard.50.7.467; HopmanRock M, 1996, J RHEUMATOL, V23, P1037; Iagnocco A, 2012, RHEUMATOLOGY, V51, P2013, DOI 10.1093/rheumatology/kes161; Jordan J, 1997, J RHEUMATOL, V24, P1344; Kapandji A., 2019, PHYSL JOINTS SPINAL, V7th; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kristoffersen H, 2006, ACTA RADIOL, V47, P281, DOI 10.1080/02841850600551508; LAWRENCE JS, 1966, ANN RHEUM DIS, V25, P1; LAWRENCE RC, 1989, J RHEUMATOL, V16, P427; Martin J., 1988, PREVALENCE DISABILIT; Mendieta EDM, 2006, OSTEOARTHR CARTILAGE, V14, P540, DOI 10.1016/j.joca.2005.12.012; Monteforte P, 2008, G Ital Med Lav Ergon, V30, P75; Naredo E, 2005, OSTEOARTHR CARTILAGE, V13, P568, DOI 10.1016/j.joca.2005.02.008; Peat G, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3779; Rutherford DJ, 2012, OSTEOARTHR CARTILAGE, V20, P974, DOI 10.1016/j.joca.2012.05.014; Woo J, 2004, J RHEUMATOL, V31, P2433	34	17	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92901	10.1371/journal.pone.0092901	http://dx.doi.org/10.1371/journal.pone.0092901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675807	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500052
J	Heisey, DM; Jennelle, CS; Russell, RE; Walsh, DP				Heisey, Dennis M.; Jennelle, Christopher S.; Russell, Robin E.; Walsh, Daniel P.			Using Auxiliary Information to Improve Wildlife Disease Surveillance When Infected Animals Are Not Detected: A Bayesian Approach	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; WHITE-TAILED DEER; SUBSTANTIATE FREEDOM; STRATEGIES; MANAGEMENT; WISCONSIN; ECOLOGY	There are numerous situations in which it is important to determine whether a particular disease of interest is present in a free-ranging wildlife population. However adequate disease surveillance can be labor-intensive and expensive and thus there is substantial motivation to conduct it as efficiently as possible. Surveillance is often based on the assumption of a simple random sample, but this can almost always be improved upon if there is auxiliary information available about disease risk factors. We present a Bayesian approach to disease surveillance when auxiliary risk information is available which will usually allow for substantial improvements over simple random sampling. Others have employed risk weights in surveillance, but this can result in overly optimistic statements regarding freedom from disease due to not accounting for the uncertainty in the auxiliary information; our approach remedies this. We compare our Bayesian approach to a published example of risk weights applied to chronic wasting disease in deer in Colorado, and we also present calculations to examine when uncertainty in the auxiliary information has a serious impact on the risk weights approach. Our approach allows "apples-to-apples" comparisons of surveillance efficiencies between units where heterogeneous samples were collected.	[Heisey, Dennis M.; Russell, Robin E.; Walsh, Daniel P.] Natl Wildlife Hlth Ctr, United States Geol Survey, Madison, WI 53711 USA; [Jennelle, Christopher S.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA	United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison	Heisey, DM (corresponding author), Natl Wildlife Hlth Ctr, United States Geol Survey, Madison, WI 53711 USA.	dheisey@usgs.gov		Walsh, Daniel/0000-0002-7772-2445; Jennelle, Christopher/0000-0003-4133-814X; Russell, Robin/0000-0001-8726-7303	United States Geological Survey-National Wildlife Health Center	United States Geological Survey-National Wildlife Health Center	The support for this study was provided by the United States Geological Survey-National Wildlife Health Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, ORDONNANCE EPIZOOTIE; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Cai TT, 2005, J STAT PLAN INFER, V131, P63, DOI 10.1016/j.jspi.2004.01.005; Cameron A., 2003, Animal disease surveillance and survey systems: methods and applications, P47, DOI 10.1002/9780470344866.ch4; Cameron AR, 1998, PREV VET MED, V34, P1, DOI 10.1016/S0167-5877(97)00081-0; Cannon RM, 2002, PREV VET MED, V52, P227, DOI 10.1016/S0167-5877(01)00262-8; Casella G, 2001, STAT SCI, V16, P121; Centers for Disease Control and Prevention, CHRON WAST DIS; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dayton PK, 1998, SCIENCE, V279, P821, DOI 10.1126/science.279.5352.821; Diefenbach DB, 2004, WILDLIFE SOC B, V32, P267, DOI 10.2193/0091-7648(2004)32[267:FTFEOD]2.0.CO;2; Doherr M. G., 2003, Animal disease surveillance and survey systems: methods and applications, P135, DOI 10.1002/9780470344866.ch9; Dufour B, 2001, VET RES, V32, P545, DOI 10.1051/vetres:2001102; Fienberg SE, 2006, BAYESIAN ANAL, V1, P1; Gelman A., 2004, BAYESIAN DATA ANAL; Ghosh M, 2001, STAT SCI, V16, P124; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Joly DO, 2009, J WILDLIFE DIS, V45, P989, DOI 10.7589/0090-3558-45.4.989; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Nusser SM, 2008, J WILDLIFE MANAGE, V72, P52, DOI 10.2193/2007-317; Osnas EE, 2009, ECOL APPL, V19, P1311, DOI 10.1890/08-0578.1; Reid N, 2003, MATH STAT APPL, P31; Salman M.D., 2003, ANIMAL DIS SURVEILLA, V1st; Samuel MD, 2003, SURV STRAT DET CHRON; Tuyl F, 2009, BAYESIAN ANAL, V4, P151, DOI 10.1214/09-BA405; Walsh DP, 2010, J WILDLIFE DIS, V46, P118, DOI 10.7589/0090-3558-46.1.118; Wobeser G, 2002, REV SCI TECH OIE, V21, P159, DOI 10.20506/rst.21.1.1326; World Organisation for Animal Health (OIE), 2010, TERR AN HLTH COD; Ziller M, 2002, PREV VET MED, V52, P333, DOI 10.1016/S0167-5877(01)00245-8	29	13	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e89843	10.1371/journal.pone.0089843	http://dx.doi.org/10.1371/journal.pone.0089843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676479	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500005
J	Kim, MY; Eiby, YA; Lumbers, ER; Wright, LL; Gibson, KJ; Barnett, AC; Lingwood, BE				Kim, Min Young; Eiby, Yvonne A.; Lumbers, Eugenie R.; Wright, Layne L.; Gibson, Karen J.; Barnett, Amanda C.; Lingwood, Barbara E.			Effects of Glucocorticoid Exposure on Growth and Structural Maturation of the Heart of the Preterm Piglet	PLOS ONE			English	Article							VENA-CAVA FLOW; CARDIAC MYOCYTES; DEXAMETHASONE TREATMENT; SINGLE COURSE; NEONATAL RAT; FETAL SHEEP; BIRTH; PROLIFERATION; CARDIOMYOCYTE; INFANTS	Inadequate maintenance of systemic blood flow in neonates following preterm birth is associated with increased morbidity and mortality, and may be due in part to structural immaturity of the myocardium. Maternal glucocorticoid administration is associated with improved cardiovascular function, and possibly promotes structural maturation of the myocardium. This study assessed the structural maturity of the myocardium in male and female preterm and term piglets, and preterm piglets exposed to a regimen of maternal glucocorticoids as used clinically. In preterm, term and glucocorticoid exposed preterm piglets cardiomyocyte maturity was examined by measuring the proportion of binucleated myocytes and the volumes of single living ventricular cardiomyocytes with fluorescence microscopy. Ventricular apoptosis and proliferation were measured by immunohistochemistry. Preterm piglet hearts had fewer binucleated myocytes, smaller myocytes, and more proliferative and fewer apoptotic nuclei than term hearts. Maternal glucocorticoid treatment resulted in increased binucleation with no increase in myocyte volume, and levels of proliferation and apoptosis that were more similar to the term heart. Atrial weights were increased and in female piglets there was an increase in the ratio of left to right ventricular weight. The observed changes in atrial mass and myocyte structural maturation correlated with changes in cardiac function of isolated hearts of littermates. In conclusion, the association between increased myocardial maturation following glucocorticoid exposure, improved cardiac function in littermates, and clinical improvement in human neonatal cardiac function exposed to antenatal glucocorticoids, suggests that glucocorticoid exposure contributes to improved cardiovascular function in preterm infants by promoting myocardial structural maturity.	[Kim, Min Young; Eiby, Yvonne A.; Lumbers, Eugenie R.; Wright, Layne L.; Barnett, Amanda C.; Lingwood, Barbara E.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Lumbers, Eugenie R.; Gibson, Karen J.] Univ New S Wales, Sch Med Sci, Dept Physiol, Sydney, NSW, Australia; [Lumbers, Eugenie R.] Univ Newcastle, Sch Biomed Sci & Pharm, Newcastle, NSW 2300, Australia	University of Queensland; University of New South Wales Sydney; University of Newcastle	Lingwood, BE (corresponding author), Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia.	b.lingwood@uq.edu.au	Lingwood, Barbara E/F-1398-2010; Eiby, Yvonne/F-2772-2010; Lumbers, Eugenie/AAS-4930-2020	Eiby, Yvonne/0000-0003-0079-7796; 	National Health and Medical Research Council of Australia [569635]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (grant number 569635) (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani M, 2011, MOL CELL BIOL, V31, P163, DOI 10.1128/MCB.01539-09; ANVERSA P, 1980, CIRC RES, V46, P495, DOI 10.1161/01.RES.46.4.495; Bal MP, 2009, PEDIATR RES, V66, P74, DOI 10.1203/PDR.0b013e3181a283a0; Barbera A, 2000, AM J PHYSIOL-REG I, V279, pR1157, DOI 10.1152/ajpregu.2000.279.4.R1157; BEINLICH CJ, 1993, MOL CELL BIOCHEM, V119, P3, DOI 10.1007/BF00926846; Bensley JG, 2010, EUR HEART J, V31, P2058, DOI 10.1093/eurheartj/ehq104; Bruel A, 2007, CARDIOVASC RES, V76, P400, DOI 10.1016/j.cardiores.2007.06.026; Burrell JH, 2003, ANAT REC PART A, V274A, P952, DOI 10.1002/ar.a.10110; Burrell JH, 2001, EXP PHYSIOL, V86, P71, DOI 10.1113/eph8602075; Choi JH, 2002, PEDIATR RES, V52, P325, DOI 10.1203/01.PDR.0000025654.32501.3D; CLUBB FJ, 1984, LAB INVEST, V50, P571; De Matteo R, 2010, REPROD SCI, V17, P724, DOI 10.1177/1933719110369182; de Vries WB, 2006, BASIC RES CARDIOL, V101, P36, DOI 10.1007/s00395-005-0557-0; Eiby YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068763; Eiby YA, 2012, AM J PHYSIOL-REG I, V303, pR769, DOI 10.1152/ajpregu.00010.2012; Elsmen E, 2004, ACTA PAEDIATR, V93, P529, DOI 10.1080/08035250410024998; French NP, 1999, AM J OBSTET GYNECOL, V180, P114, DOI 10.1016/S0002-9378(99)70160-2; Giraud GD, 2006, ENDOCRINOLOGY, V147, P3643, DOI 10.1210/en.2006-0061; GOTOH T, 1983, ACTA ANAT, V115, P168; Gregorio CC, 2000, TRENDS CELL BIOL, V10, P355, DOI 10.1016/S0962-8924(00)01793-1; Groves AM, 2012, PEDIATR RES, V71, P380, DOI 10.1038/pr.2011.77; Ikegami M, 1997, AM J RESP CRIT CARE, V156, P178, DOI 10.1164/ajrccm.156.1.9612036; ISRAEL BA, 1993, AM J PERINAT, V10, P307, DOI 10.1055/s-2007-994747; Jobe AH, 1998, AM J OBSTET GYNECOL, V178, P880, DOI 10.1016/S0002-9378(98)70518-6; Jobe AH, 2010, PEDIATR NEONATOL, V51, P7, DOI 10.1016/S1875-9572(10)60003-4; Jonker SS, 2007, J APPL PHYSIOL, V102, P1130, DOI 10.1152/japplphysiol.00937.2006; KHOURY MJ, 1985, AM J OBSTET GYNECOL, V151, P777, DOI 10.1016/0002-9378(85)90518-6; Kluckow M, 2000, ARCH DIS CHILD-FETAL, V82, pF188, DOI 10.1136/fn.82.3.F188; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Lumbers ER, 2005, AM J PHYSIOL-REG I, V288, pR567, DOI 10.1152/ajpregu.00556.2004; Lumbers ER, 2009, AM J PHYSIOL-ENDOC M, V296, pE513, DOI 10.1152/ajpendo.90497.2008; Miller DR, 2009, J ANIM SCI, V87, P3167, DOI 10.2527/jas.2009-1825; Miller SL, 2012, REPROD FERT DEVELOP, V24, P753, DOI 10.1071/RD11143; Mizuno M, 2010, CIRC J, V74, P171, DOI 10.1253/circj.CJ-09-0311; MOISE AA, 1995, PEDIATRICS, V95, P845; Newnham J P, 2001, Semin Neonatol, V6, P285, DOI 10.1053/siny.2001.0064; Osborn DA, 2003, PEDIATRICS, V112, P33, DOI 10.1542/peds.112.1.33; Osborn DA, 2007, PEDIATRICS, V120, P372, DOI 10.1542/peds.2006-3398; Quaedackers JS, 2005, BJOG-INT J OBSTET GY, V112, P182, DOI 10.1111/j.1471-0528.2004.00344.x; Rodriguez AG, 2013, INTEGR BIOL-UK, V5, P1366, DOI 10.1039/c3ib40135a; Rudolph AM, 2000, ACTA PAEDIATR, V89, P129, DOI 10.1080/080352500750028681; Rudy DE, 2001, DEV DYNAM, V221, P61, DOI 10.1002/dvdy.1125; SCHMID G, 1985, VIRCHOWS ARCH B, V48, P59, DOI 10.1007/BF02890115; Seri I, 2001, Semin Neonatol, V6, P85, DOI 10.1053/siny.2000.0034; Skelton R, 1998, ARCH DIS CHILD-FETAL, V78, pF133, DOI 10.1136/fn.78.2.F133; SMOLICH JJ, 1995, REPROD FERT DEVELOP, V7, P451, DOI 10.1071/RD9950451; Stark MJ, 2009, AM J PHYSIOL-REG I, V297, pR510, DOI 10.1152/ajpregu.00175.2009; Stevenson DK, 2000, ARCH DIS CHILD-FETAL, V83, pF182, DOI 10.1136/fn.83.3.F182; Tracy RE, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/658958; Vural M, 2006, ARCH DIS CHILD-FETAL, V91, pF118, DOI 10.1136/adc.2005.084525; ZAK R, 1974, CIRC RES, V35, P17; Zecca E, 2001, J CLIN PHARMACOL, V41, P1075, DOI 10.1177/00912700122012670	53	39	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93407	10.1371/journal.pone.0093407	http://dx.doi.org/10.1371/journal.pone.0093407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676209	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500119
J	Kraft, CE; Gordon, ERL; Angert, ER				Kraft, Clifford E.; Gordon, Eric R. L.; Angert, Esther R.			A Rapid Method for Assaying Thiaminase I Activity in Diverse Biological Samples	PLOS ONE			English	Article							DEFICIENCY; FISH; THIAMINOLYTICUS; IDENTIFICATION; INACTIVATION; SALVAGE; SHEEP; CARP	Vitamin B-1 (thiamine) deficiencies can lead to neurological disorders, reproductive failure and death in wild and domestic animal populations. In some cases, disease is brought about by the consumption of foods high in thiaminase I activity. Levels of thiaminase activity in these foods are highly variable and the factors leading to production of this enzyme are poorly understood. Here we describe improvements in a spectrophotometric thiaminase I activity assay that measures the disappearance of 4-nitrothiophenol, a favored nucleophile co-substrate that replaces the thiazole portion of thiamine during the inactivation of thiamine by the enzyme. Scalable sample processing protocols and a 96-well microtiter plate format are presented that allow the rapid evaluation of multiple, replicated samples in the course of only a few hours. Observed levels of activity in bacterial culture supernatant, fish, ferns and molluscs using this colorimetric assay were similar to previously published reports that employed a radiometric method. Organisms devoid of thiaminase I, based upon previous work, showed no activity with this assay. In addition, activity was found in a variety of fishes and one fern species from which this enzyme had not previously been reported. Overall, we demonstrate the suitability of this technique for measuring thiaminase I activity within small amounts of tissue and environmental samples with replication levels that were heretofore prohibitive. The assay provides a considerable improvement in the ability to examine and understand the properties of an enzyme that has a substantial influence on organism and ecosystem health.	[Kraft, Clifford E.] Cornell Univ, Dept Nat Resources, Ithaca, NY 14853 USA; [Gordon, Eric R. L.; Angert, Esther R.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [Gordon, Eric R. L.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	Cornell University; Cornell University; University of California System; University of California Riverside	Kraft, CE (corresponding author), Cornell Univ, Dept Nat Resources, Fernow Hall, Ithaca, NY 14853 USA.	cek7@cornell.edu	Gordon, Eric/B-6154-2016	Gordon, Eric/0000-0002-5547-0953	Cornell University Agricultural Experiment Station federal formula funds [NYC-102400]	Cornell University Agricultural Experiment Station federal formula funds	This research was supported in part by the Cornell University Agricultural Experiment Station federal formula funds, Project No. NYC-102400). http://cuaes.cornell.edu/cals/cuaes/support/index.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Arsan O. M, 1969, Gidrobiol. Zh., V5, P79; Balk L, 2009, P NATL ACAD SCI USA, V106, P12001, DOI 10.1073/pnas.0902903106; Bos M, 2000, J PROTEIN CHEM, V19, P75, DOI 10.1023/A:1007043530616; Brown SB, 2005, J AQUAT ANIM HEALTH, V17, P113, DOI 10.1577/H04-015.1; Campobasso N, 1998, BIOCHEMISTRY-US, V37, P15981, DOI 10.1021/bi981673l; Costello CA, 1996, J BIOL CHEM, V271, P3445, DOI 10.1074/jbc.271.7.3445; DEOLALKAR ST, 1954, NATURE, V173, P489, DOI 10.1038/173489a0; DOUTHIT HA, 1966, ARCH BIOCHEM BIOPHYS, V113, P331, DOI 10.1016/0003-9861(66)90194-9; EDWIN EE, 1970, NATURE, V228, P772, DOI 10.1038/228772a0; Evans W C, 1975, Vitam Horm, V33, P467; EVANS WC, 1976, BOT J LINN SOC, V73, P113, DOI 10.1111/j.1095-8339.1976.tb02017.x; Fisher Jeffrey P., 1995, Journal of Aquatic Animal Health, V7, P269, DOI 10.1577/1548-8667(1995)007&lt;0269:PABMOT&gt;2.3.CO;2; Fitzsimons JD, 2005, J AQUAT ANIM HEALTH, V17, P26, DOI 10.1577/H04-002.1; FUJITA A, 1954, ADV ENZYMOL REL S BI, V15, P389; FUJITA AKIJI, 1954, JOUR VITAMINOL, V1, P1; GREEN R. G., 1940, SCIENCE, V92, P154, DOI 10.1126/science.92.2381.154; Hanes JW, 2007, ANAL BIOCHEM, V368, P33, DOI 10.1016/j.ab.2007.06.001; Honeyfield DC, 2010, J GREAT LAKES RES, V36, P641, DOI 10.1016/j.jglr.2010.07.005; Honeyfield DC, 2005, J AQUAT ANIM HEALTH, V17, P1, DOI 10.1577/H04-012.1; Honeyfield DC, 2002, T AM FISH SOC, V131, P171, DOI 10.1577/1548-8659(2002)131&lt;0171:IOTPBF&gt;2.0.CO;2; Jenkins AH, 2007, NAT CHEM BIOL, V3, P492, DOI 10.1038/nchembio.2007.13; KENTEN RH, 1958, BIOCHEM J, V69, P439, DOI 10.1042/bj0690439; KIMURA R., 1953, Proceedings of the Japan Academy, V29, P132; Kimura R., 1965, REV JAPANESE LIT BER, P255; Krampitz LO, 1944, J BIOL CHEM, V152, P9; Kuno Y, 1951, P JPN ACAD, V27, P362, DOI [10.2183/pjab1945.27.362, DOI 10.2183/PJAB1945.27.362]; Lepak JM, 2008, J AQUAT ANIM HEALTH, V20, P63, DOI 10.1577/H07-026.1; MCCLEARY BV, 1977, PHYTOCHEMISTRY, V16, P207, DOI 10.1016/S0031-9422(00)86787-4; MOORE W. E. C., 1966, INT J SYST BACTERIOL, V16, P173; Newton AC, 2010, TRENDS MICROBIOL, V18, P365, DOI 10.1016/j.tim.2010.06.002; Onozuka M, 2008, FEMS YEAST RES, V8, P266, DOI 10.1111/j.1567-1364.2007.00333.x; OTTOSSON JG, 1983, BIOL J LINN SOC, V19, P305, DOI 10.1111/j.1095-8312.1983.tb00789.x; Ramos JJ, 2003, VET RES COMMUN, V27, P111, DOI 10.1023/A:1022807119539; Richter CA, 2012, CAN J FISH AQUAT SCI, V69, P1056, DOI [10.1139/F2012-043, 10.1139/f2012-043]; SATO M, 1994, COMP BIOCHEM PHYS A, V108, P31; Sealock RR, 1943, J AM CHEM SOC, V65, P935, DOI 10.1021/ja01245a046; Shimazono N, 1965, REV JAPANESE LIT BER; SHREEVE JE, 1974, VET REC, V94, P330, DOI 10.1136/vr.94.15.330; STOUT FM, 1963, NATURE, V197, P810, DOI 10.1038/197810a0; THOMAS KW, 1987, AUST VET J, V64, P126, DOI 10.1111/j.1751-0813.1987.tb09654.x; Tillitt DE, 2009, J GREAT LAKES RES, V35, P309, DOI 10.1016/j.jglr.2009.01.007; Toms AV, 2005, BIOCHEMISTRY-US, V44, P2319, DOI 10.1021/bi0478648; Wistbacka S, 2002, J FISH BIOL, V60, P1031, DOI 10.1006/jfbi.2002.1912; YUDKIN WH, 1949, PHYSIOL REV, V29, P389, DOI 10.1152/physrev.1949.29.4.389; Zajicek JL, 2005, J AQUAT ANIM HEALTH, V17, P82, DOI 10.1577/H03-083.1	45	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92688	10.1371/journal.pone.0092688	http://dx.doi.org/10.1371/journal.pone.0092688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675843	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500033
J	Perkins, MJ; McDonald, RA; van Veen, FJF; Kelly, SD; Rees, G; Bearhop, S				Perkins, Matthew J.; McDonald, Robbie A.; van Veen, F. J. Frank; Kelly, Simon D.; Rees, Gareth; Bearhop, Stuart			Application of Nitrogen and Carbon Stable Isotopes (delta N-15 and delta C-13) to Quantify Food Chain Length and Trophic Structure	PLOS ONE			English	Article							ECOSYSTEM SIZE; DIET; ENRICHMENT; POSITION; RATIOS; DISCRIMINATION; FRACTIONATION; DISTURBANCE; QUALITY; STRESS	Increasingly, stable isotope ratios of nitrogen (delta N-15) and carbon (delta C-13) are used to quantify trophic structure, though relatively few studies have tested accuracy of isotopic structural measures. For laboratory-raised and wild-collected plant-invertebrate food chains spanning four trophic levels we estimated nitrogen range (NR) using delta N-15, and carbon range (CR) using delta C-13, which are used to quantify food chain length and breadth of trophic resources respectively. Across a range of known food chain lengths we examined how NR and CR changed within and between food chains. Our isotopic estimates of structure are robust because they were calculated using resampling procedures that propagate variance in sample means through to quantified uncertainty in final estimates. To identify origins of uncertainty in estimates of NR and CR, we additionally examined variation in discrimination (which is change in delta N-15 or delta C-13 from source to consumer) between trophic levels and among food chains. delta N-15 discrimination showed significant enrichment, while variation in enrichment was species and system specific, ranged broadly (1.4% to 3.3%), and importantly, propagated variation to subsequent estimates of NR. However, NR proved robust to such variation and distinguished food chain length well, though some overlap between longer food chains infers a need for awareness of such limitations. delta C-13 discrimination was inconsistent; generally no change or small significant enrichment was observed. Consequently, estimates of CR changed little with increasing food chain length, showing the potential utility of delta C-13 as a tracer of energy pathways. This study serves as a robust test of isotopic quantification of food chain structure, and given global estimates of aquatic food chains approximate four trophic levels while many food chains include invertebrates, our use of four trophic level plant-invertebrate food chains makes our findings relevant for a majority of ecological systems.	[Perkins, Matthew J.; van Veen, F. J. Frank; Bearhop, Stuart] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England; [McDonald, Robbie A.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Kelly, Simon D.; Rees, Gareth] Food & Environm Res Agcy, York, Yorkshire, England	University of Exeter; University of Exeter; Food & Environment Research Agency	Perkins, MJ (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England.	matthewjperkins@outlook.com	Bearhop, Stuart/G-3105-2012; van Veen, Franciscus JF/H-2101-2013; McDonald, Robbie A/A-2931-2012; McDonald, Robbie/AAK-2718-2020	Bearhop, Stuart/0000-0002-5864-0129; McDonald, Robbie A/0000-0002-6922-3195; McDonald, Robbie/0000-0002-6922-3195; van Veen, Frank/0000-0003-0708-5492; Kelly, Simon/0000-0003-1034-1442	Food and Environment Research Agency, United Kingdom, under their Seedcorn Programme	Food and Environment Research Agency, United Kingdom, under their Seedcorn Programme	This research was funded by The Food and Environment Research Agency, United Kingdom, under their Seedcorn Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bunn SE, 2013, LIMNOL OCEANOGR, V58, P765, DOI 10.4319/lo.2013.58.3.0765; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; Cardinale BJ, 2011, NATURE, V472, P86, DOI 10.1038/nature09904; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Doi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037856; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jardine TD, 2006, ENVIRON SCI TECHNOL, V40, P7501, DOI 10.1021/es061263h; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; Matthews B, 2004, OECOLOGIA, V140, P361, DOI 10.1007/s00442-004-1579-2; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McHugh PA, 2010, ECOL LETT, V13, P881, DOI 10.1111/j.1461-0248.2010.01484.x; Oelbermann K, 2002, OECOLOGIA, V130, P337, DOI 10.1007/s004420100813; Parnell A., 2008, SIAR STABLE ISOTOPE; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Perkins MJ, 2013, METHODS ECOL EVOL, V4, P944, DOI 10.1111/2041-210X.12098; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; Price SA, 2012, P NATL ACAD SCI USA, V109, P7008, DOI 10.1073/pnas.1117133109; R Development Core Team, 2011, R LANG ENV STAT COMP; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Rooney N, 2012, TRENDS ECOL EVOL, V27, P40, DOI 10.1016/j.tree.2011.09.001; Schmidt SN, 2007, ECOLOGY, V88, P2793, DOI 10.1890/07-0121.1; Srivastava DS, 2009, ECOL LETT, V12, P1016, DOI 10.1111/j.1461-0248.2009.01357.x; Takimoto G, 2008, ECOLOGY, V89, P3001, DOI 10.1890/07-1990.1; Thompson RM, 2005, OIKOS, V108, P137, DOI 10.1111/j.0030-1299.2005.11600.x; Thompson RM, 2012, TRENDS ECOL EVOL, V27, P689, DOI 10.1016/j.tree.2012.08.005; Vander Zanden MJ, 2007, OIKOS, V116, P1378, DOI 10.1111/j.2007.0030-1299.16036.x; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; Vander Zanden MJ, 1997, CAN J FISH AQUAT SCI, V54, P1142, DOI 10.1139/cjfas-54-5-1142; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Voigt CC, 2004, J EXP BIOL, V207, P1741, DOI 10.1242/jeb.00929; Wilson ACC, 2011, P NATL ACAD SCI USA, V108, P10220, DOI 10.1073/pnas.1007065108	40	75	75	1	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93281	10.1371/journal.pone.0093281	http://dx.doi.org/10.1371/journal.pone.0093281			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676331	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000333677500102
J	Sargeant, DP; Hedden, MW; Deverasetty, S; Strong, CL; Alaniz, IJ; Bartlett, AN; Brandon, NR; Brooks, SB; Brown, FA; Bufi, F; Chakarova, M; David, RP; Dobritch, KM; Guerra, HP; Levit, KS; Mathew, KR; Matti, R; Maza, DQ; Mistry, S; Novakovic, N; Pomerantz, A; Rafalski, TF; Rathnayake, V; Rezapour, N; Ross, CA; Schooler, SG; Songao, S; Tuggle, SL; Wing, HJ; Yousif, S; Schiller, MR				Sargeant, David P.; Hedden, Michael W.; Deverasetty, Sandeep; Strong, Christy L.; Alaniz, Izua J.; Bartlett, Alexandria N.; Brandon, Nicholas R.; Brooks, Steven B.; Brown, Frederick A.; Bufi, Flaviona; Chakarova, Monika; David, Roxanne P.; Dobritch, Karlyn M.; Guerra, Horacio P.; Levit, Kelvy S.; Mathew, Kiran R.; Matti, Ray; Maza, Dorothea Q.; Mistry, Sabyasachy; Novakovic, Nemanja; Pomerantz, Austin; Rafalski, Timothy F.; Rathnayake, Viraj; Rezapour, Noura; Ross, Christian A.; Schooler, Steve G.; Songao, Sarah; Tuggle, Sean L.; Wing, Helen J.; Yousif, Sandy; Schiller, Martin R.			The Geogenomic Mutational Atlas of Pathogens (GoMAP) Web System	PLOS ONE			English	Article							DRUG-RESISTANCE; HIV-1 PROTEASE; HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL DRUGS; CROSS-RESISTANCE; NORTH-AMERICA; AMPRENAVIR; SUSCEPTIBILITY; ATAZANAVIR; PREVALENCE	We present a new approach for pathogen surveillance we call Geogenomics. Geogenomics examines the geographic distribution of the genomes of pathogens, with a particular emphasis on those mutations that give rise to drug resistance. We engineered a new web system called Geogenomic Mutational Atlas of Pathogens (GoMAP) that enables investigation of the global distribution of individual drug resistance mutations. As a test case we examined mutations associated with HIV resistance to FDA-approved antiretroviral drugs. GoMAP-HIV makes use of existing public drug resistance and HIV protein sequence data to examine the distribution of 872 drug resistance mutations in similar to 502,000 sequences for many countries in the world. We also implemented a broadened classification scheme for HIV drug resistance mutations. Several patterns for geographic distributions of resistance mutations were identified by visual mining using this web tool. GoMAP-HIV is an open access web application available at http://www.bio-toolkit.com/GoMap/project/	[Sargeant, David P.; Hedden, Michael W.; Deverasetty, Sandeep; Strong, Christy L.; Alaniz, Izua J.; Bartlett, Alexandria N.; Brandon, Nicholas R.; Brooks, Steven B.; Brown, Frederick A.; Bufi, Flaviona; Chakarova, Monika; David, Roxanne P.; Dobritch, Karlyn M.; Guerra, Horacio P.; Levit, Kelvy S.; Mathew, Kiran R.; Matti, Ray; Maza, Dorothea Q.; Mistry, Sabyasachy; Novakovic, Nemanja; Pomerantz, Austin; Rafalski, Timothy F.; Rathnayake, Viraj; Rezapour, Noura; Ross, Christian A.; Schooler, Steve G.; Songao, Sarah; Tuggle, Sean L.; Wing, Helen J.; Yousif, Sandy; Schiller, Martin R.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Schiller, MR (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	martin.schiller@unlv.edu		Wing, Helen J./0000-0003-0123-5568; Novakovic, Nemanja/0000-0002-1681-7715; Schiller, Martin R/0000-0003-1671-6823	National Institutes of Health [AI078708, DK078735, RR027140, GM07689]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health [AI078708, DK078735, RR027140, and GM07689]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvieux C, 2005, DRUGS, V65, P633, DOI 10.2165/00003495-200565050-00005; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Bandaranayake RM, 2010, J VIROL, V84, P9995, DOI 10.1128/JVI.00505-10; Blaise P, 2002, ACTA CLIN BELG, V57, P191, DOI 10.1179/acb.2002.041; Brownstein JS, 2010, NEW ENGL J MED, V362, P1731, DOI 10.1056/NEJMsr1002707; CBN: IUPAC-IUB Commission on Biochemical Nomenclature (CBN), 1970, BIOCHEM J, V120, P449; Chan Philip A., 2009, HIV Therapy, V3, P447, DOI [10.2217/hiv.09.30, 10.2217/HIV.09.30]; Colonno R, 2004, J INFECT DIS, V189, P1802, DOI 10.1086/386291; Cunyat F, 2010, ANTIVIR THER, V15, P431, DOI 10.3851/IMP1543; de Mendoza C, 2006, AIDS, V20, P1071, DOI 10.1097/01.aids.0000222084.44411.cc; Diallo K, 2003, ANTIMICROB AGENTS CH, V47, P2376, DOI 10.1128/AAC.47.7.2376-2379.2003; Gatanaga H, 2002, J BIOL CHEM, V277, P5952, DOI 10.1074/jbc.M108005200; Geretti AM, 2007, CURR OPIN INFECT DIS, V20, P22, DOI 10.1097/QCO.0b013e328013caff; Jain R, 2006, CURR PHARM DESIGN, V12, P1065, DOI 10.2174/138161206776055813; Janies DA, 2011, CLADISTICS, V27, P61, DOI 10.1111/j.1096-0031.2010.00314.x; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Kagan R, 2004, AIDS RES HUM RETROV, V20, P1, DOI 10.1089/088922204322749440; Lam E, 2003, CLIN INFECT DIS, V37, P1273, DOI 10.1086/378894; LEITNER T, 2005, HIV SEQUENCE COMPEND; Maguire M, 2002, ANTIMICROB AGENTS CH, V46, P731, DOI 10.1128/AAC.46.3.731-738.2002; Marcelin AG, 2004, J MED VIROL, V74, P16, DOI 10.1002/jmv.20140; Masquelier B, 2005, J MED VIROL, V76, P441, DOI 10.1002/jmv.20380; Menzo S, 2004, ANTIMICROB AGENTS CH, V48, P3253, DOI 10.1128/AAC.48.9.3253-3259.2004; PARKER MT, 1964, POSTGRAD MED J, VS 40, P170, DOI 10.1136/pgmj.40.Suppl.170; PARTALEDIS JA, 1995, J VIROL, V69, P5228, DOI 10.1128/JVI.69.9.5228-5235.1995; Pillay D, 2004, ANTIVIR THER, V9, P695; Prado JG, 2002, AIDS, V16, P1009, DOI 10.1097/00002030-200205030-00007; Rahim S, 2009, HIV CLIN TRIALS, V10, P94, DOI 10.1310/hct1002-94; Sargeant D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020122; Schmidt B, 2000, ANTIMICROB AGENTS CH, V44, P3213, DOI 10.1128/AAC.44.11.3213-3216.2000; Shafer RW, 2002, CLIN MICROBIOL REV, V15, P247, DOI 10.1128/CMR.15.2.247-277.2002; Shekelle Paul, 2007, Evid Rep Technol Assess (Full Rep), P1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sista P, 2008, J CLIN VIROL, V42, P405, DOI 10.1016/j.jcv.2008.03.023; Spira S, 2003, J ANTIMICROB CHEMOTH, V51, P229, DOI 10.1093/jac/dkg079; Tanne JH, 2006, BRIT MED J, V332, P1289, DOI 10.1136/bmj.332.7553.1289; Vyas J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp616; Yanchunas J, 2005, ANTIMICROB AGENTS CH, V49, P3825, DOI 10.1128/AAC.49.9.3825-3832.2005; Young TP, 2010, ANTIMICROB AGENTS CH, V54, P4903, DOI 10.1128/AAC.00906-10	39	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92877	10.1371/journal.pone.0092877	http://dx.doi.org/10.1371/journal.pone.0092877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675726	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500048
J	Shere, M; Zhao, XY; Koren, G				Shere, Mahvash; Zhao, Xiu Yan; Koren, Gideon			The Role of Social Media in Recruiting for Clinical Trials in Pregnancy	PLOS ONE			English	Article								Background: Recruitment of women in the periconceptional period to clinical studies using traditional advertising through medical establishments is difficult and slow. Given the widespread use of the internet as a source for medical information and research, we analyze the impact of social media in the second phase of an ongoing randomized, open-label clinical trial among pregnant women. This study aims to assess the effectiveness of social media as a recruitment tool through the comparison of diverse recruitment techniques in two different phases of the trial. Methods: Recruitment in Phase 1 of the study consisted solely of traditional healthcare-based sources. This was compared to Phase 2 of the study where traditional recruitment was continued and expanded, while social media was used as a supplementary source. Yearly recruitment and recruitment rates in the two phases were compared using the Mann Whitney U test. The contributions of each recruitment source to overall recruitment were analyzed, and the impact of potential confounders on recruitment rate was evaluated using a multiple regression and Interrupted Time Series Analysis. Results: In the first phase of the study, with over 56 months of recruitment using traditional sources, 35 women were enrolled in the study, resulting in a mean rate of +/- 0.62 recruits/month. In the 6 months implementing recruitment through social media, 45 women were recruited, for a 12-fold higher rate of +/- 7.5 recruits/month. Attrition rates remained constant, suggesting that social media had a positive impact on recruitment. The Interrupted Time Series Analysis detected a significant difference in recruitment after the intervention of social media (p<0.0001) with an evident increase in the number of recruits observed after the use of social media. Conclusions: Clinicians and scientists recruiting for clinical studies should learn how to use online social media platforms to improve recruitment rates, thus increasing recruitment efficiency and cost-effectiveness.	[Shere, Mahvash; Koren, Gideon] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Shere, Mahvash; Koren, Gideon] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Motherisk Program, Toronto, ON M5G 1X8, Canada; [Zhao, Xiu Yan] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Koren, G (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada.	gkoren@sickkids.ca	Koren, Gideon/AAG-7726-2019	Koren, Gideon/0000-0002-9234-0875	Duchesnay Inc., Blainville, Quebec, Canada	Duchesnay Inc., Blainville, Quebec, Canada	The study drugs used in the clinical trial associated with this study were funded by Duchesnay Inc., Blainville, Quebec, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elkin N., 2008, AM SEARCHES HLTH WEL, P1; Hughes A, 2010, USING SOCIAL MEDIA P, P1; Kenyon S, 2006, QUAL SAF HEALTH CARE, V15, P98, DOI 10.1136/qshc.2005.015636; Mapstone J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000013.pub3; Omurtag K, 2012, FERTIL STERIL, V97, P88, DOI 10.1016/j.fertnstert.2011.10.001; Pyper C, 2006, PAEDIATR PERINAT EP, V20, P51, DOI 10.1111/j.1365-3016.2006.00771.x; Tooher Rebecca L, 2008, BMC Pregnancy Childbirth, V8, P36, DOI 10.1186/1471-2393-8-36; Treweek S, 2010, COCHRANE DATABASE SY; Velott DL, 2008, WOMEN HEALTH ISS, V18, P217, DOI 10.1016/j.whi.2008.02.002; Watson Judith M, 2006, BMC Med Res Methodol, V6, P34, DOI 10.1186/1471-2288-6-34	10	47	47	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92744	10.1371/journal.pone.0092744	http://dx.doi.org/10.1371/journal.pone.0092744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671210	Green Published, gold			2022-12-27	WOS:000333677000071
J	Turner, KM; Burne, THJ				Turner, Karly M.; Burne, Thomas H. J.			Comprehensive Behavioural Analysis of Long Evans and Sprague-Dawley Rats Reveals Differential Effects of Housing Conditions on Tests Relevant to Neuropsychiatric Disorders	PLOS ONE			English	Article							GENE-ENVIRONMENT INTERACTIONS; VITAMIN-D DEFICIENCY; ELEVATED PLUS-MAZE; MOUSE MODELS; PREPULSE INHIBITION; STARTLE RESPONSE; KNOCKOUT MICE; SCHIZOPHRENIA; ENRICHMENT; STRAINS	Genetic (G) and environmental (E) manipulations are known to alter behavioural outcomes in rodents, however many animal models of neuropsychiatric disorders only use a restricted selection of strain and housing conditions. The aim of this study was to examine GxE interactions comparing two outbred rat strains, which were housed in either standard or enriched cages. The strains selected were the albino Sprague-Dawley rat, commonly used for animal models, and the other was the pigmented Long Evans rat, which is frequently used in cognitive studies. Rats were assessed using a comprehensive behavioural test battery and included well-established tests frequently employed to examine animal models of neuropsychiatric diseases, measuring aspects of anxiety, exploration, sensorimotor gating and cognition. Selective strain and housing effects were observed on a number of tests. These included increased locomotion and reduced pre-pulse inhibition in Long Evans rats compared to Sprague Dawley rats; and rats housed in enriched cages had reduced anxiety-like behaviour compared to standard housed rats. Long Evans rats required fewer sessions than Sprague Dawley rats to learn operant tasks, including a signal detection task and reversal learning. Furthermore, Long Evans rats housed in enriched cages acquired simple operant tasks faster than standard housed Long Evans rats. Cognitive phenotypes in animal models of neuropsychiatric disorders would benefit from using strain and housing conditions where there is greater potential for both enhancement and deficits in performance.	[Turner, Karly M.; Burne, Thomas H. J.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Burne, Thomas H. J.] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Wacol, Australia	University of Queensland; Queensland Centre for Mental Health Research	Burne, THJ (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.	t.burne@uq.edu.au	Turner, Karly/F-4607-2012; Burne, Thomas H/C-5656-2009	Turner, Karly/0000-0003-3714-5118; Burne, Thomas H/0000-0003-3502-9789	National Health and Medical Research Council of Australia [511066]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Project Grant no. 511066 from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS JS, 1995, PHYSIOL BEHAV, V57, P785, DOI 10.1016/0031-9384(94)00336-X; Andrews JS, 1996, COGNITIVE BRAIN RES, V3, P251, DOI 10.1016/0926-6410(96)00011-0; Arrant AE, 2013, BEHAV BRAIN RES; Aubert L, 2006, GENES BRAIN BEHAV, V5, P423, DOI 10.1111/j.1601-183X.2005.00178.x; Bayer TA, 1999, J PSYCHIATR RES, V33, P543, DOI 10.1016/S0022-3956(99)00039-4; Blokland A, 2012, BEHAV BRAIN RES, V228, P16, DOI 10.1016/j.bbr.2011.11.042; Burghardt PR, 2004, BRAIN RES, V1019, P84, DOI 10.1016/j.brainres.2004.05.086; Burne THJ, 2004, BEHAV BRAIN RES, V154, P549, DOI 10.1016/j.bbr.2004.03.023; Burrows EL, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00157; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Chen JS, 2006, BIOL PSYCHIAT, V59, P1180, DOI 10.1016/j.biopsych.2006.02.024; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; DIDRIKSEN M, 1993, PHARMACOL TOXICOL, V72, P66, DOI 10.1111/j.1600-0773.1993.tb01341.x; Duffy L, 2008, BEHAV NEUROSCI, V122, P748, DOI 10.1037/0735-7044.122.4.748; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Faraday MM, 2002, PHYSIOL BEHAV, V75, P507, DOI 10.1016/S0031-9384(02)00645-5; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Harris AP, 2009, ANIM BEHAV, V77, P1459, DOI 10.1016/j.anbehav.2009.02.019; Henquet C, 2006, NEUROPSYCHOPHARMACOL, V31, P2748, DOI 10.1038/sj.npp.1301197; Hutchinson E, 2005, ILAR J, V46, P148, DOI 10.1093/ilar.46.2.148; Jones CA, 2011, BRIT J PHARMACOL, V164, P1162, DOI 10.1111/j.1476-5381.2011.01386.x; Kalueff AV, 2005, J NEUROSCI METH, V143, P169, DOI 10.1016/j.jneumeth.2004.10.001; Karl T, 2007, GENES BRAIN BEHAV, V6, P677, DOI 10.1111/j.1601-183X.2006.00298.x; Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kesby James P, 2012, Psychopharmacology (Berl), V220, P455, DOI 10.1007/s00213-011-2492-0; Laviola G, 2008, NEUROBIOL DIS, V31, P159, DOI 10.1016/j.nbd.2008.05.001; LIPSKA BK, 1995, P NATL ACAD SCI USA, V92, P8906, DOI 10.1073/pnas.92.19.8906; McOmish CE, 2008, MOL PSYCHIATR, V13, P661, DOI 10.1038/sj.mp.4002046; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Nguyen HP, 2006, HUM MOL GENET, V15, P3177, DOI 10.1093/hmg/ddl394; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; O'Tuathaigh CMP, 2007, NEUROSCI BIOBEHAV R, V31, P60, DOI 10.1016/j.neubiorev.2006.04.002; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; Papaleo F, 2012, NEUROPHARMACOLOGY, V62, P1204, DOI 10.1016/j.neuropharm.2011.04.025; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pena Y, 2009, PSYCHONEUROENDOCRINO, V34, P1390, DOI 10.1016/j.psyneuen.2009.04.019; Pietropaolo S, 2006, BEHAV NEUROSCI, V120, P787, DOI 10.1037/0735-7044.120.4.787; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Simpson J, 2011, BEHAV BRAIN RES, V222, P246, DOI 10.1016/j.bbr.2011.04.002; Swerdlow NR, 2000, J NEUROSCI, V20, P4325; Swerdlow NR, 1999, ANN NY ACAD SCI, V877, P202, DOI 10.1111/j.1749-6632.1999.tb09269.x; Tost H, 2012, NAT MED, V18, P211, DOI 10.1038/nm.2671; Turner KM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00097; van den Buuse M, 2010, SCHIZOPHRENIA BULL, V36, P246, DOI 10.1093/schbul/sbp132; van Os J, 2002, AM J EPIDEMIOL, V156, P319, DOI 10.1093/aje/kwf043; van Os J, 2008, SCHIZOPHRENIA BULL, V34, P1066, DOI 10.1093/schbul/sbn117; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; VARTY GB, 1994, J PSYCHOPHARMACOL, V8, P148, DOI 10.1177/026988119400800302; Varty GB, 2000, BIOL PSYCHIAT, V47, P864, DOI 10.1016/S0006-3223(99)00269-3; Wray NR, 2010, SCHIZOPHRENIA BULL, V36, P14, DOI 10.1093/schbul/sbp137	57	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93411	10.1371/journal.pone.0093411	http://dx.doi.org/10.1371/journal.pone.0093411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671152	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000142
J	Das, S; Banerjee, S; Majumder, S; Chowdhury, BP; Goswami, A; Halder, K; Chakraborty, U; Pal, NK; Majumdar, S				Das, Shibali; Banerjee, Sayantan; Majumder, Saikat; Chowdhury, Bidisha Paul; Goswami, Avranil; Halder, Kuntal; Chakraborty, Urmita; Pal, Nishith K.; Majumdar, Subrata			Immune Subversion by Mycobacterium tuberculosis through CCR5 Mediated Signaling: Involvement of IL-10	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; IFN-GAMMA; T-CELLS; DENDRITIC CELLS; HIV-INFECTION; II EXPRESSION; MACROPHAGES; INHIBITION; BETA; INTERLEUKIN-10	Tuberculosis is characterized by severe immunosuppression of the host macrophages, resulting in the loss of the host protective immune responses. During Mycobacterium tuberculosis infection, the pathogen modulates C-C Chemokine Receptor 5 (CCR5) to enhance IL-10 production, indicating the possible involvement of CCR5 in regulation of the host immune response. Here, we found that Mycobacterium infection significantly increased CCR5 expression in macrophages there by facilitating the activation of its downstream signaling. These events culminated in up-regulation of the immunosuppressive cytokine IL-10 production, which was further associated with the down-regulation of macrophage MHC-II expression along with the up-regulation of CCR5 expression via engagement of STAT-3 in a positive feedback loop. Treatment of macrophages with CCR5 specific siRNA abrogated the IL-10 production and restored MHCII expression. While, in vivo CCR5 silencing was also effective for the restoration of host immune responses against tuberculosis. This study demonstrated that CCR5 played a very critical role for the immune subversion mechanism employed by the pathogen.	[Das, Shibali; Banerjee, Sayantan; Majumder, Saikat; Chowdhury, Bidisha Paul; Halder, Kuntal; Majumdar, Subrata] Bose Inst, Div Mol Med, Kolkata, India; [Goswami, Avranil; Chakraborty, Urmita; Pal, Nishith K.] Inst Post Grad Med Educ & Res, Dept Microbiol, Kolkata, India; Malda Med Coll, Dept Microbiol, Malda, India	Department of Science & Technology (India); Bose Institute; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Majumdar, S (corresponding author), Bose Inst, Div Mol Med, Kolkata, India.	subrata@bic.boseinst.ernet	Majumder, Saikat/ABC-2194-2020; BANERJEE, SAYANTAN/AAD-8420-2019; Das, Shibali/AAA-2683-2021	Majumder, Saikat/0000-0002-6591-9515; Das, Shibali/0000-0003-1263-8178	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi provided a fellowship to Shibali Das. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algood HMS, 2004, J IMMUNOL, V173, P3287; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Beamer GL, 2008, J IMMUNOL, V181, P5545, DOI 10.4049/jimmunol.181.8.5545; Bhattacharya P, 2011, PLOS ONE, V6, P1; Bhattacharyya S, 2008, SCAND J IMMUNOL, V67, P345, DOI 10.1111/j.1365-3083.2008.02076.x; Chan LLY, 2010, J LEUKOCYTE BIOL, V88, P303, DOI 10.1189/jlb.1009659; Cho H, 2005, INFECT IMMUN, V73, P1367, DOI 10.1128/IAI.73.3.1367-1376.2005; FAHEY TJ, 1992, J IMMUNOL, V148, P2764; Ferwerda G, 2007, J LEUKOCYTE BIOL, V82, P1011, DOI 10.1189/jlb.0307147; Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027; Fulton SA, 2004, INFECT IMMUN, V72, P2101, DOI 10.1128/IAI.72.4.2101-2110.2004; Gallegos AM, 2008, J EXP MED, V205, P2359, DOI 10.1084/jem.20080353; Ghosh S, 2002, INFECT IMMUN, V70, P6828, DOI 10.1128/IAI.70.12.6828-6838.2002; Green AM, 2013, J IMMUNOL, V190, P270, DOI 10.4049/jimmunol.1200061; Harris J, 2010, CLIN EXP IMMUNOL, V161, P1, DOI 10.1111/j.1365-2249.2010.04146.x; Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000; Houle M, 1999, INFLAMMATION, V23, P241; Huffnagle GB, 1999, J IMMUNOL, V163, P4642; Kuipers HF, 2008, BLOOD, V112, P1610, DOI 10.1182/blood-2008-01-135111; Lande R, 2003, J IMMUNOL, V170, P1174, DOI 10.4049/jimmunol.170.3.1174; Lee B, 1999, P NATL ACAD SCI USA, V96, P5215, DOI 10.1073/pnas.96.9.5215; Liu Y, 2010, CLIN VACCINE IMMUNOL, V17, P1377, DOI 10.1128/CVI.00242-10; Madan-Lala R, 2011, INFECT IMMUN, V79, P4828, DOI 10.1128/IAI.05574-11; MAJUMDAR S, 1993, BIOCHIM BIOPHYS ACTA, V1176, P276, DOI 10.1016/0167-4889(93)90056-U; Makuta Y, 2003, BIOL PHARM BULL, V26, P1076, DOI 10.1248/bpb.26.1076; Mayanja-Kizza H, 2001, J INFECT DIS, V183, P1801, DOI 10.1086/320724; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moreira AP, 2008, J IMMUNOL, V180, P3049, DOI 10.4049/jimmunol.180.5.3049; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Olleros ML, 2005, AM J PATHOL, V166, P1109, DOI 10.1016/S0002-9440(10)62331-0; Pai RK, 2003, J IMMUNOL, V171, P175, DOI 10.4049/jimmunol.171.1.175; Pai RK, 2002, J IMMUNOL, V169, P1326, DOI 10.4049/jimmunol.169.3.1326; Parveen N, 2013, J BIOL CHEM, V288, P24956, DOI 10.1074/jbc.M113.461004; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Redpath S, 1999, J IMMUNOL, V162, P6701; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Rosati M, 2001, J IMMUNOL, V167, P1654, DOI 10.4049/jimmunol.167.3.1654; Schafer G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008448; Simmons G, 2000, IMMUNOL REV, V177, P112, DOI 10.1034/j.1600-065X.2000.17719.x; Tomkowicz B, 2006, BLOOD, V108, P1145, DOI 10.1182/blood-2005-12-012815; Wieland CW, 2007, MICROBES INFECT, V9, P134, DOI 10.1016/j.micinf.2006.10.018; Wilkin TJ, 2012, ANNU REV MED, V63, P81, DOI 10.1146/annurev-med-052010-145454; World Health Organization, 2009, GLOB TUB CONTR EP ST; Yang XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030198; Yurchenko E, 2006, J EXP MED, V203, P2451, DOI 10.1084/jem.20060956; Zimmerli S, 1996, AM J RESP CELL MOL, V15, P760, DOI 10.1165/ajrcmb.15.6.8969271	46	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92477	10.1371/journal.pone.0092477	http://dx.doi.org/10.1371/journal.pone.0092477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695099	Green Submitted, gold, Green Published			2022-12-27	WOS:000334103000019
J	Huang, CW; Hayman-Abello, B; Hayman-Abello, S; Derry, P; McLachlan, RS				Huang, Chin-Wei; Hayman-Abello, Brent; Hayman-Abello, Susan; Derry, Paul; McLachlan, Richard S.			Subjective Memory Evaluation before and after Temporal Lobe Epilepsy Surgery	PLOS ONE			English	Article							COMPLAINTS; MOOD; PERFORMANCE; ADULTS	Subjective memory (SM), a self-evaluation of memory, in contrast to objective memory (OM) measured by neuropsychological testing, is less well studied in patients with epilepsy. We assessed SM before and after temporal lobectomy. The Frequency of Forgetting 10 scale (FOF-10), developed to evaluate SM in dementia, was given before and one year after temporal lobectomy. Reliability and validity for use in epilepsy were first assessed. Measures of depression (CES-D) and neuroticism (PANAS) were done before and after surgery as well as complete neuropsychological assessment of OM. Correlation analysis between FOF-10 results and all the other variables was implemented. In 48 patients the FOF-10 was reliable and valid showing high internal consistency in all items (Cronbach's alpha >0.82) and high reproducibility (p<0.01). The FOF-10 also correlated with the memory assessment clinics self rating scale (MAC-S) (p<0.01). FOF-10 scores improved or were unchanged postoperatively in 28 patients (58%) and worsened in 20 (42%). The FOF-10 did not significantly correlate with memory scores from neuropsychological testing but did correlate with perceived word finding difficulty (p< 0.001) and postoperative depression (p<0.05). A reduction in number of antiepileptic drugs (AEDs) after surgery distinguished those with improved postoperative SM. No correlation was found between SM and neuroticism, side of surgery or number of seizures. The FOF-10 is a brief and reliable measure of subjective memory in patients with epilepsy. Perceived memory impairment reflects more emotional state, language problems and quantity of AEDs than actual defects in memory function. These results would potentially be useful in presurgical counselling and management of memory issues after temporal lobe surgery.	[Huang, Chin-Wei; Hayman-Abello, Brent; Hayman-Abello, Susan; Derry, Paul; McLachlan, Richard S.] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada; [Huang, Chin-Wei] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Neurol, Tainan 70101, Taiwan	Western University (University of Western Ontario); National Cheng Kung University; National Cheng Kung University Hospital	Huang, CW (corresponding author), Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada.	huangcw@mail.ncku.edu.tw; rick.mclachlan@lhsc.on.ca			Physicians' Services Incorporated Foundation of Ontario, Canada [07-50]; National Science Council, Taiwan [NSC-102-2314-B-006-051-MY3]	Physicians' Services Incorporated Foundation of Ontario, Canada; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the Physicians' Services Incorporated Foundation of Ontario (07-50), Canada and a grant from National Science Council (NSC-102-2314-B-006-051-MY3), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldenkamp AP, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s4.3.x; Andelman F, 2004, EPILEPSIA, V45, P826, DOI 10.1111/j.0013-9580.2004.51703.x; Au A, 2006, EPILEPSY BEHAV, V9, P68, DOI 10.1016/j.yebeh.2006.04.004; Baxendale S, 2005, EPILEPSY BEHAV, V6, P207, DOI 10.1016/j.yebeh.2004.12.009; Bell B, 2011, NAT REV NEUROL, V7, P154, DOI 10.1038/nrneurol.2011.3; Busch RM, 2012, NEUROLOGY, V78, P1064, DOI 10.1212/WNL.0b013e31824e8efb; Canizares S, 2000, EPILEPSIA, V41, P1303, DOI 10.1111/j.1528-1157.2000.tb04609.x; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; CROOK TH, 1990, PSYCHOL AGING, V5, P48, DOI 10.1037/0882-7974.5.1.48; Elixhauser A, 1999, EPILEPSY RES, V37, P13, DOI 10.1016/S0920-1211(99)00036-4; Erk S, 2011, ARCH GEN PSYCHIAT, V68, P845, DOI 10.1001/archgenpsychiatry.2011.80; Fargo JD, 2004, EPILEPSY BEHAV, V5, P143, DOI 10.1016/j.yebeh.2003.11.023; Gauffin H, 2011, EPILEPSY BEHAV, V22, P750, DOI 10.1016/j.yebeh.2011.09.007; Giovagnoli AR, 1997, EPILEPSY RES, V28, P119, DOI 10.1016/S0920-1211(97)00036-3; Helmstaedter C, 2000, EPILEPSY RES, V41, P235, DOI 10.1016/S0920-1211(00)00148-0; Hendriks MPH, 2002, EPILEPSY BEHAV, V3, P165, DOI 10.1006/ebeh.2002.0320; Lineweaver TT, 2004, EPILEPSIA, V45, P1604, DOI 10.1111/j.0013-9580.2004.54503.x; Martin R, 2006, EPILEPSY BEHAV, V8, P239, DOI 10.1016/j.yebeh.2005.10.004; McAuley JW, 2010, EPILEPSY BEHAV, V19, P580, DOI 10.1016/j.yebeh.2010.09.001; MCGLONE J, 1994, EPILEPSIA, V35, P529, DOI 10.1111/j.1528-1157.1994.tb02473.x; Nunnally J., 1978, PSYCHOMETRIC THEORY; Piazzini A, 2001, EUR J NEUROL, V8, P613, DOI 10.1046/j.1468-1331.2001.00287.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295; Salas-Puig J, 2009, EPILEPSY BEHAV, V14, P622, DOI 10.1016/j.yebeh.2009.01.015; Sawrie SM, 1999, NEUROLOGY, V53, P1511, DOI 10.1212/WNL.53.7.1511; Streiner D. L., 2003, HLTH MEASUREMENT SCA; Thompson PJ, 2000, J NEUROL NEUROSUR PS, V69, P636, DOI 10.1136/jnnp.69.5.636; Wagner K, 2013, J NEUROL NEUROSUR PS, V84, P630, DOI 10.1136/jnnp-2012-304052; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weitzman RA, 1996, EDUC PSYCHOL MEAS, V56, P779, DOI 10.1177/0013164496056005005; Witt JA, 2012, SEIZURE-EUR J EPILEP, V21, P134, DOI 10.1016/j.seizure.2011.10.007; Yurko-Mauro K, 2010, ALZHEIMERS DEMENT, V6, P456, DOI 10.1016/j.jalz.2010.01.013; Zelinski EM, 2004, AGING MENT HEALTH, V8, P293, DOI 10.1080/13607860410001709665	34	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93382	10.1371/journal.pone.0093382	http://dx.doi.org/10.1371/journal.pone.0093382			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690769	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100071
J	Kumar, N; Gupta, S; Chandan, NK; Aklakur, M; Pal, AK; Jadhao, SB				Kumar, Neeraj; Gupta, Subodh; Chandan, Nitish Kumar; Aklakur, Md; Pal, Asim Kumar; Jadhao, Sanjay Balkrishna			Lipotropes Protect against Pathogen-Aggravated Stress and Mortality in Low Dose Pesticide-Exposed Fish	PLOS ONE			English	Article							FRESH-WATER CATFISH; IMMUNE-RESPONSE; NILE TILAPIA; SUBLETHAL CONCENTRATIONS; DNA METHYLATION; RAINBOW-TROUT; HETEROPNEUSTES-FOSSILIS; BIOCHEMICAL RESPONSES; OREOCHROMIS-NILOTICUS; DISEASE RESISTANCE	The decline of freshwater fish biodiversity corroborates the trends of unsustainable pesticide usage and increase of disease incidence in the last few decades. Little is known about the role of nonlethal exposure to pesticide, which is not uncommon, and concurrent infection of opportunistic pathogens in species decline. Moreover, preventative measures based on current knowledge of stress biology and an emerging role for epigenetic (especially methylation) dysregulation in toxicity in fish are lacking. We herein report the protective role of lipotropes/methyl donors (like choline, betaine and lecithin) in eliciting primary (endocrine), secondary (cellular and hemato-immunological and histoarchitectural changes) and tertiary (whole animal) stress responses including mortality (50%) in pesticide-exposed (nonlethal dose) and pathogen-challenged fish. The relative survival with betaine and lecithin was 10 and 20 percent higher. This proof of cause-and-effect relation and physiological basis under simulated controlled conditions indicate that sustained stress even due to nonlethal exposure to single pollutant enhances pathogenic infectivity in already nutritionally-stressed fish, which may be a driver for freshwater aquatic species decline in nature. Dietary lipotropes can be used as one of the tools in resurrecting the aquatic species decline.	[Kumar, Neeraj; Gupta, Subodh; Chandan, Nitish Kumar; Aklakur, Md; Pal, Asim Kumar; Jadhao, Sanjay Balkrishna] Cent Inst Fisheries Educ, Dept Fish Nutr Biochem & Physiol, Bombay, Maharashtra, India	Indian Council of Agricultural Research (ICAR); ICAR - Central Institute of Fisheries Education	Jadhao, SB (corresponding author), Cent Inst Fisheries Educ, Dept Fish Nutr Biochem & Physiol, Bombay, Maharashtra, India.	sbjadhao@hotmail.com		Gupta, Subodh/0000-0002-9420-480X	Central Institute of Fisheries Education (Indian Council of Agricultural Research);  [CIFE (M)-2007/T6-1]	Central Institute of Fisheries Education (Indian Council of Agricultural Research); 	SBJ acknowledges the support for institutional project [CIFE (M)-2007/T6-1]. NK and NKC received an institutional research fellowship from the Central Institute of Fisheries Education (Indian Council of Agricultural Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; Akhtar MS, 2012, PESTIC BIOCHEM PHYS, V103, P23, DOI 10.1016/j.pestbp.2012.02.004; Akhtar MS, 2010, AQUAC RES, V41, P991, DOI 10.1111/j.1365-2109.2009.02383.x; Altinok I, 2007, TOXICOL PATHOL, V35, P405, DOI 10.1080/01926230701230353; Anuradha CD, 2001, FREE RADICAL BIO MED, V31, P367, DOI 10.1016/S0891-5849(01)00591-3; AOAC, 2000, OFFICIAL METHODS ANA, V17th; Arkoosh MR, 2001, J AQUAT ANIM HEALTH, V13, P257, DOI 10.1577/1548-8667(2001)013&lt;0257:ISOJCS&gt;2.0.CO;2; Barton B.A., 1991, Annual Review of Fish Diseases, V1, P3, DOI 10.1016/0959-8030(91)90019-G; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; BENNETT RO, 1987, J FISH BIOL, V31, P375, DOI 10.1111/j.1095-8649.1987.tb05242.x; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Canlet C, 2013, J TOXICOL-US, V2013, DOI 10.1155/2013/545802; Carey C, 2005, INTEGR COMP BIOL, V45, P4, DOI 10.1093/icb/45.1.4; Tellez-Banuelos MC, 2009, FISH SHELLFISH IMMUN, V27, P105, DOI 10.1016/j.fsi.2008.11.002; Chao JCJ, 2002, J NUTR BIOCHEM, V13, P653, DOI 10.1016/S0955-2863(02)00209-7; Chaurio RA, 2009, MOLECULES, V14, P4892, DOI 10.3390/molecules14124892; Chen CH, 2012, ACTIVATION AND DETOXIFICATION ENZYMES: FUNCTIONS AND IMPLICATIONS, P1, DOI 10.1007/978-1-4614-1049-2; Chondar SL, 1999, BIOL FISH SHELLFISH; Clesceri L.S, 1998, STANDARD METHODS EST; DANIEL CS, 1986, TOXICOL LETT, V32, P113, DOI 10.1016/0378-4274(86)90056-1; Danion M, 2012, ECOTOX ENVIRON SAFE, V79, P28, DOI 10.1016/j.ecoenv.2012.01.018; Desbonnet L, 2012, BEHAV BRAIN RES, V228, P351, DOI 10.1016/j.bbr.2011.12.014; DUTTA HM, 1993, B ENVIRON CONTAM TOX, V51, P895, DOI 10.1007/BF00198287; Elliott E, 2010, NAT NEUROSCI, V13, P1351, DOI 10.1038/nn.2642; Ellis A., 1990, TECHINIQUES FISH IMM; Engstad R. E., 1992, Fish & Shellfish Immunology, V2, P287, DOI 10.1016/S1050-4648(06)80033-1; Ezemonye LIN, 2011, FOOD CHEM TOXICOL, V49, P1898, DOI 10.1016/j.fct.2010.10.025; Garg UK, 2004, TOXICOL PATHOL, V32, P364, DOI 10.1080/01926230490431745; Ghyczy M, 2001, BRIT J NUTR, V85, P409, DOI 10.1079/BJN2000274; Gilliom RJ, 2007, QUALITY OUR NATIONS, P4; Giron-Perez MI, 2008, B ENVIRON CONTAM TOX, V80, P266, DOI 10.1007/s00128-008-9358-0; GRABER CD, 1981, J INFECT DIS, V143, P101, DOI 10.1093/infdis/143.1.101; Gupta SC, 2010, LIFE SCI, V86, P377, DOI 10.1016/j.lfs.2009.12.015; Hayes TB, 2010, J EXP BIOL, V213, P921, DOI 10.1242/jeb.040865; Henics T, 1999, BIOL CELL, V91, P485, DOI 10.1016/S0248-4900(00)88205-2; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Da Cuna RH, 2011, ECOTOX ENVIRON SAFE, V74, P1065, DOI 10.1016/j.ecoenv.2011.02.002; IUCN (International Union for Conservation of Nature), 2021, THE IUCN RED LIST TH, DOI [10.2305/IUCN.UK.2015-2.RLTS.T2446A22156678.en, DOI 10.2305/IUCN.UK.2015-2.RLTS.T2446A22156678.EN]; Iwama GK, 1998, REV FISH BIOL FISHER, V8, P35, DOI 10.1023/A:1008812500650; Jia ZQ, 2007, J APPL TOXICOL, V27, P434, DOI 10.1002/jat.1218; Kennedy CJ, 2008, AQUAT TOXICOL, V90, P172, DOI 10.1016/j.aquatox.2008.08.016; Kidd MT, 1997, WORLD POULTRY SCI J, V53, P125, DOI 10.1079/WPS19970013; Klasing KC, 2002, J NUTR, V132, P2274, DOI 10.1093/jn/132.8.2274; Kreutz LC, 2011, 38 C BRAZ VET MED; Kreutz LC, 2010, FISH SHELLFISH IMMUN, V29, P694, DOI 10.1016/j.fsi.2010.06.003; Kumar Ajith, 2000, P341; Kumar N, 2011, PESTIC BIOCHEM PHYS, V99, P45, DOI 10.1016/j.pestbp.2010.10.003; Lemaire B, 2010, AQUAT BIOL, V8, P161, DOI 10.3354/ab00227; Lien RJ, 1998, POULTRY SCI, V77, P41, DOI 10.1093/ps/77.1.41; Mills LJ, 2001, AQUAT TOXICOL, V52, P157, DOI 10.1016/S0166-445X(00)00139-9; Misra CK, 2006, FISH SHELLFISH IMMUN, V20, P305, DOI 10.1016/j.fsi.2005.05.007; Misra S, 2006, FISH SHELLFISH IMMUN, V21, P346, DOI 10.1016/j.fsi.2005.12.010; Miwa S, 2000, DIS AQUAT ORGAN, V42, P227, DOI 10.3354/dao042227; MORALES MH, 1991, J EXP ZOOL, V260, P50, DOI 10.1002/jez.1402600107; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Morrow G, 2004, J BIOL CHEM, V279, P43382, DOI 10.1074/jbc.C400357200; MURRAY CK, 1976, J FISH BIOL, V9, P329, DOI 10.1111/j.1095-8649.1976.tb04681.x; Mustafa Ahmed, 2011, Journal of Applied Aquaculture, V23, P136, DOI 10.1080/10454438.2011.581573; Muthappa NA, 2014, CELL STRESS CHAPERON, V19, P61, DOI 10.1007/s12192-013-0434-y; Muthappa NA, 2011, NATL ACAD SCI LETT, V34, P211; Nair J R, 1998, ASIAN FISH SCI, V10, P179; National Research Council, 1993, NUTR REQ FISH; Paulsen SM, 2003, FISH SHELLFISH IMMUN, V14, P39, DOI 10.1006/fsim.2002.0416; PELISSERO C, 1991, GEN COMP ENDOCR, V83, P447, DOI 10.1016/0016-6480(91)90151-U; PELISSERO C, 1992, AQUACULTURE, V107, P283, DOI 10.1016/0044-8486(92)90078-Y; PLUMB JA, 1990, DEV COMP IMMUNOL, V14, P355, DOI 10.1016/0145-305X(90)90026-B; Pushpanjali, 2005, PESTIC BIOCHEM PHYS, V82, P103, DOI 10.1016/j.pestbp.2004.09.004; RAO DMR, 1980, J TOXICOL ENV HEALTH, V6, P825, DOI 10.1080/15287398009529900; REAP EA, 1990, J LAB CLIN MED, V115, P481; Rehulka J, AQUACULT RES, V34, P617; Relyea RA, 2001, P NATL ACAD SCI USA, V98, P2491, DOI 10.1073/pnas.031076198; Ren XF, 2011, ENVIRON HEALTH PERSP, V119, P11, DOI 10.1289/ehp.1002114; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Roberts R.J., 1989, P337; Roberts R.J., 1978, P55; ROGERS AE, 1991, J NUTR BIOCHEM, V2, P579, DOI 10.1016/0955-2863(91)90023-X; RUNGE CF, 2003, ENDING HUNGER OUR LI; Salvo LM, 2012, J ENVIRON SCI HEAL A, V47, P1652, DOI 10.1080/10934529.2012.687236; SANDERS BM, 1993, CRIT REV TOXICOL, V23, P49, DOI 10.3109/10408449309104074; Sang S, 1999, ENDOSULFAN REV ITS T; Sano IM, 1998, BIOCHIM BIOPHYS ACTA, V951, P157; Saravanan M, 2011, PESTIC BIOCHEM PHYS, V100, P206, DOI 10.1016/j.pestbp.2011.04.002; Sarma K, 2009, SCI TOTAL ENVIRON, V407, P3668, DOI 10.1016/j.scitotenv.2009.02.031; SCHOLFIELD CR, 1981, J AM OIL CHEM SOC, V58, P889, DOI 10.1007/BF02659652; Sharp G. J. E., 1993, Fish & Shellfish Immunology, V3, P119, DOI 10.1006/fsim.1993.1013; Shved N, 2011, FISH PHYSIOL BIOCHEM, V37, P781, DOI 10.1007/s10695-011-9477-0; Singh PB, 2004, ECOTOX ENVIRON SAFE, V58, P77, DOI 10.1016/j.ecoenv.2003.07.014; Stromqvist M, 2010, AQUAT TOXICOL, V98, P275, DOI 10.1016/j.aquatox.2010.02.023; Suarez-Alvarez B, 2012, TRENDS GENET, V28, P506, DOI 10.1016/j.tig.2012.06.005; Sweilum MA, 2006, AQUAC RES, V37, P1079, DOI 10.1111/j.1365-2109.2006.01531.x; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.2307/3432709; Tyler CR, 1996, J COMP PHYSIOL B, V166, P418, DOI 10.1007/BF02337886; Unternaehrer E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.77; Varayoud J, 2008, REPROD TOXICOL, V26, P138, DOI 10.1016/j.reprotox.2008.08.004; Vijayan MM, 1998, AQUAT TOXICOL, V40, P101, DOI 10.1016/S0166-445X(97)00057-X; Wiegertjes GF, 1996, DEV COMP IMMUNOL, V20, P365, DOI 10.1016/S0145-305X(96)00032-8; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yardimci B, 2011, ANKARA UNIV VET FAK, V58, P47, DOI 10.1501/Vetfak_0000002448	99	42	43	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93499	10.1371/journal.pone.0093499	http://dx.doi.org/10.1371/journal.pone.0093499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690771	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100091
J	Lalle, E; Bordi, L; Caglioti, C; Garbuglia, AR; Castilletti, C; Taibi, C; Cristofari, F; Capobianchi, MR				Lalle, Eleonora; Bordi, Licia; Caglioti, Claudia; Garbuglia, Anna Rosa; Castilletti, Concetta; Taibi, Chiara; Cristofari, Francesca; Capobianchi, Maria Rosaria			IFN-Alpha Receptor-1 Upregulation in PBMC from HCV Naive Patients Carrying CC Genotype. Possible Role of IFN-Lambda	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; SINGLE-NUCLEOTIDE POLYMORPHISMS; GENE-EXPRESSION; MESSENGER-RNA; RIBAVIRIN THERAPY; INTERFERON-ALPHA; INTERLEUKIN 28B; INNATE IMMUNITY; IL28B; ASSOCIATION	Background and Aims: IL-28B gene polymorphisms predict better therapeutic response and spontaneous clearance of HCV. Moreover, higher expression of IFN-lambda has been reported in patients with the rs12979860 CC favourable genotype. The study aim was to establish possible relationships between IL-28B rs12979860 genotypes and expression of IFN-alpha receptor-1 (IFNAR-1) in naive HCV patients, and to explore the possible role of IFN-lambda. Methods: IFNAR-1 mRNA levels were measured in PBMC from naive patients with chronic hepatitis C with different IL-28 genotypes. The ability of IFN-lambda to up-regulate the expression of IFNAR-1 was established in PBMC from healthy donors carrying different IL-28B genotypes. Results: Lower IFNAR-1 mRNA levels were observed in PBMC from HCV-infected naive patients as compared to healthy donors. In healthy donors, IFNAR-1 mRNA levels were independent from IL-28B genotype, while in HCV patients, an increasing gradient was observed in TT vs CT vs CC carriers. In the latter group, a direct correlation between IFNAR-1 and endogenous IL-28B expression was observed. Moreover, IFN-lambda up-regulated IFNAR-1 expression in normal PBMC in a time-and dose-dependent manner, with a more effective response in CC vs TT carriers. Conclusion: Endogenous levels of IFN-lambda may be responsible for partial restoration of IFNAR-1 expression in HCV patients with favourable IL-28 genotype. This, in turn, may confer to CC carriers a response advantage to either endogenous or exogenous IFN-alpha, representing the biological basis for the observed association between CC genotype and favourable outcome of either natural infection (clearance vs chronicization) or IFN therapy.	[Lalle, Eleonora; Bordi, Licia; Caglioti, Claudia; Garbuglia, Anna Rosa; Castilletti, Concetta; Capobianchi, Maria Rosaria] Natl Inst Infect Dis Lazzaro Spallanzani, Virol Lab, Rome, Italy; [Taibi, Chiara; Cristofari, Francesca] Natl Inst Infect Dis Lazzaro Spallanzani, Clin Dept, Rome, Italy	IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	Capobianchi, MR (corresponding author), Natl Inst Infect Dis Lazzaro Spallanzani, Virol Lab, Rome, Italy.	maria.capobianchi@inmi.it	Castilletti, Concetta/B-6545-2016; GARBUGLIA, ANNA ROSA/AAC-6556-2022; Bordi, Licia/B-6827-2017; Castilletti, Concetta/AAA-8408-2019	Castilletti, Concetta/0000-0001-9819-236X; GARBUGLIA, ANNA ROSA/0000-0002-2687-8642; Bordi, Licia/0000-0003-3962-3646; Castilletti, Concetta/0000-0001-9819-236X; lalle, eleonora/0000-0002-7063-9905; Capobianchi, Maria Rosaria/0000-0003-3465-0071	Italian Ministry of Health, Ricerca Corrente and Ricerca Finalizzata	Italian Ministry of Health, Ricerca Corrente and Ricerca Finalizzata(Ministry of Health, Italy)	This study has been partly supported by grants from Italian Ministry of Health, Ricerca Corrente and Ricerca Finalizzata. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate I, 2003, J MED VIROL, V70, P581, DOI 10.1002/jmv.10433; Abe H, 2011, J HEPATOL, V54, P1094, DOI 10.1016/j.jhep.2010.09.019; Asahina Y, 2012, HEPATOLOGY, V55, P20, DOI 10.1002/hep.24623; Booy S, 2014, J CELL MOL MED, V20, P1; Butera D, 2005, BLOOD, V106, P1175, DOI 10.1182/blood-2005-01-0126; Capobianchi MR, 2006, CELL MOL BIOL, V52, P3, DOI 10.1170/T692; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Fukuda R, 1997, J HEPATOL, V26, P455, DOI 10.1016/S0168-8278(97)80407-2; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gerotto M, 2004, ANTIVIR THER, V9, P763; Giannelli G, 2004, J INTERF CYTOK RES, V24, P659, DOI 10.1089/jir.2004.24.659; Hadigan C, 2011, JAMA-J AM MED ASSOC, V306, P294, DOI 10.1001/jama.2011.975; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Lalle E, 2008, J BIOL REG HOMEOS AG, V22, P153; Lange CM, 2011, J HEPATOL, V55, P692, DOI 10.1016/j.jhep.2011.03.006; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Mangia A, 2010, GASTROENTEROLOGY, V139, P821, DOI 10.1053/j.gastro.2010.05.079; Mathai J, 1999, J INTERF CYTOK RES, V19, P1011, DOI 10.1089/107999099313226; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; Mihm S, 2004, LAB INVEST, V84, P1148, DOI 10.1038/labinvest.3700135; Naggie S, 2012, HEPATOLOGY, V56, P444, DOI 10.1002/hep.25647; Riva E, 2012, J VIRAL HEPATITIS, V19, P650, DOI 10.1111/j.1365-2893.2012.01606.x; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Torres C, 2013, INTERFERON CYTO 0926; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; World Health Organization, 2010, 63 WORLD HLTH ASS VI	32	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93434	10.1371/journal.pone.0093434	http://dx.doi.org/10.1371/journal.pone.0093434			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691098	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100080
J	Du, HS; Li, WH; Wang, YQ; Yang, WC				Du, Heshan; Li, Wenhui; Wang, Yuqing; Yang, Wencai			Identification of Genes Differentially Expressed between Resistant and Susceptible Tomato Lines during Time-Course Interactions with Xanthomonas perforans Race T3	PLOS ONE			English	Article							CAMPESTRIS PV. VESICATORIA; BACTERIAL SPOT; CDNA-AFLP; DISEASE RESISTANCE; ANALYSIS REVEALS; PLANT; ETHYLENE; INFECTION; PEPPER; INHERITANCE	Bacterial spot caused by several Xanthomonas sp. is one of the most devastating diseases in tomato (Solanum lycopersicum L.). The genetics of hypersensitive resistance to X. perforans race T3 has been intensively investigated and regulatory genes during the infection of race T3 have been identified through transcriptional profiling. However, no work on isolating regulatory genes for field resistance has been reported. In this study, cDNA-amplified fragment length polymorphism technique was used to identify differentially expressed transcripts between resistant tomato accession PI 114490 and susceptible variety OH 88119 at 3, 4 and 5 days post-inoculation of the pathogen. Using 256 selective primer combinations, a total of 79 differentially expressed transcript-derived fragments (TDFs) representing 71 genes were obtained. Of which, 60 were up-regulated and 4 were down-regulated in both tomato lines, 4 were uniquely up-regulated and 2 were uniquely down-regulated in PI 114490, and 1 was specifically up-regulated in OH 88119. The expression patterns of 19 representative TDFs were further confirmed by semi-quantitative and/or quantitative real time RT-PCR. These results suggested that the two tomato lines activated partly similar defensive mechanism in response to race T3 infection. The data obtained here will provide some fundamental information for elucidating the molecular mechanism of response to race T3 infection in tomato plants with field resistance.	[Du, Heshan; Li, Wenhui; Wang, Yuqing; Yang, Wencai] China Agr Univ, Beijing Key Lab Growth & Dev Regulat Protected Ve, Dept Vegetable Sci, Beijing 100094, Peoples R China	China Agricultural University	Yang, WC (corresponding author), China Agr Univ, Beijing Key Lab Growth & Dev Regulat Protected Ve, Dept Vegetable Sci, Beijing 100094, Peoples R China.	yangwencai@cau.edu.cn	Wang, yuqing/HIR-1604-2022; Yang, Wencai/G-6517-2011	Yang, Wencai/0000-0001-5369-2555	National Natural Science Foundation of China [31372073]; Specialized Research Fund for the Doctoral Program of Higher Education [20110008110019]; Beijing Modern Agro-industry Technology Research System	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Beijing Modern Agro-industry Technology Research System	The work was partly supported by National Natural Science Foundation of China (31372073), Specialized Research Fund for the Doctoral Program of Higher Education (20110008110019) and Beijing Modern Agro-industry Technology Research System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles F, 1992, ETHYLENE PLANT BIOL; Astua-Monge G, 2000, MOL PLANT MICROBE IN, V13, P911, DOI 10.1094/MPMI.2000.13.9.911; Bachem CWB, 1998, PLANT MOL BIOL REP, V16, P157, DOI 10.1023/A:1007468801806; Balaji V, 2008, PLANT PHYSIOL, V146, P1797, DOI 10.1104/pp.107.115188; Balaji V, 2007, FUNCT INTEGR GENOMIC, V7, P305, DOI 10.1007/s10142-007-0050-y; BENT AF, 1992, MOL PLANT MICROBE IN, V5, P372, DOI 10.1094/MPMI-5-372; Broekaert WF, 2006, ANNU REV PHYTOPATHOL, V44, P393, DOI 10.1146/annurev.phyto.44.070505.143440; Chen J, 2009, SCI HORTIC-AMSTERDAM, V122, P6, DOI 10.1016/j.scienta.2009.03.025; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Chung HS, 2010, PLANT J, V63, P613, DOI 10.1111/j.1365-313X.2010.04265.x; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Daurelio LD, 2011, J PLANT PHYSIOL, V168, P382, DOI 10.1016/j.jplph.2010.07.014; Demianski AJ, 2012, MOL PLANT PATHOL, V13, P46, DOI 10.1111/j.1364-3703.2011.00727.x; Dinari A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052757; Froehlich JE, 2001, PLANT PHYSIOL, V125, P306, DOI 10.1104/pp.125.1.306; Gabriels SHEJ, 2006, MOL PLANT MICROBE IN, V19, P567, DOI 10.1094/MPMI-19-0567; Gibly A, 2004, MOL PLANT MICROBE IN, V17, P1212, DOI 10.1094/MPMI.2004.17.11.1212; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; Gu YQ, 2000, PLANT CELL, V12, P771, DOI 10.1105/tpc.12.5.771; Gu YQ, 2002, PLANT CELL, V14, P817, DOI 10.1105/tpc.000794; Gu YQ, 1998, PHILOS T R SOC B, V353, P1455, DOI 10.1098/rstb.1998.0301; Hoffman T, 1999, PLANT PHYSIOL, V119, P935, DOI 10.1104/pp.119.3.935; Hutton SF, 2010, THEOR APPL GENET, V121, P1275, DOI 10.1007/s00122-010-1387-5; Jones JB, 2005, ACTA HORTIC, P27, DOI 10.17660/ActaHortic.2005.695.1; Jones JB, 2000, INT J SYST EVOL MICR, V50, P1211, DOI 10.1099/00207713-50-3-1211; Lelliot R.A., 1987, METHODS DIAGNOSIS BA; Lin YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068749; Melech-Bonfil S, 2011, PLANT SIGNAL BEHAV, V6, P154, DOI 10.4161/psb.6.1.14311; Melech-Bonfil S, 2010, PLANT J, V64, P379, DOI 10.1111/j.1365-313X.2010.04333.x; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; O'Donnell PJ, 2003, PLANT J, V33, P245, DOI 10.1046/j.1365-313X.2003.01619.x; Orlowska E, 2012, PLANT CELL REP, V31, P187, DOI 10.1007/s00299-011-1155-2; Panstruga R, 2009, CELL, V136, P978, DOI 10.1016/j.cell.2009.02.020; Pei CC, 2012, THEOR APPL GENET, V124, P533, DOI 10.1007/s00122-011-1726-1; Polesani M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-142; Potnis N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-146; Reijans M, 2003, GENOMICS, V82, P606, DOI 10.1016/S0888-7543(03)00179-4; Robbins MD, 2009, PHYTOPATHOLOGY, V99, P1037, DOI 10.1094/PHYTO-99-9-1037; Santaella M, 2004, MOL PLANT PATHOL, V5, P549, DOI [10.1111/j.1364-3703.2004.00254.x, 10.1111/J.1364-3703.2004.00254.X]; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scott JW, 2003, J AM SOC HORTIC SCI, V128, P698, DOI 10.21273/JASHS.128.5.0698; Scott JW, 2001, J AM SOC HORTIC SCI, V126, P436, DOI 10.21273/JASHS.126.4.436; Scott JW., 1996, RPT TOMATO GENET COO, V46, P23; SHENG JS, 1993, PLANT PHYSIOL, V101, P1409, DOI 10.1104/pp.101.4.1409; Shi C, 2011, MOL BIOL REP, V38, P75, DOI 10.1007/s11033-010-0079-1; Stall RE, 2009, ANNU REV PHYTOPATHOL, V47, P265, DOI 10.1146/annurev-phyto-080508-081752; Sun HJ, 2014, EUR J PLANT PATHOL, V139, P125, DOI 10.1007/s10658-013-0371-8; [孙会军 Sun Huijun], 2011, [河北农业大学学报, Journal of Agricultural University of Hebei], V34, P65; Sun HuiJun, 2011, Acta Horticulturae Sinica, V38, P2297; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; Vuylsteke M, 2007, NAT PROTOC, V2, P1399, DOI 10.1038/nprot.2007.174; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; [杨文才 Yang Wencai], 2013, [园艺学报, Acta Horticulturae Sinica], V40, P1731; Yang WenCai, 2007, Scientia Agricultura Sinica, V40, P283; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhou JM, 1997, EMBO J, V16, P3207, DOI 10.1093/emboj/16.11.3207	56	9	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93476	10.1371/journal.pone.0093476	http://dx.doi.org/10.1371/journal.pone.0093476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686403	Green Submitted, Green Published, gold			2022-12-27	WOS:000340842300012
J	Kim, HA; Lim, CJ; Kim, S; Choe, JK; Jo, SH; Baek, N; Kwon, SY				Kim, Hyun A.; Lim, Chan Ju; Kim, Sangmi; Choe, Jun Kyoung; Jo, Sung-Hwan; Baek, Namkwon; Kwon, Suk-Yoon			High-Throughput Sequencing and De Novo Assembly of Brassica oleracea var. Capitata L. for Transcriptome Analysis	PLOS ONE			English	Article							NUCLEAR-DNA AMOUNTS; FULL-LENGTH CDNAS; ARABIDOPSIS-THALIANA; MOLECULAR CHARACTERIZATION; EXPRESSION ANALYSIS; NITRATE TRANSPORT; GENE-EXPRESSION; FAMILY; CONSTRUCTION; ANNOTATION	Background: The cabbage, Brassica oleracea var. capitata L., has a distinguishable phenotype within the genus Brassica. Despite the economic and genetic importance of cabbage, there is little genomic data for cabbage, and most studies of Brassica are focused on other species or other B. oleracea subspecies. The lack of genomic data for cabbage, a non-model organism, hinders research on its molecular biology. Hence, the construction of reliable transcriptomic data based on highthroughput sequencing technologies is needed to enhance our understanding of cabbage and provide genomic information for future work. Methodology/Principal Findings: We constructed cDNAs from total RNA isolated from the roots, leaves, flowers, seedlings, and calcium-limited seedling tissues of two cabbage genotypes: 102043 and 107140. We sequenced a total of six different samples using the Illumina HiSeq platform, producing 40.5 Gbp of sequence data comprising 401,454,986 short reads. We assembled 205,046 transcripts (>= 200 bp) using the Velvet and Oases assembler and predicted 53,562 loci from the transcripts. We annotated 35,274 of the loci with 55,916 plant peptides in the Phytozome database. The average length of the annotated loci was 1,419 bp. We confirmed the reliability of the sequencing assembly using reverse-transcriptase PCR to identify tissue-specific gene candidates among the annotated loci. Conclusion: Our study provides valuable transcriptome sequence data for B. oleracea var. capitata L., offering a new resource for studying B. oleracea and closely related species. Our transcriptomic sequences will enhance the quality of gene annotation and functional analysis of the cabbage genome and serve as a material basis for future genomic research on cabbage. The sequencing data from this study can be used to develop molecular markers and to identify the extreme differences among the phenotypes of different species in the genus Brassica.	[Kim, Hyun A.; Lim, Chan Ju; Kwon, Suk-Yoon] Korea Res Inst Biosci & Biotechnol KRIBB, Green Bio Res Ctr, Taejon, South Korea; [Kim, Sangmi; Choe, Jun Kyoung; Jo, Sung-Hwan] SEEDERS, Taejon, South Korea; [Baek, Namkwon] Samsung Seed Co Ltd, Pyongtaek, Kyeonggi, South Korea; [Kim, Hyun A.; Kwon, Suk-Yoon] Univ Sci & Technol, Biosyst & Bioengn Program, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kwon, SY (corresponding author), Korea Res Inst Biosci & Biotechnol KRIBB, Green Bio Res Ctr, Taejon, South Korea.	sykwon@kribb.re.kr		Kwon, Suk-Yoon/0000-0002-5787-4898	Technology Development Program for Agriculture and Forestry, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; KRIBB Research Initiative Program	Technology Development Program for Agriculture and Forestry, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; KRIBB Research Initiative Program	This work was supported by grants from the Technology Development Program for Agriculture and Forestry, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea, and the KRIBB Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NU, 2012, PLANT PHYSIOL BIOCH, V58, P106, DOI 10.1016/j.plaphy.2012.06.015; Amarasinghe BHRR, 1998, PLANTA, V206, P44, DOI 10.1007/s004250050372; Aoki K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-210; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayele M, 2005, GENOME RES, V15, P487, DOI 10.1101/gr.3176505; BENNETT MD, 1991, PHILOS T R SOC B, V334, P309, DOI 10.1098/rstb.1991.0120; BENNETT MD, 1976, PHILOS T R SOC B, V274, P227, DOI 10.1098/rstb.1976.0044; Blair MW, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-171; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; Cao BH, 2010, PLANT CELL TISS ORG, V103, P217, DOI 10.1007/s11240-010-9769-6; Carninci P, 1996, GENOMICS, V37, P327, DOI 10.1006/geno.1996.0567; Chang SX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-497; Chen G, 2011, SCI CHINA LIFE SCI, V54, P1129, DOI 10.1007/s11427-011-4256-9; Chen ZY, 2006, PLANT MOL BIOL, V60, P583, DOI 10.1007/s11103-005-5082-x; Cheng H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000440; Chitsaz H, 2011, NAT BIOTECHNOL, V29, P915, DOI 10.1038/nbt.1966; Cho SK, 2008, PLANT CELL, V20, P1899, DOI 10.1105/tpc.108.060699; Clepet C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018445; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Daniel-Vedele F, 1998, CURR OPIN PLANT BIOL, V1, P235, DOI 10.1016/S1369-5266(98)80110-6; EDERY I, 1995, MOL CELL BIOL, V15, P3363; Faltusova Z, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue3-fulltext-4; Filleur S, 1999, PLANTA, V207, P461, DOI 10.1007/s004250050505; Fowler TJ, 1999, PLANT PHYSIOL, V121, P1081, DOI 10.1104/pp.121.4.1081; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; GOLDMAN MHS, 1994, EMBO J, V13, P2976, DOI 10.1002/j.1460-2075.1994.tb06596.x; Haas BJ, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-6-RESEARCH0029; Hatey F, 1998, GENET SEL EVOL, V30, P521, DOI 10.1051/gse:19980601; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Johnston JS, 2005, ANN BOT-LONDON, V95, P229, DOI 10.1093/aob/mci016; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Liu GQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-700; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Mei J, 2012, THEOR APPL GENET; Obulareddy N, 2013, MOL PLANT MICROBE IN, V26, P844, DOI 10.1094/MPMI-03-13-0081-TA; Orsel M, 2002, PLANT PHYSIOL, V129, P886, DOI 10.1104/pp.005280; Paterson AH, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-3-reviews1011; Quesada A, 1997, PLANT MOL BIOL, V34, P265, DOI 10.1023/A:1005872816881; Reintanz B, 2002, P NATL ACAD SCI USA, V99, P4079, DOI 10.1073/pnas.052677799; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Seki M, 2009, J PLANT RES, V122, P355, DOI 10.1007/s10265-009-0239-3; Sze H, 2004, PLANT PHYSIOL, V136, P2532, DOI 10.1104/pp.104.046003; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; U. N., 1935, Japanese Journal of Botany, V7, P389; Umezawa T, 2008, DNA RES, V15, P333, DOI 10.1093/dnares/dsn024; Wang QB, 2012, MOL BREEDING, V30, P709, DOI 10.1007/s11032-011-9656-9; Wang WX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-523; Wang XJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-716; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Xiao SJ, 2010, BIOINFORMATICS, V26, P1273, DOI 10.1093/bioinformatics/btq109; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang L, 2007, 18 INT C AR RES; Zheng SJ, 2011, J CHEM ECOL, V37, P818, DOI 10.1007/s10886-011-9984-6; Zhuo DG, 1999, PLANT J, V17, P563, DOI 10.1046/j.1365-313X.1999.00396.x	62	30	31	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92087	10.1371/journal.pone.0092087	http://dx.doi.org/10.1371/journal.pone.0092087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682075	Green Submitted, Green Published, gold			2022-12-27	WOS:000333678100005
J	Kusaka, T; Nakayama, M; Nakamura, K; Ishimiya, M; Furusawa, E; Ogasawara, K				Kusaka, Toshimasa; Nakayama, Masafumi; Nakamura, Kyohei; Ishimiya, Mai; Furusawa, Emi; Ogasawara, Kouetsu			Effect of Silica Particle Size on Macrophage Inflammatory Responses	PLOS ONE			English	Article							ULTRAFINE AMORPHOUS SILICA; NALP3 INFLAMMASOME; INTRATRACHEAL INSTILLATION; PULMONARY INFLAMMATION; SURFACE MODIFICATION; NLRP3 INFLAMMASOME; NANOPARTICLES; MICE; ACTIVATION; IL-1-BETA	Amorphous silica particles, such as nanoparticles (<100 nm diameter particles), are used in a wide variety of products, including pharmaceuticals, paints, cosmetics, and food. Nevertheless, the immunotoxicity of these particles and the relationship between silica particle size and pro-inflammatory activity are not fully understood. In this study, we addressed the relationship between the size of amorphous silica (particle dose, diameter, number, and surface area) and the inflammatory activity (macrophage phagocytosis, inflammasome activation, IL-1 beta secretion, cell death and lung inflammation). Irrespective of diameter size, silica particles were efficiently internalized by mouse bone marrow-derived macrophages via an actin cytoskeleton-dependent pathway, and induced caspase-1, but not caspase-11, activation. Of note, 30 nm-1000 nm diameter silica particles induced lysosomal destabilization, cell death, and IL-1 beta secretion at markedly higher levels than did 3000 nm-10000 nm silica particles. Consistent with in vitro results, intra-tracheal administration of 30 nm silica particles into mice caused more severe lung inflammation than that of 3000 nm silica particles, as assessed by measurement of pro-inflammatory cytokines and neutrophil infiltration in bronchoalveolar lavage fluid of mice, and by the micro-computed tomography analysis. Taken together, these results suggest that silica particle size impacts immune responses, with submicron amorphous silica particles inducing higher inflammatory responses than silica particles over 1000 nm in size, which is ascribed not only to their ability to induce caspase-1 activation but also to their cytotoxicity.	[Kusaka, Toshimasa; Nakayama, Masafumi; Nakamura, Kyohei; Ishimiya, Mai; Furusawa, Emi; Ogasawara, Kouetsu] Tohoku Univ, Dept Immunobiol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Nakayama, Masafumi] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 980, Japan; [Nakamura, Kyohei] Tohoku Univ, Dept Hematol & Rheumatol, Grad Sch Med, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Ogasawara, K (corresponding author), Tohoku Univ, Dept Immunobiol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	ogasawara@idac.tohoku.ac.jp	Nakamura, Kyohei/AAH-4823-2019; Ogasawara, Kouetsu/G-9892-2011	Nakamura, Kyohei/0000-0002-6631-9028; Nakayama, Masafumi/0000-0002-9839-7143	Japan Chemical Industry Association (JCIA) Long-range Research Initiative (LRI); Takeda Science Foundation; Japan Society for the Promotion of Science (JSPS); Ministry of Health, Labour, and Welfare of Japan [H22-meneki-ippan-004]; Grants-in-Aid for Scientific Research [25118703] Funding Source: KAKEN	Japan Chemical Industry Association (JCIA) Long-range Research Initiative (LRI); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by a grant from the Japan Chemical Industry Association (JCIA) Long-range Research Initiative (LRI), by a grant from the Takeda Science Foundation, by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS), and by Grants-in-Aid for Scientific Research from the Ministry of Health, Labour, and Welfare of Japan (H22-meneki-ippan-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Bowman DM, 2010, NAT NANOTECHNOL, V5, P92, DOI 10.1038/nnano.2010.12; Brown JM, 2007, AM J RESP CELL MOL, V36, P43, DOI 10.1165/rcmb.2006-0197OC; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Cho WS, 2007, TOXICOL LETT, V175, P24, DOI 10.1016/j.toxlet.2007.09.008; Choi M, 2008, TOXICOL LETT, V182, P97, DOI 10.1016/j.toxlet.2008.08.019; Costantini LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014647; De Jong WH, 2008, BIOMATERIALS, V29, P1912, DOI 10.1016/j.biomaterials.2007.12.037; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Hamilton RF, 2006, J BIOL CHEM, V281, P34218, DOI 10.1074/jbc.M605229200; Hirai T, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-3; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kaewamatawong T, 2005, TOXICOL PATHOL, V33, P743, DOI 10.1080/01926230500416302; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Leung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Morishige T, 2012, ARCH TOXICOL, V86, P1297, DOI 10.1007/s00204-012-0823-5; Morishige T, 2010, BIOMATERIALS, V31, P6833, DOI 10.1016/j.biomaterials.2010.05.036; Mukhopadhyay S, 2011, BLOOD, V117, P1319, DOI 10.1182/blood-2010-03-276733; Nabeshi H, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/4/045101; Nabeshi H, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-1; Nabeshi H, 2011, BIOMATERIALS, V32, P2713, DOI 10.1016/j.biomaterials.2010.12.042; Nakayama M, 2007, J IMMUNOL, V178, P4250, DOI 10.4049/jimmunol.178.7.4250; Nakayama M, 2012, J IMMUNOL, V189, P5903, DOI 10.4049/jimmunol.1201940; Sandberg WJ, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-32; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Srivastava KD, 2002, AM J RESP CRIT CARE, V165, P527, DOI 10.1164/ajrccm.165.4.2106009; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Waters KM, 2009, TOXICOL SCI, V107, P553, DOI 10.1093/toxsci/kfn250; World Health Organization, 2007, GLOB OCC HLTH NETW N; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107	35	152	155	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92634	10.1371/journal.pone.0092634	http://dx.doi.org/10.1371/journal.pone.0092634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681489	gold, Green Published, Green Submitted			2022-12-27	WOS:000333678100011
J	Wang, SQ; Zhou, MN; Lin, FQ; Liu, DY; Hong, WS; Lu, LJ; Zhu, YP; Xu, A				Wang, Suiquan; Zhou, Miaoni; Lin, Fuquan; Liu, Dongyin; Hong, Weisong; Lu, Liangjun; Zhu, Yiping; Xu, Aie			Interferon-gamma Induces Senescence in Normal Human Melanocytes	PLOS ONE			English	Article							IFN-GAMMA; T-CELLS; CELLULAR SENESCENCE; AUTOIMMUNE-DISEASE; OXIDATIVE STRESS; IMMUNE-RESPONSE; MOUSE MODEL; VITILIGO; SKIN; EXPRESSION	Background: Interferon-gamma (IFN-gamma) plays an important role in the proceedings of vitiligo through recruiting lymphocytes to the lesional skin. However, the potential effects of IFN-gamma on skin melanocytes and the subsequent contribution to the vitiligo pathogenesis are still unclear. Objective: To investigate the effects of IFN-gamma on viability and cellular functions of melanocytes. Methods: Primary human melanocytes were treated with IFN-gamma. Cell viability, apoptosis, cell cycle melanin content and intracellular reactive oxygen species (ROS) level were measured. mRNA expression was examined by real-time PCR. The release of interleukin 6 (IL-6) and heat shock protein 70 (HSP-70) was monitored by ELISA. beta-galactosidase staining was utilized to evaluate melanocyte senescence. Results: Persistent IFN-gamma treatment induced viability loss, apoptosis, cell cycle arrest and senescence in melanocytes. Melanocyte senescence was characterized as the changes in pigmentation and morphology, as well as the increase of beta-galactosidase activity. Increase of p21(Cip1/Waf1) protein was evident in melanocytes after IFN-gamma treatment. IFN-gamma induction of senescence was attenuated by siRNAs against p21, Janus kinase 2 (JAK2) or signal transducer and activator of transcription 1 (STAT1), but not by JAK1 siRNA nor by p53 inhibitor pifithrin-alpha. IFN-gamma treatment increased the accumulation of intracellular ROS in melanocytes, while ROS scavenger N-acetyl cysteine (NAC) effectively inhibited IFN-gamma induced p21 expression and melanocyte senescence. IL-6 and HSP-70 release was significantly induced by IFN-gamma treatment, which was largely inhibited by NAC. The increase of IL-6 and HSP-70 release could also be observed in senescent melanocytes. Conclusion: IFN-gamma can induce senescence in melanocytes and consequently enhance their immuno-competency, leading to a vitiligo-prone milieu.	[Wang, Suiquan; Zhou, Miaoni; Lin, Fuquan; Liu, Dongyin; Hong, Weisong; Lu, Liangjun; Zhu, Yiping; Xu, Aie] Third Peoples Hosp Hangzhou, Hangzhou Inst Dermatol & Venereol, Dept Dermatol, Hangzhou, Zhejiang Provin, Peoples R China; [Lu, Liangjun; Zhu, Yiping] Zhejiang Chinese Med Univ, Hangzhou, Zhejiang Provin, Peoples R China	Zhejiang Chinese Medical University	Xu, A (corresponding author), Third Peoples Hosp Hangzhou, Hangzhou Inst Dermatol & Venereol, Dept Dermatol, Hangzhou, Zhejiang Provin, Peoples R China.	xuaiehz@msn.com	Zhou, Linjie/E-7874-2013	Zhou, Linjie/0000-0002-2792-2959	Natural Science Foundation of Zhejiang, China [LY13H110001, Z2100973]; National Natural Science Foundation of China [81071294, 81271758]; Co-construction Project of Ministry of Health and Zhejiang Province [WKJ2012-2-036]; National key clinical specialty construction project of China	Natural Science Foundation of Zhejiang, China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Co-construction Project of Ministry of Health and Zhejiang Province; National key clinical specialty construction project of China	This research was supported by grants from the Natural Science Foundation of Zhejiang, China (grant no. LY13H110001 and Z2100973), the National Natural Science Foundation of China (grant no. 81071294 and 81271758), and the Co-construction Project of Ministry of Health and Zhejiang Province (grant no. WKJ2012-2-036). This research was also supported by the National key clinical specialty construction project of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwa E, 2012, ARCH DERMATOL RES, V304, P823, DOI 10.1007/s00403-012-1269-6; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Bandyopadhyay D, 2001, EXP GERONTOL, V36, P1265, DOI 10.1016/S0531-5565(01)00098-5; Bansal R, 2010, CELL CYCLE, V9, P2782, DOI 10.4161/cc.9.14.12251; Basak PY, 2009, J AM ACAD DERMATOL, V60, P256, DOI 10.1016/j.jaad.2008.09.048; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bellei B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059782; Biedermann T, 2006, J IMMUNOL, V177, P3763, DOI 10.4049/jimmunol.177.6.3763; Carnaud C, 1999, J IMMUNOL, V163, P4647; Catalano A, 2005, EMBO J, V24, P170, DOI 10.1038/sj.emboj.7600502; Costin GE, 2005, BIOCHEM J, V391, P249, DOI 10.1042/BJ20042070; Dell'Anna ML, 2012, EXP DERMATOL, V21, P490, DOI 10.1111/j.1600-0625.2012.01506.x; Denman CJ, 2008, J INVEST DERMATOL, V128, P2041, DOI 10.1038/jid.2008.45; El Nasr HS, 2013, J EUR ACAD DERMATOL, V27, P103, DOI 10.1111/j.1468-3083.2011.04368.x; Ezzedine K, 2012, PIGM CELL MELANOMA R, V25, pE1, DOI 10.1111/j.1755-148X.2012.00997.x; Flaishon L, 2000, J EXP MED, V192, P1381, DOI 10.1084/jem.192.9.1381; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; Gauthier Y, 2003, BRIT J DERMATOL, V148, P95, DOI 10.1046/j.1365-2133.2003.05024.x; Gregg RK, 2010, J IMMUNOL, V184, P1909, DOI 10.4049/jimmunol.0902778; Harris JE, 2012, J INVEST DERMATOL, V132, P1869, DOI 10.1038/jid.2011.463; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hirobe T, 2005, PIGM CELL RES, V18, P2, DOI 10.1111/j.1600-0749.2004.00198.x; Hoffmann A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031298; Hong WS, 2011, BRIT J DERMATOL, V165, P520, DOI 10.1111/j.1365-2133.2011.10398.x; Imokawa G, 2004, PIGM CELL RES, V17, P96, DOI 10.1111/j.1600-0749.2003.00126.x; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; KIRNBAUER R, 1992, J INVEST DERMATOL, V98, P320, DOI 10.1111/1523-1747.ep12499793; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Klarquist J, 2010, PIGM CELL MELANOMA R, V23, P276, DOI 10.1111/j.1755-148X.2010.00688.x; Kroll TM, 2005, J INVEST DERMATOL, V124, P798, DOI 10.1111/j.0022-202X.2005.23653.x; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Laddha NC, 2013, EXP DERMATOL, V22, P245, DOI 10.1111/exd.12103; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; McCully ML, 2012, BLOOD, V120, P4591, DOI 10.1182/blood-2012-05-433037; Moretti S, 2002, PIGM CELL RES, V15, P87, DOI 10.1034/j.1600-0749.2002.1o049.x; Mosenson JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005127; Mosenson JA, 2012, PIGM CELL MELANOMA R, V25, P88, DOI 10.1111/j.1755-148X.2011.00916.x; Mycko MA, 2008, EUR J IMMUNOL, V38, P1999, DOI 10.1002/eji.200737661; Mycko MP, 2004, J IMMUNOL, V177, P4168; NOROSE K, 1994, INVEST OPHTH VIS SCI, V35, P33; Roy N, 2010, MOL CELL BIOL, V30, P2681, DOI 10.1128/MCB.01480-09; Sayama K, 1999, J CELL PHYSIOL, V179, P40, DOI 10.1002/(SICI)1097-4652(199904)179:1<40::AID-JCP5>3.0.CO;2-Z; Schallreuter KU, 2008, EXP DERMATOL, V17, P139, DOI [10.1111/j.1600-0625.2007.00666_1.x, 10.1111/j.1600-0625.2007.00666.x]; Schallreuter KU, 1999, J INVEST DERM SYMP P, V4, P91, DOI 10.1038/sj.jidsp.5640189; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Steitz J, 2004, EUR J CELL BIOL, V83, P797, DOI 10.1078/0171-9335-00423; Sviderskaya EV, 2003, J NATL CANCER I, V95, P723, DOI 10.1093/jnci/95.10.723; Sviderskaya EV, 2002, JNCI-J NATL CANCER I, V94, P446; Taieb A, 2009, NEW ENGL J MED, V360, P160, DOI 10.1056/NEJMcp0804388; Toosi S, 2012, J INVEST DERMATOL, V132, P2601, DOI 10.1038/jid.2012.181; van den Boorn JG, 2009, J INVEST DERMATOL, V129, P2220, DOI 10.1038/jid.2009.32; Zhou Z, 2009, BRIT J DERMATOL, V161, P504, DOI 10.1111/j.1365-2133.2009.09288.x; Zuo SG, 2012, J CANCER RES CLIN, V138, P1045, DOI 10.1007/s00432-012-1153-y	55	29	34	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93232	10.1371/journal.pone.0093232	http://dx.doi.org/10.1371/journal.pone.0093232			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681574	Green Published, gold, Green Submitted			2022-12-27	WOS:000333678100034
J	Ayres, MP; Pena, R; Lombardo, JA; Lombardero, MJ				Ayres, Matthew P.; Pena, Rebeca; Lombardo, Jeffrey A.; Lombardero, Maria J.			Host Use Patterns by the European Woodwasp, Sirex noctilio, in Its Native and Invaded Range	PLOS ONE			English	Article							ASIAN LONGHORNED BEETLE; PINE SHOOT BEETLE; HYMENOPTERA-SIRICIDAE; BIOLOGICAL-CONTROL; FABRICIUS HYMENOPTERA; UNITED-STATES; NORTH-AMERICA; POPULATION-DYNAMICS; TOMICUS-PINIPERDA; FOREST INSECT	Accelerating introductions of forest insects challenge decision-makers who might or might not respond with surveillance programs, quarantines, eradication efforts, or biological control programs. Comparing ecological controls on indigenous vs. introduced populations could inform responses to new introductions. We studied the European woodwasp, Sirex noctilio, which is not a pest in its native forests, is a serious invasive pest in the southern hemisphere, and now has an uncertain future in North America after its introduction there. Indigenous populations of S. noctilio (in Galicia, Spain) resembled those in New York in that S. noctilio were largely restricted to suppressed trees that were also dying for other reasons, and still only some dying trees showed evidence of S. noctilio: 20-40% and 35-51% in Galicia and New York, respectively. In both areas, P. sylvestris (native to Europe) was the species most likely to have attacks in non-suppressed trees. P. resinosa, native to North America, does not appear dangerously susceptible to S. noctilio. P. radiata, which sustains high damage in the southern hemisphere, is apparently not innately susceptible because in Galicia it was less often used by native S. noctilio than either native pine (P. pinaster and P. sylvestris). Silvicultural practices in Galicia that maintain basal area at 25-40 m(2)/ha limit S. noctilio abundance. More than 25 species of other xylophagous insects feed on pine in Galicia, but co-occurrences with S. noctilio were infrequent, so strong interspecific competition seemed unlikely. Evidently, S. noctilio in northeastern North America will be more similar to indigenous populations in Europe, where it is not a pest, than to introduced populations in the southern hemisphere, where it is. However, S. noctilio populations could behave differently when they reach forests of the southeastern U.S., where tree species, soils, climate, ecology, management, and landscape configurations of pine stands are different.	[Ayres, Matthew P.; Lombardo, Jeffrey A.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Pena, Rebeca; Lombardero, Maria J.] Univ Santiago, Dept Prod Vegetal, Lugo, Spain	Dartmouth College; Universidade de Santiago de Compostela	Ayres, MP (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	Matthew.P.Ayres@Dartmouth.edu	Ayres, Matthew/AAI-6873-2020; Lombardero, María J/H-1629-2015	Ayres, Matthew/0000-0001-6120-9068; Lombardero, María J/0000-0002-3245-896X	Dartmouth College; USDA APHIS; USDA Forest Service International Programs	Dartmouth College; USDA APHIS(United States Department of Agriculture (USDA)); USDA Forest Service International Programs(United States Department of Agriculture (USDA)United States Forest Service)	Support was provided by a cooperative agreement between Dartmouth College and USDA APHIS, and by a grant from USDA Forest Service International Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez P., 2004, THESIS U SANTIAGO SA; [Anonymous], PEST TRACK SIR NOCT; Bain J, 2005, P 16 USDA INT RES FO; Battisti A, 2005, ECOL APPL, V15, P2084, DOI 10.1890/04-1903; BILLINGS RF, 1972, TURRIALBA, V22, P105; Boroczky K, 2012, J CHEM ECOL, V38, P213, DOI 10.1007/s10886-012-0077-y; Boissin E, 2012, MOL ECOL, V21, P5728, DOI 10.1111/mec.12065; Botto E, 1998, P C TRAIN CONTR SIR, P89; Bruzzone OA, 2009, J EXP BIOL, V212, P731, DOI 10.1242/jeb.022517; BURKE HE, 1917, USDA B, V437; Carnegie AJ, 2006, ANN FOREST SCI, V63, P119, DOI 10.1051/forest:2005104; Carnegie Angus J., 2005, New Zealand Journal of Forestry Science, V35, P3; Cavey JF, 1998, P ENTOMOL SOC WASH, V100, P373; Ceballos Jimenez P., 1963, Graellsia Madrid, V20, P55; Ciesla WM., COLOBURA ALBOPLAGIAT; Collett NG, 2009, AGR FOREST ENTOMOL, V11, P283, DOI 10.1111/j.1461-9563.2008.00422.x; COPPEL HC, 1965, ANNU REV ENTOMOL, V10, P69, DOI 10.1146/annurev.en.10.010165.000441; Corley JC, 2007, ENTOMOL EXP APPL, V125, P231, DOI 10.1111/j.1570-7458.2007.00623.x; Corley JC, 2012, SIREX WOODWASP AND ITS FUNGAL SYMBIONT: RESEARCH AND MANAGEMENT OF A WORLDWIDE INVASIVE PEST, P51, DOI 10.1007/978-94-007-1960-6_4; Coyle DR, 2012, ENVIRON ENTOMOL, V41, P731, DOI 10.1603/EN11280; Czokajlo D, 1997, CAN J FOREST RES, V27, P1394, DOI 10.1139/cjfr-27-9-1394; Dajoz R., 1980, ECOLOGIE INSECTES FO, P489; Dans de Valle F, 1999, MANUAL SELVICULTURA; Dodds KI, 2007, NORTH J APPL FOR, V24, P165, DOI 10.1093/njaf/24.3.165; Dodds KJ, 2012, ENVIRON ENTOMOL, V41, P1350, DOI 10.1603/EN12180; Dodds KJ, 2012, SIREX WOODWASP AND ITS FUNGAL SYMBIONT: RESEARCH AND MANAGEMENT OF A WORLDWIDE INVASIVE PEST, P265, DOI 10.1007/978-94-007-1960-6_19; Dodds KJ, 2011, CAN J FOREST RES, V41, P1729, DOI [10.1139/X11-097, 10.1139/x11-097]; Dodds KJ, 2010, CAN J FOREST RES, V40, P212, DOI 10.1139/X09-181; Eager PT, 2011, ENVIRON ENTOMOL, V40, P1266, DOI 10.1603/EN10322; Eaton E.R., 2007, KAUFMAN FIELD GUIDE; Edmonds RL, 2000, FOREST HLTH PROTECTI; ELKINTON JS, 1990, ANNU REV ENTOMOL, V35, P571, DOI 10.1146/annurev.en.35.010190.003035; Fernandez I, 2006, ENVIRON SCI TECHNOL, V40, P2552, DOI 10.1021/es0519841; Fettig CJ, BUPRESTIS NOVEMMACUL; Gandhi KJK, 2010, BIOL INVASIONS, V12, P1839, DOI 10.1007/s10530-009-9594-1; Garnas JR, 2012, INT J PEST MANAGE, V58, P211, DOI 10.1080/09670874.2012.698764; Haack RA, 2006, CAN J FOREST RES, V36, P269, DOI 10.1139/x05-249; Haack Robert A., 1993, P503; Haack Robert A., 2001, Biological Invasions, V3, P307, DOI 10.1023/A:1015298114837; Hajek AE, 2013, MICROB ECOL, V65, P753, DOI 10.1007/s00248-013-0218-z; HALL M. J., 1968, Australian Forestry, V32, P155; Haugen DA, 2005, PEST ALERT SIREX WOO; Hawkeswood Trevor J., 1992, Giornale Italiano di Entomologia, V6, P207; Hawkeswood Trevor J., 1993, Giornale Italiano di Entomologia, V6, P313; Hoebeke E. R., 2005, Newsletter of the Michigan Entomological Society, V50, P24; Hofstetter RW, 2006, OECOLOGIA, V147, P679, DOI 10.1007/s00442-005-0312-0; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; Hurley BP, 2007, AGR FOREST ENTOMOL, V9, P159, DOI 10.1111/j.1461-9563.2007.00340.x; JACKSON D. S., 1955, NEW ZEALAND JOUR FOREST, V7, P26; Kaitaniemi P, 2007, SILVA FENN, V41, P259, DOI 10.14214/sf.295; Kausrud K, 2012, BIOL REV, V87, P34, DOI 10.1111/j.1469-185X.2011.00183.x; Klapwijk Maartje J., 2012, P429; KLITSCHER J A, 1987, New Zealand Forestry, V31, P23; Kovacs KF, 2010, ECOL ECON, V69, P569, DOI 10.1016/j.ecolecon.2009.09.004; Langor D, 2009, BIOL INVASIONS, V11, P5, DOI 10.1007/s10530-008-9327-x; Lavery Peter B., 1998, P432; Leal I, 2012, CAN J FOREST RES, V42, P1173, DOI [10.1139/X2012-058, 10.1139/x2012-058]; Lede ET, 1988, 201 EMBRAPACNPF, V20, P1; Letourneau DK, 2009, ANNU REV ECOL EVOL S, V40, P573, DOI 10.1146/annurev.ecolsys.110308.120320; Lewis NB, 1976, YIELD REGULATION S A; LIEBHOLD AM, 1995, FOREST SCI, V41, P1; Liebhold AM, 2012, FRONT ECOL ENVIRON, V10, P135, DOI 10.1890/110198; Linsley E. G., 1997, University of California Publications in Entomology, V117; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lombardero MJ, 2012, FOREST ECOL MANAG, V281, P121, DOI 10.1016/j.foreco.2012.06.036; Long SJ, 2009, CAN ENTOMOL, V141, P153, DOI 10.4039/n08-068; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Madden J.L., 1988, P407; MADDEN JL, 1975, B ENTOMOL RES, V65, P491, DOI 10.1017/S0007485300006155; Marini L, 2012, CLIMATIC CHANGE, V115, P327, DOI 10.1007/s10584-012-0463-z; MARM, 2011, CUART INV FOR NAC; MILLER D., 1935, BULL ENT RES, V26, P149, DOI 10.1017/S000748530003813X; MORGAN F D, 1989, New Zealand Journal of Forestry Science, V19, P198; Morgan F.D., 1960, NZ ENTOMOL, V2, P26, DOI DOI 10.1080/00779962.1960.9722791; Morgan RE, 2004, CAN J FOREST RES, V34, P2528, DOI 10.1139/X04-135; Neumann F. G., 1981, Australian Forestry, V44, P46; Nielsen C, 2009, MYCOL RES, V113, P1242, DOI 10.1016/j.mycres.2009.08.012; Nielson RM, 2004, ENVIRONMETRICS, V15, P119, DOI 10.1002/env.627; Orwig DA, 1998, J TORREY BOT SOC, V125, P60, DOI 10.2307/2997232; Pimentel C, 2011, AGR FOREST ENTOMOL, V13, P273, DOI 10.1111/j.1461-9563.2011.00520.x; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Poland TM, 2006, J FOREST, V104, P118; RA Ek, 2007, N CENTRAL REGION RED; Rebuffo S, 1988, AVISPA MADERA SIREX, VMinisterio de Ganaderi'a Agricultura y Pesca; Rodriguez-Soalleiro R. J., 1997, MANUAL SELVICULTURA; Ryan K, 2012, J INSECT BEHAV, V25, P453, DOI 10.1007/s10905-011-9313-5; Ryan K, 2012, ENVIRON ENTOMOL, V41, P289, DOI 10.1603/EN11275; Ryan K, 2013, CAN ENTOMOL, V145, P117, DOI 10.4039/tce.2012.96; Ryan K, 2012, AGR FOREST ENTOMOL, V14, P187, DOI 10.1111/j.1461-9563.2011.00558.x; Ryan K, 2011, CAN ENTOMOL, V143, P224, DOI 10.4039/n11-001; SAG, 2001, 6 SAG DEP PROT AGR, V6; SCION, PESTS DIS FOR NZ SQU; Seppala R, 2009, IUFRO WORLD SERIES, V22, P224; Slippers B, 2012, SIREX WOODWASP AND ITS FUNGAL SYMBIONT: RESEARCH AND MANAGEMENT OF A WORLDWIDE INVASIVE PEST, P1, DOI 10.1007/978-94-007-1960-6; SPRADBERY JP, 1978, B ENTOMOL RES, V68, P341, DOI 10.1017/S0007485300009330; Standley CR, 2012, P ENTOMOL SOC WASH, V114, P238, DOI 10.4289/0013-8797.114.2.238; Sun JH, 2013, ANNU REV ENTOMOL, V58, P293, DOI 10.1146/annurev-ento-120811-153624; Tribe GD, 1995, AFR ENTOMOL, V3, P215; Tribe GD, 2004, AFR ENTOMOL, V12, P9; USDA-APHIS, 2008, SIR WOODW; Verdugo A, 2005, FAUNA BUPRESTIDAE PE; Vicente C, 2012, EUR J PLANT PATHOL, V133, P89, DOI 10.1007/s10658-011-9924-x; Vives E, 2001, ATLAS FOTOGRAFICO CE; Wainhouse D, 2005, ECOLOGICAL METHODS F, P288; Weed AS, 2013, ECOL MONOGR, V83, P441, DOI 10.1890/13-0160.1; Wermelinger B, 2008, ECOL ENTOMOL, V33, P239, DOI 10.1111/j.1365-2311.2007.00960.x; Williamson M., 1996, BIOL INVASIONS; Wingfield MJ, 2006, INVASIVE FOREST INSE, P53; Wolf F., 1969, Bulletin de la Societe Royale Forestiere de Belgique, V76, P281; Wolf F., 1969, Bull Annls Soc r ent Belg, V105, P202; Wooding AL, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0342; Work TT, 2005, BIOL INVASIONS, V7, P323, DOI 10.1007/s10530-004-1663-x; Xunta de Galicia, 1992, PLAN FOR GAL; Xunta de Galicia, 2001, MONT GAL CIFR DIR XE; Yemshanov D, 2012, BIOL INVASIONS, V14, P797, DOI 10.1007/s10530-011-0117-5; Yemshanov D, 2011, J ENVIRON MANAGE, V92, P205, DOI 10.1016/j.jenvman.2010.09.002; Yemshanov D, 2009, CAN J FOREST RES, V39, P154, DOI 10.1139/X08-164; Yemshanova D, 2010, J ENVIRON MANAGE, V91, P2535, DOI 10.1016/j.jenvman.2010.07.009; Zylstra KE, 2012, J INSECT SCI, V12, P1, DOI 10.1673/031.012.8301; Zylstra KE, 2010, AGR FOREST ENTOMOL, V12, P243, DOI 10.1111/j.1461-9563.2010.00476.x	120	24	24	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e90321	10.1371/journal.pone.0090321	http://dx.doi.org/10.1371/journal.pone.0090321			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675574	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500007
J	DiRenzo, GV; Langhammer, PF; Zamudio, KR; Lips, KR				DiRenzo, Graziella V.; Langhammer, Penny F.; Zamudio, Kelly R.; Lips, Karen R.			Fungal Infection Intensity and Zoospore Output of Atelopus zeteki, a Potential Acute Chytrid Supershedder	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; POPULATION DECLINES; DISEASE; CHYTRIDIOMYCOSIS; TEMPERATURE; DYNAMICS; SUSCEPTIBILITY; HETEROGENEITY; TRANSMISSION; SURVIVAL	Amphibians vary in their response to infection by the amphibian-killing chytrid fungus, Batrachochytrium dendrobatidis (Bd). Highly susceptible species are the first to decline and/or disappear once Bd arrives at a site. These competent hosts likely facilitate Bd proliferation because of ineffective innate and/or acquired immune defenses. We show that Atelopus zeteki, a highly susceptible species that has undergone substantial population declines throughout its range, rapidly and exponentially increases skin Bd infection intensity, achieving intensities that are several orders of magnitude greater than most other species reported. We experimentally infected individuals that were never exposed to Bd (n = 5) or previously exposed to an attenuated Bd strain (JEL427-P39; n = 3). Within seven days post-inoculation, the average Bd infection intensity was 18,213 zoospores (SE: 9,010; range: 0 to 66,928). Both average Bd infection intensity and zoospore output (i.e., the number of zoospores released per minute by an infected individual) increased exponentially until time of death (t(50) = 7.018, p, 0.001, t(46) = 3.164, p = 0.001, respectively). Mean Bd infection intensity and zoospore output at death were 4,334,422 zoospores (SE: 1,236,431) and 23.55 zoospores per minute (SE: 22.78), respectively, with as many as 9,584,158 zoospores on a single individual. The daily percent increases in Bd infection intensity and zoospore output were 35.4% (SE: 0.05) and 13.1% (SE: 0.04), respectively. We also found that Bd infection intensity and zoospore output were positively correlated (t(43) = 3.926, p<0.001). All animals died between 22 and 33 days post-inoculation (mean: 28.88; SE: 1.58). Prior Bd infection had no effect on survival, Bd infection intensity, or zoospore output. We conclude that A. zeteki, a highly susceptible amphibian species, may be an acute supershedder. Our results can inform epidemiological models to estimate Bd outbreak probability, especially as they relate to reintroduction programs.	[DiRenzo, Graziella V.; Lips, Karen R.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Langhammer, Penny F.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Zamudio, Kelly R.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	University System of Maryland; University of Maryland College Park; Arizona State University; Arizona State University-Tempe; Cornell University	DiRenzo, GV (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	gdirenzo@umd.edu	Zamudio, Kelly/R-3533-2016	Zamudio, Kelly/0000-0001-5107-6206; Lips, Karen/0000-0002-2719-1551; DiRenzo, Graziella/0000-0001-5264-4762	National Science Foundation [DEB 1120161]; National Science Foundation Graduate Research Fellowship Program; Direct For Biological Sciences [1120161] Funding Source: National Science Foundation; Division Of Environmental Biology [1120249] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank the Maryland Baltimore Zoo for permission to use A. zeteki, the National Science Foundation who funded the research (DEB 1120161), and the National Science Foundation Graduate Research Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KA, 2010, FRONT ECOL ENVIRON, V8, P522, DOI 10.1890/090057; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Becker MH, 2011, ECOHEALTH, V8, P501, DOI 10.1007/s10393-012-0743-0; Berger L., 1999, ZOOS PRINT J, V15, P184, DOI DOI 10.11609/JOTT.ZPJ.15.1.184-90; Bishop PJ, 2009, DIS AQUAT ORGAN, V84, P9, DOI 10.3354/dao02028; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Bustamante HM, 2010, INTEGR ZOOL, V5, P143, DOI 10.1111/j.1749-4877.2010.00197.x; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; Cashins SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056747; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Daszak P, 2004, HERPETOL J, V14, P201; Dwyer G, 1997, AM NAT, V150, P685, DOI 10.1086/286089; Fites JS, 2013, SCIENCE, V342, P366, DOI 10.1126/science.1243316; Galvani AP, 2005, NATURE, V438, P293, DOI 10.1038/438293a; Gervasi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054490; Gopinath S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003408; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Jankowski MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072611; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; KEMPER JT, 1980, MATH BIOSCI, V48, P111, DOI 10.1016/0025-5564(80)90018-8; Kriger KM, 2006, DIS AQUAT ORGAN, V71, P149, DOI 10.3354/dao071149; La Marca E, 2005, BIOTROPICA, V37, P190, DOI 10.1111/j.1744-7429.2005.00026.x; Lampo M, 2011, BIOTROPICA, V0, P1; Langhammer PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077630; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; McCaig C, 2011, B MATH BIOL, V73, P777, DOI 10.1007/s11538-010-9603-7; Muths E, 2003, BIOL CONSERV, V110, P357, DOI 10.1016/S0006-3207(02)00239-2; Pilliod DS, 2010, CONSERV BIOL, V24, P1259, DOI 10.1111/j.1523-1739.2010.01506.x; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; R Core Team, 2012, R LANG ENV STAT COMP; Raffel TR, 2006, FUNCT ECOL, V20, P819, DOI 10.1111/j.1365-2435.2006.01159.x; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Rosenblum EB, 2012, MOL ECOL, V21, P3110, DOI 10.1111/j.1365-294X.2012.05481.x; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; Sarkar D., 2019, NLME LINEAR NONLINEA; Scherer RD, 2005, ECOL APPL, V15, P2150, DOI 10.1890/05-0431; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Small M, 2006, PHYSICA D, V215, P146, DOI 10.1016/j.physd.2006.01.021; Stice MJ, 2010, J WILDLIFE DIS, V46, P70, DOI 10.7589/0090-3558-46.1.70; Streicker DG, 2013, ECOL LETT, V16, P975, DOI 10.1111/ele.12122; Therneau T, 2012, PACKAGE SURVIVAL ANA; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107	48	49	49	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93356	10.1371/journal.pone.0093356	http://dx.doi.org/10.1371/journal.pone.0093356			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675899	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500113
J	Allison, JD; Bhandari, BD; McKenney, JL; Millar, JG				Allison, Jeremy D.; Bhandari, Basu D.; McKenney, Jessica L.; Millar, Jocelyn G.			Design Factors That Influence the Performance of Flight Intercept Traps for the Capture of Longhorned Beetles (Coleoptera: Cerambycidae) from the Subfamilies Lamiinae and Cerambycinae	PLOS ONE			English	Article							MULTIPLE-FUNNEL TRAPS; HOST-PLANT VOLATILES; TETROPIUM-FUSCUM F; UNITED-STATES; SCUTELLATUS COLEOPTERA; PHEROMONE COMPONENTS; ECONOMIC COSTS; PANEL TRAPS; GYPSY-MOTH; ECOLOGY	In North America, cerambycid beetles can have significant ecological and economic effects on forest ecosystems, and the rate of introduction and/or detection of exotic species is increasing. Detection and survey programs rely on semiochemical-baited intercept traps which are often ineffective for large woodborers like cerambycid beetles. This study examined the effects of flight intercept trap design on the capture of cerambycid beetles in the subfamilies Lamiinae and Cerambycinae. These subfamilies are the two largest in the Cerambycidae and they include many of the most damaging cerambycid pests and species on regulatory watch lists in North America. This study demonstrates that intercept trap design, treatment of trap surfaces with a lubricant, and the type of collection cup all influence the capture of beetles from the subfamilies Lamiinae and Cerambycinae. It also demonstrates that the addition of a large lubricant-treated collar to the bottom funnel of a multiple-funnel trap significantly increases the capture of some Lamiinae. The best trap design for both subfamilies was a lubricant treated multiple-funnel [MF] trap equipped with a wet cup and lubricant treated large collar on the bottom funnel. This design captured between 4 and 14 times more Lamiinae and Cerambycinae than commercially-available MF and panel traps.	[Allison, Jeremy D.; Bhandari, Basu D.; McKenney, Jessica L.] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA; [Millar, Jocelyn G.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	Louisiana State University System; Louisiana State University; University of California System; University of California Riverside	Allison, JD (corresponding author), Nat Resources Canada, Great Lakes Forestry Ctr, Sault Ste Marie, ON, Canada.	Jeremy.Allison@NRCan.gc.ca	Allison, Jeremy/AAQ-1461-2020	Allison, Jeremy/0000-0002-0765-3149	USDA-APHIS-PPQ [11-8130-1422]; LSU AgCenter; Canadian Forest Service	USDA-APHIS-PPQ(United States Department of Agriculture (USDA)); LSU AgCenter; Canadian Forest Service(Natural Resources CanadaCanadian Forest Service)	This work was supported by Canadian Forest Service, USDA-APHIS-PPQ award 11-8130-1422 and the LSU AgCenter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JD, 2004, CHEMOECOLOGY, V14, P123, DOI 10.1007/s00049-004-0277-1; Allison JD, 2003, ENVIRON ENTOMOL, V32, P23, DOI 10.1603/0046-225X-32.1.23; Allison JD, 2001, J CHEM ECOL, V27, P633, DOI 10.1023/A:1010353315939; Allison JD, 2012, ENVIRON ENTOMOL, V41, P1587, DOI 10.1603/EN12185; Allison JD, 2013, J INSECT BEHAV, V26, P321, DOI 10.1007/s10905-012-9349-1; Allison JD, 2011, J ECON ENTOMOL, V104, P1258, DOI 10.1603/EC11044; [Anonymous], 1995, AGR HDB; (APHIS) Animal and Plant Health Inspection Service, 2006, EX WOORD BOR BARK BE; Aukema JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024587; Aukema JE, 2010, BIOSCIENCE, V60, P886, DOI 10.1525/bio.2010.60.11.5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borden J.H., 1982, P74; Brockerhoff EG, 2006, CAN J FOREST RES, V36, P289, DOI [10.1139/x05-250, 10.1139/X05-250]; CHENIER JVR, 1989, CAN ENTOMOL, V121, P159, DOI 10.4039/Ent121159-2; Czokajlo D., 2001, Journal of Forest Science (Prague), V47, P34; de Groot P, 2003, J APPL ENTOMOL, V127, P548, DOI 10.1046/j.1439-0418.2003.00799.x; de Groot P, 2001, AGR FOREST ENTOMOL, V3, P107, DOI 10.1046/j.1461-9563.2001.00087.x; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Graham EE, 2010, J ECON ENTOMOL, V103, P641, DOI 10.1603/EC10013; Haack Robert A., 2003, Integrated Pest Management Reviews, V6, P253, DOI 10.1023/A:1025715200538; Hanks LM, 2013, CHEMOECOLOGY, V23, P21, DOI 10.1007/s00049-012-0116-8; Hanks LM, 2012, CAN J FOREST RES, V42, P1050, DOI [10.1139/x2012-062, 10.1139/X2012-062]; Holland JD, 2006, ENVIRON ENTOMOL, V35, P1647, DOI 10.1603/0046-225X(2006)35[1647:CLHCPT]2.0.CO;2; Imrei Z, 2013, Z NATURFORSCH C, V68, P236; Kovacs KF, 2010, ECOL ECON, V69, P569, DOI 10.1016/j.ecolecon.2009.09.004; Lacey ES, 2004, J CHEM ECOL, V30, P1493, DOI 10.1023/B:JOEC.0000042064.25363.42; Liebhold A, 2003, ECOL LETT, V6, P133, DOI 10.1046/j.1461-0248.2003.00405.x; Liebhold A. M., 1995, FOREST SCI MONOGR, V30, P1; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; LINDGREN BS, 1983, CAN ENTOMOL, V115, P299, DOI 10.4039/Ent115299-3; Lingafelter S.W., 2007, SPECIAL PUBLICATION, V3; LINSLEY EG, 1959, ANNU REV ENTOMOL, V4, P99, DOI 10.1146/annurev.en.04.010159.000531; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McIntosh RL, 2001, AGR FOREST ENTOMOL, V3, P113, DOI 10.1046/j.1461-9563.2001.00095.x; Miller DR, 2008, J ECON ENTOMOL, V101, P107, DOI 10.1603/0022-0493(2008)101[107:COABCI]2.0.CO;2; Miller DR, 2013, J ECON ENTOMOL, V106, P206, DOI 10.1603/EC12254; Mitchell RF, 2011, ENTOMOL EXP APPL, V141, P71, DOI 10.1111/j.1570-7458.2011.01167.x; Morewood WD, 2002, CAN J FOREST RES, V32, P519, DOI 10.1139/X01-224; Myers JH, 2000, TRENDS ECOL EVOL, V15, P316, DOI 10.1016/S0169-5347(00)01914-5; Nakamura K, 1999, JPN J APPL ENTOMOL Z, V43, P55, DOI 10.1303/jjaez.43.55; Nowak DJ, 2001, J ECON ENTOMOL, V94, P116, DOI 10.1603/0022-0493-94.1.116; Paine TD, 1997, ANNU REV ENTOMOL, V42, P179, DOI 10.1146/annurev.ento.42.1.179; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Rabaglia R, 2008, EARLY DETECTION RAPI; Sharov AA, 1998, ECOL APPL, V8, P1170, DOI 10.1890/1051-0761(1998)008[1170:MOSTSO]2.0.CO;2; Sharov AA, 2002, J FOREST, V100, P30; Sweeney J, 2004, ENVIRON ENTOMOL, V33, P844, DOI 10.1603/0046-225X-33.4.844; Sweeney J, 2006, ENVIRON ENTOMOL, V35, P645, DOI 10.1603/0046-225X-35.3.645; Tobin Patrick C., 2004, American Entomologist, V50, P200; Wardlaw T, 2007, BOR ROT C PERTH W AU; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; YANEGA D, 1996, ILLINOIS NATURAL HIS, V6; Yemshanov D, 2009, CAN J FOREST RES, V39, P154, DOI 10.1139/X08-164	55	29	29	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93203	10.1371/journal.pone.0093203	http://dx.doi.org/10.1371/journal.pone.0093203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671147	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000127
J	Hutton, B; Salanti, G; Chaimani, A; Caldwell, DM; Schmid, C; Thorlund, K; Mills, E; Catala-Lopez, F; Turner, L; Altman, DG; Moher, D				Hutton, Brian; Salanti, Georgia; Chaimani, Anna; Caldwell, Deborah M.; Schmid, Chris; Thorlund, Kristian; Mills, Edward; Catala-Lopez, Ferran; Turner, Lucy; Altman, Douglas G.; Moher, David			The Quality of Reporting Methods and Results in Network Meta-Analyses: An Overview of Reviews and Suggestions for Improvement	PLOS ONE			English	Review							ISPOR TASK-FORCE; MULTIPLE-TREATMENTS; HEALTH	Introduction: Some have suggested the quality of reporting of network meta-analyses (a technique used to synthesize information to compare multiple interventions) is sub-optimal. We sought to review information addressing this claim. Objective: To conduct an overview of existing evaluations of quality of reporting in network meta-analyses and indirect treatment comparisons, and to compile a list of topics which may require detailed reporting guidance to enhance future reporting quality. Methods: An electronic search of Medline and the Cochrane Registry of methodologic studies (January 2004 August 2013) was performed by an information specialist. Studies describing findings from quality of reporting assessments were sought. Screening of abstracts and full texts was performed by two team members. Descriptors related to all aspects of reporting a network meta-analysis were summarized. Results: We included eight reports exploring the quality of reporting of network meta-analyses. From past reviews, authors found several aspects of network meta-analyses were inadequately reported, including primary information about literature searching, study selection, and risk of bias evaluations; statement of the underlying assumptions for network meta-analysis, as well as efforts to verify their validity; details of statistical models used for analyses (including information for both Bayesian and Frequentist approaches); completeness of reporting of findings; and approaches for summarizing probability measures as additional important considerations. Conclusions:While few studies were identified, several deficiencies in the current reporting of network meta-analyses were observed. These findings reinforce the need to develop reporting guidance for network meta-analyses. Findings from this review will be used to guide next steps in the development of reporting guidance for network meta-analysis in the format of an extension of the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analysis) Statement.	[Hutton, Brian; Turner, Lucy; Moher, David] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Hutton, Brian; Moher, David] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Salanti, Georgia; Chaimani, Anna] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Caldwell, Deborah M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Schmid, Chris] Brown Univ, Program Publ Hlth, Ctr Evidence Based Med, Providence, RI 02912 USA; [Mills, Edward] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada; [Thorlund, Kristian; Mills, Edward] Stanford Univ, Standard Prevent Res Ctr, Stanford, CA 94305 USA; [Thorlund, Kristian] McMaster Univ, Hamilton, ON, Canada; [Catala-Lopez, Ferran] Spanish Med & Healthcare Prod Agcy AEMPS, Div Pharmacoepidemiol & Pharmacovigilance, Madrid, Spain; [Altman, Douglas G.] Univ Oxford, Oxford Ctr Stat Med, Oxford, England	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ioannina; University of Bristol; Brown University; University of Ottawa; Stanford University; McMaster University; University of Oxford	Hutton, B (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.	bhutton@ohri.ca	Catalá-López, Ferrán/N-6018-2018; Schmid, Christopher H./J-2398-2014; Moher, David/I-3408-2019; Chaimani, Anna/AAA-3048-2020	Catalá-López, Ferrán/0000-0002-3833-9312; Schmid, Christopher H./0000-0002-0855-5313; Moher, David/0000-0003-2434-4206; Chaimani, Anna/0000-0003-2828-6832; Salanti, Georgia/0000-0002-3830-8508; Hutton, Brian/0000-0001-5662-8647; , Deborah/0000-0001-8014-7480	Canadian Agency for Drugs and Technologies in Health; Canadian Institutes for Health Research (CIHR) through the Drug Safety and Effectivenss Network (DSEN) NETMAN Network Meta-Analyis team; CIHR New Investigator award; CIHR via a Canada Research Chair; University Research Chair; MRC [MR/K023233/1, G0902118] Funding Source: UKRI; Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [MR/K023233/1, G0902118] Funding Source: researchfish	Canadian Agency for Drugs and Technologies in Health; Canadian Institutes for Health Research (CIHR) through the Drug Safety and Effectivenss Network (DSEN) NETMAN Network Meta-Analyis team(Canadian Institutes of Health Research (CIHR)); CIHR New Investigator award(Canadian Institutes of Health Research (CIHR)); CIHR via a Canada Research Chair(Canadian Institutes of Health Research (CIHR)); University Research Chair; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding to support this work was received in part from the Canadian Agency for Drugs and Technologies in Health and the Canadian Institutes for Health Research (CIHR) through the Drug Safety and Effectivenss Network (DSEN) NETMAN Network Meta-Analyis team. BH is supported by a CIHR New Investigator award. FM receives salary support from CIHR via a Canada Research Chair. DM is supported by a University Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades A, 2012, 7 NICE DSU; Bafeta Aida, 2013, BMJ, V347, pf3675, DOI 10.1136/bmj.f3675; Bending MW, 2011, VALUE HEALTH, V14, pA21, DOI 10.1016/j.jval.2011.02.126; Brooks-Renney C, 2011, INT SOC PHARM OUTC R; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Buckley FF, 2009, VALUE HEALTH, V12, pA93, DOI 10.1016/S1098-3015(10)73531-2; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Coleman C, 2012, USED MIXED TREATMENT; Dias S, 2011, 2 NICE DSU; Dias S, 2011, 4 NICE DSU; Dias S, 2011, 3 NICE DSU; Donegan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011054; European Network for Health Technology Assessment, 2013, COMP COMP DIR IND CO; Greco T, 2016, STAT METHODS MED RES, V25, P1757, DOI 10.1177/0962280213500185; Haute Autorit de Sant, 2009, IND COMP METH VAL; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; Hoaglin DC, 2011, VALUE HEALTH, V14, P429, DOI 10.1016/j.jval.2011.01.011; Ioannidis JPA, 2009, CAN MED ASSOC J, V181, P488, DOI 10.1503/cmaj.081086; Ioannidis JP, 2009, PLOS MED, V6, pE; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Lee A, 2013, J CLIN EPIDEMIOL; Li TJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-79; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Mills EJ, 2012, JAMA-J AM MED ASSOC, V308, P1246, DOI 10.1001/2012.jama.11228; Mills Edward J, 2011, Clin Epidemiol, V3, P193, DOI 10.2147/CLEP.S16526; Moher D, 2015, CULT MED PSYCHIAT, V4, DOI DOI 10.1023/B:MEDI.0000005484.26741.79; Nikolakopoulou A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086754; Ohlssen D, 2013, PHARM STAT; Pharmaceutical Beneiits Advisory Committee Working Group, 2008, REP IND COMP WORK GR; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Sampson M, 2009, J CLIN EPIDEMIOL, V62, P944, DOI 10.1016/j.jclinepi.2008.10.012; Sobieraj DM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003111; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; Sutton A, 2008, PHARMACOECONOMICS, V26, P753, DOI 10.2165/00019053-200826090-00006; Tan SH, 2013, J HEALTH SERV RES PO, V18, P224, DOI 10.1177/1355819613498379; Wells GA, 2009, INDIRECT EVIDENCE IN	39	67	71	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92508	10.1371/journal.pone.0092508	http://dx.doi.org/10.1371/journal.pone.0092508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671099	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000049
J	Li, HX; Shang, HQ; Shu, DM; Zhang, HM; Ji, J; Sun, BL; Li, HM; Xie, QM				Li, Hongxin; Shang, Huiqing; Shu, Dingming; Zhang, Huanmin; Ji, Jun; Sun, Baoli; Li, Hongmei; Xie, Qingmei			gga-miR-375 Plays a Key Role in Tumorigenesis Post Subgroup J Avian Leukosis Virus Infection	PLOS ONE			English	Article							ORGAN SIZE CONTROL; HUMAN CYCLIN-E; CELL-DEATH; MYELOID LEUKOSIS; HPRS-103 STRAIN; HIPPO PATHWAY; HEPATOCELLULAR-CARCINOMA; TUMOR SUPPRESSION; BREAST-CANCER; LIVER-CANCER	Avian leukosis is a neoplastic disease caused in part by subgroup J avian leukosis virus J (ALV-J). Micro ribonucleic acids (miRNAs) play pivotal oncogenic and tumour-suppressor roles in tumour development and progression. However, little is known about the potential role of miRNAs in avian leukosis tumours. We have found a novel tumour-suppressor miRNA, gga-miR-375, associated with avian leukosis tumorigenesis by miRNA microarray in a previous report. We have also previously studied the biological function of gga-miR-375; Overexpression of gga-miR-375 significantly inhibited DF-1 cell proliferation, and significantly reduced the expression of yes-associated protein 1 (YAP1) by repressing the activity of a luciferase reporter carrying the 3'-untranslated region of YAP1. This indicates that gga-miR-375 is frequently downregulated in avian leukosis by inhibiting cell proliferation through YAP1 oncogene targeting. Overexpression of gga-miR-375 markedly promoted serum starvation induced apoptosis, and there may be the reason why the tumour cycle is so long in the infected chickens. In vivo assays, gga-miR-375 was significantly downregulated in chicken livers 20 days after infection with ALV-J, and YAP1 was significantly upregulated 20 days after ALV-J infection (P<0.05). We also found that expression of cyclin E, an important regulator of cell cycle progression, was significantly upregulated (P<0.05). Drosophila inhibitor of apoptosis protein 1 (DIAP1), which is related to caspase-dependent apoptosis, was also significantly upregulated after infection. Our data suggests that gga-miR-375 may function as a tumour suppressor thereby regulating cancer cell proliferation and it plays a key role in avian leukosis tumorigenesis.	[Li, Hongxin; Shang, Huiqing; Ji, Jun; Sun, Baoli; Li, Hongmei; Xie, Qingmei] South China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Li, Hongxin; Sun, Baoli; Li, Hongmei; Xie, Qingmei] Minist Agr, Key Lab Chicken Genet Breeding & Reprod, Guangzhou, Guangdong, Peoples R China; [Shu, Dingming] State Key Lab Livestock & Poultry Breeding, Guangzhou, Guangdong, Peoples R China; [Zhang, Huanmin] USDA ARS, Avian Dis & Oncol Lab, E Lansing, MI 48823 USA	South China Agricultural University; Ministry of Agriculture & Rural Affairs; United States Department of Agriculture (USDA)	Xie, QM (corresponding author), South China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China.	qmx@scau.edu.cn	Zhang, Huanmin/M-9792-2019	Zhang, Huanmin/0000-0003-4896-2391	National Natural Science Foundation of China [31072152]; State Key Laboratory of Biocontrol [SKLBC2010K07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Biocontrol	This work was supported by grants from the National Natural Science Foundation of China (31072152) and the Open Project of the State Key Laboratory of Biocontrol (SKLBC2010K07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2010, MOL CELL BIOL, V30, P4197, DOI 10.1128/MCB.00316-10; BABA TW, 1985, P NATL ACAD SCI USA, V82, P213, DOI 10.1073/pnas.82.1.213; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bertini E, 2009, CELL CYCLE, V8, P49, DOI 10.4161/cc.8.1.7259; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chen CY, 2012, RES VET SCI; Cheng Zi-qiang, 2005, Weishengwu Xuebao, V45, P584; Cui ZZ, 2009, AVIAN PATHOL, V38, P443, DOI 10.1080/03079450903349188; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; DULIC V, 1993, P NATL ACAD SCI USA, V90, P11034, DOI 10.1073/pnas.90.23.11034; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Fadly AM, 1999, AVIAN DIS, V43, P391, DOI 10.2307/1592636; Fassan Matteo, 2011, Front Biosci (Schol Ed), V3, P970; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gao YL, 2010, EMERG INFECT DIS, V16, P1637, DOI 10.3201/eid1610.100780; Gao YL, 2012, J CLIN MICROBIOL, V50, P953, DOI 10.1128/JCM.06179-11; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; KEYOMARSI K, 1994, CANCER RES, V54, P380; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Lee JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051592; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li HM, 2012, VIRUS RES, V169, P268, DOI 10.1016/j.virusres.2012.07.003; Li Y, 2010, INT J CLIN EXP PATHO, V3, P254; Lian L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051003; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lisi S, 2000, GENETICS, V154, P669; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Lotterman CD, 2008, CELL CYCLE, V7, P2493, DOI 10.4161/cc.7.16.6452; MAAS HJL, 1982, AVIAN PATHOL, V11, P309, DOI 10.1080/03079458208436103; Mays JK, 2006, AVIAN DIS, V50, P342, DOI 10.1637/7493-121505R.1; Nishikawa E, 2011, CANCER RES, V71, P6165, DOI 10.1158/0008-5472.CAN-11-1020; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Oka T, 2009, GENES CELLS, V14, P607, DOI 10.1111/j.1365-2443.2009.01292.x; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Payne LN, 2012, AVIAN PATHOL, V41, P11, DOI 10.1080/03079457.2011.646237; PAYNE LN, 1991, VET REC, V129, P447, DOI 10.1136/vr.129.20.447; PAYNE LN, 1993, AVIAN DIS, V37, P438, DOI 10.2307/1591671; PAYNE LN, 1992, J GEN VIROL, V73, P2995, DOI 10.1099/0022-1317-73-11-2995; PAYNE LN, 1992, LEUKEMIA, V6, P1167; Payne LN, 1998, POULTRY SCI, V77, P1204, DOI 10.1093/ps/77.8.1204; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; RUBIN H, 1962, VIROLOGY, V17, P143, DOI 10.1016/0042-6822(62)90091-0; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Stik G, 2013, J VIROL, V87, P80, DOI 10.1128/JVI.02449-12; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Wang Q, 2013, VET MICROBIOL, V162, P232, DOI 10.1016/j.vetmic.2012.10.023; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wang Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-512; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Xu S, 2011, J VIROL, V85, P276, DOI 10.1128/JVI.01392-10; Yang Y, 2010, CANCER GENET CYTOGEN, V200, P127, DOI 10.1016/j.cancergencyto.2010.03.014; Yao YX, 2008, J VIROL, V82, P4007, DOI 10.1128/JVI.02659-07; Yokokura T, 2004, J BIOL CHEM, V279, P52603, DOI 10.1074/jbc.M409691200; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang X, 2011, ANN ONCOL, V22, P2257, DOI 10.1093/annonc/mdq758; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	76	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e90878	10.1371/journal.pone.0090878	http://dx.doi.org/10.1371/journal.pone.0090878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24694742	gold, Green Submitted, Green Published			2022-12-27	WOS:000334103000010
J	Nagele, T; Mair, A; Sun, XL; Fragner, L; Teige, M; Weckwerth, W				Naegele, Thomas; Mair, Andrea; Sun, Xiaoliang; Fragner, Lena; Teige, Markus; Weckwerth, Wolfram			Solving the Differential Biochemical Jacobian from Metabolomics Covariance Data	PLOS ONE			English	Article							SYSTEMS BIOLOGY; ARABIDOPSIS; RECONSTRUCTION; NETWORK; ACCLIMATION; INTEGRATION; METABOLISM; RESPONSES; STRESSES; PLATFORM	High-throughput molecular analysis has become an integral part in organismal systems biology. In contrast, due to a missing systematic linkage of the data with functional and predictive theoretical models of the underlying metabolic network the understanding of the resulting complex data sets is lacking far behind. Here, we present a biomathematical method addressing this problem by using metabolomics data for the inverse calculation of a biochemical Jacobian matrix, thereby linking computer-based genome-scale metabolic reconstruction and in vivo metabolic dynamics. The incongruity of metabolome coverage by typical metabolite profiling approaches and genome-scale metabolic reconstruction was solved by the design of superpathways to define a metabolic interaction matrix. A differential biochemical Jacobian was calculated using an approach which links this metabolic interaction matrix and the covariance of metabolomics data satisfying a Lyapunov equation. The predictions of the differential Jacobian from real metabolomic data were found to be correct by testing the corresponding enzymatic activities. Moreover it is demonstrated that the predictions of the biochemical Jacobian matrix allow for the design of parameter optimization strategies for ODE-based kinetic models of the system. The presented concept combines dynamic modelling strategies with large-scale steady state profiling approaches without the explicit knowledge of individual kinetic parameters. In summary, the presented strategy allows for the identification of regulatory key processes in the biochemical network directly from metabolomics data and is a fundamental achievement for the functional interpretation of metabolomics data.	[Naegele, Thomas; Mair, Andrea; Sun, Xiaoliang; Fragner, Lena; Teige, Markus; Weckwerth, Wolfram] Univ Vienna, Dept Ecogen & Syst Biol, Vienna, Austria	University of Vienna	Weckwerth, W (corresponding author), Univ Vienna, Dept Ecogen & Syst Biol, Vienna, Austria.	wolfram.weckwerth@univie.ac.at	Weckwerth, Wolfram/G-5811-2010; Mair, Andrea/Y-8490-2019; Teige, Markus/R-6443-2016	Mair, Andrea/0000-0002-2492-4318; Teige, Markus/0000-0001-7204-1379; Nagele, Thomas/0000-0002-5896-238X; Weckwerth, Wolfram/0000-0002-9719-6358	EU-Marie-Curie ITN MERIT [GA 2010-264474]; Austrian Science Fund (FWF) [P23435-B12]; FWF [P26342]; Austrian Science Fund (FWF) [P 25359, P 23435] Funding Source: researchfish	EU-Marie-Curie ITN MERIT; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors thank the EU-Marie-Curie ITN MERIT (GA 2010-264474) for financial support of TN and the Austrian Science Fund (FWF) for financial support to AM and MT (FWF project P23435-B12). Thomas Nagele was funded by the FWF project P26342 "In situ studies of natural Arabidopsis thaliana populations." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Dawud R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039896; Baena-Gonzalez E, 2008, TRENDS PLANT SCI, V13, P474, DOI 10.1016/j.tplants.2008.06.006; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Banga JR, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-47; Dal'Molin CGD, 2010, PLANT PHYSIOL, V152, P579, DOI 10.1104/pp.109.148817; Doerfler H, 2013, METABOLOMICS, V9, P564, DOI 10.1007/s11306-012-0470-0; dos Santos Sandra C., 2012, Frontiers in Genetics, V3, P63, DOI 10.3389/fgene.2012.00063; Espinoza C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014101; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; Honerkamp J., 1990, STOCHASTISCHE DYNAMI; Mintz-Oron S, 2012, P NATL ACAD SCI USA, V109, P339, DOI 10.1073/pnas.1100358109; Nagele T, 2012, METABOLITES, V2, P553, DOI 10.3390/metabo2030553; Nagele T, 2012, PLANT J, V72, P102, DOI 10.1111/j.1365-313X.2012.05064.x; Nagele T, 2011, FEBS J, V278, P506, DOI 10.1111/j.1742-4658.2010.07971.x; Nagele T, 2010, PLANT PHYSIOL, V153, P260, DOI 10.1104/pp.110.154443; Patil KR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-308; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Poolman MG, 2009, PLANT PHYSIOL, V151, P1570, DOI 10.1104/pp.109.141267; Press WH., 2002, NUMERICAL RECIPES C, V2; Reed JL, 2004, GENOME RES, V14, P1797, DOI 10.1101/gr.2546004; Riedelsheimer C, 2012, P NATL ACAD SCI USA, V109, P8872, DOI 10.1073/pnas.1120813109; Rohwer JM, 2001, BIOCHEM J, V358, P437, DOI 10.1042/0264-6021:3580437; Rohwer JM, 2012, J EXP BOT, V63, P2275, DOI 10.1093/jxb/ers080; Schaber J, 2009, IET SYST BIOL, V3, P1, DOI 10.1049/iet-syb:20070042; Schallau K, 2010, PLANT PHYSIOL, V152, P1763, DOI 10.1104/pp.109.149237; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Steuer R, 2003, BIOINFORMATICS, V19, P1019, DOI 10.1093/bioinformatics/btg120; Steuer R, 2006, P NATL ACAD SCI USA, V103, P11868, DOI 10.1073/pnas.0600013103; Sun XL, 2012, METABOLOMICS, V8, pS81, DOI 10.1007/s11306-012-0399-3; Sweetlove LJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00038; vanKampen, 1992, STOCHASTIC PROCESSES; Weckwerth W, 2011, J PROTEOMICS, V75, P284, DOI 10.1016/j.jprot.2011.07.010; Weckwerth W, 2011, ANAL BIOANAL CHEM, V400, P1967, DOI 10.1007/s00216-011-4948-9; Wienkoop S, 2008, MOL CELL PROTEOMICS, V7, P1725, DOI 10.1074/mcp.M700273-MCP200; Yu HL, 2012, PLANTA, V236, P387, DOI 10.1007/s00425-012-1620-3	35	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92299	10.1371/journal.pone.0092299	http://dx.doi.org/10.1371/journal.pone.0092299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695071	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000018
J	Davis, BT; Wang, XJ; Rohret, JA; Struzynski, JT; Merricks, EP; Bellinger, DA; Rohret, FA; Nichols, TC; Rogers, CS				Davis, Bryan T.; Wang, Xiao-Jun; Rohret, Judy A.; Struzynski, Jason T.; Merricks, Elizabeth P.; Bellinger, Dwight A.; Rohret, Frank A.; Nichols, Timothy C.; Rogers, Christopher S.			Targeted Disruption of LDLR Causes Hypercholesterolemia and Atherosclerosis in Yucatan Miniature Pigs	PLOS ONE			English	Article							CYSTIC-FIBROSIS; FAMILIAL HYPERCHOLESTEROLEMIA; RECEPTOR; MICE; LESIONS; IDENTIFICATION; MODEL; CHOLESTEROL; KNOCKOUT; MUTATION	Recent progress in engineering the genomes of large animals has spurred increased interest in developing better animal models for diseases where current options are inadequate. Here, we report the creation of Yucatan miniature pigs with targeted disruptions of the low-density lipoprotein receptor (LDLR) gene in an effort to provide an improved large animal model of familial hypercholesterolemia and atherosclerosis. Yucatan miniature pigs are well established as translational research models because of similarities to humans in physiology, anatomy, genetics, and size. Using recombinant adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer, male and female LDLR+/- pigs were generated. Subsequent breeding of heterozygotes produced LDLR-/- pigs. When fed a standard swine diet (low fat, no cholesterol), LDLR+/- pigs exhibited a moderate, but consistent increase in total and LDL cholesterol, while LDLR-/- pigs had considerably elevated levels. This severe hypercholesterolemia in homozygote animals resulted in atherosclerotic lesions in the coronary arteries and abdominal aorta that resemble human atherosclerosis. These phenotypes were more severe and developed over a shorter time when fed a diet containing natural sources of fat and cholesterol. LDLR-targeted Yucatan miniature pigs offer several advantages over existing large animal models including size, consistency, availability, and versatility. This new model of cardiovascular disease could be an important resource for developing and testing novel detection and treatment strategies for coronary and aortic atherosclerosis and its complications.	[Davis, Bryan T.; Wang, Xiao-Jun; Rohret, Judy A.; Struzynski, Jason T.; Rohret, Frank A.; Rogers, Christopher S.] Exemplar Genet, Coralville, IA 52241 USA; [Merricks, Elizabeth P.; Bellinger, Dwight A.; Nichols, Timothy C.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Merricks, Elizabeth P.; Bellinger, Dwight A.; Nichols, Timothy C.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Rogers, CS (corresponding author), Exemplar Genet, Coralville, IA 52241 USA.	chris.rogers@exemplargenetics.com			National Heart, Lung, and Blood Institute of the National Institutes of Health [HL102950]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL102950, R44HL102950] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by a grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health (HL102950). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005369; Al-Mashhadi RH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004853; Bentzon JF, 2010, CURR OPIN LIPIDOL, V21, P434, DOI 10.1097/MOL.0b013e32833ded6a; Benvenuti Luiz Alberto, 2005, Clinics, V60, P355, DOI 10.1590/S1807-59322005000500002; Daugherty A, 2002, AM J MED SCI, V323, P3, DOI 10.1097/00000441-200201000-00002; Dixon JL, 1999, ARTERIOSCL THROM VAS, V19, P2981, DOI 10.1161/01.ATV.19.12.2981; Gerrity RG, 2001, DIABETES, V50, P1654, DOI 10.2337/diabetes.50.7.1654; GERRITY RG, 1985, ARTERIOSCLEROSIS, V5, P55, DOI 10.1161/01.ATV.5.1.55; Grunwald KAA, 1999, J LIPID RES, V40, P475; Hasler-Rapacz J, 1998, AM J MED GENET, V76, P379, DOI 10.1002/(SICI)1096-8628(19980413)76:5<379::AID-AJMG3>3.0.CO;2-I; Hickey RD, 2011, HEPATOLOGY, V54, P1351, DOI 10.1002/hep.24490; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Johnson GJ, 1999, THROMB HAEMOSTASIS, V81, P835; Kobayashi T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/406473; Lai LX, 2003, CLONING STEM CELLS, V5, P233, DOI 10.1089/153623003772032754; Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009; Lichtman AH, 1999, ARTERIOSCL THROM VAS, V19, P1938, DOI 10.1161/01.ATV.19.8.1938; LITTLE WC, 1988, CIRCULATION, V78, P1157, DOI 10.1161/01.CIR.78.5.1157; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; Mohammadpour AH, 2013, CLIN PHARMACOKINET, V52, P615, DOI 10.1007/s40262-013-0071-8; Mohiaddin RH, 2004, J CARDIOV MAGN RESON, V6, P517, DOI 10.1081/JCMR-120030576; Nichols TC, 2013, BLOOD, V122, P3551, DOI 10.1182/blood-2013-09-527697; Onuma Y, 2010, CIRCULATION, V122, P2288, DOI 10.1161/CIRCULATIONAHA.109.921528; Ostedgaard LS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001868; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; POMP D, 1995, J ANIM SCI, V73, P1408; PRESCOTT MF, 1991, AM J PATHOL, V139, P139; PURCELLHUYNH DA, 1995, J CLIN INVEST, V95, P2246, DOI 10.1172/JCI117915; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; RAPACZ J, 1986, SCIENCE, V234, P1573, DOI 10.1126/science.3787263; Rogan MP, 2010, P NATL ACAD SCI USA, V107, P20571, DOI 10.1073/pnas.1015281107; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Sanz J, 2013, J AM COLL CARDIOL, V62, P1131, DOI 10.1016/j.jacc.2013.06.045; Schwartz RS, 2008, CIRC-CARDIOVASC INTE, V1, P143, DOI 10.1161/CIRCINTERVENTIONS.108.789974; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Thim T, 2010, EUROINTERVENTION, V6, P261, DOI 10.4244/; THOMAS WA, 1985, ANN NY ACAD SCI, V454, P305, DOI 10.1111/j.1749-6632.1985.tb11870.x; Walker Shawn C., 2002, Cloning and Stem Cells, V4, P105, DOI 10.1089/153623002320253283; Wang J, 2002, MOL CELL, V10, P951, DOI 10.1016/S1097-2765(02)00635-4; Wen J, 2008, BIOCHEM SOC T, V36, P514, DOI 10.1042/BST0360514	45	66	70	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93457	10.1371/journal.pone.0093457	http://dx.doi.org/10.1371/journal.pone.0093457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691380	Green Submitted, Green Published, gold			2022-12-27	WOS:000334101100084
J	Gustafsson, ALS; Skrede, I; Rowe, HC; Gussarova, G; Borgen, L; Rieseberg, LH; Brochmann, C; Parisod, C				Gustafsson, A. Lovisa S.; Skrede, Inger; Rowe, Heather C.; Gussarova, Galina; Borgen, Liv; Rieseberg, Loren H.; Brochmann, Christian; Parisod, Christian			Genetics of Cryptic Speciation within an Arctic Mustard, Draba nivalis	PLOS ONE			English	Article							TERMINAL-REPEAT RETROTRANSPOSON; TRANSMISSION RATIO DISTORTION; TRANSPOSABLE ELEMENTS; CHROMOSOMAL REARRANGEMENTS; SEGREGATION DISTORTION; REPRODUCTIVE ISOLATION; POSTZYGOTIC ISOLATION; ARABIDOPSIS-THALIANA; MINIATURE TRIM; LINKAGE MAPS	Crossing experiments indicate that hybrid sterility barriers frequently have developed within diploid, circumpolar plant species of the genus Draba. To gain insight into the rapid evolution of postzygotic reproductive isolation in this system, we augmented the linkage map of one of these species, D. nivalis, and searched for quantitative trait loci (QTLs) associated with reproductive isolation. The map adds 63 new dominant markers to a previously published dataset of 31co-dominant microsatellites. These markers include 52 amplified fragment length polymorphisms (AFLPs) and 11 sequence-specific amplified polymorphisms (SSAPs) based on retrotransposon sequence. 22 markers displaying transmission ratio distortion were further included in the map. We resolved eight linkage groups with a total map length of 894 cM. Significant genotype-trait associations, or quantitative trait loci (QTL), were detected for reproductive phenotypes including pollen fertility (4 QTLs), seed set (3 QTLs), flowering time (3 QTLs) and number of flowers (4 QTLs). Observed patterns of inheritance were consistent with the influence of both nuclear-nuclear interactions and chromosomal changes on these traits. All seed set QTLs and one pollen fertility QTL displayed underdominant effects suggestive of the involvement of chromosomal rearrangements in hybrid sterility. Interestingly, D. nivalis is predominantly self-fertilizing, which may facilitate the establishment of underdominant loci and contribute to reproductive isolation.	[Gustafsson, A. Lovisa S.; Gussarova, Galina; Borgen, Liv; Brochmann, Christian; Parisod, Christian] Univ Oslo, Natl Ctr Biosystemat, Nat Hist Museum, Oslo, Norway; [Skrede, Inger] Univ Oslo, Dept Biosci, MERG, Oslo, Norway; [Rowe, Heather C.; Rieseberg, Loren H.] Univ British Columbia, Dept Bot, Vancouver, BC V5Z 1M9, Canada; [Gussarova, Galina] St Petersburg State Univ, Fac Biol & Soil Sci, Dept Bot, St Petersburg 199034, Russia; [Parisod, Christian] Univ Neuchatel, Inst Biol, Lab Evolutionary Bot, CH-2000 Neuchatel, Switzerland	University of Oslo; University of Oslo; University of British Columbia; Saint Petersburg State University; University of Neuchatel	Gustafsson, ALS (corresponding author), Univ Oslo, Natl Ctr Biosystemat, Nat Hist Museum, Oslo, Norway.	lovisa.gustafsson@nhm.uio.no	Rieseberg, Loren H/B-3591-2013; Brochmann, Christian/A-4105-2009; Gussarova, Galina/ABC-8696-2021; Parisod, Christian/A-1140-2010; Gussarova, Galina/E-4758-2015	Rieseberg, Loren H/0000-0002-2712-2417; Gussarova, Galina/0000-0001-5388-7491; Parisod, Christian/0000-0001-8798-0897; Gussarova, Galina/0000-0001-5388-7491; Skrede, Inger/0000-0002-1113-7403	Natural History Museum, University of Oslo; Swiss National Science Foundation [PBLAA122735, PZ00P3-131950]	Natural History Museum, University of Oslo; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding was obtained from the Natural History Museum, University of Oslo and the Swiss National Science Foundation (grants PBLAA122735 and PZ00P3-131950 to CP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; [Anonymous], 2003, ALPINE PLANT LIFE, DOI DOI 10.1007/978-3-642-18970-8; Bennetzen JL, 2005, CURR OPIN GENET DEV, V15, P621, DOI 10.1016/j.gde.2005.09.010; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Bonchev G, 2013, MOL ECOL RESOUR, V13, P765, DOI 10.1111/1755-0998.12133; BROCHMANN C, 1993, NORD J BOT, V13, P121, DOI 10.1111/j.1756-1051.1993.tb00023.x; Broman K. W., 2010, GENETIC MAP CONSTRUC; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Butlin RK, 2005, MOL ECOL, V14, P2621, DOI 10.1111/j.1365-294X.2005.02617.x; Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002; Colome-Tatche M, 2012, P NATL ACAD SCI USA, V109, P16240, DOI 10.1073/pnas.1212955109; Corbett-Detig RB, 2013, NATURE, V504, P135, DOI 10.1038/nature12678; Coyne J.A., 2004, SPECIATION; Coyne JA, 1998, PHILOS T ROY SOC B, V353, P287, DOI 10.1098/rstb.1998.0210; Deragon JM, 2006, SYST BIOL, V55, P949, DOI 10.1080/10635150601047843; Dooner HK, 2008, PLANT CELL, V20, P249, DOI 10.1105/tpc.107.057596; Faria R, 2010, TRENDS ECOL EVOL, V25, P660, DOI 10.1016/j.tree.2010.07.008; Fishman L, 2001, GENETICS, V159, P1701; Fishman L, 2013, EVOLUTION, V67, P2547, DOI 10.1111/evo.12154; Gaut BS, 2008, SCIENCE, V320, P484, DOI 10.1126/science.1153586; Glemin S, 2013, EVOLUTION, V67, P225, DOI 10.1111/j.1558-5646.2012.01778.x; Grundt HH, 2006, P NATL ACAD SCI USA, V103, P972, DOI 10.1073/pnas.0510270103; HEDRICK PW, 1981, EVOLUTION, V35, P322, DOI [10.1111/j.1558-5646.1981.tb04890.x, 10.2307/2407841]; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Iwata H, 2006, BREEDING SCI, V56, P371, DOI 10.1270/jsbbs.56.371; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Kwon SJ, 2007, MOL GENET GENOMICS, V278, P361, DOI 10.1007/s00438-007-0249-6; Lenoir A, 2005, CYTOGENET GENOME RES, V110, P441, DOI 10.1159/000084976; Lenoir A, 2001, MOL BIOL EVOL, V18, P2315, DOI 10.1093/oxfordjournals.molbev.a003778; Leppala J, 2008, HEREDITY, V100, P71, DOI 10.1038/sj.hdy.6801066; Leppala J, 2011, EVOLUTION, V65, P2959, DOI 10.1111/j.1558-5646.2011.01361.x; Levin D. A, 2002, OX ECOL EV; Levin DA, 2003, SYST BOT, V28, P5; Lexer C, 2008, PHILOS T R SOC B, V363, P3023, DOI 10.1098/rstb.2008.0078; Lowry DB, 2008, PHILOS T R SOC B, V363, P3009, DOI 10.1098/rstb.2008.0064; Lowry DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000500; Melamed-Bessudo C, 2012, P NATL ACAD SCI USA, V109, pE981, DOI 10.1073/pnas.1120742109; Nei M, 2011, GENOME BIOL EVOL, V3, P812, DOI 10.1093/gbe/evr028; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Orr HA, 2005, P NATL ACAD SCI USA, V102, P6522, DOI 10.1073/pnas.0501893102; Orr HA, 2001, EVOLUTION, V55, P1085; Parisod C, 2008, NEW PHYTOL, V178, P436, DOI 10.1111/j.1469-8137.2007.02361.x; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Rieseberg LH, 2006, NATURE, V440, P524, DOI 10.1038/nature04402; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Rieseberg LH, 2010, ANN BOT-LONDON, V106, P439, DOI 10.1093/aob/mcq126; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Skrede I, 2009, HEREDITY, V102, P293, DOI 10.1038/hdy.2008.120; Skrede I, 2008, EVOLUTION, V62, P1840, DOI 10.1111/j.1558-5646.2008.00418.x; STEBBINS G. L., 1971, Chromosomal evolution in higher plants.; Syed NH, 2006, NAT PROTOC, V1, P2746, DOI 10.1038/nprot.2006.407; Terol J, 2001, MOL BIOL EVOL, V18, P882, DOI 10.1093/oxfordjournals.molbev.a003870; Torjek O, 2006, THEOR APPL GENET, V113, P1551, DOI 10.1007/s00122-006-0402-3; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WALSH JB, 1982, AM NAT, V120, P510, DOI 10.1086/284008; Waugh R, 1997, MOL GEN GENET, V253, P687, DOI 10.1007/s004380050372; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x; Yang TJ, 2007, THEOR APPL GENET, V114, P627, DOI 10.1007/s00122-006-0463-3; Yin TM, 2004, THEOR APPL GENET, V109, P451, DOI 10.1007/s00122-004-1653-5	64	16	17	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93834	10.1371/journal.pone.0093834	http://dx.doi.org/10.1371/journal.pone.0093834			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691072	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100138
J	Jonas, JB; Holbach, L; Panda-Jonas, S				Jonas, Jost B.; Holbach, Leonard; Panda-Jonas, Songhomitra			Scleral Cross Section Area and Volume and Axial Length	PLOS ONE			English	Article							FORM-DEPRIVATION MYOPIA; TREE SHREW SCLERA; INTRAOCULAR SPACE; REFRACTIVE-ERROR; GENE-EXPRESSION; LAMINA-CRIBROSA; GROWTH; CHICK; EYE; PREVALENCE	Purpose: To examine whether the scleral cross sectional area and estimated scleral volume are associated with a longer axial length in human eyes. Methods: Histologic anterior-posterior sections running through the pupil and the optic nerve head were examined. Using a light microscope, we measured the thickness of the sclera at the limbus, ora serrata, equator, midpoint between equator and posterior pole (MPEPP), peripapillary region and posterior pole. Additionally we determined the length and the cross section area of the sclera. Results: The histomorphometric study included 214 human globes of 214 subjects (mean age: 62.5 +/- 13.9 years) (147 eyes enucleated due to malignant choroidal melanoma or due to other non-glaucomatous reasons; 67 eyes enucleated due to secondary angle-closure glaucoma). Mean axial length was 25.1 +/- 1.8 mm (median: 24.0 mm; range: 20-35 mm). Scleral thickness measurements decreased with increasing axial length for values taken at the equator (P = 0.008; correlation coefficient r = -0.18), MPEPP (P<0.001; r: -0.47), optic nerve head border (P<0.001; r = -0.47) and posterior pole (P<0.001; r = -0.54). Scleral cross section area decreased significantly with increasing axial lengths for the regions at or behind the equator (P = 0.002; r = -0.21), at or behind the MPEPP (P = 0.001; r = -0.25), and at or behind the optic nerve head border (P = 0.001; r = -0.24). Scleral volume measurements were not significantly associated with axial length Conclusions: Despite an associated increase in surface area, eyes with longer axial length do not have an increase in scleral volume. It may point against a scleral volume enlargement to play a role in the process of axial elongation.	[Jonas, Jost B.; Panda-Jonas, Songhomitra] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Mannheim, Germany; [Holbach, Leonard] Univ Erlangen Nurnberg, Dept Ophthalmol, Erlangen, Germany	Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg	Jonas, JB (corresponding author), Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Mannheim, Germany.	Jost.Jonas@medma.uni-heidelberg.de			Open-Access-Publikationsfonds of the University Heidelberg	Open-Access-Publikationsfonds of the University Heidelberg	Open-Access-Publikationsfonds of the University Heidelberg provided the publication funds for this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVETISOV ES, 1983, METAB PEDIATR SYST O, V7, P183; Bryant MR, 1998, J THEOR BIOL, V193, P613, DOI 10.1006/jtbi.1998.0727; Congdon N, 2008, INVEST OPHTH VIS SCI, V49, P2888, DOI 10.1167/iovs.07-1160; Cui W, 2004, EXP EYE RES, V78, P275, DOI 10.1016/j.exer.2003.10.007; CURTIN BJ, 1979, ARCH OPHTHALMOL-CHIC, V97, P912, DOI 10.1001/archopht.1979.01020010470017; Fang F, 2013, INVEST OPHTH VIS SCI, V54, P7887, DOI 10.1167/iovs.13-11999; Frost MR, 2012, INVEST OPHTH VIS SCI, V53, P322, DOI 10.1167/iovs.11-8354; Guggenheim JA, 1996, INVEST OPHTH VIS SCI, V37, P1380; Guo L, 2013, INVEST OPHTH VIS SCI, V54, P6806, DOI 10.1167/iovs.13-12551; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; Heine, 1899, ARCH AUGENHEILKD, V38, P277; Jonas JB, 2004, INVEST OPHTH VIS SCI, V45, P2660, DOI 10.1167/iovs.03-1363; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; Jones BE, 1996, EXP EYE RES, V63, P369, DOI 10.1006/exer.1996.0127; Lin Z, 2008, J OCUL PHARMACOL TH, V24, P543, DOI 10.1089/jop.2008.0041; Mathis U, 2010, EXP EYE RES, V90, P780, DOI 10.1016/j.exer.2010.03.014; McBrien NA, 2000, INVEST OPHTH VIS SCI, V41, P3713; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; McBrien NA, 2001, INVEST OPHTH VIS SCI, V42, P2179; McBrien NA, 2009, OPTOMETRY VISION SCI, V86, P23, DOI 10.1097/OPX.0b013e3181940669; Metlapally R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078984; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Nangia V, 2010, OPHTHALMOLOGY, V117, P705, DOI 10.1016/j.ophtha.2009.09.003; Norman RE, 2010, EXP EYE RES, V90, P277, DOI 10.1016/j.exer.2009.11.001; Olsen TW, 1998, AM J OPHTHALMOL, V125, P237, DOI 10.1016/S0002-9394(99)80096-8; Penha AM, 2011, MOL VIS, V17, P1436; Phillips JR, 2000, INVEST OPHTH VIS SCI, V41, P2028; Rada JA, 2000, INVEST OPHTH VIS SCI, V41, P2050; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Seet B, 2001, BRIT J OPHTHALMOL, V85, P521, DOI 10.1136/bjo.85.5.521; Siegwart JT, 2002, INVEST OPHTH VIS SCI, V43, P2067; Tse DY, 2007, INVEST OPHTH VIS SCI, V48, P5352, DOI 10.1167/iovs.07-0383; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692; Wang YX, 2006, AM J OPHTHALMOL, V141, P1078, DOI 10.1016/j.ajo.2006.01.023; Wildsoet CF, 2000, VISION RES, V40, P3273, DOI 10.1016/S0042-6989(00)00138-3; Wildsoet CF, 1997, OPHTHAL PHYSL OPT, V17, P279, DOI 10.1111/j.1475-1313.1997.tb00059.x; Wong TY, 2000, INVEST OPHTH VIS SCI, V41, P2486; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035	38	25	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93551	10.1371/journal.pone.0093551	http://dx.doi.org/10.1371/journal.pone.0093551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681550	Green Submitted, Green Published, gold			2022-12-27	WOS:000333678100052
J	Lerche, S; Hobert, M; Brockmann, K; Wurster, I; Gaenslen, A; Hasmann, S; Eschweiler, GW; Maetzler, W; Berg, D				Lerche, Stefanie; Hobert, Markus; Brockmann, Kathrin; Wurster, Isabel; Gaenslen, Alexandra; Hasmann, Sandra; Eschweiler, Gerhard W.; Maetzler, Walter; Berg, Daniela			Mild Parkinsonian Signs in the Elderly - Is There an Association with PD? Crossectional Findings in 992 Individuals	PLOS ONE			English	Article							SLEEP BEHAVIOR DISORDER; OLDER-PEOPLE; DISEASE; RISK; POPULATION; PREVALENCE; PATHOLOGY; DEMENTIA; WALKING	Background: Mild parkinsonian signs (MPS) are common in the elderly population, and have been associated with vascular diseases, mild cognitive impairment and dementia; however their relation to Parkinson's disease (PD) is unclear. Hypothesizing that individuals with MPS may reflect a pre-stage of PD, i.e. a stage in which the nigrostriatal system is already affected although to a milder degree than at the time of PD diagnosis, aim of this study was to evaluate the similarities between MPS and PD. Methods: The TREND study is a prospective cross-sectional cohort study in individuals >50 years with biennial assessments designed to identify markers for an earlier diagnosis of Parkinson's and Alzheimer's disease. For this substudy 992 individuals were included for analyses (892 controls, 73 MPS individuals, 27 PD patients). Parameters defining risk of PD (sex, age, positive family history), prodromal markers (hyposmia, REM sleep behavior disorder, depression and autonomic failure) as well as quantitative fine motor, axial motor and cognitive parameters were compared between the three cohorts. Results: As expected, PD patients differed from controls with regard to 12 of 15 of the assessed parameters. MPS individuals differed significantly from controls in 12 of the PD-associated parameters, but differed from PD only in 5 parameters. Conclusion: This study shows that individuals with MPS share many prodromal and clinical markers of PD with PD patients, implying that either a common dynamic process or similar constitutional factors occur in MPS individuals and PD patients.	[Lerche, Stefanie; Hobert, Markus; Brockmann, Kathrin; Wurster, Isabel; Gaenslen, Alexandra; Hasmann, Sandra; Maetzler, Walter; Berg, Daniela] Univ Tubingen, Ctr Neurol, Dept Neurodegenerat, Tubingen, Germany; [Lerche, Stefanie; Hobert, Markus; Brockmann, Kathrin; Wurster, Isabel; Gaenslen, Alexandra; Hasmann, Sandra; Maetzler, Walter; Berg, Daniela] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Lerche, Stefanie; Hobert, Markus; Brockmann, Kathrin; Wurster, Isabel; Gaenslen, Alexandra; Hasmann, Sandra; Maetzler, Walter; Berg, Daniela] Univ Tubingen, German Ctr Neurodegenerat Dis, Tubingen, Germany; [Eschweiler, Gerhard W.] Univ Tubingen Hosp, Geriatr Ctr, Tubingen, Germany; [Eschweiler, Gerhard W.] Univ Tubingen Hosp, Dept Psychiat & Psychotherapy, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Lerche, S (corresponding author), Univ Tubingen, Ctr Neurol, Dept Neurodegenerat, Tubingen, Germany.	Stefanie.lerche@uni-tuebingen.de	Berg, Daniela/A-8728-2019; Maetzler, Walter/AAE-5831-2020; Hobert, Markus A./AAR-3234-2020; Maetzler, Walter/A-6796-2011	Berg, Daniela/0000-0001-5796-5442; Maetzler, Walter/0000-0002-5945-4694; Hobert, Markus A./0000-0002-7558-8107; Maetzler, Walter/0000-0002-5945-4694	UCB	UCB(UCB Pharma SA)	This analysis of the TREND study was financially supported by a grant of UCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bennett DA, 1996, NEW ENGL J MED, V334, P71, DOI 10.1056/NEJM199601113340202; Berg Daniela, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS195, DOI 10.1016/S1353-8020(11)70061-X; Ble A, 2005, J AM GERIATR SOC, V53, P410, DOI 10.1111/j.1532-5415.2005.53157.x; Bleom BR, 2006, J NEUROL SCI, V248, P196, DOI 10.1016/j.jns.2006.05.010; Bock O, 2008, IEEE ENG MED BIOL, V27, P23, DOI 10.1109/MEMB.2008.919497; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Drane DL, 2002, NEUROPSY NEUROPSY BE, V15, P39; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Hobert MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027831; Hummel T, 2001, ANN OTO RHINOL LARYN, V110, P976, DOI 10.1177/000348940111001015; Iranzo A, 2013, LANCET NEUROL, V12, P443, DOI 10.1016/S1474-4422(13)70056-5; Lezak M, 1995, ORIENTATION ATTENTIO, P335; Lindemann U, 2010, MOVEMENT DISORD, V25, P1040, DOI 10.1002/mds.23023; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Louis ED, 2004, ARCH NEUROL-CHICAGO, V61, P1273, DOI 10.1001/archneur.61.8.1273; Louis ED, 2004, MOVEMENT DISORD, V19, P268, DOI 10.1002/mds.20013; Louis ED, 2003, NEUROLOGY, V61, P24, DOI 10.1212/01.WNL.0000072330.07328.D6; Louis ED, 2005, NEUROLOGY, V64, P1157, DOI 10.1212/01.WNL.0000156157.97411.5E; Louis ED, 2008, MOVEMENT DISORD, V23, P524, DOI 10.1002/mds.21777; Louis ED, 2007, MOVEMENT DISORD, V22, P1681, DOI 10.1002/mds.21433; Louis ED, 2010, MOVEMENT DISORD, V25, P172, DOI 10.1002/mds.22943; LundinOlsson L, 1997, LANCET, V349, P617, DOI 10.1016/S0140-6736(97)24009-2; Maetzler W, 2012, MOVEMENT DISORD, V27, P627, DOI 10.1002/mds.24973; Marder K, 1996, NEUROLOGY, V47, P155, DOI 10.1212/WNL.47.1.155; Postuma RB, 2012, BRAIN, V135, P1860, DOI 10.1093/brain/aws093; Postuma RB, 2010, J NEUROL NEUROSUR PS, V81, P1008, DOI 10.1136/jnnp.2009.174748; Postuma RB, 2012, MOVEMENT DISORD, V27, P617, DOI 10.1002/mds.24996; RICHARDS M, 1993, NEUROLOGY, V43, P2184, DOI 10.1212/WNL.43.11.2184; Ross G Webster, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS199, DOI 10.1016/S1353-8020(11)70062-1; Ross GW, 2004, ANN NEUROL, V56, P532, DOI 10.1002/ana.20226; Schrodt LA, 2004, GAIT POSTURE, V19, P279, DOI 10.1016/S0966-6362(03)00067-5; Stiasny-Kolster K, 2007, MOVEMENT DISORD, V22, P2386, DOI 10.1002/mds.21740; Uemura Y, 2013, ACTA NEUROL SCAND; Wenning GK, 2004, MOVEMENT DISORD, V19, P1391, DOI 10.1002/mds.20255; Wilson RS, 2003, ARCH NEUROL-CHICAGO, V60, P539, DOI 10.1001/archneur.60.4.539; Zhou GQ, 2010, J CLIN NEUROSCI, V17, P173, DOI 10.1016/j.jocn.2009.07.102	37	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92878	10.1371/journal.pone.0092878	http://dx.doi.org/10.1371/journal.pone.0092878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675747	gold, Green Submitted, Green Published			2022-12-27	WOS:000333677500049
J	Waite, IR; Kennen, JG; May, JT; Brown, LR; Cuffney, TF; Jones, KA; Orlando, JL				Waite, Ian R.; Kennen, Jonathan G.; May, Jason T.; Brown, Larry R.; Cuffney, Thomas F.; Jones, Kimberly A.; Orlando, James L.			Stream Macroinvertebrate Response Models for Bioassessment Metrics: Addressing the Issue of Spatial Scale	PLOS ONE			English	Article							FISH ASSEMBLAGE STRUCTURE; ALTERED FLOW REGIMES; PREDICTIVE MODELS; BENTHIC MACROINVERTEBRATES; BIOLOGICAL CONDITION; LAND-USE; URBANIZATION; INVERTEBRATE; HABITAT; CLASSIFICATION	We developed independent predictive disturbance models for a full regional data set and four individual ecoregions (Full Region vs. Individual Ecoregion models) to evaluate effects of spatial scale on the assessment of human landscape modification, on predicted response of stream biota, and the effect of other possible confounding factors, such as watershed size and elevation, on model performance. We selected macroinvertebrate sampling sites for model development (n = 591) and validation (n = 467) that met strict screening criteria from four proximal ecoregions in the northeastern U.S.: North Central Appalachians, Ridge and Valley, Northeastern Highlands, and Northern Piedmont. Models were developed using boosted regression tree (BRT) techniques for four macroinvertebrate metrics; results were compared among ecoregions and metrics. Comparing within a region but across the four macroinvertebrate metrics, the average richness of tolerant taxa (RichTOL) had the highest R-2 for BRT models. Across the four metrics, final BRT models had between four and seven explanatory variables and always included a variable related to urbanization (e. g., population density, percent urban, or percent manmade channels), and either a measure of hydrologic runoff (e. g., minimum April, average December, or maximum monthly runoff) and(or) a natural landscape factor (e. g., riparian slope, precipitation, and elevation), or a measure of riparian disturbance. Contrary to our expectations, Full Region models explained nearly as much variance in the macroinvertebrate data as Individual Ecoregion models, and taking into account watershed size or elevation did not appear to improve model performance. As a result, it may be advantageous for bioassessment programs to develop large regional models as a preliminary assessment of overall disturbance conditions as long as the range in natural landscape variability is not excessive.	[Waite, Ian R.] US Geol Survey, Portland, OR 97201 USA; [Kennen, Jonathan G.] US Geol Survey, West Trenton, NJ USA; [May, Jason T.; Brown, Larry R.; Orlando, James L.] US Geol Survey, Sacramento, CA USA; [Cuffney, Thomas F.] US Geol Survey, Raleigh, NC USA; [Jones, Kimberly A.] US Geol Survey, Salt Lake City, UT USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Waite, IR (corresponding author), US Geol Survey, Portland, OR 97201 USA.	iwaite@usgs.gov		Kennen, Jonathan/0000-0002-5426-4445	US Federal, National Water Quality Assessment Program (NAWQA) of the US Geological Survey; NAWQA	US Federal, National Water Quality Assessment Program (NAWQA) of the US Geological Survey(United States Geological Survey); NAWQA	This work received US Federal funding - part of the National Water Quality Assessment Program (NAWQA) of the US Geological Survey. NAWQA funded and supported all labor involved, but the authors are responsible for all design, data collection and analysis and all aspects of publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertsen W, 2010, ECOL MODEL, V221, P1119, DOI 10.1016/j.ecolmodel.2010.01.007; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; [Anonymous], 2002, US GEOLOGICAL SURVEY; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Barbour M.T., 1999, RAPID BIOASSESSMENT, V339; Bellucci CJ, 2011, NORTHEAST NAT, V18, P411, DOI 10.1656/045.018.0402; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Boulton AJ, 2003, FRESHWATER BIOL, V48, P1173, DOI 10.1046/j.1365-2427.2003.01084.x; Brakebill JW, 2011, J AM WATER RESOUR AS, V47, P916, DOI 10.1111/j.1752-1688.2011.00578.x; Brenden TO, 2006, AM FISH S S, V48, P49; Brown LR, 2012, LANDSCAPE URBAN PLAN, V108, P17, DOI 10.1016/j.landurbplan.2012.07.009; Brown LR, 2009, J N AM BENTHOL SOC, V28, P1051, DOI 10.1899/08-153.1; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Cabecinha E, 2007, ECOL MODEL, V207, P109, DOI 10.1016/j.ecolmodel.2007.04.009; Cao Y, 2011, J N AM BENTHOL SOC, V30, P680, DOI 10.1899/10-067.1; Carlisle D. M., 2008, ENVIRON MONIT ASSESS, V151, P143; Chessman BC, 2010, FRESHWATER BIOL, V55, P1780, DOI 10.1111/j.1365-2427.2010.02403.x; Clapcott J., 2011, DOC RES DEV SERIES, V365; Clausen B, 1997, FRESHWATER BIOL, V38, P327, DOI 10.1046/j.1365-2427.1997.00230.x; Connecticut Department of Environmental Protection (CTDEP), 1999, AMB MON STRAT RIV ST; Cuffney TE, 2007, J N AM BENTHOL SOC, V26, P286, DOI 10.1899/0887-3593(2007)26[286:ATEOTC]2.0.CO;2; Cuffney TF, 2005, AM FISH S S, V47, P361; CUFFNEY TF, 2003, 03172 US GEOL SURV; Cuffney TF, 2011, J N AM BENTHOL SOC, V30, P797, DOI 10.1899/10-140.1; Cuffney TF, 2010, ECOL APPL, V20, P1384, DOI 10.1890/08-1311.1; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Dodds WK, 2010, J N AM BENTHOL SOC, V29, P988, DOI 10.1899/09-148.1; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Freeman MC, 2013, RIVER RES APPL, V29, P906, DOI 10.1002/rra.2575; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Hilderbrand RH, 2010, J N AM BENTHOL SOC, V29, P1009, DOI 10.1899/09-138.1; HILSENHOFF WL, 1987, GREAT LAKES ENTOMOL, V20, P31; Kennen JG, 2005, AM FISH S S, V47, P39; Kennen JG, 2010, ECOHYDROLOGY, V3, P88, DOI 10.1002/eco.99; Leathwick JR, 2005, FRESHWATER BIOL, V50, P2034, DOI 10.1111/j.1365-2427.2005.01448.x; Leclere J, 2011, ECOL INFORM, V6, P276, DOI 10.1016/j.ecoinf.2011.05.001; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Lytle DA, 2002, ECOLOGY, V83, P370; Maloney KO, 2009, J N AM BENTHOL SOC, V28, P869, DOI 10.1899/08-142.1; Morgan RP, 2005, J N AM BENTHOL SOC, V24, P643, DOI 10.1899/0887-3593(2005)024\\[0643:UEOSFA\\]2.0.CO;2; Munn MD, 2009, ENVIRON MONIT ASSESS, V154, P1, DOI 10.1007/s10661-008-0372-9; New Jersey Department of Environmental Protection (NJDEP), 2007, STAND OP PROC AMB BI; New York State Department of Environmental Conservation (NYDEC), 2012, STAND OP PROC BIOL M; Oberdorff T, 2001, FRESHWATER BIOL, V46, P399, DOI 10.1046/j.1365-2427.2001.00669.x; Ode PR, 2008, J N AM BENTHOL SOC, V27, P967, DOI 10.1899/08-051.1; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Pennsylvania Department of Environmental Protection (PADEP), 2002, BENTH IND BIOT INT W; Pennsylvania Department of Environmental Protection (PADEP), 2012, PENNS SURF WAT QUAL; Phelps MG, 2002, NAFR0203 USDA FOR SE; Pineiro G, 2008, ECOL MODEL, V216, P316, DOI 10.1016/j.ecolmodel.2008.05.006; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; POFF NL, 1995, ECOLOGY, V76, P606, DOI 10.2307/1941217; Potapova M, 2007, ECOL INDIC, V7, P48, DOI 10.1016/j.ecolind.2005.10.001; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Pusey BJ, 2000, ECOL FRESHW FISH, V9, P30, DOI 10.1034/j.1600-0633.2000.90105.x; Qian SS, 2012, ECOL INDIC, V15, P1, DOI 10.1016/j.ecolind.2011.08.019; R Core Development Team, 2010, R LANG ENV STAT COMP; Riseng CM, 2011, ECOL APPL, V21, P3128, DOI 10.1890/11-0077.1; Roy AH, 2005, J N AM BENTHOL SOC, V24, P656, DOI 10.1899/0887-3593(2005)024\\[0656:IHAAAM\\]2.0.CO;2; Roy AH, 2003, FRESHWATER BIOL, V48, P329, DOI 10.1046/j.1365-2427.2003.00979.x; Seelbach P.W., 2011, 2095 MICH DEP NAT RE; Stevenson RJ, 2006, HYDROBIOLOGIA, V561, P149, DOI 10.1007/s10750-005-1611-5; Turak E, 2011, FRESHWATER BIOL, V56, P39, DOI 10.1111/j.1365-2427.2009.02394.x; U.S. Environmental Protection Agency, 1997, DESCR LEV 3 EC REG C; U.S. Geological Survey, 2007, NAT HYDR DAT HIGH RE; Van Sickle J, 2004, ECOL APPL, V14, P368, DOI 10.1890/02-5009; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Waite IR, 2013, J AM WATER RESOUR AS, V49, P431, DOI 10.1111/jawr.12032; Waite IR, 2012, J AM WATER RESOUR AS, V48, P570, DOI 10.1111/j.1752-1688.2011.00632.x; Waite IR, 2010, ECOL INDIC, V10, P1125, DOI 10.1016/j.ecolind.2010.03.011; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Wang LZ, 2008, ENVIRON MONIT ASSESS, V141, P1, DOI 10.1007/s10661-006-9510-4; Wang LZ, 2001, ENVIRON MANAGE, V28, P255, DOI 10.1007/s0026702409; WOODS AJ, 1996, EPA600R96077 NAT HLT	78	16	16	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e90944	10.1371/journal.pone.0090944	http://dx.doi.org/10.1371/journal.pone.0090944			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675770	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677500011
J	Etain, B; Guittet, L; Weiss, N; Gajdos, V; Katsahian, S				Etain, Bruno; Guittet, Lydia; Weiss, Nicolas; Gajdos, Vincent; Katsahian, Sandrine			Attitudes of Medical Students towards Conflict of Interest: A National Survey in France	PLOS ONE			English	Article							INTEREST DISCLOSURE; SCHOOL POLICIES; RULES	Following recent health scandals in France, the French parliament adopted law n(o)2011-2012 to regulate ties between physicians and the pharmaceutical industry. The law also requires pharmaceutical companies to publicize financial and other benefits given to medical students. In this context, we administered a survey to medical students in France, in an effort to identify priorities for future education regarding conflicts of interest (COI). This web-based survey encompassed knowledge about, training on, personal exposure to, and opinions on COI among preclinical and clinical students as well as residents. Two thousand one hundred and one (2,101) students participated. Although most students (64.6%) believed that they are able to define what a COI is, they failed to correctly identify several situations as COI (receiving a gift, being offered a meal, being invited to a conference). Most students reported feeling inadequately educated about COI (85.2%). Compared to other class levels, residents were more exposed to pharmaceutical sales representatives. This exposure is highly associated to receipt of gifts (OR 14.51, 95% CI 11.67-18.05). Medical students were aware of potential bias induced by COI with respect to drug prescriptions and research, but felt personally immune towards COI. In our survey, personal research performed by students was more likely to be associated with perception of potential bias on prescription for self (but not for others) than attending a lecture on COI. Promulgating laws that regulate ties between physicians/students and the pharmaceutical industry is a mandatory first step. However, complementary strategies should be implemented within medical schools, in particular, specific training about COI in early medical education.	[Etain, Bruno; Katsahian, Sandrine] Hop Univ Henri Mondor, AP HP, Creteil, France; [Guittet, Lydia] CHU Caen, INSERM Canc & Prevent U1086, F-14000 Caen, France; [Weiss, Nicolas] Hop La Pitie Salpetriere, AP HP, Inst Hosp Univ A, Neurol Intens Care Unit,Dept Neurol, Paris, France; [Gajdos, Vincent] Hop Antoine Beclere, APHP, Dept Pediat, Clamart, France; [Gajdos, Vincent] Univ Paris Sud, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU de Caen NORMANDIE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Universite Paris Saclay	Etain, B (corresponding author), Hop Univ Henri Mondor, AP HP, Creteil, France.	bruno.etain@inserm.fr	Guittet, Lydia/ABC-5830-2020; GUITTET, Lydia/L-7229-2015; Etain, Bruno/L-6647-2017; Weiss, Nicolas/E-7345-2011	GUITTET, Lydia/0000-0003-2660-776X; Etain, Bruno/0000-0002-5377-1488; Weiss, Nicolas/0000-0001-5155-196X; KATSAHIAN, Sandrine/0000-0002-7261-0671	Institut Phisquarea; Sanofi Pasteur MSD; Roche; LFB; Sanofi Aventis	Institut Phisquarea; Sanofi Pasteur MSD; Roche(Roche Holding); LFB; Sanofi Aventis(Sanofi-Aventis)	SK declared that no competing interests exist. BE received speaker honoraria from BMS, Otsuka, Astra-Zeneca, Servier, Lundbeck and payment for the development of educational presentation by Astra-Zeneca. VG participated in boards sponsored by Institut Phisquarea and Sanofi Pasteur MSD. LG benefited from travel/accomodations fees from Roche. NW received honoraria for lectures from Gore and benefited from travel/accomodations fees from LFB and Sanofi Aventis. This does not alter all authors' adherence to all the PLOS ONE policies on sharing data and materials.	Austad KE, 2013, J GEN INTERN MED, V28, P1064, DOI 10.1007/s11606-013-2361-0; Austad KE, 2011, JAMA-J AM MED ASSOC, V306, P991, DOI 10.1001/jama.2011.1233; Austad KE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001037; Benkimoun P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d8309; Butler D, 2011, NATURE, V478, P169, DOI 10.1038/478169a; Kao AC, 2011, ACAD MED, V86, P1454, DOI 10.1097/ACM.0b013e3182303895; Kim A, 2012, JAMA-J AM MED ASSOC, V308, P2187, DOI 10.1001/jama.2012.25315; King M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f264; Moghimi Y, 2006, PLOS MED, V3, P12, DOI 10.1371/journal.pmed.0030030; Mullard A, 2011, LANCET, V377, P890, DOI 10.1016/S0140-6736(11)60334-6; Shnier A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068633; Sierles F, 2009, ACAD PSYCHIATR, V33, P478, DOI 10.1176/appi.ap.33.6.478	12	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92858	10.1371/journal.pone.0092858	http://dx.doi.org/10.1371/journal.pone.0092858			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671179	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000085
J	Faverani, LP; Assuncao, WG; de Carvalho, PSP; Yuan, JCC; Sukotjo, C; Mathew, MT; Barao, VA				Faverani, Leonardo P.; Assuncao, Wirley G.; de Carvalho, Paulo Sergio P.; Yuan, Judy Chia-Chun; Sukotjo, Cortino; Mathew, Mathew T.; Barao, Valentim A.			Effects of Dextrose and Lipopolysaccharide on the Corrosion Behavior of a Ti-6Al-4V Alloy with a Smooth Surface or Treated with Double-Acid-Etching	PLOS ONE			English	Article							GINGIVALIS ENDOTOXIN AFFINITY; COMMERCIALLY PURE TITANIUM; FINITE-ELEMENT-ANALYSIS; DENTAL IMPLANTS; DIABETES-MELLITUS; ORAL-DISEASES; BONE; PH; PERIODONTITIS; PANCREATITIS	Diabetes and infections are associated with a high risk of implant failure. However, the effects of such conditions on the electrochemical stability of titanium materials remain unclear. This study evaluated the corrosion behavior of a Ti-6Al-4V alloy, with a smooth surface or conditioned by double-acid-etching, in simulated body fluid with different concentrations of dextrose and lipopolysaccharide. For the electrochemical assay, the open-circuit-potential, electrochemical impedance spectroscopy, and potentiodynamic test were used. The disc surfaces were characterized by scanning electron microscopy and atomic force microscopy. Their surface roughness and Vickers microhardness were also tested. The quantitative data were analyzed by Pearson's correlation and independent t-tests (alpha = 0.05). In the corrosion parameters, there was a strong lipopolysaccharide correlation with the I-pass (passivation current density), C-dl (double-layer capacitance), and R-p (polarization resistance) values (p<0.05) for the Ti-6Al-4V alloy with surface treatment by double-acid-etching. The combination of dextrose and lipopolysaccharide was correlated with the I-corr (corrosion current density) and I-pass (p<0.05). The acid-treated groups showed a significant increase in C-dl values and reduced R-p values (p<0.05, t-test). According to the topography, there was an increase in surface roughness (R-2 = 0.726, p<0.0001 for the smooth surface; R-2 = 0.405, p = 0.036 for the double-acid-etching-treated surface). The microhardness of the smooth Ti-6Al-4V alloy decreased (p<0.05) and that of the treated Ti-6Al-4V alloy increased (p<0.0001). Atomic force microscopy showed changes in the microstructure of the Ti-6Al-4V alloy by increasing the surface thickness mainly in the group associated with dextrose and lipopolysaccharide. The combination of dextrose and lipopolysaccharide affected the corrosion behavior of the Ti-6Al-4V alloy surface treated with double-acid-etching. However, no dose-response corrosion behavior could be observed. These results suggest a greater susceptibility to corrosion of titanium implants in diabetic patients with associated infections.	[Faverani, Leonardo P.; Assuncao, Wirley G.] Univ Estadual Paulista UNESP, Aracatuba Dent Sch, Dept Dent Mat & Prosthodont, Sao Paulo, Brazil; [Faverani, Leonardo P.; de Carvalho, Paulo Sergio P.] Univ Estadual Paulista UNESP, Dept Surg, Sao Paulo, Brazil; [Faverani, Leonardo P.; de Carvalho, Paulo Sergio P.] Univ Estadual Paulista UNESP, Integrated Clin, Aracatuba Dent Sch, Sao Paulo, Brazil; [Yuan, Judy Chia-Chun; Sukotjo, Cortino; Mathew, Mathew T.] Univ Illinois, Coll Dent, Dept Restorat Dent, Chicago, IL USA; [Mathew, Mathew T.] Rush Univ, Dept Orthoped Surg, Med Ctr, Chicago, IL 60612 USA; [Barao, Valentim A.] Univ Campinas UNICAMP, Piracicaba Dent Sch, Dept Prosthodont & Periodontol, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University; Universidade Estadual de Campinas	Barao, VA (corresponding author), Univ Campinas UNICAMP, Piracicaba Dent Sch, Dept Prosthodont & Periodontol, Sao Paulo, Brazil.	barao@fop.unicamp.br	Faverani, Leonardo P./E-5876-2012; Assunção, Wirley G/E-5931-2012; de Carvalho, Paulo Sergio Perri/H-4279-2012; Barão, Valentim/B-8156-2012; Carvalho, Paulo/AAQ-5563-2020	Faverani, Leonardo P./0000-0003-2249-3048; Assunção, Wirley G/0000-0002-8903-0737; Barão, Valentim/0000-0002-6391-9917; Mathew, Mathew/0000-0003-3604-7938	Sao Paulo State Research Foundation (FAPESP) [2012/14282-5, 2011/20021-7]	Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors would like to thank Sao Paulo State Research Foundation (FAPESP) for the financial support (#2012/14282-5 and #2011/20021-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082; Affronti J, 2011, PRIMARY CARE, V38, P515, DOI 10.1016/j.pop.2011.05.007; AKCA K, 2007, HEAD FACE MED, V16, P3; Al Jabbari Youssef, 2008, J Prosthodont, V17, P181; [Anonymous], J BACTERIOL, V185, P5591; Assuncao WG, 2011, J PROSTHODONT, V20, P523, DOI 10.1111/j.1532-849X.2011.00753.x; Baker P, 2012, J CLIN ENDOCR METAB, V97, pE1573, DOI 10.1210/jc.2011-2824; Barao VA, 2011, J DENT RES, V90, P613, DOI 10.1177/0022034510396880; Barao VA, 2014, J PERIODONT IN PRESS; Barao VAR, 2012, CLIN ORAL IMPLAN RES, V23, P1055, DOI 10.1111/j.1600-0501.2011.02265.x; Bollen CML, 1996, CLIN ORAL IMPLAN RES, V7, P201, DOI 10.1034/j.1600-0501.1996.070302.x; BUNDY KJ, 1994, CRIT REV BIOMED ENG, V22, P139; Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704; Chaturvedi T P, 2009, Indian J Dent Res, V20, P91; Colucci R, 2012, J AM OSTEOPATH ASSOC, V112, P374; Correa CB, 2009, J PROSTHODONT, V18, P382, DOI 10.1111/j.1532-849X.2009.00463.x; Cortada M, 2000, J MATER SCI-MATER M, V11, P287, DOI 10.1023/A:1008905229522; Darnell J A, 1990, Tex Dent J, V107, P23; Deshpande Kalyani, 2010, J Indian Soc Periodontol, V14, P207, DOI 10.4103/0972-124X.76917; Engebretson S, 2013, CONTEMP CLIN TRIALS, V36, P515, DOI 10.1016/j.cct.2013.09.010; Faverani LP, 2014, J BIOMED MATER RES B, V102, P22, DOI 10.1002/jbm.b.32949; GEORGE K, 1994, J PERIODONTOL, V65, P766, DOI 10.1902/jop.1994.65.8.766; Gittens RA, 2011, J DENT RES, V90, P1389, DOI 10.1177/0022034511408428; Gotfredsen K, 2001, CLIN ORAL IMPLAN RES, V12, P552, DOI 10.1034/j.1600-0501.2001.120602.x; Hwang AL, 2013, PANCREAS, V42, P1054, DOI 10.1097/MPA.0b013e3182965a3c; Klokkevold PR, 2007, INT J ORAL MAX IMPL, V22, P173; Knoernschild KL, 2001, J PROSTHET DENT, V86, P644, DOI 10.1067/mpr.2001.120842; Knoernschild KL, 1996, INT J PROSTHODONT, V9, P239; LAMEY PJ, 1992, DIABETIC MED, V9, P410, DOI 10.1111/j.1464-5491.1992.tb01809.x; Li B, 2013, REGUL PEPTIDES, V186, P83, DOI 10.1016/j.regpep.2013.07.005; Li JL, 2006, WEAR, V261, P1247, DOI 10.1016/j.wear.2006.03.010; Lin A, 2009, INT J ORAL MAX IMPL, V24, P808; Mabilleau G, 2006, ACTA BIOMATER, V2, P121, DOI 10.1016/j.actbio.2005.09.004; Manfredi M, 2004, ORAL DIS, V10, P187, DOI 10.1111/j.1601-0825.2004.01019.x; Mareci D, 2009, ACTA BIOMATER, V5, P3625, DOI 10.1016/j.actbio.2009.05.037; Mathew MT, 2012, J MECH BEHAV BIOMED, V8, P71, DOI 10.1016/j.jmbbm.2011.11.004; Messer RLW, 2010, J BIOMED MATER RES B, V92B, P525, DOI 10.1002/jbm.b.31548; Messer RLW, 2009, J BIOMED MATER RES B, V88B, P474, DOI 10.1002/jbm.b.31162; Meyer G, 2013, HORM METAB RES, V45, P92, DOI 10.1055/s-0032-1331766; Morgan TD, 2001, J APPL MICROBIOL, V91, P47, DOI 10.1046/j.1365-2672.2001.01338.x; NELSON RG, 1990, DIABETES CARE, V13, P836, DOI 10.2337/diacare.13.8.836; Nikolopoulou Fotoula, 2006, Implant Dent, V15, P372, DOI 10.1097/01.id.0000239320.57403.8d; Oates TW, 2013, CLIN ORAL IMPLAN RES, V24, P117, DOI 10.1111/j.1600-0501.2011.02374.x; Oliveira NTC, 2009, ACTA BIOMATER, V5, P399, DOI 10.1016/j.actbio.2008.07.010; Olmedo DG, 2010, INT J ORAL MAX SURG, V39, P503, DOI 10.1016/j.ijom.2009.11.007; Olmedo DG, 2012, J PERIODONTOL, V83, P973, DOI 10.1902/jop.2011.110392; Pai PS, 2008, TRIBOL INT, V41, P672, DOI 10.1016/j.triboint.2007.11.015; Barao VAR, 2013, J PROSTHET DENT, V110, P462, DOI 10.1016/j.prosdent.2013.04.004; Robinson FG, 1996, J PROSTHET DENT, V75, P217, DOI 10.1016/S0022-3913(96)90102-X; Savari O, 2013, ISLETS, V5, P226, DOI 10.4161/isl.26432; Skamagas M, 2008, ORAL DIS, V14, P105, DOI 10.1111/j.1601-0825.2007.01425.x; Tada S, 2003, INT J ORAL MAX IMPL, V18, P357; Tamam E, 2012, J ORAL IMPL IN PRESS, DOI [http://dx.doi.org/10.1563/AAID-JOI-D-11-00083.1., DOI 10.1563/AAID-J0I-D-11-00083.1]; Tavares MG, 2007, CLIN ORAL IMPLAN RES, V18, P452, DOI 10.1111/j.1600-0501.2007.01344.x; Tawil G, 2008, INT J ORAL MAX IMPL, V23, P744; Trisi P, 2003, J PERIODONTOL, V74, P945, DOI 10.1902/jop.2003.74.7.945; Udupa A, 2013, ANN MED HEALTH SCI R, V3, P442, DOI 10.4103/2141-9248.117954; Vieira AC, 2006, WEAR, V261, P994, DOI 10.1016/j.wear.2006.03.031; Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x; Winter W, 2013, J ORAL IMPLANTOL, V39, P23, DOI 10.1563/AAID-JOI-D-11-00221; Xavier SP, 2003, J DENT, V31, P173, DOI 10.1016/S0300-5712(03)00027-7; Yang CH, 2011, CLIN ORAL IMPLAN RES, V22, P1426, DOI 10.1111/j.1600-0501.2010.02132.x; Zhang SM, 2013, J MATER SCI-MATER M, V24, P1229, DOI 10.1007/s10856-013-4888-3; Zhoua LY, 2007, MATERIALS, V48, P380	64	20	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93377	10.1371/journal.pone.0093377	http://dx.doi.org/10.1371/journal.pone.0093377			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671257	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000136
J	Jiang, PH; Josue-Almqvist, J; Jin, XL; Li, X; Brand, JG; Margolskee, RF; Reed, DR; Beauchamp, GK				Jiang, Peihua; Josue-Almqvist, Jesusa; Jin, Xuelin; Li, Xia; Brand, Joseph G.; Margolskee, Robert F.; Reed, Danielle R.; Beauchamp, Gary K.			The Bamboo-Eating Giant Panda (Ailuropoda melanoleuca) Has a Sweet Tooth: Behavioral and Molecular Responses to Compounds That Taste Sweet to Humans	PLOS ONE			English	Article							RECEPTOR GENE TAS1R2; NEW-WORLD MONKEY; UMAMI TASTE; TRANSMEMBRANE DOMAIN; GUSTATORY RESPONSES; T1R3; PREFERENCE; EVOLUTION; PSEUDOGENIZATION; SECRETION	A growing body of behavioral and genetic information indicates that taste perception and food sources are highly coordinated across many animal species. For example, sweet taste perception is thought to serve to detect and motivate consumption of simple sugars in plants that provide calories. Supporting this is the observation that most plant-eating mammals examined exhibit functional sweet perception, whereas many obligate carnivores have independently lost function of their sweet taste receptors and exhibit no avidity for simple sugars that humans describe as tasting sweet. As part of a larger effort to compare taste structure/function among species, we examined both the behavioral and the molecular nature of sweet taste in a plant-eating animal that does not consume plants with abundant simple sugars, the giant panda (Ailuropoda melanoleuca). We evaluated two competing hypotheses: as plant-eating mammals, they should have a well-developed sweet taste system; however, as animals that do not normally consume plants with simple sugars, they may have lost sweet taste function, as has occurred in strict carnivores. In behavioral tests, giant pandas avidly consumed most natural sugars and some but not all artificial sweeteners. Cell-based assays revealed similar patterns of sweet receptor responses toward many of the sweeteners. Using mixed pairs of human and giant panda sweet taste receptor units (hT1R2+gpT1R3 and gpT1R2+hT1R3) we identified regions of the sweet receptor that may account for behavioral differences in giant pandas versus humans toward various sugars and artificial sweeteners. Thus, despite the fact that the giant panda's main food, bamboo, is very low in simple sugars, the species has a marked preference for several compounds that taste sweet to humans. We consider possible explanations for retained sweet perception in this species, including the potential extra-oral functions of sweet taste receptors that may be required for animals that consume plants.	[Jiang, Peihua; Josue-Almqvist, Jesusa; Li, Xia; Brand, Joseph G.; Margolskee, Robert F.; Reed, Danielle R.; Beauchamp, Gary K.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Jin, Xuelin] Shaanxi Wild Anim Rescue & Res Ctr, Louguantai, Peoples R China	Monell Chemical Senses Center	Jiang, PH (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	pjiang@monell.org		Margolskee, Robert/0000-0002-9572-2887; Reed, Danielle/0000-0002-4374-6107	NIH-NIDCD grant [DC0101842]; Monell Chemical Senses Center; NIH-NIDCD [1P30DC011735]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014105, P30DC011735, R01DC010842] Funding Source: NIH RePORTER	NIH-NIDCD grant; Monell Chemical Senses Center; NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by NIH-NIDCD grant DC0101842 (P.J.) and institutional funds from the Monell Chemical Senses Center; DNA analysis and calcium mobilization assays were performed at the Monell Genotyping and DNA/RNA Analysis Core and the Chemosensory Receptor Signaling Core, respectively, which are supported in part by funding from NIH-NIDCD core grant 1P30DC011735. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmanov AA, 2001, CHEM SENSES, V26, P905, DOI 10.1093/chemse/26.7.905; Breslin PAS, 2013, CURR BIOL, V23, pR409, DOI 10.1016/j.cub.2013.04.010; Danilova V, 2002, J NEUROPHYSIOL, V88, P579, DOI 10.1152/jn.2002.88.2.579; Danilova V, 1998, J NEUROPHYSIOL, V80, P2102, DOI 10.1152/jn.1998.80.4.2102; Glaser D, 1998, ANN NY ACAD SCI, V855, P169, DOI 10.1111/j.1749-6632.1998.tb10561.x; GLASER D, 1995, CHEM SENSES, V20, P573, DOI 10.1093/chemse/20.5.573; Hall JE, 2020, GUYTON HALL TXB MED; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Jiang P, 2005, CHEM SENSES, V30, pI17, DOI 10.1093/chemse/bjh091; Jiang PH, 2012, P NATL ACAD SCI USA, V109, pE1465, DOI 10.1073/pnas.1205581109; Jiang PH, 2012, P NATL ACAD SCI USA, V109, P4956, DOI 10.1073/pnas.1118360109; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; KOZUKUE E, 1983, J FOOD SCI, V48, P935, DOI 10.1111/j.1365-2621.1983.tb14934.x; Li DY, 2014, MOL BIOL EVOL, V31, P303, DOI 10.1093/molbev/mst219; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li X, 2005, PLOS GENET, V1, P27, DOI 10.1371/journal.pgen.0010003; Li X, 2009, J HERED, V100, pS90, DOI 10.1093/jhered/esp015; Liu B, 2012, BIOCHEM BIOPH RES CO, V427, P431, DOI 10.1016/j.bbrc.2012.09.083; Liu B, 2011, J NEUROSCI, V31, P11070, DOI 10.1523/JNEUROSCI.0791-11.2011; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Nofre C, 2002, J ANIM PHYSIOL AN N, V86, P90, DOI 10.1046/j.1439-0396.2002.00361.x; Sato JJ, 2012, NATURWISSENSCHAFTEN, V99, P655, DOI 10.1007/s00114-012-0939-8; Schaller G.B., 1985, GIANT PANDAS WOLONG; Winnig M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-22; Winnig M, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-66; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; Yee KK, 2011, P NATL ACAD SCI USA, V108, P5431, DOI 10.1073/pnas.1100495108; Zhang F, 2010, P NATL ACAD SCI USA, V107, P4752, DOI 10.1073/pnas.0911660107; Zhao HB, 2012, GENOME BIOL EVOL, V4, P73, DOI 10.1093/gbe/evr126; Zhao HB, 2010, MOL BIOL EVOL, V27, P2669, DOI 10.1093/molbev/msq153; Zhao HB, 2010, MOL BIOL EVOL, V27, P2642, DOI 10.1093/molbev/msq152; Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108	34	7	8	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93043	10.1371/journal.pone.0093043	http://dx.doi.org/10.1371/journal.pone.0093043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671207	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677000105
J	Li, G; Wang, HQ; Wang, LH; Chen, RP; Liu, JP				Li, Guo; Wang, Hui-qian; Wang, Li-hui; Chen, Ru-ping; Liu, Jun-ping			Distinct Pathways of ERK1/2 Activation by Hydroxy-Carboxylic Acid Receptor-1	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; SIGNAL-REGULATED KINASES; FACTOR-I RECEPTOR; MEDIATED ACTIVATION; GROWTH; GAMMA; SRC; G(I); TRANSACTIVATION; MECHANISMS	Mechanistic investigations have shown that, upon agonist activation, hydroxy-carboxylic acid receptor-1(HCA(1)) couples to a G(i) protein and inhibits adenylate cyclase activity, leading to inhibition of liberation of free fatty acid. However, the underlying molecular mechanisms for HCA(1) signaling remain largely unknown. Using CHO-K1 cells stably expressing HCA(1), and L6 cells, which endogenously express rat HCA(1) receptors, we found that activation of ERK1/2 by HCA(1) was rapid, peaking at 5 min, and was significantly blocked by pertussis toxin. Furthermore, time course experiments with different kinase inhibitors demonstrated that HCA(1) induced ERK1/2 activation via the extracellular Ca2+, PKC and IGF-I receptor transactivation-dependent pathways. In addition, we observed that pretreated the cells with M119K, an inhibitor of G(beta gamma) subunit-dependent signaling, effectively attenuated the ERK1/2 activation triggered by HCA(1), suggesting a critical role for bc-subunits in HCA(1)-activated ERK1/2 phosphorylation. Furthermore, the present results also indicated that the arrestin2/3 were not required for ERK1/2 activation. In conclusion, our findings demonstrate that upon binding to agonist, HCA(1) receptors initially activate G(i), leading to dissociation of the G(beta gamma) subunit from activated G(i), and subsequently induce ERK1/2 activation via two distinct pathways: one PKC-dependent pathway and the other IGF-IR transactivation-dependent pathway. Our results provide the first in-depth evidence that defines the molecular mechanism of HCA(1)-mediated ERK1/2 activation.	[Li, Guo; Wang, Hui-qian; Wang, Li-hui; Chen, Ru-ping; Liu, Jun-ping] Hangzhou Normal Univ, Sch Med, Inst Aging Res, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University	Li, G (corresponding author), Hangzhou Normal Univ, Sch Med, Inst Aging Res, Hangzhou, Zhejiang, Peoples R China.	liguo2000@aliyun.com; jun-ping.liu@monash.edu		Liu, Jun-Ping/0000-0001-7442-2116	National Natural Science Foundation of China [31201067, 81000955]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 31201067, No. 81000955). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed K, 2010, CELL METAB, V11, P311, DOI 10.1016/j.cmet.2010.02.012; Ahmed K, 2009, TRENDS PHARMACOL SCI, V30, P557, DOI 10.1016/j.tips.2009.09.001; Ahmed K, 2009, J BIOL CHEM, V284, P21928, DOI 10.1074/jbc.M109.019455; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Ahn S, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M808463200; Beom SR, 2004, J BIOL CHEM, V279, P28304, DOI 10.1074/jbc.M403899200; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Cai TQ, 2008, BIOCHEM BIOPH RES CO, V377, P987, DOI 10.1016/j.bbrc.2008.10.088; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Dickenson JM, 1998, EUR J PHARMACOL, V355, P85, DOI 10.1016/S0014-2999(98)00468-3; Dorn GW, 1997, BIOCHEMISTRY-US, V36, P6415, DOI 10.1021/bi970080s; Du J, 2001, CIRC RES, V88, P1044, DOI 10.1161/hh1001.090840; Ge H, 2008, J LIPID RES, V49, P797, DOI 10.1194/jlr.M700513-JLR200; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gripentrog JM, 2008, CELL SIGNAL, V20, P424, DOI 10.1016/j.cellsig.2007.11.002; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; HAWES BE, 1995, J BIOL CHEM, V270, P17148, DOI 10.1074/jbc.270.29.17148; Kirui JK, 2010, J PHARMACOL EXP THER, V333, P393, DOI 10.1124/jpet.109.164814; Kranenburg O, 1997, EMBO J, V16, P3097, DOI 10.1093/emboj/16.11.3097; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li G, 2011, J BIOL CHEM, V286, P31199, DOI 10.1074/jbc.M111.241372; Li G, 2010, J BIOL CHEM, V285, P22605, DOI 10.1074/jbc.M109.087213; Lin AL, 2008, AM J PHYSIOL-CELL PH, V294, pC1454, DOI 10.1152/ajpcell.00151.2007; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; Lopez-Ilasaca M, 1998, J BIOL CHEM, V273, P2505, DOI 10.1074/jbc.273.5.2505; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Luttrell LM, 2002, J CELL SCI, V115, P455; Peterson JE, 1996, J BIOL CHEM, V271, P31562, DOI 10.1074/jbc.271.49.31562; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Pu J, 2011, J LIPID RES, V52, P1319, DOI 10.1194/jlr.M011254; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; vanBiesen T, 1996, J BIOL CHEM, V271, P1266, DOI 10.1074/jbc.271.3.1266; Zahradka P, 2004, ENDOCRINOLOGY, V145, P2978, DOI 10.1210/en.2004-0029; Zhou Q, 2012, BR J PHARM	40	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93041	10.1371/journal.pone.0093041	http://dx.doi.org/10.1371/journal.pone.0093041			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671202	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677000104
J	Rodriguez-Ramilo, ST; Garcia-Cortes, LA; Gonzalez-Recio, O				Teresa Rodriguez-Ramilo, Silvia; Alberto Garcia-Cortes, Luis; Gonzalez-Recio, Oscar			Combining Genomic and Genealogical Information in a Reproducing Kernel Hilbert Spaces Regression Model for Genome-Enabled Predictions in Dairy Cattle	PLOS ONE			English	Article							ASSISTED PREDICTION; GENETIC VALUE; FULL PEDIGREE; SELECTION	Genome-enhanced genotypic evaluations are becoming popular in several livestock species. For this purpose, the combination of the pedigree-based relationship matrix with a genomic similarities matrix between individuals is a common approach. However, the weight placed on each matrix has been so far established with ad hoc procedures, without formal estimation thereof. In addition, when using marker-and pedigree-based relationship matrices together, the resulting combined relationship matrix needs to be adjusted to the same scale in reference to the base population. This study proposes a semi-parametric Bayesian method for combining marker-and pedigree-based information on genome-enabled predictions. A kernel matrix from a reproducing kernel Hilbert spaces regression model was used to combine genomic and genealogical information in a semi-parametric scenario, avoiding inversion and adjustment complications. In addition, the weights on marker-versus pedigree-based information were inferred from a Bayesian model with Markov chain Monte Carlo. The proposed method was assessed involving a large number of SNPs and a large reference population. Five phenotypes, including production and type traits of dairy cattle were evaluated. The reliability of the genome-based predictions was assessed using the correlation, regression coefficient and mean squared error between the predicted and observed values. The results indicated that when a larger weight was given to the pedigree-based relationship matrix the correlation coefficient was lower than in situations where more weight was given to genomic information. Importantly, the posterior means of the inferred weight were near the maximum of 1. The behavior of the regression coefficient and the mean squared error was similar to the performance of the correlation, that is, more weight to the genomic information provided a regression coefficient closer to one and a smaller mean squared error. Our results also indicated a greater accuracy of genomic predictions when using a large reference population.	[Teresa Rodriguez-Ramilo, Silvia; Alberto Garcia-Cortes, Luis; Gonzalez-Recio, Oscar] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Mejora Genet Anim, Madrid, Spain; [Teresa Rodriguez-Ramilo, Silvia] Dept Tecn Conafe, Madrid, Spain; [Gonzalez-Recio, Oscar] Dept Environm & Primary Ind, Biosci Res Div, Melbourne, Vic, Australia; [Gonzalez-Recio, Oscar] Dairy Futures Cooperat Res Ctr, Melbourne, Vic, Australia	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Gonzalez-Recio, O (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Mejora Genet Anim, Madrid, Spain.	oscar.gonzalez-recio@depi.vic.gov.au	garcia, luis/C-5971-2008; Ramilo, Silvia Teresa Rodriguez/AAC-2843-2021; Gonzalez-Recio, Oscar/C-8553-2016	garcia, luis/0000-0003-1116-7271; Ramilo, Silvia Teresa Rodriguez/0000-0001-7150-0692; Gonzalez-Recio, Oscar/0000-0002-9106-4063	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria; Conafe [CC12-038]	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria(Instituto de Investigacion Agropecuaria (INIA)); Conafe	This work was funded by the agreement between Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria and Conafe (CC12-038). Conafe has been involved on data collection as a partner in the EuroGenomics Consortium.	Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; [Anonymous], 2010, INTERBULL B; Boichard D, 2002, P 7 WORLD C GEN APPL; Christensen OF, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-2; de los Campos G, 2009, J ANIM SCI, V87, P1883, DOI 10.2527/jas.2008-1259; de los Campos G, 2010, GENET RES, V92, P295, DOI 10.1017/S0016672310000285; Forni S, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-1; Gao HD, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-8; Garcia-Cortes LA, 2006, GENET SEL EVOL, V38, P601, DOI 10.1051/gse:2006024; Gianola D, 2003, GENETICS, V163, P347; Gianola D, 2008, GENETICS, V178, P2289, DOI 10.1534/genetics.107.084285; Gianola D, 2006, GENETICS, V173, P1761, DOI 10.1534/genetics.105.049510; Gonzalez-Recio O, 2008, GENETICS, V178, P2305, DOI 10.1534/genetics.107.084293; Gonzalez-Recio O, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-3; Haile-Mariam M, 2013, J ANIM BREED GENET, V130, P20, DOI 10.1111/j.1439-0388.2013.01001.x; HARRIS B. L., 2008, P INT M NIAG FALLS N; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Jimenez-Montero JA, 2013, J DAIRY SCI, V96, P625, DOI 10.3168/jds.2012-5631; KIMELDORF G, 1971, J MATH ANAL APPL, V33, P82, DOI 10.1016/0022-247X(71)90184-3; Liu ZT, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-19; Mallick BK, 2005, J R STAT SOC B, V67, P219, DOI 10.1111/j.1467-9868.2005.00498.x; MEUWISSEN THE, 1992, GENET SEL EVOL, V24, P305, DOI 10.1051/gse:19920402; Meuwissen THE, 2001, GENETICS, V157, P1819; Misztal I, 2009, J DAIRY SCI, V92, P4648, DOI 10.3168/jds.2009-2064; Nakaya A, 2012, ANN BOT-LONDON, V110, P1303, DOI 10.1093/aob/mcs109; Neves HHR, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-100; Rutkoski J, 2012, PLANT GENOME-US, V5, P51, DOI 10.3835/plantgenome2012.02.0001; Stranden I, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-25; Toro MA, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-27; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Vitezica ZG, 2011, GENET RES, V93, P357, DOI 10.1017/S001667231100022X; Wahba G, 1999, ADVANCES IN KERNEL METHODS, P69; Wahba G., 1990, SPLINE MODELS OBSERV; WOOTTERS WK, 1981, PHYS REV D, V23, P357, DOI 10.1103/PhysRevD.23.357; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	36	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93424	10.1371/journal.pone.0093424	http://dx.doi.org/10.1371/journal.pone.0093424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671175	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000144
J	McMillon, D; Simon, CP; Morenoff, J				McMillon, David; Simon, Carl P.; Morenoff, Jeffrey			Modeling the Underlying Dynamics of the Spread of Crime	PLOS ONE			English	Article							CRIMINAL-JUSTICE SYSTEM; A-PRIORI PATHOMETRY; PROBABILITIES; IMPRISONMENT; DETERRENCE; RECIDIVISM; DIFFUSION; BEHAVIOR	The spread of crime is a complex, dynamic process that calls for a systems level approach. Here, we build and analyze a series of dynamical systems models of the spread of crime, imprisonment and recidivism, using only abstract transition parameters. To find the general patterns among these parameters-patterns that are independent of the underlying particulars-we compute analytic expressions for the equilibria and for the tipping points between high-crime and low-crime equilibria in these models. We use these expressions to examine, in particular, the effects of longer prison terms and of increased incarceration rates on the prevalence of crime, with a follow-up analysis on the effects of a Three-Strike Policy.	[McMillon, David] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA; [McMillon, David] Univ Michigan, Dept Ind & Operat Engn, Ann Arbor, MI 48109 USA; [Simon, Carl P.] Univ Michigan, Ctr Study Complex Syst, Dept Math, Ann Arbor, MI 48109 USA; [Simon, Carl P.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA; [Morenoff, Jeffrey] Univ Michigan, Ctr Populat Studies, Inst Social Res, Dept Sociol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	McMillon, D (corresponding author), Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA.	mcmillon@umich.edu	Morenoff, Jeffrey D/E-9800-2015	Morenoff, Jeffrey D/0000-0002-8146-8590	Rackham Summer Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041028] Funding Source: NIH RePORTER	Rackham Summer Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding for this work comes from the Rackham Summer Institute. The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Alexander M., 2012, NEW JIM CROW MASS IN; [Anonymous], 1967, CHALL CRIM FREE SOC; [Anonymous], 2013, ECONOMIST; AVIITZHAK B, 1973, J CRIM JUST, V1, P185, DOI 10.1016/0047-2352(73)90061-5; BECKER GS, 1968, J POLIT ECON, V76, P169, DOI 10.1086/259394; BELKIN J, 1973, J CRIM JUST, V1, P7, DOI 10.1016/0047-2352(73)90003-2; Berenji B, 2013, DYNAMIC GAME T UNPUB; BLUMSTEI.A, 1969, OPER RES, V17, P199, DOI 10.1287/opre.17.2.199; BLUMSTEIN A, 1993, CRIMINOLOGY, V31, P1, DOI 10.1111/j.1745-9125.1993.tb01119.x; Blumstein A, 1995, J CRIM LAW CRIM, V86, P10, DOI 10.2307/1143998; BLUMSTEIN A, 1971, J RES CRIME DELINQ, V8, P124, DOI 10.1177/002242787100800202; Blumstein A, 1982, LAW, V2, P265; Blumstein A, 1986, CRIMINAL CAREERS CAR; Blumstein A, 1982, SCIENCE, V238, P985; Blumstein A, 2007, OPER RES, V55, P14, DOI 10.1287/opre.1060.0340; Blumstein Alfred., 2009, NIJ J, V263, P10; CanelaCacho JA, 1997, CRIMINOLOGY, V35, P133, DOI 10.1111/j.1745-9125.1997.tb00873.x; Cantrell RS, 2012, SIAM J MATH ANAL, V44, P1340, DOI 10.1137/110843356; Cohen J, 1999, J QUANT CRIMINOL, V15, P451, DOI 10.1023/A:1007596225550; D'Orsogna MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061458; Durlauf SN, 2011, CRIMINOL PUBLIC POL, V10, P13, DOI 10.1111/j.1745-9133.2010.00680.x; Edelman M, 2007, LOSING OUR CHILDREN; Freeman S, 1996, J URBAN ECON, V40, P216, DOI 10.1006/juec.1996.0030; Garland, 2001, MASS IMPRISONMENT SO; Gottfredson M.R., 1990, GEN THEORY CRIME; Greenwood PW, 1982, R2815NIJ RAND; JACQUEZ JA, 1994, J ACQ IMMUN DEF SYND, V7, P1169; Jiang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064677; Kagiwada H, 1977, APPL MATH COMPUT, V3, P59; Matsueda RLL, HDB SOCIAL PSYCHOL I; Mauer M, 2002, INVISIBLE PUNISHMENT; Nagin DS, 2013, CRIME JUSTICE, V42, P199, DOI 10.1086/670398; Nagin DS, 2013, ANNU REV ECON, V5, P83, DOI 10.1146/annurev-economics-072412-131310; National Association for the Advancement of Colored People (NAACP), 2011, MISPL PRIOR INC ED E; Perc M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076063; Pettit B, 2004, AM SOCIOL REV, V69, P151, DOI 10.1177/000312240406900201; Pew Center on the States, 2008, AMERICA; Rodriguez N, 2010, MATH MOD METH APPL S, V20, P1425, DOI 10.1142/S0218202510004696; Ross R, 1917, P R SOC LOND A-CONTA, V93, P212, DOI 10.1098/rspa.1917.0014; Ross R, 1916, P R SOC LOND A-CONTA, V92, P204, DOI 10.1098/rspa.1916.0007; Ross R., 1917, P ROY SOC LOND B BIO, V89, P507, DOI [10.1098/rspb.1917b.0008, DOI 10.1098/RSPB.1917B.0008]; SHINNAR S, 1975, LAW SOC REV, V9, P581, DOI 10.2307/3053340; Short MB, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066114; Short MB, 2009, J QUANT CRIMINOL, V25, P325, DOI 10.1007/s10940-009-9068-8; Short MB, 2010, P NATL ACAD SCI USA, V107, P3961, DOI 10.1073/pnas.0910921107; Wang S.J., 2005, SOC EC PLAN SCI, V39, P229; Wilson J.Q., 1985, CRIME HUMAN NATURE	48	31	31	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e88923	10.1371/journal.pone.0088923	http://dx.doi.org/10.1371/journal.pone.0088923			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24694545	gold, Green Published, Green Submitted			2022-12-27	WOS:000334103000004
J	Cheriyan, VT; Wang, Y; Muthu, M; Jamal, S; Chen, D; Yang, HJ; Polin, LA; Tarca, AL; Pass, HI; Dou, QP; Sharma, S; Wali, A; Rishi, AK				Cheriyan, Vino T.; Wang, Ying; Muthu, Magesh; Jamal, Shazia; Chen, Di; Yang, Huanjie; Polin, Lisa A.; Tarca, Adi L.; Pass, Harvey I.; Dou, Q. Ping; Sharma, Sunita; Wali, Anil; Rishi, Arun K.			Disulfiram Suppresses Growth of the Malignant Pleural Mesothelioma Cells in Part by Inducing Apoptosis	PLOS ONE			English	Article							NF-KAPPA-B; BREAST-CANCER CELLS; FACTOR-BINDING PROTEIN-7; REGULATORY PROTEIN-1; IN-VITRO; PODOPLANIN; INHIBITION; CYCLE; TUMOR; CARCINOMA	Dithiocarbamate compound Disulfiram (DSF)that binds with copper and functions as an inhibitor of aldehyde dehydrogenase is a Food and Drug Administration approved agent for treatment of alcoholism. Copper complexed DSF (DSF-Cu) also possesses anti-tumor and chemosensitizing properties; however, its molecular mechanisms of action remain unclear. Here we investigated malignant pleural mesothelioma (MPM) suppressive effects of DSF-Cu and the molecular mechanisms involved. DSF-Cu inhibited growth of the murine as well as human MPM cells in part by increasing levels of ubiquitinated proteins. DSF-Cu exposure stimulated apoptosis in MPM cells that involved activation of stress-activated protein kinases (SAPKs) p38 and JNK1/2, caspase-3, and cleavage of poly-(ADP-ribose)-polymerase, as well as increased expression of sulfatase 1 and apoptosis transducing CARP-1/CCAR1 protein. Gene-array based analyses revealed that DSF-Cu suppressed cell growth and metastasis-promoting genes including matrix metallopeptidase 3 and 10. DSF inhibited MPM cell growth and survival by upregulating cell cycle inhibitor p27Kip1, IGFBP7, and inhibitors of NF-kB such as ABIN 1 and 2 and Inhibitory kB (IkB)alpha and beta proteins. DSF-Cu promoted cleavage of vimentin, as well as serine-phosphorylation and lysine-63 linked ubiquitination of podoplanin. Administration of 50 mg/kg DSF-Cu by daily i.p injections inhibited growth of murine MPM cell-derived tumors in vivo. Although podoplanin expression often correlates with metastatic disease and poor prognosis, phosphorylation of serines in cytoplasmic domain of podoplanin has recently been shown to interfere with cellular motility and migration signaling. Post-translational modification of podoplanin and cleavage of vimentin by DSF-Cu underscore a metastasis inhibitory property of this agent and together with our in vivo studies underscore its potential as an anti-MPM agent.	[Wang, Ying; Chen, Di; Polin, Lisa A.; Dou, Q. Ping; Sharma, Sunita; Wali, Anil; Rishi, Arun K.] Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA; [Cheriyan, Vino T.; Wang, Ying; Muthu, Magesh; Jamal, Shazia; Chen, Di; Polin, Lisa A.; Dou, Q. Ping; Sharma, Sunita; Rishi, Arun K.] Wayne State Univ, Dept Oncol, Detroit, MI USA; [Tarca, Adi L.] Wayne State Univ, Dept Comp Sci, Detroit, MI USA; [Muthu, Magesh; Wali, Anil; Rishi, Arun K.] John D Dingell VA Med Ctr, Detroit, MI USA; [Pass, Harvey I.] NYU, Ctr Canc, Div Cardiothorac Surg, New York, NY USA; [Yang, Huanjie] Harbin Inst Technol, Dept Life Sci & Engn, Harbin 150006, Peoples R China	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; New York University; Harbin Institute of Technology	Dou, QP (corresponding author), Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA.	doup@karmanos.org; Rishia@Karmanos.org	muthu, magesh/N-6987-2017	muthu, magesh/0000-0003-3311-8120; Dou, Qingping/0000-0002-6465-1473; Pass, Harvey/0000-0003-3222-3471; jamal, shazia/0000-0003-4555-9513	Department of Veterans Affairs Merit Review grant [RO1 CA20009]; NCI/NIH Cancer Center Support Grant; NATIONAL CANCER INSTITUTE [R21CA184788] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit Review grant(US Department of Veterans Affairs); NCI/NIH Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Veterans Affairs Merit Review grant (AKR; AW), RO1 CA20009 (QPD), and the NCI/NIH Cancer Center Support Grant to Karmanos Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2013, J IMMUNOL, V190, P6239, DOI 10.4049/jimmunol.1300448; Ashour AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066733; Brahemi G, 2010, J MED CHEM, V53, P2757, DOI 10.1021/jm901757t; Cen DZ, 2004, J MED CHEM, V47, P6914, DOI 10.1021/jm049568z; Chen D, 2006, CANCER RES, V66, P10425, DOI 10.1158/0008-5472.CAN-06-2126; Chen D, 2013, MOL THER, V21, P758, DOI 10.1038/mt.2012.282; Cvek B, 2008, DRUG DISCOV TODAY, V13, P716, DOI 10.1016/j.drudis.2008.05.003; Furuta J, 2006, CANCER RES, V66, P6080, DOI 10.1158/0008-5472.CAN-06-0157; Gilles C, 1999, J CELL SCI, V112, P4615; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Hoshino A, 2011, CANCER RES, V71, P4769, DOI 10.1158/0008-5472.CAN-10-3228; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; JOHANSSON B, 1992, ACTA PSYCHIAT SCAND, V86, P15, DOI 10.1111/j.1600-0447.1992.tb03310.x; Kamp DW, 2009, TRANSL RES, V153, P143, DOI 10.1016/j.trsl.2009.01.004; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Kimura N, 2005, PATHOL INT, V55, P83, DOI 10.1111/j.1440-1827.2005.01791.x; Komatsu S, 2000, BIOCHEM BIOPH RES CO, V267, P109, DOI 10.1006/bbrc.1999.1937; Krishnan H, 2013, J BIOL CHEM, V288, P12215, DOI 10.1074/jbc.C112.446823; Lai Jin-Ping, 2008, J Gastrointest Cancer, V39, P149, DOI 10.1007/s12029-009-9058-y; Liu CT, 2013, DIGEST DIS SCI, V58, P1256, DOI 10.1007/s10620-012-2429-4; Liu P, 2013, BRIT J CANCER, V109, P1876, DOI 10.1038/bjc.2013.534; Liu P, 2012, BRIT J CANCER, V107, P1488, DOI 10.1038/bjc.2012.442; Martin-Villar E, 2010, MOL BIOL CELL, V21, P4387, DOI 10.1091/mbc.E10-06-0489; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Morrison BW, 2010, MELANOMA RES, V20, P11, DOI 10.1097/CMR.0b013e328334131d; Nakano H, 2006, CELL DEATH DIFFER, V13, P730, DOI 10.1038/sj.cdd.4401830; NOBEL CSI, 1995, J BIOL CHEM, V270, P26202, DOI 10.1074/jbc.270.44.26202; Odaka M, 2001, CANCER RES, V61, P6201; Oh YM, 1996, J BIOL CHEM, V271, P30322, DOI 10.1074/jbc.271.48.30322; Orrenius S, 1996, BIOCHEM SOC T, V24, P1032, DOI 10.1042/bst0241032; Osman I, 2006, CLIN CANCER RES, V12, P3374, DOI 10.1158/1078-0432.CCR-05-2081; PASS HI, 1995, ANN THORAC SURG, V59, P835, DOI 10.1016/0003-4975(95)00045-M; Pass HI, 2005, NEW ENGL J MED, V353, P1564, DOI 10.1056/NEJMoa051185; Pen A, 2008, ONCOGENE, V27, P6834, DOI 10.1038/onc.2008.287; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105; Puliyappadamba VT, 2011, J BIOL CHEM, V286, P38000, DOI 10.1074/jbc.M111.222398; Rae C, 2013, J NUCL MED, V54, P953, DOI 10.2967/jnumed.112.113324; Rishi AK, 2006, J BIOL CHEM, V281, P13188, DOI 10.1074/jbc.M512279200; Rishi AK, 2003, J BIOL CHEM, V278, P33422, DOI 10.1074/jbc.M303173200; Robinson TJW, 2013, CELL CYCLE, V12, P3013, DOI 10.4161/cc.26063; Singh S, 2003, CANCER RES, V63, P2306; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Somers PK, 2000, FREE RADICAL BIO MED, V28, P1532, DOI 10.1016/S0891-5849(00)00257-4; Sprenger CC, 1999, CANCER RES, V59, P2370; Su S, 2009, SEMIN THORAC CARDIOV, V21, P125, DOI 10.1053/j.semtcvs.2009.07.006; Suzuki E, 2007, CANCER RES, V67, P2351, DOI 10.1158/0008-5472.CAN-06-2389; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Tsao AS, 2009, J CLIN ONCOL, V27, P2081, DOI 10.1200/JCO.2008.19.8523; VALERIOTE F, 1989, CANCER RES, V49, P6658; Wang WG, 2003, INT J CANCER, V104, P504, DOI 10.1002/ijc.10972; Wang Y, 2011, MOL CELL BIOCHEM, V357, P83, DOI 10.1007/s11010-011-0878-2; Wang Y, 2010, CANCER CHEMOTH PHARM, V66, P455, DOI 10.1007/s00280-009-1181-8; Xiao GT, 2011, AM J CANCER RES, V1, P192; Yang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041214; Ye F, 2007, J CANCER RES CLIN, V133, P305, DOI 10.1007/s00432-006-0171-z; Yip NC, 2011, BRIT J CANCER, V104, P1564, DOI 10.1038/bjc.2011.126; Zhang LY, 2007, MOL CANCER THER, V6, P1661, DOI 10.1158/1535-7163.MCT-06-0653	58	34	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93711	10.1371/journal.pone.0093711	http://dx.doi.org/10.1371/journal.pone.0093711			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690739	Green Submitted, gold, Green Published			2022-12-27	WOS:000334101100129
J	Bucek, A; Matouskova, P; Sychrova, H; Pichova, I; Hruskova-Heidingsfeldova, O				Bucek, Ales; Matouskova, Petra; Sychrova, Hana; Pichova, Iva; Hruskova-Heidingsfeldova, Olga			Delta 12-Fatty Acid Desaturase from Candida parapsilosis Is a Multifunctional Desaturase Producing a Range of Polyunsaturated and Hydroxylated Fatty Acids	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; HETEROLOGOUS EXPRESSION; MASS-SPECTROMETRY; 4,4-DIMETHYLOXAZOLINE DERIVATIVES; SUBSTRATE-SPECIFICITY; MORTIERELLA-ALPINA; GENE; IDENTIFICATION; BIOSYNTHESIS; REGIOSELECTIVITY	Numerous Delta 12-, Delta 15- and multifunctional membrane fatty acid desaturases (FADs) have been identified in fungi, revealing great variability in the enzymatic specificities of FADs involved in biosynthesis of polyunsaturated fatty acids (PUFAs). Here, we report gene isolation and characterization of novel Delta 12/Delta 15- and Delta 15-FADs named CpFad2 and CpFad3, respectively, from the opportunistic pathogenic yeast Candida parapsilosis. Overexpression of CpFad3 in Saccharomyces cerevisiae strains supplemented with linoleic acid (Delta 9,Delta 12-18:2) and hexadecadienoic acid (Delta 9,Delta 12-16:2) leads to accumulation of Delta 15-PUFAs, i.e., alpha-linolenic acid (Delta 9,Delta 12,Delta 15-18:3) and hexadecatrienoic acid with an unusual terminal double bond (Delta 9,Delta 12,Delta 15-16:3). CpFad2 produces a range of Delta 12- and Delta 15-PUFAs. The major products of CpFad2 are linoleic and hexadecadienoic acid (Delta 9,Delta 12-16:2), accompanied by alpha-linolenic acid and hexadecatrienoic acid (Delta 9,Delta 12,Delta 15-16:3). Using GC/MS analysis of trimethylsilyl derivatives, we identified ricinoleic acid (12-hydroxy-9-octadecenoic acid) as an additional product of CpFad2. These results demonstrate that CpFAD2 is a multifunctional FAD and indicate that detailed analysis of fatty acid derivatives might uncover a range of enzymatic selectivities in other Delta 12-FADs from budding yeasts (Ascomycota: Saccharomycotina).	[Bucek, Ales; Matouskova, Petra; Pichova, Iva; Hruskova-Heidingsfeldova, Olga] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic; [Sychrova, Hana] Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Pichova, I (corresponding author), Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic.	iva.pichova@uochb.cas.cz; olga-hh@uochb.cas.cz	HruskovaHeidingsfeld, Olga/B-2429-2009; Bucek, Ales/G-8444-2014; Matoušková, Petra/AAL-1360-2021; Matoušková, Petra/S-5687-2017; Pichova, Iva/G-7917-2014; Sychrova, Hana/B-1350-2012	HruskovaHeidingsfeld, Olga/0000-0001-9881-8473; Matoušková, Petra/0000-0002-9421-5744; Matoušková, Petra/0000-0002-9421-5744; Sychrova, Hana/0000-0001-5967-5019	Technology Agency of the Czech Republic [TA01011461];  [RVO 613 88 963]	Technology Agency of the Czech Republic; 	This study was funded by project TA01011461 from Technology Agency of the Czech Republic and by the research project RVO 613 88 963. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PS, 2006, MOL MICROBIOL, V62, P1507, DOI 10.1111/j.1365-2958.2006.05484.x; Broadwater JA, 2002, J BIOL CHEM, V277, P15613, DOI 10.1074/jbc.M200231200; Broun P, 1998, SCIENCE, V282, P1315, DOI 10.1126/science.282.5392.1315; Bucek A, 2013, INSECT BIOCHEM MOLEC, V43, P724, DOI 10.1016/j.ibmb.2013.05.003; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Calvo AM, 2001, J BIOL CHEM, V276, P25766, DOI 10.1074/jbc.M100732200; Carvalho F, 2005, ORG BIOMOL CHEM, V3, P3979, DOI 10.1039/b509612j; Certik M, 1999, J BIOSCI BIOENG, V87, P1, DOI 10.1016/S1389-1723(99)80001-2; Christie WW, 2000, EUR J LIPID SCI TECH, V102, P23, DOI 10.1002/(SICI)1438-9312(200001)102:1<23::AID-EJLT23>3.3.CO;2-I; Damude HG, 2006, P NATL ACAD SCI USA, V103, P9446, DOI 10.1073/pnas.0511079103; Diaz AR, 2002, J BIOL CHEM, V277, P48099, DOI 10.1074/jbc.M208960200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAY L, 1991, J CHROMATOGR, V541, P89, DOI 10.1016/S0021-9673(01)95986-2; GHANNOUM MA, 1986, J GEN MICROBIOL, V132, P2367; Hoffmann M, 2007, J BIOL CHEM, V282, P26666, DOI 10.1074/jbc.M705068200; Huang YS, 1999, LIPIDS, V34, P649, DOI 10.1007/s11745-999-0410-8; Kainou K, 2006, YEAST, V23, P605, DOI 10.1002/yea.1378; Kajiwara S, 1996, APPL ENVIRON MICROB, V62, P4309, DOI 10.1128/AEM.62.12.4309-4313.1996; Kikukawa H, 2013, J BIOSCI BIOENG; Krishnamurthy S, 2004, MICROBIOL-SGM, V150, P1991, DOI 10.1099/mic.0.27029-0; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Matouskova P, 2008, CHEMBIOCHEM, V9, P2534, DOI 10.1002/cbic.200800374; Meesapyodsuk D, 2000, BIOCHEMISTRY-US, V39, P11948, DOI 10.1021/bi000756a; Meesapyodsuk D, 2007, J BIOL CHEM, V282, P20191, DOI 10.1074/jbc.M702196200; MOSS CW, 1982, J CLIN MICROBIOL, V16, P1073, DOI 10.1128/JCM.16.6.1073-1079.1982; Murayama SY, 2006, MICROBIOL-SGM, V152, P1551, DOI 10.1099/mic.0.28751-0; Nguyen LN, 2011, INFECT IMMUN, V79, P136, DOI 10.1128/IAI.00753-10; NICOLAIDES N, 1983, BIOMED MASS SPECTROM, V10, P441, DOI 10.1002/bms.1200100802; Oura T, 2004, MICROBIOL-SGM, V150, P1983, DOI 10.1099/mic.0.27049-0; Oura T, 2008, BIOSCI BIOTECH BIOCH, V72, P3174, DOI 10.1271/bbb.80361; Pan ZQ, 2007, J BIOL CHEM, V282, P4326, DOI 10.1074/jbc.M606343200; Pereira SL, 2004, BIOCHEM J, V378, P665, DOI 10.1042/BJ20031319; Peyou-Ndi MM, 2000, ARCH BIOCHEM BIOPHYS, V376, P399, DOI 10.1006/abbi.2000.1733; RENUKAPRASAD M, 1980, J BIOL CHEM, V255, P2583; Rodriguez-Vargas S, 2007, APPL ENVIRON MICROB, V73, P110, DOI 10.1128/AEM.01360-06; Sakuradani E, 2005, APPL MICROBIOL BIOT, V66, P648, DOI 10.1007/s00253-004-1760-x; Sakuradani E, 1999, EUR J BIOCHEM, V261, P812, DOI 10.1046/j.1432-1327.1999.00333.x; Sayanova O, 2006, J BIOL CHEM, V281, P36533, DOI 10.1074/jbc.M605158200; Serra M, 2006, INSECT BIOCHEM MOLEC, V36, P822, DOI 10.1016/j.ibmb.2006.07.008; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; Spitzer V, 1996, PROG LIPID RES, V35, P387, DOI 10.1016/S0163-7827(96)00011-2; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trofa D, 2008, CLIN MICROBIOL REV, V21, P606, DOI 10.1128/CMR.00013-08; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Uemura H, 2012, APPL MICROBIOL BIOT, V95, P1, DOI 10.1007/s00253-012-4105-1; Watanabe K, 2004, BIOSCI BIOTECH BIOCH, V68, P721, DOI 10.1271/bbb.68.721; Wei DS, 2006, ACTA BIOCHIM POL, V53, P753, DOI 10.18388/abp.2006_3303; Wilson RA, 2004, MICROBIOL-SGM, V150, P2881, DOI 10.1099/mic.0.27207-0; Yan Z, 2013, FOOD SCI BIOTECHNOL, V22, P573, DOI DOI 10.1007/S10068-013-0116-7; Yazawa H, 2009, YEAST, V26, P167, DOI 10.1002/yea.1659; Zhan XX, 2008, YEAST, V25, P21, DOI 10.1002/yea.1546; Zhou XR, 2011, J BIOL CHEM, V286, P43644, DOI 10.1074/jbc.M111.266114	54	17	21	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93322	10.1371/journal.pone.0093322	http://dx.doi.org/10.1371/journal.pone.0093322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681902	Green Published, Green Submitted, gold			2022-12-27	WOS:000333678100043
J	Todorovic, Z; Medic, B; Basta-Jovanovic, G; Skodric, SR; Stojanovic, R; Rovcanin, B; Prostran, M				Todorovic, Zoran; Medic, Branislava; Basta-Jovanovic, Gordana; Skodric, Sanja Radojevic; Stojanovic, Radan; Rovcanin, Branislav; Prostran, Milica			Acute Pretreatment with Chloroquine Attenuates Renal I/R Injury in Rats	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ACUTE KIDNEY INJURY; NITRIC-OXIDE; PROXIMAL TUBULE; MODEL; HYDROXYCHLOROQUINE; BIOMARKERS; VASOPRESSIN; MOLECULE-1; INFLAMMATION	Background: Acute kidney injury (AKI) still remains an unresolved problem in pharmacotherapy and renal inflammation is a major factor in its development. Chloroquine, a well-known antimalarial drug, posses pleitropic effects as well: antiinflammatory, anticoagulant and vascular actions. The effects of chloroquine on renal function may involve significant increase in urine flow rate, glomerular filtration rate and sodium excretion, as well as stimulation of nitric oxide synthase. However, its role in experimental models of renal I/R injury is unknown. We aimed to analyze the acute effects of a single-dose intravenous chloroquine administered at three different times in the experimental model of I/R injury in rat. Methods: Rats were subjected to bilateral renal ischemia (45 min) followed by reperfusion with saline lasting 4 hours. Chloroquine was administered in doses of 0.3 mg/kg i.v. and 3 mg/kg i.v. 30 min before ischemia, 30 min before reperfusion and 5 min before reperfusion. Selected a hemodynamic, biochemical and morphological parameters were followed in the Sham-operated animals and rats subjected to I/R injury and pretreated with saline or chloroquine. Results: Chloroquine (0.3 and 3 mg/kg, i.v.) protected the I/R injured kidney in an U-shaped manner. Both doses were protective regarding biochemical and histological markers of the I/R injury (serum urea, creatinine and fractional excretion of sodium, as well as total histological score, tubular necrosis score and KIM-1 staining score) (P<0.05 vs. corresponding controls, i.e. rats subjected to I/R injury and treated with saline only). The protective effects of the lower dose of chloroquine were more profound. Time-related differences between pretreatments were not observed (P>0.05, all). Conclusion: Our study shows for the first time that a single dose of chloroquine (0.3 mg/kg i.v.) could afford significant protection of the injured rat kidney.	[Todorovic, Zoran; Medic, Branislava; Stojanovic, Radan; Prostran, Milica] Univ Belgrade, Dept Pharmacol Clin Pharmacol & Toxicol, Fac Med, Belgrade, Serbia; [Basta-Jovanovic, Gordana; Skodric, Sanja Radojevic] Univ Belgrade, Dept Pathol, Fac Med, Belgrade, Serbia; [Rovcanin, Branislav] Univ Belgrade, Fac Med, Dept Human Genet, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade	Prostran, M (corresponding author), Univ Belgrade, Dept Pharmacol Clin Pharmacol & Toxicol, Fac Med, Belgrade, Serbia.	mprostran@doctor.com	Rovcanin, Branislav/L-2345-2019	Rovcanin, Branislav/0000-0002-8099-3764; Todorovic, Zoran/0000-0001-8869-9976	Ministry of Education, Science and Technological Development of the Republic of Serbia [175023]	Ministry of Education, Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Project No. 175023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MH, 2003, J PHARMACOL EXP THER, V305, P123, DOI 10.1124/jpet.102.047233; Ahmed MH, 2003, J PHARMACOL EXP THER, V304, P156, DOI 10.1124/jpet.102.042523; Ahmed MH, 2007, MED HYPOTHESES, V68, P140, DOI 10.1016/j.mehy.2006.06.012; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bevan AP, 1997, J BIOL CHEM, V272, P26833, DOI 10.1074/jbc.272.43.26833; Bonventre JV, 2009, NEPHROL DIAL TRANSPL, V24, P3265, DOI 10.1093/ndt/gfp010; Chatterjee PK, 1999, EXP NEPHROL, V7, P438; Chatterjee PK, 2007, N-S ARCH PHARMACOL, V376, P1, DOI 10.1007/s00210-007-0183-5; Chatterjee Prabal K, 2003, Methods Mol Biol, V225, P223; Chiodini P, 2009, GUIDELINES MALARIA P; Coca SG, 2008, KIDNEY INT, V73, P1008, DOI 10.1038/sj.ki.5002729; Cooper RG, 2008, INDIAN J MED RES, V127, P305; Couser WG, 1998, NEPHROL DIAL TRANSPL, V13, P10, DOI 10.1093/ndt/13.suppl_1.10; Dong X, 2007, KIDNEY INT, V71, P619, DOI 10.1038/sj.ki.5002132; Edelstein CL, 2008, ADV CHRONIC KIDNEY D, V15, P222, DOI 10.1053/j.ackd.2008.04.003; Fang H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.225; Garcia-Criado FJ, 1998, TRANSPLANTATION, V66, P982, DOI 10.1097/00007890-199810270-00003; Gerstein HC, 2002, DIABETES RES CLIN PR, V55, P209, DOI 10.1016/S0168-8227(01)00325-4; Ghigo D, 1998, J CLIN INVEST, V102, P595, DOI 10.1172/JCI1052; GUSTAFSSON LL, 1983, BRIT J CLIN PHARMACO, V15, P471, DOI 10.1111/j.1365-2125.1983.tb01532.x; Harhaji-Trajkovic L, 2012, PHARM RES-DORDR, V29, P2249, DOI 10.1007/s11095-012-0753-1; Holschermann H, 2006, ATHEROSCLEROSIS, V185, P240, DOI 10.1016/j.atherosclerosis.2005.06.019; Ichimura T, 2004, AM J PHYSIOL-RENAL, V286, pF552, DOI 10.1152/ajprenal.00285.2002; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Jiang M, 2012, KIDNEY INT, V82, P1271, DOI 10.1038/ki.2012.261; Jiang M, 2010, AM J PATHOL, V176, P1181, DOI 10.2353/ajpath.2010.090594; Kalia S, 2007, DERMATOL THER, V20, P160, DOI 10.1111/j.1529-8019.2007.00131.x; Kunzendorf U, 2010, DRUGS, V70, P1099, DOI 10.2165/11535890-000000000-00000; Lameire N, 2005, LANCET, V365, P417; Magwere T, 1997, FREE RADICAL BIO MED, V22, P321; Martensson J, 2012, BRIT J ANAESTH, V109, P843, DOI 10.1093/bja/aes357; McDuffie JE, 2013, INT J TOXICOL, V32, P251, DOI 10.1177/1091581813493013; MUSABAYANE CT, 1993, J TROP MED HYG, V96, P305; Musabayane CT, 1996, TROP MED INT HEALTH, V1, P542, DOI 10.1046/j.1365-3156.1996.d01-81.x; Nesic Z, 2006, J PHARMACOL SCI, V102, P413, DOI 10.1254/jphs.SCE06002X; Nujic K, 2012, CELL IMMUNOL, V279, P78, DOI 10.1016/j.cellimm.2012.09.007; Petri M, 1996, LUPUS, V5, pS16, DOI 10.1177/096120339600500105; Petri M, 1996, SCAND J RHEUMATOL, V25, P191, DOI 10.3109/03009749609069986; Rouschop KMA, 2008, KIDNEY INT, V73, P1333, DOI 10.1038/ki.2008.156; Slocum JL, 2012, TRANSL RES, V159, P277, DOI 10.1016/j.trsl.2012.01.014; SOFOLA OA, 1981, J TROP MED HYG, V84, P249; SOLEZ K, 1979, MEDICINE, V58, P362, DOI 10.1097/00005792-197909000-00003; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; SPERBER K, 1993, J RHEUMATOL, V20, P803; Thome R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065913; Thurman JM, 2007, CLIN IMMUNOL, V123, P7, DOI 10.1016/j.clim.2006.09.008; Todorovic Z, 2009, ANAL PHARM ACTIVE CO, P217; Todorovic Z, 2008, J PHARMACOL SCI, V107, P465, DOI 10.1254/jphs.SC0070374; Tsigou E, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/361078; Urbschat A, 2011, BIOMARKERS, V16, pS22, DOI 10.3109/1354750X.2011.587129; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Vaidya VS, 2009, KIDNEY INT, V76, P108, DOI 10.1038/ki.2009.96; vandenBorne BEEM, 1997, J RHEUMATOL, V24, P55; WALLACE DJ, 1987, ARTHRITIS RHEUM, V30, P1435, DOI 10.1002/art.1780301219; Weber SM, 2000, J IMMUNOL, V165, P1534, DOI 10.4049/jimmunol.165.3.1534; Wozniacka A, 2007, LUPUS, V16, P89, DOI 10.1177/0961203306075384; Yasuda H, 2008, AM J PHYSIOL-RENAL, V294, pF1050, DOI 10.1152/ajprenal.00461.2007; Zhang PL, 2008, KIDNEY INT, V73, P608, DOI 10.1038/sj.ki.5002697; Zorica N, 2008, ACTA VET-BEOGRAD, V58, P413, DOI 10.2298/AVB0806413N	62	24	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92673	10.1371/journal.pone.0092673	http://dx.doi.org/10.1371/journal.pone.0092673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681567	gold, Green Published, Green Submitted			2022-12-27	WOS:000333678100014
J	Engert, V; Merla, A; Grant, JA; Cardone, D; Tusche, A; Singer, T				Engert, Veronika; Merla, Arcangelo; Grant, Joshua A.; Cardone, Daniela; Tusche, Anita; Singer, Tania			Exploring the Use of Thermal Infrared Imaging in Human Stress Research	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; SYMPATHETIC-NERVOUS-SYSTEM; PSYCHOSOCIAL STRESS; RESPONSES; CORTISOL; TEMPERATURE; ENDOCRINE; AXIS; ACTIVATION; HEMORRHAGE	High resolution thermal infrared imaging is a pioneering method giving indices of sympathetic activity via the contact-free recording of facial tissues (thermal imprints). Compared to established stress markers, the great advantage of this method is its non-invasiveness. The goal of our study was to pilot the use of thermal infrared imaging in the classical setting of human stress research. Thermal imprints were compared to established stress markers (heart rate, heart rate variability, finger temperature, alpha-amylase and cortisol) in 15 participants undergoing anticipation, stress and recovery phases of two laboratory stress tests, the Cold Pressor Test and the Trier Social Stress Test. The majority of the thermal imprints proved to be change-sensitive in both tests. While correlations between the thermal imprints and established stress markers were mostly non-significant, the thermal imprints (but not the established stress makers) did correlate with stress-induced mood changes. Multivariate pattern analysis revealed that in contrast to the established stress markers the thermal imprints could not disambiguate anticipation, stress and recovery phases of both tests. Overall, these results suggest that thermal infrared imaging is a valuable method for the estimation of sympathetic activity in the stress laboratory setting. The use of this non-invasive method may be particularly beneficial for covert recordings, in the study of special populations showing difficulties in complying with the standard instruments of data collection and in the domain of psychophysiological covariance research. Meanwhile, the established stress markers seem to be superior when it comes to the characterization of complex physiological states during the different phases of the stress cycle.	[Engert, Veronika; Grant, Joshua A.; Tusche, Anita; Singer, Tania] Max Planck Inst Human Cognit & Brain Sci, Dept Social Neurosci, Leipzig, Germany; [Merla, Arcangelo; Cardone, Daniela] G Dannunzio Fdn, Inst Adv Biomed Technol ITAB, Chieti, Italy; [Merla, Arcangelo; Cardone, Daniela] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy	Max Planck Society; G d'Annunzio University of Chieti-Pescara	Engert, V (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Social Neurosci, Leipzig, Germany.	engert@cbs.mpg.de	Tusche, Anita/ABB-3952-2021; Engert, Veronika/N-1572-2017; Cardone, Daniela/AAJ-2288-2021; Grant, Joshua/I-2615-2014	Engert, Veronika/0000-0001-5317-933X; Cardone, Daniela/0000-0002-1506-1995; Tusche, Anita/0000-0003-4180-8447; Grant, Joshua/0000-0003-3142-4044	Max Planck Gesellschaft	Max Planck Gesellschaft(Max Planck Society)	This work was supported by Max Planck Gesellschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	al'Absi M, 2002, PAIN, V96, P197, DOI 10.1016/S0304-3959(01)00447-X; Anbar M, 2002, ANN NY ACAD SCI, V972, P111, DOI 10.1111/j.1749-6632.2002.tb04560.x; [Anonymous], 2000, HDB PSYCHOPHYSIOLOGY; Buchanan TW, 1999, PSYCHONEUROENDOCRINO, V24, P227, DOI 10.1016/S0306-4530(98)00078-X; Camm AJ, 1996, CIRCULATION, V93, P1043; Camm AJ, 1995, GEOMETRICAL METHODS; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; CHIEN S, 1967, PHYSIOL REV, V47, P214, DOI 10.1152/physrev.1967.47.2.214; Cohen S, 2000, ANN BEHAV MED, V22, P171, DOI 10.1007/BF02895111; Dallman M. F., 2000, ENCY STRESS; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Dowdall J, 2007, COMPUT VIS IMAGE UND, V106, P205, DOI 10.1016/j.cviu.2006.08.011; DRESSENDORFER RA, 1992, J STEROID BIOCHEM, V43, P683, DOI 10.1016/0960-0760(92)90294-S; Ebisch SJ, 2012, BIOL PSYCHOL, V89, P123, DOI 10.1016/j.biopsycho.2011.09.018; Engert V, 2011, PSYCHONEUROENDOCRINO, V36, P1294, DOI 10.1016/j.psyneuen.2011.02.018; Foley P, 2010, NEUROSCI BIOBEHAV R, V35, P91, DOI 10.1016/j.neubiorev.2010.01.010; Fries E, 2009, INT J PSYCHOPHYSIOL, V72, P67, DOI 10.1016/j.ijpsycho.2008.03.014; Gleeson M, 1998, INT J SPORTS MED, V19, pS96, DOI 10.1055/s-2007-971967; HADDY FJ, 1968, ANNU REV MED, V19, P167, DOI 10.1146/annurev.me.19.020168.001123; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; Hines EA, 1932, P STAFF M MAYO CLIN, P332; Iriarte J, 2003, J CLIN NEUROPHYSIOL, V20, P249, DOI 10.1097/00004691-200307000-00004; Ivanciuc O, 2007, PROTEIN PEPTIDE LETT, V14, P903, DOI 10.2174/092986607782110257; Kajantie E, 2006, PSYCHONEUROENDOCRINO, V31, P151, DOI 10.1016/j.psyneuen.2005.07.002; Kawasaki H, 2001, NAT NEUROSCI, V4, P15, DOI 10.1038/82850; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kistler A, 1998, INT J PSYCHOPHYSIOL, V29, P35, DOI 10.1016/S0167-8760(97)00087-1; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P983, DOI 10.1016/j.psyneuen.2003.08.009; Kuraoka K, 2011, PHYSIOL BEHAV, V102, P347, DOI 10.1016/j.physbeh.2010.11.029; Lorentz K, 1999, CLIN CHEM LAB MED, V37, P1053, DOI 10.1515/CCLM.1999.154; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; Merla A, 2007, P ANN INT IEEE EMBS, P247, DOI 10.1109/IEMBS.2007.4352270; Miller R, 2013, PSYCHONEUROENDOCRINO, V38, P941, DOI 10.1016/j.psyneuen.2012.09.013; Misaki M, 2010, NEUROIMAGE, V53, P103, DOI 10.1016/j.neuroimage.2010.05.051; Mourot L, 2009, PHYSIOL RES, V58, P83, DOI 10.33549/physiolres.931360; Mur M, 2009, SOC COGN AFFECT NEUR, V4, P101, DOI 10.1093/scan/nsn044; Nakanishi R, 2008, INFANT BEHAV DEV, V31, P137, DOI 10.1016/j.infbeh.2007.09.001; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nhan BR, 2010, IEEE T BIO-MED ENG, V57, P979, DOI 10.1109/TBME.2009.2035926; Or Calvin K. L., 2007, Occupational Ergonomics, V7, P83; Pavlidis I, 2012, SCI REP-UK, V2, DOI 10.1038/srep00305; Pavlidis I, 2002, NATURE, V415, P35, DOI 10.1038/415035a; PEARCE WJ, 1980, STROKE, V11, P190, DOI 10.1161/01.STR.11.2.190; Pereira Francisco, 2009, Neuroimage, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Rohleder N, 2004, ANN NY ACAD SCI, V1032, P258, DOI 10.1196/annals.1314.033; Rohleder N, 2009, PSYCHONEUROENDOCRINO, V34, P469, DOI 10.1016/j.psyneuen.2008.12.004; Schlotz W, 2008, PSYCHOSOM MED, V70, P787, DOI 10.1097/PSY.0b013e3181810658; Schommer NC, 2003, PSYCHOSOM MED, V65, P450, DOI 10.1097/01.PSY.0000035721.12441.17; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; Shastri D, 2009, IEEE T BIO-MED ENG, V56, P477, DOI 10.1109/TBME.2008.2003265; van Stegeren A, 2006, PSYCHONEUROENDOCRINO, V31, P137, DOI 10.1016/j.psyneuen.2005.05.012; VATNER SF, 1974, J CLIN INVEST, V54, P225, DOI 10.1172/JCI107757; von Baeyer CL, 2005, J PAIN, V6, P218, DOI 10.1016/j.jpain.2005.01.349; WINNDEEN ES, 1988, CLIN CHEM, V34, P2005	54	71	72	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e90782	10.1371/journal.pone.0090782	http://dx.doi.org/10.1371/journal.pone.0090782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675709	Green Published, gold			2022-12-27	WOS:000333677500009
J	Henson, CA; Duke, SH; Livingston, DP				Henson, Cynthia A.; Duke, Stanley H.; Livingston, David P., III			Metabolic Changes in Avena sativa Crowns Recovering from Freezing	PLOS ONE			English	Article							LOW-TEMPERATURE TOLERANCE; QUANTITATIVE TRAIT LOCI; COLD-ACCLIMATION; FROST-TOLERANCE; INTRACELLULAR SUBSTANCES; AMINO-ACID; ARABIDOPSIS-THALIANA; WINTER HARDINESS; LYSINE CATABOLISM; ENZYME-ACTIVITIES	Extensive research has been conducted on cold acclimation and freezing tolerance of fall-sown cereal plants due to their economic importance; however, little has been reported on the biochemical changes occurring over time after the freezing conditions are replaced by conditions favorable for recovery and growth such as would occur during spring. In this study, GC-MS was used to detect metabolic changes in the overwintering crown tissue of oat (Avena sativa L.) during a fourteen day time-course after freezing. Metabolomic analysis revealed increases in most amino acids, particularly proline, 5-oxoproline and arginine, which increased greatly in crowns that were frozen compared to controls and correlated very significantly with days after freezing. In contrast, sugar and sugar related metabolites were little changed by freezing, except sucrose and fructose which decreased dramatically. In frozen tissue all TCA cycle metabolites, especially citrate and malate, decreased in relation to unfrozen tissue. Alterations in some amino acid pools after freezing were similar to those observed in cold acclimation whereas most changes in sugar pools after freezing were not. These similarities and differences suggest that there are common as well as unique genetic mechanisms between these two environmental conditions that are crucial to the winter survival of plants.	[Henson, Cynthia A.] USDA ARS, Cereal Crops Res Unit, Madison, WI 53706 USA; [Henson, Cynthia A.; Duke, Stanley H.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Livingston, David P., III] N Carolina State Univ, USDA ARS, Raleigh, NC 27695 USA; [Livingston, David P., III] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA	United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Henson, CA (corresponding author), USDA ARS, Cereal Crops Res Unit, Madison, WI 53706 USA.	cynthia.henson@usda.ars.gov			USDA-ARS; University of Wisconsin-Madison	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); University of Wisconsin-Madison	This study was supported by USDA-ARS and the University of Wisconsin-Madison. The fund agency provided general oversight and review but had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKAWA T, 1983, ARCH BIOCHEM BIOPHYS, V224, P169, DOI 10.1016/0003-9861(83)90201-1; ARAKAWA T, 1985, BIOPHYS J, V47, P411, DOI 10.1016/S0006-3495(85)83932-1; Briggs DE, 2009, J I BREWING, V115, P41, DOI 10.1002/j.2050-0416.2009.tb00343.x; Brouwer DJ, 2000, CROP SCI, V40, P1387, DOI 10.2135/cropsci2000.4051387x; Brouwer DJ, 1998, CROP SCI, V38, P1704, DOI 10.2135/cropsci1998.0011183X003800060047x; CAI Q, 1994, THEOR APPL GENET, V89, P606, DOI 10.1007/BF00222455; CATTIVELLI L, 1990, PLANT PHYSIOL, V93, P1504, DOI 10.1104/pp.93.4.1504; CHU TM, 1978, PHYSIOL PLANTARUM, V43, P254, DOI 10.1111/j.1399-3054.1978.tb02573.x; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; Dauwe R, 2012, NEW PHYTOL, V194, P192, DOI 10.1111/j.1469-8137.2011.04027.x; Davey MP, 2009, METABOLOMICS, V5, P138, DOI 10.1007/s11306-008-0127-1; DRAPER SR, 1972, PHYTOCHEMISTRY, V11, P639, DOI 10.1016/0031-9422(72)80025-6; DUKE SH, 1978, PLANT PHYSIOL, V62, P642, DOI 10.1104/pp.62.4.642; DUKE SH, 1981, CROP SCI, V21, P489, DOI 10.2135/cropsci1981.0011183X002100040003x; DUKE SH, 1983, PLANT PHYSIOL, V72, P919, DOI 10.1104/pp.72.4.919; DUKE SH, 1986, PHYSIOL PLANTARUM, V68, P625, DOI 10.1111/j.1399-3054.1986.tb03407.x; DUKE SH, 1981, PLANT PHYSIOL, V67, P449, DOI 10.1104/pp.67.3.449; Fowler DB, 2004, ANN BOT-LONDON, V94, P717, DOI 10.1093/aob/mch196; Francia E, 2004, THEOR APPL GENET, V108, P670, DOI 10.1007/s00122-003-1468-9; Galili G, 2001, CURR OPIN PLANT BIOL, V4, P261, DOI 10.1016/S1369-5266(00)00170-9; GALSTON AW, 1978, PLANT SCI LETT, V11, P69, DOI 10.1016/0304-4211(78)90054-8; Gaufichon L, 2010, PLANT SCI, V179, P141, DOI 10.1016/j.plantsci.2010.04.010; GOAS G, 1976, CAN J BOT, V54, P1221, DOI 10.1139/b76-132; GUO WW, 1992, PLANT PHYSIOL, V100, P915, DOI 10.1104/pp.100.2.915; GUY CL, 1990, ANNU REV PLANT PHYS, V41, P187, DOI 10.1146/annurev.pp.41.060190.001155; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Hannah MA, 2010, PLANT PHYSIOL, V152, P2120, DOI 10.1104/pp.109.147306; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; HAYES PM, 1993, GENOME, V36, P66, DOI 10.1139/g93-009; Herman EM, 2006, J EXP BOT, V57, P3601, DOI 10.1093/jxb/erl111; Hughes MA, 1996, J EXP BOT, V47, P291, DOI 10.1093/jxb/47.3.291; Jannink JL, 2005, CROP SCI, V45, P2383, DOI 10.2135/cropsci2005.0285; KANDPAL RP, 1985, PLANT SCI, V40, P73, DOI 10.1016/0168-9452(85)90044-5; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kaplan F, 2007, PLANT J, V50, P967, DOI 10.1111/j.1365-313X.2007.03100.x; Kim JS, 2007, NUCLEIC ACIDS RES, V35, P506, DOI 10.1093/nar/gkl1076; Koag MC, 2003, PLANT PHYSIOL, V131, P309, DOI 10.1104/pp.011171; Kobayashi F, 2005, J EXP BOT, V56, P887, DOI 10.1093/jxb/eri081; Korn M, 2010, MOL PLANT, V3, P224, DOI 10.1093/mp/ssp105; Kovacs Z, 2011, PLANT SCI, V180, P61, DOI 10.1016/j.plantsci.2010.08.010; KUO CG, 1986, J AM SOC HORTIC SCI, V111, P746; Le MQ, 2008, CRYOBIOLOGY, V57, P104, DOI 10.1016/j.cryobiol.2008.06.004; Lejeune-Henaut I, 2008, THEOR APPL GENET, V116, P1105, DOI 10.1007/s00122-008-0739-x; Li CD, 2000, THEOR APPL GENET, V101, P1259, DOI 10.1007/s001220051605; Limin AE, 2002, ANN BOT-LONDON, V89, P579, DOI 10.1093/aob/mcf102; Livingston DP, 2007, CRYOBIOLOGY, V54, P154, DOI 10.1016/j.cryobiol.2006.12.004; Livingston DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053468; Livingston DP, 2005, CROP SCI, V45, P1545, DOI 10.2135/cropsci2004.0579; Livingston DP, 1998, PLANT PHYSIOL, V116, P403, DOI 10.1104/pp.116.1.403; Livingston DP, 1996, CROP SCI, V36, P1568, DOI 10.2135/cropsci1996.0011183X003600060027x; MACHACKOVA I, 1989, PHYSIOL PLANTARUM, V76, P603, DOI 10.1111/j.1399-3054.1989.tb05486.x; Maloney PV, 2011, CROP SCI, V51, P490, DOI 10.2135/cropsci2010.04.0224; MATTHEWS BW, 1987, P NATL ACAD SCI USA, V84, P6663, DOI 10.1073/pnas.84.19.6663; Mazzucotelli E, 2006, J EXP BOT, V57, P3755, DOI 10.1093/jxb/erl141; MOLLER BL, 1976, PLANT PHYSIOL, V57, P687, DOI 10.1104/pp.57.5.687; Moulin M, 2006, PLANT PHYSIOL BIOCH, V44, P474, DOI 10.1016/j.plaphy.2006.08.005; Muslin EH, 2002, PROTEIN ENG, V15, P29, DOI 10.1093/protein/15.1.29; NAIDU BP, 1991, PHYTOCHEMISTRY, V30, P407, DOI 10.1016/0031-9422(91)83693-F; Ohkama-Ohtsu N, 2008, PLANT PHYSIOL, V148, P1603, DOI 10.1104/pp.108.125716; OLIEN CR, 1981, CRYOBIOLOGY, V18, P404, DOI 10.1016/0011-2240(81)90114-0; OLIEN CR, 1984, CROP SCI, V24, P51, DOI 10.2135/cropsci1984.0011183X002400010012x; PALTA JP, 1993, ADVANCES IN PLANT COLD HARDINESS, P143; PALTA JP, 1980, PHYSIOL PLANTARUM, V50, P169, DOI 10.1111/j.1399-3054.1980.tb04446.x; PALTA JP, 1977, PLANT PHYSIOL, V60, P398, DOI 10.1104/pp.60.3.398; PAN A, 1994, THEOR APPL GENET, V89, P900, DOI 10.1007/BF00224516; PEARCE RS, 1977, PLANTA, V134, P159, DOI 10.1007/BF00384966; Pearce RS, 2004, LIFE IN THE FROZEN STATE, P171, DOI 10.1201/9780203647073.ch5; Peters J., 2000, AOSA CONTR; Reinheimer JL, 2004, THEOR APPL GENET, V109, P1267, DOI 10.1007/s00122-004-1736-3; Roessner U, 2002, PLANT CELL REP, V21, P189, DOI 10.1007/s00299-002-0510-8; RUDOLPH AS, 1986, ARCH BIOCHEM BIOPHYS, V245, P134, DOI 10.1016/0003-9861(86)90197-9; Santos AG, 2006, CROP SCI, V46, P203, DOI 10.2135/cropsci2005.0152; SCHOBERT B, 1978, BIOCHIM BIOPHYS ACTA, V541, P270, DOI 10.1016/0304-4165(78)90400-2; Seki Motoaki, 2002, Funct Integr Genomics, V2, P282, DOI 10.1007/s10142-002-0070-6; Shibata S., 1986, Journal of Japanese Society of Grassland Science, V32, P197; Sinha AK, 2002, PLANT PHYSIOL, V128, P1480, DOI 10.1104/pp.010771; Skinner J, 2006, THEOR APPL GENET, V112, P832, DOI 10.1007/s00122-005-0185-y; Steponkus PL, 1998, P NATL ACAD SCI USA, V95, P14570, DOI 10.1073/pnas.95.24.14570; STEPONKUS PL, 1967, PLANT PHYSIOL, V42, P1423, DOI 10.1104/pp.42.10.1423; SULC RM, 1991, CROP SCI, V31, P1575, DOI 10.2135/cropsci1991.0011183X003100060039x; SULC RM, 1991, CROP SCI, V31, P430, DOI 10.2135/cropsci1991.0011183X003100020041x; Sung DY, 2003, TRENDS PLANT SCI, V8, P179, DOI 10.1016/S1360-1385(03)00047-5; SUZUKI Y, 1989, P JPN ACAD B-PHYS, V65, P146, DOI 10.2183/pjab.65.146; TANINO KK, 1985, CAN J BOT, V63, P432, DOI 10.1139/b85-053; Thomashow M. F., 1990, Advances in Genetics, V28, P99; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Toth B, 2003, THEOR APPL GENET, V107, P509, DOI 10.1007/s00122-003-1275-3; Trunova T., 1965, FIZIOL RAST, V12, P70; Usadel B, 2008, PLANT CELL ENVIRON, V31, P518, DOI 10.1111/j.1365-3040.2007.01763.x; Vagujfalvi A, 2003, MOL GENET GENOMICS, V269, P60, DOI 10.1007/s00438-003-0806-6; VANSWAAIJ AC, 1985, PHYSIOL PLANTARUM, V64, P230, DOI 10.1111/j.1399-3054.1985.tb02341.x; VANWAGENEN BC, 1986, TETRAHEDRON, V42, P1117, DOI 10.1016/S0040-4020(01)87515-3; Vranova V, 2011, PLANT SOIL, V342, P31, DOI 10.1007/s11104-010-0673-y; Weinberg MV, 2005, J BACTERIOL, V187, P336, DOI 10.1128/JB.187.1.336-348.2005; Wooten DR, 2007, CROP SCI, V47, P1832, DOI 10.2135/cropsci2006.12.0768; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010	96	7	7	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93085	10.1371/journal.pone.0093085	http://dx.doi.org/10.1371/journal.pone.0093085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675792	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500071
J	Kasatkar, P; Shetty, S; Ghosh, K				Kasatkar, Priyanka; Shetty, Shrimati; Ghosh, Kanjaksha			Genetic Heterogeneity in a Large Cohort of Indian Type 3 von Willebrand Disease Patients	PLOS ONE			English	Article							VONWILLEBRAND-FACTOR GENE; MOLECULAR CHARACTERIZATION; BLEEDING QUESTIONNAIRE; VWF GENE; PREVALENCE; MUTATIONS; DEFECTS; POPULATION; PSEUDOGENE; GENERATION	Background: Though von Willebrand disease (VWD) is a common coagulation disorder, due to the complexity of the molecular analysis of von Willebrand factor gene (VWF), not many reports are available from this country. Large size of the gene, heterogeneous nature of mutations and presence of a highly homologous pseudogene region are the major impediments in the genetic diagnosis of VWD. The study is aimed at unravelling the molecular pathology in a large series of VWD patients from India using an effective strategy. Method: We evaluated 85 unrelated Indian type 3 VWD families to identify the molecular defects using a combination of techniques i.e. PCR-RFLP, direct DNA sequencing and multiple ligation probe amplification (MLPA). Results: Mutations could be characterized in 77 unrelated index cases (ICs). 59 different mutations i.e. nonsense 20 (33.9%), missense 13 (22%), splice site 4 (6.8%), gene conversions 6 (10.2%), insertions 2 (3.4%), duplication 1 (1.7%), small deletions 10 (17%) and large deletions 3 (5.1%) were identified, of which 34 were novel. Two common mutations i.e. p.R1779* and p.L970del were identified in our population with founder effect. Development of alloantibodies to VWF was seen in two patients, one with nonsense mutation (p.R2434*) and the other had a large deletion spanning exons 16-52. Conclusion: The molecular pathology of a large cohort of Indian VWD patients could be identified using a combination of techniques. A wide heterogeneity was observed in the nature of mutations in Indian VWD patients.	[Kasatkar, Priyanka; Shetty, Shrimati; Ghosh, Kanjaksha] King Edward Mem Hosp, Natl Inst Immunohaematol ICMR, Dept Haemostasis & Thrombosis, Bombay, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Immunohaemotology (NIIH); Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital	Ghosh, K (corresponding author), King Edward Mem Hosp, Natl Inst Immunohaematol ICMR, Dept Haemostasis & Thrombosis, Bombay, Maharashtra, India.	kanjakshaghosh@hotmail.com	Ghosh, Kanjaksha/D-7621-2015	Ghosh, Kanjaksha/0000-0002-0645-6565	Council of Scientific and Industrial Research (CSIR); Lady Tata Junior Research Fellowship	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Lady Tata Junior Research Fellowship	This project is funded by Council of Scientific and Industrial Research (CSIR), and a Lady Tata Junior Research Fellowship was granted to one of the authors (PK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2013, THROMB HAEMOSTASIS, V109, P652, DOI 10.1160/TH12-10-0737; Ahmad F, 2013, THROMB HAEMOSTASIS, V109, P39, DOI 10.1160/TH12-07-0475; BAHNAK BR, 1991, BLOOD, V78, P1148, DOI 10.1182/blood.V78.4.1148.bloodjournal7841148; Baronciani L, 2003, BLOOD CELL MOL DIS, V30, P264, DOI 10.1016/S1079-9796(03)00033-0; Baronciani L, 2000, THROMB HAEMOSTASIS, V84, P536; Biss TT, 2010, J THROMB HAEMOST, V8, P950, DOI 10.1111/j.1538-7836.2010.03796.x; Bowman M, 2008, J THROMB HAEMOST, V6, P2062, DOI 10.1111/j.1538-7836.2008.03182.x; Bowman M, 2010, J THROMB HAEMOST, V8, P213, DOI 10.1111/j.1538-7836.2009.03661.x; Casana P, 2000, BRIT J HAEMATOL, V111, P552, DOI 10.1046/j.1365-2141.2000.02410.x; Corrales I, 2012, HAEMATOL-HEMATOL J, V97, P1003, DOI 10.3324/haematol.2011.055285; Corrales I, 2009, THROMB HAEMOSTASIS, V101, P570, DOI 10.1160/TH08-08-0500; Eikenboom JCJ, 1998, THROMB HAEMOSTASIS, V79, P709; Gupta PK, 2008, BLOOD CELL MOL DIS, V41, P219, DOI 10.1016/j.bcmd.2008.03.004; Gupta PK, 2005, BRIT J HAEMATOL, V130, P752, DOI 10.1111/j.1365-2141.2005.05660.x; Kasatkar P, 2013, J THROMB HAEMOST, V11, P1784, DOI 10.1111/jth.12323; Kasatkar P, 2014, ANN HEMATOL, V93, P173, DOI 10.1007/s00277-013-1767-4; Kasatkar P, 2010, CLIN CHIM ACTA, V411, P607, DOI 10.1016/j.cca.2009.12.024; MANCUSO DJ, 1991, BIOCHEMISTRY-US, V30, P253, DOI 10.1021/bi00215a036; Mohl A, 2008, J THROMB HAEMOST, V6, P1729, DOI 10.1111/j.1538-7836.2008.03107.x; PATRACCHINI P, 1989, HUM GENET, V83, P264, DOI 10.1007/BF00285168; RODEGHIERO F, 1987, BLOOD, V69, P454; Sadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.x; SCHNEPPENHEIM R, 1994, HUM GENET, V94, P640; Shahbazi S, 2009, HAEMOPHILIA, V15, P1058, DOI 10.1111/j.1365-2516.2009.02046.x; Solimando M, 2012, AM J HEMATOL, V87, P870, DOI 10.1002/ajh.23265; Surdhar GK, 2001, BLOOD, V98, P248, DOI 10.1182/blood.V98.1.248; Terraube V, 2010, HAEMOPHILIA, V16, P3, DOI 10.1111/j.1365-2516.2009.02005.x; Trasi S, 2006, ACTA HAEMATOL-BASEL, V115, P64, DOI 10.1159/000089468; Trasi S, 2005, INDIAN J MED RES, V121, P653; WERNER EJ, 1993, J PEDIATR-US, V123, P893, DOI 10.1016/S0022-3476(05)80384-1; Xie F, 2006, BLOOD CELL MOL DIS, V36, P385, DOI 10.1016/j.bcmd.2006.03.003; Yadegari H, 2012, THROMB HAEMOSTASIS, V108, P662, DOI 10.1160/TH12-02-0089; ZHANG ZP, 1992, AM J HUM GENET, V51, P850	33	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92575	10.1371/journal.pone.0092575	http://dx.doi.org/10.1371/journal.pone.0092575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675615	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500026
J	Muthuri, SK; Francis, CE; Wachira, LJM; LeBlanc, AG; Sampson, M; Onywera, VO; Tremblay, MS				Muthuri, Stella K.; Francis, Claire E.; Wachira, Lucy-Joy M.; LeBlanc, Allana G.; Sampson, Margaret; Onywera, Vincent O.; Tremblay, Mark S.			Evidence of an Overweight/Obesity Transition among School-Aged Children and Youth in Sub-Saharan Africa: A Systematic Review	PLOS ONE			English	Review							BODY-MASS INDEX; SENEGALESE ADOLESCENT GIRLS; ELLISRAS LONGITUDINAL GROWTH; HABITUAL PHYSICAL-ACTIVITY; BLOOD-PRESSURE PATTERNS; CROSS-SECTIONAL GROWTH; NORTH-WEST PROVINCE; VITAMIN-D STATUS; 4 ETHNIC-GROUPS; NUTRITIONAL-STATUS	Background: Prevalence of childhood overweight/obesity has increased considerably in recent years. The transition to higher rates of overweight/obesity has been well documented in high income countries; however, consistent or representative data from lower income countries is scarce. It is therefore pertinent to assess if rates of overweight/obesity are also increasing in lower income countries, to inform public health efforts. Objective: This systematic review aimed to investigate the evidence for an overweight/obesity transition occurring in school-aged children and youth in Sub Saharan Africa. Methods: Studies were identified by searching the MEDLINE, Embase, Africa Index Medicus, Global Health, Geobase, and EPPI-Centre electronic databases. Studies that used subjective or objective metrics to assess body composition in apparently healthy or population-based samples of children and youth aged 5 to 17 years were included. Results: A total of 283 articles met the inclusion criteria, and of these, 68 were used for quantitative synthesis. The four regions (West, Central, East, and South) of Sub Saharan Africa were well represented, though only 11 (3.9%) studies were nationally representative. Quantitative synthesis revealed a trend towards increasing proportions of overweight/obesity over time in school-aged children in this region, as well as a persistent problem of underweight. Weighted averages of overweight/obesity and obesity for the entire time period captured were 10.6% and 2.5% respectively. Body composition measures were found to be higher in girls than boys, and higher in urban living and higher socioeconomic status children compared to rural populations or those of lower socioeconomic status. Conclusions: This review provides evidence for an overweight/obesity transition in school-aged children in Sub Saharan Africa. The findings of this review serve to describe the region with respect to the growing concern of childhood overweight/obesity, highlight research gaps, and inform interventions.	[Muthuri, Stella K.; Francis, Claire E.; LeBlanc, Allana G.; Sampson, Margaret; Onywera, Vincent O.; Tremblay, Mark S.] Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON, Canada; [Muthuri, Stella K.; LeBlanc, Allana G.; Tremblay, Mark S.] Univ Ottawa, Ottawa, ON, Canada; [Wachira, Lucy-Joy M.; Onywera, Vincent O.; Tremblay, Mark S.] Kenyatta Univ, Nairobi, Kenya	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Kenyatta University	Muthuri, SK (corresponding author), Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON, Canada.	smuthuri@cheo.on.ca	LeBlanc, Allana/AAX-1651-2021; Tremblay, Mark/ABI-5477-2020; Tremblay, Mark/AAF-2981-2019	LeBlanc, Allana/0000-0002-4468-6783; 				Aandstad A, 2006, BRIT J SPORT MED, V40, P287, DOI 10.1136/bjsm.2005.020040; Abolarin T O, 2011, Nig Q J Hosp Med, V21, P135; Abrahams Z, 2011, PUBLIC HEALTH NUTR, V14, P1752, DOI 10.1017/S1368980011001108; Adamo KB, 2011, INT J PEDIATR OBES, V6, pE225, DOI 10.3109/17477166.2010.543683; ADAMSCAMPBELL LL, 1987, J HYPERTENS, V5, P575, DOI 10.1097/00004872-198710000-00011; ADAMSCAMPBELL LL, 1992, J HUM HYPERTENS, V6, P47; Adegoke S A, 2009, West Afr J Med, V28, P216; ADENIRAN SA, 1988, J SPORT MED PHYS FIT, V28, P267; ADENIRAN SA, 1988, J SPORT MED PHYS FIT, V28, P260; Agyemang C, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-114; Akani NA, 2012, INT ORTHOP, V36, P1247; AKESODE FA, 1983, SOC SCI MED, V17, P107, DOI 10.1016/0277-9536(83)90361-1; Akinkugbe F M, 1999, West Afr J Med, V18, P196; Alamian A, 2009, AM J EPIDEMIOL, V170, P1279, DOI 10.1093/aje/kwp284; Alaofe Halimatou, 2009, Int J Adolesc Med Health, V21, P545; Amare B, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-7; Amare B, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-108; Amusa LO, 2011, PAK J MED SCI, V27, P664; Amuta EU, 2009, PAKISTAN J NUTR, V8, P691, DOI DOI 10.3923/PJN.2009.691.694; Ansa V O, 2010, West Afr J Med, V29, P146; Anyiam J O, 2008, Niger J Med, V17, P407; ARESKOG NH, 1969, AM J CLIN NUTR, V22, P471; Armstrong MEG, 2006, SAMJ S AFR MED J, V96, P439; Armstrong MEG, 2011, EUR J CLIN NUTR, V65, P835, DOI 10.1038/ejcn.2011.46; Armstrong MEG, 2011, PERCEPT MOTOR SKILL, V113, P999, DOI 10.2466/06.10.13.PMS.113.6.999-1016; Ayoola O, 2009, ANN HUM BIOL, V36, P388, DOI 10.1080/03014460902835606; Bafor A, 2012, INT ORTHOP, V36, P1247, DOI 10.1007/s00264-011-1451-z; Bamidele James O, 2010, Int J Adolesc Med Health, V22, P461, DOI 10.1515/IJAMH.2010.22.4.461; Batty GD, 2004, BRIT MED J, V328, P1089, DOI 10.1136/bmj.328.7448.1089; Beasley M, 2002, TROP MED INT HEALTH, V7, P625, DOI 10.1046/j.1365-3156.2002.00900.x; Ben-Bassey UP, 2007, OBES REV, V8, P475, DOI 10.1111/j.1467-789X.2007.00408.x; BENEFICE E, 1992, ANN TROP PAEDIATR, V12, P55, DOI 10.1080/02724936.1992.11747547; Benefice E, 2005, ANN HUM BIOL, V32, P366, DOI 10.1080/03014460500097336; Benefice E, 1998, MED SPORT SCI, V43, P117; Benefice E, 2004, PUBLIC HEALTH NUTR, V7, P479, DOI 10.1079/PHN2003546; Benefice E, 2004, EUR J CLIN NUTR, V58, P292, DOI 10.1038/sj.ejcn.1601781; Benefice E, 1996, ANN HUM BIOL, V23, P307, DOI 10.1080/03014469600004542; Benefice E, 2001, J ADOLESCENT HEALTH, V28, P319, DOI 10.1016/S1054-139X(00)00201-9; Benefice E, 2001, AM J HUM BIOL, V13, P808, DOI 10.1002/ajhb.1126; Benefice E, 1999, EUR J CLIN NUTR, V53, P636, DOI 10.1038/sj.ejcn.1600826; Benefice E, 2011, ANN HUM BIOL, V38, P500, DOI 10.3109/03014460.2011.564207; Berntsen S, 2009, ALLERGY, V64, P1166, DOI 10.1111/j.1398-9995.2009.01979.x; Bhargava A, 2003, ECON HUM BIOL, V1, P309, DOI 10.1016/j.ehb.2003.08.003; BOOYENS J, 1977, S AFR MED J, V52, P1044; Bovet P, 2012, OBES REV, V13, P1080, DOI 10.1111/j.1467-789X.2012.01023.x; Bovet P, 2007, INTERNATIONAL JOURNA, V4, P05; Brabin L, 1997, ACTA PAEDIATR, V86, P1114, DOI 10.1111/j.1651-2227.1997.tb14819.x; Calvert J, 2005, J ALLERGY CLIN IMMUN, V116, P773, DOI 10.1016/j.jaci.2005.05.025; Cameron N, 2004, AM J CLIN NUTR, V80, P70; Cameron N, 2009, EUR J CLIN NUTR, V63, P1065, DOI 10.1038/ejcn.2009.26; Cameron N, 2011, OBESITY SILVER SPRIN; CARSWELL F, 1981, AM J CLIN NUTR, V34, P1292, DOI 10.1093/ajcn/34.7.1292; Chinedu S. N., 2012, Journal of Medical Sciences (Pakistan), V12, P239, DOI 10.3923/jms.2012.239.243; CLEGG EJ, 1978, ANN HUM BIOL, V5, P139, DOI 10.1080/03014467800002731; Cole AH, 1997, BRIT J NUTR, V77, P497, DOI 10.1079/BJN19970052; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; COOVADIA HM, 1978, TROP GEOGR MED, V30, P373; Cordeiro LS, 2012, J NUTR, V142, P1741, DOI 10.3945/jn.111.155994; CORLETT JT, 1988, ANN HUM BIOL, V15, P153, DOI 10.1080/03014468800009571; CORLETT JT, 1988, HUM BIOL, V60, P569; CORLETT JT, 1986, ANN HUM BIOL, V13, P73, DOI 10.1080/03014468600008211; Craig EM, 2012, ARCH DIS CHILD CONFE; Croteau K, 2011, J PHYS ACT HEALTH, V8, P824, DOI 10.1123/jpah.8.6.824; Dabone C, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-34; Dapi LN, 2011, PUBLIC HEALTH NUTR, V14, P904, DOI 10.1017/S1368980010003150; Dapi LN, 2009, NUTR RES, V29, P313, DOI 10.1016/j.nutres.2009.05.002; Davies C T, 1973, J Trop Pediatr Environ Child Health, V19, P110; DAVIES CTM, 1974, ANN HUM BIOL, V1, P257, DOI 10.1080/03014467400000301; DAVIES JCA, 1971, DEV MED CHILD NEUROL, V13, P779; de Onis M, 2004, INT J EPIDEMIOL, V33, P1260, DOI 10.1093/ije/dyh202; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Degarege A, 2013, J INFECT PUBLIC HEAL, V6, P125, DOI 10.1016/j.jiph.2012.11.008; Demerath EW, 2009, J PEDIATR-US, V155, P355, DOI 10.1016/j.jpeds.2009.03.016; DEVILLIERS FPR, 1987, J TROP PEDIATRICS, V33, P143, DOI 10.1093/tropej/33.3.143; Dibba B, 2000, AM J CLIN NUTR, V71, P544; Djarova T, 2006, S AFR J SCI, V102, P4; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; DUFETEL P, 1995, REV MAL RESPIR, V12, P135; Eckhardt CL, 2003, OBES RES, V11, P1553, DOI 10.1038/oby.2003.207; Ejike CECC, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-411; Ejike E. C. C. C., 2010, Pakistan Journal of Nutrition, V9, P392; EKPO EB, 1990, ANN TROP PAEDIATR, V10, P211, DOI 10.1080/02724936.1990.11747432; Ekpo UF, 2008, ANN AGR ENV MED, V15, P187; Ene-Obong H, 2012, FOOD NUTR BULL, V33, P242, DOI 10.1177/156482651203300404; Faye J, 2011, Bull Soc Pathol Exot, V104, P49, DOI 10.1007/s13149-010-0101-9; Feeley AB, 2013, PUBLIC HEALTH NUTR, V16, P693, DOI 10.1017/S1368980012003308; Fetuga M B, 2011, West Afr J Med, V30, P331; Fetuga MB, 2011, INDIAN PEDIATR, V48, P523, DOI 10.1007/s13312-011-0094-x; FISHER M, 1970, Journal of Tropical Pediatrics, V16, P103; Friedman JF, 2005, EUR J CLIN NUTR, V59, P914, DOI 10.1038/sj.ejcn.1602161; Funke O. M., 2008, Pakistan Journal of Nutrition, V7, P503, DOI 10.3923/pjn.2008.503.508; GALLO PG, 1980, HUM BIOL, V52, P547; Garnier D, 2005, AM J HUM BIOL, V17, P718, DOI 10.1002/ajhb.20435; Garnier D, 2003, PUBLIC HEALTH NUTR, V6, P535, DOI 10.1079/PHN2003463; Garnier D, 2001, ANN HUM BIOL, V28, P79; Gebre M, 2009, THE FASEB JOURNAL CO; Ginsburg C, 2013, HEALTH PLACE, V19, P99, DOI 10.1016/j.healthplace.2012.09.016; GODUKA IN, 1992, CHILD DEV, V63, P509; Goon DT, 2012, W INDIAN MED J, V61, P670; Goon DT, 2012, MINERVA PEDIATR, V64, P325; Goon DT, 2011, MINERVA PEDIATR, V63, P467; Goon D. T., 2010, GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, V169, P287; Goon D. T., 2007, African Journal for Physical, Health Education, Recreation and Dance, V13, P294; Goon DT, 2010, OBES REV, V11, P508, DOI 10.1111/j.1467-789X.2009.00682.x; Goon D. T., 2008, African Journal for Physical, Health Education, Recreation and Dance, V14, P130; Goon DT, 2011, PAK J MED SCI, V27, P832; Goon DT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-769; Goon DT, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-60; Gray SJ, 2004, AM J PHYS ANTHROPOL, V125, P193, DOI 10.1002/ajpa.10377; GRIFFIN L, 1982, CENT AFR J MED, V28, P219; Griffiths PL, 2008, ARCH DIS CHILD, V93, P862, DOI 10.1136/adc.2006.112649; Griffiths PL, 2012, J BIOSOC SCI, V44, P433, DOI 10.1017/S0021932012000107; Grillenberger M, 2003, J NUTR, V133, p3957S, DOI 10.1093/jn/133.11.3957S; Hadley C, 2011, AM J PHYS ANTHROPOL, V144, P643, DOI 10.1002/ajpa.21463; HALLER L, 1980, ACTA TROP, V37, P63; Hamidu LJ, 2000, E AFR MED J, V77, P180; Harmse B, 2010, CARDIOVASC J AFR, V21, P316; Hawkesworth S, 2010, AM J CLIN NUTR, V92, P741, DOI 10.3945/ajcn.2010.29475; Hawley NL, 2009, ANN HUM BIOL, V36, P584, DOI 10.1080/03014460903136822; Henry-Unaeze H. N., 2011, Pakistan Journal of Nutrition, V10, P317; Heroux M, 2013, ISRN OBESITY; Hofman KJ, 2006, DISEASE AND MORTALIT; JACOBS M, 1988, S AFR MED J, V74, P341; Jamison DT, 2006, DISEASE AND MORTALIT; Jeremiah Z. A., 2008, Journal of Medical Sciences (Pakistan), V8, P269; Jinabhai CC, 2007, TROP MED INT HEALTH, V12, P944, DOI 10.1111/j.1365-3156.2007.01861.x; Jinabhai CC, 2005, ANN TROP PAEDIATR, V25, P3, DOI 10.1179/146532805X23290; Jinabhai CC, 2003, EUR J CLIN NUTR, V57, P358, DOI 10.1038/sj.ejcn.1601534; Jinabhai CC, 2001, ANN TROP PAEDIATR, V21, P50, DOI 10.1080/02724930020028920; Jonsson B, 2012, HORMONE RESEARCH IN; Kemp C, 2011, SOUTH AFRICAN JOURNA, V23; Kimani-Murage EW, 2011, PUBLIC HEALTH NUTR, V14, P1114, DOI 10.1017/S1368980011000139; Kimani-Murage EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-158; Koueta Fla, 2011, Sante, V21, P227, DOI 10.1684/san.2011.0272; Kramoh KE, 2012, ANN CARDIOL ANGEIOL, V61, P145, DOI 10.1016/j.ancard.2012.04.020; Kruger HS, 2012, PUBLIC HEALTH NUTR, V15, P594, DOI 10.1017/S136898001100262X; Kruger HS, 2012, SOUTH AFRICAN JOURNA, P25; Kruger R, 2006, PUBLIC HEALTH NUTR, V9, P351, DOI 10.1079/PHN2006849; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; KULIN HE, 1982, AM J CLIN NUTR, V36, P527, DOI 10.1093/ajcn/36.3.527; Larbi IA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-469; Larsen HB, 2004, ANN HUM BIOL, V31, P159, DOI 10.1080/03014460410001663416; LAWLESS JW, 1994, J NUTR, V124, P645, DOI 10.1093/jn/124.5.645; Lawlor DA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6224; Leary P M, 1969, S Afr Med J, V43, P1165; Leman CR, 2003, ANN TROP PAEDIATR, V23, P61, DOI 10.1179/000349803125002887; Lennox A, 2008, S AFR J RES SPORT PH, V30, P59; Levitt NS, 1999, J EPIDEMIOL COMMUN H, V53, P264, DOI 10.1136/jech.53.5.264; LITTLE MA, 1983, HUM BIOL, V55, P811; Longo-Mbenza B, 2007, INT J CARDIOL, V121, P171, DOI 10.1016/j.ijcard.2006.11.004; Longo-Mbenza B, 1998, INT J CARDIOL, V63, P287, DOI 10.1016/S0167-5273(97)00311-2; Mabalia-Babela JR, 2003, ARCH PEDIATRIE, V10, P732, DOI 10.1016/S0929-693X(03)00342-7; MABROUK AAM, 1995, E AFR MED J, V72, P258; Madhavan S, 2007, SCAND J PUBLIC HEALT, V35, P107, DOI 10.1080/14034950701355700; Makgae PJ, 2007, ANN HUM BIOL, V34, P240, DOI 10.1080/03014460601144219; Malete L, 2013, J OBES, V2013, DOI 10.1155/2013/763624; Mamabolo R, 2012, JOURNAL OF SCIENCE A, pS42; MARGO G, 1976, S AFR MED J, V50, P1241; MCDONALD MA, 1994, CHILD DEV, V65, P404; Mchiza ZJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-433; McNamara RS, 1985, THE CHALLENGES FOR S; McVeigh JA, 2004, J APPL PHYSIOL, V97, P1006, DOI 10.1152/japplphysiol.00068.2004; Micklesfield L, 2012, JOURNAL OF SCIENCE A; Micklesfield LK, 2007, ANN HUM BIOL, V34, P647, DOI 10.1080/03014460701730024; Micklesfield LK, 2009, CALCIFIED TISSUE INT, V85, P317, DOI 10.1007/s00223-009-9286-y; Micklesfield LK, 2007, J BONE MINER RES, V22, P1869, DOI 10.1359/JBMR.070727; Micklesfield LK, 2011, BONE, V48, P777, DOI 10.1016/j.bone.2010.12.032; Micklesfield LK, 2004, ACTA PAEDIATR, V93, P752, DOI [10.1080/08035250410029380, 10.1111/j.1651-2227.2004.tb03013.x]; Monyeki KD, 2008, J HUM HYPERTENS, V22, P311, DOI 10.1038/jhh.2008.3; Monyeki KD, 2006, INT J EPIDEMIOL, V35, P114, DOI 10.1093/ije/dyi219; Monyeki KD, 1999, INT J EPIDEMIOL, V28, P287, DOI 10.1093/ije/28.2.287; Monyeki M, 2012, JOURNAL OF SCIENCE A; Monyeki M. A., 2004, African Journal for Physical, Health Education, Recreation and Dance, V10, P154; Monyeki MA, 2007, AM J HUM BIOL, V19, P551, DOI 10.1002/ajhb.20616; Monyeki MA, 2005, EUR J CLIN NUTR, V59, P877, DOI 10.1038/sj.ejcn.1602153; Monyeki MA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-374; Moselakgomo Violet Kankane, 2012, Rev. paul. pediatr., V30, P562; Mosha T C E, 2010, Tanzan J Health Res, V12, P6; Motswagole BS, 2011, CARDIOVASC J AFR, V22, P208, DOI 10.5830/CVJA-2010-062; Mukuddem-Petersen J, 2004, INT J OBESITY, V28, P842, DOI 10.1038/sj.ijo.0802586; Mukudi E, 2003, NUTRITION, V19, P612, DOI 10.1016/S0899-9007(03)00037-6; Munday K, 2006, CALCIFIED TISSUE INT, V79, P15, DOI 10.1007/s00223-005-0276-4; Musa DI, 2012, TROP MED INT HEALTH, V17, P1369, DOI 10.1111/j.1365-3156.2012.03083.x; Musa DI, 2012, MED SCI SPORT EXER, V44, P1978, DOI 10.1249/MSS.0b013e31825ae19d; Nagwa MA, 2011, EUR J CLIN NUTR, V65, P409, DOI 10.1038/ejcn.2010.253; Naidoo T, 2012, CARDIOVASC J AFR, V23, P501, DOI 10.5830/CVJA-2012-058; Naiho A. O., 2009, Biomedical & Pharmacology Journal, V2, P467; Naude CE, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-87; NDAMBA J, 1986, CENT AFR J MED, V32, P289; NEUMANN C, 1992, J DEV BEHAV PEDIATR, V13, P392; Neumann CG, 2013, BRIT J NUTR, V109, P1230, DOI 10.1017/S0007114512003121; Ng'andu N H, 1984, Med J Zambia, V18, P30; NGANDU NH, 1992, INT J EPIDEMIOL, V21, P246, DOI 10.1093/ije/21.2.246; NGANDU NH, 1992, S AFR MED J, V81, P408; Nienaber C, 2008, BLOOD COAGUL FIBRIN, V19, P361, DOI 10.1097/MBC.0b013e328304b61a; NNANYELUGO DO, 1982, GROWTH, V46, P220; Nwizu S E, 2011, West Afr J Med, V30, P99; Nyati LH, 2006, AM J PHYS ANTHROPOL, V130, P135, DOI 10.1002/ajpa.20318; Nyirongo L. O. N., 1999, Central African Journal of Medicine, V45, P198; Odenigbo U. M., 2010, Pakistan Journal of Nutrition, V9, P1157; Oelofse A., 1999, Central African Journal of Medicine, V45, P14; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; OGUNRANTI JO, 1987, CHILD CARE HLTH DEV, V13, P59, DOI 10.1111/j.1365-2214.1987.tb00523.x; OGUNRANTI JO, 1986, J TROP PEDIATRICS, V32, P218, DOI 10.1093/tropej/32.5.218; Ojiambo R.M., 2013, J APPL MED SCIENCES, V2, P43; Ojiambo RM, 2012, J PHYS ACT HEALTH, V9, P115, DOI 10.1123/jpah.9.1.115; Ojofeitimi EO, 2011, J PUBLIC HEALTH AFR, V2, P45, DOI 10.4081/jphia.2011.e11; Okoh BA, 2012, PAEDIATR INT CHILD H, V32, P208, DOI 10.1179/2046905512Y.0000000039; Oldewage-Theron W, 2011, S AFR J CLIN NUTR, V24, P99; OLI K, 1994, J TROP PEDIATRICS, V40, P100, DOI 10.1093/tropej/40.2.100; Olivieri F, 2008, AM J PHYS ANTHROPOL, V136, P214, DOI 10.1002/ajpa.20797; Olumakaiye MF, 2010, J NUTR EDUC BEHAV, V42, P144, DOI 10.1016/j.jneb.2008.12.004; Omigbodun OO, 2010, J BIOSOC SCI, V42, P653, DOI 10.1017/S0021932010000234; Onyewadume IU, 2006, ADAPTED PHYSICAL ACT, P23; Onywera V. O., 2013, African Journal for Physical, Health Education, Recreation and Dance, V19, P132; Onywera VO, 2012, J PHYS ACT HEALTH, V9, P554, DOI 10.1123/jpah.9.4.554; Opara D. C., 2010, Pakistan Journal of Nutrition, V9, P459; Opare-Addo PM, 2012, J OBSTET GYNAECOL, V32, P159, DOI 10.3109/01443615.2011.638092; Owa JA, 1997, J TROP PEDIATRICS, V43, P13, DOI 10.1093/tropej/43.1.13; OYEMADE A, 1981, J TROP PEDIATRICS, V27, P101, DOI 10.1093/tropej/27.2.101; Padez C, 2009, AM J HUM BIOL, V21, P200, DOI 10.1002/ajhb.20854; Pawloski LR, 2002, AM J PHYS ANTHROPOL, V117, P364, DOI 10.1002/ajpa.10037; Peltzer K, 2011, INT J ENV RES PUB HE, V8, P3859, DOI 10.3390/ijerph8103859; Perzanowski MS, 2002, J PEDIATR-US, V140, P582, DOI 10.1067/mpd.2002.122937; Pettifor JM, 1997, J BONE MINER RES, V12, P1824, DOI 10.1359/jbmr.1997.12.11.1824; Poopedi MA, 2009, BONE, V45, pS84, DOI 10.1016/j.bone.2009.04.115; Poopedi MA, 2011, PUBLIC HEALTH NUTR, V14, P334, DOI 10.1017/S136898001000234X; POWER DJ, 1982, S AFR MED J, V61, P303; PRAZUCK T, 1989, J TROP PEDIATRICS, V35, P52, DOI [10.1093/tropej/35.2.52-a, 10.1093/tropej/35.2.52]; Prentice A, 2012, AM J CLIN NUTR, V96, P1042, DOI 10.3945/ajcn.112.037481; PRINSLOO J G, 1964, S Afr Med J, V38, P601; Prista A, 2005, HUM BIOL, V77, P457, DOI 10.1353/hub.2005.0069; Prista A, 1998, MED SPORT SCI, V43, P94; Prista A, 2003, AM J CLIN NUTR, V77, P952, DOI 10.1093/ajcn/77.4.952; Prista A, 2009, PEDIATR EXERC SCI, V21, P384, DOI 10.1123/pes.21.4.384; Proctor Munro H., 1996, Ethnicity and Disease, V6, P235; Puckree T., 2011, AFR J PRIM HEALTH CA, V3, P1, DOI DOI 10.4102/phcfm.v4i1.203; Puoane TR, 2013, J HUNGER ENVIRON NUT, V8, P85, DOI 10.1080/19320248.2012.758067; Ramos EM, 2011, TROP MED INT HEALTH, V16, P307; Rankin D, 2011, EUR J CLIN NUTR, V65, P910, DOI 10.1038/ejcn.2011.60; RAO U K G, 1981, Medical Journal of Zambia, V15, P87; Reddy SP, 2012, AM J PUBLIC HEALTH, V102, P262, DOI 10.2105/AJPH.2011.300222; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; REKART ML, 1985, E AFR MED J, V62, P54; RICHARDSON BD, 1977, S AFR MED J, V51, P42; RICHARDSON BD, 1983, J TROP MED HYG, V86, P5; RICHARDSON BD, 1977, TROP GEOGR MED, V29, P82; RICHARDSON BD, 1977, T ROY SOC TROP MED H, V71, P210, DOI 10.1016/0035-9203(77)90009-8; Roberts KC, 2012, HEALTH REP, V23, P37; Rohner F, 2007, BRIT J NUTR, V97, P970, DOI 10.1017/S0007114507665180; Ross R., 2007, PHYS ACTIVITY HLTH, P173; Salman Z, 2010, INT J HYPERTENS, V2011; Schutte AE, 2003, BLOOD PRESSURE, V12, P97, DOI 10.1080/08037050310001075; Sellen DW, 1999, AM J PHYS ANTHROPOL, V109, P187, DOI 10.1002/(SICI)1096-8644(199906)109:2<187::AID-AJPA5>3.0.CO;2-P; Sellen DW, 2000, ANN HUM BIOL, V27, P345, DOI 10.1080/03014460050044838; Semproli S, 2011, NUTR HOSP, V26, P765, DOI [10.3305/nh.2011.26.4.4841, 10.1590/S0212-16112011000400015]; Semproli S, 2007, AM J PHYS ANTHROPOL, V132, P463, DOI 10.1002/ajpa.20470; Senbanjo IO, 2010, WORLD J PEDIATR, V6, P217, DOI 10.1007/s12519-010-0209-9; Senbanjo IO, 2009, ANN NUTR METAB, V54, P145, DOI 10.1159/000214833; Senbanjo IO, 2013, AM J PHYS ANTHROPOL, V150, P647, DOI 10.1002/ajpa.22241; Shields Margot, 2006, Health Rep, V17, P27; Shields M, 2010, INT J PEDIATR OBES, V5, P265, DOI 10.3109/17477160903268282; SIGMAN M, 1989, CHILD DEV, V60, P1463, DOI 10.2307/1130935; SINGER R, 1981, AM J PHYS ANTHROPOL, V54, P401, DOI 10.1002/ajpa.1330540314; Sloan A W, 1967, J Sports Med Phys Fitness, V7, P192; Smit P J, 1967, S Afr Med J, V41, P422; STEPHENSON LS, 1985, AM J TROP MED HYG, V34, P322, DOI 10.4269/ajtmh.1985.34.322; Stevens W, 2011, CLIN EXP ALLERGY, V41, P1587, DOI 10.1111/j.1365-2222.2011.03832.x; Steyn NP, 2005, NUTRITION, V21, P4, DOI 10.1016/j.nut.2004.09.003; Stoecker BJ, 2012, FASEB JOURNAL CONFER; SUKKAR MY, 1982, ANN HUM BIOL, V9, P265, DOI 10.1080/03014468200005751; SUKKAR MY, 1979, ANN HUM BIOL, V6, P147, DOI 10.1080/03014467900003481; Tanuseputro P, 2003, CAN J CARDIOL, V19, P1249; Thandrayen K, 2009, BONE, V45, pS100, DOI 10.1016/j.bone.2009.04.160; The NS, 2010, JAMA-J AM MED ASSOC, V304, P2024; Thomas D, 2010, FASEB JOURNAL CONFER; Toriola AL, 2012, SOUTH AFRICAN JOURNA, P25; Toriola OM, 2012, AFR J PHYS HLTH ED R, V18, P795; Travill A. L., 2007, African Journal for Physical, Health Education, Recreation and Dance, V13, P279; Tremblay MS, 2002, INT J OBESITY, V26, P538, DOI 10.1038/sj.ijo.0801923; Truter L, 2012, S AFR FAM PRACT, V54, P429, DOI 10.1080/20786204.2012.10874266; Truter L, 2010, S AFR FAM PRACT, V52, P227, DOI 10.1080/20786204.2010.10873979; Underhay J. H. de R., 2005, African Journal for Physical, Health Education, Recreation and Dance, V11, P121; United Nations News Center, 2011, UN LAUNCHES GLOBAL C; Unwin N, 2001, B WORLD HEALTH ORGAN, V79, P947; US Department of Health and Human Services, 1996, PHYSICAL ACTIVITY AN; Van Rooyen JM, 2002, AFRICAN JOURNAL FOR, P8; VANRENSBURG CFWJ, 1977, S AFR MED J, V52, P644; Vidulich L, 2006, OSTEOPOROSIS INT, V17, P433, DOI 10.1007/s00198-005-0004-y; Vidulich L, 2011, CALCIFIED TISSUE INT, V88, P281, DOI 10.1007/s00223-011-9460-x; Vidulich L, 2007, PAEDIATR PERINAT EP, V21, P354, DOI 10.1111/j.1365-3016.2007.00806.x; WAGSTAFF L, 1987, HUM NUTR-CLIN NUTR, V41C, P277; WALKER ARP, 1980, T ROY SOC TROP MED H, V74, P595, DOI 10.1016/0035-9203(80)90147-9; WALKER ARP, 1978, J TROP MED HYG, V81, P2; WALKER ARP, 1991, J ROY SOC HEALTH, V111, P12, DOI 10.1177/146642409111100105; WALKER ARP, 1974, S AFR MED J, V48, P1650; Walker M B, 1996, Afr J Med Med Sci, V25, P273; Wamukoya EK, 2011, AFRICAN JOURNAL FOR, V17; Williams CL, 1992, CARDIOVASCULAR RISK, V2, P45; Wilson ML, 2013, INT J ENV RES PUB HE, V10, P1763, DOI 10.3390/ijerph10051763; Wolff PT, 2012, J ASTHMA, V49, P575, DOI 10.3109/02770903.2012.696170; Wolff PT, 2012, J ALLERGY CLIN IMMUN, V129, pAB166, DOI 10.1016/j.jaci.2011.12.383; World Health Organization, 2003, GLOBAL DATABASE ON C; World Health Organization, 2009, GLOBAL HEALTH RISKS; World Health Organization (WHO), 2004, GLOBAL STRATEGY ON D; yesus A, 2010, FASEB JOURNAL CONFER; Zerfu Mesfin, 2006, Ethiop Med J, V44, P347; Zverev Y, 2001, ANN HUM BIOL, V28, P384, DOI 10.1080/03014460010013016	308	91	91	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92846	10.1371/journal.pone.0092846	http://dx.doi.org/10.1371/journal.pone.0092846			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676350	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500044
J	Lin, SC; Liu, WC; Jan, JT; Wu, SC				Lin, Shih-Chang; Liu, Wen-Chun; Jan, Jia-Tsrong; Wu, Suh-Chin			Glycan Masking of Hemagglutinin for Adenovirus Vector and Recombinant Protein Immunizations Elicits Broadly Neutralizing Antibodies against H5N1 Avian Influenza Viruses	PLOS ONE			English	Article							DNA VACCINE; PHASE-III; EPITOPE; MICE; TRANSMISSION; RECOGNITION; INFECTION; DESIGN; ADULTS	The highly pathogenic avian influenza (HPAI) H5N1 virus, a known trigger of diseases in poultry and humans, is perceived as a serious threat to public health. There is a clear need for a broadly protective H5N1 vaccine or vaccines for inducing neutralizing antibodies against multiple clades/subclades. We constructed single, double, and triple mutants of glycan-masked hemagglutiinin (HA) antigens at residues 83, 127 and 138 (i.e., g83, g127, g138, g83+g127, g127+g138, g83+g138 and g83+g127+g138), and then obtained their corresponding HA-expressing adenovirus vectors and recombinant HA proteins using a prime-boost immunization strategy. Our results indicate that the glycan-masked g127+g138 double mutant induced more potent HA-inhibition, virus neutralization antibodies, cross-clade protection against heterologous H5N1 clades, correlated with the enhanced bindings to the receptor binding sites and the highly conserved stem region of HA. The immune refocusing stem-specific antibodies elicited by the glycan-masked H5HA g127+g138 and g83+g127+g138 mutants overlapped with broadly neutralizing epitopes of the CR6261 monoclonal antibody that neutralizes most group 1 subtypes. These findings may provide useful information in the development of a broadly protective H5N1 influenza vaccine.	[Lin, Shih-Chang; Liu, Wen-Chun; Wu, Suh-Chin] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Jan, Jia-Tsrong] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Wu, Suh-Chin] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan	National Tsing Hua University; Academia Sinica - Taiwan; National Tsing Hua University	Wu, SC (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan.	scwu@mx.nthu.edu.tw	Wu, Suh-Chin/AAV-6233-2021; LIU, WEN-CHUN/ABC-8722-2020; Liu, Wen-Chun/AAU-3193-2021; LIU, WEN-CHUN/AAD-4430-2020	Liu, Wen-Chun/0000-0003-0344-4371; 	National Science Council [NSC-102-2321-B-007-002, NSC-103-2321-B-007-006]; Veterans General Hospitals University Systems of Taiwan Joint Research Program, Taiwan [VGHUST103-G6-1-2]	National Science Council(Ministry of Science and Technology, Taiwan); Veterans General Hospitals University Systems of Taiwan Joint Research Program, Taiwan	This study was supported by the National Science Council (NSC-102-2321-B-007-002, NSC-103-2321-B-007-006) and the Veterans General Hospitals University Systems of Taiwan Joint Research Program (VGHUST103-G6-1-2), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beran J, 2010, CLIN THER, V32, P2186, DOI 10.1016/S0149-2918(11)00024-5; Bommakanti G, 2012, J VIROL, V86, P13434, DOI 10.1128/JVI.01429-12; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Chen MW, 2008, P NATL ACAD SCI USA, V105, P13538, DOI 10.1073/pnas.0806901105; Chen MW, 2011, P NATL ACAD SCI USA, V108, P3510, DOI 10.1073/pnas.1019744108; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Cox RJ, 2011, VACCINE, V29, P8049, DOI 10.1016/j.vaccine.2011.08.042; Das SR, 2011, P NATL ACAD SCI USA, V108, pE1417, DOI 10.1073/pnas.1108754108; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ducatez MF, 2011, P NATL ACAD SCI USA, V108, P349, DOI 10.1073/pnas.1012457108; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Forrest HL, 2009, VACCINE, V27, P4187, DOI 10.1016/j.vaccine.2009.04.050; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Huang MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012279; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; Krause JC, 2011, J VIROL, V85, P10905, DOI 10.1128/JVI.00700-11; Langley JM, 2011, J INFECT DIS, V203, P1729, DOI 10.1093/infdis/jir172; Laursen NS, 2013, ANTIVIR RES, V98, P476, DOI 10.1016/j.antiviral.2013.03.021; Lee PS, 2012, P NATL ACAD SCI USA, V109, P17040, DOI 10.1073/pnas.1212371109; Lin SC, 2013, BIOTECHNOL J, V8, P1315, DOI 10.1002/biot.201300116; Lin SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039075; Lin SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020052; Medina RA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005996; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Rao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002432; Schneemann A, 2012, J VIROL, V86, P11686, DOI 10.1128/JVI.01694-12; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Stansell Elizabeth, 2010, Yale Journal of Biology and Medicine, V83, P201; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tsibane T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003067; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Wang SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028757; Wei C., 2012, SCI TRANSL MED, V15, P147; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; World Health Organization, CUM NUMB CONF HUM CA; Yang PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030252; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350; Zhang Y, 2013, SCIENCE, V340, P1459, DOI 10.1126/science.1229455; Zhou F, 2012, J VIROL, V86, P6970, DOI 10.1128/JVI.06930-11	48	34	34	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92822	10.1371/journal.pone.0092822	http://dx.doi.org/10.1371/journal.pone.0092822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671139	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000082
J	Morosan-Puopolo, G; Balakrishnan-Renuka, A; Yusuf, F; Chen, JC; Dai, FP; Zoidl, G; Ludtke, THW; Kispert, A; Theiss, C; Abdelsabour-Khalaf, M; Brand-Saberi, B				Morosan-Puopolo, Gabriela; Balakrishnan-Renuka, Ajeesh; Yusuf, Faisal; Chen, Jingchen; Dai, Fangping; Zoidl, Georg; Luedtke, Timo H. -W.; Kispert, Andreas; Theiss, Carsten; Abdelsabour-Khalaf, Mohammed; Brand-Saberi, Beate			Wnt11 Is Required for Oriented Migration of Dermogenic Progenitor Cells from the Dorsomedial Lip of the Avian Dermomyotome	PLOS ONE			English	Article							CHICK-EMBRYOS; DIFFERENTIAL REGULATION; MUSCLE PROGENITORS; SOMITIC MESODERM; DORSAL PLUMAGE; SEMITIC ORIGIN; NEURAL CREST; DERMIS; EXPRESSION; GENES	The embryonic origin of the dermis in vertebrates can be traced back to the dermomyotome of the somites, the lateral plate mesoderm and the neural crest. The dermal precursors directly overlying the neural tube display a unique dense arrangement and are the first to induce skin appendage formation in vertebrate embryos. These dermal precursor cells have been shown to derive from the dorsomedial lip of the dermomyotome (DML). Based on its expression pattern in the DML, Wnt11 is a candidate regulator of dorsal dermis formation. Using EGFP-based cell labelling and time-lapse imaging, we show that the Wnt11 expressing DML is the source of the dense dorsal dermis. Loss-of-function studies in chicken embryos show that Wnt11 is indeed essential for the formation of dense dermis competent to support cutaneous appendage formation. Our findings show that dermogenic progenitors cannot leave the DML to form dense dorsal dermis following Wnt11 silencing. No alterations were noticeable in the patterning or in the epithelial state of the dermomyotome including the DML. Furthermore, we show that Wnt11 expression is regulated in a manner similar to the previously described early dermal marker cDermo-1. The analysis of Wnt11 mutant mice exhibits an underdeveloped dorsal dermis and strongly supports our gene silencing data in chicken embryos. We conclude that Wnt11 is required for dense dermis and subsequent cutaneous appendage formation, by influencing the cell fate decision of the cells in the DML.	[Morosan-Puopolo, Gabriela; Balakrishnan-Renuka, Ajeesh; Yusuf, Faisal; Chen, Jingchen; Zoidl, Georg; Theiss, Carsten; Abdelsabour-Khalaf, Mohammed; Brand-Saberi, Beate] Ruhr Univ Bochum, Dept Anat & Mol Embryol, Bochum, Germany; [Morosan-Puopolo, Gabriela; Balakrishnan-Renuka, Ajeesh; Dai, Fangping] Univ Freiburg, Dept Mol Embryol, D-79106 Freiburg, Germany; [Morosan-Puopolo, Gabriela; Balakrishnan-Renuka, Ajeesh; Abdelsabour-Khalaf, Mohammed] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Luedtke, Timo H. -W.; Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, D-30623 Hannover, Germany; [Brand-Saberi, Beate] Univ Freiburg, Dept Mol Embryol, Inst Anat & Cell Biol, D-79106 Freiburg, Germany	Ruhr University Bochum; University of Freiburg; University of Freiburg; Hannover Medical School; University of Freiburg	Brand-Saberi, B (corresponding author), Ruhr Univ Bochum, Dept Anat & Mol Embryol, Univ Str 150, Bochum, Germany.	beate.brand-saberi@rub.de	Brand-Saberi, Beate/GVT-9451-2022; Abdelsabour-Khalaf, Mohammed/AAG-2804-2021	Abdelsabour-Khalaf, Mohammed/0000-0002-9551-0075	EU's Sixth Framework Program [511978]; DFG [GRK 1104]	EU's Sixth Framework Program(European Commission); DFG(German Research Foundation (DFG))	The project was supported by an EU's Sixth Framework Program grant to Prof. Dr. B. Brand-Saberi (MYORES, 511978) and by the DFG (GRK 1104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703; Anakwe K, 2003, DEVELOPMENT, V130, P3503, DOI 10.1242/dev.00538; AOYAMA H, 1988, DEVELOPMENT, V104, P15; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Beer HD, 1997, ONCOGENE, V15, P2211, DOI 10.1038/sj.onc.1201383; Ben-Yair R, 2005, DEVELOPMENT, V132, P689, DOI 10.1242/dev.01617; Ben-Yair R, 2003, DEVELOPMENT, V130, P4325, DOI 10.1242/dev.00667; BOBER E, 1994, DEVELOPMENT, V120, P603; Burgess R, 1996, NATURE, V384, P570, DOI 10.1038/384570a0; BURGESS R, 1995, DEV BIOL, V168, P296, DOI 10.1006/dbio.1995.1081; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; CHRIST B, 1995, ANAT EMBRYOL, V191, P381, DOI 10.1007/BF00304424; CHRISTIANSEN JH, 1995, MECH DEVELOP, V51, P341, DOI 10.1016/0925-4773(95)00383-5; COULY G, 1988, DEVELOPMENT, V103, P101; Dai FP, 2005, DEV BIOL, V285, P80, DOI 10.1016/j.ydbio.2005.06.005; del Barrio MG, 2002, DEVELOPMENT, V129, P1583; Delfini MC, 2009, DEV BIOL, V333, P229, DOI 10.1016/j.ydbio.2009.05.544; Dhouailly D, 2004, INT J DEV BIOL, V48, P85, DOI 10.1387/ijdb.15272373; Garriock RJ, 2007, DEV BIOL, V304, P127, DOI 10.1016/j.ydbio.2006.12.020; Geetha-Loganathan P, 2006, DEVELOPMENT, V133, P2897, DOI 10.1242/dev.02464; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Gros J, 2009, NATURE, V457, P589, DOI 10.1038/nature07564; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hornik C, 2005, DEV BIOL, V277, P42, DOI 10.1016/j.ydbio.2004.08.050; Houzelstein D, 2000, DEVELOPMENT, V127, P2155; Huang RJ, 2000, ANAT EMBRYOL, V202, P369, DOI 10.1007/s004290000130; Huang RJ, 2000, ANAT EMBRYOL, V202, P195, DOI 10.1007/s004290000110; Huang RJ, 2000, DEVELOPMENT, V127, P3789; LI L, 1995, DEV BIOL, V172, P280, DOI 10.1006/dbio.1995.0023; LOGAN C, 1992, DEV GENET, V13, P345, DOI 10.1002/dvg.1020130505; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Marcelle C, 1997, DEVELOPMENT, V124, P3955; Masyuk M, 2013, DEV DYN IN PRESS; MAUGER A, 1972, J EMBRYOL EXP MORPH, V28, P313; MAUGER A, 1972, J EMBRYOL EXP MORPH, V28, P343; Michon F, 2008, DEVELOPMENT, V135, P2797, DOI 10.1242/dev.018341; Michon F, 2007, DEV DYNAM, V236, P755, DOI 10.1002/dvdy.21080; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; Olivera-Martinez I, 2000, DEVELOPMENT, V127, P4611; Olivera-Martinez I, 2004, INT J DEV BIOL, V48, P107, DOI 10.1387/ijdb.15272376; Olivera-Martinez I, 2004, INT J DEV BIOL, V48, P93, DOI 10.1387/ijdb.15272374; Olivera-Martinez I, 2002, DEVELOPMENT, V129, P4763; Olivera-Martinez I, 2001, MECH DEVELOP, V100, P233, DOI 10.1016/S0925-4773(00)00540-2; Ordahl CP, 2001, DEVELOPMENT, V128, P1731; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pu Q, 2012, J ANAT, V221, P115, DOI 10.1111/j.1469-7580.2012.01518.x; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Scaal M, 2004, DEV DYNAM, V229, P643, DOI 10.1002/dvdy.10433; Scaal M, 2002, MECH DEVELOP, V110, P51, DOI 10.1016/S0925-4773(01)00552-4; Scaal M, 2001, ANAT EMBRYOL, V203, P1, DOI 10.1007/PL00008244; Sefton M, 1998, DEVELOPMENT, V125, P3111; Shi JL, 2011, DEVELOPMENT, V138, P3135, DOI 10.1242/dev.064394; Sosic D, 2003, CELL CYCLE, V2, P76, DOI 10.4161/cc.2.2.338; Tada M, 2000, DEVELOPMENT, V127, P2227; TANDA N, 1995, BIOCHEM BIOPH RES CO, V211, P123, DOI 10.1006/bbrc.1995.1786; TREMBLAY P, 1994, PHARMACOL THERAPEUT, V61, P205, DOI 10.1016/0163-7258(94)90063-9; Venters SJ, 2002, DEVELOPMENT, V129, P3873; Wilson-Rawls J, 1999, DEVELOPMENT, V126, P5217; Wilting J, 2000, DEV DYNAM, V217, P271, DOI 10.1002/(SICI)1097-0177(200003)217:3<271::AID-DVDY5>3.3.CO;2-U	64	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92679	10.1371/journal.pone.0092679	http://dx.doi.org/10.1371/journal.pone.0092679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671096	gold, Green Submitted, Green Published			2022-12-27	WOS:000333677000063
J	Wildeman, C; Emanuel, N				Wildeman, Christopher; Emanuel, Natalia			Cumulative Risks of Foster Care Placement by Age 18 for US Children, 2000-2011	PLOS ONE			English	Article							HEALTH-STATUS; PROTECTION	Foster care placement is among the most tragic events a child can experience because it more often than not implies that a child has experienced or is at very high risk of experiencing abuse or neglect serious enough to warrant state intervention. Yet it is unclear how many children will experience foster care placement at some point between birth and age 18. Using synthetic cohort life tables and data from the Adoption and Foster Care Analysis and Reporting System (AFCARS), we estimated how many U. S. children were placed in foster care between birth and age 18, finding support for three conclusions. First, up to 5.91% of all U. S. children were ever placed in foster care between their birth and age 18. Second, Native American (up to 15.44%) and Black (up to 11.53%) children were at far higher risk of placement. Foster care is thus quite common in the U. S., especially for historically disadvantaged racial/ethnic groups. Third, differences in foster care placement were minimal between the sexes, indicating that the high risks of foster care placement are shared almost equally by boys and girls.	[Wildeman, Christopher] Yale Univ, Dept Sociol, New Haven, CT 06520 USA; [Emanuel, Natalia] Yale Univ, Dept Econ, New Haven, CT 06520 USA	Yale University; Yale University	Wildeman, C (corresponding author), Yale Univ, Dept Sociol, New Haven, CT 06520 USA.	christopher.wildeman@yale.edu			Children's Bureau; Administration on Children, Youth and Families; Administration for Children and Families; United States Department of Health and Human Services	Children's Bureau; Administration on Children, Youth and Families; Administration for Children and Families(United States Department of Health & Human Services); United States Department of Health and Human Services	Funding for the project was provided by the Children's Bureau, Administration on Children, Youth and Families, Administration for Children and Families, United States Department of Health and Human Services. All analyses and interpretations presented here are solely those of the authors, and the collector of the data, the funder, the Archive, Cornell University and their agents or employees bear no responsibility for the analyses or interpretations presented here. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, AD FOST CAR AN REP S; [Anonymous], 2008, AD FOST CAR AN REP S; [Anonymous], 1926, REP PUBLIC HLTH MED; [Anonymous], 2007, AD FOST CAR AN REP S; [Anonymous], 2009, AD FOST CAR AN REP S; [Anonymous], 2006, AD FOST CAR AN REP S; CHERNOFF R, 1994, PEDIATRICS, V93, P594; Clausen J.M., 1998, J CHILD FAM STUD, V7, P283, DOI [DOI 10.1023/A:1022989411119, 10.1023/A:1022989411119]; Doyle JJ, 2008, J POLIT ECON, V116, P746, DOI 10.1086/590216; Doyle JJ, 2007, AM ECON REV, V97, P1583, DOI 10.1257/aer.97.5.1583; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; HALFON N, 1995, ARCH PEDIAT ADOL MED, V149, P386, DOI 10.1001/archpedi.1995.02170160040006; Harman JS, 2000, ARCH PEDIAT ADOL MED, V154, P1114, DOI 10.1001/archpedi.154.11.1114; Jee S, 2010, CHILD YOUTH SERV REV, V32, P685, DOI 10.1016/j.childyouth.2010.01.004; Magruder J, 2008, CHILD WELFARE, V87, P169; National Data Archive on Child Abuse and Neglect, 2002, AD FOST CAR AN REP S; National Data Archive on Child Abuse and Neglect, 2004, AD FOST CAR AN REP S; National Data Archive on Child Abuse and Neglect, 2003, AD FOST CAR AN REP S; National Data Archive on Child Abuse and Neglect, 2005, AD FOST CAR AN REP S; National Data Archive on Child Abuse and Neglect, 2012, AD FOST CAR AN REP S; National Data Archive on Child Abuse and Neglect, 2011, AD FOST CAR AN REP S; PAN-AFRICAN PARLIAMENT, 2012, 21 ORDINARY SESSION; Preston S., 2000, DEMOGRAPHY MEASURING; Putnam-Hornstein E, 2011, CHILD MALTREATMENT, V16, P163, DOI 10.1177/1077559511411179; StataCorp, 2021, STATA STAT SOFTWARE; U.S. Department of Health and Human Services Administration for Children and Families Administration on Children Youth and Families Children's Bureau, 2012, FED REP SYST AD FOST; U.S. Department of Health and Human Services Centers for Disease Control and Prevention National Center for Health Statistics CDC WONDER Online Database, 2011, BRIDG RAC POP EST 19	27	100	100	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92785	10.1371/journal.pone.0092785	http://dx.doi.org/10.1371/journal.pone.0092785			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24671254	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677000074
J	Wu, HY; Yang, J; Su, EM; Li, L; Zhao, CQ; Yang, X; Gao, ZW; Pan, MY; Sun, PY; Sun, W; Jiang, YY; Su, X				Wu, Haiya; Yang, Jun; Su, Emily M.; Li, Ling; Zhao, Caiqi; Yang, Xi; Gao, Zhaowei; Pan, Mengyao; Sun, Peiyu; Sun, Wei; Jiang, Yiyi; Su, Xiao			Lipoxin A4 and Platelet Activating Factor Are Involved in E. coli or LPS-Induced Lung Inflammation in CFTR-Deficient Mice	PLOS ONE			English	Article							CYSTIC-FIBROSIS; FACTOR PAF; ACETYLHYDROLASE; NEUTROPHILS; INHIBITION; INJURY; RECRUITMENT; PNEUMONIA; SEPSIS; SHOCK	CFTR (cystic fibrosis transmembrane conductance regulator) is expressed by both neutrophils and platelets. Lack of functional CFTR could lead to severe lung infection and inflammation. Here, we found that mutation of CFTR (F508del) or inhibition of CFTR in mice led to more severe thrombocytopenia, alveolar neutrocytosis and bacteriosis, and lower lipoxin A4/MIP-2 (macrophage inhibitory protein-2) or lipoxin A4/neutrophil ratios in the BAL (bronchoalveolar lavage) during acute E. coli pneumonia. In vitro, inhibition of CFTR promotes MIP-2 production in LPS-stimulated neutrophils; however, lipoxin A4 could dose-dependently suppress this effect. In LPS-induced acute lung inflammation, blockade of PSGL-1 (P-selectin glycoprotein ligand-1) or P-selectin, antagonism of PAF by WEB2086, or correction of mutated CFTR trafficking by KM11060 could significantly increase plasma lipoxin A4 levels in F508del relevant to wildtype mice. Concurrently, F508del mice had higher plasma platelet activating factor (PAF) levels and PAF-AH activity compared to wildtype under LPS challenge. Inhibiting hydrolysis of PAF by a specific PAF-AH (PAF-acetylhydrolase) inhibitor, MAFP, could worsen LPS-induced lung inflammation in F508del mice compared to vehicle treated F508del group. Particularly, depletion of platelets in F508del mice could significantly decrease plasma lipoxin A4 and PAF-AH activity and deteriorate LPS-induced lung inflammation compared to control F508del mice. Taken together, lipoxin A4 and PAF are involved in E. coli or LPS-induced lung inflammation in CFTR-deficient mice, suggesting that lipoxin A4 and PAF might be therapeutic targets for ameliorating CFTR-deficiency deteriorated lung inflammation.	[Wu, Haiya; Li, Ling; Zhao, Caiqi; Yang, Xi; Gao, Zhaowei; Pan, Mengyao; Sun, Peiyu; Sun, Wei; Jiang, Yiyi; Su, Xiao] Chinese Acad Sci, Inst Pasteur Shanghai, Unit Resp Infect & Immun, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Yang, Jun] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Su, Emily M.; Su, Xiao] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); University of California System; University of California Davis; University of California System; University of California San Francisco	Su, X (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Unit Resp Infect & Immun, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.	xsu@ips.ac.cn	Yang, Jun/B-2262-2010; Su, Xiao/CAG-9884-2022	Yang, Jun/0000-0001-8126-1728; Su, Xiao/0000-0002-8692-8365	Parker B. Francis Award; One Hundred Person Project of the Chinese Academy of Sciences [Y316P21209]; Knowledge Innovation Program of the Chinese Academy of Sciences [Y114P11209]; National Natural Science Foundation of China [81270139, 81300058]; Key Project of Science and Technology of Shanghai [12JC1408900]; Elizabeth Nash Memorial fellowship from the Cystic Fibrosis Research Inc; American Asthma Association [09-0269]	Parker B. Francis Award; One Hundred Person Project of the Chinese Academy of Sciences; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Science and Technology of Shanghai; Elizabeth Nash Memorial fellowship from the Cystic Fibrosis Research Inc; American Asthma Association	Parker B. Francis Award (X. S.); One Hundred Person Project of the Chinese Academy of Sciences (Grant No. Y316P21209, X. S.); The Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. Y114P11209, X. S.); The National Natural Science Foundation of China (Grant No. 81270139, X. S.; 81300058, H.Y.W.); The Key Project of Science and Technology of Shanghai (Grant No. 12JC1408900, X. S.). J. Yang was supported by the Elizabeth Nash Memorial fellowship from the Cystic Fibrosis Research Inc and the American Asthma Association (#09-0269). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEIJER L, 1987, BRIT J PHARMACOL, V92, P803, DOI 10.1111/j.1476-5381.1987.tb11384.x; Ciabattoni G, 2000, AM J RESP CRIT CARE, V162, P1195, DOI 10.1164/ajrccm.162.4.9911071; Dalli J, 2010, AM J PATHOL, V177, P176, DOI 10.2353/ajpath.2010.091149; Dhooghe B, 2013, CLIN BIOCH; Jehle R, 2001, BBA-MOL CELL BIOL L, V1532, P60, DOI 10.1016/S1388-1981(01)00112-3; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; Kell PJ, 2003, J PHARMACOL EXP THER, V307, P1163, DOI 10.1124/jpet.103.055392; Lam FW, 2011, AM J PHYSIOL-HEART C, V300, pH468, DOI 10.1152/ajpheart.00491.2010; Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432; MAKRISTATHIS A, 1993, INFECT IMMUN, V61, P1996, DOI 10.1128/IAI.61.5.1996-2002.1993; Matthay MA, 2007, NAT MED, V13, P780, DOI 10.1038/nm0707-780; Matute-Bello G, 2001, AM J RESP CRIT CARE, V163, P234, DOI 10.1164/ajrccm.163.1.9909034; Mitsios JV, 2006, ARTERIOSCL THROM VAS, V26, P1907, DOI 10.1161/01.ATV.0000228821.79588.ef; O'Sullivan BP, 2005, BLOOD, V105, P4635, DOI 10.1182/blood-2004-06-2098; Owen JS, 2005, J LIPID RES, V46, P373, DOI 10.1194/jlr.D400029-JLR200; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Perez A, 2007, AM J PHYSIOL-LUNG C, V292, pL383, DOI 10.1152/ajplung.00403.2005; RABINOVICI R, 1991, CIRC RES, V69, P12, DOI 10.1161/01.RES.69.1.12; Schwarz KB, 2003, J PEDIATR GASTR NUTR, V37, P187, DOI 10.1097/00005176-200308000-00019; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; SERHAN CN, 1990, J CLIN INVEST, V85, P772, DOI 10.1172/JCI114503; Su X, 2004, EXP LUNG RES, V30, P479, DOI 10.1080/01902140490476382; Su X, 2012, AM J RESP CRIT CARE, V186, P472, DOI 10.1164/rccm.201207-1235ED; Su X, 2011, INFLAMM RES, V60, P619, DOI 10.1007/s00011-011-0313-x; Su X, 2010, J IMMUNOL, V184, P401, DOI 10.4049/jimmunol.0901808; Su X, 2009, ANAT REC, V292, P580, DOI 10.1002/ar.20846; Yang JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009190; Zhao CQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082683; Zhou Y, 2013, J INNATE IMMUN, V5, P219, DOI 10.1159/000346568; Zimmerman GA, 2002, CRIT CARE MED, V30, pS294, DOI 10.1097/00003246-200205001-00020	30	11	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93003	10.1371/journal.pone.0093003	http://dx.doi.org/10.1371/journal.pone.0093003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671173	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677000098
J	Ferrari, AJ; Norman, RE; Freedman, G; Baxter, AJ; Pirkis, JE; Harris, MG; Page, A; Carnahan, E; Degenhardt, L; Vos, T; Whiteford, HA				Ferrari, Alize J.; Norman, Rosana E.; Freedman, Greg; Baxter, Amanda J.; Pirkis, Jane E.; Harris, Meredith G.; Page, Andrew; Carnahan, Emily; Degenhardt, Louisa; Vos, Theo; Whiteford, Harvey A.			The Burden Attributable to Mental and Substance Use Disorders as Risk Factors for Suicide: Findings from the Global Burden of Disease Study 2010	PLOS ONE			English	Article							DRUG-USE DISORDERS; SYSTEMATIC ANALYSIS; PSYCHOLOGICAL AUTOPSY; COMPLETED SUICIDE; 187 COUNTRIES; 21 REGIONS; PREVALENCE; HEALTH; PREVENTION; MORTALITY	Background: The Global Burden of Disease Study 2010 (GBD 2010) identified mental and substance use disorders as the 5(th) leading contributor of burden in 2010, measured by disability adjusted life years (DALYs). This estimate was incomplete as it excluded burden resulting from the increased risk of suicide captured elsewhere in GBD 2010' s mutually exclusive list of diseases and injuries. Here, we estimate suicide DALYs attributable to mental and substance use disorders. Methods: Relative-risk estimates of suicide due to mental and substance use disorders and the global prevalence of each disorder were used to estimate population attributable fractions. These were adjusted for global differences in the proportion of suicide due to mental and substance use disorders compared to other causes then multiplied by suicide DALYs reported in GBD 2010 to estimate attributable DALYs (with 95% uncertainty). Results: Mental and substance use disorders were responsible for 22.5 million (14.8-29.8 million) of the 36.2 million (26.5-44.3 million) DALYs allocated to suicide in 2010. Depression was responsible for the largest proportion of suicide DALYs (46.1% (28.0%-60.8%)) and anorexia nervosa the lowest (0.2% (0.02%-0.5%)). DALYs occurred throughout the lifespan, with the largest proportion found in Eastern Europe and Asia, and males aged 20-30 years. The inclusion of attributable suicide DALYs would have increased the overall burden of mental and substance use disorders (assigned to them in GBD 2010 as a direct cause) from 7.4% (6.2%-8.6%) to 8.3% (7.1%-9.6%) of global DALYs, and would have changed the global ranking from 5(th) to 3(rd) leading cause of burden. Conclusions: Capturing the suicide burden attributable to mental and substance use disorders allows for more accurate estimates of burden. More consideration needs to be given to interventions targeted to populations with, or at risk for, mental and substance use disorders as an effective strategy for suicide prevention.	[Ferrari, Alize J.; Norman, Rosana E.; Baxter, Amanda J.; Harris, Meredith G.; Vos, Theo; Whiteford, Harvey A.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Ferrari, Alize J.; Baxter, Amanda J.; Harris, Meredith G.; Whiteford, Harvey A.] Queensland Ctr Mental Hlth Res, Wacol, Qld, Australia; [Norman, Rosana E.] Univ Queensland, Queensland Childrens Med Res Inst, Herston, Qld, Australia; [Freedman, Greg; Carnahan, Emily; Vos, Theo] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Pirkis, Jane E.; Degenhardt, Louisa] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Page, Andrew] Univ Western Sydney, Sch Sci & Hlth, Campbelltown, NSW, Australia; [Degenhardt, Louisa] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia	University of Queensland; Queensland Centre for Mental Health Research; University of Queensland; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Melbourne; Western Sydney University; University of New South Wales Sydney	Ferrari, AJ (corresponding author), Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia.	alize_ferrari@qcmhr.uq.edu.au	Whiteford, Harvey A/A-4840-2009; Harris, Meredith/ABD-3049-2020; PACELLA, ROSANA E./F-2774-2010; Degenhardt, Louisa J/D-4515-2012; Baxter, Amanda/E-5449-2011; Ferrari, Alize J/G-1746-2011	Whiteford, Harvey A/0000-0003-4667-6623; Harris, Meredith/0000-0003-0096-729X; PACELLA, ROSANA E./0000-0002-9742-1957; Degenhardt, Louisa J/0000-0002-8513-2218; Baxter, Amanda/0000-0001-8198-9022; Ferrari, Alize J/0000-0002-7863-9117; O'donnell, Colm/0000-0002-8004-450X	Queensland Department of Health; Bill and Melinda Gates Foundation; Australian National Health and Medical Research Council (NHMRC); Australian Government under the Substance Misuse Prevention and Service Improvements Grants Fund	Queensland Department of Health; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Government under the Substance Misuse Prevention and Service Improvements Grants Fund(Australian Government)	AJF, AJB, MGH and HAW are associated with the Queensland Centre for Mental Health Research which acquires funding from the Queensland Department of Health. REN, GF, EC and TV received funding for the Global Burden of Disease project from the Bill and Melinda Gates Foundation. LD is supported by an Australian National Health and Medical Research Council (NHMRC) Principal Research Fellowship. The National Drug and Alcohol Research Centre at the University of NSW is supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvements Grants Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahmad OB, 2001, GPE DISCUSSION PAPER, V31, P1; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; [Anonymous], INTEGRATIVE METAREGR; Arsenault-Lapierre G, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-37; Barendregt J., 2010, METAXL USER GUIDE VE; Baxter AJ, 2013, PSYCHOL MED, V43, P897, DOI 10.1017/S003329171200147X; Baxter AJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-134; Bonita R., 2006, BASIC EPIDEMIOLOGY, V2nd ed.; Briffault X, 2010, ENCEPHALE, V36, pD48, DOI 10.1016/j.encep.2008.10.011; Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943; Conner KR, 2005, PSYCHOL MED, V35, P1197, DOI 10.1017/S003329170500454X; Degenhardt L, 2013, LANCET, V382, P1564, DOI 10.1016/S0140-6736(13)61530-5; Degenhardt L, 2011, DRUG ALCOHOL DEPEN, V117, P85, DOI 10.1016/j.drugalcdep.2010.11.032; Degenhardt L, 2011, DRUG ALCOHOL DEPEN, V113, P88, DOI 10.1016/j.drugalcdep.2010.07.026; Degenhardt L, 2011, ADDICTION, V106, P32, DOI 10.1111/j.1360-0443.2010.03140.x; Doi SAR, 2008, EPIDEMIOLOGY, V19, P94, DOI 10.1097/EDE.0b013e31815c24e7; Doi SAR, 2011, CONTEMP CLIN TRIALS, V32, P288, DOI 10.1016/j.cct.2010.12.006; Epigear, 2012, METAXL; Ferrari AJ, 2013, PSYCHOL MED, V43, P471, DOI 10.1017/S0033291712001511; Ferrari AJ, 2010, J AFFECT DISORDERS, V34, P1; Ferrari AJ, 2013, PLOS MED IN PRESS; Gabilondo A, 2011, PSYCHIAT SERV, V62, P152, DOI 10.1176/ps.62.2.pss6202_0152; Haagsma JA, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-10; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Isometsa ET, 2001, EUR PSYCHIAT, V16, P379, DOI 10.1016/S0924-9338(01)00594-6; Katz C, 2013, SYSTEMATIC REV SCH B; Khan MM, 2005, J ROY SOC MED, V98, P459, DOI 10.1258/jrsm.98.10.459; Kruijshaar ME, 2005, EUR J EPIDEMIOL, V20, P103, DOI 10.1007/s10654-004-1009-0; Li ZY, 2011, SOC SCI MED, V72, P608, DOI 10.1016/j.socscimed.2010.11.008; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Moffitt TE, 2010, PSYCHOL MED, V40, P899, DOI 10.1017/S0033291709991036; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Murray C.J, 1996, GLOBAL BURDEN DIS CO; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Patel V, 2012, LANCET, V379, P2343, DOI 10.1016/S0140-6736(12)60606-0; Phillips MR, 2012, LANCET, V379, P2318, DOI 10.1016/S0140-6736(12)60913-1; Phillips MR, 2010, AM J PSYCHIAT, V167, P731, DOI 10.1176/appi.ajp.2010.10040589; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Pritchard C, 2007, PSYCHOL MED, V37, P421, DOI 10.1017/S0033291706009159; Robinson J, 2011, AUST NZ J PSYCHIAT, V45, P3, DOI 10.3109/00048674.2010.511147; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Scott A., 2012, WHICH STRATEGIES SUI; SILVERMAN MM, 1995, SUICIDE LIFE-THREAT, V25, P10; Singleton J, 2009, DRUG ALCOHOL DEPEN, V105, P1, DOI 10.1016/j.drugalcdep.2009.05.028; Vijayakumar L, 2005, INT REV PSYCHIATR, V17, P109, DOI 10.1080/09540260500074735; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Whiteford HA, 2013, CURR OPIN PSYCHIATR, V26, P376, DOI 10.1097/YCO.0b013e328361e60f; Wilcox HC, 2004, DRUG ALCOHOL DEPEN, V76, pS11, DOI 10.1016/j.drugalcdep.2004.08.003; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 1992, ICD 10 CLASSIFICATIO, DOI DOI 10.1002/1520-6505(2000)9:5%3C201::AID-EVAN2%3E3.3.CO;2-P; Yang GH, 2005, BIOMED ENVIRON SCI, V18, P379; Yoshimasu Kouichi, 2008, Environmental Health and Preventive Medicine, V13, P243, DOI 10.1007/s12199-008-0037-x; Zhang J, 2010, AM J PSYCHIAT, V167, P773, DOI 10.1176/appi.ajp.2010.09101476	59	218	227	8	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e91936	10.1371/journal.pone.0091936	http://dx.doi.org/10.1371/journal.pone.0091936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24694747	gold, Green Published, Green Submitted			2022-12-27	WOS:000334103000011
J	Pol, D; Nascimento, PM; Carvalho, AB; Riccomini, C; Pires-Domingues, RA; Zaher, H				Pol, Diego; Nascimento, Paulo M.; Carvalho, Alberto B.; Riccomini, Claudio; Pires-Domingues, Ricardo A.; Zaher, Hussam			A New Notosuchian from the Late Cretaceous of Brazil and the Phylogeny of Advanced Notosuchians	PLOS ONE			English	Article							CLARKI CROCODYLIFORMES NOTOSUCHIA; NEUQUEN BASIN ARGENTINA; BAURU BASIN; ADAMANTINA FORMATION; TERRESTRIS WOODWARD; CROCODYLOMORPHA; MESOEUCROCODYLIA; MORPHOLOGY; ANATOMY; REMAINS	A new notosuchian crocodyliform from the Late Cretaceous Bauru Group found in the southeastern State of Sao Paulo ( Brazil) is described here. The new taxon, Caipirasuchus stenognathus, is referred as a new species of the recently erected genus Caipirasuchus within the clade Sphagesauridae based on a phylogenetic analysis of basal mesoeucrocodylians. Caipirasuchus stenognathus is represented by an almost complete skull and lower jaw that has autapomorphic characters that distinguish it from other species of Sphagesauridae. These autapomorphies include: maxilla forming part of the orbital margin ( absence of lacrimal-jugal contact), nasal with smooth depressions on the posterior region close to the contact with the maxilla and lacrimal, postorbital with posterior palpebral facet that extends posteriorly underneath the ear-flap groove, and a distinct anterior process of the medial flange of the retroarticular process. Additionally, the new taxon lacks autapomorphic features described in other sphagesaurids. The phylogenetic analysis results in a monophyletic genus Caipirasuchus, that is the sister group of a clade fomed by Sphagesaurus huenei, Caryonosuchus pricei, and Armadillosuchus arrudai. Sphagesaurids also include a basal clade formed by Adamantinasuchus navae and Yacarerani boliviensis. Other notosuchian taxa, such as Mariliasuchus amarali, Labidiosuchus amicum, Notosuchus terrestris, and Morrinhosuchus luziae are successive sister taxa of Sphagesauridae, forming a clade of advanced notosuchians that are restricted to the Late Cretaceous of South America. These results contrast with most previous phylogenetic hypotheses of the group that depicted some members of Sphagesauridae as more closely related to baurusuchids, or found Asian ( e. g., Chimaerasuchus) or African (Malawisuchus, Pakasuchus) forms nested within advanced notosuchians that are, according to our analysis, endemic of the Late Cretaceous of South America.	[Pol, Diego] Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Trelew, Chubut, Argentina; [Nascimento, Paulo M.; Carvalho, Alberto B.; Pires-Domingues, Ricardo A.; Zaher, Hussam] Univ Sao Paulo, Museu Zool, Sao Paulo, Brazil; [Nascimento, Paulo M.] Univ Sao Paulo, Inst Biociencias, Programa Posgrad Zool, Sao Paulo, Brazil; [Riccomini, Claudio] Univ Sao Paulo, Inst Geociencias, Sao Paulo, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Zaher, H (corresponding author), Univ Sao Paulo, Museu Zool, Sao Paulo, Brazil.	hussam.zaher@gmail.com	Zaher, Hussam/D-4000-2012; Pol, Diego/A-8007-2008; Zaher, Hussam/ABC-1701-2021; Fapesp, Biota/F-8655-2017; Riccomini, Claudio/G-1764-2010	Zaher, Hussam/0000-0002-6994-489X; Pol, Diego/0000-0002-9690-7517; Zaher, Hussam/0000-0002-6994-489X; Fapesp, Biota/0000-0002-9887-8449; Riccomini, Claudio/0000-0002-7249-5706	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [BIOTA/FAPESP 2011/50206-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq 565046/2010-1, 303545/2010-0, 401836/2010-0]; ANPCyT PICT [0736]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ANPCyT PICT(ANPCyT)	This research was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (BIOTA/FAPESP 2011/50206-9) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq 565046/2010-1, 303545/2010-0, 401836/2010-0) to H. Zaher and A. B. Carvalho, and ANPCyT PICT 0736 to D. Pol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera E, 1989, REV TECNICA YPFB, V10, P131; ANDRADE MB, 2008, HIST BIOL, V20, P101, DOI DOI 10.1080/08912960701642949; Batezelli A., 2003, GEOCIENCIAS, V22, P5; Bonaparte JF., 1991, REV MUSEO ARGENTINO, V4, P31; Bonaparte Jose F., 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P73; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Brochu CA, 1999, J VERTEBR PALEONTOL, V19, P9, DOI 10.1080/02724634.1999.10011201; Buckley GA, 1999, SPEC PAP PALAEONTOL, P149; Buckley GA, 2000, NATURE, V405, P941, DOI 10.1038/35016061; Buffetaut E., 1981, GEOL RUNDSCH, V70, P611, DOI DOI 10.1007/BF01822139; Busbey A.B. III, 1986, Journal of Vertebrate Paleontology, V6, P20; BUSBEY AB, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P173; Buscalioni AD, 2004, CRETACEOUS RES, V25, P267, DOI 10.1016/j.cretres.2003.12.004; Candeiro CRA, 2006, J S AM EARTH SCI, V22, P116, DOI 10.1016/j.jsames.2006.08.001; Carvalho I.S., 1999, GEOLOGIA COLOMBIANA, V24, P83, DOI DOI 10.15446/GC; Carvalho ID, 2004, GONDWANA RES, V7, P975, DOI 10.1016/S1342-937X(05)71079-0; Carvalho ID, 2005, GONDWANA RES, V8, P11, DOI 10.1016/S1342-937X(05)70259-8; Carvalho ID, 2007, ZOOTAXA, P35; Carvalho ID, 2011, ZOOTAXA, P19; Carvalho Ismar De Souza, 1994, Anais da Academia Brasileira de Ciencias, V66, P331; Carvalho ID, 2010, PALAEOGEOGR PALAEOCL, V297, P252, DOI 10.1016/j.palaeo.2010.08.003; Clark JM, 2011, ZOOL J LINN SOC-LOND, V163, pS152, DOI 10.1111/j.1096-3642.2011.00719.x; CLARK JM, 1994, IN THE SHADOW OF THE DINOSAURS, P84; CLARK JM, 1989, SCIENCE, V244, P1064, DOI 10.1126/science.244.4908.1064; CODDINGTON J, 1994, CLADISTICS, V10, P415; COLBERT EH, 1951, B AM MUS NAT HIST, V97, P143; de Andrade MB, 2011, ZOOL J LINN SOC-LOND, V163, pS66, DOI 10.1111/j.1096-3642.2011.00709.x; De Andrade Marco Brandalise, 2008, Arquivos do Museu Nacional Rio de Janeiro, V66, P7; De Andrade Marco Brandalise, 2008, Arquivos do Museu Nacional Rio de Janeiro, V66, P63; De Andrade Marco Brandalise, 2006, REVISTA BRASILEIRA DE PALEONTOLOGIA, V9, P323; Silva FDE, 2009, J S AM EARTH SCI, V28, P25, DOI 10.1016/j.jsames.2009.02.008; Dias-Brito Dimas, 2001, Revue de Paleobiologie, V20, P245; Dingus Lowell, 2000, American Museum Novitates, V3290, P1, DOI 10.1206/0003-0082(2000)290<0001:SAMFCF>2.0.CO;2; Endo H, 2002, ANAT HISTOL EMBRYOL, V31, P206, DOI 10.1046/j.1439-0264.2002.00396.x; Fernandes L.A., 2000, REV BRASILEIRA GEOCI, V30, P717, DOI DOI 10.25249/0375-7536.2000304717728; Fernandes L.A., 1996, AN ACAD BRAS CIENC, V68, P195; Fernandes LA, 2003, AN ACAD BRAS CIENC, V75, P173, DOI 10.1590/S0001-37652003000200006; Fiorelli Lucas, 2008, Arquivos do Museu Nacional Rio de Janeiro, V66, P83; Garrido Alberto C., 2010, Rev. Mus. Argent. Cienc. Nat., V12, P121; Gasparini, 1971, AMEGHINIANA, V8, P83; Gasparini Z., 1991, Journal of Vertebrate Paleontology, V11, P316; Gasparini Zulma, 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P159; Gasparini Zulma, 1993, Historical Biology, V7, P1; Gobbo-Rodrigues SR., 1999, ACTA GEOLOGICA LEOPO, V23, P3; Goloboff P.A., 2008, TNT TREE ANAL USING; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gomani EM, 1997, J VERTEBR PALEONTOL, V17, P280, DOI 10.1080/02724634.1997.10010975; Hecht MK., 1983, N JAHR GEOL PAL ONT, V11, P657; Holliday CM, 2007, J MORPHOL, V268, P457, DOI 10.1002/jmor.10524; Hugo C.A., 2001, HOJA GEOL GICA 3069, V308, P1; Iordansky N.N., 1973, P201; Iordansky NN, 2000, RUSSIAN J HERPETOLOG, V7, P41; Iori F. V., 2011, PALEONTOLOGIA CENARI, P585; Iori FV, 2011, J VERTEBR PALEONTOL, V31, P1255, DOI 10.1080/02724634.2011.602777; Iori FV, 2013, ZOOTAXA, V3686, P183; Iori FV., 2009, BRAZ J GEOL, V39, P717; Jouve S, 2009, J VERTEBR PALEONTOL, V29, P88, DOI 10.1080/02724634.2009.10010364; Kellner AWA, 2011, ZOOL J LINN SOC-LOND, V163, pS109, DOI 10.1111/j.1096-3642.2011.00711.x; Kellner AWA, 2011, ZOOL J LINN SOC-LOND, V163, pS57, DOI 10.1111/j.1096-3642.2011.00712.x; Kellner AWA, 2009, ZOOTAXA, P49, DOI 10.11646/zootaxa.2030.1.4; Kley NJ, 2010, J VERTEBR PALEONTOL, V30, P13, DOI 10.1080/02724634.2010.532674; Kuhn O, 1968, VORZEITLICHEN KRIKOD; Lamanna M, 2003, J VERTEBR PALEONTOL, V23, p70A; Larsson HCE, 2007, ZOOL J LINN SOC-LOND, V149, P533, DOI 10.1111/j.1096-3642.2007.00271.x; Larsson HCE, 2000, NEUES JAHRB GEOL P-A, V217, P131, DOI 10.1127/njgpa/217/2000/131; Leanza HA, 2004, CRETACEOUS RES, V25, P61, DOI 10.1016/j.cretres.2003.10.005; Lecuona A, 2008, CR PALEVOL, V7, P407, DOI 10.1016/j.crpv.2008.07.001; Legarreta L., 1989, CUENCAS SEDIMENTARIA, V6, P221; Lopez RM, 1975, INFORM ESTRATIGRAFIC; Marinho T.S, 2007, PALEONTOLOGIA CENARI, P481; Marinho TS, 2009, J S AM EARTH SCI, V27, P36, DOI 10.1016/j.jsames.2008.11.005; Leardi JM, 2009, CRETACEOUS RES, V30, P1376, DOI 10.1016/j.cretres.2009.08.002; Martinelli AG, 2003, AMEGHINIANA, V40, P559; Martinelli AG, 2012, CRETACEOUS RES, V37, P191, DOI 10.1016/j.cretres.2012.03.017; Montefeltro FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021916; Nascimento PM, 2011, ZOOL J LINN SOC-LOND, V163, pS116, DOI 10.1111/j.1096-3642.2011.00708.x; Nascimento Paulo Miranda, 2010, Pap. Avulsos Zool. (São Paulo), V50, P323, DOI 10.1590/S0031-10492010002100001; NASH D S, 1975, Annals of the South African Museum, V67, P227; Nobre PH, 2008, GONDWANA RES, V13, P139, DOI 10.1016/j.gr.2007.08.002; Nobre PH, 2006, GONDWANA RES, V10, P370, DOI 10.1016/j.gr.2006.05.008; NOBRE PH, 2007, ANUARIO I GEOCIENCIA, V30, P32; Novas FE, 2009, J VERTEBR PALEONTOL, V29, P1316, DOI 10.1671/039.029.0409; O'Connor PM, 2010, NATURE, V466, P748, DOI 10.1038/nature09061; Ortega F, 1996, GEOBIOS-LYON, V29, P353, DOI 10.1016/S0016-6995(96)80037-4; Ortega F, 2000, J VERTEBR PALEONTOL, V20, P57, DOI 10.1671/0272-4634(2000)020[0057:ANSOAC]2.0.CO;2; Osi A, 2013, HIST BIOL, V2013, P1; Paula E, 2003, GEOCIENCIAS, V22, P21, DOI DOI 10.4072/RBP.2004.3.07; Paula e Silva F., 2005, REV BRASILEIRA GEOCI, V35, P77, DOI DOI 10.25249/0375-7536.20053517788; Piacentini Pinheiro Andre Eduardo, 2008, Revista Brasileira de Paleontologia, V11, P37; Pires-Domingues Ricardo Angelim, 2007, P273; Pol D, 2005, AMEGHINIANA, V42, P21; Pol D, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)445<0001:ANCFCM>2.0.CO;2; Pol D, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)490[0001:NARFTE]2.0.CO;2; Pol D, 2003, J VERTEBR PALEONTOL, V23, P817, DOI 10.1671/A1015-7; Pol Diego, 2007, P116; Pol D, 2012, J VERTEBR PALEONTOL, V32, P328, DOI 10.1080/02724634.2012.646833; Pol D, 2011, ZOOL J LINN SOC-LOND, V163, pS7, DOI 10.1111/j.1096-3642.2011.00714.x; Pol D, 2009, CLADISTICS, V25, P515, DOI 10.1111/j.1096-0031.2009.00258.x; Pol D, 2009, J SYST PALAEONTOL, V7, P163, DOI 10.1017/S1477201908002605; Prasad Guntupalli V.R., 2002, Annales de Paleontologie, V88, P19, DOI 10.1016/S0753-3969(02)01036-4; Price L. I, 1959, Boletim Divisao de Geologia e Mineralogia Rio de Janeiro, V188, P1; Price L.I., 1945, NOTAS PRELIMINARES E, V25, P1; PRICE LLEWELLYN IVOR, 1950, AN ACAD BRASIL CIENC, V22, P77; Riccomini C., 1997, REV BRAS GEOCIENC, V27, P153; Riff D, 2011, ZOOL J LINN SOC-LOND, V163, pS37, DOI 10.1111/j.1096-3642.2011.00713.x; Rusconi C., 1933, Boletin del Instituto Geologia y Perforaciones Montevideo, V19, P1; Santucci R.M., 2001, BRAZ J GENET, V31, P307; Schumacher G. H., 1973, P101; Sereno PC, 2009, ZOOKEYS, P1, DOI 10.3897/zookeys.28.325; Sereno PC, 2003, J VERTEBR PALEONTOL, V23, P477, DOI 10.1671/0272-4634(2003)023[0477:ANNFTE]2.0.CO;2; Sereno PC, 2001, SCIENCE, V294, P1516, DOI 10.1126/science.1066521; Shu C.-K., 2005, VERTEBRAT PALASIATIC, V43, P312; SHUTE C. C. D., 1955, PROC ZOOL SOC LONDON, V124, P741; Soares P.C., 1980, REV BRASILEIRA GEOCI, V10, P177, DOI DOI 10.25249/0375-7536.1980177185; Soto M, 2011, ZOOL J LINN SOC-LOND, V163, pS173, DOI 10.1111/j.1096-3642.2011.00717.x; STROMER E, 2014, ABHANDLUNGEN KONIGLI, V27, P1; Turner AH, 2004, P ROY SOC B-BIOL SCI, V271, P2003, DOI 10.1098/rspb.2004.2840; Turner AH., 2006, HIST BIOL, V18, P255, DOI [10.1080/08912960500516112, DOI 10.1080/08912960500516112]; Turner AH, 2008, J VERTEBR PALEONTOL, V28, P382, DOI 10.1671/0272-4634(2008)28[382:MICMCA]2.0.CO;2; Turner AH, 2010, J VERTEBR PALEONTOL, V30, P177, DOI 10.1080/02724634.2010.532348; Vasc F. M., 2005, ANU INST GEOCIENC, V28, P49; Vasconcellos FM, 2006, PALEONTOLOGIA VERTEB, P229; Von Huene F., 1939, MINERACAO METALURGIA, V4, P190; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Woodward A.S., 1896, ANALES MUSEO PLATA P, V4, P1; Wu XC, 1996, J VERTEBR PALEONTOL, V16, P688, DOI 10.1080/02724634.1996.10011358; WU XC, 1995, NATURE, V376, P678, DOI 10.1038/376678a0; WU XC, 1994, J VERTEBR PALEONTOL, V14, P210, DOI 10.1080/02724634.1994.10011553; Zaher H, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3512[1:ROTCMO]2.0.CO;2	129	102	107	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93105	10.1371/journal.pone.0093105	http://dx.doi.org/10.1371/journal.pone.0093105			66	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695105	Green Published, gold			2022-12-27	WOS:000334103000040
J	Boissinot, S; Erdinger, M; Monsion, B; Ziegler-Graff, V; Brault, V				Boissinot, Sylvaine; Erdinger, Monique; Monsion, Baptiste; Ziegler-Graff, Veronique; Brault, Veronique			Both Structural and Non-Structural Forms of the Readthrough Protein of Cucurbit aphid-borne yellows virus Are Essential for Efficient Systemic Infection of Plants	PLOS ONE			English	Article							POTATO-LEAFROLL-VIRUS; MINOR CAPSID PROTEIN; COAT PROTEIN; MOVEMENT PROTEIN; DWARF VIRUS; NUCLEOTIDE-SEQUENCE; MUTATIONAL ANALYSIS; MYZUS-PERSICAE; 17-KDA PROTEIN; LUTEOVIRUS	Cucurbit aphid-borne yellows virus (CABYV) is a polerovirus (Luteoviridae family) with a capsid composed of the major coat protein and a minor component referred to as the readthrough protein (RT). Two forms of the RT were reported: a full-length protein of 74 kDa detected in infected plants and a truncated form of 55 kDa (RT*) incorporated into virions. Both forms were detected in CABYV-infected plants. To clarify the specific roles of each protein in the viral cycle, we generated by deletion a polerovirus mutant able to synthesize only the RT* which is incorporated into the particle. This mutant was unable to move systemically from inoculated leaves inferring that the C-terminal half of the RT is required for efficient long-distance transport of CABYV. Among a collection of CABYV mutants bearing point mutations in the central domain of the RT, we obtained a mutant impaired in the correct processing of the RT which does not produce the RT*. This mutant accumulated very poorly in upper non-inoculated leaves, suggesting that the RT* has a functional role in long-distance movement of CABYV. Taken together, these results infer that both RT proteins are required for an efficient CABYV movement.	[Boissinot, Sylvaine; Erdinger, Monique; Monsion, Baptiste; Brault, Veronique] INRA, Unite Mixte Rech Sante Vigne & Qual Vin 1131, Colmar, France; [Boissinot, Sylvaine; Erdinger, Monique; Monsion, Baptiste; Brault, Veronique] Univ Strasbourg, Strasbourg, France; [Monsion, Baptiste; Ziegler-Graff, Veronique] CNRS, Inst Biol Mol Plantes, Unite Propre Rech 2357, F-67084 Strasbourg, France	INRAE; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Brault, V (corresponding author), INRA, Unite Mixte Rech Sante Vigne & Qual Vin 1131, Colmar, France.	veronique.brault@colmar.inra.fr	BRAULT, Veronique/AAV-1525-2021; Boissinot, Sylvaine/GMW-7580-2022	Monsion, Baptiste/0000-0002-5174-4742	French government	French government	Funding of this project comes from the French government (public ressources). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bencharki B, 2010, MOL PLANT MICROBE IN, V23, P799, DOI 10.1094/MPMI-23-6-0799; BRAULT V, 1995, EMBO J, V14, P650, DOI 10.1002/j.1460-2075.1995.tb07043.x; Brault V, 2000, J VIROL, V74, P1140, DOI 10.1128/JVI.74.3.1140-1148.2000; Brault V, 2010, CR BIOL, V333, P524, DOI 10.1016/j.crvi.2010.04.001; Brault W, 2005, J VIROL, V79, P9685, DOI 10.1128/JVI.79.15.9685-9693.2005; Brown CM, 1996, J VIROL, V70, P5884, DOI 10.1128/JVI.70.9.5884-5892.1996; Bruyere A, 1997, VIROLOGY, V230, P323, DOI 10.1006/viro.1997.8476; Chavez JD, 2012, J PROTEOME RES, V11, P2968, DOI 10.1021/pr300041t; Chay CA, 1996, VIROLOGY, V219, P57, DOI 10.1006/viro.1996.0222; CHENG SL, 1994, VIROLOGY, V202, P1003, DOI 10.1006/viro.1994.1427; CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; de Zoeten GA, 2001, ADV VIRUS RES, V57, P323, DOI 10.1016/S0065-3527(01)57007-4; DEMLER SA, 1991, J GEN VIROL, V72, P1819, DOI 10.1099/0022-1317-72-8-1819; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; ESAU K, 1972, VIROLOGY, V48, P724, DOI 10.1016/0042-6822(72)90156-0; FILICHKIN SA, 1994, VIROLOGY, V205, P290, DOI 10.1006/viro.1994.1645; GARCIA JA, 1992, VIROLOGY, V188, P697, DOI 10.1016/0042-6822(92)90524-S; GUILLEY H, 1994, VIROLOGY, V202, P1012, DOI 10.1006/viro.1994.1429; Hamrita B, 2011, CLIN BIOCHEM, V44, P1097, DOI 10.1016/j.clinbiochem.2011.06.005; Hipper C, 2014, J GEN VIROL, V95, P496, DOI 10.1099/vir.0.058867-0; Hofius D, 2001, PLANT J, V28, P529, DOI 10.1046/j.1365-313X.2001.01179.x; JOLLY CA, 1994, VIROLOGY, V201, P182, DOI 10.1006/viro.1994.1283; LECOQ H, 1992, PLANT PATHOL, V41, P749, DOI 10.1111/j.1365-3059.1992.tb02559.x; Lee L, 2002, MOL PLANT MICROBE IN, V15, P1086, DOI 10.1094/MPMI.2002.15.10.1086; Mutterer JD, 1999, J GEN VIROL, V80, P2771, DOI 10.1099/0022-1317-80-10-2771; Nair S, 2010, VIROLOGY, V396, P106, DOI 10.1016/j.virol.2009.09.025; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Peter KA, 2009, J VIROL, V83, P5419, DOI 10.1128/JVI.02312-08; Peter KA, 2008, J GEN VIROL, V89, P2037, DOI 10.1099/vir.0.83625-0; PRUFER D, 1995, VIROLOGY, V214, P150, DOI 10.1006/viro.1995.9945; Reinbold C, 2001, J GEN VIROL, V82, P1995, DOI 10.1099/0022-1317-82-8-1995; REUTENAUER A, 1993, VIROLOGY, V195, P692, DOI 10.1006/viro.1993.1420; Revollon S, 2010, VIROLOGY, V402, P303, DOI 10.1016/j.virol.2010.03.037; Schmitz J, 1997, VIROLOGY, V235, P311, DOI 10.1006/viro.1997.8679; SHEPARDSON S, 1980, VIROLOGY, V105, P379, DOI 10.1016/0042-6822(80)90039-2; Sokolova M, 1997, FEBS LETT, V400, P201, DOI 10.1016/S0014-5793(96)01380-4; TACKE E, 1991, J GEN VIROL, V72, P2035, DOI 10.1099/0022-1317-72-8-2035; TACKE E, 1993, VIROLOGY, V197, P274, DOI 10.1006/viro.1993.1588; VandenHeuvel JFJM, 1997, J VIROL, V71, P7258, DOI 10.1128/JVI.71.10.7258-7265.1997; VANDENHEUVEL JFJM, 1991, PHYTOPATHOLOGY, V81, P150, DOI 10.1094/Phyto-81-150; WANG JY, 1995, VIROLOGY, V206, P954, DOI 10.1006/viro.1995.1018; Wilmarth PA, 2004, J PROTEOME RES, V3, P1017, DOI 10.1021/pr049911o; ZieglerGraff V, 1996, MOL PLANT MICROBE IN, V9, P501, DOI 10.1094/MPMI-9-0501	43	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93448	10.1371/journal.pone.0093448	http://dx.doi.org/10.1371/journal.pone.0093448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691251	Green Submitted, gold, Green Published			2022-12-27	WOS:000334101100083
J	Gao, JJ; Wang, FL; Wang, WS; Su, ZG; Guo, CH; Cao, SY				Gao, Junjie; Wang, Fangli; Wang, Weisong; Su, Zhiguo; Guo, Canghui; Cao, Shuyi			Emodin Suppresses Hyperglycemia-Induced Proliferation and Fibronectin Expression in Mesangial Cells via Inhibiting cFLIP	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; HIGH-GLUCOSE; DIABETIC-NEPHROPATHY; KIDNEY-DISEASE; PROTEIN-KINASE; PATHWAY; ACTIVATION; DEATH; DEGRADATION; INCREASES	As one of the most serious microvascular complications of diabetes and a major cause of end stage renal disease, diabetic nephropathy (DN) is calling for effective treatment strategies. Here, we provide evidence that hyperglycemia can induce proliferation and decreasing apoptosis of mesangial cells (MCs) and subsequent renal dysfunction by up-regulating cellular FLICE-inhibitory protein (cFLIP). Treatment with emodin significantly turns down the accelerated cell cycle and proliferation of MCs cultured in high glucose (HG) via inhibiting cFLIP. In vitro, knockdown of cFLIP can arrest cell cycle and accelerate cell death by activating caspase-8, caspase-3 and caspase-9, and down-regulate proliferating cell nuclear antigen (PCNA). Our results also suggest that emodin regulates cFLIP expression in transcriptional level. Importantly, emodin lessens proteinuria and fibronectin expression in early-stage of streptozotocin (STZ)-induced diabetic rats. These findings demonstrate that emodin represent a promising strategy to prevent renal dysfunction in early-stage of diabetes mellitus.	[Gao, Junjie; Wang, Fangli; Wang, Weisong; Su, Zhiguo; Guo, Canghui; Cao, Shuyi] Cangzhou Cent Hosp, Dept Nephrol, Cangzhou, Peoples R China		Gao, JJ (corresponding author), Cangzhou Cent Hosp, Dept Nephrol, Cangzhou, Peoples R China.	junjiegao_doc@126.com						Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963; Bangert A, 2012, ONCOGENE, V31, P4677, DOI 10.1038/onc.2011.614; BOWLUS CL, 1991, J BIOL CHEM, V266, P1122; Castiglione RC, 2013, CELL PHYSIOL BIOCHEM, V32, P699, DOI 10.1159/000354473; COSIO FG, 1995, J AM SOC NEPHROL, V5, P1600; Ding YF, 2013, KIDNEY INT, V83, P845, DOI 10.1038/ki.2012.393; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Goltsev YV, 1997, J BIOL CHEM, V272, P19641, DOI 10.1074/jbc.272.32.19641; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Jelassi B, 2013, CARCINOGENESIS, V34, P1487, DOI 10.1093/carcin/bgt099; Kim S, 2008, J CELL BIOCHEM, V105, P971, DOI 10.1002/jcb.21905; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Lan T, 2013, J CELL BIOCHEM, V114, P2562, DOI 10.1002/jcb.24601; Lan T, 2011, MOL ENDOCRINOL, V25, P2094, DOI 10.1210/me.2011-0095; Levin A, 2008, AM J KIDNEY DIS, V52, P661, DOI 10.1053/j.ajkd.2008.06.023; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li XJ, 2009, MOL CELL ENDOCRINOL, V307, P157, DOI 10.1016/j.mce.2009.03.006; Liu Y, 2009, EXP MOL MED, V41, P648, DOI 10.3858/emm.2009.41.9.071; Ljubimov AV, 2004, INVEST OPHTH VIS SCI, V45, P4583, DOI 10.1167/iovs.04-0686; Marques-Fernandez F, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.25; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; MCLENNAN SV, 1994, DIABETES, V43, P1041, DOI 10.2337/diabetes.43.8.1041; NAHMAN NS, 1992, KIDNEY INT, V41, P396, DOI 10.1038/ki.1992.55; Nam SY, 2003, CANCER SCI, V94, P1066, DOI 10.1111/j.1349-7006.2003.tb01402.x; Pennarun B, 2010, BBA-REV CANCER, V1805, P123, DOI 10.1016/j.bbcan.2009.11.004; Pesce CG, 1999, FEBS LETT, V457, P445, DOI 10.1016/S0014-5793(99)01091-1; Reddy MA, 2013, KIDNEY INT; Sanchez-Perez T, 2010, CELL DEATH DIFFER, V17, P883, DOI 10.1038/cdd.2009.176; Song P, 2013, J BIOL CHEM, V288, P5732, DOI 10.1074/jbc.M112.441477; Taniguchi K, 2013, DIABETES; Townsend RR, 2009, NEPHSAP, V8, P271; Vesely ED, 2009, AM J PHYSIOL-CELL PH, V297, pC759, DOI 10.1152/ajpcell.00213.2009; Woo SW, 2002, PHARMACOL TOXICOL, V90, P193, DOI 10.1034/j.1600-0773.2002.900404.x; Wu L, 2013, INFLAMMATION, V36, P1020, DOI 10.1007/s10753-013-9634-y; Yano N, 2009, BIOCHEM J, V423, P129, DOI 10.1042/BJ20082277; Zhang LY, 2012, INT J BIOCHEM CELL B, V44, P629, DOI 10.1016/j.biocel.2012.01.001; Zhang Z, 2009, FEBS LETT, V583, P2009, DOI 10.1016/j.febslet.2009.05.021	38	25	32	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93588	10.1371/journal.pone.0093588	http://dx.doi.org/10.1371/journal.pone.0093588			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691542	gold, Green Published, Green Submitted			2022-12-27	WOS:000334101100108
J	Huang, CY; Sheng, YY				Huang, Chunyun; Sheng, Youyu			RETRACTED: Pimecrolimus Cream 1% in the Management of Atopic Dermatitis in Pediatric Patients: A Meta-Analysis (Retracted article. See vol. 9, e108566, 2014)	PLOS ONE			English	Article; Retracted Publication							LONG-TERM MANAGEMENT; TOPICAL PIMECROLIMUS; CHILDREN; EFFICACY; INFANTS; ECZEMA; SAFETY; TACROLIMUS; QUALITY; ADULTS	Objective: To evaluate the efficacy and safety of pimecrolimus cream 1% in the treatment of AD in the pediatric population. Methods: PubMed, EMBASE, Web of Science and Cochrane library databases were searched till July 2013. The randomized and nonrandomized blinded studies of pimecrolimus cream 1% applied twice daily with Jaded score >= 3 in pediatric patients with AD were included. The efficacy outcomes included investigator global assessment ( IGA), eczema area and severity index ( EASI) scores, pruritus and care giver's assessments and flares free period. Adverse events were reviewed to assess the safety. Results: Out of 81 studies, 7 were selected that enrolled 2,170 pediatric patients. The pooled analysis reported that pimecrolimus was no better to vehicle reducing eczema at day- 8, day- 26 and six weeks ( OR 4.95, 95% CI 2.79-8.80), ( OR 9.69, 95% CI 4.12- 22.83) and ( OR 3.83. 95% CI 1.94- 7.56), respectively in children. Similarly, pimecrolimus did not show beneficial effects when analyzed for mild or absent pruritus at day 4 ( OR 8.29, 95% CI 3.88- 17.72 favoring vehicle), day 43 ( OR 1.81 95% CI 1.13-2.89 favoring vehicle) and 1 week ( OR 2.29, 95% CI 1.45 to 3.60 favoring vehicle) as compared with vehicle. One study comparing pimecrolimus with tacrolimus found no significant difference in achieving mild or absent pruritus ( OR 0.94, 95% CI 0.44-1.99). More patients showed an improvement in overall disease in vehicle group at day 8 ( OR 3.30, 95% CI 2.03-5.35), day 29 ( OR 14.14, 95% CI 6.87- 29.13) and day 43 ( OR 4.11, 95% CI 2.59-6.52) as compared with pimecrolimus 1% group, as assessed by caregivers. No significant difference was seen between the total AEs in both groups ( pimecrolimus vs vehicle/ tacrolimus) ( OR 1.19, 95% CI 0.85, 1.65) Conclusion: The results of the present meta- analysis showed that pimecrolimus cream 1% was not significantly better to vehicle for AD in pediatrics population.	[Huang, Chunyun; Sheng, Youyu] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Dermatol, Shanghai 200433, Peoples R China	Fudan University	Sheng, YY (corresponding author), Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Dermatol, Shanghai 200433, Peoples R China.	hspfsyy@163.com			Science and Technology Commission of Shanghai Municipality [12411951500]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The present work (No. 12411951500) was sponsored by Science and Technology Commission of Shanghai Municipality on the supply of data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2006, J ALLERGY CLIN IMMUN, V118, P152, DOI 10.1016/j.jaci.2006.03.045; Ashcroft DM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005500.pub2; Ashcroft DM, 2005, BMJ-BRIT MED J, V330, P516, DOI 10.1136/bmj.38376.439653.D3; Breuer K, 2004, DERMATOLOGY, V209, P314, DOI 10.1159/000080855; Chen SL, 2010, J DERMATOL TREAT, V21, P144, DOI 10.3109/09546630903401470; Deckers IAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039803; Eichenfield LF, 2002, J AM ACAD DERMATOL, V46, P495, DOI 10.1067/mjd.2002.122187; Eichenfield LF, 2005, INT J DERMATOL, V44, P70, DOI 10.1111/j.1365-4632.2004.02234.x; Emerson RM, 2001, BRIT J DERMATOL, V144, P514, DOI 10.1046/j.1365-2133.2001.04077.x; Gollnick H, 2008, BRIT J DERMATOL, V158, P1083, DOI 10.1111/j.1365-2133.2008.08484.x; Graham-Brown RAC, 2003, INT J CLIN PRACT, V57, P319; Grassberger M, 2004, EXP DERMATOL, V13, P721, DOI 10.1111/j.0906-6705.2004.00269.x; Gupta AK, 2003, J EUR ACAD DERMATOL, V17, P493, DOI 10.1046/j.1468-3083.2003.00692.x; Hanifin JM, 2001, EXP DERMATOL, V10, P11, DOI 10.1034/j.1600-0625.2001.100102.x; Hebert AA, 2006, CLIN THER, V28, P1972, DOI 10.1016/j.clinthera.2006.12.014; Ho VC, 2003, J PEDIATR-US, V142, P155, DOI 10.1067/mpd.2003.65; Hoare C, 2000, Health Technol Assess, V4, P1; Hywel C, 1997, CHALLENGE DERMATOEPI; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kapp A, 2002, J ALLERGY CLIN IMMUN, V110, P277, DOI 10.1067/mai.2002.126500; Kaufmann R, 2004, J ALLERGY CLIN IMMUN, V114, P1183, DOI 10.1016/j.jaci.2004.08.015; KAY J, 1994, J AM ACAD DERMATOL, V30, P35, DOI 10.1016/S0190-9622(94)70004-4; Kempers S, 2004, J AM ACAD DERMATOL, V51, P515, DOI 10.1016/j.jaad.2004.01.051; Krakowski AC, 2008, PEDIATRICS, V122, P812, DOI 10.1542/peds.2007-2232; LARSEN FS, 1993, MONOGR ALLERGY, V31, P9; Luger T A, 2004, J Dermatolog Treat, V15, P169; Meurer M, 2002, DERMATOLOGY, V205, P271, DOI 10.1159/000065863; Meurer M, 2004, DERMATOLOGY, V208, P365, DOI 10.1159/000078462; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Papp KA, 2005, J AM ACAD DERMATOL, V52, P240, DOI 10.1016/j.jaad.2004.09.016; Queille-Roussel C, 2001, BRIT J DERMATOL, V144, P507, DOI 10.1046/j.1365-2133.2001.04076.x; Siegfried E, 2006, J DERMATOL TREAT, V17, P143, DOI 10.1080/09546630600647297; Staab D, 2005, PEDIAT ALLERG IMM-UK, V16, P527, DOI 10.1111/j.1399-3038.2005.00306.x; Stuetz A, 2001, SEMIN CUTAN MED SURG, V20, P233, DOI 10.1053/sder.2001.29066; Su JC, 1997, ARCH DIS CHILD, V76, P159, DOI 10.1136/adc.76.2.159; Wadonda-Kabondo N, 2003, BRIT J DERMATOL, V149, P1023, DOI 10.1111/j.1365-2133.2003.05605.x; Wahn U, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e2; Wellington K, 2004, AM J CLIN DERMATOL, V5, P479, DOI 10.2165/00128071-200405060-00013; Williams H, 2002, BRIT MED J, V324, P1533, DOI 10.1136/bmj.324.7353.1533; Xu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036174	40	1	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93095	10.1371/journal.pone.0093095	http://dx.doi.org/10.1371/journal.pone.0093095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691404	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100044
J	Zhu, GP; Peterson, AT				Zhu, Gengping; Peterson, A. Townsend			Potential Geographic Distribution of the Novel Avian-Origin Influenza A (H7N9) Virus	PLOS ONE			English	Article							RISK	Background: In late March 2013, a new avian-origin influenza virus emerged in eastern China. This H7N9 subtype virus has since infected 240 people and killed 60, and has awakened global concern as a potential pandemic threat. Ecological niche modeling has seen increasing applications as a useful tool in mapping geographic potential and risk of disease transmission. Methodology/Principals: We developed two datasets based on seasonal variation in Normalized Difference Vegetation Index (NDVI) from the MODIS sensor to characterize environmental dimensions of H7N9 virus. One-third of well-documented cases was used to test robustness of models calibrated based on the remaining two-thirds, and model significance was tested using partial ROC approaches. A final niche model was calibrated using all records available. Conclusions/Significance: Central-eastern China appears to represent an area of high risk for H7N9 spread, but suitable areas were distributed more spottily in the north and only along the coast in the south; highly suitable areas also were identified in western Taiwan. Areas identified as presenting high risk for H7N9 spread tend to present consistent NDVI values through the year, whereas unsuitable areas show greater seasonal variation.	[Zhu, Gengping] Tianjin Normal Univ, Coll Life Sci, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China; [Peterson, A. Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA	Tianjin Normal University; University of Kansas	Zhu, GP (corresponding author), Tianjin Normal Univ, Coll Life Sci, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China.	gengpingzhu@hotmail.com	Zhu, Gengping/CAF-4192-2022; Peterson, A. Townsend/I-5697-2013	Zhu, Gengping/0000-0001-6823-5840; Peterson, A. Townsend/0000-0003-0243-2379	Tianjin Normal University [5RL127]	Tianjin Normal University	No current funding sources were specifically designate for this study, however, partial support was from the talent introduction program award to GZ in Tianjin Normal University (5RL127). No additional funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler D., 2013, NATURE, DOI [10.1038/nature.2013.12863, DOI 10.1038/NATURE.2013.12863]; Fang LQ, 2014, SCI REPORTS, V3, P2722; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Giles J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000925; He JK, 2013, ARXIV13041985; JK He, 2013, PREDICTING GLOBAL TR; Li X W, 2007, CHINESE J NATURE, V29, P69; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2008, NATURWISSENSCHAFTEN, V95, P483, DOI 10.1007/s00114-008-0352-5; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Reed KD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002034; Shi BY, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-8; Shi JZ, 2013, CHINESE SCI BULL, V58, P1857, DOI 10.1007/s11434-013-5873-4; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Wang CM, 2014, J INFECT DIS, V209, P34, DOI 10.1093/infdis/jit478; Williams RAJ, 2011, GEOSPATIAL HEALTH, V5, P247, DOI 10.4081/gh.2011.177; Wu SQ, 2013, LANCET, V381, P1539, DOI 10.1016/S0140-6736(13)60767-9; Xu R, 2013, SCIENCE, V342, P1230, DOI 10.1126/science.1243761	22	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93390	10.1371/journal.pone.0093390	http://dx.doi.org/10.1371/journal.pone.0093390			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690878	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100072
J	Yoshimoto, Y; Suzuki, Y; Mimura, K; Ando, K; Oike, T; Sato, H; Okonogi, N; Maruyama, T; Izawa, S; Noda, S; Fujii, H; Kono, K; Nakano, T				Yoshimoto, Yuya; Suzuki, Yoshiyuki; Mimura, Kousaku; Ando, Ken; Oike, Takahiro; Sato, Hiro; Okonogi, Noriyuki; Maruyama, Takanori; Izawa, Shinichiro; Noda, Shin-ei; Fujii, Hideki; Kono, Koji; Nakano, Takashi			Radiotherapy-Induced Anti-Tumor Immunity Contributes to the Therapeutic Efficacy of Irradiation and Can Be Augmented by CTLA-4 Blockade in a Mouse Model	PLOS ONE			English	Article							REGULATORY T-CELLS; LOCAL RADIATION; TUMORS; COMBINATION; INHIBITION; EFFECTOR; GITR	Purpose: There is growing evidence that tumor-specific immune responses play an important role in anti-cancer therapy, including radiotherapy. Using mouse tumor models we demonstrate that irradiation-induced anti-tumor immunity is essential for the therapeutic efficacy of irradiation and can be augmented by modulation of cytotoxic T lymphocyte (CTL) activity. Methods and Materials: C57BL/6 mice, syngeneic EL4 lymphoma cells, and Lewis lung carcinoma (LL/C) cells were used. Cells were injected into the right femurs of mice. Ten days after inoculation, tumors were treated with 30 Gy of local X-ray irradiation and their growth was subsequently measured. The effect of irradiation on tumor growth delay (TGD) was defined as the time (in days) for tumors to grow to 500 mm(3) in the treated group minus that of the untreated group. Cytokine production and serum antibodies were measured by ELISA and flow cytometry. Results: In the EL4 tumor model, tumors were locally controlled by X-ray irradiation and re-introduced EL4 cells were completely rejected. Mouse EL4-specific systemic immunity was confirmed by splenocyte cytokine production and detection of tumor-specific IgG1 antibodies. In the LL/C tumor model, X-ray irradiation also significantly delayed tumor growth (TGD: 15.4 days) and prolonged median survival time (MST) to 59 days (versus 28 days in the non-irradiated group). CD8(+) cell depletion using an anti-CD8 antibody significantly decreased the therapeutic efficacy of irradiation (TGD, 8.7 days; MST, 49 days). Next, we examined whether T cell modulation affected the efficacy of radiotherapy. An anti-CTLA-4 antibody significantly increased the anti-tumor activity of radiotherapy (TGD was prolonged from 13.1 to 19.5 days), while anti-FR4 and anti-GITR antibodies did not affect efficacy. Conclusions: Our results indicate that tumor-specific immune responses play an important role in the therapeutic efficacy of irradiation. Immunomodulation, including CTLA-4 blockade, may be a promising treatment in combination with radiotherapy.	[Yoshimoto, Yuya; Suzuki, Yoshiyuki; Ando, Ken; Oike, Takahiro; Sato, Hiro; Okonogi, Noriyuki; Noda, Shin-ei; Nakano, Takashi] Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gunma 371, Japan; [Mimura, Kousaku; Kono, Koji] Natl Univ Singapore, Dept Surg, Singapore 117548, Singapore; [Kono, Koji] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Mimura, Kousaku; Maruyama, Takanori; Izawa, Shinichiro; Fujii, Hideki; Kono, Koji] Univ Yamanashi, Dept Surg 1, Kofu, Yamanashi, Japan	Gunma University; National University of Singapore; National University of Singapore; University of Yamanashi	Suzuki, Y (corresponding author), Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gunma 371, Japan.	syoshi@med.gunma-u.ac.jp	/CAH-2060-2022; Sato, Hiro/GWU-7659-2022	Okonogi, Noriyuki/0000-0002-9486-1922	MEXT KAKENHI; Grants-in-Aid for Scientific Research [24591834] Funding Source: KAKEN	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was financially supported by MEXT KAKENHI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of our manuscript.	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Demaria S, 2005, CLIN CANCER RES, V11, P728; Demaria S, 2004, INT J RADIAT ONCOL, V58, P862, DOI 10.1016/j.ijrobp.2003.09.012; Dewan MZ, 2009, CLIN CANCER RES, V15, P5379, DOI 10.1158/1078-0432.CCR-09-0265; Grosso Joseph F, 2013, Cancer Immun, V13, P5; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Schaer DA, 2012, CURR OPIN IMMUNOL, V24, P217, DOI 10.1016/j.coi.2011.12.011; Suzuki Y, 2012, CANCER RES, V72, P3967, DOI 10.1158/0008-5472.CAN-12-0851; Takeda K, 2010, J IMMUNOL, V184, P5493, DOI 10.4049/jimmunol.0903033; Takeshima T, 2010, CANCER RES, V70, P2697, DOI 10.1158/0008-5472.CAN-09-2982; Verginis P, 2008, P NATL ACAD SCI USA, V105, P3479, DOI 10.1073/pnas.0800149105; von Boehmer H, 2013, NAT REV DRUG DISCOV, V12, P51, DOI 10.1038/nrd3683; Yamaguchi T, 2007, IMMUNITY, V27, P145, DOI 10.1016/j.immuni.2007.04.017	17	80	87	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e92572	10.1371/journal.pone.0092572	http://dx.doi.org/10.1371/journal.pone.0092572			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686897	Green Published, Green Submitted, gold			2022-12-27	WOS:000340842300002
J	Ling, GY; Gao, JX; Zhang, SM; Xie, ZP; Wei, L; Yu, HN; Wang, YP				Ling, Guiying; Gao, Jiuxiang; Zhang, Shumin; Xie, Zeping; Wei, Lin; Yu, Haining; Wang, Yipeng			Cathelicidins from the Bullfrog Rana catesbeiana Provides Novel Template for Peptide Antibiotic Design	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; ANTIMICROBIAL PEPTIDES; FUNCTIONAL-CHARACTERIZATION; GENE CLONING; IDENTIFICATION; LL-37; EXPRESSION; FAMILY; CATHS	Cathelicidins, a class of gene-encoded effector molecules of vertebrate innate immunity, provide a first line of defense against microbial invasions. Although cathelicidins from mammals, birds, reptiles and fishes have been extensively studied, little is known about cathelicidins from amphibians. Here we report the identification and characterization of two cathelicidins (cathelicidin-RC1 and cathelicidin-RC2) from the bullfrog Rana catesbeiana. The cDNA sequences (677 and 700 bp, respectively) encoding the two peptides were successfully cloned from the constructed lung cDNA library of R. catesbeiana. And the deduced mature peptides are composed of 28 and 33 residues, respectively. Structural analysis indicated that cathelicidin-RC1 mainly assumes an amphipathic alpha-helical conformation, while cathelicidin-RC2 could not form stable amphipathic structure. Antimicrobial and bacterial killing kinetic analysis indicated that the synthetic cathelicidin-RC1 possesses potent, broad-spectrum and rapid antimicrobial potency, while cathelicidin-RC2 exhibited very weak antimicrobial activity. Besides, the antimicrobial activity of cathelicidin-RC1 is salt-independent and highly stable. Scanning electron microscopy (SEM) analysis indicated that cathelicidin-RC1 kills microorganisms through the disruption of microbial membrane. Moreover, cathelicidin-RC1 exhibited low cytotoxic activity against mammalian normal or tumor cell lines, and low hemolytic activity against human erythrocytes. The potent, broad-spectrum and rapid antimicrobial activity combined with the salt-independence, high stability, low cytotoxic and hemolytic activities make cathelicidin-RC1 an ideal template for the development of novel peptide antibiotics.	[Wei, Lin; Wang, Yipeng] Soochow Univ, Coll Pharmaceut Sci, Suzhou, Jiangsu, Peoples R China; [Gao, Jiuxiang; Yu, Haining] Dalian Univ Technol, Dept Biosci & Biotechnol, Dalian, Peoples R China; [Zhang, Shumin; Xie, Zeping] Binzhou Med Univ, Pharmaceut Coll, Yantai, Shandong, Peoples R China; [Ling, Guiying] Guizhou Normal Univ, Dept Biol, Guiyang, Guizhou, Peoples R China	Soochow University - China; Dalian University of Technology; Binzhou Medical University; Guizhou Normal University	Yu, HN (corresponding author), Dalian Univ Technol, Dept Biosci & Biotechnol, Dalian, Peoples R China.	yuhaining@dlut.edu.cn; wyp010@163.com	Wei, Lin/AAE-3043-2022; Wang, Yipeng/AAA-1499-2020	Wei, Lin/0000-0003-3359-2471; Wang, Yipeng/0000-0003-1385-4470	Chinese National Natural Science Foundation [41206153, 41076098]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Growth Project for Liaoning Distinguished Young Scientists of Colleges and Universities [LJQ2013010]; Dalian Distinguished Young Scientists Funding [2013J21DW013]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Growth Project for Liaoning Distinguished Young Scientists of Colleges and Universities; Dalian Distinguished Young Scientists Funding	This work was supported by the grants from Chinese National Natural Science Foundation (41206153, 41076098), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, Growth Project for Liaoning Distinguished Young Scientists of Colleges and Universities (LJQ2013010) and Dalian Distinguished Young Scientists Funding (2013J21DW013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; Boman HG, 1998, SCAND J IMMUNOL, V48, P15; Chang CI, 2005, INFECT IMMUN, V73, P5053, DOI 10.1128/IAI.73.8.5053-5064.2005; Feng FF, 2011, FEBS J, V278, P1573, DOI 10.1111/j.1742-4658.2011.08080.x; Gennaro R, 2000, BIOPOLYMERS, V55, P31, DOI 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.3.CO;2-0; GENNARO R, 1989, INFECT IMMUN, V57, P3142, DOI 10.1128/IAI.57.10.3142-3146.1989; Giles FJ, 2003, LEUKEMIA LYMPHOMA, V44, P1165, DOI 10.1080/1042819031000079159; Goitsuka R, 2007, P NATL ACAD SCI USA, V104, P15063, DOI 10.1073/pnas.0707037104; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hao X, 2012, AMINO ACIDS, V43, P677, DOI 10.1007/s00726-011-1116-7; He WY, 2012, BIOCHIMIE, V94, P649, DOI 10.1016/j.biochi.2011.09.017; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Isaacson Richard E, 2003, Curr Opin Investig Drugs, V4, P999; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Lehrer RI, 2002, CURR OPIN HEMATOL, V9, P18, DOI 10.1097/00062752-200201000-00004; Li Z, 2013, FISH SHELLFISH IMMUN, V34, P1, DOI 10.1016/j.fsi.2012.07.004; Lu ZK, 2010, BIOCHIMIE, V92, P475, DOI 10.1016/j.biochi.2010.01.025; Lu ZK, 2010, FEBS J, V277, P2329, DOI 10.1111/j.1742-4658.2010.07648.x; Maier VH, 2008, MOL IMMUNOL, V45, P3723, DOI 10.1016/j.molimm.2008.06.002; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Radek K, 2007, SEMIN IMMUNOPATHOL, V29, P27, DOI 10.1007/s00281-007-0064-5; Sang Y, 2007, DEV COMP IMMUNOL, V31, P1278, DOI 10.1016/j.dci.2007.03.007; Schlusselhuber M, 2012, ANTIMICROB AGENTS CH, V56, P1749, DOI 10.1128/AAC.05797-11; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Steinstraesser L, 2011, IMMUNOBIOLOGY, V216, P322, DOI 10.1016/j.imbio.2010.07.003; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; Wang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022120; Wang YP, 2011, DEV COMP IMMUNOL, V35, P314, DOI 10.1016/j.dci.2010.10.004; Wang YP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003217; Wei L, 2013, J MED CHEM, V56, P3546, DOI 10.1021/jm4004158; Xiao YJ, 2006, J BIOL CHEM, V281, P2858, DOI 10.1074/jbc.M507180200; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yu HN, 2013, FEBS J, V280, P6022, DOI 10.1111/febs.12521; Zaiou M, 2002, J MOL MED, V80, P549, DOI 10.1007/s00109-002-0350-6; Zanetti M, 2000, ADV EXP MED BIOL, V479, P203; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao H, 2008, PEPTIDES, V29, P1685, DOI 10.1016/j.peptides.2008.06.008	40	31	35	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93216	10.1371/journal.pone.0093216	http://dx.doi.org/10.1371/journal.pone.0093216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675879	gold, Green Submitted, Green Published			2022-12-27	WOS:000333677500093
J	Ohkubo, N; Matsubara, E; Yamanouchi, J; Akazawa, R; Aoto, M; Suzuki, Y; Sakai, I; Abe, T; Kiyonari, H; Matsuda, S; Yasukawa, M; Mitsuda, N				Ohkubo, Nobutaka; Matsubara, Etsuko; Yamanouchi, Jun; Akazawa, Rie; Aoto, Mamoru; Suzuki, Yoji; Sakai, Ikuya; Abe, Takaya; Kiyonari, Hiroshi; Matsuda, Seiji; Yasukawa, Masaki; Mitsuda, Noriaki			Abnormal Behaviors and Developmental Disorder of Hippocampus in Zinc Finger Protein 521 (ZFP521) Mutant Mice	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; B-CELL FACTOR-1; PREPULSE INHIBITION; MOUSE MODEL; STEM-CELL; NEURAL DIFFERENTIATION; STARTLE REFLEX; BONE-FORMATION; RETT-SYNDROME; ADULT	Zinc finger protein 521 (ZFP521) regulates a number of cellular processes in a wide range of tissues, such as osteoblast formation and adipose commitment and differentiation. In the field of neurobiology, it is reported to be an essential factor for transition of epiblast stem cells into neural progenitors in vitro. However, the role of ZFP521 in the brain in vivo still remains elusive. To elucidate the role of ZFP521 in the mouse brain, we generated mice lacking exon 4 of the ZFP521 gene. The birth ratio of our ZFP521(Delta/Delta) mice was consistent with Mendel's laws. Although ZFP521(Delta/Delta) pups had no apparent defect in the body and were indistinguishable from ZFP521(+/+) and ZFP521(+/Delta) littermates at the time of birth, ZFP521(Delta/Delta) mice displayed significant weight reduction as they grew, and most of them died before 10 weeks of age. They displayed abnormal behavior, such as hyper-locomotion, lower anxiety and impaired learning, which correspond to the symptoms of schizophrenia. The border of the granular cell layer of the dentate gyrus in the hippocampus of the mice was indistinct and granular neurons were reduced in number. Furthermore, Sox1-positive neural progenitor cells in the dentate gyrus and cerebellum were significantly reduced in number. Taken together, these findings indicate that ZFP521 directly or indirectly affects the formation of the neuronal cell layers of the dentate gyrus in the hippocampus, and thus ZFP521(Delta/Delta) mice displayed schizophrenia-relevant symptoms. ZFP521(Delta/Delta) mice may be a useful research tool as an animal model of schizophrenia.	[Ohkubo, Nobutaka; Akazawa, Rie; Aoto, Mamoru; Suzuki, Yoji; Mitsuda, Noriaki] Ehime Univ, Dept Circulatory Physiol, Toon, Ehime, Japan; [Matsubara, Etsuko; Yamanouchi, Jun; Yasukawa, Masaki] Ehime Univ, Grad Sch Med, Dept Hematol Clin Immunol & Infect Dis, Toon, Ehime, Japan; [Matsuda, Seiji] Ehime Univ, Grad Sch Med, Dept Anat & Embryol, Toon, Ehime, Japan; [Sakai, Ikuya] Matsuyama Univ, Coll Pharmaceut Sci, Sch Clin Pharm, Dept Pathophysiol, Matsuyama, Ehime, Japan; [Abe, Takaya; Kiyonari, Hiroshi] RIKEN, Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo, Japan	Ehime University; Ehime University; Ehime University; RIKEN	Ohkubo, N (corresponding author), Ehime Univ, Dept Circulatory Physiol, Toon, Ehime, Japan.	nobu@m.ehime-u.ac.jp	Kiyonari, Hiroshi/N-7936-2015		KAKENHI grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan [KAKENHI:25870486]; Grants-in-Aid for Scientific Research [24390245] Funding Source: KAKEN	KAKENHI grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI (Grants-in-Aid for Scientific Research) grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI:25870486) and Grant-in-Aid for Research Promotion, Ehime University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKSHI VP, 1994, J PHARMACOL EXP THER, V271, P787; Balu DT, 2009, NEUROSCI BIOBEHAV R, V33, P232, DOI 10.1016/j.neubiorev.2008.08.007; BARBU V, 1989, NUCLEIC ACIDS RES, V17, P7115, DOI 10.1093/nar/17.17.7115; Bond HM, 2008, INT J BIOCHEM CELL B, V40, P848, DOI 10.1016/j.biocel.2007.04.006; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; BRAFF D, 1978, PSYCHOPHYSIOLOGY, V15, P339, DOI 10.1111/j.1469-8986.1978.tb01390.x; Brandon NJ, 2009, J NEUROSCI, V29, P12768, DOI 10.1523/JNEUROSCI.3355-09.2009; Castellanos FX, 1996, BIOL PSYCHIAT, V39, P33, DOI 10.1016/0006-3223(95)00101-8; Correa D, 2010, DEV CELL, V19, P533, DOI 10.1016/j.devcel.2010.09.008; Gainetdinov RR, 2001, P NATL ACAD SCI USA, V98, P11047, DOI 10.1073/pnas.191353298; Gong R, 2011, SCIENCE, V333, P1642, DOI 10.1126/science.1207675; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Han R, 2012, NEUROSCI LETT, V515, P147, DOI 10.1016/j.neulet.2012.03.032; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Hesse E, 2010, J CELL BIOL, V191, P1271, DOI 10.1083/jcb.201009107; Hesse E, 2010, ANN NY ACAD SCI, V1192, P32, DOI 10.1111/j.1749-6632.2009.05347.x; Jeon B, 2012, NEUROSCIENCE, V224, P191, DOI 10.1016/j.neuroscience.2012.08.035; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Kang S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001433; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Koike H, 2009, BEHAV BRAIN RES, V202, P114, DOI 10.1016/j.bbr.2009.03.028; Kuroda K, 2011, HUM MOL GENET, V20, P4666, DOI 10.1093/hmg/ddr400; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Lobo MK, 2008, J NEUROSCI RES, V86, P2134, DOI 10.1002/jnr.21666; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Matsubara E, 2009, J BIOL CHEM, V284, P3480, DOI 10.1074/jbc.M805874200; Matsuoka Y, 2005, P NATL ACAD SCI USA, V102, P16066, DOI 10.1073/pnas.0504908102; Mega T, 2011, CELL CYCLE, V10, P2129, DOI 10.4161/cc.10.13.16045; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Ohkubo N, 2002, FASEB J, V16, P295, DOI 10.1096/fj.02-0434fje; Ohkubo N, 2007, J NEUROCHEM, V103, P820, DOI 10.1111/j.1471-4159.2007.04804.x; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; Pfeiffer V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058259; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Rolland B, 2012, SCHIZOPHR RES TREAT, V2012, DOI 10.1155/2012/839853; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Seriwatanachai D, 2011, FASEB J, V25, P3057, DOI 10.1096/fj.11-183277; Shen SB, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt61; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Takahashi K, 2007, BIOL PSYCHIAT, V62, P148, DOI 10.1016/j.biopsych.2006.06.035; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Tomita K, 2011, HUM MOL GENET, V20, P2834, DOI 10.1093/hmg/ddr194; Varty GB, 1995, PSYCHOPHARMACOLOGY, V122, P15, DOI 10.1007/BF02246437; Wang R, 2011, BRAIN RES, V1372, P127, DOI 10.1016/j.brainres.2010.11.059; Warming S, 2003, BLOOD, V101, P1934, DOI 10.1182/blood-2002-08-2652; Wu M, 2009, BONE, V44, P528, DOI 10.1016/j.bone.2008.11.011; Wu WL, 2010, GENES BRAIN BEHAV, V9, P603, DOI 10.1111/j.1601-183X.2010.00591.x; Yamashita M, 2013, PSYCHOPHARMACOLOGY, V227, P741, DOI 10.1007/s00213-013-3009-9	50	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92848	10.1371/journal.pone.0092848	http://dx.doi.org/10.1371/journal.pone.0092848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676388	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677500045
J	Canaud, B; Vallee, AG; Molinari, N; Chenine, L; Leray-Moragues, H; Rodriguez, A; Chalabi, L; Morena, M; Cristol, JP				Canaud, Bernard; Vallee, Alexandre Granger; Molinari, Nicolas; Chenine, Leila; Leray-Moragues, Helene; Rodriguez, Annie; Chalabi, Lotfi; Morena, Marion; Cristol, Jean-Paul			Creatinine Index as a Surrogate of Lean Body Mass Derived from Urea Kt/V, Pre-Dialysis Serum Levels and Anthropometric Characteristics of Haemodialysis Patients	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; QUALITY-OF-LIFE; NUTRITIONAL-STATUS; MUSCLE MASS; PERITONEAL-DIALYSIS; MORTALITY; SURVIVAL; PREDICTORS; INDICATORS; HOSPITALIZATION	Background and Objectives: Protein-energy wasting is common in long-term haemodialysis (HD) patients with chronic kidney disease and is associated with increased morbidity and mortality. The creatinine index (CI) is a simple and useful nutritional parameter reflecting the dietary skeletal muscle protein intake and skeletal muscle mass of the patient. Because of the complexity of creatinine kinetic modeling (CKM) to derive CI, we developed a more simplified formula to estimate CI in HD patients. Design, Setting, Participants & Measurements: A large database of 549 HD patients followed over more than 20 years including monthly CKM-derived CI values was used to develop a simple equation based on patient demographics, predialysis serum creatinine values and dialysis dose ((sp)Kt/V) using mixed regression models. Results: The equation to estimate CI was developed based on age, gender, pre-dialysis serum creatinine concentrations and (sp)Kt/V urea. The equation-derived CI correlated strongly with the measured CI using CKM (correlation coefficient = 0.79, p-value < 0.001). The mean error of CI prediction using the equation was 13.47%. Preliminary examples of few typical HD patients have been used to illustrate the clinical relevance and potential usefulness of CI. Conclusions: The elementary equation used to derive CI using demographic parameters, pre-dialysis serum creatinine concentrations and dialysis dose is a simple and accurate surrogate measure for muscle mass estimation. However, the predictive value of the simplified CI assessment method on mortality deserves further evaluation in large cohorts of HD patients.	[Canaud, Bernard; Vallee, Alexandre Granger; Chenine, Leila; Leray-Moragues, Helene] CHRU, Nephrol Dialysis & Intens Care Unit, Montpellier, France; [Canaud, Bernard; Chenine, Leila; Leray-Moragues, Helene; Rodriguez, Annie; Morena, Marion; Cristol, Jean-Paul] Dialysis Res & Training Inst, Montpellier, France; [Molinari, Nicolas] CHRU, DIM, MISTEA, UMR 729, Montpellier, France; [Chalabi, Lotfi] AIDER, Montpellier, France; [Morena, Marion; Cristol, Jean-Paul] CHRU, Biochem Lab, Montpellier, France; [Morena, Marion; Cristol, Jean-Paul] Univ Montpellier I, UMR 204, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Cristol, JP (corresponding author), Dialysis Res & Training Inst, Montpellier, France.	jp-cristol@chu-montpellier.fr	molinari, nicolas/Y-9681-2019	RODRIGUEZ, Annie/0000-0002-9503-4523; MORENA CARRERE, Marion/0000-0001-9563-5217				[Anonymous], 2000, AM J KIDNEY DIS, V35, pS1, DOI DOI 10.1053/AJKD.2000.V35.AAJKD03517; Aparicio M, 1999, NEPHROL DIAL TRANSPL, V14, P1679, DOI 10.1093/ndt/14.7.1679; BHATLA B, 1995, ASAIO J, V41, pM442, DOI 10.1097/00002480-199507000-00048; CANAUD B, 1995, NEPHROL DIAL TRANSPL, V10, P1405; Chauveau P, 2005, AM J KIDNEY DIS, V45, P565, DOI 10.1053/j.ajkd.2004.11.014; Combe C, 2001, AM J KIDNEY DIS, V37, pS81, DOI 10.1053/ajkd.2001.20756; Daugirdas J T, 1995, Adv Ren Replace Ther, V2, P295; Desmeules S, 2004, NEPHROL DIAL TRANSPL, V19, P1182, DOI 10.1093/ndt/gfh016; Dwyer JT, 2005, KIDNEY INT, V68, P1766, DOI 10.1111/j.1523-1755.2005.00593.x; Fouque D, 2000, KIDNEY INT, V57, P646, DOI 10.1046/j.1523-1755.2000.057002646.x; Friedman AN, 2010, J AM SOC NEPHROL, V21, P223, DOI 10.1681/ASN.2009020213; Gotch F, 1977, T AUST C HEAT MASS T, P29; GRODSTEIN GP, 1980, AM J CLIN NUTR, V33, P1411, DOI 10.1093/ajcn/33.7.1411; Guebre-Egziabher F, 2009, J CLIN ENDOCR METAB, V94, P2299, DOI 10.1210/jc.2008-2262; HORBER FF, 1992, BRIT J RADIOL, V65, P895, DOI 10.1259/0007-1285-65-778-895; Huang CX, 2010, KIDNEY INT, V77, P624, DOI 10.1038/ki.2009.524; Huang JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054976; Kalantar-Zadeh K, 2004, SEMIN DIALYSIS, V17, P455, DOI 10.1111/j.0894-0959.2004.17606.x; Kalantar-Zadeh K, 2003, J RENAL NUTR, V13, P15, DOI 10.1053/jren.2003.50005; Kalantar-Zadeh K, 2012, AM J EPIDEMIOL, V175, P793, DOI 10.1093/aje/kwr384; Kaysen GA, 2004, KIDNEY INT, V65, P1408, DOI 10.1111/j.1523-1755.2004.00520.x; KESHAVIAH PR, 1994, J AM SOC NEPHROL, V4, P1475; Lertdumrongluk P, 2012, NEPHROL DIAL TRANSPL, V27, P2130, DOI 10.1093/ndt/gfs042; LOWRIE EG, 1995, AM J KIDNEY DIS, V26, P220, DOI 10.1016/0272-6386(95)90177-9; Mak RHK, 1996, AM J PHYSIOL-RENAL, V271, pF114, DOI 10.1152/ajprenal.1996.271.1.F114; Mapes DL, 2003, KIDNEY INT, V64, P339, DOI 10.1046/j.1523-1755.2003.00072.x; Moreau-Gaudry X, 2011, J RENAL NUTR, V21, P369, DOI 10.1053/j.jrn.2010.08.005; Noori N, 2010, CLIN J AM SOC NEPHRO, V5, P2258, DOI 10.2215/CJN.02080310; Ohkawa S, 2000, AM J CLIN NUTR, V71, P485; Park J, 2013, NEPHROL DIAL TRANSPL, V28, P2146, DOI 10.1093/ndt/gft213; Park J, 2013, MAYO CLIN PROC, V88, P479, DOI 10.1016/j.mayocp.2013.01.025; Pickering WP, 2002, KIDNEY INT, V61, P1286, DOI 10.1046/j.1523-1755.2002.00276.x; Pifer TB, 2002, KIDNEY INT, V62, P2238, DOI 10.1046/j.1523-1755.2002.00658.x; Pupim LB, 2004, J RENAL NUTR, V14, P6, DOI 10.1053/j.jrn.2003.10.001; Rocco MV, 2002, AM J KIDNEY DIS, V39, P245, DOI 10.1053/ajkd.2002.30543; Rosansky SJ, 2011, KIDNEY INT, V79, P1259, DOI 10.1038/ki.2011.70; Sarkar SR, 2006, KIDNEY INT, V70, P1832, DOI 10.1038/sj.ki.5001895; Terrier N, 2008, NEPHROL DIAL TRANSPL, V23, P345, DOI 10.1093/ndt/gfm573; Walther CP, 2012, NEPHROL DIAL TRANSPL, V27, P771, DOI 10.1093/ndt/gfr389; Workeneh BT, 2010, AM J CLIN NUTR, V91, p1128S, DOI 10.3945/ajcn.2010.28608B	40	62	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93286	10.1371/journal.pone.0093286	http://dx.doi.org/10.1371/journal.pone.0093286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671212	gold, Green Published			2022-12-27	WOS:000333677000131
J	Kaur, S; Momi, N; Chakraborty, S; Wagner, DG; Horn, AJ; Lele, SM; Theodorescu, D; Batra, SK				Kaur, Sukhwinder; Momi, Navneet; Chakraborty, Subhankar; Wagner, David G.; Horn, Adam J.; Lele, Subodh M.; Theodorescu, Dan; Batra, Surinder K.			Altered Expression of Transmembrane Mucins, MUC1 and MUC4, in Bladder Cancer: Pathological Implications in Diagnosis	PLOS ONE			English	Article							MAMMARY-GLAND; CARCINOMA; SURVIVAL; OVEREXPRESSION; GROWTH	Purpose: Radical changes in both expression and glycosylation pattern of transmembrane mucins have been observed in various malignancies. We and others have shown that MUC1 and MUC4, two transmembrane mucins, play a sentinel role in cell signaling events that drive several epithelial malignancies. In the present study, we investigated the expression profile of MUC1 and MUC4 in the non-neoplastic bladder urothelium, in various malignant neoplasms of bladder and in bladder carcinoma cell lines. Material and Methods: Immunohistochemistry was performed on tissue sections from the urinary bladder biopsies, resection samples and tissue microarrays (TMAs) with monoclonal antibodies specific for MUC1 and MUC4. We also investigated their expression in bladder carcinoma cell lines by RT-PCR and immunoblotting. Results: MUC1 is expressed on the apical surface or in umbrella cells of the normal non-neoplastic bladder urothelium. Strong expression of MUC1 was also observed in urothelial carcinoma (UC). MUC1 staining increased from normal urothelium (n = 27, 0.35 +/- 0.12) to urothelial carcinoma (UC, n = 323, H-score, 2.4 +/- 0.22, p <= 0.0001). In contrast to MUC1, MUC4 was expressed in all the layers of non-neoplastic bladder urothelium (n = 14, 2.5 +/- 0.28), both in the cell membrane and cytoplasm. In comparison to non-neoplastic urothelium, the loss of MUC4 expression was observed during urothelial carcinoma (n = 211, 0.56 +/- 0.06). However, re-expression of MUC4 was observed in a subset of metastatic cases of urothelial carcinoma (mean H-score 0.734 +/- 0.9). Conclusion: The expression of MUC1 is increased while that of MUC4 decreased in UC compared to the normal nonneoplastic urothelium. Expression of both MUC1 and MUC4, however, are significantly higher in urothelial carcinoma metastatic cases compared to localized UC. These results suggest differential expression of MUC1 and MUC4 during development and progression of bladder carcinoma.	[Kaur, Sukhwinder; Momi, Navneet; Chakraborty, Subhankar; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Wagner, David G.; Horn, Adam J.; Lele, Subodh M.; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Batra, Surinder K.] Univ Nebraska Med Ctr, Buffett Canc Ctr, Eppley Canc Inst, Omaha, NE USA; [Theodorescu, Dan] Univ Colorado, Ctr Comprehens Canc, Aurora, CO USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Lele, SM (corresponding author), Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.	slele@unmc.edu; sbatra@unmc.edu			National Institutes of Health [RO1 CA 138791, U54 CA163120, UO1 CA111294, P50 CA127297]; NATIONAL CANCER INSTITUTE [P50CA127297, R01CA138791, U54CA163120, U01CA111294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the grants from the National Institutes of Health (RO1 CA 138791, U54 CA163120, UO1 CA111294, and P50 CA127297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Elazeez TA, 2011, UROL ANNALS, V3, P8, DOI 10.4103/0974-7796.75857; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Chaturvedi P, 2007, MOL CANCER RES, V5, P309, DOI 10.1158/1541-7786.MCR-06-0353; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Hauber Hans-Peter, 2006, Can Respir J, V13, P327; Inata J, 2007, INT J CANCER, V120, P2643, DOI 10.1002/ijc.22613; Jacobs BL, 2010, CA-CANCER J CLIN, V60, P244, DOI 10.3322/caac.20077; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Kaur S, 2013, CLIN CANC RES; Kawano T, 2008, INT J ONCOL, V33, P153; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Lotan Y, 2005, J CLIN ONCOL, V23, P6533, DOI 10.1200/JCO.2005.05.516; McDermott KM, 2001, INT J CANCER, V94, P783, DOI 10.1002/ijc.1554; Moniaux N, 2004, J HISTOCHEM CYTOCHEM, V52, P253, DOI 10.1177/002215540405200213; Nassar H, 2004, MODERN PATHOL, V17, P1045, DOI 10.1038/modpathol.3800166; Park Hee-Ug, 2003, Pancreas, V26, pe48, DOI 10.1097/00006676-200304000-00022; Patriarca C, 2009, INT J SURG PATHOL, V17, P99, DOI 10.1177/1066896908326918; Patton S, 1995, BBA-REV BIOMEMBRANES, V1241, P407, DOI 10.1016/0304-4157(95)00014-3; Rachagani S, 2009, BIOFACTORS, V35, P509, DOI 10.1002/biof.64; Schroeder JA, 2004, ONCOGENE, V23, P5739, DOI 10.1038/sj.onc.1207713; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simms MS, 1999, BJU INT, V84, P350; Singh AP, 2007, CANCER RES, V67, P433, DOI 10.1158/0008-5472.CAN-06-3114; Singh AP, 2006, PROSTATE, V66, P421, DOI 10.1002/pros.20372; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Xiang Song-tao, 2005, Di Yi Jun Yi Da Xue Xue Bao, V25, P1114	26	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92742	10.1371/journal.pone.0092742	http://dx.doi.org/10.1371/journal.pone.0092742			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671186	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000070
J	Pawelzyk, P; Mucke, N; Herrmann, H; Willenbacher, N				Pawelzyk, Paul; Muecke, Norbert; Herrmann, Harald; Willenbacher, Norbert			Attractive Interactions among Intermediate Filaments Determine Network Mechanics In Vitro	PLOS ONE			English	Article							COMPLEX FLUIDS; VISCOELASTIC PROPERTIES; BIOPOLYMER NETWORKS; ACTIN SOLUTIONS; TAIL DOMAIN; F-ACTIN; ELASTICITY; KERATINS; MODULUS; NANOMECHANICS	Mechanical and structural properties of K8/K18 and vimentin intermediate filament (IF) networks have been investigated using bulk mechanical rheometry and optical microrheology including diffusing wave spectroscopy and multiple particle tracking. A high elastic modulus G(0) at low protein concentration c, a weak concentration dependency of G(0) (G(0)similar to c(0.5 +/- 0.1)) and pronounced strain stiffening are found for these systems even without external crossbridgers. Strong attractive interactions among filaments are required to maintain these characteristic mechanical features, which have also been reported for various other IF networks. Filament assembly, the persistence length of the filaments and the network mesh size remain essentially unaffected when a nonionic surfactant is added, but strain stiffening is completely suppressed, G(0) drops by orders of magnitude and exhibits a scaling G(0)similar to c(1.9 +/- 0.2) in agreement with microrheological measurements and as expected for entangled networks of semi-flexible polymers. Tailless K8 Delta/K18 Delta T and various other tailless filament networks do not exhibit strain stiffening, but still show high G(0) values. Therefore, two binding sites are proposed to exist in IF networks. A weaker one mediated by hydrophobic amino acid clusters in the central rod prevents stretched filaments between adjacent cross-links from thermal equilibration and thus provides the high G(0) values. Another strong one facilitating strain stiffening is located in the tail domain with its high fraction of hydrophobic amino acid sequences. Strain stiffening is less pronounced for vimentin than for K8/K18 due to electrostatic repulsion forces partly compensating the strong attraction at filament contact points.	[Pawelzyk, Paul; Willenbacher, Norbert] Karlsruhe Inst Technol, Inst Mech Proc Engn & Mech, D-76021 Karlsruhe, Germany; [Muecke, Norbert] German Canc Res Ctr, Heidelberg, Germany; [Herrmann, Harald] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Willenbacher, N (corresponding author), Karlsruhe Inst Technol, Inst Mech Proc Engn & Mech, D-76021 Karlsruhe, Germany.	norbert.willenbacher@kit.edu		Mucke, Norbert/0000-0002-0683-4386	German Research Foundation;  [HE 1853/8-1]	German Research Foundation(German Research Foundation (DFG)); 	Harald Herrmann received support from the German Research Foundation (http://www.dfg.de). The grant number is HE 1853/8-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apgar J, 2000, BIOPHYS J, V79, P1095, DOI 10.1016/S0006-3495(00)76363-6; Bar H, 2010, J MOL BIOL, V397, P1188, DOI 10.1016/j.jmb.2010.02.024; Bousquet O, 2001, J CELL BIOL, V155, P747, DOI 10.1083/jcb.200104063; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Crassous JJ, 2005, J RHEOL, V49, P851, DOI 10.1122/1.1917843; DEGENNES PG, 1976, MACROMOLECULES, V9, P587, DOI 10.1021/ma60052a011; Gardel ML, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.158302; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Gittes F, 1998, PHYS REV E, V58, pR1241, DOI 10.1103/PhysRevE.58.R1241; HATZFELD M, 1990, J CELL SCI, V97, P317; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3; Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Hinner B, 1998, PHYS REV LETT, V81, P2614, DOI 10.1103/PhysRevLett.81.2614; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; Kasza KE, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041928; Kayser J, 2012, SOFT MATTER, V8, P8873, DOI 10.1039/c2sm26032h; Kim AJ, 2005, J AM CHEM SOC, V127, P1592, DOI 10.1021/ja0450051; Koster S, 2010, SOFT MATTER, V6, P1910, DOI 10.1039/c000113a; Kroy K, 1996, PHYS REV LETT, V77, P306, DOI 10.1103/PhysRevLett.77.306; Kroy K, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/416; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leitner A, 2012, BIOPHYS J, V103, P195, DOI 10.1016/j.bpj.2012.06.014; Lichtenstern T, 2012, J STRUCT BIOL, V177, P54, DOI 10.1016/j.jsb.2011.11.003; Lin YC, 2010, J MOL BIOL, V399, P637, DOI 10.1016/j.jmb.2010.04.054; Lin YC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.058101; Ma LL, 2001, NAT CELL BIOL, V3, P503, DOI 10.1038/35074576; Ma LL, 1999, J BIOL CHEM, V274, P19145, DOI 10.1074/jbc.274.27.19145; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; Morse DC, 1998, MACROMOLECULES, V31, P7044, DOI 10.1021/ma980304u; Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038; OBUKHOV SP, 1994, MACROMOLECULES, V27, P3191, DOI 10.1021/ma00090a012; Oelschlaeger C, 2009, LANGMUIR, V25, P716, DOI 10.1021/la802323x; Pawelzyk P, 2013, SOFT MATTER, V9, P8871, DOI 10.1039/c3sm51999f; Schopferer M, 2009, J MOL BIOL, V388, P133, DOI 10.1016/j.jmb.2009.03.005; Semmrich C, 2007, P NATL ACAD SCI USA, V104, P20199, DOI 10.1073/pnas.0705513104; Steinmetz MO, 1998, J MOL BIOL, V276, P1, DOI 10.1006/jmbi.1997.1529; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Tseng Y, 2001, BIOPHYS J, V81, P1643, DOI 10.1016/S0006-3495(01)75818-3; Willenbacher N, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.068302; Wolff L, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/053024; Yamada S, 2003, J STRUCT BIOL, V143, P45, DOI 10.1016/S1047-8477(03)00101-1	47	42	42	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93194	10.1371/journal.pone.0093194	http://dx.doi.org/10.1371/journal.pone.0093194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690778	Green Submitted, Green Published, gold			2022-12-27	WOS:000334101100051
J	Fang, C; Stiegeler, E; Cook, GM; Mascher, T; Gebhard, S				Fang, Chong; Stiegeler, Emanuel; Cook, Gregory M.; Mascher, Thorsten; Gebhard, Susanne			Bacillus subtilis as a Platform for Molecular Characterisation of Regulatory Mechanisms of Enterococcus faecalis Resistance against Cell Wall Antibiotics	PLOS ONE			English	Article							GLYCOPEPTIDE ANTIBIOTICS; ANTIMICROBIAL PEPTIDES; VANCOMYCIN RESISTANCE; ESCHERICHIA-COLI; ABC TRANSPORTER; STRESS-RESPONSE; IN-VIVO; BACITRACIN; EXPRESSION; SYSTEM	To combat antibiotic resistance of Enterococcus faecalis, a better understanding of the molecular mechanisms, particularly of antibiotic detection, signal transduction and gene regulation is needed. Because molecular studies in this bacterium can be challenging, we aimed at exploiting the genetically highly tractable Gram-positive model organism Bacillus subtilis as a heterologous host. Two fundamentally different regulators of E. faecalis resistance against cell wall antibiotics, the bacitracin sensor BcrR and the vancomycin-sensing two-component system VanSB-VanRB, were produced in B. subtilis and their functions were monitored using target promoters fused to reporter genes (lacZ and luxABCDE). The bacitracin resistance system BcrR-BcrAB of E. faecalis was fully functional in B. subtilis, both regarding regulation of bcrAB expression and resistance mediated by the transporter BcrAB. Removal of intrinsic bacitracin resistance of B. subtilis increased the sensitivity of the system. The lacZ and luxABCDE reporters were found to both offer sensitive detection of promoter induction on solid media, which is useful for screening of large mutant libraries. The VanSB-VanRB system displayed a gradual dose-response behaviour to vancomycin, but only when produced at low levels in the cell. Taken together, our data show that B. subtilis is a well-suited host for the molecular characterization of regulatory systems controlling resistance against cell wall active compounds in E. faecalis. Importantly, B. subtilis facilitates the careful adjustment of expression levels and genetic background required for full functionality of the introduced regulators.	[Fang, Chong; Stiegeler, Emanuel; Mascher, Thorsten; Gebhard, Susanne] Univ Munich, Dept Biol 1, Martinsried, Germany; [Cook, Gregory M.] Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, Dunedin, New Zealand	University of Munich; University of Otago	Gebhard, S (corresponding author), Univ Munich, Dept Biol 1, Martinsried, Germany.	susanne.gebhard@bio.lmu.de	Mascher, Thorsten/G-2074-2011; Gebhard, Susanne/F-4154-2012; Cook, Gregory/ABF-4208-2020	Gebhard, Susanne/0000-0003-4783-6115; Mascher, Thorsten/0000-0002-6300-5541	Deutsche Forschungsgemeinschaft (DFG) [GE2164/3-1]; Fonds der Chemischen Industrie; DFG [MA2837/1-3]; James Cook Fellowship; Marsden Fund from the Royal Society of New Zealand; China Scholarship Council	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); DFG(German Research Foundation (DFG)); James Cook Fellowship; Marsden Fund from the Royal Society of New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); China Scholarship Council(China Scholarship Council)	Work in the laboratory of SG was supported by grants of the Deutsche Forschungsgemeinschaft (DFG; GE2164/3-1) and the Fonds der Chemischen Industrie. TM would like to acknowledge financial support by the DFG (MA2837/1-3). GMC was supported by a James Cook Fellowship and the Marsden Fund from the Royal Society of New Zealand. CF was supported by a PhD scholarship from the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Arthur M, 1996, TRENDS MICROBIOL, V4, P401, DOI 10.1016/0966-842X(96)10063-9; Arthur M, 2001, ANTIMICROB AGENTS CH, V45, P375, DOI 10.1128/AAC.45.2.375-381.2001; Baptista M, 1997, MOL MICROBIOL, V25, P93, DOI 10.1046/j.1365-2958.1997.4401812.x; BARNA JCJ, 1984, ANNU REV MICROBIOL, V38, P339, DOI 10.1146/annurev.mi.38.100184.002011; Bevins CL, 1999, GUT, V45, P911, DOI 10.1136/gut.45.6.911; Bisicchia P, 2011, MOL MICROBIOL, V81, P157, DOI 10.1111/j.1365-2958.2011.07684.x; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Clinical and Laboratory Standards Institute, 2006, M2A9 CLSI, P1; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Derre I, 2000, MOL MICROBIOL, V38, P335, DOI 10.1046/j.1365-2958.2000.02124.x; Gauntlett JC, 2008, J BIOL CHEM, V283, P8591, DOI 10.1074/jbc.M709503200; Gebhard S, 2014, ANTIMICROB AGENTS CH, V58, P1425, DOI 10.1128/AAC.02111-13; Gebhard S, 2012, MOL MICROBIOL, V86, P1295, DOI 10.1111/mmi.12078; Gebhard S, 2011, MOL MICROBIOL, V81, P581, DOI 10.1111/j.1365-2958.2011.07747.x; Gebhard S, 2009, MOL MICROBIOL, V73, P482, DOI 10.1111/j.1365-2958.2009.06787.x; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hiron A, 2011, MOL MICROBIOL, V81, P602, DOI 10.1111/j.1365-2958.2011.07735.x; Hong HJ, 2008, ADV EXP MED BIOL, V631, P200; Joseph P, 2004, MICROBIOL-SGM, V150, P2609, DOI 10.1099/mic.0.27155-0; Kallenberg F, 2013, J BACTERIOL, V195, P3287, DOI 10.1128/JB.00419-13; Kingston AW, 2013, MOL MICROBIOL, V90, P502, DOI 10.1111/mmi.12380; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Manson JM, 2004, ANTIMICROB AGENTS CH, V48, P3743, DOI 10.1128/AAC.48.10.3743-3748.2004; Mascher T, 2003, MOL MICROBIOL, V50, P1591, DOI 10.1046/j.1365-2958.2003.03786.x; Matos R, 2009, INT J ANTIMICROB AG, V34, P142, DOI 10.1016/j.ijantimicag.2009.02.008; Ohki R, 2003, MOL MICROBIOL, V49, P1135, DOI 10.1046/j.1365-2958.2003.03653.x; Pietiainen M, 2005, MICROBIOL-SGM, V151, P1577, DOI 10.1099/mic.0.27761-0; Radeck J, 2013, J BIOL ENG IN PRESS; Rietkotter E, 2008, MOL MICROBIOL, V68, P768, DOI 10.1111/j.1365-2958.2008.06194.x; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Schmalisch M, 2010, J BACTERIOL, V192, P5402, DOI 10.1128/JB.00534-10; Silva JC, 1998, P NATL ACAD SCI USA, V95, P11951, DOI 10.1073/pnas.95.20.11951; Staron A, 2011, ANTIMICROB AGENTS CH, V55, P515, DOI 10.1128/AAC.00352-10; STORM DR, 1973, J BIOL CHEM, V248, P3940; Stulke J, 1997, MOL MICROBIOL, V25, P65, DOI 10.1046/j.1365-2958.1997.4351797.x; Ulijasz AT, 1996, J BACTERIOL, V178, P6305, DOI 10.1128/jb.178.21.6305-6309.1996; Wecke T, 2011, J ANTIMICROB CHEMOTH, V66, P2689, DOI 10.1093/jac/dkr373	40	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93169	10.1371/journal.pone.0093169	http://dx.doi.org/10.1371/journal.pone.0093169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676422	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500085
J	Fischer, NO; Weilhammer, DR; Dunkle, A; Thomas, C; Hwang, M; Corzett, M; Lychak, C; Mayer, W; Urbin, S; Collette, N; Chang, JC; Loots, GG; Rasley, A; Blanchette, CD				Fischer, Nicholas O.; Weilhammer, Dina R.; Dunkle, Alexis; Thomas, Cynthia; Hwang, Mona; Corzett, Michele; Lychak, Cheri; Mayer, Wasima; Urbin, Salustra; Collette, Nicole; Chang, Jiun Chiun; Loots, Gabriela G.; Rasley, Amy; Blanchette, Craig D.			Evaluation of Nanolipoprotein Particles (NLPs) as an In Vivo Delivery Platform	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEINS; GOLD NANOPARTICLES; DRUG-DELIVERY; FUNCTIONALIZED NANOPARTICLES; CHOLESTEROL EFFLUX; MEMBRANE-PROTEINS; TARGETED DELIVERY; AMPHOTERICIN-B; TOXICITY; APOLIPOPROTEIN	Nanoparticles hold great promise for the delivery of therapeutics, yet limitations remain with regards to the use of these nanosystems for efficient long-lasting targeted delivery of therapeutics, including imparting functionality to the platform, in vivo stability, drug entrapment efficiency and toxicity. To begin to address these limitations, we evaluated the functionality, stability, cytotoxicity, toxicity, immunogenicity and in vivo biodistribution of nanolipoprotein particles (NLPs), which are mimetics of naturally occurring high-density lipoproteins (HDLs). We found that a wide range of molecules could be reliably conjugated to the NLP, including proteins, single-stranded DNA, and small molecules. The NLP was also found to be relatively stable in complex biological fluids and displayed no cytotoxicity in vitro at doses as high as 320 mu g/ml. In addition, we observed that in vivo administration of the NLP daily for 14 consecutive days did not induce significant weight loss or result in lesions on excised organs. Furthermore, the NLPs did not display overt immunogenicity with respect to antibody generation. Finally, the biodistribution of the NLP in vivo was found to be highly dependent on the route of administration, where intranasal administration resulted in prolonged retention in the lung tissue. Although only a select number of NLP compositions were evaluated, the findings of this study suggest that the NLP platform holds promise for use as both a targeted and non-targeted in vivo delivery vehicle for a range of therapeutics.	[Fischer, Nicholas O.; Weilhammer, Dina R.; Dunkle, Alexis; Thomas, Cynthia; Hwang, Mona; Corzett, Michele; Lychak, Cheri; Mayer, Wasima; Urbin, Salustra; Collette, Nicole; Loots, Gabriela G.; Rasley, Amy; Blanchette, Craig D.] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Livermore, CA 94550 USA; [Chang, Jiun Chiun; Loots, Gabriela G.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Merced	Rasley, A (corresponding author), Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Livermore, CA 94550 USA.	rasley2@llnl.gov; blanchette2@llnl.gov	Loots, Gabriela G/AGA-4868-2022; Fischer, Nicholas/AAE-2409-2019	Loots, Gabriela G/0000-0001-9546-5561; Fischer, Nicholas/0000-0001-7575-4390; Weilhammer, Dina/0000-0002-7618-4702; Rasley, Amy/0000-0002-4767-6628; Collette, Nicole/0000-0002-9068-8712	LLNL LDRD [09-LW-077, 11-LW-015, 11-ERD-016]	LLNL LDRD	LLNL LDRD 09-LW-077; LLNL LDRD 11-LW-015; LLNL LDRD 11-ERD-016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann L, 2008, ORG LETT, V10, P3081, DOI 10.1021/ol801078r; Azarmi S, 2008, ADV DRUG DELIVER REV, V60, P863, DOI 10.1016/j.addr.2007.11.006; Baylon JL, 2013, J AM CHEM SOC, V135, P8542, DOI 10.1021/ja4003525; Bhatt RL, 2003, J MED CHEM, V46, P190, DOI 10.1021/jm020022r; Bhattacharya P, 2010, J VIROL, V84, P361, DOI 10.1128/JVI.01355-09; Blanchette CD, 2008, J LIPID RES, V49, P1420, DOI 10.1194/jlr.M700586-JLR200; Blanchette CD, 2010, BIOCONJUGATE CHEM, V21, P1321, DOI 10.1021/bc100129s; Blanchette CD, 2009, BBA-BIOMEMBRANES, V1788, P724, DOI 10.1016/j.bbamem.2008.11.019; Cappuccio JA, 2008, MOL CELL PROTEOMICS, V7, P2246, DOI 10.1074/mcp.M800191-MCP200; Cappuccio Jenny A., 2009, V498, P273, DOI 10.1007/978-1-59745-196-3_18; CHAPMAN MJ, 1980, J LIPID RES, V21, P789; Chen HT, 2004, J AM CHEM SOC, V126, P10044, DOI 10.1021/ja048548j; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; Chromy BA, 2007, J AM CHEM SOC, V129, P14348, DOI 10.1021/ja074753y; Corbierre MK, 2004, LANGMUIR, V20, P2867, DOI 10.1021/la0355702; Courrier HM, 2002, CRIT REV THER DRUG, V19, P425, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i45.40; Cuenca AG, 2006, CANCER-AM CANCER SOC, V107, P459, DOI 10.1002/cncr.22035; Ding Y, 2012, BIOMATERIALS, V33, P8893, DOI 10.1016/j.biomaterials.2012.08.057; Fischer NO, 2013, J AM CHEM SOC, V135, P2044, DOI 10.1021/ja3063293; Fischer NO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011643; Fischer NO, 2010, BIOCONJUGATE CHEM, V21, P1018, DOI 10.1021/bc100083d; Fischer NO, 2009, BIOCONJUGATE CHEM, V20, P460, DOI 10.1021/bc8003155; Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001; Frias JC, 2006, NANO LETT, V6, P2220, DOI 10.1021/nl061498r; Gaidukov Leonid, 2009, BMC Clin Pharmacol, V9, P18, DOI 10.1186/1472-6904-9-18; Gao TJ, 2011, PROTEIN SCI, V20, P437, DOI 10.1002/pro.577; Goodman CM, 2004, BIOCONJUGATE CHEM, V15, P897, DOI 10.1021/bc049951i; GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245; Hoang A, 2012, EUR HEART J, V33, P657, DOI 10.1093/eurheartj/ehr103; Irngartinger M, 2004, EUR J PHARM BIOPHARM, V58, P7, DOI 10.1016/j.ejpb.2004.03.016; Jia H, 2009, NANOMEDICINE-UK, V4, P951, DOI [10.2217/nnm.09.81, 10.2217/NNM.09.81]; Justesen BH, 2013, ANAL CHEM, V85, P3497, DOI 10.1021/ac4000915; Karver MR, 2012, ANGEW CHEM INT EDIT, V51, P920, DOI 10.1002/anie.201104389; Kim TY, 2004, CLIN CANCER RES, V10, P3708, DOI 10.1158/1078-0432.CCR-03-0655; Lattuada M, 2007, LANGMUIR, V23, P2158, DOI 10.1021/la062092x; Lynch I, 2007, ADV COLLOID INTERFAC, V134-35, P167, DOI 10.1016/j.cis.2007.04.021; Ma CIJ, 2012, BIOCHEM CELL BIOL, V90, P636, DOI [10.1139/O2012-015, 10.1139/o2012-015]; Malik N, 1999, ANTI-CANCER DRUG, V10, P767, DOI 10.1097/00001813-199909000-00010; Manchester M, 2006, ADV DRUG DELIVER REV, V58, P1505, DOI 10.1016/j.addr.2006.09.014; Mareeva T, 2010, J IMMUNOL METHODS, V353, P78, DOI 10.1016/j.jim.2009.11.010; Markman M, 2006, EXPERT OPIN PHARMACO, V7, P1469, DOI 10.1517/14656566.7.11.1469; Miyazaki M, 2013, BBA-BIOMEMBRANES, V1828, P1340, DOI 10.1016/j.bbamem.2013.01.012; Murphy CJ, 2008, ACCOUNTS CHEM RES, V41, P1721, DOI 10.1021/ar800035u; NESTLER JE, 1985, ENDOCRINOLOGY, V117, P502, DOI 10.1210/endo-117-2-502; Nguyen CA, 2003, INT J PHARMACEUT, V254, P69, DOI 10.1016/S0378-5173(02)00685-3; NIVEN RW, 1995, CRIT REV THER DRUG, V12, P151, DOI 10.1615/CritRevTherDrugCarrierSyst.v12.i2-3.20; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; Rensen PCN, 2001, ADV DRUG DELIVER REV, V47, P251, DOI 10.1016/S0169-409X(01)00109-0; Rollett A, 2012, INT J PHARMACEUT, V427, P460, DOI 10.1016/j.ijpharm.2012.02.028; RUBIN EM, 1991, P NATL ACAD SCI USA, V88, P434, DOI 10.1073/pnas.88.2.434; Salvati A, 2013, NAT NANOTECHNOL, V8, P137, DOI [10.1038/nnano.2012.237, 10.1038/NNANO.2012.237]; Simon M, 2012, BIOCONJUGATE CHEM, V23, P279, DOI 10.1021/bc200591x; Toledo JD, 2012, J CELL BIOCHEM, V113, P1208, DOI 10.1002/jcb.23453; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Tufteland M, 2008, J PHARM SCI-US, V97, P4425, DOI 10.1002/jps.21325; Wadsater M, 2012, J BIOL CHEM, V287, P34596, DOI 10.1074/jbc.M112.400085; Weilhammer DR, 2013, BIOMATERIALS, V34, P10305, DOI 10.1016/j.biomaterials.2013.09.038; Wu W, 2005, ANGEW CHEM INT EDIT, V44, P6358, DOI 10.1002/anie.200501613; Yuan Y, 2013, J DRUG TARGET, V21, P367, DOI 10.3109/1061186X.2012.757769; Zhang P, 2012, J AM CHEM SOC; Ziv O, 2008, J BIOMED MATER RES A, V85A, P1011, DOI 10.1002/jbm.a.31518	61	39	43	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93342	10.1371/journal.pone.0093342	http://dx.doi.org/10.1371/journal.pone.0093342			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675794	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677500110
J	Huang, FF; Ben Aissa, M; Magron, A; Huard, CC; Godin, C; Levesque, G; Carreau, M				Huang, FengFei; Ben Aissa, Manel; Magron, Audrey; Huard, Caroline C.; Godin, Chantal; Levesque, Georges; Carreau, Madeleine			The Fanconi Anemia Group C Protein Interacts with Uncoordinated 5A and Delays Apoptosis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HEMATOPOIETIC-CELLS; GENE-PRODUCT; EXPRESSION; RECEPTORS; SUPPRESS; CYTOPLASM; RESPONSES; NETRIN-1; PATHWAY	The Fanconi anemia group C protein (FANCC) is one of the several proteins that comprise the Fanconi anemia (FA) network involved in genomic surveillance. FANCC is mainly cytoplasmic and has many functions, including apoptosis suppression through caspase-mediated proteolytic processing. Here, we examined the role of FANCC proteolytic fragments by identifying their binding partners. We performed a yeast two-hybrid screen with caspase-mediated FANCC cleavage products and identified the dependence receptor uncoordinated-5A (UNC5A) protein. Here, we show that FANCC physically interacts with UNC5A, a pro-apoptotic dependence receptor. FANCC interaction occurs through the UNC5A intracellular domain, specifically via its death domain. FANCC modulates cell sensitivity to UNC5A-mediated apoptosis; we observed reduced UNC5A-mediated apoptosis in the presence of FANCC and increased apoptosis in FANCC-depleted cells. Our results show that FANCC interferes with UNC5A's functions in apoptosis and suggest that FANCC may participate in developmental processes through association with the dependence receptor UNC5A.	[Huang, FengFei; Ben Aissa, Manel; Magron, Audrey; Huard, Caroline C.; Carreau, Madeleine] Univ Quebec, Ctr Hosp, Dept Pediat, Quebec City, PQ, Canada; [Godin, Chantal; Levesque, Georges] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada	Laval University; University of Quebec; Laval University	Carreau, M (corresponding author), Univ Quebec, Ctr Hosp, Dept Pediat, Quebec City, PQ, Canada.	madeleine.carreau@crchul.ulaval.ca		Huard, Caroline/0000-0001-9646-0500; Carreau, Madeleine/0000-0002-0582-6114	Canadian Institutes of Health Research (CIHR); Canadian Blood Services; Fanconi Anemia Research Fund Inc.; Fanconi Canada (the Canadian Fanconi Anemia Research Fund/La Fondation Canadienne de Recherche de l'Anemie de Fanconi); FRSQ; Foundation of Stars; CIHR; Fanconi Canada (the Canadian Fanconi Anemia Research Fund)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Blood Services; Fanconi Anemia Research Fund Inc.; Fanconi Canada (the Canadian Fanconi Anemia Research Fund/La Fondation Canadienne de Recherche de l'Anemie de Fanconi); FRSQ(Fonds de la Recherche en Sante du Quebec); Foundation of Stars; CIHR(Canadian Institutes of Health Research (CIHR)); Fanconi Canada (the Canadian Fanconi Anemia Research Fund)	This work was supported in part by grants to MC and GL from the Canadian Institutes of Health Research (CIHR) in partnership with the Canadian Blood Services, the Fanconi Anemia Research Fund Inc., Fanconi Canada (the Canadian Fanconi Anemia Research Fund/La Fondation Canadienne de Recherche de l'Anemie de Fanconi), and FRSQ Senior Investigator Awards (GL and MC). Additional support was provided by training award from the "Foundation of Stars" (FFH, AM and CH) and CIHR in partnership with Fanconi Canada (the Canadian Fanconi Anemia Research Fund, to CH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Issa R, 1999, BLOOD, V94, P818, DOI 10.1182/blood.V94.2.818.414k33_818_824; Arakawa H, 2004, NAT REV CANCER, V4, P978, DOI 10.1038/nrc1504; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Brodeur I, 2004, J BIOL CHEM, V279, P4713, DOI 10.1074/jbc.M301291200; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; Cumming RC, 2001, NAT MED, V7, P814, DOI 10.1038/89937; Cumming RC, 1996, BLOOD, V88, P4558, DOI 10.1182/blood.V88.12.4558.bloodjournal88124558; Dokal I, 2008, BLOOD REV, V22, P141, DOI 10.1016/j.blre.2007.11.003; Engelkamp D, 2002, MECH DEVELOP, V118, P191, DOI 10.1016/S0925-4773(02)00248-4; Gordon SM, 2003, BLOOD, V102, P136, DOI 10.1182/blood-2002-11-3517; Guenebeaud C, 2010, MOL CELL, V40, P863, DOI 10.1016/j.molcel.2010.11.021; Haneline LS, 1998, BLOOD, V91, P4092; Hoatlin ME, 1998, BLOOD, V91, P1418, DOI 10.1182/blood.V91.4.1418; Huard CC, 2013, BLOOD, V121, P1729, DOI 10.1182/blood-2012-02-408997; Kaddar T, 2012, ANEMIA, V2012, DOI 10.1155/2012/425814; Kashiyama K, 2013, AM J HUM GENET, V92, P807, DOI 10.1016/j.ajhg.2013.04.007; Koh PS, 1999, EXP HEMATOL, V27, P1, DOI 10.1016/S0301-472X(98)00064-2; Krasnoshtein F, 1996, HUM MOL GENET, V5, P85, DOI 10.1093/hmg/5.1.85; Kruyt FAE, 1996, BLOOD, V87, P938, DOI 10.1182/blood.V87.3.938.bloodjournal873938; Leveille F, 2006, DNA REPAIR AMST; Llambi F, 2005, EMBO J, V24, P1192, DOI 10.1038/sj.emboj.7600584; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Marathi UK, 1996, BLOOD, V88, P2298, DOI 10.1182/blood.V88.6.2298.bloodjournal8862298; Mehlen P, 2011, NAT REV CANCER, V11, P188, DOI 10.1038/nrc3005; Miyamoto Y, 2010, INT J ONCOL, V36, P1253, DOI 10.3892/ijo_00000609; Mukhopadhyay SS, 2006, J CELL BIOL, V175, P225, DOI 10.1083/jcb.200607061; Otsuki T, 1999, J CELL PHYSIOL, V179, P79, DOI 10.1002/(SICI)1097-4652(199904)179:1<79::AID-JCP10>3.0.CO;2-O; Porter AG, 2004, BIOESSAYS, V26, P656, DOI 10.1002/bies.20037; Rathbun RK, 1997, BLOOD, V90, P974, DOI 10.1182/blood.V90.3.974.974_974_985; Rosenberg PS, 2003, BLOOD, V101, P822, DOI 10.1182/blood-2002-05-1498; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Tanikawa C, 2003, NAT CELL BIOL, V5, P216, DOI 10.1038/ncb943; Tremblay CS, 2008, BLOOD, V112, P2062, DOI 10.1182/blood-2008-04-152710; Wang JX, 1998, CANCER RES, V58, P3538; WEVRICK R, 1993, HUM MOL GENET, V2, P655, DOI 10.1093/hmg/2.6.655; Williams ME, 2003, J BIOL CHEM, V278, P17483, DOI 10.1074/jbc.M300415200; YOUSSOUFIAN H, 1994, P NATL ACAD SCI USA, V91, P7975, DOI 10.1073/pnas.91.17.7975	38	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92811	10.1371/journal.pone.0092811	http://dx.doi.org/10.1371/journal.pone.0092811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676280	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500042
J	Main, AR; Headley, JV; Peru, KM; Michel, NL; Cessna, AJ; Morrissey, CA				Main, Anson R.; Headley, John V.; Peru, Kerry M.; Michel, Nicole L.; Cessna, Allan J.; Morrissey, Christy A.			Widespread Use and Frequent Detection of Neonicotinoid Insecticides in Wetlands of Canada's Prairie Pothole Region	PLOS ONE			English	Article							CLIMATE-CHANGE; PESTICIDES; EXPOSURE; RECOVERY	Neonicotinoids currently dominate the insecticide market as seed treatments on Canada's major Prairie crops (e. g., canola). The potential impact to ecologically significant wetlands in this dominantly agro-environment has largely been overlooked while the distribution of use, incidence and level of contamination remains unreported. We modelled the spatial distribution of neonicotinoid use across the three Prairie Provinces in combination with temporal assessments of water and sediment concentrations in wetlands to measure four active ingredients (clothianidin, thiamethoxam, imidacloprid and acetamiprid). From 2009 to 2012, neonicotinoid use was increasing; by 2012, applications covered an estimated similar to 11 million hectares (44% of Prairie cropland) with >216,000 kg of active ingredients. Thiamethoxam, followed by clothianidin, were the dominant seed treatments by mass and area. Areas of high neonicotinoid use were identified as high density canola or soybean production. Water sampled four times from 136 wetlands (spring, summer, fall 2012 and spring 2013) across four rural municipalities in Saskatchewan similarly revealed clothianidin and thiamethoxam in the majority of samples. In spring 2012 prior to seeding, 36% of wetlands contained at least one neonicotinoid. Detections increased to 62% in summer 2012, declined to 16% in fall, and increased to 91% the following spring 2013 after ice-off. Peak concentrations were recorded during summer 2012 for both thiamethoxam (range: <LOQ - 1490 ng/L, canola) and clothianidin (range: <LOQ - 3110 ng/L, canola). Sediment samples collected during the same period rarely (6%) contained neonicotinoid concentrations (which did not exceed 20 ng/L). Wetlands situated in barley, canola and oat fields consistently contained higher mean concentrations of neonicotinoids than in grasslands, but no individual crop singularly influenced overall detections or concentrations. Distribution maps indicate neonicotinoid use is increasing and becoming more widespread with concerns for environmental loading, while frequently detected neonicotinoid concentrations in Prairie wetlands suggest high persistence and transport into wetlands.	[Main, Anson R.; Michel, Nicole L.; Morrissey, Christy A.] Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK, Canada; [Headley, John V.; Peru, Kerry M.] Environm Canada, Water Sci & Technol Directorate, Aquat Contaminants Res Div, Saskatoon, SK, Canada; [Cessna, Allan J.] Agr & Agri Food Canada, Sci & Technol Branch, Saskatoon, SK, Canada; [Morrissey, Christy A.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; Environment & Climate Change Canada; Agriculture & Agri Food Canada; University of Saskatchewan	Morrissey, CA (corresponding author), Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK, Canada.	christy.morrissey@usask.ca	Soares, Amadeu/A-8304-2008; Main, Anson/AAP-5899-2020; Serrano, Jose/A-2854-2009	Soares, Amadeu/0000-0003-0879-9470; Serrano, Jose/0000-0002-1565-5216; Morrissey, Christy/0000-0001-8128-4209	Natural Science and Engineering Research Council (NSERC); Environment Canada; University of Saskatchewan's College of Graduate Studies; School of Environment and Sustainability	Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Environment Canada(CGIAR); University of Saskatchewan's College of Graduate Studies; School of Environment and Sustainability	This study was funded by the Natural Science and Engineering Research Council (NSERC) (http://www.nserc-crsng.gc.ca/index_eng.asp), Environment Canada (http://www.ec.gc.ca/?lang=En) and graduate scholarships from the University of Saskatchewan's College of Graduate Studies (http://www.usask.ca/cgsr/) and the School of Environment and Sustainability (www.usask.ca/sens). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Alexander AC, 2007, ENVIRON TOXICOL CHEM, V26, P1726, DOI 10.1897/07-015R.1; American Bird Conservancy, 2013, IMP NAT MOST WID US; Anderson TA, 2013, CHEMOSPHERE, V92, P84, DOI 10.1016/j.chemosphere.2013.02.054; [Anonymous], ENCY BIODIVERSITY; [Anonymous], [No title captured]; Bartzen BA, 2010, ECOL APPL, V20, P525, DOI 10.1890/08-1650.1; Beketov MA, 2008, SCI TOTAL ENVIRON, V405, P96, DOI 10.1016/j.scitotenv.2008.07.001; Beketov MA, 2008, ENVIRON TOXICOL CHEM, V27, P461, DOI 10.1897/07-322R.1; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Canada Council of Ministers of the Environment,, 2007, CAN ENV QUAL GUID 19; Conly FM, 2001, ENVIRON MONIT ASSESS, V67, P195, DOI 10.1023/A:1006486607040; Donald DB, 2005, ENVIRON TOXICOL CHEM, V24, P2, DOI 10.1897/03-668.1; Donald DB, 1999, SCI TOTAL ENVIRON, V231, P173, DOI 10.1016/S0048-9697(99)00091-1; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Erwin KL, 2009, WETL ECOL MANAG, V17, P71, DOI 10.1007/s11273-008-9119-1; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Gotelli NJ, 2013, ECOSIMR 1 00; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Liess M, 1999, WATER RES, V33, P239, DOI 10.1016/S0043-1354(98)00174-2; Meehan TD, 2011, P NATL ACAD SCI USA, V108, P11500, DOI 10.1073/pnas.1100751108; Pestana JLT, 2009, ENVIRON POLLUT, V157, P2328, DOI 10.1016/j.envpol.2009.03.027; Phillips PJ, 2004, PEST MANAG SCI, V60, P531, DOI 10.1002/ps.879; Rosario-Martinez H., 2013, PHIA POSTHOC INTERAC; SANCHEZBAYO F, 2013, INSECTICIDES DEV SAF, DOI DOI 10.5772/52831; Starner K, 2012, B ENVIRON CONTAM TOX, V88, P316, DOI 10.1007/s00128-011-0515-5; Stoughton SJ, 2008, ARCH ENVIRON CON TOX, V54, P662, DOI 10.1007/s00244-007-9073-6; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; van der Kamp G, 2009, HYDROGEOL J, V17, P203, DOI 10.1007/s10040-008-0367-1; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Xie W, 2011, J CHROMATOGR A, V1218, P4426, DOI 10.1016/j.chroma.2011.05.026; Xing ZS, 2013, ARCH ENVIRON CON TOX, V64, P208, DOI 10.1007/s00244-012-9833-9; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	45	210	217	5	176	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92821	10.1371/journal.pone.0092821	http://dx.doi.org/10.1371/journal.pone.0092821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671127	gold, Green Submitted, Green Published			2022-12-27	WOS:000333677000081
J	Raudies, F; Zilli, EA; Hasselmo, ME				Raudies, Florian; Zilli, Eric A.; Hasselmo, Michael E.			Deep Belief Networks Learn Context Dependent Behavior	PLOS ONE			English	Article							DECISION-PROCESS STRUCTURE; POSSIBLE STRATEGIC USE; PREFRONTAL CORTEX; WORKING-MEMORY; MODEL; SWITCHES; SYSTEMS; NEURONS; RULE	With the goal of understanding behavioral mechanisms of generalization, we analyzed the ability of neural networks to generalize across context. We modeled a behavioral task where the correct responses to a set of specific sensory stimuli varied systematically across different contexts. The correct response depended on the stimulus (A,B,C,D) and context quadrant (1,2,3,4). The possible 16 stimulus-context combinations were associated with one of two responses (X,Y), one of which was correct for half of the combinations. The correct responses varied symmetrically across contexts. This allowed responses to previously unseen stimuli (probe stimuli) to be generalized from stimuli that had been presented previously. By testing the simulation on two or more stimuli that the network had never seen in a particular context, we could test whether the correct response on the novel stimuli could be generated based on knowledge of the correct responses in other contexts. We tested this generalization capability with a Deep Belief Network (DBN), Multi-Layer Perceptron (MLP) network, and the combination of a DBN with a linear perceptron (LP). Overall, the combination of the DBN and LP had the highest success rate for generalization.	[Raudies, Florian; Hasselmo, Michael E.] Boston Univ, Ctr Computat Neurosci & Neural Technol, Boston, MA 02215 USA; [Raudies, Florian; Hasselmo, Michael E.] Boston Univ, Ctr Excellence Learning Educ Sci & Technol, Boston, MA 02215 USA; [Zilli, Eric A.] Facebook, Menlo Pk, CA USA; [Hasselmo, Michael E.] Boston Univ, Dept Psychol, Boston, MA 02215 USA; [Hasselmo, Michael E.] Boston Univ, Grad Program Neurosci, Boston, MA 02215 USA	Boston University; Boston University; Facebook Inc; Boston University; Boston University	Raudies, F (corresponding author), Boston Univ, Ctr Computat Neurosci & Neural Technol, Boston, MA 02215 USA.	fraudies@bu.edu		Hasselmo, Michael/0000-0002-9925-6377	NIMH [P50 MH094263, MH60013]; Office of Naval Research [ONR MURI N00014-10-1-0936]; CELEST, a NSF Science of Learning Center [NSF SMA-0835976]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060013, P50MH094263] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of Naval Research(Office of Naval Research); CELEST, a NSF Science of Learning Center(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	MH is supported in part by NIMH P50 MH094263 and MH60013. MH and FR are supported in part by the Office of Naval Research (ONR MURI N00014-10-1-0936) and by CELEST, a NSF Science of Learning Center (NSF SMA-0835976). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2010, NEURON, V66, P315, DOI 10.1016/j.neuron.2010.03.025; Chapelle O., 2006, IEEE T NEURAL NETWOR, V20, P542; Chapman D., 1991, P 12 INT JOINT C ART, P726; Fischer Asja, 2012, Progress in Pattern Recognition, Image Analysis, ComputerVision, and Applications. Proceedings 17th Iberoamerican Congress, CIARP 2012, P14, DOI 10.1007/978-3-642-33275-3_2; Givan R, 2003, ARTIF INTELL, V147, P163, DOI 10.1016/S0004-3702(02)00376-4; Hasselmo ME, 2005, J COGNITIVE NEUROSCI, V17, P1115, DOI 10.1162/0898929054475190; Hinton G.E., 2009, SCHOLARPEDIA, V4; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hyman JM, 2005, HIPPOCAMPUS, V15, P739, DOI 10.1002/hipo.20106; Koene RA, 2005, CEREB CORTEX, V15, P1964, DOI 10.1093/cercor/bhi072; Kumaran D, 2009, NEURON, V63, P889, DOI 10.1016/j.neuron.2009.07.030; McCallum A. K., 1995, THESIS U ROCHESTER R; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Narayanamurthy SM, 2008, P 25 INT C ICML 2008; Navawongse R, 2013, J NEUROSCI, V33, P1002, DOI 10.1523/JNEUROSCI.3891-12.2013; Petrides M, 1996, PHILOS T ROY SOC B, V351, P1455, DOI 10.1098/rstb.1996.0130; Pyeatt LD, 1998, CS98112 COL STAT U; Ranganath C., 2008, LEARNING MEMORY COMP, V2008, P261; Ravindran B, 2003, ALGEBRAIC APPROACH A; Rich EL, 2007, J NEUROSCI, V27, P4747, DOI 10.1523/JNEUROSCI.0369-07.2007; Rich EL, 2009, J NEUROSCI, V29, P7208, DOI 10.1523/JNEUROSCI.6068-08.2009; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Taylor ME, 2009, J MACH LEARN RES, V10, P1633; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Wallis JD, 2003, J NEUROPHYSIOL, V90, P1790, DOI 10.1152/jn.00086.2003; Young JJ, 2009, BEHAV NEUROSCI, V123, P1028, DOI 10.1037/a0016822; Zilli EA, 2008, HIPPOCAMPUS, V18, P193, DOI 10.1002/hipo.20382; Zilli EA, 2008, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.006.2008; Zilli EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002756	32	5	6	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93250	10.1371/journal.pone.0093250	http://dx.doi.org/10.1371/journal.pone.0093250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671178	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000129
J	Arnold, BF; Priest, JW; Hamlin, KL; Moss, DM; Colford, JM; Lammie, PJ				Arnold, Benjamin F.; Priest, Jeffrey W.; Hamlin, Katy L.; Moss, Delynn M.; Colford, John M., Jr.; Lammie, Patrick J.			Serological Measures of Malaria Transmission in Haiti: Comparison of Longitudinal and Cross-Sectional Methods	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; WUCHERERIA-BANCROFTI; ANTIBODIES; INFECTION; AREA	Background: Efforts to monitor malaria transmission increasingly use cross-sectional surveys to estimate transmission intensity from seroprevalence data using malarial antibodies. To date, seroconversion rates estimated from cross-sectional surveys have not been compared to rates estimated in prospective cohorts. Our objective was to compare seroconversion rates estimated in a prospective cohort with those from a cross-sectional survey in a low-transmission population. Methods and Findings: The analysis included two studies from Haiti: a prospective cohort of 142 children ages <= 11 years followed for up to 9 years, and a concurrent cross-sectional survey of 383 individuals ages 0-90 years old. From all individuals, we analyzed 1,154 blood spot specimens for the malaria antibody MSP-1(19) using a multiplex bead antigen assay. We classified individuals as positive for malaria using a cutoff derived from the mean plus 3 standard deviations in antibody responses from a negative control set of unexposed individuals. We estimated prospective seroconversion rates from the longitudinal cohort based on 13 incident seroconversions among 646 person-years at risk. We also estimated seroconversion rates from the cross-sectional survey using a reversible catalytic model fit with maximum likelihood. We found the two approaches provided consistent results: the seroconversion rate for ages <= 11 years was 0.020 ( 0.010, 0.032) estimated prospectively versus 0.023 ( 0.001, 0.052) in the cross-sectional survey. Conclusions: The estimation of seroconversion rates using cross-sectional data is a widespread and generalizable problem for many infectious diseases that can be measured using antibody titers. The consistency between these two estimates lends credibility to model-based estimates of malaria seroconversion rates using cross-sectional surveys. This study also demonstrates the utility of including malaria antibody measures in multiplex assays alongside targets for vaccine coverage and other neglected tropical diseases, which together could comprise an integrated, large-scale serological surveillance platform.	[Arnold, Benjamin F.; Colford, John M., Jr.] Univ Calif Berkeley, Sch Publ Hlth, Dept Epidemiol, Berkeley, CA 94720 USA; [Priest, Jeffrey W.; Moss, Delynn M.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA; [Hamlin, Katy L.; Lammie, Patrick J.] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA	University of California System; University of California Berkeley; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Arnold, BF (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Dept Epidemiol, Berkeley, CA 94720 USA.	benarnold@berkeley.edu	Arnold, Benjamin/AAE-9656-2020	Arnold, Benjamin/0000-0001-6105-7295	National Institutes of Health; CDC; UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases [920528, 940441]; CDC/APHL Emerging Infectious Disease Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases; CDC/APHL Emerging Infectious Disease Fellowship	The authors appreciate the financial support of the National Institutes of Health, CDC and the UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (grants #920528 and #940441). Katy Hamlin was supported by a CDC/APHL Emerging Infectious Disease Fellowship. Besides the CDC, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Use of trade names is for identification only and does not imply endorsement by the Public Health Service of by the U. S. Department of Health and Human Services. The findings and conclusions in this report do not represent the official position of the Centers for Disease Control and Prevention.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000396; Badu K, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-50; BEKESSY A, 1976, B WORLD HEALTH ORGAN, V54, P685; Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; Bretscher MT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-21; Charlwood JD, 1998, AM J TROP MED HYG, V59, P243, DOI 10.4269/ajtmh.1998.59.243; Cook J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-86; Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137; Cook J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-169; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Drakeley C, 2009, ADV PARASIT, V69, P299, DOI 10.1016/S0065-308X(09)69005-9; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Freeman AR, 2001, AM J TROP MED HYG, V65, P865, DOI 10.4269/ajtmh.2001.65.865; Hamlin KL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001941; Kitua AY, 1996, TROP MED INT HEALTH, V1, P475, DOI 10.1046/j.1365-3156.1996.d01-89.x; LAMMIE PJ, 1994, AM J TROP MED HYG, V51, P348, DOI 10.4269/ajtmh.1994.51.348; Lammie PJ, 1998, AM J TROP MED HYG, V59, P217, DOI 10.4269/ajtmh.1998.59.217; Moss DM, 2011, AM J TROP MED HYG, V85, P229, DOI 10.4269/ajtmh.2011.11-0029; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Tibshirani R., 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]	21	37	39	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93684	10.1371/journal.pone.0093684	http://dx.doi.org/10.1371/journal.pone.0093684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691467	Green Submitted, gold, Green Published			2022-12-27	WOS:000334101100126
J	Feron, G; Ayed, C; Qannari, EM; Courcoux, P; Laboure, H; Guichard, E				Feron, Gilles; Ayed, Charfedinne; Qannari, El Mostafa; Courcoux, Philippe; Laboure, Helene; Guichard, Elisabeth			Understanding Aroma Release from Model Cheeses by a Statistical Multiblock Approach on Oral Processing	PLOS ONE			English	Article							PARTIAL LEAST-SQUARES; FOOD BOLUS PROPERTIES; FLAVOR RELEASE; IN-VIVO; HUMAN SALIVA; DIFFERENT TEXTURES; CHEWING ACTIVITY; MOUTH; BEHAVIOR; PLS	For human beings, the mouth is the first organ to perceive food and the different signalling events associated to food breakdown. These events are very complex and as such, their description necessitates combining different data sets. This study proposed an integrated approach to understand the relative contribution of main food oral processing events involved in aroma release during cheese consumption. In vivo aroma release was monitored on forty eight subjects who were asked to eat four different model cheeses varying in fat content and firmness and flavoured with ethyl propanoate and nonan-2-one. A multiblock partial least square regression was performed to explain aroma release from the different physiological data sets ( masticatory behaviour, bolus rheology, saliva composition and flux, mouth coating and bolus moistening). This statistical approach was relevant to point out that aroma release was mostly explained by masticatory behaviour whatever the cheese and the aroma, with a specific influence of mean amplitude on aroma release after swallowing. Aroma release from the firmer cheeses was explained mainly by bolus rheology. The persistence of hydrophobic compounds in the breath was mainly explained by bolus spreadability, in close relation with bolus moistening. Resting saliva poorly contributed to the analysis whereas the composition of stimulated saliva was negatively correlated with aroma release and mostly for soft cheeses, when significant.	[Feron, Gilles; Ayed, Charfedinne; Laboure, Helene; Guichard, Elisabeth] INRA, UMR1324, Ctr Sci Gout & Alimentat, F-21034 Dijon, France; [Feron, Gilles; Ayed, Charfedinne; Laboure, Helene; Guichard, Elisabeth] CNRS, UMR6265, Ctr Sci Gout & Alimentat, Dijon, France; [Feron, Gilles; Ayed, Charfedinne; Laboure, Helene; Guichard, Elisabeth] Univ Bourgogne, UMR, Ctr Sci Gout & Alimentat, Dijon, France; [Qannari, El Mostafa; Courcoux, Philippe] LUNAM Univ, ONIRIS, Ecole Natl Vet Agroalimentaire & Alimentat, USC Sensometr & Chemometr Lab, Nantes, France	INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Guichard, E (corresponding author), INRA, UMR1324, Ctr Sci Gout & Alimentat, F-21034 Dijon, France.	elisabeth.guichard@dijon.inra.fr	FERON, Gilles/AAW-8714-2020; Laboure, Helene/S-3006-2016; Ayed, Charfedinne/G-5348-2017	Laboure, Helene/0000-0002-8173-6145; Ayed, Charfedinne/0000-0002-1045-6314; Feron, Gilles/0000-0002-9522-9654	French National Research Agency [ANR-07-PNRA-014]; Regional Council for Burgundy; FEDER (European Union)	French National Research Agency(French National Research Agency (ANR)); Regional Council for Burgundy(Region Bourgogne-Franche-Comte); FEDER (European Union)(European Commission)	This work received financial support from the French National Research Agency (ANR-07-PNRA-014), the Regional Council for Burgundy and FEDER (European Union). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilanti L, 2013, INT DAIRY J, V29, P42, DOI 10.1016/j.idairyj.2012.11.001; BENNICK A, 1982, MOL CELL BIOCHEM, V45, P83; Blissett A, 2006, J TEXTURE STUD, V37, P476, DOI 10.1111/j.1745-4603.2006.00064.x; Bougeard S, 2011, INFORMATICA-LITHUAN, V22, P11; Bras LP, 2005, CHEMOMETR INTELL LAB, V75, P91, DOI 10.1016/j.chemolab.2004.05.007; BUTTERY RG, 1973, J AGR FOOD CHEM, V21, P198, DOI 10.1021/jf60186a029; Cappellin L, 2012, CHEMOMETR INTELL LAB, V118, P301, DOI 10.1016/j.chemolab.2012.05.008; Carpenter G, 2012, ROLE SALIVA ORAL PRO, P45; Choi SW, 2005, J PROCESS CONTR, V15, P295, DOI 10.1016/j.jprocont.2004.06.010; de Roos KB, 2003, INT DAIRY J, V13, P593, DOI 10.1016/S0958-6946(03)00108-0; de Wijk RA, 2004, PHYSIOL BEHAV, V83, P81, DOI 10.1016/j.physbeh.2004.07.014; DEROOS KB, 1994, DEV FOOD SCI, V35, P15; Doyennette M, 2014, J THEOR BIOL, V340, P209, DOI 10.1016/j.jtbi.2013.09.005; Doyennette M, 2011, FOOD RES INT, V44, P3174, DOI 10.1016/j.foodres.2011.07.034; Doyennette M, 2011, FOOD CHEM, V128, P380, DOI 10.1016/j.foodchem.2011.03.039; Drago SR, 2011, FOOD HYDROCOLLOID, V25, P659, DOI 10.1016/j.foodhyd.2010.07.024; Dresselhuis DM, 2008, FOOD HYDROCOLLOID, V22, P1170, DOI 10.1016/j.foodhyd.2007.06.013; Emorine M, 2013, FOOD RES INT, V51, P641, DOI 10.1016/j.foodres.2013.01.006; Genovese A, 2009, FOOD CHEM, V114, P100, DOI 10.1016/j.foodchem.2008.09.022; GERLACH RW, 1979, ANAL CHIM ACTA-COMP, V3, P417, DOI 10.1016/S0003-2670(01)85039-X; Guinard JX, 1997, PHYSIOL BEHAV, V61, P591, DOI 10.1016/S0031-9384(96)00508-2; Haahr AM, 2004, PHYSIOL BEHAV, V82, P531, DOI 10.1016/j.physbeh.2004.04.061; Hansson A, 2003, J AGR FOOD CHEM, V51, P4732, DOI 10.1021/jf030050y; Harrison M, 1998, J AGR FOOD CHEM, V46, P2736, DOI 10.1021/jf980090f; Hassani S, 2012, CHEMOMETR INTELL LAB, V117, P42, DOI 10.1016/j.chemolab.2011.06.001; HUSSEIN MM, 1983, J FOOD SCI, V48, P1884, DOI 10.1111/j.1365-2621.1983.tb05113.x; Kohonen J, 2008, J CHEMOMETR, V22, P281, DOI 10.1002/cem.1120; Kohonen J, 2009, CHEMOMETR INTELL LAB, V97, P18, DOI 10.1016/j.chemolab.2008.06.015; Malone ME, 2003, FOOD HYDROCOLLOID, V17, P775, DOI 10.1016/S0268-005X(03)00098-5; Mevik B.-H., 2007, J STAT SOFTWARE, V18; Mioche L, 2003, ARCH ORAL BIOL, V48, P193, DOI 10.1016/S0003-9969(03)00002-5; Mioche L, 2002, FOOD QUAL PREFER, V13, P583, DOI 10.1016/S0950-3293(02)00056-3; Mishellany-Dutour A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041276; Mounayar R, 2013, CHEMOSENS PERCEPT, P1; Moyon T, 2012, METABOLOMICS, V8, P1090, DOI 10.1007/s11306-012-0415-7; NAES T, 1985, COMMUN STAT-SIMUL C, V14, P545, DOI 10.1080/03610918508812458; Neyraud E, 2012, ARCH ORAL BIOL, V57, P556, DOI 10.1016/j.archoralbio.2011.09.016; Normand V, 2004, CHEM SENSES, V29, P235, DOI 10.1093/chemse/bjh028; Odake S, 1998, NAHRUNG, V42, P385, DOI [10.1002/(SICI)1521-3803(199812)42:06<385::AID-FOOD385>3.0.CO;2-B, 10.1002/(SICI)1521-3803(199812)42:06&lt;385::AID-FOOD385&gt;3.0.CO;2-B]; Ono T, 2004, DYSPHAGIA, V19, P259, DOI 10.1007/s00455-004-0010-9; Piombino P, 2013, FOOD RES INT, V50, P409, DOI 10.1016/j.foodres.2012.10.033; Pionnier E, 2004, J AGR FOOD CHEM, V52, P557, DOI 10.1021/jf030544v; Poette J, 2014, FLAVOUR FRAG J, V29, P39, DOI 10.1002/ffj.3177; Prinz JF, 1997, P ROY SOC B-BIOL SCI, V264, P1715, DOI 10.1098/rspb.1997.0238; Reinikainen SP, 2007, ANAL CHIM ACTA, V595, P248, DOI 10.1016/j.aca.2007.02.019; Repoux M, 2012, ARCH ORAL BIOL, V57, P81, DOI 10.1016/j.archoralbio.2011.07.011; Repoux M, 2012, FLAVOUR FRAG J, V27, P414, DOI 10.1002/ffj.3110; Repoux M, 2012, FLAVOUR FRAG J, V27, P40, DOI 10.1002/ffj.2077; SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161, DOI 10.1177/10454411950060020501; Schipper RG, 2007, ARCH ORAL BIOL, V52, P1114, DOI 10.1016/j.archoralbio.2007.06.009; Silletti E, 2008, FOOD BIOPHYS, V3, P318, DOI 10.1007/s11483-008-9089-0; Silletti E, 2007, J COLLOID INTERF SCI, V313, P485, DOI 10.1016/j.jcis.2007.05.030; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Tarrega A, 2008, INT DAIRY J, V18, P849, DOI 10.1016/j.idairyj.2007.09.008; Tarrega A, 2011, INT DAIRY J, V21, P358, DOI 10.1016/j.idairyj.2010.12.010; Trelea IC, 2008, CHEM SENSES, V33, P181, DOI 10.1093/chemse/bjm077; van Ruth SM, 2000, FOOD CHEM, V71, P339, DOI 10.1016/S0308-8146(00)00186-2; VANDERREIJDEN WA, 1993, BIORHEOLOGY, V30, P141; VANRUTH SM, 1995, J SCI FOOD AGR, V67, P189, DOI 10.1002/jsfa.2740670208; Vingerhoeds MH, 2005, FOOD HYDROCOLLOID, V19, P915, DOI 10.1016/j.foodhyd.2004.12.005; Vingerhoeds MH, 2009, FOOD HYDROCOLLOID, V23, P773, DOI 10.1016/j.foodhyd.2008.04.014; Westerhuis JA, 1998, J CHEMOMETR, V12, P301, DOI 10.1002/(SICI)1099-128X(199809/10)12:5<301::AID-CEM515>3.0.CO;2-S; WOLD S, 1984, ANALUSIS, V12, P477; Wright KM, 2003, INT J FOOD SCI TECH, V38, P361, DOI 10.1046/j.1365-2621.2003.00682.x; Wright KM, 2003, INT J FOOD SCI TECH, V38, P343, DOI 10.1046/j.1365-2621.2003.00680.x; Yven C, 2012, J TEXTURE STUD, V43, P309, DOI 10.1111/j.1745-4603.2011.00340.x	66	51	51	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93113	10.1371/journal.pone.0093113	http://dx.doi.org/10.1371/journal.pone.0093113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691625	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100047
J	Kitchen, MJ; Siew, ML; Wallace, MJ; Fouras, A; Lewis, RA; Yagi, N; Uesugi, K; te Pas, AB; Hooper, SB				Kitchen, Marcus J.; Siew, Melissa L.; Wallace, Megan J.; Fouras, Andreas; Lewis, Robert A.; Yagi, Naoto; Uesugi, Kentaro; te Pas, Arjan B.; Hooper, Stuart B.			Changes in Positive End-Expiratory Pressure Alter the Distribution of Ventilation within the Lung Immediately after Birth in Newborn Rabbits	PLOS ONE			English	Article							FUNCTIONAL RESIDUAL CAPACITY; RESPIRATORY-DISTRESS-SYNDROME; PRETERM INFANTS; SUSTAINED INFLATION; NEONATAL RESUSCITATION; REGIONAL-DISTRIBUTION; LIQUID CLEARANCE; PREMATURE LAMBS; SURFACTANT; VOLUME	Current recommendations suggest the use of positive end-expiratory pressures (PEEP) to assist very preterm infants to develop a functional residual capacity (FRC) and establish gas exchange at birth. However, maintaining a consistent PEEP is difficult and so the lungs are exposed to changing distending pressures after birth, which can affect respiratory function. Our aim was to determine how changing PEEP levels alters the distribution of ventilation within the lung. Preterm rabbit pups (28 days gestation) were delivered and mechanically ventilated with one of three strategies, whereby PEEP was changed in sequence; 0-5-10-5-0 cmH(2)O, 5-10-0-5-0 cmH(2)O or 10-5-0-10-0 cmH(2)O. Phase contrast X-ray imaging was used to analyse the distribution of ventilation in the upper left (UL), upper right (UR), lower left (LL) and lower right (LR) quadrants of the lung. Initiating ventilation with 10PEEP resulted in a uniform increase in FRC throughout the lung whereas initiating ventilation with 5PEEP or 0PEEP preferentially aerated the UR than both lower quadrants (p<0.05). Consequently, the relative distribution of incoming V-T was preferentially directed into the lower lobes at low PEEP, primarily due to the loss of FRC in those lobes. Following ventilation at 10PEEP, the distribution of air at end-inflation was uniform across all quadrants and remained so regardless of the PEEP level. Uniform distribution of ventilation can be achieved by initiating ventilation with a high PEEP. After the lungs have aerated, small and stepped reductions in PEEP result in more uniform changes in ventilation.	[Kitchen, Marcus J.] Monash Inst Med Res, Sch Phys, Clayton, Vic, Australia; [Siew, Melissa L.; Wallace, Megan J.; Hooper, Stuart B.] Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [te Pas, Arjan B.] Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands; [Fouras, Andreas] Monash Univ, Dept Mech & Aerosp Engn, Clayton, Vic, Australia; [Lewis, Robert A.] Monash Univ, Dept Med Imaging & Radiat Sci, Clayton, Vic, Australia; [Lewis, Robert A.] Univ Saskatchewan, Saskatoon, SK, Canada; [Yagi, Naoto; Uesugi, Kentaro] SPring 8 Japan Synchrotron Radiat Res Inst, Sayo, Hyogo, Japan	Monash University; Monash University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Monash University; Monash University; University of Saskatchewan; Japan Synchrotron Radiation Research Institute	Hooper, SB (corresponding author), Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia.	stuart.hooper@monash.edu	Kitchen, Marcus/A-1355-2008; pas, arjan te/AAA-9019-2020; Fouras, Andreas/A-9410-2008	Kitchen, Marcus/0000-0002-0029-6660; pas, arjan te/0000-0001-7831-8797; Fouras, Andreas/0000-0002-8933-1759; Wallace, Megan/0000-0001-5785-5120; Hooper, Stuart/0000-0003-1676-4825; Uesugi, Kentaro/0000-0003-2579-513X	Australian Research Council; Australian National Health and Medical Research Council; Victorian Government's Operational Infrastructure Support Program; Access to Major Research Facilities Programme; SPring-8 Program Review Committee; ARC Australian Research Fellowship; NHMRC Career Development Fellowships; Netherlands Organisation for Health Research and Development [91612027]	Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Access to Major Research Facilities Programme; SPring-8 Program Review Committee; ARC Australian Research Fellowship(Australian Research Council); NHMRC Career Development Fellowships(National Health and Medical Research Council (NHMRC) of Australia); Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This research was supported by the Australian Research Council (http://www.arc.gov.au), the Australian National Health and Medical Research Council (http://www.nhmrc.gov.au) and the Victorian Government's Operational Infrastructure Support Program (http://www.business.vic.gov.au). The authors acknowledge financial support from the Access to Major Research Facilities Programme (http://www.ansto.gov.au/) which is a component of the International Science Linkages Programme established under the Australian Government's innovation statement, Backing Australia's Ability. The authors also gratefully acknowledge the support provided by the SPring-8 synchrotron facility (http://www.spring8.or.jp) which was granted by the SPring-8 Program Review Committee. Marcus J. Kitchen and Andreas Fouras are the recipients of ARC Australian Research Fellowship and NHMRC Career Development Fellowships respectively. Arjan B. te Pas is recipient of a Veni-grant, The Netherlands Organisation for Health Research and Development (http://www.zonmw.nl/en), part of the Innovational Research Incentives Scheme Veni-Vidi-Vici (project nos. 91612027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dawson JA, 2011, J PAEDIATR CHILD H, V47, P698, DOI 10.1111/j.1440-1754.2011.02036.x; Dinger J, 2001, J PERINAT MED, V29, P137, DOI 10.1515/JPM.2001.018; ENHORNING G, 1975, AM J OBSTET GYNECOL, V121, P475, DOI 10.1016/0002-9378(75)90078-2; Frerichs I, 2003, INTENS CARE MED, V29, P787, DOI 10.1007/s00134-003-1726-y; GERHARDT T, 1980, ACTA PAEDIATR SCAND, V69, P359, DOI 10.1111/j.1651-2227.1980.tb07093.x; Hjalmarson O, 2002, AM J RESP CRIT CARE, V165, P83, DOI 10.1164/ajrccm.165.1.2107093; Hooper SB, 2007, FASEB J, V21, P3329, DOI 10.1096/fj.07-8208com; Hooper SB, 2005, CURR RESPIR MED REV, V1, P185, DOI 10.2174/1573398054023037; Hooper SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070895; Hough JL, 2013, PEDIATR CRIT CARE ME, V14, P171, DOI 10.1097/PCC.0b013e31826e708a; Jobe AH, 2000, ANNU REV PHYSIOL, V62, P825, DOI 10.1146/annurev.physiol.62.1.825; KELLY E, 1993, PEDIATR PULM, V15, P225, DOI 10.1002/ppul.1950150408; Kitchen MJ, 2008, PHYS MED BIOL, V53, P6065, DOI 10.1088/0031-9155/53/21/012; Morley CJ, 2010, J PAEDIATR CHILD H, V46, P51, DOI 10.1111/j.1440-1754.2009.01617.x; MORTOLA JP, 1984, J APPL PHYSIOL, V56, P1533, DOI 10.1152/jappl.1984.56.6.1533; Naik AS, 2001, AM J RESP CRIT CARE, V164, P494, DOI 10.1164/ajrccm.164.3.2010127; Nieszkowska A, 2004, CRIT CARE MED, V32, P1496, DOI 10.1097/01.CCM.0000130170.88512.07; NILSSON R, 1980, ACTA PAEDIATR SCAND, V69, P597, DOI 10.1111/j.1651-2227.1980.tb07328.x; Pas ABT, 2008, PEDIATR RES, V64, P281, DOI 10.1203/PDR.0b013e31817d9c35; Pas ABT, 2011, NEONATOLOGY, V99, P266, DOI 10.1159/000318663; Polglase GR, 2005, J APPL PHYSIOL, V99, P1453, DOI 10.1152/japplphysiol.00055.2005; Probyn ME, 2004, PEDIATR RES, V56, P198, DOI 10.1203/01.PDR.0000132752.94155.13; Puybasset L, 2000, INTENS CARE MED, V26, P1215, DOI 10.1007/s001340051340; Schilleman K, 2011, RESUSCITATION, V82, P920, DOI 10.1016/j.resuscitation.2011.02.029; SCHLESSEL JS, 1989, J NUCL MED, V30, P1342; Schmolzer GM, 2010, ARCH DIS CHILD-FETAL, V95, pF393, DOI 10.1136/adc.2009.174003; Siew ML, 2011, PEDIATR RES, V70, P50, DOI 10.1203/PDR.0b013e31821be094; Siew ML, 2009, J APPL PHYSIOL, V106, P1888, DOI 10.1152/japplphysiol.91526.2008; Siew ML, 2009, J APPL PHYSIOL, V106, P1487, DOI 10.1152/japplphysiol.91591.2008; Sobotka KS, 2011, PEDIATR RES, V70, P56, DOI 10.1203/PDR.0b013e31821d06a1; te Pas AB, 2009, PEDIATR RES, V66, P295, DOI 10.1203/PDR.0b013e3181b1bca4; te Pas AB, 2009, PEDIATR RES, V65, P537, DOI 10.1203/PDR.0b013e31819da21b; Thome U, 1998, EUR J PEDIATR, V157, P831, DOI 10.1007/s004310050946; Tingay DG, 2010, INTENS CARE MED, V36, P888, DOI 10.1007/s00134-010-1849-x; VILSTRUP CT, 1992, J APPL PHYSIOL, V73, P276, DOI 10.1152/jappl.1992.73.1.276; Wolf GK, 2007, CRIT CARE MED, V35, P1972, DOI 10.1097/01.CCM.0000275390.71601.83	36	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93391	10.1371/journal.pone.0093391	http://dx.doi.org/10.1371/journal.pone.0093391			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690890	gold, Green Published, Green Submitted			2022-12-27	WOS:000334101100073
J	Lim, JJ; Shim, MS; Lee, JE; Lee, DR				Lim, Jung Jin; Shim, Myung Sun; Lee, Jeoung Eun; Lee, Dong Ryul			Three-Step Method for Proliferation and Differentiation of Human Embryonic Stem Cell (hESC)-Derived Male Germ Cells	PLOS ONE			English	Article							LONG-TERM PROLIFERATION; IN-VITRO; RETINOIC ACID; MOUSE; CULTURE; GENERATION; DERIVATION; INDUCTION; PROTEINS; THERAPY	The low efficiency of differentiation into male germ cell (GC)-like cells and haploid germ cells from human embryonic stem cells (hESCs) reflects the culture method employed in the two-dimensional (2D)-microenvironment. In this study, we applied a three-step media and calcium alginate-based 3D-culture system for enhancing the differentiation of hESCs into male germ stem cell (GSC)-like cells and haploid germ cells. In the first step, embryoid bodies (EBs) were derived from hESCs cultured in EB medium for 3 days and re-cultured for 4 additional days in EB medium with BMP4 and RA to specify GSC-like cells. In the second step, the resultant cells were cultured in GC-proliferation medium for 7 days. The GSC-like cells were then propagated after selection using GFR-alpha 1 and were further cultured in GC-proliferation medium for 3 weeks. In the final step, a 3D-co-culture system using calcium alginate encapsulation and testicular somatic cells was applied to induce differentiation into haploid germ cells, and a culture containing approximately 3% male haploid germ cells was obtained after 2 weeks of culture. These results demonstrated that this culture system could be used to efficiently induce GSC-like cells in an EB population and to promote the differentiation of ESCs into haploid male germ cells.	[Lim, Jung Jin; Shim, Myung Sun; Lee, Jeoung Eun; Lee, Dong Ryul] CHA Univ, Coll Med, CHA Gangnam Med Ctr, Fertil Ctr, Seoul, South Korea; [Lee, Dong Ryul] CHA Univ, Coll Life Sci, Dept Biomed Sci, Seoul, South Korea	Pochon Cha University; Pochon Cha University	Lee, DR (corresponding author), CHA Univ, Coll Med, CHA Gangnam Med Ctr, Fertil Ctr, Seoul, South Korea.	drleedr@cha.ac.kr			Bio & Medical Technology Development Program of the National Research Foundation (NRF) [2012M3A9C6049723]; Ministry of Education, Science and Technology, South Korea	Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology, South Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Bio & Medical Technology Development Program (2012M3A9C6049723; PI: D.R.L) of the National Research Foundation (NRF) funded by the Ministry of Education, Science and Technology, South Korea. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflatoonian B, 2005, CURR OPIN BIOTECH, V16, P530, DOI 10.1016/j.copbio.2005.08.008; Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Brady-Kalnay SM, 1998, J CELL BIOL, V141, P287, DOI 10.1083/jcb.141.1.287; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Chladek D, 2000, Ceska Gynekol, V65, P28; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; DEFELICI M, 1993, DEV BIOL, V157, P277, DOI 10.1006/dbio.1993.1132; Fujiwara T, 2001, P NATL ACAD SCI USA, V98, P13739, DOI 10.1073/pnas.241508898; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Hamra FK, 2004, DEV BIOL, V269, P393, DOI 10.1016/j.ydbio.2004.01.027; Huang ZQ, 1996, BIOTECHNIQUES, V20, P1012; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kawai K, 2010, ADV ENZYME REGUL, V50, P202, DOI 10.1016/j.advenzreg.2009.10.013; Kee K, 2006, STEM CELLS DEV, V15, P831, DOI 10.1089/scd.2006.15.831; Kerkis A, 2007, CLONING STEM CELLS, V9, P535, DOI 10.1089/clo.2007.0031; Kim S, 2007, STEM CELLS DEV, V16, P537, DOI 10.1089/scd.2006.0088; KOSHIMIZU U, 1995, DEV BIOL, V168, P683, DOI 10.1006/dbio.1995.1113; Kubota H, 2006, NAT CLIN PRACT ENDOC, V2, P99, DOI 10.1038/ncpendmet0098; Lee DR, 2006, HUM REPROD, V21, P471, DOI 10.1093/humrep/dei319; Lee DR, 2001, BIOL REPROD, V65, P873, DOI 10.1095/biolreprod65.3.873; Lee JE, 2010, CELL TRANSPLANT, V19, P1383, DOI 10.3727/096368910X513991; Li CY, 2007, DEVELOPMENT, V134, P167, DOI 10.1242/dev.02701; Lim JJ, 2010, CELL PROLIFERAT, V43, P405, DOI 10.1111/j.1365-2184.2010.00691.x; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Nagaraja GM, 2004, BIOCHEM BIOPH RES CO, V313, P654, DOI 10.1016/j.bbrc.2003.12.001; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Park SY, 2005, DEVELOPMENT, V132, P2415, DOI 10.1242/dev.01826; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Shang QX, 2001, J CRANIOFAC SURG, V12, P586, DOI 10.1097/00001665-200111000-00017; Starz-Gaiano M, 2001, MECH DEVELOP, V105, P5, DOI 10.1016/S0925-4773(01)00392-6; Thomas S, 2000, J Wound Care, V9, P56; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; von Schonfeldt V, 2004, CYTOGENET GENOME RES, V105, P235, DOI 10.1159/000078194; Wadham C, 2003, MOL BIOL CELL, V14, P2520, DOI 10.1091/mbc.E02-09-0577; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Ying Y, 2001, P NATL ACAD SCI USA, V98, P7858, DOI 10.1073/pnas.151242798; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0; Zhou Q, 2008, BIOL REPROD, V78, P537, DOI 10.1095/biolreprod.107.064337	43	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e90454	10.1371/journal.pone.0090454	http://dx.doi.org/10.1371/journal.pone.0090454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690677	Green Submitted, Green Published, gold			2022-12-27	WOS:000334101100010
J	Nestor, KA; Jones, JD; Butson, CR; Morishita, T; Jacobson, CE; Peace, DA; Chen, D; Foote, KD; Okun, MS				Nestor, Kelsey A.; Jones, Jacob D.; Butson, Christopher R.; Morishita, Takashi; Jacobson, Charles E.; Peace, David A.; Chen, Dennis; Foote, Kelly D.; Okun, Michael S.			Coordinate-Based Lead Location Does Not Predict Parkinson's Disease Deep Brain Stimulation Outcome	PLOS ONE			English	Article							HIGH-FREQUENCY STIMULATION; BILATERAL SUBTHALAMIC STIMULATION; GLOBUS-PALLIDUS; TECHNICAL APPROACH; MEDICAL THERAPY; IMAGE FUSION; NUCLEUS; ACCURACY; DBS; IMPLANTATION	Background: Effective target regions for deep brain stimulation (DBS) in Parkinson's disease (PD) have been well characterized. We sought to study whether the measured Cartesian coordinates of an implanted DBS lead are predictive of motor outcome(s). We tested the hypothesis that the position and trajectory of the DBS lead relative to the mid-commissural point (MCP) are significant predictors of clinical outcomes. We expected that due to neuroanatomical variation among individuals, a simple measure of the position of the DBS lead relative to MCP (commonly used in clinical practice) may not be a reliable predictor of clinical outcomes when utilized alone. Methods: 55 PD subjects implanted with subthalamic nucleus (STN) DBS and 41 subjects implanted with globus pallidus internus (GPi) DBS were included. Lead locations in AC-PC space (x, y, z coordinates of the active contact and sagittal and coronal entry angles) measured on high-resolution CT-MRI fused images, and motor outcomes (Unified Parkinson's Disease Rating Scale) were analyzed to confirm or refute a correlation between coordinate-based lead locations and DBS motor outcomes. Results: Coordinate-based lead locations were not a significant predictor of change in UPDRS III motor scores when comparing pre- versus post-operative values. The only potentially significant individual predictor of change in UPDRS motor scores was the antero-posterior coordinate of the GPi lead (more anterior lead locations resulted in a worse outcome), but this was only a statistical trend (p<.082). Conclusion: The results of the study showed that a simple measure of the position of the DBS lead relative to the MCP is not significantly correlated with PD motor outcomes, presumably because this method fails to account for individual neuroanatomical variability. However, there is broad agreement that motor outcomes depend strongly on lead location. The results suggest the need for more detailed identification of stimulation location relative to anatomical targets.	[Nestor, Kelsey A.; Jacobson, Charles E.; Chen, Dennis; Okun, Michael S.] Univ Florida, Ctr Movement Disorders & Neurorestorat, McKnight Brain Inst, Dept Neurol, Gainesville, FL 32610 USA; [Nestor, Kelsey A.; Morishita, Takashi; Peace, David A.; Chen, Dennis; Foote, Kelly D.; Okun, Michael S.] Univ Florida, Ctr Movement Disorders & Neurorestorat, McKnight Brain Inst, Dept Neurosurg, Gainesville, FL USA; [Jones, Jacob D.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Butson, Christopher R.] Med Coll Wisconsin, Dept Neurol, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Medical College of Wisconsin	Okun, MS (corresponding author), Univ Florida, Ctr Movement Disorders & Neurorestorat, McKnight Brain Inst, Dept Neurol, Gainesville, FL 32610 USA.	okun@neurology.ufl.edu	jones, jacob/AAC-1920-2021	jones, jacob/0000-0003-3544-7294; Foote, Kelly/0000-0002-2436-4138; Okun, Michael/0000-0002-6247-9358; Jacobson, Charles/0000-0002-7598-5217	National Institutes of Health (NIH); NPF; Michael J. Fox Foundation; Parkinson Alliance; Smallwood Foundation; Bachmann-Strauss Foundation; Tourette Syndrome Association; UF Foundation; PeerView; Prime; Vanderbilt University; Medtronic; ANS/St. Jude	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NPF; Michael J. Fox Foundation; Parkinson Alliance; Smallwood Foundation; Bachmann-Strauss Foundation; Tourette Syndrome Association; UF Foundation; PeerView; Prime; Vanderbilt University; Medtronic(Medtronic); ANS/St. Jude	Dr. Okun serves as a consultant for the National Parkinson Foundation, and has received research grants from National Institutes of Health (NIH), NPF, the Michael J. Fox Foundation, the Parkinson Alliance, Smallwood Foundation, the Bachmann-Strauss Foundation, the Tourette Syndrome Association, and the UF Foundation. Dr. Okun has previously received honoraria, but in the past months has received no support from industry. Dr. Okun has received royalties for publications with Demos, Manson, Amazon, and Cambridge (movement disorders books). Dr. Okun is an associate editor for New England Journal of Medicine Journal Watch Neurology. Dr. Okun has participated in CME activities on movement disorders in the last 36 months sponsored by PeerView, Prime, and by Vanderbilt University. The institution and not Dr. Okun receives grants from Medtronic and ANS/St. Jude, and the PI has no financial interest in these grants. Dr. Okun has participated as a site PI and/or co-I for several NIH, foundation, and industry sponsored trials over the years but has not received honoraria. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Benabid AL, 2000, NEUROLOGY, V55, pS40; Butson CR, 2011, NEUROIMAGE, V54, P2096, DOI 10.1016/j.neuroimage.2010.10.059; CAIRE F, 2013, ACTA NEUROCHIR WIEN; Chaudhuri KR, 2006, MOVEMENT DISORD, V21, P916, DOI 10.1002/mds.20844; Connolly PJ, 2012, J CLIN NEUROSCI, V19, P1029, DOI 10.1016/j.jocn.2011.12.002; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Factor S., 2002, PARKINSONS DIS DIAGN; Garcia L, 2003, J NEUROSCI, V23, P8743; Gorgulho AA, 2009, J NEUROSURG, V110, P1317, DOI 10.3171/JNS.2008.10.JNS08835; Hamel W, 2003, J NEUROL NEUROSUR PS, V74, P1036, DOI 10.1136/jnnp.74.8.1036; Hamid NA, 2005, J NEUROL NEUROSUR PS, V76, P409, DOI 10.1136/jnnp.2003.032029; Herzog J, 2004, MOVEMENT DISORD, V19, P1050, DOI 10.1002/mds.20056; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Johnsen EL, 2010, EUR J NEUROL, V17, P746, DOI 10.1111/j.1468-1331.2010.02962.x; Kleiner-Fisman G, 2006, MOVEMENT DISORD, V21, pS290, DOI 10.1002/mds.20962; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Lalys F, 2013, J NEUROSCI METH, V212, P297, DOI 10.1016/j.jneumeth.2012.11.002; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; LEHMAN RM, 2012, WORLD NEUROSURG; Lyons KE, 2005, J NEUROSURG, V103, P252, DOI 10.3171/jns.2005.103.2.0252; MCCLELLAND S, 2005, NEUROSURG FOCUS, pE12; Morishita T, 2011, NEUROLOGIST, V17, P263, DOI 10.1097/NRL.0b013e31822d1069; Morishita T, 2010, PARKINSONISM RELAT D, V16, P153, DOI 10.1016/j.parkreldis.2009.10.003; O'Gorman RL, 2009, STEREOT FUNCT NEUROS, V87, P205, DOI 10.1159/000225973; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; Odekerken VJJ, 2013, LANCET NEUROL, V12, P37, DOI 10.1016/S1474-4422(12)70264-8; Okun MS, 2013, NEW ENGL J MED, V368, P483, DOI 10.1056/NEJMc1214078; Okun MS, 2010, EXPERT REV NEUROTHER, V10, P1847, DOI 10.1586/ERN.10.156; Okun MS, 2009, ANN NEUROL, V65, P586, DOI 10.1002/ana.21596; Paek SH, 2008, NEUROSURGERY, V63, P925, DOI 10.1227/01.NEU.0000334045.43940.FB; Pahwa R, 2003, J NEUROSURG, V99, P71, DOI 10.3171/jns.2003.99.1.0071; Parent B, 2011, J NEUROSURG, V114, P927, DOI 10.3171/2010.10.JNS10756; Pilitsis JG, 2008, J NEUROSURG, V109, P640, DOI 10.3171/JNS/2008/109/10/0640; Rodriguez-Oroz MC, 2005, BRAIN, V128, P2240, DOI 10.1093/brain/awh571; SCHLAIER JR, 2012, ACTA NEUROCHIR WIEN; Shahlaie K, 2011, NEUROSURGERY, V68, P114, DOI 10.1227/NEU.0b013e31820781bc; Starr PA, 2006, J NEUROSURG, V104, P488, DOI 10.3171/jns.2006.104.4.488; Starr PA, 2002, J NEUROSURG, V97, P370, DOI 10.3171/jns.2002.97.2.0370; Thani NB, 2011, NEUROSURGERY, V69, P207, DOI 10.1227/NEU.0b013e318218c7ae; Tsai ST, 2009, STEREOT FUNCT NEUROS, V87, P241, DOI 10.1159/000225977; Vergani F, 2007, SURG NEUROL, V67, P140, DOI 10.1016/j.surneu.2006.06.054; Volkmann J, 1998, ANN NEUROL, V44, P953, DOI 10.1002/ana.410440615; Walter U, 2011, ULTRASOUND MED BIOL, V37, P1382, DOI 10.1016/j.ultrasmedbio.2011.05.017; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929; Wharen R, 2010, EUR J NEUROL, V17, P639, DOI 10.1111/j.1468-1331.2010.02968.x; Williams A, 2010, LANCET NEUROL, V9, P581, DOI 10.1016/S1474-4422(10)70093-4; York MK, 2009, J NEUROL SCI, V287, P159, DOI 10.1016/j.jns.2009.08.003	48	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93524	10.1371/journal.pone.0093524	http://dx.doi.org/10.1371/journal.pone.0093524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691109	gold, Green Published, Green Submitted			2022-12-27	WOS:000334101100098
J	Sun, M; Yang, PZ; Du, LP; Yang, Y; Ye, J				Sun, Min; Yang, Peizeng; Du, Liping; Yang, Yan; Ye, Jian			The Role of Interleukin-1 Receptor-Associated Kinases in Vogt-Koyanagi-Harada Disease	PLOS ONE			English	Article							NF-KAPPA-B; T-CELLS; BACTERIAL-INFECTIONS; SIGNALING PATHWAYS; IRAK-4; ACTIVATION; IMMUNITY; FAMILY	Purpose: To explore whether IRAK1 and IRAK4 are involved in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease. Methods: Thirty-nine VKH patients and thirty-two healthy controls were included in this study. The mRNA levels of IRAK1 and IRAK4 from active VKH patients, inactive VKH patients, and normal controls in peripheral blood mononuclear cells (PBMCs) were detected using real-time quantitative PCR. CD4(+)T cells were purified from PBMCs obtained from active VKH patients and normal controls. The effect of IRAK1/4 inhibition on CD4(+)T cell proliferation following stimulation with IL-18 or IL-1 beta was measured using a modified MTT assay. CD4(+)T cell expression of IFN-gamma and IL-17 were detected by flow cytometry (FCM) and enzyme-linked immunosorbent assay (ELISA). The effect of IRAK1/4 inhibition on NF-kappa B, STAT1, and STAT3 activation was detected by FCM. Results: The mRNA levels of IRAK1 and IRAK4 were both significantly increased in active VKH patients compared to inactive VKH patients and healthy controls. No difference in the IRAK1 or IRAK4 mRNA level could be detected between inactive patients and healthy controls. After incubation with IRAK1/4 inhibitor, the proliferation of CD4(+)T cells was inhibited both in the active VKH patients and in the healthy controls. IRAK1/4 inhibition was also associated with a decreased expression of IFN-gamma and IL-17. Phosphorylation of NF-kappa B, STAT1, and STAT3 in CD4(+)T from healthy controls was significantly decreased after inhibition of IRAK1/4. Conclusions: High mRNA levels of IRAK1 and IRAK4 correlated with VKH disease activity. IRAK1 and IRAK4 play a role in the activation and proliferation of CD4(+)T cells and the higher expression observed in VKH may contribute to the pathogenesis of this blinding condition.	[Sun, Min; Ye, Jian] Third Mil Med Univ, Inst Surg Res, Dept Ophthalmol, Chongqing, Peoples R China; [Sun, Min; Ye, Jian] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China; [Sun, Min; Yang, Peizeng; Du, Liping; Yang, Yan] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Eye Inst, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Chongqing Medical University	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Eye Inst, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China.	peizengycmu@126.com; yejian1979@163.com	Du, Liping/M-9495-2019		National Natural Science Foundation [81200679, 81070722]; Natural Science Foundation Project of ChongQing [CSTC2013jcyjA10015]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of ChongQing(Natural Science Foundation of Chongqing)	This study was supported by National Natural Science Foundation Project Grant 81200679, National Natural Science Foundation Project Grant 81070722 and Natural Science Foundation Project of ChongQing CSTC2013jcyjA10015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2011, CLIN IMMUNOL, V139, P177, DOI 10.1016/j.clim.2011.01.014; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bykhovskaya I, 2005, AM J OPHTHALMOL, V140, P674, DOI 10.1016/j.ajo.2005.04.052; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chi W, 2007, J ALLERGY CLIN IMMUN, V119, P1218, DOI 10.1016/j.jaci.2007.01.010; Egwuagu CE, 2009, CYTOKINE, V47, P149, DOI 10.1016/j.cyto.2009.07.003; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Greene CM, 2000, J IMMUNOL, V165, P4718, DOI 10.4049/jimmunol.165.8.4718; Haseeb A, 2013, RHEUMATOLOGY, V52, P998, DOI 10.1093/rheumatology/kes363; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Jacob CO, 2009, P NATL ACAD SCI USA, V106, P6256, DOI 10.1073/pnas.0901181106; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Li B, 2005, BRIT J OPHTHALMOL, V89, P1410, DOI 10.1136/bjo.2005.074062; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Noble A, 2003, IMMUNOLOGY, V109, P476, DOI 10.1046/j.1365-2567.2003.01687.x; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Rao NA, 2010, OPHTHALMOLOGY, V117, P591, DOI 10.1016/j.ophtha.2009.08.030; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Rosenbaum JT, 2011, INVEST OPHTH VIS SCI, V52, P6472, DOI 10.1167/iovs.11-7742; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Wang ZL, 2009, CURR TOP MED CHEM, V9, P724, DOI 10.2174/156802609789044407; Yamamoto Yumi, 2001, Current Molecular Medicine (Hilversum), V1, P287; Yang PZ, 2005, CURR EYE RES, V30, P943, DOI 10.1080/02713680500263606; Zhai Y, 2013, INFLAMM RES	29	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93214	10.1371/journal.pone.0093214	http://dx.doi.org/10.1371/journal.pone.0093214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690905	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100053
J	Chen, RJ; Chang, CY; Chang, LW; Siao, SH; Ho, YS; Wu, CH; Foo, NP; Lin, PP; Wang, YJ				Chen, Rong-Jane; Chang, Chu-Yung; Chang, Louis W.; Siao, Shih-He; Ho, Yuan-Soon; Wu, Chih-Hsiung; Foo, Ning-Ping; Lin, Pinpin; Wang, Ying-Jan			The Regulation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-Induced Lung Tumor Promotion by Estradiol in Female A/J Mice	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; NF-KAPPA-B; ESTROGEN-RECEPTOR; CANCER; BETA; EXPRESSION; CELLS; WOMEN; EPIDEMIOLOGY; EXPOSURE	Epidemiological studies indicate that women are at a higher risk developing lung cancer than men are. It is suggested that estrogen is one of the most important factors in lung cancer development in females. Additionally, cigarette smoke, and environmental pollutants, such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), may play salient roles in female lung carcinogenesis. However, the mechanisms responsible for the interaction of these factors in the promotion of lung cancer are still poorly understood. The present study was designed to explore two ideas: first, the synergistic lung tumorigenic effects of 4-(methylnitrosamino)-1-(3-pyridyl)-butanol (NNK) combined with TCDD, 17 beta-estradiol (E2) or both through a long-term treatment experiment, and second, to identify early changes in the inflammatory and signaling pathways through short-term treatment experiments. The results indicate that A/J mice given E2 had strong effects in potentiating NNK-induced activation of MAPK signaling, NF kappa B, and COX-2 expression. In the long-term exposure model, E2 had a strong tumor promoting effect, whereas TCDD antagonized this effect in A/J mice. We conclude that treatment with NNK combined with either E2 or TCDD induces lung carcinogenesis and the promotion effects could be correlated with lung inflammation. E2 was shown to potentiate NNK-induced inflammation, cell proliferation, thereby leading to lung tumorigenesis.	[Chen, Rong-Jane; Chang, Chu-Yung; Siao, Shih-He; Foo, Ning-Ping; Wang, Ying-Jan] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Chen, Rong-Jane] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Ho, Yuan-Soon] Taipei Med Univ, Sch Med Technol & Biotechnol, Taipei, Taiwan; [Wu, Chih-Hsiung] Taipei Med Univ, Shuang Ho Hosp, Dept Surg, Sch Med, Taipei, Taiwan; [Ho, Yuan-Soon; Wu, Chih-Hsiung] Taipei Med Univ, Ctr Excellence Canc Res, Taipei, Taiwan; [Foo, Ning-Ping] Chi Mei Med Ctr, Dept Emergency Med, Tainan, Taiwan; [Foo, Ning-Ping] China Med Univ, Tainan Municipal An Nan Hosp, Dept Emergency Med, Tainan, Taiwan; [Lin, Pinpin] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan Town, Taiwan	National Cheng Kung University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Chi Mei Hospital; China Medical University Taiwan; National Health Research Institutes - Taiwan	Lin, PP (corresponding author), Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan Town, Taiwan.	pplin@nhri.org.tw; yjwang@mail.ncku.edu.tw	Lin, Pinpin/B-2668-2010; Lin, PinPin/A-2006-2019	Lin, Pinpin/0000-0001-5459-907X; Lin, PinPin/0000-0001-5459-907X	National Science Council (NSC) [102-2314-B-006-034]; Taipei Medical University, Center of Excellence for Cancer Research (TMU-CECR) [DOH101-TD-C-111-008]; Division of Environmental Health and Occupation Medicine (DEHOM), National Health Research Institutes (NHRI), Taiwan [EO-097-PP-03]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Taipei Medical University, Center of Excellence for Cancer Research (TMU-CECR); Division of Environmental Health and Occupation Medicine (DEHOM), National Health Research Institutes (NHRI), Taiwan	The study by the National Science Council (NSC 102-2314-B-006-034), Taipei Medical University, Center of Excellence for Cancer Research (TMU-CECR, DOH101-TD-C-111-008), and (EO-097-PP-03) from the Division of Environmental Health and Occupation Medicine (DEHOM), National Health Research Institutes (NHRI), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2011, RESPIRATION, V81, P265, DOI 10.1159/000324601; Al-Wadei HAN, 2010, LUNG CANCER, V69, P33, DOI 10.1016/j.lungcan.2009.09.011; Anumanthan G, 2005, BRIT J CANCER, V93, P1157, DOI 10.1038/sj.bjc.6602831; Babbar N, 2006, CANCER RES, V66, P11125, DOI 10.1158/0008-5472.CAN-06-3174; Barta P, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-4; Belani CP, 2007, LUNG CANCER, V55, P15, DOI 10.1016/j.lungcan.2006.09.008; Belcher SM, 2012, ENDOCRINOLOGY, V153, P712, DOI 10.1210/en.2011-1772; Biselli PJC, 2011, BRAZ J MED BIOL RES, V44, P460, DOI 10.1590/S0100-879X2011007500040; Chang LW, 2007, CARCINOGENESIS, V28, P1606, DOI 10.1093/carcin/bgm013; Chen RJ, 2011, J ONCOL, V2011, DOI 10.1155/2011/654931; Chen ZL, 2011, CANCER LETT, V308, P14, DOI 10.1016/j.canlet.2011.04.007; Egleston BL, 2009, SEMIN ONCOL, V36, P506, DOI 10.1053/j.seminoncol.2009.09.003; Fu JB, 2005, CHEST, V127, P768, DOI 10.1378/chest.127.3.768; Fucic A, 2010, TOXICOL PATHOL, V38, P849, DOI 10.1177/0192623310378136; Gordon T, 2009, CANCER LETT, V275, P213, DOI 10.1016/j.canlet.2008.10.012; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hammoud Z, 2008, ENDOCR-RELAT CANCER, V15, P475, DOI 10.1677/ERC-08-0002; IgnarTrowbridge DM, 1996, ENDOCRINOLOGY, V137, P1735, DOI 10.1210/en.137.5.1735; Kalkhoven E, 1996, J BIOL CHEM, V271, P6217, DOI 10.1074/jbc.271.11.6217; Karabela SP, 2011, NEOPLASIA, V13, P1143, DOI 10.1593/neo.111224; Kitajima M, 2004, REPROD TOXICOL, V18, P793, DOI 10.1016/j.reprotox.2004.04.012; Klass BR, 2009, POSTGRAD MED J, V85, P9, DOI 10.1136/pgmj.2008.069831; Kohle C, 2002, ARCH BIOCHEM BIOPHYS, V402, P172, DOI 10.1016/S0003-9861(02)00076-0; Liu C, 2011, CANCER PREV RES, V4, P1255, DOI 10.1158/1940-6207.CAPR-10-0384; Majidi M, 2007, CANCER RES, V67, P6863, DOI 10.1158/0008-5472.CAN-07-0483; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; Mountzios G, 2008, CLIN CANCER RES, V14, P4096, DOI 10.1158/1078-0432.CCR-07-4150; MOUSTAKAS A, 1993, J BIOL CHEM, V268, P22215; Niikawa H, 2008, CLIN CANCER RES, V14, P4417, DOI 10.1158/1078-0432.CCR-07-1950; Palvimo JJ, 1996, J BIOL CHEM, V271, P24151, DOI 10.1074/jbc.271.39.24151; Peng J, 2013, CARCINOGENESIS; Seymour Brian W P, 2002, Dev Immunol, V9, P47, DOI 10.1080/1044667021000003989; Siegfried JM, 2009, SEMIN ONCOL, V36, P524, DOI 10.1053/j.seminoncol.2009.10.004; Stabile LP, 2002, CANCER RES, V62, P2141; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Takemoto K, 2004, ARCH TOXICOL, V78, P309, DOI 10.1007/s00204-004-0550-7; Tan AR, 2009, BREAST CANCER RES TR, V115, P453, DOI 10.1007/s10549-008-0184-1; Tang HX, 2013, INT J CANCER, V133, P2473, DOI 10.1002/ijc.28262; Thomas L, 2005, CHEST, V128, P370, DOI 10.1378/chest.128.1.370; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; Wang WL, 1998, ARCH BIOCHEM BIOPHYS, V356, P239, DOI 10.1006/abbi.1998.0782; Wang YJ, 2011, J HAZARD MATER, V186, P869, DOI 10.1016/j.jhazmat.2010.11.082; Wolff H, 1998, CANCER RES, V58, P4997; Zang EA, 1996, JNCI-J NATL CANCER I, V88, P183, DOI 10.1093/jnci/88.3-4.183	45	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93152	10.1371/journal.pone.0093152	http://dx.doi.org/10.1371/journal.pone.0093152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682076	Green Published, gold, Green Submitted			2022-12-27	WOS:000333678100027
J	Song, Y; Demmer, DL; Pinniger, GJ; Lavin, T; MacMillan, MV; Pillow, JJ; Bakker, AJ				Song, Yong; Demmer, Denise L.; Pinniger, Gavin J.; Lavin, Tina; MacMillan, Mia V.; Pillow, Jane J.; Bakker, Anthony J.			Effect of Maternal Steroid on Developing Diaphragm Integrity	PLOS ONE			English	Article							RAT DIAPHRAGM; SKELETAL-MUSCLE; CONTRACTILE PROPERTIES; MECHANISMS; FETAL; STIMULATION; CAPACITY; PRETERM	Antenatal steroids reduce the severity of initial respiratory distress of premature newborn babies but may have an adverse impact on other body organs. The study aimed to examine the effect of maternal steroids on postnatal respiratory muscle function during development and elucidate the mechanisms underlying the potential myopathy in newborn rats. Pregnant rats were treated with intramuscular injections of 0.5 mg/kg betamethasone 7 d and 3 d before birth. Newborn diaphragms were dissected for assessment of contractile function at 2 d, 7 d or 21 d postnatal age (PNA), compared with age-matched controls. The expression of myosin heavy chain (MHC) isoforms and atrophy-related genes and activity of intracellular molecular signalling were measured using quantitative PCR and/or Western blot. With advancing PNA, neonatal MHC gene expression decreased progressively while MHC IIb and IIx isoforms increased. Protein metabolic signalling showed high baseline activity at 2 d PNA, and significantly declined at 7 d and 21 d. Antenatal administration of betamethasone significantly decreased diaphragm force production, fatigue resistance, total fast fibre content and anabolic signalling activity (Akt and 4E-BP1) in 21 d diaphragm. These responses were not observed in 2 d or 7 d postnatal diaphragm. Results demonstrate that maternal betamethasone treatment causes postnatal diaphragmatic dysfunction at 21 d PNA, which is attributed to MHC II protein loss and impairment of the anabolic signalling pathway. Developmental modifications in MHC fibre composition and protein signalling account for the age-specific diaphragm dysfunction.	[Song, Yong; Demmer, Denise L.; Pinniger, Gavin J.; Lavin, Tina; MacMillan, Mia V.; Pillow, Jane J.; Bakker, Anthony J.] Univ Western Australia, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia; [Song, Yong; Lavin, Tina; Pillow, Jane J.] Univ Western Australia, Ctr Neonatal Res & Educ, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Pillow, Jane J.] King Edward Mem Hosp, Women & Newborns Hlth Serv, Perth, WA, Australia; [Pillow, Jane J.] Princess Margaret Hosp, Perth, WA, Australia	University of Western Australia; University of Western Australia; King Edward Memorial Hospital	Bakker, AJ (corresponding author), Univ Western Australia, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia.	tony.bakker@uwa.edu.au	Pinniger, Gavin/F-1421-2013; Song, Yong/C-2407-2013; Pillow, Jane/A-3335-2009	Pinniger, Gavin/0000-0002-4400-0817; Pillow, Jane/0000-0002-6500-0138; Song, Yong/0000-0002-8178-5641; Demmer, Denise/0000-0003-0751-7304	University of Western Australia Research Development Award; Women and Infants Research Foundation; National Health and Medical Research Foundation [APP1010665]	University of Western Australia Research Development Award; Women and Infants Research Foundation; National Health and Medical Research Foundation	This study was supported by the University of Western Australia Research Development Award (YS), Women and Infants Research Foundation (TL) and National Health and Medical Research Foundation APP1010665 (JJP, GJP, AJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davis TA, 2001, AM J PHYSIOL-ENDOC M, V280, pE770, DOI 10.1152/ajpendo.2001.280.5.E770; Davis TA, 2009, CURR OPIN CLIN NUTR, V12, P78, DOI 10.1097/MCO.0b013e32831cef9f; Dehoux MJM, 2003, FEBS LETT, V544, P214, DOI 10.1016/S0014-5793(03)00505-2; Dekhuijzen PNR, 1996, AM J RESP CRIT CARE, V153, P769, DOI 10.1164/ajrccm.153.2.8564131; Dimitriou G, 2003, PEDIATR PULM, V35, P17, DOI 10.1002/ppul.10209; Dureuil B, 1998, REPROD NUTR DEV, V38, P175, DOI 10.1051/rnd:19980204; Eason JM, 2000, PHYS THER, V80, P160, DOI 10.1093/ptj/80.2.160; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Geiger PC, 2006, J APPL PHYSIOL, V101, P1546, DOI 10.1152/japplphysiol.00221.2006; Geiger PC, 2000, J APPL PHYSIOL, V89, P695, DOI 10.1152/jappl.2000.89.2.695; Geiger PC, 2001, J APPL PHYSIOL, V90, P380, DOI 10.1152/jappl.2001.90.1.380; Gokulakrishnan G, 2012, AM J PHYSIOL-REG I, V302, pR1143, DOI 10.1152/ajpregu.00466.2011; HEINER L, 1980, ACTA PHYSIOL HUNG, V55, P51; KEENS TG, 1978, J APPL PHYSIOL, V44, P909, DOI 10.1152/jappl.1978.44.6.909; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Kowalski KE, 2013, EXP NEUROL, V247, P689, DOI 10.1016/j.expneurol.2013.03.006; LASZEWSKI B, 1985, AM J PHYSIOL, V248, pE363, DOI 10.1152/ajpendo.1985.248.3.E363; Lavin T, 2013, PEDIATR PULM, V48, P640, DOI 10.1002/ppul.22762; MOORE BJ, 1989, J APPL PHYSIOL, V67, P2420, DOI 10.1152/jappl.1989.67.6.2420; Nava S, 1996, AM J RESP CRIT CARE, V153, P1888, DOI 10.1164/ajrccm.153.6.8665051; Niedzwiecka A, 2002, BIOCHEMISTRY-US, V41, P12140, DOI 10.1021/bi0258142; Orellana RA, 2012, AM J PHYSIOL-REG I, V302, pR682, DOI 10.1152/ajpregu.00259.2011; PETER JB, 1970, BIOCHEM PHARMACOL, V19, P1627, DOI 10.1016/0006-2952(70)90151-6; POLLA B, 1994, ACTA PHYSIOL SCAND, V151, P353, DOI 10.1111/j.1748-1716.1994.tb09754.x; Racz GZ, 2003, AM J RESP CRIT CARE, V168, P297, DOI 10.1164/rccm.200206-541OC; Sassoon CSH, 2008, MUSCLE NERVE, V38, P1161, DOI 10.1002/mus.21048; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; Shanely RA, 2003, CHEST, V123, P195, DOI 10.1378/chest.123.1.195; SHOJI S, 1976, EXP NEUROL, V51, P304, DOI 10.1016/0014-4886(76)90255-7; SMITH D, 1988, AM J PHYSIOL, V254, pC661, DOI 10.1152/ajpcell.1988.254.5.C661; Song Y, 2013, AM J RESP CELL MOL, V49, P866, DOI 10.1165/rcmb.2013-0107OC; Song Y, 2013, EXP BIOL MED, V238, P913, DOI 10.1177/1535370213494562; Song Y, 2012, ANAT REC, V295, P864, DOI 10.1002/ar.22436; TRANG TTH, 1992, AM REV RESPIR DIS, V146, P26, DOI 10.1164/ajrccm/146.1.26; VanBalkom RHH, 1997, J APPL PHYSIOL, V83, P1062, DOI 10.1152/jappl.1997.83.4.1062; Watchko JF, 1998, COMP BIOCHEM PHYS B, V119, P459, DOI 10.1016/S0305-0491(98)00006-6	36	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93224	10.1371/journal.pone.0093224	http://dx.doi.org/10.1371/journal.pone.0093224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681552	gold, Green Published, Green Submitted			2022-12-27	WOS:000333678100033
J	Bonfiglio, L; Piarulli, A; Olcese, U; Andre, P; Arrighi, P; Frisoli, A; Rossi, B; Bergamasco, M; Carboncini, MC				Bonfiglio, Luca; Piarulli, Andrea; Olcese, Umberto; Andre, Paolo; Arrighi, Pieranna; Frisoli, Antonio; Rossi, Bruno; Bergamasco, Massimo; Carboncini, Maria Chiara			Spectral Parameters Modulation and Source Localization of Blink-Related Alpha and Low-Beta Oscillations Differentiate Minimally Conscious State from Vegetative State/Unresponsive Wakefulness Syndrome	PLOS ONE			English	Article							DEFAULT MODE NETWORK; ELECTROMAGNETIC TOMOGRAPHY; BRAIN ACTIVITY; RESTING-STATE; DIFFERENT REFERENCES; OBJECT RECOGNITION; DELTA OSCILLATIONS; EEG; CONNECTIVITY; MEMORY	Recently, the cortical source of blink-related delta oscillations (delta BROs) in resting healthy subjects has been localized in the posterior cingulate cortex/precuneus (PCC/PCu), one of the main core-hubs of the default-mode network. This has been interpreted as the electrophysiological signature of the automatic monitoring of the surrounding environment while subjects are immersed in self-reflecting mental activities. Although delta BROs were directly correlated to the degree of consciousness impairment in patients with disorders of consciousness, they failed to differentiate vegetative state/unresponsive wakefulness syndrome (VS/UWS) from minimally conscious state (MCS). In the present study, we have extended the analysis of BROs to frequency bands other than delta in the attempt to find a biological marker that could support the differential diagnosis between VS/UWS and MCS. Four patients with VS/UWS, 5 patients with MCS, and 12 healthy matched controls (CTRL) underwent standard 19-channels EEG recordings during resting conditions. Three-second-lasting EEG epochs centred on each blink instance were submitted to time-frequency analyses in order to extract the normalized Blink-Related Synchronization/Desynchronization (nBRS/BRD) of three bands of interest (low-alpha, high-alpha and low-beta) in the time-window of 50-550 ms after the blink-peak and to estimate the corresponding cortical sources of electrical activity. VS/UWS nBRS/BRD levels of all three bands were lower than those related to both CTRL and MCS, thus enabling the differential diagnosis between MCS and VS/UWS. Furthermore, MCS showed an intermediate signal intensity on PCC/PCu between CTRL and VS/UWS and a higher signal intensity on the left temporo-parieto-occipital junction and inferior occipito-temporal regions when compared to VS/UWS. This peculiar pattern of activation leads us to hypothesize that resting MCS patients have a bottom-up driven activation of the task positive network and thus are tendentially prone to respond to environmental stimuli, even though in an almost unintentional way.	[Bonfiglio, Luca; Arrighi, Pieranna; Rossi, Bruno; Carboncini, Maria Chiara] Univ Pisa, Sch Phys Med & Rehabil, Dept Translat Res New Technol Med & Surg, Pisa, Italy; [Piarulli, Andrea; Frisoli, Antonio; Bergamasco, Massimo] Scuola Super Sant Anna, PERCRO Lab, TeCIP Inst, Pisa, Italy; [Olcese, Umberto] Italian Inst Technol, Dept Neurosci & Brain Technol, Genoa, Italy; [Andre, Paolo] Univ Siena, Dept Med & Surg Sci & Neurosci, I-53100 Siena, Italy	University of Pisa; Scuola Superiore Sant'Anna; Istituto Italiano di Tecnologia - IIT; University of Siena	Bonfiglio, L (corresponding author), Univ Pisa, Sch Phys Med & Rehabil, Dept Translat Res New Technol Med & Surg, Pisa, Italy.	bubobis@gmail.com	; Carboncini, Maria Chiara/I-9445-2018	ROSSI, BRUNO/0000-0003-1914-8593; Carboncini, Maria Chiara/0000-0002-3345-1524; Olcese, Umberto/0000-0001-6968-2503; BERGAMASCO, Massimo/0000-0002-7418-2332; Bonfiglio, Luca/0000-0001-5097-1014; piarulli, andrea/0000-0003-4516-2671	Scuola Superiore Sant'Anna	Scuola Superiore Sant'Anna	This study has been partially supported by a scholarship from Scuola Superiore Sant'Anna (AP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anticevic A, 2010, NEUROIMAGE, V49, P2638, DOI 10.1016/j.neuroimage.2009.11.008; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Bardin JC, 2012, ARCH NEUROL-CHICAGO, V69, P176, DOI 10.1001/archneurol.2011.892; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Basar E, 2006, PROG BRAIN RES, V159, P43, DOI 10.1016/S0079-6123(06)59004-1; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Boly M, 2007, NEUROIMAGE, V36, P979, DOI 10.1016/j.neuroimage.2007.02.047; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Boly M, 2011, CURR OPIN NEUROL, V24, P394, DOI 10.1097/WCO.0b013e328347da94; Bonfiglio L, 2013, HUM BRAIN MAPP, V34, P2178, DOI 10.1002/hbm.22056; Bonfiglio L, 2011, INT J PSYCHOPHYSIOL, V80, P44, DOI 10.1016/j.ijpsycho.2011.01.002; Bonfiglio L, 2009, NEUROSCI LETT, V449, P57, DOI 10.1016/j.neulet.2008.10.039; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Bruno MA, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-35; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Burianova H, 2010, NEUROIMAGE, V49, P865, DOI 10.1016/j.neuroimage.2009.08.066; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cincotti F, 2004, METHOD INFORM MED, V43, P114; Clemens B, 2010, CLIN NEUROPHYSIOL, V121, P848, DOI 10.1016/j.clinph.2010.01.020; Collette F, 2001, MEMORY, V9, P249, DOI 10.1080/09658210143000056; Crick F., 1990, Seminars in the Neurosciences, V2, P263; Crone JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026373; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Damasio AR, 1999, FEELING WHAT APPENS; DiQuattro NE, 2011, J NEUROSCI, V31, P18026, DOI 10.1523/JNEUROSCI.4040-11.2011; Dobson A. J., 2010, INTRO GEN LINEAR MOD, V2nd; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Gerlach C, 2002, NEUROPSYCHOLOGIA, V40, P1254, DOI 10.1016/S0028-3932(01)00222-6; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gosseries O, 2011, FUNCT NEUROL, V26, P25; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hagan C., 1979, REHABILITATION HEAD; Hayes SM, 2007, HIPPOCAMPUS, V17, P873, DOI 10.1002/hipo.20319; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Huberle E, 2012, BRAIN STRUCT FUNCT, V217, P735, DOI 10.1007/s00429-011-0369-y; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Kassuba T, 2011, NEUROIMAGE, V56, P1566, DOI 10.1016/j.neuroimage.2011.02.032; Kayser J, 2006, CLIN NEUROPHYSIOL, V117, P369, DOI 10.1016/j.clinph.2005.08.033; Kochan NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023960; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Laureys S, 2006, J CLIN INVEST, V116, P1823, DOI 10.1172/JCI29172; Liljestrom M, 2008, NEUROIMAGE, V41, P1132, DOI 10.1016/j.neuroimage.2008.03.016; Makeig S, 1996, ADV NEUR IN, V8, P145; Manly BFJ, 1997, RANDOMIZATION BOOTST; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mayberg HS, 1997, NEUROREPORT, V8, P1057, DOI 10.1097/00001756-199703030-00048; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Moore CJ, 1999, NEUROIMAGE, V10, P181, DOI 10.1006/nimg.1999.0450; Nakamura K, 2005, NEUROIMAGE, V28, P521, DOI 10.1016/j.neuroimage.2004.11.055; Nakano T, 2013, P NATL ACAD SCI USA, V110, P702, DOI 10.1073/pnas.1214804110; Noirhomme Q, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00160; Nunez PL, 1999, CLIN NEUROPHYSIOL, V110, P469, DOI 10.1016/S1388-2457(98)00043-1; Olbrich S, 2009, NEUROIMAGE, V45, P319, DOI 10.1016/j.neuroimage.2008.11.014; Ovadia-Caro S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037238; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Park H, 2012, BRAIN RES, V1471, P81, DOI 10.1016/j.brainres.2012.07.012; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; PERRIN F, 1987, IEEE T BIO-MED ENG, V34, P283, DOI 10.1109/TBME.1987.326089; Phillips JS, 2009, NEUROIMAGE, V46, P1209, DOI 10.1016/j.neuroimage.2009.02.044; Picard N, 2003, CEREB CORTEX, V13, P977, DOI 10.1093/cercor/13.9.977; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Roberts DJ, 2013, CEREB CORTEX, V23, P2568, DOI 10.1093/cercor/bhs224; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Sabes PN, 2011, PROG BRAIN RES, V191, P195, DOI 10.1016/B978-0-444-53752-2.00004-7; Schendan HE, 2009, NEUROIMAGE, V44, P1423, DOI 10.1016/j.neuroimage.2008.09.061; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Silva S, 2010, NEUROLOGY, V74, P313, DOI 10.1212/WNL.0b013e3181cbcd96; Smallwood J, 2012, BRAIN RES, V1428, P60, DOI 10.1016/j.brainres.2011.03.072; Sommer WH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003167; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Steinvorth S, 2006, NEUROIMAGE, V30, P285, DOI 10.1016/j.neuroimage.2005.09.025; Talairach J., 1988, COPLANAR STEREOTAXIC, V147; Thibaut A, 2012, J REHABIL MED, V44, P487, DOI 10.2340/16501977-0940; Thut G, 2005, CEREB CORTEX, V15, P628, DOI 10.1093/cercor/bhh164; TOWLE VL, 1993, ELECTROEN CLIN NEURO, V86, P1, DOI 10.1016/0013-4694(93)90061-Y; Uecker A, 1997, LEARN MEMORY, V4, P337, DOI 10.1101/lm.4.4.337; Valdes-Hernandez PA, 2009, J NEUROSCI METH, V185, P125, DOI 10.1016/j.jneumeth.2009.09.005; van Leeuwen C, 2011, HUMANA MENTE, P35; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Ward AM, 2014, HUM BRAIN MAPP, V35, P1061, DOI 10.1002/hbm.22234; Weisberg S., 2005, WILEY SERIES PROBABI, V528; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wierenga CE, 2009, J INT NEUROPSYCH SOC, V15, P169, DOI 10.1017/S1355617709090468; Wu DY, 2011, CLIN NEUROPHYSIOL, V122, P490, DOI 10.1016/j.clinph.2010.05.036; Yao DZ, 2007, COMPUT BIOL MED, V37, P1529, DOI 10.1016/j.compbiomed.2007.02.002; Yao DZ, 2005, PHYSIOL MEAS, V26, P173, DOI 10.1088/0967-3334/26/3/003	95	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93252	10.1371/journal.pone.0093252	http://dx.doi.org/10.1371/journal.pone.0093252			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676098	Green Published, gold			2022-12-27	WOS:000333677500098
J	Dong, XF; Li, R; Xiu, P; Dong, XS; Xu, ZZ; Zhai, B; Liu, F; Jiang, HC; Sun, XY; Li, J; Qiao, HQ				Dong, Xiaofeng; Li, Rui; Xiu, Peng; Dong, Xuesong; Xu, Zongzhen; Zhai, Bo; Liu, Feng; Jiang, Hongchi; Sun, Xueying; Li, Jie; Qiao, Haiquan			Meloxicam Executes Its Antitumor Effects against Hepatocellular Carcinoma in COX-2-Dependent and -Independent Pathways	PLOS ONE			English	Article							E-CADHERIN; GROWTH-FACTOR; CELL-PROLIFERATION; DOWN-REGULATION; AUTOPHAGY; CYCLOOXYGENASE-2; INVASION; EXPRESSION; APOPTOSIS; MIGRATION	Background: Cyclooxygenase (COX)-2 is overexpressed in many types of cancers including hepatocellular carcinoma (HCC). Meloxicam, a selective COX-2 inhibitor, has shown potential therapeutic effects against HCC, but the mechanisms accounting for its anti-cancer activities remain unclear. Methods and Findings: Meloxicam inhibited the ability of human HCC cells expressing higher levels of COX-2 to migrate, invade, adhere and form colonies through upregulating the expression of E-cadherin and downregulating the expression of matrix metalloproteinase (MMP) -2. Meloxicam induced cell apoptosis by upregulating pro-apoptotic proteins including Bax and Fas-L, and downregulating anti-apoptotic proteins including survivin and myeloid cell leukemia-1 (Mcl-1), through inhibiting phosphorylation of AKT. Addition of prostaglandin E2 (PGE2), the major product of COX-2, could abrogate the effects of meloxicam on the expression of survivin and myeloid cell leukemia-1 (Mcl-1), but not Bax and Fas-L, indicating that meloxicam induces cell apoptosis via both COX-2-dependent and -independent pathways. Meloxicam also induced cell autophagy by upregulating Beclin 1 and light chain 3-II. Specific inhibition of autophagy by 3-methyladenine and chloroquine had little effect on cell apoptosis but could enhance the pro-apoptotic effects of meloxicam by further upregulating the expression of Bax. Conclusions: Meloxicam executes its antitumor effects by targeting the COX-2/MMP-2/E-cadherin, AKT, apoptotic and autophagic pathways in COX-2-dependent and -independent pathways, and inhibition of cell autophagy could help to overcome the resistance to meloxicam-induced apoptosis in HCC.	[Dong, Xiaofeng; Xiu, Peng; Xu, Zongzhen; Liu, Feng; Li, Jie] Shandong Univ, Qianfoshan Hosp, Dept Gen Surg, Jinan 250100, Peoples R China; [Li, Rui] Liaocheng Peoples Hosp, Dept Gen Surg, Liaocheng, Peoples R China; [Dong, Xuesong; Zhai, Bo; Jiang, Hongchi; Sun, Xueying; Qiao, Haiquan] Harbin Med Univ, Affiliated Hosp 1, Hepatosplen Surg Ctr, Dept Gen Surg, Harbin, Peoples R China; [Sun, Xueying] Univ Auckland, Fac Med & Hlth Sci, Dept Mol Med & Pathol, Auckland 1, New Zealand	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Harbin Medical University; University of Auckland	Li, J (corresponding author), Shandong Univ, Qianfoshan Hosp, Dept Gen Surg, Jinan 250100, Peoples R China.	lijie0503@126.com; qiaohaiquan@hotmail.com	Jiang, HongChi/M-5031-2018	Jiang, HongChi/0000-0001-8215-8984; Sun, Xueying/0000-0002-8065-8747; Li, Jie/0000-0002-2540-7494	National Natural Scientific Foundation of China [30972890, 81172331]; Shandong Provincial Science and Technology Development Planning, China [2010GSF10230]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Science and Technology Development Planning, China	This research was supported from the National Natural Scientific Foundation of China (http://www.nsfc.gov.cn) (30972890 and 81172331), and Shandong Provincial Science and Technology Development Planning, China (www.sdstc.gov.cn) (2010GSF10230). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali-Fehmi R, 2005, AM J OBSTET GYNECOL, V192, P819, DOI 10.1016/j.ajog.2004.10.587; Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Banu SK, 2008, ENDOCRINOLOGY, V149, P1180, DOI 10.1210/en.2007-1168; Brouxhon SM, 2014, ONCOGENE, V33, P225, DOI 10.1038/onc.2012.563; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249; David Rachel, 2012, Nat Rev Mol Cell Biol, V13, P136, DOI 10.1038/nrm3287; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Dohadwala M, 2006, CANCER RES, V66, P5338, DOI 10.1158/0008-5472.CAN-05-3635; Grabowska MM, 2012, FRONT BIOSCI-LANDMRK, V17, P1948, DOI 10.2741/4031; He CJ, 2012, CANCER SCI, V103, P528, DOI 10.1111/j.1349-7006.2011.02177.x; Huang SB, 2010, AUTOPHAGY, V6, P256, DOI 10.4161/auto.6.2.11124; Jang TJ, 2010, VIRCHOWS ARCH, V457, P319, DOI 10.1007/s00428-010-0943-3; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang X, 2009, CANCER SCI, V100, P2226, DOI 10.1111/j.1349-7006.2009.01306.x; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kern MA, 2004, CARCINOGENESIS, V25, P1193, DOI 10.1093/carcin/bgh110; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kwon SH, 2012, CLIN MOL HEPATOL, V18, P287, DOI 10.3350/cmh.2012.18.3.287; Larkins TL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-181; Lau MT, 2011, ONCOGENE, V30, P2753, DOI 10.1038/onc.2011.6; Lau MT, 2012, CANCER LETT, V326, P191, DOI 10.1016/j.canlet.2012.08.016; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li J, 2006, J GASTROEN HEPATOL, V21, P1814, DOI 10.1111/j.1440-1746.2006.04366.x; Liu DL, 2011, MED ONCOL, V28, P105, DOI 10.1007/s12032-009-9397-3; Ma LX, 2012, INVEST NEW DRUG, V30, P508, DOI 10.1007/s10637-010-9578-0; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Margineanu Eliana, 2008, Rev Med Chir Soc Med Nat Iasi, V112, P432; Mima K, 2013, ONCOL LETT, V5, P149, DOI 10.3892/ol.2012.954; Naruse T, 2006, CARCINOGENESIS, V27, P584, DOI 10.1093/carcin/bgi240; Rizzo MT, 2011, CLIN CHIM ACTA, V412, P671, DOI 10.1016/j.cca.2010.12.026; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; Su MF, 2013, J ONCOL, V2013, DOI 10.1155/2013/102735; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vo BT, 2013, ENDOCRINOLOGY, V154, P1768, DOI 10.1210/en.2012-2074; Wang DZ, 2005, GASTROENTEROLOGY, V128, P1445, DOI 10.1053/j.gastro.2004.09.080; Wang JZ, 2011, J HEPATOL, V55, P359, DOI 10.1016/j.jhep.2010.10.043; Wei Z, 2013, CELL SIGNAL, V25, P931, DOI 10.1016/j.cellsig.2013.01.011; Xiu P, 2013, CANCER SCI, V104, P375, DOI 10.1111/cas.12088; Zhang CH, 2012, J SURG RES, V174, P120, DOI 10.1016/j.jss.2010.10.030; Zhou LD, 2010, MED ONCOL, V27, P255, DOI 10.1007/s12032-009-9201-4; Zhou L, 2013, DIGEST DIS SCI, V58, P1016, DOI 10.1007/s10620-012-2434-7	44	34	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92864	10.1371/journal.pone.0092864	http://dx.doi.org/10.1371/journal.pone.0092864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675684	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677500047
J	Justa, S; Zhou, XQ; Sarkar, S				Justa, Shivali; Zhou, Xiaoqun; Sarkar, Sujata			Endogenous IL-22 Plays a Dual Role in Arthritis: Regulation of Established Arthritis via IFN-gamma Responses	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; INTERFERON-GAMMA; RHEUMATOID-ARTHRITIS; INTERLEUKIN 22; TH17 CELLS; T-CELLS; B-CELLS; AIRWAY INFLAMMATION; PROTECTIVE ROLE; DEFICIENT MICE	Objective: IL-22 is elevated in patients with inflammatory arthritis and correlates with disease activity. IL-22 deficient mice have reduced incidence of arthritis. Recombinant IL-22 restrains progression of arthritis via increase in IL-10 responses when administered prior to onset of arthritis. These findings imply a possible dual role of IL-22 in inflammatory arthritis depending on the phase of arthritis. Experiments outlined here were designed to elucidate the contribution of endogenous IL-22 before and after the onset of arthritis. Methods: Collagen induced arthritis (CIA) was induced in DBA1 or IFN-gamma deficient mice following immunization with collagen and complete Freund's adjuvant. Anti-IL-22 antibody or isotype control were administered prior to or after onset of arthritis and disease progression assessed by clinical scoring and histopathology. IL-22, IL-17 and IFN-gamma responses were measured by ELISA and flowcytometry. Anti-collagen antibody responses were analyzed by ELISA. Expression of IL-22R1 in CD4+ cells was elucidated by flowcytometry and real time PCR. Results: Collagen specific IL-22 responses were expanded during arthritis and IL-22 producing cells were discrete from IL-17 or IFN-gamma producing cells. Neutralization of IL-22 after onset of arthritis resulted in significant increase in Th1 responses and significantly reduced severity of arthritis. CD4+ cells from arthritic mice showed increased surface expression of IL-22R1. In vitro, CD4+ T cells cultured with antigen presenting cells in the presence or absence of IL-22 suppressed or induced IFN-gamma, respectively. The protective effect of anti-IL-22 was reversed in IFN-gamma deficient mice. Moreover, administration of anti-IL-22 prior to onset of arthritis augmented arthritis severity. Conclusion: We show for the first time that IL-22 plays a dual role: protective prior to the onset of arthritis and pathogenic after onset of arthritis. The pathogenic effect of IL-22 is dependent on suppression of IFN-gamma responses. IL-17 responses remained unchanged with the administration of anti-IL22 antibody. IL-22R1 is upregulated on CD4+ T cells during arthritis and regulates IFN-gamma in T cells.	[Sarkar, Sujata] Univ Arizona, Dept Med, Rheumatol Sect, Tucson, AZ 85721 USA; Univ Arizona, Arizona Arthrit Ctr, Tucson, AZ USA	University of Arizona; University of Arizona	Sarkar, S (corresponding author), Univ Arizona, Dept Med, Rheumatol Sect, Tucson, AZ 85721 USA.	ssarkar@email.arizona.edu		Justa, Shivali/0000-0002-1166-844X	National Institutes of Health [AR054323]; Arthritis National Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR054323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis National Research Foundation(National Research Foundation of Korea); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health AR054323 (http://www.nih.gov/), Arthritis National Research Foundation (http://www.curearthritis.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bard JD, 2008, LEUKEMIA, V22, P1595, DOI 10.1038/leu.2008.129; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Chang H, 2006, J IMMUNOL, V177, P3635, DOI 10.4049/jimmunol.177.6.3635; Chu CQ, 2007, ARTHRITIS RHEUM, V56, P1145, DOI 10.1002/art.22453; Chu CQ, 2003, ANN RHEUM DIS, V62, P983, DOI 10.1136/ard.62.10.983; da Rocha LF, 2012, J RHEUMATOL, V39, P1320, DOI 10.3899/jrheum.111027; Geboes L, 2009, ARTHRITIS RHEUM-US, V60, P390, DOI 10.1002/art.24220; Gelebart P, 2011, TRANSL ONCOL, V4, P9, DOI 10.1593/tlo.10172; Guedez YB, 2001, ARTHRITIS RHEUM, V44, P2413, DOI 10.1002/1529-0131(200110)44:10<2413::AID-ART406>3.0.CO;2-E; Ikeuchi H, 2005, ARTHRITIS RHEUM-US, V52, P1037, DOI 10.1002/art.20965; Irmler I, 2007, Z RHEUMATOL, V66, P17; Kagami S, 2010, J INVEST DERMATOL, V130, P1373, DOI 10.1038/jid.2009.399; Ke Y, 2011, J IMMUNOL, V187, P2130, DOI 10.4049/jimmunol.1100482; Kelchtermans H, 2007, J LEUKOCYTE BIOL, V81, P1044, DOI 10.1189/jlb.0806486; Kim KW, 2012, ARTHRITIS RHEUM-US, V64, P1015, DOI 10.1002/art.33446; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; Lecart S, 2002, INT IMMUNOL, V14, P1351, DOI 10.1093/intimm/dxf096; Leipe J, 2011, ANN RHEUM DIS, V70, P1453, DOI 10.1136/ard.2011.152074; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; ManourySchwartz B, 1997, J IMMUNOL, V158, P5501; Marijnissen RJ, 2011, ARTHRITIS RHEUM-US, V63, P2939, DOI 10.1002/art.30469; Mitra A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3781; Nakagome K, 2011, J IMMUNOL, V187, P5077, DOI 10.4049/jimmunol.1001560; Nakahama T, 2011, P NATL ACAD SCI USA, V108, P14222, DOI 10.1073/pnas.1111786108; NAKAJIMA H, 1990, CLIN EXP IMMUNOL, V81, P441; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Oral HB, 2006, EUR J IMMUNOL, V36, P380, DOI 10.1002/eji.200425523; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Sarkar S, 2013, ARTHRITIS RHEUM-US, V65, P960, DOI 10.1002/art.37849; Sarkar S, 2010, RHEUM DIS CLIN N AM, V36, P345, DOI 10.1016/j.rdc.2010.02.006; Sarkar S, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2838; Savan R, 2011, BLOOD, V117, P575, DOI 10.1182/blood-2010-05-285908; Schurgers E, 2011, J INTERF CYTOK RES, V31, P917, DOI 10.1089/jir.2011.0056; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; SNAPPER CM, 1988, J IMMUNOL, V140, P2121; Snapper CM, 1996, INT IMMUNOL, V8, P877, DOI 10.1093/intimm/8.6.877; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Sugita S, 2013, J IMMUNOL, V190, P5799, DOI 10.4049/jimmunol.1202677; van Hamburg JP, 2013, ANN RHEUM DIS; Vermeire K, 1997, J IMMUNOL, V158, P5507; Williams AS, 2007, ARTHRITIS RHEUM-US, V56, P2244, DOI 10.1002/art.22732; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2005, GENES IMMUN, V6, P8, DOI 10.1038/sj.gene.6364144; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031000, 10.1371/journal.pone.0037865]; Zhang L, 2011, J CLIN IMMUNOL, V31, P606, DOI 10.1007/s10875-011-9540-8; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	53	39	39	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93279	10.1371/journal.pone.0093279	http://dx.doi.org/10.1371/journal.pone.0093279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676270	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677500101
J	Liu, S; An, J; Lin, JH; Liu, YL; Bao, LD; Zhang, W; Zhao, JJ				Liu, Shuang; An, Jie; Lin, Jianhong; Liu, Yanli; Bao, Lidao; Zhang, Wen; Zhao, Jian-Jun			Single Nucleotide Polymorphisms of MicroRNA Processing Machinery Genes and Outcome of Hepatocellular Carcinoma	PLOS ONE			English	Article							NUCLEAR EXPORT; CANCER; EPIDEMIOLOGY; PRECURSORS; CHINA; RISK	MicroRNA (miRNA)-related single nucleotide polymorphisms (miR-SNPs) can affect cancer development, treatment efficacy and patients prognosis. We examined 6 miR-SNPs in miRNA processing machinery genes including exportin 5 (XPO5) (rs11077), Ran-GTPase (RAN) (rs14035), Dicer (rs3742330), Trinucleotide Repeat Containing 6B (TNRC6B) (rs9623117), GEMIN3 (rs197412), GEMIN4 (rs2740348) in 108 surgically resected HCC patients and evaluated the impact of these miR-SNPs on HCC outcome. Among the 6 SNPs, only the A/A genotype of rs11077 located in XPO5 3'UTR was identified to associated independently with worse survival in HCC patients by multivariate analysis with relative risk, 0.395; 95% CI, 0.167-0.933; p = 0.034. This is the first study reporting that polymorphisms related to miRSNPs have prognostic value in hepatocellular carcinoma and identify the A/A genotype of rs11077 SNP site located in XPO5 3'UTR can help to predict worse prognosis in patients.	[Liu, Shuang; An, Jie; Liu, Yanli; Zhang, Wen] Bethune Int Peace Hosp, Dept Pathol, Shijiazhuang, Peoples R China; [Lin, Jianhong; Bao, Lidao; Zhao, Jian-Jun] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Liu, S (corresponding author), Bethune Int Peace Hosp, Dept Pathol, Shijiazhuang, Peoples R China.	Liu_Shuang11@hotmail.com; Jianjun_zhao@dfci.harvard.edu			Bethune International Peace Hospital (BIPH) research grant; SPORE career development award from Dana-Farber Cancer Institute (DFCI); Multiple Myeloma Research Foundation (MMRF) award	Bethune International Peace Hospital (BIPH) research grant; SPORE career development award from Dana-Farber Cancer Institute (DFCI); Multiple Myeloma Research Foundation (MMRF) award	SL is supported by Bethune International Peace Hospital (BIPH) research grant. JL is supported by SPORE career development award from Dana-Farber Cancer Institute (DFCI). JJZ is supported by Multiple Myeloma Research Foundation (MMRF) award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boni V, 2011, PHARMACOGENOMICS J, V11, P429, DOI 10.1038/tpj.2010.58; Caldwell S, 2009, J GASTROENTEROL, V44, P96, DOI 10.1007/s00535-008-2258-6; Campayo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022509; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; de Larrea CF, 2012, CLIN CANCER RES, V18, P3697, DOI 10.1158/1078-0432.CCR-12-0191; Gomaa AI, 2008, WORLD J GASTROENTERO, V14, P4300, DOI 10.3748/wjg.14.4300; Guo ZJ, 2012, INT J CANCER, V131, P1318, DOI 10.1002/ijc.27352; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lu L, 2008, ANN NY ACAD SCI, V1141, P304, DOI 10.1196/annals.1441.025; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Maki A, 2007, ANN SURG ONCOL, V14, P1182, DOI 10.1245/s10434-006-9049-1; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Minagawa M, 2003, ANN SURG, V238, P703, DOI 10.1097/01.sla.0000094549.11754.e6; OKADA S, 1994, GASTROENTEROLOGY, V106, P1618, DOI 10.1016/0016-5085(94)90419-7; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Wang CJ, 2011, BIOCHEM BIOPH RES CO, V406, P493, DOI 10.1016/j.bbrc.2011.02.088; Yao GB, 2000, J MED VIROL, V61, P392, DOI 10.1002/1096-9071(200007)61:3&lt;392::AID-JMV19&gt;3.0.CO;2-V; Ye YQ, 2008, CANCER PREV RES, V1, P460, DOI 10.1158/1940-6207.CAPR-08-0135; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	23	35	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92791	10.1371/journal.pone.0092791	http://dx.doi.org/10.1371/journal.pone.0092791			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676133	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500039
J	Luo, JY; Hu, YC; Kong, WJ; Yang, MH				Luo, Jiaoyang; Hu, Yichen; Kong, Weijun; Yang, Meihua			Evaluation and Structure-Activity Relationship Analysis of a New Series of Arylnaphthalene lignans as Potential Anti-Tumor Agents	PLOS ONE			English	Article							JUSTICIA-PROCUMBENS; TOPOISOMERASE-II; 6'-HYDROXY JUSTICIDIN; ANTIVIRAL ACTIVITY; CANCER; APOPTOSIS; GL331; MITOCHONDRIA; GLYCOSIDES; DIPHYLLIN	Arylnaphthalene lignan lactones have attracted considerable interest because of their anti-tumor and anti-hyperlipidimic activities. However, to our knowledge, few studies have explored the effects of these compounds on human leukemia cell lines. In this study, five arylnaphthalene lignans including 6'-hydroxy justicidin A (HJA), 6'-hydroxy justicidin B (HJB), justicidin B (JB), chinensinaphthol methyl ether (CME) and Taiwanin E methyl ether (TEME) were isolated from Justicia procumbens and their effects on the proliferation and apoptosis of the human leukemia K562 cell line were investigated then used to assess structure-activity relationships. To achieve these aims, cytotoxicity was assayed using the MTT assay, while intracellular SOD activity was detected using the SOD Activity Assay kit. Apoptosis was measured by both the using a cycle TEST PLUS DNA reagent kit as well as the FITC Annexin V apoptosis detection kit in combination with flow cytometry. Activation of caspase-mediated apoptosis was evaluated using a FITC active Caspase-3 apoptosis kit and flow cytometry. The results indicated that HJB, HJA and JB significantly inhibited the growth of K562 cells by decreasing both proliferation and SOD activity and inducing apoptosis. The sequence of anti-proliferative activity induced by the five tested arylnaphthalenes by decreasing strength was HJB > HJA > JB > CME > TEME > HJB, HJA and JB also decreased SOD activity and induced apoptosis in a dose-dependent manner. Activation of caspase-3 further indicated that HJB, HJA and JB induced caspase-dependent intrinsic and/or extrinsic apoptosis pathways. Together, these assays suggest that arylnaphthalene lignans derived from Justicia procumbens induce apoptosis to varying degrees, through a caspase-dependent pathway in human leukemia K562 cells. Furthermore, analysis of structure-activity relationships suggest that hydroxyl substitution at C-1 and C-6' significantly increased the antiproliferative activity of arylnaphthalene lignans while a methoxyl at C-1 significantly decreased the effect.	[Yang, Meihua] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, MH (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.	yangmeihua15@hotmail.com			Beijing Natural Science Foundation of China [7112092]; Program for PUMC Innovative Foundation; Specialized Research Fund for the Doctoral Program of Higher Education [20111106110034]	Beijing Natural Science Foundation of China(Beijing Natural Science Foundation); Program for PUMC Innovative Foundation; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work received financial support from the Beijing Natural Science Foundation of China (7112092), the Program for PUMC Innovative Foundation and Specialized Research Fund for the Doctoral Program of Higher Education (20111106110034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MAGN RESON CHEM, V44, P727; Asano J, 1996, PHYTOCHEMISTRY, V42, P713, DOI 10.1016/0031-9422(96)00024-6; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Barret JM, 2002, ANTICANCER RES, V22, P187; Bechtel W, 2009, ANTICANCER RES, V29, P4559; BRINGMANN G, 1990, ANGEW CHEM INT EDIT, V29, P977, DOI 10.1002/anie.199009771; Charlton JL, 1998, J NAT PROD, V61, P1447, DOI 10.1021/np980136z; Chen CC, 1996, J NAT PROD, V59, P1149, DOI 10.1021/np960443+; Daley L, 1997, TETRAHEDRON LETT, V38, P2673, DOI 10.1016/S0040-4039(97)00450-4; Daley L, 1998, J MED CHEM, V41, P4475, DOI 10.1021/jm9800752; Day SH, 2002, J NAT PROD, V65, P379, DOI 10.1021/np0101651; Deng J.Y., 2009, CHINESE PHARMACOL B, V25, P190; DIGIORGIO C, 2005, PLANTA MED, V71, P366; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Elfahmi, 2006, J NAT PROD, V69, P55, DOI 10.1021/np050288b; FUKAMIYA N, 1986, J NAT PROD, V49, P348, DOI 10.1021/np50044a030; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He XL, 2012, J ETHNOPHARMACOL, V144, P284, DOI 10.1016/j.jep.2012.09.010; Huang TS, 1999, PHARMACEUT RES, V16, P997, DOI 10.1023/A:1018971313256; Huang TS, 2000, APOPTOSIS, V5, P79, DOI 10.1023/A:1009693811093; Ionkova I, 2013, PHARMACOGN MAG, V9, P39, DOI 10.4103/0973-1296.108138; Jiang H, 2007, EUR J PHARMACOL, V559, P98, DOI 10.1016/j.ejphar.2006.12.017; KIMURA M, 1985, PLANTA MED, V51, P291, DOI 10.1055/s-2007-969493; Lee CC, 2001, PHARMACEUT RES, V18, P846, DOI 10.1023/A:1011048831698; Lin SK, 2001, MOL PHARMACOL, V60, P768; Luo ZL, 2013, J SEP SCI, V36, P699, DOI 10.1002/jssc.201200851; MCGAHON A, 1994, BLOOD, V83, P1179, DOI 10.1182/blood.V83.5.1179.bloodjournal8351179; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Potokar M, 2003, FEBS LETT, V544, P153, DOI 10.1016/S0014-5793(03)00494-0; Qiu F, 2012, J PHARMACEUT BIOMED, V70, P539, DOI 10.1016/j.jpba.2012.05.002; Ramesh C, 2003, CHEM PHARM BULL, V51, P1299, DOI 10.1248/cpb.51.1299; Rassmann I, 1999, INVEST NEW DRUG, V16, P319, DOI 10.1023/A:1006293830585; Roth W, 2002, NAT MED, V8, P216, DOI 10.1038/nm0302-216; Su CL, 2006, FEBS LETT, V580, P3185, DOI 10.1016/j.febslet.2006.04.085; Susplugas S, 2005, J NAT PROD, V68, P734, DOI 10.1021/np050028u; Utsugi T, 1996, CANCER RES, V56, P2809; VanVliet DS, 1999, TETRAHEDRON LETT, V40, P2259, DOI 10.1016/S0040-4039(99)00220-8; WANG JZ, 1993, ANTI-CANCER DRUG DES, V8, P193; Wu SJ, 2006, CHEM PHARM BULL, V54, P1223, DOI 10.1248/cpb.54.1223; Yang MH, 2006, MAGN RESON CHEM, V44, P727, DOI 10.1002/mrc.1830; Yang MH, 2006, J PHARMACEUT BIOMED, V41, P662, DOI 10.1016/j.jpba.2005.12.014; Zhang P., 2009, CHINESE PHARMACOL B, V25, P173; Zhang Peng, 2010, Zhongguo Yaolixue Yu Dulixue Zazhi, V24, P207, DOI 10.3867/j.issn.1000-3002.2010.03.009; Zhou SJ, 2012, J CHROMATOGR B, V903, P75, DOI 10.1016/j.jchromb.2012.06.045	46	19	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93516	10.1371/journal.pone.0093516	http://dx.doi.org/10.1371/journal.pone.0093516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675875	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500133
J	Reverchon, M; Rame, C; Cognie, J; Briant, E; Elis, S; Guillaume, D; Dupont, J				Reverchon, Maxime; Rame, Christelle; Cognie, Juliette; Briant, Eric; Elis, Sebastien; Guillaume, Daniel; Dupont, Joelle			Resistin in Dairy Cows: Plasma Concentrations during Early Lactation, Expression and Potential Role in Adipose Tissue	PLOS ONE			English	Article							REGULATE LIPID-METABOLISM; GROWTH-HORMONE RECEPTOR; NEGATIVE-ENERGY BALANCE; HUMAN GRANULOSA-CELLS; GENE-EXPRESSION; MESSENGER-RNA; BOVINE HEPATOCYTES; TRANSITION PERIOD; SIGNALING PATHWAY; INSULIN	Resistin is an adipokine that has been implicated in energy metabolism regulation in rodents but has been little studied in dairy cows. We determined plasma resistin concentrations in early lactation in dairy cows and investigated the levels of resistin mRNA and protein in adipose tissue and the phosphorylation of several components of insulin signaling pathways one week post partum (1 WPP) and at five months of gestation (5 MG). We detected resistin in mature bovine adipocytes and investigated the effect of recombinant bovine resistin on lipolysis in bovine adipose tissue explants. ELISA showed that plasma resistin concentration was low before calving, subsequently increasing and reaching a peak at 1 WPP, decreasing steadily thereafter to reach pre-calving levels at 6 WPP. Plasma resistin concentration was significantly positively correlated with plasma non esterified fatty acid (NEFA) levels and negatively with milk yield, dry matter intake and energy balance between WPP1 to WPP22. We showed, by quantitative RT-PCR and western blotting, that resistin mRNA and protein levels in adipose tissue were higher at WPP1 than at 5 MG. The level of phosphorylation of several early and downstream insulin signaling components (IR beta, IRS-1, IRS-2, Akt, MAPK ERK1/2, P70S6K and S6) in adipose tissue was also lower at 1 WPP than at 5 MG. Finally, we showed that recombinant bovine resistin increased the release of glycerol and mRNA levels for ATGL (adipose triglyceride lipase) and HSL (hormone-sensitive lipase) in adipose tissue explants. Overall, resistin levels were high in the plasma and adipose tissue and were positively correlated with NEFA levels after calving. Resistin is expressed in bovine mature adipocytes and promotes lipid mobilization in adipose explants in vitro.	[Reverchon, Maxime; Rame, Christelle; Cognie, Juliette; Briant, Eric; Elis, Sebastien; Guillaume, Daniel; Dupont, Joelle] INRA, Physiol Reprod & Comportements, UMR 7247, F-37380 Nouzilly, France; [Reverchon, Maxime; Rame, Christelle; Cognie, Juliette; Briant, Eric; Elis, Sebastien; Guillaume, Daniel; Dupont, Joelle] CNRS, Physiol Reprod & Comportements, UMR6175, Nouzilly, France; [Reverchon, Maxime; Rame, Christelle; Cognie, Juliette; Briant, Eric; Elis, Sebastien; Guillaume, Daniel; Dupont, Joelle] Univ Tours, Tours, France; [Reverchon, Maxime; Rame, Christelle; Cognie, Juliette; Briant, Eric; Elis, Sebastien; Guillaume, Daniel; Dupont, Joelle] Inst Francais Cheval, Nouzilly, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Universite de Tours	Dupont, J (corresponding author), INRA, Physiol Reprod & Comportements, UMR 7247, F-37380 Nouzilly, France.	jdupont@tours.fr	Elis, Sebastien/K-6158-2019	Juliette, Cognie/0000-0003-0908-9833; reverchon, maxime/0000-0001-8329-7708	Institut National de la Recherche Agronomique; Region Centre "Adipofertikines proposal''	Institut National de la Recherche Agronomique; Region Centre "Adipofertikines proposal''(Region Centre-Val de Loire)	This work was financially supported by Institut National de la Recherche Agronomique and partly by Region Centre "Adipofertikines proposal''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes KM, 2009, CURR PROTEIN PEPT SC, V10, P96, DOI 10.2174/138920309787315239; Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865; BAUMAN DE, 1980, J DAIRY SCI, V63, P1514, DOI 10.3168/jds.S0022-0302(80)83111-0; Bauman DE, 2000, GROWTH REPROD, V2000, P331; Bell AW, 1997, J MAMMARY GLAND BIOL, V2, P265, DOI 10.1023/A:1026336505343; BELL AW, 1995, J ANIM SCI, V73, P2804, DOI 10.2527/1995.7392804x; Benomar Y, 2013, DIABETES, V62, P102, DOI 10.2337/db12-0237; Block SS, 2001, J ENDOCRINOL, V171, P339, DOI 10.1677/joe.0.1710339; BLUM JW, 1973, J DAIRY SCI, V56, P459, DOI 10.3168/jds.S0022-0302(73)85200-2; Bossaert P, 2008, J DAIRY SCI, V91, P3363, DOI 10.3168/jds.2008-0994; Butler ST, 2003, J ENDOCRINOL, V176, P205, DOI 10.1677/joe.0.1760205; Chen H, 2013, J STEROID BIOCHEM, V138, P445, DOI 10.1016/j.jsbmb.2013.08.013; Coyral-Castel S, 2013, ANIMAL, V7, P610, DOI 10.1017/S1751731112002133; Coyral-Castel S, 2010, DOMEST ANIM ENDOCRIN, V38, P272, DOI 10.1016/j.domaniend.2009.12.002; Delhanty PJD, 2002, ENDOCRINOLOGY, V143, P2445, DOI 10.1210/en.143.6.2445; Derosa G, 2013, INFLAMMATION, V36, P914, DOI 10.1007/s10753-013-9620-4; Dupont J, 2000, J BIOL CHEM, V275, P35893, DOI 10.1074/jbc.M006741200; Dupont J, 2003, RECENT PROG HORM RES, V58, P325, DOI 10.1210/rp.58.1.325; Dupont J, 2001, HORM RES, V55, P22, DOI 10.1159/000063469; Etherton TD, 1998, PHYSIOL REV, V78, P745, DOI 10.1152/physrev.1998.78.3.745; Giesy SL, 2012, ENDOCRINOLOGY, V153, P5834, DOI 10.1210/en.2012-1765; Ingvartsen KL, 2001, DOMEST ANIM ENDOCRIN, V21, P215, DOI 10.1016/S0739-7240(02)00119-4; Jarrige R., 1989, RUMINANT NUTR RECOMM; Kaser S, 2003, BIOCHEM BIOPH RES CO, V309, P286, DOI 10.1016/j.bbrc.2003.07.003; Koltes DA, 2012, DOMEST ANIM ENDOCRIN, V43, P307, DOI 10.1016/j.domaniend.2012.05.004; Koltes DA, 2011, J DAIRY SCI, V94, P1839, DOI 10.3168/jds.2010-3769; Komatsu T, 2003, J ENDOCRINOL, V178, pR1, DOI 10.1677/joe.0.178R001; Lemor A, 2009, DOMEST ANIM ENDOCRIN, V37, P37, DOI 10.1016/j.domaniend.2009.01.004; Li XW, 2013, CELL BIOCHEM BIOPHYS, V67, P1157, DOI 10.1007/s12013-013-9629-1; Lim CT, 2010, J MOL ENDOCRINOL, V44, P87, DOI 10.1677/JME-09-0063; Locher LF, 2012, J DAIRY SCI, V95, P2497, DOI 10.3168/jds.2011-4830; Maillard V, 2011, REPRODUCTION, V141, P467, DOI 10.1530/REP-10-0419; MCNAMARA JP, 1986, J DAIRY SCI, V69, P3042, DOI 10.3168/jds.S0022-0302(86)80767-6; MCNAMARA JP, 1991, J DAIRY SCI, V74, P706, DOI 10.3168/jds.S0022-0302(91)78217-9; Mielenz M, 2013, J DAIRY SCI, V96, P278, DOI 10.3168/jds.2012-5816; Mostowik M, 2013, CARDIOVASC DRUG THER, V27, P289, DOI 10.1007/s10557-013-6457-x; Mukesh M, 2010, DOMEST ANIM ENDOCRIN, V38, P168, DOI 10.1016/j.domaniend.2009.10.001; Nozue H, 2007, METABOLISM, V56, P1514, DOI 10.1016/j.metabol.2007.06.018; Ohtani Y, 2012, ANIM SCI J, V83, P788, DOI 10.1111/j.1740-0929.2012.01029.x; Opsomer G, 1999, ANIM REPROD SCI, V56, P211, DOI 10.1016/S0378-4320(99)00048-2; Ort T, 2005, ENDOCRINOLOGY, V146, P2200, DOI 10.1210/en.2004-1421; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Radcliff RP, 2003, J DAIRY SCI, V86, P3920, DOI 10.3168/jds.S0022-0302(03)74000-4; Reverchon M, 2013, FERTIL STERIL, V100, P247, DOI 10.1016/j.fertnstert.2013.03.008; Reverchon M, 2012, HUM REPROD, V27, P1790, DOI 10.1093/humrep/des089; Rhoads RP, 2004, J NUTR, V134, P1020, DOI 10.1093/jn/134.5.1020; Sadri H, 2010, J ANIM PHYSIOL AN N, V94, pe194, DOI 10.1111/j.1439-0396.2010.01005.x; Sanchez-Solana B, 2012, MOL ENDOCRINOL, V26, P110, DOI 10.1210/me.2011-1027; Saremi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086211; SAS S., 2009, STAT US GUID VERS 9; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; Singh SP, 2014, J DAIRY SCI IN PRESS; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sumner JM, 2007, J DAIRY SCI, V90, P5237, DOI 10.3168/jds.2007-0307; Takahashi H, 2013, J DERMATOL, V40, P475, DOI 10.1111/1346-8138.12122; VAZQUEZANON M, 1994, J DAIRY SCI, V77, P1521, DOI 10.3168/jds.S0022-0302(94)77092-2; Wathes DC, 2013, REPROD FERT DEVELOP, V25, P48, DOI 10.1071/RD12272	57	32	37	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93198	10.1371/journal.pone.0093198	http://dx.doi.org/10.1371/journal.pone.0093198			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675707	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677500087
J	Yasuda, M; Tanaka, Y; Ryu, M; Tsuda, S; Nakazawa, T				Yasuda, Masayuki; Tanaka, Yuji; Ryu, Morin; Tsuda, Satoru; Nakazawa, Toru			RNA Sequence Reveals Mouse Retinal Transcriptome Changes Early after Axonal Injury	PLOS ONE			English	Article							GANGLION-CELL DEATH; OPEN-ANGLE GLAUCOMA; UNFOLDED PROTEIN RESPONSE; NORMAL-TENSION GLAUCOMA; OPTIC-NERVE CRUSH; GENE-EXPRESSION; OXIDATIVE STRESS; KAINIC ACID; RAT RETINA; INDUCED NEUROTOXICITY	Glaucoma is an ocular disease characterized by progressive retinal ganglion cell (RGC) death caused by axonal injury. However, the underlying mechanisms involved in RGC death remain unclear. In this study, we investigated changes in the transcriptome profile following axonal injury in mice (C57BL/6) with RNA sequencing (RNA-seq) technology. The experiment group underwent an optic nerve crush (ONC) procedure to induce axonal injury in the right eye, and the control group underwent a sham procedure. Two days later, we extracted the retinas and performed RNA-seq and a pathway analysis. We identified 177 differentially expressed genes with RNA-seq, notably the endoplasmic reticulum (ER) stress-related genes Atf3, Atf4, Atf5, Chac1, Chop, Egr1 and Trb3, which were significantly upregulated. The pathway analysis revealed that ATF4 was the most significant upstream regulator. The antioxidative response-related genes Hmox1 and Srxn1, as well as the immune response-related genes C1qa, C1qb and C1qc, were also significantly upregulated. To our knowledge, this is the first reported RNA-seq investigation of the retinal transcriptome and molecular pathways in the early stages after axonal injury. Our results indicated that ER stress plays a key role under these conditions. Furthermore, the antioxidative defense and immune responses occurred concurrently in the early stages after axonal injury. We believe that our study will lead to a better understanding of and insight into the molecular mechanisms underlying RGC death after axonal injury.	[Yasuda, Masayuki; Tanaka, Yuji; Ryu, Morin; Tsuda, Satoru; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 980, Japan	Tohoku University	Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 980, Japan.	ntoru@oph.med.tohoku.ac.jp			Ministry of Education, Science and Technology of Japan [24659756, 40625513]; JST Center for Revitalization Promotion; Great East Japan Earthquake Reconstruction Support project of the RIKEN Omics Science Center; RIKEN Genome Analysis Service (GeNAS); Illumina Co.; CLC Bio Co.	Ministry of Education, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST Center for Revitalization Promotion; Great East Japan Earthquake Reconstruction Support project of the RIKEN Omics Science Center; RIKEN Genome Analysis Service (GeNAS); Illumina Co.; CLC Bio Co.	This study was supported in part by Grants-in-Aid from the Ministry of Education, Science and Technology of Japan (24659756 for T.N. and 40625513 for Y.T.) (http://www.mext.go.jp/english/). This study was also supported by JST Center for Revitalization Promotion (http://www.jst.go.jp/fukkou/), All Japan Coffee Association (http://coffee.ajca.or.jp/news/othernews/h26josei), Senju Pharmaceutical Co., Ltd. (http://www.senju.co.jp/) and NIDEK Co., Ltd. (http://www.nidek.co.jp/index-j.html). This study was also supported by the Great East Japan Earthquake Reconstruction Support project of the RIKEN Omics Science Center, the RIKEN Genome Analysis Service (GeNAS), Illumina Co. and CLC Bio Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLCUTT D, 1984, DEV BRAIN RES, V16, P231, DOI 10.1016/0165-3806(84)90028-2; Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Calkins DJ, 2012, PROG RETIN EYE RES, V31, P702, DOI 10.1016/j.preteyeres.2012.07.001; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Chiba N, 2011, CLIN OPHTHALMOL, V5, P1549, DOI 10.2147/OPTH.S22097; Chidlow G, 2005, MOL VIS, V11, P387; Crehan H, 2012, IMMUNOBIOLOGY, V217, P244, DOI 10.1016/j.imbio.2011.07.017; Dabney A., QVALUE Q VALUE ESTIM; De Moraes CGV, 2011, ARCH OPHTHALMOL-CHIC, V129, P562, DOI 10.1001/archophthalmol.2011.72; EHRLICH D, 1987, BRAIN RES, V415, P342, DOI 10.1016/0006-8993(87)90217-4; Fernandes KA, 2013, EXP EYE RES, V112, P106, DOI 10.1016/j.exer.2013.04.021; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Folkersen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007677; Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892; Greenwald JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034804; Gusberti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078457; Harada C, 2010, CELL DEATH DIFFER, V17, P1751, DOI 10.1038/cdd.2010.62; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Himori N, 2013, J NEUROCHEM; Hollands H, 2013, JAMA-J AM MED ASSOC, V309, P2035, DOI 10.1001/jama.2013.5099; Honjo M, 2000, INVEST OPHTH VIS SCI, V41, P552; Hu Y, 2012, NEURON, V73, P445, DOI 10.1016/j.neuron.2011.11.026; Huang TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028768; Kamei S, 2005, INVEST OPHTH VIS SCI, V46, P4288, DOI 10.1167/iovs.03-1407; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim C, 2006, MOL VIS, V12, P1640; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kitaoka Y, 2006, INVEST OPHTH VIS SCI, V47, P1448, DOI 10.1167/iovs.05-0299; Kumar A, 2012, EMBO REP, V13, P1095, DOI 10.1038/embor.2012.156; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lam TT, 1999, INVEST OPHTH VIS SCI, V40, P2391; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Levkovitch-Verbin H, 2000, INVEST OPHTH VIS SCI, V41, P4169; Li Y, 1999, INVEST OPHTH VIS SCI, V40, P1004; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Liu Y, 2012, FREE RADICAL BIO MED, V52, P909, DOI 10.1016/j.freeradbiomed.2011.12.013; Logue SE, 2013, APOPTOSIS, V18, P537, DOI 10.1007/s10495-013-0818-6; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Nakazawa T, 2008, J NEUROSCI RES, V86, P136, DOI 10.1002/jnr.21472; Nakazawa T, 2007, J NEUROCHEM, V100, P1018, DOI 10.1111/j.1471-4159.2006.04274.x; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Prat-Vidal C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054785; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; Rowley JW, 2013, BLOOD, V121, P5255, DOI 10.1182/blood-2013-03-487991; Ryu M, 2012, J NEUROSCI RES, V90, P802, DOI 10.1002/jnr.22800; Saili KS, 2013, REPROD TOXICOL, V38, P89, DOI 10.1016/j.reprotox.2013.03.009; Seki T, 2006, ANN NY ACAD SCI, V1070, P531, DOI 10.1196/annals.1317.074; Shanab AY, 2012, NEUROBIOL DIS, V48, P556, DOI 10.1016/j.nbd.2012.07.025; SILIPRANDI R, 1992, VISUAL NEUROSCI, V8, P567, DOI 10.1017/S0952523800005666; Singh A, 2009, FREE RADICAL BIO MED, V46, P376, DOI 10.1016/j.freeradbiomed.2008.10.026; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tanaka H, 2004, NEUROSCIENCE, V127, P155, DOI 10.1016/j.neuroscience.2004.05.010; Team RC, 2013, R LANGUAGE ENV STAT; Templeton JP, 2013, INVEST OPHTH VIS SCI, V54, P2599, DOI 10.1167/iovs.12-11175; Tong M, 2012, CANCER RES, V72, P6024, DOI 10.1158/0008-5472.CAN-12-1269; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Warnes GR, 2013, GPLOTS VARIOUS R PRO; Watkins TA, 2013, P NATL ACAD SCI USA, V110, P4039, DOI 10.1073/pnas.1211074110; Weinreb RN, 2004, AM J OPHTHALMOL, V138, P458, DOI 10.1016/j.ajo.2004.04.054; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	78	57	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93258	10.1371/journal.pone.0093258	http://dx.doi.org/10.1371/journal.pone.0093258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676137	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500099
J	Gates, MC; Woolhouse, MEJ				Gates, M. Carolyn; Woolhouse, Mark E. J.			Suboptimal Herd Performance Amplifies the Spread of Infectious Disease in the Cattle Industry	PLOS ONE			English	Article							VIRAL DIARRHEA VIRUS; LEVEL RISK-FACTORS; DAIRY HERDS; REPRODUCTIVE-PERFORMANCE; BOVINE TUBERCULOSIS; CALVING INTERVAL; REPLACEMENT POLICIES; LIVESTOCK MOVEMENTS; BREEDING OBJECTIVES; NETWORK ANALYSIS	Farms that purchase replacement breeding cattle are at increased risk of introducing many economically important diseases. The objectives of this analysis were to determine whether the total number of replacement breeding cattle purchased by individual farms could be reduced by improving herd performance and to quantify the effects of such reductions on the industry-level transmission dynamics of infectious cattle diseases. Detailed information on the performance and contact patterns of British cattle herds was extracted from the national cattle movement database as a case example. Approximately 69% of beef herds and 59% of dairy herds with an average of at least 20 recorded calvings per year purchased at least one replacement breeding animal. Results from zero-inflated negative binomial regression models revealed that herds with high average ages at first calving, prolonged calving intervals, abnormally high or low culling rates, and high calf mortality rates were generally more likely to be open herds and to purchase greater numbers of replacement breeding cattle. If all herds achieved the same level of performance as the top 20% of herds, the total number of replacement beef and dairy cattle purchased could be reduced by an estimated 34% and 51%, respectively. Although these purchases accounted for only 13% of between-herd contacts in the industry trade network, they were found to have a disproportionately strong influence on disease transmission dynamics. These findings suggest that targeting extension services at herds with suboptimal performance may be an effective strategy for controlling endemic cattle diseases while simultaneously improving industry productivity.	[Gates, M. Carolyn; Woolhouse, Mark E. J.] Univ Edinburgh, Ctr Immun Infect & Evolut, Sch Biol Sci, Epidemiol Grp,Ashworth Labs, Edinburgh, Midlothian, Scotland	University of Edinburgh	Gates, MC (corresponding author), Univ Edinburgh, Ctr Immun Infect & Evolut, Sch Biol Sci, Epidemiol Grp,Ashworth Labs, Edinburgh, Midlothian, Scotland.	CarolynGatesVMD@gmail.com		Woolhouse, Mark/0000-0003-3765-8167; Gates, M Carolyn/0000-0002-7790-1945	Scottish Government; Principal's Career Development Scholarship; Scottish Overseas Research Student Award Scheme through the University of Edinburgh	Scottish Government; Principal's Career Development Scholarship; Scottish Overseas Research Student Award Scheme through the University of Edinburgh	This work was undertaken through the Centre of Expertise on Animal Disease Outbreaks (EPIC) supported by the Scottish Government and has made use of the resources provided by the Edinburgh Compute and Data Facility (ECDF). MCG was supported by the Principal's Career Development Scholarship and Scottish Overseas Research Student Award Scheme through the University of Edinburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadland D, 2004, J ECON DYN CONTROL, V28, P1977, DOI 10.1016/j.jedc.2003.08.003; Abernethy DA, 2013, VET REC, V172, DOI 10.1136/vr.100969; Alvarez LG, 2011, EPIDEMIOL INFECT, V139, P1863, DOI 10.1017/S0950268811000070; Amer PR, 2001, LIVEST PROD SCI, V67, P223, DOI 10.1016/S0301-6226(00)00201-3; [Anonymous], 2010, R LANG ENV STAT COMP; Arbel R, 2001, J DAIRY SCI, V84, P600, DOI 10.3168/jds.S0022-0302(01)74513-4; Aznar MN, 2011, PREV VET MED, V98, P119, DOI 10.1016/j.prevetmed.2010.11.004; Baptista Filipa Matos, 2007, Vet Ital, V43, P611; Bascom SS, 1998, J DAIRY SCI, V81, P2299, DOI 10.3168/jds.S0022-0302(98)75810-2; Berry DP, 2009, LIVEST SCI, V123, P44, DOI 10.1016/j.livsci.2008.10.005; Bigras-Poulin M, 2006, PREV VET MED, V76, P11, DOI 10.1016/j.prevetmed.2006.04.004; Borman JM, 2004, AUST J EXP AGR, V44, P507, DOI 10.1071/EA02217; BOURDON RM, 1983, J ANIM SCI, V57, P1412, DOI 10.2527/jas1983.5761412x; Brickell JS, 2009, ANIMAL, V3, P1175, DOI 10.1017/S175173110900456X; BRITT JH, 1985, J DAIRY SCI, V68, P1585, DOI 10.3168/jds.S0022-0302(85)80997-8; Brooks-Pollock E, 2009, PREV VET MED, V92, P360, DOI 10.1016/j.prevetmed.2009.08.022; Carslake D, 2011, PHILOS T R SOC B, V366, P1975, DOI 10.1098/rstb.2010.0396; Dal Zotto R, 2009, J ANIM SCI, V87, P3053, DOI 10.2527/jas.2008-1620; Department for Environment Food and Rural Affairs, 2010, BOV SPONG ENC CHRON; Ersboll A., 2003, ACTA VET SCAND, V44, P49, DOI [10.1186/1751-0147-44-S1-P49, DOI 10.1186/1751-0147-44-S1-P49]; Ettema JF, 2004, J DAIRY SCI, V87, P2730, DOI 10.3168/jds.S0022-0302(04)73400-1; Ezanno P, 2006, ANIM RES, V55, P189, DOI 10.1051/animres:2006013; Ezanno P, 2008, VET RES, V39, DOI 10.1051/vetres:2008016; Funston RN, 2004, J ANIM SCI, V82, P3094; GARTNER JA, 1981, AGR SYST, V7, P289, DOI 10.1016/0308-521X(81)90040-8; Gates MC, 2013, VET J, V198, P631, DOI 10.1016/j.tvjl.2013.09.017; Gates MC, 2013, VET REC, V173, P499, DOI 10.1136/vr.101488; Gilbert M, 2005, NATURE, V435, P491, DOI 10.1038/nature03548; Green DM, 2007, VET REC, V161, P439, DOI 10.1136/vr.161.13.439; Groenendaal H, 2004, J DAIRY SCI, V87, P2146, DOI 10.3168/jds.S0022-0302(04)70034-X; Grohn YT, 2000, ANIM REPROD SCI, V60, P605, DOI 10.1016/S0378-4320(00)00085-3; Hadley GL, 2006, J DAIRY SCI, V89, P2286, DOI 10.3168/jds.S0022-0302(06)72300-1; Haworth GM, 2008, VET REC, V162, P643, DOI 10.1136/vr.162.20.643; Heikkila AM, 2008, J DAIRY SCI, V91, P2342, DOI 10.3168/jds.2007-0736; Hickson RE, 2010, ANIM PROD SCI, V50, P354, DOI 10.1071/AN09180; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; KORVER S, 1979, LIVEST PROD SCI, V6, P29, DOI 10.1016/0301-6226(79)90029-0; Le Cozler Y, 2008, ANIMAL, V2, P1393, DOI 10.1017/S1751731108002498; Lombard JE, 2007, J DAIRY SCI, V90, P1751, DOI 10.3168/jds.2006-295; MacGregor RG, 1999, LIVEST PROD SCI, V57, P181, DOI 10.1016/S0301-6226(98)00158-4; Madders B, 2006, REV LIVESTOCK MOVEME, P36; Mitchell A, 2005, ANIM SCI, V80, P265, DOI 10.1079/ASC50020265; Natale F, 2011, PREV VET MED, V98, P111, DOI 10.1016/j.prevetmed.2010.11.013; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Ortiz-Pelaez A, 2008, VET J, V176, P177, DOI 10.1016/j.tvjl.2007.02.006; Raboisson D, 2013, J DAIRY SCI, V96, P2913, DOI 10.3168/jds.2012-6010; Rautureau S, 2012, ANIMAL, V6, P1152, DOI 10.1017/S1751731111002631; Rautureau S, 2011, TRANSBOUND EMERG DIS, V58, P110, DOI 10.1111/j.1865-1682.2010.01187.x; Robinson SE, 2007, PREV VET MED, V81, P21, DOI 10.1016/j.prevetmed.2007.04.011; Robinson SE, 2007, J R SOC INTERFACE, V4, P669, DOI 10.1098/rsif.2007.0214; Robinson Susan E, 2006, BMC Vet Res, V2, P11, DOI 10.1186/1746-6148-2-11; Roughsedge T, 2003, ANIM SCI, V77, P403, DOI 10.1017/S1357729800054357; Rufenacht J, 2001, THERIOGENOLOGY, V56, P199, DOI 10.1016/S0093-691X(01)00556-8; Stahl K, 2008, PREV VET MED, V83, P285, DOI 10.1016/j.prevetmed.2007.08.005; Svensson C, 2003, PREV VET MED, V58, P179, DOI 10.1016/S0167-5877(03)00046-1; Thomsen PT, 2006, VET REC, V158, P622, DOI 10.1136/vr.158.18.622; Tinsley M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-11; Tiwari A, 2005, VET MICROBIOL, V109, P147, DOI 10.1016/j.vetmic.2005.05.011; Valle PS, 2001, PREV VET MED, V51, P17, DOI 10.1016/S0167-5877(01)00204-5; van Schaik G, 1998, PREV VET MED, V34, P125, DOI 10.1016/S0167-5877(97)00085-8; VANARENDONK JAM, 1985, LIVEST PROD SCI, V13, P101, DOI 10.1016/0301-6226(85)90014-4; Vargas B, 2001, LIVEST PROD SCI, V69, P17, DOI 10.1016/S0301-6226(00)00250-5; Veerkamp RF, 2002, LIVEST PROD SCI, V76, P137, DOI 10.1016/S0301-6226(02)00006-4; Vernon MC, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-31; Vernon MC, 2009, P ROY SOC B-BIOL SCI, V276, P469, DOI 10.1098/rspb.2008.1009; Volkova VV, 2010, EPIDEMICS-NETH, V2, P116, DOI 10.1016/j.epidem.2010.05.004; Wathes DC, 2008, ANIMAL, V2, P1135, DOI 10.1017/S1751731108002322; Woodbine KA, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-5; Woodbine KA, 2009, PREV VET MED, V89, P102, DOI 10.1016/j.prevetmed.2009.02.005; Youngquist R S., 1997, CURRENT THERAPY LARG, V2nd	71	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93410	10.1371/journal.pone.0093410	http://dx.doi.org/10.1371/journal.pone.0093410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671129	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000141
J	Szygula, Z; Lubkowska, A; Giemza, C; Skrzek, A; Bryczkowska, I; Dolegowska, B				Szygula, Zbigniew; Lubkowska, Anna; Giemza, Czeslaw; Skrzek, Anna; Bryczkowska, Iwona; Dolegowska, Barbara			Hematological Parameters, and Hematopoietic Growth Factors: Epo and IL-3 in Response to Whole-Body Cryostimulation (WBC) in Military Academy Students	PLOS ONE			English	Article							COLD EXPOSURES; ERYTHROPOIETIN; CRYOTHERAPY; HEALTHY; BLOOD; MEN; INTERLEUKIN-3; CYTOKINES; CAPACITY; SESSIONS	The effects of extreme cold on the human body are not fully understood, there are also no reports on the effect of cryogenic temperatures on the levels of erythropoietin (EPO) and interleukin 3 (IL-3), two important factors that regulate hematopoiesis. Aim: determination of changes in peripheral blood cell counts and EPO and IL-3 levels induced by a series of 10, 20 and 30 standard whole-body cryostimulation (WBC) treatments. The study involved 45 men, experimental group (EXp<n = 30) subjected to 30 WBC treatments (-130 degrees C, treatment duration: 3 minutes) and a control group (CON, n = 15). Blood samples were collected before the series of treatments and after 10, 20 and 30 treatments. After 10 and 20 treatments we observed lower red blood cell counts and hematocrit and hemoglobin levels compared to baseline (p<0.05) and the control group (p<0.05). Additionally we observed an increase in hemoglobin concentration in plasma (p<0.05), and bilirubin after 10 and 20 treatments, and a decrease in plasma concentration of haptoglobin after 10, 20 and 30 treatments (p<0.05). The number of leukocytes was higher after 10 and 20 WBC treatments compared to baseline and the CON group. EPO concentration in plasma was elevated and the concentration of IL-3 was lower after 10, 20 and 30 WBC treatments. The decrease in indices of the erythrocytic system, plasma hemoglobin and bilirubin, with a simultaneous decrease in haptoglobin concentrations after 10 and 20 WBC treatments, may be due to increased intravascular hemolysis. At the same time there was a small, but statistically significant increase in the concentration of EPO stimulated erythropoiesis which could facilitate a return of erythrocytic system indices to initial levels after 30 WBC treatments. Changes in the white blood cell system showed transient mobilization of this system under the influence of WBC.	[Szygula, Zbigniew] Univ Sch Phys Educ, Inst Human Physiol, Krakow, Poland; [Lubkowska, Anna; Bryczkowska, Iwona] Pomeranian Med Univ, Fac Hlth Sci, Dept Funct Diagnost & Phys Med, Szczecin, Poland; [Lubkowska, Anna] Univ Szczecin, Fac Nat Sci, Dept Physiol, PL-70453 Szczecin, Poland; [Giemza, Czeslaw; Skrzek, Anna] Univ Sch Phys Educ Wroclaw, Fac Physiotherapy, Wroclaw, Poland; [Dolegowska, Barbara] Pomeranian Med Univ, Dept Lab Diagnost & Mol Med, Szczecin, Poland	Pomeranian Medical University; University of Szczecin; Pomeranian Medical University	Lubkowska, A (corresponding author), Pomeranian Med Univ, Fac Hlth Sci, Dept Funct Diagnost & Phys Med, Szczecin, Poland.	annalubkowska@gmail.com	Bryczkowska, Iwona/A-4607-2015; Lubkowska, Anna/A-4623-2015; Dolegowska, Barbara/O-4851-2014	Lubkowska, Anna/0000-0002-5378-5409; Dolegowska, Barbara/0000-0003-3138-1013; Szygula, Zbigniew/0000-0002-6685-6579; Skrzek, Anna/0000-0003-1533-0291	National Science Centre [N N404 312940]	National Science Centre(National Science Centre, Poland)	This paper was supported by the National Science Centre No: N N404 312940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banffi G, 2008, BRIT J SPORT MED, V42, P858; Banfi G, 2009, J HUM SPORT EXERC, V4, P189, DOI 10.4100/jhse.2009.42.11; Banfi G, 2010, SPORTS MED, V40, P509, DOI 10.2165/11531940-000000000-00000; Banfi G, 2009, J THERM BIOL, V34, P55, DOI 10.1016/j.jtherbio.2008.10.003; BAUER J, 1999, MEDYCYNA SPORTOWA, V15, P3; Brizzi MF, 2001, CIRCULATION, V103, P549, DOI 10.1161/01.CIR.103.4.549; Broxmeyer HE, 2013, J EXP MED, V210, P205, DOI 10.1084/jem.20122760; Chapman RF, 1998, J APPL PHYSIOL, V85, P1448, DOI 10.1152/jappl.1998.85.4.1448; Eder M, 1997, STEM CELLS, V15, P327, DOI 10.1002/stem.150327; Elfar JC, 2008, J BONE JOINT SURG AM, V90A, P1644, DOI 10.2106/JBJS.G.00557; Feng QP, 2006, CARDIOVASC RES, V71, P615, DOI 10.1016/j.cardiores.2006.07.001; Hausswirth C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072658; Hausswirth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027749; Jansky L, 1996, EUR J APPL PHYSIOL O, V72, P445, DOI 10.1007/BF00242274; JELKMANN W, 1994, CLIN INVESTIGATOR, V72, pS3; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Jelkmann W., 2007, MED SPORTIVA, V11, P32, DOI DOI 10.2478/V10036-007-0007-1; Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x; Jurk K, 2005, SEMIN THROMB HEMOST, V31, P381, DOI 10.1055/s-2005-916671; Klimek AT, 2010, INT J OCCUP MED ENV, V23, P181, DOI 10.2478/v10001-010-0019-2; Krasuski Marek, 2005, Ortop Traumatol Rehabil, V7, P60; Leppaluoto J, 2008, SCAND J CLIN LAB INV, V68, P145, DOI 10.1080/00365510701516350; Lombardi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055803; Lotem J, 2002, ONCOGENE, V21, P3284, DOI 10.1038/sj.onc.1205319; Lubkowska A, 2009, SCAND J CLIN LAB INV, V69, P387, DOI 10.1080/00365510802699246; Lubkowska A., 2012, PHYS THERAPY PERSPEC; Lubkowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046352; Lubkowska A, 2011, SCAND J CLIN LAB INV, V71, P419, DOI 10.3109/00365513.2011.580859; Lubkowska A, 2010, INT J OCCUP MED ENV, V23, P367, DOI 10.2478/v10001-010-0037-0; Lubkowska A, 2010, CRYOBIOLOGY, V61, P22, DOI 10.1016/j.cryobiol.2010.03.010; Lubkowska A, 2010, EUR J APPL PHYSIOL, V109, P67, DOI 10.1007/s00421-009-1207-2; Lubkowska A, 2008, J THERM BIOL, V33, P464, DOI 10.1016/j.jtherbio.2008.08.003; Maiese K, 2005, JAMA-J AM MED ASSOC, V293, P90, DOI 10.1001/jama.293.1.90; Mangi MH, 1999, CYTOKINES CELL MOL T, V5, P87; Nadler Scott F, 2004, Pain Physician, V7, P395; Pournot H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022748; Semple J. W., 2012, ISBT SCI SER, V7, P269; SMITH JA, 1995, EUR J APPL PHYSIOL O, V70, P427, DOI 10.1007/BF00618494; Smolander J, 2009, CRYOBIOLOGY, V58, P275, DOI 10.1016/j.cryobiol.2009.02.001; Stanek A., 2006, ACTA BIOOPTICA INFOR, V12, P207; Straburzynska-Lupa A., 2007, FIZJOTERAPIA POL POL, V7, P15; Szygula Z, 2013, P 18 ANN C EUR COLL; Trivedi S, 2012, J VACCINES VACCIN, V3, P166, DOI DOI 10.4172/2157-7560.1000166; YAUMAUCHI T, 1981, PHYSIOTHER REHABIL, V5, P35; Ziemann E, 2012, J ATHL TRAINING, V47, P664, DOI 10.4085/1062-6050-47.6.13	45	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93096	10.1371/journal.pone.0093096	http://dx.doi.org/10.1371/journal.pone.0093096			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695100	Green Submitted, Green Published, gold			2022-12-27	WOS:000334103000039
J	Brakel, J; Werner, FJ; Tams, V; Reusch, TBH; Bockelmann, AC				Brakel, Janina; Werner, Franziska Julie; Tams, Verena; Reusch, Thorsten B. H.; Bockelmann, Anna-Christina			Current European Labyrinthula zosterae Are Not Virulent and Modulate Seagrass (Zostera marina) Defense Gene Expression	PLOS ONE			English	Article							EELGRASS WASTING DISEASE; CELL-DEATH; PHENOLIC-COMPOUNDS; TALL FESCUE; ENDOPHYTE; STRESS; INFECTION; IMMUNITY; POPULATIONS; RECURRENCE	Pro- and eukaryotic microbes associated with multi-cellular organisms are receiving increasing attention as a driving factor in ecosystems. Endophytes in plants can change host performance by altering nutrient uptake, secondary metabolite production or defense mechanisms. Recent studies detected widespread prevalence of Labyrinthula zosterae in European Zostera marina meadows, a protist that allegedly caused a massive amphi-Atlantic seagrass die-off event in the 1930's, while showing only limited virulence today. As a limiting factor for pathogenicity, we investigated genotypexgenotype interactions of host and pathogen from different regions (10-100 km-scale) through reciprocal infection. Although the endophyte rapidly infected Z. marina, we found little evidence that Z. marina was negatively impacted by L. zosterae. Instead Z. marina showed enhanced leaf growth and kept endophyte abundance low. Moreover, we found almost no interaction of protistxeelgrass-origin on different parameters of L. zosterae virulence/Z. marina performance, and also no increase in mortality after experimental infection. In a target gene approach, we identified a significant down-regulation in the expression of 6/11 genes from the defense cascade of Z. marina after real-time quantitative PCR, revealing strong immune modulation of the host's defense by a potential parasite for the first time in a marine plant. Nevertheless, one gene involved in phenol synthesis was strongly up-regulated, indicating that Z. marina plants were probably able to control the level of infection. There was no change in expression in a general stress indicator gene (HSP70). Mean L. zosterae abundances decreased below 10% after 16 days of experimental runtime. We conclude the under non-stress conditions L. zosterae infection in the study region is not associated with substantial virulence.	[Brakel, Janina; Werner, Franziska Julie; Bockelmann, Anna-Christina] Geomar Helmholtz Ctr Ocean Res Kiel, Expt Ecol Food webs, Kiel, Germany; [Tams, Verena; Reusch, Thorsten B. H.] Geomar Helmholtz Ctr Ocean Res Kiel, Evolutionary Ecol Marine Fishes, Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Bockelmann, AC (corresponding author), Geomar Helmholtz Ctr Ocean Res Kiel, Expt Ecol Food webs, Kiel, Germany.	abockelmann@geomar.de	Reusch, Thorsten B. H./B-9311-2019; Reusch, Thorsten B.H./G-4141-2011	Reusch, Thorsten B. H./0000-0002-8961-4337; Tams, Verena/0000-0002-9539-2603	State Agency for Agriculture, Environment and Rural Areas for Schleswig-Holstein(LLUR); excellence cluster "The Future Ocean"; Claussen-Simon-Foundation	State Agency for Agriculture, Environment and Rural Areas for Schleswig-Holstein(LLUR); excellence cluster "The Future Ocean"; Claussen-Simon-Foundation	The State Agency for Agriculture, Environment and Rural Areas for Schleswig-Holstein(LLUR) (http://www.schleswig-holstein.de/LLUR/EN/LLUR_node.html) and the excellence cluster "The Future Ocean" (http://www.futureocean.org/en/index.php) have funded the research project. The Claussen-Simon-Foundation provided funding for AC Bockelmann (http://www.claussen-simon-stiftung.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; ARACHEVALETA M, 1989, AGRON J, V81, P83, DOI 10.2134/agronj1989.00021962008100010015x; Arnold TM, 2002, J CHEM ECOL, V28, P1919, DOI 10.1023/A:1020737609151; Belesky DP, 1996, ANN BOT-LONDON, V78, P499, DOI 10.1006/anbo.1996.0147; Bergmann N, 2010, MOL ECOL, V19, P2870, DOI 10.1111/j.1365-294X.2010.04731.x; Bockelmann AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062169; Bockelmann AC, 2012, MAR ECOL PROG SER, V445, P109, DOI 10.3354/meps09398; BUCHSBAUM RN, 1990, AQUAT BOT, V37, P291, DOI 10.1016/0304-3770(90)90075-V; BUSH LP, 1993, AGR ECOSYST ENVIRON, V44, P81, DOI 10.1016/0167-8809(93)90040-V; CHRISTIANSEN C, 1981, SEDIMENT GEOL, V28, P163, DOI 10.1016/0037-0738(81)90063-4; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; da Cunha L, 2006, MICROBES INFECT, V8, P1372, DOI 10.1016/j.micinf.2005.12.018; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; DENHARTOG C, 1987, AQUAT BOT, V27, P3, DOI 10.1016/0304-3770(87)90082-9; DenHartog C, 1970, SEA GRASSES WORLD; Duarte CM, 1999, AQUAT BOT, V65, P159, DOI 10.1016/S0304-3770(99)00038-8; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Faeth SH, 2002, OIKOS, V98, P25, DOI 10.1034/j.1600-0706.2002.980103.x; Gachon CMM, 2010, TRENDS PLANT SCI, V15, P633, DOI 10.1016/j.tplants.2010.08.005; Garrett KA, 2006, ANNU REV PHYTOPATHOL, V44, P489, DOI 10.1146/annurev.phyto.44.070505.143420; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; HARRISON PG, 1982, MAR BIOL, V67, P225, DOI 10.1007/BF00401288; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; Hofius D, 2007, SEMIN CANCER BIOL, V17, P166, DOI 10.1016/j.semcancer.2006.12.001; Jacobs S, 2013, ROOT BASED INNATE IM, P223; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Malinowski DP, 1998, PLANT SOIL, V205, P1, DOI 10.1023/A:1004331932018; Malinowski DP, 2000, CROP SCI, V40, P923, DOI 10.2135/cropsci2000.404923x; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; McKone KL, 2009, MAR ECOL PROG SER, V377, P123, DOI 10.3354/meps07860; MUEHLSTEIN LK, 1988, MAR BIOL, V99, P465, DOI 10.1007/BF00392553; MUEHLSTEIN LK, 1989, DIS AQUAT ORGAN, V7, P211, DOI 10.3354/dao007211; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Popay AJ, 2005, NEOTYPHODIUM IN COOL-SEASON GRASSES, P163, DOI 10.1002/9780470384916.ch7; Prestidge R., 1982, P 35 NZ WEED PEST CO, V35, P119; QUACKENBUSH RC, 1986, AQUAT BOT, V24, P83, DOI 10.1016/0304-3770(86)90119-1; Renn CE, 1936, BIOL BULL-US, V70, P148, DOI 10.2307/1537320; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Robb J, 2007, PLANTA, V226, P299, DOI 10.1007/s00425-007-0482-6; Romero J, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P227; Schlink K, 2010, FUNCT INTEGR GENOMIC, V10, P253, DOI 10.1007/s10142-009-0143-x; Shiraishi T, 1997, INT REV CYTOL, V172, P55, DOI 10.1016/S0074-7696(08)62358-X; SHORT FT, 1986, MAR ECOL PROG SER, V29, P89, DOI 10.3354/meps029089; SHORT FT, 1988, AQUAT BOT, V30, P295, DOI 10.1016/0304-3770(88)90062-9; SHORT FT, 1987, BIOL BULL, V173, P557, DOI 10.2307/1541701; SIEGEL MR, 1990, J CHEM ECOL, V16, P3301, DOI 10.1007/BF00982100; Smith D. M., 2005, INTRO R NOTES R PROG; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Steele L, 2005, MAR ECOL PROG SER, V303, P123, DOI 10.3354/meps303123; Tanaka A, 2012, CURR OPIN PLANT BIOL, V15, P462, DOI 10.1016/j.pbi.2012.03.007; TODD JS, 1993, PHYTOCHEMISTRY, V34, P401, DOI 10.1016/0031-9422(93)80017-M; Tomas F, 2011, ECOLOGY, V92, P1807, DOI 10.1890/10-2095.1; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Van der Veen TT, 1999, WILDFOWL WETLAND TRU, V50, P57; van Katwijk MM, 2010, BIOL CONSERV, V143, P248, DOI 10.1016/j.biocon.2009.08.014; VERGEER LHT, 1995, AQUAT BOT, V52, P35, DOI 10.1016/0304-3770(95)00480-N; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; WATERMAN PG, 1984, J CHEM ECOL, V10, P387, DOI 10.1007/BF00988087; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Winters G, 2011, MAR ECOL PROG SER, V435, P83, DOI 10.3354/meps09213; Wissler L, 2009, DR ZOMPO ONLINE DATA, DOI 010.1093/database/bap1009; Wohlenberg E, 1935, BEITRAGE HEIMATFORSC, V11, P1; Wooldridge SA, 2010, BIOESSAYS, V32, P615, DOI 10.1002/bies.200900182	70	27	27	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92448	10.1371/journal.pone.0092448	http://dx.doi.org/10.1371/journal.pone.0092448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691450	Green Published, gold, Green Accepted			2022-12-27	WOS:000334101100025
J	Fancello, L; Monteil, S; Popgeorgiev, N; Rivet, R; Gouriet, F; Fournier, PE; Raoult, D; Desnues, C				Fancello, Laura; Monteil, Sonia; Popgeorgiev, Nikolay; Rivet, Romain; Gouriet, Frederique; Fournier, Pierre-Edouard; Raoult, Didier; Desnues, Christelle			Viral Communities Associated with Human Pericardial Fluids in Idiopathic Pericarditis	PLOS ONE			English	Article							TT VIRUS-INFECTION; SEQUENCE HETEROGENEITY; ETIOLOGIC DIAGNOSIS; MONOZYGOTIC TWINS; COMPLETE GENOME; DNA; HEPATITIS; GENES	Pericarditis is a common human disease defined by inflammation of the pericardium. Currently, 40% to 85% of pericarditis cases have no identified etiology. Most of these cases are thought to be caused by an infection of undetected, unsuspected or unknown viruses. In this work, we used a culture-and sequence-independent approach to investigate the viral DNA communities present in human pericardial fluids. Seven viral metagenomes were generated from the pericardial fluid of patients affected by pericarditis of unknown etiology and one metagenome was generated from the pericardial fluid of a sudden infant death case. As a positive control we generated one metagenome from the pericardial fluid of a patient affected by pericarditis caused by herpesvirus type 3. Furthermore, we used as negative controls a total of 6 pericardial fluids from 6 different individuals affected by pericarditis of non-infectious origin: 5 of them were sequenced as a unique pool and the remaining one was sequenced separately. The results showed a significant presence of torque teno viruses especially in one patient, while herpesviruses and papillomaviruses were present in the positive control. Co-infections by different genotypes of the same viral type (torque teno viruses) or different viruses (herpesviruses and papillomaviruses) were observed. Sequences related to bacteriophages infecting Staphylococcus, Enterobacteria, Streptococcus, Burkholderia and Pseudomonas were also detected in three patients. This study detected torque teno viruses and papillomaviruses, for the first time, in human pericardial fluids.	[Fancello, Laura; Monteil, Sonia; Popgeorgiev, Nikolay; Rivet, Romain; Gouriet, Frederique; Fournier, Pierre-Edouard; Raoult, Didier; Desnues, Christelle] Aix Marseille Univ, URMITE, CNRS, Unite Rech Maladies Infect & Trop Emergentes,UMR, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Desnues, C (corresponding author), Aix Marseille Univ, URMITE, CNRS, Unite Rech Maladies Infect & Trop Emergentes,UMR, Marseille, France.	christelle.desnues@univ-amu.fr	Desnues, Christelle/B-1383-2010; Fournier, Pierre-Edouard/AAC-6155-2021; RAOULT, Didier/A-8434-2008; Desnues, Christelle/ABG-2910-2021; Fancello, Laura/K-2218-2013	Desnues, Christelle/0000-0002-2178-0355; Fournier, Pierre-Edouard/0000-0001-8463-8885; RAOULT, Didier/0000-0002-0633-5974; Desnues, Christelle/0000-0002-2178-0355; Popgeorgiev, Nikolay/0000-0002-4835-5201; Fancello, Laura/0000-0003-4708-4080; RIVET, Romain/0000-0002-7290-6069	European Research Council [242729]	European Research Council(European Research Council (ERC)European Commission)	The research of LF and CD is financed through a starting grant number 242729 from the European Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1999, J CLIN MICROBIOL, V37, P2703, DOI 10.1128/JCM.37.8.2703-2705.1999; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; Balding C, 2005, ENVIRON MICROBIOL, V7, P1558, DOI 10.1111/j.1462-2920.2005.00845.x; Ball JK, 1999, J GEN VIROL, V80, P1759, DOI 10.1099/0022-1317-80-7-1759; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Biagini P, 1999, J GEN VIROL, V80, P419, DOI 10.1099/0022-1317-80-2-419; Delius H, 1994, Curr Top Microbiol Immunol, V186, P13; Delius H, 1998, VIROLOGY, V240, P359, DOI 10.1006/viro.1997.8943; dHerelle f, 1922, BACTERIOPHAGE ITS RO; Dwivedi B, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-37; FAVRE M, 1989, J VIROL, V63, P4910, DOI 10.1128/JVI.63.11.4910-.1989; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Fournier PE, 2010, CLIN INFECT DIS, V51, P131, DOI 10.1086/653675; Gaidelyte A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001145; Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82; Hallett RL, 2000, J GEN VIROL, V81, P2273, DOI 10.1099/0022-1317-81-9-2273; Holler F, 2001, BIOCHEM BIOPH RES CO, V289, P937, DOI 10.1006/bbrc.2001.6089; Hsieh SY, 1999, J CLIN MICROBIOL, V37, P1829, DOI 10.1128/JCM.37.6.1829-1831.1999; Imazio M, 2010, INT J CLIN PRACT, V64, P1384, DOI 10.1111/j.1742-1241.2009.02178.x; Irving WL, 1999, J INFECT DIS, V180, P27, DOI 10.1086/314825; Kao KL, 2010, PEDIATR CARDIOL, V31, P703, DOI 10.1007/s00246-009-9637-5; Khudyakov YE, 2000, J VIROL, V74, P2990, DOI 10.1128/JVI.74.7.2990-3000.2000; Knowlton KU, 2000, PRINCIPLES PRACTICE, P925; Levy PY, 2006, FUTURE MICROBIOL, V1, P229, DOI 10.2217/17460913.1.2.229; Levy PY, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.04.027; Levy PY, 2003, MEDICINE, V82, P385, DOI 10.1097/01.md.0000101574.54295.73; Li JJ, 2012, J VIROL, V86, P11936, DOI 10.1128/JVI.01988-12; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lysholm F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030875; McMullan LK, 2012, VIROLOGY, V422, P1, DOI 10.1016/j.virol.2011.08.024; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Pantucek R, 2004, ARCH VIROL, V149, P1689, DOI 10.1007/s00705-004-0335-6; Peng YH, 2002, ARCH VIROL, V147, P21, DOI 10.1007/s705-002-8301-7; Pride DT, 2012, ISME J, V6, P915, DOI 10.1038/ismej.2011.169; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Roux S, 2011, BIOINFORMATICS, V27, P3074, DOI 10.1093/bioinformatics/btr519; Rozen S, 2000, Methods Mol Biol, V132, P365; SEDDON DJ, 1986, POSTGRAD MED J, V62, P1133, DOI 10.1136/pgmj.62.734.1133; Sullivan PF, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-2; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Troughton RW, 2004, LANCET, V363, P717, DOI 10.1016/S0140-6736(04)15648-1; Willner D, 2011, P NATL ACAD SCI USA, V108, P4547, DOI 10.1073/pnas.1000089107; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wommack KE, 1999, APPL ENVIRON MICROB, V65, P241; Zhong S, 2002, J MED VIROL, V66, P428, DOI 10.1002/jmv.2163	49	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93367	10.1371/journal.pone.0093367	http://dx.doi.org/10.1371/journal.pone.0093367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690743	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100070
J	Kadye, WT; Booth, AJ				Kadye, Wilbert T.; Booth, Anthony J.			Alternative Responses to Predation in Two Headwater Stream Minnows Is Reflected in Their Contrasting Diel Activity Patterns	PLOS ONE			English	Article							DIURNAL ACTIVITY; HABITAT USE; ANTIPREDATOR BEHAVIOR; SHOALING BEHAVIOR; FISH PREDATION; SELFISH HERD; RISK; PLASTICITY; COMPETITION; AVOIDANCE	Animals exhibit diel periodicity in their activity in part to meet energy requirements whilst evading predation. A competing hypothesis suggests that partitioning of diel activities is less important because animals capitalise on opportunity. To test these hypotheses we examined the diel activity patterns for two cyprinid minnows, chubbyhead barb Barbus anoplus and the Eastern Cape redfin minnow Pseudobarbus afer that both occur within headwater streams in the Eastern Cape, South Africa. Chubbyhead barbs exhibited consistent nocturnal activity based on both field and laboratory observations. Due to the absence of fish predators within its habitat, its nocturnal behaviour suggests a response to the cost associated with diurnal activity, such as predation risk by diving and wading birds. In contrast, redfin minnows showed high diurnal activity and a shoaling behaviour in the wild, whereas, in the laboratory, they showed high refuge use during the diel cycle. Despite their preference for refuge in the laboratory, they were diurnally active, a behaviour that was consistent with observations in the wild. The diurnal activity of this species suggests a response to the cost associated with nocturnal activity. Such a cost could be inferred from the presence of the longfin eel, a native predator that was active at night, whereas the daytime shoaling behaviour suggests an anti-predator mechanism to diurnal visual predators. The implications of these findings relate to the impacts associated with the potential invasions by non-native piscivores that occur in the mainstem sections. Diurnal activity patterns for redfin minnows, that are IUCN-listed as endangered, may, in part, explain their susceptibility to high predation by visual non-native piscivores, such as bass and trout. In contrast, the nocturnal habits of chubbyhead barbs suggest a probable pre-adaptation to visual predation. The likelihood of invasion by nocturnally-active sharptooth catfish Clarias gariepinus, however, may compromise this prior advantage.	[Kadye, Wilbert T.; Booth, Anthony J.] Rhodes Univ, Dept Ichthyol & Fisheries Sci, ZA-6140 Grahamstown, South Africa	Rhodes University	Kadye, WT (corresponding author), Rhodes Univ, Dept Ichthyol & Fisheries Sci, ZA-6140 Grahamstown, South Africa.	kadyew@yahoo.com	Booth, Anthony/C-9932-2012	Booth, Anthony/0000-0002-5561-9260; Kadye, Wilbert/0000-0002-5273-8360	South Africa's National Research Foundation; Rufford Small Grants Foundation; Research Committee of Rhodes University	South Africa's National Research Foundation(National Research Foundation - South Africa); Rufford Small Grants Foundation; Research Committee of Rhodes University	Funding provided by South Africa's National Research Foundation, Rufford Small Grants Foundation, Research Committee of Rhodes University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Alanara A, 2001, J ANIM ECOL, V70, P980, DOI 10.1046/j.0021-8790.2001.00550.x; Ayala JR, 2007, BIOL INVASIONS, V9, P857, DOI 10.1007/s10530-006-9087-4; BAKER RL, 1995, FRESHWATER BIOL, V34, P101, DOI 10.1111/j.1365-2427.1995.tb00427.x; Barton K., 2011, MUMIN MULTIMODEL INF; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bool JD, 2011, MAR FRESHWATER RES, V62, P1230, DOI 10.1071/MF11140; Botham MS, 2008, ECOLOGY, V89, P3174, DOI 10.1890/07-0490.1; BOUSKILA A, 1995, ECOLOGY, V76, P165, DOI 10.2307/1940639; BOUSKILA A, 1992, AM NAT, V139, P161, DOI 10.1086/285318; Bovee K. D., 1986, 867 US FISH WILDL SE; Bradford MJ, 2001, CAN J FISH AQUAT SCI, V58, P365, DOI 10.1139/f00-253; Brook LA, 2012, J APPL ECOL, V49, P1278, DOI 10.1111/j.1365-2664.2012.02207.x; Bruton M.N., 1979, TRANSACTIONS OF THE ZOOLOGICAL SOCIETY OF LONDON, V35, P47; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CAMBRAY JA, 1985, ENVIRON BIOL FISH, V12, P131, DOI 10.1007/BF00002765; Cambray JA, 1995, J AFR ZOOL, V109, P350; Clavero M, 2005, J FISH BIOL, V67, P72, DOI 10.1111/j.0022-1112.2005.00934.x; Cohen R, 2006, PHYSIOL BEHAV, V87, P563, DOI 10.1016/j.physbeh.2005.12.010; Correa C, 2012, ECOL APPL, V22, P828, DOI 10.1890/11-1174.1; Crook DA, 2001, OECOLOGIA, V129, P525, DOI 10.1007/s004420100750; Dupuch A, 2009, J FISH BIOL, V74, P1371, DOI 10.1111/j.1095-8649.2009.02183.x; Ellender BR, 2011, AFR ZOOL, V46, P39, DOI 10.3377/004.046.0116; FLECKER AS, 1992, ECOLOGY, V73, P438, DOI 10.2307/1940751; FOSTER WA, 1981, NATURE, V293, P466, DOI 10.1038/293466a0; Fox RJ, 2011, FUNCT ECOL, V25, P1096, DOI 10.1111/j.1365-2435.2011.01874.x; Fraser DF, 2004, ECOLOGY, V85, P312, DOI 10.1890/03-3023; Fraser NHC, 1997, FUNCT ECOL, V11, P385, DOI 10.1046/j.1365-2435.1997.00098.x; Gutman R, 2005, ECOLOGY, V86, P164, DOI 10.1890/03-0369; Halle S, 2006, FOLIA PRIMATOL, V77, P15, DOI 10.1159/000089693; Harrington LA, 2009, ECOLOGY, V90, P1207, DOI 10.1890/08-0302.1; Havird JC, 2013, HYDROBIOLOGIA, V716, P189, DOI 10.1007/s10750-013-1568-8; Helfman G.S., 1993, BEHAV TELEOST FISHES, P479, DOI DOI 10.1007/978-94-011-1578-0; IUCN, 2013, IUCN RED LIST THREAT; Jones M, 2001, ECOLOGY, V82, P2164, DOI 10.1890/0012-9658(2001)082[2164:COTPSM]2.0.CO;2; Kadye WT, 2013, RIVER RES APPL, V29, P1131, DOI 10.1002/rra.2599; Kadye WT, 2012, J APPL ICHTHYOL, V28, P791, DOI 10.1111/j.1439-0426.2012.02027.x; Kramer Donald L., 1997, P37; Krause J, 2002, LIVING GROUPS; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Kronfeld-Schor N, 2001, AM NAT, V158, P451, DOI 10.1086/321991; LAMPERT W, 1989, FUNCT ECOL, V3, P21, DOI 10.2307/2389671; Levy O, 2007, CHRONOBIOL INT, V24, P599, DOI 10.1080/07420520701534640; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Loppnow Grace L., 2013, Management of Biological Invasions, V4, P191; Lowe Steven R., 2008, African Journal of Aquatic Science, V33, P51, DOI 10.2989/AJAS.2007.33.1.6.390; Metcalfe NB, 1999, J ANIM ECOL, V68, P371, DOI 10.1046/j.1365-2656.1999.00289.x; Metcalfe NB, 2001, FUNCT ECOL, V15, P304, DOI 10.1046/j.1365-2435.2001.00527.x; Metcalfe NB, 1998, P ROY SOC B-BIOL SCI, V265, P1503, DOI 10.1098/rspb.1998.0464; Miller SA, 2014, ENVIRON BIOL FISH, V97, P357, DOI 10.1007/s10641-013-0157-z; Mueller R, 2010, COPEIA, P47, DOI 10.1643/CE-08-154; Orpwood JE, 2008, ANIM BEHAV, V76, P143, DOI 10.1016/j.anbehav.2008.01.016; Payne NL, 2012, P R SOC B, V280, P2012; POWER ME, 1984, ECOLOGY, V65, P523, DOI 10.2307/1941414; Queiroz H, 2005, BIOL LETTERS, V1, P155, DOI 10.1098/rsbl.2004.0267; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Railsback SF, 2005, ECOLOGY, V86, P947, DOI 10.1890/04-1178; Reebs SG, 2002, REV FISH BIOL FISHER, V12, P349, DOI 10.1023/A:1025371804611; REEBS SG, 1995, CAN J ZOOL, V73, P1221, DOI 10.1139/z95-146; Relyea RA, 2004, ECOLOGY, V85, P172, DOI 10.1890/03-0169; Roll U., 2002, ISR J ZOOL, V48, P177; Russell IA, 2011, AFR ZOOL, V46, P117, DOI 10.3377/004.046.0103; SCHLOSSER IJ, 1987, ECOLOGY, V68, P651, DOI 10.2307/1938470; Schoener T.W., 1986, P91; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Skelton P.H., 2001, COMPLETE GUTIDE FRES, V2nd ed.; Stuble KL, 2013, OECOLOGIA, V171, P981, DOI 10.1007/s00442-012-2459-9; TIKKANEN P, 1994, OECOLOGIA, V99, P252, DOI 10.1007/BF00627737; Tweddle D., 2009, STATUS DISTRIBUTION, P21; Wasserberg G, 2006, OIKOS, V112, P573, DOI 10.1111/j.0030-1299.2006.14302.x	72	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93666	10.1371/journal.pone.0093666	http://dx.doi.org/10.1371/journal.pone.0093666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691382	gold, Green Published, Green Submitted			2022-12-27	WOS:000334101100123
J	Reinke, EN; Ekoue, DN; Bera, S; Mahmud, N; Diamond, AM				Reinke, Emily N.; Ekoue, Dede N.; Bera, Soumen; Mahmud, Nadim; Diamond, Alan M.			Translational Regulation of GPx-1 and GPx-4 by the mTOR Pathway	PLOS ONE			English	Article							HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; CHRONIC MYELOGENOUS LEUKEMIA; MESSENGER-RNA; SELENOCYSTEINE INCORPORATION; CELL-LINE; SELENOPROTEIN SYNTHESIS; GENE-EXPRESSION; MEDIATED DECAY; RAT-TISSUES; PROTEIN	Glutathione peroxidase activity was previously determined to be elevated in lymphocytes obtained from patients treated with the Bcr-Abl kinase inhibitor imatinib mesylate. In order to expand upon this observation, the established chronic myelogenous leukemia cell lines KU812 and MEG-01 were treated with imatinib and the effect on several anti-oxidant proteins was determined. The levels of GPx-1 were significantly increased following treatment with imatinib. This increase was not due to altered steady-state mRNA levels, and appeared to be dependent on the expression of Bcr-Abl, as no increases were observed following imatinib treatment of cells that did not express the fusion protein. The nutrient-sensing signaling protein, mammalian target of rapamycin (mTOR), can be activated by Bcr-Abl and its activity regulates the translation of many different proteins. Treatment of those same cells used in the imatinib studies with rapamycin, an inhibitor of mTOR, resulted in elevated GPx-1 and GPx-4 protein levels independent of Bcr-Abl expression. These proteins all belong to the selenoprotein family of peptides that contain the UGA-encoded amino acid selenocysteine. Collectively, these data provide evidence of a novel means of regulating anti-oxidants of the selenoprotein family via the mTOR pathway.	[Reinke, Emily N.; Ekoue, Dede N.; Bera, Soumen; Diamond, Alan M.] Univ Illinois, Dept Pathol, Chicago, IL 60612 USA; [Mahmud, Nadim] Univ Illinois, Dept Med, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Diamond, AM (corresponding author), Univ Illinois, Dept Pathol, Chicago, IL 60612 USA.	adiamond@uic.edu	Bera, Soumen/ABG-1233-2021	Reinke, Emily/0000-0003-0995-7792	Public Health Service from the National Cancer Institute [CA129590, CA127943]; American Institute for Cancer Research [10A072]; NATIONAL CANCER INSTITUTE [R21CA129590, R01CA127943] Funding Source: NIH RePORTER	Public Health Service from the National Cancer Institute; American Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Service Grants CA129590 and CA127943 to AMD from the National Cancer Institute (http://www.NIH.gov), and Post-Doctoral Fellowship # 10A072 to SB from the American Institute for Cancer Research (http://www.aicr.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M, 1999, J BIOL CHEM, V274, P4924, DOI 10.1074/jbc.274.8.4924; Baliga MS, 2007, BIOL TRACE ELEM RES, V115, P227, DOI 10.1007/BF02685998; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Budiman ME, 2009, MOL CELL, V35, P479, DOI 10.1016/j.molcel.2009.06.026; Caban K, 2006, CELL MOL LIFE SCI, V63, P73, DOI 10.1007/s00018-005-5402-y; Cao C, 2003, J BIOL CHEM, V278, P39609, DOI 10.1074/jbc.M305770200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Diamond AM, 2012, MUTAGENESIS; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Esworthy RS, 1997, ARCH BIOCHEM BIOPHYS, V340, P59, DOI 10.1006/abbi.1997.9901; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; FLOHE L, 1971, H-S Z PHYSIOL CHEM, V352, P1401, DOI 10.1515/bchm2.1971.352.2.1401; Fritz KS, 2012, J PROTEOME RES, V11, P1633, DOI 10.1021/pr2008384; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hu YJ, 2003, CANCER RES, V63, P3347; Iglesias-Bartolome R, 2012, CELL STEM CELL, V11, P401, DOI 10.1016/j.stem.2012.06.007; Jameson RR, 2004, RNA, V10, P1142, DOI 10.1261/rna.7370104; Kharas NG, 2005, CANCER RES, V65, P2047, DOI 10.1158/0008-5472.CAN-04-3888; Kim JH, 2005, BLOOD, V105, P1717, DOI 10.1182/blood-2004-03-0849; Klejman A, 2002, ONCOGENE, V21, P5868, DOI 10.1038/sj.onc.1205724; Kollmus H, 1996, NUCLEIC ACIDS RES, V24, P1195, DOI 10.1093/nar/24.7.1195; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Ly C, 2003, CANCER RES, V63, P5716; Martin GW, 2001, GENES CELLS, V6, P121, DOI 10.1046/j.1365-2443.2001.00402.x; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Nasim MT, 2000, J BIOL CHEM, V275, P14846, DOI 10.1074/jbc.275.20.14846; OGURA M, 1985, BLOOD, V66, P1384; Patel S, 2013, CURR ONCOL REP, V15, P386, DOI 10.1007/s11912-013-0316-6; SAMUELS BL, 1991, CANCER RES, V51, P521; Shepard BD, 2010, ALCOHOL CLIN EXP RES, V34, P280, DOI 10.1111/j.1530-0277.2009.01091.x; Sinclair A, 2013, BRIT J PHARMACOL, V169, P1693, DOI 10.1111/bph.12183; Stoytcheva Z, 2006, MOL CELL BIOL, V26, P9177, DOI 10.1128/MCB.00856-06; Sun XL, 2001, MOL BIOL CELL, V12, P1009, DOI 10.1091/mbc.12.4.1009; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Terry EN, 2012, LEUKEMIA RES, V35, P831; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; UTSUNOMIYA H, 1991, J HISTOCHEM CYTOCHEM, V39, P1167, DOI 10.1177/39.9.1918936; Xing HY, 2012, LEUKEMIA RES, V36, P509, DOI 10.1016/j.leukres.2011.12.018; Yuan HF, 2010, J BIOL CHEM, V285, P5085, DOI 10.1074/jbc.M109.039206; Zhuo P, 2009, CANCER RES, V69, P8183, DOI 10.1158/0008-5472.CAN-09-1791	43	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93472	10.1371/journal.pone.0093472	http://dx.doi.org/10.1371/journal.pone.0093472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691473	Green Submitted, Green Published, gold			2022-12-27	WOS:000334101100087
J	Uri, K; Fagyas, M; Siket, IM; Kertesz, A; Csanadi, Z; Sandorfi, G; Clemens, M; Fedor, R; Papp, Z; Edes, I; Toth, A; Lizanecz, E				Uri, Katalin; Fagyas, Miklos; Siket, Ivetta Manyine; Kertesz, Attila; Csanadi, Zoltan; Sandorfi, Gabor; Clemens, Marcell; Fedor, Roland; Papp, Zoltan; Edes, Istvan; Toth, Attila; Lizanecz, Erzsebet			New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) IV: Circulating ACE2 as a Biomarker of Systolic Dysfunction in Human Hypertension and Heart Failure	PLOS ONE			English	Article							CONVERTING ENZYME; BLOOD-PRESSURE; ESC GUIDELINES; ANGIOTENSIN-CONVERTING-ENZYME-2; ASSOCIATION; RECEPTOR; OVEREXPRESSION; POLYMORPHISM; EXPRESSION; THERAPY	Background: Growing evidence exists for soluble Angiotensin Converting Enzyme-2 (sACE2) as a biomarker in definitive heart failure (HF), but there is little information about changes in sACE2 activity in hypertension with imminent heart failure and in reverse remodeling. Methods, Findings: Patients with systolic HF (NYHAII-IV, enrolled for cardiac resynchronisation therapy, CRT, n = 100) were compared to hypertensive patients (n = 239) and to a healthy cohort (n = 45) with preserved ejection fraction (EF>50%) in a single center prospective clinical study. The status of the heart failure patients were checked before and after CRT. Biochemical (ACE and sACE2 activity, ACE concentration) and echocardiographic parameters (EF, left ventricular end-diastolic (EDD) and end-systolic diameter (ESD) and dP/dt) were measured. sACE2 activity negatively correlated with EF and positively with ESD and EDD in all patient's populations, while it was independent in the healthy cohort. sACE2 activity was already increased in the hypertensive group, where signs for imminent heart failure (slightly decreased EF and barely increased NT-proBNP levels) were detected. sACE2 activities further increased in patients with definitive heart failure (EF<50%), while sACE2 activities decreased with the improvement of the heart failure after CRT (reverse remodeling). Serum angiotensin converting enzyme (ACE) concentrations were lower in the diseased populations, but did not show a strong correlation with the echocardiographic parameters. Conclusions: Soluble ACE2 activity appears to be biomarker in heart failure, and in hypertension, where heart failure may be imminent. Our data suggest that sACE2 is involved in the pathomechanism of hypertension and HF.	[Uri, Katalin; Fagyas, Miklos; Siket, Ivetta Manyine; Papp, Zoltan; Toth, Attila] Univ Debrecen, Med & Hlth Sci Ctr, Inst Cardiol, Div Clin Physiol, H-4012 Debrecen, Hungary; [Kertesz, Attila; Csanadi, Zoltan; Sandorfi, Gabor; Clemens, Marcell; Edes, Istvan; Lizanecz, Erzsebet] Univ Debrecen, Med & Hlth Sci Ctr, Inst Cardiol, H-4012 Debrecen, Hungary; [Fedor, Roland] Univ Debrecen, Med & Hlth Sci Ctr, Inst Surg, H-4012 Debrecen, Hungary; [Papp, Zoltan; Edes, Istvan; Toth, Attila] Univ Debrecen, Med & Hlth Sci Ctr, Res Ctr Mol Med, H-4012 Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen	Lizanecz, E (corresponding author), Univ Debrecen, Med & Hlth Sci Ctr, Inst Cardiol, H-4012 Debrecen, Hungary.	lizanecz@yahoo.com	Fagyas, Miklós/AAQ-1013-2020; Tóth, Attila/F-4859-2010; Papp, Zoltán/HDO-3347-2022	Fagyas, Miklós/0000-0003-3262-884X; Tóth, Attila/0000-0001-6503-3653; 	 [TAMOP 4.2.2.A-11/1/KONV-2012-0045];  [TAMOP-4.2.2/B-10/1-2010-0024]	; 	The work was supported by TAMOP 4.2.2.A-11/1/KONV-2012-0045 and TAMOP-4.2.2/B-10/1-2010-0024 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENETEAU B, 1986, CLIN CHEM, V32, P884; Bodiga S, 2011, CARDIOVASC RES, V91, P151, DOI 10.1093/cvr/cvr036; Burrell LM, 2005, EUR HEART J, V26, P369, DOI 10.1093/eurheartj/ehi114; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Der Sarkissian S, 2006, PROG BIOPHYS MOL BIO, V91, P163, DOI 10.1016/j.pbiomolbio.2005.05.011; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Dickstein K, 2010, EUR HEART J, V31, P2677, DOI 10.1093/eurheartj/ehq337; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088; Epelman S, 2009, J CARD FAIL, V15, P565, DOI 10.1016/j.cardfail.2009.01.014; Fagyas M, 2014, PLOS ONE; FERRARIO CM, 1990, J CARDIOVASC PHARM, V15, pS1, DOI 10.1097/00005344-199000153-00001; Gallagher PE, 2008, AM J PHYSIOL-HEART C, V295, pH2373, DOI 10.1152/ajpheart.00426.2008; Goulter AB, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-19; Gurley SB, 2006, J CLIN INVEST, V116, P2218, DOI 10.1172/JCI16980; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; Lehmann HI, 2012, INT J CARDIOL, DOI 10.1016/j.ijcard.2012. 09. 083; Lu N, 2012, MOL BIOL REP, V39, P6581, DOI 10.1007/s11033-012-1487-1; Nicholls MG, 1998, J HUM HYPERTENS, V12, P295, DOI 10.1038/sj.jhh.1000638; Patel SK, 2012, AM J HYPERTENS, V25, P216, DOI 10.1038/ajh.2011.188; Patel SK, 2013, CLIN EXP PHARM PHYSL; Rentzsch B, 2008, HYPERTENSION, V52, P967, DOI 10.1161/HYPERTENSIONAHA.108.114322; RONCATESTONI S, 1983, CLIN CHEM, V29, P1093; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Tang WHW, 2007, CIRCULATION, V115, P161, DOI 10.1161/CIRCULATIONAHA.106.669879; van Kimmenade RRJ, 2012, CLIN CHEM, V58, P127, DOI 10.1373/clinchem.2011.165720; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Wang W, 2012, HEART FAIL REV, V17, P683, DOI 10.1007/s10741-011-9259-x; Wysocki J, 2010, HYPERTENSION, V55, P90, DOI 10.1161/HYPERTENSIONAHA.109.138420; Yamamoto K, 2006, HYPERTENSION, V47, P718, DOI 10.1161/01.HYP.0000205833.89478.5b; Yamazato M, 2007, HYPERTENSION, V49, P926, DOI 10.1161/01.HYP.0000259942.38108.20; Zhong J, 2006, J LAB CLIN MED, V147, P91, DOI 10.1016/j.lab.2005.10.001; Zhong JC, 2010, CIRCULATION, V122, P717, DOI 10.1161/CIRCULATIONAHA.110.955369	34	56	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e87845	10.1371/journal.pone.0087845	http://dx.doi.org/10.1371/journal.pone.0087845			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691269	gold, Green Published			2022-12-27	WOS:000334101100004
J	Shi, Y; Xu, XT; Tan, Y; Mao, S; Fang, SR; Gu, W				Shi, Ying; Xu, Xiantao; Tan, Yan; Mao, Shan; Fang, Surong; Gu, Wei			A Liver-X-Receptor Ligand, T0901317, Attenuates IgE Production and Airway Remodeling in Chronic Asthma Model of Mice	PLOS ONE			English	Article							CHOLESTEROL EFFLUX; MURINE MODEL; LXR-ALPHA; INFLAMMATION; EXPRESSION; AGONIST; GROWTH; CELLS; BETA	The liver-X-receptors have shown anti-inflammatory ability in several animal models of respiratory disease. Our purpose is to investigate the effect of LXR ligand in allergen-induced airway remodeling in mice. Ovalbumin-sensitized mice were chronically challenged with aerosolized ovalbumin for 8 weeks. Some mice were administered a LXR agonist, T0901317 (12.5, 25, 50 mg/kg bodyweight) before challenge. Then mice were evaluated for airway inflammation, airway hyperresponsiveness and airway remodeling. T0901317 failed to attenuate the inflammatory cells and Th2 cytokines in bronchoalveolar lavage fluid. But the application of T0901317 reduced the thickness of airway smooth muscle and the collagen deposition. Meanwhile, T0901317 treatment evidently abolished the high level of OVA-specific IgE, TGF-beta 1 and MMP-9 in lung. So LXRs may attenuate the progressing of airway remodeling, providing a potential treatment of asthma.	[Shi, Ying; Xu, Xiantao; Tan, Yan; Mao, Shan; Fang, Surong; Gu, Wei] Nanjing Med Univ, Dept Resp Med, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Gu, W (corresponding author), Nanjing Med Univ, Dept Resp Med, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China.	sykxss@163.com			National Natural Science Foundation of China [81100010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by the National Natural Science Foundation of China grant 81100010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benayoun L, 2003, M S-MED SCI, V19, P319, DOI 10.1051/medsci/2003193319; Birrell MA, 2008, J IMMUNOL, V181, P4265, DOI 10.4049/jimmunol.181.6.4265; Blaschke F, 2004, CIRC RES, V95, pE110, DOI 10.1161/01.RES.0000150368.56660.4f; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Brown SD, 2012, J ALLERGY CLIN IMMUN, V129, P388, DOI 10.1016/j.jaci.2011.11.037; BRUSSELLE GG, 1994, CLIN EXP ALLERGY, V24, P73, DOI 10.1111/j.1365-2222.1994.tb00920.x; Castrillo A, 2003, J BIOL CHEM, V278, P10443, DOI 10.1074/jbc.M213071200; Costet P, 2000, J BIOL CHEM, V275, P28240; Crisafulli C, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-19; Delvecchio CJ, 2007, MOL ENDOCRINOL, V21, P1324, DOI 10.1210/me.2007-0017; Fowler AJ, 2003, J INVEST DERMATOL, V120, P246, DOI 10.1046/j.1523-1747.2003.12033.x; Hamelmann E, 1999, ALLERGY, V54, P297, DOI 10.1034/j.1398-9995.1999.00085.x; Heine G, 2009, J IMMUNOL, V182, P5276, DOI 10.4049/jimmunol.0801804; Houck KA, 2004, MOL GENET METAB, V83, P184, DOI 10.1016/j.ymgme.2004.07.007; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Lee YC, 2001, J ALLERGY CLIN IMMUN, V108, P1021, DOI 10.1067/mai.2001.120132; Li YTY, 2007, ARTERIOSCL THROM VAS, V27, P2606, DOI 10.1161/ATVBAHA.107.152694; Louis R, 2012, CLIN CHEST MED, V33, P531, DOI 10.1016/j.ccm.2012.05.004; Makinde T, 2007, IMMUNOL CELL BIOL, V85, P348, DOI 10.1038/sj.icb.7100044; Nunomura S, 2010, FEBS LETT, V584, P1143, DOI 10.1016/j.febslet.2010.02.006; Park MC, 2010, RHEUMATOLOGY, V49, P882, DOI 10.1093/rheumatology/keq007; Smoak K, 2008, J IMMUNOL, V180, P3305, DOI 10.4049/jimmunol.180.5.3305; Solan PD, 2011, SHOCK, V35, P367, DOI 10.1097/SHK.0b013e3181f7d742; Tagaya Etsuko, 2007, Allergol Int, V56, P331; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; Walter DM, 2001, J IMMUNOL, V167, P4668, DOI 10.4049/jimmunol.167.8.4668; Wang DM, 2011, INT IMMUNOPHARMACOL, V11, P2098, DOI 10.1016/j.intimp.2011.09.002; Warner SM, 2008, CURR OPIN ALLERGY CL, V8, P44, DOI 10.1097/ACI.0b013e3282f3b5cb	30	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92668	10.1371/journal.pone.0092668	http://dx.doi.org/10.1371/journal.pone.0092668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681543	gold, Green Published, Green Submitted			2022-12-27	WOS:000333678100013
J	Basner, M; Dinges, DF; Mollicone, DJ; Savelev, I; Ecker, AJ; Di Antonio, A; Jones, CW; Hyder, EC; Kan, K; Morukov, BV; Sutton, JP				Basner, Mathias; Dinges, David F.; Mollicone, Daniel J.; Savelev, Igor; Ecker, Adrian J.; Di Antonio, Adrian; Jones, Christopher W.; Hyder, Eric C.; Kan, Kevin; Morukov, Boris V.; Sutton, Jeffrey P.			Psychological and Behavioral Changes during Confinement in a 520-Day Simulated Interplanetary Mission to Mars	PLOS ONE			English	Article							INTERNATIONAL-SPACE-STATION; VIGILANCE TEST PVT; SLEEP-DEPRIVATION; MOOD STATES; SOCIAL DESIRABILITY; POLAR EXPEDITIONS; DOSE-RESPONSE; PERFORMANCE; DURATION; VALIDITY	Behavioral health risks are among the most serious and difficult to mitigate risks of confinement in space craft during long-duration space exploration missions. We report on behavioral and psychological reactions of a multinational crew of 6 healthy males confined in a 550 m(3) chamber for 520 days during the first Earth-based, high-fidelity simulated mission to Mars. Rest-activity of crewmembers was objectively measured throughout the mission with wrist-worn actigraphs. Once weekly throughout the mission crewmembers completed the Beck Depression Inventory-II (BDI-II), Profile of Moods State short form (POMS), conflict questionnaire, the Psychomotor Vigilance Test (PVT-B), and series of visual analogue scales on stress and fatigue. We observed substantial inter-individual differences in the behavioral responses of crewmembers to the prolonged mission confinement and isolation. The crewmember with the highest average POMS total mood disturbance score throughout the mission also reported symptoms of depression in 93% of mission weeks, which reached mild-to-moderate levels in >10% of mission weeks. Conflicts with mission control were reported five times more often than conflicts among crewmembers. Two crewmembers who had the highest ratings of stress and physical exhaustion accounted for 85% of the perceived conflicts. One of them developed a persistent sleep onset insomnia with ratings of poor sleep quality, which resulted in chronic partial sleep deprivation, elevated ratings of daytime tiredness, and frequent deficits in behavioral alertness. Sleep-wake timing was altered in two other crewmembers, beginning in the first few months of the mission and persisting throughout. Two crewmembers showed neither behavioral disturbances nor reports of psychological distress during the 17-month period of mission confinement. These results highlight the importance of identifying behavioral, psychological, and biological markers of characteristics that predispose prospective crewmembers to both effective and ineffective behavioral reactions during the confinement of prolonged spaceflight, to inform crew selection, training, and individualized countermeasures.	[Basner, Mathias; Dinges, David F.; Ecker, Adrian J.; Di Antonio, Adrian; Jones, Christopher W.; Hyder, Eric C.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Mollicone, Daniel J.; Kan, Kevin] Pulsar Informat, Philadelphia, PA USA; [Savelev, Igor] Wyle, Houston, TX USA; [Savelev, Igor; Sutton, Jeffrey P.] Natl Space Biomed Res Inst, Houston, TX USA; [Morukov, Boris V.] Minist Publ Hlth Russia, Inst Biomed Problems, Moscow, Russia; [Sutton, Jeffrey P.] Baylor Coll Med, Ctr Space Med, Houston, TX 77030 USA; [Sutton, Jeffrey P.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	University of Pennsylvania; Pennsylvania Medicine; Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences; Baylor College of Medicine; Baylor College of Medicine	Basner, M (corresponding author), Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA.	basner@upenn.edu	Jones, Christopher W./AAA-2754-2020; Dinges, David/P-7183-2019	Jones, Christopher W./0000-0002-8173-721X; 	National Space Biomedical Research Institute (NSBRI) [NASA NCC 9-58]; Institute for Experimental Psychiatry Research Foundation	National Space Biomedical Research Institute (NSBRI); Institute for Experimental Psychiatry Research Foundation	The research was supported by the National Space Biomedical Research Institute (NSBRI) through NASA NCC 9-58, and by the Institute for Experimental Psychiatry Research Foundation. The funders had no role in study design, data collection and analysis, and decision to publish. Jeffrey Sutton is President, CEO and Institute Director of NSBRI. He helped in the preparation of the manuscript. The Friedkin Chair for Research in Sensory System Integration and Space Medicine to Jeffrey Sutton is also acknowledged.	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Antonovsky A., 1987, UNRAVELING MYSTERY H; Baisden DL, 2008, AVIAT SPACE ENVIR MD, V79, P629, DOI 10.3357/ASEM.2314.2008; Ball H., 2001, SAFE PASSAGE ASTRONA; Basner M, 2013, P NATL ACAD SCI USA, V110, P2635, DOI 10.1073/pnas.1212646110; Basner M, 2011, ACTA ASTRONAUT, V69, P949, DOI 10.1016/j.actaastro.2011.07.015; Basner M, 2011, J OCCUP ENVIRON MED, V53, P1146, DOI 10.1097/JOM.0b013e31822b8356; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Blake BF, 2006, PERS INDIV DIFFER, V40, P1625, DOI 10.1016/j.paid.2005.12.007; Boyd JE, 2007, ACTA ASTRONAUT, V61, P668, DOI 10.1016/j.actaastro.2006.12.002; CURRAN SL, 1995, PSYCHOL ASSESSMENT, V7, P80, DOI 10.1037/1040-3590.7.1.80; Feichtinger E, 2012, AER C; Griofa MO, 2011, AVIAT SPACE ENVIR MD, V82, P434, DOI 10.3357/ASEM.2570.2011; Inoue N, 2004, AVIAT SPACE ENVIR MD, V75, pC28; Kanas N, 2009, ACTA ASTRONAUT, V64, P659, DOI 10.1016/j.actaastro.2008.12.005; KELLY AD, 1993, AVIAT SPACE ENVIR MD, V64, P795; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lapierrea J, 2009, ACTA ASTRONAUT, V64, P1304, DOI 10.1016/j.actaastro.2009.01.002; Leon GR, 2011, J ENVIRON PSYCHOL, V31, P353, DOI 10.1016/j.jenvp.2011.08.001; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Mollicone DJ, 2008, ACTA ASTRONAUT, V63, P833, DOI 10.1016/j.actaastro.2007.12.005; Palinkas LA, 2008, LANCET, V371, P153, DOI 10.1016/S0140-6736(07)61056-3; Rosnet E, 1998, ACTA ASTRONAUT, V42, P265; Sandal GM, 2004, AVIAT SPACE ENVIR MD, V75, pC44; Sandal GM, 1996, AVIAT SPACE ENVIR MD, V67, P227; SHACHAM S, 1983, J PERS ASSESS, V47, P305, DOI 10.1207/s15327752jpa4703_14; Shved D M, 2013, Aviakosm Ekolog Med, V47, P19; Slack KJ, 2009, RISK BEHAV PSYCHIAT; Stober J, 2001, EUR J PSYCHOL ASSESS, V17, P222, DOI 10.1027//1015-5759.17.3.222; Stuster J, 2005, AVIAT SPACE ENVIR MD, V76, pB78; Stuster J, 2000, AVIAT SPACE ENVIR MD, V71, pA17; Suedfeld P, 1998, J ENVIRON PSYCHOL, V18, P95, DOI 10.1006/jevp.1998.0090; SUEDFELD P, 1991, ENVIRON BEHAV, V23, P653, DOI 10.1177/0013916591236001; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117	37	94	98	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93298	10.1371/journal.pone.0093298	http://dx.doi.org/10.1371/journal.pone.0093298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SW	24675720	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677500107
J	Coverdale, TC; Brisson, CP; Young, EW; Yin, SF; Donnelly, JP; Bertness, MD				Coverdale, Tyler C.; Brisson, Caitlin P.; Young, Eric W.; Yin, Stephanie F.; Donnelly, Jeffrey P.; Bertness, Mark D.			Indirect Human Impacts Reverse Centuries of Carbon Sequestration and Salt Marsh Accretion	PLOS ONE			English	Article							GLOBAL CLIMATE-CHANGE; SEA-LEVEL RISE; DIE-OFF; CORAL-REEF; TROPHIC CASCADES; ECOSYSTEMS; DEGRADATION; DISTURBANCE; RESILIENCE; FLUX	Direct and indirect human impacts on coastal ecosystems have increased over the last several centuries, leading to unprecedented degradation of coastal habitats and loss of ecological services. Here we document a two-century temporal disparity between salt marsh accretion and subsequent loss to indirect human impacts. Field surveys, manipulative experiments and GIS analyses reveal that crab burrowing weakens the marsh peat base and facilitates further burrowing, leading to bank calving, disruption of marsh accretion, and a loss of over two centuries of sequestered carbon from the marsh edge in only three decades. Analogous temporal disparities exist in other systems and are a largely unrecognized obstacle in attaining sustainable ecosystem services in an increasingly human impacted world. In light of the growing threat of indirect impacts worldwide and despite uncertainties in the fate of lost carbon, we suggest that estimates of carbon emissions based only on direct human impacts may significantly underestimate total anthropogenic carbon emissions.	[Coverdale, Tyler C.; Brisson, Caitlin P.; Young, Eric W.; Yin, Stephanie F.; Bertness, Mark D.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Donnelly, Jeffrey P.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Brown University; Woods Hole Oceanographic Institution	Coverdale, TC (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	Tyler_Coverdale@Brown.edu		Brisson, Caitlin/0000-0001-8567-1863; Coverdale, Tyler/0000-0003-0910-9187	National Science Foundation Biological Oceanography Program; Brown University Undergraduate Teaching and Research Award Program	National Science Foundation Biological Oceanography Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Brown University Undergraduate Teaching and Research Award Program	This research was made possible by a grant from the National Science Foundation Biological Oceanography Program and the Brown University Undergraduate Teaching and Research Award Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardy T., 2005, ECOSYSTEM HUMAN WELL; Alongi DM, 2008, ESTUAR COAST SHELF S, V76, P1, DOI 10.1016/j.ecss.2007.08.024; Altieri AH, 2013, ECOLOGY, V94, P1647, DOI 10.1890/12-1781.1; Altieri AH, 2012, ECOLOGY, V93, P1402, DOI 10.1890/11-1314.1; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bell SS, 2002, ECOL APPL, V12, P206, DOI 10.1890/1051-0761(2002)012[0206:ATIOBP]2.0.CO;2; Bertness MD, 2008, CONSERV BIOL, V22, P618, DOI 10.1111/j.1523-1739.2008.00962.x; Chmura GL, 2013, OCEAN COAST MANAGE, V83, P25, DOI 10.1016/j.ocecoaman.2011.09.006; Coverdale TC, 2013, CONSERV BIOL, V27, P1041, DOI 10.1111/cobi.12052; Coverdale TC, 2013, FRONT ECOL ENVIRON, V11, P69, DOI 10.1890/120130; Coverdale TC, 2012, ECOLOGY, V93, P2085, DOI 10.1890/12-0010.1; Craft C, 2009, FRONT ECOL ENVIRON, V7, P73, DOI 10.1890/070219; Dean WE, 1998, GEOLOGY, V26, P535, DOI 10.1130/0091-7613(1998)026<0535:MASOCB>2.3.CO;2; Deegan LA, 2012, NATURE, V490, P388, DOI 10.1038/nature11533; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Ellison AM, 1996, BIOTROPICA, V28, P549, DOI 10.2307/2389096; Erftemeijer PLA, 2006, MAR POLLUT BULL, V52, P1553, DOI 10.1016/j.marpolbul.2006.09.006; Escapa M, 2007, LIMNOL OCEANOGR, V52, P2340, DOI 10.4319/lo.2007.52.6.2340; GEDAN KB, 2009, HUMAN IMPACTS SALT M, P253; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jefferies RL, 2006, J ECOL, V94, P234, DOI 10.1111/j.1365-2745.2005.01086.x; Korner C, 2003, SCIENCE, V300, P1242, DOI 10.1126/science.1084460; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; LORD CJ, 1983, GEOCHIM COSMOCHIM AC, V47, P1381, DOI 10.1016/0016-7037(83)90296-X; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2004, ECOL APPL, V14, P1428, DOI 10.1890/03-5027; Macreadie PI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069244; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Metz ORDB, 2007, CLIMATE CHANGE 2007; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; ODUM E. P., 1959, PROC NATL ACAD SCI, V45, P617, DOI 10.1073/pnas.45.4.617; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; OSGOOD DT, 1993, ESTUARIES, V16, P815, DOI 10.2307/1352440; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Ranasinghe R, 2013, NAT CLIM CHANGE, V3, P83, DOI [10.1038/NCLIMATE1664, 10.1038/nclimate1664]; SEILER W, 1980, CLIMATIC CHANGE, V2, P207, DOI 10.1007/BF00137988; Siikamaki J, 2012, P NATL ACAD SCI USA, V109, P14369, DOI 10.1073/pnas.1200519109; Silliman BR, 2005, SCIENCE, V310, P1803, DOI 10.1126/science.1118229; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; Stuiver M, 1998, RADIOCARBON, V40, P1127, DOI 10.1017/S0033822200019172; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; Wilmers CC, 2012, FRONT ECOL ENVIRON, V10, P409, DOI 10.1890/110176	51	60	60	4	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93296	10.1371/journal.pone.0093296	http://dx.doi.org/10.1371/journal.pone.0093296			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675669	gold, Green Published			2022-12-27	WOS:000333677500106
J	Macabelli, CH; Ferreira, RM; Gimenes, LU; de Carvalho, NAT; Soares, JG; Ayres, H; Ferraz, ML; Watanabe, YF; Watanabe, OY; Sangalli, JR; Smith, LC; Baruselli, PS; Meirelles, FV; Chiaratti, MR				Macabelli, Carolina Habermann; Ferreira, Roberta Machado; Gimenes, Lindsay Unno; Tonizza de Carvalho, Nelcio Antonio; Soares, Julia Gleyci; Ayres, Henderson; Ferraz, Marcio Leao; Watanabe, Yeda Fumie; Watanabe, Osnir Yoshime; Sangalli, Juliano Rodrigues; Smith, Lawrence Charles; Baruselli, Pietro Sampaio; Meirelles, Flavio Vieira; Chiaratti, Marcos Roberto			Reference Gene Selection for Gene Expression Analysis of Oocytes Collected from Dairy Cattle and Buffaloes during Winter and Summer	PLOS ONE			English	Article							REAL-TIME PCR; HEAT-STRESS; IN-VITRO; MESSENGER-RNA; DEVELOPMENTAL COMPETENCE; EMBRYO PRODUCTION; ENVIRONMENTAL-TEMPERATURE; PREIMPLANTATION EMBRYOS; BOVINE OOCYTES; MOUSE OOCYTES	Oocytes from dairy cattle and buffaloes have severely compromised developmental competence during summer. While analysis of gene expression is a powerful technique for understanding the factors affecting developmental hindrance in oocytes, analysis by real-time reverse transcription PCR (RT-PCR) relies on the correct normalization by reference genes showing stable expression. Furthermore, several studies have found that genes commonly used as reference standards do not behave as expected depending on cell type and experimental design. Hence, it is recommended to evaluate expression stability of candidate reference genes for a specific experimental condition before employing them as internal controls. In acknowledgment of the importance of seasonal effects on oocyte gene expression, the aim of this study was to evaluate the stability of expression levels of ten well-known reference genes (ACTB, GAPDH, GUSB, HIST1H2AG, HPRT1, PPIA, RPL15, SDHA, TBP and YWHAZ) using oocytes collected from different categories of dairy cattle and buffaloes during winter and summer. A normalization factor was provided for cattle (RPL15, PPIA and GUSB) and buffaloes (YWHAZ, GUSB and GAPDH) based on the expression of the three most stable reference genes in each species. Normalization of non-reference target genes by these reference genes was shown to be considerably different from normalization by less stable reference genes, further highlighting the need for careful selection of internal controls. Therefore, due to the high variability of reference genes among experimental groups, we conclude that data normalized by internal controls can be misleading and should be compared to not normalized data or to data normalized by an external control in order to better interpret the biological relevance of gene expression analysis.	[Macabelli, Carolina Habermann; Chiaratti, Marcos Roberto] Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet & Evolucao, BR-13560 Sao Carlos, SP, Brazil; [Macabelli, Carolina Habermann; Ferreira, Roberta Machado; Sangalli, Juliano Rodrigues; Meirelles, Flavio Vieira; Chiaratti, Marcos Roberto] Univ Sao Paulo, Fac Zootecnia & Engn Alimentos, Dept Med Vet, Pirassununga, SP, Brazil; [Ferreira, Roberta Machado; Soares, Julia Gleyci; Ayres, Henderson; Baruselli, Pietro Sampaio] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Reprod Anim, Sao Paulo, Brazil; [Gimenes, Lindsay Unno] Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Reprod Anim, Jaboticabal, SP, Brazil; [Tonizza de Carvalho, Nelcio Antonio] APTA, Unidade Pesquisa Desenvolvimento Registro, Registro, SP, Brazil; [Ayres, Henderson] Vida Reprod Consultoria, Cravinhos, SP, Brazil; [Ferraz, Marcio Leao] MSD Saude Anim, Sao Paulo, Brazil; [Watanabe, Yeda Fumie; Watanabe, Osnir Yoshime] LTDA, WTA Tecnol Aplicada, Cravinhos, SP, Brazil; [Sangalli, Juliano Rodrigues; Meirelles, Flavio Vieira; Chiaratti, Marcos Roberto] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Cirurgia, Sao Paulo, Brazil; [Smith, Lawrence Charles] Univ Montreal, Fac Med Vet, Ctr Rech Reprod Anim, St Hyacinthe, PQ J2S 7C6, Canada	Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Universite de Montreal	Chiaratti, MR (corresponding author), Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet & Evolucao, BR-13560 Sao Carlos, SP, Brazil.	chiarattimr@gmail.com	Chiaratti, Marcos R/C-2727-2012; Smith, Lawrence C/K-4658-2012; Gimenes, Lindsay U./B-6510-2013; Meirelles, Flavio V/B-5048-2010; Sangalli, Juliano Rodrigues/C-1834-2013; Baruselli, Pietro Sampaio/C-7600-2012; Macabelli, Carolina/G-5355-2016; Smith, Lawrence/AAP-4321-2021; CTC USP, CEPID 13 18/J-8951-2014	Chiaratti, Marcos R/0000-0001-8805-9469; Gimenes, Lindsay U./0000-0002-7644-675X; Meirelles, Flavio V/0000-0003-0372-4920; Baruselli, Pietro Sampaio/0000-0002-6773-4450; Smith, Lawrence/0000-0001-8766-0148; CTC USP, CEPID 13 18/0000-0002-7123-9524	Sao Paulo Research Foundation (FAPESP) [2009/00938-3, 2010/13384-3, 2010/09561-7, 2011/14207-0, 2012/07510-1]; National Counsel of Technological and Scientific Development (CNPq) [476229/2011-1]; Coordination for the Improvement of Higher Level Personnel (CAPES)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Level Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The research was granted by Sao Paulo Research Foundation (FAPESP; grant numbers 2009/00938-3, 2010/13384-3, 2010/09561-7, 2011/14207-0 and 2012/07510-1), National Counsel of Technological and Scientific Development (CNPq; grant number 476229/2011-1) and Coordination for the Improvement of Higher Level Personnel (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Katanani YM, 2002, J DAIRY SCI, V85, P390, DOI 10.3168/jds.S0022-0302(02)74086-1; Andre G, 2011, J DAIRY SCI, V94, P4502, DOI 10.3168/jds.2010-4139; Bettegowda A, 2006, MOL REPROD DEV, V73, P267, DOI 10.1002/mrd.20333; Biase F. H., 2012, ZYGOTE, V10, P1; Bower NI, 2007, BIOTECHNIQUES, V42, P197, DOI 10.2144/000112314; Camargo LSA, 2007, THERIOGENOLOGY, V68, P626, DOI 10.1016/j.theriogenology.2007.03.029; CAVESTANY D, 1985, J DAIRY SCI, V68, P1471, DOI 10.3168/jds.S0022-0302(85)80985-1; Chiaratti MR, 2010, BIOL REPROD, V82, P76, DOI 10.1095/biolreprod.109.077776; Das GK, 2010, REPROD DOMEST ANIM, V45, pe483, DOI 10.1111/j.1439-0531.2010.01598.x; De Bem THC, 2011, CELL REPROGRAM, V13, P419, DOI 10.1089/cell.2011.0010; Desitter I, 2011, ANTICANCER RES, V31, P427; Di Francesco S, 2012, THERIOGENOLOGY, V78, P1839, DOI 10.1016/j.theriogenology.2012.07.022; Di Francesco S, 2012, THERIOGENOLOGY, V77, P148, DOI 10.1016/j.theriogenology.2011.07.028; Di Francesco S, 2011, ANIM REPROD SCI, V123, P48, DOI 10.1016/j.anireprosci.2010.11.009; Donnison M, 2004, BIOL REPROD, V71, P1813, DOI 10.1095/biolreprod.104.032367; Duncan FE, 2010, METHOD ENZYMOL, V477, P457, DOI 10.1016/S0076-6879(10)77023-3; EALY AD, 1993, J DAIRY SCI, V76, P2899, DOI 10.3168/jds.S0022-0302(93)77629-8; Ferreira RM, 2011, J DAIRY SCI, V94, P2383, DOI 10.3168/jds.2010-3904; Gendelman M, 2012, ANIM REPROD SCI, V134, P125, DOI 10.1016/j.anireprosci.2012.07.009; Gendelman M, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092882; Gimenes LU, 2011, ANIM REPROD SCI, V123, P175, DOI 10.1016/j.anireprosci.2010.12.004; Gimenes LU, 2010, REPROD FERT DEVELOP, V22, P293, DOI 10.1071/RDv22n1Ab273; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Hansen PJ, 2009, PHILOS T R SOC B, V364, P3341, DOI 10.1098/rstb.2009.0131; Hansen PJ, 2001, THERIOGENOLOGY, V55, P91, DOI 10.1016/S0093-691X(00)00448-9; Hansen PJ, 1999, J ANIM SCI, V77, P36; Haque N, 2012, J ANIM PHYSIOL AN N, V96, P920, DOI 10.1111/j.1439-0396.2011.01208.x; Hayashi S, 2003, BIOL REPROD, V69, P1170, DOI 10.1095/biolreprod.103.016832; Kadokawa H, 2012, ANIM SCI J, V83, P439, DOI 10.1111/j.1740-0929.2012.01011.x; Klatsky PC, 2010, MOL HUM REPROD, V16, P938, DOI 10.1093/molehr/gaq077; Kumar P, 2012, REPROD DOMEST ANIM, V47, pe88, DOI 10.1111/j.1439-0531.2012.01998.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Mamo S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-151; Manjunatha BM, 2009, ANIM REPROD SCI, V111, P376, DOI 10.1016/j.anireprosci.2008.03.003; Megahed GA, 2008, REPROD DOMEST ANIM, V43, P672, DOI 10.1111/j.1439-0531.2007.00968.x; Nandi S, 2001, VET REC, V148, P278, DOI 10.1136/vr.148.9.278; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Robert C, 2002, BIOL REPROD, V67, P1465, DOI 10.1095/biolreprod.102.006320; Roth Z, 2008, REPROD DOMEST ANIM, V43, P238, DOI 10.1111/j.1439-0531.2008.01168.x; Sakatani M, 2012, J DAIRY SCI, V95, P3080, DOI 10.3168/jds.2011-4986; Sakatani M, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-3; Schmitz KJ, 2011, J CLIN PATHOL, V64, P529, DOI 10.1136/jcp.2010.085621; Sharma GT, 2012, REPROD DOMEST ANIM, V47, P975, DOI 10.1111/j.1439-0531.2012.02002.x; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Thelie A, 2009, MOL REPROD DEV, V76, P773, DOI 10.1002/mrd.21031; Thundathil J, 2005, MOL REPROD DEV, V71, P405, DOI 10.1002/mrd.20260; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vigneault C, 2007, MOL REPROD DEV, V74, P703, DOI 10.1002/mrd.20665; Wolfenson D, 2000, ANIM REPROD SCI, V60, P535, DOI 10.1016/S0378-4320(00)00102-0; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yadav A, 2013, REPROD DOMEST ANIM; Zicarelli L, 2010, SOC REPROD FERTIL, V67, P443	55	37	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93287	10.1371/journal.pone.0093287	http://dx.doi.org/10.1371/journal.pone.0093287			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676354	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500103
J	Patrick, SK; Musselman, KE; Tajino, J; Ou, HC; Bastian, AJ; Yang, JF				Patrick, Susan K.; Musselman, Kristin E.; Tajino, Junichi; Ou, Hsiu-Chung; Bastian, Amy J.; Yang, Jaynie F.			Prior Experience but Not Size of Error Improves Motor Learning on the Split-Belt Treadmill in Young Children	PLOS ONE			English	Article							LOCOMOTOR ADAPTATION; CEREBELLAR CONTRIBUTIONS; VISUOMOTOR ADAPTATION; KINEMATIC COORDINATION; INTERNAL-MODEL; WALKING; PROPRIOCEPTION; PROGRESSION; GENERATION; PATTERNS	Children can modify learned motor skills, such as walking, to adapt to new environments. Movement errors in these new situations drive the learning. We used split-belt walking to determine whether size of the error affects the degree of learning. Twenty-two children (aged 2-5 y) walked on the split-belt treadmill on two separate days spaced 1 week apart. Twenty-eight adults served as controls. On Day 1, children experienced an abrupt change in belt speeds (from 1: 1 to 2: 1 differential) resulting in large errors, or a gradual change (same change in speed over 12-15 min), resulting in small errors. Learning was measured by the size of the aftereffect upon return to a 1: 1 differential. On Day 2 (1 week later), the leg on the fast belt was reversed, as was the method of introducing the speed differential. We found that the error size did not affect learning. Unexpectedly, learning was greater on Day 2 compared to Day 1, especially for children under 4 y of age, despite the fact that the task was opposite to that of Day 1, and did not influence learning in adults. Hence, 11 additional children under 4 y of age were tested with belts running at the same speed on Day 1, and with a 2: 1 speed differential (abrupt introduction) on Day 2. Surprisingly, learning was again greater on Day 2. We conclude that size of error during split-belt walking does not affect learning, but experience on a treadmill does, especially for younger children.	[Patrick, Susan K.; Tajino, Junichi; Ou, Hsiu-Chung; Yang, Jaynie F.] Univ Alberta, Dept Phys Therapy, Edmonton, AB, Canada; [Patrick, Susan K.; Tajino, Junichi; Ou, Hsiu-Chung; Yang, Jaynie F.] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada; [Musselman, Kristin E.; Bastian, Amy J.] Kennedy Krieger Inst, Baltimore, MD USA; [Musselman, Kristin E.; Bastian, Amy J.] Johns Hopkins Sch Med, Baltimore, MD USA	University of Alberta; University of Alberta; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins Medicine	Yang, JF (corresponding author), Univ Alberta, Dept Phys Therapy, Edmonton, AB, Canada.	jaynie.yang@ualberta.ca	Ou, Hsiu-Chung/AAQ-2489-2020	Ou, Hsiu-Chung/0000-0001-6794-3431; Musselman, Kristin/0000-0001-8336-8211; Yang, Jaynie/0000-0002-7507-8924	Natural Sciences and Engineering Research Council of Canada [13818-2011]; National Institutes of Health USA [HD048741]; Canadian Institutes of Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD048741] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Natural Sciences and Engineering Research Council of Canada 13818-2011 to JFY, National Institutes of Health USA HD048741 to AJB, Canadian Institutes of Health Research Fellowship to KEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPS R, 1989, NEUROSCI LETT, V102, P205, DOI 10.1016/0304-3940(89)90079-7; Barthelemy D, 2011, PROG BRAIN RES, V192, P181, DOI 10.1016/B978-0-444-53355-5.00012-9; Bastian AJ, 2008, CURR OPIN NEUROL, V21, P628, DOI 10.1097/WCO.0b013e328315a293; Bosco G, 2001, PHYSIOL REV, V81, P539, DOI 10.1152/physrev.2001.81.2.539; Braun DA, 2010, BEHAV BRAIN RES, V206, P157, DOI 10.1016/j.bbr.2009.08.031; Brown TG, 1914, J PHYSIOL-LONDON, V48, P18; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; Capio CM, 2013, J INTELL DISABIL RES, V57, P295, DOI 10.1111/j.1365-2788.2012.01535.x; Capio CM, 2012, BMC SPORTS SCI MED R, V4, DOI 10.1186/1758-2555-4-1; Caviness VS, 1996, CEREB CORTEX, V6, P726, DOI 10.1093/cercor/6.5.726; Cheron G, 2001, EXP BRAIN RES, V137, P455, DOI 10.1007/s002210000663; Choi JT, 2009, BRAIN, V132, P722, DOI 10.1093/brain/awn333; Criscimagna-Hemminger SE, 2010, J NEUROPHYSIOL, V103, P2275, DOI 10.1152/jn.00822.2009; Gibo TL, 2013, J NEUROPHYSIOL, V110, P322, DOI 10.1152/jn.00745.2012; Haslam C, 2012, NEUROPSYCHOL REHABIL, V22, P697, DOI 10.1080/09602011.2012.686820; Huang VS, 2009, J NEUROPHYSIOL, V102, P931, DOI 10.1152/jn.00237.2009; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Ingram HA, 2000, EXP BRAIN RES, V132, P114, DOI 10.1007/s002219900322; Ivanenko YP, 2004, J EXP BIOL, V207, P3797, DOI 10.1242/jeb.01214; Jayaram G, 2012, J NEUROPHYSIOL, V107, P2950, DOI 10.1152/jn.00645.2011; Jayaram G, 2011, CEREB CORTEX, V21, P1901, DOI 10.1093/cercor/bhq263; Kagerer FA, 2006, HUM MOVEMENT SCI, V25, P622, DOI 10.1016/j.humov.2006.06.003; Kagerer FA, 1997, EXP BRAIN RES, V115, P557, DOI 10.1007/PL00005727; Klassen J, 2005, EXP BRAIN RES, V164, P250, DOI 10.1007/s00221-005-2247-4; Kluzik J, 2008, J NEUROPHYSIOL, V100, P1455, DOI 10.1152/jn.90334.2008; Krakauer JW, 2011, CURR OPIN NEUROBIOL, V21, P636, DOI 10.1016/j.conb.2011.06.012; Le Ray D, 2011, PROG BRAIN RES, V188, P51, DOI 10.1016/B978-0-444-53825-3.00009-7; Malone LA, 2013, NEUROREHABIL NEURAL; Malone LA, 2012, J NEUROPHYSIOL, V108, P672, DOI 10.1152/jn.00391.2011; Malone LA, 2011, J NEUROSCI, V31, P15136, DOI 10.1523/JNEUROSCI.1367-11.2011; Malone LA, 2010, J NEUROPHYSIOL, V103, P1954, DOI 10.1152/jn.00832.2009; Martin TA, 1996, BRAIN, V119, P1183, DOI 10.1093/brain/119.4.1183; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Michel C, 2007, J COGNITIVE NEUROSCI, V19, P341, DOI 10.1162/jocn.2007.19.2.341; MOORE R, 1964, J EXP ANAL BEHAV, V7, P269, DOI 10.1901/jeab.1964.7-269; Morton SM, 2004, J NEUROPHYSIOL, V92, P2497, DOI 10.1152/jn.00129.2004; Morton SM, 2006, J NEUROSCI, V26, P9107, DOI 10.1523/JNEUROSCI.2622-06.2006; Musselman KE, 2011, J NEUROPHYSIOL, V105, P2195, DOI 10.1152/jn.01002.2010; Reisman DS, 2013, NEUROREHAB NEURAL RE, V27, P460, DOI 10.1177/1545968312474118; Reisman DS, 2005, J NEUROPHYSIOL, V94, P2403, DOI 10.1152/jn.00089.2005; Robertson EM, 1999, NEUROREPORT, V10, P1029, DOI 10.1097/00001756-199904060-00025; Rossignol S, 2011, ANNU REV NEUROSCI, V34, P413, DOI 10.1146/annurev-neuro-061010-113746; Saksena S, 2008, CEREBELLUM, V7, P392, DOI 10.1007/s12311-008-0041-0; Savin DN, 2013, NEUROREHAB NEURAL RE, V27, P24, DOI 10.1177/1545968311434552; Schlerf JE, 2013, J NEUROPHYSIOL, V109, P1164, DOI 10.1152/jn.00654.2011; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Tiemeier H, 2010, NEUROIMAGE, V49, P63, DOI 10.1016/j.neuroimage.2009.08.016; Torres-Oviedo G, 2012, J NEUROPHYSIOL, V107, P346, DOI 10.1152/jn.00570.2011; Vasudevan EVL, 2011, J NEUROSCI, V31, P3055, DOI 10.1523/JNEUROSCI.5781-10.2011; Vasudevan EVL, 2010, J NEUROPHYSIOL, V103, P183, DOI 10.1152/jn.00501.2009; Xu-Wilson M, 2009, J NEUROSCI, V29, P12930, DOI 10.1523/JNEUROSCI.3115-09.2009	53	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93349	10.1371/journal.pone.0093349	http://dx.doi.org/10.1371/journal.pone.0093349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SW	24675816	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500111
J	Yoshimura, H; Takumi, Y; Nishio, S; Suzuki, N; Iwasa, Y; Usami, S				Yoshimura, Hidekane; Takumi, Yutaka; Nishio, Shin-ya; Suzuki, Nobuyoshi; Iwasa, Yoh-ichiro; Usami, Shin-ichi			Deafness Gene Expression Patterns in the Mouse Cochlea Found by Microarray Analysis	PLOS ONE			English	Article							NONSYNDROMIC DEAFNESS; WFS1 GENE; MUTATIONS; DOMINANT; IMPAIRMENT; FAMILY; TMC1	Background: Tonotopy is one of the most fundamental principles of auditory function. While gradients in various morphological and physiological characteristics of the cochlea have been reported, little information is available on gradient patterns of gene expression. In addition, the audiograms in autosomal dominant non syndromic hearing loss can be distinctive, however, the mechanism that accounts for that has not been clarified. We thought that it is possible that tonotopic gradients of gene expression within the cochlea account for the distinct audiograms. Methodology/Principal Findings: We compared expression profiles of genes in the cochlea between the apical, middle, and basal turns of the mouse cochlea by microarray technology and quantitative RT-PCR. Of 24,547 genes, 783 annotated genes expressed more than 2-fold. The most remarkable finding was a gradient of gene expression changes in four genes (Pou4f3, Slc17a8, Tmc1, and Crym) whose mutations cause autosomal dominant deafness. Expression of these genes was greater in the apex than in the base. Interestingly, expression of the Emilin-2 and Tectb genes, which may have crucial roles in the cochlea, was also greater in the apex than in the base. Conclusions/Significance: This study provides baseline data of gradient gene expression in the cochlea. Especially for genes whose mutations cause autosomal dominant non syndromic hearing loss (Pou4f3, Slc17a8, Tmc1, and Crym) as well as genes important for cochlear function (Emilin-2 and Tectb), gradual expression changes may help to explain the various pathological conditions.	[Yoshimura, Hidekane; Takumi, Yutaka; Nishio, Shin-ya; Suzuki, Nobuyoshi; Iwasa, Yoh-ichiro; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan	Shinshu University	Takumi, Y (corresponding author), Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan.	takumi@shinshu-u.ac.jp		Nishio, Shin-ya/0000-0001-6640-2297	Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Science and Culture of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan (S.U.), and by a Grant-in-Aid for Scientific Research from the (then) Ministry of Education, Science and Culture of Japan (http://www.mext.go.jp/english/) (S.U., Y.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2003, AM J HUM GENET, V72, P73, DOI 10.1086/345398; Amma LL, 2003, MOL CELL NEUROSCI, V23, P460, DOI 10.1016/S1044-7431(03)00075-7; Bosl WJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-93; Cook DL, 1998, P NATL ACAD SCI USA, V95, P15641, DOI 10.1073/pnas.95.26.15641; Cryns K, 2003, HUM MUTAT, V22, P275, DOI 10.1002/humu.10258; de Heer AMR, 2009, ANN OTO RHINOL LARYN, V118, P313, DOI 10.1177/000348940911800413; Frucht CS, 2011, JARO-J ASSOC RES OTO, V412, P23; Fukuoka H, 2007, J HUM GENET, V52, P510, DOI 10.1007/s10038-007-0144-3; Ghaffari R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1094; Hildebrand MS, 2008, GENET MED, V10, P297, DOI 10.1097/GIM.0b013e318187e106; Hilgert N, 2008, CLIN GENET, V74, P223, DOI 10.1111/j.1399-0004.2008.01053.x; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Lee HK, 2010, BIOCHEM BIOPH RES CO, V396, P626, DOI 10.1016/j.bbrc.2010.04.132; Mann ZF, 2011, HEARING RES, V276, P2, DOI 10.1016/j.heares.2011.01.011; Morris KA, 2005, JARO-J ASSOC RES OTO, V6, P75, DOI 10.1007/s10162-004-5046-x; Ruel J, 2008, AM J HUM GENET, V83, P278, DOI 10.1016/j.ajhg.2008.07.008; Russell IJ, 2007, NAT NEUROSCI, V10, P215, DOI 10.1038/nn1828; Sato T, 2009, ACTA OTO-LARYNGOL, V129, P12, DOI 10.1080/00016480902926464; Smith R.J.H., 1993, GENEREVIEWS	19	25	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92547	10.1371/journal.pone.0092547	http://dx.doi.org/10.1371/journal.pone.0092547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676347	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500024
J	Zhang, L; Ma, LY; Wang, Z; Wang, Y; Zhang, J; Wang, HN; Shao, YM				Zhang, Lei; Ma, Liying; Wang, Zheng; Wang, Yan; Zhang, Jing; Wang, Haining; Shao, Yiming			Alterations in HIV-1 gp120 V3 Region Are Necessary but Not Sufficient for Coreceptor Switching in CRF07_BC in China	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SYNCYTIUM-INDUCING PHENOTYPE; AMINO-ACID SUBSTITUTIONS; BIOLOGICAL PHENOTYPE; DISEASE PROGRESSION; SEQUENCE VARIATION; USAGE PREDICTION; CXCR4 TROPISM; TYPE-1 CLONES; CELL TROPISM	The most predominant HIV-1 strains in China's current epidemic is the Circulating Recombinant Form 07_BC (CRF07_BC). CRF07_BC is mainly considered as a CCR5-tropic (R5) virus, since CXCR4-tropic (X4) viruses have thus far not been found in this subtype, and the molecular determinants of coreceptor switching remain unknown. To investigate the mechanisms underlying coreceptor requirement in CRF07_BC viruses, we characterized a panel of pNL4-3-based chimeric viruses with mutated V3 loop regions derived from an HIV-1 CRF07_BC infectious clone pXJDC13. Among 17 chimeric viruses, seven were dual-tropic and induced syncytium formation in MT-2 cells. Two amino acid insertions between positions 13 and 14, as well as arginine substitution at position 11 or 16 (IG insertion and P16R mutation or MG insertion and S11R mutation), conferred the chimeric viruses CXCR4-tropic features, which were same as subtype C X4 viruses. Next, to construct CRF07_BC X4 variants, mutated V3 loops were cloned into the CRF07_BC infectious clone pXJDC13. These V3 loops, which in the pNL4-3 backbone conferred chimeric viruses with CXCR4-using ability, abrogated infectivity completely in the CRF07_BC pXJDC13 genetic background. Similarly, IG insertion or MG insertion and S11R mutation dramatically diminished or completely abolished viral infectivity in other envelopes of subtype C or CRF07_BC. These results suggest that the effects of IG insertion and P16R mutation or MG insertion and S11R mutation on CXCR4 usage are context dependent, and additional mutations elsewhere in the envelope are needed to compensate for these fitness-reducing alterations.	[Zhang, Lei; Ma, Liying; Wang, Zheng; Wang, Yan; Zhang, Jing; Wang, Haining; Shao, Yiming] China CDC, Natl Ctr AIDS STD Control & Prevent NCAIDS, State Key Lab Infect Dis Prevent & Control, Div Res Virol & Immunol, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Shao, YM (corresponding author), China CDC, Natl Ctr AIDS STD Control & Prevent NCAIDS, State Key Lab Infect Dis Prevent & Control, Div Res Virol & Immunol, Beijing, Peoples R China.	yshao08@gmail.com		Wang, Yan/0000-0002-8031-0716	National Science and Technology Major Project [2012ZX10001008]; National Natural Science Foundation of China [81020108030, 81261120384, 81172733, 81101281]; State Key Laboratory for Infectious Diseases Prevention and Control [2011SKLID102]	National Science and Technology Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory for Infectious Diseases Prevention and Control	This work was supported by National Science and Technology Major Project (grant 2012ZX10001008), the National Natural Science Foundation of China (grants 81020108030, 81261120384, 81172733 and 81101281), and the Key Project of the State Key Laboratory for Infectious Diseases Prevention and Control (No. 2011SKLID102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorndal A, 1997, J VIROL, V71, P7478; Brumme ZL, 2004, AIDS, V18, pF1, DOI 10.1097/00002030-200403050-00001; Cashin K, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-24; Cilliers T, 2003, J VIROL, V77, P4449, DOI 10.1128/JVI.77.7.4449-4456.2003; Coetzer M, 2006, VIROLOGY, V356, P95, DOI 10.1016/j.virol.2006.07.030; Coetzer M, 2011, JAIDS-J ACQ IMM DEF, V56, P9, DOI 10.1097/QAI.0b013e3181f63906; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Dash PK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-25; DEJONG JJ, 1992, J VIROL, V66, P757, DOI 10.1128/JVI.66.2.757-765.1992; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Doms RW, 1997, VIROLOGY, V235, P179, DOI 10.1006/viro.1997.8703; Esbjornsson J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; He X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047289; Hoffman NG, 2002, J VIROL, V76, P3852, DOI 10.1128/JVI.76.8.3852-3864.2002; Huang W, 2008, J VIROL, V82, P5584, DOI 10.1128/JVI.02676-07; Huang W, 2007, J VIROL, V81, P7885, DOI 10.1128/JVI.00218-07; Huang W, 2011, VIROLOGY, V409, P308, DOI 10.1016/j.virol.2010.09.026; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Jakobsen MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065950; Jensen MA, 2006, J VIROL, V80, P4698, DOI 10.1128/JVI.80.10.4698-4704.2006; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; KARLSSON A, 1994, J CLIN MICROBIOL, V32, P364, DOI 10.1128/JCM.32.2.364-370.1994; Kato K, 1999, J VIROL, V73, P5520, DOI 10.1128/JVI.73.7.5520-5526.1999; KOOT M, 1992, AIDS, V6, P49, DOI 10.1097/00002030-199201000-00006; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Lin NH, 2012, VIROLOGY, V433, P296, DOI 10.1016/j.virol.2012.08.013; Ma LY, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-45; Pastore C, 2004, J VIROL, V78, P7565, DOI 10.1128/JVI.78.14.7565-7574.2004; Pastore C, 2007, J VIROL, V81, P8165, DOI 10.1128/JVI.02792-06; Rana S, 1997, J VIROL, V71, P3219, DOI 10.1128/JVI.71.4.3219-3227.1997; RICHMAN DD, 1994, J INFECT DIS, V169, P968, DOI 10.1093/infdis/169.5.968; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Sing T, 2007, ANTIVIR THER, V12, P1097; Singh A, 2009, TEXTS COMPUT SCI, P1; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Taylor BM, 2008, J VIROL, V82, P5460, DOI 10.1128/JVI.01049-07; TERSMETTE M, 1989, J VIROL, V63, P2118, DOI 10.1128/JVI.63.5.2118-2125.1989; United States Food and Drug Administration, 2014, ANT DRUGS US TREATM; van Rij RP, 2002, J VIROL, V76, P3054, DOI 10.1128/JVI.76.6.3054-3058.2002; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079177; Yu XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017605; Zhang CY, 2009, INT J INFECT DIS, V13, pE212, DOI 10.1016/j.ijid.2008.12.010; Zhang H, 2010, VIROLOGY, V407, P68, DOI 10.1016/j.virol.2010.07.047	46	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93426	10.1371/journal.pone.0093426	http://dx.doi.org/10.1371/journal.pone.0093426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676404	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500123
J	Zhao, GY; Liu, CF; Kou, ZH; Gao, TT; Pan, T; Wu, XH; Yu, H; Guo, Y; Zeng, Y; Du, LY; Jiang, SB; Sun, SH; Zhou, YS				Zhao, Guangyu; Liu, Chenfeng; Kou, Zhihua; Gao, Tongtong; Pan, Ting; Wu, Xiaohong; Yu, Hong; Guo, Yan; Zeng, Yang; Du, Lanying; Jiang, Shibo; Sun, Shihui; Zhou, Yusen			Differences in the Pathogenicity and Inflammatory Responses Induced by Avian Influenza A/H7N9 Virus Infection in BALB/c and C57BL/6 Mouse Models	PLOS ONE			English	Article							A H7N9 VIRUS; NECROSIS-FACTOR RECEPTORS; T-CELL RESPONSES; TNF-ALPHA; LUNG INJURY; NEUTROPHILS; MICE; IMMUNOPATHOLOGY; INTERLEUKIN-1; PATHOGENESIS	Avian influenza A/H7N9 virus infection causes pneumonia in humans with a high case fatality rate. However, virus-induced modulation of immune responses is being recognized increasingly as a factor in the pathogenesis of this disease. In this study, we compared the pathogenicity of A/H7N9 infection in BALB/c and C57BL/6 mouse models, and investigated the putative involvement of proinflammatory cytokines in lung injury and viral clearance. In both mouse strains, A/Anhui/1/2013(H7N9) infection with 10(6) TCID50 resulted in viral replication in lung, severe body weight loss and acute lung injury. During the early infection stage, infected C57BL/6 mice exhibited more severe lung injury, slower recovery from lung damage, less effective viral clearance, higher levels of interlukine (IL)-6, monocyte chemotactic protein (MCP)-1, and IL-1 beta, and lower levels of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma than infected BALB/c mice. These results suggest that TNF-alpha and IFN-gamma may help suppress viral gene expression and increase viral clearance, and that IL-6 and MCP-1 may contribute to lung injury in A/H7N9-infected individuals. In addition, lung damage and the distribution of virus antigen in tissues were similar in young and middle-aged mice. These results suggest that the more serious lung injury in middle-aged or older H7N9 cases is not mainly caused by differences in viral replication in the lung but probably by a dysregulated immune response induced by underlying comorbidities. These results indicate that the extent of dysregulation of the host immune response after H7N9 virus infection most probably determines the outcome of H7N9 virus infection.	[Zhao, Guangyu; Liu, Chenfeng; Kou, Zhihua; Gao, Tongtong; Pan, Ting; Wu, Xiaohong; Yu, Hong; Guo, Yan; Zeng, Yang; Sun, Shihui; Zhou, Yusen] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Du, Lanying; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Educ & Hlth, Shanghai, Peoples R China; [Jiang, Shibo] Fudan Univ, Inst Med Microbiol, Shanghai, Peoples R China	Beijing Institute of Microbiology & Epidemiology; New York Blood Center; Fudan University; Fudan University	Sun, SH (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	sunsh01@163.com; yszhou@bmi.ac.cn	Jiang, Shibo/L-4500-2014; Yu, Hongwei/L-3754-2017	Jiang, Shibo/0000-0001-8283-7135; Yu, Hongwei/0000-0002-5607-0628	Project on Human H7N9 from the Ministry of Science and Technology of China [KJYJ-2013-01-04]; National Projects of Infectious Disease [2012ZX10004502]; NSFC of China [81371805]; Shanghai Joint Research Projects on the Prevention and Control of Avian Influenza H7N9 Virus [2013QLG010]	Project on Human H7N9 from the Ministry of Science and Technology of China; National Projects of Infectious Disease; NSFC of China(National Natural Science Foundation of China (NSFC)); Shanghai Joint Research Projects on the Prevention and Control of Avian Influenza H7N9 Virus	This work was supported by grants from the Project on Human H7N9 from the Ministry of Science and Technology of China (KJYJ-2013-01-04), the National Projects of Infectious Disease (2012ZX10004502), the NSFC of China (81371805), and Shanghai Joint Research Projects on the Prevention and Control of Avian Influenza H7N9 Virus (2013QLG010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANKS WA, 1994, NEUROSCI LETT, V179, P53, DOI 10.1016/0304-3940(94)90933-4; Belisle SE, 2010, J VIROL, V84, P12576, DOI 10.1128/JVI.01310-10; Buczynski BW, 2013, AM J PHYSIOL-LUNG C, V305, pL282, DOI 10.1152/ajplung.00112.2013; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Chi Y, 2013, J INFECT DIS, V208, P1962, DOI 10.1093/infdis/jit440; Chiaretti A, 2013, INT J INFECT DIS, V17, pE1186, DOI 10.1016/j.ijid.2013.07.006; Damjanovic D, 2011, AM J PATHOL, V179, P2963, DOI 10.1016/j.ajpath.2011.09.003; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Decker T, 2002, J CLIN INVEST, V109, P1271, DOI 10.1172/JCI200215770; Fujisawa H, 2008, J VIROL, V82, P2772, DOI 10.1128/JVI.01210-07; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liang S, 2009, MECH AGEING DEV, V130, P538, DOI 10.1016/j.mad.2009.06.006; Maue AC, 2009, TRENDS IMMUNOL, V30, P301, DOI 10.1016/j.it.2009.04.007; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; Mok CKP, 2013, MBIO, V4, DOI 10.1128/mBio.00362-13; Otte A, 2011, AM J PATHOL, V179, P230, DOI 10.1016/j.ajpath.2011.03.041; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Singh A, 2007, J VIROL, V81, P6502, DOI 10.1128/JVI.00163-07; Smallman-Raynor M, 2007, EMERG INFECT DIS, V13, P510, DOI 10.3201/eid1303.060849; Sun SH, 2013, AM J RESP CELL MOL, V49, P221, DOI 10.1165/rcmb.2012-0428OC; Suresh M, 2005, J VIROL, V79, P202, DOI 10.1128/JVI.79.1.202-213.2005; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; van Helden MJG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052027; Weber O, 2003, J GEN VIROL, V84, P1843, DOI 10.1099/vir.0.19138-0; WHO, 2013, HUM INF AV INFL A H7; Wortzman ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068911; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6; Zaghouani H, 2009, TRENDS IMMUNOL, V30, P585, DOI 10.1016/j.it.2009.09.002; Zganiacz A, 2004, J CLIN INVEST, V113, P401, DOI 10.1172/JCI200418991; Zhao GY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-9; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379	37	15	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92987	10.1371/journal.pone.0092987	http://dx.doi.org/10.1371/journal.pone.0092987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676272	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500062
J	Noisette, F; Comtet, T; Legrand, E; Bordeyne, F; Davoult, D; Martin, S				Noisette, Fanny; Comtet, Thierry; Legrand, Erwann; Bordeyne, Francois; Davoult, Dominique; Martin, Sophie			Does Encapsulation Protect Embryos from the Effects of Ocean Acidification? The Example of Crepidula fornicata	PLOS ONE			English	Article							CARBON-DIOXIDE CONCENTRATIONS; OYSTER SACCOSTREA-GLOMERATA; LIFE-HISTORY STAGES; LARVAL DEVELOPMENT; ELEVATED PCO(2); EGG CAPSULES; REDUCED PH; SEA-WATER; FUTURE; GASTROPOD	Early life history stages of marine organisms are generally thought to be more sensitive to environmental stress than adults. Although most marine invertebrates are broadcast spawners, some species are brooders and/or protect their embryos in egg or capsules. Brooding and encapsulation strategies are typically assumed to confer greater safety and protection to embryos, although little is known about the physico-chemical conditions within egg capsules. In the context of ocean acidification, the protective role of encapsulation remains to be investigated. To address this issue, we conducted experiments on the gastropod Crepidula fornicata. This species broods its embryos within capsules located under the female and veliger larvae are released directly into the water column. C. fornicata adults were reared at the current level of CO2 partial pressure (pCO(2)) (390 mu atm) and at elevated levels (750 and 1400 mu atm) before and after fertilization and until larval release, such that larval development occurred entirely at a given pCO(2). The pCO(2) effects on shell morphology, the frequency of abnormalities and mineralization level were investigated on released larvae. Shell length decreased by 6% and shell surface area by 11% at elevated pCO(2) (1400 matm). The percentage of abnormalities was 1.5-to 4-fold higher at 750 matm and 1400 matm pCO(2), respectively, than at 390 mu atm. The intensity of birefringence, used as a proxy for the mineralization level of the larval shell, also decreased with increasing pCO(2). These negative results are likely explained by increased intracapsular acidosis due to elevated pCO(2) in extracapsular seawater. The encapsulation of C. fornicata embryos did not protect them against the deleterious effects of a predicted pCO(2) increase. Nevertheless, C. fornicata larvae seemed less affected than other mollusk species. Further studies are needed to identify the critical points of the life cycle in this species in light of future ocean acidification.	[Noisette, Fanny; Comtet, Thierry; Legrand, Erwann; Bordeyne, Francois; Davoult, Dominique; Martin, Sophie] Univ Paris 06, Sorbonne Univ, Stn Biol Roscoff, UMR 7144, Roscoff, France; [Noisette, Fanny; Comtet, Thierry; Legrand, Erwann; Bordeyne, Francois; Davoult, Dominique; Martin, Sophie] CNRS, Stn Biol Roscoff, UMR 7144, Roscoff, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Noisette, F (corresponding author), Univ Paris 06, Sorbonne Univ, Stn Biol Roscoff, UMR 7144, Roscoff, France.	fanny.noisette@sb-roscoff.fr	Davoult, dominique/D-5932-2012; Comtet, Thierry/ABE-3212-2021	Davoult, dominique/0000-0001-8678-3998; MARTIN, Sophie/0000-0002-1256-3674; Legrand, Erwann/0000-0001-5224-5227	CALCAO project; Region Bretagne; European Community [211384]; Interreg IV a France (Channel) - England Marinexus project [4073]; FEDER programme	CALCAO project; Region Bretagne(Region Bretagne); European Community(European Commission); Interreg IV a France (Channel) - England Marinexus project; FEDER programme(European Commission)	This work was supported by the CALCAO project, which received funding from the Region Bretagne, and contributed to the "European Project on Ocean Acidification" (EPOCA) funded by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 211384. It was also supported by the Interreg IV a France (Channel) - England Marinexus project no4073 funded by the FEDER programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TR, 2012, STUDENT RES PAPERS; Andersen S, 2013, BIOGEOSCIENCES, V10, P6161, DOI 10.5194/bg-10-6161-2013; Anil AC, 2001, J EXP MAR BIOL ECOL, V263, P125, DOI 10.1016/S0022-0981(01)00280-5; [Anonymous], 2009, BIOGEOSCI DISCUSS, DOI DOI 10.5194/BGD-6-3109-2009; Auzoux-Bordenave S, 2010, J STRUCT BIOL, V171, P277, DOI 10.1016/j.jsb.2010.05.012; Barros P, 2013, J EXP MAR BIOL ECOL, V440, P200, DOI 10.1016/j.jembe.2012.12.014; Barry J. P., 2010, GUIDE BEST PRACTICES, P260; Bechmann RK, 2011, J TOXICOL ENV HEAL A, V74, P424, DOI 10.1080/15287394.2011.550460; Blanchard M, 1995, HALIOTIS, V24, P75; Blanchard Michel, 1997, Scientia Marina, V61, P109; Brante A, 2008, MAR ECOL PROG SER, V368, P197, DOI 10.3354/meps07605; Brante A, 2009, J EXP BIOL, V212, P2287, DOI 10.1242/jeb.016329; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Byrne M, 2011, P ROY SOC B-BIOL SCI, V278, P2376, DOI 10.1098/rspb.2010.2404; Chan KYK, 2011, J EXP BIOL, V214, P3857, DOI 10.1242/jeb.054809; Chaparro OR, 2009, J EXP MAR BIOL ECOL, V377, P107, DOI 10.1016/j.jembe.2009.07.001; Chaparro OR, 2009, MAR ECOL PROG SER, V374, P145, DOI 10.3354/meps07777; Chua CM, 2013, MAR ECOL PROG SER, V475, P85, DOI 10.3354/meps10077; Crim RN, 2011, J EXP MAR BIOL ECOL, V400, P272, DOI 10.1016/j.jembe.2011.02.002; Davis AR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064808, 10.1371/journal.pone.0055939]; de Mahieu G.C., 1974, Cahiers Biol Mar, V15, P215; Dickson A.G., 2007, GUIDE BEST PRACTICES; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dorey N, 2013, MAR BIOL, V160, P2007, DOI 10.1007/s00227-012-2059-6; Dupont S, 2013, MAR BIOL, V160, P1835, DOI 10.1007/s00227-012-1921-x; Dupont S, 2010, ESTUAR COAST SHELF S, V89, P182, DOI 10.1016/j.ecss.2010.06.013; Dupont S, 2008, MAR ECOL PROG SER, V373, P285, DOI 10.3354/meps07800; Egilsdottir H, 2009, MAR POLLUT BULL, V58, P1187, DOI 10.1016/j.marpolbul.2009.03.017; Ellis RP, 2009, AQUAT BIOL, V5, P41, DOI 10.3354/ab00118; EYSTER LS, 1986, BIOL BULL-US, V170, P211, DOI 10.2307/1541804; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Fernandes DAO, 2012, INTEGR COMP BIOL, V52, pE244; Gaylord B, 2011, J EXP BIOL, V214, P2586, DOI 10.1242/jeb.055939; Gazeau F, 2010, BIOGEOSCIENCES, V7, P2051, DOI 10.5194/bg-7-2051-2010; Gazeau F, 2013, MAR BIOL, V160, P2207, DOI 10.1007/s00227-013-2219-3; Gazeau F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023010; Ginger KWK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064147; Gutowska MA, 2009, MAR BIOL, V156, P515, DOI 10.1007/s00227-008-1096-7; Hettinger A, 2013, BIOGEOSCIENCES, V10, P6629, DOI 10.5194/bg-10-6629-2013; Hickman CS, 1999, INVERTEBR BIOL, V118, P346, DOI 10.2307/3227006; Hickman CS, 2001, EVOL DEV, V3, P18, DOI 10.1046/j.1525-142x.2001.01003.x; Hoegh-Guldberg O, 2009, CORAL REEFS, V28, P569, DOI 10.1007/s00338-009-0508-6; IPCC, 2013, CLIM CAHGN 2013 PHYS; Jansson A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068198; Kim K-S, 2013, BIOGEOSCI DISCUSS, V10, P7413, DOI DOI 10.5194/BGD-10-7413-; Kimura R, 2011, FISH OCEANOGR, V20, P357, DOI 10.1111/j.1365-2419.2011.00589.x; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Kurihara H, 2007, AQUAT BIOL, V1, P91, DOI 10.3354/ab00009; Kurihara H, 2009, AQUAT BIOL, V4, P225, DOI 10.3354/ab00109; Lenz M, 2011, ENVIRON RES, V111, P943, DOI 10.1016/j.envres.2011.05.001; Lewis E., 1998, PROGRAM DEV CO2 SYST; Li JQ, 2013, MAR POLLUT BULL, V74, P320, DOI 10.1016/j.marpolbul.2013.06.035; Maeda-Martinez AN, 2008, MAR BIOL, V154, P643, DOI 10.1007/s00227-008-0957-4; MAEDAMARTINEZ AN, 1987, COMP BIOCHEM PHYS A, V86, P21, DOI 10.1016/0300-9629(87)90270-2; Martin S, 2011, J EXP BIOL, V214, P1357, DOI 10.1242/jeb.051169; Marxen JC, 2003, J MOLLUS STUD, V69, P113, DOI 10.1093/mollus/69.2.113; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; Montory JA, 2009, MAR ECOL PROG SER, V374, P157, DOI 10.3354/meps07780; Moran D, 2011, AQUAT TOXICOL, V102, P24, DOI 10.1016/j.aquatox.2010.12.014; Munday PL, 2011, MAR ECOL PROG SER, V423, P211, DOI 10.3354/meps08990; Nguyen HD, 2012, GLOBAL CHANGE BIOL, V18, P2466, DOI 10.1111/j.1365-2486.2012.02714.x; Noisette F, 2013, J PHYCOL, V49, P746, DOI 10.1111/jpy.12085; Occhipinti-Ambrogi A, 2007, MAR POLLUT BULL, V55, P342, DOI 10.1016/j.marpolbul.2006.11.014; ORTON J.H., 1912, J MAR BIOL ASSOC UK, V9, P437, DOI DOI 10.1017/S0025315400048372; Padilla-Gamino JL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0155; Pansch C, 2013, ICES J MAR SCI, V70, P805, DOI 10.1093/icesjms/fst092; Parker Laura M., 2013, Biology - Basel, V2, P651, DOI 10.3390/biology2020651; Parker LM, 2012, GLOBAL CHANGE BIOL, V18, P82, DOI 10.1111/j.1365-2486.2011.02520.x; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; PECHENIK JA, 1983, J EXP MAR BIOL ECOL, V71, P165, DOI 10.1016/0022-0981(93)90071-U; PECHENIK JA, 1982, J EXP MAR BIOL ECOL, V63, P195, DOI 10.1016/0022-0981(82)90178-2; PECHENIK JA, 1984, J EXP MAR BIOL ECOL, V74, P241, DOI 10.1016/0022-0981(84)90128-X; Peck LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066033; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Przeslawski Rachel, 2004, Molluscan Research, V24, P43, DOI 10.1071/MR04001; Putnam HM, 2013, MAR BIOL, V160, P2157, DOI 10.1007/s00227-012-2129-9; R Core Team, 2021, R LANGUAGE ENV STAT; Range P, 2012, J EXP MAR BIOL ECOL, V424, P89, DOI 10.1016/j.jembe.2012.05.010; Rasband WS, 2012, HEALTH USNIO; Richard J, 2006, MAR BIOL, V149, P789, DOI 10.1007/s00227-005-0157-4; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rigal F, 2009, THESIS U PM CURIE; Ross PM, 2011, WATER-SUI, V3, P1005, DOI 10.3390/w3041005; Scherrer B., 1984, BIOSTATISTIQUES; Schonitzer V, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-71; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Talmage SC, 2009, LIMNOL OCEANOGR, V54, P2072, DOI 10.4319/lo.2009.54.6.2072; Thiyagarajan V, 2012, AQUACULTURE, V370, P90, DOI 10.1016/j.aquaculture.2012.09.025; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Van Colen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044655; Vehmaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048538; Watson SA, 2009, J SHELLFISH RES, V28, P431, DOI 10.2983/035.028.0302; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; White MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061065; Widdicombe S, 2008, J EXP MAR BIOL ECOL, V366, P187, DOI 10.1016/j.jembe.2008.07.024; Zar JH, 1974, BIOSTATISTICAL ANAL	104	28	28	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93021	10.1371/journal.pone.0093021	http://dx.doi.org/10.1371/journal.pone.0093021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671195	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000102
J	Reid, KJ; Santostasi, G; Baron, KG; Wilson, J; Kang, J; Zee, PC				Reid, Kathryn J.; Santostasi, Giovanni; Baron, Kelly G.; Wilson, John; Kang, Joseph; Zee, Phyllis C.			Timing and Intensity of Light Correlate with Body Weight in Adults	PLOS ONE			English	Article							HIGH-FAT DIET; BRIGHT LIGHT; SLEEP DURATION; EXPOSURE; MELATONIN; ACTIGRAPHY; ASSOCIATION; SENSITIVITY; SUPPRESSION; ACCURACY	Light exposure can influence sleep and circadian timing, both of which have been shown to influence weight regulation. The goal of this study was to evaluate the relationship between ambient light, sleep and body mass index. Participants included 54 individuals (26 males, mean age 30.6, SD = 11.7 years). Light levels, sleep midpoint and duration were measured with wrist actigraphy (Actiwatch-L) for 7 days. BMI was derived from self-reported height and weight. Caloric intake was determined from 7 days of food logs. For each participant, light and activity data were output in 2 minute epochs, smoothed using a 5 point (10 minute) moving average and then aggregated over 24 hours. The mean light timing above 500 lux (MLiT500) was defined as the average clock time of all aggregated data points above 500 lux. MLiT500 was positively correlated with BMI (r = 0.51, p<0.001), and midpoint of sleep (r = 0.47, p<0.01). In a multivariable linear regression model including MLiT500 and midpoint of sleep, MLiT500 was a significant predictor of BMI (B = 1.26 SE = 0.34, beta = 0.53 p = 0.001, r(Delta)(2) = 0.22). Adjusting for covariates, MLiT500 remained an independent predictor of BMI (B = 1.28 SE = 0.36, beta = 0.54, p = 0.002, r(Delta)(2) = 0.20). The full model accounted for 34.7% of the variance in BMI (p = 0.01). Exposure to moderate levels of light at biologically appropriate times can influence weight, independent of sleep timing and duration.	[Reid, Kathryn J.; Santostasi, Giovanni; Baron, Kelly G.; Wilson, John; Zee, Phyllis C.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Kang, Joseph] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Zee, PC (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA.	p-zee@northwestern.edu	Zee, Phyllis C/GPF-3704-2022	Wilson, John/0000-0002-8553-9253	 [R01HL069988];  [P01 AG11412];  [5K12 HD055884];  [1K23HL109110]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD055884] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL109110, R01HL069988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011412] Funding Source: NIH RePORTER	; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work on this project was funded through Grants R01HL069988, P01 AG11412, 5K12 HD055884, and 1K23HL109110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Auger RR, 2011, CHRONOBIOL INT, V28, P911, DOI 10.3109/07420528.2011.619906; Baron KG, 2011, OBESITY, V19, P1374, DOI 10.1038/oby.2011.100; Chang AM, 2011, J PHYSIOL-LONDON, V589, P1095, DOI 10.1113/jphysiol.2010.201194; Coomans CP, 2013, FASEB J, V27, P1721, DOI 10.1096/fj.12-210898; Danilenko KV, 2013, OBESITY FACTS, V6, P28, DOI 10.1159/000348549; Dunai A, 2007, OBESITY, V15, P1749, DOI 10.1038/oby.2007.208; Figueiro MG, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/530726; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Golley RK, 2013, INT J OBESITY, V37, P546, DOI 10.1038/ijo.2012.212; Gonnissen HK, 2013, PHYSL BEHAV; Goulet G, 2007, J BIOL RHYTHM, V22, P151, DOI 10.1177/0748730406297780; Hebert M, 2002, J PINEAL RES, V33, P198, DOI 10.1034/j.1600-079X.2002.01885.x; Jardim ACN, 2011, CHRONOBIOL INT, V28, P834, DOI 10.3109/07420528.2011.611603; Jung CM, 2010, J BIOL RHYTHM, V25, P208, DOI 10.1177/0748730410368413; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; Lockley SW, 2003, J CLIN ENDOCR METAB, V88, P4502, DOI 10.1210/jc.2003-030570; Lucassen EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056519; Maglione JE, 2013, SLEEP, V36, P1209, DOI 10.5665/sleep.2888; Marino M, 2013, SLEEP, V36, P1747, DOI 10.5665/sleep.3142; MATSON RJ, 1984, SOL CELLS, V11, P105, DOI 10.1016/0379-6787(84)90022-X; McMullan CJ, 2013, JAMA-J AM MED ASSOC, V309, P1388, DOI 10.1001/jama.2013.2710; Morgenthaler T, 2007, SLEEP, V30, P519, DOI 10.1093/sleep/30.4.519; Munch M, 2006, AM J PHYSIOL-REG I, V290, pR1421, DOI 10.1152/ajpregu.00478.2005; Obayashi K, 2012, J CLIN ENDOCR METAB, V97, P4166, DOI 10.1210/jc.2012-1873; Osterhaus W, 1993, OFFICE LIGHTING REV; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Patel SR, 2006, AM J EPIDEMIOL, V164, P947, DOI 10.1093/aje/kwj280; Peschke E, 2013, INT J MOL SCI, V14, P6981, DOI 10.3390/ijms14046981; Philips Respironics, 2008, CHAR LIGHT SENS PERF; Poslusna K, 2009, BRIT J NUTR, V101, pS73, DOI 10.1017/S0007114509990602; Puchalski SS, 2003, ENDOCRINE, V21, P163, DOI 10.1385/ENDO:21:2:163; Rabinovich RA, 2013, EUR RESPIR J, V42, P1205, DOI 10.1183/09031936.00134312; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Ruger M, 2006, AM J PHYSIOL-REG I, V290, pR1413, DOI 10.1152/ajpregu.00121.2005; Sakakibara S, 2000, PSYCHIAT CLIN NEUROS, V54, P363, DOI 10.1046/j.1440-1819.2000.00716.x; Smith KA, 2004, J CLIN ENDOCR METAB, V89, P3610, DOI 10.1210/jc.2003-032100; Staples VSL, 2009, J SLEEP RES, V18, P466, DOI 10.1111/j.1365-2869.2009.00762.x; Stommel M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-421; Tasali E, 2008, P NATL ACAD SCI USA, V105, P1044, DOI 10.1073/pnas.0706446105; Thorne HC, 2009, CHRONOBIOL INT, V26, P854, DOI 10.1080/07420520903044315; Zanuto R, 2013, J PINEAL RES	44	60	60	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92251	10.1371/journal.pone.0092251	http://dx.doi.org/10.1371/journal.pone.0092251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24694994	Green Published, gold			2022-12-27	WOS:000334103000017
J	Corso, B; Greenberg, DA				Corso, Barbara; Greenberg, David A.			Using Linkage Analysis to Detect Gene-Gene Interaction by Stratifying Family Data on Known Disease, or Disease-Associated, Alleles	PLOS ONE			English	Article							SIMULATION; MODELS; POWER	Detecting gene-gene interaction in complex diseases is a major challenge for common disease genetics. Most interaction detection approaches use disease-marker associations and such methods have low power and unknown reliability in real data. We developed and tested a powerful linkage-analysis-based gene-gene interaction detection strategy based on conditioning the family data on a known disease-causing allele or disease-associated marker allele. We computer-generated multipoint linkage data for a disease caused by two epistatically interacting loci (A and B). We examined several two-locus epistatic inheritance models: dominant-dominant, dominant-recessive, recessive-dominant, recessive-recessive. At one of the loci (A), there was a known disease-related allele. We stratified the family data on the presence of this allele, eliminating family members who were without it. This elimination step has the effect of raising the "penetrance" at the second locus (B). We then calculated the lod score at the second locus (B) and compared the pre- and post-stratification lod scores at B. A positive difference indicated interaction. We also examined if it was possible to detect interaction with locus B based on a disease-marker association (instead of an identified disease allele) at locus A. We also tested whether the presence of genetic heterogeneity would generate false positive evidence of interaction. The power to detect interaction for a known disease allele was 60-90%. The probability of false positives, based on heterogeneity, was low. Decreasing linkage disequilibrium between the disease and marker at locus A decreased the likelihood of detecting interaction. The allele frequency of the associated marker made little difference to the power.	[Corso, Barbara] CNR, Inst Neurosci, Padua, Italy; [Greenberg, David A.] Nationwide Childrens Hosp, Battelle Ctr Math Med, Columbus, OH 43205 USA; [Greenberg, David A.] Ohio State Univ, Dept Pediat, Wexner Med Ctr, Columbus, OH 43210 USA	Consiglio Nazionale delle Ricerche (CNR); University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University	Greenberg, DA (corresponding author), Nationwide Childrens Hosp, Battelle Ctr Math Med, Columbus, OH 43205 USA.	david.greenberg@nationwidechildrens.org	Corso, Barbara/P-1796-2018	Corso, Barbara/0000-0002-0684-9078	Nationwide Children's Hospital, Columbus OH [T32-MH65213, NINDS NS27941, NIMH MH48858, NS61829, NS70323]; New York State Psychiatric Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048858, T32MH065213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027941, R01NS061829, R21NS070323] Funding Source: NIH RePORTER	Nationwide Children's Hospital, Columbus OH; New York State Psychiatric Institute; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants T32-MH65213, NINDS NS27941, NIMH MH48858, NS61829, NS70323, Nationwide Children's Hospital, Columbus OH, and the New York State Psychiatric Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu PC, 1999, AM J HUM GENET, V65, P847, DOI 10.1086/302536; Cavalli-Sforza L.L., 1971, GENETICS HUMAN POPUL; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; GREENBERG DA, 1981, AM J HUM GENET, V33, P519; Greenberg DA, 2001, GENET EPIDEMIOL, V21, P299, DOI 10.1002/gepi.1036; Greenberg DA, 2011, HUM HERED, V72, P247, DOI 10.1159/000330633; Hodge SE, 1997, AM J HUM GENET, V60, P217; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Rodriguez-Murillo L, 2010, J HEART LUNG TRANSPL, V29, P174, DOI 10.1016/j.healun.2009.08.022; Rodriguez-Murillo L, 2008, INT J ANDROL, V31, P546, DOI 10.1111/j.1365-2605.2008.00896.x	12	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93398	10.1371/journal.pone.0093398	http://dx.doi.org/10.1371/journal.pone.0093398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690899	Green Submitted, Green Published, gold			2022-12-27	WOS:000334101100074
J	Farooq, SM; Boppana, NB; Asokan, D; Sekaran, SD; Shankar, EM; Li, CY; Gopal, K; Bakar, SA; Karthik, HS; Ebrahim, AS				Farooq, Shukkur M.; Boppana, Nithin B.; Asokan, Devarajan; Sekaran, Shamala D.; Shankar, Esaki M.; Li, Chunying; Gopal, Kaliappan; Bakar, Sazaly A.; Karthik, Harve S.; Ebrahim, Abdul S.			C- Phycocyanin Confers Protection against Oxalate-Mediated Oxidative Stress and Mitochondrial Dysfunctions in MDCK Cells	PLOS ONE			English	Article							RENAL EPITHELIAL-CELLS; LIPID-PEROXIDATION; ANTIOXIDANT; KINASE; INJURY; ACID; INFLAMMATION; GLUTATHIONE; ACTIVATION; INHIBITION	Oxalate toxicity is mediated through generation of reactive oxygen species ( ROS) via a process that is partly dependent on mitochondrial dysfunction. Here, we investigated whether C- phycocyanin ( CP) could protect against oxidative stress-mediated intracellular damage triggered by oxalate in MDCK cells. DCFDA, a fluorescence- based probe and hexanoyl- lysine adduct ( HEL), an oxidative stress marker were used to investigate the effect of CP on oxalate- induced ROS production and membrane lipid peroxidation ( LPO). The role of CP against oxalate- induced oxidative stress was studied by the evaluation of mitochondrial membrane potential by JC1 fluorescein staining, quantification of ATP synthesis and stress- induced MAP kinases ( JNK/ SAPK and ERK1/ 2). Our results revealed that oxalate- induced cells show markedly increased ROS levels and HEL protein expression that were significantly decreased following pre- treatment with CP. Further, JC1 staining showed that CP pre- treatment conferred significant protection from mitochondrial membrane permeability and increased ATP production in CP- treated cells than oxalate- alone- treated cells. In addition, CP treated cells significantly decreased the expression of phosphorylated JNK/ SAPK and ERK1/ 2 as compared to oxalate- alone- treated cells. We concluded that CP could be used as a potential free radical- scavenging therapeutic strategy against oxidative stress- associated diseases including urolithiasis.	[Farooq, Shukkur M.] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharm Practice, Detroit, MI 48202 USA; [Boppana, Nithin B.] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Detroit, MI USA; [Asokan, Devarajan] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Sekaran, Shamala D.] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Shankar, Esaki M.; Bakar, Sazaly A.] Univ Malaya, Fac Med, TIDREC, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Li, Chunying] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI USA; [Gopal, Kaliappan] Univ Malaya, Fac Med, Natl Orthoped Ctr Excellence Res & Learning NOCER, Dept Orthoped, Kuala Lumpur, Malaysia; [Karthik, Harve S.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore; [Ebrahim, Abdul S.] Wayne State Univ, Dept Internal Med, Detroit, MI 48202 USA	Wayne State University; Wayne State University; University of California System; University of California Los Angeles; Universiti Malaya; Universiti Malaya; Wayne State University; Universiti Malaya; National University of Singapore; Wayne State University	Farooq, SM (corresponding author), Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharm Practice, Detroit, MI 48202 USA.	mabdulsh@med.wayne.edu; shankarem@um.edu.my; eabdulsh@med.wayne.edu	Muthu, Shankar Esaki/B-3132-2019; Sekaran, Shamala Devi/B-8482-2008; Shankar, EM/G-6444-2011; Devi, Shamala Devi/B-9735-2010; abubakar, sazaly/B-3957-2010; Boppana, Nithin B/I-8118-2019; K, Gopal/D-6751-2012	Muthu, Shankar Esaki/0000-0002-7866-9818; Sekaran, Shamala Devi/0000-0002-0478-0425; Devi, Shamala Devi/0000-0002-0478-0425; abubakar, sazaly/0000-0002-9267-1420; 				Aronson PS, 2002, CELL BIOCHEM BIOPHYS, V36, P147, DOI 10.1385/CBB:36:2-3:147; Bagga HS, 2013, UROL CLIN N AM, V40, P1, DOI 10.1016/j.ucl.2012.09.006; Benedetti S, 2004, LIFE SCI, V75, P2353, DOI 10.1016/j.lfs.2004.06.004; Bhat VB, 2000, BIOCHEM BIOPH RES CO, V275, P20, DOI 10.1006/bbrc.2000.3270; Brzica H, 2013, ARH HIG RADA TOKSIKO, V64, P609, DOI 10.2478/10004-1254-64-2013-2428; Cao LC, 2004, KIDNEY INT, V66, P1890, DOI 10.1111/j.1523-1755.2004.00963.x; Chang CJ, 2011, AM J RESP CRIT CARE, V183, P15, DOI 10.1164/rccm.201001-0009OC; Cherdkiatikul T, 2014, J BIOMOL SCREEN, V19, P959, DOI 10.1177/1087057113520565; Davalos M, 2010, J ENDOUROL, V24, P339, DOI 10.1089/end.2009.0205; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dimroth P, 2000, J EXP BIOL, V203, P51; Farooq SM, 2006, MOL CELL BIOCHEM, V284, P95, DOI 10.1007/s11010-005-9019-0; Farooq SM, 2004, CLIN CHIM ACTA, V348, P199, DOI 10.1016/j.cccn.2004.05.016; Farooq SM, 2004, CHEM-BIOL INTERACT, V149, P1, DOI 10.1016/j.cbi.2004.05.006; Fosslien E, 2001, ANN CLIN LAB SCI, V31, P25; Gantar M, 2012, J BIOTECHNOL, V159, P21, DOI 10.1016/j.jbiotec.2012.02.004; GARRIDO MC, 1992, J CLIN PATHOL, V45, P860, DOI 10.1136/jcp.45.10.860; Gonzalez R, 1999, PHARMACOL RES, V39, P55, DOI 10.1006/phrs.1998.0409; Guo Q, 2004, J BIOL CHEM, V279, P13272, DOI 10.1074/jbc.M310034200; Huang HS, 2003, UROLOGY, V62, P1123, DOI 10.1016/S0090-4295(03)00764-7; Ishihara K, 2009, J NEUROCHEM, V110, P1965, DOI 10.1111/j.1471-4159.2009.06294.x; Itoh Y, 2005, UROL RES, V33, P261, DOI 10.1007/s00240-005-0465-7; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Johri N, 2010, NEPHRON CLIN PRACT, V116, pC159, DOI 10.1159/000317196; Joshi S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/462361; Kato Y, 1999, J BIOL CHEM, V274, P20406, DOI 10.1074/jbc.274.29.20406; Khand FD, 2002, FREE RADICAL BIO MED, V32, P1339, DOI 10.1016/S0891-5849(02)00846-8; KURIEN TB, 1989, INDIAN J EXP BIOL, V27, P450; Lee HC, 2007, EXP BIOL MED, V232, P592; Leung PO, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/916590; Li ZY, 2011, BIOCHEM BIOPH RES CO, V414, P5, DOI 10.1016/j.bbrc.2011.09.046; Lissi EA, 2000, FREE RADICAL BIO MED, V28, P1051, DOI 10.1016/S0891-5849(00)00193-3; Molinari BL, 2003, ANAL QUANT CYTOL, V25, P254; Mulay SR, 2013, J CLIN INVEST, V123, P236, DOI 10.1172/JCI63679; Musatov A, 2012, FREE RADICAL RES, V46, P1313, DOI 10.3109/10715762.2012.717273; Ou Y, 2010, CHEM-BIOL INTERACT, V185, P94, DOI 10.1016/j.cbi.2010.03.013; Park C, 2003, BIOCHEM PHARMACOL, V66, P1287, DOI 10.1016/S0006-2952(03)00478-7; Park J, 1997, J BIOL CHEM, V272, P16725, DOI 10.1074/jbc.272.27.16725; Poonkuzhali B., 1994, Indian Journal of Experimental Biology, V32, P20; Rashed T, 2004, AM J NEPHROL, V24, P557, DOI 10.1159/000082043; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rimbau V, 1999, NEUROSCI LETT, V276, P75, DOI 10.1016/S0304-3940(99)00792-2; Romay C, 2000, J PHARM PHARMACOL, V52, P367, DOI 10.1211/0022357001774093; Romay C, 2003, CURR PROTEIN PEPT SC, V4, P207, DOI 10.2174/1389203033487216; Runchel C, 2011, ANTIOXID REDOX SIGN, V15, P205, DOI 10.1089/ars.2010.3733; Sakhaee K, 2012, J CLIN ENDOCR METAB, V97, P1847, DOI 10.1210/jc.2011-3492; Saxena Anil K, 2003, Saudi J Kidney Dis Transpl, V14, P531; Scheid C, 1996, KIDNEY INT, V49, P413, DOI 10.1038/ki.1996.60; Selivanov VA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001115; Selvakumar D, 2013, J BIOL CHEM, V288, P7215, DOI 10.1074/jbc.M112.443226; Selvakumar D, 2012, BIOCHEM J, V443, P463, DOI 10.1042/BJ20111255; Shih CM, 2009, ANESTH ANALG, V108, P1303, DOI 10.1213/ane.0b013e318193e919; Shukkur EA, 2006, HUM MOL GENET, V15, P2752, DOI 10.1093/hmg/ddl211; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Sun YX, 2011, ENVIRON TOXICOL PHAR, V32, P168, DOI 10.1016/j.etap.2011.04.008; Thaakur S, 2010, J NEURAL TRANSM, V117, P1083, DOI 10.1007/s00702-010-0440-5; Thamilselvan S, 2003, UROL RES, V31, P3, DOI 10.1007/s00240-002-0286-x; Thamilselvan S, 2000, J UROLOGY, V164, P224, DOI 10.1016/S0022-5347(05)67499-X; Thamilselvan V, 2014, BJU INT, V114, P140, DOI 10.1111/bju.12642; Thamilselvan V, 2012, UROL RES, V40, P415, DOI 10.1007/s00240-011-0405-7; Ukuku DO, 2001, J FOOD PROTECT, V64, P813, DOI 10.4315/0362-028X-64.6.813; Vijaya LB, 2005, FREE RADICAL BIO MED, V38, P1614, DOI 10.1016/j.freeadbiomed.2005.02.029; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yin TG, 1997, J BIOL CHEM, V272, P19943, DOI 10.1074/jbc.272.32.19943	66	35	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93056	10.1371/journal.pone.0093056	http://dx.doi.org/10.1371/journal.pone.0093056			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691130	gold, Green Submitted, Green Published			2022-12-27	WOS:000334101100040
J	Fujie, S; Sato, K; Miyamoto-Mikami, E; Hasegawa, N; Fujita, S; Sanada, K; Hamaoka, T; Iemitsu, M				Fujie, Shumpei; Sato, Koji; Miyamoto-Mikami, Eri; Hasegawa, Natsuki; Fujita, Satoshi; Sanada, Kiyoshi; Hamaoka, Takafumi; Iemitsu, Motoyuki			Reduction of Arterial Stiffness by Exercise Training Is Associated with Increasing Plasma Apelin Level in Middle-Aged and Older Adults	PLOS ONE			English	Article							NITRIC-OXIDE; HYPERTENSIVE PATIENTS; CARDIOVASCULAR RISK; PHYSICAL-ACTIVITY; BLOOD-PRESSURE; APJ; ATHEROSCLEROSIS; RECEPTOR; DISEASE; EXPRESSION	Aging-induced deterioration of arterial stiffness is decreased by regular exercise, and increased nitric oxide (NO) production participates in this effect. Apelin regulates endothelial NO synthase in endothelial cells, promoting NO production. However, the effect of aerobic exercise training on circulating apelin levels in healthy middle-aged and older adults remains unknown. Accordingly, this study aimed to clarify the effects of regular aerobic exercise on apelin concentrations in middle-aged and older adults. Thirty-four healthy middle-aged and older subjects (67.0 +/- 1.3 years) were randomly divided into two groups: exercise intervention and sedentary controls. Subjects in the training group completed 8-week of aerobic exercise training (60-70% peak oxygen uptake [VO2peak] for 45 min, 3 days/week). Before and after the intervention, we evaluated plasma apelin and nitrite/nitrate (NOx) concentrations, VO2peak, and arterial stiffness index. In the training group, VO2peak was significantly increased, and carotid beta-stiffness was significantly decreased, after the intervention (P<0.05). Moreover, plasma apelin and NOx levels were significantly increased in the training group after the intervention (P<0.05). Additionally, there was a correlation between the training effects of plasma apelin levels and carotid beta-stiffness (r = -0.508, P = 0.032) and plasma NOx levels (r = 0.494, P = 0.037). By contrast, none of these parameters changed significantly in the control group. These results suggest that the increased in plasma apelin levels may be associated with exercise training-induced alternation of arterial stiffness in middle-aged and older adults.	[Fujie, Shumpei; Sato, Koji; Miyamoto-Mikami, Eri; Hasegawa, Natsuki; Fujita, Satoshi; Sanada, Kiyoshi; Hamaoka, Takafumi; Iemitsu, Motoyuki] Ritsumeikan Univ, Fac Sport & Hlth Sci, Shiga, Japan	Ritsumeikan University	Iemitsu, M (corresponding author), Ritsumeikan Univ, Fac Sport & Hlth Sci, Shiga, Japan.	iemitsu@fc.ritsumei.ac.jp	MIYAMOTO-MIKAMI, ERI/AAT-3245-2020	Miyamoto-Mikami, Eri/0000-0002-4864-8581; Sanada, Kiyoshi/0000-0003-3703-4098	Ministry of Education, Culture, Sports, Science and Technology of Japan [23680071, 25560378]; Grants-in-Aid for Scientific Research [25560378] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#23680071 and #25560378, M. Iemitsu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen Charlotte U, 2011, Pulm Circ, V1, P334, DOI 10.4103/2045-8932.87299; ARNETT DK, 1994, AM J EPIDEMIOL, V140, P669, DOI 10.1093/oxfordjournals.aje.a117315; Blacher J, 1999, HYPERTENSION, V33, P1111, DOI 10.1161/01.HYP.33.5.1111; Goetze JP, 2006, REGUL PEPTIDES, V133, P134, DOI 10.1016/j.regpep.2005.09.032; Hambrecht R, 2003, CIRCULATION, V107, P3152, DOI 10.1161/01.CIR.0000074229.93804.5C; HIRAI T, 1989, CIRCULATION, V80, P78, DOI 10.1161/01.CIR.80.1.78; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; Jia Yue Xia, 2007, Peptides, V28, P2023, DOI 10.1016/j.peptides.2007.07.016; Kadoglou NPE, 2013, DIABETIC MED, V30, pE41, DOI 10.1111/dme.12055; Kadoglou NPE, 2012, EUR J INTERN MED, V23, P137, DOI 10.1016/j.ejim.2011.10.020; Kawano H, 2006, J HYPERTENS, V24, P1753, DOI 10.1097/01.hjh.0000242399.60838.14; Kleinz MJ, 2005, REGUL PEPTIDES, V126, P233, DOI 10.1016/j.regpep.2004.10.019; Kleinz MJ, 2005, PHARMACOL THERAPEUT, V107, P198, DOI 10.1016/j.pharmthera.2005.04.001; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Lee DK, 2005, ENDOCRINOLOGY, V146, P231, DOI 10.1210/en.2004-0359; Maeda S, 2004, HYPERTENS RES, V27, P947, DOI 10.1291/hypres.27.947; MOHIADDIN RH, 1989, BRIT HEART J, V62, P90; Napoli C, 2001, NITRIC OXIDE-BIOL CH, V5, P88, DOI 10.1006/niox.2001.0337; Przewlocka-Kosmala M, 2011, J HYPERTENS, V29, P971, DOI 10.1097/HJH.0b013e328344da76; ROWE JW, 1987, AM J CARDIOL, V60, pG68, DOI 10.1016/0002-9149(87)90594-7; Tanabe T, 2003, ACTA PHYSIOL SCAND, V178, P3, DOI 10.1046/j.1365-201X.2003.01100.x; Tanaka H, 1998, ARTERIOSCL THROM VAS, V18, P127, DOI 10.1161/01.ATV.18.1.127; Tanaka H, 2000, CIRCULATION, V102, P1270, DOI 10.1161/01.CIR.102.11.1270; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; VAITKEVICIUS PV, 1993, CIRCULATION, V88, P1456, DOI 10.1161/01.CIR.88.4.1456; Zhang J, 2006, LIFE SCI, V79, P1153, DOI 10.1016/j.lfs.2006.03.040	28	47	48	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93545	10.1371/journal.pone.0093545	http://dx.doi.org/10.1371/journal.pone.0093545			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691252	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100101
J	Naish, S; Dale, P; Mackenzie, JS; McBride, J; Mengersen, K; Tong, SL				Naish, Suchithra; Dale, Pat; Mackenzie, John S.; McBride, John; Mengersen, Kerrie; Tong, Shilu			Spatial and Temporal Patterns of Locally- Acquired Dengue Transmission in Northern Queensland, Australia, 1993-2012	PLOS ONE			English	Article							FOREST VIRUS-DISEASE; METEOROLOGICAL FACTORS; CLIMATE-CHANGE; OUTBREAK; VECTORS	Background: Dengue has been a major public health concern in Australia since it re- emerged in Queensland in 1992- 1993. We explored spatio- temporal characteristics of locally- acquired dengue cases in northern tropical Queensland, Australia during the period 1993- 2012. Methods: Locally- acquired notified cases of dengue were collected for northern tropical Queensland from 1993 to 2012. Descriptive spatial and temporal analyses were conducted using geographic information system tools and geostatistical techniques. Results: 2,398 locally- acquired dengue cases were recorded in northern tropical Queensland during the study period. The areas affected by the dengue cases exhibited spatial and temporal variation over the study period. Notified cases of dengue occurred more frequently in autumn. Mapping of dengue by statistical local areas ( census units) reveals the presence of substantial spatio- temporal variation over time and place. Statistically significant differences in dengue incidence rates among males and females ( with more cases in females) ( chi 2 = 15.17, d. f. = 1, p < 0.01). Differences were observed among age groups, but these were not statistically significant. There was a significant positive spatial autocorrelation of dengue incidence for the four sub- periods, with the Moran's I statistic ranging from 0.011 to 0.463 ( p < 0.01). Semi- variogram analysis and smoothed maps created from interpolation techniques indicate that the pattern of spatial autocorrelation was not homogeneous across the northern Queensland. Conclusions: Tropical areas are potential high- risk areas for mosquito- borne diseases such as dengue. This study demonstrated that the locally- acquired dengue cases have exhibited a spatial and temporal variation over the past twenty years in northern tropical Queensland, Australia. Therefore, this study provides an impetus for further investigation of clusters and risk factors in these high- risk areas.	[Naish, Suchithra; Tong, Shilu] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld 4001, Australia; [Naish, Suchithra; Tong, Shilu] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Dale, Pat] Griffith Univ, Griffith Sch Environm, Environm Futures Ctr, Australian Rivers Inst, Brisbane, Qld 4111, Australia; [Mackenzie, John S.] Curtin Univ, Australian Biosecur CRC, Perth, WA 6845, Australia; [Mackenzie, John S.] Curtin Univ, Fac Hlth Sci, Perth, WA 6845, Australia; [McBride, John] James Cook Univ, Sch Med & Dent, Cairns, Qld, Australia; [Mengersen, Kerrie] Queensland Univ Technol, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Griffith University; Curtin University; Curtin University; James Cook University; Queensland University of Technology (QUT)	Naish, S (corresponding author), Queensland Univ Technol, Sch Publ Hlth & Social Work, Kelvin Grove Campus, Brisbane, Qld 4001, Australia.	s.naish@qut.edu.au	Mengersen, Kerrie/AHC-4096-2022; /S-4986-2019; McBride, William John Hannan/B-9145-2008	/0000-0002-5918-2190; McBride, William John Hannan/0000-0001-8894-533X; Mengersen, Kerrie/0000-0001-8625-9168	ARC [DP 110 100 651]	ARC(Australian Research Council)	Authors would like to acknowledge ARC grant (#DP 110 100 651). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, MAPINFO PROF SOFTW V; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Anselin L, 1999, INTERACTIVE TECHNIQU; Australian Bureau of Statistics (ABS), 2012, CENS POP HOUS BAS CO; Beebe NW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000429; Collinge SK, 2010, NATURE, V1, P69; Earnest A, 2012, EPIDEMIOL INFECT, V140, P1244, DOI 10.1017/S095026881100183X; Er A., 2010, INT J HUMAN SOCIAL S, V5, P3410, DOI DOI 10.5281/ZENODO.1327911; Fotheringham AS, 2009, SAGE HDB SPATIAL ANA; Githeko AK, 2012, INDIAN J MED RES, V136, P7; Haining R., 2003, SPATIAL DATA ANAL TH; Hu WB, 2012, ENVIRON HEALTH PERSP, V120, P260, DOI 10.1289/ehp.1003270; Hu WB, 2010, OCCUP ENVIRON MED, V67, P307, DOI 10.1136/oem.2008.044966; Huang F, 2011, AM J TROP MED HYG, V85, P560, DOI 10.4269/ajtmh.2011.11-0156; Impoinvil DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022192; Indaratna Kaemthong, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P669; Isaaks EH, 1989, APPL GEOSTATISTICS; Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011; Keim DA, 2002, IEEE T VIS COMPUT GR, V8, P1, DOI 10.1109/2945.981847; Kitron U, 2000, PARASITOL TODAY, V16, P324, DOI 10.1016/S0169-4758(00)01708-7; Knope KGC, 2013, COMMUN DIS INTELL, V37, pE5; Lloyd C, 2005, ENVIRON PLANN A, V37, P81, DOI 10.1068/a36116; Lloyd C., 2010, SPATIAL DATA ANAL IN; Lloyd CD, 2009, ANN ASSOC AM GEOGR, V99, P27, DOI 10.1080/00045600802224638; Moore DA, 1999, EPIDEMIOL REV, V21, P143, DOI 10.1093/oxfordjournals.epirev.a017993; Naish S, 2011, TROP MED INT HEALTH, V16, P884, DOI 10.1111/j.1365-3156.2011.02775.x; Naish S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025688; Nakhapakorn K., 2006, Dengue Bulletin, V30, P177; National Notificable Disease surveillance system N, 2013, NUMB NOT DENG VIR IN; Queensland Health, 2013, DENG FEV; Queensland Health, 2013, MOSQ BORN DIS; Queensland Treasury and Trade, 2013, POP GROWTH HIGHL TRE; Quinn HE, 2005, J MED ENTOMOL, V42, P882, DOI 10.1603/0022-2585(2005)042[0882:AOBFVD]2.0.CO;2; Rezaeian M, 2008, MIDDLE E J FAMILY ME, V7, P42; Rochlin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023280; Russell R. C., 1994, Bulletin of the Society for Vector Ecology, V19, P73; Russell RC, 1998, J VECTOR ECOL, V23, P1; Russell RC, 2009, MED J AUSTRALIA, V190, P265, DOI 10.5694/j.1326-5377.2009.tb02393.x; Schwartz E, 2008, EMERG INFECT DIS, V14, P1081, DOI 10.3201/eid1407.071412; Tstuzuki A, 2009, AM J TROP MED HYG, V81, P645, DOI 10.4269/ajtmh.2009.08-0175; WHO, 2013, DENG NEGL TROP DIS R; Williams CR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000922; Woodruff RE, 2006, EPIDEMIOLOGY, V17, P569, DOI 10.1097/01.ede.0000229467.92742.7b; World Health Organization, 2012, GLOB STRAT DENG PREV; [No title captured]	45	25	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92524	10.1371/journal.pone.0092524	http://dx.doi.org/10.1371/journal.pone.0092524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691549	Green Published, gold, Green Accepted			2022-12-27	WOS:000334101100028
J	Pietrantonio, F; Maggi, C; Di Bartolomeo, M; Facciorusso, MG; Perrone, F; Testi, A; Iacovelli, R; Miceli, R; Bossi, I; Leone, G; Milione, M; Pelosi, G; de Braud, F				Pietrantonio, Filippo; Maggi, Claudia; Di Bartolomeo, Maria; Facciorusso, Maria Grazia; Perrone, Federica; Testi, Adele; Iacovelli, Roberto; Miceli, Rosalba; Bossi, Ilaria; Leone, Giorgia; Milione, Massimo; Pelosi, Giuseppe; de Braud, Filippo			Gain of ALK Gene Copy Number May Predict Lack of Benefit from Anti-EGFR Treatment in Patients with Advanced Colorectal Cancer and RAS-RAF-PI3KCA Wild-Type Status	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; ANAPLASTIC LYMPHOMA KINASE; PHASE-III TRIAL; 1ST-LINE TREATMENT; MONOCLONAL-ANTIBODIES; RAS MUTATIONS; SOLID TUMORS; CETUXIMAB; KRAS	Introduction: Although cetuximab and panitumumab show an increased efficacy for patients with KRAS-NRAS-BRAF and PI3KCA wild-type metastatic colorectal cancer, primary resistance occurs in a relevant subset of molecularly enriched populations. Patients and Methods: We evaluated the outcome of 68 patients with advanced colorectal cancer and RAS, BRAF and PI3KCA status according to ALK gene status (disomic vs. gain of ALK gene copy number - defined as mean of 3 to 5 fusion signals in >= 10% of cells). All consecutive patients received cetuximab and irinotecan or panitumumab alone for chemorefractory disease. Results: No ALK translocations or amplifications were detected. ALK gene copy number gain was found in 25 (37%) tumors. Response rate was significantly higher in patients with disomic ALK as compared to those with gain of gene copy number (70% vs. 32%; p = 0.0048). Similarly, progression-free survival was significantly different when comparing the two groups (6.7 vs. 5.3 months; p = 0.045). A trend was observed also for overall survival (18.5 vs. 15.6 months; p = 0.885). Conclusion: Gain of ALK gene copy number might represent a negative prognostic factor in mCRC and may have a role in resistance to anti-EGFR therapy.	[Pietrantonio, Filippo; Maggi, Claudia; Di Bartolomeo, Maria; Iacovelli, Roberto; Bossi, Ilaria; de Braud, Filippo] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy; [Facciorusso, Maria Grazia; Perrone, Federica; Testi, Adele; Leone, Giorgia; Milione, Massimo; Pelosi, Giuseppe] Fdn IRCCS Ist Nazl Tumori, Dept Pathol, Milan, Italy; [Miceli, Rosalba] Fdn IRCCS Ist Nazl Tumori, Unit Med Stat Biometry & Bioinformat, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan	Pietrantonio, F (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy.	filippo.pietrantonio@istitutotumori.mi.it	Miceli, Rosalba/C-1215-2017; de Braud, Filippo/B-9997-2017; maggi, claudia/J-6831-2018; Testi, Maria Adele/D-6994-2017; Di Bartolomeo, Maria/D-1655-2017; Pietrantonio, Filippo/C-2180-2017; Milione, Massimo/B-8644-2017; Iacovelli, Roberto/AAB-9850-2019; Perrone, Federica/S-6171-2016; Pelosi, Giuseppe/F-5073-2012	Miceli, Rosalba/0000-0003-0954-375X; de Braud, Filippo/0000-0003-0103-730X; maggi, claudia/0000-0001-8780-0606; Testi, Maria Adele/0000-0002-9462-0336; Di Bartolomeo, Maria/0000-0002-7954-6609; Pietrantonio, Filippo/0000-0002-8530-8420; Milione, Massimo/0000-0002-1202-139X; Iacovelli, Roberto/0000-0002-1750-2117; Perrone, Federica/0000-0003-4406-8245; Pelosi, Giuseppe/0000-0003-4725-4692	Italian law Law [183]	Italian law Law	This work was supported in part by funds obtained through Italian law Law 12 november 2011 n. 183 that allows taxpayers to allocate 0.5 percent share of their income tax contribution to a research institution of their choice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisner DL, 2014, MOL CANCER RES, V12, P111, DOI 10.1158/1541-7786.MCR-13-0479-T; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Bavi P, 2013, BRIT J CANCER, V109, P2735, DOI 10.1038/bjc.2013.641; Bokemeyer C, 2012, EUR J CANCER, V48, P1466, DOI 10.1016/j.ejca.2012.02.057; Cappuzzo F, 2005, J CLIN ONCOL, V23, P5007, DOI 10.1200/JCO.2005.09.111; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; de Braud F, 2013, ANN ONCOL; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Bartolomeo M, 2013, TARGET ONCOL; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Inno A, 2011, CLIN COLORECTAL CANC, V10, P325, DOI 10.1016/j.clcc.2011.03.028; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lin E, 2009, MOL CANCER RES, V7, P1466, DOI 10.1158/1541-7786.MCR-08-0522; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Mao C, 2012, ANN ONCOL, V23, P1518, DOI 10.1093/annonc/mdr464; Molinari F, 2011, CLIN CANCER RES, V17, P4901, DOI 10.1158/1078-0432.CCR-10-3137; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Pelosi G, 2012, LUNG CANCER, V77, P507, DOI 10.1016/j.lungcan.2012.05.093; Perrone F, 2009, ANN ONCOL, V20, P84, DOI 10.1093/annonc/mdn541; Pietrantonio F, 2013, CANC BIOL THER, V14; Salido M, 2011, J THORAC ONCOL, V6, P21, DOI 10.1097/JTO.0b013e3181fb7cd6; Sartore-Bianchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007287; Scartozzi M, 2011, ONCOLOGIST, V16, P53, DOI 10.1634/theoncologist.2010-0119; Scartozzi M, 2010, INT J CANCER, V127, P1941, DOI 10.1002/ijc.25193; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Tanizaki J, 2012, CLIN CANCER RES, V18, P6219, DOI 10.1158/1078-0432.CCR-12-0392; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; van Essen HF, 2012, METHODS MOL BIOL, V838, P329, DOI 10.1007/978-1-61779-507-7_16; Von Hoff DD, 2010, J CLIN ONCOL, V28, P4877, DOI 10.1200/JCO.2009.26.5983	37	15	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92147	10.1371/journal.pone.0092147	http://dx.doi.org/10.1371/journal.pone.0092147			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691006	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100016
J	Song, JY; Nahm, MH; Cheong, HJ; Kim, WJ				Song, Joon Young; Nahm, Moon H.; Cheong, Hee Jin; Kim, Woo Joo			Impact of Preceding Flu-Like Illness on the Serotype Distribution of Pneumococcal Pneumonia	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; PANDEMIC INFLUENZA; INVASIVE DISEASE; BACTERIAL PNEUMONIA; CONJUGATE VACCINE; RECEPTOR; KOREA; COLONIZATION; SURVEILLANCE; POPULATION	Background: Even though the pathogenicity and invasiveness of pneumococcus largely depend on capsular types, the impact of serotypes on post-viral pneumococcal pneumonia is unknown. Methods and Findings: This study was performed to evaluate the impact of capsular serotypes on the development of pneumococcal pneumonia after preceding respiratory viral infections. Patients with a diagnosis of pneumococcal pneumonia were identified. Pneumonia patients were divided into two groups (post-viral pneumococcal pneumonia versus primary pneumococcal pneumonia), and then their pneumococcal serotypes were compared. Nine hundred and nineteen patients with pneumococcal pneumonia were identified during the study period, including 327 (35.6%) cases with post-viral pneumococcal pneumonia and 592 (64.4%) cases with primary pneumococcal pneumonia. Overall, serotypes 3 and 19A were the most prevalent, followed by serotypes 19F, 6A, and 11A/11E. Although relatively uncommon (33 cases, 3.6%), infrequently colonizing invasive serotypes (4, 5, 7F/7A, 8, 9V/9A, 12F, and 18C) were significantly associated with preceding respiratory viral infections (69.7%, P<0.01). Multivariate analysis revealed several statistically significant risk factors for post-viral pneumococcal pneumonia: immunodeficiency (OR 1.66; 95% CI, 1.10-2.53), chronic lung diseases (OR 1.43; 95% CI, 1.09-1.93) and ICI serotypes (OR 4.66; 95% CI, 2.07-10.47). Conclusions: Infrequently colonizing invasive serotypes would be more likely to cause pneumococcal pneumonia after preceding respiratory viral illness, particularly in patients with immunodeficiency or chronic lung diseases.	[Song, Joon Young; Nahm, Moon H.] Univ Alabama Birmingham, Sch Med, Dept Pathol, Birmingham, AL 35233 USA; [Nahm, Moon H.] Univ Alabama Birmingham, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA; [Song, Joon Young; Cheong, Hee Jin; Kim, Woo Joo] Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul 136705, South Korea	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Korea University; Korea University Medicine (KU Medicine)	Song, JY (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Pathol, Birmingham, AL 35233 USA.	infection@korea.ac.kr	Kim, Woo Joo/D-2733-2015	Kim, Woo Joo/0000-0002-4546-3880; Song, Joon Young/0000-0002-0148-7194; Cheong, Hee Jin/0000-0002-2532-1463; Nahm, Moon/0000-0002-6922-1042	NIH [AI-30021]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported in part by funding from NIH (AI-30021) to MHN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; AVERY OSWALD T., 1931, JOUR EXP MED, V54, P73, DOI 10.1084/jem.54.1.73; Ballinger MN, 2010, J INTERF CYTOK RES, V30, P643, DOI 10.1089/jir.2010.0049; Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816; Blaschke AJ, 2011, CLIN INFECT DIS, V52, pS331, DOI 10.1093/cid/cir048; Bodi M, 2005, CLIN INFECT DIS, V41, P1709, DOI 10.1086/498119; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cho EY, 2012, J KOREAN MED SCI, V27, P716, DOI 10.3346/jkms.2012.27.7.716; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Diavatopoulos DA, 2010, FASEB J, V24, P1789, DOI 10.1096/fj.09-146779; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; Giannella M, 2011, CLIN MICROBIOL INFEC, V17, P1160, DOI 10.1111/j.1469-0691.2010.03399.x; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Ihekweazu C, 2010, J INFECTION, V61, P21, DOI 10.1016/j.jinf.2010.03.032; Kabra SK, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004874.pub3; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Kieninger DM, 2010, VACCINE, V28, P4192, DOI 10.1016/j.vaccine.2010.04.008; Kronenberg A, 2006, J CLIN MICROBIOL, V44, P2032, DOI 10.1128/JCM.00275-06; Lee JS, 2007, EPIDEMIOL INFECT, V135, P1117, DOI 10.1017/S0950268807007820; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Magee AD, 2001, INFECT IMMUN, V69, P3755, DOI 10.1128/IAI.69.6.3755-3761.2001; McCullers JA, 2010, J INFECT DIS, V202, P1287, DOI 10.1086/656333; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Musher DM, 2012, CLIN INFECT DIS, V55, P265, DOI 10.1093/cid/cis364; Neill DR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002660; Nelson AL, 2007, INFECT IMMUN, V75, P83, DOI 10.1128/IAI.01475-06; Niederman MS, 2004, AM J MED, V117, P51, DOI 10.1016/j.amjmed.2004.07.008; NUGENT KM, 1983, INFECT IMMUN, V42, P1102, DOI 10.1128/IAI.42.3.1102-1108.1983; Park IH, 2012, MBIO, V3, DOI 10.1128/mBio.00035-12; Pinsky BA, 2010, EMERG INFECT DIS, V16, P1165, DOI 10.3201/eid1607.091248; Rakov AV, 2011, INFECT GENET EVOL, V11, P1929, DOI 10.1016/j.meegid.2011.08.016; Rothberg MB, 2008, AM J MED, V121, P258, DOI 10.1016/j.amjmed.2007.10.040; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Sanz JC, 2011, CLIN MICROBIOL INFEC, V17, P1094, DOI 10.1111/j.1469-0691.2011.03495.x; Scott JR, 2012, J INFECT DIS, V206, P73, DOI 10.1093/infdis/jis307; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Shouval DS, 2006, PEDIATR INFECT DIS J, V25, P602, DOI 10.1097/01.inf.0000220231.79968.f6; Shrestha S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0233; Singanayagam A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-27; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Song JY, 2011, INFLUENZA OTHER RESP, V5, pR535, DOI 10.1111/j.1750-2659.2011.00269.x; Song JY, 2013, INFECT CHEMOTHER, V45, P351, DOI 10.3947/ic.2013.45.4.351; Song JY, 2013, J MED VIROL, V85, P910, DOI 10.1002/jmv.23548; Song JY, 2013, J KOREAN MED SCI, V28, P4, DOI 10.3346/jkms.2013.28.1.4; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Vainio A, 2009, APMIS, V117, P488, DOI 10.1111/j.1600-0463.2009.02463.x; Vanderkooi OG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028547; Walter ND, 2010, CLIN INFECT DIS, V50, P175, DOI 10.1086/649208; Werno AM, 2008, CLIN INFECT DIS, V46, P926, DOI 10.1086/528798; Yeh SH, 2010, PEDIATRICS, V126, pE493, DOI 10.1542/peds.2009-3027; Yildirim I, 2010, VACCINE, V29, P283, DOI 10.1016/j.vaccine.2010.10.032; Yu JG, 2011, CLIN VACCINE IMMUNOL, V18, P1900, DOI 10.1128/CVI.05312-11; Zhou H, 2012, EMERG INFECT DIS, V18, P294, DOI 10.3201/eid1802.102025	54	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93477	10.1371/journal.pone.0093477	http://dx.doi.org/10.1371/journal.pone.0093477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691515	gold, Green Submitted, Green Published			2022-12-27	WOS:000334101100088
J	Thomson, CJ; Rajala, AK; Carlson, SR; Rupert, JL				Thomson, Cynthia J.; Rajala, Amelia K.; Carlson, Scott R.; Rupert, Jim L.			Variants in the Dopamine-4-Receptor Gene Promoter Are Not Associated with Sensation Seeking in Skiers	PLOS ONE			English	Article							DOPAMINE-D4 RECEPTOR GENE; TANDEM DUPLICATION POLYMORPHISM; DEFICIT HYPERACTIVITY DISORDER; PERSONALITY-TRAITS; NOVELTY SEEKING; DRD4 GENE; REGION; ADHD; SCHIZOPHRENIA; METAANALYSIS	Sensation seeking is a personality trait that has been associated with disinhibited behaviours including substance use and gambling, but also with high-risk sport practices including skydiving, paragliding, and downhill skiing. Twin studies have shown that sensation seeking is moderately heritable, and candidate genes encoding components involved in dopaminergic transmission have been investigated as contributing to this type of behaviour. To determine whether variants in the regulatory regions of the dopamine-4-receptor gene (DRD4) influenced sport-specific sensation seeking, we analyzed five polymorphisms (-1106T/C, -906T/C, -809G/A, -291C/T, 120-bp duplication) in the promoter region of the gene in a cohort of skiers and snowboarders (n = 599) that represented a broad range of sensation seeking behaviours. We grouped subjects by genotype at each of the five loci and compared impulsive sensation seeking and domain-specific (skiing) sensation seeking between groups. There were no significant associations between genotype(s) and general or domain-specific sensation seeking in the skiers and snowboarders, suggesting that while DRD4 has previously been implicated in sensation seeking, the promoter variants investigated in this study do not contribute to sensation seeking in this athlete population.	[Thomson, Cynthia J.; Rupert, Jim L.] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada; [Rajala, Amelia K.] Univ British Columbia, Dept Sci, Vancouver, BC V5Z 1M9, Canada; [Carlson, Scott R.] Univ Minnesota, Dept Psychol, Duluth, MN 55812 USA	University of British Columbia; University of British Columbia; University of Minnesota System; University of Minnesota Duluth	Thomson, CJ (corresponding author), Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada.	cynthia.thomson@questu.ca	Carlson, Scott R/Q-2375-2019	Carlson, Scott R/0000-0002-5417-4343; THOMSON, CYNTHIA/0000-0002-7767-2820	Canadian Institute for Health Research; British Columbia Mental Health and Addictions Research; Deutscher Akademischer Austausch Dienst (DAAD; German Academic Exchange Service)	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); British Columbia Mental Health and Addictions Research; Deutscher Akademischer Austausch Dienst (DAAD; German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD))	Canadian Graduate Scholarship from Canadian Institute for Health Research to C.J. Thomson (CANADA), British Columbia Mental Health and Addictions Research to J.L. Rupert (CANADA), and Deutscher Akademischer Austausch Dienst (DAAD; German Academic Exchange Service) to N. Hase (GERMANY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi SM, 2003, BEHAV PROCESS, V64, P345, DOI 10.1016/S0376-6357(03)00150-5; Attia J, 2009, JAMA-J AM MED ASSOC, V301, P191, DOI 10.1001/jama.2008.946; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Cam FS, 2010, TURK KLIN TIP BILIM, V30, P1459, DOI 10.5336/medsci.2009-14839; Carlson SR, 2010, ADDICT BEHAV, V35, P242, DOI 10.1016/j.addbeh.2009.10.020; Cross CP, 2011, PSYCHOL BULL, V137, P97, DOI 10.1037/a0021591; D'Souza UM, 2004, BIOL PSYCHIAT, V56, P691, DOI 10.1016/j.biopsych.2004.08.008; Derringer J, 2010, PSYCHOL SCI, V21, P1282, DOI 10.1177/0956797610380699; Dick DM, 2010, HANDBOOK OF BEHAVIOR GENETICS, P433, DOI 10.1007/978-0-387-76727-7_29; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Golimbet VE, 2005, RUSS J GENET+, V41, P789, DOI 10.1007/s11177-005-0161-2; Freixanet MGI, 2012, AN PSICOL-SPAIN, V28, P223; Heck A, 2009, GENES BRAIN BEHAV, V8, P464, DOI 10.1111/j.1601-183X.2009.00494.x; Kereszturi E, 2007, AM J MED GENET B, V144B, P231, DOI 10.1002/ajmg.b.30444; Lai JH, 2010, BRAIN RES, V1359, P227, DOI 10.1016/j.brainres.2010.08.064; Lasky-Su J, 2007, BIOL PSYCHIAT, V62, P985, DOI 10.1016/j.biopsych.2007.03.006; Lauzon NM, 2010, BEHAV BRAIN RES, V208, P12, DOI 10.1016/j.bbr.2009.11.037; McCracken JT, 2000, MOL PSYCHIATR, V5, P531, DOI 10.1038/sj.mp.4000770; McGeary JE, 2007, PHARMACOL BIOCHEM BE, V86, P401, DOI 10.1016/j.pbb.2006.11.001; Mitsuyasu H, 2001, J HUM GENET, V46, P26, DOI 10.1007/s100380170120; Mitsuyasu H, 2007, J PSYCHIATR RES, V41, P763, DOI 10.1016/j.jpsychires.2006.05.014; Munafo MR, 2008, BIOL PSYCHIAT, V63, P197, DOI 10.1016/j.biopsych.2007.04.006; Nakajima M, 2007, J HUM GENET, V52, P86, DOI 10.1007/s10038-006-0084-3; Oades RD, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-48; Okuyama Y, 2000, MOL PSYCHIATR, V5, P64, DOI 10.1038/sj.mp.4000563; Paunonen SV, 2001, J PERS SOC PSYCHOL, V81, P524, DOI 10.1037/0022-3514.81.3.524; Rogers G, 2004, AM J MED GENET B, V126B, P95, DOI 10.1002/ajmg.b.20133; Saftlas AF, 2004, AM J EPIDEMIOL, V160, P77, DOI 10.1093/aje/kwh171; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P389, DOI 10.1007/s00213-006-0623-9; Sanchez-Mora C, 2011, AM J MED GENET B, V156B, P600, DOI 10.1002/ajmg.b.31202; Schinka JA, 2002, AM J MED GENET, V114, P643, DOI 10.1002/ajmg.10649; Seaman MI, 1999, AM J MED GENET, V88, P705, DOI 10.1002/(SICI)1096-8628(19991215)88:6<705::AID-AJMG22>3.0.CO;2-F; Stoel RD, 2006, BEHAV GENET, V36, P229, DOI 10.1007/s10519-005-9028-5; Thomson CJ, 2013, SCAND J MED SCI SPOR, V23, pe108, DOI 10.1111/sms.12031; Thomson CJ, 2012, INT J SPORT PSYCHOL, V43, P503, DOI 10.7352/IJSP2012.43.033; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; ZUCKERMAN M, 1993, J PERS SOC PSYCHOL, V65, P757, DOI 10.1037/0022-3514.65.4.757; ZUCKERMAN M, 1978, J CONSULT CLIN PSYCH, V46, P139, DOI 10.1037/0022-006X.46.1.139; ZUCKERMAN M, 1983, PERS INDIV DIFFER, V4, P285, DOI 10.1016/0191-8869(83)90150-2	41	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93521	10.1371/journal.pone.0093521	http://dx.doi.org/10.1371/journal.pone.0093521			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691022	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100096
J	Shimizu, F; Tasaki, A; Sano, Y; Ju, MH; Nishihara, H; Oishi, M; Koga, M; Kawai, M; Kanda, T				Shimizu, Fumitaka; Tasaki, Ayako; Sano, Yasuteru; Ju, Mihua; Nishihara, Hideaki; Oishi, Mariko; Koga, Michiaki; Kawai, Motoharu; Kanda, Takashi			Sera from Remitting and Secondary Progressive Multiple Sclerosis Patients Disrupt the Blood-Brain Barrier	PLOS ONE			English	Article							CLINICAL-COURSE; WHITE-MATTER; LESIONS; MATRIX-METALLOPROTEINASE-9; NATALIZUMAB; EXPRESSION; PHASES; IMMUNE	Background: Pathological destruction of blood-brain barrier (BBB) has been thought to be the initial key event in the process of developing multiple sclerosis (MS). The purpose of the present study was to clarify the possible molecular mechanisms responsible for the malfunction of BBB by sera from relapse-remitting MS (RRMS) and secondary progressive MS (SPMS) patients. Methods: We evaluated the effects of sera from the patients in the relapse phase of RRMS (RRMS-R), stable phase of RRMS (RRMS-S) and SPMS on the expression of tight junction proteins and vascular cell adhesion protein-1 (VCAM-1), and on the transendothelial electrical resistance (TEER) in human brain microvascular endothelial cells (BMECs). Results: Sera from the RRMS-R or SPMS patients decreased the claudin-5 protein expression and the TEER in BMECs. In RRMS-R, this effect was restored after adding an MMP inhibitor, and the MMP-2/9 secretion by BMECs was significantly increased after the application of patients' sera. In SPMS, the immunoglobulin G (IgG) purified from patients' sera also decreased the claudin-5 protein expression and the TEER in BMECs. The sera and purified IgG from all MS patients increased the VCAM-1 protein expression in BMECs. Conclusions: The up-regulation of autocrine MMP-2/9 by BMECs after exposure to sera from RRMS-R patients or the autoantibodies against BMECs from SPMS patients can compromise the BBB. Both RRMS-S and SPMS sera increased the VCAM-1 expression in the BBB, thus indicating that targeting the VCAM-1 in the BBB could represent a possible therapeutic strategy for even the stable phase of MS and SPMS.	[Shimizu, Fumitaka; Tasaki, Ayako; Sano, Yasuteru; Ju, Mihua; Nishihara, Hideaki; Oishi, Mariko; Koga, Michiaki; Kawai, Motoharu; Kanda, Takashi] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Ube, Yamaguchi 755, Japan	Yamaguchi University	Kanda, T (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Ube, Yamaguchi 755, Japan.	tkanda@yamaguchi-u.ac.jp	Koga, Michiaki/L-4825-2019; Nishihara, Hideaki/AAJ-7563-2021	Koga, Michiaki/0000-0002-1356-955X; Nishihara, Hideaki/0000-0002-2990-835X	Japan Society for the Promotion of Science, Tokyo, Japan [24790886, 22790821, 23659457]; Ministry of Health, Labor and Welfare of Japan [K2002528]; Yamaguchi University Hospital	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Yamaguchi University Hospital	This work was supported in part by research grants (Nos. 24790886, Nos. 22790821, and Nos. 23659457) from the Japan Society for the Promotion of Science, Tokyo, Japan, by a Health and Labor Sciences Research Grant for research on intractable diseases (Neuroimmunological Disease Research Committee) from the Ministry of Health, Labor and Welfare of Japan (K2002528) and also by a Translational Research Promotion Grant from Yamaguchi University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; Anderson VM, 2006, J MAGN RESON IMAGING, V23, P605, DOI 10.1002/jmri.20550; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Benesova Y, 2009, MULT SCLER J, V15, P316, DOI 10.1177/1352458508099482; Bradl M, 2009, SEMIN IMMUNOPATHOL, V31, P455, DOI 10.1007/s00281-009-0182-3; BROSNAN CF, 1995, NEUROLOGY, V45, pS16, DOI 10.1212/WNL.45.6_Suppl_6.S16; Cadavid D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053297; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; Cotton F, 2003, NEUROLOGY, V60, P640, DOI 10.1212/01.WNL.0000046587.83503.1E; Engelhardt B, 2010, CLIN EXP NEUROIMMUNO, V1, P79, DOI DOI 10.1111/J.1759-1961.2010.009.X; Engelhardt B, 2008, NEURODEGENER DIS, V5, P16, DOI 10.1159/000109933; GIJBELS K, 1994, J CLIN INVEST, V94, P2177, DOI 10.1172/JCI117578; Hochmeister S, 2006, J NEUROPATH EXP NEUR, V65, P855, DOI 10.1097/01.jnen.0000235119.52311.16; Kirk J, 2003, J PATHOL, V201, P319, DOI 10.1002/path.1434; Larochelle C, 2011, FEBS LETT, V585, P3770, DOI 10.1016/j.febslet.2011.04.066; Lassmann H, 2007, CURR NEUROL NEUROSCI, V7, P239, DOI 10.1007/s11910-007-0036-0; Leech S, 2007, NEUROPATH APPL NEURO, V33, P86, DOI 10.1111/j.1365-2990.2006.00781.x; Leppert D, 1998, BRAIN, V121, P2327, DOI 10.1093/brain/121.12.2327; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Miller DH, 2007, NEUROLOGY, V68, P1390, DOI 10.1212/01.wnl.0000260064.77700.fd; Minagar A, 2003, MULT SCLER, V9, P235, DOI 10.1191/1352458503ms916oa; Murphy G, 1997, MATRIX BIOL, V15, P511, DOI 10.1016/S0945-053X(97)90025-1; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Plumb J, 2002, BRAIN PATHOL, V12, P154; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Sano Y, 2010, J CELL PHYSIOL, V225, P519, DOI 10.1002/jcp.22232; Shimizu F, 2013, ADV NEUROBIOL, V7, P157, DOI 10.1007/978-1-4614-8313-7_10; Shimizu F, 2012, J NEUROL NEUROSUR PS, V83, P288, DOI 10.1136/jnnp-2011-300434; Su JJ, 2006, J NEUROL SCI, V243, P21, DOI 10.1016/j.jns.2005.11.006; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Zamvil SS, 2003, NEURON, V38, P685, DOI 10.1016/S0896-6273(03)00326-X; Zivadinov R, 2007, INT REV NEUROBIOL, V79, P449, DOI 10.1016/S0074-7742(07)79020-7; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	37	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e92872	10.1371/journal.pone.0092872	http://dx.doi.org/10.1371/journal.pone.0092872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686948	Green Submitted, Green Published, gold			2022-12-27	WOS:000340842300003
J	Kiuru, A; Kamarainen, M; Heinavaara, S; Pylkas, K; Chapman, K; Koivistoinen, A; Parviainen, T; Winqvist, R; Kadhim, M; Launonen, V; Lindholm, C				Kiuru, Anne; Kamarainen, Meerit; Heinavaara, Sirpa; Pylkas, Katri; Chapman, Kim; Koivistoinen, Armi; Parviainen, Teuvo; Winqvist, Robert; Kadhim, Munira; Launonen, Virpi; Lindholm, Carita			Assessment of Targeted and Non-Targeted Responses in Cells Deficient in ATM Function following Exposure to Low and High Dose X-Rays	PLOS ONE			English	Article							ATAXIA-TELANGIECTASIA HETEROZYGOTES; NIJMEGEN BREAKAGE SYNDROME; NORMAL HUMAN FIBROBLASTS; IONIZING-RADIATION; BREAST-CANCER; SENSITIVE INDIVIDUALS; LET RADIATION; IN-VITRO; RADIOSENSITIVITY; DAMAGE	Radiation sensitivity at low and high dose exposure to X-rays was investigated by means of chromosomal aberration (CA) analysis in heterozygous ATM mutation carrier and A-T patient (biallelic ATM mutation) lymphoblastoid cell lines (LCLs). Targeted and non-targeted responses to acutely delivered irradiation were examined by applying a co-culture system that enables study of both directly irradiated cells and medium-mediated bystander effects in the same experimental setting. No indication of radiation hypersensitivity was observed at doses of 0.01 Gy or 0.1 Gy for the ATM mutation carrier LCL. The A-T patient cells also did not show low-dose response. There was significant increase in unstable CA yields for both ATM mutation carrier and A-T LCLs at 1 and 2 Gy, the A-T cells displaying more distinct dose dependency. Both chromosome and chromatid type aberrations were induced at an increased rate in the irradiated A-T cells, whereas for ATM carrier cells, only unstable chromosomal aberrations were increased above the level observed in the wild type cell line. No bystander effect could be demonstrated in any of the cell lines or doses applied. Characteristics typical for the A-T cell line were detected, i.e., high baseline frequency of CA that increased with dose. In addition, dose-dependent loss of cell viability was observed. In conclusion, CA analysis did not demonstrate low-dose (<= 100 mGy) radiosensitivity in ATM mutation carrier cells or A-T patient cells. However, both cell lines showed increased radiosensitivity at high dose exposure.	[Kiuru, Anne; Kamarainen, Meerit; Heinavaara, Sirpa; Koivistoinen, Armi; Parviainen, Teuvo; Launonen, Virpi; Lindholm, Carita] STUK Radiat & Nucl Safety Author, Helsinki, Finland; [Pylkas, Katri; Winqvist, Robert] Univ Oulu, Dept Clin Chem, Lab Canc Genet & Tumor Biol, Oulu Univ Hosp, Oulu, Finland; [Pylkas, Katri; Winqvist, Robert] Univ Oulu, Bioctr Oulu, Oulu Univ Hosp, Oulu, Finland; [Chapman, Kim; Kadhim, Munira] Oxford Brookes Univ, Oxford OX3 0BP, England	Radiation & Nuclear Safety Authority (STUK); University of Oulu; University of Oulu; Oxford Brookes University	Lindholm, C (corresponding author), STUK Radiat & Nucl Safety Author, Helsinki, Finland.	carita.lindholm@stuk.fi		Heinavaara, Sirpa/0000-0002-8308-9922; Pylkas, Katri/0000-0002-2449-0521; Winqvist, Robert/0000-0003-0932-9104	EU FP6 [NOTE IP 036465 (FI6R)]; Cancer Foundation Finland sr [130168] Funding Source: researchfish	EU FP6(European Commission); Cancer Foundation Finland sr	This work was financially supported by the EU FP6 (NOTE IP 036465 (FI6R), and the institutes where the work has been performed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athma P, 1996, CANCER GENET CYTOGEN, V92, P130, DOI 10.1016/S0165-4608(96)00328-7; Baskar R, 2007, INT J RADIAT BIOL, V83, P551, DOI 10.1080/09553000701384499; Burdak-Rothkamm S, 2008, CANCER RES, V68, P7059, DOI 10.1158/0008-5472.CAN-08-0545; Dauer LT, 2010, RADIAT PROT DOSIM, V140, P103, DOI 10.1093/rpd/ncq141; George KA, 2009, RADIAT RES, V171, P752, DOI 10.1667/RR1680.1; Groesser T, 2008, RADIAT RES, V170, P794, DOI 10.1667/RR1458.1; Guertler A, 2011, RADIAT PROT DOSIM, V143, P487, DOI 10.1093/rpd/ncq515; Hada M, 2011, MUTAT RES-FUND MOL M, V716, P76, DOI 10.1016/j.mrfmmm.2011.08.006; HIGURASHI M, 1973, CANCER-AM CANCER SOC, V32, P380, DOI 10.1002/1097-0142(197308)32:2<380::AID-CNCR2820320214>3.0.CO;2-2; Jeggo P, 2010, RADIAT RES, V174, P825, DOI 10.1667/RR1844.1; Kadhim M, 2013, MUTAT RES-REV MUTAT, V752, P84, DOI 10.1016/j.mrrev.2012.12.001; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Morgan WF, 2012, RADIAT RES, V178, pAV223, DOI 10.1667/RRAV19.1; Neubauer S, 2002, RADIAT RES, V157, P312, DOI 10.1667/0033-7587(2002)157[0312:ROATAN]2.0.CO;2; PANDITA TK, 1992, RADIAT RES, V131, P214, DOI 10.2307/3578443; Pincheira J, 2001, MUTAGENESIS, V16, P419, DOI 10.1093/mutage/16.5.419; Prasad KN, 2004, EXP BIOL MED, V229, P378, DOI 10.1177/153537020422900505; Pylkas K, 2007, CARCINOGENESIS, V28, P1040, DOI 10.1093/carcin/bgl237; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Scientific Committee on the Effects of Atomic Radiation UNSCEAR, 2006, EFF ION RAD, V1; Sowa MB, 2011, RADIAT PROT DOSIM, V143, P311, DOI 10.1093/rpd/ncq487; Sowa MB, 2010, INT J RADIAT BIOL, V86, P102, DOI 10.3109/09553000903419957; Stumm M, 2001, CYTOGENET CELL GENET, V92, P186, DOI 10.1159/000056900; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; Taylor AMR, 2005, J CLIN PATHOL, V58, P1009, DOI 10.1136/jcp.2005.026062; WAGHRAY M, 1990, HUM GENET, V84, P532; WEEKS DE, 1991, RADIAT RES, V128, P90, DOI 10.2307/3578071; WIENCKE JK, 1992, CANCER CAUSE CONTROL, V3, P237, DOI 10.1007/BF00124257; Wright EG, 2010, MUTAT RES-FUND MOL M, V687, P28, DOI 10.1016/j.mrfmmm.2010.01.014; Yang H, 2007, Radiats Biol Radioecol, V47, P302; Yang HY, 2005, ONCOGENE, V24, P2096, DOI 10.1038/sj.onc.1208439	31	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93211	10.1371/journal.pone.0093211	http://dx.doi.org/10.1371/journal.pone.0093211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681528	Green Published, Green Submitted, gold			2022-12-27	WOS:000333678100032
J	Kuo, YH; Lu, SN; Chen, CH; Chang, KC; Hung, CH; Tai, WC; Tsai, MC; Tseng, PL; Hu, TH; Wang, JH				Kuo, Yuan-Hung; Lu, Sheng-Nan; Chen, Chien-Hung; Chang, Kuo-Chin; Hung, Chao-Hung; Tai, Wei-Chen; Tsai, Ming-Chao; Tseng, Po-Lin; Hu, Tsung-Hui; Wang, Jing-Houng			The Changes of Liver Stiffness and Its Associated Factors for Chronic Hepatitis B Patients with Entecavir Therapy	PLOS ONE			English	Article							TRANSIENT ELASTOGRAPHY; HEPATOCELLULAR-CARCINOMA; ANTIVIRAL THERAPY; DIABETES-MELLITUS; NATURAL-HISTORY; VIRUS INFECTION; FIBROSIS; BIOPSY; MECHANISMS; LAMIVUDINE	Liver stiffness measurement (LSM) using transient elastography has been proposed to assess liver fibrosis well in various liver diseases. This study was to determine the changes of LSM and its associated factors for chronic hepatitis B (CHB) patients undergoing Entecavir therapy. Consecutive CHB patients underwent Entecavir therapy with two LSMs were enrolled. Patients with aspartate transaminase (AST) and/or alanine transaminase >= 200 IU/L were excluded. The retrospective study enrolled 233 patients including 132 without cirrhosis (group 1) and 101 with cirrhosis (group 2). The mean values of initial liver stiffness were 7.9 and 16.6 kPa for patients in group 1 and group 2, respectively (p<0.001). In addition to the decline of transaminase levels, there was significant reduction of liver stiffness value in a mean interval of 52.8 and 61.9 weeks between the two LSMs for patients in group 1 and 2, respectively (p<0.001). Multivariate analysis showed that higher initial LSM value and presence of hepatitis B e-antigen were associated with a greater decline of LSM value, whereas follow-up AST >= 40 IU/L with increased LSM value for group 1 patients. For group 2 patients, longer interval between the two LSMs, higher initial LSM value and AST >= 40 IU/L were associated with a greater decline of LSM value, whereas presence of diabetes mellitus (DM) contributed to increased LSM value. In conclusion, CHB patients improved their LSM values after Entecavir therapy. Higher initial LSM value contributed to greater LSM reduction. However, in cirrhotic patients, DM was associated with an increased LSM value after therapy.	[Wang, Jing-Houng] Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Wang, JH (corresponding author), Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan.	wajing@cgmh.org.tw	Tsai, Ming Chao/ABA-9806-2020	, Ming-Chao/0000-0002-3613-2051	Chang Gung Memorial Hospital; National Council of Science, Taiwan	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Council of Science, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by research grants from Chang Gung Memorial Hospital and the National Council of Science, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arase Y, 2013, HEPATOLOGY, V57, P964, DOI 10.1002/hep.26087; Benvegnu L, 2004, GUT, V53, P744, DOI 10.1136/gut.2003.020263; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Hung CH, 2011, EXPERT REV ANTI-INFE, V9, P525, DOI [10.1586/eri.11.33, 10.1586/ERI.11.33]; Corpechot C, 2006, HEPATOLOGY, V43, P1118, DOI 10.1002/hep.21151; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Fung J, 2010, HEPATOL INT, V4, P716, DOI 10.1007/s12072-010-9189-z; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gao C, 2010, WORLD J GASTROENTERO, V16, P4467, DOI 10.3748/wjg.v16.i35.4467; Hung CH, 2003, J GASTROENTEROL, V38, P153, DOI 10.1007/s005350300025; Hung CH, 2011, INT J CANCER, V128, P2344, DOI 10.1002/ijc.25585; Ko WH, 2012, HEPATOL RES, V42, P774, DOI 10.1111/j.1872-034X.2012.00979.x; Lam Yuk-Fai, 2011, Curr Hepat Rep, V10, P235, DOI 10.1007/s11901-011-0109-z; Lampertico P, 2012, GUT, V61, P18, DOI 10.1136/gutjnl-2012-302085; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; MAHARAJ B, 1986, LANCET, V1, P523; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; Masuzaki R, 2009, HEPATOLOGY, V49, P1954, DOI 10.1002/hep.22870; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Ogawa E, 2009, ANTIVIR RES, V83, P127, DOI 10.1016/j.antiviral.2009.04.002; Osakabe K, 2011, J GASTROENTEROL, V46, P1324, DOI 10.1007/s00535-011-0444-4; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Wang JH, 2010, J GASTROEN HEPATOL, V25, P964, DOI 10.1111/j.1440-1746.2009.06194.x; Wang JH, 2009, J GASTROENTEROL, V44, P439, DOI 10.1007/s00535-009-0017-y; Wong GLH, 2011, ANTIVIR THER, V16, P165, DOI 10.3851/IMP1726; Yuen MF, 2005, ALIMENT PHARM THERAP, V21, P841, DOI 10.1111/j.1365-2036.2005.02410.x	30	21	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93160	10.1371/journal.pone.0093160	http://dx.doi.org/10.1371/journal.pone.0093160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682088	Green Published, gold, Green Submitted			2022-12-27	WOS:000333678100028
J	Flis, S; Gnyszka, A; Flis, K				Flis, Sylwia; Gnyszka, Agnieszka; Flis, Krzysztof			DNA Methyltransferase Inhibitors Improve the Effect of Chemotherapeutic Agents in SW48 and HT-29 Colorectal Cancer Cells	PLOS ONE			English	Article							EPIGENETIC THERAPY; METHYLATION INHIBITOR; COLON-CANCER; ZEBULARINE; DECITABINE; DAMAGE; DRUG; 5-AZA-2'-DEOXYCYTIDINE; DEMETHYLATION; AZACITIDINE	DNA methylation is an epigenetic phenomenon known to play an important role in the development and progression of human cancer. Enzyme responsible for this process is DNA methyltransferase 1 (DNMT1) that maintains an altered methylation pattern by copying it from parent to daughter DNA strands after replication. Aberrant methylation of the promoter regions of genes critical for normal cellular functions is potentially reversible. Therefore, inactivation of DNMT1 seems to be a valuable target for the development of cancer therapies. Currently, the most popular DNMT inhibitors (DNMTi) are cytidine analogues like 5-azacytidine, 5-aza-2'-deoxycytidine (decitabine) and pyrimidin-2-one ribonucleoside (zebularine). In colorectal cancer, epigenetic modifications play an essential role at each step of carcinogenesis. Therefore, we have addressed the hypothesis that DNA methyltransferase inhibitors may potentiate inhibitory effects of classical chemotherapeutic agents, such as oxaliplatin and 5-fluorouracil (5-FU), commonly used in colorectal cancer therapy. Here, our report shows that DNMTi can have positive interactions with standard chemotherapeutics in colorectal cancer treatment. Using pharmacological models for the drug-drug interaction analysis, we have revealed that the combination of decitabine with 5-FU or oxaliplatin shows the most attractive interaction (synergism), whereas the effect of zebularine in combinations with chemotherapeutics is moderate and may be depended on genetic/epigenetic background of a cell line or secondary drug used in combination. Our results suggest that DNMTi administered in combination with standard chemotherapeutics might improve the treatment of patients with colorectal cancers.	[Flis, Sylwia; Gnyszka, Agnieszka] Natl Med Inst, Dept Pharmacol, Warsaw, Poland; [Flis, Krzysztof] Polish Acad Sci, Inst Biochem & Biophys, Dept Genet, Warsaw, Poland	National Medicines Institute Lekow (NIL); Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Flis, S (corresponding author), Natl Med Inst, Dept Pharmacol, Warsaw, Poland.	sylwia.flis@yahoo.pl	Flis, Sylwia/N-6795-2013; FLIS, Krzysztof/K-6559-2012	Flis, Sylwia/0000-0002-6071-9952	National Science Center of Poland [N405 139139]	National Science Center of Poland(National Science Centre, Poland)	This study was supported by grant no. N405 139139 from the National Science Center of Poland (http://www.ncn.gov.pl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleton K, 2007, J CLIN ONCOL, V25, P4603, DOI 10.1200/JCO.2007.10.8688; Bardhan Kankana, 2013, Cancers (Basel), V5, P676, DOI 10.3390/cancers5020676; Ben-Kasus T, 2005, BIOCHEM PHARMACOL, V70, P121, DOI 10.1016/j.bcp.2005.04.010; Blinman P, 2010, EUR J CANCER, V46, P1800, DOI 10.1016/j.ejca.2009.12.032; Chau I, 2006, ANN ONCOL, V17, P1347, DOI 10.1093/annonc/mdl029; Cheng JC, 2004, MOL CELL BIOL, V24, P1270, DOI 10.1128/MCB.24.3.1270-1278.2004; Cheng JC, 2004, CANCER CELL, V6, P151, DOI 10.1016/j.ccr.2004.06.023; CHOU TC, 1983, TRENDS PHARMACOL SCI, V4, P450, DOI 10.1016/0165-6147(83)90490-X; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cowan LA, 2010, EPIGENOMICS-UK, V2, P71, DOI 10.2217/EPI.09.44; Crea F, 2009, MOL CANCER THER, V8, P1964, DOI 10.1158/1535-7163.MCT-09-0027; Deng G, 2002, BRIT J CANCER, V86, P574, DOI 10.1038/sj.bjc.6600148; Esteller M, 2001, CANCER RES, V61, P2816; Flis S, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-10; Flotho C, 2009, LEUKEMIA, V23, P1019, DOI 10.1038/leu.2008.397; Gessner PK, 1995, TOXICOLOGY, V105, P161, DOI 10.1016/0300-483X(95)03210-7; Gnyszka A, 2013, ANTICANCER RES, V33, P2989; Goffin J, 2002, ANN ONCOL, V13, P1699, DOI 10.1093/annonc/mdf314; Hellebrekers DMEI, 2007, BBA-REV CANCER, V1775, P76, DOI 10.1016/j.bbcan.2006.07.003; Holleran JL, 2005, CLIN CANCER RES, V11, P3862, DOI 10.1158/1078-0432.CCR-04-2406; Issa JP, 2000, ANN NY ACAD SCI, V910, P140; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; LEE T, 1974, CANCER RES, V34, P2482; Lemaire M, 2005, ANTI-CANCER DRUG, V16, P301, DOI 10.1097/00001813-200503000-00009; Lind GE, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-28; Mahyar-Roemer M, 2001, INT J CANCER, V94, P615, DOI 10.1002/ijc.1516; Marquez VE, 2005, ANN NY ACAD SCI, V1058, P246, DOI 10.1196/annals.1359.037; Mossman D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-366; National Cancer Institute website, CANC DRUG INF FDA AP; Nowsheen S., 2012, Experimental Oncology, V34, P243; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Pogribny IP, 2013, CANCER LETT, V334, P39, DOI 10.1016/j.canlet.2012.09.010; Riches LC, 2008, MUTAGENESIS, V23, P331, DOI 10.1093/mutage/gen039; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Skladanowski A, 2009, CHEM REV, V109, P2951, DOI 10.1021/cr900026u; Toledo LI, 2011, MOL ONCOL, V5, P368, DOI 10.1016/j.molonc.2011.07.002; Yoo CB, 2004, BIOCHEM SOC T, V32, P910, DOI 10.1042/BST0320910; Yoo CB, 2008, CANCER PREV RES, V1, P233, DOI 10.1158/1940-6207.CAPR-07-0008	39	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92305	10.1371/journal.pone.0092305	http://dx.doi.org/10.1371/journal.pone.0092305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676085	gold, Green Submitted, Green Published			2022-12-27	WOS:000333677500019
J	Meric, G; Yahara, K; Mageiros, L; Pascoe, B; Maiden, MCJ; Jolley, KA; Sheppard, SK				Meric, Guillaume; Yahara, Koji; Mageiros, Leonardos; Pascoe, Ben; Maiden, Martin C. J.; Jolley, Keith A.; Sheppard, Samuel K.			A Reference Pan-Genome Approach to Comparative Bacterial Genomics: Identification of Novel Epidemiological Markers in Pathogenic Campylobacter	PLOS ONE			English	Article							BY-GENE APPROACH; METHYLCITRATE CYCLE; ESCHERICHIA-COLI; HOST-SPECIFICITY; JEJUNI; SEQUENCE; ASSOCIATION; METABOLISM; EVOLUTION; GENOTYPES	The increasing availability of hundreds of whole bacterial genomes provides opportunities for enhanced understanding of the genes and alleles responsible for clinically important phenotypes and how they evolved. However, it is a significant challenge to develop easy-to-use and scalable methods for characterizing these large and complex data and relating it to disease epidemiology. Existing approaches typically focus on either homologous sequence variation in genes that are shared by all isolates, or non-homologous sequence variation - focusing on genes that are differentially present in the population. Here we present a comparative genomics approach that simultaneously approximates core and accessory genome variation in pathogen populations and apply it to pathogenic species in the genus Campylobacter. A total of 7 published Campylobacter jejuni and Campylobacter coli genomes were selected to represent diversity across these species, and a list of all loci that were present at least once was compiled. After filtering duplicates a 7-isolate reference pan-genome, of 3,933 loci, was defined. A core genome of 1,035 genes was ubiquitous in the sample accounting for 59% of the genes in each isolate (average genome size of 1.68 Mb). The accessory genome contained 2,792 genes. A Campylobacter population sample of 192 genomes was screened for the presence of reference pan-genome loci with gene presence defined as a BLAST match of >= 70% identity over >= 50% of the locus length - aligned using MUSCLE on a gene-by-gene basis. A total of 21 genes were present only in C. coli and 27 only in C. jejuni, providing information about functional differences associated with species and novel epidemiological markers for population genomic analyses. Homologs of these genes were found in several of the genomes used to define the pan-genome and, therefore, would not have been identified using a single reference strain approach.	[Meric, Guillaume; Yahara, Koji; Mageiros, Leonardos; Pascoe, Ben; Sheppard, Samuel K.] Swansea Univ, Inst Life Sci, Coll Med, Swansea, W Glam, Wales; [Yahara, Koji] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan; [Maiden, Martin C. J.; Jolley, Keith A.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Swansea University; University of Tokyo; University of Oxford	Sheppard, SK (corresponding author), Swansea Univ, Inst Life Sci, Coll Med, Swansea, W Glam, Wales.	s.k.sheppard@swansea.ac.uk	Maiden, Martin/N-6805-2019; Méric, Guillaume/AAD-2364-2019; Pascoe, Ben/C-2253-2009; Jolley, Keith/ABE-8587-2020; Pascoe, Ben/AAD-2728-2019; Maiden, Martin C J/C-5055-2014; Méric, Guillaume/R-3947-2017	Maiden, Martin/0000-0001-6321-5138; Méric, Guillaume/0000-0001-6288-9958; Pascoe, Ben/0000-0001-6376-5121; Jolley, Keith/0000-0002-0751-0287; Maiden, Martin C J/0000-0001-6321-5138; Méric, Guillaume/0000-0001-6288-9958; Sheppard, Samuel/0000-0001-6901-3203	Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust; BBSRC [BB/I02464X/1] Funding Source: UKRI; MRC [G0801929] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I02464X/1] Funding Source: researchfish; Medical Research Council [G0801929] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by various funding sources from the Biotechnology and Biological Sciences Research Council (BBSRC), and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Biggs PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027121; Chen YS, 2013, ANTIMICROB AGENTS CH, V57, P5398, DOI 10.1128/AAC.00669-13; de Haan CPA, 2012, APPL ENVIRON MICROB, V78, P5550, DOI 10.1128/AEM.01023-12; Duncan SH, 2004, BRIT J NUTR, V91, P915, DOI 10.1079/BJN20041150; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Friis C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012253; Griekspoor P, 2013, MOL ECOL, V22, P1463, DOI 10.1111/mec.12144; Gripp E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-584; Gundogdu O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-162; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Katz LS, 2013, MBIO, V4, DOI 10.1128/mBio.00398-13; Kessel A S, 2001, Commun Dis Public Health, V4, P171; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; OLSVIK O, 1993, J CLIN MICROBIOL, V31, P22, DOI 10.1128/JCM.31.1.22-25.1993; Pearson BM, 2007, J BACTERIOL, V189, P8402, DOI 10.1128/JB.01404-07; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Sheppard SK, 2008, SCIENCE, V320, P237, DOI 10.1126/science.1155532; Sheppard SK, 2013, P NATL ACAD SCI USA, V110, P11923, DOI 10.1073/pnas.1305559110; Sheppard SK, 2013, MOL ECOL, V22, P1051, DOI 10.1111/mec.12162; Sheppard SK, 2012, GENES-BASEL, V3, P261, DOI 10.3390/genes3020261; Sheppard SK, 2011, MOL ECOL, V20, P3484, DOI 10.1111/j.1365-294X.2011.05179.x; Sheppard SK, 2011, MICROBIOL-SGM, V157, P1066, DOI 10.1099/mic.0.045153-0; Sheppard SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015708; Sheppard SK, 2010, APPL ENVIRON MICROB, V76, P5269, DOI 10.1128/AEM.00124-10; Sheppard SK, 2009, INT J FOOD MICROBIOL, V134, P96, DOI 10.1016/j.ijfoodmicro.2009.02.010; Sheppard SK, 2009, CLIN INFECT DIS, V48, P1072, DOI 10.1086/597402; Snipen L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-385; Stahl M, 2011, P NATL ACAD SCI USA, V108, P7194, DOI 10.1073/pnas.1014125108; Upton AM, 2007, MICROBIOL-SGM, V153, P3973, DOI 10.1099/mic.0.2007/011726-0; Young BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/pnas.1113219109; Zhang W, 2006, GENOME RES, V16, P757, DOI 10.1101/gr.4759706	43	87	87	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92798	10.1371/journal.pone.0092798	http://dx.doi.org/10.1371/journal.pone.0092798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676150	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500040
J	Riedel, C; von Kries, R; Buyken, AE; Diethelm, K; Keil, T; Grabenhenrich, L; Muller, MJ; Plachta-Danielzik, S				Riedel, Christina; von Kries, Ruediger; Buyken, Anette E.; Diethelm, Katharina; Keil, Thomas; Grabenhenrich, Linus; Mueller, Manfred J.; Plachta-Danielzik, Sandra			Overweight in Adolescence Can Be Predicted at Age 6 Years: A CART Analysis in German Cohorts	PLOS ONE			English	Article							BODY-MASS INDEX; SCHOOL-BASED INTERVENTIONS; KIEL OBESITY PREVENTION; PHYSICAL-ACTIVITY; RISK-FACTORS; CHILDHOOD OVERWEIGHT; PARENTAL OBESITY; YOUNG ADULTHOOD; BIRTH COHORT; CHILDREN	Objective: To examine, whether overweight in adolescents can be predicted from the body mass index (BMI) category, at the age of 6, the mother's education level and mother's obesity and to quantify the proportion of overweight at the age of 14 that can be explained by these predictors. Method: Pooled data from three German cohorts providing anthropometric and other relevant data to a total of 1 287 children. We used a classification and regression tree (CART) approach to identify the contribution of BMI category at the age of 6 (obese: BMI>97th percentile (P97); overweight: P90<BMI <= P97; high normal weight: P75<BMI <= P90; third quartile: P50<BMI <= P75; below the median: <= P50), maternal education level and maternal obesity for prediction of overweight/obesity (BMI>P90) at the age of 14. Results: While 4.8% [95% CI: 3.2; 7.0] of 651 boys and 4.1% [95% CI: 2.6; 6.2] of 636 girls with a BMI<P75 at age 6 were overweight/obese in adolescence, prevalence increased to 41.3% [95% CI: 31.9; 51.1] and 42.5% [95% CI: 33.8; 51.6], respectively, in those with BMI >= P75. The lowest prevalence was 1.9% [95% CI: 0.8; 3.8] in boys with a BMI <= P50 and the highest prevalence 91.7% [95% CI: 61.5; 99.8] with a BMI>P97 (similar results for girls). BMI >= P75 at the age of 6 explained 63.5% [95% CI: 51.1; 74.5]) and 72.0% [95% CI: 60.4; 81.8] of overweight/obesity at the age of 14 in boys and girls, respectively. Conclusions: Overweight/obesity in adolescence can be predicted by BMI category at the age of 6 allowing for parent counselling or risk guided interventions in children with BMI >= P75, who accounted for >2/3 of overweight/obesity in adolescents.	[Riedel, Christina; von Kries, Ruediger] Univ Munich, Inst Social Paediat & Adolescent Med, Munich, Germany; [Buyken, Anette E.; Diethelm, Katharina] Univ Bonn, IEL Nutr Epidemiol, DONALD Study, Res Inst Child Nutr, Dortmund, Germany; [Keil, Thomas; Grabenhenrich, Linus] Charite, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany; [Mueller, Manfred J.; Plachta-Danielzik, Sandra] Univ Kiel, Inst Human Nutr & Food Sci, Kiel, Germany	University of Munich; University of Bonn; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Kiel	Riedel, C (corresponding author), Univ Munich, Inst Social Paediat & Adolescent Med, Munich, Germany.	christina.riedel@med.uni-muenchen.de		Sobotzki, Christina/0000-0002-0956-0050; Grabenhenrich, Linus/0000-0002-9300-6625	Ministry of Science and Research of North Rhine Westphalia, Germany; Deutsche Forschungsgemeinschaft [DFG Mu 5.1, 5.2, 5.3, 5.5]; German Federal Ministry of Education and Research (Competence Network Obesity) [FKZ: 01GI1121A]	Ministry of Science and Research of North Rhine Westphalia, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (Competence Network Obesity)	The DONALD Study is funded by the Ministry of Science and Research of North Rhine Westphalia, Germany. KOPS was funded by Deutsche Forschungsgemeinschaft (DFG Mu 5.1, 5.2, 5.3 and 5.5). This analysis was supported by the German Federal Ministry of Education and Research (Competence Network Obesity; project: "Life Course Approach To Obesity Research: From Epidemiology to Future Strategies of Prevention - EPI Germany" [FKZ: 01GI1121A]). Neither of the funding agencies had any influence on the study conduct and report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer O, 2011, OBESITY, V19, P1069, DOI 10.1038/oby.2010.250; Bergmann R L, 1994, Pediatr Allergy Immunol, V5, P19, DOI 10.1111/j.1399-3038.1994.tb00343.x; Breiman L., 1984, CLASSIFICATION REGRE; Brown T, 2009, OBES REV, V10, P110, DOI 10.1111/j.1467-789X.2008.00515.x; Buyken AE, 2012, BUNDESGESUNDHEITSBLA, V55, P875, DOI 10.1007/s00103-012-1503-6; Clark L A., 1992, TREE BASED MODELS ST, P377; Clopper C, 1934, BIOMETRIKA, V26; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Fallon B, 2013, CHILD ADOL PSYCH MEN, V7, DOI 10.1186/1753-2000-7-4; Field AE, 2005, OBES RES, V13, P163, DOI 10.1038/oby.2005.21; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; Fryar C.D., 2012, PREVALENCE OBESITY C, V1960; Guo SS, 2002, AM J CLIN NUTR, V76, P653, DOI 10.1093/ajcn/76.3.653; GUO SS, 1994, AM J CLIN NUTR, V59, P810, DOI 10.1093/ajcn/59.4.810; Haines J, 2013, JAMA PEDIAT; Harris KC, 2009, CAN MED ASSOC J, V180, P719, DOI 10.1503/cmaj.080966; Hector D., 2012, EVIDENCE UPDATE OBES; Herman KM, 2009, INT J PEDIATR OBES, V4, P281, DOI 10.3109/17477160802596171; Hoffmann S, 2012, OBESITY; Hughes AR, 2011, PREV MED, V52, P300, DOI 10.1016/j.ypmed.2011.02.014; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Jackson-Leach R, 2006, INT J PEDIATR OBES, V1, P26, DOI 10.1080/17477160600586614; Karaolis-Danckert N, 2008, AM J CLIN NUTR, V87, P1356, DOI 10.1093/ajcn/87.5.1356; Katz DL, 2008, INT J OBESITY, V32, P1780, DOI 10.1038/ijo.2008.158; Kroke A, 2004, EUR J NUTR, V43, P45, DOI 10.1007/s00394-004-0445-7; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Lavelle HV, 2012, J PUBLIC HEALTH-UK, V34, P360, DOI 10.1093/pubmed/fdr116; Lazaar N, 2007, ACTA PAEDIATR, V96, P1321, DOI 10.1111/j.1651-2227.2007.00426.x; Lemon SC, 2003, ANN BEHAV MED, V26, P172, DOI 10.1207/S15324796ABM2603_02; Li CY, 2007, OBESITY, V15, P760, DOI 10.1038/oby.2007.585; Linabery AM, 2013, PEDIATR OBES, V8, P159, DOI 10.1111/j.2047-6310.2012.00100.x; Magarey AM, 2003, INT J OBESITY, V27, P505, DOI 10.1038/sj.ijo.0802251; Must A, 1996, AM J CLIN NUTR, V63, P445, DOI 10.1093/ajcn/63.3.445; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Ogden CL, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.4.e1; Padez C, 2005, ACTA PAEDIATR, V94, P1550, DOI 10.1080/08035250510042924; Pei Z, 2013, EUR J CLIN NUTR, V67, P855, DOI 10.1038/ejcn.2013.80; PISUNYER FX, 1991, AM J CLIN NUTR, V53, pS1595; Plachta-Danielzik S, 2012, BUNDESGESUNDHEITSBLA, V55, P885, DOI 10.1007/s00103-012-1494-3; Plachta-Danielzik S, 2007, OBESITY, V15, P3159, DOI 10.1038/oby.2007.376; Plachta-Danielzik S, 2012, PEDIATRICS, V130, pE865, DOI 10.1542/peds.2011-3296; Plachta-Danielzik S, 2008, OBESITY FACTS, V1, P325, DOI 10.1159/000176609; Power C, 1997, AM J CLIN NUTR, V66, P1094, DOI 10.1093/ajcn/66.5.1094; Rochat MK, 2010, J ALLERGY CLIN IMMUN, V126, P1170, DOI 10.1016/j.jaci.2010.09.008; Rokach L, 2007, DATA MINING DECISION; Shih YS, 2001, STAT PROBABIL LETT, V54, P341, DOI 10.1016/S0167-7152(00)00188-7; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Starc G, 2011, PUBLIC HEALTH NUTR, V14, P49, DOI 10.1017/S1368980010000741; Sung YW, 2012, OBES REV; TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005; von Kries R, 2012, INT J OBESITY, V36, P505, DOI 10.1038/ijo.2011.251; von Kries R, 2012, PEDIAT OBES IN PRESS; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Williams S, 2001, INT J OBESITY, V25, P158, DOI 10.1038/sj.ijo.0801512; Yohannes Y, 1999, CLASSIFICAITON REGRE	56	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93581	10.1371/journal.pone.0093581	http://dx.doi.org/10.1371/journal.pone.0093581			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676281	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500141
J	Tevy, MF; Seyres, D; Traina, C; Perrin, L; Capovilla, M				Tevy, Maria Florencia; Seyres, Denis; Traina, Concetta; Perrin, Laurent; Capovilla, Maria			Ndae1 Expression and Regulation in Drosophila Embryos	PLOS ONE			English	Article							DORSAL-VENTRAL PATTERN; SIGNALING PATHWAY; SLC4 FAMILY; PROTEIN; GRADIENT; AMNIOSEROSA; MORPHOGEN; CLOSURE; TOLL; LOCALIZATION	The construction and prediction of cell fate maps at the whole embryo level require the establishment of an accurate atlas of gene expression patterns throughout development and the identification of the corresponding cis-regulatory sequences. However, while the expression and regulation of genes encoding upstream developmental regulators such as transcription factors or signaling pathway components have been analyzed in detail, up to date the number of cis-regulatory sequences identified for downstream effector genes, like ion channels, pumps and exchangers, is very low. The control and regulation of ion homeostasis in each cell, including at blastoderm stages, are essential for normal embryonic development. In this study, we analyzed in detail the embryonic expression pattern and cis-regulatory modules of the Drosophila Na+-driven anion exchanger 1 (Ndae1) gene, involved in the regulation of pH homeostasis. We show that Ndae1 is expressed in a tight and complex spatial-temporal pattern. In particular, we report that this downstream effector gene is under the control of the canonical dorsal-ventral patterning cascade through dorsal, Toll, twist and snail at early embryogenesis. Moreover, we identify several cis-regulatory modules, some of which control discrete and non-overlapping aspects of endogenous gene expression throughout development.	[Tevy, Maria Florencia; Traina, Concetta] Univ Ferrara, Dulbecco Telethon Inst, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy; [Seyres, Denis; Perrin, Laurent] INSERM, UMR 1090, TAGC, F-13258 Marseille, France; [Seyres, Denis; Perrin, Laurent] Aix Marseille Univ, UMR 1090, TAGC, Marseille, France; [Perrin, Laurent] CNRS, Marseille, France; [Capovilla, Maria] INRA CNRS UNS, UMR 7254, Inst Sophia Agrobiotech, Sophia Antipolis, France	Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Ferrara; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Capovilla, M (corresponding author), INRA CNRS UNS, UMR 7254, Inst Sophia Agrobiotech, Sophia Antipolis, France.	Maria.Capovilla@sophia.inra.fr	Seyres, Denis/ABE-3666-2021; Perrin, Laurent/L-8301-2016; Tevy, Florencia/AAF-6583-2019; Capovilla, Maria/O-8483-2016	Perrin, Laurent/0000-0002-4139-8743; Tevy, Florencia/0000-0002-8915-1328; Capovilla, Maria/0000-0002-1308-7964; Seyres, Denis/0000-0002-2066-6980	Dulbecco Telethon Institute [3021]	Dulbecco Telethon Institute(Fondazione Telethon)	Funding provided by Dulbecco Telethon Institute grant n. 3021 (http://dti.telethon.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio V, 2012, DEV DYNAM, V241, P190, DOI 10.1002/dvdy.22763; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Bernardoni R, 1999, DEV BIOL, V216, P265, DOI 10.1006/dbio.1999.9511; Buecker C, 2012, TRENDS GENET, V28, P276, DOI 10.1016/j.tig.2012.02.008; Cerrone M, 2012, CURR OPIN CARDIOL, V27, P242, DOI 10.1097/HCO.0b013e328352429d; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Cordat E, 2009, BIOCHEM J, V417, P423, DOI 10.1042/BJ20081634; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Fernandez BG, 2007, MECH DEVELOP, V124, P884, DOI 10.1016/j.mod.2007.09.002; FitzHarris G, 2009, REPRODUCTION, V138, P619, DOI 10.1530/REP-09-0112; Fontenele M, 2009, MECH DEVELOP, V126, P737, DOI 10.1016/j.mod.2009.04.005; Fowlkes CC, 2008, CELL, V133, P364, DOI 10.1016/j.cell.2008.01.053; Frise E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.102; Ganetzky B, 2000, KIDNEY INT, V57, P766, DOI 10.1046/j.1523-1755.2000.00913.x; Gurnett CA, 2008, ARCH NEUROL-CHICAGO, V65, P550, DOI 10.1001/archneur.65.4.550; Herrmann C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks543; Hong JW, 2008, P NATL ACAD SCI USA, V105, P20072, DOI 10.1073/pnas.0806476105; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Ip YT, 2002, CURR OPIN GENET DEV, V12, P423, DOI 10.1016/S0959-437X(02)00320-9; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; Jacobs S, 2008, P NATL ACAD SCI USA, V105, P311, DOI 10.1073/pnas.0705487105; JARIAL MS, 1987, TISSUE CELL, V19, P559, DOI 10.1016/0040-8166(87)90048-6; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Kazemian M, 2010, PLOS BIOL, DOI [10.1371/journal.-pbio.1000456, DOI 10.1371/J0URNAL.-PBI0.1000456]; Keyser P, 2007, INSECT BIOCHEM MOLEC, V37, P356, DOI 10.1016/j.ibmb.2006.12.009; Lamka ML, 1999, DEV BIOL, V214, P102, DOI 10.1006/dbio.1999.9409; Marban E, 2002, NATURE, V415, P213, DOI 10.1038/415213a; Mehta A, 2008, BIOCHEM SOC T, V36, P1313, DOI 10.1042/BST0361313; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Narasimha M, 2004, CURR BIOL, V14, P381, DOI 10.1016/j.cub.2004.02.033; Naval-Sanchez M, 2013, GENOME RES, V23, P74, DOI 10.1101/gr.140426.112; Parker MD, 2012, J PHYSIOL-LONDON, V590, P2009, DOI 10.1113/jphysiol.2011.224733; Perrin L, 2004, DEV BIOL, V272, P419, DOI 10.1016/j.ydbio.2004.04.036; Pym ECG, 2006, NEURAL DEV, V1, DOI 10.1186/1749-8104-1-3; Reeves GT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000836; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; Romero MF, 2000, J BIOL CHEM, V275, P24552, DOI 10.1074/jbc.M003476200; Romero MF, 2013, MOL ASPECTS MED, V34, P159, DOI 10.1016/j.mam.2012.10.008; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Sciortino CM, 2001, AM J PHYSIOL-CELL PH, V281, pC449, DOI 10.1152/ajpcell.2001.281.2.C449; Scuderi A, 2005, DEV DYNAM, V232, P791, DOI 10.1002/dvdy.20306; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Sinning A, 2011, J NEUROSCI, V31, P7300, DOI 10.1523/JNEUROSCI.0269-11.2011; Soleimani M, 2000, KIDNEY INT, V57, P371, DOI 10.1046/j.1523-1755.2000.00857.x; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; STEWARD R, 1989, CELL, V59, P1179, DOI 10.1016/0092-8674(89)90773-3; Krepischi AC, 2010, EPILEPSIA, V51, P2457, DOI 10.1111/j.1528-1167.2010.02742.x; Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136; Wada A, 2007, DEV BIOL, V301, P340, DOI 10.1016/j.ydbio.2006.09.020; WINANS KA, 1995, MOL BIOL CELL, V6, P587, DOI 10.1091/mbc.6.5.587; Winkelmann A, 2014, J CLIN INVEST, V124, P696, DOI 10.1172/JCI71472; Wolfram V, 2012, NEURON, V75, P663, DOI 10.1016/j.neuron.2012.06.015	60	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92956	10.1371/journal.pone.0092956	http://dx.doi.org/10.1371/journal.pone.0092956			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676142	Green Published, gold			2022-12-27	WOS:000333677500060
J	Zheng, LB; Sun, XY; Zhu, X; Lv, FX; Zhong, ZY; Zhang, F; Guo, WH; Cao, WW; Yang, LM; Tian, Y				Zheng, Longbin; Sun, Xinyong; Zhu, Xing; Lv, Fengxiang; Zhong, Zhaoyu; Zhang, Feng; Guo, Wenhui; Cao, Wenwu; Yang, Liming; Tian, Ye			Apoptosis of THP-1 Derived Macrophages Induced by Sonodynamic Therapy Using a New Sonosensitizer Hydroxyl Acetylated Curcumin	PLOS ONE			English	Article							HEMATOPORPHYRIN MONOMETHYL ETHER; REGULATORY ELEMENT PATHWAY; LDL RECEPTOR EXPRESSION; CELLS IN-VITRO; PROTOPORPHYRIN IX; ATHEROSCLEROTIC PLAQUES; 5-AMINOLEVULINIC ACID; PHOTODYNAMIC THERAPY; SARCOMA-180 CELLS; MDA-MB-231 CELLS	Curcumin is extracted from the rhizomes of the traditional Chinese herb Curcuma longa. Our previous study indicated curcumin was able to function as a sonosensitizer. Hydroxyl acylated curcumin was synthesized from curcumin to eliminate the unstable hydroxy perssad in our group. The potential use of Hydroxyl acylated curcumin as a sonosensitizer for sonodynamic therapy (SDT) requires further exploration. This study investigated the sonodynamic effect of Hydroxyl acylated curcumin on THP-1 macrophage. THP-1 macrophages were cultured with Hydroxyl acylated curcumin at a concentration of 5.0 mu g/mL for 4 hours and then exposed to pulse ultrasound irradiation (0.5 W/cm(2) with 1.0 MHz) for 5 min, 10 min and 15 min. Six hours later, cell viability decreased significantly by CCK-8 assay. After ultrasound irradiation, the ratio of apoptosis and necrosis in SDT group was higher than that in control, Hydroxyl acylated curcumin alone and ultrasound alone. Moreover, the apoptotic rate was higher than necrotic rate with the flow cytometry analysis. Furthermore, Hydroxyl acylated curcumin-SDT induced reactive oxygen species (ROS) generation in THP-1 macrophages immediately after the ultrasound treatment while ROS generation was reduced significantly with the scavenger of singlet oxygen Sodium azide (NaN3). Hydroxyl acylated curcumin-SDT led to a conspicuous loss of mitochondrial membrane potential (MMP) compared with other groups, while MMP was increased significantly with the scavenger of singlet oxygen Sodium azide (NaN3), ROS inhibitor N-acetyl cysteine (NAC) and Mitochondrial Permeability Transition Pore (MPTP) inhibitor Cyclosporin A (CsA). The cytochrome C, cleaved-Caspase-9, cleaved-Caspase-3 and cleaved-PARP upregulated after SDT through Western blotting. These findings suggested that Hydroxyl acylated curcumin under low-intensity ultrasound had sonodynamic effect on THP-1 macrophages via generation of intracellular singlet oxygen and mitochondria-caspase signaling pathway, indicating that Hydroxyl acylated curcumin could be used as a novel sonosensitizer in SDT for atherosclerosis.	[Zheng, Longbin; Zhu, Xing; Zhong, Zhaoyu; Zhang, Feng; Guo, Wenhui; Yang, Liming; Tian, Ye] Harbin Med Univ, Dept Pathophysiol, Key Lab Myocardial Ischemia, Minist Educ, Harbin, Heilongjiang, Peoples R China; [Sun, Xinyong; Tian, Ye] Harbin Med Univ, Affiliated Hosp 1, Div Cardiol, Harbin, Heilongjiang, Peoples R China; [Lv, Fengxiang] Peking Univ, Inst Mol Med, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; [Cao, Wenwu] Harbin Inst Technol, Lab Sono & Photo Theranost Technol, Harbin 150006, Heilongjiang, Peoples R China; [Cao, Wenwu] Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA	Harbin Medical University; Harbin Medical University; Peking University; Harbin Institute of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Yang, LM (corresponding author), Harbin Med Univ, Dept Pathophysiol, Key Lab Myocardial Ischemia, Minist Educ, Harbin, Heilongjiang, Peoples R China.	limingyang@ems.hrbmu.edu.cn; yetian@ems.hrbmu.edu.cn	Cao, Wenwu/F-6091-2012	Cao, Wenwu/0000-0002-2447-1486	National Natural Science Foundation of China [81000688, 81271734]; Heilongjiang Provincial Youth Science Foundation [QC2011C002]; Foundation of Science and Technology Innovation Talent of Harbin Science and Technology Bureau [2011RFQXS072]; Wu Liande Youth Science Foundation of Harbin Medical University [WLD-QN1104]; Postdoctoral Science-research Developmental Foundation of Heilongjiang Province [LBH-Q12049]; Key Laboratory of Myocardial Ischemia, Harbin Medical University, Chinese Ministry of Education [KF201212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Provincial Youth Science Foundation; Foundation of Science and Technology Innovation Talent of Harbin Science and Technology Bureau; Wu Liande Youth Science Foundation of Harbin Medical University; Postdoctoral Science-research Developmental Foundation of Heilongjiang Province; Key Laboratory of Myocardial Ischemia, Harbin Medical University, Chinese Ministry of Education	This study was supported by the National Natural Science Foundation of China (81000688, 81271734), Heilongjiang Provincial Youth Science Foundation (QC2011C002), Foundation of Science and Technology Innovation Talent of Harbin Science and Technology Bureau (2011RFQXS072), Wu Liande Youth Science Foundation of Harbin Medical University (WLD-QN1104), Postdoctoral Science-research Developmental Foundation of Heilongjiang Province (LBH-Q12049), and Key Laboratory of Myocardial Ischemia, Harbin Medical University, Chinese Ministry of Education (KF201212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JC, 2012, INT J ONCOL, V41, P2184, DOI 10.3892/ijo.2012.1661; Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; [许川山 Xu Chuanshan], 2005, [激光杂志, Laser Journal], V26, P86; Cheng JL, 2013, INT J NANOMED, V8, P669, DOI 10.2147/IJN.S39844; Cheng JL, 2010, J PHOTOCH PHOTOBIO B, V101, P9, DOI 10.1016/j.jphotobiol.2010.06.005; Croons V, 2010, CURR VASC PHARMACOL, V8, P495, DOI 10.2174/157016110791330816; Dai SC, 2009, ACTA NEUROCHIR, V151, P1655, DOI 10.1007/s00701-009-0456-5; De Meyer I, 2012, BRIT J CLIN PHARMACO, V74, P246, DOI 10.1111/j.1365-2125.2012.04211.x; Dou XB, 2008, PLANTA MED, V74, P1374, DOI 10.1055/s-2008-1081316; [窦晓兵 Dou Xiaobing], 2005, [中国药学杂志, Chinese Pharmaceutical Journal], V40, P980; Estronca LMBB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034822; Fan CL, 2006, PHARMACOL REP, V58, P577; [范春雷 Fan Chunlei], 2006, [中国药学杂志, Chinese Pharmaceutical Journal], V41, P664; Fan CL, 2006, J ETHNOPHARMACOL, V105, P251, DOI 10.1016/j.jep.2005.11.009; Feril LB, 2005, CANCER LETT, V221, P145, DOI 10.1016/j.canlet.2004.08.034; Gao QP, 2011, ULTRASOUND MED BIOL, V37, P1478, DOI 10.1016/j.ultrasmedbio.2011.05.846; Guo SY, 2013, INT J NANOMED, V8, P2239, DOI 10.2147/IJN.S43717; Honda H, 2004, ULTRASOUND MED BIOL, V30, P683, DOI 10.1016/j.ultrasmedbio.2004.02.008; Jin H, 2011, J CELL BIOCHEM, V112, P169, DOI 10.1002/jcb.22912; Kzhyshkowska J, 2012, IMMUNOBIOLOGY, V217, P492, DOI 10.1016/j.imbio.2012.02.015; Li HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059473; Li JH, 2011, INT J RADIAT BIOL, V87, P1061, DOI 10.3109/09553002.2011.584938; Li YX, 2012, ULTRASONICS, V52, P490, DOI 10.1016/j.ultras.2011.10.013; Lotta LA, 2010, EUR J INTERN MED, V21, P74, DOI 10.1016/j.ejim.2009.11.003; Martinet W, 2007, TRENDS CARDIOVAS MED, V17, P69, DOI 10.1016/j.tcm.2006.12.004; Mi N, 2009, ULTRASOUND MED BIOL, V35, P680, DOI 10.1016/j.ultrasmedbio.2008.07.002; Newman CMH, 2007, GENE THER, V14, P465, DOI 10.1038/sj.gt.3302925; Ohmura T, 2011, ANTICANCER RES, V31, P2527; Peng CH, 2011, J PHOTOCH PHOTOBIO B, V102, P26, DOI 10.1016/j.jphotobiol.2010.09.001; Perdiguero EG, 2013, COLD SH Q B, V78, P91, DOI 10.1101/sqb.2013.78.020032; Qian Ying, 2006, Zhongguo Yaolixue Tongbao, V22, P828; Rossi A, 2006, INT J CARDIOL, V111, P263, DOI 10.1016/j.ijcard.2005.08.030; Sharma RA, 2007, ADV EXP MED BIOL, V595, P453; Sheridan C, 2010, MITOCHONDRION, V10, P640, DOI 10.1016/j.mito.2010.08.005; Shibaguchi H, 2011, ANTICANCER RES, V31, P2425; Shohet RV, 2000, CIRCULATION, V101, P2554, DOI 10.1161/01.CIR.101.22.2554; Song W, 2011, ANTICANCER RES, V31, P39; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tachibana K, 2008, ULTRASONICS, V48, P253, DOI 10.1016/j.ultras.2008.02.003; Tang W, 2008, J ULTRAS MED, V27, P645, DOI 10.7863/jum.2008.27.4.645; Tang W, 2010, ULTRASONICS, V50, P567, DOI 10.1016/j.ultras.2009.12.001; Tang W, 2009, ULTRASONICS, V49, P786, DOI 10.1016/j.ultras.2009.06.002; Wang FP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/737264; Wang HP, 2013, ULTRASOUND MED BIOL, V39, P1713, DOI 10.1016/j.ultrasmedbio.2013.03.017; Wang XB, 2010, ULTRASOUND MED BIOL, V36, P667, DOI 10.1016/j.ultrasmedbio.2009.09.006; Wang XB, 2011, ULTRASONICS, V51, P539, DOI 10.1016/j.ultras.2010.12.001; Wang XB, 2010, ULTRASONICS, V50, P803, DOI 10.1016/j.ultras.2010.04.004; Xiang JY, 2011, ULTRASONICS, V51, P390, DOI 10.1016/j.ultras.2010.11.005; Xu ZY, 2013, ULTRASONICS, V53, P232, DOI 10.1016/j.ultras.2012.06.005; Yumita N, 2010, CANCER CHEMOTH PHARM, V66, P1071, DOI 10.1007/s00280-010-1264-6; Zolochevska O, 2011, HUM GENE THER, V22, P1537, DOI 10.1089/hum.2011.076	51	48	54	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93133	10.1371/journal.pone.0093133	http://dx.doi.org/10.1371/journal.pone.0093133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676101	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677500079
J	Cortelazzo, A; De Felice, C; Pecorelli, A; Belmonte, G; Signorini, C; Leoncini, S; Zollo, G; Capone, A; Della Giovampaola, C; Sticozzi, C; Valacchi, G; Ciccoli, L; Guerranti, R; Hayek, J				Cortelazzo, Alessio; De Felice, Claudio; Pecorelli, Alessandra; Belmonte, Giuseppe; Signorini, Cinzia; Leoncini, Silvia; Zollo, Gloria; Capone, Antonietta; Della Giovampaola, Cinzia; Sticozzi, Claudia; Valacchi, Giuseppe; Ciccoli, Lucia; Guerranti, Roberto; Hayek, Joussef			Beta-Actin Deficiency with Oxidative Posttranslational Modifications in Rett Syndrome Erythrocytes: Insights into an Altered Cytoskeletal Organization	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; MECP2 DEFICIENCY; DELAYED MATURATION; MENTAL-RETARDATION; CEREBRAL-CORTEX; STRESS; REVERSIBILITY; EXPRESSION; MODELS; MICE	Beta-actin, a critical player in cellular functions ranging from cell motility and the maintenance of cell shape to transcription regulation, was evaluated in the erythrocyte membranes from patients with typical Rett syndrome (RTT) and methyl CpG binding protein 2 (MECP2) gene mutations. RTT, affecting almost exclusively females with an average frequency of 1:10,000 female live births, is considered the second commonest cause of severe cognitive impairment in the female gender. Evaluation of beta-actin was carried out in a comparative cohort study on red blood cells (RBCs), drawn from healthy control subjects and RTT patients using mass spectrometry-based quantitative analysis. We observed a decreased expression of the beta-actin isoforms (relative fold changes for spots 1, 2 and 3:-1.82 +/- 0.15, -2.15 +/- 0.06, and -2.59 +/- 0.48, respectively) in pathological RBCs. The results were validated by western blotting and immunofluorescence microscopy. In addition, betaactin from RTT patients also showed a dramatic increase in oxidative posttranslational modifications (PTMs) as the result of its binding with the lipid peroxidation product 4-hydroxy-2-nonenal (4-HNE). Our findings demonstrate, for the first time, a beta-actin down-regulation and oxidative PTMs for RBCs of RTT patients, thus indicating an altered cytoskeletal organization.	[Cortelazzo, Alessio; Guerranti, Roberto] Univ Siena, Dept Med Biotechnol, I-53100 Siena, Italy; [Cortelazzo, Alessio; Pecorelli, Alessandra; Leoncini, Silvia; Zollo, Gloria; Hayek, Joussef] AOUS, Univ Hosp, Child Neuropsychiat Unit, Siena, Italy; [De Felice, Claudio] AOUS, Univ Hosp, Neonatal Intens Care Unit, Siena, Italy; [Pecorelli, Alessandra; Signorini, Cinzia; Leoncini, Silvia; Zollo, Gloria; Ciccoli, Lucia] Univ Siena, Dept Mol & Dev Med, I-53100 Siena, Italy; [Belmonte, Giuseppe] AOUS, Univ Hosp, Dept Med Sci Surg & Neurosci, Siena, Italy; [Capone, Antonietta; Della Giovampaola, Cinzia] Univ Siena, Dept Life Sci, I-53100 Siena, Italy; [Sticozzi, Claudia; Valacchi, Giuseppe] Univ Ferrara, Dept Sci Life & Biotechnol, I-44100 Ferrara, Italy; [Valacchi, Giuseppe] Kyung Hee Univ, Dept Food & Nutr, Seoul, South Korea	University of Siena; University of Siena; University Hospital of Siena; University of Siena; University Hospital of Siena; University of Siena; University of Siena; University Hospital of Siena; University of Siena; University of Ferrara; Kyung Hee University	Cortelazzo, A (corresponding author), Univ Siena, Dept Med Biotechnol, Via Laterina 8, I-53100 Siena, Italy.	alessio.cortelazzo@ao-siena.toscana.it	De Felice, Claudio/AAB-6859-2022; Leoncini, Silvia/ABG-5652-2020; Cortelazzo, Alessio/Q-4005-2016	De Felice, Claudio/0000-0002-9881-3119; Leoncini, Silvia/0000-0002-7027-1207; Cortelazzo, Alessio/0000-0003-1010-5255; Ciccoli, Lucia/0000-0002-0120-3980; hayek, joussef/0000-0002-0440-2491	Tuscany Region [Bando Salute], Italy	Tuscany Region [Bando Salute], Italy	The work was supported by Tuscany Region [Bando Salute 2009, "Antioxidants (omega-3 Polyunsaturated Fatty Acids, lipoic acid) supplementation in Rett syndrome: A novel approach to therapy"], Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuhatzira L, 2009, HUM MOL GENET, V18, P1415, DOI 10.1093/hmg/ddp048; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; Belichenko NP, 2009, NEUROBIOL DIS, V34, P71, DOI 10.1016/j.nbd.2008.12.016; Belichenko PV, 2009, J COMP NEUROL, V514, P240, DOI 10.1002/cne.22009; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; Ciccoli L, 2012, BBA-GEN SUBJECTS, V1820, P511, DOI 10.1016/j.bbagen.2011.12.002; Cobb S, 2010, BIOCHEM SOC T, V38, P498, DOI 10.1042/BST0380498; De Felice C, 2012, ANN NY ACAD SCI, V1259, P121, DOI 10.1111/j.1749-6632.2012.06611.x; De Felice C, 2009, FREE RADICAL BIO MED, V47, P440, DOI 10.1016/j.freeradbiomed.2009.05.016; Delepine C, 2013, FEBS LETT, V587, P245, DOI 10.1016/j.febslet.2012.11.033; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Farah ME, 2011, CYTOSKELETON, V68, P340, DOI 10.1002/cm.20516; Francke U, 2006, NAT CLIN PRACT NEURO, V2, P212, DOI 10.1038/ncpneuro0148; Fukuda T, 2005, J NEUROPATH EXP NEUR, V64, P537, DOI 10.1093/jnen/64.6.537; Gadalla KKE, 2011, BIOCHEM J, V439, P1, DOI 10.1042/BJ20110648; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Herman IM, 1993, CURR OPIN CELL BIOL, V5, P48, DOI 10.1016/S0955-0674(05)80007-9; Kaufmann WE, 2000, CEREB CORTEX, V10, P992, DOI 10.1093/cercor/10.10.992; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kishi N, 2010, EXP NEUROL, V222, P51, DOI 10.1016/j.expneurol.2009.12.007; KUNZE D, 1993, EUR J CLIN CHEM CLIN, V31, P477; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leoncini S, 2011, REDOX REP, V16, P145, DOI 10.1179/1351000211Y.0000000004; Nans A, 2011, BIOPHYS J, V101, P2341, DOI 10.1016/j.bpj.2011.09.050; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; Pecorelli A, 2011, CLIN BIOCHEM, V44, P368, DOI 10.1016/j.clinbiochem.2011.01.007; Signorini C, 2011, CLIN CHIM ACTA, V412, P1399, DOI 10.1016/j.cca.2011.04.016; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Sticozzi C, 2013, EUR J PHARM SCI, V49, P133, DOI 10.1016/j.ejps.2013.02.009; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6	36	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93181	10.1371/journal.pone.0093181	http://dx.doi.org/10.1371/journal.pone.0093181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671107	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000125
J	Kapoor, A; Forman, M; Arav-Boger, R				Kapoor, Arun; Forman, Michael; Arav-Boger, Ravit			Activation of Nucleotide Oligomerization Domain 2 (NOD2) by Human Cytomegalovirus Initiates Innate Immune Responses and Restricts Virus Replication	PLOS ONE			English	Article							HUMAN INFECTIOUS-DISEASE; CROHNS-DISEASE; CYTOKINE RESPONSES; HOST-DEFENSE; SUSCEPTIBILITY; RECEPTORS; GENETICS; RNA; TRANSPLANTATION; PEPTIDOGLYCAN	Nucleotide-binding oligomerization domain 2 (NOD2) is an important innate immune sensor of bacterial pathogens. Its induction results in activation of the classic NF-kappa B pathway and alternative pathways including type I IFN and autophagy. Although the importance of NOD2 in recognizing RNA viruses has recently been identified, its role in sensing DNA viruses has not been studied. We report that infection with human cytomegalovirus (HCMV) results in significant induction of NOD2 expression, beginning as early as 2 hours post infection and increasing steadily 24 hours post infection and afterwards. Infection with human herpesvirus 1 and 2 does not induce NOD2 expression. While the HCMV-encoded glycoprotein B is not required for NOD2 induction, a replication competent virion is necessary. Lentivirus-based NOD2 knockdown in human foreskin fibroblasts (HFFs) and U373 glioma cells leads to enhanced HCMV replication along with decreased levels of interferon beta (IFN-beta) and the pro-inflammatory cytokine, IL8. NOD2 induction in HCMV-infected cells activates downstream NF-kappa B and interferon pathways supported by reduced nuclear localization of NF-kappa B and pIRF3 in NOD2 knockdown HFFs. Stable overexpression of NOD2 in HFFs restricts HCMV replication in association with increased levels of IFN-b and IL8. Similarly, transient overexpression of NOD2 in U373 cells or its downstream kinase, RIPK2, results in decreased HCMV replication and enhanced cytokine responses. However, overexpression of a mutant NOD2, 3020insC, associated with severe Crohn's disease, results in enhanced HCMV replication and decreased levels of IFN-b in U373 cells. These results show for the first time that NOD2 plays a significant role in HCMV replication and may provide a model for studies of HCMV recognition by the host cell and HCMV colitis in Crohn's disease.	[Kapoor, Arun; Arav-Boger, Ravit] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Forman, Michael] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Arav-Boger, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.	boger@jhmi.edu	Kapoor, Arun/E-8333-2016; Kapoor, Arun/AGR-6910-2022; Kapoor, Arun/AAE-8373-2020	Kapoor, Arun/0000-0002-5811-9093; Kapoor, Arun/0000-0002-5811-9093; Kapoor, Arun/0000-0002-5811-9093	Open Access Promotion Fund of the Johns Hopkins University Libraries	Open Access Promotion Fund of the Johns Hopkins University Libraries	Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehme KW, 2006, J IMMUNOL, V177, P7094, DOI 10.4049/jimmunol.177.10.7094; Borm MEA, 2008, GENES IMMUN, V9, P274, DOI 10.1038/gene.2008.9; Browne EP, 2001, J VIROL, V75, P12319, DOI 10.1128/JVI.75.24.12319-12330.2001; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Child SJ, 2002, J VIROL, V76, P4912, DOI 10.1128/JVI.76.10.4912-4918.2002; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; DeFilippis VR, 2010, J VIROL, V84, P585, DOI 10.1128/JVI.01748-09; Deshmukh HS, 2009, INFECT IMMUN, V77, P1376, DOI 10.1128/IAI.00940-08; Gariano GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002498; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Griffiths PD, 2000, J ANTIMICROB CHEMOTH, V45, P29, DOI 10.1093/jac/45.suppl_4.29; He R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-40; Hill AVS, 2001, ANNU REV GENOM HUM G, V2, P373, DOI 10.1146/annurev.genom.2.1.373; Homer CR, 2010, GASTROENTEROLOGY, V139, P1630, DOI 10.1053/j.gastro.2010.07.006; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hysi P, 2005, HUM MOL GENET, V14, P935, DOI 10.1093/hmg/ddi087; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kapoor A, 2013, ANTIMICROB AGENTS CH, V57, P2761, DOI 10.1128/AAC.00029-13; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Kijpittayarit S, 2007, CLIN INFECT DIS, V44, P1315, DOI 10.1086/514339; Kim JJ, 2010, DIGEST DIS SCI, V55, P1059, DOI 10.1007/s10620-010-1126-4; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kuenzel S, 2010, J IMMUNOL, V184, P1990, DOI 10.4049/jimmunol.0900557; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Matsuoka K, 2007, AM J GASTROENTEROL, V102, P331, DOI 10.1111/j.1572-0241.2006.00989.x; MOLVIG J, 1988, SCAND J IMMUNOL, V27, P705, DOI 10.1111/j.1365-3083.1988.tb02404.x; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Paludan SR, 2011, NAT REV IMMUNOL, V11, P143, DOI 10.1038/nri2937; Pandey AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000500; Rahbar A, 2003, INFLAMM BOWEL DIS, V9, P154, DOI 10.1097/00054725-200305000-00002; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Shaw MH, 2011, TRENDS IMMUNOL, V32, P73, DOI 10.1016/j.it.2010.12.007; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Tanaka Y, 2002, BONE MARROW TRANSPL, V30, P315, DOI 10.1038/sj.bmt.1703661; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Travassos LH, 2010, AUTOPHAGY, V6, P409, DOI 10.4161/auto.6.3.11305; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Watanabe T, 2011, GUT MICROBES, V2, P61, DOI 10.4161/gmic.2.1.15162; Watanabe T, 2010, J CLIN INVEST, V120, P1645, DOI 10.1172/JCI39481; Westendorp RGJ, 1997, LANCET, V349, P170, DOI 10.1016/S0140-6736(96)06413-6; Xu YX, 2001, J VIROL, V75, P10683, DOI 10.1128/JVI.75.22.10683-10695.2001; YOW MD, 1992, NEW ENGL J MED, V326, P702, DOI 10.1056/NEJM199203053261010	49	40	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92704	10.1371/journal.pone.0092704	http://dx.doi.org/10.1371/journal.pone.0092704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671169	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000067
J	Wu, HH; Wang, HT; Jin, JJ; Cui, GB; Zhou, KC; Chen, Y; Chen, GZ; Dong, YL; Wang, W				Wu, Huang-Hui; Wang, Hong-Tao; Jin, Jun-Jie; Cui, Guang-Bin; Zhou, Ke-Cheng; Chen, Yu; Chen, Guo-Zhong; Dong, Yu-Lin; Wang, Wen			Does Dexmedetomidine as a Neuraxial Adjuvant Facilitate Better Anesthesia and Analgesia? A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RANDOMIZED CLINICAL-TRIALS; SPINAL DORSAL-HORN; INTRATHECAL DEXMEDETOMIDINE; POSTOPERATIVE PAIN; ALPHA-2 AGONISTS; BUPIVACAINE; CLONIDINE; ROPIVACAINE; MORPHINE; SURGERY	Background: Neuraxial application of dexmedetomidine (DEX) as adjuvant analgesic has been invetigated in some randomized controlled trials (RCTs) but not been approved because of the inconsistency of efficacy and safety in these RCTs. We performed this meta-analysis to access the efficacy and safety of neuraxial DEX as local anaesthetic (LA) adjuvant. Methods: We searched PubMed, PsycINFO, Scopus, EMBASE, and CENTRAL databases from inception to June 2013 for RCTs that investigated the analgesia efficacy and safety for neuraxial application DEX as LA adjuvant. Effects were summarized using standardized mean differences (SMDs), weighed mean differences (WMDs) or odds ratio (OR) with suitable effect model. The primary outcomes were postoperative pain intensity and analgesic duration, bradycardia and hypotension. Results: Sixteen RCTs involving 1092 participants were included. Neuraxial DEX significantly decreased postoperative pain intensity (SMD, -1.29; 95% confidence interval (CI), -1.70 to -0.89; P < 0.00001), prolonged analgesic duration (WMD, 6.93 hours; 95% CI, 5.23 to 8.62; P < 0.00001) and increased the risk of bradycardia (OR, 2.68; 95% CI, 1.18 to 6.10; P = 0.02). No evidence showed that neuraxial DEX increased the risk of other adverse events, such as hypotension (OR, 1.54; 95% CI, 0.83 to 2.85; P = 0.17). Additionally, neuraxial DEX was associated with beneficial alterations in postoperative sedation scores and number of analgesic requirements, sensory and motor block characteristics, and intro-operative hemodynamics. Conclusion: Neuraxial DEX is a favorable LA adjuvant with better and longer analgesia. The greatest concern is bradycardia. Further large sample trials with strict design and focusing on long-term outcomes are needed.	[Wu, Huang-Hui; Chen, Yu; Chen, Guo-Zhong] Fuzhou Gen Hosp Nanjing Mil Reg, Dept Anesthesiol, Fuzhou, Peoples R China; [Wu, Huang-Hui; Wang, Hong-Tao; Jin, Jun-Jie; Cui, Guang-Bin; Zhou, Ke-Cheng; Dong, Yu-Lin; Wang, Wen] Fourth Mil Med Univ, Unit Evidence Based Med, Dept Anat Histol & Embryol, Preclin Sch Med, Xian 710032, Peoples R China; [Wu, Huang-Hui; Wang, Hong-Tao; Jin, Jun-Jie; Cui, Guang-Bin; Zhou, Ke-Cheng; Dong, Yu-Lin; Wang, Wen] Fourth Mil Med Univ, KK Leung Brain Res Ctr, Preclin Sch Med, Xian 710032, Peoples R China; [Wang, Hong-Tao] Fourth Mil Med Univ, Xijing Hosp, Dept Burn & Cutaneous Surg, Xian 710032, Peoples R China; [Jin, Jun-Jie] Fuzhou Gen Hosp Nanjing Mil Reg, Dept Neurosurg, Fuzhou, Peoples R China; [Cui, Guang-Bin] Fourth Mil Med Univ, Dept Diagnost Radiol, Tangdu Hosp, Xian 710032, Peoples R China; [Zhou, Ke-Cheng] China Pharmaceut Univ, Nanjing, Jiangsu, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; China Pharmaceutical University	Chen, GZ (corresponding author), Fuzhou Gen Hosp Nanjing Mil Reg, Dept Anesthesiol, Fuzhou, Peoples R China.	cgzssq2000@sina.com; donganat@fmmu.edu.cn; wangwen@fmmu.edu.cn			Fourth Military Medical University;  [NSFC: 31070976];  [81271230]	Fourth Military Medical University; ; 	This work is partly supported by the NSFC: 31070976, 81271230 and intramural grant of the Fourth Military Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah FW, 2013, BRIT J ANAESTH, V110, P915, DOI 10.1093/bja/aet066; Abdallah FW, 2013, ANESTH ANALG, V117, P271, DOI 10.1213/ANE.0b013e318290c566; Abdel-Aleem M, 2012, INT J GYNECOL OBSTET, V116, P158, DOI 10.1016/j.ijgo.2011.10.002; Adams R, 2013, BRIT J ANAESTH, V111, P703, DOI 10.1093/bja/aet194; Al-Mustafa MM, 2009, SAUDI MED J, V30, P365; Anand VG, 2011, INDIAN J ANAESTH, V55, P340, DOI 10.4103/0019-5049.84835; Bagatini Airton, 2002, Rev. Bras. Anestesiol., V52, P606, DOI 10.1590/S0034-70942002000500012; Becker Daniel E, 2012, Anesth Prog, V59, P90, DOI 10.2344/0003-3006-59.2.90; Becker DE, 2012, ANESTH PROG, V59, P102; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BERO L, 1995, JAMA-J AM MED ASSOC, V274, P1935, DOI 10.1001/jama.274.24.1935; Blaudszun G, 2012, ANESTHESIOLOGY, V116, P1312, DOI 10.1097/ALN.0b013e31825681cb; Borenstein M, 2009, INTRO META ANAL; Chan AKM, 2010, EXPERT OPIN PHARMACO, V11, P2849, DOI 10.1517/14656566.2010.511613; Degos V, 2013, ANESTHESIOLOGY, V118, P1123, DOI 10.1097/ALN.0b013e318286cf36; DeKock M, 1997, ANESTHESIOLOGY, V86, P285, DOI 10.1097/00000542-199702000-00003; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eid HE., 2011, AIN SHAMS J ANESTHES, V4, P83, DOI [10.7860/JCDR/2017/26241.9654, DOI 10.7860/JCDR/2017/26241.9654, DOI 10.9790/0853-14788490]; Ekatodramis G., 2001, Current Topics in Medicinal Chemistry, V1, P183; El-Hennawy AM, 2009, BRIT J ANAESTH, V103, P268, DOI 10.1093/bja/aep159; Elhakim M, 2010, ACTA ANAESTH SCAND, V54, P703, DOI 10.1111/j.1399-6576.2009.02199.x; Fairbanks CA, 2009, PHARMACOL THERAPEUT, V123, P224, DOI 10.1016/j.pharmthera.2009.04.001; Ginosar Y, 2013, BRIT J ANAESTH, V111, P256, DOI 10.1093/bja/aet027; Gupta R, 2011, INDIAN J ANAESTH, V55, P347, DOI 10.4103/0019-5049.84841; Gurbet A, 2006, CAN J ANAESTH, V53, P646, DOI 10.1007/BF03021622; Gurusamy KS, 2009, BRIT J SURG, V96, P342, DOI 10.1002/bjs.6558; Higgins J., 2009, COCHRANE HDB SYSTEMA; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kairaluoma P, 2013, ACTA ANAESTH SCAND, V57, P118, DOI 10.1111/j.1399-6576.2012.02794.x; Kanazi GE, 2006, ACTA ANAESTH SCAND, V50, P222, DOI 10.1111/j.1399-6576.2006.00919.x; Khalili G, 2011, J ANESTH, V25, P892, DOI 10.1007/s00540-011-1227-z; Kim JE, 2013, BIOL PHARM BULL, V36, P959, DOI 10.1248/bpb.b12-01067; Kuchalik J, 2013, BRIT J ANAESTH, V111, P793, DOI 10.1093/bja/aet248; LI SS, 2013, NEUROSCIENCE LETT; Lilot M, 2013, ANESTH ANALG, V117, P259, DOI 10.1213/ANE.0b013e31828f29f8; Liu L, 2012, BRAIN RES, V1427, P1, DOI 10.1016/j.brainres.2011.08.019; Liu YL, 2007, NEUROPHARMACOLOGY, V52, P708, DOI 10.1016/j.neuropharm.2006.09.011; Mohamed AA, 2012, PAIN PHYSICIAN, V15, P339; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Niu XY, 2013, CNS NEUROSCI THER, V19, P897, DOI 10.1111/cns.12172; Prochazka J, 2011, PAIN MED, V12, P1309, DOI 10.1111/j.1526-4637.2011.01218.x; Ramadhyani Usha, 2010, Anesthesiol Clin, V28, P709, DOI 10.1016/j.anclin.2010.08.008; Saadawy I, 2009, ACTA ANAESTH SCAND, V53, P251, DOI 10.1111/j.1399-6576.2008.01818.x; Salgado PFS, 2008, REV ASSOC MED BRAS, V54, P110, DOI 10.1590/S0104-42302008000200011; Schnaider Taylor Brandão, 2005, Rev. Bras. Anestesiol., V55, P525, DOI 10.1590/S0034-70942005000500007; Selim Mohamed Fouad, 2012, J Prenat Med, V6, P47; Shukla Deepika, 2011, J Anaesthesiol Clin Pharmacol, V27, P495, DOI 10.4103/0970-9185.86594; Solanki SL, 2013, ANAESTH INTENS CARE, V41, P51, DOI 10.1177/0310057X1304100110; Song JW, 2013, BRIT J ANAESTH, V111, P630, DOI 10.1093/bja/aet192; Tziavrangos E, 2006, CURR OPIN ANESTHESIO, V19, P521, DOI 10.1097/01.aco.0000245278.22658.1e; Xiang Q, 2013, BRIT J ANAESTH, V110, P420, DOI 10.1093/bja/aes385	52	47	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93114	10.1371/journal.pone.0093114	http://dx.doi.org/10.1371/journal.pone.0093114			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671181	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677000115
J	Damiens, D; Ayrinhac, A; Van Bortel, W; Versteirt, V; Dekoninck, W; Hance, T				Damiens, David; Ayrinhac, Audrey; Van Bortel, Wim; Versteirt, Veerle; Dekoninck, Wouter; Hance, Thierry			Invasive Process and Repeated Cross-Sectional Surveys of the Mosquito Aedes japonicus japonicus Establishment in Belgium	PLOS ONE			English	Article							HOST-FEEDING PATTERNS; OCHLEROTATUS-JAPONICUS; EXPERIMENTAL TRANSMISSION; INTRODUCED MOSQUITO; ENCEPHALITIS-VIRUS; DIPTERA-CULICIDAE; VECTOR COMPETENCE; FINLAYA; COQUILLETTIDIA; CLASSIFICATION	When accidentally introduced in a new location, a species does not necessarily readily become invasive, but it usually needs several years to adapt to its new environment. In 2009, a national mosquito survey (MODIRISK) reported the introduction and possible establishment of an invasive mosquito species, Aedes j. japonicus, in Belgium. First collected in 2002 in the village of Natoye from a second-hand tire company, then sampled in 2003 and 2004, the presence of adults and larvae was confirmed in 2007 and 2008. A repeated cross-sectional survey of Ae. j. japonicus was then conducted in 2009 in Natoye to study the phenology of the species on two different sites using three kinds of traps: Mosquito Magnet Liberty Plus traps, BG sentinel traps and CDC Gravid traps. An analysis of the blood meals was done on females to assess the epidemiological risks. Five species of mosquitos were caught using the different kind of traps: Culex pipiens, Cx torrentium, Anopheles claviger, Aedes geniculatus and Ae. j. japonicus, Cx pipiens being the most abundant. The CDC gravid traps gave the best results. Surprisingly Ae. j. japonicus was only found on one site although both sites seem similar and are only distant of 2.5 km. Its population peak was reached in July. Most of the engorged mosquitoes tested acquired blood meals from humans (60%). No avian blood meals were unambiguously identified. Larvae were also collected, mostly from tires but also from buckets and from one tree hole. Only one larva was found in a puddle at 100 m of the tire storage. A first local treatment of Ae. j. japonicus larvae population was done in May 2012 using Bacillus thuringiensis subsp. israelensis (Bti) and was followed by preventive actions and public information. A monitoring is also presently implemented.	[Damiens, David; Ayrinhac, Audrey; Hance, Thierry] Catholic Univ Louvain, Earth & Life Inst, Biodivers Res Ctr, B-1348 Louvain, Belgium; [Damiens, David] IAEA, Insect Pest Control Lab, A-1400 Vienna, Austria; [Van Bortel, Wim; Versteirt, Veerle] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Versteirt, Veerle] Avia GIS, Precis Pest Management Unit, Zoersel, Belgium; [Dekoninck, Wouter] Royal Belgian Inst Nat Sci, KBIN IRSNB, Brussels, Belgium	Universite Catholique Louvain; International Atomic Energy Agency; Institute of Tropical Medicine (ITM); Royal Belgian Institute of Natural Sciences	Hance, T (corresponding author), Catholic Univ Louvain, Earth & Life Inst, Biodivers Res Ctr, B-1348 Louvain, Belgium.	thierry.hance@uclouvain.be	Van Bortel, Wim/AAU-5948-2021; Van Bortel, Wim/AFV-4687-2022	Van Bortel, Wim/0000-0002-6644-518X	Belgium federal government (Belspo) [SD/BD/04A, SD/BD/04B]; FSR grant of the Universite catholique de Louvain, UCL	Belgium federal government (Belspo)(Belgian Federal Science Policy Office); FSR grant of the Universite catholique de Louvain, UCL	This work was funded by the Belgium federal government (Belspo; SD/BD/04A and SD/BD/04B) and by a FSR grant of the Universite catholique de Louvain, UCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadis TG, 2001, J MED ENTOMOL, V38, P774, DOI 10.1603/0022-2585-38.6.774; Andreadis TG, 2010, J MED ENTOMOL, V47, P43, DOI 10.1603/033.047.0106; [Anonymous], 2003, MOSQUITOES THEIR CON; Apperson CS, 2004, VECTOR-BORNE ZOONOT, V4, P71, DOI 10.1089/153036604773083013; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Kent RJ, 2005, AM J TROP MED HYG, V73, P336, DOI 10.4269/ajtmh.2005.73.336; LACASSE W, 1948, MOSQUITO FAUNA JAP 2; Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017; Maniatis T., 1982, MOL CLONING; Marfin AA, 2001, CLIN INFECT DIS, V33, P1713, DOI 10.1086/322700; Molaei G, 2008, J MED ENTOMOL, V45, P1143, DOI 10.1603/0022-2585(2008)45[1143:HPOPMV]2.0.CO;2; Molaei G, 2009, J AM MOSQUITO CONTR, V25, P210, DOI 10.2987/09-0012.1; Morris JA, 2007, J AM MOSQUITO CONTR, V23, P243, DOI 10.2987/8756-971X(2007)23[243:FROAJJ]2.0.CO;2; Ngo KA, 2003, J MED ENTOMOL, V40, P215, DOI 10.1603/0022-2585-40.2.215; Oliver J, 2003, J AM MOSQUITO CONTR, V19, P121; Peyton EL, 1999, J AM MOSQUITO CONTR, V15, P238; Puth LM, 2005, ECOL LETT, V8, P715, DOI 10.1111/j.1461-0248.2005.00774.x; Reinert JF, 2000, J AM MOSQUITO CONTR, V16, P175; Reinert JF, 2006, ZOOL J LINN SOC-LOND, V148, P1, DOI 10.1111/j.1096-3642.2006.00254.x; Saenz VL, 2006, J AM MOSQUITO CONTR, V22, P754, DOI 10.2987/8756-971X(2006)22[754:OJJITS]2.0.CO;2; Sardelis MR, 2003, J AM MOSQUITO CONTR, V19, P159; Sardelis MR, 2002, J MED ENTOMOL, V39, P635, DOI 10.1603/0022-2585-39.4.635; Sardelis MR, 2002, J MED ENTOMOL, V39, P480, DOI 10.1603/0022-2585-39.3.480; Sardelis MR, 2001, J AM MOSQUITO CONTR, V17, P137; Sardelis MR, 2001, EMERG INFECT DIS, V7, P1018, DOI 10.3201/eid0706.010617; Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189; Schaffner F, 2009, MED VET ENTOMOL, V23, P448, DOI 10.1111/j.1365-2915.2009.00825.x; Schaffner F, 2003, J AM MOSQUITO CONTR, V19, P1; Schaffner F., 2001, MOSQUITOES EUROPE ID; Schaffner Francis, 2003, European Mosquito Bulletin, V16, P7; Scott JJ, 2001, J AM MOSQUITO CONTR, V17, P142; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; TANAKA K, 1979, Contributions of the American Entomological Institute, V16, P1; Theobald F.V., 1901, MONOGRAPH CULICIDAE, V1; Thielman A, 2006, J MED ENTOMOL, V43, P138, DOI 10.1603/0022-2585(2006)043[0138:EOOJDC]2.0.CO;2; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Versteirt V, 2013, B ENTOMOL RES, V103, P193, DOI 10.1017/S0007485312000521; Versteirt V, 2009, J MED ENTOMOL, V46, P1464, DOI 10.1603/033.046.0632; Williges E, 2008, J AM MOSQUITO CONTR, V24, P591, DOI 10.2987/5714.1	39	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e89358	10.1371/journal.pone.0089358	http://dx.doi.org/10.1371/journal.pone.0089358			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24694576	gold, Green Published, Green Submitted			2022-12-27	WOS:000334103000005
J	Pereira, C; Queiros, S; Galaghar, A; Sousa, H; Pimentel-Nunes, P; Brandao, C; Moreira-Dias, L; Medeiros, R; Dinis-Ribeiro, M				Pereira, Carina; Queiros, Sara; Galaghar, Ana; Sousa, Hugo; Pimentel-Nunes, Pedro; Brandao, Catarina; Moreira-Dias, Luis; Medeiros, Rui; Dinis-Ribeiro, Mario			Genetic Variability in Key Genes in Prostaglandin E-2 Pathway (COX-2, HPGD, ABCC4 and SLCO2A1) and Their Involvement in Colorectal Cancer Development	PLOS ONE			English	Article							15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; CYCLOOXYGENASE-2; POLYMORPHISMS; RISK; ASPIRIN; SUSCEPTIBILITY; EXPRESSION; RESISTANCE	The pro-carcinogenic effects of prostaglandin E2 (PGE2) in colonic mucosa are not only regulated by the rates between Cyclooxygenase-2 (COX-2) biosynthesis and 15-Hydroxyprostaglandin Dehydrogenase (15-PGDH)-dependent degradation but also the steady-state levels of PGE2 in extracellular microenvironment, maintained by key specific prostaglandin transporters, the Multidrug Resistance Protein (MRP4) (efflux carrier) and Prostaglandin Transporter (PGT) (influx carrier). To understand the contribution of genetic variability in genes coding for COX-2/15-PGDH/MRP4/PGT proteins in CRC development, we conducted a hospital-based case-control study involving 246 CRC patients and 480 cancer-free controls. A total of 51 tagSNPs were characterized using the Sequenom platform through multiplexed amplification followed by mass-spectrometric product separation or allelic discrimination using real-time PCR. Seven tagSNPs were implicated in CRC development: the rs689466 in COX-2 gene, the rs1346271 and rs1426945 in 15-PGDH, the rs6439448 and rs7616492 in PGT and rs1751051 and rs1751031 in MRP4 coding genes. Upon a stratified analysis a measurable gene-environment interaction was noticed between rs689466 and smoking habits, with individuals ever-smokers carriers of rs689466 GG homozygous genotype having a nearly 6-fold increased susceptibility for CRC onset (95% Cl: 1.49-22.42, P = 0.011). Furthermore, the multifactor dimensionality reduction (MDR) analysis identified an overall four-factor best gene-gene interactive model, including the rs1426945, rs6439448, rs1751051 and rs1751031 polymorphisms. This model had the highest cross-validation consistency (10/10, P<0.0001) and an accuracy of 0.6957 and was further associated with a 5-fold increased risk for CRC development (95% Cl: 3.89-7.02, P<0.0001). In conclusion, specific low penetrance genes in the pro-carcinogenic PGE2 pathway appear to modulate the genetic susceptibility for CRC development. A clearer understanding on CRC etiology through the identification of biomarkers of colorectal carcinogenesis might allow a better definition of risk models that are more likely to benefit from targeted preventive strategies to reduce CRC burden.	[Pereira, Carina; Queiros, Sara; Sousa, Hugo; Medeiros, Rui] Portuguese Inst Oncol, Invest Ctr, Mol Oncol Grp, Oporto, Portugal; [Pereira, Carina; Medeiros, Rui] Univ Porto, Abel Salazar Inst Biomed Sci, P-4100 Oporto, Portugal; [Pereira, Carina; Medeiros, Rui] Portuguese League Canc, Res Dept, Oporto, Portugal; [Galaghar, Ana] Portuguese Inst Oncol, Dept Pathol, Oporto, Portugal; [Pimentel-Nunes, Pedro; Brandao, Catarina; Moreira-Dias, Luis; Dinis-Ribeiro, Mario] Portuguese Inst Oncol, Dept Gastroenterol, Oporto, Portugal; [Pimentel-Nunes, Pedro] Univ Porto, Fac Med, Dept Physiol, P-4100 Oporto, Portugal; [Medeiros, Rui] Fernando Pessoa Univ Porto, Fac Hlth Sci, CEBIMED, Oporto, Portugal; [Dinis-Ribeiro, Mario] Univ Porto, Fac Med, Dept Biostat & Med Informat, CINTESIS, P-4100 Oporto, Portugal	Universidade de Coimbra; Universidade do Porto; Universidade de Coimbra; Universidade de Coimbra; Universidade do Porto; Universidade Fernando Pessoa; Universidade do Porto	Pereira, C (corresponding author), Portuguese Inst Oncol, Invest Ctr, Mol Oncol Grp, Oporto, Portugal.	anacmpereira@gmail.com	Sousa, Hugo/B-7714-2011; Pimentel-Nunes, Pedro/K-4934-2013; Medeiros, Rui/C-7938-2009; Dinis-Ribeiro, Mario/A-9248-2010	Sousa, Hugo/0000-0001-5795-2131; Pimentel-Nunes, Pedro/0000-0002-7308-3295; Medeiros, Rui/0000-0003-3010-8373; Dinis-Ribeiro, Mario/0000-0003-0121-6850; Pereira, Carina/0000-0003-4302-2501	Portuguese Institute of Oncology of Porto; FCT-Fundacao para a Ciencia e Tecnologia [SFRH/BD/64805/2009]; European Social Funds (ESF) under Human Potential Operation Programme (POPH) from National Strategic Reference Framework (NSRF)	Portuguese Institute of Oncology of Porto(Portuguese Institute of Oncology); FCT-Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); European Social Funds (ESF) under Human Potential Operation Programme (POPH) from National Strategic Reference Framework (NSRF)	This study was supported by a research grant from the Portuguese Institute of Oncology of Porto. Furthermore, CP is a recipient of a PhD grant (SFRH/BD/64805/2009) from FCT-Fundacao para a Ciencia e Tecnologia, co-financed by European Social Funds (ESF) under Human Potential Operation Programme (POPH) from National Strategic Reference Framework (NSRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuli A, 2011, BRIT J CANCER, V105, P870, DOI 10.1038/bjc.2011.296; Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Backlund MG, 2005, J BIOL CHEM, V280, P3217, DOI 10.1074/jbc.M411221200; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Ferlay J, 2010, GLOBOCAN 2008 V2 0; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Frank B, 2011, CARCINOGENESIS, V32, P190, DOI 10.1093/carcin/bgq231; Garcia AZG, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/483417; Hoeft B, 2010, CARCINOGENESIS, V31, P466, DOI 10.1093/carcin/bgp325; Holla VR, 2008, CANCER PREV RES, V1, P93, DOI 10.1158/1940-6207.CAPR-07-0009; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Liu F, 2006, GASTROENTEROLOGY, V130, P1975, DOI 10.1053/j.gastro.2006.03.021; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Martey CA, 2004, AM J PHYSIOL-LUNG C, V287, pL981, DOI 10.1152/ajplung.00239.2003; Moore AE, 2012, ONCOGENE, V31, P1592, DOI 10.1038/onc.2011.349; Myung SJ, 2006, P NATL ACAD SCI USA, V103, P12098, DOI 10.1073/pnas.0603235103; Pereira C, 2014, MOL CARCINOGEN, V53, pE92, DOI 10.1002/mc.22049; Pereira C, 2010, EUR J GASTROEN HEPAT, V22, P607, DOI 10.1097/MEG.0b013e3283352cbb; Pereira C, 2009, EUR J GASTROEN HEPAT, V21, P76, DOI 10.1097/MEG.0b013e32830ce7ba; Peters WHM, 2009, ONCOL RES, V17, P347, DOI 10.3727/096504009788428451; Reid G, 2003, P NATL ACAD SCI USA, V100, P9244, DOI 10.1073/pnas.1033060100; Rodriguez LA, 2009, GASTROENTEROLOGY, V132, P4498; Sakaki M, 2010, HEPATOL RES, V40, P1219, DOI 10.1111/j.1872-034X.2010.00727.x; Schuster VL, 2002, PROSTAG OTH LIPID M, V68-9, P633, DOI 10.1016/S0090-6980(02)00061-8; Sinibaldi L, 2010, CLIN EXP RHEUMATOL, V28, P153; Tai HH, 2002, PROSTAG OTH LIPID M, V68-9, P483, DOI 10.1016/S0090-6980(02)00050-3; Tan W, 2007, CARCINOGENESIS, V28, P1197, DOI 10.1093/carcin/bgl242; Thompson CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064122; Ueda N, 2008, CANCER SCI, V99, P576, DOI 10.1111/j.1349-7006.2007.00711.x; Vane J. R., 1998, AM J MED, V104, p2S, DOI [DOI 10.1016/S0002-9343(97)00203-9, 10.1016/S0002-9343(97)00203-9]; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang DZ, 2005, GASTROENTEROLOGY, V128, P1445, DOI 10.1053/j.gastro.2004.09.080; Wong HPS, 2007, TOXICOL SCI, V97, P279, DOI 10.1093/toxsci/kfm060; Yan M, 2009, P NATL ACAD SCI USA, V106, P9409, DOI 10.1073/pnas.0902367106; Yan ZP, 2000, J BIOL CHEM, V275, P4949, DOI 10.1074/jbc.275.7.4949; Zhang XM, 2005, GASTROENTEROLOGY, V129, P565, DOI 10.1053/j.gastro.2005.05.003	38	31	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92000	10.1371/journal.pone.0092000	http://dx.doi.org/10.1371/journal.pone.0092000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24694755	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000013
J	Kissick, HT; Sanda, MG; Dunn, LK; Arredouani, MS				Kissick, Haydn T.; Sanda, Martin G.; Dunn, Laura K.; Arredouani, Mohamed S.			Immunization with a Peptide Containing MHC Class I and II Epitopes Derived from the Tumor Antigen SIM2 Induces an Effective CD4 and CD8 T-Cell Response	PLOS ONE			English	Article							CANCER; MELANOMA; VACCINE; EXPRESSION; INDUCTION; IMMUNITY; IMMUNOTHERAPY; INTERLEUKIN-2; LYMPHOCYTES; GENERATION	Here, we sought to determine whether peptide vaccines designed harbor both class I as well as class II restricted antigenic motifs could concurrently induce CD4 and CD8 T cell activation against autologous tumor antigens. Based on our prior genome-wide interrogation of human prostate cancer tissues to identify genes over-expressed in cancer and absent in the periphery, we targeted SIM2 as a prototype autologous tumor antigen for these studies. Using humanized transgenic mice we found that the 9aa HLA-A*0201 epitope, SIM2(237-245), was effective at inducing an antigen specific response against SIM2-expressing prostate cancer cell line, PC3. Immunization with a multi-epitope peptide harboring both MHC-I and MHC-II restricted epitopes induced an IFN-gamma response in CD8 T cells to the HLA-A*0201-restricted SIM2(237-245) epitope, and an IL-2 response by CD4 T cells to the SIM2(240-254) epitope. This peptide was also effective at inducing CD8(+) T-cells that responded specifically to SIM2-expressing tumor cells. Collectively, the data presented in this study suggest that a single peptide containing multiple SIM2 epitopes can be used to induce both a CD4 and CD8 T cell response, providing a peptide-based vaccine formulation for potential use in immunotherapy of various cancers.	[Kissick, Haydn T.; Dunn, Laura K.; Arredouani, Mohamed S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg,Urol Div, Boston, MA 02215 USA; [Sanda, Martin G.] Emory Univ, Sch Med, Dept Urol, Atlanta, GA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Emory University	Arredouani, MS (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg,Urol Div, Boston, MA 02215 USA.	marredou@bidmc.harvard.edu	Kissick, Haydn/AAS-6292-2021; Sanda, Martin G/B-2023-2015	Kissick, Haydn/0000-0001-7624-5598; 	National Institutes of Health-National Cancer Institute Early Detection Research Network [UO1-CA113913]; National Cancer Institute Prostate Specialized Program of Research Excellence Career Development Award [2P50CA90381-06]; Prostate Cancer Foundation Young Investigator Award; Prostate Cancer Foundation A. Mazzone Challenge Award; US Department of Defense Prostate Cancer Research Program New Investigator Award [W81XWH-09-1-0448]; US Department of Defense Prostate Cancer Research Program Laboratory-Clinical Transition Award [W81XWH-09-1-0156]; US Department of Defense Prostate Cancer Research Program Laboratory-Postdoctoral Training Award [W81XWH-12-PCRP-PTA]; NATIONAL CANCER INSTITUTE [P50CA090381, U01CA113913] Funding Source: NIH RePORTER	National Institutes of Health-National Cancer Institute Early Detection Research Network; National Cancer Institute Prostate Specialized Program of Research Excellence Career Development Award; Prostate Cancer Foundation Young Investigator Award; Prostate Cancer Foundation A. Mazzone Challenge Award; US Department of Defense Prostate Cancer Research Program New Investigator Award(United States Department of Defense); US Department of Defense Prostate Cancer Research Program Laboratory-Clinical Transition Award(United States Department of Defense); US Department of Defense Prostate Cancer Research Program Laboratory-Postdoctoral Training Award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding came from: A) National Institutes of Health-National Cancer Institute Early Detection Research Network grant UO1-CA113913 (M. G. Sanda), B) National Cancer Institute Prostate Specialized Program of Research Excellence Career Development Award 2P50CA90381-06 (M. S. Arredouani), C) Prostate Cancer Foundation Young Investigator Award (M. S. Arredouani), D) Prostate Cancer Foundation A. Mazzone Challenge Award (M. G. Sanda), E) US Department of Defense Prostate Cancer Research Program New Investigator Award W81XWH-09-1-0448 (M. S. Arredouani), F) US Department of Defense Prostate Cancer Research Program Laboratory-Clinical Transition Award W81XWH-09-1-0156 (M. S. Arredouani & M. G. Sanda, Co-PI), G) US Department of Defense Prostate Cancer Research Program Laboratory-Postdoctoral Training Award W81XWH-12-PCRP-PTA (H. T. Kissick). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; Arredouani MS, 2009, CLIN CANCER RES, V15, P5794, DOI 10.1158/1078-0432.CCR-09-0911; Bhasin M, 2003, BIOINFORMATICS, V19, P665, DOI 10.1093/bioinformatics/btg055; Bijker MS, 2007, J IMMUNOL, V179, P5033, DOI 10.4049/jimmunol.179.8.5033; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; FEARON ER, 1990, CELL, V60, P397, DOI 10.1016/0092-8674(90)90591-2; Gluck S, 2012, BREAST CANCER RES TR, V132, P781, DOI 10.1007/s10549-011-1412-7; GOLUMBEK PT, 1991, SCIENCE, V254, P713, DOI 10.1126/science.1948050; Halvorsen OJ, 2007, CLIN CANCER RES, V13, P892, DOI 10.1158/1078-0432.CCR-06-1207; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; KAHN M, 1991, J IMMUNOL, V146, P3235; KAST WM, 1989, CELL, V59, P603, DOI 10.1016/0092-8674(89)90006-8; Kayaga J, 1999, GENE THER, V6, P1475, DOI 10.1038/sj.gt.3300961; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Kissick HT, 2013, CANCER IMMUNOL IMMUN, V62, P1831, DOI 10.1007/s00262-013-1482-y; Krug LM, 2010, CANCER IMMUNOL IMMUN, V59, P1467, DOI 10.1007/s00262-010-0871-8; Kwak HI, 2007, CARCINOGENESIS, V28, P259, DOI 10.1093/carcin/bgl122; Lu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028837; Maeurer MJ, 1996, CLIN CANCER RES, V2, P641; Matsui S, 1999, J IMMUNOL, V163, P184; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Ossendorp F, 2000, IMMUNOL LETT, V74, P75, DOI 10.1016/S0165-2478(00)00252-2; Ossendorp F, 1998, J EXP MED, V187, P693, DOI 10.1084/jem.187.5.693; Pardoll DM, 1998, CURR OPIN IMMUNOL, V10, P588, DOI 10.1016/S0952-7915(98)80228-8; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Speetjens FM, 2009, CLIN CANCER RES, V15, P1086, DOI 10.1158/1078-0432.CCR-08-2227; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; WEISS WR, 1993, J IMMUNOL, V151, P2690; Welters MJP, 2008, CLIN CANCER RES, V14, P178, DOI 10.1158/1078-0432.CCR-07-1880; Welters MJP, 2007, VACCINE, V25, P1379, DOI 10.1016/j.vaccine.2006.10.049; Yamada A, 2013, CANCER SCI, V104, P15, DOI 10.1111/cas.12050; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zwaveling S, 2002, J IMMUNOL, V169, P350, DOI 10.4049/jimmunol.169.1.350	44	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93231	10.1371/journal.pone.0093231	http://dx.doi.org/10.1371/journal.pone.0093231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690990	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100055
J	Li, JY; Zou, L; Chen, W; Zhu, BB; Shen, N; Ke, JT; Lou, J; Song, RR; Zhong, R; Miao, XP				Li, Jiaoyuan; Zou, Li; Chen, Wei; Zhu, Beibei; Shen, Na; Ke, Juntao; Lou, Jiao; Song, Ranran; Zhong, Rong; Miao, Xiaoping			Dietary Mushroom Intake May Reduce the Risk of Breast Cancer: Evidence from a Meta-Analysis of Observational Studies	PLOS ONE			English	Article							DOSE-RESPONSE RELATIONSHIP; LIFE-STYLE; GREEN TEA; EPIDEMIOLOGY; VEGETABLES; ANTITUMOR; FRUITS	Epidemiological studies have investigated the potential anticancer effects of mushroom intake. This review aims to clarify the evidence on the association of dietary mushroom intake with breast cancer risk and to quantify its dose-response relationship. Relevant studies were identified by a search of PubMed, Web of Science and Google Scholar up to December 31, 2013. Observational studies with relative risks (RRs) or hazard ratios (HRs) or odd ratios (ORs) and 95% confidence intervals (CIs) of breast cancer for three or more categories of mushroom intake were eligible. The quality of included studies was assessed by using Newcastle-Ottawa Scale. A dose-response meta-analysis was performed by utilizing generalized least squares trend estimation. Eight case-control studies and two cohort studies with a total of 6890 cases were ultimately included. For dose-response analysis, there was no evidence of non-linear association between mushroom consumption and breast cancer risk (P = 0.337) and a 1 g/d increment in mushroom intake conferred an RR of 0.97 (95% CI: 0.96-0.98) for breast cancer risk, with moderate heterogeneity (I-2 = 56.3%, P = 0.015). Besides, available menopause data extracted from included studies were used to evaluate the influence of menopausal statues. The summary RRs of mushroom consumption on breast cancer were 0.96 (95% CI: 0.91-1.00) for premenopausal women and 0.94 (95% CI: 0.91-0.97) for postmenopausal women, respectively. Our findings demonstrated that mushroom intake may be inversely associated with risk of breast cancer, which need to be confirmed with large-scale prospective studies further.	[Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, State Key Lab Environm Hlth Incubat,MOE Minist Ed, Wuhan 430074, Peoples R China; Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Miao, XP (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, State Key Lab Environm Hlth Incubat,MOE Minist Ed, Wuhan 430074, Peoples R China.	rongzhong91@gmail.com; miaoxp@mail.hust.edu.cn	Zhong, Rong/Q-1813-2019; Song, Ranran/Z-3997-2019; miao, xiaoping/C-4336-2011; 李, 娇元/GVS-6952-2022	Song, Ranran/0000-0002-8354-7698; miao, xiaoping/0000-0002-6818-9722; Zhong, Rong/0000-0002-5060-895X				Adlercreutz H, 2002, LANCET ONCOL, V3, P364, DOI 10.1016/S1470-2045(02)00777-5; Aune D, 2012, ANN ONCOL, V23, P1394, DOI 10.1093/annonc/mdr589; Bao PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039343; Borchers AT, 2004, EXP BIOL MED, V229, P393, DOI 10.1177/153537020422900507; Novaes MRCG, 2011, CLINICS, V66, P2133, DOI 10.1590/S1807-59322011001200021; Chen W, 2012, BREAST CANCER RES TR, V136, P847, DOI 10.1007/s10549-012-2309-9; Coleman WB, 2013, PLOS ONE, V8; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Eliza WLY, 2012, RECENT PATENTS INFLA, V6, P78, DOI [10.2174/187221312798889275, 10.2174/187221312798889310]; Gerber B, 2003, BREAST CANCER RES TR, V79, P265, DOI 10.1023/A:1023959818513; Goss PE, 2001, J CLIN ONCOL, V19, P881, DOI 10.1200/JCO.2001.19.3.881; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; HIROSE K, 1995, JPN J CANCER RES, V86, P146, DOI 10.1111/j.1349-7006.1995.tb03032.x; Hong SA, 2008, INT J CANCER, V122, P919, DOI 10.1002/ijc.23134; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong SC, 2012, J MED FOOD, V15, P58, DOI 10.1089/jmf.2011.1704; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; LEE HP, 1992, CANCER CAUSE CONTROL, V3, P313, DOI 10.1007/BF00146884; Lee SA, 2004, EXP MOL MED, V36, P116, DOI 10.1038/emm.2004.17; Liu XJ, 2013, BREAST, V22, P309, DOI 10.1016/j.breast.2012.07.013; MACMAHON B, 1973, JNCI-J NATL CANCER I, V50, P21, DOI 10.1093/jnci/50.1.21; Malin AS, 2003, INT J CANCER, V105, P413, DOI 10.1002/ijc.11088; Masala G, 2012, BREAST CANCER RES TR, V132, P1127, DOI 10.1007/s10549-011-1939-7; Mizoo T, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-565; Peto J, 2001, NATURE, V411, P390, DOI 10.1038/35077256; Rastogi T, 2008, INT J EPIDEMIOL, V37, P147, DOI 10.1093/ije/dym219; Ren L, 2012, FOOD FUNCT, V3, P1118, DOI 10.1039/c2fo10279j; Sarangi I, 2006, INT IMMUNOPHARMACOL, V6, P1287, DOI 10.1016/j.intimp.2006.04.002; Shi XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064266; Shin A, 2010, NUTR CANCER, V62, P476, DOI 10.1080/01635580903441212; Sliva D, 2008, BRIT J CANCER, V98, P1348, DOI 10.1038/sj.bjc.6604319; SMITH PL, 1979, AM STAT, V33, P57, DOI 10.2307/2683222; Suarez-Arroyo IJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057431; Sun CL, 2006, CARCINOGENESIS, V27, P1310, DOI 10.1093/carcin/bgi276; Tang NP, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.019; van Gils CH, 2005, JAMA-J AM MED ASSOC, V293, P183, DOI 10.1001/jama.293.2.183; Wang F, 2013, ANN ONCOL, V24, P2724, DOI 10.1093/annonc/mdt283; Wasser SP, 2011, APPL MICROBIOL BIOT, V89, P1323, DOI 10.1007/s00253-010-3067-4; Wells G.A., NEWCASTLE OTTAWA SCA; Wu AH, 2008, BRIT J CANCER, V98, P9, DOI 10.1038/sj.bjc.6604145; Wu W, 2013, BRIT J CANCER, V109, P1926, DOI 10.1038/bjc.2013.438; Zhang CX, 2009, INT J CANCER, V125, P181, DOI 10.1002/ijc.24358; Zhang M, 2009, INT J CANCER, V124, P1404, DOI 10.1002/ijc.24047; Zheng JS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3706; Zhou LB, 2011, INT J BIOL MACROMOL, V48, P1, DOI 10.1016/j.ijbiomac.2010.09.004; Zou L, 2014, EUR J CANCER, V50, P193, DOI 10.1016/j.ejca.2013.08.014	48	18	18	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93437	10.1371/journal.pone.0093437	http://dx.doi.org/10.1371/journal.pone.0093437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691133	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100081
J	Ojo, KK; Reid, MC; Siddaramaiah, LK; Muller, J; Winzer, P; Zhang, ZS; Keyloun, KR; Vidadala, RSR; Merritt, EA; Hol, WGJ; Maly, DJ; Fan, EK; Van Voorhis, WC; Hemphill, A				Ojo, Kayode K.; Reid, Molly C.; Siddaramaiah, Latha Kallur; Mueller, Joachim; Winzer, Pablo; Zhang, Zhongsheng; Keyloun, Katelyn R.; Vidadala, Rama Subba Rao; Merritt, Ethan A.; Hol, Wim G. J.; Maly, Dustin J.; Fan, Erkang; Van Voorhis, Wesley C.; Hemphill, Andrew			Neospora caninum Calcium-Dependent Protein Kinase 1 Is an Effective Drug Target for Neosporosis Therapy	PLOS ONE			English	Article							TOXOPLASMA-GONDII TACHYZOITES; HOST-CELLS; INHIBITORS; INVASION; MICE; CDPK1; TRANSMISSION; CHALLENGE; SECRETION; INFECTION	Despite the enormous economic importance of Neospora caninum related veterinary diseases, the number of effective therapeutic agents is relatively small. Development of new therapeutic strategies to combat the economic impact of neosporosis remains an important scientific endeavor. This study demonstrates molecular, structural and phenotypic evidence that N. caninum calcium-dependent protein kinase 1 (NcCDPK1) is a promising molecular target for neosporosis drug development. Recombinant NcCDPK1 was expressed, purified and screened against a select group of bumped kinase inhibitors (BKIs) previously shown to have low IC(50)s against Toxoplasma gondii CDPK1 and T. gondii tachyzoites. NcCDPK1 was inhibited by low concentrations of BKIs. The three-dimensional structure of NcCDPK1 in complex with BKIs was studied crystallographically. The BKI-NcCDPK1 structures demonstrated the structural basis for potency and selectivity. Calcium-dependent conformational changes in solution as characterized by small-angle X-ray scattering are consistent with previous structures in low Calcium-state but different in the Calcium-bound active state than predicted by X-ray crystallography. BKIs effectively inhibited N. caninum tachyzoite proliferation in vitro. Electron microscopic analysis of N. caninum cells revealed ultra-structural changes in the presence of BKI compound 1294. BKI compound 1294 interfered with an early step in Neospora tachyzoite host cell invasion and egress. Prolonged incubation in the presence of 1294 interfered produced observable interference with viability and replication. Oral dosing of BKI compound 1294 at 50 mg/kg for 5 days in established murine neosporosis resulted in a 10-fold reduced cerebral parasite burden compared to untreated control. Further experiments are needed to determine the PK, optimal dosage, and duration for effective treatment in cattle and dogs, but these data demonstrate proof-of-concept for BKIs, and 1294 specifically, for therapy of bovine and canine neosporosis.	[Ojo, Kayode K.; Reid, Molly C.; Keyloun, Katelyn R.; Van Voorhis, Wesley C.] Univ Washington, Dept Med, Div Allergy & Infect Dis, CERID, Seattle, WA 98195 USA; [Siddaramaiah, Latha Kallur; Zhang, Zhongsheng; Merritt, Ethan A.; Hol, Wim G. J.; Fan, Erkang] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Mueller, Joachim; Winzer, Pablo; Hemphill, Andrew] Univ Bern, Vetsuisse Fac, Inst Parasitol, Bern, Switzerland; [Vidadala, Rama Subba Rao; Maly, Dustin J.] Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Bern; University of Washington; University of Washington Seattle	Ojo, KK (corresponding author), Univ Washington, Dept Med, Div Allergy & Infect Dis, CERID, Seattle, WA 98195 USA.	ojo67kk@u.washington.edu; wesley@uw.edu; andrew.hemphill@vetsuisse.unibe.ch	Ojo, Kayode/AAB-2490-2019; Ojo, Kayode K/X-9307-2019; Zhang, zs/GXN-3521-2022	Ojo, Kayode K/0000-0002-2007-2170; Muller, Joachim/0000-0001-8189-9270; Maly, Dustin/0000-0003-0094-0177; Hemphill, Andrew/0000-0002-0622-2128	National Institutes of Health [1 R01 AI089441, 5 R01 AI080625, R01GM086858]; University of Washington Plein Endowment for Geriatric Pharmacy Research; Swiss National Science Foundation [310030 146162]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089441, R01AI080625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Plein Endowment for Geriatric Pharmacy Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants (1 R01 AI089441 and 5 R01 AI080625 to WCVV) and (R01GM086858 to DJM). KRK was supported by a training scholarship from the University of Washington Plein Endowment for Geriatric Pharmacy Research. The Hemphill lab was supported by the Swiss National Science Foundation grant 310030 146162. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber JS, 1996, VET REC, V139, P439, DOI 10.1136/vr.139.18.439; Barna F, 2013, ANTIMICROB AGENTS CH, V57, P5747, DOI 10.1128/AAC.02446-12; Brumlik MJ, 2004, INT J PARASITOL, V34, P1245, DOI 10.1016/j.ijpara.2004.07.007; Castellanos-Gonzalez A, 2013, J INFECT DIS, V208, P1342, DOI 10.1093/infdis/jit327; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; Darius AK, 2004, PARASITOL RES, V92, P520, DOI 10.1007/s00436-003-1062-8; Debache K, 2010, PARASITOLOGY, V137, P229, DOI 10.1017/S0031182009991259; Dubey JP, 2007, CLIN MICROBIOL REV, V20, P323, DOI 10.1128/CMR.00031-06; Dubey JP, 1996, VET PARASITOL, V67, P1, DOI 10.1016/S0304-4017(96)01035-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esposito M, 2007, INT J PARASITOL, V37, P183, DOI 10.1016/j.ijpara.2006.10.009; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Hemphill A, 2006, PARASITOLOGY, V133, P261, DOI 10.1017/S0031182006000485; Hemphill A, 2004, MICROSC MICROANAL, V10, P602, DOI 10.1017/S1431927604040930; Hemphill A, 1996, PARASITOLOGY, V112, P183, DOI 10.1017/S0031182000084754; Johnson SM, 2012, J MED CHEM, V55, P2416, DOI 10.1021/jm201713h; Kayode KO, 2011, MOL BIOCHEM PARASIT, V176, P98, DOI 10.1016/j.molbiopara.2010.12.009; Kieschnick H, 2001, J BIOL CHEM, V276, P12369, DOI 10.1074/jbc.M011045200; Kim JT, 2002, VET PARASITOL, V103, P53, DOI 10.1016/S0304-4017(01)00580-5; Kritzner Sandra, 2002, Ann Clin Microbiol Antimicrob, V1, P4, DOI 10.1186/1476-0711-1-4; Kropf C, 2012, PARASITOLOGY, V139, P208, DOI 10.1017/S0031182011001776; Kuster T, 2012, J AM ASSOC LAB ANIM, V51, P219; Kwon HJ, 2003, VET PARASITOL, V112, P269, DOI 10.1016/S0304-4017(03)00035-9; Larson ET, 2012, J MED CHEM, V55, P2803, DOI 10.1021/jm201725v; Leepin A, 2008, ANTIMICROB AGENTS CH, V52, P1999, DOI 10.1128/AAC.01236-07; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LINDSAY DS, 1994, AM J VET RES, V55, P976; Lindsay DS, 1999, VET PARASITOL, V82, P327, DOI 10.1016/S0304-4017(99)00054-0; Liu HG, 2012, ACTA CRYSTALLOGR A, V68, P278, DOI 10.1107/S010876731104788X; Lourido S, 2013, ACS CHEM BIOL; Lourido S, 2012, EMBO J, V31, P4524, DOI 10.1038/emboj.2012.299; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; Lovett JL, 2002, J BIOL CHEM, V277, P25870, DOI 10.1074/jbc.M202553200; Mazuz ML, 2012, VET PARASITOL, V187, P99, DOI 10.1016/j.vetpar.2011.12.020; McAllister MM, 1998, INT J PARASITOL, V28, P1473, DOI 10.1016/S0020-7519(98)00138-6; Mccoy JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003066; Murphy RC, 2010, ACS MED CHEM LETT, V1, P331, DOI 10.1021/ml100096t; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ojo KK, 2014, J INFECT DIS, V209, P275, DOI 10.1093/infdis/jit522; Ojo KK, 2012, J CLIN INVEST, V122, P2301, DOI 10.1172/JCI61822; Ojo KK, 2010, NAT STRUCT MOL BIOL, V17, P602, DOI 10.1038/nsmb.1818; Reichel MP, 2013, INT J PARASITOL, V43, P133, DOI 10.1016/j.ijpara.2012.10.022; Romero JJ, 2004, VET PARASITOL, V123, P149, DOI 10.1016/j.vetpar.2004.06.016; Schorer M, 2012, INT J PARASITOL-DRUG, V2, P109, DOI 10.1016/j.ijpddr.2012.03.001; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sugi T, 2010, EUKARYOT CELL, V9, P667, DOI 10.1128/EC.00351-09; Wernimont AK, 2010, NAT STRUCT MOL BIOL, V17, P596, DOI 10.1038/nsmb.1795; Weston JF, 2012, PREV VET MED, V103, P136, DOI 10.1016/j.prevetmed.2011.08.010; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495	50	49	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92929	10.1371/journal.pone.0092929	http://dx.doi.org/10.1371/journal.pone.0092929			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681759	Green Submitted, Green Published, gold			2022-12-27	WOS:000333678100019
J	da Costa, WKA; de Souza, EL; Beltrao, EM; Vasconcelos, GKV; Santi-Gadelha, T; Gadelha, CAD; Franco, OL; Queiroga, RDRD; Magnani, M				Almeida da Costa, Whyara Karoline; de Souza, Evandro Leite; Beltrao-Filho, Edvaldo Mesquita; Vieira Vasconcelos, Gracy Kelly; Santi-Gadelha, Tatiane; de Almeida Gadelha, Carlos Alberto; Franco, Octavio Luiz; Ramos do Egypto Queiroga, Rita de Cassia; Magnani, Marciane			Comparative Protein Composition Analysis of Goat Milk Produced by the Alpine and Saanen Breeds in Northeastern Brazil and Related Antibacterial Activities	PLOS ONE			English	Article							CAPRINE BETA-CASEIN; GENETIC-VARIANTS; PEPTIDES; WHEY; ALPHA(S1)-CASEIN; IDENTIFICATION; POLYMORPHISM; FRACTIONS; BOVINE; SHEEP	The protein composition of goat milk differs between goat breeds and could present regional trends. The aim of this study was to comparatively analyze the protein composition of goat milk produced by the Alpine and Saanen breeds in northeastern Brazil and to evaluate the antibacterial activity of its protein fractions. SDS-PAGE, 2-DE electrophoresis and RP-HPLC analyses revealed the absence of alpha s1-casein in the milk of both breeds and no differences between the alpha s2-casein, beta-casein, beta-lactoglobulin and alpha-lactalbumin profiles. The amounts of soluble proteins and beta-casein hydrolysis residues were higher in Saanen milk. Only the protein fraction containing the largest amounts of casein (F60-90%) inhibited bacterial growth, with MIC values between 50 and 100 mg/mL. This study describe for the first time three important points about the goat milk protein of two Brazilian goat breeders: absence of alpha-s1 casein in the protein profile, differences between the milk protein composition produced by goats of Alpine and Saanen breeders and antibacterial activity of unbroken proteins (casein-rich fraction) present in these milk.	[Almeida da Costa, Whyara Karoline; Beltrao-Filho, Edvaldo Mesquita; Magnani, Marciane] Univ Fed Paraiba, Ctr Technol, Dept Food Engn, BR-58059900 Joao Pessoa, Paraiba, Brazil; [de Souza, Evandro Leite; Ramos do Egypto Queiroga, Rita de Cassia] Univ Fed Paraiba, Hlth Sci Ctr, Dept Nutr, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Vieira Vasconcelos, Gracy Kelly; Santi-Gadelha, Tatiane; de Almeida Gadelha, Carlos Alberto] Univ Fed Paraiba, Exact & Nat Sci Ctr, Dept Cellular Biol, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Franco, Octavio Luiz] Univ Catolica Brasilia, Ctr Biochem & Prote Analyses, Brasilia, DF, Brazil	Universidade Federal da Paraiba; Universidade Federal da Paraiba; Universidade Federal da Paraiba; Universidade Catolica de Brasilia	Franco, OL (corresponding author), Univ Catolica Brasilia, Ctr Biochem & Prote Analyses, Brasilia, DF, Brazil.	ocfranco@gmail.com	Gadelha, Tatiane santi/L-6060-2016; Franco, Octavio L/T-3020-2017; Magnani, Marciane/P-4265-2016	Magnani, Marciane/0000-0002-7771-0479; Franco, Octavio/0000-0001-9546-0525; Costa, Whyara/0000-0002-2556-6380	Ministry of Science and Technology (MCTI) [Call 06/2011]; National Counsel of Technological and Scientific Development (CNPq); Coordination for the Improvement of Higher Level Personnel (CAPES) [552098/2011-6]	Ministry of Science and Technology (MCTI); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Level Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The financial support of this manuscript was provided by projects approved at Call 06/2011 of Ministry of Science and Technology (MCTI), National Counsel of Technological and Scientific Development (CNPq), and Coordination for the Improvement of Higher Level Personnel (CAPES) under process number 552098/2011-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albenzio M, 2006, SMALL RUMINANT RES, V64, P35, DOI 10.1016/j.smallrumres.2005.03.010; Almaas H, 2008, SMALL RUMINANT RES, V79, P11, DOI 10.1016/j.smallrumres.2008.07.013; AOAC International - Association of Analytical Communities, 2012, OFFICIAL METHODS ANA; APHA - American Public Health Association, 2001, COMPENDIUM METHODS M; Bevilacqua C, 2001, J DAIRY RES, V68, P217, DOI 10.1017/S0022029901004861; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Demers-Mathieu V, 2013, INT DAIRY J, V28, P94, DOI 10.1016/j.idairyj.2012.09.003; Queiroga RDRD, 2007, REV BRAS ZOOTECN, V36, P430, DOI 10.1590/S1516-35982007000200021; Drewnowski A, 2008, NUTR REV, V66, P23, DOI 10.1111/j.1753-4887.2007.00003.x; Egito AS, 2006, ARQ BRAS MED VET ZOO, V58, P932, DOI 10.1590/S0102-09352006000500032; Erdem YK, 2000, J FOOD ENG, V44, P63, DOI 10.1016/S0260-8774(99)00165-X; Eriksen EK, 2008, SMALL RUMINANT RES, V79, P29, DOI 10.1016/j.smallrumres.2008.07.003; Haenlein GFW, 2004, SMALL RUMINANT RES, V51, P155, DOI 10.1016/j.smallrumres.2003.08.010; Hinz K, 2012, J DAIRY RES, V79, P185, DOI 10.1017/S0022029912000015; JAUBERT A, 1992, LAIT, V72, P235; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lara-Villoslada F, 2005, J DAIRY SCI, V88, P1654, DOI 10.3168/jds.S0022-0302(05)72837-X; Exposito IL, 2006, INT DAIRY J, V16, P1294, DOI 10.1016/j.idairyj.2006.06.002; Lopez-Exposito I, 2008, J DAIRY SCI, V91, P2184, DOI 10.3168/jds.2007-0037; Maga EA, 2009, J ANIM SCI, V87, P3464, DOI 10.2527/jas.2009-1854; Marletta D, 2004, J ANIM BREED GENET, V121, P52, DOI 10.1046/j.0931-2668.2003.00413.x; MCKENZIE HA, 1991, ADV PROTEIN CHEM, V41, P173; Meisel H, 1996, KIELER MILCHW FORSCH, V48, P343; Moatsou G, 2008, FOOD CHEM, V106, P509, DOI 10.1016/j.foodchem.2007.06.014; Moatsou G, 2004, FOOD CHEM, V87, P75, DOI 10.1016/j.foodchem.2003.10.020; Murata M, 2013, J DAIRY SCI, V96, P4891, DOI 10.3168/jds.2013-6612; NCCLS, 2003, M7A6 NCCLS; Neveu C, 2002, J PROTEIN CHEM, V21, P557, DOI 10.1023/A:1022433823559; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Olalla M, 2009, FOOD CHEM, V113, P835, DOI 10.1016/j.foodchem.2008.10.022; Park YW, 2007, SMALL RUMINANT RES, V68, P88, DOI 10.1016/j.smallrumres.2006.09.013; Pihlanto Anne, 2003, Adv Food Nutr Res, V47, P175; Prinzenberg EM, 2005, J DAIRY SCI, V88, P1490, DOI 10.3168/jds.S0022-0302(05)72817-4; Roncada P, 2012, J PROTEOMICS, V75, P4259, DOI 10.1016/j.jprot.2012.05.028; Santillo A, 2009, INT DAIRY J, V19, P655, DOI 10.1016/j.idairyj.2009.06.011; Santos A, 2010, PEDIAT ALLERG IMM-UK, V21, P1127, DOI 10.1111/j.1399-3038.2010.01040.x; Ceballos LS, 2009, J FOOD COMPOS ANAL, V22, P322, DOI 10.1016/j.jfca.2008.10.020; Sardina MT, 2012, MOL BIOL REP, V39, P3203, DOI 10.1007/s11033-011-1087-5; Scopes R. K, 1994, PROTEIN PURIFICATION, V3rd, DOI 10.1007/978-1-4757-2333-5; Sgarbieri V. C., 2005, Brazilian Journal of Food Technology, V8, P43; Silanikove N, 2010, SMALL RUMINANT RES, V89, P110, DOI 10.1016/j.smallrumres.2009.12.033; Silva MMC, 2009, ARQ BRAS MED VET ZOO, V61, P682, DOI 10.1590/S0102-09352009000300023; Trujillo AJ, 1997, J DAIRY SCI, V80, P2258, DOI 10.3168/jds.S0022-0302(97)76174-5; Vargas M, 2008, INT DAIRY J, V18, P1146, DOI 10.1016/j.idairyj.2008.06.007; Wang FX, 2011, PROTEOMICS, V11, P4296, DOI 10.1002/pmic.201100062; Yuksel Z, 2012, SMALL RUMINANT RES, V106, P137, DOI 10.1016/j.smallrumres.2012.03.022	46	34	38	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93361	10.1371/journal.pone.0093361	http://dx.doi.org/10.1371/journal.pone.0093361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675996	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677500115
J	Chen, J; Xu, X; Wu, J; Ling, Q; Wang, K; Wang, WL; Zhang, M; Shen, Y; Zhou, L; Xie, HY; Zheng, SS				Chen, Jun; Xu, Xiao; Wu, Jian; Ling, Qi; Wang, Kai; Wang, Weilin; Zhang, Min; Shen, Yan; Zhou, Lin; Xie, Haiyang; Zheng, Shusen			The Stratifying Value of Hangzhou Criteria in Liver Transplantation for Hepatocellular Carcinoma	PLOS ONE			English	Article							LIVING DONOR; MILAN CRITERIA; ADULT PATIENTS; RECURRENCE; EXPERIENCE; SURVIVAL; KOREA	Background/Aims: The selection criteria for patients with hepatocellular carcinoma (HCC) as candidates for deceased donor liver transplantation (DDLT) are well studied. In this era of limited deceased donor organs, the value of living donor liver transplantation (LDLT) for HCC remains controversial. The aim of the present study was to verify the stratification value of the Hangzhou criteria for LDLT. Methods: The data of 47 LDLT recipients and 94 matched DDLT recipients at our center were evaluated. Overall survival and tumor-free survival were calculated. Prognostic factors influencing post-liver transplantation (LT) survival were identified. The stratification values of the Hangzhou criteria and Milan criteria were compared. Results: LDLT recipients spent much less time on the waiting list. The post-LT survival of recipients fulfilling the Milan criteria and recipients fulfilling the Hangzhou criteria were comparable (P>0.05). The overall and tumor-free survival did not differ statistically between the two groups. In both groups, more recipients not meeting the Milan criteria but with a satisfactory outcome were identified by the Hangzhou criteria. Among recipients who did not meet the Hangzhou criteria, tumor-free survival was better for the LDLT recipients than the DDLT recipients (P = 0.024). Conclusions: The Hangzhou criteria are reliable for stratifying HCC patients in terms of prognosis. HCC patients fulfilling the Hangzhou criteria gain satisfactory survival from LT. Outcomes after LDLT are better than those after DDLT for HCC patients who do not meet the Hangzhou criteria.	[Chen, Jun; Xu, Xiao; Wu, Jian; Ling, Qi; Wang, Kai; Wang, Weilin; Zhang, Min; Shen, Yan; Zhou, Lin; Xie, Haiyang; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Surg,Div Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Xiao; Zheng, Shusen] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Zheng, SS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Surg,Div Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China.	zyzss@zju.edu.cn			Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81121002]; National ST Major Project [2012ZX10002017]; Zhejiang Provincial Medical Foundation for Young Excellent Scholars [2008QN012]; National High-tech R&D Program of China (863 Program) [2012AA020204]; Medical science and technology plan of Zhejiang province [2011ZDA007]	Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National ST Major Project; Zhejiang Provincial Medical Foundation for Young Excellent Scholars; National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); Medical science and technology plan of Zhejiang province	This study is supported by the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (Grant No. 81121002); the National S&T Major Project (No. 2012ZX10002017); the Grant from Zhejiang Provincial Medical Foundation for Young Excellent Scholars (NO. 2008QN012); the National High-tech R&D Program of China (863 Program) (No. 2012AA020204); the Medical science and technology plan of Zhejiang province (No. 2011ZDA007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audet M, 2009, LIVER TRANSPLANT, V15, P822, DOI 10.1002/lt.21765; Bhangui P, 2011, HEPATOLOGY, V53, P1570, DOI 10.1002/hep.24231; Busuttil RW, 2008, HEPATOB PANCREAT DIS, V7, P235; Di Sandro S, 2009, TRANSPL P, V41, P1283, DOI 10.1016/j.transproceed.2009.03.022; Fan ST, 2008, HEPATOB PANCREAT DIS, V7, P233; Fisher RA, 2007, AM J TRANSPLANT, V7, P1601, DOI 10.1111/j.1600-6143.2007.01802.x; Hsu HT, 2006, TRANSPLANT P, V38, P2102, DOI 10.1016/j.transproceed.2006.07.021; Hwang S, 2007, TRANSPL P, V39, P1526, DOI 10.1016/j.transproceed.2007.03.066; Hwang S, 2005, LIVER TRANSPLANT, V11, P1265, DOI 10.1002/lt.20549; Kulik L, 2004, GASTROENTEROLOGY, V127, pS277, DOI 10.1053/j.gastro.2004.09.042; Lee KK, 2010, J SURG ONCOL, V101, P47, DOI 10.1002/jso.21415; Lee SG, 2012, TRANSPL P, V44, P520, DOI 10.1016/j.transproceed.2012.02.003; Lee SG, 2008, LIVER TRANSPLANT, V14, P935, DOI 10.1002/lt.21445; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Lo CM, 2007, BRIT J SURG, V94, P78, DOI 10.1002/bjs.5528; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Todo S, 2004, ANN SURG, V240, P451, DOI 10.1097/01.sla.0000137129.98894.42; Vakili K, 2009, LIVER TRANSPLANT, V15, P1861, DOI 10.1002/lt.21940; Woo HY, 2008, LIVER INT, V28, P1120, DOI 10.1111/j.1478-3231.2008.01785.x; Yao FY, 2002, LIVER TRANSPLANT, V8, P873, DOI 10.1053/jlts.2002.34923; Yao FY, 2002, LIVER TRANSPLANT, V8, P765, DOI 10.1053/jlts.2002.34892; Zheng SS, 2008, TRANSPLANTATION, V85, P1726, DOI 10.1097/TP.0b013e31816b67e4	23	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93128	10.1371/journal.pone.0093128	http://dx.doi.org/10.1371/journal.pone.0093128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676010	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500077
J	Murphy, CFB; Pagan-Neves, LO; Wertzner, HF; Schochat, E				Murphy, Cristina F. B.; Pagan-Neves, Luciana O.; Wertzner, Haydee F.; Schochat, Eliane			Auditory and Visual Sustained Attention in Children with Speech Sound Disorder	PLOS ONE			English	Article							CONTINUOUS PERFORMANCE-TEST; LANGUAGE IMPAIRMENT; DEVELOPMENTAL DYSLEXIA; READING-DISABILITY; PERCEPTION; INHIBITION; AWARENESS; VALIDITY; DEFICITS; SKILLS	Although research has demonstrated that children with specific language impairment (SLI) and reading disorder (RD) exhibit sustained attention deficits, no study has investigated sustained attention in children with speech sound disorder (SSD). Given the overlap of symptoms, such as phonological memory deficits, between these different language disorders (i.e., SLI, SSD and RD) and the relationships between working memory, attention and language processing, it is worthwhile to investigate whether deficits in sustained attention also occur in children with SSD. A total of 55 children (18 diagnosed with SSD (8.11 +/- 1.231) and 37 typically developing children (8.76 +/- 1.461)) were invited to participate in this study. Auditory and visual sustained-attention tasks were applied. Children with SSD performed worse on these tasks; they committed a greater number of auditory false alarms and exhibited a significant decline in performance over the course of the auditory detection task. The extent to which performance is related to auditory perceptual difficulties and probable working memory deficits is discussed. Further studies are needed to better understand the specific nature of these deficits and their clinical implications.	[Murphy, Cristina F. B.; Pagan-Neves, Luciana O.; Wertzner, Haydee F.; Schochat, Eliane] Univ Sao Paulo, Sch Med, Dept Phys Therapy Speech Language Pathol & Occupa, Sao Paulo, Brazil	Universidade de Sao Paulo	Murphy, CFB (corresponding author), Univ Sao Paulo, Sch Med, Dept Phys Therapy Speech Language Pathol & Occupa, Sao Paulo, Brazil.	crist78@yahoo.com	WERTZNER, HAYDEE F/B-8429-2013; Murphy, Cristina F/C-4104-2012; Schochat, Eliane/B-5460-2014	Schochat, Eliane/0000-0002-1775-7603; Murphy, Cristina/0000-0002-2732-2283	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/50453-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2009/50453-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade CRF, 2004, TESTE LINGUAGEM INFA; Angelini A. L, 1999, MANUAL MATRIZES PROG; Aylward GP, 2002, DEV NEUROPSYCHOL, V21, P285, DOI 10.1207/S15326942DN2103_5; Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; BIRD J, 1995, J SPEECH HEAR RES, V38, P446, DOI 10.1044/jshr.3802.446; BIRD J, 1992, EUR J DISORDER COMM, V27, P289; Bishop DVM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015112; Broomfield J, 2004, INT J LANG COMM DIS, V39, P303, DOI 10.1080/13682820310001625589; Dancey CP., 2006, ESTATISTICA SEM MATE; Davies DR, 1982, PSYCHOL VIGILANCE; DIAMOND A, 1990, ANN NY ACAD SCI, V608, P637, DOI 10.1111/j.1749-6632.1990.tb48913.x; Ebert KD, 2011, J SPEECH LANG HEAR R, V54, P1372, DOI 10.1044/1092-4388(2011/10-0231); Facoetti A, 2000, COGNITIVE BRAIN RES, V10, P185, DOI 10.1016/S0926-6410(00)00031-8; Facoetti A, 2006, COGN NEUROPSYCHOL, V23, P841, DOI 10.1080/02643290500483090; Fey ME, 2008, LANG SPEECH HEAR SER, V23, P225, DOI DOI 10.1044/0161-1461.2303.225; Finneran DA, 2009, J SPEECH LANG HEAR R, V52, P915, DOI 10.1044/1092-4388(2009/07-0053); Fisher SE, 2002, NAT REV NEUROSCI, V3, P767, DOI 10.1038/nrn936; Gomes H, 2000, FRONT BIOSCI-LANDMRK, V5, pD108, DOI 10.2741/Gomes; Gordon M, 1983, GORDON DIAGNOSTIC SY; Guy J, 2013, CHILD NEUROPSYCHOL, V19, P601, DOI 10.1080/09297049.2012.710321; Kenney MK, 2006, BRAIN LANG, V96, P178, DOI 10.1016/j.bandl.2005.04.002; Larrivee LS, 1999, AM J SPEECH-LANG PAT, V8, P118, DOI 10.1044/1058-0360.0802.118; Leitao S, 2004, INT J LANG COMM DIS, V39, P245, DOI 10.1080/13682820310001619478; Mahone EM, 2005, DEV NEUROPSYCHOL, V27, P11, DOI 10.1207/s15326942dn2701_2; Marzocchi GM, 2009, CHILD NEUROPSYCHOL, V15, P567, DOI 10.1080/09297040902740660; McGrath LM, 2008, J ABNORM CHILD PSYCH, V36, P151, DOI 10.1007/s10802-007-9166-8; Musiek F E, 1994, J Am Acad Audiol, V5, P265; Musiek FE, 2005, EAR HEARING, V26, P608, DOI 10.1097/01.aud.0000188069.80699.41; PARASURAMAN R, 1979, SCIENCE, V205, P924, DOI 10.1126/science.472714; Pennington BF, 2009, ANNU REV PSYCHOL, V60, P283, DOI 10.1146/annurev.psych.60.110707.163548; Peterson RL, 2009, J SPEECH LANG HEAR R, V52, P1175, DOI 10.1044/1092-4388(2009/08-0024); Petit L, 1998, J NEUROSCI, V18, P9429; Raitano NA, 2004, J CHILD PSYCHOL PSYC, V45, P821, DOI 10.1111/j.1469-7610.2004.00275.x; Riccio CA, 1996, J LEARN DISABIL, V29, P561, DOI 10.1177/002221949602900510; Seli P, 2012, CAN J EXP PSYCHOL, V66, P44, DOI 10.1037/a0025111; Shriberg LD, 1997, J SPEECH LANG HEAR R, V40, P708, DOI 10.1044/jslhr.4004.708; Smith SD, 2005, J CHILD PSYCHOL PSYC, V46, P1057, DOI 10.1111/j.1469-7610.2005.01534.x; Spaulding TJ, 2008, J SPEECH LANG HEAR R, V51, P16, DOI 10.1044/1092-4388(2008/002); Strauss E, 2006, COMPENDIUM NEUROPSYC; TALLAL P, 1973, NEUROPSYCHOLOGIA, V11, P389, DOI 10.1016/0028-3932(73)90025-0; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; Tkach JA, 2011, BRAIN LANG, V119, P42, DOI 10.1016/j.bandl.2011.02.002; Vocabulario Befi-Lopes DM, 2004, TESTE LINGUAGEM INFA, P33; Wertzner H., 2004, ABFW TESTE LINGUAGEM, P5; Wertzner HF, 2007, SAO PAULO MED J, V125, P309, DOI 10.1590/S1516-31802007000600002; Wertzner Haydée Fiszbein, 2013, Audiol., Commun. Res., V18, P213; Wertzner Haydée Fiszbein, 2012, Rev. soc. bras. fonoaudiol., V17, P189, DOI 10.1590/S1516-80342012000200015; Willcutt EG, 2002, AM J MED GENET, V114, P260, DOI 10.1002/ajmg.10205	49	15	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93091	10.1371/journal.pone.0093091	http://dx.doi.org/10.1371/journal.pone.0093091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SW	24675815	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500072
J	Scheinost, D; Shen, XL; Finn, E; Sinha, R; Constable, RT; Papademetris, X				Scheinost, Dustin; Shen, Xilin; Finn, Emily; Sinha, Rajita; Constable, R. Todd; Papademetris, Xenophon			Coupled Intrinsic Connectivity Distribution Analysis: A Method for Exploratory Connectivity Analysis of Paired fMRI Data	PLOS ONE			English	Article							VOXEL-BASED MEASURE; FUNCTIONAL CONNECTIVITY; BRAIN; PARCELLATION	We present a novel voxel-based connectivity approach for paired functional magnetic resonance imaging (fMRI) data collected under two different conditions labeled the Coupled Intrinsic Connectivity Distribution (coupled-ICD). Our proposed method jointly models both conditions to incorporate additional paired information into the connectivity metric. Voxel-based connectivity holds promise as a clinical tool to characterize a wide range of neurological and psychiatric diseases, and monitor their treatment. As such, examining paired connectivity data such as scans acquired pre- and post-intervention is an important application for connectivity methodologically. When presented with data from paired conditions, conventional voxel-based methods analyze each condition separately. However, summarizing each connection separately can misrepresent patterns of changes in connectivity. We show that commonly used methods can underestimate functional changes and subsequently introduce and evaluate our solution to this problem, the coupled-ICD metric, using two studies: 1) healthy controls scanned awake and under anesthesia, and 2) cocaine-dependent subjects and healthy controls scanned while being presented with relaxing or drug-related imagery cues. The coupled-ICD approach detected differences between paired conditions in similar brain regions as the conventional approaches while also revealing additional changes in regions not identified using conventional voxel-based connectivity analyses. Follow-up seed-based analyses on data independent from the voxel-based results also showed connectivity differences between conditions in regions detected by coupled-ICD. This approach of jointly analyzing paired resting-state scans provides a new and important tool with many applications for clinical and basic neuroscience research.	[Scheinost, Dustin; Constable, R. Todd; Papademetris, Xenophon] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA; [Shen, Xilin; Constable, R. Todd; Papademetris, Xenophon] Yale Univ, Dept Diagnost Radiol, New Haven, CT 06510 USA; [Finn, Emily] Yale Univ, Interdept Neurosci Program, New Haven, CT USA; [Sinha, Rajita] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Constable, R. Todd] Yale Univ, Dept Neurosurg, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Scheinost, D (corresponding author), Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.	dustin.scheinost@yale.edu	Finn, Emily S./I-2205-2019; Constable, R. Todd/ABE-8038-2021; Scheinost, Dustin/Q-2857-2018	Finn, Emily S./0000-0001-8591-3068; Constable, R. Todd/0000-0001-5661-9521; Scheinost, Dustin/0000-0002-6301-1167	National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health [R01 EB009666]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009666] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health (R01 EB009666) http://www.nibib.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beu M, 2009, J NEUROSCI METH, V176, P263, DOI 10.1016/j.jneumeth.2008.08.036; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Constable RT, 2013, NEUROIMAGE, V64, P371, DOI 10.1016/j.neuroimage.2012.09.008; Finn ES, 2014, BIOL PSYCHIAT, V76, P397, DOI 10.1016/j.biopsych.2013.08.031; Hampson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044067; Hampson M, 2011, BRAIN CONNECT, V1, P91, DOI 10.1089/brain.2011.0002; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Joshi A, 2011, NEUROINFORMATICS, V9, P69, DOI 10.1007/s12021-010-9092-8; Li CSR, 2008, NEUROSCI BIOBEHAV R, V32, P581, DOI 10.1016/j.neubiorev.2007.10.003; Lui S, 2010, ARCH GEN PSYCHIAT, V67, P783, DOI 10.1001/archgenpsychiatry.2010.84; Martuzzi R, 2011, NEUROIMAGE, V58, P1044, DOI 10.1016/j.neuroimage.2011.06.075; Martuzzi R, 2010, NEUROIMAGE, V49, P823, DOI 10.1016/j.neuroimage.2009.07.028; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Papademetris X, 2004, LECT NOTES COMPUT SC, V3216, P763; Potenza MN, 2012, AM J PSYCHIAT, V169, P406, DOI 10.1176/appi.ajp.2011.11020289; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Scheinost D, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.24; Scheinost D, 2012, NEUROIMAGE, V62, P1510, DOI 10.1016/j.neuroimage.2012.05.073; Seo D, 2011, HUM BRAIN MAPP, V32, P1998, DOI 10.1002/hbm.21165; Shen X, 2013, NEUROIMAGE, V82, P403, DOI 10.1016/j.neuroimage.2013.05.081; Shen X, 2010, NEUROIMAGE, V50, P1027, DOI 10.1016/j.neuroimage.2009.12.119; Simpson SL, 2012, NEUROIMAGE, V60, P1117, DOI 10.1016/j.neuroimage.2012.01.071; Smith SM, 2012, NEUROIMAGE, V62, P1257, DOI 10.1016/j.neuroimage.2012.01.022; Tomasi D, 2012, BIOL PSYCHIAT, V71, P443, DOI 10.1016/j.biopsych.2011.11.003; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wexler BE, 2001, AM J PSYCHIAT, V158, P86, DOI 10.1176/appi.ajp.158.1.86; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041	30	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93544	10.1371/journal.pone.0093544	http://dx.doi.org/10.1371/journal.pone.0093544			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676034	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677500137
J	Chen, C; Bales, P; Greenfield, J; Heselpoth, RD; Nelson, DC; Herzberg, O				Chen, Chen; Bales, Patrick; Greenfield, Julia; Heselpoth, Ryan D.; Nelson, Daniel C.; Herzberg, Osnat			Crystal Structure of ORF210 from E. coli O157:H1 Phage CBA120 (TSP1), a Putative Tailspike Protein	PLOS ONE			English	Article							SUBSTRATE-ASSISTED CATALYSIS; ESCHERICHIA-COLI; BETA-HELICES; TAIL SPIKE; LIPOPOLYSACCHARIDE; CRYSTALLOGRAPHY; DENSITY; SYSTEM; PHENIX	Bacteriophage tailspike proteins act as primary receptors, often possessing endoglycosidase activity toward bacterial lipopolysaccharides or other exopolysaccharides, which enable phage absorption and subsequent DNA injection into the host. Phage CBA120, a contractile long-tailed Viunalikevirus phage infects the virulent Escherichia coli O157:H7. This phage encodes four putative tailspike proteins exhibiting little amino acid sequence identity, whose biological roles and substrate specificities are unknown. Here we focus on the first tailspike, TSP1, encoded by the orf210 gene. We have discovered that TSP1 is resistant to protease degradation, exhibits high thermal stability, but does not cleave the O157 antigen. An immunedot blot has shown that TSP1 binds strongly to non-O157:H7 E. coli cells and more weakly to K. pneumoniae cells, but exhibits little binding to E. coli O157:H7 strains. To facilitate structure-function studies, we have determined the crystal structure of TSP1 to a resolution limit of 1.8 angstrom. Similar to other tailspikes proteins, TSP1 assembles into elongated homotrimers. The receptor binding region of each subunit adopts a right-handed parallel beta helix, reminiscent yet not identical to several known tailspike structures. The structure of the N-terminal domain that binds to the virion particle has not been seen previously. Potential endoglycosidase catalytic sites at the three subunit interfaces contain two adjacent glutamic acids, unlike any catalytic machinery observed in other tailspikes. To identify potential sugar binding sites, the crystal structures of TSP1 in complexes with glucose, alpha-maltose, or alpha-lactose were determined. These structures revealed that each sugar binds in a different location and none of the environments appears consistent with an endoglycosidase catalytic site. Such sites may serve to bind sugar units of a yet to be identified bacterial exopolysaccharide.	[Chen, Chen; Bales, Patrick; Greenfield, Julia; Heselpoth, Ryan D.; Nelson, Daniel C.; Herzberg, Osnat] Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA; [Greenfield, Julia; Herzberg, Osnat] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Nelson, Daniel C.] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Herzberg, O (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA.	osnat@umd.edu	Nelson, Daniel C./I-2198-2012	Nelson, Daniel C./0000-0003-3248-4831; Herzberg, Osnat/0000-0003-2823-7627	Department of Defense [DM102823]	Department of Defense(United States Department of Defense)	Support was provided by the Department of Defense, award DM102823 (to DCN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Adriaenssens EM, 2012, ARCH VIROL, V157, P2035, DOI 10.1007/s00705-012-1360-5; Andres D, 2012, MOL MICROBIOL, V83, P1244, DOI 10.1111/j.1365-2958.2012.08006.x; Barbirz S, 2008, MOL MICROBIOL, V69, P303, DOI 10.1111/j.1365-2958.2008.06311.x; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Casjens SR, 2012, ADV EXP MED BIOL, V726, P143, DOI 10.1007/978-1-4614-0980-9_7; Casjens SR, 2011, VIROLOGY, V411, P393, DOI 10.1016/j.virol.2010.12.046; Chao KL, 2007, BIOCHEMISTRY-US, V46, P6911, DOI 10.1021/bi700382g; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hughes KA, 1998, MICROBIOL-UK, V144, P3039, DOI 10.1099/00221287-144-11-3039; Ikegami T, 2000, J BIOL CHEM, V275, P13654, DOI 10.1074/jbc.275.18.13654; Iseli B, 1996, FEBS LETT, V382, P186, DOI 10.1016/0014-5793(96)00174-3; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Kryshtafovych A, 2014, PROTEINS, V82, P26, DOI 10.1002/prot.24489; Kutter EM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-430; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leiman PG, 2008, MOL MICROBIOL, V69, P287, DOI 10.1111/j.1365-2958.2008.06241.x; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mitraki A, 2002, J STRUCT BIOL, V137, P236, DOI 10.1006/jsbi.2002.4447; Moult J, 2014, PROTEINS, V82, P1, DOI 10.1002/prot.24452; Muller JJ, 2008, STRUCTURE, V16, P766, DOI 10.1016/j.str.2008.01.019; Rezania Simin, 2011, Avicenna Journal of Medical Biotechnology, V3, P3; Steinbacher S, 1996, P NATL ACAD SCI USA, V93, P10584, DOI 10.1073/pnas.93.20.10584; STURTEVANT JM, 1989, J BIOL CHEM, V264, P10693; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; Walter M, 2008, J VIROL, V82, P2265, DOI 10.1128/JVI.01641-07; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Xiang Y, 2009, MOL CELL, V34, P375, DOI 10.1016/j.molcel.2009.04.009; YODER MD, 1995, FASEB J, V9, P335, DOI 10.1096/fasebj.9.5.7896002	40	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93156	10.1371/journal.pone.0093156	http://dx.doi.org/10.1371/journal.pone.0093156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671238	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677000122
J	Huybrechts, KF; Sanghani, RS; Avorn, J; Urato, AC				Huybrechts, Krista F.; Sanghani, Reesha Shah; Avorn, Jerry; Urato, Adam C.			Preterm Birth and Antidepressant Medication Use during Pregnancy: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; PERSISTENT PULMONARY-HYPERTENSION; POPULATION-BASED COHORT; PRENATAL EXPOSURE; MATERNAL USE; NEONATAL OUTCOMES; FETAL-GROWTH; IN-UTERO; CONGENITAL-MALFORMATIONS; DEPRESSION	Introduction: Preterm birth is a major contributor to neonatal morbidity and mortality and its rate has been increasing over the past two decades. Antidepressant medication use during pregnancy has also been rising, with rates up to 7.5% in the US. The objective was to systematically review the literature to determine the strength of the available evidence relating to a possible association between antidepressant use during pregnancy and preterm birth. Methods: We conducted a computerized search in PUBMED, MEDLINE and PsycINFO through September 2012, supplemented with a manual search of reference lists, to identify original published research on preterm birth rates in women taking antidepressants during pregnancy. Data were independently extracted by two reviewers, and absolute and relative risks abstracted or calculated. Our a priori design was to group studies by level of confounding adjustment and by timing of antidepressant use during pregnancy; we used random-effects models to calculate summary measures of effect. Results: Forty-one studies met inclusion criteria. Pooled adjusted odds ratios (95% CI) were 1.53 (1.40-1.66) for antidepressant use at any time and 1.96 (1.62-2.38) for 3rd trimester use. Controlling for a diagnosis of depression did not eliminate the effect. There was no increased risk [1.16 (0.92-1.45)] in studies that identified patients based on 1st trimester exposure. Sensitivity analyses demonstrated unmeasured confounding would have to be strong to account for the observed association. Discussion: Published evidence is consistent with an increased risk of preterm birth in women taking antidepressants during the 2nd and 3rd trimesters, although the possibility of residual confounding cannot be completely ruled out.	[Huybrechts, Krista F.; Avorn, Jerry] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Huybrechts, Krista F.; Avorn, Jerry] Harvard Univ, Sch Med, Boston, MA USA; [Sanghani, Reesha Shah] Vanderbilt Univ, Dept Obstet & Gynecol, Nashville, TN USA; [Urato, Adam C.] Tufts Univ, Sch Med, MetroWest Med Ctr, Framingham, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Vanderbilt University; Tufts University	Huybrechts, KF (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.	khuybrechts@partners.org			National Institute of Mental Health [K01MH099141]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH099141] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	There are no current funding sources for this study. Krista Huybrechts is supported by a career development grant K01MH099141 from the National Institute of Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker MK, 2008, BRIT J CLIN PHARMACO, V65, P600, DOI 10.1111/j.1365-2125.2007.03048.x; Behrman RE, 2007, PRETERM BIRTH CAUSES; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Borenstein M, 2009, INTRO META ANAL; Calderon-Margalit R, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.061; Casper RC, 2003, J PEDIATR-US, V142, P402, DOI 10.1067/mpd.2003.139; Casper RC, 2011, PSYCHOPHARMACOLOGY, V217, P211, DOI 10.1007/s00213-011-2270-z; Chambers CD, 1996, NEW ENGL J MED, V335, P1010, DOI 10.1056/NEJM199610033351402; Cohen LS, 2000, BIOL PSYCHIAT, V48, P996, DOI 10.1016/S0006-3223(00)00877-5; Colvin L, 2011, BIRTH DEFECTS RES A, V91, P142, DOI 10.1002/bdra.20773; Costei AM, 2002, ARCH PEDIAT ADOL MED, V156, P1129, DOI 10.1001/archpedi.156.11.1129; Coverdale JH, 2008, OBSTET GYNECOL, V112, P1361, DOI 10.1097/AOG.0b013e31818c2a27; Davis RL, 2007, PHARMACOEPIDEM DR S, V16, P1086, DOI 10.1002/pds.1462; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diav-Citrin O, 2008, BRIT J CLIN PHARMACO, V66, P695, DOI 10.1111/j.1365-2125.2008.03261.x; Djulus J, 2006, J CLIN PSYCHIAT, V67, P1280, DOI 10.4088/JCP.v67n0817; Einarson A, 2011, J POPUL THER CLIN PH, V18, pE390; Einarson A, 2010, DEPRESS ANXIETY, V27, P35, DOI 10.1002/da.20598; El Marroun H, 2012, ARCH GEN PSYCHIAT, V69, P706, DOI 10.1001/archgenpsychiatry.2011.2333; Engle WA, 2007, PEDIATRICS, V120, P1390, DOI 10.1542/peds.2007-2952; Ericson A, 1999, EUR J CLIN PHARMACOL, V55, P503, DOI 10.1007/s002280050664; Ferreira E, 2007, PEDIATRICS, V119, P52, DOI 10.1542/peds.2006-2133; FISHER ES, 1992, AM J PUBLIC HEALTH, V82, P243, DOI 10.2105/AJPH.82.2.243; Fowles J B, 1995, Health Care Financ Rev, V16, P189; Gavin AR, 2009, WOMEN HEALTH ISS, V19, P325, DOI 10.1016/j.whi.2009.05.004; Glynn RJ, 1999, AM J EPIDEMIOL, V149, P541; GOLDSTEIN DJ, 1995, J CLIN PSYCHOPHARM, V15, P417, DOI 10.1097/00004714-199512000-00005; Goyal NK, 2011, PEDIATRICS, V128, pE830, DOI 10.1542/peds.2011-0809; Grigoriadis S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f6932; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE321, DOI 10.4088/JCP.12r07968; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Grzeskowiak LE, 2012, J CLIN PSYCHOPHARM, V32, P615, DOI 10.1097/JCP.0b013e31826686bc; Hayes RM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.04.028; Hedges LV, 2014, STAT METHODS META AN; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huybrechts KF, 2013, GEN HOSP PSYCHIAT, V35, P265, DOI 10.1016/j.genhosppsych.2012.12.010; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; Kallen B, 2004, ARCH PEDIAT ADOL MED, V158, P312, DOI 10.1001/archpedi.158.4.312; Kieler H, 2012, BMJ-BRIT MED J, V344, pd8012, DOI DOI 10.1136/BMJ.D8012; Klieger-Grossmann C, 2012, J CLIN PHARMACOL, V52, P766, DOI 10.1177/0091270011405524; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; Kulin NA, 1998, JAMA-J AM MED ASSOC, V279, P609, DOI 10.1001/jama.279.8.609; Latendresse G, 2011, J MIDWIFERY WOM HEAL, V56, P118, DOI 10.1111/j.1542-2011.2010.00023.x; Lennestal R, 2007, J CLIN PSYCHOPHARM, V27, P607, DOI 10.1097/jcp.0b013e31815ac4d2; Leone A, 2012, ACTA PAEDIATR, V101, pE6, DOI 10.1111/j.1651-2227.2011.02459.x; Lewis AJ, 2010, AUST NZ J PSYCHIAT, V44, P482, DOI 10.3109/00048670903559593; Lund N, 2009, ARCH PEDIAT ADOL MED, V163, P949, DOI 10.1001/archpediatrics.2009.164; Malm H, 2005, OBSTET GYNECOL, V106, P1289, DOI 10.1097/01.AOG.0000187302.61812.53; Mangham LJ, 2009, PEDIATRICS, V123, pE312, DOI 10.1542/peds.2008-1827; Maschi S, 2008, BJOG-INT J OBSTET GY, V115, P283, DOI 10.1111/j.1471-0528.2007.01518.x; McElhatton PR, 1996, REPROD TOXICOL, V10, P285, DOI 10.1016/0890-6238(96)00057-3; Mitchell AA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.029; Mulder EJH, 2011, NEUROPSYCHOPHARMACOL, V36, P1961, DOI 10.1038/npp.2011.67; Munk-Olsen T, 2012, ACTA PSYCHIAT SCAND, V125, P318, DOI 10.1111/j.1600-0447.2011.01784.x; Nakhai-Pour HR, 2010, CAN MED ASSOC J, V182, P1031, DOI 10.1503/cmaj.091208; Nordeng H, 2012, J CLIN PSYCHOPHARM, V32, P186, DOI 10.1097/JCP.0b013e3182490eaf; Nulman I, 1997, NEW ENGL J MED, V336, P258, DOI 10.1056/NEJM199701233360404; Nulman I, 2002, AM J PSYCHIAT, V159, P1889, DOI 10.1176/appi.ajp.159.11.1889; Oberlander TF, 2008, BRIT J PSYCHIAT, V192, P338, DOI 10.1192/bjp.bp.107.037101; Oberlander TF, 2006, ARCH GEN PSYCHIAT, V63, P898, DOI 10.1001/archpsyc.63.8.898; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Palmsten K, 2012, EPIDEMIOLOGY, V23, P686, DOI 10.1097/EDE.0b013e318258fbb2; PASTUSZAK A, 1993, JAMA-J AM MED ASSOC, V269, P2246, DOI 10.1001/jama.269.17.2246; Pearson KH, 2007, J CLIN PSYCHIAT, V68, P1284, DOI 10.4088/JCP.v68n0817; Pedersen LH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3569; Petersen I, 2011, J CLIN PSYCHIAT, V72, P979, DOI 10.4088/JCP.10m06090blu; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Roca A, 2011, J AFFECT DISORDERS, V135, P208, DOI 10.1016/j.jad.2011.07.022; ROMANO PS, 1994, MED CARE, V32, P81, DOI 10.1097/00005650-199401000-00006; Ross LE, 2013, JAMA PSYCHIAT, V70, P436, DOI 10.1001/jamapsychiatry.2013.684; Rurak D, 2011, PEDIATR RES, V70, P96, DOI 10.1203/PDR.0b013e31821ba11a; Sanz EJ, 2005, LANCET, V365, P482, DOI 10.1016/S0140-6736(05)17865-9; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Shapiro-Mendoza CK, 2008, PEDIATRICS, V121, pE223, DOI 10.1542/peds.2006-3629; Simon GE, 2002, AM J PSYCHIAT, V159, P2055, DOI 10.1176/appi.ajp.159.12.2055; Sivojelezova A, 2005, AM J OBSTET GYNECOL, V193, P2004, DOI 10.1016/j.ajog.2005.05.012; Slattery MM, 2002, LANCET, V360, P1489, DOI 10.1016/S0140-6736(02)11476-0; Suri R, 2004, Arch Womens Ment Health, V7, P193; Suri R, 2007, AM J PSYCHIAT, V164, P1206, DOI 10.1176/appi.ajp.2007.06071172; Suri R, 2011, J CLIN PSYCHIAT, V72, P1002, DOI 10.4088/JCP.10m06135; Toh S, 2009, J CLIN PSYCHOPHARM, V29, P555, DOI 10.1097/JCP.0b013e3181bf344c; Wen SW, 2006, AM J OBSTET GYNECOL, V194, P961, DOI 10.1016/j.ajog.2006.02.019; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563; WEST SL, 1994, J CLIN EPIDEMIOL, V47, P165, DOI 10.1016/0895-4356(94)90021-3; Wisner KL, 2009, AM J PSYCHIAT, V166, P557, DOI 10.1176/appi.ajp.2008.08081170; Wogelius P, 2006, EPIDEMIOLOGY, V17, P701, DOI 10.1097/01.ede.0000239581.76793.ae; Yonkers KA, 2012, EPIDEMIOLOGY, V23, P677, DOI 10.1097/EDE.0b013e31825838e9; Yonkers KA, 2009, OBSTET GYNECOL, V114, P703, DOI 10.1097/AOG.0b013e3181ba0632; Zeskind PS, 2004, PEDIATRICS, V113, P368, DOI 10.1542/peds.113.2.368	89	79	83	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92778	10.1371/journal.pone.0092778	http://dx.doi.org/10.1371/journal.pone.0092778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671232	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000073
J	Jelbert, SA; Taylor, AH; Cheke, LG; Clayton, NS; Gray, RD				Jelbert, Sarah A.; Taylor, Alex H.; Cheke, Lucy G.; Clayton, Nicola S.; Gray, Russell D.			Using the Aesop's Fable Paradigm to Investigate Causal Understanding of Water Displacement by New Caledonian Crows	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; ORANGUTANS PONGO-PYGMAEUS; MONKEYS CEBUS-APELLA; CORVUS-MONEDULOIDES; TOOL-USE; FOLK PHYSICS; HOOK-TOOLS; TUBE TASK; SOLVE; COGNITION	Understanding causal regularities in the world is a key feature of human cognition. However, the extent to which non-human animals are capable of causal understanding is not well understood. Here, we used the Aesop's fable paradigm - in which subjects drop stones into water to raise the water level and obtain an out of reach reward - to assess New Caledonian crows' causal understanding of water displacement. We found that crows preferentially dropped stones into a water-filled tube instead of a sand-filled tube; they dropped sinking objects rather than floating objects; solid objects rather than hollow objects, and they dropped objects into a tube with a high water level rather than a low one. However, they failed two more challenging tasks which required them to attend to the width of the tube, and to counter-intuitive causal cues in a U-shaped apparatus. Our results indicate that New Caledonian crows possess a sophisticated, but incomplete, understanding of the causal properties of displacement, rivalling that of 5-7 year old children.	[Jelbert, Sarah A.; Taylor, Alex H.; Gray, Russell D.] Univ Auckland, Dept Psychol, Auckland, New Zealand; [Cheke, Lucy G.; Clayton, Nicola S.] Univ Cambridge, Dept Psychol, Cambridge, England	University of Auckland; University of Cambridge	Jelbert, SA (corresponding author), Univ Auckland, Dept Psychol, Auckland, New Zealand.	s.jelbert@auckland.ac.nz	Taylor, Alex H/D-6428-2012; Gray, Russell/H-2078-2015	Gray, Russell/0000-0002-9858-0191; Taylor, Alex/0000-0003-3492-7667; Clayton, Nicola/0000-0003-1835-423X; Cheke, Lucy/0000-0001-5588-7575; Jelbert, Sarah/0000-0002-7503-0648	New Zealand Marsden Fund; University of Auckland Doctoral Scholarship	New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); University of Auckland Doctoral Scholarship	This work was supported by a grant from the New Zealand Marsden Fund (RDG) and a University of Auckland Doctoral Scholarship (SAJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird CD, 2009, P NATL ACAD SCI USA, V106, P10370, DOI 10.1073/pnas.0901008106; Bird CD, 2009, CURR BIOL, V19, P1410, DOI 10.1016/j.cub.2009.07.033; Call J, 2004, J COMP PSYCHOL, V118, P232, DOI 10.1037/0735-7036.118.2.232; Chappell J, 2002, ANIM COGN, V5, P71, DOI 10.1007/s10071-002-0130-2; Chappell J, 2004, ANIM COGN, V7, P121, DOI 10.1007/s10071-003-0202-y; Cheke LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040574; Cheke LG, 2011, ANIM COGN, V14, P441, DOI 10.1007/s10071-011-0379-4; Hanus D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019555; Heinrich B, 2005, ETHOLOGY, V111, P962, DOI 10.1111/j.1439-0310.2005.01133.x; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; Hunt GR, 2002, EMU, V102, P283, DOI 10.1071/MU01037; Hunt GR, 2004, P ROY SOC B-BIOL SCI, V271, pS88, DOI 10.1098/rsbl.2003.0085; Hunt GR, 2004, ANIM COGN, V7, P114, DOI 10.1007/s10071-003-0200-0; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; Kenward B, 2004, IBIS, V146, P652, DOI 10.1111/j.1474-919x.2004.00299.x; LIMONGELLI L, 1995, J COMP PSYCHOL, V109, P18, DOI 10.1037/0735-7036.109.1.18; Martin-Ordas G, 2008, ANIM COGN, V11, P423, DOI 10.1007/s10071-007-0132-1; Mendes N, 2007, BIOL LETTERS, V3, P453, DOI 10.1098/rsbl.2007.0198; Mulcahy NJ, 2006, ANIM COGN, V9, P193, DOI 10.1007/s10071-006-0019-6; Mulcahy NJ, 2009, J COMP PSYCHOL, V123, P304, DOI 10.1037/a0016222; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; Penn DC, 2007, ANNU REV PSYCHOL, V58, P97, DOI 10.1146/annurev.psych.58.110405.085555; Povinelli D.J., 2000, FOLK PHYS APES CHIMP; Seed AM, 2006, CURR BIOL, V16, P697, DOI 10.1016/j.cub.2006.02.066; Seed A, 2012, PHILOS T R SOC B, V367, P2743, DOI 10.1098/rstb.2012.0222; Seed A, 2010, CURR BIOL, V20, pR1032, DOI 10.1016/j.cub.2010.09.042; Seed AM, 2009, J EXP PSYCHOL ANIM B, V35, P23, DOI 10.1037/a0012925; Silva FJ, 2005, LEARN BEHAV, V33, P47; SMITH C, 1985, COGNITION, V21, P177, DOI 10.1016/0010-0277(85)90025-3; Spelke ES, 2007, DEVELOPMENTAL SCI, V10, P89, DOI 10.1111/j.1467-7687.2007.00569.x; SPELKE ES, 1991, J PIAGET SY, P133; Taylor AH, 2009, P R SOC B, V276, P247, DOI 10.1098/rspb.2008.1107; Taylor AH, 2007, CURR BIOL, V17, P1504, DOI 10.1016/j.cub.2007.07.057; Taylor AH, 2012, P ROY SOC B-BIOL SCI, V279, P4977, DOI 10.1098/rspb.2012.1998; Taylor AH, 2012, P NATL ACAD SCI USA, V109, P16389, DOI 10.1073/pnas.1208724109; Taylor AH, 2012, BEHAV BRAIN SCI, V35, P241, DOI 10.1017/S0140525X11001956; Taylor AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026887; Taylor AH, 2010, P ROY SOC B-BIOL SCI, V277, P2637, DOI 10.1098/rspb.2010.0285; Taylor AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009345; Taylor AH, 2009, CURR BIOL, V19, pR731, DOI 10.1016/j.cub.2009.07.055; Tebbich S, 2007, ANIM COGN, V10, P225, DOI 10.1007/s10071-006-0061-4; Tecwyn EC, 2012, ANIM COGN, V15, P121, DOI 10.1007/s10071-011-0438-x; Teschke I, 2011, ANIM COGN, V14, P555, DOI 10.1007/s10071-011-0390-9; Troscianko J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2111; VISALBERGHI E, 1995, J COMP PSYCHOL, V109, P52, DOI 10.1037/0735-7036.109.1.52; Visalberghi E, 1998, BEHAV PROCESS, V42, P189, DOI 10.1016/S0376-6357(97)00076-4; VISALBERGHI E, 1994, J COMP PSYCHOL, V108, P15, DOI 10.1037/0735-7036.108.1.15; von Bayern AMP, 2009, CURR BIOL, V19, P1965, DOI 10.1016/j.cub.2009.10.037; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433; Weir AAS, 2006, ANIM COGN, V9, P317, DOI 10.1007/s10071-006-0052-5	50	58	59	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92895	10.1371/journal.pone.0092895	http://dx.doi.org/10.1371/journal.pone.0092895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671252	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677000090
J	Ogino, K; Zhang, R; Takahashi, H; Takemoto, K; Kubo, M; Murakami, I; Wang, DH; Fujikura, Y				Ogino, Keiki; Zhang, Ran; Takahashi, Hidekazu; Takemoto, Kei; Kubo, Masayuki; Murakami, Ikuo; Wang, Da-Hong; Fujikura, Yoshihisa			Allergic Airway Inflammation by Nasal Inoculation of Particulate Matter (PM2.5) in NC/Nga Mice	PLOS ONE			English	Article							ASTHMA-LIKE RESPONSES; CYTOKINE EXPRESSION; NALP3 INFLAMMASOME; PRIMER DATABASE; SKIN-LESIONS; POLLUTION; MORTALITY; HYPERRESPONSIVENESS; ACTIVATION; ARGINASE	To evaluate the effect of airborne particulate matter 2.5 (PM2.5) in winter on airway inflammation, water-soluble supernatant (Sup) and water-insoluble precipitate (Pre) in PM2.5 were inoculated in NC/Nga mice with high sensitivity to mite allergens. Sup with aluminum oxide was injected intraperitoneally for sensitization. Five days later, Sup, Pre or both Sup and Pre were inoculated via the nasal route five times for more sensitization and a challenge inoculation on the 11th day in NC/Nga mice. On the 12th day, mice were examined for airway hyperresponsiveness (AHR), BALF cell count and IL-1 beta concentration, mRNA expression of Th-1 and Th-2 cytokines, chemokines such as eotaxin 1 and eotaxin 2, inflammasomal complex molecules such as IL-1 beta, caspase 1 and the nucleotide-binding domain and leucine-rich repeat protein 3 (NLRP3) in lung tissue as well as histopathology. The synergistic effect of Sup and Pre was observed in terms of increases in AHR, BALF cells, the mRNA expression of IL-13, eotaxin1 and IL-1 beta, and the IL-1 beta concentration in BALF. Intracellular deposits of insoluble particulates were observed in macrophages around inflammatory granulation of the mouse group treated with Sup and Pre. These results suggest that PM2.5 can induce airway hyperresponsiveness in mice with genetically high sensitivity to mite allergens by an inflammasome-associated mechanism and synergistic action of insoluble particulates and soluble components.	[Ogino, Keiki; Zhang, Ran; Takemoto, Kei; Kubo, Masayuki; Wang, Da-Hong] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Publ Hlth, Okayama 7008530, Japan; [Takahashi, Hidekazu] Yamaguchi Univ, Grad Sch Med, Dept Publ Hlth, Ube, Yamaguchi 755, Japan; [Murakami, Ikuo] Otsuka Pharmaceut Co Ltd, Inst New Drug Discovery 3, Tokushima, Japan; [Fujikura, Yoshihisa] Oita Univ, Fac Med, Dept Mol Anat, Yufu, Oita, Japan	Okayama University; Yamaguchi University; Otsuka Pharmaceutical; Oita University	Ogino, K (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Publ Hlth, Okayama 7008530, Japan.	kogino@md.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government [21659156]	Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Science Research No. 21659156 from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 1999, NATURE, V402, pB31, DOI 10.1038/35037026; Bengalli R, 2013, BIOMED RES INT, DOI [10.1155/2013/158093, DOI 10.1155/2013/158093)]; Costa DL, 1997, ENVIRON HEALTH PERSP, V105, P1053, DOI 10.2307/3433509; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Fujimaki H, 1997, TOXICOLOGY, V116, P227, DOI 10.1016/S0300-483X(96)03539-1; Ganz M, 2011, WORLD J GASTROENTERO, V17, P4772, DOI 10.3748/wjg.v17.i43.4772; Gavett SH, 2003, ENVIRON HEALTH PERSP, V111, P1471, DOI 10.1289/ehp.6300; Gavett SH, 1997, ENVIRON RES, V72, P162, DOI 10.1006/enrs.1997.3732; Gonzalez-Benitez JF, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/614345; Hirota JA, 2012, J ALLERGY CLIN IMMUN, V129, P1116, DOI 10.1016/j.jaci.2011.11.033; Inoue K, 2005, ARCH TOXICOL, V79, P595, DOI 10.1007/s00204-005-0668-2; Kubo M, 2005, FREE RADICAL RES, V39, P719, DOI 10.1080/10715760500139260; LE JM, 1986, J IMMUNOL, V136, P4525; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; NAGAI H, 1993, LIFE SCI, V53, pPL243, DOI 10.1016/0024-3205(93)90545-E; Nakae S, 2003, INT IMMUNOL, V15, P483, DOI 10.1093/intimm/dxg054; OBERDORSTER G, 1994, ENVIRON HEALTH PERSP, V102, P173, DOI 10.2307/3432080; Ogino K, 2012, ENVIRON TOXICOL, DOI [10.1002/tox.21791, DOI 10.1002/T0X.21791)]; Ormstad H, 1998, TOXICOLOGY, V129, P227, DOI 10.1016/S0300-483X(98)00079-1; Ormstad H, 2000, TOXICOLOGY, V152, P53, DOI 10.1016/S0300-483X(00)00292-4; PlattsMills TAE, 1997, NEW ENGL J MED, V336, P1382, DOI 10.1056/NEJM199705083361909; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; POPE CA, 1989, AM J PUBLIC HEALTH, V79, P623, DOI 10.2105/AJPH.79.5.623; Rodriguez D, 2003, J IMMUNOL, V171, P1001, DOI 10.4049/jimmunol.171.2.1001; Sasakawa T, 2001, INT ARCH ALLERGY IMM, V126, P239, DOI 10.1159/000049520; Schmitz N, 2003, EUR J IMMUNOL, V33, P991, DOI 10.1002/eji.200323801; SCHWARTZ J, 1994, ENVIRON RES, V64, P36, DOI 10.1006/enrs.1994.1005; Schwarze PE, 2006, HUM EXP TOXICOL, V25, P559, DOI 10.1177/096032706072520; Shibamori M, 2006, LIFE SCI, V78, P987, DOI 10.1016/j.lfs.2005.06.020; Suto H, 1999, INT ARCH ALLERGY IMM, V120, P70, DOI 10.1159/000053599; Takahashi N, 2010, AM J PHYSIOL-LUNG C, V299, pL17, DOI 10.1152/ajplung.00216.2009; Takano H, 1997, AM J RESP CRIT CARE, V156, P36, DOI 10.1164/ajrccm.156.1.9610054; Takemoto K, 2007, AM J PHYSIOL-LUNG C, V293, pL1419, DOI 10.1152/ajplung.00418.2006; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tran HB, 2012, J ALLERGY, DOI [10.1155/2012/819176, DOI 10.1155/2012/819176)]; Utell MJ, 1995, TOXICOL LETT, V82-3, P47, DOI 10.1016/0378-4274(95)03467-6; Walters DM, 2001, AM J RESP CRIT CARE, V164, P1438, DOI 10.1164/ajrccm.164.8.2007121; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Yin Y, 2013, FRONT BIOSCI-LANDMRK, V18, P638, DOI 10.2741/4127	43	75	85	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92710	10.1371/journal.pone.0092710	http://dx.doi.org/10.1371/journal.pone.0092710			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671176	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677000068
J	Spaans, VM; Trietsch, MD; Crobach, S; Stelloo, E; Kremer, D; Osse, EM; ter Haar, NT; van Eijk, R; Muller, S; van Wezel, T; Trimbos, JB; Bosse, T; Smit, VTHBM; Fleuren, GJ				Spaans, Vivian M.; Trietsch, Marjolijn D.; Crobach, Stijn; Stelloo, Ellen; Kremer, Dennis; Osse, Elisabeth M.; ter Haar, Natalja T.; van Eijk, Ronald; Muller, Susanne; van Wezel, Tom; Trimbos, J. Baptist; Bosse, Tjalling; Smit, Vincent T. H. B. M.; Fleuren, Gert Jan			Designing a High-Throughput Somatic Mutation Profiling Panel Specifically for Gynaecological Cancers	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; PRIMARY ENDOMETRIAL; TP53 MUTATIONS; GENE-MUTATIONS; OVARIAN; PTEN; P53; CARCINOMAS; SURVIVAL; RECEPTOR	Somatic mutations play a major role in tumour initiation and progression. The mutation status of a tumour may predict prognosis and guide targeted therapies. The majority of techniques to study oncogenic mutations require high quality and quantity DNA or are analytically challenging. Mass-spectrometry based mutation analysis however is a relatively simple and high-throughput method suitable for formalin-fixed, paraffin-embedded (FFPE) tumour material. Targeted gene panels using this technique have been developed for several types of cancer. These current cancer hotspot panels are not focussed on the genes that are most relevant in gynaecological cancers. In this study, we report the design and validation of a novel, mass-spectrometry based panel specifically for gynaecological malignancies and present the frequencies of detected mutations. Using frequency data from the online Catalogue of Somatic Mutations in Cancer, we selected 171 somatic hotspot mutations in the 13 most important genes for gynaecological cancers, being BRAF, CDKN2A, CTNNB1, FBXW7, FGFR2, FGFR3, FOXL2, HRAS, KRAS, NRAS, PIK3CA, PPP2R1A and PTEN. A total of 546 tumours (205 cervical, 227 endometrial, 89 ovarian, and 25 vulvar carcinomas) were used to test and validate our panel, and to study the prevalence and spectrum of somatic mutations in these types of cancer. The results were validated by testing duplicate samples and by allele-specific qPCR. The panel presented here using mass-spectrometry shows to be reproducible and high-throughput, and is usefull in FFPE material of low quality and quantity. It provides new possibilities for studying large numbers of gynaecological tumour samples in daily practice, and could be useful in guided therapy selection.	[Spaans, Vivian M.; Trietsch, Marjolijn D.; Crobach, Stijn; Stelloo, Ellen; Osse, Elisabeth M.; ter Haar, Natalja T.; van Eijk, Ronald; van Wezel, Tom; Bosse, Tjalling; Smit, Vincent T. H. B. M.; Fleuren, Gert Jan] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Spaans, Vivian M.; Trimbos, J. Baptist] Leiden Univ, Dept Gynaecol, Med Ctr, Leiden, Netherlands; [Kremer, Dennis] Leiden Univ, Dept Mol Epidemiol, Med Ctr, Leiden, Netherlands; [Muller, Susanne] Sequenom GmbH, Hamburg, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Trietsch, MD (corresponding author), Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands.	M.D.Trietsch@lumc.nl	van Wezel, Tom/AAL-5626-2021; van Wezel, Tom/A-9599-2008; van Wezel, Tom/Z-3092-2019; Smit, Vincent/AAD-1811-2022; Bosse, Tjalling/AFX-6970-2022	van Wezel, Tom/0000-0001-5773-7730; van Wezel, Tom/0000-0001-5773-7730; Smit, Vincent/0000-0003-3730-5652; Bosse, Tjalling/0000-0002-6881-8437; van Eijk, Ronald/0000-0001-7955-6295				Bell DA, 2005, MODERN PATHOL, V18, pS19, DOI 10.1038/modpathol.3800306; Berek JS, 2010, GYNECOLOGIC ONCOLOGY; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Choschzick M, 2011, INT J GYNECOL PATHOL, V30, P497, DOI 10.1097/PGP.0b013e3182184c7a; Cote ML, 2012, INT J GYNECOL CANCER, V22, P1367, DOI 10.1097/IGC.0b013e31826b1110; Cottrell CE, 2014, J MOL DIAGN, V16, P89, DOI 10.1016/j.jmoldx.2013.10.002; de Jong AE, 2004, CLIN CANCER RES, V10, P972, DOI 10.1158/1078-0432.CCR-0956-3; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Dutton-Regester K, 2012, MOL CANCER THER, V11, P888, DOI 10.1158/1535-7163.MCT-11-0676; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Fumagalli D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-101; Garcia-Dios DA, 2013, GYNECOL ONCOL, V128, P327, DOI 10.1016/j.ygyno.2012.11.037; Gemignani ML, 2003, GYNECOL ONCOL, V90, P378, DOI 10.1016/S0090-8258(03)00264-6; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Ho CM, 2009, GYNECOL ONCOL, V112, P307, DOI 10.1016/j.ygyno.2008.09.040; Holway AH, 2000, CLIN CANCER RES, V6, P3228; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kanagal-Shamanna R, 2013, MOD PATHOL, V10; Kinde I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004952; Krakstad C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052795; Lax SF, 2000, CANCER-AM CANCER SOC, V88, P814, DOI 10.1002/(SICI)1097-0142(20000215)88:4<814::AID-CNCR12>3.3.CO;2-L; Liang H, 2012, GENOME RES, V22, P2120, DOI 10.1101/gr.137596.112; Loyo M, 2013, HEAD NECK-J SCI SPEC, V35, P454, DOI 10.1002/hed.23100; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Maeng CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041655; McCluggage WG, 2002, INT J GYNECOL PATHOL, V21, P11, DOI 10.1097/00004347-200201000-00003; McConechy MK, 2011, J PATHOL, V223, P567, DOI 10.1002/path.2848; Nagendra DC, 2012, MOL CARCINOGEN, V51, P826, DOI 10.1002/mc.20850; Nout RA, 2012, GYNECOL ONCOL, V126, P466, DOI 10.1016/j.ygyno.2012.05.012; Santarpia L, 2012, BREAST CANCER RES TR, V134, P333, DOI 10.1007/s10549-012-2035-3; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Shih IM, 2011, AM J PATHOL, V178, P1442, DOI 10.1016/j.ajpath.2011.01.009; Soufir N, 2007, BRIT J DERMATOL, V156, P448, DOI 10.1111/j.1365-2133.2006.07604.x; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tornesello ML, 2013, GYNECOL ONCOL, V128, P442, DOI 10.1016/j.ygyno.2012.11.017; Ulahannan D, 2013, BRIT J CANCER, V109, P827, DOI 10.1038/bjc.2013.416; van Eijk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017791; Wegman P, 2011, INT J GYNECOL CANCER, V21, P86, DOI 10.1097/IGC.0b013e3182049924; Wright AA, 2013, CANCER-AM CANCER SOC, V119, P3776, DOI 10.1002/cncr.28288	46	35	36	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93451	10.1371/journal.pone.0093451	http://dx.doi.org/10.1371/journal.pone.0093451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671188	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000146
J	Carroll, EL; Jackson, JA; Paton, D; Smith, TD				Carroll, Emma L.; Jackson, Jennifer A.; Paton, David; Smith, Tim D.			Two Intense Decades of 19(th) Century Whaling Precipitated Rapid Decline of Right Whales around New Zealand and East Australia	PLOS ONE			English	Article							SOUTHERN RIGHT WHALES	Right whales (Eubalaenaspp.)werethe focus of worldwide whaling activities from the 16 (th) to the 20(th) century. During the first part of the 19 th century, the southern right whale (E. australis) was heavily exploited on whaling grounds around New Zealand (NZ) and east Australia (EA). Here we build upon previous estimates of the total catch of NZ and EA right whales by improving and combining estimates from four different fisheries. Two fisheries have previously been considered: shorebased whaling in bays and ship-based whaling offshore. These were both improved by comparison with primary sources and the American offshore whaling catch record was improved by using a sample of logbooks to produce a more accurate catch record in terms of location and species composition. Two fisheries had not been previously integrated into the NZ and EA catch series: ship-based whaling in bays and whaling in the 20 th century. To investigate the previously unaddressed problem of offshore whalers operating in bays, we identified a subset of vessels likely to be operating in bays and read available extant logbooks. This allowed us to estimate the total likely catch from bay-whaling by offshore whalers from the number of vessels seasons and whales killed per season: it ranged from 2,989 to 4,652 whales. The revised total estimate of 53,000 to 58,000 southern right whales killed is a considerable increase on the previous estimate of 26,000, partly because it applies fishery-specific estimates of struck and loss rates. Over 80% of kills were taken between 1830 and 1849, indicating a brief and intensive fishery that resulted in the commercial extinction of southern right whales in NZ and EA in just two decades. This conforms to the global trend of increasingly intense and destructive southern right whale fisheries over time.	[Carroll, Emma L.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Jackson, Jennifer A.] British Antarctic Survey, Cambridge CB3 0ET, Cambs, England; [Paton, David] Blue Planet Marine, Canberra, ACT, Australia; [Smith, Tim D.] World Whaling Hist, Redding, CA USA	University of Auckland; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Carroll, EL (corresponding author), Univ St Andrews, Scottish Oceans Inst, St Andrews, Fife, Scotland.	elc6@st-andrews.ac.uk	Carroll, Emma/U-9133-2019	Carroll, Emma/0000-0003-3193-7288	New Zealand Ministry of Fisheries [ZBD200505]; Atmospheric Research (NIWA); Oregon State University General Research Fund; Lenfest Ocean Program of the Pew Charitable Trust; Tertiary Education Commission; TS through the History of Marine Animal Populations (HMAP); Natural Environment Research Council [bas0100026] Funding Source: researchfish; NERC [bas0100026] Funding Source: UKRI	New Zealand Ministry of Fisheries; Atmospheric Research (NIWA); Oregon State University General Research Fund; Lenfest Ocean Program of the Pew Charitable Trust; Tertiary Education Commission; TS through the History of Marine Animal Populations (HMAP); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for the review and report preparation was provided by the New Zealand Ministry of Fisheries through Project ZBD200505 to the National Institute of Water and Atmospheric Research (NIWA), Oregon State University General Research Fund to JJ and CS Baker and the Lenfest Ocean Program of the Pew Charitable Trust to SR Palumbi. EC was supported by a fellowship from the Tertiary Education Commission and TS through the History of Marine Animal Populations (HMAP) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GREAT BRITAIN PARLIA; Bannister J. L., 1986, REP INT WHAL COMM, P255; Bannister JL, 2011, INT WHAL COMM WORKSH; Brandao A, 2010, SC62BRG30; Carroll E, 2011, MAR ECOL PROG SER, V432, P257, DOI 10.3354/meps09145; Carroll EL, 2013, ECOL APPL, V23, P1677, DOI 10.1890/12-1657.1; Carroll EL, 2014, MAR MAMMAL SCI, V30, P206, DOI 10.1111/mms.12031; CLAPHAM PJ, 2002, ENCY MARINE MAMMALS, P1328; Dawbin W, 1985, HIST DOCUMENTS RELAT; Dawbin W., 1986, REPORT INT WHALING C, V10, P261; Dorsey, 2014, WHALES NATIONS ENV D; Du Pasquier T, 1986, REPORT INT WHALING C, V10, P268; Fujiwara M, 2001, NATURE, V414, P537, DOI 10.1038/35107054; GASKIN D. E., 1964, TUATARA, V12, P115; Great Britain Colonial Office, 1853, BLUE BOOK STAT 1841; Hjort J., 1933, HVALRADETS SKRIFTER, V7, P7; IWC, 2012, SC64REP5 IWC; IWC, 1986, REPORT INT WHALING C, V44, P146; IWC, 2001, J CETACEAN RES MANAG, V2, P1; Jackson JA, 2008, MOL ECOL, V17, P236, DOI 10.1111/j.1365-294X.2007.03497.x; Josephson E, 2008, OCEANS PAST MANAGEMN; Josephson E, 2008, FISH FISH, V9, P155, DOI 10.1111/j.1467-2979.2008.00275.x; Kato H, 2007, SC59SH10; Lund JN, 2010, PLOS ONE, VI; McNab R, 1909, DISCOVERY ISLANDS SU, VI; McNab R, 1908, HIST RECORDS NZ, V1; McNab R., 1913, OLD WHALING DAYS HIS; McNab R, 1907, MURIHIKU SO ISLANDS; Morton H., 1982, WHALES WAKE; Papworth SK, 2009, CONSERV LETT, V2, P93, DOI 10.1111/j.1755-263X.2009.00049.x; Patenaude NJ, 2007, J HERED, V98, P147, DOI 10.1093/jhered/esm005; Patenaude NJ, 2002, THESIS U AUCKLAND AU; Reeves R. R., 2010, US NMFS MAR FISH REV, V72, P26; Reeves R. R., 2007, WHALES WHALING OCEAN; Reeves RR, 2006, URBAN WHALE; Reilly SB, 2008, IUCN 2009 IUCN RED L; Richards R, 2002, J ROY SOC NEW ZEAL, V32, P355, DOI 10.1080/03014223.2002.9517699; Richards R, 2009, GREAT CIRCLE, V31, P59; Richards R., 1992, BAY ISLANDS SHIPPING; Seber G.A.F., 1973, ESTIMATION ANIMAL AB; Sherrin RAA, 1886, HDB FISHES NZ; Smith T. D., 1994, SCALING FISHERIES; Smith TD, 2010, MAR FISH REV, V72, P1; Smith TD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034905; Starbuck A., 1878, HIST AM WHALE FISH 4; Statistics New Zealand, 1900, STAT NZ 1854 1900; Tormosov DD, 1998, BIOL CONSERV, V86, P185, DOI 10.1016/S0006-3207(98)00008-1; Wade PR, 2011, BIOL LETTERS, V7, P83, DOI 10.1098/rsbl.2010.0477; Wakefield E.J., 1848, HDB NZ	49	16	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93789	10.1371/journal.pone.0093789	http://dx.doi.org/10.1371/journal.pone.0093789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690918	gold, Green Published, Green Accepted			2022-12-27	WOS:000334101100134
J	Cochain, C; Chaudhari, SM; Koch, M; Wiendl, H; Eckstein, HH; Zernecke, A				Cochain, Clement; Chaudhari, Sweena M.; Koch, Miriam; Wiendl, Heinz; Eckstein, Hans-Henning; Zernecke, Alma			Programmed Cell Death-1 Deficiency Exacerbates T Cell Activation and Atherogenesis despite Expansion of Regulatory T Cells in Atherosclerosis-Prone Mice	PLOS ONE			English	Article							PATHWAY; PD-1; COSTIMULATION; PROGRESSION; RESPONSES	T cell activation represents a double-edged sword in atherogenesis, as it promotes both pro-inflammatory T cell activation and atheroprotective Foxp3(+) regulatory T cell (Treg) responses. Here, we investigated the role of the co-inhibitory receptor programmed cell death-1 (PD-1) in T cell activation and CD4(+) T cell polarization towards pro-atherogenic or atheroprotective responses in mice. Mice deficient for both low density lipoprotein receptor and PD-1 (Ldlr(-/-)Pd1(-/-)) displayed striking increases in systemic CD4(+) and CD8(+) T cell activation after 9 weeks of high fat diet feeding, associated with an expansion of both pro-atherogenic IFN gamma-secreting T helper 1 cells and atheroprotective Foxp3+ Tregs. Importantly, PD-1 deficiency did not affect Treg suppressive function in vitro. Notably, PD-1 deficiency exacerbated atherosclerotic lesion growth and entailed a massive infiltration of T cells in atherosclerotic lesions. In addition, aggravated hypercholesterolemia was observed in Ldlr(-/-) Pd1(-/-) mice. In conclusion, we here demonstrate that although disruption of PD-1 signaling enhances both pro-and anti-atherogenic T cell responses in Ldlr(-/-) mice, pro-inflammatory T cell activation prevails and enhances dyslipidemia, vascular inflammation and atherosclerosis.	[Cochain, Clement; Chaudhari, Sweena M.; Koch, Miriam; Zernecke, Alma] Univ Hosp Wurzburg, Inst Clin Biochem & Pathobiochem, Wurzburg, Germany; [Cochain, Clement; Chaudhari, Sweena M.; Eckstein, Hans-Henning; Zernecke, Alma] Tech Univ Munich, Klinikum Rechts Isar, Dept Vasc Surg, D-80290 Munich, Germany; [Wiendl, Heinz] Univ Munster, Dept Neurol, D-48149 Munster, Germany; [Eckstein, Hans-Henning] DZHK German Ctr Cardiovasc Res, Munich Heart Alliance, Munich, Germany	University of Wurzburg; Technical University of Munich; University of Munster; German Centre for Cardiovascular Research; Munich Heart Alliance	Zernecke, A (corresponding author), Univ Hosp Wurzburg, Inst Clin Biochem & Pathobiochem, Wurzburg, Germany.	alma.zernecke@uni-wuerzburg.de	Eckstein, Hans-Henning/AAF-9200-2022; Eckstein, Hans-Henning/AFK-1881-2022; Wiendl, Heinz/AAX-6041-2021	Wiendl, Heinz/0000-0003-4310-3432; Eckstein, Hans-Henning/0000-0002-0743-1642	Deutsche Forschungsgemeinschaft [SFB1009, SFB688, FOR809 ZE 827/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB1009, project A3, to H. W., and SFB688 project A12 and A22, and FOR809 ZE 827/1-2 to A.Z.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. or preparation of the manuscript.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Benagiano M, 2003, P NATL ACAD SCI USA, V100, P6658, DOI 10.1073/pnas.1135726100; Bu DX, 2011, ARTERIOSCL THROM VAS, V31, P1100, DOI 10.1161/ATVBAHA.111.224709; Buono C, 2004, CIRCULATION, V109, P2009, DOI 10.1161/01.CIR.0000127121.16815.F1; Cardilo-Reis L, 2012, EMBO MOL MED, V4, P1072, DOI 10.1002/emmm.201201374; Franceschini D, 2009, J CLIN INVEST, V119, P551, DOI 10.1172/JCI36604; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Gotsman I, 2008, CIRC RES, V103, P1220, DOI 10.1161/CIRCRESAHA.108.182428; Gotsman I, 2007, J CLIN INVEST, V117, P2974, DOI 10.1172/JCI31344; Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Klingenberg R, 2013, J CLIN INVEST, V123, P1323, DOI 10.1172/JCI63891; Kuipers H, 2006, EUR J IMMUNOL, V36, P2472, DOI 10.1002/eji.200635978; Kyaw T, 2013, CIRCULATION, V127, P1028, DOI 10.1161/CIRCULATIONAHA.112.001347; Ma KF, 2012, DIABETES-METAB RES, V28, P388, DOI 10.1002/dmrr.2291; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Salama AD, 2003, J EXP MED, V198, P71, DOI 10.1084/jem.20022119; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Subramanian M, 2013, J CLIN INVEST, V123, P179, DOI 10.1172/JCI64617; Taleb S, 2010, CURR OPIN LIPIDOL, V21, P404, DOI 10.1097/MOL.0b013e32833dc7f9; Dinh TN, 2012, CIRCULATION, V126, P1256, DOI 10.1161/CIRCULATIONAHA.112.099044; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415	23	65	68	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93280	10.1371/journal.pone.0093280	http://dx.doi.org/10.1371/journal.pone.0093280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691202	Green Submitted, Green Published, gold			2022-12-27	WOS:000334101100061
J	Macneale, KH; Spromberg, JA; Baldwin, DH; Scholz, NL				Macneale, Kate H.; Spromberg, Julann A.; Baldwin, David H.; Scholz, Nathaniel L.			A Modeled Comparison of Direct and Food Web-Mediated Impacts of Common Pesticides on Pacific Salmon	PLOS ONE			English	Article							MACROINVERTEBRATE COMMUNITY RESPONSE; CHINOOK SALMON; BEHAVIORAL IMPAIRMENT; INSECTICIDE; CHLORPYRIFOS; POPULATION; TOXICITY; RIVER; DIAZINON; EXPOSURE	In the western United States, pesticides used in agricultural and urban areas are often detected in streams and rivers that support threatened and endangered Pacific salmon. Although concentrations are rarely high enough to cause direct salmon mortality, they can reach levels sufficient to impair juvenile feeding behavior and limit macroinvertebrate prey abundance. This raises the possibility of direct adverse effects on juvenile salmon health in tandem with indirect effects on salmon growth as a consequence of reduced prey abundance. We modeled the growth of ocean-type Chinook salmon (Oncorhynchus tshawytscha) at the individual and population scales, investigating insecticides that differ in how long they impair salmon feeding behavior and in how toxic they are to salmon compared to macroinvertebrates. The relative importance of these direct vs. indirect effects depends both on how quickly salmon can recover and on the relative toxicity of an insecticide to salmon and their prey. Model simulations indicate that when exposed to a long-acting organophosphate insecticide that is highly toxic to salmon and invertebrates (e. g., chlorpyrifos), the long-lasting effect on salmon feeding behavior drives the reduction in salmon population growth with reductions in prey abundance having little additional impact. When exposed to short-acting carbamate insecticides at concentrations that salmon recover from quickly but are lethal to invertebrates (e. g., carbaryl), the impacts on salmon populations are due primarily to reductions in their prey. For pesticides like carbaryl, prey sensitivity and how quickly the prey community can recover are particularly important in determining the magnitude of impact on their predators. In considering both indirect and direct effects, we develop a better understanding of potential impacts of a chemical stressor on an endangered species and identify data gaps (e.g., prey recovery rates) that contribute uncertainty to these assessments.	[Macneale, Kate H.; Spromberg, Julann A.; Baldwin, David H.; Scholz, Nathaniel L.] NOAA, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Macneale, KH (corresponding author), NOAA, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	Kate.Macneale@gmail.com	Scholz, Nathaniel L/L-1642-2013	Scholz, Nathaniel L/0000-0001-6207-0272	National Oceanic and Atmospheric Administration	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	The National Oceanic and Atmospheric Administration provided funding for the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BS, 2006, ENVIRON TOXICOL CHEM, V25, P1160, DOI 10.1897/05-231R.1; Ashauer R, 2007, ENVIRON SCI TECHNOL, V41, P5535, DOI 10.1021/es070283w; Beauvais SL, 2000, ENVIRON TOXICOL CHEM, V19, P1875, DOI [10.1002/etc.5620190722, 10.1897/1551-5028(2000)019&lt;1875:PMONOD&gt;2.3.CO;2]; BRAZNER JC, 1990, CAN J FISH AQUAT SCI, V47, P1157, DOI 10.1139/f90-135; BRETT JR, 1969, J FISH RES BOARD CAN, V26, P2363, DOI 10.1139/f69-230; Caswell, 2000, MATRIX POPULATION MO; Chambers JE, 2002, HUM ECOL RISK ASSESS, V8, P165, DOI 10.1080/20028091056809; Chen XD, 2010, ECOTOXICOLOGY, V19, P1124, DOI 10.1007/s10646-010-0495-y; Colville A, 2008, ECOTOXICOLOGY, V17, P173, DOI 10.1007/s10646-007-0181-x; CUFFNEY T F, 1984, Freshwater Invertebrate Biology, V3, P153, DOI 10.2307/1467120; DAVIES PE, 1993, AQUAT TOXICOL, V27, P201, DOI 10.1016/0166-445X(93)90055-6; Ferrari A, 2004, ECOTOX ENVIRON SAFE, V57, P420, DOI 10.1016/S0147-6513(02)00069-6; Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4; Gilliom RJ, 2007, ENVIRON SCI TECHNOL, V41, P3407; Greene CM, 2004, CAN J FISH AQUAT SCI, V61, P590, DOI 10.1139/F04-024; Groner ML, 2011, FRESHWATER BIOL, V56, P2391, DOI 10.1111/j.1365-2427.2011.02667.x; HEALEY MC, 1984, CAN J FISH AQUAT SCI, V41, P476, DOI 10.1139/f84-057; Heckmann LH, 2005, ENVIRON TOXICOL CHEM, V24, P582, DOI 10.1897/04-117R.1; Howell P., 1985, STOCK ASSESSMENT COL; Hutchens JJ, 1998, J N AM BENTHOL SOC, V17, P518, DOI 10.2307/1468369; Johnson HM, 2011, J AM WATER RESOUR AS, V47, P265, DOI 10.1111/j.1752-1688.2010.00507.x; Johnson LL, 2007, SCI TOTAL ENVIRON, V374, P342, DOI 10.1016/j.scitotenv.2006.11.051; Kohler HR, 2013, SCIENCE, V341, P759, DOI 10.1126/science.1237591; Kostow K, 1995, BIENNIAL REPORT STAT; KREUTZWEISER DP, 1990, CAN J FISH AQUAT SCI, V47, P1387, DOI 10.1139/f90-158; KREUTZWEISER DP, 1991, ARCH ENVIRON CON TOX, V20, P330, DOI 10.1007/BF01064398; Labenia JS, 2007, MAR ECOL PROG SER, V329, P1, DOI 10.3354/meps329001; Laetz CA, 2013, ENVIRON SCI TECHNOL, V47, P2925, DOI 10.1021/es305058y; Laetz CA, 2009, ENVIRON HEALTH PERSP, V117, P348, DOI 10.1289/ehp.0800096; Liess M, 1999, ENVIRON TOXICOL CHEM, V18, P1948, DOI [10.1897/1551-5028(1999)018&lt;1948:LICAPR&gt;2.3.CO;2, 10.1002/etc.5620180913]; LUGTHART GJ, 1990, FRESHWATER BIOL, V24, P417, DOI 10.1111/j.1365-2427.1990.tb00721.x; Lydy MJ, 2004, ARCH ENVIRON CON TOX, V48, P49, DOI 10.1007/s00244-004-0056-6; Mohr S, 2012, AQUAT TOXICOL, V110, P25, DOI 10.1016/j.aquatox.2011.11.016; Moore A, 1996, J FISH BIOL, V48, P758, DOI 10.1111/j.1095-8649.1996.tb01470.x; MORGAN MJ, 1990, ENVIRON TOXICOL CHEM, V9, P489, DOI [10.1897/1552-8618(1990)9[489:EOFOTF]2.0.CO;2, 10.1002/etc.5620090412]; Naiman RJ, 2012, P NATL ACAD SCI USA, V109, P21201, DOI 10.1073/pnas.1213408109; Nelson T.S., 2004, JUVENILE CHINOOK MIG; [NRC] National Research Council, 2013, ASS RISKS END THREAT, P142; Power M., 1998, J AQUAT ECOSYST STRE, V6, P253, DOI DOI 10.1023/A:1009991620319; PSCCTC, 2002, PAC SALM COMM JOINT; PUSEY BJ, 1994, ECOTOX ENVIRON SAFE, V27, P221, DOI 10.1006/eesa.1994.1019; Ratner S, 1997, CONSERV BIOL, V11, P879, DOI 10.1046/j.1523-1739.1997.95457.x; RAVEN PJ, 1989, ENVIRON POLLUT, V59, P55, DOI 10.1016/0269-7491(89)90021-3; Relyea RA, 2008, ECOL APPL, V18, P1728, DOI 10.1890/08-0454.1; Rohr JR, 2006, TRENDS ECOL EVOL, V21, P606, DOI 10.1016/j.tree.2006.07.002; Roni Philip, 1995, North American Journal of Fisheries Management, V15, P325, DOI 10.1577/1548-8675(1995)015<0325:GVISAA>2.3.CO;2; Sandahl JF, 2005, ENVIRON TOXICOL CHEM, V24, P136, DOI 10.1897/04-195R.1; Scholz NL, 2000, CAN J FISH AQUAT SCI, V57, P1911, DOI 10.1139/cjfas-57-9-1911; Schulz R, 2004, J ENVIRON QUAL, V33, P419, DOI 10.2134/jeq2004.0419; Schulz R, 2002, ENVIRON TOXICOL CHEM, V21, P2172, DOI [10.1002/etc.5620211021, 10.1897/1551-5028(2002)021&lt;2172:ACMAFA&gt;2.0.CO;2]; den Brink PJ, 2006, HUM ECOL RISK ASSESS, V12, P645, DOI 10.1080/10807030500430559; vandenBrink PJ, 1996, ENVIRON TOXICOL CHEM, V15, P1143, DOI [10.1897/1551-5028(1996)015&lt;1143:EOTIDA&gt;2.3.CO;2, 10.1002/etc.5620150719]; WALLACE JB, 1989, HYDROBIOLOGIA, V179, P135, DOI 10.1007/BF00007601; WARD S, 1995, ECOTOX ENVIRON SAFE, V30, P2, DOI 10.1006/eesa.1995.1002; Weatherley AH, 1995, PHYSL ECOLOGY PACIFI, P103; Werner I, 2000, ENVIRON TOXICOL CHEM, V19, P215, DOI [10.1897/1551-5028(2000)019&lt;0215:ICTTCD&gt;2.3.CO;2, 10.1002/etc.5620190126]; Weston DP, 2012, ENVIRON TOXICOL CHEM, V31, P1579, DOI 10.1002/etc.1847	57	17	17	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e92436	10.1371/journal.pone.0092436	http://dx.doi.org/10.1371/journal.pone.0092436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686837	Green Published, gold, Green Submitted			2022-12-27	WOS:000340842300001
J	Valles, SM; Bell, S; Firth, AE				Valles, Steven M.; Bell, Susanne; Firth, Andrew E.			Solenopsis invicta virus 3: Mapping of Structural Proteins, Ribosomal Frameshifting, and Similarities to Acyrthosiphon pisum virus and Kelp fly virus	PLOS ONE			English	Article							HEMORRHAGIC-DISEASE VIRUS; TRANSLATION TERMINATION-REINITIATION; FELINE CALICIVIRUS; CAPSID PROTEIN; NUCLEOTIDE-SEQUENCE; SOLENOPSIS-INVICTA; MURINE NOROVIRUS; RNA VIRUSES; IN-VITRO; FIRE ANT	Solenopsis invicta virus 3 (SINV-3) is a positive-sense single-stranded RNA virus that infects the red imported fire ant, Solenopsis invicta. We show that the second open reading frame (ORF) of the dicistronic genome is expressed via a frameshifting mechanism and that the sequences encoding the structural proteins map to both ORF2 and the 3' end of ORF1, downstream of the sequence that encodes the RNA-dependent RNA polymerase. The genome organization and structural protein expression strategy resemble those of Acyrthosiphon pisum virus (APV), an aphid virus. The capsid protein that is encoded by the 3' end of ORF1 in SINV-3 and APV is predicted to have a jelly-roll fold similar to the capsid proteins of picornaviruses and caliciviruses. The capsid-extension protein that is produced by frameshifting, includes the jelly-roll fold domain encoded by ORF1 as its N-terminus, while the C-terminus encoded by the 5' half of ORF2 has no clear homology with other viral structural proteins. A third protein, encoded by the 3' half of ORF2, is associated with purified virions at substoichiometric ratios. Although the structural proteins can be translated from the genomic RNA, we show that SINV-3 also produces a subgenomic RNA encoding the structural proteins. Circumstantial evidence suggests that APV may also produce such a subgenomic RNA. Both SINV-3 and APV are unclassified picorna-like viruses distantly related to members of the order Picornavirales and the family Caliciviridae. Within this grouping, features of the genome organization and capsid domain structure of SINV-3 and APV appear more similar to caliciviruses, perhaps suggesting the basis for a "Calicivirales" order.	[Valles, Steven M.] ARS, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL USA; [Bell, Susanne; Firth, Andrew E.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	United States Department of Agriculture (USDA); University of Cambridge	Firth, AE (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	aef24@cam.ac.uk		Firth, Andrew/0000-0002-7986-9520	Wellcome Trust [088789]; U.K. Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J007072/1, BB/J015652/1]; BBSRC [BB/J007072/1, BB/J015652/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J015652/1, BB/J007072/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); U.K. Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work in the AEF lab was funded by grants from the Wellcome Trust (www.wellcome.ac.uk) (088789) and the U.K. Biotechnology and Biological Sciences Research Council (BBSRC; www.bbsrc.ac.uk) (BB/J007072/1 and BB/J015652/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abente EJ, 2013, J VIROL, V87, P3003, DOI 10.1128/JVI.02480-12; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], [No title captured]; BRAULT V, 1995, EMBO J, V14, P650, DOI 10.1002/j.1460-2075.1995.tb07043.x; Brown CM, 1996, J VIROL, V70, P5884, DOI 10.1128/JVI.70.9.5884-5892.1996; Chen R, 2006, P NATL ACAD SCI USA, V103, P8048, DOI 10.1073/pnas.0600421103; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Firth AE, 2011, NUCLEIC ACIDS RES, V39, P6679, DOI 10.1093/nar/gkr224; Glass PJ, 2000, J VIROL, V74, P6581, DOI 10.1128/JVI.74.14.6581-6591.2000; Goodfellow I, 2011, CURR OPIN VIROL, V1, P355, DOI 10.1016/j.coviro.2011.09.003; Graff J, 2005, J VIROL, V79, P1017, DOI 10.1128/JVI.79.2.1017-1026.2005; GUILLEY H, 1994, VIROLOGY, V202, P1012, DOI 10.1006/viro.1994.1429; Hartley CJ, 2005, J VIROL, V79, P13385, DOI 10.1128/JVI.79.21.13385-13398.2005; Herbert TP, 1996, J GEN VIROL, V77, P123, DOI 10.1099/0022-1317-77-1-123; Katpally U, 2010, J VIROL, V84, P5836, DOI 10.1128/JVI.00314-10; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koonin EV, 2008, NAT REV MICROBIOL, V6, P925, DOI 10.1038/nrmicro2030; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Gall O, 2008, ARCH VIROL, V153, P715, DOI 10.1007/s00705-008-0041-x; Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205; LIU BL, 1995, ARCH VIROL, V140, P1345, DOI 10.1007/BF01322662; LOH EY, 1989, SCIENCE, V243, P217, DOI 10.1126/science.2463672; Loughran G, 2011, P NATL ACAD SCI USA, V108, pE1111, DOI 10.1073/pnas.1102932108; Luttermann C, 2007, J BIOL CHEM, V282, P7056, DOI 10.1074/jbc.M608948200; McCormick CJ, 2008, J VIROL, V82, P8917, DOI 10.1128/JVI.02362-07; McFadden N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002413; MEYERS G, 1991, VIROLOGY, V184, P677, DOI 10.1016/0042-6822(91)90437-G; Morales M, 2004, J BIOL CHEM, V279, P17013, DOI 10.1074/jbc.M313674200; Napthine S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008390; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; PRASAD BVV, 1994, J VIROL, V68, P5117, DOI 10.1128/JVI.68.8.5117-5125.1994; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ryabov EV, 2009, P NATL ACAD SCI USA, V106, P8465, DOI 10.1073/pnas.0901389106; Sanfacon H, 2009, ARCH VIROL, V154, P899, DOI 10.1007/s00705-009-0367-z; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; SCOTTI PD, 1976, J GEN VIROL, V30, P1, DOI 10.1099/0022-1317-30-1-1; Simmonds P, 2008, NUCLEIC ACIDS RES, V36, P2530, DOI 10.1093/nar/gkn096; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Song YT, 2012, P NATL ACAD SCI USA, V109, P14301, DOI 10.1073/pnas.1211484109; Sosnovtsev SV, 2000, VIROLOGY, V277, P193, DOI 10.1006/viro.2000.0579; Sosnovtsev SV, 2005, J VIROL, V79, P4012, DOI 10.1128/JVI.79.7.4012-4024.2005; Sosnovtsev SV, 1998, J VIROL, V72, P3051, DOI 10.1128/JVI.72.4.3051-3059.1998; Subba-Reddy CV, 2012, J VIROL, V86, P10138, DOI 10.1128/JVI.01208-12; Valles SM, 2013, J INVERTEBR PATHOL, V113, P198, DOI 10.1016/j.jip.2013.04.003; Valles SM, 2009, VIROLOGY, V388, P354, DOI 10.1016/j.virol.2009.03.028; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; vandenHeuvel JFJM, 1997, J INVERTEBR PATHOL, V70, P169, DOI 10.1006/jipa.1997.4691; vanderWilk F, 1997, VIROLOGY, V238, P353, DOI 10.1006/viro.1997.8835; Vongpunsawad S, 2013, J VIROL, V87, P4818, DOI 10.1128/JVI.03508-12	52	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93497	10.1371/journal.pone.0093497	http://dx.doi.org/10.1371/journal.pone.0093497			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686475	gold, Green Published, Green Submitted			2022-12-27	WOS:000340842300015
J	Abate-Daga, D; Speiser, DE; Chinnasamy, N; Zheng, ZL; Xu, H; Feldman, SA; Rosenberg, SA; Morgan, RA				Abate-Daga, Daniel; Speiser, Daniel E.; Chinnasamy, Nachimuthu; Zheng, Zhili; Xu, Hui; Feldman, Steven A.; Rosenberg, Steven A.; Morgan, Richard A.			Development of a T Cell Receptor Targeting an HLA-A*0201 Restricted Epitope from the Cancer-Testis Antigen SSX2 for Adoptive Immunotherapy of Cancer	PLOS ONE			English	Article							MULTIPLE-MYELOMA; CANCER/TESTIS ANTIGENS; HUMAN-LYMPHOCYTES; GENE-THERAPY; TCR; EXPRESSION; REGRESSION; RESPONSES; TOXICITY; IDENTIFICATION	The clinical success of adoptive immunotherapy of cancer relies on the selection of target antigens that are highly expressed in tumor cells but absent in essential normal tissues. A group of genes that encode the cancer/testis or cancer germline antigens have been proposed as ideal targets for immunotherapy due to their high expression in multiple cancer types and their restricted expression in immunoprivileged normal tissues. In the present work we report the isolation and characterization of human T cell receptors (TCRs) with specificity for synovial sarcoma X breakpoint 2 (SSX2), a cancer/testis antigen expressed in melanoma, prostate cancer, lymphoma, multiple myeloma and pancreatic cancer, among other tumors. We isolated seven HLA-A2 restricted T cell receptors from natural T cell clones derived from tumor-infiltrated lymph nodes of two SSX2-seropositive melanoma patients, and selected four TCRs for cloning into retroviral vectors. Peripheral blood lymphocytes (PBL) transduced with three of four SSX2 TCRs showed SSX2(41-49) (KASEKIFYV) peptide specific reactivity, tumor cell recognition and tetramer binding. One of these, TCR-5, exhibited tetramer binding in both CD4 and CD8 cells and was selected for further studies. Antigen-specific and HLA-A*0201-restricted interferon-gamma release, cell lysis and lymphocyte proliferation was observed following culture of TCR engineered human PBL with relevant tumor cell lines. Codon optimization was found to increase TCR-5 expression in transduced T cells, and this construct has been selected for development of clinical grade viral vector producing cells. The tumor-specific pattern of expression of SSX2, along with the potent and selective activity of TCR-5, makes this TCR an attractive candidate for potential TCR gene therapy to treat multiple cancer histologies.	[Abate-Daga, Daniel; Chinnasamy, Nachimuthu; Zheng, Zhili; Xu, Hui; Feldman, Steven A.; Rosenberg, Steven A.; Morgan, Richard A.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA; [Speiser, Daniel E.] Univ Lausanne, Dept Oncol, Ludwig Ctr, Lausanne, Switzerland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Lausanne	Abate-Daga, D (corresponding author), NCI, Surg Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	daniel.abate-daga@nih.gov	Speiser, Daniel E./F-2173-2013	Abate-Daga, Daniel/0000-0002-2571-0215	Milstein Family Foundation; Intramural Research Program of The Center for Cancer Research, National Cancer Institute, Bethesda MD; NATIONAL CANCER INSTITUTE [ZIABC010985] Funding Source: NIH RePORTER	Milstein Family Foundation; Intramural Research Program of The Center for Cancer Research, National Cancer Institute, Bethesda MD; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported in part by a contribution from the Milstein Family Foundation and by the Intramural Research Program of The Center for Cancer Research, National Cancer Institute, Bethesda MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanackovic D, 2007, BLOOD, V109, P1103, DOI 10.1182/blood-2006-04-014480; Atanackovic D, 2009, CLIN CANCER RES, V15, P1343, DOI 10.1158/1078-0432.CCR-08-0989; Ayyoub M, 2002, J IMMUNOL, V168, P1717, DOI 10.4049/jimmunol.168.4.1717; Ayyoub M, 2003, CANCER RES, V63, P5601; Bricard G, 2005, J IMMUNOL, V174, P1709, DOI 10.4049/jimmunol.174.3.1709; Chinnasamy N, 2011, J IMMUNOL, V186, P685, DOI 10.4049/jimmunol.1001775; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; CREW AJ, 1995, EMBO J, V14, P2333, DOI 10.1002/j.1460-2075.1995.tb07228.x; Davis JL, 2010, CLIN CANCER RES, V16, P5852, DOI 10.1158/1078-0432.CCR-10-1280; dos Santos NR, 2000, CANCER RES, V60, P1654; Dubovsky JA, 2007, PROSTATE, V67, P1781, DOI 10.1002/pros.20665; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Garcia CB, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-189; Guo ZS, 2006, CANCER RES, V66, P1105, DOI 10.1158/0008-5472.CAN-05-3020; Gure AO, 2002, INT J CANCER, V101, P448, DOI 10.1002/ijc.10634; Hoffman-Censits J, 2013, SEMIN ONCOL, V40, P361, DOI 10.1053/j.seminoncol.2013.04.015; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Hughes MS, 2005, HUM GENE THER, V16, P457, DOI 10.1089/hum.2005.16.457; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kharfan-Dabaja MA, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-2; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Ochi T, 2011, BLOOD, V118, P1495, DOI 10.1182/blood-2011-02-337089; Onodera M, 1997, HUM GENE THER, V8, P1189, DOI 10.1089/hum.1997.8.10-1189; Parkhurst MR, 2011, MOL THER, V19, P620, DOI 10.1038/mt.2010.272; Parkhurst MR, 2009, CLIN CANCER RES, V15, P169, DOI 10.1158/1078-0432.CCR-08-1638; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Przybyl Joanna, 2012, Sarcoma, V2012, P249219, DOI 10.1155/2012/249219; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Robbins PF, 2008, J IMMUNOL, V180, P6116, DOI 10.4049/jimmunol.180.9.6116; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosenberg SA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003634; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Shiraishi T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-153; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Smith HA, 2011, CANCER RES, V71, P6785, DOI 10.1158/0008-5472.CAN-11-2127; Suri A, 2006, EXPERT OPIN BIOL TH, V6, P379, DOI 10.1517/14712598.6.4.379; Taylor BJ, 2005, J IMMUNOTHER, V28, P564, DOI 10.1097/01.cji.0000175685.36239.e5; Tureci O, 1996, CANCER RES, V56, P4766; Wargo JA, 2009, CANCER IMMUNOL IMMUN, V58, P383, DOI 10.1007/s00262-008-0562-x; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Zhao YB, 2005, J IMMUNOL, V174, P4415, DOI 10.4049/jimmunol.174.7.4415	49	18	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93321	10.1371/journal.pone.0093321	http://dx.doi.org/10.1371/journal.pone.0093321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681846	Green Published, Green Submitted, gold			2022-12-27	WOS:000333678100042
J	Tjokro, NO; Rocco, CJ; Priyadarshini, R; Davey, ME; Goodman, SD				Tjokro, Natalia O.; Rocco, Christopher J.; Priyadarshini, Richa; Davey, Mary E.; Goodman, Steven D.			A Biochemical Analysis of the Interaction of Porphyromonas gingivalis HU PG0121 Protein with DNA	PLOS ONE			English	Article							6 CAPSULAR SEROTYPES; ESCHERICHIA-COLI HU; BINDING PROTEIN; CRUCIFORM DNA; HIGH-AFFINITY; BACILLUS-SUBTILIS; STRANDED-DNA; TRANSCRIPTION; GENE; BACTERIA	K-antigen capsule, a key virulence determinant of the oral pathogen Porphyromonas gingivalis, is synthesized by proteins encoded in a series of genes transcribed as a large polycistronic message. Previously, we identified a 77-base pair inverted repeat region with the potential to form a large stem-loop structure at the 5' end of this locus. PG0121, one of two genes flanking the capsule operon, was found to be co-transcribed with the operon and to share high similarity to the DNA binding protein HU from Escherichia coli. A null mutation in PG0121 results in down-regulation of transcription of the capsule synthesis genes and production of capsule. Furthermore, we have also shown that PG0121 gene can complement multiple deficiencies in a strain of E. coli that is deficient for both the alpha and beta subunits of HU. Here, we examined the biochemical properties of the interaction of PG0121 to DNA with the emphasis on the kinds of nucleic acid architectures that may be encountered at the 77-bp inverted repeat. We have concluded that although some DNA binding characteristics are shared with E. coli HU, HU PG0121 also shows some distinct characteristics that set it apart from other HU-like proteins tested to date. We discuss our results in the context of how PG0121 may affect the regulation of the K-antigen capsule expression.	[Tjokro, Natalia O.] Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA USA; [Priyadarshini, Richa; Davey, Mary E.] Forsyth Inst, Dept Mol Genet, Boston, MA USA; [Rocco, Christopher J.; Goodman, Steven D.] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Res Inst, Columbus, OH USA	University of Southern California; Harvard University; Forsyth Institute; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Davey, ME (corresponding author), Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA.	mdavey@dental.ufl.edu; steven.goodman@nationwidechildrens.org	Davey, Mary Ellen/H-6259-2019; Goodman, Steven/C-5732-2013	Davey, Mary Ellen/0000-0001-8129-0537	National Institutes of Health [5R01DE019117-06]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019117] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grant 5R01DE019117-06 (NIH; www.nih.gov) to MED and SDG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti-Segui C, 2010, J BACTERIOL, V192, P6217, DOI 10.1128/JB.00106-10; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Balandina A, 2002, J BIOL CHEM, V277, P27622, DOI 10.1074/jbc.M201978200; Balandina A, 2001, MOL MICROBIOL, V39, P1069, DOI 10.1046/j.1365-2958.2001.02305.x; Bensaid A, 1996, J MOL BIOL, V256, P292, DOI 10.1006/jmbi.1996.0086; BONNEFOY E, 1994, J MOL BIOL, V242, P116, DOI 10.1006/jmbi.1994.1563; BOUBRIK F, 1995, P NATL ACAD SCI USA, V92, P3958, DOI 10.1073/pnas.92.9.3958; Brunner J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-5; CASTAING B, 1995, J BIOL CHEM, V270, P10291, DOI 10.1074/jbc.270.17.10291; Chatzidaki-Livanis M, 2009, J BACTERIOL, V191, P7288, DOI 10.1128/JB.00500-09; Chen C, 2004, BIOCHEM J, V383, P343, DOI 10.1042/BJ20040938; Claret L, 1997, J MOL BIOL, V273, P93, DOI 10.1006/jmbi.1997.1310; Dierickx K, 2003, J PERIODONTOL, V74, P844, DOI 10.1902/jop.2003.74.6.844; DRI AM, 1991, J BACTERIOL, V173, P2852, DOI 10.1128/JB.173.9.2852-2863.1991; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; DURRENBERGER M, 1988, J BACTERIOL, V170, P4757; FILUTOWICZ M, 1983, MOL GEN GENET, V191, P282, DOI 10.1007/BF00334827; GELLERT M, 1983, P NATL ACAD SCI-BIOL, V80, P5545, DOI 10.1073/pnas.80.18.5545; Ghosh S, 2004, J MOL BIOL, V337, P561, DOI 10.1016/j.jmb.2004.02.010; Giangrossi M, 2002, MOL MICROBIOL, V44, P205, DOI 10.1046/j.1365-2958.2002.02868.x; Gonzalez D, 2003, INFECT IMMUN, V71, P2283, DOI 10.1128/IAI.71.4.2283-2287.2003; Grove A, 1996, J MOL BIOL, V260, P196, DOI 10.1006/jmbi.1996.0392; Grove A, 2001, J MOL BIOL, V311, P491, DOI 10.1006/jmbi.2001.4763; Grove A, 2011, CURR ISSUES MOL BIOL, V13, P1; Hashimoto M, 2003, J BIOL CHEM, V278, P28501, DOI 10.1074/jbc.M303970200; HODGESGARCIA Y, 1989, J BIOL CHEM, V264, P14621; HORWITZ MSZ, 1988, SCIENCE, V241, P703, DOI 10.1126/science.2456617; Jia X, 1996, J MOL BIOL, V263, P259, DOI 10.1006/jmbi.1996.0573; Kamashev D, 1999, EMBO J, V18, P5434, DOI 10.1093/emboj/18.19.5434; Kamashev D, 2000, EMBO J, V19, P6527, DOI 10.1093/emboj/19.23.6527; Kamashev D, 2008, NUCLEIC ACIDS RES, V36, P1026, DOI 10.1093/nar/gkm667; KELLENBERGER E, 1992, FEMS MICROBIOL LETT, V100, P361, DOI 10.1016/0378-1097(92)90233-E; KOHNO K, 1990, J MOL BIOL, V213, P27, DOI 10.1016/S0022-2836(05)80119-6; KOHNO K, 1994, J BIOCHEM-TOKYO, V115, P1113, DOI 10.1093/oxfordjournals.jbchem.a124466; Kreth J, 2007, MICROBIOL-SGM, V153, P1799, DOI 10.1099/mic.0.2007/005975-0; Laine ML, 1997, J DENT RES, V76, P1840, DOI 10.1177/00220345970760120601; Laine ML, 1998, ORAL MICROBIOL IMMUN, V13, P322, DOI 10.1111/j.1399-302X.1998.tb00714.x; LAVOIE BD, 1994, J BIOL CHEM, V269, P15571; Lewis DEA, 1999, MOL MICROBIOL, V31, P451, DOI 10.1046/j.1365-2958.1999.01186.x; Li SS, 1998, J BACTERIOL, V180, P3750, DOI 10.1128/JB.180.15.3750-3756.1998; LILLEY DMJ, 1993, ANNU REV BIOPH BIOM, V22, P299, DOI 10.1146/annurev.bb.22.060193.001503; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Miyabe I, 2000, INT J RADIAT BIOL, V76, P43; OGASAWARA N, 1981, MOL GEN GENET, V181, P332, DOI 10.1007/BF00425607; ORR E, 1979, MOL GEN GENET, V177, P103, DOI 10.1007/BF00267259; PANAYOTATOS N, 1987, J BIOL CHEM, V262, P11364; PANYUTIN IG, 1994, P NATL ACAD SCI USA, V91, P2021, DOI 10.1073/pnas.91.6.2021; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pinson V, 1999, J MOL BIOL, V287, P485, DOI 10.1006/jmbi.1999.2631; PONTIGGIA A, 1993, MOL MICROBIOL, V7, P343, DOI 10.1111/j.1365-2958.1993.tb01126.x; Priyadarshini R, 2013, MICROBIOL-SGM, V159, P219, DOI 10.1099/mic.0.061002-0; PRUSS GJ, 1989, CELL, V56, P521, DOI 10.1016/0092-8674(89)90574-6; Rouviere-Yaniv J, 1990, AM SOC MICROBIOL; ROUVIEREYANIV J, 1979, FEBS LETT, V106, P297, DOI 10.1016/0014-5793(79)80518-9; ROUVIEREYANIV J, 1979, CELL, V17, P265, DOI 10.1016/0092-8674(79)90152-1; Sharadamma N, 2010, NUCLEIC ACIDS RES, V38, P3555, DOI 10.1093/nar/gkq064; SINDEN RR, 1983, P NATL ACAD SCI-BIOL, V80, P1797, DOI 10.1073/pnas.80.7.1797; SINGLETON CK, 1982, J BIOL CHEM, V257, P6292; TANAKA I, 1984, NATURE, V310, P376, DOI 10.1038/310376a0; VANWINKELHOFF AJ, 1993, ORAL MICROBIOL IMMUN, V8, P259; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0	62	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93266	10.1371/journal.pone.0093266	http://dx.doi.org/10.1371/journal.pone.0093266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681691	gold, Green Published, Green Submitted			2022-12-27	WOS:000333678100037
J	Keck, BP; Marion, ZH; Martin, DJ; Kaufman, JC; Harden, CP; Schwartz, JS; Strange, RJ				Keck, Benjamin P.; Marion, Zachary H.; Martin, Derek J.; Kaufman, Jason C.; Harden, Carol P.; Schwartz, John S.; Strange, Richard J.			Fish Functional Traits Correlated with Environmental Variables in a Temperate Biodiversity Hotspot	PLOS ONE			English	Article							FRESH-WATER FISHES; LIFE-HISTORY TRAITS; STREAM FISH; LAND-USE; TELEOSTEI PERCIDAE; BIOTIC INTEGRITY; SPECIES TRAITS; DIVERSITY; ASSEMBLAGES; DIVERSIFICATION	The global biodiversity crisis has invigorated the search for generalized patterns in most disciplines within the natural sciences. Studies based on organismal functional traits attempt to broaden implications of results by identifying the response of functional traits, instead of taxonomic units, to environmental variables. Determining the functional trait responses enables more direct comparisons with, or predictions for, communities of different taxonomic composition. The North American freshwater fish fauna is both diverse and increasingly imperiled through human mediated disturbances, including climate change. The Tennessee River, USA, contains one of the most diverse assemblages of freshwater fish in North America and has more imperiled species than other rivers, but there has been no trait-based study of community structure in the system. We identified 211 localities in the upper Tennessee River that were sampled by the Tennessee Valley Authority between 2009 and 2011 and compiled fish functional traits for the observed species and environmental variables for each locality. Using fourth corner analysis, we identified significant correlations between many fish functional traits and environmental variables. Functional traits associated with an opportunistic life history strategy were correlated with localities subject to greater land use disturbance and less flow regulation, while functional traits associated with a periodic life history strategy were correlated with localities subject to regular disturbance and regulated flow. These are patterns observed at the continental scale, highlighting the generalizability of trait-based methods. Contrary to studies that found no community structure differences when considering riparian buffer zones, we found that fish functional traits were correlated with different environmental variables between analyses with buffer zones vs. entire catchment area land cover proportions. Using existing databases and fourth corner analysis, our results support the broad application potential for trait-based methods and indicate trait-based methods can detect environmental filtering by riparian zone land cover.	[Keck, Benjamin P.; Strange, Richard J.] Univ Tennessee, Dept Forestry Wildlife & Fisheries, Knoxville, TN 37996 USA; [Marion, Zachary H.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA; [Martin, Derek J.; Kaufman, Jason C.; Harden, Carol P.] Univ Tennessee, Dept Geog, Knoxville, TN 37996 USA; [Schwartz, John S.] Univ Tennessee, Dept Civil & Environm Engn, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Keck, BP (corresponding author), Univ Tennessee, Dept Forestry Wildlife & Fisheries, Knoxville, TN 37996 USA.	bkeck@utk.edu	Marion, Zachary/I-9102-2016	Marion, Zachary/0000-0002-7351-1819; Kaufman, Jason/0000-0001-5482-6914	University of Tennessee Institute for a Secure and Sustainable Environment; University of Tennessee AgResearch	University of Tennessee Institute for a Secure and Sustainable Environment; University of Tennessee AgResearch	The University of Tennessee Institute for a Secure and Sustainable Environment (http://isse.utk.edu/) and University of Tennessee AgResearch (http://agresearch.tennessee.edu/) provided funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 1997, FRESHWATER BIOL, V37, P149, DOI 10.1046/j.1365-2427.1997.d01-546.x; Anderson J. M., 1976, GEOLOGICAL SURVEY PR; Angermeier PL, 1999, ECOL APPL, V9, P335, DOI 10.2307/2641189; Aubin I, 2013, BIODIVERS CONSERV, V22, P2957, DOI 10.1007/s10531-013-0565-6; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Berendzen PB, 2008, MOL PHYLOGENET EVOL, V46, P721, DOI 10.1016/j.ympev.2007.07.008; Blanton RE, 2013, MOL PHYLOGENET EVOL, V66, P679, DOI 10.1016/j.ympev.2012.10.022; Blanton RE, 2008, ZOOTAXA, P1; Brind'Amour A, 2011, ECOL APPL, V21, P363, DOI 10.1890/09-2178.1; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Clements MD, 2012, MOL PHYLOGENET EVOL, V63, P159, DOI 10.1016/j.ympev.2012.01.001; Deyton EB, 2009, WATER AIR SOIL POLL, V196, P3, DOI 10.1007/s11270-008-9753-5; Doledec S, 1996, ENVIRON ECOL STAT, V3, P143, DOI 10.1007/BF02427859; Douglas M, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0672; Dray S, 2008, ECOLOGY, V89, P3400, DOI 10.1890/08-0349.1; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dudgeon D, 2010, CURR OPIN ENV SUST, V2, P422, DOI 10.1016/j.cosust.2010.09.001; ETNIER D A, 1991, Journal of the Tennessee Academy of Science, V66, P129; Etnier D. A., 1993, FISHES TENNESSEE; Etnier David A., 1997, P87; Fischer JR, 2010, T AM FISH SOC, V139, P185, DOI 10.1577/T09-050.1; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Frimpong EA, 2009, FISHERIES, V34, P487, DOI 10.1577/1548-8446-34.10.487; Frimpong EA, 2010, AM FISH S S, V73, P109; George AL, 2009, FISHERIES, V34, P529, DOI 10.1577/1548-8446-34.11.529; Gillson L, 2013, TRENDS ECOL EVOL, V28, P135, DOI 10.1016/j.tree.2012.10.008; Goldsworthy CA, 2006, AM MIDL NAT, V156, P331, DOI 10.1674/0003-0031(2006)156[331:GBCRAS]2.0.CO;2; Helms BS, 2011, J N AM BENTHOL SOC, V30, P1095, DOI 10.1899/10-093.1; Hocutt C. H., 1986, ZOOGEOGRAPHY N AM FR; Hollingsworth PR, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-272; Hollingsworth PR, 2009, EVOLUTION, V63, P228, DOI 10.1111/j.1558-5646.2008.00531.x; HOLM S, 1979, SCAND J STAT, V6, P65; Institute ESR, 2011, ARCGIS DESKT REL 10; Jaramillo-Villa U, 2010, J FISH BIOL, V76, P2401, DOI 10.1111/j.1095-8649.2010.02629.x; Jelks HL, 2008, FISHERIES, V33, P372, DOI 10.1577/1548-8446-33.8.372; Keck BP, 2013, B PEABODY MUS NAT HI, V54, P3, DOI 10.3374/014.054.0101; Keck BP, 2010, MOL ECOL, V19, P5030, DOI 10.1111/j.1365-294X.2010.04866.x; Krober W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035742; Lamouroux N, 2002, ECOLOGY, V83, P1792, DOI 10.2307/3071765; Larson ER, 2012, GLOBAL ECOL BIOGEOGR, V21, P1114, DOI 10.1111/j.1466-8238.2012.00758.x; Layman Steven R., 2012, Bulletin Alabama Museum of Natural History, V30, P1; Legendre P, 1997, ECOLOGY, V78, P547; Leidy Robert A., 1998, P187; Leveque C, 2008, HYDROBIOLOGIA, V595, P545, DOI 10.1007/s10750-007-9034-0; Logez M, 2013, ECOGRAPHY, V36, P80, DOI 10.1111/j.1600-0587.2012.07447.x; Lujan NK, 2013, J BIOGEOGR, V40, P1715, DOI 10.1111/jbi.12131; Luther ET, 1977, OUR RESTLES EARTH GE; Marzin A, 2013, HYDROBIOLOGIA, V704, P375, DOI 10.1007/s10750-012-1254-2; Matono P, 2013, ENVIRON MANAGE, V52, P1213, DOI 10.1007/s00267-013-0152-3; McDonald RI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050219; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mims MC, 2010, ECOL FRESHW FISH, V19, P390, DOI 10.1111/j.1600-0633.2010.00422.x; Mims MC, 2013, FRESHWATER BIOL, V58, P50, DOI 10.1111/fwb.12037; Moodley D, 2013, PLOS ONE, V8; Naiman RJ, 2011, ECOL RES, V26, P865, DOI 10.1007/s11284-010-0693-3; Near TJ, 2011, SYST BIOL, V60, P565, DOI 10.1093/sysbio/syr052; Olden JD, 2010, DIVERS DISTRIB, V16, P496, DOI 10.1111/j.1472-4642.2010.00655.x; Oliveira JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045787; Pease AA, 2012, FRESHWATER BIOL, V57, P1060, DOI 10.1111/j.1365-2427.2012.02768.x; Piller KR, 2008, MOL PHYLOGENET EVOL, V46, P974, DOI 10.1016/j.ympev.2007.11.023; Poff NL, 2006, J N AM BENTHOL SOC, V25, P730, DOI 10.1899/0887-3593(2006)025[0730:FTNONA]2.0.CO;2; Rakes PL, 1999, ENVIRON BIOL FISH, V55, P31, DOI 10.1023/A:1007531927209; Rashleigh B, 2004, SOUTHEAST NAT, V3, P621, DOI 10.1656/1528-7092(2004)003[0621:FAGITU]2.0.CO;2; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; ROBINS CR, 1961, COPEIA, P305; Roth NE, 1996, LANDSCAPE ECOL, V11, P141, DOI 10.1007/BF02447513; Roy AH, 2007, LANDSCAPE ECOL, V22, P385, DOI 10.1007/s10980-006-9034-x; Schloss CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028788; Schuldt A, 2012, ECOL LETT, V15, P732, DOI 10.1111/j.1461-0248.2012.01792.x; Schwartz JS, 2008, AQUAT CONSERV, V18, P852, DOI 10.1002/aqc.905; Schwartz JS, 2011, ENVIRON MONIT ASSESS, V179, P347, DOI 10.1007/s10661-010-1741-8; Shute JR, 2005, SOUTHEAST NAT, V4, P93, DOI 10.1656/1528-7092(2005)004[0093:ROFIFI]2.0.CO;2; Sternberg D, 2013, FRESHWATER BIOL, V58, P1767, DOI 10.1111/fwb.12166; Team R. D. C., 2008, R LANG ENV STAT COMP; Tedesco PA, 2008, OECOLOGIA, V156, P691, DOI 10.1007/s00442-008-1021-2; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thornbury, 1965, REGIONAL GEOMORPHOLO; Wang LZ, 1997, FISHERIES, V22, P6, DOI 10.1577/1548-8446(1997)022&lt;0006:IOWLUO&gt;2.0.CO;2; Wiescher PT, 2012, OECOLOGIA, V169, P1063, DOI 10.1007/s00442-012-2262-7; WINEMILLER KO, 1992, CAN J FISH AQUAT SCI, V49, P2196, DOI 10.1139/f92-242	81	29	29	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93237	10.1371/journal.pone.0093237	http://dx.doi.org/10.1371/journal.pone.0093237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676053	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500097
J	Lunina, AA; Vereshchaka, AL				Lunina, Anastasia A.; Vereshchaka, Alexandr L.			Distribution of Hydrothermal Alvinocaridid Shrimps: Effect of Geomorphology and Specialization to Extreme Biotopes	PLOS ONE			English	Article							CENTRAL INDIAN RIDGE; CARIDEA ALVINOCARIDIDAE; DECAPOD CRUSTACEANS; VENT SHRIMPS; COLD SEEPS; GENUS; BRESILIIDAE; BIOGEOGRAPHY; FIELD; PACIFIC	The aim of this study is to review of our knowledge about distribution of recently known species of vent shrimps and to analyze factors influencing distribution patterns. Analyses are based upon (1) original material taken during eight cruises in the Atlantic Ocean (a total of 5861 individuals) and (2) available literature data from the Atlantic, Pacific, and Indian Oceans. Vent shrimps have two patterns of the species ranges: local (single vent site) and regional (three - six vent sites). Pacific species ranges are mainly of the local type and the Atlantic species ranges are of the regional type. The regional type of species ranges may be associated with channels providing easy larval dispersal (rift valleys, trenches), while the local type is characteristic for other areas. Specialization of a shrimp genus to extreme vent habitats leads to two effects: (1) an increase in the number of vent fields inhabited by the genus and (2) a decrease of species number within the genus.	[Lunina, Anastasia A.; Vereshchaka, Alexandr L.] Russian Acad Sci, PP Shirshov Inst Oceanol, Lab Struct & Dynam Plankton Communities, Moscow, Russia	Russian Academy of Sciences; Shirshov Institute of Oceanology	Lunina, AA (corresponding author), Russian Acad Sci, PP Shirshov Inst Oceanol, Lab Struct & Dynam Plankton Communities, Moscow, Russia.	yalunina@list.ru	Lunina, Anastasia/L-3699-2014; Vereshchaka, Alexander L/E-6205-2014	Lunina, Anastasia/0000-0002-1105-8027; Vereshchaka, Alexander L/0000-0002-6756-2468	Ministry of Education and Science of the Russian Federation; Russian Foundation for Basic Research; Program for a Basic Research of the Presidium of the Russian Academy of Sciences	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program for a Basic Research of the Presidium of the Russian Academy of Sciences(Russian Academy of Sciences)	The studies were supported by the Ministry of Education and Science of the Russian Federation, by the Russian Foundation for Basic Research, and by the Program for a Basic Research of the Presidium of the Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahyong ST, 2009, CRUSTACEANA, V82, P775, DOI 10.1163/156854009X427333; Bachraty C, 2009, DEEP-SEA RES PT I, V56, P1371, DOI 10.1016/j.dsr.2009.01.009; Beltenev V., 2009, INTERRIDGE NEWS, V18, P13; Bogdanov Y, 2002, GEOLOGICAL DEEP SEA; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; Desbruyeres D, 1982, HDB DEEP SEA HYDROTH, P191; Desbruyeres D, 1986, HDB DEEP SEA HYDROTH, P191; Fabri MC, 2011, J MAR BIOL ASSOC UK, V91, P1, DOI 10.1017/S0025315410000731; Foote M, 2012, BIOL LETTERS, V8, P135, DOI 10.1098/rsbl.2011.0521; Fujikura Katsunori, 1996, JAMSTEC Journal of Deep Sea Research, V12, P133; Fujikura Katsunori, 1995, JAMSTEC Journal of Deep Sea Research, V11, P227; Gebruk A.V., 2006, EKOSISTEMY ATLANTICH, P119; Gebruk A.V, 2002, BIOL HYDROTHERMAL SY, P185; Gebruk AV, 1997, ADV MAR BIOL, V32, P93; Gebruk AV, 2000, J MAR BIOL ASSOC UK, V80, P485, DOI 10.1017/S0025315400002186; Gurvich E, 1998, METALLLIFEROUS SEDIM; Hilario A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016309; KIKUCHI T, 1995, J CRUSTACEAN BIOL, V15, P771, DOI 10.2307/1548826; Kikuchi Tomohiko, 2000, Species Diversity, V5, P135; Komai T, 2006, SCI MAR, V70, P109, DOI 10.3989/scimar.2006.70n1109; Komai T, 2004, J MAR BIOL ASSOC UK, V84, P1179, DOI 10.1017/S0025315404010628h; Komai T, 2006, DENISIA, V18, P410; Komai Tomoyuki, 2007, Species Diversity, V12, P237; Komai T, 2010, ZOOTAXA, P15; Lavin AM, 2003, DEEP-SEA RES PT I, V50, P1099, DOI 10.1016/S0967-0637(03)00095-5; Limen H, 2006, CAH BIOL MAR, V47, P457; Lunina A, 2011, THESIS PP SHIRSHOV I; Lunina A A, 2008, Dokl Biol Sci, V421, P266, DOI 10.1134/S0012496608040133; Lunina AA, 2010, ZOOTAXA, P69; Martin J.W., 2005, CONTRIBUTIONS SCI NA, V145, P445, DOI 10.1111/j.1096-3642.2005.00178.x; Martin JW, 2005, ZOOL J LINN SOC-LOND, V145, P445, DOI 10.1111/j.1096-3642.2005.00178.x; Martin JW, 2005, P BIOL SOC WASH, V118, P183, DOI 10.2988/0006-324X(2005)118[183:ANSOTS]2.0.CO;2; MARTIN JW, 1995, P BIOL SOC WASH, V108, P220; Martin W, 2008, NAT REV MICROBIOL, V6, P805, DOI 10.1038/nrmicro1991; Mironov A.N., 2002, BIOLOGIYA GIDROTERMA, P410; Morozov EG, 2010, ABYSSAL CHANNELS IN THE ATLANTIC OCEAN: WATER STRUCTURE AND FLOWS, P1, DOI 10.1007/978-90-481-9358-5; Nakamura K, 2012, PLOS ONE, V7, P1; NYE V, 2011, J MAR BIOL ASSOC UK, V92, P1; Pedersen RB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1124; Ramirez-Llodra E, 2006, J MAR BIOL ASSOC UK, V86, P1347, DOI 10.1017/S0025315406014378; Ramirez-Llodra E, 2007, OCEANOGRAPHY, V20, P30, DOI 10.5670/oceanog.2007.78; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; Roterman CN, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0718; Rouse GW, 2009, MAR BIOL, V156, P395, DOI 10.1007/s00227-008-1091-z; SEGONZAC M, 1993, CAH BIOL MAR, V34, P535; Shank TM, 2003, P BIOL SOC WASH, V116, P158; Shank TM, 1999, MOL PHYLOGENET EVOL, V13, P244, DOI 10.1006/mpev.1999.0642; SHANK TM, 1997, HDB DEEP SEA HYDROTH, P191; SMITH DK, 1993, NATURE, V365, P707, DOI 10.1038/365707a0; Stephens JC, 2000, J PHYS OCEANOGR, V30, P622, DOI 10.1175/1520-0485(2000)030<0622:DPOABW>2.0.CO;2; Tunnicliffe V, 1998, ADV MAR BIOL, V34, P353, DOI 10.1016/S0065-2881(08)60213-8; Tyler PA, 2003, HYDROBIOLOGIA, V503, P9, DOI 10.1023/B:HYDR.0000008492.53394.6b; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; Van Dover CL, 2001, SCIENCE, V294, P818, DOI 10.1126/science.1064574; Vereshchaka AL, 1997, DEEP-SEA RES PT I, V44, P1905, DOI 10.1016/S0967-0637(97)00031-9; Vereshchaka AL, 1998, DOKL AKAD NAUK, V360, P269; Vereshchaka Alexander L., 2000, Galathea Report, V18, P69; Watabe H, 2002, ZOOL SCI, V19, P1167, DOI 10.2108/zsj.19.1167; Watabe Hajime, 2000, JAMSTEC Journal of Deep Sea Research, V17, P29; WEATHERLY GL, 1982, J MAR RES, V40, P985; Webber WR, 2004, ZOOTAXA, P1; Wheeler AJ, 2013, GEOCHEM GEOPHY GEOSY, V14, P4170, DOI 10.1002/ggge.20243; WILLIAMS A B, 1982, Journal of Crustacean Biology, V2, P136, DOI 10.2307/1548118; WILLIAMS AB, 1995, P BIOL SOC WASH, V108, P228; WILLIAMS AB, 1988, FISH B-NOAA, V86, P263; WILLIAMS AB, 1986, J CRUSTACEAN BIOL, V6, P446, DOI 10.2307/1548184; WUNSCH C, 1984, J PHYS OCEANOGR, V14, P1712, DOI 10.1175/1520-0485(1984)014<1712:AEAOCM>2.0.CO;2; Yang JS, 2013, MOL BIOL EVOL, V30, P305, DOI 10.1093/molbev/mss224; Zelnio KA, 2009, P BIOL SOC WASH, V122, P52, DOI 10.2988/07-28.1; Zierenberg RA, 2000, P NATL ACAD SCI USA, V97, P12961, DOI 10.1073/pnas.210395997; Zonnenshine L, 1992, HYDROTHERMAL FORMATI, P12	71	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92802	10.1371/journal.pone.0092802	http://dx.doi.org/10.1371/journal.pone.0092802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676215	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677500041
J	Maciel-de-Freitas, R; Avendanho, FC; Santos, R; Sylvestre, G; Araujo, SC; Lima, JBP; Martins, AJ; Coelho, GE; Valle, D				Maciel-de-Freitas, Rafael; Avendanho, Fernando Campos; Santos, Rosangela; Sylvestre, Gabriel; Araujo, Simone Costa; Pereira Lima, Jose Bento; Martins, Ademir Jesus; Coelho, Giovanini Evelim; Valle, Denise			Undesirable Consequences of Insecticide Resistance following Aedes aegypti Control Activities Due to a Dengue Outbreak	PLOS ONE			English	Article							RIO-DE-JANEIRO; SCALE FIELD TRIAL; CONTAINER PRODUCTIVITY; MANAGEMENT STRATEGIES; CULICIDAE; DIPTERA; SURVEILLANCE; POPULATIONS; MOSQUITOS	Background: During a dengue outbreak with co-circulation of DENV-1 and -2 in the city of Boa Vista, one patient was diagnosed with DENV-4, a serotype supposed absent from Brazil for almost 30 years. The re-emergence of DENV-4 triggered the intensification of mechanical and chemical Aedes aegypti control activities in order to reduce vector density and avoid DENV-4 dissemination throughout the country. Methods/Principal Findings: Vector control activities consisted of (a) source reduction, (b) application of diflubenzuron against larvae and (c) vehicle-mounted space spraying of 2% deltamethrin to eliminate adults. Control activity efficacy was monitored by comparing the infestation levels and the number of eggs collected in ovitraps before and after interventions, performed in 22 Boa Vista districts, covering an area of similar to 80% of the city and encompassing 56,837 dwellings. A total of 94,325 containers were eliminated or treated with diflubenzuron. The most frequently positive containers were small miscellaneous receptacles, which corresponded to 59% of all positive breeding sites. Insecticide resistance to deltamethrin was assessed before, during and after interventions by dose-response bioassays adopting WHO-based protocols. The intense use of the pyrethroid increased fourfold the resistance ratio of the local Ae. aegypti population only six months after the beginning of vector control. Curiously, this trend was also observed in the districts in which no deltamethrin was applied by the public health services. On the other hand, changes in the resistance ratio to the organophosphate temephos seemed less influenced by insecticide in Boa Vista. Conclusions: Despite the intense effort, mosquito infestation levels were only slightly reduced. Besides, the median number of eggs in ovitraps remained unaltered after control activity intensification. The great and rapid increase in pyrethroid resistance levels of natural Ae. aegypti populations is discussed in the context of both public and domestic intensification of chemical control due to a dengue outbreak.	[Maciel-de-Freitas, Rafael; Sylvestre, Gabriel] Fiocruz MS, Inst Oswaldo Cruz, Lab Transmissores Hematozoarios, BR-21045900 Rio De Janeiro, Brazil; [Avendanho, Fernando Campos; Coelho, Giovanini Evelim] Minist Saude, Secretaria Vigilancia Saude, Brasilia, DF, Brazil; [Santos, Rosangela] Secretaria Estadual Saude Roraima, Boa Vista, Brazil; [Araujo, Simone Costa; Pereira Lima, Jose Bento; Martins, Ademir Jesus] Fiocruz MS, Inst Oswaldo Cruz, Lab Fisiol & Controle Artropodes Vetores, BR-21045900 Rio De Janeiro, Brazil; [Araujo, Simone Costa; Pereira Lima, Jose Bento; Martins, Ademir Jesus] Inst Biol Exercito, Rio De Janeiro, Brazil; [Martins, Ademir Jesus; Valle, Denise] INCT EM, Rio De Janeiro, Brazil; [Valle, Denise] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Maciel-de-Freitas, R (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Transmissores Hematozoarios, BR-21045900 Rio De Janeiro, Brazil.	freitas@ioc.fiocruz.br; dvalle@ioc.fiocruz.br	Martins, Ademir J./B-4117-2009; Maciel-de-Freitas, Rafael/J-1997-2012; Martins, Ademir/W-3251-2019; Valle, Denise/F-5069-2013	Martins, Ademir/0000-0001-5739-1215; Maciel-de-Freitas, Rafael/0000-0002-2198-6492				[Anonymous], 2002, PNCD PROGR NAC CONTR; [Anonymous], 1981, INSTRUCTIONS DETERMI; Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2; Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878; Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004; David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019; de Souza RP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001439; Eisen L, 2009, J MED ENTOMOL, V46, P1245, DOI 10.1603/033.046.0601; Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Hemingway J, 1997, PESTIC SCI, V51, P375, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;375::AID-PS636&gt;3.0.CO;2-K; Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5; Linss JGB, 2014, PARASITES V IN PRESS; Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056; Maciel-de-Freitas R, 2011, TROP MED INT HEALTH, V16, P965, DOI 10.1111/j.1365-3156.2011.02797.x; MALLET J, 1989, TRENDS ECOL EVOL, V4, P336, DOI 10.1016/0169-5347(89)90088-8; Marcombe S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001202; Martins AJ, 2009, TROP MED INT HEALTH, V14, P1351, DOI 10.1111/j.1365-3156.2009.02378.x; Ministerio da Saude, 2009, BRAZ GUID PREV CONTR; Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Nathan MB, 2007, RECENT EPIDEMIOLOGIC, P30; Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001; Penilla RP, 1998, MED VET ENTOMOL, V12, P217, DOI 10.1046/j.1365-2915.1998.00123.x; Pilger D, 2011, TROP MED INT HEALTH, V16, P1143, DOI 10.1111/j.1365-3156.2011.02818.x; Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531; RAYMOND M, 1985, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V23, P117; Reiter P., 2001, GUIDELINES ASSESSING; Rozendaal J.A., 1997, VECTOR CONTROL METHO; Saavedra-Rodriguez K, 2012, INSECT MOL BIOL, V21, P61, DOI 10.1111/j.1365-2583.2011.01113.x; SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922; Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681; WHO, 1998, WHOCDSCPCMAL9812; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002	35	87	92	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92424	10.1371/journal.pone.0092424	http://dx.doi.org/10.1371/journal.pone.0092424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676277	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500022
J	Wansleeben, C; Bowie, E; Hotten, DF; Yu, YRA; Hogan, BLM				Wansleeben, Carolien; Bowie, Emily; Hotten, Danielle F.; Yu, Yen-Rei A.; Hogan, Brigid L. M.			Age-Related Changes in the Cellular Composition and Epithelial Organization of the Mouse Trachea	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; LYMPHOID-TISSUE BALT; STEM-CELLS; INNATE IMMUNITY; BASAL-CELLS; LUNG; AIRWAY; MICE; SENESCENCE; HOMEOSTASIS	We report here senescent changes in the structure and organization of the mucociliary pseudostratified epithelium of the mouse trachea and main stem bronchi. We confirm previous reports of the gradual appearance of age-related, gland-like structures (ARGLS) in the submucosa, especially in the intercartilage regions and carina. Immunohistochemistry shows these structures contain ciliated and secretory cells and Krt5+ basal cells, but not the myoepithelial cells or ciliated ducts typical of normal submucosal glands. Data suggest they arise de novo by budding from the surface epithelium rather than by delayed growth of rudimentary or cryptic submucosal glands. In old mice the surface epithelium contains fewer cells per unit length than in young mice and the proportion of Krt5+, p63+ basal cells is reduced in both males and females. However, there appears to be no significant difference in the ability of basal stem cells isolated from individual young and old mice to form clonal tracheospheres in culture or in the ability of the epithelium to repair after damage by inhaled sulfur dioxide. Gene expression analysis by Affymetrix microarray and quantitative PCR, as well as immunohistochemistry and flow sorting studies, are consistent with low-grade chronic inflammation in the tracheas of old versus young mice and an increase in the number of immune cells. The significance of these changes for ARGL formation are not clear since several treatments that induce acute inflammation in young mice did not result in budding of the surface epithelium.	[Wansleeben, Carolien; Bowie, Emily; Hogan, Brigid L. M.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Hotten, Danielle F.; Yu, Yen-Rei A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University	Hogan, BLM (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	brigid.hogan@dm.duke.edu		Bowie, Emily/0000-0002-5694-6044	National Institutes of Health [HL 4R37-HL07103-21]; Ellison Medical Foundation; American Lung Association [R225818-N]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040372] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL071303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); American Lung Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was from the National Institutes of Health (HL 4R37-HL07103-21 to BLMH) and the Ellison Medical Foundation. (www.ellisonfoundation.org). CW was supported by an American Lung Association Fellowship R225818-N (www.lung.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Calvi CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020712; Chilosi M, 2013, TRANSL RES, V162, P156, DOI 10.1016/j.trsl.2013.06.004; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Doles J, 2012, GENE DEV, V26, P2144, DOI 10.1101/gad.192294.112; Driskell RR, 2007, DEV BIOL, V305, P90, DOI 10.1016/j.ydbio.2007.01.038; ENGELHARDT JF, 1995, DEVELOPMENT, V121, P2031; Faner R, 2012, AM J RESP CRIT CARE, V186, P306, DOI 10.1164/rccm.201202-0282PP; Ferrer-Vaquer A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-121; Giangreco A, 2011, J PATHOL, V224, P190, DOI 10.1002/path.2876; HERNANDEZ JA, 1965, J AM GERIATR SOC, V13, P799, DOI 10.1111/j.1532-5415.1965.tb02060.x; Huang JM, 2013, EXP GERONTOL, V48, P717, DOI 10.1016/j.exger.2013.04.001; Ledford JG, 2009, J IMMUNOL, V182, P7818, DOI 10.4049/jimmunol.0900452; Lucchetta EM, 2012, WIRES DEV BIOL, V1, P781, DOI 10.1002/wdev.51; Madsen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064441; Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; MAYS PK, 1989, AM REV RESPIR DIS, V140, P410, DOI 10.1164/ajrccm/140.2.410; Mollenhauer J, 2000, CANCER RES, V60, P1704; Muller H, 2008, CLIN EXP IMMUNOL, V151, P123, DOI 10.1111/j.1365-2249.2007.03528.x; NETTESHEIM P, 1970, JNCI-J NATL CANCER I, V44, P687; O'Koren EG, 2013, AM J RESP CELL MOL, V49, P788, DOI 10.1165/rcmb.2012-0369OC; PABST R, 1990, AM J RESP CELL MOL, V3, P131, DOI 10.1165/ajrcmb/3.2.131; Paxson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023232; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Randall TD, 2010, ADV IMMUNOL, V107, P187, DOI [10.1016/S0065-2776(10)07002-1, 10.1016/B978-0-12-381300-8.00007-1]; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Seiler C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001386; Shaykhiev R, 2013, GERONTOLOGY, V59, P481, DOI 10.1159/000354173; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Shore SA, 2003, J APPL PHYSIOL, V95, P938, DOI 10.1152/japplphysiol.00336.2003; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Wallace KN, 2005, DEV CELL, V8, P717, DOI 10.1016/j.devcel.2005.02.015; Wansleeben C, 2010, DEVELOPMENT, V137, P1067, DOI 10.1242/dev.041434; Watanabe H, 2005, GASTROENTEROLOGY, V128, P1391, DOI 10.1053/j.gastro.2005.03.016; Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Zeng N, 2013, AGING CELL	42	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93496	10.1371/journal.pone.0093496	http://dx.doi.org/10.1371/journal.pone.0093496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675804	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677500131
J	Belter, CW				Belter, Christopher W.			Measuring the Value of Research Data: A Citation Analysis of Oceanographic Data Sets	PLOS ONE			English	Article							BIBLIOMETRIC INDICATORS; BIODIVERSITY DATA; IOC CONTRIBUTIONS; SCIENCE; PUBLICATION; REGISTRATION; JOURNALS; WORLD; PAPER	Evaluation of scientific research is becoming increasingly reliant on publication-based bibliometric indicators, which may result in the devaluation of other scientific activities - such as data curation - that do not necessarily result in the production of scientific publications. This issue may undermine the movement to openly share and cite data sets in scientific publications because researchers are unlikely to devote the effort necessary to curate their research data if they are unlikely to receive credit for doing so. This analysis attempts to demonstrate the bibliometric impact of properly curated and openly accessible data sets by attempting to generate citation counts for three data sets archived at the National Oceanographic Data Center. My findings suggest that all three data sets are highly cited, with estimated citation counts in most cases higher than 99% of all the journal articles published in Oceanography during the same years. I also find that methods of citing and referring to these data sets in scientific publications are highly inconsistent, despite the fact that a formal citation format is suggested for each data set. These findings have important implications for developing a data citation format, encouraging researchers to properly curate their research data, and evaluating the bibliometric impact of individuals and institutions.	NOAA, LAC Grp, Cent Lib, Silver Spring, MD 20910 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Belter, CW (corresponding author), NOAA, LAC Grp, Cent Lib, Silver Spring, MD 20910 USA.	Chris.Belter@noaa.gov	Belter, Christopher W/L-6487-2013	Belter, Christopher W/0000-0001-5221-6880				Abramo G, 2011, SCIENTOMETRICS, V89, P929, DOI 10.1007/s11192-011-0459-x; Aguillo IF, 2012, SCIENTOMETRICS, V91, P343, DOI 10.1007/s11192-011-0582-8; Allen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005910; Altman Micah, 2007, D-Lib Magazine, V13, DOI 10.1045/march2007-altman; [Anonymous], 2011, SCIENCE, V331, P692; [Anonymous], 2009, NATURE, V461; Antonov J.I., 2010, NOAA ATLAS NESDIS, V2, P184, DOI DOI 10.13140/2.1.1115.4889; Antonov J.I., 2010, NOAA ATLAS NESDIS 69, V69, P184; Borgman CL, 2012, J AM SOC INF SCI TEC, V63, P1059, DOI 10.1002/asi.22634; Bornmann L., 2008, ETHICS SCI ENV POLIT, V2014, DOI [10.3354/esep00084, DOI 10.3354/ESEP00084]; Boyd PW, 2012, OCEANOGRAPHY, V25, P64, DOI 10.5670/oceanog.2012.104; Boyer T. P., 2009, NOAA ATLAS NESDIS, V66, P216; Brase J, 2004, LECT NOTES COMPUT SC, V3232, P488; Casey KS, 2010, OCEANOGRAPHY FROM SPACE: REVISITED, P273, DOI 10.1007/978-90-481-8681-5_16; Chandler RE, 2012, ENVIRONMETRICS, V23, P373, DOI 10.1002/env.2141; Chao, 2011, P AM SOC INFORM SCI, V48, P1, DOI [10.1002/meet.2011.14504801125, DOI 10.1002/MEET.2011.14504801125]; Chavan V, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S15-S2; Chavan VS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S2; CINKOSKY MJ, 1991, SCIENCE, V252, P1273, DOI 10.1126/science.1925538; Conway EM, 2006, HIST STUD PHYS BIOL, V37, P127, DOI 10.1525/hsps.2006.37.1.127; Costas R, 2011, SCIENTOMETRICS, V89, P177, DOI 10.1007/s11192-011-0436-4; Costello MJ, 2013, TRENDS ECOL EVOL, V28, P454, DOI 10.1016/j.tree.2013.05.002; Costello MJ, 2009, BIOSCIENCE, V59, P418, DOI 10.1525/bio.2009.59.5.9; De Schutter E, 2010, NEUROINFORMATICS, V8, P151, DOI 10.1007/s12021-010-9084-8; Dodge C, 1996, J VISUAL COMP ANIMAT, V7, P159, DOI 10.1002/(SICI)1099-1778(199607)7:3<159::AID-VIS149>3.0.CO;2-T; Donlon C, 2007, B AM METEOROL SOC, V88, P1197, DOI 10.1175/BAMS-88-8-1197; Donlon CJ, 2009, OCEANOGRAPHY, V22, P34, DOI 10.5670/oceanog.2009.64; Eom YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024926; Franceschet M, 2010, SCIENTOMETRICS, V83, P243, DOI 10.1007/s11192-009-0021-2; Garcia H.E., 2010, NOAA WORLD OCEAN ATL, V71, P398, DOI [10.1182/blood-2011-06-357442, DOI 10.1182/BLOOD-2011-06-357442]; Garcia H.E., 2010, NOAA ATLAS NESDIS, V70; Garfield E, 1979, CITATION INDEXING IT; Glover DM, 2010, OCEANOGRAPHY, V23, P140, DOI 10.5670/oceanog.2010.29; Goodman L, 2012, NATURE, V492, P356, DOI 10.1038/492356d; Gorgolewski KJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00009; Gould J., 2011, EOS T AGU, V85, P185, DOI [10.1029/2004EO190002, DOI 10.1029/2004EO190002]; Haeffner-Cavaillon N, 2009, ARCH IMMUNOL THER EX, V57, P33, DOI 10.1007/s00005-009-0004-2; Helly J, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000318; Hofmann EE, 2010, OCEANOGRAPHY, V23, P152, DOI 10.5670/oceanog.2010.30; ICPSR, 2011, ICPSR BIBL DAT REL L; Jacso P, 2010, ONLINE INFORM REV, V34, P175, DOI 10.1108/14684521011024191; Klump J., 2006, DATA SCI J, V5, P79, DOI DOI 10.2481/DSJ.5.79; Kostoff RN, 2007, J INFORMETR, V1, P103, DOI 10.1016/j.joi.2007.02.002; Kousha K, 2010, J INFORMETR, V4, P124, DOI 10.1016/j.joi.2009.10.003; Levitus S., 1982, NOAA PROFESSIONAL PA, P173; Moed H.F., 2007, SCI PUBL POLICY, V34, P575, DOI [10.3152/030234207X255179, DOI 10.3152/030234207X255179]; Moed HF, 2008, SCIENTOMETRICS, V74, P153, DOI 10.1007/s11192-008-0108-1; Mons B, 2011, NAT GENET, V43, P281, DOI 10.1038/ng0411-281; Mooney H, 2012, J LIBRARIANSHIP SCHO, V1, DOI [10.7710/2162-3309.1035, DOI 10.7710/2162-3309.1035]; Moritz T, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S15-S1; Parsons MA., 2010, EOS T AM GEOPHYS UN, V91, P297, DOI [10.1029/2010EO340001, DOI 10.1029/2010E0340001, DOI 10.1029/2010EO340001]; Peterson J, 2010, NAT GENET, V42, P919, DOI 10.1038/ng1110-919; Piwowar HA, 2011, P AM SOC INFORM SCI, V48, P1, DOI DOI 10.1002/MEET.2011.14504801337; Piwowar HA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000308; Piwowar HA, 2013, PEERJ, V1, DOI 10.7717/peerj.175; Piwowar HA, 2011, NATURE, V473, P285, DOI 10.1038/473285a; Priem J, 2010, 1 MONDAY, V15, P2874; Schindler U, 2005, LECT NOTES COMPUT SC, V3652, P128, DOI 10.1007/11551362_12; SCImago Research Group, 2012, SCIMAGO I RANK SIR W; Sedransk N, 2010, STAT SCI, V25, P41, DOI 10.1214/10-STS320; ShanghaiRanking Consultancy, 2012, AC RANK WORLD U; Starr J, 2011, DATACITE, DOI [10.5438/0003, DOI 10.5438/0003]; Staudigel H, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000314; Staudigel H, 2001, GEOCHEM GEOPHY GEOSY, V2, part. no.; Tenopir C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021101; Thorisson GA, 2009, NAT BIOTECHNOL, V27, P984, DOI 10.1038/nbt1109-984b; Times Higher Education, 2013, TIM HIGH ED WORLD U; Uhlir PF, 2012, ATTR DEV DAT ATTR CI; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; van Dalen HP, 2012, J AM SOC INF SCI TEC, V63, P1282, DOI 10.1002/asi.22636; vanRaan AFJ, 1996, SCIENTOMETRICS, V36, P397, DOI 10.1007/BF02129602; Waltman L, 2012, J AM SOC INF SCI TEC, V63, P2419, DOI 10.1002/asi.22708; Walton DWH, 2010, ANTARCT SCI, V22, P333, DOI 10.1017/S0954102010000520; Weingart P, 2005, SCIENTOMETRICS, V62, P117, DOI 10.1007/s11192-005-0007-7	75	49	50	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92590	10.1371/journal.pone.0092590	http://dx.doi.org/10.1371/journal.pone.0092590			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671177	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000054
J	Jin, Y; Sun, CJ; Feng, LQ; Li, PC; Xiao, LJ; Ren, YZ; Wang, DM; Li, CF; Chen, L				Jin, Yi; Sun, Caijun; Feng, Liqiang; Li, Pingchao; Xiao, Lijun; Ren, Yizhong; Wang, Dimin; Li, Chufang; Chen, Ling			Regulation of SIV Antigen-Specific CD4+T Cellular Immunity via Autophagosome-Mediated MHC II Molecule-Targeting Antigen Presentation in Mice	PLOS ONE			English	Article							CD4(+) T-CELLS; IMMUNODEFICIENCY-VIRUS TYPE-1; VACCINE-INDUCED IMMUNITY; HIV-1 VACCINE; CROSS-PRESENTATION; AIDS RESEARCH; DOUBLE-BLIND; RESPONSES; INFECTION; EFFICACY	CD4+ T cell-mediated immunity has increasingly received attention due to its contribution in the control of HIV viral replication; therefore, it is of great significance to improve CD4+ T cell responses to enhance the efficacy of HIV vaccines. Recent studies have suggested that macroautophagy plays a crucial role in modulating adaptive immune responses toward CD4+ T cells or CD8+ T cells. In the present study, a new strategy based on a macroautophagy degradation mechanism is investigated to enhance CD4+ T cell responses against the HIV/SIV gag antigen. Our results showed that when fused to the autophagosome-associated LC3b protein, SIVgag protein can be functionally targeted to autophagosomes, processed by autophagy-mediated degradation in autolysosomes/lysosomes, presented to MHC II compartments and elicit effective potential CD4 T cell responses in vitro. Importantly, compared with the SIVgag protein alone, SIVgag-LC3b fusion antigen can induce a stronger antigen-specific CD4+ T cell response in mice, which is characterized by an enhanced magnitude and polyfunctionality. This study provides insight for the immunological modulation between viral and mammalian cells via autophagy, and it also presents an alternative strategy for the design of new antigens in the development of effective HIV vaccines.	[Jin, Yi; Sun, Caijun; Feng, Liqiang; Li, Pingchao; Xiao, Lijun; Ren, Yizhong; Wang, Dimin; Chen, Ling] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China; [Jin, Yi; Xiao, Lijun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ren, Yizhong] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Wang, Dimin] Anhui Univ, Sch Life Sci, Hefei 230039, Peoples R China; [Li, Chufang; Chen, Ling] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Sun, CJ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China.	Sun_caijun@gibh.ac.cn; chen_ling@gibh.ac.cn			National Natural Science Foundation of China [31370923, 81000737, 31200693]; National Science and Technology Major Project "Development of Novel Mucosal Vaccines against HIV-1 Infection" [2012ZX10001-009]; CAS Youth Innovation Promotion Association	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project "Development of Novel Mucosal Vaccines against HIV-1 Infection"; CAS Youth Innovation Promotion Association	This work was supported by the National Natural Science Foundation of China (31370923, 81000737 and 31200693), the National Science and Technology Major Project "Development of Novel Mucosal Vaccines against HIV-1 Infection" (2012ZX10001-009), and the grant of CAS Youth Innovation Promotion Association to Dr. Caijun Sun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2010, CURR OPIN HIV AIDS, V5, P386, DOI 10.1097/COH.0b013e32833cfe4c; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Campbell GR, 2013, CURR OPIN MICROBIOL, V16, P349, DOI 10.1016/j.mib.2013.05.006; Casimiro DR, 2003, J VIROL, V77, P7663, DOI 10.1128/JVI.77.13.7663-7668.2003; Chevalier MF, 2011, J VIROL, V85, P733, DOI 10.1128/JVI.02030-10; Cohen J, 2007, SCIENCE, V318, P28, DOI 10.1126/science.318.5847.28; Cohen J, 2013, SCIENCE, V340, P667, DOI 10.1126/science.340.6133.667; de Souza MS, 2012, J IMMUNOL, V188, P5166, DOI 10.4049/jimmunol.1102756; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Dongre AR, 2001, EUR J IMMUNOL, V31, P1485, DOI 10.1002/1521-4141(200105)31:5<1485::AID-IMMU1485>3.0.CO;2-A; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Esparza J, 2013, VACCINE, V31, P3502, DOI 10.1016/j.vaccine.2013.05.018; Gannage Monique, 2013, Methods Mol Biol, V960, P473, DOI 10.1007/978-1-62703-218-6_35; Gauduin MC, 2006, J EXP MED, V203, P2661, DOI 10.1084/jem.20060134; Gilbert PB, 2011, J INFECT DIS, V203, P969, DOI 10.1093/infdis/jiq152; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Heeney Jonathan L, 2006, Nat Immunol, V7, P1281, DOI 10.1038/ni1206-1281; Ireland JM, 2011, J EXP MED, V208, P2625, DOI 10.1084/jem.20110640; Kadowaki Motoni, 2006, Molecular Aspects of Medicine, V27, P426, DOI 10.1016/j.mam.2006.08.010; Kuballa P, 2012, ANNU REV IMMUNOL, V30, P611, DOI 10.1146/annurev-immunol-020711-074948; Kumamoto Y, 2011, P NATL ACAD SCI USA, V108, P8749, DOI 10.1073/pnas.1100567108; Li YH, 2008, CANCER RES, V68, P6889, DOI 10.1158/0008-5472.CAN-08-0161; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; McDermott AB, 2012, AIDS, V26, P1281, DOI 10.1097/QAD.0b013e328353bcaf; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McEnery Regina, 2011, IAVI Rep, V15, P17; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Moog C, 2008, AIDS, V22, P1461, DOI 10.1097/QAD.0b013e3282fdf625; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; Nimmerjahn F, 2003, EUR J IMMUNOL, V33, P1250, DOI 10.1002/eji.200323730; Oh JE, 2012, YONSEI MED J, V53, P241, DOI 10.3349/ymj.2012.53.2.241; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Porichis F, 2011, CURR OPIN HIV AIDS, V6, P174, DOI 10.1097/COH.0b013e3283454058; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richetta C, 2013, CELL MICROBIOL, V15, P368, DOI 10.1111/cmi.12043; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165; Soghoian DZ, 2010, EXPERT REV VACCINES, V9, P1453, DOI 10.1586/ERV.10.132; Streeck H, 2013, NAT MED, V19, P143, DOI 10.1038/nm.3054; Sun CJ, 2013, J VIROL, V87, P5669, DOI 10.1128/JVI.03247-12; Sun CJ, 2010, J INFECTION, V60, P371, DOI 10.1016/j.jinf.2010.03.005; Sun YX, 2013, IMMUNOLOGY, V138, P370, DOI 10.1111/imm.12049; Sun Y, 2007, J VIROL, V81, P8009, DOI 10.1128/JVI.00482-07; Sun Y, 2006, J VIROL, V80, P10950, DOI 10.1128/JVI.01458-06; Tey SK, 2012, AUTOPHAGY, V8, P1839, DOI 10.4161/auto.21860; Valdor R, 2012, PHARMACOL RES, V66, P475, DOI 10.1016/j.phrs.2012.10.003; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484	53	29	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93143	10.1371/journal.pone.0093143	http://dx.doi.org/10.1371/journal.pone.0093143			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671203	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000120
J	Monteiro, J; Aires, R; Becker, JD; Jacinto, A; Certal, AC; Rodriguez-Leon, J				Monteiro, Joana; Aires, Rita; Becker, Joerg D.; Jacinto, Antonio; Certal, Ana C.; Rodriguez-Leon, Joaquin			V-ATPase Proton Pumping Activity Is Required for Adult Zebrafish Appendage Regeneration	PLOS ONE			English	Article							VERTEBRATE REGENERATION; BLASTEMA FORMATION; MEMBRANE VOLTAGE; VACUOLAR-ATPASE; FIN; PROLIFERATION; EXPRESSION; INDUCTION; MECHANISM; SURVIVAL	The activity of ion channels and transporters generates ion-specific fluxes that encode electrical and/or chemical signals with biological significance. Even though it is long known that some of those signals are crucial for regeneration, only in recent years the corresponding molecular sources started to be identified using mainly invertebrate or larval vertebrate models. We used adult zebrafish caudal fin as a model to investigate which and how ion transporters affect regeneration in an adult vertebrate model. Through the combined use of biophysical and molecular approaches, we show that V-ATPase activity contributes to a regeneration-specific H+ ef'flux. The onset and intensity of both V-ATPase expression and H+ efflux correlate with the different regeneration rate along the proximal-distal axis. Moreover, we show that V-ATPase inhibition impairs regeneration in adult vertebrate. Notably, the activity of this H+ pump is necessary for aldh1a2 and mkp3 expression, blastema cell proliferation and fin innervation. To the best of our knowledge, this is the first report on the role of V-ATPase during adult vertebrate regeneration.	[Monteiro, Joana; Aires, Rita; Becker, Joerg D.; Certal, Ana C.; Rodriguez-Leon, Joaquin] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Monteiro, Joana] Fac Med Lisbon, Inst Med Mol, Lisbon, Portugal; [Jacinto, Antonio] Fac Ciencias Med, Ctr Estudos Doencas Cron, Lisbon, Portugal; [Certal, Ana C.] Champalimaud Fdn, Lisbon, Portugal; [Rodriguez-Leon, Joaquin] Univ Extremadura, Fac Med, Dept Anat Humana Biol Celular & Zool, Badajoz, Spain	Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Universidade Nova de Lisboa; Fundacao Champalimaud; Universidad de Extremadura	Certal, AC (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	catarina.certal@fundacaochampalimaud.pt; jrleon@unex.es	Becker, Jorg/A-5930-2011; Monteiro, Joana F./AAU-9357-2020; Leon, Joaquin Maria Rodriguez/C-6957-2013; Jacinto, Antonio/F-5729-2013; Leon, Joaquin Maria Rodriguez/S-9814-2019; Certal, Ana Catarina/M-4028-2013	Becker, Jorg/0000-0002-6845-6122; Monteiro, Joana F./0000-0002-0057-7307; Leon, Joaquin Maria Rodriguez/0000-0002-9582-5480; Jacinto, Antonio/0000-0002-4193-6089; Leon, Joaquin Maria Rodriguez/0000-0002-9582-5480; Certal, Ana Catarina/0000-0002-5091-0083; Aires, Rita/0000-0002-3537-0453	Fundacao para a Ciencia e Tecnologia (FCT), Portugal [SFRH/BD/45131/2008, SFRH/BPD/29957/2006]; european FP6-Cells into Organs, FCT [PTDC/BIA-BCM/100867/2008, POCTI-ISFL-4-664]; Ministerio de Ciencia e Innovacion, Spain [RYC-2008-02753, BFU2009-12279]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BCM/100867/2008] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); european FP6-Cells into Organs, FCT; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundação para a Ciência e a Tecnologia	JJM was supported by a fellowship (SFRH/BD/45131/2008) from Fundacao para a Ciencia e Tecnologia (FCT), Portugal. ACC was supported by a postdocoral fellowship (SFRH/BPD/29957/2006) from Fundacao para a Ciencia e Tecnologia (FCT), Portugal. This work was supported by the following grants: european FP6-Cells into Organs, FCT (Grant PTDC/BIA-BCM/100867/2008 and POCTI-ISFL-4-664) and Ministerio de Ciencia e Innovacion, Spain (Subprograma Ramon y Cajal, reference RYC-2008-02753 and grant BFU2009-12279). JRL is supported by the Subprogram Ramon y Cajal from Ministerio de Ciencia e Innovacion, Spain (RYC-2008-02753). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DS, 2007, DEVELOPMENT, V134, P1323, DOI 10.1242/dev.02812; AKIMENKO MA, 1995, DEVELOPMENT, V121, P347; Beane WS, 2011, CHEM BIOL, V18, P77, DOI 10.1016/j.chembiol.2010.11.012; BECERRA J, 1983, CELL TISSUE RES, V230, P127; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Bjornsson CS, 2004, J EXP BIOL, V207, P2835, DOI 10.1242/jeb.01089; Blum N, 2013, CELL MOL LIFE SCI, V12; Blum N, 2012, DEVELOPMENT, V139, P107, DOI 10.1242/dev.065391; BORGENS RB, 1981, SCIENCE, V213, P611, DOI 10.1126/science.7256258; BORGENS RB, 1979, J EXP ZOOL, V209, P377, DOI 10.1002/jez.1402090304; BORGENS RB, 1977, P NATL ACAD SCI USA, V74, P4528, DOI 10.1073/pnas.74.10.4528; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hyde DR, 2012, JOVE-J VIS EXP, DOI 10.3791/3632; Illingworth C. M., 1980, Clinical Physics and Physiological Measurement, V1, P87, DOI 10.1088/0143-0815/1/1/007; Kawakami A, 2004, DEV DYNAM, V231, P693, DOI 10.1002/dvdy.20181; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Levin M, 2007, TRENDS CELL BIOL, V17, P261, DOI 10.1016/j.tcb.2007.04.007; Li C., 2001, GENOME BIOL, V2, DOI [10.1186/gb-2001-2-8-research0032, DOI 10.1186/GB-2001-2-8-RESEARCH0032]; Lin G, 2008, DEV BIOL, V316, P323, DOI 10.1016/j.ydbio.2008.01.032; Lin LY, 2006, AM J PHYSIOL-CELL PH, V290, pC371, DOI 10.1152/ajpcell.00281.2005; Mateus R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051766; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Nechiporuk A, 2002, DEVELOPMENT, V129, P2607; Nishisho T, 2011, MOL CANCER RES, V9, P845, DOI 10.1158/1541-7786.MCR-10-0449; Nuckels RJ, 2009, INVEST OPHTH VIS SCI, V50, P893, DOI 10.1167/iovs.08-2743; Petzoldt AG, 2013, DIS MODEL MECH, V6, P689, DOI 10.1242/dmm.010660; Poleo G, 2001, DEV DYNAM, V221, P380, DOI 10.1002/dvdy.1152; Reid B, 2011, JOVE-J VIS EXP, DOI 10.3791/2358; Reid B, 2009, DEV BIOL, V335, P198, DOI 10.1016/j.ydbio.2009.08.028; Sasazawa Y, 2009, CANCER SCI, V100, P1460, DOI 10.1111/j.1349-7006.2009.01194.x; Shipley AM, 1999, FERTILIZATION HIGHER, P235; Smith PJS, 1999, MICROSC RES TECHNIQ, V46, P398, DOI 10.1002/(SICI)1097-0029(19990915)46:6<398::AID-JEMT8>3.0.CO;2-H; Song B, 2004, J CELL SCI, V117, P4681, DOI 10.1242/jcs.01341; Sousa S, 2011, DEVELOPMENT, V138, P3897, DOI 10.1242/dev.064717; Stock C, 2005, J PHYSIOL-LONDON, V567, P225, DOI 10.1113/jphysiol.2005.088344; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; Sundelacruz S, 2009, STEM CELL REV REP, V5, P231, DOI 10.1007/s12015-009-9080-2; Suzuki M, 2005, DEV BIOL, V286, P361, DOI 10.1016/j.ydbio.2005.08.021; Tal TL, 2010, GERONTOLOGY, V56, P231, DOI 10.1159/000259327; Tseng AS, 2010, J NEUROSCI, V30, P13192, DOI 10.1523/JNEUROSCI.3315-10.2010; Tu S, 2011, DEV CELL, V20, P725, DOI 10.1016/j.devcel.2011.04.013; Vaccari T, 2010, DEVELOPMENT, V137, P1825, DOI 10.1242/dev.045484; Vieira AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017411; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yoshinari N, 2011, BIOL BULL-US, V221, P62, DOI 10.1086/BBLv221n1p62; Yoshinari N, 2009, DEV BIOL, V325, P71, DOI 10.1016/j.ydbio.2008.09.028; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009	51	28	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92594	10.1371/journal.pone.0092594	http://dx.doi.org/10.1371/journal.pone.0092594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671205	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000056
J	Arrowsmith, ME; Majeed, A; Lee, JT; Saxena, S				Arrowsmith, Myat E.; Majeed, Azeem; Lee, John Tayu; Saxena, Sonia			Impact of Pay for Performance on Prescribing of Long-Acting Reversible Contraception in Primary Care: An Interrupted Time Series Study	PLOS ONE			English	Article							QUALITY-OF-CARE; FOR-PERFORMANCE; COST-EFFECTIVENESS; PRACTICE SIZE; WOMEN; DEPRIVATION; OUTCOMES; UK; PHYSICIANS; ATTITUDES	Background: The aim of this study was to evaluate the impact of Quality and Outcomes Framework (QOF), a major pay-for-performance programme in the United Kingdom, on prescribing of long-acting reversible contraceptives (LARC) in primary care. Methods: Negative binomial interrupted time series analysis using practice level prescribing data from April 2007 to March 2012. The main outcome measure was the prescribing rate of long-acting reversible contraceptives (LARC), including hormonal and non hormonal intrauterine devices and systems (IUDs and IUSs), injectable contraceptives and hormonal implants. Results: Prescribing rates of Long-Acting Reversible Contraception (LARC) were stable before the introduction of contraceptive targets to the QOF and increased afterwards by 4% annually (rate ratios = 1.04, 95% Cl = 1.03, 1.06). The increase in LARC prescribing was mainly driven by increases in injectables (increased by 6% annually), which was the most commonly prescribed LARC method. Of other types of LARC, the QOF indicator was associated with a step increase of 20% in implant prescribing (RR = 1.20, 95% Cl = 1.09, 1.32). This change is equivalent to an additional 110 thousand women being prescribed with LARC had QOF points not been introduced. Conclusions: Pay for performance incentives for contraceptive counselling in primary care with women seeking contraceptive advice has increased uptake of LARC methods.	[Arrowsmith, Myat E.; Majeed, Azeem; Lee, John Tayu; Saxena, Sonia] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England	Imperial College London	Saxena, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England.	s.saxena@imperial.ac.uk	Saxena, Sonia/ABD-7737-2021; Saxena, Sonia K/G-4821-2013	Saxena, Sonia/0000-0003-3787-2083; Saxena, Sonia K/0000-0003-3787-2083; Majeed, Azeem/0000-0002-2357-9858; Lee, John Tayu/0000-0002-1551-4923	NIHR Collaboration for Leadership in Applied Health Research & Care (CLAHRC) Scheme; NIHR Biomedical Research Centre scheme; Imperial Centre for Patient Safety and Service Quality; NIHR Career Development Fellowship; National Institute for Health Research [CDF-2011-04-048] Funding Source: researchfish	NIHR Collaboration for Leadership in Applied Health Research & Care (CLAHRC) Scheme; NIHR Biomedical Research Centre scheme(National Institute for Health Research (NIHR)); Imperial Centre for Patient Safety and Service Quality; NIHR Career Development Fellowship; National Institute for Health Research(National Institute for Health Research (NIHR))	The Department of Primary Care and Public Health at Imperial College London is grateful for support from the NIHR Collaboration for Leadership in Applied Health Research & Care (CLAHRC) Scheme, the NIHR Biomedical Research Centre scheme, and the Imperial Centre for Patient Safety and Service Quality. SS is funded by an NIHR Career Development Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabbadi I, 2010, PHARM WORLD SCI, V32, P43, DOI 10.1007/s11096-009-9339-3; BMA & NHS Employers, 2008, QUAL OUTC FRAM GUID; BMA & NHS Employers, 2009, QUAL OUTC FRAM GUID; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; de Irala J, 2011, CONTRACEPTION, V84, P558, DOI 10.1016/j.contraception.2011.04.004; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Downing A, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-166; Fleming CF, 2009, OBSTET GYNAECOL, V11, P83, DOI 10.1576/toag.11.2.083.27480; Gillam SJ, 2012, ANN FAM MED, V10, P461, DOI 10.1370/afm.1377; Glasier A, 2008, J FAM PLAN REPROD H, V34, P213, DOI 10.1783/147118908786000497; Gupta S, 2000, BRIT J FAM PLAN, V26, P81; Halpern V, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004317.pub3; Hippisley-Cox J, 2004, BRIT MED J, V329, P1267, DOI 10.1136/bmj.38279.588125.7C; Lader D, 2009, 41 NHS INF CTR; Lee JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027236; MacBride-Stewart SP, 2008, FAM PRACT, V25, P27, DOI 10.1093/fampra/cmm074; Majeed A, 1997, BRIT MED J, V315, P1515, DOI 10.1136/bmj.315.7121.1515; Mansour D, 1994, CONT REV OBSTET GYNE, V6, P89; Mansour D, 2010, EUR J CONTRACEP REPR, V15, P4, DOI 10.3109/13625180903427675; Mavranezouli I, 2008, HUM REPROD, V23, P1338, DOI 10.1093/humrep/den091; Middleton AJ, 2011, EUR J CONTRACEP REPR, V16, P311, DOI 10.3109/13625187.2011.580864; Millett C, 2007, PLOS MED, V4, P1087, DOI 10.1371/journal.pmed.0040191; Millett C, 2007, J ROY SOC MED, V100, P275, DOI 10.1258/jrsm.100.6.275; Moran JL, 2011, J EVAL CLIN PRACT, V17, P45, DOI 10.1111/j.1365-2753.2010.01368.x; National Institute of Clinical Excellence (NICE), 2005, CG 30 LONG ACT REV C; NICE (National Institute for Health and Clinical Excellence), 2005, LONG ACT REV CONTR E; Peterson HB, 2005, NEW ENGL J MED, V353, P2169, DOI 10.1056/NEJMcp044148; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Saxena S, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-96; Sbarbaro JA, 2001, CLIN INFECT DIS, V33, pS240, DOI 10.1086/321856; Serumaga B, 2011, BRIT MED J      0101, V25, P342; Sonfield A, 2007, GUTTMACHER POLICY RE, V10, P19; Speidel JJ, 2008, CONTRACEPTION, V78, P197, DOI 10.1016/j.contraception.2008.06.001; Tanfer K, 2000, FAM PLANN PERSPECT, V32, P176, DOI 10.2307/2648234; TRUSSELL J, 1995, AM J PUBLIC HEALTH, V85, P494, DOI 10.2105/AJPH.85.4.494; Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021; Trussell J, 2009, BEST PRACT RES CL OB, V23, P199, DOI 10.1016/j.bpobgyn.2008.11.008; Trussell J, 2009, CONTRACEPTION, V79, P5, DOI 10.1016/j.contraception.2008.08.003; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD CONTR US 2011; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; Wellings K, 2007, CONTRACEPTION, V76, P208, DOI 10.1016/j.contraception.2007.05.085; Zhang F, 2009, J CLIN EPIDEMIOL, V62, P143, DOI 10.1016/j.jclinepi.2008.08.007	43	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92205	10.1371/journal.pone.0092205	http://dx.doi.org/10.1371/journal.pone.0092205			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24694949	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000016
J	Gao, JL; Cheung, RTF; Chan, YS; Chu, LW; Mak, HKF; Lee, TMC				Gao, Junling; Cheung, Raymond T. F.; Chan, Ying-Shing; Chu, Leung-Wing; Mak, Henry K. F.; Lee, Tatia M. C.			The Relevance of Short-Range Fibers to Cognitive Efficiency and Brain Activation in Aging and Dementia	PLOS ONE			English	Article							PROSPECTIVE MEMORY; ALZHEIMERS-DISEASE; STRUCTURAL CONNECTIVITY; DISCONNECTION SYNDROME; PREFRONTAL CORTEX; SMALL-WORLD; PERFORMANCE; DEFICITS; TRACTOGRAPHY; IMPAIRMENT	The integrity of structural connectivity in a functional brain network supports the efficiency of neural processing within relevant brain regions. This study aimed to quantitatively investigate the short- and long-range fibers, and their differential roles in the lower cognitive efficiency in aging and dementia. Three groups of healthy young, healthy older adults and patients with Alzheimer's disease (AD) participated in this combined functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI) study on prospective memory (PM). Short- and long-range fiber tracts within the PM task engaged brain networks were generated. The correlation between the fMRI signal change, PM performance and the DTI characters were calculated. FMRI results showed that the PM-specific frontal activations in three groups were distributed hierarchically along the rostrocaudal axis in the frontal lobe. In an overall PM condition generally activated brain network among the three groups, tractography was used to generate the short-range fibers, and they were found impaired in both healthy older adults and AD patients. However, the long-range fiber tracts were only impaired in AD. Additionally, the mean diffusivity (MD) of short- range but not long-range fibers was positively correlated with fMRI signal change and negatively correlated with the efficiency of PM performance. This study suggests that the disintegrity of short-range fibers may contribute more to the lower cognitive efficiency and higher compensatory brain activation in healthy older adults and more in AD patients.	[Gao, Junling; Cheung, Raymond T. F.; Chu, Leung-Wing] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Gao, Junling; Chu, Leung-Wing] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Cheung, Raymond T. F.; Chan, Ying-Shing] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China; [Chan, Ying-Shing] Univ Hong Kong, Li Ka Shing Fac Med, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Mak, Henry K. F.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Radiol, Hong Kong, Hong Kong, Peoples R China; [Lee, Tatia M. C.] Univ Hong Kong, Li Ka Shing Fac Med, Lab Cognit Affect Neurosci, Hong Kong, Hong Kong, Peoples R China; [Lee, Tatia M. C.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Lee, Tatia M. C.] Univ Hong Kong, Fac Social Sci, Neuropsychol Lab, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Cheung, RTF (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Hong Kong, Hong Kong, Peoples R China.	rtcheung@hku.hk	GAO, Junling/U-9633-2018; Mak, Henry Ka Fung/C-4362-2009	GAO, Junling/0000-0003-4024-4694; Mak, Henry Ka Fung/0000-0002-2007-0650	Stanley Ho Alumni Challenge Fund [20810027, 20731020]	Stanley Ho Alumni Challenge Fund	This study was supported by Stanley Ho Alumni Challenge Fund (20810027 & 20731020) awarded to Professor R. T. F. Cheung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2012, NEURON, V73, P595, DOI 10.1016/j.neuron.2011.12.025; Badre D, 2009, NAT NEUROSCI, V12, P515, DOI 10.1038/nn.2277; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bennett IJ, 2013, NEUROSCI BIOBEHAV R, V37, P1201, DOI 10.1016/j.neubiorev.2013.04.008; Blanco-Campal A, 2009, J INT NEUROPSYCH SOC, V15, P154, DOI 10.1017/S1355617708090127; Bozzali M, 2011, CURR MED CHEM, V18, P2452, DOI 10.2174/092986711795843263; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; CASE R, 1993, CONTRIB HUM DEV, V23, P71; Catani M, 2012, CORTEX, V48, P273, DOI 10.1016/j.cortex.2011.12.001; Chang J, 2014, PERS INDIV DIFFER, V56, P40, DOI 10.1016/j.paid.2013.08.016; Cheng HD, 2010, BEHAV NEUROSCI, V124, P152, DOI 10.1037/a0018306; Chua LW, 2009, J ALZHEIMERS DIS, V17, P223, DOI 10.3233/JAD-2009-1043; Delbeuck X, 2007, NEUROPSYCHOLOGIA, V45, P3315, DOI 10.1016/j.neuropsychologia.2007.05.001; Delprado J, 2013, PSYCHOL AGING, V28, P322, DOI 10.1037/a0029785; Desai MK, 2010, AM J PATHOL, V177, P1422, DOI 10.2353/ajpath.2010.100087; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Duchek JM, 2006, NEUROPSYCHOLOGY, V20, P633, DOI 10.1037/0894-4105.20.6.633; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; EINSTEIN GO, 1992, PSYCHOL AGING, V7, P471, DOI 10.1037/0882-7974.7.3.471; Farias ST, 2013, J INT NEUROPSYCH SOC, V19, P430, DOI 10.1017/S1355617712001609; Farina N, 2013, J CLIN EXP NEUROPSYC, V35, P983, DOI 10.1080/13803395.2013.844772; Farrow TFD, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00349; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fischer FU, 2012, J MAGN RESON IMAGING, V36, P84, DOI 10.1002/jmri.23621; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fuster JM, 2004, TRENDS COGN SCI, V8, P143, DOI 10.1016/j.tics.2004.02.004; Gallos LK, 2012, P NATL ACAD SCI USA, V109, P2825, DOI 10.1073/pnas.1106612109; Gao J, 2011, J ALZHEIMERS DIS; Gao JL, 2013, AGING NEUROPSYCHOL C, V20, P80, DOI 10.1080/13825585.2012.672948; Glascher J, 2009, NEUROINFORMATICS, V7, P73, DOI 10.1007/s12021-008-9042-x; Gordon BA, 2011, NEUROPSYCHOLOGIA, V49, P3795, DOI 10.1016/j.neuropsychologia.2011.09.035; Graf P, 2001, CONSCIOUS COGN, V10, P437, DOI 10.1006/ccog.2001.0504; Hachinski VC, 1983, DIFFERENTIAL DIAGNOS; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Heller R, 2007, NEUROIMAGE, V37, P1178, DOI 10.1016/j.neuroimage.2007.05.051; Huppert FA, 2000, APPL COGNITIVE PSYCH, V14, pS63, DOI 10.1002/acp.771; Jagust W, 2013, NEURON, V77, P219, DOI 10.1016/j.neuron.2013.01.002; Jeon HA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3041; Jones DT, 2011, NEUROLOGY, V77, P1524, DOI 10.1212/WNL.0b013e318233b33d; Kamagata K, 2013, MAGN RESON IMAGING, V31, P1501, DOI 10.1016/j.mri.2013.06.009; Kamminga J, 2014, J ALZHEIMERS DIS, V38, P669, DOI 10.3233/JAD-131118; Keihaninejad S, 2013, NEUROIMAGE, V72, P153, DOI 10.1016/j.neuroimage.2013.01.044; Kilimann I, 2013, CURR PHARM DESIGN, V19, P6416, DOI 10.2174/1381612811319360003; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Maier A, 2008, NAT NEUROSCI, V11, P1193, DOI 10.1038/nn.2173; McBride DM, 2013, AGING NEUROPSYCHOL C, V20, P700, DOI 10.1080/13825585.2013.765937; McDaniel MA, 2011, NEUROPSYCHOLOGIA, V49, P2147, DOI 10.1016/j.neuropsychologia.2010.12.029; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nezamzadeh M, 2010, EUR J RADIOL, V75, pE29, DOI 10.1016/j.ejrad.2009.06.019; Nunez P, 2010, BRAIN MIND STRUCTURE; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452; Rusted J, 2011, NEUROPSYCHOLOGIA, V49, P2362, DOI 10.1016/j.neuropsychologia.2011.04.009; Rypma B, 2006, NEUROIMAGE, V33, P969, DOI 10.1016/j.neuroimage.2006.05.065; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Schwindt GC, 2009, NEUROIMAGE, V45, P181, DOI 10.1016/j.neuroimage.2008.11.024; Sepulcre J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000808; Shukla DK, 2011, NEUROPSYCHOLOGIA, V49, P1378, DOI 10.1016/j.neuropsychologia.2011.02.022; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Stern Y, 2008, INT J PSYCHOL, V43, P536; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tamiya S, 1973, Nippon Ganka Gakkai Zasshi, V77, P413; Uretzky S, 2010, J COGNITIVE NEUROSCI, V22, P2745, DOI 10.1162/jocn.2010.21419; Uttl B., 2008, PLOS ONE, V3; Vallet GT, 2013, CORTEX, V49, P2402, DOI 10.1016/j.cortex.2012.10.010; Van der Linden M, 2004, EUR PSYCHIAT, V19, p107S; Voineskos AN, 2012, NEUROBIOL AGING, V33, P21, DOI 10.1016/j.neurobiolaging.2010.02.009; Wang RP, 2007, P INT SOC MAG RES, V3720; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; White L, 2014, J GERIATR PHYS THER, V37, P35, DOI 10.1519/JPT.0b013e3182862d2c; Yeterian EH, 2012, CORTEX, V48, P58, DOI 10.1016/j.cortex.2011.03.004; Ziegler DA, 2010, NEUROBIOL AGING, V31, P1912, DOI 10.1016/j.neurobiolaging.2008.10.015	78	21	22	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e90307	10.1371/journal.pone.0090307	http://dx.doi.org/10.1371/journal.pone.0090307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24694731	gold, Green Published			2022-12-27	WOS:000334103000008
J	Chen, JH; Jin, EH; He, W; Zhao, LQ				Chen, Jiang-Hong; Jin, Er-Hu; He, Wen; Zhao, Li-Qin			Combining Automatic Tube Current Modulation with Adaptive Statistical Iterative Reconstruction for Low-Dose Chest CT Screening	PLOS ONE			English	Article							FILTERED BACK-PROJECTION; IMAGE-QUALITY; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; REDUCTION; ALGORITHM; PATIENT; IMPACT; SIZE	Objective: To reduce radiation dose while maintaining image quality in low-dose chest computed tomography (CT) by combining adaptive statistical iterative reconstruction (ASIR) and automatic tube current modulation (ATCM). Methods: Patients undergoing cancer screening (n = 200) were subjected to 64-slice multidetector chest CT scanning with ASIR and ATCM. Patients were divided into groups 1, 2, 3, and 4 (n = 50 each), with a noise index (NI) of 15, 20, 30, and 40, respectively. Each image set was reconstructed with 4 ASIR levels (0% ASIR, 30% ASIR, 50% ASIR, and 80% ASIR) in each group. Two radiologists assessed subjective image noise, image artifacts, and visibility of the anatomical structures. Objective image noise and signal-to-noise ratio (SNR) were measured, and effective dose (ED)was recorded. Results: Increased NI was associated with increased subjective and objective image noise results (P<0.001), and SNR decreased with increasing NI (P<0.001). These values improved with increased ASIR levels (P, <0.001). Images from all 4 groups were clinically diagnosable. Images with NI = 30 and 50% ASIR had average subjective image noise scores and nearly average anatomical structure visibility scores, with a mean objective image noise of 23.42 HU. The EDs for groups 1, 2, 3 and 4 were 2.79 +/- 1.17, 1.69 +/- 0.59, 0.74 +/- 0.29, and 0.37 +/- 0.22 mSv, respectively. Compared to group 1 (NI = 15), the ED reductions were 39.43%, 73.48%, and 86.74% for groups 2, 3, and 4, respectively. Conclusions: Using NI = 30 with 50% ASIR in the chest CT protocol, we obtained average or above-average image quality but a reduced ED.	[Chen, Jiang-Hong; Jin, Er-Hu; He, Wen; Zhao, Li-Qin] Capital Med Univ, Beijing Friendship Hosp, Dept Radiol, Beijing, Peoples R China	Capital Medical University	Jin, EH (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Radiol, Beijing, Peoples R China.	erhujin1@hotmail.com						Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Baumueller S, 2012, EUR RADIOL, V22, P2597, DOI 10.1007/s00330-012-2524-0; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Carr SR, 2012, J THORAC CARDIOV SUR, V143, P390, DOI 10.1016/j.jtcvs.2011.10.023; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; Desai GS, 2012, EUR RADIOL, V22, P1631, DOI 10.1007/s00330-012-2424-3; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Ghetti C, 2012, PHYS MEDICA, V28, P161, DOI 10.1016/j.ejmp.2011.03.003; Hall EJ, 2008, BRIT J RADIOL, V81, P362, DOI 10.1259/bjr/01948454; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; Heyer CM, 2007, RADIOLOGY, V245, P577, DOI 10.1148/radiol.2452061919; Hu XH, 2011, CLIN RADIOL, V66, P1023, DOI 10.1016/j.crad.2011.04.008; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalra MK, 2004, RADIOLOGY, V232, P409, DOI 10.1148/radiol.2322031151; Kalra MK, 2004, RADIOLOGY, V230, P619, DOI 10.1148/radiol.2303021726; Katsura M, 2013, INVEST RADIOL, V48, P206, DOI 10.1097/RLI.0b013e31827efc3a; Kubo T, 2008, AM J ROENTGENOL, V190, P335, DOI 10.2214/AJR.07.2556; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; Lee Y, 2012, J COMPUT ASSIST TOMO, V36, P512, DOI 10.1097/RCT.0b013e318260ce39; Leipsic J, 2010, AM J ROENTGENOL, V195, P1095, DOI 10.2214/AJR.09.4050; Marin D, 2010, RADIOLOGY, V254, P145, DOI 10.1148/radiol.09090094; May MS, 2011, INVEST RADIOL, V46, P465, DOI 10.1097/RLI.0b013e31821690a1; McCollough CH, 2006, RADIOGRAPHICS, V26, P503, DOI 10.1148/rg.262055138; Mitsumori LM, 2012, EUR RADIOL, V22, P138, DOI 10.1007/s00330-011-2186-3; Neroladaki A, 2013, EUR RADIOL, V23, P360, DOI 10.1007/s00330-012-2627-7; Pontana F, 2011, EUR RADIOL, V21, P627, DOI 10.1007/s00330-010-1990-5; Pontana F, 2011, EUR RADIOL, V21, P636, DOI 10.1007/s00330-010-1991-4; Prakash P, 2010, RADIOLOGY, V256, P261, DOI 10.1148/radiol.10091487; Prakash P, 2010, J COMPUT ASSIST TOMO, V34, P40, DOI 10.1097/RCT.0b013e3181b26c67; Prakash P, 2010, KOREAN J RADIOL, V11, P46, DOI 10.3348/kjr.2010.11.1.46; Rampado O, 2012, EUR J RADIOL, V81, P3172, DOI 10.1016/j.ejrad.2012.06.017; Sagara Y, 2010, AM J ROENTGENOL, V195, P713, DOI 10.2214/AJR.09.2989; Singh S, 2011, RADIOLOGY, V259, P565, DOI 10.1148/radiol.11101450; Uppot RN, 2006, RADIOLOGY, V240, P435, DOI 10.1148/radiol.2402051110; Yanagawa M, 2012, EUR J RADIOL, V81, P2877, DOI 10.1016/j.ejrad.2011.09.011	37	22	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92414	10.1371/journal.pone.0092414	http://dx.doi.org/10.1371/journal.pone.0092414			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691208	gold, Green Published, Green Submitted			2022-12-27	WOS:000334101100022
J	Chung, LP; Baltic, S; Ferreira, M; Temple, S; Waterer, G; Thompson, PJ				Chung, Li Ping; Baltic, Svetlana; Ferreira, Manuel; Temple, Suzanna; Waterer, Grant; Thompson, Philip J.			Beta2 Adrenergic Receptor (ADRb beta) Haplotype Pair (2/4) Is Associated with Severe Asthma	PLOS ONE			English	Article							HUMAN BETA(2)-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; BRONCHODILATOR RESPONSE; CROHNS-DISEASE; CD14 PROMOTER; TOTAL IGE; POLYMORPHISMS; GENE; GENOTYPE; ALBUTEROL	Background: ss 2 adrenergic receptor (ADRb2) polymorphisms including ADRb2+46G > A have been reported to cause adverse outcomes in mild asthmatics. The extent to which ADRb2 polymorphisms and in particular their haplotypes contribute to severe asthma is unknown. Objective: To determine the association of ADRb2 polymorphisms and haplotypes with asthma severity. Methods: Caucasians (n = 2979) were genotyped for 11 ADRb2 polymorphisms. The cohort (mean age 39.6, 60% female) included 2296 non-asthmatics, 386 mild asthmatics, 172 moderate asthmatics and 125 severe asthmatics. Haplotype frequency and haplotype pair for each subject was determined using the PHASE algorithm. Results: The three asthmatic cohorts were comparable in age and gender but were distinguishable from each other in terms of symptoms, spirometry, medication use and health care utilisation (p < 0.001). None of the polymorphisms showed a genotypic or allelic association with asthma diagnosis or severity. Nine haplotypes were identified and no association was found with asthma diagnosis or severity per se. Haplotype pair 2/4 was associated with asthma severity (Trend Test, OR 1.42, p = 0.0008) but not with asthma per se. Prevalence of haplotype pair 2/2 appeared to decrease with asthma severity ( Trend Test, OR 0.78, p = 0.067). Two new haplotypes were identified, occurring exclusively in asthmatics at a frequency of >= 1%. In addition, a positive association between carriage of ADRb2 +523*C and increased risk of atopy was discovered. Conclusions: ADRb2 haplotype pair 2/4 is associated with severe asthma and is consistent with findings of poor bronchodilator response in mild asthmatics who are also haplotype 2/4.	[Chung, Li Ping; Baltic, Svetlana; Temple, Suzanna; Thompson, Philip J.] Univ Western Australia, Lung Inst Western Australia, Mol Genet & Inflammat Unit, Nedlands, WA 6009, Australia; [Chung, Li Ping; Baltic, Svetlana; Temple, Suzanna; Thompson, Philip J.] Univ Western Australia, Ctr Asthma Allergy & Resp Res, Nedlands, WA 6009, Australia; [Chung, Li Ping; Baltic, Svetlana; Temple, Suzanna; Waterer, Grant; Thompson, Philip J.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Ferreira, Manuel] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Thompson, Philip J.] Royal Perth Hosp, Dept Resp Med, Perth, WA 6001, Australia	University of Western Australia; University of Western Australia; University of Western Australia; QIMR Berghofer Medical Research Institute; Royal Perth Hospital; University of Western Australia	Chung, LP (corresponding author), Univ Western Australia, Lung Inst Western Australia, Mol Genet & Inflammat Unit, Nedlands, WA 6009, Australia.	lichung@liwa.uwa.edu.au	Ferreira, Manuel A R/D-3609-2013; Waterer, Grant/AAG-2385-2021	Ferreira, Manuel A R/0000-0001-9059-1825; Baltic, Svetlana/0000-0002-3428-940X	Lung Institute of Western Australia	Lung Institute of Western Australia	The funding for this report was derived from the Lung Institute of Western Australia as part of a PhD project. There were no external sources of funding that would otherwise affect the study design, data collection and analysis, decision to publish or presentation of the manuscript.	Anderson HR, 2005, BRIT MED J, V330, P117, DOI 10.1136/bmj.38316.729907.8F; Barbato E, 2007, HEART, V93, P856, DOI 10.1136/hrt.2006.091959; Beghe B, 2003, CLIN EXP ALLERGY, V33, P1111, DOI 10.1046/j.1365-2222.2003.01731.x; Bleecker ER, 2007, LANCET, V370, P2118, DOI 10.1016/S0140-6736(07)61906-0; Bleecker ER, 2006, J ALLERGY CLIN IMMUN, V118, P809, DOI 10.1016/j.jaci.2006.06.036; Brest P, 2010, CURR MOL MED, V10, P486, DOI 10.2174/156652410791608252; Brodde OE, 2001, CIRCULATION, V103, P1048, DOI 10.1161/01.CIR.103.8.1048; Buckova D, 2003, ALLERGY, V58, P1023, DOI 10.1034/j.1398-9995.2003.00271.x; Carroll CL, 2012, J ASTHMA, V49, P563, DOI 10.3109/02770903.2012.701362; Chung L, 2010, CLIN EXP AL IN PRESS; Deretic V, 2011, CURR OPIN IMMUNOL; Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; GREEN SA, 1993, J BIOL CHEM, V268, P23116; Hawkins GA, 2006, AM J RESP CRIT CARE, V174, P1101, DOI 10.1164/rccm.200509-1405OC; Heinzmann A, 2003, J ALLERGY CLIN IMMUN, V112, P735, DOI 10.1016/S0091-6749(03)01887-6; Holloway JW, 2000, CLIN EXP ALLERGY, V30, P1097; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Israel E, 2001, INT ARCH ALLERGY IMM, V124, P183, DOI 10.1159/000053705; Kabesch M, 2004, CLIN EXP ALLERGY, V34, P340, DOI 10.1111/j.1365-2222.2004.01860.x; Kabesch M, 2003, J ALLERGY CLIN IMMUN, V112, P893, DOI 10.1016/j.jaci.2003.08.033; Kedda MA, 2004, J ALLERGY CLIN IMMUN, V113, P889, DOI 10.1016/j.jaci.2004.02.008; KOBILKA BK, 1987, J BIOL CHEM, V262, P7321; Leung TF, 2003, PEDIAT ALLERG IMM-UK, V14, P255, DOI 10.1034/j.1399-3038.2003.00048.x; Manoharan A, 2013, ANN ALLERG ASTHMA IM, V110, P161, DOI 10.1016/j.anai.2012.12.019; Martinez FD, 1997, J CLIN INVEST, V100, P3184, DOI 10.1172/JCI119874; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McGraw DW, 1998, J CLIN INVEST, V102, P1927, DOI 10.1172/JCI4862; Moffatt MF, 2004, CLIN EXP ALLERGY, V34, P325, DOI 10.1111/j.1365-2222.2004.01915.x; Moore PE, 2008, CTS-CLIN TRANSL SCI, V1, P155, DOI 10.1111/j.1752-8062.2008.00036.x; O'Donnell AR, 2004, AM J RESP CRIT CARE, V169, P615, DOI 10.1164/rccm.200302-278OC; Palmer CNA, 2006, THORAX, V61, P940, DOI 10.1136/thx.2006.059386; Panebra A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011819; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Proceedings of the ATS workshop on refractory asthma, 2000, AM J RESP CRIT CARE, V162, P2341, DOI DOI 10.1164/AJRCCM.162.6.ATS9-00; Qiu YY, 2010, ALLERGY ASTHMA PROC, V31, pE91, DOI 10.2500/aap.2010.31.3371; REIHSAUS E, 1993, AM J RESP CELL MOL, V8, P334, DOI 10.1165/ajrcmb/8.3.334; Silverman EK, 2003, J ALLERGY CLIN IMMUN, V112, P870, DOI 10.1016/S0091-6749(03)02023-2; Tan S, 1997, LANCET, V350, P995, DOI 10.1016/S0140-6736(97)03211-X; Taylor DR, 2000, THORAX, V55, P762, DOI 10.1136/thorax.55.9.762; Taylor DR, 2005, AM J RESP CRIT CARE, V172, P700, DOI 10.1164/rccm.200501-092OC; Torjussen TM, 2013, ACTA PAEDIATR, V102, P727, DOI 10.1111/apa.12221; Wan YI, 2012, THORAX, V67, P762, DOI 10.1136/thoraxjnl-2011-201262; Wechsler ME, 2006, AM J RESP CRIT CARE, V173, P519, DOI 10.1164/rccm.200509-1519OC; Wechsler ME, 2009, LANCET, V374, P1754, DOI 10.1016/S0140-6736(09)61492-6; Weir TD, 1998, AM J RESP CRIT CARE, V158, P787, DOI 10.1164/ajrccm.158.3.9801035; Weiss ST, 2006, PHARMACOGENOMICS J, V6, P311, DOI 10.1038/sj.tpj.6500387; Westland R, 2004, IMMUNOGENETICS, V56, P625, DOI 10.1007/s00251-004-0732-8; Wilson AM, 2006, ALLERGY, V61, P254, DOI 10.1111/j.1398-9995.2006.01001.x; Woo JG, 2003, J ALLERGY CLIN IMMUN, V112, P438, DOI 10.1067/mai.2003.1634; Woszczek G, 2005, ALLERGY, V60, P1412, DOI 10.1111/j.1398-9995.2005.00869.x	54	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93695	10.1371/journal.pone.0093695	http://dx.doi.org/10.1371/journal.pone.0093695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691493	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100127
J	Han, S; Meng, LX; Han, S; Wang, YJ; Wu, AH				Han, Sheng; Meng, Lingxuan; Han, Shuai; Wang, Yunjie; Wu, Anhua			Plasma IGFBP-2 Levels after Postoperative Combined Radiotherapy and Chemotherapy Predict Prognosis in Elderly Glioblastoma Patients	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-2; SERUM-LEVELS; GROWTH; EXPRESSION; PROLIFERATION; SURVIVAL; CELLS; TEMOZOLOMIDE; PROGRESSION; MARKERS	It has been found that preoperative plasma IGFBP-2 levels correlate with prognosis in glioma patients. The prognostic value of plasma IGFBP-2 after postoperative combined radiotherapy and chemotherapy in glioma patients is unknown. Plasma IGFBP-2 levels in 83 glioblastoma patients after postoperative radiotherapy plus chemotherapy were analyzed using an IGFBP-2 ELISA kit. We found that after standard therapy plasma IGFBP-2 levels significantly correlated with the patient's age (R =0.738, P < 0.001) and Karnofsky performance status (KPS, R = -0.633, P < 0.05). Cox proportional hazards models were used to calculate hazard ratios (HRs) of death according to plasma IGFBP-2 levels adjusted for patient clinical characteristics. Plasma IGFBP-2 levels significantly correlated with overall survival in glioblastoma patients (multivariate HR=1.035; 95% CI, 1.024-1.047; P < 0.001). The effect of plasma IGFBP-2 levels on survival seemed to differ according to patients' age. Among patients older than 60, high plasma IGFBP-2 levels were associated with a significant increase in overall mortality (HR = 1.097; 95% CI, 1.055-1.140; P < 0.001). In contrast, plasma IGFBP-2 levels conferred no significant effect on mortality among patients younger than 60. Elevated plasma IGFBP-2 levels after combined postoperative radiotherapy and chemotherapy in elderly glioblastoma patients correlate with poor KPS score and predicts poor prognosis.	[Han, Sheng; Meng, Lingxuan; Han, Shuai; Wang, Yunjie; Wu, Anhua] China Med Univ, Hosp 1, Dept Neurosurg, Shenyang, Peoples R China	China Medical University	Wu, AH (corresponding author), China Med Univ, Hosp 1, Dept Neurosurg, Shenyang, Peoples R China.	cmuwuanhua@aliyun.com			National High Technology Research and Development Program of China (863) [2012AA02A508]; National Natural Science Foundation of China [81172409]; Science and Technology Department of Liaoning Province [2011225034]	National High Technology Research and Development Program of China (863)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Liaoning Province	This work was supported by grants from the National High Technology Research and Development Program of China (863) (No. 2012AA02A508), National Natural Science Foundation of China (No. 81172409) and Science and Technology Department of Liaoning Province (No. 2011225034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin S, 2007, J BONE MINER RES, V22, P799, DOI 10.1359/JBMR.070306; Azar WJ, 2014, ONCOGENE, V33, P578, DOI 10.1038/onc.2012.630; Carico C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033684; Chakrabarty S, 2006, CANCER BIOL THER, V5, P189, DOI 10.4161/cbt.5.2.2333; Chatterjee S, 2004, INT J UROL, V11, P876, DOI 10.1111/j.1442-2042.2004.00898.x; Clemmons DR, 2007, ENDOCRIN METAB CLIN, V36, P109, DOI 10.1016/j.ecl.2006.11.008; Duarte CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029653; Foulstone EJ, 2013, ENDOCRINOLOGY, V154, P1780, DOI 10.1210/en.2012-1970; Han S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.433; Han S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076717; Hoeflich A, 2003, HORM METAB RES, V35, P816; Hoeflich A, 2001, CANCER RES, V61, P8601; Hu DL, 2009, J AM GERIATR SOC, V57, P1213, DOI 10.1111/j.1532-5415.2009.02318.x; Iliadis G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-3; Kitszel A, 2007, ADV MED SCI-POLAND, V52, P147; Kulkarni A, 2012, PATHOL ONCOL RES, V18, P961, DOI 10.1007/s12253-012-9526-8; Lancaster JM, 2006, INT J GYNECOL CANCER, V16, P1529, DOI 10.1111/j.1525-1438.2006.00623.x; Li SW, 2012, NEURO-ONCOLOGY, V14, P109, DOI 10.1093/neuonc/nor185; Lin Y, 2009, NEURO-ONCOLOGY, V11, P468, DOI 10.1215/15228517-2008-114; Malkoun N, 2012, J NEURO-ONCOL, V106, P127, DOI 10.1007/s11060-011-0643-0; Mattsson A, 2008, GROWTH HORM IGF RES, V18, P506, DOI 10.1016/j.ghir.2008.04.005; Natsume A, 2012, ONCOGENE, V31, P2715, DOI 10.1038/onc.2011.466; Quaranta M, 2007, TUMORI J, V93, P275; Russo VC, 2005, ENDOCRINOLOGY, V146, P4445, DOI 10.1210/en.2005-0467; Santosh V, 2010, CANCER EPIDEM BIOMAR, V19, P1399, DOI 10.1158/1055-9965.EPI-09-1213; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; van den Beld AW, 2003, EUR J ENDOCRINOL, V148, P627, DOI 10.1530/eje.0.1480627; Wang YZ, 2012, NEURO-ONCOLOGY, V14, P518, DOI 10.1093/neuonc/nor232; Zhang JX, 2011, NEURO-ONCOLOGY, V13, P600, DOI 10.1093/neuonc/nor034; Zhang W, 2002, BRAIN PATHOL, V12, P87; Zhou YH, 2005, NEURO-ONCOLOGY, V7, P485, DOI 10.1215/S1152851704000730	31	15	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93791	10.1371/journal.pone.0093791	http://dx.doi.org/10.1371/journal.pone.0093791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690948	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100135
J	Provencal, N; Suderman, MJ; Guillemin, C; Vitaro, F; Cote, SM; Hallett, M; Tremblay, RE; Szyf, M				Provencal, Nadine; Suderman, Matthew J.; Guillemin, Claire; Vitaro, Frank; Cote, Sylvana M.; Hallett, Michael; Tremblay, Richard E.; Szyf, Moshe			Association of Childhood Chronic Physical Aggression with a DNA Methylation Signature in Adult Human T Cells	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR; DEVELOPMENTAL ORIGINS; CHROMATIN-STRUCTURE; PRENATAL EXPOSURE; TRAJECTORIES; WIDE; BEHAVIOR; EXPRESSION; SEROTONIN; DOPAMINE	Background: Chronic physical aggression ( CPA) is characterized by frequent use of physical aggression from early childhood to adolescence. Observed in approximately 5% of males, CPA is associated with early childhood adverse environments and long-term negative consequences. Alterations in DNA methylation, a covalent modification of DNA that regulates genome function, have been associated with early childhood adversity. Aims: To test the hypothesis that a trajectory of chronic physical aggression during childhood is associated with a distinct DNA methylation profile during adulthood. Methods: We analyzed genome-wide promoter DNA methylation profiles of T cells from two groups of adult males assessed annually for frequency of physical aggression between 6 and 15 years of age: a group with CPA and a control group. Methylation profiles covering the promoter regions of 20 000 genes and 400 microRNAs were generated using MeDIP followed by hybridization to microarrays. Results: In total, 448 distinct gene promoters were differentially methylated in CPA. Functionally, many of these genes have previously been shown to play a role in aggression and were enriched in biological pathways affected by behavior. Their locations in the genome tended to form clusters spanning millions of bases in the genome. Conclusions: This study provides evidence of clustered and genome-wide variation in promoter DNA methylation in young adults that associates with a history of chronic physical aggression from 6 to 15 years of age. However, longitudinal studies of methylation during early childhood will be necessary to determine if and how this methylation variation in T cells DNA plays a role in early development of chronic physical aggression.	[Provencal, Nadine; Suderman, Matthew J.; Guillemin, Claire; Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Provencal, Nadine; Guillemin, Claire; Vitaro, Frank; Cote, Sylvana M.; Tremblay, Richard E.] Univ Montreal, Res Unit Childrens Psychosocial Maladjustment, Montreal, PQ, Canada; [Provencal, Nadine; Guillemin, Claire; Vitaro, Frank; Cote, Sylvana M.; Tremblay, Richard E.] Univ Montreal, St Justine Hosp Res Ctr, Montreal, PQ, Canada; [Provencal, Nadine; Suderman, Matthew J.; Guillemin, Claire; Szyf, Moshe] McGill Univ, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Montreal, Dept Psychol & Pediat, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin, Ireland; [Suderman, Matthew J.; Hallett, Michael] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Vitaro, Frank] Univ Montreal, Sch Psychoeduc, Montreal, PQ, Canada; [Cote, Sylvana M.] Univ Montreal, Sch Social & Prevent Med, Montreal, PQ, Canada	McGill University; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; McGill University; Universite de Montreal; University College Dublin; McGill University; Universite de Montreal; Universite de Montreal	Tremblay, RE (corresponding author), Univ Montreal, Res Unit Childrens Psychosocial Maladjustment, Montreal, PQ, Canada.	richard.tremblay@ucd.ie; moshe.szyf@mcgill.ca	Tremblay, Richard E./O-1360-2014; Côté, Sylvana M./T-4600-2019; Cote, Silvana Maria/O-1356-2014	Côté, Sylvana M./0000-0001-7944-0647; Suderman, Matthew/0000-0002-2715-9930; Hallett, Michael/0000-0001-6738-6786; Provencal, Nadine/0000-0002-2079-8393	Genes, Environment, and Health Training Program from CIHR; Quebec Training Network in Perinatal Research (QTNPR) Program from CIHR; Canadian Institutes of Health Research; Social Sciences Humanities Research Council of Canada; Quebec Health Research Fund (FRSQ); Quebec Social Science and Culture Fund (FQRSC); Canadian Institutes of Health Research [MOP-42411]; Sackler Program in Psychobiology and Epigenetics at McGill University; Canadian Institute for Advanced Research	Genes, Environment, and Health Training Program from CIHR(Canadian Institutes of Health Research (CIHR)); Quebec Training Network in Perinatal Research (QTNPR) Program from CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Social Sciences Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Quebec Health Research Fund (FRSQ)(Fonds de la Recherche en Sante du Quebec); Quebec Social Science and Culture Fund (FQRSC); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Sackler Program in Psychobiology and Epigenetics at McGill University; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR))	This work was supported by a fellowship from the Genes, Environment, and Health Training Program from CIHR to NP; a fellowship from the Quebec Training Network in Perinatal Research (QTNPR) Program from CIHR to CG; grants from the Canadian Institutes of Health Research; the Social Sciences Humanities Research Council of Canada; the Quebec Health Research Fund (FRSQ) and the Quebec Social Science and Culture Fund (FQRSC) to RET and SMC; and grants from the Canadian Institutes of Health Research MOP-42411, the Sackler Program in Psychobiology and Epigenetics at McGill University, and the Canadian Institute for Advanced Research to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alink LRA, 2006, CHILD DEV, V77, P954, DOI 10.1111/j.1467-8624.2006.00912.x; Alleva E, 1998, EUR J NEUROSCI, V10, P3664, DOI 10.1046/j.1460-9568.1998.00377.x; Arsenio W. F., 2004, MONOGRAPHS SOC RES C, V69, P1, DOI DOI 10.1111/J.0037-976X.2004.00312.X; Barker ED, 2008, ARCH GEN PSYCHIAT, V65, P1185, DOI 10.1001/archpsyc.65.10.1185; Barker ED, 2007, ARCH GEN PSYCHIAT, V64, P592, DOI 10.1001/archpsyc.64.5.592; Bell CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014040; Bennett AJ, 2002, MOL PSYCHIATR, V7, P118, DOI 10.1038/sj/mp/4000949; Berlivet S, 2012, HUM GENET; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Borghol N, 2006, GENOMICS, V87, P417, DOI 10.1016/j.ygeno.2005.10.008; Borghol N, 2012, INT J EPIDEMIOL, V41, P62, DOI 10.1093/ije/dyr147; Brendgen M, 2008, CHILD DEV, V79, P13, DOI 10.1111/j.1467-8624.2007.01108.x; Broidy LM, 2003, DEV PSYCHOL, V39, P222, DOI 10.1037/0012-1649.39.2.222; Campbell SB, 2006, J CHILD PSYCHOL PSYC, V47, P791, DOI 10.1111/j.1469-7610.2006.01636.x; Campbell SB, 2010, DEV PSYCHOPATHOL, V22, P133, DOI 10.1017/S0954579409990319; Cheng ASL, 2008, CANCER RES, V68, P1786, DOI 10.1158/0008-5472.CAN-07-5547; Cheung HH, 2010, BRIT J CANCER, V102, P419, DOI 10.1038/sj.bjc.6605505; Cote SM, 2007, ARCH GEN PSYCHIAT, V64, P1305, DOI 10.1001/archpsyc.64.11.1305; Cote SM, 2006, J ABNORM CHILD PSYCH, V34, P71, DOI 10.1007/s10802-005-9001-z; David S, 2011, CANCER BIOMARK, V9, P493, DOI 10.3233/CBM-2011-0169; de Almeida RMM, 2005, EUR J PHARMACOL, V526, P51, DOI 10.1016/j.ejphar.2005.10.004; Dionne G, 2003, DEV PSYCHOL, V39, P261, DOI 10.1037/0012-1649.39.2.261; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Falkenberg VR, 2011, NEUROMOL MED, V13, P66, DOI 10.1007/s12017-010-8138-2; Feber A, 2011, GENOME RES, V21, P515, DOI 10.1101/gr.109678.110; Ferris CF, 2006, PHARMACOL BIOCHEM BE, V83, P169, DOI 10.1016/j.pbb.2006.01.001; Ferris Craig, 2005, Novartis Foundation Symposium, V268, P190; Flanagan JM, 2010, AM J HUM GENET, V86, P420, DOI 10.1016/j.ajhg.2010.02.008; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gunther T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000935; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Guo G, 2007, HUM GENET, V121, P125, DOI 10.1007/s00439-006-0244-8; Hassanain M, 2005, BRAIN RES, V1048, P1, DOI 10.1016/j.brainres.2005.04.086; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Hicks BM, 2004, ARCH GEN PSYCHIAT, V61, P922, DOI 10.1001/archpsyc.61.9.922; Hiura H, 2010, NUCLEIC ACIDS RES, V38, P4929, DOI 10.1093/nar/gkq200; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Jia Jinsong, 2010, BMC Res Notes, V3, P240, DOI 10.1186/1756-0500-3-240; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Ke X, 2006, PHYSIOL GENOMICS, V25, P16, DOI 10.1152/physiolgenomics.00093.2005; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Kim-Cohen J, 2006, MOL PSYCHIATR, V11, P903, DOI 10.1038/sj.mp.4001851; Kinnally EL, 2011, BRAIN BEHAV IMMUN; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Kokko K, 2009, J RES ADOLESCENCE, V19, P9, DOI 10.1111/j.1532-7795.2009.00579.x; Lempiainen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018216; Liu YL, 2009, EPIGENETICS-US, V4, P500, DOI 10.4161/epi.4.7.9925; MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004; McGowan PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014739; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Miczek KA, 2005, BIOL AGGRESSION; Morris MR, 2011, ONCOGENE, V30, P1390, DOI 10.1038/onc.2010.525; Movassagh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008564; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Murphy DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008154; Nagin D, 1999, CHILD DEV, V70, P1181, DOI 10.1111/1467-8624.00086; Nagin DS, 2001, ARCH GEN PSYCHIAT, V58, P389, DOI 10.1001/archpsyc.58.4.389; Nair SS, 2011, EPIGENETICS-US, V6, P34, DOI 10.4161/epi.6.1.13313; Navarro JF, 2006, EUR J PHARMACOL, V551, P67, DOI 10.1016/j.ejphar.2006.08.055; Nelson RJ, 2001, TRENDS NEUROSCI, V24, P713, DOI 10.1016/S0166-2236(00)01996-2; Ngwa Julius S, 2011, BMC Proc, V5 Suppl 9, pS18, DOI 10.1186/1753-6561-5-S9-S18; Novak JP, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-27; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Pavlov KA, 2011, J APPL GENET; Pesce M, 2011, J BIOL REG HOMEOS AG, V25, P323; Pingault JB, 2011, AM J PSYCHIAT; Provencal N, 2012, J NEUROSCI; Provencal N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071691; Provencal N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069481; Rajendram R, 2011, EPIGENETICS-US, V6, P410, DOI 10.4161/epi.6.4.14763; RAZIN A, 1984, BIOCHIM BIOPHYS ACTA, V782, P331, DOI 10.1016/0167-4781(84)90043-5; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Robinson MD, 2010, GENOME RES, V20, P1719, DOI 10.1101/gr.110601.110; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Seguin JR, 1999, J CHILD PSYCHOL PSYC, V40, P1197, DOI 10.1111/1469-7610.00536; Siegel A, 2007, CURR NEUROPHARMACOL, V5, P135, DOI 10.2174/157015907780866929; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Smith AK, 2011, AM J MED GENET B, V156B, P700, DOI 10.1002/ajmg.b.31212; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sweet RA, 1998, ARCH NEUROL-CHICAGO, V55, P1335, DOI 10.1001/archneur.55.10.1335; Szyf M, 2011, EPIGENETICS-US, V6, P971, DOI 10.4161/epi.6.8.16793; Takahashi A., 2012, CURR TOP BEHAV NEURO; Takeshima H, 2009, GENOME RES, V19, P1974, DOI 10.1101/gr.093310.109; Tomazou EM, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-19; Tremblay RE, 2010, EPIGENOMICS-UK, V2, P495, DOI 10.2217/EPI.10.40; Tremblay RE, 2010, J CHILD PSYCHOL PSYC, V51, P341, DOI 10.1111/j.1469-7610.2010.02211.x; Tsai KW, 2009, EPIGENETICS-US, V4, P587, DOI 10.4161/epi.4.8.10230; Tsui DWY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015069; Uddin M, 2011, PSYCHOL MED, V41, P997, DOI 10.1017/S0033291710001674; Uddin M, 2010, P NATL ACAD SCI USA, V107, P9470, DOI 10.1073/pnas.0910794107; Vage J, 2010, GENES BRAIN BEHAV, V9, P372, DOI 10.1111/j.1601-183X.2010.00568.x; van Ijzendoorn MH, 2010, BIOL PSYCHIAT, V68, P405, DOI 10.1016/j.biopsych.2010.05.008; van Lier PAC, 2007, J CHILD PSYCHOL PSYC, V48, P601, DOI 10.1111/j.1469-7610.2006.01724.x; Vaughn MG, 2009, CRIM JUSTICE BEHAV, V36, P1113, DOI 10.1177/0093854809342839; Wang DX, 2012, AQUAT ECOSYST HEALTH, V15, P4, DOI 10.1080/14634988.2012.663631; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weaver ICG, 2004, ANN NY ACAD SCI, V1024, P182, DOI 10.1196/annals.1321.099; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yang L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-10; Yukawa K, 2005, INT J MOL MED, V15, P819; Zalcman SS, 2006, BRAIN BEHAV IMMUN, V20, P507, DOI 10.1016/j.bbi.2006.05.002; Zhang S, 2006, STAT APPL GENET MOL, V5	107	62	64	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e89839	10.1371/journal.pone.0089839	http://dx.doi.org/10.1371/journal.pone.0089839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6KM	24691403	Green Published, gold			2022-12-27	WOS:000334101100006
J	Sridhar, A; de Boer, HL; van den Berg, A; Le Gac, S				Sridhar, Adithya; de Boer, Hans L.; van den Berg, Albert; Le Gac, Severine			Microstamped Petri Dishes for Scanning Electrochemical Microscopy Analysis of Arrays of Microtissues	PLOS ONE			English	Article							OXYGEN-CONSUMPTION; CELLULAR-ACTIVITY; SOFT LITHOGRAPHY; EMBRYOID BODIES; LIVING CELLS; CULTURE; RESPIRATION; TISSUE; MOLDS; CHIP	While scanning electrochemical microscopy (SECM) is a powerful technique for non-invasive analysis of cells, SECM-based assays remain scarce and have been mainly limited so far to single cells, which is mostly due to the absence of suitable platform for experimentation on 3D cellular aggregates or microtissues. Here, we report stamping of a Petri dish with a microwell array for large-scale production of microtissues followed by their in situ analysis using SECM. The platform is realized by hot embossing arrays of microwells (200 mu m depth; 400 mu m diameter) in commercially available Petri dishes, using a PDMS stamp. Microtissues form spontaneously in the microwells, which is demonstrated here using various cell lines (e. g., HeLa, C2C12, HepG2 and MCF-7). Next, the respiratory activity of live HeLa microtissues is assessed by monitoring the oxygen reduction current in constant height mode and at various distances above the platform surface. Typically, at a 40 mu m distance from the microtissue, a 30% decrease in the oxygen reduction current is measured, while above 250 mu m, no influence of the presence of the microtissues is detected. After exposure to a model drug (50% ethanol), no such changes in oxygen concentration are found at any height in solution, which reflects that microtissues are not viable anymore. This is furthermore confirmed using conventional live/dead fluorescent stains. This live/dead assay demonstrates the capability of the proposed approach combining SECM and microtissue arrays formed in a stamped Petri dish for conducting cellular assays in a non-invasive way on 3D cellular models.	[Sridhar, Adithya; de Boer, Hans L.; van den Berg, Albert; Le Gac, Severine] Univ Twente, MESA Inst Nanotechnol, BIOS Lab Chip Grp, NL-7500 AE Enschede, Netherlands	University of Twente	Le Gac, S (corresponding author), Univ Twente, MESA Inst Nanotechnol, BIOS Lab Chip Grp, POB 217, NL-7500 AE Enschede, Netherlands.	s.legac@utwente.nl	van den Berg, Albert/B-4648-2013; Sridhar, Adithya/AAU-9891-2021; Le Gac, Séverine/B-7806-2013	van den Berg, Albert/0000-0001-9019-933X; Sridhar, Adithya/0000-0003-2986-4884; Le Gac, Séverine/0000-0002-4546-6184	eLab4Life ERC advanced grant	eLab4Life ERC advanced grant	This work is supported by the eLab4Life ERC advanced grant of Prof. van den Berg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amphlett JL, 1998, J PHYS CHEM B, V102, P9946, DOI 10.1021/jp982829u; Beaulieu I, 2011, ANAL CHEM, V83, P1485, DOI 10.1021/ac101906a; Bergner S, 2013, ANAL CHIM ACTA, V775, P1, DOI 10.1016/j.aca.2012.12.042; Berthier E, 2012, LAB CHIP, V12, P1224, DOI 10.1039/c2lc20982a; Date Y, 2011, BIOSENS BIOELECTRON, V30, P100, DOI 10.1016/j.bios.2011.08.037; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Goral VN, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/1/017002; Higuchi A, 2006, J BIOMED MATER RES A, V79A, P380, DOI 10.1002/jbm.a.30773; Ino K, 2012, ANGEW CHEM INT EDIT, V51, P6648, DOI 10.1002/anie.201201602; Kaya T, 2003, BIOSENS BIOELECTRON, V18, P1379, DOI 10.1016/S0956-5663(03)00083-6; Kuss S, 2013, P NATL ACAD SCI USA, V110, P9249, DOI 10.1073/pnas.1214809110; Li X, 2009, J ELECTROANAL CHEM, V628, P35, DOI 10.1016/j.jelechem.2009.01.002; Liu B, 2000, P NATL ACAD SCI USA, V97, P9855, DOI 10.1073/pnas.97.18.9855; Malek CK, 2007, MICROSYST TECHNOL, V13, P475, DOI 10.1007/s00542-006-0184-1; Matsumae Y, 2013, CHEM COMMUN, V49, P6498, DOI 10.1039/c3cc43126f; Mauzeroll J, 2003, ANAL CHEM, V75, P3880, DOI 10.1021/ac034088l; Mehta G, 2012, J CONTROL RELEASE, V164, P192, DOI 10.1016/j.jconrel.2012.04.045; Mehta G, 2009, ANAL CHEM, V81, P3714, DOI 10.1021/ac802178u; Moresco J, 2010, SENSOR ACTUAT B-CHEM, V145, P698, DOI 10.1016/j.snb.2010.01.020; Obregon R, 2012, TALANTA, V94, P30, DOI 10.1016/j.talanta.2012.01.059; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Rivron NC, 2009, MICRO TAS, V2009, P9; Rivron NC, 2012, P NATL ACAD SCI USA, V109, P6886, DOI 10.1073/pnas.1201626109; Roberts WS, 2007, BIOSENS BIOELECTRON, V23, P301, DOI 10.1016/j.bios.2007.06.020; Shiku H, 2004, ANAL CHIM ACTA, V522, P51, DOI 10.1016/j.aca.2004.06.054; Shiku H, 2001, ANAL CHEM, V73, P3751, DOI 10.1021/ac010339j; Shiku H, 2009, ANALYST, V134, P182, DOI 10.1039/b808428a; Stephens DJ, 2003, SCIENCE, V300, P82, DOI 10.1126/science.1082160; Sun P, 2007, PHYS CHEM CHEM PHYS, V9, P802, DOI 10.1039/b612259k; Torisawa YS, 2007, BIOMATERIALS, V28, P559, DOI 10.1016/j.biomaterials.2006.08.054; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; Wang YL, 2011, LAB CHIP, V11, P3089, DOI 10.1039/c1lc20281b; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yasukawa T, 1998, CHEM LETT, P767, DOI 10.1246/cl.1998.767; Young EWK, 2011, ANAL CHEM, V83, P1408, DOI 10.1021/ac102897h; Zhan DP, 2013, J ELECTROANAL CHEM, V688, P61, DOI 10.1016/j.jelechem.2012.07.008	36	24	26	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93618	10.1371/journal.pone.0093618	http://dx.doi.org/10.1371/journal.pone.0093618			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690887	Green Submitted, Green Published, gold			2022-12-27	WOS:000334101100112
J	Lind, C; Russell, ML; MacDonald, J; Collins, R; Frank, CJ; Davis, AE				Lind, Candace; Russell, Margaret L.; MacDonald, Judy; Collins, Ramona; Frank, Christine J.; Davis, Amy E.			School-Based Influenza Vaccination: Parents' Perspectives	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; SEASONAL INFLUENZA; HERD-IMMUNITY; CHILDREN; IMPACT; SCHOOLCHILDREN; IMMUNIZATION; ADULTS; HOSPITALIZATION; INFORMATION	Background: School-age children are important drivers of annual influenza epidemics yet influenza vaccination coverage of this population is low despite universal publicly funded influenza vaccination in Alberta, Canada. Immunizing children at school may potentially increase vaccine uptake. As parents are a key stakeholder group for such a program, it is important to consider their concerns. Purpose: We explored parents' perspectives on the acceptability of adding an annual influenza immunization to the immunization program that is currently delivered in Alberta schools, and obtained suggestions for structuring such a program. Participants: Forty-eight parents of children aged 5-18 years participated in 9 focus groups. Participants lived in urban areas of the Alberta Health Services Calgary Zone. Findings: Three major themes emerged: Advantages of school-based influenza vaccination (SBIV), Disadvantages of SBIV, and Implications for program design & delivery. Advantages were perceived to occur for different populations: children (e.g. emotional support), families (e.g. convenience), the community (e.g. benefits for school and multicultural communities), the health sector (e.g. reductions in costs due to burden of illness) and to society at large (e.g. indirect conduit of information about health services, building structure for pandemic preparedness, building healthy lifestyles). Disadvantages, however, might also occur for children (e.g. older children less likely to be immunized), families (e.g. communication challenges, perceived loss of parental control over information, choices and decisions) and the education sector (loss of instructional time). Nine second-level themes emerged within the major theme of Implications for program design & delivery: program goals/objectives, consent process, stakeholder consultation, age-appropriate program, education, communication, logistics, immunizing agent, and clinic process. Conclusions: Parents perceived advantages and disadvantages to delivering annual seasonal influenza immunizations to children at school. Their input gives a framework of issues to address in order to construct robust, acceptable programs for delivering influenza or other vaccines in schools.	[Lind, Candace; Collins, Ramona; Frank, Christine J.] Univ Calgary, Fac Nursing, Calgary, AB, Canada; [Russell, Margaret L.; MacDonald, Judy; Davis, Amy E.] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB, Canada; [MacDonald, Judy] Univ Calgary, Fac Med, Alberta Hlth Serv, Calgary, AB, Canada	University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary	Lind, C (corresponding author), Univ Calgary, Fac Nursing, Calgary, AB, Canada.	cylind@ucalgary.ca		MacDonald, Judy/0000-0001-9774-7220	M.S.I. Foundation [859]	M.S.I. Foundation	This research was funded by the M.S.I. Foundation, grant #859 (http://www.msifoundation.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ALB HLTH, 2012, ALB IMM POL GEN GUID; *ALB HLTH SERV, 2013, ALB RESP VIR SURV RE; *ALB HLTH SERV, 2013, 2013 2014 INFL VACC; *ALB HLTH SERV, 2010, DEM ALB HLTH SYST DE; *ALB HLTH SERV, 2013, IMM SCH SERV; Allison MA, 2010, PEDIATR INFECT DIS J, V29, P751, DOI 10.1097/INF.0b013e3181d8562c; ALPHONSO C, 2011, GLOBE MAIL; Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; Basta NE, 2009, AM J EPIDEMIOL, V170, P679, DOI 10.1093/aje/kwp237; Betsch C, 2011, EUROSURVEILLANCE, V16, P15; Betsch C, 2013, HEALTH PSYCHOL, V32, P146, DOI 10.1037/a0027387; Betsch C, 2012, VACCINE, V30, P3727, DOI 10.1016/j.vaccine.2012.02.025; Betsch C, 2011, MED DECIS MAKING, V31, P742, DOI 10.1177/0272989X11400419; Brabin L, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-20; Cawley J, 2010, J SCHOOL HEALTH, V80, P167, DOI 10.1111/j.1746-1561.2009.00482.x; CDC, 1999, MMWR-MORBID MORTAL W, V48, P1; *COMM BRANCH AH, ALB ENC FALL ROUT GE; Cresswell J., 2007, QUAL INQ, V3th; Esposito S, 2003, VACCINE, V21, P3162, DOI 10.1016/S0264-410X(03)00253-6; Flood EM, 2010, CLIN THER, V32, P1448, DOI 10.1016/j.clinthera.2010.06.020; FORS SW, 1989, HEALTH EDUC QUART, V16, P255, DOI 10.1177/109019818901600209; Fraaij PLA, 2011, VACCINE, V29, P7524, DOI 10.1016/j.vaccine.2011.08.010; Gargano LM, 2011, PEDIATRICS, V128, pE1092, DOI 10.1542/peds.2011-0453; Gellin BG, 2000, PEDIATRICS, V106, P1097, DOI 10.1542/peds.106.5.1097; Glezen WP, 2006, J CLIN VIROL, V37, P237, DOI 10.1016/j.jcv.2006.08.020; Grijalva Carlos G, 2010, PLoS One, V5, pe15097, DOI 10.1371/journal.pone.0015097; Guest G, 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Hamilton N., 1996, POPULATION HLTH PROM; Hull HF, 2011, HUM VACCINES, V7, P153, DOI 10.4161/hv.7.2.13668; Kimmel SR, 1996, AM FAM PHYSICIAN, V53, P1648; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; King JC, 2010, VACCINE, V28, P7737, DOI 10.1016/j.vaccine.2010.09.064; KOMARNICKI J, 2013, CALGARY HERALD; KWONG JC, 2008, EVALUATION EFFECT ON; Kwong JC, 2010, VACCINE, V28, P2722, DOI 10.1016/j.vaccine.2010.01.024; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; Loring BJ, 2009, NEW ZEAL MED J, V122, P14; McLaughlin CG, 2002, HEALTH SERV RES, V37, P1441, DOI 10.1111/1475-6773.12171; MCLAUGHLIN JF, 1992, INT J QUALITATIVE ST, V5, P147; Middleman AB, 2012, HUM VACC IMMUNOTHER, V8, P1395, DOI 10.4161/hv.21575; Morgan D.L, 1996, FOCUS GROUPS QUALITA; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; Musto R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-640; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Neuzil KM, 2002, ARCH PEDIAT ADOL MED, V156, P986, DOI 10.1001/archpedi.156.10.986; Piedra PA, 2005, VACCINE, V23, P1540, DOI 10.1016/j.vaccine.2004.09.025; Pineda D, 2011, PEDIATRICS, V127, pS134, DOI 10.1542/peds.2010-1722T; Poehling KA, 2009, VACCINE, V27, P2695, DOI 10.1016/j.vaccine.2009.02.043; *PUBL HLTH AG CAN, 2013, PUBL FUND INFL VACC; Public Health Agency of Canada, 2013, PUBL FUND IMM PROGR; Quadri-Sheriff M, 2012, PEDIATRICS, V130, P522, DOI 10.1542/peds.2012-0140; Schanzer DL, 2007, EPIDEMIOL INFECT, V135, P1109, DOI 10.1017/S0950268807007923; Schanzer DL, 2008, INFLUENZA OTHER RESP, V2, P1, DOI 10.1111/j.1750-2659.2008.00035.x; Schanzer DL, 2006, PEDIATR INFECT DIS J, V25, P795, DOI 10.1097/01.inf.0000232632.86800.8c; Schwandt T. A, 2015, SAGE DICT QUALITATIV, V4th; SHORT MB, 2013, HUMAN VACCINES IMMUN, V10; Sim J, 1998, J ADV NURS, V28, P345, DOI 10.1046/j.1365-2648.1998.00692.x; *STAT CAN, 2012, INFL IMM LESS ON YEA; *SURV ASS BRANCH A, 2012, INT HLTH DAT APPL PO; Talbot HK, 2009, VACCINE, V27, P1923, DOI 10.1016/j.vaccine.2009.01.108; Vynnycky E, 2008, VACCINE, V26, P5321, DOI 10.1016/j.vaccine.2008.06.101; ZAZA S, 2005, GUIDE COMMUNITY PREV, P223	64	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93490	10.1371/journal.pone.0093490	http://dx.doi.org/10.1371/journal.pone.0093490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN8GP	24686406	Green Published, Green Submitted, gold			2022-12-27	WOS:000340842300013
J	Schenk, AN; Souza, MJ				Schenk, Ashley N.; Souza, Marcy J.			Major Anthropogenic Causes for and Outcomes of Wild Animal Presentation to a Wildlife Clinic in East Tennessee, USA, 2000-2011	PLOS ONE			English	Article							INFECTIOUS-DISEASES; URBAN ENVIRONMENTS; CONSERVATION; BIODIVERSITY; MANAGEMENT; IMPACTS	To determine the reasons for presentation and outcome of wildlife cases in East Tennessee, a retrospective analysis was performed using 14,303 records from cases presented to the wildlife clinic of the University of Tennessee Veterinary Teaching Hospital between 2000 and 2011. The cases were first categorized into amphibian/non-avian reptile, mammal, or avian and then classified into groups based on the primary admitting/presenting sign. There are a variety of reasons animals were presented to the clinic, and some were directly or indirectly anthropogenic in origin, including cat related, dog related, hit by automobile, and other human encounters leading to trauma; of the cases reviewed, 4,443 (31.1%) presented for one of these 4 reasons. Overall case fatality risk in regard to these 4 admitting/presenting signs was 0.519 for the amphibian/non-avian reptile cases, 0.675 for mammal cases, and 0.687 for avian cases. This study confirms the importance of monitoring wildlife morbidity and mortality and of focusing efforts to reduce the anthropogenic threat on native habitats and resident wildlife populations.	[Schenk, Ashley N.; Souza, Marcy J.] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Souza, MJ (corresponding author), Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA.	msouza@utk.edu		Wellehan, Jim/0000-0001-5692-6134				Ament R, 2008, ENVIRON MANAGE, V42, P480, DOI 10.1007/s00267-008-9112-8; Arlettaz R, 2007, P R SOC B, V274, P1219, DOI 10.1098/rspb.2006.0434; Barron OV, 2013, SCI TOTAL ENVIRON, V443, P491, DOI 10.1016/j.scitotenv.2012.10.085; Brown JD, 2002, J WILDLIFE DIS, V38, P699, DOI 10.7589/0090-3558-38.4.699; Cooper CB, 2007, ECOL SOC, V12; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Jenkins PT, 1996, CONSERV BIOL, V10, P300, DOI 10.1046/j.1523-1739.1996.10010300.x; Leu M, 2008, ECOL APPL, V18, P1119, DOI 10.1890/07-0480.1; Lumpkin HA, 2013, CONSERV BIOL, V27, P1069, DOI 10.1111/cobi.12085; Molina-Lopez RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024603; Pavlacky DC, 2012, J ANIM ECOL, V81, P940, DOI 10.1111/j.1365-2656.2012.01975.x; Robertson ID, 1998, AUST VET J, V76, P551, DOI 10.1111/j.1751-0813.1998.tb10214.x; Romano MC, 2010, NEUROIMMUNOMODULAT, V17, P209, DOI 10.1159/000258726; Rosenberg DK, 1997, BIOSCIENCE, V47, P677, DOI 10.2307/1313208; Schrader GM, 2010, J WILDLIFE DIS, V46, P1079, DOI 10.7589/0090-3558-46.4.1079; Segelbacher G, 2008, MOL ECOL, V17, P2356, DOI 10.1111/j.1365-294X.2008.03767.x; Shepherd B, 2006, ECOL SOC, V11; Taylor J, 2011, ENVIRON INT, V37, P1019, DOI 10.1016/j.envint.2011.03.015; Trocme M, 2006, P 6 SWISS TRANSP RES, P1; Tsipoura N, 2011, ENVIRON RES, V111, P775, DOI 10.1016/j.envres.2011.05.013; U.S. Fish and Wildlife Service, 2003, REC PLAN RED COCK WO	23	25	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93517	10.1371/journal.pone.0093517	http://dx.doi.org/10.1371/journal.pone.0093517			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686490	Green Published, gold			2022-12-27	WOS:000340842300016
J	Haskelberg, H; Cordery, DV; Amin, J; Kelleher, AD; Cooper, DA; Emery, S				Haskelberg, Hila; Cordery, Damien V.; Amin, Janaki; Kelleher, Anthony D.; Cooper, David A.; Emery, Sean		STEAL Study Grp	HLA Alleles Association with Changes in Bone Mineral Density in HIV-1-Infected Adults Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine	PLOS ONE			English	Article							OSTEOCLAST DIFFERENTIATION; HIV-1; MASS; RESORPTION; SUPERTYPES; PATHWAY; RANKL; LOCI	Background: There are limited data regarding the influence of human leukocyte antigen (HLA) polymorphisms on reduced bone mineral density (BMD). We investigated the relationship between HLA supertypes and BMD in HIV-infected adults changing their existing treatment to tenofovir-emtricitabine (TDF-FTC) or abacavir-lamivudine (ABC-3TC) in the STEAL study. Methods: Lumbar spine and right hip BMD were measured by Dual-energy X-ray absorptiometry (DXA). HLA genotypes at the 2-digit level were classified into class I and II supertypes. Student's t-tests were used to test the association between HLA supertypes and changes in hip and spine BMD over 96 weeks for the whole cohort and stratified by randomised groups. The relationship between HLA supertypes and BMD was also assessed in the subgroup of participants that were naive to both ABC and TDF at study entry. Results: Class II supertypes were mainly associated with hip BMD change. Overall, compared to participants not carrying HLA-DQ3, participants expressing DQ3 had less bone loss over 96 weeks at both the hip and spine (hip: 0.003 vs. -0.006 g/cm(2), 95%CI 0.002 to 0.017, p = 0.016; spine: 0.006 vs. -0.006 g/cm(2), 95%CI 0.001 to 0.023, p = 0.041). In participants that were naive to both ABC and TDF at baseline and randomised to TDF-FTC, DQ3 was significantly associated with less bone loss compared with those not carrying DQ3 (hip: 0.001 vs. -0.032 g/cm(2); diff 0.033; 95%CI 0.017 to 0.049; p<0.001; spine: 0.007 vs. -0.023 g/cm(2); diff 0.035; 95%CI 0.014 to 0.056; p = 0.001). Conclusions: In this cohort of HIV-infected adults, there was an association between bone status and HLA supertypes, particularly HLA-DQ3.	[Haskelberg, Hila; Cordery, Damien V.; Amin, Janaki; Kelleher, Anthony D.; Cooper, David A.; Emery, Sean] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Kelleher, Anthony D.; Cooper, David A.] St Vincents Ctr Appl Med Res, Darlinghurst, NSW, Australia	University of New South Wales Sydney; Kirby Institute	Haskelberg, H (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	hhaskelberg@kirby.unsw.edu.au	Emery, Sean/O-9122-2019; Emery, Sean/J-3825-2017	Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309; Amin, Janaki/0000-0003-2161-9366; Boyd, Mark/0000-0002-6848-3307	Kirby Institute; Australian Government Department of Health and Ageing	Kirby Institute; Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	This work was supported by The Kirby Institute, funded by the Australian Government Department of Health and Ageing. The Kirby Institute is affiliated with the Faculty of Medicine, University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden NK, 1996, J BONE MINER RES, V11, P530; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Chantarangsu S, 2009, PHARMACOGENET GENOM, V19, P139, DOI 10.1097/FPC.0b013e32831d0faf; Cordery DV, 2012, AIDS, V26, P2337, DOI 10.1097/QAD.0b013e32835ab213; Domingo P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067035; Douroudis K, 2007, TISSUE ANTIGENS, V69, P592, DOI 10.1111/j.1399-0039.2007.00833.x; Doytchinova IA, 2005, J IMMUNOL, V174, P7085, DOI 10.4049/jimmunol.174.11.7085; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Gratacos J, 1999, ARTHRITIS RHEUM, V42, P2319, DOI 10.1002/1529-0131(199911)42:11<2319::AID-ANR9>3.0.CO;2-G; Hajeer AH, 2001, HUM IMMUNOL, V62, P1191, DOI 10.1016/S0198-8859(01)00322-6; Haskelberg H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038377; Hsu YH, 2006, HUM GENET, V118, P568, DOI 10.1007/s00439-005-0062-4; Kim JH, 2010, CELL SIGNAL, V22, P1341, DOI 10.1016/j.cellsig.2010.05.001; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Martin A, 2009, CLIN INFECT DIS, V49, P1591, DOI 10.1086/644769; Papet I., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P251; Roshandel D, 2010, J BONE MINER RES, V25, P1830, DOI 10.1002/jbmr.78; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Slemenda CW, 1996, OSTEOPOROSIS INT, V6, P178, DOI 10.1007/BF01623944; Steeve KT, 2004, CYTOKINE GROWTH F R, V15, P49, DOI 10.1016/j.cytogfr.2003.10.005; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tsuji S, 1998, HUM IMMUNOL, V59, P243, DOI 10.1016/S0198-8859(98)00009-3; Wangsomboonsiri W, 2010, CLIN INFECT DIS, V50, P597, DOI 10.1086/650003	28	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93333	10.1371/journal.pone.0093333	http://dx.doi.org/10.1371/journal.pone.0093333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681993	Green Submitted, gold, Green Published			2022-12-27	WOS:000333678100044
J	Pollack, AZ; Sjaarda, L; Ahrens, KA; Mumford, SL; Browne, RW; Wactawski-Wende, J; Schisterman, EF				Pollack, Anna Z.; Sjaarda, Lindsey; Ahrens, Katherine A.; Mumford, Sunni L.; Browne, Richard W.; Wactawski-Wende, Jean; Schisterman, Enrique F.			Association of Cadmium, Lead and Mercury with Paraoxonase 1 Activity in Women	PLOS ONE			English	Article							OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; BLOOD CADMIUM; EXPOSURE; RISK; POLYMORPHISMS; PEROXIDATION; SMOKING; ADULTS; Q192R	Background: The activity of paraoxonase 1 (PON1), an antioxidant enzyme whose polymorphisms have been associated with cancer risk, may be associated with metals exposure. Objective: To evaluate PON1 activity in relation to cadmium, lead, and mercury levels in healthy, premenopausal women. Methods: Women from upstate New York were followed for >= two menstrual cycles. Repeated measures linear mixed models estimated the association between cadmium, lead, and mercury levels (by tertile: T1, T2, T3) and PON1 arylesterase (PON1A) and PON1 paraoxonase (PON1P) activity, separately. Analyses were stratified by PON1 Q192R phenotype and unstratified. Results: Median blood cadmium, lead, and mercury concentrations were 0.30 mu g/L, 0.87 mu g/dL, and 1.15 mu g/L. In unstratified analyses cadmium and mercury were associated with decreased PON1A activity (T2 vs. T1; not T3 vs. T1) but metals were not associated with PON1P. Phenotypes were distributed between QQ (n = 99), QR (n = 117), and RR (n = 34). Cadmium was associated with decreased PON1A activity for QR and RR phenotypes comparing T2 vs. T1 (-14.4% 95% confidence interval [CI] [-20.1, -8.4] and -27.9% [-39.5, -14.0],). Lead was associated with decreased PON1A (RR phenotype, T3 vs. T1 -18.9% [-32.5, -2.5]; T2 vs. T1 -19.6% [-32.4, -4.4]). Cadmium was associated with lower PON1P comparing T2 vs. T1 for the RR (-34.9% [-51.5, -12.5]) and QR phenotypes (-9.5% [-18.1, 0.0]) but not comparing T3 vs. T1. Cadmium was associated with increases in PON1P levels (QQ phenotype, T3 vs. T1 24.5% [7.0, 44.9]) and mercury was associated with increased PON1A levels (QQ phenotype, T3 vs. T1 6.2% [0.2, 12.6]). Mercury was associated with decreased PON1P (RR phenotype, T2 vs. T1 -22.8 [-37.8, -4.1]). Conclusion: Blood metals were associated with PON1 activity and these effects varied by phenotype. However, there was not a linear dose-response and these findings await replication.	[Pollack, Anna Z.; Sjaarda, Lindsey; Ahrens, Katherine A.; Mumford, Sunni L.; Schisterman, Enrique F.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Intramural Populat Hlth Res, NIH, Bethesda, MD 20892 USA; [Pollack, Anna Z.] George Mason Univ, Dept Global & Community Hlth, Sch Hlth & Human Serv, Fairfax, VA 22030 USA; [Browne, Richard W.] SUNY Buffalo, Dept Biotech & Clin Lab Sci, Buffalo, NY 14260 USA; [Wactawski-Wende, Jean] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); George Mason University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Schisterman, EF (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Intramural Populat Hlth Res, NIH, Bethesda, MD 20892 USA.	schistee@mail.nih.gov	Wactawski-Wende, Jean/AGH-5457-2022; Pollack, Anna/L-7652-2018	Wactawski-Wende, Jean/0000-0003-3096-9595; Sjaarda, Lindsey/0000-0003-0539-8110; Ahrens, Katherine/0000-0001-5139-9208; Schisterman, Enrique/0000-0003-3757-641X; Pollack, Anna/0000-0002-4313-3298; Mumford, Sunni/0000-0003-0133-3176	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health [HHSN275200403394C]; Long-Range Research Initiative grant of the American Chemistry Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008762] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Long-Range Research Initiative grant of the American Chemistry Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (Contract # HHSN275200403394C). Anna Z. Pollack was partially supported by the Long-Range Research Initiative grant of the American Chemistry Council to Dr. Schisterman, PI, and partially supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayotte P, 2011, ENVIRON HEALTH PERSP, V119, P1077, DOI 10.1289/ehp.1003296; Bayrak A, 2012, J ATHEROSCLER THROMB, V19, P376, DOI 10.5551/jat.11320; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Browne RW, 2007, CLIN CHEM, V53, P310, DOI 10.1373/clinchem.2006.074559; Browne RW, 2000, CLIN CHEM, V46, P829; Cancer IAfRo, 2006, IARC MONOGRAPHS EVAL, V87; CDC, 2009, 4 CDCP; Centers for Disease Control and Prevention (CDC),, 2012, ADV COMM CHILDH LEAD; Davis KA, 2009, ENVIRON HEALTH PERSP, V117, P1226, DOI 10.1289/ehp.0900569; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; ECKERSON HW, 1983, AM J HUM GENET, V35, P1126; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Fang DH, 2012, MOL BIOL REP, V39, P6801, DOI 10.1007/s11033-012-1505-3; Furlong CE, 2002, PHARMACOGENOMICS, V3, P341, DOI 10.1517/14622416.3.3.341; Guallar E, 2002, NEW ENGL J MED, V347, P1747, DOI 10.1056/NEJMoa020157; HAAGEN L, 1992, EUR J CLIN CHEM CLIN, V30, P391; Hernandez AF, 2009, NEUROTOXICOLOGY, V30, P628, DOI 10.1016/j.neuro.2009.04.003; Howards PP, 2009, AM J EPIDEMIOL, V169, P105, DOI 10.1093/aje/kwn287; LEWIS GP, 1972, LANCET, V1, P291; Li WF, 2006, ENV HLTH PERSPECT, V114; Ferramola ML, 2011, ENVIRON TOXICOL PHAR, V32, P17, DOI 10.1016/j.etap.2011.03.002; Mackness B, 2001, ARTERIOSCL THROM VAS, V21, P1451, DOI 10.1161/hq0901.094247; Mackness B, 1998, FEBS LETT, V423, P57, DOI 10.1016/S0014-5793(98)00064-7; Mahaffey KR, 2009, ENVIRON HEALTH PERSP, V117, P47, DOI 10.1289/ehp.11674; McEneny J, 2013, J NUTR BIOCHEM, V24, P163, DOI 10.1016/j.jnutbio.2012.03.015; Milne GL, 2007, NAT PROTOC, V2, P221, DOI 10.1038/nprot.2006.375; Mozaffarian D, 2012, HYPERTENSION, V60, P645, DOI 10.1161/HYPERTENSIONAHA.112.196154; Mozaffarian D, 2011, NEW ENGL J MED, V364, P1116, DOI 10.1056/NEJMoa1006876; Nakanishi Mamoru, 2003, J Atheroscler Thromb, V10, P337; Navas-Acien A, 2004, CIRCULATION, V109, P3196, DOI 10.1161/01.CIR.0000130848.18636.B2; Navas-Acien A, 2007, ENVIRON HEALTH PERSP, V115, P472, DOI 10.1289/ehp.9785; Navas-Acien A, 2009, AM J EPIDEMIOL, V170, P1156, DOI 10.1093/aje/kwp248; Permpongpaiboon T, 2011, HUM EXP TOXICOL, V30, P1196, DOI 10.1177/0960327110388536; Pollack AZ, 2012, AM J EPIDEMIOL, V175, P645, DOI 10.1093/aje/kwr375; Schisterman EF, 2006, AM J EPIDEMIOL, V163, P374, DOI 10.1093/aje/kwj039; She ZG, 2012, ANTIOXID REDOX SIGN, V16, P597, DOI 10.1089/ars.2010.3774; Soran H, 2009, CURR OPIN LIPIDOL, V20, P265, DOI 10.1097/MOL.0b013e32832ec141; Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200; Wactawski-Wende J, 2009, PAEDIATR PERINAT EP, V23, P171, DOI 10.1111/j.1365-3016.2008.00985.x; Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6; WHO INT AGCY RES CANC, 1993, IARC MONOG EVAL CARC, V58, P239	42	29	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92152	10.1371/journal.pone.0092152	http://dx.doi.org/10.1371/journal.pone.0092152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682159	Green Submitted, Green Published, gold			2022-12-27	WOS:000333678100007
J	Sengoda, VG; Cooper, WR; Swisher, KD; Henne, DC; Munyaneza, JE				Sengoda, Venkatesan G.; Cooper, W. Rodney; Swisher, Kylie D.; Henne, Donald C.; Munyaneza, Joseph E.			Latent Period and Transmission of "Candidatus Liberibacter solanacearum" by the Potato Psyllid Bactericera cockerelli (Hemiptera: Triozidae)	PLOS ONE			English	Article							ZEBRA CHIP DISEASE; UNITED-STATES; ASSOCIATION; HAPLOTYPES; ASIATICUS; VECTOR; TIME; ACQUISITION; YELLOWS; BIOLOGY	"Candidatus Liberibacter solanacearum'' (Lso) is an economically important pathogen of solanaceous crops and the putative causal agent of zebra chip disease of potato (Solanum tuberosum L.). This pathogen is transmitted to solanaceous species by the potato psyllid, Bactericera cockerelli (Sulc), but many aspects of the acquisition and transmission processes have yet to be elucidated. The present study was conducted to assess the interacting effects of acquisition access period, incubation period, and host plant on Lso titer in psyllids, the movement of Lso from the alimentary canal to the salivary glands of the insect, and the ability of psyllids to transmit Lso to non-infected host plants. Following initial pathogen acquisition, the probability of Lso presence in the alimentary canal remained constant from 0 to 3 weeks, but the probability of Lso being present in the salivary glands increased with increasing incubation period. Lso copy numbers in psyllids peaked two weeks after the initial pathogen acquisition and psyllids were capable of transmitting Lso to non-infected host plants only after a two-week incubation period. Psyllid infectivity was associated with colonization of insect salivary glands by Lso and with Lso copy numbers >10,000 per psyllid. Results of our study indicate that Lso requires a two-week latent period in potato psyllids and suggest that acquisition and transmission of Lso by psyllids follows a pattern consistent with a propagative, circulative, and persistent mode of transmission.	[Sengoda, Venkatesan G.; Cooper, W. Rodney; Swisher, Kylie D.; Munyaneza, Joseph E.] ARS, Yakima Agr Res Lab, USDA, Wapato, WA USA; [Sengoda, Venkatesan G.; Henne, Donald C.] Texas A&M AgriLife Res, Subtrop Pest Management Lab, Dept Entomol, Weslaco, TX USA	United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	Munyaneza, JE (corresponding author), ARS, Yakima Agr Res Lab, USDA, Wapato, WA USA.	Joseph.Munyaneza@ars.usda.gov	Cooper, William/ABB-1389-2020	Cooper, William/0000-0001-7983-3627	Frito-Lay Inc.; Washington State Potato Commission; USDA-NIFA-RAMP [2009-51101-05892]; USDA-NIFA-SCRI [2009-51181-20176]	Frito-Lay Inc.; Washington State Potato Commission; USDA-NIFA-RAMP; USDA-NIFA-SCRI	Financial support for this research was partially provided by Frito-Lay Inc., Washington State Potato Commission, USDA-NIFA-RAMP (Project #2009-51101-05892) and USDA-NIFA-SCRI (Project #2009-51181-20176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar ED, 2011, J PHYTOPATHOL, V159, P726, DOI 10.1111/j.1439-0434.2011.01836.x; Casteel CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035191; Chapman R. I., 2010, P 10 ANN ZEBR CHIP R, P64; Cooper WR, 2014, ANN ENTOMOL SOC AM, V107, P204, DOI 10.1603/AN13087; Crosslin JM, 2011, SOUTHWEST ENTOMOL, V36, P125, DOI 10.3958/059.036.0202; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Inoue H, 2009, ANN APPL BIOL, V155, P29, DOI 10.1111/j.1744-7348.2009.00317.x; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Liefting LW, 2008, PLANT DIS, V92, P1474, DOI 10.1094/PDIS-92-10-1474A; Liefting LW, 2009, PLANT DIS, V93, P208, DOI 10.1094/PDIS-93-3-0208; Lin H, 2012, EUR J PLANT PATHOL, V132, P297, DOI 10.1007/s10658-011-9874-3; Marzachi C, 2005, MOL BIOTECHNOL, V30, P117, DOI 10.1385/MB:30:2:117; Miles GP, 2010, AM J POTATO RES, V87, P337, DOI 10.1007/s12230-010-9140-9; Munyaneza JE, 2007, J ECON ENTOMOL, V100, P656, DOI 10.1603/0022-0493(2007)100[656:AOBCHP]2.0.CO;2; MUNYANEZA JE, 2007, SUBTROPICAL PLANT SC, V59, P30; Munyaneza JE, 2012, AM J POTATO RES, V89, P329, DOI 10.1007/s12230-012-9262-3; Munyaneza JE, 2010, J ECON ENTOMOL, V103, P1060, DOI 10.1603/EC10027; Navarre DA, 2009, AM J POTATO RES, V86, P88, DOI 10.1007/s12230-008-9060-0; Nelson WR, 2011, EUR J PLANT PATHOL, V130, P5, DOI 10.1007/s10658-010-9737-3; Ng JCK, 2006, ANNU REV PHYTOPATHOL, V44, P183, DOI 10.1146/annurev.phyto.44.070505.143325; Pastrik KH, 2000, J PHYTOPATHOL, V148, P619, DOI 10.1046/j.1439-0434.2000.00567.x; Pelz-Stelinski KS, 2010, J ECON ENTOMOL, V103, P1531, DOI 10.1603/EC10123; Secor GA, 2009, PLANT DIS, V93, P574, DOI 10.1094/PDIS-93-6-0574; Sengoda VG, 2013, J ECON ENTOMOL, V106, P1964, DOI 10.1603/EC13129; Sengoda VG, 2010, AM J POTATO RES, V87, P41, DOI 10.1007/s12230-009-9115-x; Stokes ME, 2000, CATEGORICAL DATA ANA; Swisher K. D., 2014, J INSECT SC IN PRESS; Swisher KD, 2013, AM J POTATO RES, V90, P570, DOI 10.1007/s12230-013-9330-3; Swisher KD, 2013, ENVIRON ENTOMOL, V42, P381, DOI 10.1603/EN12261; Swisher KD, 2012, ENVIRON ENTOMOL, V41, P1019, DOI 10.1603/EN12066; Wen AM, 2013, AM J POTATO RES, V90, P229, DOI 10.1007/s12230-012-9293-9; Zhang YP, 1998, J VIROL METHODS, V71, P45, DOI 10.1016/S0166-0934(97)00190-0	33	47	48	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93475	10.1371/journal.pone.0093475	http://dx.doi.org/10.1371/journal.pone.0093475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682175	Green Submitted, Green Published, gold			2022-12-27	WOS:000333678100049
J	Xu, X; Lv, QM; Shang, JJ; Pang, ZQ; Zhou, ZZ; Wang, J; Jiang, GH; Tao, Y; Xu, Q; Li, XB; Zhao, XF; Li, SG; Xu, JC; Zhu, LH				Xu, Xiao; Lv, Qiming; Shang, Junjun; Pang, Zhiqian; Zhou, Zhuangzhi; Wang, Jing; Jiang, Guanghuai; Tao, Yong; Xu, Qian; Li, Xiaobing; Zhao, Xianfeng; Li, Shigui; Xu, Jichen; Zhu, Lihuang			Excavation of Pid3 Orthologs with Differential Resistance Spectra to Magnaporthe oryzae in Rice Resource	PLOS ONE			English	Article							BLAST RESISTANCE; NUCLEOTIDE-BINDING; RUFIPOGON GRIFF.; FUNCTIONAL-ANALYSIS; DNA POLYMORPHISM; REPEAT CLASS; GENES; PIK; ALLELE; LOCUS	Twenty-six orthologs of the rice blast resistance gene Pid3 from cultivated varieties and wild rice accessions distributed in different areas were cloned by allele mining. Sequence analysis showed that while each of the orthologous genes from indica varieties and most wild accessions encodes a complete NBS-LRR protein, each of the proteins encoded by those from japonica varieties and few wild rice accessions presents a premature termination. Eleven of the 26 orthologs were selected for blast resistance testing by transforming into the blast susceptible rice variety TP309, respectively. Inoculation of 23 M. oryzae strains collected from diverse regions of China to the respective transgenic plants revealed that 6 Pid3 orthologs showed susceptible to all the tested strains, while the other 5 orthologs showed differential resistance spectra in a gradually spectrum-widen order as Pid3-W3, Pid3-W4, Pid3-I3, Pid3-W5 and Pid3-I1. Amino acid sequences alignment of these orthologs indicated that the sequence diversities between the blast resistance orthologs were mostly located in the LRR domain such as the substitutions of Q694H, D856H, Q896R, D899E etc. However, the differences between the resistance orthologs and the susceptible ones were mostly located in the NBS domain. The present experiments provide an example of that the ortholog evaluation of plant R genes could be an efficient way to expand the rice blast resistance and some other plant disease resistance as well for breeding.	[Xu, Xiao; Xu, Qian; Xu, Jichen] Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China; [Xu, Xiao; Lv, Qiming; Zhou, Zhuangzhi; Wang, Jing; Jiang, Guanghuai; Li, Xiaobing; Zhao, Xianfeng; Zhu, Lihuang] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, State Key Lab Plant Genom, Beijing, Peoples R China; [Lv, Qiming; Li, Shigui] Sichuan Agr Univ, Rice Res Inst, Chengdu, Peoples R China; [Lv, Qiming] Natl Key Lab Hybrid Rice, Changsha, Hunan, Peoples R China; [Shang, Junjun] Nanchang Univ, Coll Life Sci, Key Lab Mol Biol & Gene Engn, Nanchang, Peoples R China; [Pang, Zhiqian; Tao, Yong] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Sichuan Agricultural University; Nanchang University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Li, SG (corresponding author), Sichuan Agr Univ, Rice Res Inst, Chengdu, Peoples R China.	lishigui@sicau.edu.cn; jcxu282@sina.com; lhzhu@genetics.ac.cn			National Basic Research Program of China [2012CB114005, 2011CB100706]; National Transgenic Research Project [2013ZX08009-001, 2013ZX08009-003]; National High Technology Research and Development Program of China [2012AA101101]; Beijing Natural Science Foundation [5122019]; Bill and Melinda Gates Foundation [51587-24]; Special Fund for Agroscientific Research in the Public Interest [201303007]	National Basic Research Program of China(National Basic Research Program of China); National Transgenic Research Project; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Special Fund for Agroscientific Research in the Public Interest	This work was supported by grants from the National Basic Research Program of China (2012CB114005 and 2011CB100706), the National Transgenic Research Project (2013ZX08009-001, 2013ZX08009-003), the National High Technology Research and Development Program of China (2012AA101101), Beijing Natural Science Foundation (5122019), Bill and Melinda Gates Foundation (51587-24), Special Fund for Agroscientific Research in the Public Interest (201303007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikawa I, 2008, GENETICS, V180, P2267, DOI 10.1534/genetics.108.095034; Chen DH, 1996, PLANT DIS, V80, P52, DOI 10.1094/PD-80-0052; Chen Hong-qi, 2008, Zhongguo Shuidao Kexue, V22, P23; Chen J, 2011, J GENET GENOMICS, V38, P209, DOI 10.1016/j.jgg.2011.03.010; Chen XW, 2011, TRENDS PLANT SCI, V16, P451, DOI 10.1016/j.tplants.2011.04.003; Chen Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002595; Das A, 2012, FUNCT INTEGR GENOMIC, V12, P215, DOI 10.1007/s10142-012-0284-1; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Delteil A, 2010, RICE, V3, P56, DOI 10.1007/s12284-009-9035-x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hayashi K, 2009, PLANT J, V57, P413, DOI 10.1111/j.1365-313X.2008.03694.x; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hittalmani S, 2000, THEOR APPL GENET, V100, P1121, DOI 10.1007/s001220051395; Hua LX, 2012, THEOR APPL GENET, V125, P1047, DOI 10.1007/s00122-012-1894-7; Hulbert SH, 2001, ANNU REV PHYTOPATHOL, V39, P285, DOI 10.1146/annurev.phyto.39.1.285; Jeon JS, 2003, MOL GENET GENOMICS, V269, P280, DOI 10.1007/s00438-003-0834-2; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jiang Nan, 2012, Journal of Hunan Agricultural University, V38, P506, DOI 10.3724/SP.J.1238.2012.00506; Kanzaki H, 2012, PLANT J, V72, P894, DOI 10.1111/j.1365-313X.2012.05110.x; Koide Y, 2010, PLANT BREEDING, V129, P670, DOI 10.1111/j.1439-0523.2010.01781.x; Kumar GR, 2010, BIOTECHNOL ADV, V28, P451, DOI 10.1016/j.biotechadv.2010.02.007; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu G, 2002, MOL GENET GENOMICS, V267, P472, DOI 10.1007/s00438-002-0677-2; Lv QM, 2013, PHYTOPATHOLOGY, V103, P594, DOI 10.1094/PHYTO-10-12-0260-R; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; Rai AK, 2011, J PLANT BIOCHEM BIOT, V20, P55, DOI 10.1007/s13562-010-0026-1; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Ravensdale M, 2011, MOL PLANT PATHOL, V12, P93, DOI 10.1111/j.1364-3703.2010.00657.x; RONALD PC, 1992, MOL GEN GENET, V236, P113, DOI 10.1007/BF00279649; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shang J, 2007, THESIS CHINESE ACAD; Shang JJ, 2009, GENETICS, V182, P1303, DOI 10.1534/genetics.109.102871; Shen JD, 2006, GENETICS, V172, P1243, DOI 10.1534/genetics.105.047290; Shen QH, 2003, PLANT CELL, V15, P732, DOI 10.1105/tpc.009258; Skamnioti P, 2009, TRENDS BIOTECHNOL, V27, P141, DOI 10.1016/j.tibtech.2008.12.002; Sun CQ, 2001, THEOR APPL GENET, V102, P157, DOI 10.1007/s001220051631; Sun CQ, 2002, THEOR APPL GENET, V104, P1335, DOI 10.1007/s00122-002-0878-4; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian F, 2006, THEOR APPL GENET, V112, P570, DOI 10.1007/s00122-005-0165-2; Wang L, 2009, PHYTOPATHOLOGY, V99, P900, DOI 10.1094/PHYTO-99-8-0900; Wang ZX, 1999, PLANT J, V19, P55, DOI 10.1046/j.1365-313X.1999.00498.x; Xiao H, 2003, PLANT MOL BIOL, V52, P957, DOI 10.1023/A:1025401611354; Yang SH, 2008, THEOR APPL GENET, V116, P165, DOI 10.1007/s00122-007-0656-4; Yoshida K, 2009, GENES GENET SYST, V84, P121, DOI 10.1266/ggs.84.121; YU ZH, 1991, THEOR APPL GENET, V81, P471, DOI 10.1007/BF00219436; Yuan B, 2011, THEOR APPL GENET, V122, P1017, DOI 10.1007/s00122-010-1506-3; Zhai C, 2011, NEW PHYTOL, V189, P321, DOI 10.1111/j.1469-8137.2010.03462.x; Zhou B, 2006, MOL PLANT MICROBE IN, V19, P1216, DOI 10.1094/MPMI-19-1216; Zhu XY, 2012, THEOR APPL GENET, V124, P1295, DOI 10.1007/s00122-012-1787-9	50	18	24	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93275	10.1371/journal.pone.0093275	http://dx.doi.org/10.1371/journal.pone.0093275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681716	Green Published, gold, Green Submitted			2022-12-27	WOS:000333678100038
J	Auer, R; Gencer, B; Raber, L; Klingenberg, R; Carballo, S; Carballo, D; Nanchen, D; Cornuz, J; Vader, JP; Vogt, P; Juni, P; Matter, CM; Windecker, S; Luscher, TF; Mach, F; Rodondi, N				Auer, Reto; Gencer, Baris; Raeber, Lorenz; Klingenberg, Roland; Carballo, Sebastian; Carballo, David; Nanchen, David; Cornuz, Jacques; Vader, John-Paul; Vogt, Pierre; Jueni, Peter; Matter, Christian M.; Windecker, Stephan; Luescher, Thomas Felix; Mach, Francois; Rodondi, Nicolas			Quality of Care after Acute Coronary Syndromes in a Prospective Cohort with Reasons for Non-Prescription of Recommended Medications	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ST-ELEVATION; GLOBAL REGISTRY; HEART-DISEASE; ASSOCIATION; MANAGEMENT; HOSPITALS; OUTCOMES; THERAPY	Background: Adherence to guidelines is associated with improved outcomes of patients with acute coronary syndrome (ACS). Clinical registries developed to assess quality of care at discharge often do not collect the reasons for nonprescription for proven efficacious preventive medication in Continental Europe. In a prospective cohort of patients hospitalized for an ACS, we aimed at measuring the rate of recommended treatment at discharge, using pre-specified quality indicators recommended in cardiologic guidelines and including systematic collection of reasons for nonprescription for preventive medications. Methods: In a prospective cohort with 1260 patients hospitalized for ACS, we measured the rate of recommended treatment at discharge in 4 academic centers in Switzerland. Performance measures for medication at discharge were pre-specified according to guidelines, systematically collected for all patients and included in a centralized database. Results: Six hundred and eighty eight patients(54.6%) were discharged with a main diagnosis of STEMI, 491(39%) of NSTEMI and 81(6.4%) of unstable angina. Mean age was 64 years and 21.3% were women. 94.6% were prescribed angiotensin converting enzyme inhibitors/angiotensin II receptor blockers at discharge when only considering raw prescription rates, but increased to 99.5% when including reasons non-prescription. For statins, rates increased from 98% to 98.6% when including reasons for non-prescription and for beta-blockers, from 82% to 93%. For aspirin, rates further increased from 99.4% to 100% and from to 99.8% to 100% for P2Y12 inhibitors. Conclusions: We found a very high adherence to ACS guidelines for drug prescriptions at discharge when including reasons for non-prescription to drug therapy. For beta-blockers, prescription rates were suboptimal, even after taking into account reason for non-prescription. In an era of improving quality of care to achieve 100% prescription rates at discharge unless contra-indicated, pre-specification of reasons for non-prescription for cardiovascular preventive medication permits to identify remaining gaps in quality of care at discharge.	[Auer, Reto] UCSF, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Gencer, Baris; Carballo, David; Mach, Francois] Univ Hosp Geneva, Fac Med, Div Cardiol, Geneva, Switzerland; [Raeber, Lorenz; Windecker, Stephan] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; [Klingenberg, Roland; Matter, Christian M.; Luescher, Thomas Felix] Univ Zurich Hosp, Dept Cardiol, CH-8091 Zurich, Switzerland; [Carballo, Sebastian] Univ Hosp Geneva, Fac Med, Div Internal Med, Geneva, Switzerland; [Nanchen, David; Cornuz, Jacques] Univ Lausanne, Dept Ambulatory & Community Med, Lausanne, Switzerland; [Vader, John-Paul] Univ Lausanne, Inst Social & Prevent Med, Lausanne, Switzerland; [Vogt, Pierre] Univ Lausanne Hosp, Dept Cardiol, Lausanne, Switzerland; [Jueni, Peter] Univ Bern, Dept Clin Res, Inst Social & Prevent Med, Bern, Switzerland; [Jueni, Peter] Univ Bern, Dept Clin Res, Clin Trials Unit, Bern, Switzerland; [Rodondi, Nicolas] Univ Hosp Bern, Dept Gen Internal Med, CH-3010 Bern, Switzerland	University of California System; University of California San Francisco; University of Geneva; University of Bern; University Hospital of Bern; University of Zurich; University Zurich Hospital; University of Geneva; University of Lausanne; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University of Bern; University of Bern; University Hospital of Bern	Auer, R (corresponding author), UCSF, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	reto.auer@ucsf.edu	Juni, Peter/Q-8700-2016; Nanchen, David/AAQ-1118-2021; Gencer, Baris/AAO-2305-2020	Juni, Peter/0000-0002-5985-0670; Nanchen, David/0000-0002-2493-3505; Auer, Reto/0000-0003-4222-4849; Rodondi, Nicolas/0000-0001-9083-6896; Gencer, Baris/0000-0002-8954-9694	Swiss National Science Foundation [SNSF 33CM30-124112, PBLAP3-136774]; Inflammation and acute coronary syndromes (ACS) - Novel strategies for prevention and clinical management; Department of University Medicine and Community Care (DUMSC) of the University of Lausanne, Switzerland; Swiss Heart Foundation; Societe Academique Vaudoise and the SICPA Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Inflammation and acute coronary syndromes (ACS) - Novel strategies for prevention and clinical management; Department of University Medicine and Community Care (DUMSC) of the University of Lausanne, Switzerland; Swiss Heart Foundation; Societe Academique Vaudoise and the SICPA Foundation	The SPUM-ACS cohort is supported by the Swiss National Science Foundation (SNSF 33CM30-124112, Inflammation and acute coronary syndromes (ACS) - Novel strategies for prevention and clinical management). The specific report on quality of care at discharge is supported by a grant from the Department of University Medicine and Community Care (DUMSC) of the University of Lausanne, Switzerland and the Swiss Heart Foundation. The authors acknowledge the cooperation of all participating centers, practicing physicians, referring doctors and institutions. Dr. Auer and Dr Rodondi's research on cardiovascular prevention is supported by grants from the Swiss Heart Foundation. Dr Auer's research on cardiovascular prevention is additionally supported by a grant for prospective researchers from the Swiss National Science Foundation PBLAP3-136774, the Societe Academique Vaudoise and the SICPA Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KP, 2006, EUR HEART J, V27, P1558, DOI 10.1093/eurheartj/ehl067; [Anonymous], HEDIS HLTH PLAN EMPL; Avezum A, 2005, AM HEART J, V149, P67, DOI 10.1016/j.ahj.2004.06.003; Bajaj RR, 2013, AM J CARDIOL, V111, P202, DOI 10.1016/j.amjcard.2012.09.018; Belle L, 2012, AM J MED, V125, P365, DOI 10.1016/j.amjmed.2011.11.015; Butler J, 2002, J AM COLL CARDIOL, V40, P1589, DOI 10.1016/S0735-1097(02)02379-3; Carballo David, 2010, Rev Med Suisse, V6, P520; Ferrieres J, 2009, ATHEROSCLEROSIS, V204, P491, DOI 10.1016/j.atherosclerosis.2008.09.031; Fiore MC, 2012, NEW ENGL J MED, V366, P1172, DOI 10.1056/NEJMp1115176; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Jernberg T, 2011, JAMA-J AM MED ASSOC, V305, P1677, DOI 10.1001/jama.2011.522; Krumholz HM, 2008, CIRCULATION, V118, P2596, DOI 10.1161/CIRCULATIONAHA.108.191099; Levy DE, 2011, ARCH INTERN MED, V171, P1682, DOI 10.1001/archinternmed.2011.451; Luthi JC, 2005, INT J QUAL HEALTH C, V17, P229, DOI 10.1093/intqhc/mzi024; Luthi JC, 2002, SWISS MED WKLY, V132, P461; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; Matter CM, 2010, KARDIOVASKULARE MED, V13, P31; McManus DD, 2011, AM J MED, V124, P40, DOI 10.1016/j.amjmed.2010.07.023; Peterson ED, 2010, HEART, V96, P1798, DOI 10.1136/hrt.2010.200261; Radovanovic D, 2012, EUROPEAN HEART J ACU; Radovanovic D, 2010, SWISS MED WKLY, V140, P314, DOI smw-12986; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Setoguchi S, 2008, J AM COLL CARDIOL, V51, P1247, DOI 10.1016/j.jacc.2007.10.063; Smith CS, 2005, AM HEART J, V149, P444, DOI 10.1016/j.ahj.2004.06.033; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Wieser S, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13655; Zeymer U, 2012, EUR J PREV CARDIOL	28	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93147	10.1371/journal.pone.0093147	http://dx.doi.org/10.1371/journal.pone.0093147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676282	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000333677500082
J	Chen, R; Robinson, A; Chung, SH				Chen, Rong; Robinson, Anna; Chung, Shin-Ho			Mechanism of mu-Conotoxin PIIIA Binding to the Voltage-Gated Na+ Channel Na(V)1.4	PLOS ONE			English	Article							RESISTANT SODIUM-CHANNELS; SOLUTION NMR STRUCTURE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; OUTER VESTIBULE; SKELETAL-MUSCLE; VENOM PEPTIDES; ION CHANNELS; FREE-ENERGY; GIIIA	Several subtypes of voltage-gated Na+ (Na-V) channels are important targets for pain management. mu-Conotoxins isolated from venoms of cone snails are potent and specific blockers of different Na-V channel isoforms. The inhibitory effect of mu-conotoxins on Na-V channels has been examined extensively, but the mechanism of toxin specificity has not been understood in detail. Here the known structure of m-conotoxin PIIIA and a model of the skeletal muscle channel Na(V)1.4 are used to elucidate elements that contribute to the structural basis of m-conotoxin binding and specificity. The model of Na(V)1.4 is constructed based on the crystal structure of the bacterial Na-V channel, Na(V)Ab. Six different binding modes, in which the side chain of each of the basic residues carried by the toxin protrudes into the selectivity filter of Na(V)1.4, are examined in atomic detail using molecular dynamics simulations with explicit solvent. The dissociation constants (K-d) computed for two selected binding modes in which Lys9 or Arg14 from the toxin protrudes into the filter of the channel are within 2 fold; both values in close proximity to those determined from dose response data for the block of Na-V currents. To explore the mechanism of PIIIA specificity, a double mutant of Na(V)1.4 mimicking Na-V channels resistant to m-conotoxins and tetrodotoxin is constructed and the binding of PIIIA to this mutant channel examined. The double mutation causes the affinity of PIIIA to reduce by two orders of magnitude.	[Chen, Rong; Robinson, Anna; Chung, Shin-Ho] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	Australian National University	Chen, R (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	rong.chen@anu.edu.au			Australian Commonwealth Government; National Health and Medical Research Council of Australia; Medical Advances Without Animals Trust (MAWA)	Australian Commonwealth Government(Australian Government); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Medical Advances Without Animals Trust (MAWA)	This research was undertaken on the National Computational Infrastructure in Canberra, Australia, which is supported by the Australian Commonwealth Government. This work was supported by the National Health and Medical Research Council of Australia and The Medical Advances Without Animals Trust (MAWA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriel H, 2007, CARDIOVASC RES, V76, P381, DOI 10.1016/j.cardiores.2007.07.019; ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025; BECKER S, 1992, BIOCHEMISTRY-US, V31, P8229, DOI 10.1021/bi00150a016; Bulaj G, 2005, BIOCHEMISTRY-US, V44, P7259, DOI 10.1021/bi0473408; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chagot B, 2011, J MOL BIOL, V406, P106, DOI 10.1016/j.jmb.2010.11.046; Chagot B, 2009, J BIOL CHEM, V284, P6436, DOI 10.1074/jbc.M807747200; Chen R, 2013, BIOCHEMISTRY-US, V52, P3765, DOI 10.1021/bi4003327; Chen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047253; Chen R, 2012, BIOPHYS J, V102, P483, DOI 10.1016/j.bpj.2011.12.041; Choudhary G, 2007, CHANNELS, V1, P344, DOI 10.4161/chan.5112; Cummins TR, 2002, MOL PHARMACOL, V61, P1192, DOI 10.1124/mol.61.5.1192; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Dudley SC, 2000, J GEN PHYSIOL, V116, P679, DOI 10.1085/jgp.116.5.679; Eriksson MAL, 2002, BIOPHYS J, V83, P2595, DOI 10.1016/S0006-3495(02)75270-3; Fallon JL, 2009, P NATL ACAD SCI USA, V106, P5135, DOI 10.1073/pnas.0807487106; Gordon D, 2013, PHYSIOL REV, V93, P767, DOI 10.1152/physrev.00035.2012; Hui KY, 2003, J GEN PHYSIOL, V122, P63, DOI 10.1085/jgp.200308842; Hui KY, 2002, J GEN PHYSIOL, V119, P45, DOI 10.1085/jgp.119.1.45; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khoo KK, 2011, J MED CHEM, V54, P7558, DOI 10.1021/jm200839a; Khoo KK, 2009, BIOCHEMISTRY-US, V48, P1210, DOI 10.1021/bi801998a; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Knapp O, 2012, TOXINS, V4, P1236, DOI 10.3390/toxins4111236; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Lee CH, 2008, CHANNELS, V2, P407, DOI 10.4161/chan.2.6.7429; Leipold E, 2011, NEUROPHARMACOLOGY, V61, P105, DOI 10.1016/j.neuropharm.2011.03.008; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; Li RA, 2003, J BIOL CHEM, V278, P8717, DOI 10.1074/jbc.M210882200; Li RA, 2001, J BIOL CHEM, V276, P11072, DOI 10.1074/jbc.M010862200; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McArthur JR, 2011, MOL PHARMACOL, V80, P573, DOI 10.1124/mol.111.073460; McArthur JR, 2011, MOL PHARMACOL, V80, P219, DOI 10.1124/mol.111.071779; McArthur JR, 2011, BIOCHEMISTRY-US, V50, P116, DOI 10.1021/bi101316y; Mills JEJ, 1996, J COMPUT AID MOL DES, V10, P607, DOI 10.1007/BF00134183; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Nielsen KJ, 2002, J BIOL CHEM, V277, P27247, DOI 10.1074/jbc.M201611200; Norton RS, 2010, MOLECULES, V15, P2825, DOI 10.3390/molecules15042825; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rashid MH, 2013, MAR DRUGS, V11, P848, DOI 10.3390/md11030848; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; SATO K, 1991, J BIOL CHEM, V266, P16989; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shon KJ, 1998, J NEUROSCI, V18, P4473; Smith JJ, 2013, CELL MOL LIFE SCI, V70, P3665, DOI 10.1007/s00018-013-1315-3; Stevens M, 2012, J BIOL CHEM, V287, P31382, DOI 10.1074/jbc.M112.375733; Stevens M, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00071; Tietze AA, 2012, ANGEW CHEM INT EDIT, V51, P4058, DOI 10.1002/anie.201107011; Tikhonov DB, 2012, MOL PHARMACOL, V82, P97, DOI 10.1124/mol.112.078212; WAKAMATSU K, 1992, BIOCHEMISTRY-US, V31, P12577, DOI 10.1021/bi00165a006; West PJ, 2002, BIOCHEMISTRY-US, V41, P15388, DOI 10.1021/bi0265628; Wilson M, 2011, J PETROL, V52, P1, DOI 10.1093/petrology/egq092; Wimley WC, 1996, P NATL ACAD SCI USA, V93, P2985, DOI 10.1073/pnas.93.7.2985; Xia MD, 2013, BIOPHYS J, V104, P2401, DOI 10.1016/j.bpj.2013.04.035; Zhang MM, 2007, J BIOL CHEM, V282, P30699, DOI 10.1074/jbc.M704616200; Zhang MM, 2010, J NEUROPHYSIOL, V104, P88, DOI 10.1152/jn.00145.2010; Zhang MM, 2010, BIOCHEMISTRY-US, V49, P4804, DOI 10.1021/bi100207k; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	62	34	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93267	10.1371/journal.pone.0093267	http://dx.doi.org/10.1371/journal.pone.0093267			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676211	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500100
J	Kumar, B; Yadav, A; Hideg, K; Kuppusamy, P; Teknos, TN; Kumar, P				Kumar, Bhavna; Yadav, Arti; Hideg, Kalman; Kuppusamy, Periannan; Teknos, Theodoros N.; Kumar, Pawan			A Novel Curcumin Analog (H-4073) Enhances the Therapeutic Efficacy of Cisplatin Treatment in Head and Neck Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; SIGNALING INDUCES APOPTOSIS; CONSTITUTIVE ACTIVATION; ANTICANCER EFFICACY; PROSTATE-CANCER; IN-VIVO; STAT3; EXPRESSION; RESISTANCE; SURVIVAL	Chemotherapy constitutes the standard modality of treatment for localized head and neck squamous cell carcinomas (HNSCC). However, many patients fail to respond and relapse after this treatments due to the acquisition of chemoresistance. Therefore, there is an urgent need to develop novel drugs that could reverse the resistant phenotype. Curcumin, the constituent of the spice turmeric has been shown to have anti-inflammatory, anti-oxidant and anti-proliferative properties in several tumor types. However, use of curcumin has been limited due to its poor bio-absorption. Recently, a novel class of curcumin analogs, based on diarylidenylpiperidones (DAP), has been developed by incorporating a piperidone link to the beta-diketone structure and fluoro substitutions on the phenyl groups. In this study, we evaluated the effectiveness of H-4073, a parafluorinated variant of DAP, using both in vitro and in vivo head and neck cancer models. Our results demonstrate that H-4073 is a potent anti-tumor agent and it significantly inhibited cell proliferation in all the HNSCC cell lines tested in a dose-dependent manner. In addition, pretreatment of cisplatin-resistant HNSCC cell lines with H-4073 significantly reversed the chemo-resistance as observed by cell viability assay (MTT), apoptosis assay (Annexin V binding) and cleaved caspase-3 (Western blot). H-4073 mediated its anti-tumor effects by inhibiting JAK/STAT3, FAK, Akt and VEGF signaling pathways that play important roles in cell proliferation, migration, survival and angiogenesis. In the SCID mouse xenograft model, H-4073 significantly enhanced the anti-tumor and anti-angiogenesis effects of cisplatin, with no added systemic toxicity. Interestingly, H-4073 inhibited tumor angiogenesis by blocking VEGF production by tumor cells as well as directly inhibiting endothelial cell function. Taken together, our results suggest that H-4073 is a potent anti-tumor agent and it can be used to overcome chemotherapy resistance in HNSCC.	[Kumar, Bhavna; Teknos, Theodoros N.; Kumar, Pawan] Ohio State Univ, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA; [Kumar, Bhavna; Yadav, Arti; Teknos, Theodoros N.; Kumar, Pawan] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Hideg, Kalman] Univ Pecs, Inst Organ & Med Chem, Pecs, Hungary; [Kuppusamy, Periannan] Geisel Sch Med, Hanover, NH USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Pecs; Dartmouth College	Teknos, TN (corresponding author), Ohio State Univ, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA.	Ted.Teknos@osumc.edu; Pawan.Kumar@osumc.edu			National Institutes of Health [NIH/NCI-CA133250]; Joan's Fund Research Grant; Experimental therapeutics seed grant from The Ohio State University Comprehensive Cancer Center; Arthur G. James Cancer Hospital; Richard J. Solove Research Institute; NATIONAL CANCER INSTITUTE [K12CA133250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joan's Fund Research Grant; Experimental therapeutics seed grant from The Ohio State University Comprehensive Cancer Center; Arthur G. James Cancer Hospital; Richard J. Solove Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health (NIH/NCI-CA133250, P. Kumar), Joan's Fund Research Grant (BK P. Kumar), Experimental therapeutics seed grant from The Ohio State University Comprehensive Cancer Center (P. Kumar), Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (TT, P. Kumar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez James V, 2007, Transl Oncogenomics, V2, P99; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Azare J, 2007, MOL CELL BIOL, V27, P4444, DOI 10.1128/MCB.02404-06; Barton BE, 2004, MOL CANCER THER, V3, P11; Bourguignon LYW, 2012, ONCOGENE, V31, P149, DOI 10.1038/onc.2011.222; Bradford CR, 2003, HEAD NECK-J SCI SPEC, V25, P654, DOI 10.1002/hed.10274; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Carden CP, 2012, MOL CANC THERAPEUTIC; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; DIMERY IW, 1993, JNCI-J NATL CANCER I, V85, P95, DOI 10.1093/jnci/85.2.95; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Girouard J, 2013, GYNECOL ONCOL, V128, P335, DOI 10.1016/j.ygyno.2012.11.016; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Gu F, 2010, ONCOL REP, V23, P671, DOI 10.3892/or_00000683; Gupta AK, 2003, INT J RADIAT ONCOL, V56, P846, DOI 10.1016/S0360-3016(03)00214-1; Haura EB, 2005, CLIN CANCER RES, V11, P8288, DOI 10.1158/1078-0432.CCR-05-0827; Huang SL, 2012, CANCER LETT, V315, P198, DOI 10.1016/j.canlet.2011.10.011; Jun HJ, 2008, BRIT J CANCER, V99, P167, DOI 10.1038/sj.bjc.6604464; Kalavrezos N, 2010, ORAL ONCOL, V46, P429, DOI 10.1016/j.oraloncology.2010.03.007; Kim DY, 2009, J GASTROEN HEPATOL, V24, P646, DOI 10.1111/j.1440-1746.2008.05671.x; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Kumar B, 2012, MOL CANCER THER, V11, P1988, DOI 10.1158/1535-7163.MCT-12-0167; Kumar P, 2008, MOL CANCER THER, V7, P2060, DOI 10.1158/1535-7163.MCT-08-0287; Lai SY, 2010, DRUG RESIST UPDATE, V13, P67, DOI 10.1016/j.drup.2010.04.001; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Marur S, 2008, MAYO CLIN PROC, V83, P489, DOI 10.4065/83.4.489; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mora LB, 2002, CANCER RES, V62, P6659; Nisi KW, 1998, INT J RADIAT ONCOL, V41, P371, DOI 10.1016/S0360-3016(98)00059-5; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Real PJ, 2002, ONCOGENE, V21, P7611, DOI 10.1038/sj.onc.1206004; Schlessinger K, 2005, CANCER RES, V65, P5828, DOI 10.1158/0008-5472.CAN-05-0317; Selvendiran K, 2010, MOL CANCER THER, V9, P1169, DOI 10.1158/1535-7163.MCT-09-1207; Selvendiran K, 2010, FREE RADICAL BIO MED, V48, P1228, DOI 10.1016/j.freeradbiomed.2010.02.009; Sen M, 2012, CLIN CANCER RES, V18, P4986, DOI 10.1158/1078-0432.CCR-12-0792; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sturgis EM, 2004, SEMIN ONCOL, V31, P726, DOI 10.1053/j.seminoncol.2004.09.013; Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010; Takemoto S, 2009, BRIT J CANCER, V101, P967, DOI 10.1038/sj.bjc.6605212; WATSON CJ, 1995, BRIT J CANCER, V71, P840, DOI 10.1038/bjc.1995.162; Worden FP, 2008, J CLIN ONCOL, V26, P3138, DOI 10.1200/JCO.2007.12.7597; Yadav A, 2011, MOL CANC TH IN PRESS; Yadav A, 2011, MOL CANC RES; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang XL, 2007, ONCOL REP, V17, P1377; Zhao M, 2011, LUNG CANCER, V73, P366, DOI 10.1016/j.lungcan.2011.01.002	51	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93208	10.1371/journal.pone.0093208	http://dx.doi.org/10.1371/journal.pone.0093208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675768	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677500089
J	Hernandez-Avila, I				Hernandez-Avila, Ivan			Patterns of Deep-Water Coral Diversity in the Caribbean Basin and Adjacent Southern Waters: An Approach based on Records from the R/V Pillsbury Expeditions	PLOS ONE			English	Article							GLOBAL HABITAT SUITABILITY; SPECIES RICHNESS; AZOOXANTHELLATE CORALS; CONTINENTAL MARGINS; SEA; ATLANTIC; BIOGEOGRAPHY; COASTAL; SHELF; BIOTA	The diversity of deep-water corals in the Caribbean Sea was studied using records from oceanographic expeditions performed by the R/V Pillsbury. Sampled stations were sorted according to broad depth ranges and ecoregions and were analyzed in terms of species accumulation curves, variance in the species composition and contributions to alpha, beta and gamma diversity. According to the analysis of species accumulation curves using the Chao2 estimator, more diversity occurs on the continental slope (200-2000 m depth) than on the upper continental shelf (60-200 m depth). In addition to the effect of depth sampling, differences in species composition related to depth ranges were detected. However, the differences between ecoregions are dependent on depth ranges, there were fewer differences among ecoregions on the continental slope than on the upper continental shelf. Indicator species for distinctness of ecoregions were, in general, Alcyonaria and Antipatharia for the upper continental shelf, but also the scleractinians Madracis myriabilis and Cladocora debilis. In the continental slope, the alcyonarian Placogorgia and the scleractinians Stephanocyathus and Fungiacyathus were important for the distinction of ecoregions. Beta diversity was the most important component of gamma diversity in the Caribbean Basin. The contribution of ecoregions to alpha, beta and gamma diversity differed with depth range. On the upper continental shelf, the Southern Caribbean ecoregion contributed substantially to all components of diversity. In contrast, the northern ecoregions contributed substantially to the diversity of the Continental Slope. Strategies for the conservation of deep-water coral diversity in the Caribbean Basin must consider the variation between ecoregions and depth ranges.	[Hernandez-Avila, Ivan] Univ Oriente, Nucleo Nueva Esparta, Dept Ciencias, Unidad Cursos Basicos, Margarita Isl, Venezuela; [Hernandez-Avila, Ivan] IFREMER, Unite Rech Etud Ecosyst Profonds, Lab Environm, Plouzane, France	Ifremer	Hernandez-Avila, I (corresponding author), Univ Oriente, Nucleo Nueva Esparta, Dept Ciencias, Unidad Cursos Basicos, Margarita Isl, Venezuela.	ivan.hernandez@ifremer.fr	caputo, carlo/N-3747-2014; Avila, Ivan IHA Hernandez/F-8715-2014	Hernandez, Ivan/0000-0002-6722-5226	Comision de Investigacion, Universidad de Oriente	Comision de Investigacion, Universidad de Oriente	Research visit to RSMAS was partially supported by Comision de Investigacion, Universidad de Oriente. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2008, PERMANOVA PRIMER GUI, P214; Arantes RCM, 2009, MAR ECOL PROG SER, V397, P71, DOI 10.3354/meps08230; Briggs KB, 1996, J MAR RES, V54, P705, DOI 10.1357/0022240963213736; Bryan TL, 2007, MAR ECOL PROG SER, V330, P113, DOI 10.3354/meps330113; Bryan TL, 2006, DEEP-SEA RES PT I, V53, P1865, DOI 10.1016/j.dsr.2006.09.006; CAIRNS S D, 1986, Smithsonian Contributions to Zoology, P1; Cairns S. D., 1979, STUD FAUNA CURACAO, V57, P341; Cairns S.D., 2001, P 1 INT S DEEP SEA C, P30; Cairns SD, 2007, B MAR SCI, V81, P311; Cairns SD, 2007, P BIOL SOC WASH, V120, P1, DOI 10.2988/0006-324X(2007)120[1:SOWAOG]2.0.CO;2; Cairns SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021670; Cairns Stephen D., 2000, Uitgaven Natuurwetenschappelijke Studiekring voor het Caraibisch Gebied, V143, P1; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chazdon RL, 1998, MAN BIOSPH, V20, P285; Clark M.R., 2006, SEAMOUNTS DEEP SEA C; Clark MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029232; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Colwell RK, 2013, ESTIMATES STAT ESTIM; Connelly DP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1636; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; Dawson JP, 2002, CORAL REEFS, V21, P27, DOI 10.1007/s00338-001-0207-4; DAYTON PK, 1972, DEEP-SEA RES, V19, P199, DOI 10.1016/0011-7471(72)90031-9; Urriago Juan Diego, 2011, Bol. Invest. Mar. Cost., V40, P89; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; Garcia E, 2011, CIENC MAR, V37, P141, DOI 10.7773/cm.v37i2.1763; German CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023259; GORDON AL, 1967, J GEOPHYS RES, V72, P6207, DOI 10.1029/JZ072i024p06207; Gracia A, 2012, J MAR BIOL ASSOC UK, V92, P1367, DOI 10.1017/S0025315411001421; GRASSLE JF, 1992, AM NAT, V139, P313, DOI 10.1086/285329; GRASSLE JF, 1991, BIOSCIENCE, V41, P464, DOI 10.2307/1311803; Gray JS, 1997, MAR ECOL PROG SER, V159, P97, DOI 10.3354/meps159097; Gray JS, 2000, J EXP MAR BIOL ECOL, V250, P23, DOI 10.1016/S0022-0981(00)00178-7; Guerra-Castro EJ, 2012, THESIS IVIC VENEZUEL; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Hellweger FL, 2002, J MAR RES, V60, P537, DOI 10.1357/002224002762324202; Henry Lea-Anne, 2011, University of British Columbia Fisheries Centre Research Reports, V19, P120; Hubscher C, 2010, INT J EARTH SCI, V99, pS191, DOI 10.1007/s00531-010-0558-6; Jones DOB, 2012, J MAR BIOL ASSOC UK, V92, P245, DOI 10.1017/S0025315411001123; Kitchingman A, 2005, SEAMOUNTS BIODIVERSI, P7; Leverette TL, 2005, ERLANGEN EARTH C SER, P467, DOI 10.1007/3-540-27673-4_23; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Levin LA, 2009, TRENDS ECOL EVOL, V24, P606, DOI 10.1016/j.tree.2009.04.012; Lu HP, 2007, BASIC APPL ECOL, V8, P1, DOI 10.1016/j.baae.2006.06.004; Lutz MJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003706; Lutz S. J., 2007, STATE DEEP CORAL ECO; MacCready P, 1999, J GEOPHYS RES-OCEANS, V104, P25913, DOI 10.1029/1999JC900206; McClain CR, 2010, P ROY SOC B-BIOL SCI, V277, P3533, DOI 10.1098/rspb.2010.1057; Miller K, 2011, TLS-TIMES LIT SUPPL, P6; Miloslavich P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011916; Mosher CV, 2009, MAR ECOL PROG SER, V397, P81, DOI 10.3354/meps08113; MULLERKARGER FE, 1994, CONT SHELF RES, V14, P199, DOI 10.1016/0278-4343(94)90013-2; Paterson GLJ, 1998, DEEP-SEA RES PT II, V45, P225, DOI 10.1016/S0967-0645(97)00084-2; Priede IG, 2010, MAR ECOL-EVOL PERSP, V31, P247, DOI 10.1111/j.1439-0485.2009.00330.x; Ramirez-Llodra E., 2010, BIOGEOSCI DISCUSS, V7, P2361, DOI DOI 10.5194/BGD-7-2361-2010; Reed JK, 2013, CARIBB J SCI, V47, P13; REX MA, 1973, SCIENCE, V181, P1051, DOI 10.1126/science.181.4104.1051; Reyes J, 2005, ERLANGEN EARTH C SER, P309, DOI 10.1007/3-540-27673-4_15; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Santodomingo N, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P273; Santodomingo N, 2013, MAR BIODIVERS, V43, P7, DOI 10.1007/s12526-012-0131-6; Schmitz Jr W.J., 1996, WHOI9603, V1; Snelgrove PVR, 2002, OCEANOGR MAR BIOL, V40, P311; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Staiger J, 1970, TECHNICAL REPORT; Staiger J, 1968, TECHNICAL REPORT; Staiger J, 1969, TECHNICAL REPORT; Stuart CT, 2003, ECOSY WORLD, V28, P295; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Ugland KI, 2003, J ANIM ECOL, V72, P888, DOI 10.1046/j.1365-2656.2003.00748.x; Voss GL, 1971, TECHNICAL REPORT; Voss GL, 1977, COOPERATIVE INVESTIG; Voss GL, 1966, TECHNICAL REPORT; Watling L, 2013, PROG OCEANOGR, V111, P91, DOI 10.1016/j.pocean.2012.11.003; White HK, 2012, P NATL ACAD SCI USA, V109, P20303, DOI 10.1073/pnas.1118029109; Woodby D, 2009, MAR ECOL PROG SER, V397, P227, DOI 10.3354/meps08358; Yesson C, 2012, J BIOGEOGR, V39, P1278, DOI 10.1111/j.1365-2699.2011.02681.x	80	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92834	10.1371/journal.pone.0092834	http://dx.doi.org/10.1371/journal.pone.0092834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671156	Green Published, gold			2022-12-27	WOS:000333677000083
J	Jiang, Z; Li, C; Arrick, DM; Yang, S; Baluna, AE; Sun, H				Jiang, Zheng; Li, Chun; Arrick, Denise M.; Yang, Shu; Baluna, Alexandra E.; Sun, Hong			Role of Nitric Oxide Synthases in Early Blood-Brain Barrier Disruption following Transient Focal Cerebral Ischemia	PLOS ONE			English	Article							MITOCHONDRIAL RESPIRATORY-CHAIN; ARTERY OCCLUSION; PROTECTS; PEROXYNITRITE; ARTERIOLES; ACTIVATION; EXPRESSION; GENERATION; REACTIVITY; NEURONS	The role of nitric oxide synthases (NOSs) in early blood-brain barrier (BBB) disruption was determined using a new mouse model of transient focal cerebral ischemia. Ischemia was induced by ligating the middle cerebral artery (MCA) at its M2 segment and reperfusion was induced by releasing the ligation. The diameter alteration of the MCA, arterial anastomoses and collateral arteries were imaged and measured in real time. BBB disruption was assessed by Evans Blue (EB) and sodium fluorescein (Na-F) extravasation at 3 hours of reperfusion. The reperfusion produced an extensive vasodilation and a sustained hyperemia. Although expression of NOSs was not altered at 3 hours of reperfusion, L-NAME (a non-specific NOS inhibitor) abolished reperfusion-induced vasodilation/hyperemia and significantly reduced EB and Na-F extravasation. L-NIO (an endothelial NOS (eNOS) inhibitor) significantly attenuated cerebral vasodilation but not BBB disruption, whereas L-NPA and 7-NI (neuronal NOS (nNOS) inhibitors) significantly reduced BBB disruption but not cerebral vasodilation. In contrast, aminoguanidine (AG) (an inducible NOS (iNOS) inhibitor) had less effect on either cerebral vasodilation or BBB disruption. On the other hand, papaverine (PV) not only increased the vasodilation/hyperemia but also significantly reduced BBB disruption. Combined treatment with L-NAME and PV preserved the vasodilation/hyperemia and significantly reduced BBB disruption. Our findings suggest that nNOS may play a major role in early BBB disruption following transient focal cerebral ischemia via a hyperemia-independent mechanism.	[Jiang, Zheng; Li, Chun; Arrick, Denise M.; Yang, Shu; Baluna, Alexandra E.; Sun, Hong] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Sun, H (corresponding author), Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA.	hsun1@lsuhsc.edu			Louisiana State University Health Sciences Center-Shreveport	Louisiana State University Health Sciences Center-Shreveport	This study was supported by funds from Louisiana State University Health Sciences Center-Shreveport. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CL, 2009, INT J STROKE, V4, P461, DOI 10.1111/j.1747-4949.2009.00387.x; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Bolanos JP, 1999, BBA-BIOENERGETICS, V1411, P415, DOI 10.1016/S0005-2728(99)00030-4; BOLANOS JP, 1995, J NEUROCHEM, V64, P1965; Bouley J, 2007, NEUROSCI LETT, V412, P185, DOI 10.1016/j.neulet.2006.11.003; Chen B, 2009, STROKE, V40, pE666, DOI 10.1161/STROKEAHA.109.551341; Fassbender K, 2000, STROKE, V31, P2208, DOI 10.1161/01.STR.31.9.2208; Grandati M, 1997, BRIT J PHARMACOL, V122, P625, DOI 10.1038/sj.bjp.0701427; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Hartkamp MJ, 1999, STROKE, V30, P2671, DOI 10.1161/01.STR.30.12.2671; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P52, DOI 10.1038/jcbfm.1995.6; Koizumi J., 1986, JPN J STROKE, V8, P1, DOI DOI 10.3995/JSTROKE.8.1; Latour LL, 2004, ANN NEUROL, V56, P468, DOI 10.1002/ana.20199; Lekontseva O, 2011, J PHARM EXPT THERAPE; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; MALINSKI T, 1993, J CEREBR BLOOD F MET, V13, P355, DOI 10.1038/jcbfm.1993.48; Mayhan WG, 2008, MICROCIRCULATION, V15, P225, DOI 10.1080/10739680701641421; Miclescu A, 2010, CRIT CARE MED, V38, P2199, DOI 10.1097/CCM.0b013e3181f26b0c; Mohammadi MT, 2011, PATHOPHYSIOLOGY OFFI; MOORADIAN AD, 1992, MECH AGEING DEV, V64, P247, DOI 10.1016/0047-6374(92)90082-O; MORO MA, 1995, BRIT J PHARMACOL, V116, P1999, DOI 10.1111/j.1476-5381.1995.tb16404.x; Moro MA, 2005, FREE RADICAL BIO MED, V39, P1291, DOI 10.1016/j.freeradbiomed.2005.07.010; Moro MA, 2004, CELL CALCIUM, V36, P265, DOI 10.1016/j.ceca.2004.02.011; Mundy AL, 2007, CARDIOVASC RES, V73, P368, DOI 10.1016/j.cardiores.2006.11.019; Perez-Asensio FJ, 2010, J CEREBR BLOOD F MET, V30, P638, DOI 10.1038/jcbfm.2009.237; Peterson EC, 2011, INT J VASC MED, V2011, DOI 10.1155/2011/823525; Rodionov RN, 2010, CIRC RES, V106, P551, DOI 10.1161/CIRCRESAHA.109.200360; Stewart JM, 2011, AM J PHYSIOL-HEART C, V301, pH704, DOI 10.1152/ajpheart.00171.2011; Sun H, 2002, ALCOHOL CLIN EXP RES, V26, P663; Suofu Y, 2010, J NEUROCHEM, V115, P1266, DOI 10.1111/j.1471-4159.2010.07026.x; Toda N, 2009, CAN J PHYSIOL PHARM, V87, P581, DOI [10.1139/Y09-048, 10.1139/y09-048]; TOMINAGA T, 1994, J CEREBR BLOOD F MET, V14, P715, DOI 10.1038/jcbfm.1994.92; Uetsuka S, 2002, J NEUROTRAUM, V19, P1105, DOI 10.1089/089771502760342009; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; ZHANG J, 1995, STROKE, V26, P298, DOI 10.1161/01.STR.26.2.298; ZHANG ZG, 1994, BRAIN RES, V654, P85; ZHANG ZG, 1993, STROKE, V24, P2016, DOI 10.1161/01.STR.24.12.2016; Zhao HG, 2008, BRAIN RES, V1246, P158, DOI 10.1016/j.brainres.2008.08.096	38	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93134	10.1371/journal.pone.0093134	http://dx.doi.org/10.1371/journal.pone.0093134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671193	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000117
J	Muller, LPD; Sargoy, A; Rodriguez, AR; Brecha, NC				Mueller, Luis Perez de Sevilla; Sargoy, Allison; Rodriguez, Allen R.; Brecha, Nicholas C.			Melanopsin Ganglion Cells Are the Most Resistant Retinal Ganglion Cell Type to Axonal Injury in the Rat Retina	PLOS ONE			English	Article							OPTIC-NERVE SECTION; SURVIVAL; PROTEIN; NEURONS; AKT; MORPHOLOGY; RESPONSES; AXOTOMY; DEATH; PTEN	We report that the most common retinal ganglion cell type that remains after optic nerve transection is the M1 melanopsin ganglion cell. M1 ganglion cells are members of the intrinsically photosensitive retinal ganglion cell population that mediates non-image-forming vision, comprising similar to 2.5% of all ganglion cells in the rat retina. In the present study, M1 ganglion cells comprised 1.7 +/- 1%, 28 +/- 14%, 55 +/- 13% and 82 +/- 8% of the surviving ganglion cells 7, 14, 21 and 60 days after optic nerve transection, respectively. Average M1 ganglion cell somal diameter and overall morphological appearance remained unchanged in non-injured and injured retinas, suggesting a lack of injury-induced degeneration. Average M1 dendritic field size increased at 7 and 60 days following optic nerve transection, while average dendritic field size remained similar in non-injured retinas and in retinas at 14 and 21 days after optic nerve transection. These findings demonstrate that M1 ganglion cells are more resistant to injury than other ganglion cell types following optic nerve injury, and provide an opportunity to develop pharmacological or genetic therapeutic approaches to mitigate ganglion cell death and save vision following optic nerve injury.	[Mueller, Luis Perez de Sevilla; Sargoy, Allison; Rodriguez, Allen R.; Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Sargoy, Allison; Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, CURE Digest Dis Res Ctr, Los Angeles, CA 90095 USA; [Brecha, Nicholas C.] Vet Adm Greater Los Angeles Hlth Syst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Muller, LPD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	luisperez@mednet.ucla.edu			Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD [W81XWH-10-2-0077]; NIH [EY04067]; NIDDK [P30 DK41301]; VA Merit Review; VA Career Research Scientist; NATIONAL EYE INSTITUTE [R56EY004067, T32EY007026, R01EY004067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000764] Funding Source: NIH RePORTER	Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); VA Merit Review(US Department of Veterans Affairs); VA Career Research Scientist; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This research and development project was conducted by the authors at the David Geffen School of Medicine at UCLA and is made possible by a contract agreement that was awarded and administered by the U.S. Army Medical Research & Materiel Command (USAMRMC) and the Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD under Contract Number: W81XWH-10-2-0077. Support for these studies also came from NIH EY04067, NIDDK P30 DK41301 (UCLA Cure Center Core) and a VA Merit Review (NB). NCB is a VA Career Research Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cenni MC, 1996, EUR J NEUROSCI, V8, P1735, DOI 10.1111/j.1460-9568.1996.tb01317.x; Chow DK, 2009, NAT NEUROSCI, V12, P116, DOI 10.1038/nn.2255; de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109; DeParis SW, 2012, MOL VIS, V18, P2814; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; DRAGER UC, 1984, NATURE, V309, P624, DOI 10.1038/309624a0; DRAGER UC, 1981, INVEST OPHTH VIS SCI, V20, P285; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Estevez ME, 2012, J NEUROSCI, V32, P13608, DOI 10.1523/JNEUROSCI.1422-12.2012; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Hannibal J, 2004, INVEST OPHTH VIS SCI, V45, P4202, DOI 10.1167/iovs.04-0313; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HOLLANDER H, 1984, EXP BRAIN RES, V55, P483; Ingham ES, 2009, J COMP NEUROL, V516, P125, DOI 10.1002/cne.22103; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Joly S, 2008, J NEUROSCI, V28, P13765, DOI 10.1523/JNEUROSCI.5114-08.2008; Joo HR, 2013, VISUAL NEUROSCI, V9, P1; Kameritsch P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.105; Kitaoka Y, 2004, IN VIVO, V18, P311; Kreuzberg MM, 2006, P NATL ACAD SCI USA, V103, P5959, DOI 10.1073/pnas.0508512103; Krysko DV, 2005, APOPTOSIS, V10, P459, DOI 10.1007/s10495-005-1875-2; Kwong JMK, 2010, INVEST OPHTH VIS SCI, V51, P1052, DOI 10.1167/iovs.09-4098; Lai JP, 2009, BRIT J PHARMACOL, V156, P189, DOI 10.1111/j.1476-5381.2008.00020.x; Li RS, 2006, INVEST OPHTH VIS SCI, V47, P2951, DOI 10.1167/iovs.05-1295; Li SY, 2008, CELL MOL NEUROBIOL, V28, P1095, DOI 10.1007/s10571-008-9286-x; LINDEN R, 1982, NEUROSCIENCE, V7, P2813, DOI 10.1016/0306-4522(82)90104-X; LIU ZH, 1986, NEUROSCI LETT, V67, P239, DOI 10.1016/0304-3940(86)90315-0; MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J; Muller LPD, 2010, VISUAL NEUROSCI, V27, P91, DOI 10.1017/S0952523810000131; Muller LPD, 2010, J COMP NEUROL, V518, P4813, DOI 10.1002/cne.22490; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Ota T, 2002, J OCUL PHARMACOL TH, V18, P241, DOI 10.1089/108076802760116160; Pan F, 2010, J COMP NEUROL, V518, P911, DOI 10.1002/cne.22254; Pang JJ, 2011, INVEST OPHTH VIS SCI, V52, P4886, DOI 10.1167/iovs.10-5921; Perez de Sevilla L, J COMP NEUR IN PRESS; PERRY VH, 1982, NATURE, V297, P683, DOI 10.1038/297683a0; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rane SG, 2000, ONCOGENE, V19, P5662, DOI 10.1038/sj.onc.1203925; Reglodi D, 2012, J MOL NEUROSCI, V48, P482, DOI 10.1007/s12031-012-9762-0; ROBINSON GA, 1994, MOL BRAIN RES, V24, P43, DOI 10.1016/0169-328X(94)90116-3; Robinson GA, 2004, VISION RES, V44, P2667, DOI 10.1016/j.visres.2004.06.010; Rodriguez-Sinovas A, 2007, PROG BIOPHYS MOL BIO, V94, P219, DOI 10.1016/j.pbiomolbio.2007.03.003; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Schubert T, 2005, J COMP NEUROL, V490, P29, DOI 10.1002/cne.20621; SHAW G, 1984, EUR J CELL BIOL, V33, P95; SILVEIRA LCL, 1994, J NEUROCYTOL, V23, P75, DOI 10.1007/BF01183863; STRAZNICKY C, 1992, BRAIN RES, V582, P123, DOI 10.1016/0006-8993(92)90325-4; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Sun WZ, 2002, VISUAL NEUROSCI, V19, P483, DOI 10.1017/S0952523802194107; Vaarmann A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.194; VICKERS JC, 1992, NEUROSCIENCE, V49, P73, DOI 10.1016/0306-4522(92)90077-F; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; VILLEGASPEREZ MP, 1988, J NEUROSCI, V8, P265; Vugler AA, 2007, EXP NEUROL, V205, P26, DOI 10.1016/j.expneurol.2007.01.032; Wang L, 2003, INVEST OPHTH VIS SCI, V44, P2, DOI 10.1167/iovs.02-0333; WATANABE M, 1993, J NEUROSCI, V13, P2105; Zhang C, 2008, EXP EYE RES, V86, P991, DOI 10.1016/j.exer.2008.03.020	62	65	65	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93274	10.1371/journal.pone.0093274	http://dx.doi.org/10.1371/journal.pone.0093274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671191	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677000130
J	Reparaz, LB; van Oers, K; Naguib, M; Doutrelant, C; Visser, ME; Caro, SP				Reparaz, Laura B.; van Oers, Kees; Naguib, Marc; Doutrelant, Claire; Visser, Marcel E.; Caro, Samuel P.			Mate Preference of Female Blue Tits Varies with Experimental Photoperiod	PLOS ONE			English	Article							PARUS-CAERULEUS POPULATIONS; EXTRAPAIR PATERNITY; GREAT TITS; PLUMAGE COLORATION; GENETIC-VARIATION; QUALITY MALES; BODY-SIZE; SONG; HERITABILITY; EXPRESSION	Organisms use environmental cues to time their life-cycles and among these cues, photoperiod is the main trigger of reproductive behaviours such as territory defence or song activity. Whether photoperiod is also important for another behaviour closely associated with reproduction, mate choice, is unknown. In many bird species, mate choice occurs at two different times during the annual cycle that strongly differ in daylength: in late winter when photoperiod is short and social mates are chosen, and again around egg-laying when photoperiod is longer and extra-pair mates are chosen. This duality makes the role that photoperiod plays on mate choice behaviours intriguing. We investigated the effect of photoperiod on mate choice using three experimental photoperiodic treatments (9 L:15 D, 14 L:10 D, 18 L:6 D), using blue tits (Cyanistes caeruleus) as a biological model. We show that female choice was stronger under long photoperiods. In addition, female blue tits spent significantly more time near males with long tarsi and long wings. This latter preference was only expressed under long photoperiods, suggesting that some indices of male quality only become significant to females when they are strongly photostimulated, and therefore that females could select their social and extra-pair mates based on different phenotypic traits. These results shed light on the roles that photoperiod may play in stimulating pair-bonding and in refining female selectivity for male traits.	[Reparaz, Laura B.; van Oers, Kees; Visser, Marcel E.; Caro, Samuel P.] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [Reparaz, Laura B.; Naguib, Marc] Wageningen Univ WUR, Dept Anim Sci, Behav Ecol Grp, Wageningen, Netherlands; [Doutrelant, Claire; Caro, Samuel P.] CEFE CNRS, Dept Evolutionary Ecol, Montpellier, France	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; Universite de Montpellier	Caro, SP (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands.	samuel.caro@cefe.cnrs.fr	Visser, Marcel E/A-9151-2009; P, Samuel/A-5750-2008; Naguib, Marc/C-2650-2009; van Oers, Kees/B-2562-2009; KNAW, NIOO-KNAW/A-4320-2012	Visser, Marcel E/0000-0002-1456-1939; P, Samuel/0000-0002-5405-7753; van Oers, Kees/0000-0001-6984-906X; Naguib, Marc/0000-0003-0494-4888; KNAW, NIOO-KNAW/0000-0002-3835-159X; Reparaz, Laura/0000-0001-8404-8340	Netherlands Organisation for Scientific Research (NWO); Wallonie-Bruxelles International (WBI)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Wallonie-Bruxelles International (WBI)	This work was supported by the Netherlands Organisation for Scientific Research (NWO) [VICI-grant to M. E. V., VENI-grant to S. P. C.], and by Wallonie-Bruxelles International (WBI) [World-grant to S. P. C.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E, 1998, AM ZOOL, V38, P166; Andersson Malte, 1994; Baker J. R., 1938, P161; Bentley GE, 2000, HORM BEHAV, V37, P179, DOI 10.1006/hbeh.2000.1573; BIRKHEAD T, 1993, TRENDS ECOL EVOL, V8, P100, DOI 10.1016/0169-5347(93)90060-3; Blondel J, 1999, SCIENCE, V285, P1399, DOI 10.1126/science.285.5432.1399; Blondel J, 2006, BIOSCIENCE, V56, P661, DOI 10.1641/0006-3568(2006)56[661:ATSOPA]2.0.CO;2; Botero CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032311; Bradshaw WE, 2007, ANNU REV ECOL EVOL S, V38, P1, DOI 10.1146/annurev.ecolsys.37.091305.110115; Braillet C, 2002, J AVIAN BIOL, V33, P446, DOI 10.1034/j.1600-048X.2002.02956.x; Bro-Jorgensen J, 2010, TRENDS ECOL EVOL, V25, P292, DOI 10.1016/j.tree.2009.11.003; Buchanan KL, 2011, BEHAV ECOL, V22, P12, DOI 10.1093/beheco/arq083; Chakraborty M, 2009, HORM BEHAV, V55, P106, DOI 10.1016/j.yhbeh.2008.09.001; Challenger WO, 2001, PHYSIOL BIOCHEM ZOOL, V74, P356, DOI 10.1086/320427; Charmantier A, 2004, J AVIAN BIOL, V35, P524, DOI 10.1111/j.0908-8857.2004.03296.x; CLAYTON DH, 1990, AM ZOOL, V30, P251, DOI 10.1093/icb/30.2.251; David M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024778; Davies NB, 2012, INTRO BEHAV ECOLOGY; DAWSON A, 1991, IBIS, V133, P312, DOI 10.1111/j.1474-919X.1991.tb04575.x; DAWSON A, 1983, GEN COMP ENDOCR, V49, P286, DOI 10.1016/0016-6480(83)90146-6; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; DHONDT AA, 1982, EVOLUTION, V36, P418, DOI 10.1111/j.1558-5646.1982.tb05061.x; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Doutrelant C, 2001, ARDEA, V89, P375; Doutrelant C, 2000, J AVIAN BIOL, V31, P360, DOI 10.1034/j.1600-048X.2000.310312.x; Drent PJ, 2003, P ROY SOC B-BIOL SCI, V270, P45, DOI 10.1098/rspb.2002.2168; FERKIN MH, 1991, J REPROD FERTIL, V92, P433; FREEMAN S, 1990, AUK, V107, P69; Garcia-Del-Rey E, 2012, IBIS, V154, P862, DOI 10.1111/j.1474-919X.2012.01241.x; GARNETT MC, 1981, IBIS, V123, P31, DOI 10.1111/j.1474-919X.1981.tb00170.x; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Harper DGC, 1999, ANIM BEHAV, V58, P553, DOI 10.1006/anbe.1999.1154; Hau M, 1998, P ROY SOC B-BIOL SCI, V265, P89, DOI 10.1098/rspb.1998.0268; Hinde RA, 1952, BEHAVIOUR S; Holveck MJ, 2010, P ROY SOC B-BIOL SCI, V277, P153, DOI 10.1098/rspb.2009.1222; Hunt KE, 2004, GEN COMP ENDOCR, V137, P248, DOI 10.1016/j.ygcen.2004.03.015; Kempenaers B, 1997, BEHAV ECOL, V8, P481, DOI 10.1093/beheco/8.5.481; KEMPENAERS B, 1992, NATURE, V357, P494, DOI 10.1038/357494a0; Kurvers RHJM, 2010, IBIS, V152, P393; LAMBRECHTS M, 1986, BEHAV ECOL SOCIOBIOL, V19, P57, DOI 10.1007/BF00303843; Lambrechts MM, 1997, EVOL ECOL, V11, P599, DOI 10.1007/s10682-997-1515-0; Lambrechts MM, 2004, OECOLOGIA, V141, P555, DOI 10.1007/s00442-004-1681-5; Lambrechts MM, 1997, P NATL ACAD SCI USA, V94, P5153, DOI 10.1073/pnas.94.10.5153; Lambrechts MM, 1996, P ROY SOC B-BIOL SCI, V263, P19, DOI 10.1098/rspb.1996.0004; Lambrechts MM, 2000, P ROY SOC B-BIOL SCI, V267, P585, DOI 10.1098/rspb.2000.1041; Leboucher G, 2012, ADV STUD BEHAV, V44, P183, DOI 10.1016/B978-0-12-394288-3.00005-8; Maney DL, 2006, EUR J NEUROSCI, V23, P1523, DOI 10.1111/j.1460-9568.2006.04673.x; Maney DL, 2008, J COMP NEUROL, V511, P173, DOI 10.1002/cne.21830; Meddle SL, 1997, J NEUROSCI, V17, P8909; Merila J, 1998, GENETICS, V148, P1233; MOLLER AP, 1992, AM NAT, V139, P1089, DOI 10.1086/285374; Naguib M, 2008, ETHOLOGY, V114, P255, DOI 10.1111/j.1439-0310.2007.01466.x; Naguib M, 2013, ANIM BEHAV, V85, P949, DOI 10.1016/j.anbehav.2013.02.015; Perfito N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034997; Roney JR, 2008, HORM BEHAV, V53, P14, DOI 10.1016/j.yhbeh.2007.09.008; Safran RJ, 2004, BEHAV ECOL, V15, P455, DOI 10.1093/beheco/arh035; Schielzeth H, 2008, ANIM BEHAV, V76, P1927, DOI 10.1016/j.anbehav.2008.08.014; Schuett W, 2010, BIOL REV, V85, P217, DOI 10.1111/j.1469-185X.2009.00101.x; Sockman KW, 2009, DEV NEUROBIOL, V69, P339, DOI 10.1002/dneu.20707; Sockman KW, 2004, BIOL REPROD, V71, P979, DOI 10.1095/biolreprod.104.029751; STOKES ALLEN W., 1960, IBIS, V102, P507, DOI 10.1111/j.1474-919X.1960.tb07127.x; Thompson CW, 1997, AM NAT, V149, P270, DOI 10.1086/285990; Titulaer M, 2012, ANIM BEHAV, V83, P723, DOI 10.1016/j.anbehav.2011.12.020; Van Oers K, 2008, ANIM BEHAV, V76, P555, DOI 10.1016/j.anbehav.2008.03.011; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344; Williams TD, 2012, GEN COMP ENDOCR, V176, P286, DOI 10.1016/j.ygcen.2011.11.028; Wingfield J.C., 1991, P181; WINGFIELD JC, 1984, GEN COMP ENDOCR, V56, P406, DOI 10.1016/0016-6480(84)90083-2; Woodgate JL, 2011, BEHAV ECOL, V22, P566, DOI 10.1093/beheco/arr006	69	9	10	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92527	10.1371/journal.pone.0092527	http://dx.doi.org/10.1371/journal.pone.0092527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671133	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677000051
J	Wang, J; Land, D; Ono, K; Galvez, J; Zhao, W; Vempati, P; Steele, JW; Cheng, A; Yamada, M; Levine, S; Mazzola, P; Pasinetti, GM				Wang, Jun; Land, David; Ono, Kenjiro; Galvez, Jorge; Zhao, Wei; Vempati, Prashant; Steele, John W.; Cheng, Alice; Yamada, Masahito; Levine, Samara; Mazzola, Paolo; Pasinetti, Giulio M.			Molecular Topology as Novel Strategy for Discovery of Drugs with A beta Lowering and Anti-Aggregation Dual Activities for Alzheimer's Disease	PLOS ONE			English	Article							MOUSE MODEL; PROTEIN; OLIGOMERS; NEUROPATHOLOGY; TOXICITY	Background and Purpose: In this study, we demonstrate the use of Molecular topology (MT) in an Alzheimer's disease (AD) drug discovery program. MT uses and expands upon the principles governing the molecular connectivity theory of numerically characterizing molecular structures, in the present case, active anti-AD drugs/agents, using topological descriptors to build models. Topological characterization has been shown to embody sufficient molecular information to provide strong correlation to therapeutic efficacy. Experimental Approach: We used MT to include multiple bioactive properties that allows for the identification of multifunctional single agent compounds, in this case, the dual functions of beta-amyloid (A beta) -lowering and anti-oligomerization. Using this technology, we identified and designed novel compounds in chemical classes unrelated to current anti-AD agents that exert dual A beta lowering and anti-A beta oligomerization activities in animal models of AD. AD is a multifaceted disease with different pathological features. Conclusion and Implications: Our study, for the first time, demonstrated that MT can provide novel strategy for discovering drugs with A beta lowering and anti-aggregation dual activities for AD.	[Wang, Jun; Zhao, Wei; Vempati, Prashant; Steele, John W.; Cheng, Alice; Levine, Samara; Mazzola, Paolo; Pasinetti, Giulio M.] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Land, David] Medisyn Technol Inc, Minnetonka, MN USA; [Ono, Kenjiro; Yamada, Masahito] Kanazawa Univ, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan; [Galvez, Jorge] Univ Valencia, Mol Topol & Drug Design Unit, Valencia, Spain; [Wang, Jun; Pasinetti, Giulio M.] James J Peters Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Bronx, NY USA	Icahn School of Medicine at Mount Sinai; Kanazawa University; University of Valencia; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Pasinetti, GM (corresponding author), Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA.	giulio.pasinetti@mssm.edu	Mazzola, Paolo/AAC-2448-2019; Zhao, Wei/A-2206-2010	Mazzola, Paolo/0000-0002-0484-1136; Zhao, Wei/0000-0002-3449-2395; Pasinetti, Giulio/0000-0002-1524-5196	Altschul Foundation; Icahn School of Medicine at Mount Sinai; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER	Altschul Foundation; Icahn School of Medicine at Mount Sinai; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported in part by the Altschul Foundation and by Discretionary Funds to Giulio Maria Pasinetti from the Icahn School of Medicine at Mount Sinai.	*ALZH ASS, 2006, FACT SHEET ALZH DIS; Alzheimer's Study Group, 2010, NAT ALZH STRAT PLAN; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Boado RJ, 2007, BIOCONJUGATE CHEM, V18, P447, DOI 10.1021/bc060349x; Braak H, 1997, Int Psychogeriatr, V9 Suppl 1, P257, DOI 10.1017/S1041610297004973; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; de Leon MJ, 2007, ANN NY ACAD SCI, V1097, P114, DOI 10.1196/annals.1379.012; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Dudek AZ, 2006, COMB CHEM HIGH T SCR, V9, P213, DOI 10.2174/138620706776055539; Emilien G, 2000, ARCH NEUROL-CHICAGO, V57, P176, DOI 10.1001/archneur.57.2.176; GALVEZ J, 1995, J CHEM INF COMP SCI, V35, P272, DOI 10.1021/ci00024a017; Galvez J, 1996, J MOL GRAPH MODEL, V14, P272, DOI 10.1016/S0263-7855(96)00081-1; Garcia-Domenech R, 2008, CHEM REV, V108, P1127, DOI 10.1021/cr0780006; Giacobini E, 2007, J ALZHEIMERS DIS, V12, P37; HOSOYA H, 1971, B CHEM SOC JPN, V44, P2332, DOI 10.1246/bcsj.44.2332; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jasinski P, 2008, INVEST NEW DRUG, V26, P223, DOI 10.1007/s10637-007-9096-x; Kier L., 1986, MOL CONNECTIVITY STR; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Knopman DS, 2003, J NEUROPATH EXP NEUR, V62, P1087, DOI 10.1093/jnen/62.11.1087; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Morgan D, 2005, NEURODEGENER DIS, V2, P261, DOI 10.1159/000090366; Ono K, 2008, J BIOL CHEM, V283, P32176, DOI 10.1074/jbc.M806154200; RANDIC M, 1975, J AM CHEM SOC, V97, P6609, DOI 10.1021/ja00856a001; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Todeschini R, 2000, HDB MOL DESCRIPTORS, P11; Vollers Sabrina S., 2004, V299, P11; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang J, 2005, FASEB J, V19, P659, DOI 10.1096/fj.04-3182fje; Wang J, 2008, J NEUROSCI, V28, P6388, DOI 10.1523/JNEUROSCI.0364-08.2008; Wang J, 2006, FASEB J, V20, P2313, DOI 10.1096/fj.06-6281com	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92750	10.1371/journal.pone.0092750	http://dx.doi.org/10.1371/journal.pone.0092750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671215	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677000072
J	Cai, X; Wang, JF; Huang, X; Fu, WL; Xia, WR; Zou, MJ; Wang, YY; Wang, JX; Xu, DG				Cai, Xin; Wang, JinFeng; Huang, Xin; Fu, Wenliang; Xia, Wenrong; Zou, Minji; Wang, YuanYuan; Wang, Jiaxi; Xu, Donggang			Identification and Characterization of MT-1X as a Novel FHL3-Binding Partner	PLOS ONE			English	Article							METALLOTHIONEIN EXPRESSION; BINDING PROTEIN; LIM DOMAIN; CELL-CYCLE; FHL3; CARCINOMA; APOPTOSIS; FAMILY; CANCER; ROLES	Four and a half LIM domain protein 3 ( FHL3) is a member of the FHL protein family that plays roles in the regulation of cell survival, cell adhesion and signal transduction. However, the mechanism of action for FHL3 is not yet clear. The aim of present study was to identify novel binding partner of FHL3 and to explore the underlying mechanism. With the use of yeast two-hybrid screening system, FHL3 was used as the bait to screen human fetal hepatic cDNA library for interacting proteins. Methionine-1X was identified as a novel FHL3 binding partner. The interaction between FHL3 and the full length MT-1X was further confirmed by yeast two-hybrid assay, co-immunoprecipitation and GST pull-down assays. Furthermore, the result demonstrated that MT-1X knockdown promoted the FHL3-induced inhibitory effect on HepG2 cells by regulating FHL3-mediated Smad signaling and involving in the modulation the expression of G2/M phase-related proteins through interaction with FHL3. These findings suggest that functional interactions between FHL3 and MT-1X may provide some clues to the mechanisms of FHL3-regulated cell proliferation.	[Cai, Xin; Wang, JinFeng; Huang, Xin; Fu, Wenliang; Xia, Wenrong; Zou, Minji; Wang, YuanYuan; Wang, Jiaxi; Xu, Donggang] Beijing Inst Basic Med Sci, Lab Genome Engn, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Xu, DG (corresponding author), Beijing Inst Basic Med Sci, Lab Genome Engn, Beijing, Peoples R China.	xudg@bmi.ac.cn	Lv, Yuanjie/AER-0767-2022		China Natural Scientific Foundation [81001175, 81071928]	China Natural Scientific Foundation(National Natural Science Foundation of China (NSFC))	This research was supported by China Natural Scientific Foundation (NO. 81001175; NO. No. 81071928). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Baba HA, 2000, J HEART LUNG TRANSPL, V19, P668, DOI 10.1016/S1053-2498(00)00074-7; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Cherian MG, 2003, MUTAT RES-FUND MOL M, V533, P201, DOI 10.1016/j.mrfmmm.2003.07.013; Coghill ID, 2003, J BIOL CHEM, V278, P24139, DOI 10.1074/jbc.M213259200; Cottle DL, 2007, J CELL SCI, V120, P1423, DOI 10.1242/jcs.004739; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Ding LH, 2009, J CLIN INVEST, V119, P349, DOI 10.1172/JCI35930; Dulic V, 1998, MOL CELL BIOL, V18, P546, DOI 10.1128/MCB.18.1.546; Endo T, 2004, J GASTROENTEROL, V39, P1196, DOI 10.1007/s00535-004-1471-1; Fimia GM, 2000, MOL CELL BIOL, V20, P8613, DOI 10.1128/MCB.20.22.8613-8622.2000; Greenbaum LE, 2004, CANCER BIOL THER, V3, P1200, DOI 10.4161/cbt.3.12.1392; Han W, 2013, J CLIN INVEST, V123, P2103, DOI 10.1172/JCI61820; Henkel G, 2004, CHEM REV, V104, P801, DOI 10.1021/cr020620d; Huang X, 2009, BIOTECHNOL LETT, V31, P1499, DOI 10.1007/s10529-009-0054-x; Hubbi ME, 2012, J BIOL CHEM, V287, P6139, DOI 10.1074/jbc.M111.278630; Jacob ST, 2002, ENVIRON HEALTH PERSP, V110, P827, DOI 10.1289/ehp.02110s5827; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; KAGI JHR, 1988, BIOCHEMISTRY-US, V27, P8509, DOI 10.1021/bi00423a001; Mao J, 2012, CARCINOGENESIS, V33, P2568, DOI 10.1093/carcin/bgs287; Meeson AP, 2007, EMBO J, V26, P1902, DOI 10.1038/sj.emboj.7601635; Mils V, 2003, EXP CELL RES, V285, P99, DOI 10.1016/S0014-4827(03)00018-1; Moleirinho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018487; Morgan MJ, 2000, BIOCHEM BIOPH RES CO, V273, P776, DOI 10.1006/bbrc.2000.3006; Morgan MJ, 1996, BIOCHEM BIOPH RES CO, V225, P632, DOI 10.1006/bbrc.1996.1222; Niu C, 2011, IUBMB LIFE, V63, P764, DOI 10.1002/iub.502; Romero-Isart N, 2002, J INORG BIOCHEM, V88, P388, DOI 10.1016/S0162-0134(01)00347-6; Ruttkay-Nedecky B, 2013, INT J MOL SCI, V14, P6044, DOI 10.3390/ijms14036044; Singhal S, 2005, CLIN CANCER RES, V11, P3974, DOI 10.1158/1078-0432.CCR-04-2661; Takahashi K, 2005, BIOCHEM J, V386, P191, DOI 10.1042/BJ20040775; Tao X, 2007, HEPATOL RES, V37, P820, DOI 10.1111/j.1872-034X.2007.00113.x; Theocharis SE, 2004, HISTOPATHOLOGY, V45, P103, DOI 10.1111/j.1365-2559.2004.01922.x; Vasak M, 2005, J TRACE ELEM MED BIO, V19, P13, DOI 10.1016/j.jtemb.2005.03.003; Xia WR, 2012, GENE, V504, P233, DOI 10.1016/j.gene.2012.05.019; Xu K, 2011, ANTI-CANCER DRUG, V22, P875, DOI 10.1097/CAD.0b013e328349597d	36	1	1	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93723	10.1371/journal.pone.0093723	http://dx.doi.org/10.1371/journal.pone.0093723			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690879	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100131
J	Fujita, H; Aoki, S; Kawaguchi, M				Fujita, Hironori; Aoki, Seishiro; Kawaguchi, Masayoshi			Evolutionary Dynamics of Nitrogen Fixation in the Legume-Rhizobia Symbiosis	PLOS ONE			English	Article							CONTINUOUS PRISONERS-DILEMMA; PARTNER CHOICE; MUTUALISM STABILITY; MIXED INFECTIONS; SNOWDRIFT GAME; COOPERATION; SANCTIONS; POPULATIONS; TRIFOLII; NEGOTIATION	The stabilization of host-symbiont mutualism against the emergence of parasitic individuals is pivotal to the evolution of cooperation. One of the most famous symbioses occurs between legumes and their colonizing rhizobia, in which rhizobia extract nutrients (or benefits) from legume plants while supplying them with nitrogen resources produced by nitrogen fixation (or costs). Natural environments, however, are widely populated by ineffective rhizobia that extract benefits without paying costs and thus proliferate more efficiently than nitrogen-fixing cooperators. How and why this mutualism becomes stabilized and evolutionarily persists has been extensively discussed. To better understand the evolutionary dynamics of this symbiosis system, we construct a simple model based on the continuous snowdrift game with multiple interacting players. We investigate the model using adaptive dynamics and numerical simulations. We find that symbiotic evolution depends on the cost-benefit balance, and that cheaters widely emerge when the cost and benefit are similar in strength. In this scenario, the persistence of the symbiotic system is compatible with the presence of cheaters. This result suggests that the symbiotic relationship is robust to the emergence of cheaters, and may explain the prevalence of cheating rhizobia in nature. In addition, various stabilizing mechanisms, such as partner fidelity feedback, partner choice, and host sanction, can reinforce the symbiotic relationship by affecting the fitness of symbionts in various ways. This result suggests that the symbiotic relationship is cooperatively stabilized by various mechanisms. In addition, mixed nodule populations are thought to encourage cheater emergence, but our model predicts that, in certain situations, cheaters can disappear from such populations. These findings provide a theoretical basis of the evolutionary dynamics of legume-rhizobia symbioses, which is extendable to other single-host, multiple-colonizer systems.	[Fujita, Hironori; Kawaguchi, Masayoshi] Natl Inst Nat Sci, Natl Inst Basic Biol, Div Symbiot Syst, Okazaki, Aichi 4448585, Japan; [Aoki, Seishiro] Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Meguro Ku, Tokyo, Japan; [Kawaguchi, Masayoshi] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); University of Tokyo; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Fujita, H (corresponding author), Natl Inst Nat Sci, Natl Inst Basic Biol, Div Symbiot Syst, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	hfujita@nibb.ac.jp		Kawaguchi, Masayoshi/0000-0002-1032-6261; Fujita, Hironori/0000-0003-4916-2994	Ministry of Education, Culture, Sports, Science and Technology of Japan [22128006]; Grants-in-Aid for Scientific Research [26660057] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grants-in-Aid for Scientific Research (22128006) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay E, 2007, P ROY SOC B-BIOL SCI, V274, P25, DOI 10.1098/rspb.2006.3689; Akcay E, 2011, AM NAT, V178, P1, DOI 10.1086/659997; Archetti M, 2011, ECOL LETT, V14, P1300, DOI 10.1111/j.1461-0248.2011.01697.x; Bever JD, 2000, HEREDITY, V85, P366, DOI 10.1046/j.1365-2540.2000.00772.x; BOTTOMLEY PJ, 1983, SOIL SCI SOC AM J, V47, P1153, DOI 10.2136/sssaj1983.03615995004700060019x; Brannstrom A, 2011, J MATH BIOL, V63, P263, DOI 10.1007/s00285-010-0367-3; Burdon JJ, 1999, J APPL ECOL, V36, P398, DOI 10.1046/j.1365-2664.1999.00409.x; DEMEZAS DH, 1986, APPL ENVIRON MICROB, V52, P1020, DOI 10.1128/AEM.52.5.1020-1025.1986; Denison RF, 2004, FEMS MICROBIOL LETT, V237, P187, DOI [10.1111/j.1574-6968.2004.tb09695.x, 10.1016/j.femsle.2004.07.013]; Denison RF, 2000, AM NAT, V156, P567, DOI 10.1086/316994; Doebeli M, 2004, SCIENCE, V306, P859, DOI 10.1126/science.1101456; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Douglas AE, 2008, NEW PHYTOL, V177, P849, DOI 10.1111/j.1469-8137.2007.02326.x; Ezoe H, 2012, J THEOR BIOL, V314, P138, DOI 10.1016/j.jtbi.2012.08.037; Friesen ML, 2010, J EVOLUTION BIOL, V23, P323, DOI 10.1111/j.1420-9101.2009.01902.x; Friesen ML, 2012, NEW PHYTOL, V194, P1096, DOI 10.1111/j.1469-8137.2012.04099.x; Friesen ML, 2012, METHODS MOL BIOL, V804, P481, DOI 10.1007/978-1-61779-361-5_24; Gage DJ, 2002, J BACTERIOL, V184, P7042, DOI 10.1128/JB.184.24.7042-7046.2002; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; GIBSON AH, 1975, SOIL BIOL BIOCHEM, V7, P95, DOI 10.1016/0038-0717(75)90005-X; Gubry-Rangin C, 2010, P ROY SOC B-BIOL SCI, V277, P1947, DOI 10.1098/rspb.2009.2072; Kiers ET, 2008, ANNU REV ECOL EVOL S, V39, P215, DOI 10.1146/annurev.ecolsys.39.110707.173423; Kiers ET, 2011, P NATL ACAD SCI USA, V108, pE7, DOI 10.1073/pnas.1014546108; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; Killingback T, 1999, P ROY SOC B-BIOL SCI, V266, P1723, DOI 10.1098/rspb.1999.0838; Laguerre G, 2012, NEW PHYTOL, V195, P437, DOI 10.1111/j.1469-8137.2012.04159.x; Le S, 2007, J THEOR BIOL, V245, P258, DOI 10.1016/j.jtbi.2006.09.016; Marco DE, 2009, J THEOR BIOL, V259, P423, DOI 10.1016/j.jtbi.2009.03.033; Marco DE, 2009, ACTA OECOL, V35, P664, DOI 10.1016/j.actao.2009.06.005; Moawad H, 1998, PLANT SOIL, V204, P95, DOI 10.1023/A:1004335112402; MOAWAD M, 1987, BIOL FERT SOILS, V5, P112, DOI 10.1007/BF00257644; Nowak MA, 2004, SCIENCE, V303, P793, DOI 10.1126/science.1093411; Oono R, 2009, NEW PHYTOL, V183, P967, DOI 10.1111/j.1469-8137.2009.02941.x; Parvinen K, 2011, B MATH BIOL, V73, P2605, DOI 10.1007/s11538-011-9638-4; Provorov NA, 2000, J THEOR BIOL, V205, P105, DOI 10.1006/jtbi.2000.2051; Provorov NA, 2006, THEOR POPUL BIOL, V70, P262, DOI 10.1016/j.tpb.2006.06.002; Provorov NA, 2008, THEOR POPUL BIOL, V74, P345, DOI 10.1016/j.tpb.2008.09.005; ROLFE BG, 1980, AUST J BIOL SCI, V33, P491; Sachs JL, 2010, J EVOLUTION BIOL, V23, P1919, DOI 10.1111/j.1420-9101.2010.02056.x; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Schumpp O, 2010, TRENDS PLANT SCI, V15, P189, DOI 10.1016/j.tplants.2010.01.001; Simms EL, 2006, P ROY SOC B-BIOL SCI, V273, P77, DOI 10.1098/rspb.2005.3292; Simms EL, 2002, INTEGR COMP BIOL, V42, P369, DOI 10.1093/icb/42.2.369; Wahl LM, 1999, J THEOR BIOL, V200, P307, DOI 10.1006/jtbi.1999.0996; Waxman D, 2005, J EVOLUTION BIOL, V18, P1139, DOI 10.1111/j.1420-9101.2005.00948.x; West SA, 2002, J EVOLUTION BIOL, V15, P830, DOI 10.1046/j.1420-9101.2002.00441.x; West SA, 2002, P ROY SOC B-BIOL SCI, V269, P685, DOI 10.1098/rspb.2001.1878; Weyl EG, 2011, P NATL ACAD SCI USA, V108, pE8, DOI 10.1073/pnas.1015734108; Weyl EG, 2010, P NATL ACAD SCI USA, V107, P15712, DOI 10.1073/pnas.1005294107; Zhong LX, 2008, CHINESE PHYS LETT, V25, P2315, DOI 10.1088/0256-307X/25/6/107	50	22	22	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93670	10.1371/journal.pone.0093670	http://dx.doi.org/10.1371/journal.pone.0093670			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691447	gold, Green Submitted, Green Published			2022-12-27	WOS:000334101100125
J	Hohmann, N; Wei, WW; Dahmen, U; Dirsch, O; Deutsch, A; Voss-Bohme, A				Hohmann, Nadine; Wei Weiwei; Dahmen, Uta; Dirsch, Olaf; Deutsch, Andreas; Voss-Boehme, Anja			How Does a Single Cell Know When the Liver Has Reached Its Correct Size?	PLOS ONE			English	Article							SHEAR-STRESS; REGENERATION	The liver is a multi-functional organ that regulates major physiological processes and that possesses a remarkable regeneration capacity. After loss of functional liver mass the liver grows back to its original, individual size through hepatocyte proliferation and apoptosis. How does a single hepatocyte 'know' when the organ has grown to its final size? This work considers the initial growth phase of liver regeneration after partial hepatectomy in which the mass is restored. There are strong and valid arguments that the trigger of proliferation after partial hepatectomy is mediated through the portal blood flow. It remains unclear, if either or both the concentration of metabolites in the blood or the shear stress are crucial to hepatocyte proliferation and liver size control. A cell-based mathematical model is developed that helps discriminate the effects of these two potential triggers. Analysis of the mathematical model shows that a metabolic load and a hemodynamical hypothesis imply different feedback mechanisms at the cellular scale. The predictions of the developed mathematical model are compared to experimental data in rats. The assumption that hepatocytes are able to buffer the metabolic load leads to a robustness against short-term fluctuations of the trigger which can not be achieved with a purely hemodynamical trigger.	[Hohmann, Nadine; Deutsch, Andreas; Voss-Boehme, Anja] Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, D-01062 Dresden, Germany; [Wei Weiwei; Dahmen, Uta] Univ Hosp Jena, Dept Gen Visceral & Transplantat Surg, Jena, Germany; [Dirsch, Olaf] Univ Hosp Jena, Inst Pathol, Jena, Germany	Technische Universitat Dresden; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Hohmann, N (corresponding author), Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, D-01062 Dresden, Germany.	nadine.hohmann@tu-dresden.de	Voss-Böhme, Anja/O-6869-2017	Voss-Böhme, Anja/0000-0001-6510-8694	German Ministry of Education and Research (BMBF); German Research Foundation; Open Access Publication Funds of TU Dresden	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of TU Dresden	This research was supported by the German Ministry of Education and Research (BMBF) in the program "Virtual Liver Network". The authors acknowledge support by the German Research Foundation and the Open Access Publication Funds of TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abshagen K, 2012, LANGENBECK ARCH SURG, V397, P579, DOI 10.1007/s00423-012-0913-0; Aegerter-Wilmsen T, 2007, MECH DEV, V124; Alberts B., 2008, MOL BIOL CELL REFERE; Baumann U, 2009, DIS LIVER BILIARY SY, P117; Binder BJ, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031912; Dahmen U, 2008, J SURG RES, V149, P15, DOI 10.1016/j.jss.2007.09.010; Day SJ, 2000, DEVELOPMENT, V127, P2977; Dell Ralph B, 2002, ILAR J, V43, P207; Dirsch O, 2008, J INVEST SURG, V21, P288, DOI 10.1080/08941930802216823; Eipel C, 2010, TRANSPLANT INT, V23; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2005, J HEPATO-BILIARY-PAN, V12, P181, DOI 10.1007/s00534-005-0979-y; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Furchtgott LA, 2009, BIOPHYS J, V96, P3926, DOI 10.1016/j.bpj.2009.01.061; Gebhardt R, 2010, DEV DYNAM, V239, P45, DOI 10.1002/dvdy.22041; Gock M, 2011, MICROVASC RES, V81, P274, DOI 10.1016/j.mvr.2011.03.005; Huang H, 2010, LAB ANIM-UK, V44, P254, DOI 10.1258/la.2009.009055; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Jin H, 2012, EUR SURG RES, V49, P53, DOI 10.1159/000333395; KAM I, 1987, HEPATOLOGY, V7, P362, DOI 10.1002/hep.1840070225; Klauss T., 2008, MATH MODELING BIOL S, VII, P353, DOI DOI 10.1007/978-0-8176-4556-4_31; Koniaris LG, 2003, J AM COLL SURGEONS, V197, P634, DOI 10.1016/S1072-7515(03)00374-0; Liggett T. M, 1985, INTERACTING PARTICLE, V276; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mortensen KE, 2011, EUR SURG RES, V46, P1, DOI 10.1159/000321361; Niiya T, 1999, J HEPATOBILIARY PANC, V6; Nijhout HF, 2003, DEV BIOL, V261; Papp V, 2009, LIVER TRANSPLANT, V15, P177, DOI 10.1002/lt.21665; Rabes H M, 1977, Ciba Found Symp, P31; Sato Y, 1997, SURG TODAY, V27, P518, DOI 10.1007/BF02385805; Sato Y, 1999, SURG TODAY, V29, P1, DOI 10.1007/BF02482962; Schoen JM, 2001, NITRIC OXIDE-BIOL CH, V5, P453, DOI 10.1006/niox.2001.0373; Schulte-Hermann R, 1974, CRC CR REV TOXICOL, V3; Schwank G, 2009, COLD SPRING HARB PER, V2; STARZL TE, 1993, LANCET, V341, P65, DOI 10.1016/0140-6736(93)92553-6; Taira K, 2001, EUR SURG RES, V33, P334, DOI 10.1159/000049727; Vogel G, 2013, SCIENCE, V340, P1156, DOI 10.1126/science.340.6137.1156-b; Voss-Bohme A, 2010, J THEOR BIOL, V263, P419, DOI 10.1016/j.jtbi.2009.12.011; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037	41	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93207	10.1371/journal.pone.0093207	http://dx.doi.org/10.1371/journal.pone.0093207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690888	Green Submitted, Green Published, gold			2022-12-27	WOS:000334101100052
J	Jacquemin, SJ; Doll, JC				Jacquemin, Stephen J.; Doll, Jason C.			Body Size and Geographic Range Do Not Explain Long Term Variation in Fish Populations: A Bayesian Phylogenetic Approach to Testing Assembly Processes in Stream Fish Assemblages	PLOS ONE			English	Article							NICHE CONSERVATISM; ABUNDANCE; EVOLUTION; HABITAT; RIVER; DIVERSIFICATION; VARIABLES; ECOLOGY; BREADTH; TRAITS	We combine evolutionary biology and community ecology to test whether two species traits, body size and geographic range, explain long term variation in local scale freshwater stream fish assemblages. Body size and geographic range are expected to influence several aspects of fish ecology, via relationships with niche breadth, dispersal, and abundance. These traits are expected to scale inversely with niche breadth or current abundance, and to scale directly with dispersal potential. However, their utility to explain long term temporal patterns in local scale abundance is not known. Comparative methods employing an existing molecular phylogeny were used to incorporate evolutionary relatedness in a test for covariation of body size and geographic range with long term (1983 - 2010) local scale population variation of fishes in West Fork White River (Indiana, USA). The Bayesian model incorporating phylogenetic uncertainty and correlated predictors indicated that neither body size nor geographic range explained significant variation in population fluctuations over a 28 year period. Phylogenetic signal data indicated that body size and geographic range were less similar among taxa than expected if trait evolution followed a purely random walk. We interpret this as evidence that local scale population variation may be influenced less by species-level traits such as body size or geographic range, and instead may be influenced more strongly by a taxon's local scale habitat and biotic assemblages.	[Jacquemin, Stephen J.] Wright State Univ, Dept Biol Sci, Celina, OH 45822 USA; [Doll, Jason C.] Ball State Univ, Dept Biol, Muncie, IN 47306 USA	University System of Ohio; Wright State University Dayton; Ball State University	Jacquemin, SJ (corresponding author), Wright State Univ, Dept Biol Sci, Lake Campus, Celina, OH 45822 USA.	stephen.jacquemin@wright.edu; jcdoll@bsu.edu						Betancur-R R, 2013, PLOS CURRENTS TREE L; BLACKBURN TM, 1993, J ANIM ECOL, V62, P519, DOI 10.2307/5201; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; de Villemereuil P, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-102; Doosey MH, 2010, MOL PHYLOGENET EVOL, V54, P1028, DOI 10.1016/j.ympev.2009.06.006; Frimpong EA, 2009, FISHERIES, V34, P487, DOI 10.1577/1548-8446-34.10.487; GASTON KJ, 1988, AM NAT, V132, P662, DOI 10.1086/284881; Gaston KJ, 1996, J ANIM ECOL, V65, P701, DOI 10.2307/5669; Gelman A., 2004, BAYESIAN DATA ANAL; GORMAN OT, 1978, ECOLOGY, V59, P507, DOI 10.2307/1936581; Grossman GD, 1998, ECOL MONOGR, V68, P395, DOI 10.1890/0012-9615(1998)068[0395:AOISFE]2.0.CO;2; GROSSMAN GD, 1982, AM NAT, V120, P423, DOI 10.1086/284004; Harding JS, 1998, P NATL ACAD SCI USA, V95, P14843, DOI 10.1073/pnas.95.25.14843; Hardman M, 2008, SYST BIOL, V57, P116, DOI 10.1080/10635150801902193; Jackson DA, 2001, CAN J FISH AQUAT SCI, V58, P157, DOI 10.1139/f00-239; Jacquemin SJ, 2013, ECOL FRESHW FISH, V22, P280, DOI 10.1111/eff.12025; Jacquemin SJ, 2011, J BIOGEOGR, V38, P982, DOI 10.1111/j.1365-2699.2010.02457.x; Johnson MTJ, 2007, TRENDS ECOL EVOL, V22, P250, DOI 10.1016/j.tree.2007.01.014; Jonsson T, 2005, ADV ECOL RES, V36, P1, DOI 10.1016/S0065-2504(05)36001-6; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Mayden RL, 2006, STUDIES N AM DESERT; Near TJ, 2011, SYST BIOL, V60, P565, DOI 10.1093/sysbio/syr052; Near TJ, 2005, EVOLUTION, V59, P1768, DOI 10.1111/j.0014-3820.2005.tb01825.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Plummer M., 2013, RJAGS BAYESIAN GRAPH; Plummer M., 2003, P 3 INT WORKSH DISTR; Pyron M, 1999, J BIOGEOGR, V26, P549, DOI 10.1046/j.1365-2699.1999.00303.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rabinowitz D., 1981, 7 FORMS RARITY BIOLO; Schonhuth S, 2010, MOL PHYLOGENET EVOL, V55, P77, DOI 10.1016/j.ympev.2009.10.030; Simon TP, 1997, 905R96002 US EPA WAT; Simons AM, 2003, ZOOL J LINN SOC-LOND, V139, P63, DOI 10.1046/j.1096-3642.2003.00076.x; Slatyer R. A., 2013, ECOL LETT, DOI 10.1111/ele.12140; Smith C.L, 1971, American Mus Novit, VNo. 2458, P1; Strong D.R., 1984, ECOLOGICAL COMMUNITI; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Trautman M.B., 1981, FISHES OHIO; Trumpickas J, 2011, AQUAT CONSERV, V21, P338, DOI 10.1002/aqc.1192; van Kleunen M, 2007, PROG PHYS GEOG, V31, P447, DOI 10.1177/0309133307081295; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Waite IR, 2000, T AM FISH SOC, V129, P754, DOI 10.1577/1548-8659(2000)129<0754:AAFASA>2.3.CO;2; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431	48	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93522	10.1371/journal.pone.0093522	http://dx.doi.org/10.1371/journal.pone.0093522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691075	Green Published, gold			2022-12-27	WOS:000334101100097
J	Magaye, R; Zhou, Q; Bowman, L; Zou, BB; Mao, GC; Xu, J; Castranova, V; Zhao, JS; Ding, M				Magaye, Ruth; Zhou, Qi; Bowman, Linda; Zou, Baobo; Mao, Guochuan; Xu, Jin; Castranova, Vincent; Zhao, Jinshun; Ding, Min			Metallic Nickel Nanoparticles May Exhibit Higher Carcinogenic Potential than Fine Particles in JB6 Cells	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATOR PROTEIN-1; LUNG; P53; GENOTOXICITY; APOPTOSIS; GROWTH; TRANSFORMATION; MECHANISMS; INHIBITION	While numerous studies have described the pathogenic and carcinogenic effects of nickel compounds, little has been done on the biological effects of metallic nickel. Moreover, the carcinogenetic potential of metallic nickel nanoparticles is unknown. Activator protein-1 (AP- 1) and nuclear factor-kappa B (NF-kappa B) have been shown to play pivotal roles in tumor initiation, promotion, and progression. Mutation of the p53 tumor suppressor gene is considered to be one of the steps leading to the neoplastic state. The present study examines effects of metallic nickel fine and nanoparticles on tumor promoter or suppressor gene expressions as well as on cell transformation in JB6 cells. Our results demonstrate that metallic nickel nanoparticles caused higher activation of AP- 1 and NF-kappa B, and a greater decrease of p53 transcription activity than fine particles. Western blot indicates that metallic nickel nanoparticles induced a higher level of protein expressions for R-Ras, c-myc, C-Jun, p65, and p50 in a time-dependent manner. In addition, both metallic nickel nano- and fine particles increased anchorage-independent colony formation in JB6 P+ cells in the soft agar assay. These results imply that metallic nickel fine and nanoparticles are both carcinogenetic in vitro in JB6 cells. Moreover, metallic nickel nanoparticles may exhibit higher carcinogenic potential, which suggests that precautionary measures should be taken in the use of nickel nanoparticles or its compounds in nanomedicine.	[Magaye, Ruth; Zhou, Qi; Zou, Baobo; Mao, Guochuan; Xu, Jin; Zhao, Jinshun] Ningbo Univ, Sch Med, Dept Publ Hlth, Zhejiang Prov Key Lab Pathol & Physiol Technol, Ningbo 315211, Zhejiang, Peoples R China; [Bowman, Linda; Castranova, Vincent; Zhao, Jinshun; Ding, Min] NIOSH, Hlth Effects Lab Div, Pathol & Physiol Res Branch, Morgantown, WV USA	Ningbo University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Zhao, JS (corresponding author), Ningbo Univ, Sch Med, Dept Publ Hlth, Zhejiang Prov Key Lab Pathol & Physiol Technol, Ningbo 315211, Zhejiang, Peoples R China.	zhaojinshun@nbu.edu.cn; mid5@cdc.gov		Magaye, Ruth Rebecca/0000-0002-8296-8466	National Nature Science Foundation of China [81273111]; Foundations of Innovative Research Team of Educational Commission of Zhejiang Province [T200907]; Nature Science Foundation of Ningbo city [2012A610185]; Ningbo Scientific Project [2012C5019, SZX11073]; Scientific Innovation Team Project of Ningbo [2011B82014]; Innovative Research Team of Ningbo [2009B21002]; K.C. Wong Magna Fund in Ningbo University	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundations of Innovative Research Team of Educational Commission of Zhejiang Province; Nature Science Foundation of Ningbo city; Ningbo Scientific Project; Scientific Innovation Team Project of Ningbo; Innovative Research Team of Ningbo; K.C. Wong Magna Fund in Ningbo University	This work was supported by the National Nature Science Foundation of China (Grant No. 81273111), the Foundations of Innovative Research Team of Educational Commission of Zhejiang Province (T200907), the Nature Science Foundation of Ningbo city (Grant No. 2012A610185), the Ningbo Scientific Project (Grant No. 2012C5019 and SZX11073), the Scientific Innovation Team Project of Ningbo (No. 2011B82014), Innovative Research Team of Ningbo (2009B21002) and K.C. Wong Magna Fund in Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Assar O, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-13; Al-Qubaisi MS, 2013, INT J NANOMED, V8, P2497, DOI 10.2147/IJN.S42367; BENSON JM, 1989, TOXICOLOGY, V57, P255, DOI 10.1016/0300-483X(89)90115-7; BERNSTEIN LR, 1989, SCIENCE, V244, P566, DOI 10.1126/science.2541502; Bode A M, 2000, Lancet Oncol, V1, P181, DOI 10.1016/S1470-2045(00)00029-2; Bredel M, 1999, BRAIN RES REV, V29, P232, DOI 10.1016/S0165-0173(98)00057-5; Cai WB, 2008, NANOTECHNOL SCI APPL, V1, P17, DOI 10.2147/NSA.S3788; COLBURN NH, 1981, P NATL ACAD SCI-BIOL, V78, P6912, DOI 10.1073/pnas.78.11.6912; COOGAN TP, 1989, CRC CR REV TOXICOL, V19, P341, DOI 10.3109/10408448909029327; Cosse JPJ, 2009, NEOPLASIA, V11, P976, DOI 10.1593/neo.09632; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Ding M, 2006, J BIOL CHEM, V281, P17359, DOI 10.1074/jbc.M600861200; DONG ZG, 1994, P NATL ACAD SCI USA, V91, P609, DOI 10.1073/pnas.91.2.609; DRISCOLL KE, 1990, TOXICOL APPL PHARM, V106, P88, DOI 10.1016/0041-008X(90)90109-8; Enriquez GG, 2013, INT J NANOMED, V8, P1393, DOI 10.2147/IJN.S43479; Feng RT, 2005, J BIOL CHEM, V280, P27888, DOI 10.1074/jbc.M503347200; HARTWIG A, 1994, TOXICOL LETT, V72, P353, DOI 10.1016/0378-4274(94)90048-5; Huang LE, 2008, CELL DEATH DIFFER, V15, P672, DOI 10.1038/sj.cdd.4402302; Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021; Ke QD, 2008, CARCINOGENESIS, V29, P1276, DOI 10.1093/carcin/bgn084; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li JJ, 1997, CANCER RES, V57, P3569; Lim Eun-Kyung, 2013, Pharmaceutics, V5, P294, DOI 10.3390/pharmaceutics5020294; Long TC, 2007, ENVIRON HEALTH PERSP, V115, P1631, DOI 10.1289/ehp.10216; Lu HT, 2005, MOL CELL BIOCHEM, V279, P45, DOI 10.1007/s11010-005-8215-2; Magaye R, 2012, ENVIRON TOXICOL PHAR, V34, P644, DOI 10.1016/j.etap.2012.08.012; Magaye R, 2012, EXP THER MED, V4, P551, DOI 10.3892/etm.2012.656; Maynard AD, 2005, J NANOPART RES, V7, P587, DOI 10.1007/s11051-005-6770-9; Mudshinge SR, 2011, SAUDI PHARM J, V19, P129, DOI 10.1016/j.jsps.2011.04.001; NiPERA, 2013, NAT NAN PROGR PROP L, P4; NIPERA, 2008, SAF US NICK WORKPL; O'Donnell JL, 2006, CANCER TREAT REV, V32, P407, DOI 10.1016/j.ctrv.2006.05.003; Oberdorster G, 2001, INT ARCH OCC ENV HEA, V74, P1; OBERDORSTER G, 1994, ENVIRON HEALTH PERSP, V102, P173, DOI 10.2307/3432080; OREN M, 1992, CANCER METAST REV, V11, P141, DOI 10.1007/BF00048060; Rosen J.E., 2011, J NANOMED NANOTECHNO, V2, P1; Roy HK, 2002, CARCINOGENESIS, V23, P201, DOI 10.1093/carcin/23.1.201; Santarpia L, 2008, J CLIN ENDOCR METAB, V93, P278, DOI 10.1210/jc.2007-1076; Shen GX, 2005, ANTIOXID REDOX SIGN, V7, P1648, DOI 10.1089/ars.2005.7.1648; Sivulka DJ, 2005, REGUL TOXICOL PHARM, V43, P117, DOI 10.1016/j.yrtph.2005.06.014; US Department of Health and Human Services PHS National Toxicology Program, 2009, REP CARC; Vormer TL, 2008, MOL CELL BIOL, V28, P7263, DOI 10.1128/MCB.00313-08; Wang LY, 2005, AM J PHYSIOL-LUNG C, V288, pL488, DOI 10.1152/ajplung.00123.2003; Wong VC, 2013, TOXICOL APPL PHARM, V269, P233, DOI 10.1016/j.taap.2013.03.023; Young MR, 1999, P NATL ACAD SCI USA, V96, P9827, DOI 10.1073/pnas.96.17.9827; Zhang QW, 2003, J OCCUP HEALTH, V45, P23, DOI 10.1539/joh.45.23; Zhang ZW, 1999, WORLD J GASTROENTERO, V5, P369; Zhao JS, 2009, J TOXICOL ENV HEAL A, V72, P1141, DOI 10.1080/15287390903091764; Zhao Jinshun, 2009, Journal of Nanobiotechnology, V7, P2, DOI 10.1186/1477-3155-7-2	51	33	34	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92418	10.1371/journal.pone.0092418	http://dx.doi.org/10.1371/journal.pone.0092418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691273	Green Published, gold			2022-12-27	WOS:000334101100023
J	Sun, W; Zhang, K; Liu, GW; Ding, W; Zhao, CQ; Xie, YZ; Yuan, JJ; Sun, XJ; Li, H; Liu, CS; Tang, TT; Zhao, J				Sun, Wei; Zhang, Kai; Liu, Guangwang; Ding, Wei; Zhao, Changqing; Xie, Youzhuan; Yuan, Junjie; Sun, Xiaojiang; Li, Hua; Liu, Changsheng; Tang, Tingting; Zhao, Jie			Sox9 Gene Transfer Enhanced Regenerative Effect of Bone Marrow Mesenchymal Stem Cells on the Degenerated Intervertebral Disc in a Rabbit Model	PLOS ONE			English	Article							IN-VITRO; CHONDROGENIC DIFFERENTIATION; MORPHOGENETIC PROTEIN-4; CARTILAGE FORMATION; TRANSPLANTATION; THERAPY; TGF-BETA-1; SCAFFOLDS; HYDROGELS; DISEASE	Objective: The effect of Sox9 on the differentiation of bone marrow mesenchymal stem cells (BMSCs) to nucleus pulposus (NP)-like (chondrocyte-like) cells in vitro has been demonstrated. The objective of this study is to investigate the efficacy and feasibility of Sox9-transduced BMSCs to repair the degenerated intervertebral disc in a rabbit model. Materials and Methods: Fifty skeletally mature New Zealand white rabbits were used. In the treatment groups, NP tissue was aspirated from the L2-L3, L3-L4, and L4-L5 discs in accordance with a previously validated rabbit model of intervertebral disc degeneration and then treated with thermogelling chitosan (C/Gp), GFP-transduced autologous BMSCs with C/Gp or Sox9-transduced autologous BMSCs with C/Gp. The role of Sox9 in the chondrogenic differentiation of BMSCs embedded in C/Gp gels in vitro and the repair effect of Sox9-transduced BMSCs on degenerated discs were evaluated by real-time PCR, conventional and quantitative MRI, macroscopic appearance, histology and immunohistochemistry. Results: Sox9 could induce the chondrogenic differentiation of BMSCs in C/Gp gels and BMSCs could survive in vivo for at least 12 weeks. A higher T2-weighted signal intensity and T2 value, better preserved NP structure and greater amount of extracellular matrix were observed in discs treated with Sox9-transduced BMSCs compared with those without transduction. Conclusion: Sox9 gene transfer could significantly enhance the repair effect of BMSCs on the degenerated discs.	[Sun, Wei; Zhang, Kai; Ding, Wei; Zhao, Changqing; Xie, Youzhuan; Yuan, Junjie; Sun, Xiaojiang; Li, Hua; Tang, Tingting; Zhao, Jie] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Orthopaed Surg, Shanghai 200030, Peoples R China; [Sun, Wei; Zhang, Kai; Zhao, Changqing; Xie, Youzhuan; Yuan, Junjie; Sun, Xiaojiang; Li, Hua; Tang, Tingting; Zhao, Jie] Shanghai Key Lab Orthopaed Implants, Shanghai, Peoples R China; [Sun, Wei] Affiliated Hosp, Xuzhou Med Coll, Dept Orthopaed Surg, Xuzhou, Peoples R China; [Liu, Guangwang] Southeast Univ, Affiliated Hosp, Cent Hosp Xuzhou, Coll Med,Dept Orthopaed Surg, Xuzhou, Peoples R China; [Liu, Changsheng] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	Shanghai Jiao Tong University; Xuzhou Medical University; Southeast University - China; East China University of Science & Technology	Zhao, J (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Orthopaed Surg, Shanghai 200030, Peoples R China.	prozhaojie@163.com	Tang, Tingting/B-1361-2013	Tang, Tingting/0000-0002-1670-7452	National Natural Science Foundation of China [81071453, 81071503, 81272038]; Program for Innovative Research Team of Shanghai Municipal Education Commission; Fund for Key Discipline of Shanghai Municipal Education Commission [J50206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team of Shanghai Municipal Education Commission; Fund for Key Discipline of Shanghai Municipal Education Commission	This research was supported by the National Natural Science Foundation of China (grant no. 81071453, 81071503 and 81272038), Program for Innovative Research Team of Shanghai Municipal Education Commission, and Fund for Key Discipline of Shanghai Municipal Education Commission (J50206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Cao L, 2011, BIOMATERIALS, V32, P3910, DOI 10.1016/j.biomaterials.2011.02.014; Diao HJ, 2009, TISSUE ENG PT A, V15, P2687, DOI [10.1089/ten.tea.2008.0621, 10.1089/ten.TEA.2008.0621]; Gruber HE, 2005, SPINE, V30, P625, DOI 10.1097/01.brs.0000155420.01444.c6; Henriksson HB, 2009, SPINE, V34, P141, DOI 10.1097/BRS.0b013e31818f8c20; Hiyama A, 2008, J ORTHOP RES, V26, P589, DOI 10.1002/jor.20584; Ju WJ, 2000, J BONE MINER RES, V15, P1889, DOI 10.1359/jbmr.2000.15.10.1889; Kupcsik L, 2010, TISSUE ENG PT A, V16, P1845, DOI [10.1089/ten.tea.2009.0531, 10.1089/ten.TEA.2009.0531]; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2198; Link TM, 2007, EUR RADIOL, V17, P1135, DOI 10.1007/s00330-006-0453-5; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; Marinelli NL, 2009, SPINE, V34, P520, DOI 10.1097/BRS.0b013e318195dd44; Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20; Miljkovic ND, 2008, OSTEOARTHR CARTILAGE, V16, P1121, DOI 10.1016/j.joca.2008.03.003; NENADOVICH N, 2002, SPINE, V2, P50; O'Halloran DM, 2007, TISSUE ENG, V13, P1927, DOI 10.1089/ten.2005.0608; Okuma M, 2000, J ORTHOPAED RES, V18, P988, DOI 10.1002/jor.1100180620; Paul R, 2003, SPINE, V28, P755, DOI 10.1097/00007632-200304150-00006; Pereira DR, 2013, J TISSUE ENG REGEN M, V7, P85, DOI 10.1002/term.500; Richardson SM, 2006, STEM CELLS, V24, P707, DOI 10.1634/stemcells.2005-0205; Richardson SM, 2006, BIOMATERIALS, V27, P4069, DOI 10.1016/j.biomaterials.2006.03.017; Richardson SM, 2008, BIOMATERIALS, V29, P85, DOI 10.1016/j.biomaterials.2007.09.018; Risbud MV, 2004, SPINE, V29, P2627, DOI 10.1097/01.brs.0000146462.92171.7f; Rodrigues-Pinto R, 2013, BONE JOINT RES, V2, P169, DOI 10.1302/2046-3758.28.2000184; Roughley P, 2006, BIOMATERIALS, V27, P388, DOI 10.1016/j.biomaterials.2005.06.037; Sakai D, 2006, BIOMATERIALS, V27, P335, DOI 10.1016/j.biomaterials.2005.06.038; Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9; Sakai D, 2008, EUR SPINE J, V17, pS452, DOI 10.1007/s00586-008-0743-5; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Sive JI, 2002, J CLIN PATHOL-MOL PA, V55, P91, DOI 10.1136/mp.55.2.91; Sobajima S, 2008, SPINE J, V8, P888, DOI 10.1016/j.spinee.2007.09.011; Steck E, 2005, STEM CELLS, V23, P403, DOI 10.1634/stemcells.2004-0107; Steinert AF, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2822; Sun W, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-357; Toh WS, 2005, GROWTH FACTORS, V23, P313, DOI 10.1080/08977190500252763; Tsuchiya H, 2003, BIOCHEM BIOPH RES CO, V301, P338, DOI 10.1016/S0006-291X(02)03026-7; Vadala G, 2012, J TISSUE ENG REGEN M, V6, P348, DOI 10.1002/term.433; van Beuningen HM, 2000, OSTEOARTHR CARTILAGE, V8, P25, DOI 10.1053/joca.1999.0267; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Yan JH, 2010, J BIOMATER APPL, V24, P625, DOI 10.1177/0885328208100536; Yang HN, 2009, BIOMATERIALS, V30, P6374, DOI 10.1016/j.biomaterials.2009.07.062; Zhang YG, 2005, CLIN ORTHOP RELAT R, P219, DOI 10.1097/01.blo.0000146534.31120.cf; Zhao CQ, 2007, AGEING RES REV, V6, P247, DOI 10.1016/j.arr.2007.08.001	44	26	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93570	10.1371/journal.pone.0093570	http://dx.doi.org/10.1371/journal.pone.0093570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691466	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100105
J	Xu, GW; Toth, JI; da Silva, SR; Paiva, SL; Lukkarila, JL; Hurren, R; Maclean, N; Sukhai, MA; Bhattacharjee, RN; Goard, CA; Gunning, PT; Dhe-Paganon, S; Petroski, MD; Schimmer, AD				Xu, G. Wei; Toth, Julia I.; da Silva, Sara R.; Paiva, Stacey-Lynn; Lukkarila, Julie L.; Hurren, Rose; Maclean, Neil; Sukhai, Mahadeo A.; Bhattacharjee, Rabindra N.; Goard, Carolyn A.; Gunning, Patrick T.; Dhe-Paganon, Sirano; Petroski, Matthew D.; Schimmer, Aaron D.			Mutations in UBA3 Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Human Leukemic Cells	PLOS ONE			English	Article							UBIQUITIN-LIKE PROTEINS; SUBSTRATE-ASSISTED INHIBITION; MULTIDRUG-RESISTANCE; ACTIVATING ENZYME; NEDD8; CANCER; CONJUGATION; IDENTIFICATION; REREPLICATION; APOPTOSIS	The NEDD8-activating enzyme (NAE) initiates neddylation, the cascade of post-translational NEDD8 conjugation onto target proteins. MLN4924, a selective NAE inhibitor, has displayed preclinical anti-tumor activity in vitro and in vivo, and promising clinical activity has been reported in patients with refractory hematologic malignancies. Here, we sought to understand the mechanisms of resistance to MLN4924. K562 and U937 leukemia cells were exposed over a 6 month period to MLN4924 and populations of resistant cells (R-K562(MLN), R-U937(MLN)) were selected. R-K562(MLN) and R-U937(MLN) cells contain I310N and Y352H mutations in the NAE catalytic subunit UBA3, respectively. Biochemical analyses indicate that these mutations increase the enzyme's affinity for ATP while decreasing its affinity for NEDD8. These mutations effectively contribute to decreased MLN4924 potency in vitro while providing for sufficient NAE function for leukemia cell survival. Finally, R-K562(MLN) cells showed cross-resistance to other NAE-selective inhibitors, but remained sensitive to a pan-E1 (activating enzyme) inhibitor. Thus, our work provides insight into mechanisms of MLN4924 resistance to facilitate the development of more effective second-generation NAE inhibitors.	[Xu, G. Wei; Hurren, Rose; Maclean, Neil; Sukhai, Mahadeo A.; Bhattacharjee, Rabindra N.; Goard, Carolyn A.; Schimmer, Aaron D.] Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Toronto, ON, Canada; [Toth, Julia I.; Petroski, Matthew D.] Sanford Burnham Med Res Inst, NCI Designated Canc Ctr, La Jolla, CA 92037 USA; [da Silva, Sara R.; Paiva, Stacey-Lynn; Lukkarila, Julie L.; Gunning, Patrick T.] Univ Toronto, Dept Chem, Mississauga, ON L5L 1C6, Canada; [Lukkarila, Julie L.] Sheridan Inst Technol & Adv Learning, HalTech Reg Innovat Ctr, Oakville, ON, Canada; [Dhe-Paganon, Sirano] Harvard Univ, Childrens Hosp, Sch Med, Div Nephrol, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Sanford Burnham Prebys Medical Discovery Institute; University of Toronto; University Toronto Mississauga; Harvard University; Boston Children's Hospital; Harvard Medical School	Petroski, MD (corresponding author), Sanford Burnham Med Res Inst, NCI Designated Canc Ctr, La Jolla, CA 92037 USA.	petroski@sanfordburnham.org; aaron.schimmer@utoronto.ca		Paiva, Stacey-Lynn/0000-0002-6639-5303; Medeiros, Bruno/0000-0001-6972-8137; Schimmer, Aaron/0000-0003-4023-3899	Canadian Cancer Society Research Institute; Leukemia & Lymphoma Society; American Cancer Society; V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); American Cancer Society(American Cancer Society); V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Canadian Cancer Society Research Institute, the Leukemia & Lymphoma Society, the American Cancer Society (M.D.P.), and the V Foundation for Cancer Research (M.D.P.). M.D.P. is an American Cancer Society Research Scholar (RSG-11-224-01-DMC). A.D.S. is a Leukemia and Lymphoma Society Scholar in Clinical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 2002, J BIOL CHEM, V277, P23253, DOI 10.1074/jbc.M200967200; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Bruzzese FJ, 2012, METHODS MOL BIOL, V832, P577, DOI 10.1007/978-1-61779-474-2_40; Chen JJ, 2011, J BIOL CHEM, V286, P40867, DOI 10.1074/jbc.M111.279984; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Innis MA, 1990, PCR PROTOCOLS GUIDE; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Lin JJ, 2010, CANCER RES, V70, P10310, DOI 10.1158/0008-5472.CAN-10-2062; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Lukkarila JL, 2011, ACS MED CHEM LETT, V2, P577, DOI 10.1021/ml2000615; McMillin DW, 2012, MOL CANCER THER, V11, P942, DOI 10.1158/1535-7163.MCT-11-0563; Milhollen MA, 2012, CANCER CELL, V21, P388, DOI 10.1016/j.ccr.2012.02.009; Milhollen MA, 2011, CANCER RES, V71, P3042, DOI 10.1158/0008-5472.CAN-10-2122; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Persidis A, 1999, NAT BIOTECHNOL, V17, P94, DOI 10.1038/5289; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Swords RT, 2010, BLOOD, V115, P3796, DOI 10.1182/blood-2009-11-254862; Toth JI, 2012, BLOOD, V116, P658; Toth JI, 2012, CELL REP, V1, P309, DOI 10.1016/j.celrep.2012.02.006; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Watson IR, 2011, CANCER CELL, V19, P168, DOI 10.1016/j.ccr.2011.01.002; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105	35	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93530	10.1371/journal.pone.0093530	http://dx.doi.org/10.1371/journal.pone.0093530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691136	Green Published, gold			2022-12-27	WOS:000334101100099
J	Yu, YL; Su, KJ; Hsieh, MJ; Wang, SS; Wang, PH; Weng, WC; Yang, SF				Yu, Yung-Luen; Su, Kuo-Jung; Hsieh, Ming-Ju; Wang, Shian-Shiang; Wang, Po-Hui; Weng, Wei-Chun; Yang, Shun-Fa			Impact of EZH2 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathologic Features	PLOS ONE			English	Article							POLYCOMB GROUP PROTEIN; INCREASED EXPRESSION; BREAST-CANCER; GROUP GENE; BLADDER; IMMUNOTHERAPY; REPRESSION; RISK	Background: The gene EZH2, the polycomb group protein enhancer of zeste 2, encodes a transcriptional repressor that also serves as a histone methyltransferase that is associated with progression to more advanced disease in a variety of malignancies. EZH2 expression level in urothelial cell carcinoma (UCC) is highly correlated with tumor aggressiveness, but it has not been determined if specific EZH2 genetic variants are associated with UCC risk. This study investigated the potential associations of EZH2 single-nucleotide polymorphisms with UCC susceptibility and its clinicopathologic characteristics. Methodology/Principal Findings: A total of 233 UCC patients and 552 cancer-free controls, all of whom were from Taiwan, were analyzed for four EZH2 single-nucleotide polymorphisms (rs6950683, rs2302427, rs3757441, and rs41277434) using real-time PCR genotyping. After adjusting for other co-variants, we found that individuals carrying at least one C allele at EZH2 rs6950683 had a lower risk of developing UCC than did major allele carriers. The CCCA or TGTA haplotype among the four EZH2 sites was also associated with a reduced risk of UCC. Furthermore, UCC patients who carried at least one G allele at rs2302427 had a lower invasive tumor stage than did patients carrying the major allele. Conclusions: The rs6950683 SNPs of EZH2 might contribute to the prediction of UCC susceptibility. This is the first study to provide insight into risk factors associated with EZH2 variants in carcinogenesis of UCC in Taiwan.	[Yu, Yung-Luen] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Yu, Yung-Luen] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Yu, Yung-Luen; Su, Kuo-Jung] China Med Univ, Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Yu, Yung-Luen] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Hsieh, Ming-Ju; Wang, Shian-Shiang; Wang, Po-Hui; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Hsieh, Ming-Ju] Changhua Christian Hosp, Canc Res Ctr, Changhua, Taiwan; [Wang, Shian-Shiang] Taichung Vet Gen Hosp, Dept Surg, Div Urol, Taichung, Taiwan; [Wang, Po-Hui] Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Weng, Wei-Chun] Tungs Taichung MetroHarbor Hosp, Dept Surg, Div Urol, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Chung Shan Medical University; Changhua Christian Hospital; Taichung Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Tungs' Taichung MetroHarbor Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Weng, WC (corresponding author), Tungs Taichung MetroHarbor Hosp, Dept Surg, Div Urol, Taichung, Taiwan.	wcweng27@gmail.com; ysf@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020; Hsieh, Ming-Ju/GQB-3025-2022	Yang, Shun-Fa/0000-0002-0365-7927; Hsieh, Ming-Ju/0000-0001-9726-3234	Chung Shan Medical University and Tungs' Taichung Metro Harbor Hospital [CSMU-TTM-102-01];  [NSC-101-2321-B-039-004];  [NHRI-EX102-10245BI]	Chung Shan Medical University and Tungs' Taichung Metro Harbor Hospital; ; 	This work was supported by the following grants: NSC-101-2321-B-039-004, NHRI-EX102-10245BI and Chung Shan Medical University and Tungs' Taichung Metro Harbor Hospital (CSMU-TTM-102-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aben KKH, 2002, INT J CANCER, V98, P274, DOI 10.1002/ijc.10191; [Anonymous], 2003, NATURE, V426, P789; Arisan S, 2005, UROL INT, V75, P252, DOI 10.1159/000087804; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cardoso C, 2000, EUR J HUM GENET, V8, P174, DOI 10.1038/sj.ejhg.5200439; Chung TT, 2011, CARCINOGENESIS, V32, P1063, DOI 10.1093/carcin/bgr083; Chung YT, 2009, CARCINOGENESIS, V30, P286, DOI 10.1093/carcin/bgn283; Crea F, 2012, ANN ONCOL, V23, P1207, DOI 10.1093/annonc/mdr387; Di Paolo A, 2004, PHARMACOL RES, V49, P331, DOI 10.1016/j.phrs.2003.05.002; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Gu J, 2011, PERS MED, V8, P365, DOI 10.2217/PME.11.15; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Heyn H, 2013, CANCER CELL, V23, P563, DOI 10.1016/j.ccr.2013.04.028; Hinz S, 2008, J CANCER RES CLIN, V134, P331, DOI 10.1007/s00432-007-0288-8; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Lauss M, 2012, EPIGENETICS-US, V7, P858, DOI 10.4161/epi.20837; Raman JD, 2005, CLIN CANCER RES, V11, P8570, DOI 10.1158/1078-0432.CCR-05-1047; Ren G, 2012, CANCER RES, V72, P3091, DOI 10.1158/0008-5472.CAN-11-3546; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shastry BS, 2002, J HUM GENET, V47, P561, DOI 10.1007/s100380200086; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Stenzl A, 2011, EUR UROL, V59, P1009, DOI 10.1016/j.eururo.2011.03.023; Wu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039466; Yiang GT, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-47; Yoon KA, 2010, J THORAC ONCOL, V5, P10, DOI 10.1097/JTO.0b013e3181c422d9; Yu YL, 2012, J BIOL CHEM, V287, P31015, DOI 10.1074/jbc.M112.358077; Yu YL, 2012, J CELL PHYSIOL, V227, P213, DOI 10.1002/jcp.22719; Yu YL, 2010, INT J ONCOL, V36, P365, DOI 10.3892/ijo_00000508	31	15	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93635	10.1371/journal.pone.0093635	http://dx.doi.org/10.1371/journal.pone.0093635			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691023	gold, Green Submitted, Green Published			2022-12-27	WOS:000334101100116
J	Li, Y; Xu, SS; Gao, J; Pan, S; Wang, GX				Li, Yan; Xu, Shan-Shan; Gao, Jing; Pan, Sha; Wang, Gen-Xuan			Chlorella Induces Stomatal Closure via NADPH Oxidase-Dependent ROS Production and Its Effects on Instantaneous Water Use Efficiency in Vicia faba	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; ABSCISIC-ACID; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; GUARD-CELLS; DEFICIT IRRIGATION; METHYL JASMONATE; INNATE IMMUNITY; PLANT STOMATA; NITRIC-OXIDE	Reactive oxygen species (ROS) have been established to participate in stomatal closure induced by live microbes and microbe-associated molecular patterns (MAMPs). Chlorella as a beneficial microorganism can be expected to trigger stomatal closure via ROS production. Here, we reported that Chlorella induced stomatal closure in a dose-and time-dependent manner in epidermal peels of Vicia faba. Using pharmacological methods in this work, we found that the Chlorella-induced stomatal closure was almost completely abolished by a hydrogen peroxide (H2O2) scavenger, catalase (CAT), significantly suppressed by an NADPH oxidase inhibitor, diphenylene iodonium chloride (DPI), and slightly affected by a peroxidase inhibitor, salicylhydroxamic acid (SHAM), suggesting that ROS production involved in Chlorella-induced stomatal closure is mainly mediated by DPI-sensitive NADPH oxidase. Additionally, Exogenous application of optimal concentrations of Chlorella suspension improved instantaneous water use efficiency (WUEi) in Vicia faba via a reduction in leaf transpiration rate (E) without a parallel reduction in net photosynthetic rate (P-n) assessed by gas-exchange measurements. The chlorophyll fluorescence and content analysis further demonstrated that short-term use of Chlorella did not influence plant photosynthetic reactions center. These results preliminarily reveal that Chlorella can trigger stomatal closure via NADPH oxidase-dependent ROS production in epidermal strips and improve WUEi in leave levels.	[Li, Yan; Xu, Shan-Shan; Gao, Jing; Pan, Sha; Wang, Gen-Xuan] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wang, GX (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	11207018@zju.edu.cn			National High-Tech R & D Program (863 Program) for the 12th Five-Year Plan [2011AA100503]; Natural Science Fund of China [31330010]; Zhejiang Provincial Natural Science Foundation of China [LZ13C030002]	National High-Tech R & D Program (863 Program) for the 12th Five-Year Plan; Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work is supported by the National High-Tech R & D Program (863 Program) for the 12th Five-Year Plan (2011AA100503), Natural Science Fund of China (31330010), and Zhejiang Provincial Natural Science Foundation of China (LZ13C030002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya B, 2009, PLANT MOL BIOL, V69, P451, DOI 10.1007/s11103-008-9427-0; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; Chaves MM, 2007, ANN APPL BIOL, V150, P237, DOI 10.1111/j.1744-7348.2006.00123.x; Chaves MM, 2004, J EXP BOT, V55, P2365, DOI 10.1093/jxb/erh269; Cherng JY, 2005, LIFE SCI, V77, P980, DOI 10.1016/j.lfs.2004.12.036; Cona A, 2006, TRENDS PLANT SCI, V11, P80, DOI 10.1016/j.tplants.2005.12.009; Condon AG, 2004, J EXP BOT, V55, P2447, DOI 10.1093/jxb/erh277; Condon AG, 2002, CROP SCI, V42, P122, DOI 10.2135/cropsci2002.0122; Cuevas JC, 2004, FUNCT PLANT BIOL, V31, P921, DOI 10.1071/FP04007; de Souza CR, 2005, J EXP BOT, V56, P2163, DOI 10.1093/jxb/eri216; del Rio LA, 2002, J EXP BOT, V53, P1255, DOI 10.1093/jexbot/53.372.1255; Desikan R, 2004, FUNCT PLANT BIOL, V31, P913, DOI 10.1071/FP04035; Desikan R, 2006, PLANT J, V47, P907, DOI 10.1111/j.1365-313X.2006.02842.x; Gao J, 2013, PLANT PHYSIOL BIOCH, V65, P27, DOI 10.1016/j.plaphy.2013.01.008; Gerken HG, 2013, PLANTA, V237, P239, DOI 10.1007/s00425-012-1765-0; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Grimmer MK, 2012, J EXP BOT, V63, P4321, DOI 10.1093/jxb/ers143; Guidi L, 2005, PLANT SCI, V168, P153, DOI 10.1016/j.plantsci.2004.07.027; Guzman S, 2001, PHYTOTHER RES, V15, P224, DOI 10.1002/ptr.715; He JM, 2013, PLANT PHYSIOL, V161, P1570, DOI 10.1104/pp.112.211623; He JM, 2011, J EXP BOT, V62, P2657, DOI 10.1093/jxb/erq431; Henderson RK, 2008, WATER RES, V42, P3435, DOI 10.1016/j.watres.2007.10.032; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hoque TS, 2012, J PLANT PHYSIOL, V169, P979, DOI 10.1016/j.jplph.2012.02.007; Iriti M, 2009, ENVIRON EXP BOT, V66, P493, DOI 10.1016/j.envexpbot.2009.01.004; Jiang K, 2012, PLANT CELL, V24, P2031, DOI 10.1105/tpc.112.096263; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Keffer JE, 2002, J IND MICROBIOL BIOT, V29, P275, DOI 10.1038/sj.jim.7000313; Khokon MAR, 2011, PLANT CELL ENVIRON, V34, P1900, DOI 10.1111/j.1365-3040.2011.02385.x; Khokon MAR, 2011, PLANT CELL ENVIRON, V34, P434, DOI 10.1111/j.1365-3040.2010.02253.x; Khokon MAR, 2010, BIOSCI BIOTECH BIOCH, V74, P2313, DOI 10.1271/bbb.100340; Khokon MAR, 2010, PLANT CELL PHYSIOL, V51, P1915, DOI 10.1093/pcp/pcq145; Koers S, 2011, PLANT J, V68, P670, DOI 10.1111/j.1365-313X.2011.04719.x; Koscielniak J, 2006, PHOTOSYNTHETICA, V44, P174, DOI 10.1007/s11099-006-0003-z; Krupenina NA, 2008, PHOTOCH PHOTOBIO SCI, V7, P681, DOI 10.1039/b802243g; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; Lee HS, 2009, J MED FOOD, V12, P1029, DOI 10.1089/jmf.2008.1269; Lee S, 1999, PLANT PHYSIOL, V121, P147, DOI 10.1104/pp.121.1.147; Li X, 2010, JIANGSU AGR SCI, V4, P160; Macho AP, 2012, PLANT PHYSIOL, V159, P1845, DOI 10.1104/pp.112.199810; Marino D, 2012, TRENDS PLANT SCI, V17, P9, DOI 10.1016/j.tplants.2011.10.001; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Melotto M, 2008, ANNU REV PHYTOPATHOL, V46, P101, DOI 10.1146/annurev.phyto.121107.104959; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Miranda M S, 2001, Boll Chim Farm, V140, P165; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Mori IC, 2001, PLANT CELL PHYSIOL, V42, P1383, DOI 10.1093/pcp/pce176; Munemasa S, 2007, PLANT PHYSIOL, V143, P1398, DOI 10.1104/pp.106.091298; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Neill S, 2008, J EXP BOT, V59, P165, DOI 10.1093/jxb/erm293; Park JY, 2005, CLIN CHIM ACTA, V351, P185, DOI 10.1016/j.cccn.2004.09.013; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Pereira EG, 2013, PLANT SCI, V201, P81, DOI 10.1016/j.plantsci.2012.12.003; Rivero RM, 2009, PLANT PHYSIOL, V150, P1530, DOI 10.1104/pp.109.139378; Sawinski K, 2013, MOL PLANT MICROBE IN, V26, P626, DOI 10.1094/MPMI-12-12-0288-CR; Schulze-Lefert P, 2006, CELL, V126, P831, DOI 10.1016/j.cell.2006.08.020; Silva Junior JMd, 2012, ACTA SCI-AGRON, V35, P65; Suhita D, 2004, PLANT PHYSIOL, V134, P1536, DOI 10.1104/pp.103.032250; TREJO CL, 1993, PLANT PHYSIOL, V102, P497, DOI 10.1104/pp.102.2.497; Underwood W, 2007, CELL MICROBIOL, V9, P1621, DOI 10.1111/j.1462-5822.2007.00938.x; Vahisalu T, 2010, PLANT J, V62, P442, DOI 10.1111/j.1365-313X.2010.04159.x; Vranova E, 2002, J EXP BOT, V53, P1227, DOI 10.1093/jexbot/53.372.1227; Wan JX, 2009, CROP SCI, V49, P1539, DOI 10.2135/cropsci2008.09.0568; Wang GX, 2001, PLANT SCI, V160, P1007, DOI 10.1016/S0168-9452(01)00344-2; Yang HM, 2003, PLANT SCI, V165, P1117, DOI 10.1016/S0168-9452(03)00319-4; Yun H, 2011, J HEALTH SCI, V57, P245, DOI 10.1248/jhs.57.245; Zeng WQ, 2010, CURR OPIN BIOTECH, V21, P599, DOI 10.1016/j.copbio.2010.05.006; Zhang HM, 2008, PLANT J, V56, P264, DOI 10.1111/j.1365-313X.2008.03593.x; Zhang X, 2001, PLANT PHYSIOL, V126, P1438, DOI 10.1104/pp.126.4.1438; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	76	6	10	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93290	10.1371/journal.pone.0093290	http://dx.doi.org/10.1371/journal.pone.0093290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24687099	gold, Green Submitted, Green Published			2022-12-27	WOS:000340842300006
J	Valero, C; Javierre, E; Garcia-Aznar, JM; Gomez-Benito, MJ				Valero, Clara; Javierre, Etelvina; Manuel Garcia-Aznar, Jose; Jose Gomez-Benito, Maria			A Cell-Regulatory Mechanism Involving Feedback between Contraction and Tissue Formation Guides Wound Healing Progression	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; GROWTH-FACTOR-BETA; MECHANOCHEMICAL MODEL; MATRIX CONTRACTION; GRANULATION-TISSUE; FORCE GENERATION; STIFFNESS; COLLAGEN; FIBROBLASTS; MIGRATION	Wound healing is a process driven by cells. The ability of cells to sense mechanical stimuli from the extracellular matrix that surrounds them is used to regulate the forces that cells exert on the tissue. Stresses exerted by cells play a central role in wound contraction and have been broadly modelled. Traditionally, these stresses are assumed to be dependent on variables such as the extracellular matrix and cell or collagen densities. However, we postulate that cells are able to regulate the healing process through a mechanosensing mechanism regulated by the contraction that they exert. We propose that cells adjust the contraction level to determine the tissue functions regulating all main activities, such as proliferation, differentiation and matrix production. Hence, a closed-regulatory feedback loop is proposed between contraction and tissue formation. The model consists of a system of partial differential equations that simulates the evolution of fibroblasts, myofibroblasts, collagen and a generic growth factor, as well as the deformation of the extracellular matrix. This model is able to predict the wound healing outcome without requiring the addition of phenomenological laws to describe the time-dependent contraction evolution. We have reproduced two in vivo experiments to evaluate the predictive capacity of the model, and we conclude that there is feedback between the level of cell contraction and the tissue regenerated in the wound.	[Valero, Clara; Manuel Garcia-Aznar, Jose; Jose Gomez-Benito, Maria] Univ Zaragoza, Aragon Inst Engn Res I3A, Zaragoza, Spain; [Javierre, Etelvina] Ctr Univ Def Zaragoza, Acad Gen Militar, Zaragoza, Spain	University of Zaragoza	Valero, C (corresponding author), Univ Zaragoza, Aragon Inst Engn Res I3A, Zaragoza, Spain.	claraval@unizar.es	Javierre, Etelvina/J-9524-2015; Garcia-Aznar, Jose Manuel/F-8256-2010; Valero, Clara/AAY-9640-2021; Gomez-Benito, Maria Jose/A-5368-2010; Javierre, Etelvina/J-9524-2015	Javierre, Etelvina/0000-0002-8117-1674; Garcia-Aznar, Jose Manuel/0000-0002-9864-7683; Gomez-Benito, Maria Jose/0000-0002-1878-8997; Valero Lazaro, Clara/0000-0001-9318-7107; Javierre, Etelvina/0000-0002-5554-5054	Spanish Ministry of Economy and Competitiveness [DPI2012-32880, BES2010-037281]; European Research Council (ERC) [ERC-2012-StG 306751]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Research Council (ERC)(European Research Council (ERC)European Commission)	This research was supported by the Spanish Ministry of Economy and Competitiveness (Grant DPI2012-32880 and BES2010-037281) (http://www.mineco.gob.es/portal/site/mineco/?lang_choosen = en). Financial support of the European Research Council (ERC) through project ERC-2012-StG 306751 is gratefully acknowledged (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi S, 2007, FASEB J, V21, P3250, DOI 10.1096/fj.07-8218com; Adam JA, 2000, MATH COMPUT MODEL, V31, P237, DOI 10.1016/S0895-7177(00)00054-6; Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Bidan CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036336; Bluestein D, 2008, AM FAM PHYSICIAN, V78, P1186; Borau C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049174; Chiquet M, 2003, MATRIX BIOL, V22, P73, DOI 10.1016/S0945-053X(03)00004-0; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038; Grinnell F, 2000, TRENDS CELL BIOL, V10, P362, DOI 10.1016/S0962-8924(00)01802-X; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; GROTENDORST GR, 1981, P NATL ACAD SCI-BIOL, V78, P3669, DOI 10.1073/pnas.78.6.3669; GUIDRY C, 1992, CANCER METAST REV, V11, P45, DOI 10.1007/BF00047602; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Harland B, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015011; Hinz B, 2003, CURR OPIN BIOTECH, V14, P538, DOI 10.1016/j.copbio.2003.08.006; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Javierre E, 2009, INT J SOLIDS STRUCT, V46, P3597, DOI 10.1016/j.ijsolstr.2009.06.010; Jones C, 2011, EXP MOL PATHOL, V91, P394, DOI 10.1016/j.yexmp.2011.04.007; Khatyr F, 2004, SKIN RES TECHNOL, V10, P96, DOI 10.1111/j.1600-0846.2004.00057.x; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; MCGRATH MH, 1983, PLAST RECONSTR SURG, V72, P66, DOI 10.1097/00006534-198307000-00015; Mitrossilis D, 2010, P NATL ACAD SCI USA, V107, P16518, DOI 10.1073/pnas.1007940107; Mitrossilis D, 2009, P NATL ACAD SCI USA, V106, P18243, DOI 10.1073/pnas.0903994106; Moreo P, 2008, ACTA BIOMATER, V4, P613, DOI 10.1016/j.actbio.2007.10.014; Murphy KE, 2012, B MATH BIOL, V74, P1143, DOI 10.1007/s11538-011-9712-y; Murphy KE, 2011, J THEOR BIOL, V272, P145, DOI 10.1016/j.jtbi.2010.12.011; Murray JD, 1998, J FRANKLIN I, V335B, P303, DOI 10.1016/S0016-0032(97)00034-3; Ogawa R, 2011, WOUND REPAIR REGEN, V19, pS2, DOI 10.1111/j.1524-475X.2011.00707.x; OLSEN L, 1995, J THEOR BIOL, V177, P113, DOI 10.1006/jtbi.1995.0230; Olsen L, 1996, B MATH BIOL, V58, P787, DOI 10.1016/0092-8240(96)00003-1; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Radovanac K, 2013, EMBO J, V32, P1409, DOI 10.1038/emboj.2013.90; Reina-Romo E, 2010, P I MECH ENG H, V224, P1245, DOI 10.1243/09544119JEIM787; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Roy S, 2009, PHYSIOL GENOMICS, V37, P211, DOI 10.1152/physiolgenomics.90362.2008; Saez A, 2007, P NATL ACAD SCI USA, V104, P8281, DOI 10.1073/pnas.0702259104; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Serra-Picamal X, 2012, NAT PHYS, V8, P628, DOI [10.1038/NPHYS2355, 10.1038/nphys2355]; SHERRATT JA, 1991, J MATH BIOL, V29, P389, DOI 10.1007/BF00160468; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; TRANQUILLO RT, 1992, J THEOR BIOL, V158, P135, DOI 10.1016/S0022-5193(05)80715-5; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193	51	39	40	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92774	10.1371/journal.pone.0092774	http://dx.doi.org/10.1371/journal.pone.0092774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681636	gold, Green Published			2022-12-27	WOS:000333678100016
J	Betsch, M; Thelen, S; Santak, L; Herten, M; Jungbluth, P; Miersch, D; Hakimi, M; Wild, M				Betsch, Marcel; Thelen, Simon; Santak, Laila; Herten, Monika; Jungbluth, Pascal; Miersch, Daniel; Hakimi, Mohssen; Wild, Michael			The Role of Erythropoietin and Bone Marrow Concentrate in the Treatment of Osteochondral Defects in Mini-Pigs	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; RECOMBINANT-HUMAN-ERYTHROPOIETIN; BETA-TRICALCIUM PHOSPHATE; CARTILAGE DEFECTS; ANIMAL-MODELS; REPAIR; REGENERATION; PLUG; KNEE; MICROFRACTURE	Background: All available treatment options for osteochondral and chondral defects do not restore hyaline cartilage and are limited to decreasing associated pain, and maintaining or improving joint function. The purpose of this study was to evaluate the potential of erythropoietin (EPO) in combination with bone marrow aspiration concentrate (BMAC) in the treatment of osteochondral defects of mini-pigs. Methods: 14 Goettinger mini-pigs, in which a 6610 mm osteochondral defect in the medial femoral condyle of both knee joints was created, were randomized into four groups: biphasic scaffold alone, scaffold with EPO, scaffold with BMAC and scaffold in combination with EPO and BMAC. After 26 weeks all animals were euthanized and histological slides were evaluated using a modified ODriscoll Score. Results: In the therapy groups, areas of chondrogenic tissue that contained collagen II were present. Adding EPO (p = 0.245) or BMAC (p = 0.099) alone to the scaffold led to a non-significant increase in the score compared to the control group. However, the combination of EPO and BMAC in the implanted scaffold showed a significant improvement (p = 0.02) in the histological score. Conclusion: The results of our study show that in mini-pigs, the combination of EPO and BMAC leads to an enhanced osteochondral healing. However, additional research is necessary to further improve the repair tissue and to define the role of MSCs and EPO in cartilage repair.	[Betsch, Marcel; Thelen, Simon; Santak, Laila; Jungbluth, Pascal; Miersch, Daniel; Hakimi, Mohssen] Univ Hosp Duesseldorf, Dept Trauma & Hand Surg, Dusseldorf, Germany; [Herten, Monika] Univ Hosp Muenster, Dept & Endovasc Surg, Munster, Germany; [Wild, Michael] Klinikum Darmstadt, Dept Trauma & Orthopaed Surg, Darmstadt, Germany	University of Munster; Klinikum Darmstadt	Thelen, S (corresponding author), Univ Hosp Duesseldorf, Dept Trauma & Hand Surg, Dusseldorf, Germany.	simon.thelen@med.uni-duesseldorf.de	Herten, Monika/J-1547-2015; Jungbluth, Pascal/L-6703-2017	Herten, Monika/0000-0001-9697-0287; Wild, Michael/0000-0002-6306-4867	Medical Faculty, Heinrich Heine University Duesseldorf, Germany	Medical Faculty, Heinrich Heine University Duesseldorf, Germany	This study was funded by a research grant of the Medical Faculty, Heinrich Heine University Duesseldorf, Germany. The TRUFIT BGS scaffolds were provided by Smith & Nephew, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcasoy MO, 2008, BRIT J HAEMATOL, V141, P14, DOI 10.1111/j.1365-2141.2008.07014.x; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Brittberg M, 1999, CLIN ORTHOP RELAT R, pS147; Carmont MR, 2009, ARTHROSCOPY, V25, P810, DOI 10.1016/j.arthro.2009.01.023; CASTROMALASPINA H, 1980, BLOOD, V56, P289; Chen FH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2514; Chen Long, 2008, Zhonghua Xue Ye Xue Za Zhi, V29, P811; Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]; De Spiegelaere W, 2010, MOL CELL BIOCHEM, V337, P287, DOI 10.1007/s11010-009-0310-3; Dennis JE, 2007, STEM CELLS, V25, P2575, DOI 10.1634/stemcells.2007-0204; Dhollander AAM, 2012, ARTHROSCOPY, V28, P225, DOI 10.1016/j.arthro.2011.07.017; DONATH K, 1985, PATHOL RES PRACT, V179, P631, DOI 10.1016/S0344-0338(85)80209-0; Fortier LA, 2010, J BONE JOINT SURG AM, V92A, P1927, DOI 10.2106/JBJS.I.01284; Galeano M, 2006, CRIT CARE MED, V34, P1139, DOI 10.1097/01.CCM.0000206468.18653.EC; Gan YK, 2008, BIOMATERIALS, V29, P3973, DOI 10.1016/j.biomaterials.2008.06.026; Grassel S, 2012, ORTHOPADE, V41, P415, DOI 10.1007/s00132-012-1933-8; Hatzokos I, 2011, J BONE JOINT SURG AM, V93A, P671, DOI 10.2106/JBJS.J.00514; Hendrich C, 2009, ORTHOP REV, V1, P99, DOI 10.4081/or.2009.e32; Hermann PC, 2007, CELL TRANSPLANT, V16, P1059, DOI 10.3727/000000007783472363; Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215; Hernigou P, 2006, J BONE JOINT SURG AM, V88A, P2565, DOI 10.2106/JBJS.E.01455; Hettrich CM, 2008, SPORTS MED ARTHROSC, V16, P230, DOI 10.1097/JSA.0b013e31818cdc98; Holstein JH, 2007, LIFE SCI, V80, P893, DOI 10.1016/j.lfs.2006.11.023; Huang AH, 2008, ANN BIOMED ENG, V36, P1909, DOI 10.1007/s10439-008-9562-4; Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbrc.2004.06.029; Jackson DW, 2001, J BONE JOINT SURG AM, V83A, P53, DOI 10.2106/00004623-200101000-00008; Jager M, 2011, J ORTHOP RES, V29, P173, DOI 10.1002/jor.21230; Joshi N, 2012, AM J SPORT MED, V40, P1289, DOI 10.1177/0363546512441585; Martin DR, 2002, EXP HEMATOL, V30, P879, DOI 10.1016/S0301-472X(02)00864-0; Melton JTK, 2010, EXPERT REV MED DEVIC, V7, P333, DOI 10.1586/ERD.10.15; Mihmanli A, 2009, J ORAL MAXIL SURG, V67, P2337, DOI 10.1016/j.joms.2008.06.082; Moon C, 2005, CARDIOVASC DRUG THER, V19, P243, DOI 10.1007/s10557-005-3189-6; Muschler GF, 2001, J ORTHOP RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3; Pastides P, 2013, OSTEOARTHR CARTILAGE, V21, P646, DOI 10.1016/j.joca.2013.02.008; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rudert M, 2002, CELLS TISSUES ORGANS, V171, P229, DOI 10.1159/000063125; Sauerbier S, 2010, TISSUE ENG PART C-ME, V16, P215, DOI [10.1089/ten.tec.2009.0269, 10.1089/ten.TEC.2009.0269]; Schwarz F, 2007, INT J ORAL MAX SURG, V36, P1198, DOI 10.1016/j.ijom.2007.07.014; Shiozawa Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010853; Smiler Dennis, 2006, Implant Dent, V15, P229, DOI 10.1097/01.id.0000236125.70742.86; Sorg H, 2013, MED RES REV, V33, P637, DOI 10.1002/med.21259; Thiemermann C, 2007, CRIT CARE, V11, DOI 10.1186/cc5912; Thoesen MS, 2006, AM J VET RES, V67, P1655, DOI 10.2460/ajvr.67.10.1655; von Rechenberg B, 2003, OSTEOARTHR CARTILAGE, V11, P265, DOI 10.1016/S1063-4584(03)00006-2; Yen YM, 2008, MED SCI SPORT EXER, V40, P200, DOI 10.1249/mss.0b013e31815cb212; Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004	46	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92766	10.1371/journal.pone.0092766	http://dx.doi.org/10.1371/journal.pone.0092766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676029	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500037
J	Fregel, R; Seetah, K; Betancor, E; Suarez, NM; Calaon, D; Caval, S; Janoo, A; Pestano, J				Fregel, Rosa; Seetah, Krish; Betancor, Eva; Suarez, Nicolas M.; Calaon, Diego; Caval, Sasa; Janoo, Anwar; Pestano, Jose			Multiple Ethnic Origins of Mitochondrial DNA Lineages for the Population of Mauritius	PLOS ONE			English	Article							GENETIC DIVERSITY; MACROHAPLOGROUP M; ADMIXTURE; MTDNA; SETTLEMENT; MALAGASY; SEQUENCES; ANCESTRY; INSIGHTS; EURASIA	This article reports on the first genetic assessment of the contemporary Mauritian population. Small island nodes such as Mauritius played a critical role in historic globalization processes and revealing high-resolution details of labour sourcing is crucial in order to better understand early-modern diaspora events. Mauritius is a particularly interesting case given detailed historic accounts attesting to European (Dutch, French and British), African and Asian points of origin. Ninety-seven samples were analysed for mitochondrial DNA to begin unravelling the complex dynamics of the island's modern population. In corroboration with general demographic information, the majority of maternal lineages were derived from South Asia (58.76%), with Malagasy (16.60%), East/Southeast Asian (11.34%) and Sub-Saharan African (10.21%) also making significant contributions. This study pinpoints specific regional origins for the South Asian genetic contribution, showing a greater influence on the contemporary population from northern and southeast India. Moreover, the analysis of lineages related to the slave trade demonstrated that Madagascar and East Asia were the main centres of origin, with less influence from West Africa.	[Fregel, Rosa; Suarez, Nicolas M.; Pestano, Jose] Univ Las Palmas Gran Canaria, Fac Med, Dept Genet, Las Palmas Gran Canaria, Spain; [Fregel, Rosa] Univ La Laguna, Fac Biol, Dept Genet, E-38207 San Cristobal la Laguna, Spain; [Fregel, Rosa; Seetah, Krish; Calaon, Diego; Caval, Sasa] Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA; [Betancor, Eva; Pestano, Jose] Inst Legal Med Las Palmas, Forens Genet Lab, Las Palmas Gran Canaria, Spain; [Calaon, Diego] Ca Foscari Univ, IDEAS Interdepartmental Ctr, Venice, Italy; [Janoo, Anwar] Univ Mauritius, Dept Hist, Reduit, Mauritius	Universidad de Las Palmas de Gran Canaria; Universidad de la Laguna; Stanford University; Universita Ca Foscari Venezia; University of Mauritius	Fregel, R (corresponding author), Univ Las Palmas Gran Canaria, Fac Med, Dept Genet, Las Palmas Gran Canaria, Spain.	rfregel@gmail.com	Pestano, Jose/A-9640-2017; Fregel, Rosa/H-4942-2015; Čaval, Saša/E-2291-2017; Calaon, Diego/L-8333-2015	Pestano, Jose/0000-0001-6454-4785; Fregel, Rosa/0000-0002-2951-6508; Čaval, Saša/0000-0002-9337-3951; Seetah, Krish/0000-0001-8549-4692; Betancor Hernandez, Eva/0000-0002-9958-9382; Calaon, Diego/0000-0003-1911-5599				Allen R.B., 1999, UNFREE LABOURCASE ST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Behar DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002062; Berniell-Lee G, 2008, AM J PHYS ANTHROPOL, V136, P100, DOI 10.1002/ajpa.20783; Carter M., 1995, SERVANTS SIRDARS SET; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Chaubey G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-227; Dubut V, 2009, HUM BIOL, V81, P495, DOI 10.3378/027.081.0407; Dubut V, 2009, ANN HUM GENET, V73, P314, DOI 10.1111/j.1469-1809.2009.00519.x; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; DUPON JF, 1974, CAH CTR U REUNION, V4, P67; Filliot J. -M., 1974, TRAITE ESCLAVES VERS; Fregel R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-181; Fuller DQ, 2011, ANTIQUITY, V85, P544, DOI 10.1017/S0003598X00067934; Gourjon G, 2011, AM J PHYS ANTHROPOL, V144, P653, DOI 10.1002/ajpa.21474; Hurles ME, 2005, AM J HUM GENET, V76, P894, DOI 10.1086/430051; Kumar S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-173; Lacpatia F, 1982, INDIENS REUNION; LONG JC, 1991, GENETICS, V127, P417; Maca-Meyer N, 2005, AM J PHYS ANTHROPOL, V127, P418, DOI 10.1002/ajpa.20148; Maca-Meyer N, 2004, EUR J HUM GENET, V12, P155, DOI 10.1038/sj.ejhg.5201075; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Mendizabal I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-213; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Msaidie S, 2011, EUR J HUM GENET, V19, P89, DOI 10.1038/ejhg.2010.128; Nei N, 1987, MOL EVOLUTIONARY GEN; Razafindrazaka H, 2010, EUR J HUM GENET, V18, P575, DOI 10.1038/ejhg.2009.222; Ricaut FX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-605; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Schneider S., 2000, ARLEQUIN SOFTWARE PO; SINGHVI LM, 2001, REPORTH HIGH LEVEL C, P61; SLATKIN M, 1995, GENETICS, V139, P457; SOODYALL H, 1995, NAT GENET, V10, P377, DOI 10.1038/ng0895-377; Thangaraj K, 2008, HUM HERED, V66, P1, DOI 10.1159/000114160; Tofanelli S, 2009, MOL BIOL EVOL, V26, P2109, DOI 10.1093/molbev/msp120; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921	36	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93294	10.1371/journal.pone.0093294	http://dx.doi.org/10.1371/journal.pone.0093294			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SW	24676463	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000333677500105
J	Jerng, HH; Pfaffinger, PJ				Jerng, Henry H.; Pfaffinger, Paul J.			S-Glutathionylation of an Auxiliary Subunit Confers Redox Sensitivity to Kv4 Channel Inactivation	PLOS ONE			English	Article							N-TYPE INACTIVATION; 2-IODOMELATONIN PREVENTS APOPTOSIS; CEREBELLAR GRANULE NEURONS; CLOSED-STATE INACTIVATION; GATED K+ CHANNELS; FUNCTIONAL-CHARACTERIZATION; MOLECULAR PHYSIOLOGY; BUTYL HYDROPEROXIDE; OXIDATIVE STRESS; BETA-SUBUNIT	Reactive oxygen species (ROS) regulate ion channels, modulate neuronal excitability, and contribute to the etiology of neurodegenerative disorders. ROS differentially suppress fast "ball-and-chain'' N-type inactivation of cloned Kv1 and Kv3 potassium channels but not of Kv4 channels, likely due to a lack of reactive cysteines in Kv4 N-termini. Recently, we discovered that N-type inactivation of Kv4 channel complexes can be independently conferred by certain N-terminal variants of Kv4 auxiliary subunits (DPP6a, DPP10a). Here, we report that both DPP6a and DPP10a, like Kv subunits with redox-sensitive N-type inactivation, contain a highly conserved cysteine in their N-termini (Cys-13). To test if N-type inactivation mediated by DPP6a or DPP10a is redox sensitive, Xenopus oocyte recordings were performed to examine the effects of two common oxidants, tert-butyl hydroperoxide (tBHP) and diamide. Both oxidants markedly modulate DPP6a- or DPP10a-conferred N-type inactivation of Kv4 channels, slowing the overall inactivation and increasing the peak current. These functional effects are fully reversed by the reducing agent dithiothreitol (DTT) and appear to be due to a selective modulation of the N-type inactivation mediated by these auxiliary subunits. Mutation of DPP6a Cys-13 to serine eliminated the tBHP or diamide effects, confirming the importance of Cys-13 to the oxidative regulation. Biochemical studies designed to elucidate the underlying molecular mechanism show no evidence of protein-protein disulfide linkage formation following cysteine oxidation. Instead, using a biotinylated glutathione (BioGEE) reagent, we discovered that oxidation by tBHP or diamide leads to S-glutathionylation of Cys-13, suggesting that S-glutathionylation underlies the regulation of fast N-type inactivation by redox. In conclusion, our studies suggest that Kv4-based A-type current in neurons may show differential redox sensitivity depending on whether DPP6a or DPP10a is highly expressed, and that the S-glutathionylation mechanism may play a previously unappreciated role in mediating excitability changes and neuropathologies associated with ROS.	[Jerng, Henry H.; Pfaffinger, Paul J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine	Jerng, HH (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	hjerng@cns.bcm.edu			National Institute of Health [R01 GM090029, P30HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090029] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institute of Health (R01 GM090029, P30HD024064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahring R, 2001, J PHYSIOL-LONDON, V535, P65, DOI 10.1111/j.1469-7793.2001.00065.x; Barghaan J, 2009, J GEN PHYSIOL, V133, P205, DOI 10.1085/jgp.200810073; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; BRIGELIUS R, 1983, BIOCHEM PHARMACOL, V32, P2529, DOI 10.1016/0006-2952(83)90014-X; BRIGELIUS R, 1983, H-S Z PHYSIOL CHEM, V364, P989, DOI 10.1515/bchm2.1983.364.2.989; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Chen JG, 2000, BIOPHYS J, V78, P174, DOI 10.1016/S0006-3495(00)76583-0; COLLISON MW, 1986, BIOCHIM BIOPHYS ACTA, V885, P58, DOI 10.1016/0167-4889(86)90038-8; Covarrubias M, 2008, NEUROCHEM RES, V33, P1558, DOI 10.1007/s11064-008-9650-8; DUPRAT F, 1995, P NATL ACAD SCI USA, V92, P11796, DOI 10.1073/pnas.92.25.11796; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Gebauer M, 2004, BIOPHYS J, V86, P210, DOI 10.1016/S0006-3495(04)74097-7; GILBERT HF, 1984, METHOD ENZYMOL, V107, P330; Heinemann SH, 1996, J PHYSIOL-LONDON, V493, P625, DOI 10.1113/jphysiol.1996.sp021409; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Hsieh CP, 2008, BIOCHEM BIOPH RES CO, V370, P445, DOI 10.1016/j.bbrc.2008.03.097; Hu CL, 2005, J PINEAL RES, V38, P53, DOI 10.1111/j.1600-079X.2004.00174.x; Jerng HH, 2007, MOL CELL NEUROSCI, V35, P604, DOI 10.1016/j.mcn.2007.03.008; Jerng HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038205; Jerng HH, 2009, CHANNELS, V3, P448, DOI 10.4161/chan.3.6.10216; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Jerng HH, 2004, BIOPHYS J, V87, P2380, DOI 10.1529/biophysj.104.042358; Jiao S, 2004, J PINEAL RES, V36, P109, DOI 10.1046/j.1600-079X.2003.00104.x; Keck RG, 1996, ANAL BIOCHEM, V236, P56, DOI 10.1006/abio.1996.0131; Kiehn J, 1996, CIRCULATION, V94, P2572, DOI 10.1161/01.CIR.94.10.2572; Kirichok YV, 1998, NEUROREPORT, V9, P625, DOI 10.1097/00001756-199803090-00012; Kolbe K, 2010, J PHYSIOL-LONDON, V588, P2999, DOI 10.1113/jphysiol.2010.192468; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; KOSOWER NS, 1995, METHOD ENZYMOL, V251, P123, DOI 10.1016/0076-6879(95)51116-4; KURANTSINMILLS J, 1981, BIOCHIM BIOPHYS ACTA, V641, P129, DOI 10.1016/0005-2736(81)90576-9; Lee TE, 1996, J MEMBRANE BIOL, V151, P225, DOI 10.1007/s002329900073; Leicher T, 1998, J BIOL CHEM, V273, P35095, DOI 10.1074/jbc.273.52.35095; Leicher T, 1996, NEUROPHARMACOLOGY, V35, P787, DOI 10.1016/0028-3908(96)00133-5; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lock JT, 2012, J PHYSL; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Maffie J, 2009, NEUROSCI LETT, V449, P189, DOI 10.1016/j.neulet.2008.10.098; Maffie J, 2008, J PHYSIOL-LONDON, V586, P5609, DOI 10.1113/jphysiol.2008.161620; Marionneau C, 2011, SEMIN CELL DEV BIOL, V22, P145, DOI 10.1016/j.semcdb.2010.10.004; Massaad CA, 2011, ANTIOXID REDOX SIGN, V14, P2013, DOI 10.1089/ars.2010.3208; Muller W, 2002, J NEUROPHYSIOL, V87, P2990, DOI 10.1152/jn.00790.2001; OCHI T, 1993, ARCH TOXICOL, V67, P401, DOI 10.1007/BF01977401; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Rasmusson RL, 1997, ADV EXP MED BIOL, V430, P29; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHUPPE I, 1992, BIOCHEM PHARMACOL, V44, P1757, DOI 10.1016/0006-2952(92)90069-U; SERODIO P, 1994, J NEUROPHYSIOL, V72, P1516, DOI 10.1152/jn.1994.72.4.1516; Sesti F, 2010, TRENDS CELL BIOL, V20, P45, DOI 10.1016/j.tcb.2009.09.008; STEPHENS GJ, 1995, J PHYSIOL-LONDON, V484, P1; Stephens GJ, 1996, PFLUG ARCH EUR J PHY, V431, P435, DOI 10.1007/BF02207283; STEPHENS GJ, 1994, J PHYSIOL-LONDON, V477, P187, DOI 10.1113/jphysiol.1994.sp020183; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; VEGA-SAENZ DE MIERA E, 1992, BIOCHEM BIOPH RES CO, V186, P1681; Wang GY, 2005, J GEN PHYSIOL, V126, P55, DOI 10.1085/jgp.200509288; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wang W, 2005, J GEN PHYSIOL, V125, P127, DOI 10.1085/jgp.200409115; Wang ZG, 1996, J BIOL CHEM, V271, P28311, DOI 10.1074/jbc.271.45.28311; Wissmann R, 1999, J BIOL CHEM, V274, P35521, DOI 10.1074/jbc.274.50.35521; Yang Y, 2010, J BIOL CHEM, V285, P38641, DOI 10.1074/jbc.M110.162578; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Zhang ZH, 2004, J BIOL CHEM, V279, P29226, DOI 10.1074/jbc.M403290200; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; ZIEGLER DM, 1985, ANNU REV BIOCHEM, V54, P305, DOI 10.1146/annurev.bi.54.070185.001513	67	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93315	10.1371/journal.pone.0093315	http://dx.doi.org/10.1371/journal.pone.0093315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675763	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677500109
J	Schmitt, C; Kail, D; Mariano, M; Empting, M; Weber, N; Paul, T; Hartmann, RW; Engel, M				Schmitt, Christian; Kail, Dagmar; Mariano, Marica; Empting, Martin; Weber, Nadja; Paul, Tamara; Hartmann, Rolf W.; Engel, Matthias			Design and Synthesis of a Library of Lead-Like 2,4-Bisheterocyclic Substituted Thiophenes as Selective Dyrk/Clk Inhibitors	PLOS ONE			English	Article							PROTEIN-KINASE INHIBITORS; SKELETAL-MUSCLE DIFFERENTIATION; GLYCOGEN-SYNTHASE KINASE; PANCREATIC-CANCER CELLS; CROSS-COUPLING REACTION; DUAL-SPECIFICITY; DOWN-SYNDROME; IN-VITRO; NEUROFIBRILLARY DEGENERATION; TYROSINE PHOSPHORYLATION	The Dyrk family of protein kinases is implicated in the pathogenesis of several diseases, including cancer and neurodegeneration. Pharmacological inhibitors were mainly described for Dyrk1A so far, but in fewer cases for Dyrk1B, Dyrk2 or other isoforms. Herein, we report the development and optimization of 2,4-bisheterocyclic substituted thiophenes as a novel class of Dyrk inhibitors. The optimized hit compounds displayed favorable pharmacokinetic properties and high ligand efficiencies, and inhibited Dyrk1B in intact cells. In a larger selectivity screen, only Clk1 and Clk4 were identified as additional targets of compound 48, but no other kinases frequently reported as off-targets. Interestingly, Dyrk1A is implicated in the regulation of alternative splicing, a function shared with Clk1/Clk4; thus, some of the dual inhibitors might be useful as efficient splicing modulators. A further compound (29) inhibited Dyrk1A and 1B with an IC50 of 130 nM, showing a moderate selectivity over Dyrk2. Since penetration of the central nervous system (CNS) seems possible based on the physicochemical properties, this compound might serve as a lead for the development of potential therapeutic agents against glioblastoma. Furthermore, an inhibitor selective for Dyrk2 (24) was also identified, which might be are suitable as a pharmacological tool to dissect Dyrk2 isoform-mediated functions.	[Schmitt, Christian; Mariano, Marica; Weber, Nadja; Paul, Tamara; Hartmann, Rolf W.; Engel, Matthias] Univ Saarland, Dept Pharmaceut & Med Chem, D-66123 Saarbrucken, Germany; [Kail, Dagmar] PharmBioTec GmbH, Saarbrucken, Germany; [Empting, Martin; Hartmann, Rolf W.] Helmholtz Inst Pharmazeut Forsch Saarland, Dept Drug Design & Optimizat, Saarbrucken, Germany	Saarland University; Helmholtz Association; Helmholtz-Center for Infection Research	Engel, M (corresponding author), Univ Saarland, Dept Pharmaceut & Med Chem, D-66123 Saarbrucken, Germany.	ma.engel@mx.uni-saarland.de	Engel, Matthias/AAH-5823-2021	Engel, Matthias/0000-0001-5065-8634; Empting, Martin/0000-0002-0503-5830	Deutsche Forschungsgemeinschaft (DFG) [EN381/3-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank the Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de/) for financial support to M.E. (EN381/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akue-Gedu R, 2009, BIOORGAN MED CHEM, V17, P4420, DOI 10.1016/j.bmc.2009.05.017; Alvarez M, 2003, J CELL SCI, V116, P3099, DOI 10.1242/jcs.00618; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Anderson K, 2013, BIOORG MED CHEM LETT, V23, P6610, DOI 10.1016/j.bmcl.2013.10.055; Avrutina O, 2012, ORG BIOMOL CHEM, V10, P7753, DOI 10.1039/c2ob26162f; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bartholome A, 2010, ARCH BIOCHEM BIOPHYS, V501, P58, DOI 10.1016/j.abb.2010.05.024; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Becker W, 2012, CELL CYCLE, V11, P3389, DOI 10.4161/cc.21404; Besselievre F, 2008, J ORG CHEM, V73, P3278, DOI 10.1021/jo7027135; Bey E, 2008, J MED CHEM, V51, P6725, DOI 10.1021/jm8006917; BIRD CW, 1992, TETRAHEDRON, V48, P335, DOI 10.1016/S0040-4020(01)88145-X; Boeira JM, 2001, PHARMACOL TOXICOL, V89, P287, DOI 10.1034/j.1600-0773.2001.d01-162.x; Boeira JM, 2002, MUTAT RES-FUND MOL M, V500, P39, DOI 10.1016/S0027-5107(01)00294-9; Chang HS, 2007, INT J CANCER, V120, P2377, DOI 10.1002/ijc.22573; Cuny GD, 2010, BIOORG MED CHEM LETT, V20, P3491, DOI 10.1016/j.bmcl.2010.04.150; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; de Graaf Katrin, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-7; Debdab M, 2011, J MED CHEM, V54, P4172, DOI 10.1021/jm200274d; Debray J, 2012, MOL DIVERS, V16, P659, DOI 10.1007/s11030-012-9397-7; Deng XB, 2006, CANCER RES, V66, P4149, DOI 10.1158/0008-5472.CAN-05-3089; Deng XB, 2005, J BIOL CHEM, V280, P4894, DOI 10.1074/jbc.M411894200; Deng XB, 2004, J BIOL CHEM, V279, P22498, DOI 10.1074/jbc.M400479200; Deng XB, 2003, J BIOL CHEM, V278, P41347, DOI 10.1074/jbc.M306780200; Deng XB, 2009, CANCER RES, V69, P3317, DOI 10.1158/0008-5472.CAN-08-2903; DONDONI A, 1988, J ORG CHEM, V53, P1748, DOI 10.1021/jo00243a029; Du CP, 2011, CANCER LETT, V309, P54, DOI 10.1016/j.canlet.2011.05.016; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ertl P, 2000, J MED CHEM, V43, P3714, DOI 10.1021/jm000942e; Ewton DZ, 2011, MOL CANCER THER, V10, P2104, DOI 10.1158/1535-7163.MCT-11-0498; Fedorov O, 2011, CHEM BIOL, V18, P67, DOI 10.1016/j.chembiol.2010.11.009; Friedman E, 2007, J CELL BIOCHEM, V102, P274, DOI 10.1002/jcb.21451; Frohner W, 2011, J MED CHEM, V54, P6714, DOI 10.1021/jm2005892; Gao JC, 2012, INT J ONCOL, V40, P1203, DOI 10.3892/ijo.2011.1293; Geiger JN, 2001, BLOOD, V97, P901, DOI 10.1182/blood.V97.4.901; Giraud F, 2011, J MED CHEM, V54, P4474, DOI 10.1021/jm200464w; Grzmil M, 2011, CANCER RES, V71, P2392, DOI 10.1158/0008-5472.CAN-10-3112; Hartmann AM, 2001, MOL CELL NEUROSCI, V18, P80, DOI 10.1006/mcne.2001.1000; Hoppstadter J, 2012, EUR J IMMUNOL, V42, P1282, DOI 10.1002/eji.201142081; Hu J, 2011, INT J CANCER, V129, P307, DOI 10.1002/ijc.25692; Jimenez J, 2008, EXP TOXICOL PATHOL, V60, P381, DOI 10.1016/j.etp.2007.12.003; Jin K, 2007, CANCER RES, V67, P7247, DOI 10.1158/0008-5472.can-06-4099; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Jung HY, 2013, J BIOL CHEM, V288, P7252, DOI 10.1074/jbc.M112.416792; KATO R, 1965, J PHARMACOL EXP THER, V150, P279; Kim H, 1997, ARCH BIOCHEM BIOPHYS, V337, P137, DOI 10.1006/abbi.1996.9771; Kimura R, 2007, HUM MOL GENET, V16, P15, DOI 10.1093/hmg/ddl437; Koo KA, 2009, BIOORG MED CHEM LETT, V19, P2324, DOI 10.1016/j.bmcl.2009.02.062; Koon N, 2004, GUT, V53, P235, DOI 10.1136/gut.2003.021238; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Kurabayashi N, 2010, MOL CELL BIOL, V30, P1757, DOI 10.1128/MCB.01047-09; Laurence C, 2009, J MED CHEM, V52, P4073, DOI 10.1021/jm801331y; Liu F, 2008, FASEB J, V22, P3224, DOI 10.1096/fj.07-104539; Loidreau Y, 2012, EUR J MED CHEM, V58, P171, DOI 10.1016/j.ejmech.2012.10.006; Lord KA, 2000, BLOOD, V95, P2838, DOI 10.1182/blood.V95.9.2838.009k29_2838_2846; Mazmanian G, 2010, GENESIS, V48, P20, DOI 10.1002/dvg.20578; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Mercer SE, 2005, J BIOL CHEM, V280, P25788, DOI 10.1074/jbc.M413594200; Mercer SE, 2006, CELL BIOCHEM BIOPHYS, V45, P303, DOI 10.1385/CBB:45:3:303; Miller CT, 2003, CANCER RES, V63, P4136; Miralles A, 2005, EUR J PHARMACOL, V518, P234, DOI 10.1016/j.ejphar.2005.06.023; Miyata Y, 2011, BBA-MOL CELL RES, V1813, P1728, DOI 10.1016/j.bbamcr.2011.06.023; MIYAURA N, 1981, SYNTHETIC COMMUN, V11, P513, DOI 10.1080/00397918108063618; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mott BT, 2009, BIOORG MED CHEM LETT, V19, P6700, DOI 10.1016/j.bmcl.2009.09.121; Obach RS, 1999, DRUG METAB DISPOS, V27, P1350; Ogawa Y, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1090; Pagano MA, 2008, BIOCHEM J, V415, P353, DOI 10.1042/BJ20080309; Pin F, 2011, MEDCHEMCOMM, V2, P899, DOI 10.1039/c1md00141h; Pozo N, 2013, J CLIN INVEST, V123, P2475, DOI 10.1172/JCI63623; Primas N, 2009, TETRAHEDRON, V65, P5739, DOI 10.1016/j.tet.2009.05.013; Rosenthal AS, 2011, BIOORG MED CHEM LETT, V21, P3152, DOI 10.1016/j.bmcl.2011.02.114; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Shi JH, 2008, J BIOL CHEM, V283, P28660, DOI 10.1074/jbc.M802645200; Skurat AV, 2004, J BIOL CHEM, V279, P2490, DOI 10.1074/jbc.M301769200; Slepak TI, 2012, CYTOSKELETON, V69, P514, DOI 10.1002/cm.21021; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Steinhilb ML, 2007, MOL BIOL CELL, V18, P5060, DOI 10.1091/mbc.E07-04-0327; Tahtouh T, 2012, J MED CHEM, V55, P9312, DOI 10.1021/jm301034u; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Taira N, 2012, J CLIN INVEST, V122, P859, DOI 10.1172/JCI60818; Teague SJ, 1999, ANGEW CHEM INT EDIT, V38, P3743, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U; Urbich C, 2009, BLOOD, V113, P5669, DOI 10.1182/blood-2009-01-196485; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Wager TT, 2010, ACS CHEM NEUROSCI, V1, P420, DOI 10.1021/cn100007x; Wang D, 2012, BIOORG MED CHEM LETT, V22, P168, DOI 10.1016/j.bmcl.2011.11.043; Wang K, 2002, ONCOGENE, V21, P7598, DOI 10.1038/sj.onc.1205953; Wegiel J, 2008, ACTA NEUROPATHOL, V116, P391, DOI 10.1007/s00401-008-0419-6; Wegiel J, 2011, J NEUROPATH EXP NEUR, V70, P36, DOI 10.1097/NEN.0b013e318202bfa1; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Yabut O, 2010, J NEUROSCI, V30, P4004, DOI 10.1523/JNEUROSCI.4711-09.2010; Yamashita SI, 2009, ANTICANCER RES, V29, P2753; Yang C, 2010, CARCINOGENESIS, V31, P552, DOI 10.1093/carcin/bgp330; Yara S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063456; Yin XM, 2012, J BIOL CHEM, V287, P30497, DOI 10.1074/jbc.M112.355412; Zou YL, 2004, J BIOL CHEM, V279, P27790, DOI 10.1074/jbc.M403042200	100	34	35	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e87851	10.1371/journal.pone.0087851	http://dx.doi.org/10.1371/journal.pone.0087851			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676346	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500002
J	Lin, C; Kuo, FW; Chavanich, S; Viyakarn, V				Lin, Chiahsin; Kuo, Fu-Wen; Chavanich, Suchana; Viyakarn, Voranop			Membrane Lipid Phase Transition Behavior of Oocytes from Three Gorgonian Corals in Relation to Chilling Injury	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; BOVINE OOCYTES; THERMOTROPIC BEHAVIOR; SEASONAL-CHANGES; MOUSE OOCYTES; COLD SHOCK; SENSITIVITY; TEMPERATURE; PRESERVATION; CYTOSKELETAL	The lipid phase transition (LPT) from the fluid liquid crystalline phase to the more rigid gel structure phase that occurs upon exposure to low temperatures can affect physical structure and function of cellular membranes. This study set out to investigate the membrane phase behavior of oocytes of three gorgonian corals; Junceela fragilis, J. juncea and Ellisella robusta, at different developmental stages after exposure to reduced temperatures. Oocytes were chilled to 5 degrees C for 48, 96 or 144 h, and the LPT temperature (LPTT) was determined with Fourier Transform Infrared (FTIR) spectroscopy. The J. fragilis oocytes had a higher LPTT (similar to 23.0-23.7 degrees C) than those of J. juncea and E. robusta oocytes (approximately 18.3-20.3 degrees C). Upon chilling for 96 h at 5 degrees C, the LPTTs of J. juncea and E. robusta oocytes in the early (18.0 +/- 1.0 and 18.3 +/- 0.6 degrees C, respectively) and late (17.3 +/- 0.6 and 17.7 +/- 1.2 degrees C, respectively) stages were significantly lower than those of J. fragilis oocytes (20.3 +/- 2.1 and 19.3 +/- 1.5 degrees C for the early and late stages, respectively). The LPTTs of early stage gorgonian oocytes was significantly lower than those of late stage oocytes. These results suggest that the LPT of three gorgonian oocytes at different developmental stages may have been influenced by the phospholipid composition of their plasma membranes, which could have implications for their low temperature resistance.	[Lin, Chiahsin; Kuo, Fu-Wen] Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan; [Lin, Chiahsin] Natl Dong Hwa Univ, Inst Marine Biotechnol, Checheng, Pingtung, Taiwan; [Chavanich, Suchana; Viyakarn, Voranop] Chulalongkorn Univ, Fac Sci, Dept Marine Sci, Reef Biol Res Grp, Bangkok, Thailand	National Museum of Marine Biology & Aquarium; National Dong Hwa University; Chulalongkorn University	Lin, C (corresponding author), Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan.	chiahsin@nmmba.gov.tw	Viyakarn, Voranop/Q-9182-2019; Chavanich, Suchana/AAU-8266-2020		National Science Council [NSC 102-2313-B-291-002]	National Science Council(Ministry of Science and Technology, Taiwan)	This research was supported by funds from the National Science Council (NSC 102-2313-B-291-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTINI DF, 1995, DEV GENET, V16, P13, DOI 10.1002/dvg.1020160105; ALBERTINI DF, 1992, MUTAT RES, V296, P57, DOI 10.1016/0165-1110(92)90032-5; AMAN RR, 1994, BIOL REPROD, V50, P103, DOI 10.1095/biolreprod50.1.103; Arav A, 1996, CRYOBIOLOGY, V33, P589, DOI 10.1006/cryo.1996.0062; Arav A, 2000, CRYO-LETT, V21, P179; Coull GD, 1998, THERIOGENOLOGY, V49, P179, DOI 10.1016/S0093-691X(98)90532-5; CROWE JH, 1989, CRYOBIOLOGY, V26, P76, DOI 10.1016/0011-2240(89)90035-7; DROBNIS EZ, 1993, J EXP ZOOL, V265, P432, DOI 10.1002/jez.1402650413; Gerelchimeg B, 2009, CRYOBIOLOGY, V59, P54, DOI 10.1016/j.cryobiol.2009.04.005; Ghetler Y, 2005, HUM REPROD, V20, P3385, DOI 10.1093/humrep/dei236; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; HOMA ST, 1986, J REPROD FERTIL, V77, P425, DOI 10.1530/jrf.0.0770425; Imbs AB, 2007, LIPIDS, V42, P1035, DOI 10.1007/s11745-007-3109-6; Kim JY, 2001, REPRODUCTION, V122, P131, DOI 10.1530/rep.0.1220131; Lin C, 2012, THERIOGENOLOGY, V77, P1257, DOI 10.1016/j.theriogenology.2011.09.021; Lin C, 2011, CRYOLETTERS, V32, P141; Lin CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057823; Lin CH, 2013, CRYOBIOLOGY, V66, P3, DOI 10.1016/j.cryobiol.2012.05.005; Lin CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038689; Pang ZG, 2010, CHIN J OCEANOL LIMN, V28, P533, DOI 10.1007/s00343-010-9009-2; Pearl M, 2000, CRYO-LETT, V21, P171; Pielak RM, 2004, DEV BIOL, V269, P421, DOI 10.1016/j.ydbio.2004.01.033; Pielak RM, 2003, BIOL BULL-US, V205, P192, DOI 10.2307/1543247; QUINN PJ, 1985, CRYOBIOLOGY, V22, P128, DOI 10.1016/0011-2240(85)90167-1; Sanina NM, 2002, COMP BIOCHEM PHYS B, V133, P143; Sanina NM, 2001, COMP BIOCHEM PHYS B, V128, P295, DOI 10.1016/S1096-4959(00)00328-6; SATHANANTHAN AH, 1988, HUM REPROD, V3, P968, DOI 10.1093/oxfordjournals.humrep.a136827; SATHANANTHAN AH, 1992, J ASSIST REPROD GEN, V9, P139, DOI 10.1007/BF01203754; Songsasen N, 2002, FERTIL STERIL, V77, P818, DOI 10.1016/S0015-0282(01)03240-X; Thompson JG, 1996, THERIOGENOLOGY, V45, P27, DOI 10.1016/0093-691X(95)00352-9; Treignier C, 2008, LIMNOL OCEANOGR, V53, P2702, DOI 10.4319/lo.2008.53.6.2702; Tsai S, 2009, CRYOBIOLOGY, V58, P279, DOI 10.1016/j.cryobiol.2009.02.002; Ulrich K, 1994, COMP ANIMAL BIOCH; Watson P F, 1987, Symp Soc Exp Biol, V41, P311; WHITE IG, 1993, REPROD FERT DEVELOP, V5, P639, DOI 10.1071/RD9930639; Wu B, 1999, MOL REPROD DEV, V54, P388, DOI 10.1002/(SICI)1098-2795(199912)54:4&lt;388::AID-MRD9&gt;3.0.CO;2-7; Zenes MT, 2001, FERTIL STERIL, V75, P769; Zeron Y, 2002, CRYOBIOLOGY, V45, P143, DOI 10.1016/S0011-2240(02)00123-2; Zeron Y, 2002, MOL REPROD DEV, V61, P271, DOI 10.1002/mrd.1156; Zeron Y, 2001, REPRODUCTION, V121, P447, DOI 10.1530/rep.0.1210447	40	14	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92812	10.1371/journal.pone.0092812	http://dx.doi.org/10.1371/journal.pone.0092812			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671092	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000079
J	Pilkington, R; Taylor, AW; Hugo, G; Wittert, G				Pilkington, Rhiannon; Taylor, Anne W.; Hugo, Graeme; Wittert, Gary			Are Baby Boomers Healthier than Generation X? A Profile of Australia's Working Generations Using National Health Survey Data	PLOS ONE			English	Article							UNITED-STATES; OBESITY; PREVALENCE; OVERWEIGHT; FUTURE; ADULTS; COSTS	Background: To determine differences in sociodemographic and health related characteristics of Australian Baby Boomers and Generation X at the same relative age. Methods: The 1989/90 National Health Survey (NHS) for Boomers (1946-1965) and the 2007/08 NHS for Generation Xers (1966-1980) was used to compare the cohorts at the same age of 25-44 years. Generational differences for males and females in education, employment, smoking, physical activity, Body Mass Index (BMI), self-rated health, and diabetes were determined using Z tests. Prevalence estimates and p-values are reported. Logistic regression models examining overweight/obesity (BMI >= 25) and diabetes prevalence as the dependent variables, with generation as the independent variable were adjusted for sex, age, education, physical activity, smoking and BMI(diabetes model only). Adjusted odds ratios (OR) and 95% confidence intervals are reported. Results: At the same age, tertiary educational attainment was higher among Generation X males (27.6% vs. 15.2% p<0.001) and females (30.0% vs. 10.6% p<0.001). Boomer females had a higher rate of unemployment (5.6% vs. 2.5% p<0.001). Boomer males and females had a higher prevalence of "excellent'' self-reported health (35.9% vs. 21.8% p<0.001; 36.3% vs. 25.1% p<0.001) and smoking (36.3% vs. 30.4% p<0.001; 28.3% vs. 22.3% p<0.001). Generation X males (18.3% vs. 9.4% p<0.001) and females (12.7% vs. 10.4% p = 0.015) demonstrated a higher prevalence of obesity (BMI>30). There were no differences in physical activity. Modelling indicated that Generation X were more likely than Boomers to be overweight/obese (OR: 2.09, 1.77-2.46) and have diabetes (OR: 1.79, 1.47-2.18). Conclusion: Self-rated health has deteriorated while obesity and diabetes prevalence has increased. This may impact workforce participation and health care utilization in the future.	[Pilkington, Rhiannon; Taylor, Anne W.; Wittert, Gary] Univ Adelaide, Discipline Med, Adelaide, SA, Australia; [Hugo, Graeme] Univ Adelaide, Australian Populat & Migrat Res Ctr, Adelaide, SA, Australia; [Wittert, Gary] Univ Adelaide, Freemasons Fdn Ctr Mens Hlth, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; University of Adelaide	Pilkington, R (corresponding author), Univ Adelaide, Discipline Med, Adelaide, SA, Australia.	rhiannon.pilkington@adelaide.edu.au	Taylor, Anne w/F-5708-2010; wittert, gary/AAE-2398-2019	Taylor, Anne w/0000-0002-4422-7974; Wittert, Gary/0000-0001-6818-6065; Pilkington, Rhiannon/0000-0001-6974-8496	Australian Research Council [LP0990065]	Australian Research Council(Australian Research Council)	This work was supported by an Australian Research Council Linkage project grant (LP0990065, http://www.arc.gov.au/). The funders had no role in the study design, data analysis, decision to publish or preparation of the manuscript.	Aitken RJ, 2009, ASIA PAC J CLIN NUTR, V18, P63; Allman-Farinelli MA, 2008, EUR J CLIN NUTR, V62, P898, DOI 10.1038/sj.ejcn.1602769; [Anonymous], 2005, PRODUCTIVITY COMMISS; Australian Bureau of Statistics, 2006, 2006 CENS POP HOUS L; Australian Bureau of Statistics, 2003, S AUSTR BAB BOOM PRO; Australian Bureau of Statistics, 1991, 1989 90 HLTH SURV US; Australian Bureau of Statistics, 2011, DIAB AUST SNAPSH 200; Australian Bureau of Statistics, 2012, POP AG AUSTR; Australian Bureau of Statistics, 2007, NAT HLTH SURV US GUI; Australian Institute of Health and Welfare, 2012, AUSTR HLTH 2012; Australian Institute of Health and Welfare, 2010, AUSTR HLTH 2010; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Buckley J, 2008, OBES RES CLIN PRACT, V2, P73, DOI 10.1016/j.orcp.2008.04.002; Commonwealth of Australia, 2010, AUSTR 2050 FUT CHALL; Dal Grande E, 2005, AUST NZ J PUBL HEAL, V29, P343, DOI 10.1111/j.1467-842X.2005.tb00205.x; Daley J., 2012, GAME CHANGERS EC REF; Donath SM, 2005, AUST NZ J PUBL HEAL, V29, P565, DOI 10.1111/j.1467-842X.2005.tb00252.x; French SA, 2001, ANNU REV PUBL HEALTH, V22, P309, DOI 10.1146/annurev.publhealth.22.1.309; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Hugo G, 2008, OBES RES CLIN PRACT, V2, P203, DOI 10.1016/j.orcp.2008.05.001; Humpel N, 2010, AUSTRALAS J AGEING, V29, P8, DOI 10.1111/j.1741-6612.2010.00412.x; Institute for digital research and education UCLA, 2013, STAT LIB REPL WEIGHT; Keith SW, 2006, INT J OBESITY, V30, P1585, DOI 10.1038/sj.ijo.0803326; King DE, 2013, JAMA INTERN MED, V173, P385, DOI 10.1001/jamainternmed.2013.2006; Kreuter F, 2007, STATA J, V7, P1; Lee JM, 2010, INT J OBESITY, V34, P614, DOI 10.1038/ijo.2009.235; Leveille SG, 2005, AM J PUBLIC HEALTH, V95, P1607, DOI 10.2105/AJPH.2004.060418; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; McKee-Ryan FM, 2005, J APPL PSYCHOL, V90, P53, DOI 10.1037/0021-9010.90.1.53; National Research Council Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, V8th, P1, DOI DOI 10.17226/12910; Okosun IS, 2001, PREV MED, V32, P429, DOI 10.1006/pmed.2001.0840; Peters J C, 2002, Obes Rev, V3, P69, DOI 10.1046/j.1467-789X.2002.00059.x; Pierce MB, 2009, DIABETIC MED, V26, P679, DOI 10.1111/j.1464-5491.2009.02755.x; Prosper MH, 2009, AM J HEALTH BEHAV, V33, P319; Quetelet A, 1986, TREATISE; Rice NE, 2010, REJUV RES, V13, P105, DOI 10.1089/rej.2009.0896; Robinson WR, 2013, INT J OBESITY, V37, P1129, DOI 10.1038/ijo.2012.198; Robinson WR, 2012, INT J OBESITY; Stewart S, 2008, AUSTR FUT FAT BOMB R, P1; Svedberg P, 2006, EUR J EPIDEMIOL, V21, P767, DOI 10.1007/s10654-006-9064-3; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Taylor AW, 2006, AUST NZ J PUBL HEAL, V30, P238, DOI 10.1111/j.1467-842X.2006.tb00864.x; United Nations, 2011, A6683A6683 UN; Walls HL, 2011, OBESITY; Zhang YD, 2009, POPUL HEALTH MANAG, V12, P95, DOI 10.1089/pop.2009.12202	45	13	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93087	10.1371/journal.pone.0093087	http://dx.doi.org/10.1371/journal.pone.0093087			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671114	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677000111
J	da Silva, VC; Fernandes, L; Haseyama, EJ; Agamme, ALDA; Shinohara, EMG; Muniz, MTC; D'Almeida, V				da Silva, Vanessa Cavalcante; Fernandes, Leandro; Haseyama, Eduardo Jun; Dias Abdo Agamme, Ana Luiza; Guerra Shinohara, Elvira Maria; Cartaxo Muniz, Maria Tereza; D'Almeida, Vania			Effect of Vitamin B Deprivation during Pregnancy and Lactation on Homocysteine Metabolism and Related Metabolites in Brain and Plasma of Mice Offspring	PLOS ONE			English	Article							SEX-DIFFERENCES; FOLIC-ACID; S-ADENOSYLHOMOCYSTEINE; GLUTATHIONE SYNTHESIS; FOLATE-DEFICIENCY; DNA METHYLATION; RISK FACTOR; HYPERHOMOCYSTEINEMIA; SERUM; RATS	Epidemiological and experimental studies indicate that the altered fetal and neonatal environment influences physiological functions and may increase the risk of developing chronic diseases in adulthood. Because homocysteine (Hcy) metabolic imbalance is considered a risk factor for neurodegenerative diseases, we investigated whether maternal Vitamin B deficiency during early development alters the offspring's methionine-homocysteine metabolism in their brain. To this end, the dams were submitted to experimental diet one month before and during pregnancy or pregnancy/lactation. After birth, the offspring were organized into the following groups: control (CT), deficient diet during pregnancy and lactation (DPL) and deficient diet during pregnancy (DP). The mice were euthanized at various stages of development. Hcy, cysteine, glutathione (GSH), S-adenosylmethionine (SAM), S-adenosylhomocysteine (SAH), folate and cobalamin concentrations were measured in the plasma and/or brain. At postnatal day (PND) 0, total brain of female and male offspring exhibited decreased SAM/SAH ratios. Moreover, at PND 28, we observed decreased GSH/GSSG ratios in both females and males in the DPL group. Exposure to a Vitamin B-deficient diet during the ontogenic plasticity period had a negative impact on plasma folate and brain cortex SAM concentrations in aged DPL males. We also observed decreased plasma GSH concentrations in both DP and DPL males (PND 210). Additionally, this manipulation seemed to affect the female and male offspring differently. The decreased plasma GSH concentration may reflect redox changes in tissues and the decreased brain cortex SAM may be involved in changes of gene expression, which could contribute to neurodegenerative diseases over the long term.	[da Silva, Vanessa Cavalcante; D'Almeida, Vania] Univ Fed Sao Paulo, Dept Pediat, Sao Paulo, Brazil; [da Silva, Vanessa Cavalcante; Fernandes, Leandro; Haseyama, Eduardo Jun; Dias Abdo Agamme, Ana Luiza; D'Almeida, Vania] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil; [Guerra Shinohara, Elvira Maria] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil; [Cartaxo Muniz, Maria Tereza] Univ Pernambuco, Pediat Hematol & Oncol Ctr, Inst Biol Sci, Recife, PE, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Pernambuco (UPE)	D'Almeida, V (corresponding author), Univ Fed Sao Paulo, Dept Pediat, Sao Paulo, Brazil.	vaniadalmeida@uol.com.br	D'Almeida, Vânia/AAV-3955-2020; Guerra-Shinohara, Elvira M/E-5610-2012; Silva, Vanessa C/A-8441-2015; D'Almeida, Vania/AAB-7115-2020	D'Almeida, Vânia/0000-0003-0947-5312; Guerra-Shinohara, Elvira M/0000-0001-6681-2210; cartaxo muniz, maria tereza/0000-0001-9498-5223	FAPESP [2010/00075-2]; CAPES; CNPq; AFIP	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); AFIP	This work was supported by FAPESP (Process # 2010/00075-2 and scholarship to EJH), CAPES (scholarship to VCS and LF), CNPq (fellowship to VDA) and AFIP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman G, 2001, REV INVEST CLIN, V53, P141; Amouzou EK, 2004, AM J CLIN NUTR, V79, P619; Barbosa PR, 2008, CLIN CHIM ACTA, V388, P139, DOI 10.1016/j.cca.2007.10.023; BARKER DJP, 1986, LANCET, V1, P1077; Blaise S, 2005, PEDIATR RES, V57, P777, DOI 10.1203/01.PDR.0000161406.19231.98; Blaise SA, 2007, AM J PATHOL, V170, P667, DOI 10.2353/ajpath.2007.060339; Bolton JL, 2012, FASEB J, V26, P4743, DOI 10.1096/fj.12-210989; Botto LD, 2005, BMJ-BRIT MED J, V330, P571, DOI 10.1136/bmj.38336.664352.82; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; CUNNINGHAM FG, 1993, WILLIAMS OBSTET, P209; da Silva VC, 2006, ARQ NEURO-PSIQUIAT, V64, P941, DOI 10.1590/S0004-282X2006000600010; DORNER G, 1988, EXP CLIN ENDOCRINOL, V91, P247; DURNIN JVGA, 1976, P NUTR SOC, V35, P145, DOI 10.1079/PNS19760026; Fahrenkrog S, 2004, J NUTR, V134, P648, DOI 10.1093/jn/134.3.648; Galdieri LC, 2007, ARCH MED RES, V38, P212, DOI 10.1016/j.arcmed.2006.09.012; Garcia MM, 2011, J PATHOL, V225, P324, DOI 10.1002/path.2881; GoddijnWessel TAW, 1996, EUR J OBSTET GYN R B, V66, P23, DOI 10.1016/0301-2115(96)02383-4; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; Guerra-Shinohara EM, 2004, AM J CLIN NUTR, V80, P1312, DOI 10.1093/ajcn/80.5.1312; Guerra-Shinohara EM, 2002, BJOG-INT J OBSTET GY, V109, P784, DOI 10.1111/j.1471-0528.2002.01307.x; Halicioglu O, 2011, INT J VITAM NUTR RES, V81, P328, DOI 10.1024/0300-9831/a000080; HIRAYAMA K, 1987, BIOCHEM PHARMACOL, V36, P1919; HOYENGA KB, 1982, PHYSIOL BEHAV, V28, P545, DOI 10.1016/0031-9384(82)90153-6; JATHAR VS, 1970, ARCH DIS CHILD, V45, P236, DOI 10.1136/adc.45.240.236; Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Kim JM, 2009, J NUTR BIOCHEM, V20, P172, DOI 10.1016/j.jnutbio.2008.01.010; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Kulkarni A, 2011, DNA CELL BIOL, V30, P79, DOI 10.1089/dna.2010.1084; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Maler JM, 2003, NEUROSCI LETT, V347, P85, DOI 10.1016/S0304-3940(03)00655-4; McCaddon A, 1998, INT J GERIATR PSYCH, V13, P235, DOI 10.1002/(SICI)1099-1166(199804)13:4<235::AID-GPS761>3.0.CO;2-8; Mislanova C, 2011, REPRODUCTION, V142, P467, DOI 10.1530/REP-10-0484; Nelen WLDM, 2000, FERTIL STERIL, V74, P1196, DOI 10.1016/S0015-0282(00)01595-8; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Pfeiffer CM, 1999, CLIN CHEM, V45, P290; Pliushch G, 2010, AM J PATHOL, V176, P1084, DOI 10.2353/ajpath.2010.090764; RALLS K, 1976, Q REV BIOL, V51, P245, DOI 10.1086/409310; REED DJ, 1986, BIOCHEM PHARMACOL, V35, P7, DOI 10.1016/0006-2952(86)90545-9; Reis EA, 2002, METAB BRAIN DIS, V17, P211, DOI 10.1023/A:1019982223034; Roy S, 2013, BRAIN DEV; Sandovici I, 2011, P NATL ACAD SCI USA, V108, P5449, DOI 10.1073/pnas.1019007108; Stead LM, 2006, AM J CLIN NUTR, V83, P5; Steenweg-de Graaff J, 2012, AM J CLIN NUTR, V95, P1413, DOI 10.3945/ajcn.111.030791; Vitvitsky V, 2003, REDOX REP, V8, P57, DOI 10.1179/135100003125001260; Vitvitsky V, 2007, AM J PHYSIOL-RENAL, V293, pF594, DOI 10.1152/ajprenal.00171.2007; Vollset SE, 2000, AM J CLIN NUTR, V71, P962; Wilcken B, 2003, J MED GENET, V40, P619, DOI 10.1136/jmg.40.8.619; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200	50	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92683	10.1371/journal.pone.0092683	http://dx.doi.org/10.1371/journal.pone.0092683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695104	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000024
J	Lu, DF; Yao, Y; Su, ZZ; Zeng, ZH; Xing, XW; He, ZY; Zhang, CX				Lu, Dong-feng; Yao, Yan; Su, Zi-zhuo; Zeng, Zhao-hua; Xing, Xiao-wen; He, Zhi-yu; Zhang, Chunxiang			Downregulation of HDAC1 Is Involved in the Cardiomyocyte Differentiation from Mesenchymal Stem Cells in a Myocardial Microenvironment	PLOS ONE			English	Article								Under myocardial microenvironment, bone marrow-derived mesenchymal stem cells (MSCs) can transdifferentiate into cardiomyocytes (CMs). However, the role of histone deacetylase 1 (HDAC1) in this directed differentiation process remains unclear. The current study is to determine the acetylation regulatory mechanisms that may be involved in the directed CM differentiation from MSCs. MSCs isolated from male Sprague-Dawley (SD) rats were marked with Ad-EGFP and co-cultured with CMs. Flow cytometry was used to sort EGFP-positive (EGFP+) MSCs from the co-culture system. Then, the expression of cardiac troponin T (cTnT) in these MSCs was detected by immunofluorescence assay. In addition, HDAC1 levels at different co-culture times were measured by quantitative real-time polymerase chain reaction (QT-PCR) and Western blotting. At 4 days after co-culture with CMs, the MSCs began to expression detectable levels of cTnT. The expression of HDAC1 in CMs was much lower than that in MSCs. After co-culture with CMs, the expression of HDAC1 in MSCs was significantly decreased in a time dependent manner. In addition, our recent study has also identified that knockdown of the HDAC1 could promote the directed differentiation of MSCs into CMs. The results suggest that HDAC1 has a negative correlation with cardiac cell differentiation from MSCs under a myocardial microenvironment. HDAC1 might play an important role in the directed differentiation of MSCs into CMs in heart.	[Lu, Dong-feng; Yao, Yan; Su, Zi-zhuo; Zeng, Zhao-hua; Xing, Xiao-wen; He, Zhi-yu] Guangzhou Med Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Lu, Dong-feng; Yao, Yan; Su, Zi-zhuo; Zeng, Zhao-hua; Xing, Xiao-wen; He, Zhi-yu] Guangzhou Med Univ, Affiliated Hosp 1, Sino US Cardiovas Res Ctr, Guangzhou, Guangdong, Peoples R China; [Zhang, Chunxiang] Rush Univ, Rush Med Coll, Dept Pharmacol, Chicago, IL 60612 USA; [Zhang, Chunxiang] Rush Univ, Rush Med Coll, Cardiovasc Res Ctr, Chicago, IL 60612 USA	Guangzhou Medical University; Guangzhou Medical University; Rush University; Rush University	Lu, DF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Guangdong, Peoples R China.	497440817@qq.com; chunxiang_zhang@rush.edu	zhang, xiang chun/HCH-7063-2022	zhang, xiang chun/0000-0001-8303-6495	Scientific Foundation of Guangdong, China [2009B030801358, 10151009504000008, 2012A030400028, 7003080]	Scientific Foundation of Guangdong, China	This research was supported by the Scientific Foundation of Guangdong, China (No. 2009B030801358; No. 10151009504000008; No. 2012A030400028; No. 7003080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng YH, 2010, CARDIOVASC RES, V87, P431, DOI 10.1093/cvr/cvq082; Cheng YH, 2010, CLIN SCI, V119, P87, DOI 10.1042/CS20090645; Collas P, 2009, BBA-GEN SUBJECTS, V1790, P900, DOI 10.1016/j.bbagen.2008.10.006; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Feng C, 2009, EXP CELL RES, V315, P3044, DOI 10.1016/j.yexcr.2009.05.005; Haberland M, 2010, J BIOL CHEM, V285, P14663, DOI 10.1074/jbc.M109.081679; Huang XP, 2010, CIRCULATION, V122, P2419, DOI 10.1161/CIRCULATIONAHA.110.955971; Leu YW, 2013, ADV EXP MED BIOL, V754, P195, DOI 10.1007/978-1-4419-9967-2_10; Li HW, 2006, BIOCHEM BIOPH RES CO, V341, P320, DOI 10.1016/j.bbrc.2005.12.182; Liu ZQ, 2009, BBA-MOL CELL RES, V1793, P300, DOI 10.1016/j.bbamcr.2008.08.013; Mahapatra Saswati, 2010, Ethn Dis, V20, pS1; Muscari C, 2008, J CELL BIOCHEM, V103, P1046, DOI 10.1002/jcb.21683; Snykers S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-24; Wang JP, 2011, DIFFERENTIATION, V81, P119, DOI 10.1016/j.diff.2010.10.003; Xu MF, 2004, CIRCULATION, V110, P2658, DOI 10.1161/01.CIR.0000145609.20435.36; Xu S, 2013, ACTA PHARMACOL SIN, V34, P699, DOI 10.1038/aps.2012.182; Zhu Jing, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P43	17	15	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93222	10.1371/journal.pone.0093222	http://dx.doi.org/10.1371/journal.pone.0093222			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690943	gold, Green Published, Green Submitted			2022-12-27	WOS:000334101100054
J	Miao, YL; Ma, HS; Guo, WZ; Wu, JG; Liu, Y; Shi, WZ; Wang, XP; Mi, WD; Fang, WW				Miao, Yu-Liang; Ma, Hua-Song; Guo, Wen-Zhi; Wu, Ji-Gong; Liu, Yan; Shi, Wen-Zhu; Wang, Xiao-Ping; Mi, Wei-Dong; Fang, Wei-Wu			The Efficacy and Cost-Effectiveness of Cell Saver Use in Instrumented Posterior Correction and Fusion Surgery for Scoliosis in School-Aged Children and Adolescents	PLOS ONE			English	Article							ADULT LUMBAR FUSION; BLOOD-TRANSFUSIONS; SPINE SURGERY; AUTOTRANSFUSION	Posterior spinal instrumentation and fusion surgery in school- aged children and adolescents is associated with the potential for massive intraoperative blood loss, which requires significant allogeneic blood transfusion. Until now, the intraoperative use of the cell saver has been extensively adopted; however, its efficacy and cost- effectiveness have not been well established. Therefore, the aim of this study is to determine the efficacy and cost- effectiveness of intraoperative cell saver use. This study was a single- center, retrospective study of 247 school- aged and adolescent patients who underwent posterior spinal instrumentation and fusion surgery between August 2007 and June 2013. A cell saver was used intraoperatively in 67 patients and was not used in 180 patients. Matched case- control pairs were selected using a propensity score to balance potential confounders in baseline characteristics. Allogeneic red blood cell ( RBC) and plasma transfusions as well as blood transfusion costs were analyzed. The propensity score matching produced 60 matched pairs. Compared to the control group, the cell saver group had significantly fewer intraoperative allogeneic RBC transfusions (P=0.012). However, when the combined postoperative and total perioperative periods were evaluated for the use of allogeneic RBC transfusion, no significant differences were observed between the two groups (P=0.813 and P= 0.101, respectively). With regard to the total cost of perioperative transfusion of all blood products (RBC and plasma), costs for the control group were slightly lower than those of the cell saver group, but this variance did not reach statistical significance (P=0.095). The use of the cell saver in posterior spinal instrumentation and fusion surgery in school-aged children and adolescents was able to decrease the amount of intraoperative allogeneic RBC transfusion but failed to decrease total perioperative allogeneic RBC transfusion. Moreover, the use of the cell saver was not cost- effective.	[Miao, Yu-Liang; Shi, Wen-Zhu; Mi, Wei-Dong] Chinese Peoples Liberat Army Gen Hosp, Anesthesia & Operat Ctr, Beijing, Peoples R China; [Miao, Yu-Liang; Liu, Yan; Fang, Wei-Wu] Chinese PLA, Hosp 360, Dept Anesthesiol, Beijing, Peoples R China; [Ma, Hua-Song; Wu, Ji-Gong; Wang, Xiao-Ping] Chinese PLA, Hosp 360, Dept Orthopaed & Spine Surg, Beijing, Peoples R China; [Guo, Wen-Zhi] Beijing Mil Gen Hosp, PLA, Dept Anesthesiol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Mi, WD (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Anesthesia & Operat Ctr, Beijing, Peoples R China.	elite2005gg@163.com; ranger1999@163.com						Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Bowen RE, 2010, SPINE, V35, P246, DOI 10.1097/BRS.0b013e3181bdf22a; Canan CE, 2013, SPINE, V38, P703, DOI 10.1097/BRS.0b013e3182767c8c; Carless PA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001888.pub4; Chanda A, 2002, J NEUROSURG, V96, P298, DOI 10.3171/spi.2002.96.3.0298; Elgafy H, 2010, SPINE, V35, pS47, DOI 10.1097/BRS.0b013e3181d833f6; Ersen Omer, 2012, Musculoskelet Surg, V96, P107, DOI 10.1007/s12306-012-0203-6; Gause PR, 2008, SPINE, V33, P571, DOI 10.1097/BRS.0b013e3181657cc1; Guo S. Y., 2009, PROPENSITY SCORE ANA; Hill GE, 2003, J TRAUMA, V54, P908, DOI 10.1097/01.TA.0000022460.21283.53; Joseph SA, 2008, SPINE, V33, P2310, DOI 10.1097/BRS.0b013e31818047f2; Lavoie J, 2011, PEDIATR ANESTH, V21, P14, DOI 10.1111/j.1460-9592.2010.03470.x; Owens RK, 2013, SPINE, V38, pE217, DOI 10.1097/BRS.0b013e31827f044e; Reitman CA, 2004, SPINE, V29, P1580, DOI 10.1097/01.BRS.0000131433.05946.4F; Savvidou C, 2009, TRANSFUSION MED, V19, P202, DOI 10.1111/j.1365-3148.2009.00929.x; Shander A, 2010, TRANSFUSION, V50, P753, DOI 10.1111/j.1537-2995.2009.02518.x; Thompson ME, 2013, SPINE, V18; Weiss JM, 2007, J CHILD ORTHOP, V1, P221, DOI 10.1007/s11832-007-0032-6; [杨宁 Yang Ning], 2013, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V17, P4161; Yu XR, 2013, SPINE, V38, P350, DOI 10.1097/BRS.0b013e31826c63cb	20	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92997	10.1371/journal.pone.0092997	http://dx.doi.org/10.1371/journal.pone.0092997			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691056	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100038
J	Wang, H; Guan, WJ; Yang, WZ; Wang, Q; Zhao, H; Yang, F; Lv, XW; Li, J				Wang, He; Guan, Wenjie; Yang, Wanzhi; Wang, Qi; Zhao, Han; Yang, Feng; Lv, Xiongwen; Li, Jun			Caffeine Inhibits the Activation of Hepatic Stellate Cells Induced by Acetaldehyde via Adenosine A2A Receptor Mediated by the cAMP/PKA/SRC/ERK1/2/P38 MAPK Signal Pathway	PLOS ONE			English	Article							ALCOHOLIC LIVER-DISEASE; PROTEIN-KINASE; COLLAGEN PRODUCTION; METABOLIC SYNDROME; EXPRESSION; PATHOGENESIS; CONSUMPTION; MECHANISMS; FIBROSIS; UPDATE	Hepatic stellate cell (HSC) activation is an essential event during alcoholic liver fibrosis. Evidence suggests that adenosine aggravates liver fibrosis via the adenosine A2A receptor (A2AR). Caffeine, which is being widely consumed during daily life, inhibits the action of adenosine. In this study, we attempted to validate the hypothesis that caffeine influences acetaldehyde-induced HSC activation by acting on A2AR. Acetaldehyde at 50, 100, 200, and 400 mu M significantly increased HSC-T6 cells proliferation, and cell proliferation reached a maximum at 48 h after exposure to 200 mu M acetaldehyde. Caffeine and the A2AR antagonist ZM241385 decreased the cell viability and inhibited the expression of procollagen type I and type III in acetaldehyde-induced HSC-T6 cells. In addition, the inhibitory effect of caffeine on the expression of procollagen type I was regulated by A2AR-mediated signal pathway involving cAMP, PKA, SRC, and ERK1/2. Interestingly, caffeine's inhibitory effect on the expression of procollagen type III may depend upon the A2AR-mediated P38 MAPK-dependent pathway. Conclusions: Caffeine significantly inhibited acetaldehyde-induced HSC-T6 cells activation by distinct A2AR mediated signal pathway via inhibition of cAMP-PKA-SRC-ERK1/2 for procollagen type I and via P38 MAPK for procollagen type III.	[Wang, He; Wang, Qi; Zhao, Han; Yang, Feng; Lv, Xiongwen; Li, Jun] Anhui Med Univ, Sch Pharm, Hefei, Anhui, Peoples R China; [Wang, He; Wang, Qi; Zhao, Han; Yang, Feng; Lv, Xiongwen; Li, Jun] Anhui Med Univ, Inst Liver Dis, Hefei, Anhui, Peoples R China; [Guan, Wenjie] PLA, Hosp 105, Hefei, Anhui, Peoples R China; [Yang, Wanzhi] First Hosp Anqing, Anqing, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Lv, XW (corresponding author), Anhui Med Univ, Sch Pharm, Hefei, Anhui, Peoples R China.	xiongwenlv@gmail.com	lv, xiongwen/ABE-6452-2021	lv, xiongwen/0000-0003-2354-0168	National Science Foundation of China [81270498]; Anhui Provincial Natural Science Foundation [11040606M194]; Anhui Provincial Key Projects of Scientific Research in Universities [KJ2012A148]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Anhui Provincial Key Projects of Scientific Research in Universities	This project was supported by the National Science Foundation of China (No.81270498), Anhui Provincial Natural Science Foundation (No. 11040606M194) and Anhui Provincial Key Projects of Scientific Research in Universities (No.KJ2012A148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala S, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/498232; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; CASINI A, 1991, HEPATOLOGY, V13, P758, DOI 10.1016/0270-9139(91)92576-T; Chan ESL, 2006, BRIT J PHARMACOL, V148, P1144, DOI 10.1038/sj.bjp.0706812; Chan ESL, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4229; Che J, 2007, MOL PHARMACOL, V72, P1626, DOI 10.1124/mol.107.038760; Chen A, 2002, BIOCHEM J, V368, P683, DOI 10.1042/BJ20020949; Chiang DJ, 2014, CLIN LIVER DIS, V18, P157, DOI 10.1016/j.cld.2013.09.006; Chiang DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069114; Cohen DE, 2012, CURRENT DIAGNOSIS TR; Cronstein Bruce N, 2011, F1000 Biol Rep, V3, P21, DOI 10.3410/B3-21; Daly J, 1993, CAFFEINE COFFEE HLTH, P97; Duddempudi AT, 2012, CLIN LIVER DIS, V16, P687, DOI 10.1016/j.cld.2012.08.003; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Gessi S, 2011, ADV PHARMACOL, V61, P41, DOI 10.1016/B978-0-12-385526-8.00002-3; Ha MH, 2008, HEPATO-GASTROENTEROL, V55, P1059; Hashmi AZ, 2007, AM J PHYSIOL-GASTR L, V292, pG395, DOI 10.1152/ajpgi.00208.2006; Klinger M, 2002, CELL SIGNAL, V14, P99, DOI 10.1016/S0898-6568(01)00235-2; Li YM, 2011, J DIGEST DIS, V12, P45, DOI 10.1111/j.1751-2980.2010.00477.x; Lin JG, 2011, MOL CELL ENDOCRINOL, V333, P160, DOI 10.1016/j.mce.2010.12.028; Liu YD, 2011, ALCOHOL CLIN EXP RES, V35, P921, DOI 10.1111/j.1530-0277.2010.01422.x; Lv XW, 2010, INFLAMM RES, V59, P635, DOI 10.1007/s00011-010-0176-6; Mandel HG, 2002, FOOD CHEM TOXICOL, V40, P1231, DOI 10.1016/S0278-6915(02)00093-5; Mello T, 2008, MOL ASPECTS MED, V29, P17, DOI 10.1016/j.mam.2007.10.001; Miranda-Mendez A, 2010, INT J ENV RES PUB HE, V7, P1872, DOI 10.3390/ijerph7051872; Modi AA, 2010, HEPATOLOGY, V51, P201, DOI 10.1002/hep.23279; Molloy JW, 2012, HEPATOLOGY, V55, P429, DOI 10.1002/hep.24731; Nakata H, 2007, BIOCHEM BIOPH RES CO, V355, P842, DOI 10.1016/j.bbrc.2007.02.045; Nieto N, 2012, LIVER INT, V32, P189, DOI 10.1111/j.1478-3231.2011.02573.x; Orman ES, 2013, J GASTROEN HEPATOL, V28, P77, DOI 10.1111/jgh.12030; Panchal SK, 2012, NUTRITION, V28, P1055, DOI 10.1016/j.nut.2012.02.013; Peng Z, 2008, FASEB J, V22, P2263, DOI 10.1096/fj.07-100685; Peng Z, 2009, J CLIN INVEST, V119, P582, DOI 10.1172/JCI37409; Perez-Aso M, 2014, FASEB J, V28, P802, DOI 10.1096/fj.13-241646; Purohit V, 2006, HEPATOLOGY, V43, P872, DOI 10.1002/hep.21107; Ramaiah SK, 2004, INT J TOXICOL, V23, P217, DOI 10.1080/10915810490502069; Saab S, 2014, LIVER INT, V34, P495, DOI 10.1111/liv.12304; SAWYNOK J, 1993, PHARMACOL REV, V45, P43; Schulte G, 2000, MOL PHARMACOL, V58, P477, DOI 10.1124/mol.58.3.477; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Siegmund SV, 2005, DIGEST DIS, V23, P264, DOI 10.1159/000090174; Silva E, 2010, TOXICOL APPL PHARM, V245, P159, DOI 10.1016/j.taap.2010.02.015; Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667; Sohail MA, 2009, HEPATOLOGY, V49, P185, DOI 10.1002/hep.22589; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Sun CX, 2005, J CLIN INVEST, V115, P35, DOI 10.1172/JCI200522656; Svegliati-Baroni G, 2005, HEPATOLOGY, V42, P343, DOI 10.1002/hep.20798; Svegliati-Baroni G, 2001, HEPATOLOGY, V33, P1130, DOI 10.1053/jhep.2001.23788; Wallacides A, 2012, MOL CELL ENDOCRINOL, V350, P61, DOI 10.1016/j.mce.2011.11.021; Wang JH, 2006, WORLD J GASTROENTERO, V12, P6926, DOI 10.3748/wjg.v12.i43.6926; Yan KF, 2012, MOL MED, V18, P10, DOI 10.2119/molmed.2011.00243; Zhang X, 2014, ARCH ENVIRON CON TOX, V67, P97, DOI 10.1007/s00244-013-9976-3	53	42	47	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92482	10.1371/journal.pone.0092482	http://dx.doi.org/10.1371/journal.pone.0092482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682220	Green Published, Green Submitted, gold			2022-12-27	WOS:000333678100009
J	Kianoush, N; Adler, CJ; Nguyen, KAT; Browne, GV; Simonian, M; Hunter, N				Kianoush, Nima; Adler, Christina J.; Nguyen, Ky-Anh T.; Browne, Gina V.; Simonian, Mary; Hunter, Neil			Bacterial Profile of Dentine Caries and the Impact of pH on Bacterial Population Diversity	PLOS ONE			English	Article							REAL-TIME PCR; STREPTOCOCCUS-MUTANS; MOLECULAR ANALYSIS; PORPHYROMONAS-GINGIVALIS; PYROSEQUENCING ANALYSIS; MICROBIAL DIVERSITY; ORAL MICROFLORA; CARIOUS DENTIN; ACID TOLERANCE; IN-VITRO	Dental caries is caused by the release of organic acids from fermentative bacteria, which results in the dissolution of hydroxyapatite matrices of enamel and dentine. While low environmental pH is proposed to cause a shift in the consortium of oral bacteria, favouring the development of caries, the impact of this variable has been overlooked in microbial population studies. This study aimed to detail the zonal composition of the microbiota associated with carious dentine lesions with reference to pH. We used 454 sequencing of the 16S rRNA gene (V3-V4 region) to compare microbial communities in layers ranging in pH from 4.5-7.8 from 25 teeth with advanced dentine caries. Pyrosequencing of the amplicons yielded 449,762 sequences. Nine phyla, 97 genera and 409 species were identified from the quality-filtered, de-noised and chimera-free sequences. Among the microbiota associated with dentinal caries, the most abundant taxa included Lactobacillus sp., Prevotella sp., Atopobium sp., Olsenella sp. and Actinomyces sp. We found a disparity between microbial communities localised at acidic versus neutral pH strata. Acidic conditions were associated with low diversity microbial populations, with Lactobacillus species including L. fermentum, L. rhamnosus and L. crispatus, being prominent. In comparison, the distinctive species of a more diverse flora associated with neutral pH regions of carious lesions included Alloprevotella tanerrae, Leptothrix sp., Sphingomonas sp. and Streptococcus anginosus. While certain bacteria were affected by the pH gradient, we also found that similar to 60% of the taxa associated with caries were present across the investigated pH range, representing a substantial core. We demonstrated that some bacterial species implicated in caries progression show selective clustering with respect to pH gradient, providing a basis for specific therapeutic strategies.	[Kianoush, Nima; Adler, Christina J.; Nguyen, Ky-Anh T.; Browne, Gina V.; Simonian, Mary; Hunter, Neil] Westmead Ctr Oral Hlth, Inst Dent Res, Sydney, NSW, Australia; [Kianoush, Nima; Adler, Christina J.; Nguyen, Ky-Anh T.; Browne, Gina V.; Simonian, Mary; Hunter, Neil] Westmead Millennium Inst, Sydney, NSW, Australia; [Kianoush, Nima; Adler, Christina J.; Nguyen, Ky-Anh T.; Hunter, Neil] Univ Sydney, Fac Dent, Dept Oral Biol, Sydney, NSW 2006, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney	Kianoush, N (corresponding author), Westmead Ctr Oral Hlth, Inst Dent Res, Sydney, NSW, Australia.	nima.kianoush@sydney.edu.au	Nguyen, Ky-Anh/A-4971-2010	Nguyen, Ky-Anh/0000-0002-1643-6576; Adler, Christina/0000-0002-4731-5291	NIH/NIDCR [R01 DEO15272-07]; Australian National Health and Medical Research Council (NHMRC) [512524.3]; Australian Dental Research Foundation (ADRF) [92-2012]	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Dental Research Foundation (ADRF)	The authors acknowledge funding from NIH/NIDCR (Grant#R01 DEO15272-07), the Australian National Health and Medical Research Council (NHMRC) (Grant# 512524.3), and the Australian Dental Research Foundation (ADRF) (Grant# 92-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Ahn JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022788; Badet MC, 2001, J APPL MICROBIOL, V90, P1015, DOI 10.1046/j.1365-2672.2001.01340.x; Bagramian RA, 2009, AM J DENT, V22, P3; Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; Beighton D, 2005, COMMUNITY DENT ORAL, V33, P248, DOI 10.1111/j.1600-0528.2005.00232.x; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; BOYAR RM, 1989, J DENT RES, V68, P1734, DOI 10.1177/00220345890680120301; Bradshaw DJ, 1998, CARIES RES, V32, P456, DOI 10.1159/000016487; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chhour KL, 2005, J CLIN MICROBIOL, V43, P843, DOI 10.1128/JCM.43.2.843-849.2005; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Coenye T, 2007, ANTIMICROB AGENTS CH, V51, P1541, DOI 10.1128/AAC.00999-06; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Downes J, 2013, INT J SYST EVOL MICR, V63, P1214, DOI 10.1099/ijs.0.041376-0; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Gross EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047722; Gross EL, 2010, J CLIN MICROBIOL, V48, P4121, DOI 10.1128/JCM.01232-10; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; HOJO S, 1994, J DENT RES, V73, P1853, DOI 10.1177/00220345940730121001; HOJO S, 1991, J DENT RES, V70, P182, DOI 10.1177/00220345910700030501; Huang X, 2012, J DENT RES, V91, P1130, DOI 10.1177/0022034512461652; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Jiang W, 2013, CURR MICROBIOL, V67, P537, DOI 10.1007/s00284-013-0393-7; Karpievitch YV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007087; Kawasaki K, 1997, J DENT RES, V76, P588, DOI 10.1177/00220345970760011001; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; KLEIN JP, 1988, EUR J EPIDEMIOL, V4, P419; Kleinberg I, 2002, CRIT REV ORAL BIOL M, V13, P108, DOI 10.1177/154411130201300202; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; LOESCHE WJ, 1984, INFECT IMMUN, V46, P765, DOI 10.1128/IAI.46.3.765-772.1984; LOESCHE WJ, 1976, J DENT RES, V55, pA87, DOI 10.1177/002203457605500127011; MACPHERSON LMD, 1990, J DENT RES, V69, P1712, DOI 10.1177/00220345900690110201; Marsh P D, 1994, Adv Dent Res, V8, P263; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; Martin FE, 2002, J CLIN MICROBIOL, V40, P1698, DOI 10.1128/JCM.40.5.1698-1704.2002; McLean JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032219; Munson MA, 2004, J CLIN MICROBIOL, V42, P3023, DOI 10.1128/JCM.42.7.3023-3029.2004; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nascimento MM, 2004, CARIES RES, V38, P454, DOI 10.1159/000079627; Petersen PE, 2009, COMMUNITY DENT ORAL, V37, P1, DOI 10.1111/j.1600-0528.2008.00448.x; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; SANSONE C, 1993, J DENT RES, V72, P508, DOI 10.1177/00220345930720020701; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; TAKAHASHI N, 1990, J DENT RES, V69, P1266, DOI 10.1177/00220345900690060801; Takahashi N, 1999, ORAL MICROBIOL IMMUN, V14, P43, DOI 10.1034/j.1399-302X.1999.140105.x; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Takahashi N, 1997, ORAL MICROBIOL IMMUN, V12, P323, DOI 10.1111/j.1399-302X.1997.tb00733.x; TAUBMAN MA, 1974, INFECT IMMUN, V9, P1079, DOI 10.1128/IAI.9.6.1079-1091.1974; VANHOUTE J, 1994, J DENT RES, V73, P672, DOI 10.1177/00220345940730031301; VANHOUTE J, 1991, J DENT RES, V70, P1503, DOI 10.1177/00220345910700120601; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WHILEY RA, 1988, INT J SYST BACTERIOL, V38, P25, DOI 10.1099/00207713-38-1-25; WHO, 2012, FACT SHEET 318; Wolff D, 2013, CARIES RES, V47, P69, DOI 10.1159/000344022; Yang F, 2012, ISME J, V6, P1, DOI 10.1038/ismej.2011.71; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	71	85	90	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92940	10.1371/journal.pone.0092940	http://dx.doi.org/10.1371/journal.pone.0092940			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675997	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677500057
J	Kim, SH; Joung, JY; Chung, J; Park, WS; Lee, KH; Seo, HK				Kim, Sung Han; Joung, Jae Young; Chung, Jinsoo; Park, Weon Seo; Lee, Kang Hyun; Seo, Ho Kyung			Detection of Human Papillomavirus Infection and p16 Immunohistochemistry Expression in Bladder Cancer with Squamous Differentiation	PLOS ONE			English	Article							P53 MUTATION ANALYSIS; CELL CARCINOMAS; HPV GENOTYPES; VIRUS DNA; RISK; METAANALYSIS; TYPE-16; WASHES; SITES	Objectives: To determine the potential association between HPV infection and the squamous cell component of urothelial carcinoma (UC) of the bladder and to validate p16 overexpression as a surrogate marker for HPV infection in these cancers among Koreans. Methods: We analyzed the presence of HPV infection using an HPV-DNA chip and the expression of p16 using immunohistochemistry in 47 subjects between July 2001 and March 2011. The study group (n = 35) included patients with squamous differentiation of UC of the bladder. The control group (n = 12) included patients with squamous metaplasia of the bladder. Results: Baseline characteristics of control and study groups were similar. HPV DNA detection rates were approximately 2-fold higher in the study than the control group (17.1% [6/35] versus 8.3% [1/12], respectively), but the difference was not statistically significant. P16 overexpression was detected in 16/35 (45.7%) study group and 1/12 (8.3%) control group samples (p = 0.034). Both HPV-positivity and p16 overexpression were present in 3/35 (8.8%) study group samples, but none of the control group (p = 0.295). In the study group, the percentage of HPV-positive cases who were non-smokers was 2-fold higher than the percentage of HPV-negative cases who were non-smokers (66.7% [4/6] versus 31.0% [9/29], respectively); however, statistical significance was not achieved due to the small sample size. Conclusions: HPV infection may be associated with UC of the bladder with squamous differentiation, especially in non-smokers. However, p16 expression does not appear to be a strong surrogate marker for evidence of HPV infection in this type of cancer.	[Kim, Sung Han; Joung, Jae Young; Chung, Jinsoo; Park, Weon Seo; Lee, Kang Hyun; Seo, Ho Kyung] Natl Canc Ctr, Ctr Prostate Canc, Goyang, South Korea	National Cancer Center - Korea (NCC)	Seo, HK (corresponding author), Natl Canc Ctr, Ctr Prostate Canc, Goyang, South Korea.	seohk@ncc.re.kr		Seo, Ho Kyung/0000-0003-2601-1093	National Cancer Center, Republic of Korea [NCC-1110510]	National Cancer Center, Republic of Korea	This work was supported by a grant from the National Cancer Center (NCC-1110510), Republic of Korea. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abol-Enein H, 2008, SCAND J UROL NEPHROL, V42, P79, DOI 10.1080/03008880802325309; AGLIANO AM, 1994, UROL INT, V52, P208, DOI 10.1159/000282610; Alexander RE, 2012, MODERN PATHOL, V25, P1526, DOI 10.1038/modpathol.2012.103; ANWAR K, 1992, CANCER-AM CANCER SOC, V70, P1967, DOI 10.1002/1097-0142(19921001)70:7<1967::AID-CNCR2820700726>3.0.CO;2-8; Badawi Hala, 2008, Medscape J Med, V10, P232; Blochin EB, 2012, MODERN PATHOL, V25, P1534, DOI 10.1038/modpathol.2012.112; Boucher N R, 1997, Int Urogynecol J Pelvic Floor Dysfunct, V8, P354, DOI 10.1007/BF02765596; Buitrago-Perez A, 2009, CURR GENOMICS, V10, P26, DOI 10.2174/138920209787581235; Bussu F, 2013, BRIT J CANCER, V108, P1157, DOI 10.1038/bjc.2013.55; Cai T, 2008, EUR UROL, V53, P858, DOI 10.1016/j.eururo.2007.09.041; Cai T, 2011, ONCOL REP, V25, P485, DOI 10.3892/or.2010.1083; Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183; Choi YD, 2005, GYNECOL ONCOL, V98, P369, DOI 10.1016/j.ygyno.2005.04.044; Doxtader EE, 2012, HUM PATHOL, V43, P327, DOI 10.1016/j.humpath.2011.05.010; Freedman ND, 2011, JAMA-J AM MED ASSOC, V306, P737, DOI 10.1001/jama.2011.1142; Grignon DJ, 2004, SQUAMOUS CELL CARCIN; Gutierrez J, 2006, J UROLOGY, V176, P2474, DOI 10.1016/j.juro.2006.07.157; Helal TEA, 2006, PATHOL ONCOL RES, V12, P173, DOI 10.1007/BF02893365; Jimenez-Pacheco A, 2012, KOREAN J UROL, V53, P240, DOI 10.4111/kju.2012.53.4.240; Khaled HM, 2001, TUMORI, V87, P256, DOI 10.1177/030089160108700409; Kim CJ, 2003, GYNECOL ONCOL, V89, P210, DOI 10.1016/S0090-8258(02)00069-0; Lehoux M, 2009, PUBLIC HEALTH GENOM, V12, P268, DOI 10.1159/000214918; LI Y, 1994, CANCER RES, V54, P6078; LopezBeltran A, 1997, BIOMED PHARMACOTHER, V51, P252, DOI 10.1016/S0753-3322(97)83540-8; Moonen PMJ, 2007, EUR UROL, V52, P464, DOI 10.1016/j.eururo.2006.11.017; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Polesel J, 2012, BRIT J CANCER, V106, P222, DOI 10.1038/bjc.2011.519; SANO T, 1995, PATHOL INT, V45, P506, DOI 10.1111/j.1440-1827.1995.tb03493.x; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Shaker OG, 2013, BIOMED PHARMACOTHER, V67, P183, DOI 10.1016/j.biopha.2012.10.019; Shigehara K, 2011, J MED VIROL, V83, P277, DOI 10.1002/jmv.21966; SILVERMAN DT, 1992, HEMATOL ONCOL CLIN N, V6, P1; Steinestel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065189; Um TH, 2011, ANN CLIN LAB SCI, V41, P48; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wiwanitkit Viroj, 2005, Asian Pac J Cancer Prev, V6, P217; Youshya S, 2005, J CLIN PATHOL, V58, P207, DOI 10.1136/jcp.2004.017152; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	38	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93525	10.1371/journal.pone.0093525	http://dx.doi.org/10.1371/journal.pone.0093525			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675970	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500135
J	Li, LQ; Cui, X; Yu, SJ; Zhang, Y; Luo, Z; Yang, H; Zhou, Y; Zheng, XQ				Li, Liqi; Cui, Xiang; Yu, Sanjiu; Zhang, Yuan; Luo, Zhong; Yang, Hua; Zhou, Yue; Zheng, Xiaoqi			PSSP-RFE: Accurate Prediction of Protein Structural Class by Recursive Feature Extraction from PSI-BLAST Profile, Physical-Chemical Property and Functional Annotations	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; PRINCIPAL COMPONENT ANALYSIS; AMINO-ACID-COMPOSITION; SUBCELLULAR-LOCALIZATION; SEQUENCE REPRESENTATION; SECONDARY STRUCTURE; ALGORITHM; CLASSIFICATION; INFORMATION; SIMILARITY	Protein structure prediction is critical to functional annotation of the massively accumulated biological sequences, which prompts an imperative need for the development of high-throughput technologies. As a first and key step in protein structure prediction, protein structural class prediction becomes an increasingly challenging task. Amongst most homological-based approaches, the accuracies of protein structural class prediction are sufficiently high for high similarity datasets, but still far from being satisfactory for low similarity datasets, i.e., below 40% in pairwise sequence similarity. Therefore, we present a novel method for accurate and reliable protein structural class prediction for both high and low similarity datasets. This method is based on Support Vector Machine (SVM) in conjunction with integrated features from position-specific score matrix (PSSM), PROFEAT and Gene Ontology (GO). A feature selection approach, SVM-RFE, is also used to rank the integrated feature vectors through recursively removing the feature with the lowest ranking score. The definitive top features selected by SVM-RFE are input into the SVM engines to predict the structural class of a query protein. To validate our method, jackknife tests were applied to seven widely used benchmark datasets, reaching overall accuracies between 84.61% and 99.79%, which are significantly higher than those achieved by state-of-the-art tools. These results suggest that our method could serve as an accurate and cost-effective alternative to existing methods in protein structural classification, especially for low similarity datasets.	[Li, Liqi; Yang, Hua] Third Mil Med Univ, Xinqiao Hosp, Dept Gen Surg, Chongqing, Peoples R China; [Cui, Xiang; Zhang, Yuan; Zhou, Yue] Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China; [Yu, Sanjiu] Third Mil Med Univ, Xinqiao Hosp, Inst Cardiovasc Dis PLA, Chongqing, Peoples R China; [Luo, Zhong] Chongqing Univ, Coll Bioengn, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 630044, Peoples R China; [Yang, Hua] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI USA; [Zhou, Yue] Shanghai Normal Univ, Dept Math, Shanghai, Peoples R China; [Zheng, Xiaoqi] Harvard Univ, Sch Publ Hlth, Dept Biostat & Computat Biol, Boston, MA USA	Army Medical University; Army Medical University; Army Medical University; Chongqing University; University of Michigan System; University of Michigan; Shanghai Normal University; Harvard University; Harvard T.H. Chan School of Public Health	Yang, H (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Gen Surg, Chongqing, Peoples R China.	Yanghuaxq@163.com; xqzheng@shnu.edu.cn	Luo, Zhong/AAU-2225-2020	Luo, Zhong/0000-0002-9019-3314	National Natural Science Foundation of China [81302134, 31100953]; Innovation Program of Shanghai Municipal Education Commission [12YZ088]; Program of Shanghai Normal University [DZL121]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Program of Shanghai Normal University	This work was partially supported by the grants from National Natural Science Foundation of China (No. 81302134 and No. 31100953), Innovation Program of Shanghai Municipal Education Commission (No. 12YZ088) and the Program of Shanghai Normal University (DZL121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck D, 2012, BIOINFORMATICS, V28, P1062, DOI 10.1093/bioinformatics/bts085; Cai YD, 2006, J THEOR BIOL, V238, P172, DOI 10.1016/j.jtbi.2005.05.034; Cao YF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-20; Chen C, 2006, ANAL BIOCHEM, V357, P116, DOI 10.1016/j.ab.2006.07.022; Chen K, 2008, J COMPUT CHEM, V29, P1596, DOI 10.1002/jcc.20918; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Ding SY, 2014, BIOCHIMIE, V97, P60, DOI 10.1016/j.biochi.2013.09.013; Ding SY, 2012, BIOCHIMIE, V94, P1166, DOI 10.1016/j.biochi.2012.01.022; Dong LH, 2006, J BIOMOL STRUCT DYN, V24, P239; Feng KY, 2005, BIOCHEM BIOPH RES CO, V334, P213, DOI 10.1016/j.bbrc.2005.06.075; Gao JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064704; Hu CX, 2013, MED PHYS, V40, DOI 10.1118/1.4804054; Kurgan L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-226; Kurgan L, 2007, BIOCHEM BIOPH RES CO, V357, P453, DOI 10.1016/j.bbrc.2007.03.164; Kurgan LA, 2006, PATTERN RECOGN, V39, P2323, DOI 10.1016/j.patcog.2006.02.014; Lertampaiporn S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks878; Li LQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031057, 10.1371/journal.pone.0045115]; Li ZC, 2008, AMINO ACIDS, V35, P581, DOI 10.1007/s00726-008-0084-z; Li ZC, 2009, AMINO ACIDS, V37, P415, DOI 10.1007/s00726-008-0170-2; Liang CL, 2013, J MED SYST, V37, DOI 10.1007/s10916-013-9932-9; Liu TG, 2012, AMINO ACIDS, V42, P2243, DOI 10.1007/s00726-011-0964-5; Liu TG, 2010, AMINO ACIDS, V38, P721, DOI 10.1007/s00726-009-0276-1; Liu TA, 2010, J THEOR BIOL, V267, P272, DOI 10.1016/j.jtbi.2010.09.007; Million M, 2013, P NATL ACAD SCI USA, V110, pE1, DOI 10.1073/pnas.1218418110; Mizianty MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-414; Niu XH, 2014, J THEOR BIOL, V343, P186, DOI 10.1016/j.jtbi.2013.10.009; Ota K, 2014, J NEUROSCI METH, V221, P139, DOI 10.1016/j.jneumeth.2013.10.003; Paik YK, 2012, NAT BIOTECHNOL, V30, P221, DOI 10.1038/nbt.2152; Park CY, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002957; Qin YF, 2012, PROTEIN PEPTIDE LETT, V19, P388, DOI 10.2174/092986612799789350; Raghuraj R, 2008, COMPUT BIOL CHEM, V32, P302, DOI 10.1016/j.compbiolchem.2008.03.009; Rao HB, 2011, NUCLEIC ACIDS RES, V39, pW385, DOI 10.1093/nar/gkr284; Wan SB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-290; Wang ZX, 2000, PROTEINS, V38, P165, DOI 10.1002/(SICI)1097-0134(20000201)38:2<165::AID-PROT5>3.0.CO;2-V; Xia XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037653; Yang JY, 2009, J THEOR BIOL, V257, P618, DOI 10.1016/j.jtbi.2008.12.027; Zhang JJ, 2011, TALANTA, V83, P1401, DOI 10.1016/j.talanta.2010.11.020; Zhang SL, 2012, J BIOMOL STRUCT DYN, V29, P634, DOI 10.1080/07391102.2011.672627; Zhao B, 2013, J PROTEOMICS, V81, P56, DOI 10.1016/j.jprot.2012.12.021; Zheng XQ, 2010, J COMPUT CHEM, V31, P1201, DOI 10.1002/jcc.21406	40	25	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92863	10.1371/journal.pone.0092863	http://dx.doi.org/10.1371/journal.pone.0092863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675610	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677500046
J	Palacio, S; Maestro, M; Montserrat-Marti, G				Palacio, Sara; Maestro, Melchor; Montserrat-Marti, Gabriel			Differential Nitrogen Cycling in Semiarid Sub-Shrubs with Contrasting Leaf Habit	PLOS ONE			English	Article							SHOOT GROWTH DYNAMICS; SOUTHERN-CALIFORNIA; DECIDUOUS SHRUBS; SENESCING LEAVES; BUD MORPHOLOGY; NUTRIENT-USE; STORAGE; REMOBILIZATION; RESORPTION; PHENOLOGY	Nitrogen (N) is, after water, the most limiting resource in semiarid ecosystems. However, knowledge on the N cycling ability of semiarid woody plants is still very rudimentary. This study analyzed the seasonal change in the N concentrations and pools of the leaves and woody organs of two species of semiarid sub-shrubs with contrasting leaf habit. The ability of both species to uptake, remobilize and recycle N, plus the main storage organ for N during summer drought were evaluated. We combined an observational approach in the field with experimental N-15 labelling of adult individuals grown in sand culture. Seasonal patterns of N concentrations were different between species and organs and foliar N concentrations of the summer deciduous Lepidium subulatum were almost double those of the evergreen Linum suffruticosum. L. subulatum up took ca. 60% more external N than the evergreen and it also had a higher N resorption efficiency and proficiency. Contrastingly, L. suffruticosum relied more on internal N remobilization for shoot growth. Differently to temperate species, the evergreen stored N preferentially in the main stem and old trunks, while the summer deciduous stored it in the foliage and young stems. The higher ability of L. subulatum to uptake external N can be related to its ability to perform opportunistic growth and exploit the sporadic pulses of N typical of semiarid ecosystems. Such ability may also explain its high foliar N concentrations and its preferential storage of N in leaves and young stems. Finally, L. suffruticosum had a lower ability to recycle N during leaf senescence. These strategies contrast with those of evergreen and deciduous species from temperate and boreal areas, highlighting the need of further studies on semiarid and arid plants.	[Palacio, Sara] CSIC, IPE, Jaca, Huesca, Spain; [Maestro, Melchor; Montserrat-Marti, Gabriel] CSIC, IPE, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE)	Palacio, S (corresponding author), CSIC, IPE, Avda Nuestra Senora Victoria, Jaca, Huesca, Spain.	s.palacio@ipe.csic.es	Palacio, Sara/B-3907-2011	Palacio, Sara/0000-0002-8362-6820	ARBALMONT [786-2012]; Ministerio de Economia y Competitividad, Spain [CGL2011-26654]; Juan de la Cierva from the MEC (Spain);  [GA-LC-011/2008]	ARBALMONT; Ministerio de Economia y Competitividad, Spain; Juan de la Cierva from the MEC (Spain); 	This study was funded by projects GA-LC-011/2008 [DGA], ARBALMONT (786-2012) [Organismo Autonomo de Parques Nacionales], and CGL2011-26654 [Ministerio de Economia y Competitividad, Spain]. SP was funded by a Juan de la Cierva contract from the MEC (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS R, 1993, OIKOS, V66, P144, DOI 10.2307/3545208; Alvarado JJ, 2000, J PLANT PHYSIOL, V156, P612, DOI 10.1016/S0176-1617(00)80220-5; BRAUN-BLANQUET J., 1957, AN ESTAC EXPTL AULA DEI, V5, P1; CHRISTODOULAKIS NS, 1990, ANN BOT-LONDON, V65, P291, DOI 10.1093/oxfordjournals.aob.a087937; COLEMAN GD, 1991, PLANT PHYSIOL, V96, P686, DOI 10.1104/pp.96.3.686; Delgado-Baquerizo M, 2011, PEDOSPHERE, V21, P309, DOI 10.1016/S1002-0160(11)60131-8; Delgado-Baquerizo M, 2013, EFECTOS CAMBIO CLIMA; ESCUDERO A, 1992, VEGETATIO, V100, P225; GALLARDO A, 1993, ECOLOGY, V74, P152, DOI 10.2307/1939510; GRAY JT, 1983, J ECOL, V71, P21, DOI 10.2307/2259961; GRAY JT, 1983, J ECOL, V71, P43, DOI 10.2307/2259962; Grelet GA, 2001, J EXP BOT, V52, P993, DOI 10.1093/jexbot/52.358.993; Guerrero-Campo J, 1999, J ARID ENVIRON, V41, P411, DOI 10.1006/jare.1999.0493; Hodge A, 2009, PLANT SOIL, V321, P153, DOI 10.1007/s11104-009-9929-9; Killingbeck KT, 1996, ECOLOGY, V77, P1716, DOI 10.2307/2265777; MEYER SE, 1992, J VEG SCI, V3, P429, DOI 10.2307/3235799; Milla R, 2005, PLANT SOIL, V278, P303, DOI 10.1007/s11104-005-8770-z; Milla R, 2005, NEW PHYTOL, V168, P167, DOI 10.1111/j.1469-8137.2005.01477.x; Milla R, 2005, PLANT BIOLOGY, V7, P182, DOI 10.1055/s-2005-837469; Milla R, 2004, ANN BOT-LONDON, V93, P671, DOI 10.1093/aob/mch094; MILLARD P, 1992, TREE PHYSIOL, V10, P33, DOI 10.1093/treephys/10.1.33; MILLARD P, 1991, NEW PHYTOL, V117, P587, DOI 10.1111/j.1469-8137.1991.tb00963.x; MILLARD P, 1989, J EXP BOT, V40, P1285, DOI 10.1093/jxb/40.11.1285; Millard P, 1996, Z PFLANZ BODENKUNDE, V159, P1; Millard P, 2010, TREE PHYSIOL, V30, P1083, DOI 10.1093/treephys/tpq042; Mota JF, 2003, PHYTOCOENOLOGIA, V33, P13, DOI 10.1127/0340-269X/2003/0033-0013; Orshan G, 1989, PLANT PHENO MORPHOLO; Palacio S, 2007, J ARID ENVIRON, V68, P522, DOI 10.1016/j.jaridenv.2006.07.008; Palacio S, 2007, PLANT BIOLOGY, V9, P49, DOI 10.1055/s-2006-924224; Palacio S, 2007, ENVIRON EXP BOT, V59, P34, DOI 10.1016/j.envexpbot.2005.10.003; Palacio S, 2005, ANN BOT-LONDON, V95, P949, DOI 10.1093/aob/mci110; Palacio S., 2006, PIRINEOS, V161, P159; Palacio S, 2007, ANN BOT-LONDON, V99, P333, DOI 10.1093/aob/mcl263; Palacio S, 2006, FLORA, V201, P612, DOI 10.1016/j.flora.2006.02.002; Palacio S, 2006, BOT J LINN SOC, V151, P527, DOI 10.1111/j.1095-8339.2006.00542.x; Proe MF, 2000, NEW PHYTOL, V146, P461, DOI 10.1046/j.1469-8137.2000.00658.x; Quirantes J., 1977, ESTUDIO SEDIMENTOLOG; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Reynolds JF, 2004, OECOLOGIA, V141, P194, DOI 10.1007/s00442-004-1524-4; Rivas-Martinez S., 1987, MEMORIA MAPA SERIES; Ruiz JM, 2003, INT J PHYTOREMEDIAT, V5, P203, DOI 10.1080/713779220; Schlesinger W.M., 1996, BIOGEOCHEMISTRY ANAL; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; Silla F, 2003, OECOLOGIA, V136, P28, DOI 10.1007/s00442-003-1232-5; Silla F, 2008, TREES-STRUCT FUNCT, V22, P785, DOI 10.1007/s00468-008-0239-2; Uscola M, 2013, ECOPHYSIOLOGY NITROG; van der Aart P.J.M., 1988, PLANT FORM VEGETATIO, P211; VANCLEVE B, 1993, PLANTA, V189, P157, DOI 10.1007/BF00201357; Vizoso S, 2008, TREE PHYSIOL, V28, P1729, DOI 10.1093/treephys/28.11.1729; Yuan ZY, 2005, J ARID ENVIRON, V63, P191, DOI 10.1016/j.jaridenv.2005.01.023	50	4	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93184	10.1371/journal.pone.0093184	http://dx.doi.org/10.1371/journal.pone.0093184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675650	Green Published, gold			2022-12-27	WOS:000333677500086
J	Pyles, RB; Vincent, KL; Baum, MM; Elsom, B; Miller, AL; Maxwell, C; Eaves-Pyles, TD; Li, GY; Popov, VL; Nusbaum, RJ; Ferguson, MR				Pyles, Richard B.; Vincent, Kathleen L.; Baum, Marc M.; Elsom, Barry; Miller, Aaron L.; Maxwell, Carrie; Eaves-Pyles, Tonyia D.; Li, Guangyu; Popov, Vsevolod L.; Nusbaum, Rebecca J.; Ferguson, Monique R.			Cultivated Vaginal Microbiomes Alter HIV-1 Infection and Antiretroviral Efficacy in Colonized Epithelial Multilayer Cultures	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BACTERIAL-VAGINOSIS; SIMULTANEOUS DELIVERY; SENSORY GANGLIA; GENITAL-TRACT; TENOFOVIR; RISK; EPIDEMIOLOGY; MICROBICIDES; DISEASE	There is a pressing need for modeling of the symbiotic and at times dysbiotic relationship established between bacterial microbiomes and human mucosal surfaces. In particular clinical studies have indicated that the complex vaginal microbiome (VMB) contributes to the protection against sexually-transmitted pathogens including the life-threatening human immunodeficiency virus (HIV-1). The human microbiome project has substantially increased our understanding of the complex bacterial communities in the vagina however, as is the case for most microbiomes, very few of the community member species have been successfully cultivated in the laboratory limiting the types of studies that can be completed. A genetically controlled ex vivo model system is critically needed to study the complex interactions and associated molecular dialog. We present the first vaginal mucosal culture model that supports colonization by both healthy and dysbiotic VMB from vaginal swabs collected from routine gynecological patients. The immortalized vaginal epithelial cells used in the model and VMB cryopreservation methods provide the opportunity to reproducibly create replicates for lab-based evaluations of this important mucosal/bacterial community interface. The culture system also contains HIV-1 susceptible cells allowing us to study the impact of representative microbiomes on replication. Our results show that our culture system supports stable and reproducible colonization by VMB representing distinct community state types and that the selected representatives have significantly different effects on the replication of HIV-1. Further, we show the utility of the system to predict unwanted alterations in efficacy or bacterial community profiles following topical application of a front line antiretroviral.	[Pyles, Richard B.; Elsom, Barry; Miller, Aaron L.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Pyles, Richard B.; Maxwell, Carrie; Eaves-Pyles, Tonyia D.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Vincent, Kathleen L.] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Baum, Marc M.] Oak Crest Inst Sci, Pasadena, CA USA; [Li, Guangyu] E Tennessee State Univ, Dept Internal Med, Div Infect Dis, Johnson City, TN 37614 USA; [Popov, Vsevolod L.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Nusbaum, Rebecca J.] Univ Texas Med Branch, Human Pathophysiol & Translat Med Grad program, Galveston, TX 77555 USA; [Ferguson, Monique R.] Univ Texas Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; East Tennessee State University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Pyles, RB (corresponding author), Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.	rbpyles@utmb.edu		Vincent, Kathleen/0000-0003-3051-9551; Baum, Marc/0000-0003-1558-5649; Nusbaum, Rebecca/0000-0002-8378-8037	Institute for Translational Sciences at the University of Texas Medical Branch; Clinical and Translational Science Award from the National Center for Advancing Translational Sciences, National Institutes of Health (NIH) [UL1TR000071]; National Institute Of Allergy And Infectious Diseases of the NIH [R01AI100744]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100744, P30AI036211] Funding Source: NIH RePORTER	Institute for Translational Sciences at the University of Texas Medical Branch; Clinical and Translational Science Award from the National Center for Advancing Translational Sciences, National Institutes of Health (NIH); National Institute Of Allergy And Infectious Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was conducted with the support of the Institute for Translational Sciences at the University of Texas Medical Branch, supported in part by a Clinical and Translational Science Award (UL1TR000071) from the National Center for Advancing Translational Sciences, National Institutes of Health (NIH). This research also was supported by the National Institute Of Allergy And Infectious Diseases of the NIH under Award Number R01AI100744. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum MM, 2012, J PHARM SCI-US, V101, P2833, DOI 10.1002/jps.23208; Bell BA, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046010; Bird MD, 2007, J VIROL, V81, P423, DOI 10.1128/JVI.01455-06; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Brotman RM, 2008, AM J EPIDEMIOL, V168, P188, DOI 10.1093/aje/kwn103; Chu CF, 2008, J REPROD IMMUNOL, V78, P58, DOI 10.1016/j.jri.2007.08.004; Cohen CR, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001251; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Eaves-Pyles T, 2013, MOL MED, V19, P263, DOI 10.2119/molmed.2013.00081; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Givan AL, 1997, AM J REPROD IMMUNOL, V38, P350; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hickey RJ, 2012, TRANSL RES, V160, P267, DOI 10.1016/j.trsl.2012.02.008; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Johnson AJ, 2008, J VIROL, V82, P9678, DOI 10.1128/JVI.01159-08; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Keller MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046901; Kenyon C, 2013, AM J OBSTET GYNECOL; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Lambert JA, 2013, APPL ENVIRON MICROB, V79, P4181, DOI 10.1128/AEM.01160-13; Losikoff Phyllis, 2007, Infect Dis Obstet Gynecol, V2007, P92307, DOI 10.1155/2007/92307; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Mayer KH, 2006, AIDS, V20, P543, DOI 10.1097/01.aids.0000210608.70762.c3; Milligan GN, 2005, J VIROL, V79, P11537, DOI 10.1128/JVI.79.17.11537-11540.2005; Mirmonsef P, 2011, AM J REPROD IMMUNOL, V65, P190, DOI 10.1111/j.1600-0897.2010.00943.x; Moss JA, 2012, ANTIMICROB AGENTS CH, V56, P5952, DOI 10.1128/AAC.01198-12; Moss JA, 2012, ANTIMICROB AGENTS CH, V56, P875, DOI 10.1128/AAC.05662-11; Nies AT, 2012, EXPERT OPIN DRUG MET, V8, P1565, DOI 10.1517/17425255.2012.722996; Palmer S, 2001, AIDS RES HUM RETROV, V17, P1167, DOI 10.1089/088922201316912772; Pennock JW, 2009, VACCINE, V27, P5830, DOI 10.1016/j.vaccine.2009.07.052; Petrova MI, 2013, FEMS MICROBIOL REV, V37, P762, DOI 10.1111/1574-6976.12029; Pirrone V, 2011, ANTIVIR RES, V90, P168, DOI 10.1016/j.antiviral.2011.03.176; PYLES RB, 1994, J VIROL, V68, P4514, DOI 10.1128/JVI.68.7.4514-4524.1994; Ramjee Gita, 2007, AIDS Res Ther, V4, P20, DOI 10.1186/1742-6405-4-20; Ravel J, 2012, MBIO, V3, DOI 10.1128/mBio.00370-12; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rose WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032728; Schellenberg JJ, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/131243; Segarra TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027675; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; Shattock RJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007385; Sobel JD, 2005, INFECT DIS CLIN N AM, V19, P387, DOI 10.1016/j.idc.2005.03.001; Spear Gregory T, 2007, AIDS Res Ther, V4, P25, DOI 10.1186/1742-6405-4-25; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Thomas S, 1928, J INFECT DIS, V43, P218, DOI 10.1093/infdis/43.3.218; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Verstraelen H, 2013, CURR OPIN INFECT DIS, V26, P86, DOI 10.1097/QCO.0b013e32835c20cd; Verstraelen H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-81; Vincent KL, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.025; Wahren B, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-72; Weinstein L, 1937, Yale J Biol Med, V10, P185; Yeoman CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056111	55	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93419	10.1371/journal.pone.0093419	http://dx.doi.org/10.1371/journal.pone.0093419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676219	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500120
J	Shang, J; Fu, YC; Ren, ZJ; Zhang, T; Du, MY; Gong, QY; Lui, S; Zhang, W				Shang, Jing; Fu, Yuchuan; Ren, Zhengjia; Zhang, Tao; Du, Mingying; Gong, Qiyong; Lui, Su; Zhang, Wei			The Common Traits of the ACC and PFC in Anxiety Disorders in the DSM-5: Meta-Analysis of Voxel-Based Morphometry Studies	PLOS ONE			English	Article							GRAY-MATTER VOLUME; ANTERIOR CINGULATE CORTEX; PANIC DISORDER; SOCIAL ANXIETY; DRUG-NAIVE; ORBITOFRONTAL CORTEX; AMYGDALA VOLUME; REDUCTION; ABNORMALITIES; 1ST-EPISODE	Background: The core domains of social anxiety disorder (SAD), generalized anxiety disorder (GAD), panic disorder (PD) with and without agoraphobia (GA), and specific phobia (SP) are cognitive and physical symptoms that are related to the experience of fear and anxiety. It remains unclear whether these highly comorbid conditions that constitute the anxiety disorder subgroups of the Diagnostic and Statistical Manual for Mental Disorders - Fifth Edition (DSM-5) represent distinct disorders or alternative presentations of a single underlying pathology. Methods: A systematic search of voxel-based morphometry (VBM) studies of SAD, GAD, PD, GA, and SP was performed with an effect-size signed differential mapping (ES-SDM) meta-analysis to estimate the clusters of significant gray matter differences between patients and controls. Results: Twenty-four studies were eligible for inclusion in the meta-analysis. Reductions in the right anterior cingulate gyrus and the left inferior frontal gyrus gray matter volumes (GMVs) were noted in patients with anxiety disorders when potential confounders, such as comorbid major depressive disorder (MDD), age, and antidepressant use were controlled for. We also demonstrated increased GMVs in the right dorsolateral prefrontal cortex (DLPFC) in comorbid depression-anxiety (CDA), drug-naive and adult patients. Furthermore, we identified a reduced left middle temporal gyrus and right precentral gyrus in anxiety patients without comorbid MDD. Conclusion: Our findings indicate that a reduced volume of the right ventral anterior cingulate gyrus and left inferior frontal gyrus is common in anxiety disorders and is independent of comorbid depression, medication use, and age. This generic effect supports the notion that the four types of anxiety disorders have a clear degree of overlap that may reflect shared etiological mechanisms. The results are consistent with neuroanatomical DLPFC models of physiological responses, such as worry and fear, and the importance of the ventral anterior cingulate (ACC)/medial prefrontal cortex (mPFC) in mediating anxiety symptoms.	[Shang, Jing; Ren, Zhengjia; Zhang, Wei] Sichuan Univ, West China Hosp, Dept Psychiat, Mental Hlth Ctr, Chengdu 610064, Peoples R China; [Fu, Yuchuan; Lui, Su] Wenzhou Med Univ, Affiliated Hosp 2, Dept Radiol, Wenzhou, Peoples R China; [Zhang, Tao] Sichuan Univ, West China Sch Publ Hlth, Chengdu 610064, Peoples R China; [Du, Mingying; Gong, Qiyong; Lui, Su] Sichuan Univ, West China Hosp, Dept Radiol, Huaxi MR Res Ctr HMRRC, Chengdu 610064, Peoples R China	Sichuan University; Wenzhou Medical University; Sichuan University; Sichuan University	Lui, S (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Radiol, Wenzhou, Peoples R China.	lusuwcums@tom.com; weizhang27@163.com	Gong, Qiyong/W-3052-2019; Lui, Su/S-9132-2019	Gong, Qiyong/0000-0002-5912-4871; 				Androutsos Ch, 2012, Psychiatriki, V23 Suppl 1, P82; Asami T, 2008, PSYCHIAT CLIN NEUROS, V62, P322, DOI 10.1111/j.1440-1819.2008.01800.x; Asami T, 2009, PSYCHIAT RES-NEUROIM, V173, P128, DOI 10.1016/j.pscychresns.2008.10.004; Barrera TL, 2009, J ANXIETY DISORD, V23, P1086, DOI 10.1016/j.janxdis.2009.07.011; Boshuisen ML, 2002, BIOL PSYCHIAT, V52, P126, DOI 10.1016/S0006-3223(02)01355-0; Bruce SE, 2005, AM J PSYCHIAT, V162, P1179, DOI 10.1176/appi.ajp.162.6.1179; Bruhl AB, 2013, HUMAN BRAIN MAPPING; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cannistraro Paul A, 2003, Psychopharmacol Bull, V37, P8; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craske MG, 2009, DEPRESS ANXIETY, V26, P1066, DOI 10.1002/da.20633; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Ferrari MCF, 2008, REV BRAS PSIQUIATR, V30, P251, DOI 10.1590/S1516-44462008000300013; Frick A, 2013, NEUROSCI LETT, V536, P52, DOI 10.1016/j.neulet.2012.12.060; Gabbard G. O., 1994, PSYCHODYNAMIC PSYCHI; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Gorman JM, 2000, AM J PSYCHIAT, V157, P493, DOI 10.1176/appi.ajp.157.4.493; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hayano F, 2009, PSYCHIAT CLIN NEUROS, V63, P266, DOI 10.1111/j.1440-1819.2009.01960.x; Kadosh KC, 2013, CEREB CORTEX, V23, P1630, DOI 10.1093/cercor/bhs150; Kilts CD, 2006, NEUROPSYCHOPHARMACOL, V31, P2243, DOI 10.1038/sj.npp.1301053; Lai CH, 2013, J PSYCHIATR RES, V47, P122, DOI 10.1016/j.jpsychires.2012.09.013; Lai CH, 2012, J AFFECT DISORDERS, V140, P285, DOI 10.1016/j.jad.2012.01.049; Lai CH, 2011, J CLIN PSYCHOPHARM, V31, P287, DOI 10.1097/JCP.0b013e31821a1045; Lai CH, 2011, INT J NEUROPSYCHOPH, V14, P225, DOI 10.1017/S1461145710000829; Lai CH, 2010, EUR NEUROPSYCHOPHARM, V20, P676, DOI 10.1016/j.euroneuro.2010.06.002; Lavretsky H, 2005, J CLIN PSYCHIAT; Lebeau RT, 2012, INT J METH PSYCH RES, V21, P258, DOI 10.1002/mpr.1369; Liao M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071898; Liao W, 2011, BRAIN RES, V1388, P167, DOI 10.1016/j.brainres.2011.03.018; Martin EI, 2009, PSYCHIAT CLIN N AM, V32, P549, DOI 10.1016/j.psc.2009.05.004; Massana G, 2003, AM J PSYCHIAT, V160, P566, DOI 10.1176/appi.ajp.160.3.566; Matsubara M, 2004, J COGNITIVE NEUROSCI, V16, P944, DOI 10.1162/0898929041502643; Meng YJ, 2013, PSYCHIAT RES-NEUROIM, V214, P9, DOI 10.1016/j.pscychresns.2013.06.002; Milham MP, 2005, BIOL PSYCHIAT, V57, P961, DOI 10.1016/j.biopsych.2005.01.038; Na KS, 2013, PROG NEURO-PSYCHOPH, V45, P195, DOI 10.1016/j.pnpbp.2013.04.014; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Pittig A, 2013, INT J PSYCHOPHYSIOL, V87, P19, DOI 10.1016/j.ijpsycho.2012.10.012; Protopopescu X, 2006, NEUROREPORT, V17, P361, DOI 10.1097/01.wnr.0000203354.80438.1; Radua J, 2012, EUR PSYCHIAT, V27, P605, DOI 10.1016/j.eurpsy.2011.04.001; Radua J, 2010, ARCH GEN PSYCHIAT, V67, P701, DOI 10.1001/archgenpsychiatry.2010.70; Ramsawh HJ, 2009, PSYCHOL MED, V39, P615, DOI 10.1017/S0033291708003954; Rauch SL, 2003, ANN NY ACAD SCI, V985, P389; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Roppongi T, 2010, PSYCHIAT CLIN NEUROS, V64, P318, DOI 10.1111/j.1440-1819.2010.02085.x; Schienle A, 2011, EUR ARCH PSY CLIN N, V261, P303, DOI 10.1007/s00406-010-0147-5; Schiller D, 2010, TRENDS COGN SCI, V14, P268, DOI 10.1016/j.tics.2010.04.002; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Siegle GJ, 2003, ANN NY ACAD SCI, V985, P481; Sobanski T, 2010, PSYCHOL MED, V40, P1879, DOI 10.1017/S0033291709991930; Strawn JR, 2013, DEPRESS ANXIETY, V30, P842, DOI 10.1002/da.22089; Suarez L, 2001, BEHAV THER, V32, P425, DOI 10.1016/S0005-7894(01)80029-0; Talati A, 2013, BIOL PSYCHIAT, V73, P75, DOI 10.1016/j.biopsych.2012.05.022; Uchida RR, 2008, PSYCHIAT RES-NEUROIM, V163, P21, DOI 10.1016/j.pscychresns.2007.04.015; van Tol MJ, 2010, ARCH GEN PSYCHIAT, V67, P1002, DOI 10.1001/archgenpsychiatry.2010.121; Wager TD, 2008, HDB EMOTION, P249; Xu P, 2014, NEUROIMAGE; Yoo HK, 2005, EUR J NEUROSCI, V22, P2089, DOI 10.1111/j.1460-9568.2005.04394.x	61	90	94	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93432	10.1371/journal.pone.0093432	http://dx.doi.org/10.1371/journal.pone.0093432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676455	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500124
J	Wu, YZ; Yu, YH; Szabo, A; Han, M; Huang, XF				Wu, Yizhen; Yu, Yinghua; Szabo, Alexander; Han, Mei; Huang, Xu-Feng			Central Inflammation and Leptin Resistance Are Attenuated by Ginsenoside Rb1 Treatment in Obese Mice Fed a High-Fat Diet	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; KAPPA-B; ADIPOSE; INHIBITION; ACTIVATION; SECRETION; PTP1B; LIVER; BETA	A low-grade pro-inflammatory state is at the pathogenic core of obesity and type 2 diabetes. We tested the hypothesis that the plant terpenoid compound ginsenoside Rb1 (Rb1), known to exert anti-inflammatory effects, would ameliorate obesity, obesity-associated inflammation and glucose intolerance in the high-fat diet-induced obese mouse model. Furthermore, we examined the effect of Rb1 treatment on central leptin sensitivity and the leptin signaling pathway in the hypothalamus. We found that intraperitoneal injections of Rb1 (14 mg/kg, daily) for 21 days significantly reduced body weight gain, fat mass accumulation, and improved glucose tolerance in obese mice on a HF diet compared to vehicle treatment. Importantly, Rb1 treatment also reduced levels of pro-inflammatory cytokines (TNF-alpha, IL-6 and/or IL-1 beta) and NF-kappa B pathway molecules (p-IKK and p-IkB alpha) in adipose tissue and liver. In the hypothalamus, Rb1 treatment decreased the expression of inflammatory markers (IL-6, IL-1 beta and p-IKK) and negative regulators of leptin signaling (SOCS3 and PTP1B). Furthermore, Rb1 treatment also restored the anorexic effect of leptin in high-fat fed mice as well as leptin pSTAT3 signaling in the hypothalamus. Ginsenoside Rb1 has potential for use as an anti-obesity therapeutic agent that modulates obesity-induced inflammation and improves central leptin sensitivity in HF diet-induced obesity.	[Wu, Yizhen; Yu, Yinghua; Szabo, Alexander; Han, Mei; Huang, Xu-Feng] Univ Wollongong, Illawarra Hlth & Med Res Inst, Sch Med, Wollongong, NSW, Australia; [Yu, Yinghua; Huang, Xu-Feng] Schizophrenia Res Inst, Sydney, NSW, Australia; [Szabo, Alexander] Australian Nucl Sci & Technol Org, ANSTO LifeSci, Sydney, NSW, Australia	University of Wollongong; Australian Nuclear Science & Technology Organisation	Yu, YH (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Sch Med, Wollongong, NSW, Australia.	yinghua@uow.edu.au; xhuang@uow.edu.au	Huang, Xu-Feng/D-6053-2013; Huang, Xu-Feng/H-7408-2015	Huang, Xu-Feng/0000-0002-5895-2253; Huang, Xu-Feng/0000-0002-5895-2253; Yu, Yinghua/0000-0003-2508-7512	Diabetes Australia Research Trust Research Projects; National Health and Medical Research Council of Australia [NHMRC 573441]	Diabetes Australia Research Trust Research Projects; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by Diabetes Australia Research Trust Research Projects to XFH and YHY. YHY is supported by the National Health and Medical Research Council of Australia (NHMRC 573441). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda AP, 2011, ENDOCRINOLOGY, V152, P1314, DOI 10.1210/en.2010-0659; Boey D, 2008, NEUROPEPTIDES, V42, P19, DOI 10.1016/j.npep.2007.11.003; Cai DS, 2011, ANN NY ACAD SCI, V1243, pE1, DOI 10.1111/j.1749-6632.2011.06388.x; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Calegari VC, 2011, J BIOL CHEM, V286, P12870, DOI 10.1074/jbc.M110.173021; Chelikani PK, 2004, AM J PHYSIOL-REG I, V287, pR1064, DOI 10.1152/ajpregu.00376.2004; Cho JY, 2004, J CLIN ENDOCR METAB, V89, P3510, DOI 10.1210/jc.2003-031823; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; du Bois TM, 2012, EUROPEAN NEUROPSYCHO; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Joh EH, 2011, BIOCHEM PHARMACOL, V82, P278, DOI 10.1016/j.bcp.2011.05.003; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Li H, 2008, METABOLISM, V57, P1704, DOI 10.1016/j.metabol.2008.07.029; Li QY, 2011, J AGR FOOD CHEM, V59, P6312, DOI 10.1021/jf200424k; Lihn AS, 2005, OBES REV, V6, P13, DOI 10.1111/j.1467-789X.2005.00159.x; Lin N, 2013, CELL BIOCHEM BIOPHYS, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Milanski M, 2012, DIABETES, V61, P1455, DOI 10.2337/db11-0390; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Paget G.E., 1964, EVALUATION DRUG ACTI, P135, DOI DOI 10.1016/B978-1-4832-2845-7.50012-8; Paxinos G, 2002, MOUSE BRAIN STEREOTA, V1st; Pritchard LE, 2002, J ENDOCRINOL, V172, P411, DOI 10.1677/joe.0.1720411; Rigamonti AE, 2011, EUR J ENDOCRINOL, V165, P421, DOI 10.1530/EJE-11-0312; Salminen A, 2008, CELL MOL LIFE SCI, V65, P2979, DOI 10.1007/s00018-008-8103-5; Schmidt PT, 2005, EUR J GASTROEN HEPAT, V17, P207, DOI 10.1097/00042737-200502000-00012; Song JH, 2012, PHYTOTHER RES; Stanton MC, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-8; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174; Washida D, 2003, CHEM PHARM BULL, V51, P1314, DOI 10.1248/cpb.51.1314; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; White CL, 2009, AM J PHYSIOL-ENDOC M, V296, pE291, DOI 10.1152/ajpendo.90513.2008; Wilusz J, 2008, POSTTRANSCRIPTIONAL, P303; Xiong Y, 2010, DIABETES, V59, P2505, DOI 10.2337/db10-0315; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhu J, 2012, NEUROSCIENCE, V202, P342, DOI 10.1016/j.neuroscience.2011.11.070	43	65	70	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92618	10.1371/journal.pone.0092618	http://dx.doi.org/10.1371/journal.pone.0092618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675731	Green Published, gold			2022-12-27	WOS:000333677500029
J	Butz, MV; Kutter, EF; Lorenz, C				Butz, Martin V.; Kutter, Esther F.; Lorenz, Corinna			Rubber Hand Illusion Affects Joint Angle Perception	PLOS ONE			English	Article							BODY; TOUCH; INFORMATION; OWNERSHIP; PLAUSIBILITY; INTEGRATION; OBJECTS; CORTEX; FRAME; FEEL	The Rubber Hand Illusion (RHI) is a well-established experimental paradigm. It has been shown that the RHI can affect hand location estimates, arm and hand motion towards goals, the subjective visual appearance of the own hand, and the feeling of body ownership. Several studies also indicate that the peri-hand space is partially remapped around the rubber hand. Nonetheless, the question remains if and to what extent the RHI can affect the perception of other body parts. In this study we ask if the RHI can alter the perception of the elbow joint. Participants had to adjust an angular representation on a screen according to their proprioceptive perception of their own elbow joint angle. The results show that the RHI does indeed alter the elbow joint estimation, increasing the agreement with the position and orientation of the artificial hand. Thus, the results show that the brain does not only adjust the perception of the hand in body-relative space, but it also modifies the perception of other body parts. In conclusion, we propose that the brain continuously strives to maintain a consistent internal body image and that this image can be influenced by the available sensory information sources, which are mediated and mapped onto each other by means of a postural, kinematic body model.	[Butz, Martin V.; Kutter, Esther F.; Lorenz, Corinna] Univ Tubingen, Fac Sci, Dept Psychol, Dept Comp Sci, Tubingen, Germany	Eberhard Karls University of Tubingen	Butz, MV (corresponding author), Univ Tubingen, Fac Sci, Dept Psychol, Dept Comp Sci, Tubingen, Germany.	martin.butz@uni-tuebingen.de		Lorenz, Corinna/0000-0001-5869-1017	Emmy Noether program of the German Research Foundation (DFG) [BU1335/3-1]; DFG	Emmy Noether program of the German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	Funding from the Emmy Noether program (grant BU1335/3-1) of the German Research Foundation (DFG) is acknowledged. We also acknowledge support by the DFG for the Open Access Publishing Fund of Tubingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Austen EL, 2004, COGN AFFECT BEHAV NE, V4, P170, DOI 10.3758/CABN.4.2.170; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Ehrenfeld S, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00148; Ehrenfeld S, 2013, BIOL CYBERN, V107, P61, DOI 10.1007/s00422-012-0526-2; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Farne A, 2000, BRAIN, V123, P2350, DOI 10.1093/brain/123.11.2350; Folegatti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006920; Gallagher S., 2005, BODY SHAPES MIND; Graziano MSA, 2002, ATTENTION PERFORM, V19, P136; Haggard P., 2005, HIGHER ORDER MOTOR D, P261; Heed T, 2011, ACTA PSYCHOL, V138, P263, DOI [10.1016/j.actpsy.2011.07.003, 10.1016/j.actpsy2011.07.003]; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; Ide M, 2013, PERCEPTION, V42, P103, DOI 10.1068/p7322; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kammers MPM, 2010, EXP BRAIN RES, V202, P203, DOI 10.1007/s00221-009-2124-7; LACKNER JR, 1988, BRAIN, V111, P281, DOI 10.1093/brain/111.2.281; Lloyd D, 2006, J NEUROPHYSIOL, V95, P205, DOI 10.1152/jn.00614.2005; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Paillard J., 1999, MOTOR CONTROL TODAY, P197, DOI DOI 10.1016/J.NEUROPSYCHOLOGIA.2009.09.022; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Pavani F, 2007, PERCEPTION, V36, P1547, DOI 10.1068/p5853; Preston C, 2013, ACTA PSYCHOL, V142, P177, DOI 10.1016/j.actpsy.2012.12.005; Riemer M, 2013, EXP BRAIN RES, V229, P383, DOI 10.1007/s00221-012-3374-3; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Snijders HJ, 2007, NEUROPSYCHOLOGIA, V45, P496, DOI 10.1016/j.neuropsychologia.2006.01.003; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Zopf R, 2011, NEUROPSYCHOLOGIA, V49, P1287, DOI 10.1016/j.neuropsychologia.2011.02.012	31	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92854	10.1371/journal.pone.0092854	http://dx.doi.org/10.1371/journal.pone.0092854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671172	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000084
J	Durairajan, SSK; Huang, YY; Yuen, PY; Chen, LL; Kwok, KY; Liu, LF; Song, JX; Han, QB; Xue, L; Chung, SK; Huang, JD; Baum, L; Senapati, S; Li, M				Durairajan, Siva Sundara Kumar; Huang, Ying-Yu; Yuen, Pui-Yee; Chen, Lei-Lei; Kwok, Ka-Yan; Liu, Liang-Feng; Song, Ju-Xian; Han, Quan-Bin; Xue, Lei; Chung, Sookja K.; Huang, Jian-Dong; Baum, Larry; Senapati, Sanjib; Li, Min			Effects of Huanglian-Jie-Du-Tang and Its Modified Formula on the Modulation of Amyloid-beta Precursor Protein Processing in Alzheimer's Disease Models	PLOS ONE			English	Article							OREN-GEDOKU-TO; SCUTELLARIA-BAICALENSIS GEORGI; TRANSIENT CEREBRAL-ISCHEMIA; TRANSGENIC MOUSE MODEL; PHOSPHORYLATION; EXTRACT; GENERATION; IMPAIRMENT; CELLS; MICE	Huanglian-Jie-Du-Tang (HLJDT) is a famous traditional Chinese herbal formula that has been widely used clinically to treat cerebral ischemia. Recently, we found that berberine, a major alkaloid compound in HLJDT, reduced amyloid-beta (A beta) accumulation in an Alzheimer's disease (AD) mouse model. In this study, we compared the effects of HLJDT, four single component herbs of HLJDT (Rhizoma coptidis (RC), Radix scutellariae (RS), Cortex phellodendri (CP) and Fructus gardenia (FG)) and the modified formula of HLJDT (HLJDT-M, which is free of RS) on the regulatory processing of amyloid-beta precursor protein (APP) in an in vitro model of AD. Here we show that treatment with HLJDT-M and its components RC, CP, and the main compound berberine on N2a mouse neuroblastoma cells stably expressing human APP with the Swedish mutation (N2a-SwedAPP) significantly decreased the levels of full-length APP, phosphorylated APP at threonine 668, C-terminal fragments of APP, soluble APP (sAPP)-alpha and sAPP beta-Swedish and reduced the generation of A beta peptide in the cell lysates of N2a-SwedAPP. HLJDT-M showed more significant APP- and A beta-reducing effects than berberine, RC or CP treatment alone. In contrast, HLJDT, its component RS and the main active compound of RS, baicalein, strongly increased the levels of all the metabolic products of APP in the cell lysates. The extract from FG, however, did not influence APP modulation. Interestingly, regular treatment of TgCRND8 APP transgenic mice with baicalein exacerbated the amyloid plaque burden, APP metabolism and A beta production. Taken together, these data provide convincing evidence that HLJDT and baicalein treatment can increase the amyloidogenic metabolism of APP which is at least partly responsible for the baicalein-mediated A beta plaque increase in the brains of TgCRND8 mice. On the other hand, HLJDT-M significantly decreased all the APP metabolic products including A beta. Further study of HLJDT-M for therapeutic use in treating AD is warranted.	[Durairajan, Siva Sundara Kumar; Huang, Ying-Yu; Yuen, Pui-Yee; Chen, Lei-Lei; Liu, Liang-Feng; Song, Ju-Xian; Li, Min] Hong Kong Baptist Univ, Sch Chinese Med, Neurosci Res Lab, Kowloon Tong, Hong Kong, Peoples R China; [Kwok, Ka-Yan; Han, Quan-Bin] Hong Kong Baptist Univ, Sch Chinese Med, Nat Prod Chem & Anal Lab, Kowloon Tong, Hong Kong, Peoples R China; [Xue, Lei] Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Shanghai 200092, Peoples R China; [Chung, Sookja K.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Huang, Jian-Dong] Univ Hong Kong, Li Ka Shing Fac Med, Dept Biochem, Pokfulam, Hong Kong, Peoples R China; [Baum, Larry] Chinese Univ Hong Kong, Sch Pharm, Shatin, Hong Kong, Peoples R China; [Senapati, Sanjib] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Hong Kong Baptist University; Hong Kong Baptist University; Tongji University; University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Durairajan, SSK (corresponding author), Hong Kong Baptist Univ, Sch Chinese Med, Neurosci Res Lab, Kowloon Tong, Hong Kong, Peoples R China.	dsskumar@hkbu.edu.hk; limin@hkbu.edu.hk	Durairajan, Siva Sundara Kumar/AAW-4617-2020; Baum, Lawrence/B-1005-2013; /C-4277-2009	Durairajan, Siva Sundara Kumar/0000-0001-7376-7163; Baum, Lawrence/0000-0002-5345-9355; /0000-0001-7531-2816; Li, Min/0000-0002-7113-2700; Song, Ju-Xian/0000-0001-7266-2060; Han, Quanbin/0000-0001-9051-1485	NSFC-RGC from the Hong Kong Government [RGC-N_HKBU 213/11, SCM/10-11/03, IRMS/12-13/1A, FRG1/11-12/045, FRG II/12-13/038, FRG1/12-13/037, HMRF/1112251]; Hong Kong Baptist University [38-40-115]	NSFC-RGC from the Hong Kong Government; Hong Kong Baptist University	This study was partly supported by NSFC-RGC joint research grant (RGC-N_HKBU 213/11) from the Hong Kong Government, research grants SCM/10-11/03, IRMS/12-13/1A, FRG1/11-12/045, FRG II/12-13/038, FRG1/12-13/037, and HMRF/1112251, and RC Start up grant for new academics for Dr. Durairajan Siva Sundara Kumar (38-40-115) from Hong Kong Baptist University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badiola N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058837; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Boyd M.R., 1997, ANTICANCER DRUG DEV, P23, DOI [DOI 10.1007/978-1-4615-8152-9_2, 10.1007/978-1-4615-8152-9_2]; Chen GH, 2007, J EMERG TCM, V16, P386; Chen JH, 2008, ANAL CHIM ACTA, V613, P184, DOI 10.1016/j.aca.2008.02.060; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Colombo A, 2009, NEUROBIOL DIS, V33, P518, DOI 10.1016/j.nbd.2008.12.014; De Strooper B, 2000, J CELL SCI, V113, P1857; Durairajan SSK, 2008, NEUROCHEM INT, V52, P741, DOI 10.1016/j.neuint.2007.09.006; Durairajan SSK, 2012, NEUROBIOL AGING, V33, P2903, DOI 10.1016/j.neurobiolaging.2012.02.016; Durairajan SSK, 2011, J ALZHEIMERS DIS, V25, P245, DOI 10.3233/JAD-2011-102085; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hayes CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045841; Hu YH, 2012, J ETHNOPHARMACOL, V141, P728, DOI 10.1016/j.jep.2011.08.011; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; Ito E, 1991, GERIATR MED, V29, P303; Khoddami A, 2013, MOLECULES, V18, P2328, DOI 10.3390/molecules18022328; Kondo Y, 2000, NEUROCHEM RES, V25, P205, DOI 10.1023/A:1007515318434; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Lewczuk P, 2010, MOL PSYCHIATR, V15, P138, DOI 10.1038/mp.2008.84; Li Y, 2006, FASEB J, V20, P285, DOI 10.1096/fj.05-4986com; Lleo A, 2006, ANNU REV MED, V57, P513, DOI 10.1146/annurev.med.57.121304.131442; Lu JH, 2011, CHEMBIOCHEM, V12, P615, DOI 10.1002/cbic.201000604; Luo JL, 2012, J FOOD DRUG ANAL, V20, P887, DOI 10.6227/jfda.2012200419; Nam Y, 2013, J TRADIT CHIN MED, V33, P223, DOI 10.1016/S0254-6272(13)60129-6; Okamoto H, 2013, NEUROPSYCH DIS TREAT, V9, P151, DOI 10.2147/NDT.S38318; Otomo E, 1991, GERIAT MED, V29, P121; Paris D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-17; Peng Y, 2007, NEUROSCIENCE, V150, P386, DOI 10.1016/j.neuroscience.2007.09.022; Pham TQ, 2000, J AGR FOOD CHEM, V48, P1455, DOI 10.1021/jf991263j; Qiu Xin, 2011, Zhongguo Zhong Xi Yi Jie He Za Zhi, V31, P1379; Quan QK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059155; Rockenstein E, 2007, J NEUROSCI, V27, P1981, DOI 10.1523/JNEUROSCI.4321-06.2007; Sekiya N, 2005, BIOL PHARM BULL, V28, P294, DOI 10.1248/bpb.28.294; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Shang YZ, 2006, PHYTOTHER RES, V20, P53, DOI 10.1002/ptr.1802; Shao ZH, 1999, J MOL CELL CARDIOL, V31, P1885, DOI 10.1006/jmcc.1999.1021; Silva EFDE, 2003, NEUROCHEM RES, V28, P1553, DOI 10.1023/A:1025630627319; Suzuki T, 2006, J BIOCHEM, V139, P949, DOI 10.1093/jb/mvj121; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Tsai TH, 2002, BRIT J PHARMACOL, V137, P1314, DOI 10.1038/sj.bjp.0704959; Wang GX, 2010, VET PARASITOL, V171, P305, DOI 10.1016/j.vetpar.2010.03.032; Wang L, 2012, MOL NEURODEGENER, V7, pS4; Wang Shan, 2007, Zhongguo Zhong Yao Za Zhi, V32, P2289; Wang XL, 2005, LIFE SCI, V77, P3058, DOI 10.1016/j.lfs.2005.02.033; Xu JH, 2000, J ETHNOPHARMACOL, V73, P405, DOI 10.1016/S0378-8741(00)00303-2; Ye YL, 2012, BIOL PHARM BULL, V35, P355, DOI 10.1248/bpb.35.355; Youmans KL, 2011, J NEUROSCI METH, V196, P51, DOI 10.1016/j.jneumeth.2010.12.025; Yun SM, 2013, NEUROBIOL AGING, V34, P650, DOI 10.1016/j.neurobiolaging.2012.08.005; Zeng HW, 2011, J ETHNOPHARMACOL, V135, P561, DOI 10.1016/j.jep.2011.03.055; Zhang SQ, 2013, J NEUROSCI RES, V91, P1239, DOI 10.1002/jnr.23244; Zhu HX, 2013, PHYTOMEDICINE, V20, P767, DOI 10.1016/j.phymed.2012.11.012	54	31	35	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92954	10.1371/journal.pone.0092954	http://dx.doi.org/10.1371/journal.pone.0092954			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671102	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000094
J	Tranquilla, LAM; Montevecchi, WA; Fifield, DA; Hedd, A; Gaston, AJ; Robertson, GJ; Phillips, RA				Tranquilla, Laura A. McFarlane; Montevecchi, William A.; Fifield, David A.; Hedd, April; Gaston, Anthony J.; Robertson, Gregory J.; Phillips, Richard A.			Individual Winter Movement Strategies in Two Species of Murre ( Uria spp.) in the Northwest Atlantic	PLOS ONE			English	Article							TRANS-EQUATORIAL MIGRATION; HABITAT USE; PHENOTYPIC PLASTICITY; LAYING DATE; SEABIRD; TRACKING; OCEAN; DIET; REPEATABILITIES; DECISIONS	Individual wintering strategies and patterns of winter site fidelity in successive years are highly variable among seabird species. Yet, an understanding of consistency in timing of movements and the degree of site fidelity is essential for assessing how seabird populations might be influenced by, and respond to, changing conditions on wintering grounds. To explore annual variation in migratory movements and wintering areas, we applied bird-borne geolocators on Thick-billed Murres (Uria lomvia, n = 19) and Common Murres (U. aalge, n = 20) from 5 colonies in the Northwest Atlantic for 2-4 consecutive years. Thick-billed Murres ranged widely and among-individual wintering strategies were highly variable, whereas most Common Murres wintered relatively near their colonies, with among-individual variation represented more by the relative use of inshore vs. offshore habitat. Within individuals, some aspects of the wintering strategy were more repeatable than others: colony arrival and departure dates were more consistent by individual Common than Thick-billed Murres, while the sizes of home ranges (95% utilization distributions) and distances travelled to wintering area were more repeatable for both species. In consecutive years, individual home ranges overlapped from 0- 64% (Thick-billed Murres) and 0-95% (Common Murres); and the winter centroids were just 239 km and 169 km apart (respectively). Over the 3-4 year timescale of our study, individuals employed either fixed or flexible wintering strategies; although most birds showed high winter site fidelity, some shifted core ranges after 2 or 3 years. The capacity among seabird species for a combination of fidelity and flexibility, in which individuals may choose from a range of alternative strategies, deserves further, longer term attention.	[Tranquilla, Laura A. McFarlane; Montevecchi, William A.; Fifield, David A.; Hedd, April] Mem Univ Newfoundland, Dept Psychol, St John, NF, Canada; [Gaston, Anthony J.] Carleton Univ, Natl Wildlife Res Ctr, Environm Canada, Ottawa, ON K1S 5B6, Canada; [Robertson, Gregory J.] Environm Canada, Wildlife Res Div, Mt Pearl, NF, Canada; [Phillips, Richard A.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	Memorial University Newfoundland; Carleton University; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; Environment & Climate Change Canada; Canadian Wildlife Service; Wildlife Research Division - Environment Canada; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Tranquilla, LAM (corresponding author), Mem Univ Newfoundland, Dept Psychol, St John, NF, Canada.	lat@alumni.sfu.ca	Robertson, Greg/AAI-5849-2020	Robertson, Greg/0000-0001-8452-5506; Hedd, April/0000-0003-2222-2627	National Sciences and Engineering Research Council (NSERC); Wildlife Habitat Canada and Bird Studies Canada Murre Fund of Newfoundland and Labrador; Government of Canada's International Polar Year; Northern Scientific Training Programs; Polar Continental Shelf Project of Natural Resources Canada; NSERC PGS-D Scholarship; Environment Canada; Natural Environment Research Council [bas0100025] Funding Source: researchfish; NERC [bas0100025] Funding Source: UKRI	National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Wildlife Habitat Canada and Bird Studies Canada Murre Fund of Newfoundland and Labrador; Government of Canada's International Polar Year; Northern Scientific Training Programs; Polar Continental Shelf Project of Natural Resources Canada; NSERC PGS-D Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Environment Canada(CGIAR); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by a National Sciences and Engineering Research Council (NSERC) Discovery Grant (WAM); the Wildlife Habitat Canada and Bird Studies Canada Murre Fund of Newfoundland and Labrador (WAM); the Government of Canada's International Polar Year (WAM, AJG) and Northern Scientific Training Programs (LMT), the Polar Continental Shelf Project of Natural Resources Canada (AJG), an NSERC PGS-D Scholarship (LMT) and by logistical and financial support from Environment Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agashe D, 2010, P ROY SOC B-BIOL SCI, V277, P2915, DOI 10.1098/rspb.2010.0232; AINLEY DG, 2002, BIRDS N AM, V666; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; BAKER RR, 1980, BIRD STUDY, V27, P41, DOI 10.1080/00063658009476655; BIRKHEAD TR, 1982, ECOLOGY, V63, P300, DOI 10.2307/1938946; Bogdanova MI, 2011, P ROY SOC B-BIOL SCI, V278, P2412, DOI 10.1098/rspb.2010.2601; Burke CM, 2011, ARCTIC, V64, P302; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Catry P, 1999, OIKOS, V84, P473, DOI 10.2307/3546426; Catry P, 2013, ECOLOGY, V94, P1230, DOI 10.1890/12-2177.1; Conklin JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054535; Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; DeForest LN, 1996, ECOLOGY, V77, P1501, DOI 10.2307/2265547; Dias MP, 2011, P ROY SOC B-BIOL SCI, V278, P1786, DOI 10.1098/rspb.2010.2114; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Esler D, 2000, CONSERV BIOL, V14, P366, DOI 10.1046/j.1523-1739.2000.98147.x; Fifield DA, 2013, ORNITHHOL M IN PRESS; Fort J, 2013, DIVERS DISTRIB, V19, P1322, DOI 10.1111/ddi.12105; Fort J, 2013, J AVIAN BIOL, V44, P255, DOI 10.1111/j.1600-048X.2012.00128.x; Fort J, 2012, FRONT ECOL ENVIRON, V10, P237, DOI 10.1890/110194; Frederiksen M, 2012, DIVERS DISTRIB, V18, P530, DOI 10.1111/j.1472-4642.2011.00864.x; GASTON AJ, 2000, BIRDS N AM, V497; Gaston AJ, 2002, 106 CAN WILDL SERV; Gaston AJ, 2011, MAR BIOL, V158, P1929, DOI 10.1007/s00227-011-1704-9; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Guilford T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021336; Harris MP, 1996, BIRD STUDY, V43, P220, DOI 10.1080/00063659609461014; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; Hedd A, 2011, ANIM CONSERV, V14, P630, DOI 10.1111/j.1469-1795.2011.00479.x; Hedd A, 2012, MAR ECOL PROG SER, V449, P277, DOI 10.3354/meps09538; HILL R.D., 2001, ELECT TAGGING TRACKI; Kernaleguen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032916; Kopp M, 2011, MAR ECOL PROG SER, V435, P263, DOI 10.3354/meps09229; Kubetzki U, 2009, MAR ECOL PROG SER, V391, P257, DOI 10.3354/meps08254; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lisovski S, 2012, METHODS ECOL EVOL, V3, P603, DOI 10.1111/j.2041-210X.2012.00185.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Oppel S, 2009, J ANIM ECOL, V78, P524, DOI 10.1111/j.1365-2656.2008.01513.x; Phillips RA, 2005, ECOLOGY, V86, P2386, DOI 10.1890/04-1885; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Phillips RA, 2009, OECOLOGIA, V160, P795, DOI 10.1007/s00442-009-1342-9; Pulido F, 2007, CLIM RES, V35, P5, DOI 10.3354/cr00711; Quillfeldt P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1157, DOI 10.1007/s00265-010-0931-2; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Reed TE, 2010, P ROY SOC B-BIOL SCI, V277, P3391, DOI 10.1098/rspb.2010.0771; Reed TE, 2009, J ANIM ECOL, V78, P376, DOI 10.1111/j.1365-2656.2008.01503.x; Regular PM, 2013, ANIM BEHAV, V86, P545, DOI 10.1016/j.anbehav.2013.06.008; Roshier DA, 2008, OECOLOGIA, V156, P465, DOI 10.1007/s00442-008-0987-0; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Smith PA, 2012, MAR ECOL PROG SER, V454, P237, DOI 10.3354/meps09589; Sorensen MC, 2009, J ANIM ECOL, V78, P460, DOI 10.1111/j.1365-2656.2008.01492.x; Stenhouse IJ, 2012, IBIS, V154, P42, DOI 10.1111/j.1474-919X.2011.01180.x; Tranquilla LAM, 2013, MAR ECOL PROG SER, V472, P287, DOI 10.3354/meps10053; Tuck L.M, 1961, CANADIAN WILDLIFE SE, V1; WANLESS S, 1988, ORNIS SCAND, V19, P205, DOI 10.2307/3676560; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Woo KJ, 2008, J ANIM ECOL, V77, P1082, DOI 10.1111/j.1365-2656.2008.01429.x	57	44	44	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e90583	10.1371/journal.pone.0090583	http://dx.doi.org/10.1371/journal.pone.0090583			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24694734	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000334103000009
J	Bao, YB; Zhang, LL; Dong, YH; Lin, ZH				Bao, Yongbo; Zhang, Lili; Dong, Yinghui; Lin, Zhihua			Identification and Comparative Analysis of the Tegillarca granosa Haemocytes MicroRNA Transcriptome in Response to Cd Using a Deep Sequencing Approach	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; HEAVY-METALS; CADMIUM; EXPRESSION; TARGETS; PHYTOCHELATINS; DROSOPHILA; EVOLUTION; MIR-100; STRESS	Background: MicroRNAs (miRNAs) are endogenous non-coding small RNAs (sRNAs) that can base pair with their target mRNAs, which represses their translation or induces their degradation in various biological processes. To identify miRNAs regulated by heavy metal stress, we constructed two sRNA libraries for the blood clam Tegillarca granosa: one for organisms exposed to toxic levels of cadmium (Cd) and one for a control group. Results: Sequencing of the two libraries and subsequent analysis revealed 215 conserved and 39 new miRNAs. Most of the new miRNAs in T. granosa were up-or down-regulated in response to Cd exposure. There were significant differences in expression between the Cd and control groups for 16 miRNAs. Of these, five miRNAs were significantly up-regulated and 11 were significantly down-regulated in the Cd stress library. Potential targets were predicted for the 16 differential miRNAs in pre-miRNAs identified according to sequence homology. Some of the predicted miRNA targets are associated with regulation of the response to stress induced by heavy metals. Five differentially expressed miRNAs (Tgr-nmiR-8, Tgr-nmiR-21, Tgr-miR-2a, Tgr-miR-10a-5p, and Tgr-miR-184b) were validated by qRT-PCR. Conclusion: Our study is the first large-scale identification of miRNAs in T. granosa haemocytes. Our findings suggest that some miRNAs and their target genes and pathways may play critical roles in the responses of this species to environmental heavy metal stresses.	[Bao, Yongbo; Zhang, Lili; Dong, Yinghui; Lin, Zhihua] Zhejiang Wanli Univ, Zhejiang Key Lab Aquat Germplasm Resources, Ningbo, Zhejiang, Peoples R China	Zhejiang Wanli University	Bao, YB (corresponding author), Zhejiang Wanli Univ, Zhejiang Key Lab Aquat Germplasm Resources, Ningbo, Zhejiang, Peoples R China.	bobbao2001@gmail.com; zhihua9988@126.com			National High-tech R&D Program of China [2012AA10A410]; Chinese Agriculture Research System [CARS-48]; Zhejiang Major Program of Science and Technology [2012C12907-4]; Ningbo Innovation Team of Marine Shellfish Science and Technology [2011B82017]	National High-tech R&D Program of China(National High Technology Research and Development Program of China); Chinese Agriculture Research System; Zhejiang Major Program of Science and Technology; Ningbo Innovation Team of Marine Shellfish Science and Technology	This research was supported by National High-tech R&D Program of China (2012AA10A410), Chinese Agriculture Research System (CARS-48), Zhejiang Major Program of Science and Technology (2012C12907-4) and Ningbo Innovation Team of Marine Shellfish Science and Technology (2011B82017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboobaker AA, 2005, P NATL ACAD SCI USA, V102, P18017, DOI 10.1073/pnas.0508823102; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blaudez D, 2003, PLANT CELL, V15, P2911, DOI 10.1105/tpc.017541; BOQUIST L, 1971, GEN COMP ENDOCR, V17, P236, DOI 10.1016/0016-6480(71)90172-9; Campbell SJ, 2012, J BIOL CHEM, V287, P23900, DOI 10.1074/jbc.M112.359653; Cobbett CS, 2000, PLANT PHYSIOL, V123, P825, DOI 10.1104/pp.123.3.825; Cristino AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019350; Ding YF, 2009, BIOCHEM BIOPH RES CO, V386, P6, DOI 10.1016/j.bbrc.2009.05.137; Enright AJ, 2004, GENOME BIOL, V5; Ernst WHO, 2008, PLANT CELL ENVIRON, V31, P123, DOI 10.1111/j.1365-3040.2007.01746.x; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Guzman F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049811; Hammond-Martel I, 2012, CELL SIGNAL, V24, P410, DOI 10.1016/j.cellsig.2011.10.009; Han FXX, 2002, NATURWISSENSCHAFTEN, V89, P497, DOI 10.1007/s00114-002-0373-4; Harada E, 2002, J PLANT PHYSIOL, V159, P445, DOI 10.1078/0176-1617-00733; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Herbette S, 2006, BIOCHIMIE, V88, P1751, DOI 10.1016/j.biochi.2006.04.018; Huang SQ, 2009, J INORG BIOCHEM, V103, P282, DOI 10.1016/j.jinorgbio.2008.10.019; Jiao Y, 2014, MAR BIOTECHNOL, V16, P54, DOI 10.1007/s10126-013-9528-x; Kefaloyianni E, 2005, J EXP BIOL, V208, P4427, DOI 10.1242/jeb.01924; Li BH, 2011, EUR J CANCER, V47, P2166, DOI 10.1016/j.ejca.2011.04.037; Li CH, 2012, FISH SHELLFISH IMMUN, V33, P436, DOI 10.1016/j.fsi.2012.04.013; Li P, 2011, MOL BIOL REP, V38, P355, DOI 10.1007/s11033-010-0115-1; Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; Marco A, 2012, RNA BIOL, V9, P242, DOI 10.4161/rna.19160; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; MERALI Z, 1976, BRIT J PHARMACOL, V57, P573, DOI 10.1111/j.1476-5381.1976.tb10387.x; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; Pal R, 2010, APPL BIOCHEM BIOTECH, V160, P945, DOI 10.1007/s12010-009-8565-4; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Schmidt Ulrike, 2013, Front Psychiatry, V4, P66, DOI 10.3389/fpsyt.2013.00066; Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94; Shan Z, 2013, CHINESE MED J-PEKING, V126, P515, DOI 10.3760/cma.j.issn.0366-6999.20122289; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Sun YM, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-6; Takiguchi M, 2003, EXP CELL RES, V286, P355, DOI 10.1016/S0014-4827(03)00062-4; VIARENGO A, 1993, COMP BIOCHEM PHYS C, V104, P355, DOI 10.1016/0742-8413(93)90001-2; Wang C, 2011, PHYSIOL PLANTARUM, V143, P64, DOI 10.1111/j.1399-3054.2011.01481.x; Wang SL, 2013, MAR POLLUT BULL, V76, P7, DOI 10.1016/j.marpolbul.2013.08.025; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Wu ZH, 2012, ENVIRON EARTH SCI, V66, P2417, DOI 10.1007/s12665-011-1466-1; Zhou ZS, 2012, J EXP BOT, V63, P4597, DOI 10.1093/jxb/ers136; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x	46	16	21	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93619	10.1371/journal.pone.0093619	http://dx.doi.org/10.1371/journal.pone.0093619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690903	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100113
J	Fagyas, M; Uri, K; Siket, IM; Fulop, GA; Csato, V; Darago, A; Boczan, J; Banyai, E; Szentkiralyi, IE; Maros, TM; Szerafin, T; Edes, I; Papp, Z; Toth, A				Fagyas, Miklos; Uri, Katalin; Siket, Ivetta M.; Fueloep, Gabor A.; Csato, Viktoria; Darago, Andrea; Boczan, Judit; Banyai, Emese; Szentkiralyi, Istvan Elek; Maros, Tamas Miklos; Szerafin, Tamas; Edes, Istvan; Papp, Zoltan; Toth, Attila			New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) II: Albumin Suppresses Angiotensin Converting Enzyme (ACE) Activity in Human	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; HUMAN-SERUM-ALBUMIN; EUROPEAN-SOCIETY; TASK-FORCE; TRYPTIC HYDROLYSATE; ENDOGENOUS INHIBITOR; CARDIOLOGY ESC; GUIDELINES; ASSOCIATION; DISEASE	About 8% of the adult population is taking angiotensin-converting enzyme (ACE) inhibitors to treat cardiovascular disease including hypertension, myocardial infarction and heart failure. These drugs decrease mortality by up to one-fifth in these patients. We and others have reported previously that endogenous inhibitory substances suppress serum ACE activity, in vivo, similarly to the ACE inhibitor drugs. Here we have made an effort to identify this endogenous ACE inhibitor substance. ACE was crosslinked with interacting proteins in human sera. The crosslinked products were immunoprecipitated and subjected to Western blot. One of the crosslinked products was recognized by both anti-ACE and anti-HSA (human serum albumin) antibodies. Direct ACE-HSA interaction was confirmed by binding assays using purified ACE and HSA. HSA inhibited human purified (circulating) and human recombinant ACE with potencies (IC50) of 5.7 +/- 0.7 and 9.5 +/- 1.1 mg/mL, respectively. Effects of HSA on the tissue bound native ACE were tested on human saphenous vein samples. Angiotensin I evoked vasoconstriction was inhibited by HSA in this vascular tissue (maximal force with HSA: 6.14 +/- 1.34 mN, without HSA: 13.54 +/- 2.63 mN), while HSA was without effects on angiotensin II mediated constrictions (maximal force with HSA: 18.73 +/- 2.17 mN, without HSA: 19.22 +/- 3.50 mN). The main finding of this study is that HSA was identified as a potent physiological inhibitor of the ACE. The enzymatic activity of ACE appears to be almost completely suppressed by HSA when it is present in its physiological concentration. These data suggest that angiotensin I conversion is limited by low physiological ACE activities, in vivo.	[Fagyas, Miklos; Uri, Katalin; Siket, Ivetta M.; Fueloep, Gabor A.; Csato, Viktoria; Darago, Andrea; Edes, Istvan; Papp, Zoltan; Toth, Attila] Univ Debrecen, Inst Cardiol, Div Clin Physiol, H-4012 Debrecen, Hungary; [Boczan, Judit] Univ Debrecen, Dept Neurol, H-4012 Debrecen, Hungary; [Banyai, Emese] Univ Debrecen, Div Nephrol, Inst Internal Med, H-4012 Debrecen, Hungary; [Szentkiralyi, Istvan Elek; Maros, Tamas Miklos; Szerafin, Tamas] Univ Debrecen, Inst Cardiol, Dept Cardiac Surg, H-4012 Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen	Toth, A (corresponding author), Univ Debrecen, Inst Cardiol, Div Clin Physiol, H-4012 Debrecen, Hungary.	atitoth@med.unideb.hu	Fagyas, Miklós/AAQ-1013-2020; Tóth, Attila/F-4859-2010	Fagyas, Miklós/0000-0003-3262-884X; Tóth, Attila/0000-0001-6503-3653	Hungarian Academy of Sciences OTKA [K84300]; Hungarian Ministry of Health [ETT 377/2009]; MSD Magyarorszag Kft; Pfizer Magyarorszag Kft; European Social Fund; National Innovation Office of Hungary; Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences;  [TAMOP 4.2.1./B-09/1/KONV-2010-0007];  [TAMOP-4.2.2.A-11/1/KONV-2012-0045];  [REG-EA-09-1-2009-0013]	Hungarian Academy of Sciences OTKA(Hungarian Academy of SciencesOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Ministry of Health; MSD Magyarorszag Kft; Pfizer Magyarorszag Kft; European Social Fund(European Social Fund (ESF)); National Innovation Office of Hungary; Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); ; ; 	The study was supported by the Hungarian Academy of Sciences OTKA (K84300 toAT) and by the Hungarian Ministry of Health (ETT 377/2009 to AT); the work is supported by the TAMOP 4.2.1./B-09/1/KONV-2010-0007 TAMOP-4.2.2.A-11/1/KONV-2012-0045, REG-EA-09-1-2009-0013 projects (to AT, IE and ZP); MSD Magyarorszag Kft, Pfizer Magyarorszag Kft also supported some of the research. The project is implemented through the New Hungary Development Plan, co-financed by the European Social Fund; and by the National Innovation Office of Hungary (Baross Gabor Project, EletMent). Finally, AT was supported by the Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PLOS ONE; BENETEAU B, 1986, CLIN CHEM, V32, P884; Brecher AS, 1996, ARCH INT PHARMACOD T, V331, P301; Carmona AK, 2006, NAT PROTOC, V1, P1971, DOI 10.1038/nprot.2006.306; CORVOL P, 1995, J HYPERTENS, V13, pS3, DOI 10.1097/00004872-199509003-00002; CUSHMAN DW, 1971, BIOCHIM BIOPHYS ACTA, V250, P261, DOI 10.1016/0005-2744(71)90142-2; Davidson NC, 1996, CIRCULATION, V93, P1155, DOI 10.1161/01.CIR.93.6.1155; Dzau VJ, 2001, AM J CARDIOL, V88, p1L; Fagyas M, 2014, PLOS ONE; Fagyas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087843; Fox KM, 2003, LANCET, V362, P782; GREENBERG B, 1995, CIRCULATION, V91, P2573, DOI 10.1161/01.CIR.91.10.2573; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hoogwerf BJ, 2000, CLEV CLIN J MED, V67, P287, DOI 10.3949/ccjm.67.4.287; Howard G, 2001, ANAESTH INTENS CARE, V29, P591, DOI 10.1177/0310057X0102900604; HUBERT C, 1991, J BIOL CHEM, V266, P15377; IKEMOTO F, 1989, BIOCHEM BIOPH RES CO, V159, P1093, DOI 10.1016/0006-291X(89)92221-3; KLAUSER RJ, 1979, HYPERTENSION, V1, P281, DOI 10.1161/01.HYP.1.3.281; Leon-Ruiz V, 2013, FOOD FUNCT, V4, P1617, DOI 10.1039/c3fo60221d; LIEBERMAN J, 1986, CHEST, V90, P869, DOI 10.1378/chest.90.6.869; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Nakagomi K, 1998, FEBS LETT, V438, P255, DOI 10.1016/S0014-5793(98)01311-8; Nakagomi K, 2000, BIOL PHARM BULL, V23, P879; OPPONG SY, 1993, BIOCHEM J, V292, P597, DOI 10.1042/bj2920597; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; ROGERSON FM, 1989, NEUROPEPTIDES, V14, P213, DOI 10.1016/0143-4179(89)90048-6; Ryan J W, 1979, Adv Exp Med Biol, V120B, P599; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; SNYDER RA, 1986, BIOCHIM BIOPHYS ACTA, V871, P1, DOI 10.1016/0167-4838(86)90125-1; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Tauzin J, 2002, FEBS LETT, V531, P369, DOI 10.1016/S0014-5793(02)03576-7; Taylor J, 2012, EUR HEART J, V33, P1539, DOI 10.1093/eurheartj/ehs137; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; Thevananther S, 1999, CAN J PHYSIOL PHARM, V77, P216, DOI 10.1139/cjpp-77-3-216; van Dijk MA, 2000, J CARDIOVASC PHARM, V35, P484, DOI 10.1097/00005344-200003000-00020; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; WEI L, 1991, J BIOL CHEM, V266, P5540	37	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e87844	10.1371/journal.pone.0087844	http://dx.doi.org/10.1371/journal.pone.0087844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691203	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100003
J	Song, HM; Liu, Y; Li, Q; Gao, N; Ma, YY; Zhang, YH				Song, Huiming; Liu, Yu; Li, Qiang; Gao, Na; Ma, Yongyong; Zhang, Yanhua			Tree-Ring Based May-July Temperature Reconstruction Since AD 1630 on the Western Loess Plateau, China	PLOS ONE			English	Article							DROUGHT RECONSTRUCTION; CLIMATE; PRECIPITATION; RECORDS; SUN	Tree-ring samples from Chinese Pine (Pinus tabulaeformis Carr.) collected at Mt. Shimen on the western Loess Plateau, China, were used to reconstruct the mean May-July temperature during AD 1630-2011. The regression model explained 48% of the adjusted variance in the instrumentally observed mean May-July temperature. The reconstruction revealed significant temperature variations at interannual to decadal scales. Cool periods observed in the reconstruction coincided with reduced solar activities. The reconstructed temperature matched well with two other tree-ring based temperature reconstructions conducted on the northern slope of the Qinling Mountains (on the southern margin of the Loess Plateau of China) for both annual and decadal scales. In addition, this study agreed well with several series derived from different proxies. This reconstruction improves upon the sparse network of high-resolution paleoclimatic records for the western Loess Plateau, China.	[Song, Huiming; Liu, Yu; Li, Qiang; Ma, Yongyong; Zhang, Yanhua] Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian, Peoples R China; [Liu, Yu] Xi An Jiao Tong Univ, Sch Human Settlements & Civil Engn, Dept Environm Sci & Technol, Xian 710049, Peoples R China; [Song, Huiming; Ma, Yongyong; Zhang, Yanhua] Univ Chinese Acad Sci, Beijing, Peoples R China; [Gao, Na] China Earthquake Adm, Inst Geol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Earth Environment, CAS; Xi'an Jiaotong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; China Earthquake Administration	Liu, Y (corresponding author), Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian, Peoples R China.	liuyu@loess.llqg.ac.cn	Liu, Yu/I-8125-2014; Liu, Yu/AAA-6165-2019	liu, yu/0000-0002-1402-0737	National Basic Research Program of China [2013CB955900]; Chinese Academy of Sciences [KZZD - EW - 04 - 01]; CAS/SAFEA International Partnership Program for Creative Research Teams [KZZD - EW - TZ - 03]; CAS; Institute of Earth Environment; State Key Laboratory of Loess and Quaternary Geology (SKLLQG)	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); CAS(Chinese Academy of Sciences); Institute of Earth Environment; State Key Laboratory of Loess and Quaternary Geology (SKLLQG)(Chinese Academy of Sciences)	This study was supported by grants from the National Basic Research Program of China (no. 2013CB955900), the Chinese Academy of Sciences (KZZD - EW - 04 - 01), the CAS/SAFEA International Partnership Program for Creative Research Teams (KZZD - EW - TZ - 03), the CAS Hundred Talents Program, the Key Project of the Institute of Earth Environment and the Project of State Key Laboratory of Loess and Quaternary Geology (SKLLQG). This research is an initiative of the Sino-Swedish Tree-Ring Research Center (SISTRR): Contribution (No. 025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer J, 2000, QUATERNARY SCI REV, V19, P403, DOI 10.1016/S0277-3791(99)00072-4; Cai QF, 2008, SCI CHINA SER D, V51, P1099, DOI 10.1007/s11430-008-0084-6; Cayan DR, 1998, J CLIMATE, V11, P3148, DOI 10.1175/1520-0442(1998)011<3148:DVOPOW>2.0.CO;2; Cook ER, 1990, METHODS DENDROCHRONO, DOI DOI 10.1007/978-94-015-7879-0; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Deng Y, 2013, CLIMATE RES IN PRESS; Fan ZM, 2012, PROCEDIA ENVIRON SCI, V13, P715, DOI 10.1016/j.proenv.2012.01.064; Fang KY, 2010, INT J CLIMATOL, V30, P1137, DOI 10.1002/joc.1974; Fritts HC, 1976, TREE RINGS CLIMATES; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Kang SY, 2012, CLIMATIC CHANGE, V115, P519, DOI 10.1007/s10584-012-0440-6; Li JB, 2007, INT J CLIMATOL, V27, P903, DOI 10.1002/joc.1450; Li Q, 2013, QUATERN INT, V283, P11, DOI 10.1016/j.quaint.2012.03.017; Li Z, 2010, QUATERN INT, V226, P92, DOI 10.1016/j.quaint.2010.03.003; Liang EY, 2008, GLOBAL PLANET CHANGE, V61, P313, DOI 10.1016/j.gloplacha.2007.10.008; Liang EY, 2003, ANN FOREST SCI, V60, P145, DOI 10.1051/forest:2003007; Lin X, 2013, CHINESE SCI BULL, V58, P4497, DOI 10.1007/s11434-013-5969-x; Liu Y, 2007, TREE-RING RES, V63, P3, DOI 10.3959/1536-1098-63.1.3; Liu Y, 2013, INT J BIOMETEOROL, V57, P927, DOI 10.1007/s00484-012-0618-7; Liu Y, 2009, BOREAS, V38, P285, DOI 10.1111/j.1502-3885.2008.00065.x; Mishra AK, 2010, J HYDROL, V391, P204, DOI 10.1016/j.jhydrol.2010.07.012; Oberhuber W, 1998, TREES-STRUCT FUNCT, V13, P19; Qian L. Q., 1991, CLIMATE LOESS PLATEA; Rehman S, 2010, INT J CLIMATOL, V30, P445, DOI 10.1002/joc.1907; SNEE RD, 1977, TECHNOMETRICS, V19, P415, DOI 10.2307/1267881; Song HM, 2013, QUATERN INT, V283, P30, DOI 10.1016/j.quaint.2012.03.033; Song HM, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016220; Stokes M.A., 1996, INTRO TREE RING DATI; Tan LC, 2008, CLIM PAST, V4, P19; [田沁花 TIAN Qinhua], 2009, [地理学报, Acta Geographica Sinica], V64, P879; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Yang YH, 2012, THEOR APPL CLIMATOL, V107, P143, DOI 10.1007/s00704-011-0467-z; Yi L, 2012, CLIMATIC CHANGE, V110, P469, DOI 10.1007/s10584-011-0052-6; Zhang PZ, 2008, SCIENCE, V322, P940, DOI 10.1126/science.1163965	34	22	28	7	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93504	10.1371/journal.pone.0093504	http://dx.doi.org/10.1371/journal.pone.0093504			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690885	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100092
J	Valles, AS; Aveldano, MI; Furland, NE				Valles, Ana S.; Aveldano, Marta I.; Furland, Natalia E.			Altered Lipid Homeostasis in Sertoli Cells Stressed by Mild Hyperthermia	PLOS ONE			English	Article							APOPTOTIC SPERMATOGENIC CELLS; POLYENOIC FATTY-ACIDS; LONG-CHAIN; IN-VITRO; MITOCHONDRIAL DYSFUNCTION; PHAGOCYTIC FUNCTION; DROPLET FORMATION; MEMBRANE BARRIER; HEAT-STRESS; RAT TESTIS	Spermatogenesis is known to be vulnerable to temperature. Exposures of rat testis to moderate hyperthermia result in loss of germ cells with survival of Sertoli cells (SC). Because SC provide structural and metabolic support to germ cells, our aim was to test the hypothesis that these exposures affect SC functions, thus contributing to germ cell damage. In vivo, regularly repeated exposures (one of 15 min per day, once a day during 5 days) of rat testes to 43 degrees C led to accumulation of neutral lipids. This SC-specific lipid function took 1-2 weeks after the last of these exposures to be maximal. In cultured SC, similar daily exposures for 15 min to 43 degrees C resulted in significant increase in triacylglycerol levels and accumulation of lipid droplets. After incubations with [H-3] arachidonate, the labeling of cardiolipin decreased more than that of other lipid classes. Another specifically mitochondrial lipid metabolic function, fatty acid oxidation, also declined. These lipid changes suggested that temperature affects SC mitochondrial physiology, which was confirmed by significantly increased degrees of membrane depolarization and ROS production. This concurred with reduced expression of two SC-specific proteins, transferrin, and Wilms' Tumor 1 protein, markers of SC secretion and differentiation functions, respectively, and with an intense SC cytoskeletal perturbation, evident by loss of microtubule network (alpha-tubulin) and microfilament (f-actin) organization. Albeit temporary and potentially reversible, hyperthermia-induced SC structural and metabolic alterations may be long-lasting and/or extensive enough to respond for the decreased survival of the germ cells they normally foster.	[Furland, Natalia E.] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Bahi Blanca, Bahia Blanca, Buenos Aires, Argentina; Univ Nacl Sur, RA-8000 Bahia Blanca, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South	Furland, NE (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Bahi Blanca, Bahia Blanca, Buenos Aires, Argentina.	nfurland@criba.edu.ar	Vallés, Ana Sofía/GVU-5374-2022		Consejo Nacional de Investigaciones Cientificas y Tecnicas; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT); Universidad Nacional del Sur, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT)(ANPCyT); Universidad Nacional del Sur, Argentina	This work was supported by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas, Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT), and Universidad Nacional del Sur, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk A, 2006, NEUROCHEM INT, V49, P407, DOI 10.1016/j.neuint.2006.01.025; Appaix F, 2003, EXP PHYSIOL, V88, P175, DOI 10.1113/eph8802511; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boren J, 2012, CELL DEATH DIFFER, V19, P1561, DOI 10.1038/cdd.2012.34; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Butler A, 2002, AM J PATHOL, V161, P1061, DOI 10.1016/S0002-9440(10)64267-8; CHEMES H, 1986, ENDOCRINOLOGY, V119, P1673, DOI 10.1210/endo-119-4-1673; Chen M, 2008, ENDOCRINOLOGY, V149, P4871, DOI 10.1210/en.2007-1093; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; Furland NE, 2007, BIOL REPROD, V77, P181, DOI 10.1095/biolreprod.106.056556; Furland NE, 2011, LIPIDS, V46, P443, DOI 10.1007/s11745-011-3527-3; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; Guitton N, 1999, INT J RADIAT BIOL, V75, P327, DOI 10.1080/095530099140500; Hikim APS, 1999, REV REPROD, V4, P38; Hikim APS, 2003, ENDOCRINOLOGY, V144, P3167, DOI 10.1210/en.2003-0175; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Kanter M, 2013, TOXICOL IND HEALTH, V29, P99, DOI 10.1177/0748233711425082; KERR JB, 1974, J REPROD FERTIL, V36, P439; Kiebish MA, 2013, J LIPID RES, V54, P1312, DOI 10.1194/jlr.M034728; Kiebish MA, 2012, J BIOL CHEM, V287, P25086, DOI 10.1074/jbc.M112.340521; Linden D, 2004, J LIPID RES, V45, P1279, DOI 10.1194/jlr.M400010-JLR200; Liu MX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045694; Lue YH, 1999, ENDOCRINOLOGY, V140, P1709, DOI 10.1210/en.140.4.1709; Lue YH, 2000, ENDOCRINOLOGY, V141, P1414, DOI 10.1210/en.141.4.1414; Maguire SM, 1997, J MOL ENDOCRINOL, V19, P67, DOI 10.1677/jme.0.0190067; MATHER JP, 1980, BIOL REPROD, V23, P243, DOI 10.1095/biolreprod23.1.243; Moore CR, 1924, SCIENCE, V59, P41, DOI 10.1126/science.59.1515.41; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakanishi Y, 2004, BIOL PHARM BULL, V27, P13, DOI 10.1248/bpb.27.13; Nauciene Z, 2012, MEDICINA-LITHUANIA, V48, P249, DOI 10.3390/medicina48050036; Oresti GM, 2013, REPRODUCTION, V146, P471, DOI 10.1530/REP-13-0199; Oresti GM, 2010, J LIPID RES, V51, P2909, DOI 10.1194/jlr.M006429; Oresti GM, 2010, J LIPID RES, V51, P2600, DOI 10.1194/jlr.M006395; Paradies G, 2010, FREE RADICAL BIO MED, V48, P1286, DOI 10.1016/j.freeradbiomed.2010.02.020; PINEAU C, 1991, CELL TISSUE RES, V264, P589, DOI 10.1007/BF00319048; POORTHUIS BJHM, 1976, J LIPID RES, V17, P433; Ritzen E.M, 1989, TESTIS, P269; Rockett JC, 2001, BIOL REPROD, V65, P229, DOI 10.1095/biolreprod65.1.229; RUSSELL LD, 1977, ANAT RECORD, V187, P347, DOI 10.1002/ar.1091870307; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Scharnhorst V, 2001, GENE, V273, P141, DOI 10.1016/S0378-1119(01)00593-5; Setchell BP, 1998, J REPROD FERTIL, V114, P179, DOI 10.1530/jrf.0.1140179; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; SKINNER MK, 1980, J BIOL CHEM, V255, P9523; Tatsuta T, 2014, TRENDS CELL BIOL, V24, P44, DOI 10.1016/j.tcb.2013.07.011; Vance D. E., 1991, BIOCH LIPIDS LIPOPRO; Wang HZ, 2006, REPRODUCTION, V132, P485, DOI 10.1530/rep.1.01213; Xiong WP, 2009, REPRODUCTION, V137, P469, DOI 10.1530/REP-08-0343; Yamamoto CM, 2000, BIOL REPROD, V63, P1683, DOI 10.1095/biolreprod63.6.1683; Yin HY, 2012, FREE RADICAL RES, V46, P959, DOI 10.3109/10715762.2012.676642; Zukiene R, 2010, INT J HYPERTHER, V26, P56, DOI 10.3109/02656730903262140	53	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e91127	10.1371/journal.pone.0091127	http://dx.doi.org/10.1371/journal.pone.0091127			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690895	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100013
J	Zhang, D; He, XJ				Zhang, Duo; He, Xijing			A Meta-Analysis of the Motion Function through the Therapy of Spinal Cord Injury with Intravenous Transplantation of Bone Marrow Mesenchymal Stem Cells in Rats	PLOS ONE			English	Article							STROMAL CELLS; ADULT RATS; RECOVERY; REGENERATION; REPAIR	Background: To compare the efficacy of the therapy of spinal cord injury with intravenous transplantation of bone marrow mesenchymal stem cells (BMSCs) by Meta-analysis. Methods: Studies of the BBB scores after intravenous transplantation of BMSCs were searched out from Pubmed, SCI, Cochrane Library, Chinese journal full-text database, China Biology Medicinedisc and Wanfang data-base and analyzed by Review Manager 5.2.5. Results: Nine randomized controlled animal trials were selected with 235 rats enrolled. The studies are divided to different subgroups by different models of SCI and different time to transplantion. The results of Meta-analysis in different subgroups both indicated that the rats of experimental group (BMSCs group) got better BBB scores than control group at 1, 3 and over 5 weeks after intravenous transplantation of BMSCs with significant differences. The heterogeneity between impacted injury model and oppressed injury model subgroups decreased with the passage of time (I-2 = 75.8%, 39.7%, 0%). No heterogeneity was found between 3 d and 7 d subgroups. Conclusion: The intravenous transplantation of BMSCs is an efficient way to cure spinal cord injury, which can improve the motor function of rats. The therapeutic window is wide.	[Zhang, Duo; He, Xijing] Xi An Jiao Tong Univ, Affiliated Hosp 2, Coll Med, Dept Orthopaed, Xian 710049, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University	He, XJ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Coll Med, Dept Orthopaed, Xian 710049, Shaanxi Provinc, Peoples R China.	xijing_h@vip.tom.com	He, Xijing/AAE-7424-2021	He, Xijing/0000-0002-0465-5376				Allen AR, 1911, JAMA 57, P878, DOI [10.1001/jama.1911.04260090100008, DOI 10.1001/JAMA.1911.04260090100008]; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; [陈东 Chen Dong], 2007, [神经解剖学杂志, Chinese Journal of Neuroanatomy], V23, P635; Chen SQ, 2012, NEURAL REGEN RES, V7, P1445, DOI 10.3969/j.issn.1673-5374.2012.19.001; Chen XR, 2004, SPINAL CORD, V14, P547; Dergham P, 2002, J NEUROSCI, V22, P6570; Feng DX, 2006, CHINESE J SPINE SPIN, V23, P1379; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Himes BT, 2006, NEUROREHAB NEURAL RE, V20, P278, DOI 10.1177/1545968306286976; Ide C, 2010, BRAIN RES, V1332, P32, DOI 10.1016/j.brainres.2010.03.043; Iihoshi S, 2004, BRAIN RES, V1007, P1, DOI 10.1016/j.brainres.2003.09.084; [景文莉 Jing Wenli], 2008, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V12, P10045; Kang DZ, 2006, CHINESE J NEUROMEDIC, V6, P1117; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Kassem M, 2004, BASIC CLIN PHARMACOL, V95, P209, DOI 10.1111/j.1742-7843.2004.pto950502.x; Kiehn O, 2003, PROG NEUROBIOL, V70, P347, DOI 10.1016/S0301-0082(03)00091-1; Li BK, 2012, ORTHOPEDIC J CHINA, V20, P2291; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Parr AM, 2007, J NEUROTRAUM, V24, P835, DOI 10.1089/neu.2006.3771; Pierdomenico L, 2005, TRANSPLANTATION, V80, P836, DOI 10.1097/01.tp.0000173794.72151.88; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sheth RN, 2008, J NEUROSURG-SPINE, V8, P153, DOI 10.3171/SPI/2008/8/2/153; Urdzikova L, 2006, J NEUROTRAUM, V23, P1379, DOI 10.1089/neu.2006.23.1379; vonEuler M, 1997, EXP NEUROL, V145, P502, DOI 10.1006/exnr.1997.6481; Xu XL, 2009, STUDY REPAIRABLE EFF; You SW, 2003, RESTOR NEUROL NEUROS, V21, P39; [于长申 Yu Changshen], 2011, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V15, P8463; Yuan PW, 2011, CHINA J ORTHOPAEDICS, V24, P51; Zhao XZ, 2011, EXPT INVESTIGATION G	30	8	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93487	10.1371/journal.pone.0093487	http://dx.doi.org/10.1371/journal.pone.0093487			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690752	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100090
J	Fachal, L; Blanco, A; Santamarina, M; Carracedo, A; Vega, A				Fachal, Laura; Blanco, Ana; Santamarina, Marta; Carracedo, Angel; Vega, Ana			Large Genomic Rearrangements of BRCA1 and BRCA2 among Patients Referred for Genetic Analysis in Galicia (NW Spain): Delimitation and Mechanism of Three Novel BRCA1 Rearrangements	PLOS ONE			English	Article							BREAST/OVARIAN CANCER FAMILIES; BREAST-CANCER; HEREDITARY BREAST; SPANISH FAMILIES; MUTATIONS; IDENTIFICATION; DELETION; SPECTRUM; MLPA	In the Iberian Peninsula, which includes mainly Spain and Portugal, large genomic rearrangements (LGRs) of BRCA1 and BRCA2 have respectively been found in up to 2.33% and 8.4% of families with hereditary breast and/or ovarian cancer (HBOC) that lack point mutations and small indels. In Galicia (Northwest Spain), the spectrum and frequency of BRCA1/BRCA2 point mutations differs from the rest of the Iberian populations. However, to date there are no Galician frequency reports of BRCA1/BRCA2 LGRs. Here we used multiplex ligation-dependent probe amplification (MLPA) to screen 651 Galician index cases (out of the 830 individuals referred for genetic analysis) without point mutations or small indels. We identified three different BRCA1 LGRs in four families. Two of them have been previously classified as pathogenic LGRs: the complete deletion of BRCA1 (identified in two unrelated families) and the deletion of exons 1 to 13. We also identified the duplication of exons 1 and 2 that is a LGR with unknown pathogenicity. Determination of the breakpoints of the BRCA1 LGRs using CNV/SNP arrays and sequencing identified them as NG_005905.2: g.70536_180359del, NG_005905.2: g.90012_97270dup, and NC_000017.10: g.41230935_41399840delinsAluSx1, respectively; previous observations of BRCA1 exon1-24del, exon1-2dup, and exon1-13del LGRs have not characterized them in such detail. All the BRCA1 LGRs arose from unequal homologous recombination events involving Alu elements. We also detected, by sequencing, one BRCA2 LGR, the Portuguese founder mutation c.156_157insAluYa5. The low frequency of BRCA1 LGRs within BRCA1 mutation carriers in Galicia (2.34%, 95% CI: 0.61-7.22) seems to differ from the Spanish population (9.93%, 95% CI: 6.76-14.27, P-value = 0.013) and from the rest of the Iberian population (9.76%, 95% CI: 6.69-13.94, P-value = 0.014).	[Fachal, Laura; Blanco, Ana; Carracedo, Angel; Vega, Ana] Fdn Publ Galega Med Xen SERGAS, Grp Med Xen, CIBERER, IDIS, Santiago De Compostela, Spain; [Santamarina, Marta] Univ Santiago de Compostela, Grp Med Xen USC, CIBERER, IDIS, Santiago De Compostela, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela	Vega, A (corresponding author), Fdn Publ Galega Med Xen SERGAS, Grp Med Xen, CIBERER, IDIS, Santiago De Compostela, Spain.	ana.vega@usc.es	Carracedo, Angel/D-4257-2012; Fachal, Laura/N-5560-2014; Pérez, Ana/T-4583-2019; Vega, Ana/R-4758-2019	Carracedo, Angel/0000-0003-1085-8986; Fachal, Laura/0000-0002-7256-9752; Blanco Perez, Ana/0000-0002-2535-8311	Xunta de Galicia [10 PXIB 9101 297 PR]; Fundacion Mutua Madrilena; Isabel Barreto programme of the Xunta de Galicia; European Social Fund	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Isabel Barreto programme of the Xunta de Galicia; European Social Fund(European Social Fund (ESF))	This work was supported by grants to AV from the Xunta de Galicia (10 PXIB 9101 297 PR) and the Fundacion Mutua Madrilena. LF is supported by the Isabel Barreto programme of the Xunta de Galicia and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blay P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-243; Bunyan DJ, 2004, BRIT J CANCER, V91, P1155, DOI 10.1038/sj.bjc.6602121; De Brakeleer S, 2013, HUM MUTAT, V34, P785, DOI 10.1002/humu.22297; de la Hoya M, 2006, CLIN CHEM, V52, P1480, DOI 10.1373/clinchem.2006.070110; del Valle J, 2010, BREAST CANCER RES TR, V122, P733, DOI 10.1007/s10549-009-0613-9; Engert S, 2008, HUM MUTAT, V29, P948, DOI 10.1002/humu.20723; Fachal L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033580; Feliubadalo L, 2012, EUR J HUM GENET; Galician Society of Medical Oncology, 2011, GAL HER CANC GUID; Garcia-Casado Z, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-134; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Gutierrez-Enriquez S, 2007, BREAST CANCER RES TR, V103, P103, DOI 10.1007/s10549-006-9376-8; Hartmann Carolin, 2004, Hum Mutat, V24, P534, DOI 10.1002/humu.9291; Juan Jimenez I, 2013, FAM CANCER, P1; Konecny M, 2008, BREAST CANCER RES TR, V109, P581, DOI 10.1007/s10549-007-9670-0; Loidi L, 2006, CLIN ENDOCRINOL, V64, P330, DOI 10.1111/j.1365-2265.2006.02465.x; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Miramar MD, 2008, BREAST CANCER RES TR, V112, P353, DOI 10.1007/s10549-007-9868-1; Palanca S, 2013, FAM CANCER, V12, P119, DOI 10.1007/s10689-012-9579-6; Suela SP, 2008, BREAST CANCER RES TR, V112, P63, DOI 10.1007/s10549-007-9839-6; Peixoto A, 2011, BREAST CANCER RES TR, V127, P671, DOI 10.1007/s10549-010-1036-3; Peixoto A, 2009, BREAST CANCER RES TR, V114, P31, DOI 10.1007/s10549-008-9978-4; Peixoto A, 2006, FAM CANCER, V5, P379, DOI 10.1007/s10689-006-0009-5; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Pylkas K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-146; Rodriguez M, 2010, CLIN GENET, V78, P405, DOI 10.1111/j.1399-0004.2010.01463.x; de Garibay G, 2012, BREAST CANCER RES TR, V133, P273, DOI 10.1007/s10549-011-1909-0; Sluiter MD, 2011, BREAST CANCER RES TR, V125, P325, DOI 10.1007/s10549-010-0817-z; Vega A, 2002, ANN HUM GENET, V66, P29, DOI 10.1017/S0003480001001014; Vega A, 2001, Hum Mutat, V17, P520, DOI 10.1002/humu.1136; Walsh T, 2006, JAMA-J AM MED ASSOC, V295, P1379, DOI 10.1001/jama.295.12.1379; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	32	14	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93306	10.1371/journal.pone.0093306	http://dx.doi.org/10.1371/journal.pone.0093306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686251	Green Published, Green Submitted, gold			2022-12-27	WOS:000340842300007
J	Huang, GH; Zhang, YC; Chen, L; Zhang, N; Huang, T; Cai, YD				Huang, Guohua; Zhang, Yuchao; Chen, Lei; Zhang, Ning; Huang, Tao; Cai, Yu-Dong			Prediction of Multi-Type Membrane Proteins in Human by an Integrated Approach	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; COUPLED RECEPTORS; DRUG DISCOVERY; TOPOLOGY; NETWORKS; SPECTRUM; DATABASE; MODEL	Membrane proteins were found to be involved in various cellular processes performing various important functions, which are mainly associated to their types. However, it is very time-consuming and expensive for traditional biophysical methods to identify membrane protein types. Although some computational tools predicting membrane protein types have been developed, most of them can only recognize one kind of type. Therefore, they are not as effective as one membrane protein can have several types at the same time. To our knowledge, few methods handling multiple types of membrane proteins were reported. In this study, we proposed an integrated approach to predict multiple types of membrane proteins by employing sequence homology and protein-protein interaction network. As a result, the prediction accuracies reached 87.65%, 81.39% and 70.79%, respectively, by the leave-one-out test on three datasets. It outperformed the nearest neighbor algorithm adopting pseudo amino acid composition. The method is anticipated to be an alternative tool for identifying membrane protein types. New metrics for evaluating performances of methods dealing with multi-label problems were also presented. The program of the method is available upon request.	[Huang, Guohua; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Huang, Guohua] Shaoyang Univ, Dept Math, Shaoyang, Hunan, Peoples R China; [Zhang, Yuchao] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Zhang, Yuchao] Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci, Shanghai Inst Biol Sci,Inst Hlth Sci,State Key La, Shanghai 200030, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Zhang, Ning] Tianjin Univ, Dept Biomed Engn, Tianjin Key Lab BME Measurement, Tianjin 300072, Peoples R China; [Huang, Tao] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA	Shanghai University; Shaoyang University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Maritime University; Tianjin University; Icahn School of Medicine at Mount Sinai	Chen, L (corresponding author), Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China.	chen_lei1@163.com; zhni@tju.edu.cn; tao.huang@mssm.edu; cai_yud@126.com	Huang, Guohua/A-2215-2019; Chen, Lei/A-2275-2011	Huang, Guohua/0000-0001-6954-3933; Chen, Lei/0000-0003-3068-1583; Zhang, Ning/0000-0002-1559-111X; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510101, 2011CB510102]; National Natural Science Foundation of China [31371335, 81171342, 81201148]; Innovation Program of Shanghai Municipal Education Commission [12ZZ087]; The First-class Discipline of Universities in Shanghai; Scientific Research Fund of Hunan Provincial Science and Technology Department [2011FJ3197]; Hunan National Science Foundation [13JJ3118]; Scientific Research Fund of Hunan Provincial Education Department [11C1125]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); The First-class Discipline of Universities in Shanghai; Scientific Research Fund of Hunan Provincial Science and Technology Department; Hunan National Science Foundation; Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department)	This work was supported by grants from National Basic Research Program of China (2011CB510101, 2011CB510102), National Natural Science Foundation of China (31371335, 81171342, 81201148), Innovation Program of Shanghai Municipal Education Commission (12ZZ087), the grant of "The First-class Discipline of Universities in Shanghai", Scientific Research Fund of Hunan Provincial Science and Technology Department (2011FJ3197), Hunan National Science Foundation (Grant: 13JJ3118), and Scientific Research Fund of Hunan Provincial Education Department (Grant: 11C1125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Arinaminpathy Y, 2009, DRUG DISCOV TODAY, V14, P1130, DOI 10.1016/j.drudis.2009.08.006; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Bourne Philip E, 2003, Methods Biochem Anal, V44, P501; Cai YD, 2004, J THEOR BIOL, V226, P373, DOI 10.1016/j.jtbi.2003.08.015; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Chen L, 2014, MOL BIOSYST, V10, P868, DOI 10.1039/c3mb70490d; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Chen YK, 2013, J THEOR BIOL, V318, P1, DOI 10.1016/j.jtbi.2012.10.033; Chou KC, 2005, J CHEM INF MODEL, V45, P407, DOI 10.1021/ci049686v; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Davey J, 2004, EXPERT OPIN THER TAR, V8, P165, DOI 10.1517/eott.8.2.165.30250; de Ridder D, 2003, LECT NOTES COMPUT SC, V2714, P333; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Ding C, 2012, J PROTEOMICS, V77, P321, DOI 10.1016/j.jprot.2012.09.006; Gao QB, 2010, ANAL BIOCHEM, V398, P52, DOI 10.1016/j.ab.2009.10.040; Guo YZ, 2006, AMINO ACIDS, V30, P397, DOI 10.1007/s00726-006-0332-z; Hayat M, 2012, ANAL BIOCHEM, V424, P35, DOI 10.1016/j.ab.2012.02.007; Hayat M, 2012, AMINO ACIDS, V42, P2447, DOI 10.1007/s00726-011-1053-5; Hayat M, 2012, J THEOR BIOL, V292, P93, DOI 10.1016/j.jtbi.2011.09.026; Hayat M, 2011, J THEOR BIOL, V271, P10, DOI 10.1016/j.jtbi.2010.11.017; Hedman M, 2002, PROTEIN SCI, V11, P652, DOI 10.1110/ps.39402; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jia PL, 2008, J PROTEOME RES, V7, P1131, DOI 10.1021/pr700715c; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Koh IYY, 2003, NUCLEIC ACIDS RES, V31, P3311, DOI 10.1093/nar/gkg619; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033393; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu H, 2005, BIOCHEM BIOPH RES CO, V336, P737, DOI 10.1016/j.bbrc.2005.08.160; Mandavi A, 2011, J THEOR BIOL, V276, P132, DOI 10.1016/j.jtbi.2011.01.048; Moult J, 2005, CURR OPIN STRUC BIOL, V15, P285, DOI 10.1016/j.sbi.2005.05.011; Nussinov R, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-2; Petrey D, 2005, MOL CELL, V20, P811, DOI 10.1016/j.molcel.2005.12.005; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Pua X, 2007, J THEOR BIOL, V247, P259, DOI 10.1016/j.jtbi.2007.01.016; Qiu JD, 2010, PROTEIN J, V29, P114, DOI 10.1007/s10930-010-9230-z; Rezaei MA, 2008, J THEOR BIOL, V254, P817, DOI 10.1016/j.jtbi.2008.07.012; Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009; Rychlewski L, 2005, PROTEIN SCI, V14, P240, DOI 10.1110/ps.04888805; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Terstappen GC, 2001, TRENDS PHARMACOL SCI, V22, P23, DOI 10.1016/S0165-6147(00)01584-4; Wang JY, 2012, COMPUT BIOL MED, V42, P564, DOI 10.1016/j.compbiomed.2012.01.012; Wang LP, 2010, IEICE ELECTRON EXPR, V7, P397, DOI 10.1587/elex.7.397; Wang M, 2005, J THEOR BIOL, V232, P7, DOI 10.1016/j.jtbi.2004.07.023; Wang M, 2004, PROTEIN ENG DES SEL, V17, P509, DOI 10.1093/protein/gzh061; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Wang SQ, 2006, J THEOR BIOL, V242, P941, DOI 10.1016/j.jtbi.2006.05.006; Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101	56	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93553	10.1371/journal.pone.0093553	http://dx.doi.org/10.1371/journal.pone.0093553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676214	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500140
J	Kelmo, F; Bell, JJ; Moraes, SS; Gomes, RDT; Mariano-Neto, E; Attrill, MJ				Kelmo, Francisco; Bell, James J.; Moraes, Simone Souza; Tourinho Gomes, Rilza da Costa; Mariano-Neto, Eduardo; Attrill, Martin J.			Differential Responses of Emergent Intertidal Coral Reef Fauna to a Large-Scale El-Nino Southern Oscillation Event: Sponge and Coral Resilience	PLOS ONE			English	Article							NORTHERN BAHIA; CNIDARIAN COMMUNITY; CLIMATE-CHANGE; TEMPERATURE; PATTERNS; MORTALITY	There is a paucity of information on the impacts of the 1997-8 El Nino event and subsequent climatic episodes on emergent intertidal coral reef assemblages. Given the environmental variability intertidal reefs experience, such reefs may potentially be more resilient to climatic events and provide important insights into the adaptation of reef fauna to future ocean warming. Here we report the results of a 17-year (1995-2011) biodiversity survey of four emergent coral reef ecosystems in Bahia, Brazil, to assess the impact of a major El Nino event on the reef fauna, and determine any subsequent recovery. The densities of two species of coral, Favia gravida and Siderastrea stellata, did not vary significantly across the survey period, indicating a high degree of tolerance to the El Nino associated stress. However, there were marked decreases in the diversity of other taxa. Molluscs, bryozoans and ascidians suffered severe declines in diversity and abundance and had not recovered to pre-El Nino levels by the end of the study. Echinoderms were reduced to a single species in 1999, Echinometra lucunter, although diversity levels had recovered by 2002. Sponge assemblages were not impacted by the 1997-8 event and their densities had increased by the study end. Multivariate analysis indicated that a stable invertebrate community had re-established on the reefs after the El Nino event, but it has a different overall composition to the pre-El Nino community. It is unclear if community recovery will continue given more time, but our study highlights that any increase in the frequency of large-scale climatic events to more than one a decade is likely to result in a persistent lower-diversity state. Our results also suggest some coral and sponge species are particularly resilient to the El Nino-associated stress and therefore represent suitable models to investigate temperature adaptation in reef organisms.	[Kelmo, Francisco; Mariano-Neto, Eduardo] Univ Fed Bahia, Inst Biol, Salvador, BA, Brazil; [Bell, James J.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Moraes, Simone Souza] Univ Fed Bahia, Inst Geociencias, Salvador, BA, Brazil; [Tourinho Gomes, Rilza da Costa] Fundacao Visconde Cairu, Curso Posgrad Desenvolvimento Humano & Responsabi, Salvador, BA, Brazil; [Attrill, Martin J.] Univ Plymouth, Drake Circus, Inst Marine, Plymouth PL4 8AA, Devon, England	Universidade Federal da Bahia; Victoria University Wellington; Universidade Federal da Bahia; Fundacao Visconde de Cairu; University of Plymouth	Kelmo, F (corresponding author), Univ Fed Bahia, Inst Biol, Campus Univ Ondina, Salvador, BA, Brazil.	kelmo@ufba.br	Moraes, Simone/AAC-6211-2021; Mariano-Neto, Eduardo/F-3441-2010	Moraes, Simone/0000-0002-5432-6781; Mariano-Neto, Eduardo/0000-0002-4204-0882; Attrill, Martin/0000-0002-4039-031X; Bell, James/0000-0001-9996-945X	Plymouth University Marine Institute	Plymouth University Marine Institute	This work is funded by the corresponding author, Francisco Kelmo, with additional support from the Plymouth University Marine Institute to FK. The funders coordinated the overall research objectives and organised the sampling, identification of organisms and data collation throughout the survey, developed sampling methodology, input information on species biology and wrote the paper.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Attrill MJ, 2007, ESTUAR COAST SHELF S, V73, P243, DOI 10.1016/j.ecss.2007.01.007; Attrill MJ, 2004, CLIM RES, V26, P151, DOI 10.3354/cr026151; BARBER RT, 1986, NATURE, V319, P279, DOI 10.1038/319279a0; BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; Bell JJ, 2013, GLOBAL CHANGE BIOL, V19, P2613, DOI 10.1111/gcb.12212; Bittencourt ACDP, 2000, AN ACAD BRAS CIENC, V72, P271, DOI 10.1590/S0001-37652000000200012; Burke L., 2011, REEFS RISK REVISITED; Causey BD, 1988, P ASS IS MAR LAB CAR, V21, P48; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLAUSEN CD, 1975, MAR BIOL, V33, P93, DOI 10.1007/BF00390713; COLES SL, 1977, MAR BIOL, V43, P209, DOI 10.1007/BF00402313; COLES SL, 1976, PAC SCI, V30, P159; Coles SL, 1988, P 6 INT COR REEF S T, V3, P211; Freedman D., 1983, J BUS ECON STAT, V1, P292, DOI [10.2307/1391660, DOI 10.2307/1391660]; Glynn P.W., 1990, Elsevier Oceanography Series, V52, P55; Glynn PW, 2001, B MAR SCI, V69, P79; GLYNN PW, 1988, ANNU REV ECOL SYST, V19, pU309; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Goenaga C., 1988, P ASS ISLAND MAR LAB, V21, P49; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Kelmo F, 2006, HYDROBIOLOGIA, V555, P231, DOI 10.1007/s10750-005-1119-z; Kelmo F, 2003, CORAL REEFS, V22, P541, DOI 10.1007/s00338-003-0343-0; Kelmo F, 2004, BIOL CONSERV, V118, P609, DOI 10.1016/j.biocon.2003.10.010; Kelmo F, 2001, B MAR SCI, V69, P547; Kelmo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076441; Kelmo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065073; Kelmo F, 2013, ECOL INDIC, V30, P148, DOI 10.1016/j.ecolind.2013.02.009; Koplovitz G, 2011, J EXP MAR BIOL ECOL, V407, P48, DOI 10.1016/j.jembe.2011.06.038; Kurn U, 2011, BIOL BULL-US, V221, P43, DOI 10.1086/BBLv221n1p43; Kumar A, 2001, J CLIMATE, V14, P345, DOI 10.1175/1520-0442(2001)014<0345:TSNAWO>2.0.CO;2; Kvitt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028665; Lang JC, 1988, NOAAS UNDERSEA RES P, V88, P30; Leao Z.M.A.N., 1997, P583; Leao ZMAN, 2008, BIOTA NEOTROPICA, V8; Nolasco M. C., 1986, QUATERNARY S AM ANTA, V4, P159; Nozawa Y, 2006, MAR BIOL, V149, P1047, DOI 10.1007/s00227-006-0285-5; Pernice M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016095; Perry CT, 2003, CORAL REEFS, V22, P427, DOI 10.1007/s00338-003-0330-5; Randall CJ, 2009, BIOL BULL-US, V217, P269, DOI 10.1086/BBLv217n3p269; Riegl BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024802; Rodrigues RR, 2011, J CLIMATE, V24, P3402, DOI 10.1175/2011JCLI3983.1; Sanderman IM, 1988, P ASS ISLAND MAR LAB, V21, P50; Vargas-Angel B, 2011, B MAR SCI, V87, P623, DOI 10.5343/bms.2010.1095; Wilkinson C, 1999, AMBIO, V28, P188; Wipf P, 2000, J ORG CHEM, V65, P1037, DOI 10.1021/jo9914566	51	8	8	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93209	10.1371/journal.pone.0093209	http://dx.doi.org/10.1371/journal.pone.0093209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675785	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677500090
J	Zemp, N; Minder, A; Widmer, A				Zemp, Niklaus; Minder, Aria; Widmer, Alex			Identification of Internal Reference Genes for Gene Expression Normalization between the Two Sexes in Dioecious White Campion	PLOS ONE			English	Article							PLANT SILENE-LATIFOLIA; QUANTITATIVE RT-PCR; REAL-TIME PCR; HOUSEKEEPING GENES; SEXUAL-DIMORPHISM; Y-CHROMOSOME; MIQE GUIDELINES; ABIOTIC STRESS; SELECTION; EVOLUTION	Quantitative real time (qRT)-PCR is a precise and efficient method for studying gene expression changes between two states of interest, and is frequently used for validating interesting gene expression patterns in candidate genes initially identified in genome-wide expression analyses, such as RNA-seq experiments. For an adequate normalisation of qRT-PCR data, it is essential to have reference genes available whose expression intensities are constant among the different states of interest. In this study we present and validate a catalogue of traditional and newly identified reference genes that were selected from RNA-seq data from multiple individuals from the dioecious plant Silene latifolia with the aim of studying gene expression differences between the two sexes in both reproductive and vegetative tissues. The catalogue contains more than 15 reference genes with both stable expression intensities and a range of expression intensities in flower buds and leaf tissues. These reference genes were used to normalize expression differences between reproductive and vegetative tissues in eight candidate genes with sex-biased expression. Our results suggest a trend towards a reduced sex-bias in sex-linked gene expression in vegetative tissues. In this study, we report on the systematic identification and validation of internal reference genes for adequate normalization of qRT-PCR-based analyses of gene expression differences between the two sexes in S. latifolia. We also show how RNA-seq data can be used efficiently to identify suitable reference genes in a wide diversity of species.	[Zemp, Niklaus; Widmer, Alex] ETH, Inst Integrat Biol IBZ, Zurich, Switzerland; [Minder, Aria] ETH, Genet Div Ctr, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Widmer, A (corresponding author), ETH, Inst Integrat Biol IBZ, Zurich, Switzerland.	alex.widmer@env.ethz.ch	Zemp, Niklaus/K-7467-2012; Widmer, Alex/B-6841-2009	Zemp, Niklaus/0000-0002-0991-5130; Widmer, Alex/0000-0001-8253-5137	SNF [31003A_141260]	SNF	This study was supported by SNF Grant 31003A_141260 to AW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageez A, 2005, GENES GENET SYST, V80, P403, DOI 10.1266/ggs.80.403; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergero R, 2011, CURR BIOL, V21, P1470, DOI 10.1016/j.cub.2011.07.032; Bernasconi G, 2009, HEREDITY, V103, P5, DOI 10.1038/hdy.2009.34; Blavet N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-376; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cappelli K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-49; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Chibalina MV, 2011, CURR BIOL, V21, P1475, DOI 10.1016/j.cub.2011.07.045; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Delph LF, 2010, EVOLUTION, V64, P2873, DOI 10.1111/j.1558-5646.2010.01048.x; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Fernandez-Aparicio M, 2013, MOL BIOL REP, V40, P3395, DOI 10.1007/s11033-012-2417-y; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Kazama Y, 2009, PLANT CELL PHYSIOL, V50, P1127, DOI 10.1093/pcp/pcp064; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mank JE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-148; Manoli A, 2012, J PLANT PHYSIOL, V169, P807, DOI 10.1016/j.jplph.2012.01.019; Marais GAB, 2008, CURR BIOL, V18, P545, DOI 10.1016/j.cub.2008.03.023; Marais GAB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021915; Matsunaga S, 2004, SEX PLANT REPROD, V17, P189, DOI 10.1007/s00497-004-0230-z; Matsunaga S, 2003, MOL BIOL EVOL, V20, P1062, DOI 10.1093/molbev/msg114; Meisel RP, 2012, GENOME RES, V22, P1255, DOI 10.1101/gr.132100.111; Moore RC, 2003, GENETICS, V163, P321; Muyle A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001308; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405; Zluvova J, 2006, P NATL ACAD SCI USA, V103, P18854, DOI 10.1073/pnas.0606622103; Zluvova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-208	51	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92893	10.1371/journal.pone.0092893	http://dx.doi.org/10.1371/journal.pone.0092893			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675788	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500051
J	Zhang, Q; Hou, XY; Li, FYH; Niu, JM; Zhou, YL; Ding, Y; Zhao, LQ; Li, X; Ma, WJ; Kang, S				Zhang, Qing; Hou, Xiangyang; Li, Frank Yonghong; Niu, Jianming; Zhou, Yanlin; Ding, Yong; Zhao, Liqing; Li, Xin; Ma, Wenjing; Kang, Sarula			Alpha, Beta and Gamma Diversity Differ in Response to Precipitation in the Inner Mongolia Grassland	PLOS ONE			English	Article							SPECIES-RICHNESS; LATITUDINAL GRADIENTS; AREA RELATIONSHIPS; SPATIAL SCALE; PATTERNS; BIODIVERSITY; CONSEQUENCES; PRODUCTIVITY; COEXISTENCE; SIMILARITY	Understanding the distribution pattern and maintenance mechanism of species diversity along environmental gradients is essential for developing biodiversity conservation strategies under environmental change. We have surveyed the species diversity at 192 vegetation sites across different steppe zones in Inner Mongolia, China. We analysed the total species diversity (gamma diversity) and its composition (alpha diversity and beta diversity) of different steppe types, and their changes along a precipitation gradient. Our results showed that (i) beta diversity contributed more than alpha diversity to the total (gamma) diversity in the Inner Mongolia grassland; the contribution of beta diversity increased with precipitation, thus the species-rich (meadow steppe) grassland had greater contribution of beta diversity than species-poor (desert steppe) grassland. (ii) All alpha, beta and gamma species diversity increased significantly (P < 0.05) with precipitation, but their sensitivity to precipitation (diversity change per mm precipitation increase) was different between the steppe types. The sensitivity of alpha diversity of different steppe community types was negatively (P < 0.05) correlated with mean annual precipitation, whereas the sensitivity of beta and gamma diversity showed no trend along the precipitation gradient (P >= 0.10). (iii) The alpha diversity increased logarithmically, while b diversity increased exponentially, with gamma diversity. Our results suggest that for local species diversity patterns, the site species pool is more important in lower precipitation areas, while local ecological processes are more important in high precipitation areas. In addition, for beta diversity maintenance niche processes and diffusion processes are more important in low and high precipitation areas, respectively. Our results imply that a policy of "multiple small reserves'' is better than one of a "single large reserve'' for conserving species diversity of a steppe ecosystem, and indicate an urgent need to develop management strategies for climate-sensitive desert steppe ecosystem.	[Zhang, Qing; Niu, Jianming; Zhou, Yanlin; Zhao, Liqing; Ma, Wenjing; Kang, Sarula] Inner Mongolia Univ, Sch Life Sci, Hohhot, Peoples R China; [Hou, Xiangyang; Ding, Yong] Chinese Acad Agr Sci, Grassland Res Inst, Hohhot, Peoples R China; [Zhang, Qing; Niu, Jianming; Li, Xin] Inner Mongolia Univ, Sino US Ctr Conservat Energy & Sustainabil Sci, Hohhot, Peoples R China; [Li, Frank Yonghong] AgRes Grasslands Res Ctr, Palmerston North, New Zealand	Inner Mongolia University; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS; Inner Mongolia University; AgResearch - New Zealand	Niu, JM (corresponding author), Inner Mongolia Univ, Sch Life Sci, Hohhot, Peoples R China.	jmniu2005@163.com	Li, Frank Yonghong/AAN-3093-2020; Niu, Jianming/K-3597-2019	Li, Frank Yonghong/0000-0002-5137-8017; 	State Key Basic Research Development Programme of China [2012CB722201, 2014CB138805]; National Basic Research Programme of China [31200414]; Specialised Research Fund for the Doctoral Programme of Higher Education of China [20121501120006]; Inner Mongolia University [125106]	State Key Basic Research Development Programme of China; National Basic Research Programme of China(National Basic Research Program of China); Specialised Research Fund for the Doctoral Programme of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Inner Mongolia University	This study was supported by the State Key Basic Research Development Programme of China (Grant nos. 2012CB722201 and 2014CB138805), The National Basic Research Programme of China (Grant no. 31200414), The Specialised Research Fund for the Doctoral Programme of Higher Education of China (Grant no. 20121501120006), and the Start Research Funding Project of Inner Mongolia University (Grant no. 125106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2007, OIKOS, V116, P221, DOI [10.1111/j.2006.0030-1299.15327.x, 10.1111/j.0030-1299.2007.15327.x]; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Bai YF, 2007, J APPL ECOL, V44, P1023, DOI 10.1111/j.1365-2664.2007.01351.x; Boieiro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064591; CASE TJ, 1974, P NATL ACAD SCI USA, V71, P3073, DOI 10.1073/pnas.71.8.3073; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chiarucci A, 2010, PERSPECT PLANT ECOL, V12, P83, DOI 10.1016/j.ppees.2010.01.001; Cleland EE, 2013, ECOLOGY, V94, P1687, DOI 10.1890/12-1006.1; CODY ML, 1970, ECOLOGY, V51, P455, DOI 10.2307/1935380; Collins SL, 2012, FUNCT ECOL, V26, P1450, DOI 10.1111/j.1365-2435.2012.01995.x; Colwell RK, 2004, AM NAT, V163, pE1, DOI 10.1086/382056; Crist TO, 2006, ECOL LETT, V9, P923, DOI 10.1111/j.1461-0248.2006.00941.x; de Andrade RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026208; de Juan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065575; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; FANG J-Y, 1990, Ecological Research, V5, P9, DOI 10.1007/BF02348460; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Gering JC, 2002, ECOL LETT, V5, P433, DOI 10.1046/j.1461-0248.2002.00335.x; Green JL, 2003, ECOLOGY, V84, P3090, DOI 10.1890/02-3096; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Inner Mongolia-Ningxia Joint Inspection Group of Chinese Sciences of Academy, 1985, VEG INN MONG; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jurasinski G, 2009, OECOLOGIA, V159, P15, DOI 10.1007/s00442-008-1190-z; Kluge J, 2006, GLOBAL ECOL BIOGEOGR, V15, P358, DOI [10.1111/j.1466-822X.2006.00223.x, 10.1111/j.1466-822x.2006.00223.x]; Koleff P, 2003, GLOBAL ECOL BIOGEOGR, V12, P483, DOI 10.1046/j.1466-822X.2003.00056.x; La Sorte FA, 2008, GLOBAL ECOL BIOGEOGR, V17, P363, DOI 10.1111/j.1466-8238.2007.00369.x; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Leprieur F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042760; Li B, 1962, ACTA SCI NAT U NEIMO, V4, P42; Li Y, 1996, ACTA PHYTOECOLOGICA, V22, P1; Li YH, 2008, RESTOR ECOL, V16, P572, DOI 10.1111/j.1526-100X.2007.00332.x; Loreau M, 2000, ECOL LETT, V3, P73, DOI 10.1046/j.1461-0248.2000.00127.x; Ma YQ, 1995, FLORA INNER MONGOLIA; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Melo AS, 2009, ECOGRAPHY, V32, P226, DOI 10.1111/j.1600-0587.2008.05502.x; Meynard CN, 2011, GLOBAL ECOL BIOGEOGR, V20, P893, DOI 10.1111/j.1466-8238.2010.00647.x; Niu JM, 2001, ACTA ECOL SIN, V21, P1064; Novotny V, 2007, NATURE, V448, P692, DOI 10.1038/nature06021; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; Qian H, 2007, ECOL LETT, V10, P737, DOI 10.1111/j.1461-0248.2007.01066.x; Russell R, 2006, AM NAT, V167, pE158, DOI 10.1086/504603; SALA OE, 1988, ECOLOGY, V69, P40, DOI 10.2307/1943158; Sfenthourakis S, 2012, J BIOGEOGR, V39, P750, DOI 10.1111/j.1365-2699.2011.02639.x; Suttie J. M., 2006, P1; Tang ZY, 2012, ECOGRAPHY, V35, P1083, DOI 10.1111/j.1600-0587.2012.06882.x; Turnbull LA, 2013, ECOL LETT, V16, P116, DOI 10.1111/ele.12056; Veech JA, 2010, ECOLOGY, V91, P1964, DOI 10.1890/08-1727.1; Volder A, 2013, GLOBAL CHANGE BIOL, V19, P843, DOI 10.1111/gcb.12068; Wang ZH, 2009, P NATL ACAD SCI USA, V106, P13388, DOI 10.1073/pnas.0905030106; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Wiersma YF, 2005, CONSERV BIOL, V19, P1262, DOI 10.1111/j.1523-1739.2005.00099.x; Wimp GM, 2001, ECOLOGY, V82, P440, DOI 10.1890/0012-9658(2001)082[0440:BCOPAH]2.0.CO;2; World Conservation Monitoring Centre, 1992, GLOBAL BIODIVERSITY; Zhang PJ, 2011, PLANT SOIL, V347, P79, DOI 10.1007/s11104-011-0813-z; Zhang Q, 2011, ECOL RES, V26, P649, DOI 10.1007/s11284-011-0825-4; ZOBEL M, 1992, OIKOS, V65, P314, DOI 10.2307/3545024	62	25	32	11	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93518	10.1371/journal.pone.0093518	http://dx.doi.org/10.1371/journal.pone.0093518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675900	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500134
J	Ji, K; Luan, J; Liu, CJ; Mu, DL; Mu, LH; Xin, MQ; Sun, JJ; Yin, SL; Chen, L				Ji, Kai; Luan, Jie; Liu, Chunjun; Mu, Dali; Mu, Lanhua; Xin, Minqiang; Sun, Jingjing; Yin, Shilu; Chen, Lin			A Prospective Study of Breast Dynamic Morphological Changes after Dual-plane Augmentation Mammaplasty with 3D Scanning Technique	PLOS ONE			English	Article							IMAGING-SYSTEM; VOLUME; DIMENSIONS; PREVENTION; OUTCOMES; CONTOUR	Background: The dual-plane technique has been widely used in augmentation mammaplasty procedures. However, there are some concerns about aesthetic contour maintenance for long time after muscle releasing. This study aims to track and analyze breast dynamic morphological changes after dual-plane breast augmentation with three-dimensional (3D) scanning technique. Methods: Thirteen dual-plane anatomic implant augmentation patients underwent 3D scanning preoperatively (pre-OP) and postoperatively in four time points (1 month: post-1M, 3 months: post-3M, 6 months: post-6M and 12 months: post-12M). The linear distance, breast projection, nipple position, breast volume and breast surface area were measured and analyzed on the 3D models over time. Results: Compared with post-12M, no significant differences were found in distances of nipple to midline, nipple to inframammary fold and sternal notch to the level of inframammary fold after 6 months in both straight-line distance and its projection on surface. The distances between sternal notch and nipple had no significant difference after post-1M. Breast volume changes had no significant difference after post-3M. The volume and area percentage of upper pole decreased while the lower pole's increased gradually. The surface showed no significant changes after post-1M. The changes of breast projection had no significance after post-1M either. The nipple moved 1.0 +/- 0.6 cm laterally(X axis), 0.6 +/- 0.7 cm upward(Y axis) and 2.3 +/- 1.1 cm anteriorly (Z axis) at post-12M, and the differences were not significant after post-1M. Conclusions: 3D scanning technique provides an objective and effective way to evaluate breast morphological changes after augmentation mammaplasty over time. Dual-plane augmentation optimizes breast shape especially in the lower pole and maintains stable aesthetic outcome during the 12 months follow-up. Most of the contour changes and the interadaptation with the implant have completed 6 months after operation. Therefore, 6 months could be chosen as a relatively stable observing period in the assessment of postoperative outcomes of dual-plane breast augmentation.	[Ji, Kai; Luan, Jie; Liu, Chunjun; Mu, Dali; Mu, Lanhua; Xin, Minqiang; Sun, Jingjing; Yin, Shilu; Chen, Lin] Chinese Acad Med Sci, Breast Plast & Reconstruct Surg Ctr, Plast Surg Hosp, Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Plastic Surgery Hospital - CAMS	Luan, J (corresponding author), Chinese Acad Med Sci, Breast Plast & Reconstruct Surg Ctr, Plast Surg Hosp, Peking Union Med Coll, Beijing 100730, Peoples R China.	doctorluanjie@sina.com		liu, chunjun/0000-0002-4741-058X	Peking Union Medical College Graduate Students Creation Foundation [20121002009]; Beijing Municipal Science & Technology Commission [Z131107002213104]	Peking Union Medical College Graduate Students Creation Foundation; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported by the Peking Union Medical College Graduate Students Creation Foundation(20121002009) and the Beijing Municipal Science & Technology Commission No.Z131107002213104. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blondeel PN, 2009, PLAST RECONSTR SURG, V124, P372, DOI 10.1097/PRS.0b013e3181aeeb21; Catanuto G, 2009, AESTHET SURG J, V29, P505, DOI 10.1016/j.asj.2009.09.004; Creasman CN, 2011, AESTHET SURG J, V31, P925, DOI 10.1177/1090820X11424147; Creasman CN, 2011, AESTHET SURG J, V31, P914, DOI 10.1177/1090820X11423916; de Chardon VM, 2010, ANN PLAS SURG, V64, P390, DOI 10.1097/SAP.0b013e3181b14284; Eder M, 2013, J PLAST RECONSTR AES, V66, P776, DOI 10.1016/j.bjps.2013.02.008; Eder M, 2012, BREAST, V21, P152, DOI 10.1016/j.breast.2011.07.016; Eder M, 2011, J PLAST RECONSTR AES, V64, P1152, DOI 10.1016/j.bjps.2011.03.037; Esme DL, 2009, AESTHET PLAST SURG, V33, P191, DOI 10.1007/s00266-008-9259-y; Gryskiewicz J, 2013, AESTHET SURG J, V33, P43, DOI 10.1177/1090820X12469534; Hall-Findlay EJ, 2010, PLAST RECONSTR SURG, V125, P1632, DOI 10.1097/PRS.0b013e3181ccdb97; Handel N, 2013, PLAST RECONSTR SURG, V132, P1434, DOI 10.1097/01.prs.0000434405.91316.96; Henseler H, 2011, J PLAST RECONSTR AES, V64, P577, DOI 10.1016/j.bjps.2010.08.044; Isogai N, 2006, ANN PLAS SURG, V56, P237, DOI 10.1097/01.sap.0000200716.82945.b2; Kovacs L, 2006, ANN PLAS SURG, V56, P229, DOI 10.1097/01.sap.0000197774.80832.24; Kovacs L, 2007, BREAST, V16, P137, DOI 10.1016/j.breast.2006.08.001; Kovacs L, 2006, ANN PLAS SURG, V57, P602, DOI 10.1097/01.sap.0000235455.21775.6a; Kovacs L, 2012, AESTHET PLAST SURG, V36, P879, DOI 10.1007/s00266-012-9892-3; Liu CJ, 2012, AESTHET PLAST SURG, V36, P1134, DOI 10.1007/s00266-012-9944-8; Liu CJ, 2010, PLAST RECONSTR SURG, V126, P2125, DOI 10.1097/PRS.0b013e3181f46ec6; Longo B, 2013, PLAST RECONSTR SURG, V132, p1E, DOI 10.1097/PRS.0b013e318290f6bd; Losken A, 2005, ANN PLAS SURG, V54, P471, DOI 10.1097/01.sap.0000155278.87790.a1; Luan J, 2009, J PLAST RECONSTR AES, V62, P1459, DOI 10.1016/j.bjps.2008.05.044; Mohanna PN, 2012, PLAST RECONSTR SURG, V129, p756E, DOI 10.1097/PRS.0b013e318245e8b4; Spear SL, 2006, PLAST RECONSTR SURG, V118, p197S, DOI 10.1097/01.prs.0000247298.27098.7a; Tebbetts JB, 2001, PLAST RECONSTR SURG, V107, P1255, DOI 10.1097/00006534-200104150-00027; Tebbetts JB, 2006, PLAST RECONSTR SURG, V118, p81S, DOI 10.1097/00006534-200612001-00012; Tebbetts JB, 2006, PLAST RECONSTR SURG, V118, p99S, DOI 10.1097/01.prs.0000247256.52442.b9; Tebbetts JB, 2006, PLAST RECONSTR SURG, V118, p53S, DOI 10.1097/01.prs.0000247314.92351.99; Tepper OM, 2009, ANN PLAS SURG, V62, P570, DOI 10.1097/SAP.0b013e31819faff9	30	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93010	10.1371/journal.pone.0093010	http://dx.doi.org/10.1371/journal.pone.0093010			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671190	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000101
J	Kennedy, SM; Aiken, EJ; Beres, KA; Hahn, AR; Kamin, SJ; Hagness, SC; Booske, JH; Murphy, WL				Kennedy, Stephen M.; Aiken, Erik J.; Beres, Kaytlyn A.; Hahn, Adam R.; Kamin, Samantha J.; Hagness, Susan C.; Booske, John H.; Murphy, William L.			Cationic Peptide Exposure Enhances Pulsed-Electric-Field-Mediated Membrane Disruption	PLOS ONE			English	Article							BILAYER LIPID-MEMBRANES; IRREVERSIBLE ELECTROPORATION; GENE DELIVERY; STOCHASTIC THEORY; DEFECT FORMATION; MAMMALIAN-CELLS; KINETIC STAGE; I PROCOLLAGEN; BREAKDOWN; DNA	Background: The use of pulsed electric fields (PEFs) to irreversibly electroporate cells is a promising approach for destroying undesirable cells. This approach may gain enhanced applicability if the intensity of the PEF required to electrically disrupt cell membranes can be reduced via exposure to a molecular deliverable. This will be particularly impactful if that reduced PEF minimally influences cells that are not exposed to the deliverable. We hypothesized that the introduction of charged molecules to the cell surfaces would create regions of enhanced transmembrane electric potential in the vicinity of each charged molecule, thereby lowering the PEF intensity required to disrupt the plasma membranes. This study will therefore examine if exposure to cationic peptides can enhance a PEF's ability to disrupt plasma membranes. Methodology/Principal Findings: We exposed leukemia cells to 40 mu s PEFs in media containing varying concentrations of a cationic peptide, polyarginine. We observed the internalization of a membrane integrity indicator, propidium iodide (PI), in real time. Based on an individual cell's PI fluorescence versus time signature, we were able to determine the relative degree of membrane disruption. When using 1-2 kV/cm, exposure to >50 mu g/ml of polyarginine resulted in immediate and high levels of PI uptake, indicating severe membrane disruption, whereas in the absence of peptide, cells predominantly exhibited signatures indicative of no membrane disruption. Additionally, PI entered cells through the anode-facing membrane when exposed to cationic peptide, which was theoretically expected. Conclusions/Significance: Exposure to cationic peptides reduced the PEF intensity required to induce rapid and irreversible membrane disruption. Critically, peptide exposure reduced the PEF intensities required to elicit irreversible membrane disruption at normally sub-electroporation intensities. We believe that these cationic peptides, when coupled with current advancements in cell targeting techniques will be useful tools in applications where targeted destruction of unwanted cell populations is desired.	[Kennedy, Stephen M.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Kennedy, Stephen M.; Aiken, Erik J.; Beres, Kaytlyn A.; Hahn, Adam R.; Kamin, Samantha J.; Hagness, Susan C.; Booske, John H.] Univ Wisconsin, Dept Elect & Comp Engn, Madison, WI 53706 USA; [Murphy, William L.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA; [Murphy, William L.] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI USA	Harvard University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kennedy, SM (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	skennedy@seas.harvard.edu	Murphy, William L/I-4096-2014		Duane H. and Dorothy M. Bleumke endowed professorship; Philip Dunham Reed endowed professorship; National Science Foundation [0745563]; University of Wisconsin Stem Cell and Regenerative Medicine Center; National Institutes (NIH) of Health Ruth L. Kirschstein National Research Service Award (NRSA) [F31 EB007903]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [F31EB007903] Funding Source: NIH RePORTER	Duane H. and Dorothy M. Bleumke endowed professorship; Philip Dunham Reed endowed professorship; National Science Foundation(National Science Foundation (NSF)); University of Wisconsin Stem Cell and Regenerative Medicine Center; National Institutes (NIH) of Health Ruth L. Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Duane H. and Dorothy M. Bleumke endowed professorship, the Philip Dunham Reed endowed professorship, the National Science Foundation (CAREER award 0745563), the University of Wisconsin Stem Cell and Regenerative Medicine Center, and a National Institutes (NIH) of Health Ruth L. Kirschstein National Research Service Award (NRSA) for individual predoctoral fellows (F31 EB007903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibor IG, 1979, BIOELECTROCH BIOENER, V6, P37; Aina OH, 2002, BIOPOLYMERS, V66, P184, DOI 10.1002/bip.10257; Al-Sakere B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001135; Andre F, 2004, GENE THER, V11, pS33, DOI 10.1038/sj.gt.3302367; ARAKELYAN VB, 1979, BIOELECTROCH BIOENER, V6, P81, DOI 10.1016/0302-4598(79)85009-6; Bagheri M, 2009, ANTIMICROB AGENTS CH, V53, P1132, DOI 10.1128/AAC.01254-08; BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P1139, DOI 10.1021/bi00274a023; BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P5213, DOI 10.1021/bi00291a023; Binder H, 2003, BIOPHYS J, V85, P982, DOI 10.1016/S0006-3495(03)74537-8; Chang C, 1992, GUIDE ELECTROPORATIO; CHIZMADZHEV YA, 1979, BIOELECTROCH BIOENER, V6, P63, DOI 10.1016/0302-4598(79)85007-2; CONSTANTINOU CD, 1991, MATRIX, V11, P1; De Smedt SC, 2000, PHARMACEUT RES, V17, P113, DOI 10.1023/A:1007548826495; Dev SB, 2000, IEEE T PLASMA SCI, V28, P206, DOI 10.1109/27.842905; Esser AT, 2007, TECHNOL CANCER RES T, V6, P261, DOI 10.1177/153303460700600402; EXPOSITO JY, 1992, J BIOL CHEM, V267, P15559; Ferreira E, 2008, GENE THER, V15, P537, DOI 10.1038/gt.2008.9; Gabriel B, 1997, BIOPHYS J, V73, P2630, DOI 10.1016/S0006-3495(97)78292-4; Gabriel GJ, 2007, MAT SCI ENG R, V57, P28, DOI 10.1016/j.mser.2007.03.002; Gehl J, 2003, ACTA PHYSIOL SCAND, V177, P437, DOI 10.1046/j.1365-201X.2003.01093.x; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Golzio M, 2002, P NATL ACAD SCI USA, V99, P1292, DOI 10.1073/pnas.022646499; HAENSLER J, 1993, BIOCONJUGATE CHEM, V4, P372, DOI 10.1021/bc00023a012; IMAZATO S, 1995, J DENT, V23, P177, DOI 10.1016/0300-5712(95)93576-N; Ivorra A, 2010, PHYS CHEM CHEM PHYS, V12, P10055, DOI 10.1039/c004419a; Joshi RP, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011913; Joshi RP, 2000, PHYS REV E, V62, P1025, DOI 10.1103/PhysRevE.62.1025; Kennedy SM, 2008, BIOPHYS J, V94, P5018, DOI 10.1529/biophysj.106.103218; Kennedy SM, 2009, IEEE T DIELECT EL IN, V16, P1251, DOI 10.1109/TDEI.2009.5293935; Kosciuczuk EM, 2012, MOL BIOL REP, V39, P10957, DOI 10.1007/s11033-012-1997-x; Kunath K, 2003, J CONTROL RELEASE, V89, P113, DOI 10.1016/S0168-3659(03)00076-2; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Li P, 2010, NAT MATER, V12, P1; Lin JQ, 2009, BIOSENS BIOELECTRON, V25, P388, DOI 10.1016/j.bios.2009.07.027; Maor E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004757; Mislick KA, 1996, P NATL ACAD SCI USA, V93, P1249; Miteva M, 1999, FEBS LETT, V462, P155, DOI 10.1016/S0014-5793(99)01520-3; Muller KJ, 2001, J MEMBRANE BIOL, V184, P161, DOI 10.1007/s00232-001-0084-3; NEUMANN E, 1992, BIOELECTROCH BIOENER, V28, P247, DOI 10.1016/0302-4598(92)80017-B; Neumann E., 1989, ELECTROPORATION ELEC; Nishi T, 1996, CANCER RES, V56, P1050; Niu YH, 2013, ORG BIOMOL CHEM, V11, P4283, DOI 10.1039/c3ob40444g; Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354; Pakhomova ON, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017100; Palm-Apergi C, 2009, FASEB J, V23, P214, DOI 10.1096/fj.08-110254; PASTUSHENKO VF, 1979, BIOELECTROCH BIOENER, V6, P53, DOI 10.1016/0302-4598(79)85006-0; PASTUSHENKO VF, 1979, BIOELECTROCH BIOENER, V6, P71, DOI 10.1016/0302-4598(79)85008-4; PASTUSHENKO VF, 1979, BIOELECTROCH BIOENER, V6, P97, DOI 10.1016/0302-4598(79)85011-4; PASTUSHENKO VF, 1979, BIOELECTROCH BIOENER, V6, P89, DOI 10.1016/0302-4598(79)85010-2; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Pouton CW, 1998, J CONTROL RELEASE, V53, P289, DOI 10.1016/S0168-3659(98)00015-7; Puc M, 2003, BIOELECTROCHEMISTRY, V60, P1, DOI 10.1016/S1567-5394(03)00021-5; Pucihar G, 2001, BIOELECTROCHEMISTRY, V54, P107, DOI 10.1016/S1567-5394(01)00117-7; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P255, DOI 10.1177/153303460700600401; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Sambhy V, 2008, ANGEW CHEM INT EDIT, V47, P1250, DOI 10.1002/anie.200702287; Schelly ZA, 2007, COLLOID SURFACE B, V56, P281, DOI 10.1016/j.colsurfb.2006.10.031; Stratton TR, 2009, BIOMACROMOLECULES, V10, P2550, DOI 10.1021/bm9005003; Tang MX, 1997, GENE THER, V4, P823, DOI 10.1038/sj.gt.3300454; Tew GN, 2006, BBA-BIOMEMBRANES, V1758, P1387, DOI 10.1016/j.bbamem.2006.03.001; Wadia JS, 2005, ADV DRUG DELIVER REV, V57, P579, DOI 10.1016/j.addr.2004.10.005; Weaver JC, 2000, IEEE T PLASMA SCI, V28, P24, DOI 10.1109/27.842820; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; ZHELEV DV, 1993, BIOCHIM BIOPHYS ACTA, V1147, P89, DOI 10.1016/0005-2736(93)90319-U; ZIMMERMAN U, 1996, ELECTROMANIPULATION	65	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92528	10.1371/journal.pone.0092528	http://dx.doi.org/10.1371/journal.pone.0092528			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671150	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677000052
J	Jiang, W; Li, YQ; Liu, N; Sun, Y; He, QM; Jiang, N; Xu, YF; Chen, L; Ma, J				Jiang, Wei; Li, Ying-Qin; Liu, Na; Sun, Ying; He, Qing-Mei; Jiang, Ning; Xu, Ya-Fei; Chen, Lei; Ma, Jun			5-Azacytidine Enhances the Radiosensitivity of CNE2 and SUNE1 Cells In Vitro and In Vivo Possibly by Altering DNA Methylation	PLOS ONE			English	Article							SUPPRESSES TUMOR-GROWTH; GENE-EXPRESSION; CANCER; 5-AZA-2'-DEOXYCYTIDINE; APOPTOSIS; REPRIMO; PROTEIN; HEAD; PHOSPHORYLATION; DEMETHYLATION	The radioresistance of tumor cells remains a major cause of treatment failure in nasopharyngeal carcinoma (NPC). Recently, several reports have highlighted the importance of epigenetic changes in radiation-induced responses. Here, we investigated whether the demethylating agent 5-azacytidine (5-azaC) enhances the radiosensitivity of NPC cells. The NPC cell lines CNE2 and SUNE1 were treated with 1 mu mol/L 5-azaC for 24 h before irradiation (IR); clonogenic survival was then assessed. Tumor growth was investigated in a mouse xenograft model in vivo. The apoptosis, cell cycle progression and DNA damage repair were examined using flow cytometry, immunofluorescent staining and western blotting. Promoter methylation and the expression of four genes epigenetically silenced during the development of NPC were evaluated by pyrosequencing and real-time PCR. We found that pretreatment with 5-azaC significantly decreased clonogenic survival after IR compared to IR alone; the sensitivity-enhancement ratio of 5-azaC was 1.4 and 1.2 for CNE2 and SUNE1 cells, respectively. The combined administration of 5-azaC and IR significantly inhibited tumor growth in the mouse xenograft model, and enhanced radiation-induced apoptosis in vitro compared to 5-azaC alone or IR alone. 5-AzaC also decreased promoter methylation and upregulated the expression of genes which are epigenetically silenced both in vitro and in vivo in NPC. Thus, 5-azaC enhance the radiosensitivity of both the CNE2 and SUNE1 cell lines, possibly by altering DNA methylation levels and increasing the ability of irradiated cells to undergo apoptosis. The use of 5-azaC combined with IR maybe represent an attractive strategy for the treatment of NPC.	[Jiang, Wei; Li, Ying-Qin; Liu, Na; Sun, Ying; He, Qing-Mei; Jiang, Ning; Xu, Ya-Fei; Chen, Lei; Ma, Jun] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Ma, J (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	drjunma@hotmail.com		Liu, Na/0000-0001-8654-3636	Guangdong Province Universities; Colleges Pearl River Scholar Funded Scheme [2050205]; National Natural Science Foundation of China [81230056]; Innovation Team Development Plan of the Ministry of Education [IRT1297]; Science and Technology Project of Guangzhou City [12BppZXaa2060002]; Guangdong Translational Medicine Public Platform [4202037]	Guangdong Province Universities; Colleges Pearl River Scholar Funded Scheme; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Team Development Plan of the Ministry of Education; Science and Technology Project of Guangzhou City; Guangdong Translational Medicine Public Platform	This work was supported by grants from the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2011, 2050205), the National Natural Science Foundation of China (No. 81230056), the Innovation Team Development Plan of the Ministry of Education (No. IRT1297), the Science and Technology Project of Guangzhou City (No. 12BppZXaa2060002), and the Guangdong Translational Medicine Public Platform (No. 4202037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalaf HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021111; Andorfer P, 2011, ONCOGENE, V30, P2679, DOI 10.1038/onc.2010.639; Barendsen GW, 1997, INT J RADIAT BIOL, V71, P649, DOI 10.1080/095530097143653; Brieger J, 2012, INT J MOL MED, V29, P505, DOI 10.3892/ijmm.2011.843; Carr M, 2011, MOL CELL BIOCHEM, V353, P205, DOI 10.1007/s11010-011-0788-3; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; De Schutter H, 2009, INT J RADIAT ONCOL, V73, P904, DOI 10.1016/j.ijrobp.2008.10.032; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; FOWLER JF, 1989, BRIT J RADIOL, V62, P679, DOI 10.1259/0007-1285-62-740-679; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fueyo J, 1998, NAT MED, V4, P685, DOI 10.1038/nm0698-685; Hofstetter B, 2010, INT J RADIAT ONCOL, V76, P1512, DOI 10.1016/j.ijrobp.2009.10.037; Italiano A, 2009, CLIN CANCER RES, V15, P5696, DOI 10.1158/1078-0432.CCR-08-3185; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Karam JA, 2007, INT J CANCER, V120, P1795, DOI 10.1002/ijc.22405; Kim HJ, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-39; Kwong J, 2002, CLIN CANCER RES, V8, P131; Lee AWM, 2012, ORAL ONCOL, V48, P768, DOI 10.1016/j.oraloncology.2012.02.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Malpeli G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-351; Muschel RJ, 1998, ONCOGENE, V17, P3359, DOI 10.1038/sj.onc.1202580; NAITO S, 1986, CANCER RES, V46, P4109; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Patties I, 2009, STRAHLENTHER ONKOL, V185, P331, DOI 10.1007/s00066-009-1956-1; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Qiu H, 2009, CANCER SCI, V100, P181, DOI 10.1111/j.1349-7006.2008.01004.x; Redon CE, 2011, METHODS MOL BIOL, V682, P249, DOI 10.1007/978-1-60327-409-8_18; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sato N, 2006, CANCER-AM CANCER SOC, V107, P251, DOI 10.1002/cncr.21977; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang GL, 1999, BRIT J CANCER, V81, P1122, DOI 10.1038/sj.bjc.6690818; Wang XM, 1998, ANN SURG, V227, P922, DOI 10.1097/00000658-199806000-00016; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wong TS, 2005, INT J CANCER, V117, P697, DOI 10.1002/ijc.21208; Xing JL, 2008, CANCER-AM CANCER SOC, V112, P2756, DOI 10.1002/cncr.23533; Xu M, 2012, ENDOCRINOLOGY, V153, P2963, DOI 10.1210/en.2011-2021; Yang HL, 2006, MOL CANCER THER, V5, P253, DOI 10.1158/1535-7163.MCT-05-0395; Yang QF, 2002, ANTICANCER RES, V22, P2753; Zheng ZX, 2012, FASEB J, V26, P449, DOI 10.1096/fj.11-190025	43	24	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93273	10.1371/journal.pone.0093273	http://dx.doi.org/10.1371/journal.pone.0093273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691157	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100060
J	Jin, J; Xu, GX; Yuan, ZL				Jin, Ji; Xu, Guo-xu; Yuan, Zhi-lan			Influence of the Hypothalamic Arcuate Nucleus on Intraocular Pressure and the Role of Opioid Peptides	PLOS ONE			English	Article							OCULAR HYDRODYNAMICS; NATRIURETIC-PEPTIDE; NITRIC-OXIDE; STIMULATION; BREMAZOCINE; INHIBITION; MODULATION; ACTIVATION; REDUCTION; RECEPTORS	Background: An opioid peptide neuron/humoral feedback regulation might be involved in changes of intraocular pressure (IOP). The aims of this study are to investigate the effects of arcuate nucleus (ARC) and opioid peptides on intraocular pressure (IOP). Methods: Fifty-four healthy purebred New Zealand white rabbits (108eyes) were randomly divided into 4 groups, including control group, electrical stimulation group, [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin (DAMGO) group, and [D-Pen 2, D-Pen5]-enkephalin (DPDPE) group. Bilateral IOP was measured after unilateral electrical stimulation of the ARC or unilateral microinjection into the ARC of the selective mu-opioid receptor agonist DAMGO or the selective delta opioid receptor agonist DPDPE, both alone and after pre-administration of either the non-selective opioid receptor antagonist naloxone or saline. Results: Both electrical stimulation in ARC and micro-injection either mu or delta opioid receptor agonists, DAMGO or DPDPE, respectively, caused a significant bilateral reduction in IOP (P<0.05) which was more pronounced in the ipsilateral than in the contralateral eye. Pretreatment with naloxone prevented some, but not all IOP reductions. Conclusion: The ARC takes part in the negative regulation of IOP, an action that may involve opioid neurons.	[Jin, Ji; Xu, Guo-xu] Soochow Univ, Affiliated Hosp 2, Dept Ophthalmol, Suzhou, Jiangsu, Peoples R China; [Yuan, Zhi-lan] Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China	Soochow University - China; Nanjing Medical University	Yuan, ZL (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China.	zhilanyuan@vip.sina.com						Bonfiglio V, 2006, EUR J PHARMACOL, V534, P227, DOI 10.1016/j.ejphar.2006.01.045; Bucolo C, 2012, BIOCHEM PHARMACOL, V83, P680, DOI 10.1016/j.bcp.2011.11.031; Chu TC, 2002, J OCUL PHARMACOL TH, V18, P293, DOI 10.1089/10807680260218461; Dortch-Carnes J, 2006, PHARMACOLOGY, V77, P17, DOI 10.1159/000091993; DRAGO F, 1980, N-S ARCH PHARMACOL, V315, P1, DOI 10.1007/BF00504223; FANCIULLACCI M, 1980, EUR J PHARMACOL, V61, P319, DOI 10.1016/0014-2999(80)90136-3; Fuxe K, 1997, NEUROSCI LETT, V225, P49, DOI 10.1016/S0304-3940(97)00184-5; Georgiou AL, 2012, VISUAL NEUROSCI, V29, P237, DOI 10.1017/S0952523812000193; Ludwig M, 2000, NEUROSCI LETT, V281, P195, DOI 10.1016/S0304-3940(00)00846-6; MAO LM, 1990, PEPTIDES, V11, P1045, DOI 10.1016/0196-9781(90)90032-Z; Miagkov A V, 2002, Ross Fiziol Zh Im I M Sechenova, V88, P972; Myagkov A V, 2004, Neurosci Behav Physiol, V34, P97, DOI 10.1023/B:NEAB.0000003252.77752.40; Myagkov AV, 2004, B EXP BIOL MED+, V137, P132, DOI 10.1023/B:BEBM.0000028121.61962.6a; Ostermeier AM, 2000, ANESTHESIOLOGY, V93, P1053, DOI 10.1097/00000542-200010000-00029; Potter DE, 2004, J PHARMACOL EXP THER, V309, P548, DOI 10.1124/jpet.103.063107; ROHDE BH, 1993, OPHTHALMIC RES, V25, P378, DOI 10.1159/000267340; Russell KRM, 2000, EXP EYE RES, V70, P675, DOI 10.1006/exer.2000.0832; Russell KRM, 2002, EXP EYE RES, V75, P259, DOI 10.1006/exer.2002.2024; Russell-Randall KR, 2011, INVEST OPHTH VIS SCI, V52, P5233, DOI 10.1167/iovs.10-6613; Salomone S, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00009; Selbach JM, 2005, J ANAT, V206, P237, DOI 10.1111/j.1469-7580.2005.00379.x; Suzuki T, 2000, EUR J PHARMACOL, V396, P23, DOI 10.1016/S0014-2999(00)00183-7; Wang J, 2001, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V17, P153	23	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e82315	10.1371/journal.pone.0082315	http://dx.doi.org/10.1371/journal.pone.0082315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691128	Green Submitted, gold, Green Published			2022-12-27	WOS:000334101100001
J	McIntosh, JD; Manning, K; Chokshi, S; Naoumov, NV; Fraser, JD; Dunbar, PR; Taylor, JA				McIntosh, Julie D.; Manning, Kristy; Chokshi, Shilpa; Naoumov, Nikolai V.; Fraser, John D.; Dunbar, P. Rod; Taylor, John A.			An Engineered Non-Toxic Superantigen Increases Cross Presentation of Hepatitis B Virus Nucleocapsids by Human Dendritic Cells	PLOS ONE			English	Article							ANTIGEN PRESENTATION; CORE ANTIGEN; ENDOPLASMIC-RETICULUM; ESCHERICHIA-COLI; IMMUNE-RESPONSE; CAPSID PROTEIN; RECEPTOR; PARTICLES; EPITOPES; PEPTIDE	Virus like particles (VLPs) are potent immunogens capable of priming strong protective antibody responses due to their repetitive structural arrangement and affinity for specific B cell receptors. By contrast, T cell responses to VLPs can be weak due to inefficient uptake and processing by antigen presenting cells. We report here a novel strategy for increasing the T cell reactivity of a VLP, the nucleocapsid of hepatitis B virus, through covalent coupling of M1, an engineered form of the Streptococcal superantigen SMEZ2, that binds MHC II with high affinity but lacks its T cell mitogenic capability. M1: HBcAg conjugates bound to dendritic cells and were efficiently endocytosed into late endosomes. Human dendritic cells pulsed with M1: HBcAgs stimulated HBV-specific CD8(+) T cells more effectively than cells pulsed with native capsids indicating that the modified VLP was more effectively cross presented by APCs. Coupling of M1 was also able to induce significantly greater reactivity of human CD4(-) T cells specific for a common T-helper epitope. These studies indicate the potential of recombinant superantigens to act as flexible molecular adjuvants that can be incorporated into various subunit vaccine platforms leading to enhanced T cell reactivity in humans.	[McIntosh, Julie D.; Manning, Kristy; Dunbar, P. Rod; Taylor, John A.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [McIntosh, Julie D.; Manning, Kristy; Dunbar, P. Rod; Taylor, John A.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand; [Fraser, John D.] Univ Auckland, Sch Med Sci, Auckland 1, New Zealand; [Chokshi, Shilpa; Naoumov, Nikolai V.] UCL, Inst Hepatol, London, England	University of Auckland; University of Auckland; University of Auckland; University of London; University College London	Taylor, JA (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	ja.taylor@auckland.ac.nz	Dunbar, Rod/C-2570-2012	Dunbar, Rod/0000-0001-9626-2600	Health Research Council of New Zealand [05/252]	Health Research Council of New Zealand(Health Research Council of New Zealand)	This research was funded by a Project Grant awarded by the Health Research Council of New Zealand (05/252). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2005, NAT IMMUNOL, V6, P107, DOI 10.1038/ni1147; Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Akbar SMF, 2012, ANTIVIR RES, V96, P59, DOI 10.1016/j.antiviral.2012.07.011; Arcus VL, 2000, J MOL BIOL, V299, P157, DOI 10.1006/jmbi.2000.3725; Bachmann MF, 1997, ANNU REV IMMUNOL, V15, P235, DOI 10.1146/annurev.immunol.15.1.235; Basha G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003247; Bertoletti A, 2000, CURR OPIN IMMUNOL, V12, P403, DOI 10.1016/S0952-7915(00)00108-4; Birkholz K, 2010, BLOOD, V116, P2277, DOI 10.1182/blood-2010-02-268425; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Broos K, 2007, PROTEIN EXPRES PURIF, V54, P30, DOI 10.1016/j.pep.2007.02.006; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; CLARKE BE, 1987, NATURE, V330, P381, DOI 10.1038/330381a0; COHEN BJ, 1982, NATURE, V296, P677, DOI 10.1038/296677a0; Cooper A, 2005, J IMMUNOL, V175, P3165, DOI 10.4049/jimmunol.175.5.3165; Dickgreber N, 2009, J IMMUNOL, V182, P1260, DOI 10.4049/jimmunol.182.3.1260; Freire T, 2010, BLOOD, V116, P3526, DOI 10.1182/blood-2010-04-279133; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Gehring AJ, 2007, J VIROL, V81, P2940, DOI 10.1128/JVI.02415-06; GORGA JC, 1987, J BIOL CHEM, V262, P16087; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Heathcote J, 1999, HEPATOLOGY, V30, P531, DOI 10.1002/hep.510300208; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; ILAN Y, 1993, GASTROENTEROLOGY, V104, P1818, DOI 10.1016/0016-5085(93)90664-X; Jegerlehner A, 2002, VACCINE, V20, P3104, DOI 10.1016/S0264-410X(02)00266-9; Lau GKK, 2002, GASTROENTEROLOGY, V122, P614, DOI 10.1053/gast.2002.31887; Lazdina U, 2001, J VIROL, V75, P6367, DOI 10.1128/JVI.75.14.6367-6374.2001; Lee RS, 1998, EUR J IMMUNOL, V28, P2726, DOI 10.1002/(SICI)1521-4141(199809)28:09<2726::AID-IMMU2726>3.3.CO;2-N; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Lunde E, 1999, NAT BIOTECHNOL, V17, P670, DOI 10.1038/10883; Lunde E, 2002, J IMMUNOL, V168, P2154, DOI 10.4049/jimmunol.168.5.2154; Lunde E, 2001, BIOMOL ENG, V18, P109, DOI 10.1016/S1389-0344(01)00091-0; Mayer S, 2002, IMMUNOBIOLOGY, V205, P282, DOI 10.1078/0171-2985-00131; Menne S, 2007, J VIROL, V81, P10614, DOI 10.1128/JVI.00691-07; Mizukoshi E, 2004, J IMMUNOL, V173, P5863, DOI 10.4049/jimmunol.173.9.5863; Proft T, 2007, J INTERF CYTOK RES, V27, P553, DOI 10.1089/jir.2006.0173; Rigopoulou EI, 2005, HEPATOLOGY, V42, P1028, DOI 10.1002/hep.20888; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Schatz D, 1998, CLIN DIAGN LAB IMMUN, V5, P894, DOI 10.1128/CDLI.5.6.894-896.1998; Song R, 1996, J IMMUNOL, V156, P4182; STAHL S, 1982, P NATL ACAD SCI-BIOL, V79, P1606, DOI 10.1073/pnas.79.5.1606; Storni T, 2002, J IMMUNOL, V168, P2880, DOI 10.4049/jimmunol.168.6.2880; Susumu S, 2008, CANCER SCI, V99, P107, DOI 10.1111/j.1349-7006.2007.00654.x; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; Wang XH, 2005, CANCER IMMUNOL IMMUN, V54, P971, DOI 10.1007/s00262-005-0662-9; Watts NR, 2002, EMBO J, V21, P876, DOI 10.1093/emboj/21.5.876; Win SJ, 2011, IMMUNOL CELL BIOL, V89, P681, DOI 10.1038/icb.2010.161; Zlotnick A, 1996, BIOCHEMISTRY-US, V35, P7412, DOI 10.1021/bi9604800	52	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93598	10.1371/journal.pone.0093598	http://dx.doi.org/10.1371/journal.pone.0093598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690680	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100109
J	Ren, LY; Qian, XC; Zhai, LJ; Sun, M; Miao, ZG; Li, JZ; Xu, XS				Ren, Liyan; Qian, Xuanchen; Zhai, Lijing; Sun, Miao; Miao, Zhigang; Li, Jizhen; Xu, Xingshun			Loss of Ahi1 Impairs Neurotransmitter Release and Causes Depressive Behaviors in Mice	PLOS ONE			English	Article							TAIL SUSPENSION TEST; BRAIN; GENE; PATHOPHYSIOLOGY; CEREBELLAR; MUTATIONS; SUPPORT	Major depression is becoming one of the most prevalent forms of psychiatric disorders. However, the mechanisms of major depression are still not well-understood. Most antidepressants are only effective in some patients and produce some serious side effects. Animal models of depression are therefore essential to unravel the mechanisms of depression and to develop novel therapeutic strategies. Our previous studies showed that Abelson helper integration site-1 (Ahi1) deficiency causes depression-like behaviors in mice. In this study, we characterized the biochemical and behavioral changes in Ahi1 knockout (KO) mice. In Ahi1 KO mice, neurotransmitters including serotonin and dopamine were significantly decreased in different brain regions. However, glutamate and GABA levels were not affected by Ahi1 deficiency. The antidepressant imipramine attenuated depressive behaviors and partially restored brain serotonin level in Ahi1 KO mice. Our findings suggest that Ahi1 KO mice can be used for studying the mechanisms of depression and screening therapeutic targets.	[Ren, Liyan; Qian, Xuanchen; Zhai, Lijing; Xu, Xingshun] Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou, Jiangsu, Peoples R China; [Ren, Liyan; Qian, Xuanchen; Zhai, Lijing; Xu, Xingshun] Soochow Univ, Affiliated Hosp 2, Jiangsu Key Lab Translat Res & Therapy Neuro Psyc, Suzhou, Jiangsu, Peoples R China; [Sun, Miao] Soochow Univ, Affiliated Hosp 1, Inst Fetol, Suzhou, Jiangsu, Peoples R China; [Miao, Zhigang; Xu, Xingshun] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China; [Li, Jizhen] Suzhou Kowloon Hosp, Dept Neurol, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Xu, XS (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou, Jiangsu, Peoples R China.	Xingshunxu@suda.edu.cn	miao, sun/E-2834-2018; Xu, Xingshun/AAF-8183-2020; Miao, Zhigang/AHD-1316-2022	Xu, Xingshun/0000-0003-0205-6342	National Natural Science Foundation of China [81071095, 81120108011, 813111078]; Suzhou science and technology development program [SYS201232]; Priority Academic Program Development of Jiangsu Higher Education Institutions of China; Jiangsu Province's Key Provincial Talents Program; National Basic Research Program of China (973 Program) [2013CB945401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou science and technology development program; Priority Academic Program Development of Jiangsu Higher Education Institutions of China; Jiangsu Province's Key Provincial Talents Program; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by grants 81071095, 81120108011, and 813111078 (to XX) from the National Natural Science Foundation of China, Suzhou science and technology development program (SYS201232), the Priority Academic Program Development of Jiangsu Higher Education Institutions of China, Jiangsu Province's Key Provincial Talents Program (to XX), and the National Basic Research Program of China (973 Program, 2013CB945401, to MS). The funders, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Retuerto AI, 2008, HUM MOL GENET, V17, P3887, DOI 10.1093/hmg/ddn291; Amann-Zalcenstein D, 2006, EUR J HUM GENET, V14, P1111, DOI 10.1038/sj.ejhg.5201675; Bakish D, 2001, J CLIN PSYCHIAT, V62, P5; Caspi A1, 2003, GENE SCI, V301; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; GUZE SB, 1970, BRIT J PSYCHIAT, V117, P437, DOI 10.1192/bjp.117.539.437; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; Ingason A, 2007, EUR J HUM GENET, V15, P988, DOI 10.1038/sj.ejhg.5201848; Ingason A, 2010, HUM MOL GENET, V19, P1379, DOI 10.1093/hmg/ddq009; Meyer JH, 2006, ARCH GEN PSYCHIAT, V63, P1209, DOI 10.1001/archpsyc.63.11.1209; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Pothion S, 2004, BEHAV BRAIN RES, V155, P135, DOI 10.1016/j.bbr.2004.04.008; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W; SCHILDKRAUT JJ, 1965, AM J PSYCHIAT, V122, P509, DOI 10.1176/ajp.122.5.509; SHAW DM, 1967, BRIT J PSYCHIAT, V113, P1407, DOI 10.1192/bjp.113.505.1407; Sheng G, 2008, J CLIN INVEST, V118, P2785, DOI 10.1172/JCI35339; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Tomida S, 2009, NAT GENET, V41, P688, DOI 10.1038/ng.344; Willner P, 2002, BEHAV PHARMACOL, V13, P169, DOI 10.1097/00008877-200205000-00001; Xu XS, 2010, P NATL ACAD SCI USA, V107, P19126, DOI 10.1073/pnas.1013032107; Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883	24	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93640	10.1371/journal.pone.0093640	http://dx.doi.org/10.1371/journal.pone.0093640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691070	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100117
J	Sharma, R; Callaway, D; Vanegas, D; Bendele, M; Lopez-Cruzan, M; Horn, D; Guda, T; Fajardo, R; Abboud-Werner, S; Herman, B				Sharma, Ramaswamy; Callaway, Danielle; Vanegas, Difernando; Bendele, Michelle; Lopez-Cruzan, Marisa; Horn, Diane; Guda, Teja; Fajardo, Roberto; Abboud-Werner, Sherry; Herman, Brian			Caspase-2 Maintains Bone Homeostasis by Inducing Apoptosis of Oxidatively-Damaged Osteoclasts	PLOS ONE			English	Article							CELL-DEATH; ISOCITRATE DEHYDROGENASE; HYDROGEN-PEROXIDE; MINERAL DENSITY; CYTOCHROME-C; CRUCIAL ROLE; IN-VITRO; STRESS; OSTEOPOROSIS; MICE	Osteoporosis is a silent disease, characterized by a porous bone micro-structure that enhances risk for fractures and associated disabilities. Senile, or age-related osteoporosis ( SO), affects both men and women, resulting in increased morbidity and mortality. However, cellular and molecular mechanisms underlying senile osteoporosis are not fully known. Recent studies implicate the accumulation of reactive oxygen species (ROS) and increased oxidative stress as key factors in SO. Herein, we show that loss of caspase-2, a cysteine aspartate protease involved in oxidative stress-induced apoptosis, results in total body and femoral bone loss in aged mice (20% decrease in bone mineral density), and an increase in bone fragility (30% decrease in fracture strength). Importantly, we demonstrate that genetic ablation or selective inhibition of caspase-2 using zVDVAD-fmk results in increased numbers of bone-resorbing osteoclasts and enhanced tartrate-resistant acid phosphatase ( TRAP) activity. Conversely, transfection of osteoclast precursors with wild type caspase-2 but not an enzymatic mutant, results in a decrease in TRAP activity. We demonstrate that caspase-2 expression is induced in osteoclasts treated with oxidants such as hydrogen peroxide and that loss of caspase-2 enhances resistance to oxidants, as measured by TRAP activity, and decreases oxidative stress-induced apoptosis of osteoclasts. Moreover, oxidative stress, quantified by assessment of the lipid peroxidation marker, 4-HNE, is increased in Casp2 (-/-) bone, perhaps due to a decrease in antioxidant enzymes such as SOD2. Taken together, our data point to a critical and novel role for caspase-2 in maintaining bone homeostasis by modulating ROS levels and osteoclast apoptosis during conditions of enhanced oxidative stress that occur during aging.	[Sharma, Ramaswamy; Callaway, Danielle; Vanegas, Difernando; Bendele, Michelle; Lopez-Cruzan, Marisa; Herman, Brian] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Horn, Diane; Abboud-Werner, Sherry] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Fajardo, Roberto] Univ Texas Hlth Sci Ctr San Antonio, Dept Orthoped, San Antonio, TX 78229 USA; [Guda, Teja] Univ Texas San Antonio, Dept Biomed Engn, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA)	Herman, B (corresponding author), Univ Minnesota, Off Vice President Res, Minneapolis, MN 55455 USA.	herman@umn.edu	Guda, Teja/A-7286-2009; Guda, Teja/AAZ-5176-2020	Guda, Teja/0000-0002-3218-2916; Guda, Teja/0000-0002-3218-2916; Lopez-Cruzan, Marisa/0000-0003-0285-1012	National Institute of Aging [AG 007218, P01-AG19316]; NATIONAL INSTITUTE ON AGING [P01AG019316, R01AG045040, R37AG007218, R01AG007218] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by grants (AG 007218 and P01-AG19316) from the National Institute of Aging (NIA;www.nia.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Altindag O, 2008, RHEUMATOL INT, V28, P317, DOI 10.1007/s00296-007-0452-0; Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Blair HC, 1998, BIOESSAYS, V20, P837, DOI 10.1002/(SICI)1521-1878(199810)20:10<837::AID-BIES9>3.3.CO;2-4; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Braga M, 2008, APOPTOSIS, V13, P822, DOI 10.1007/s10495-008-0216-7; Cooper C., 1997, AM J MED, V103, p17S; Cooper Cyrus, 1997, American Journal of Medicine, V103, p12S, DOI 10.1016/S0002-9343(97)90022-X; Deng FY, 2011, J BONE MINER RES, V26, P2695, DOI 10.1002/jbmr.471; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Kil IS, 2005, J BIOL CHEM, V280, P10846, DOI 10.1074/jbc.M411306200; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lean JM, 2005, ENDOCRINOLOGY, V146, P728, DOI 10.1210/en.2004-1021; Lean JM, 2003, J CLIN INVEST, V112, P915, DOI 10.1172/JCI200318859; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Lee SM, 2001, BIOCHIMIE, V83, P1057, DOI 10.1016/S0300-9084(01)01351-7; Li Q, 2006, FREE RADICAL BIO MED, V40, P173, DOI 10.1016/j.freeradbiomed.2005.09.037; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; Manolagas SC, 2010, TRENDS ENDOCRIN MET, V21, P369, DOI 10.1016/j.tem.2010.01.010; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Miyazaki T, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.385369; Monroe DG, 2002, MOL ENDOCRINOL, V16, P1322, DOI 10.1210/me.16.6.1322; Muthusami S, 2005, CLIN CHIM ACTA, V360, P81, DOI 10.1016/j.cccn.2005.04.014; Nojiri H, 2011, J BONE MINER RES, V26, P2682, DOI 10.1002/jbmr.489; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Oursler MJ, 2005, AM J PHYSIOL-CELL PH, V288, pC156, DOI 10.1152/ajpcell.00092.2004; Sanchez-Rodriguez MA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-124; Sato N, 1997, GENE, V202, P127, DOI 10.1016/S0378-1119(97)00463-0; Seales EC, 2006, J CELL BIOCHEM, V97, P45, DOI 10.1002/jcb.20659; Sendur OF, 2009, JOINT BONE SPINE, V76, P514, DOI 10.1016/j.jbspin.2009.02.005; SHALINI S, 2012, CELL DEATH DIFFER; Smietana MJ, 2010, BIOCHEM BIOPH RES CO, V403, P149, DOI 10.1016/j.bbrc.2010.11.006; Szymczyk KH, 2006, J CELL PHYSIOL, V209, P836, DOI 10.1002/jcp.20770; Tiwari M, 2011, J BIOL CHEM, V286, P8493, DOI 10.1074/jbc.M110.163824; Uchibayashi R, 2011, J NEUROSCI RES, V89, P1783, DOI 10.1002/jnr.22691; Vashishth D, 2001, BONE, V28, P195, DOI 10.1016/S8756-3282(00)00434-8; Wakeyama H, 2007, J BONE MINER RES, V22, P1631, DOI 10.1359/JBMR.070619; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Wauquier F, 2009, TRENDS MOL MED, V15, P468, DOI 10.1016/j.molmed.2009.08.004; Wu XJ, 2003, ENDOCRINOLOGY, V144, P5545, DOI 10.1210/en.2003-0296; Yalin S, 2005, CLIN EXP RHEUMATOL, V23, P689; Zhang YP, 2007, MECH AGEING DEV, V128, P213, DOI 10.1016/j.mad.2006.11.030; Zhang YP, 2002, EXP GERONTOL, V37, P777, DOI 10.1016/S0531-5565(02)00013-X	45	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93696	10.1371/journal.pone.0093696	http://dx.doi.org/10.1371/journal.pone.0093696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691516	gold, Green Published, Green Submitted			2022-12-27	WOS:000334101100128
J	Westerholz, J; Schack, T; Schutz, C; Koester, D				Westerholz, Jan; Schack, Thomas; Schuetz, Christoph; Koester, Dirk			Habitual vs Non- Habitual Manual Actions: An ERP Study on Overt Movement Execution	PLOS ONE			English	Article							END-STATE COMFORT; COMPONENTS; PRECISION; SELECTION; COGNITION	This study explored the neurophysiological mechanisms underlying the planning and execution of an overt goal- related handle rotation task. More specifically, we studied the neural basis of motor actions concerning the influence of the grasp choice. The aim of the present study was to differentiate cerebral activity between grips executed in a habitual and a nonhabitual mode, and between specified and free grip choices. To our knowledge, this is the first study to differentiate cerebral activity underlying overt goal-related actions executed with a focus on the habitual mode. In a handle rotation task, participants had to use thumb-toward (habitual) or thumb- away ( non- habitual) grips to rotate a handle to a given target position. Reaction and reach times were shorter for the habitual compared to the non- habitual mode indicating that the habitual mode requires less cognitive processing effort than the non- habitual mode. Neural processes for action execution ( measured by event-related potentials ( ERPs)) differed between habitual and non-habitual conditions. We found differential activity between habitual and non- habitual conditions in left and right frontal areas from -600 to 200 ms time- locked to reaching the target position. No differential neural activity could be traced for the specification of the grip. The results suggested that the frontal negativity reflected increased difficulty in movement precision control in the non- habitual mode compared to the habitual mode during the homing in phase of grasp and rotation actions.	[Westerholz, Jan; Schack, Thomas; Koester, Dirk] CITEC, Bielefeld, Germany; [Westerholz, Jan; Schack, Thomas; Schuetz, Christoph; Koester, Dirk] Univ Bielefeld, Fac Psychol & Sports Sci, Neurocognit & Act Res Grp, D-33615 Bielefeld, Germany; [Schack, Thomas] Res Inst Cognit & Robot, CoR Lab, Bielefeld, Germany	University of Bielefeld	Westerholz, J (corresponding author), CITEC, Bielefeld, Germany.	jwesterh@cit-ec.uni-bielefeld.de	Koester, Dirk/B-2438-2008	Koester, Dirk/0000-0003-3940-8559	German Research Foundation [DFG EXC 277]; Deutsche Forschungsgemeinschaft; Open Access Publication Funds of Bielefeld University Library	German Research Foundation(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Funds of Bielefeld University Library	This research was supported by German Research Foundation Grant DFG EXC 277 "Cognitive Interaction Technology" (CITEC). The authors acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOTWINICK J, 1966, J EXP PSYCHOL, V71, P9, DOI 10.1037/h0022634; Bozzacchi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047783; Bozzacchi C, 2012, BIOL PSYCHOL, V89, P503, DOI 10.1016/j.biopsycho.2011.12.020; Cohen RG, 2004, EXP BRAIN RES, V157, P486, DOI 10.1007/s00221-004-1862-9; Elliott D, 2010, PSYCHOL BULL, V136, P1023, DOI 10.1037/a0020958; Filimon F, 2010, NEUROSCIENTIST, V16, P388, DOI 10.1177/1073858410375468; Fleming SM, 2009, CEREB CORTEX, V19, P2352, DOI 10.1093/cercor/bhn252; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Herbort O, 2011, EXP BRAIN RES, V213, P371, DOI 10.1007/s00221-011-2787-8; Hughes CML, 2012, J MOTOR BEHAV, V44, P195, DOI 10.1080/00222895.2012.672483; Kunzell S, 2013, ACTA PSYCHOL, V143, P310, DOI 10.1016/j.actpsy.2013.04.013; Lange JJ, 1999, BIOL PSYCHOL, V50, P203, DOI 10.1016/S0301-0511(99)00009-5; MARTENIUK RG, 1990, HUM MOVEMENT SCI, V9, P149, DOI 10.1016/0167-9457(90)90025-9; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; ROSENBAUM DA, 1992, J EXP PSYCHOL LEARN, V18, P1058, DOI 10.1037/0278-7393.18.5.1058; ROSENBAUM DA, 1993, ATTENTION PERFORM, V14, P803; ROSENBAUM DA, 1990, ATTENTION PERFORM, V8, P321; Rosenbaum DA, 1996, ACTA PSYCHOL, V94, P59, DOI 10.1016/0001-6918(95)00062-3; ROSENBAUM DA, 1992, HUM MOVEMENT SCI, V11, P61, DOI 10.1016/0167-9457(92)90050-L; Rosenbaum DA, 2012, PSYCHOL BULL, V138, P924, DOI 10.1037/a0027839; Short MW, 1999, ACTA PSYCHOL, V100, P243, DOI 10.1016/S0001-6918(98)00020-1; van Elk M, 2008, EXP BRAIN RES, V189, P99, DOI 10.1007/s00221-008-1408-7; van Elk M, 2012, EXP BRAIN RES, V218, P189, DOI 10.1007/s00221-012-3016-9; van Schie HT, 2007, BRAIN RES, V1148, P183, DOI 10.1016/j.brainres.2007.02.085; Waszak F, 2012, NEUROSCI BIOBEHAV R, V36, P943, DOI 10.1016/j.neubiorev.2011.11.004; Weigelt M, 2007, EXP BRAIN RES, V179, P191, DOI 10.1007/s00221-006-0780-4; Weigelt M, 2006, EXP PSYCHOL, V53, P143, DOI 10.1027/1618-3169.53.2.143; Westerholz J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068501, DOI 10.1371/JOURNAL.PONE. 0068501]	29	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93116	10.1371/journal.pone.0093116	http://dx.doi.org/10.1371/journal.pone.0093116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6KM	24691654	Green Submitted, Green Published, gold			2022-12-27	WOS:000334101100048
J	Zhang, YT; Xu, LH; Lu, Q; Liu, KP; Liu, PY; Ji, F; Liu, XM; Ouyang, DY; He, XH				Zhang, Yan-Ting; Xu, Li-Hui; Lu, Qun; Liu, Kun-Peng; Liu, Pei-Yan; Ji, Fang; Liu, Xiao-Ming; Ouyang, Dong-Yun; He, Xian-Hui			VASP Activation via the G alpha 13/RhoA/PKA Pathway Mediates Cucurbitacin-B-Induced Actin Aggregation and Cofilin-Actin Rod Formation	PLOS ONE			English	Article							VASODILATOR-STIMULATED-PHOSPHOPROTEIN; BREAST-CANCER CELLS; POTENT ANTITUMOR-ACTIVITY; ENA/VASP PROTEINS; CARCINOMA-CELLS; CYCLE ARREST; IN-VIVO; PHOSPHORYLATION; CYTOSKELETON; INHIBITOR	Cucurbitacin B (CuB), a potent antineoplastic agent of cucurbitacin triterpenoids, induces rapid disruption of actin cytoskeleton and aberrant cell cycle inhibiting carcinogenesis. However, the underlying molecular mechanism of such anticancer effects remains incompletely understood. In this study, we showed that CuB treatment rapidly induced vasodilator-stimulated phosphoprotein (VASP) phosphorylation (i.e. activation) at the Ser157 residue and generated VASP clumps which were co-localized with amorphous actin aggregates prior to the formation of highly-ordered cofilin-actin rods in melanoma cells. Knockdown of VASP or inhibition of VASP activation using PKA-specific inhibitor H89 suppressed CuB-induced VASP activation, actin aggregation and cofilin-actin rod formation. The VASP activation was mediated by cAMP-independent PKA activation as CuB decreased the levels of cAMP while MDL12330A, an inhibitor of adenylyl cyclase, had weak effect on VASP activation. Knockdown of either G alpha 13 or RhoA not only suppressed VASP activation, but also ameliorated CuB-induced actin aggregation and abrogated cofilin-actin rod formation. Collectively, our studies highlighted that the CuB-induced actin aggregation and cofilin-actin rod formation was mediated via the G alpha 13/RhoA/PKA/VASP pathway.	[Zhang, Yan-Ting; Liu, Kun-Peng; Ouyang, Dong-Yun; He, Xian-Hui] Jinan Univ, Dept Immunobiol, Guangzhou, Guangdong, Peoples R China; [Xu, Li-Hui] Jinan Univ, Dept Cell Biol, Guangzhou, Guangdong, Peoples R China; [Lu, Qun] E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC USA; [Liu, Pei-Yan] Jinan Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China; [Ji, Fang] Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China; [Liu, Xiao-Ming] Southern China Primate Res Ctr, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; University of North Carolina; East Carolina University; Jinan University; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Ouyang, DY (corresponding author), Jinan Univ, Dept Immunobiol, Guangzhou, Guangdong, Peoples R China.	dongyun1967@aliyun.com; thexh@jnu.edu.cn	Liu, Kunpeng/AAR-7582-2021; Ouyang, Dong-Yun/P-7305-2019; He, Xian-Hui/H-3153-2019; Ouyang, dong-yun/GSD-5233-2022	Liu, Kunpeng/0000-0003-3452-880X; Ouyang, Dong-Yun/0000-0002-4743-942X; He, Xian-Hui/0000-0001-7433-7392; Xu, Li-hui/0000-0002-2633-9999	National Natural Science Foundation of China [81173604]; Specialized Research Program of "Twelfth Five-Year Plan" of China [2011ZX09307-303-03]; Fundamental Research Funds for the Central Universities [21611387]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Program of "Twelfth Five-Year Plan" of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Natural Science Foundation of China (No. 81173604), the Specialized Research Program of "Twelfth Five-Year Plan" of China (2011ZX09307-303-03), and the Fundamental Research Funds for the Central Universities (21611387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bear JE, 2009, J CELL SCI, V122, P1947, DOI 10.1242/jcs.038125; Benz PM, 2008, J CELL BIOL, V180, P205, DOI 10.1083/jcb.200709181; Benz PM, 2009, J CELL SCI, V122, P3954, DOI 10.1242/jcs.044537; Blaskovich MA, 2003, CANCER RES, V63, P1270; Boykin C, 2011, BRIT J CANCER, V104, P781, DOI 10.1038/bjc.2011.10; Chan KT, 2010, CANCER LETT, V289, P46, DOI 10.1016/j.canlet.2009.07.015; Chen XP, 2012, ANTI-CANCER DRUG, V23, P777, DOI 10.1097/CAD.0b013e3283541384; Chern YJ, 2000, CELL SIGNAL, V12, P195, DOI 10.1016/S0898-6568(99)00084-4; Dinan L, 1997, BIOCHEM J, V327, P643, DOI 10.1042/bj3270643; Duncan KLK, 1996, BIOCHEM PHARMACOL, V52, P1553, DOI 10.1016/S0006-2952(96)00557-6; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; Haritunians T, 2008, LEUKEMIA RES, V32, P1366, DOI 10.1016/j.leukres.2008.01.019; Juneja J, 2009, BRIT J PHARMACOL, V158, P32, DOI 10.1111/j.1476-5381.2009.00180.x; Kataoka A, 2011, PURINERG SIGNAL, V7, P403, DOI 10.1007/s11302-011-9237-8; Knecht DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014039; KONOSHIMA T, 1995, BIOL PHARM BULL, V18, P284, DOI 10.1248/bpb.18.284; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Lang AE, 2011, N-S ARCH PHARMACOL, V383, P227, DOI 10.1007/s00210-010-0579-5; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lopez-Haber C, 2013, MOL PHARMACOL, V83, P1141, DOI 10.1124/mol.112.084293; Lui VWY, 2009, CARCINOGENESIS, V30, P2085, DOI 10.1093/carcin/bgp253; Mannock DA, 2010, CHEM PHYS LIPIDS, V163, P403, DOI 10.1016/j.chemphyslip.2010.03.011; Momma K, 2008, CYTOTECHNOLOGY, V56, P33, DOI 10.1007/s10616-007-9100-5; Nakashima S, 2010, BIOORG MED CHEM LETT, V20, P2994, DOI 10.1016/j.bmcl.2010.02.062; Oates J, 2011, CURR OPIN STRUC BIOL, V21, P802, DOI 10.1016/j.sbi.2011.09.007; Paila YD, 2009, GLYCOCONJUGATE J, V26, P711, DOI 10.1007/s10719-008-9218-5; Profirovic J, 2005, J BIOL CHEM, V280, P32866, DOI 10.1074/jbc.M501361200; Promkan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055732; Ren S, 2012, CANCER CHEMOTH PHARM, V70, P415, DOI 10.1007/s00280-012-1921-z; Sun JZ, 2005, ONCOGENE, V24, P3236, DOI 10.1038/sj.onc.1208470; Tannin-Spitz T, 2007, BIOCHEM PHARMACOL, V73, P56, DOI 10.1016/j.bcp.2006.09.012; Thoennissen NH, 2009, CANCER RES, V69, P5876, DOI 10.1158/0008-5472.CAN-09-0536; Thomson DM, 2011, BIOCHEM BIOPH RES CO, V414, P215, DOI 10.1016/j.bbrc.2011.09.059; Trichet L, 2008, J CELL BIOL, V181, P19, DOI 10.1083/jcb.200710168; Wakimoto N, 2008, CANCER SCI, V99, P1793, DOI 10.1111/j.1349-7006.2008.00899.x; Walders-Harbeck B, 2002, FEBS LETT, V529, P275, DOI 10.1016/S0014-5793(02)03356-2; Yin D, 2008, INT J CANCER, V123, P1364, DOI 10.1002/ijc.23648; Zhang YT, 2013, J CELL BIOCHEM, V114, P2415, DOI 10.1002/jcb.24587; Zhang YT, 2011, ACTA BIOCH BIOPH SIN, V43, P556, DOI 10.1093/abbs/gmr042; Zhu JS, 2012, PHARMACOLOGY, V89, P348, DOI 10.1159/000338757	43	21	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93547	10.1371/journal.pone.0093547	http://dx.doi.org/10.1371/journal.pone.0093547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691407	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100103
J	Park, S; Stromstedt, AA; Goransson, U				Park, Sungkyu; Stromstedt, Adam A.; Goransson, Ulf			Cyclotide Structure-Activity Relationships: Qualitative and Quantitative Approaches Linking Cytotoxic and Anthelmintic Activity to the Clustering of Physicochemical Forces	PLOS ONE			English	Article							CYCLIC-CYSTINE-KNOT; ANTIMICROBIAL PEPTIDES; PLANT CYCLOTIDES; CIRCULAR PROTEIN; KALATA B1; INSECTICIDAL ACTIVITY; SCANNING MUTAGENESIS; CYCLOVIOLACIN O2; MEMBRANE-BINDING; VIOLA-ODORATA	Cyclotides are a family of plant-derived proteins that are characterized by a cyclic backbone and a knotted disulfide topology. Their cyclic cystine knot (CCK) motif makes them exceptionally resistant to thermal, chemical, and enzymatic degradation. Cyclotides exert much of their biological activity via interactions with cell membranes. In this work, we qualitatively and quantitatively analyze the cytotoxic and anthelmintic membrane activities of cyclotides. The qualitative and quantitative models describe the potency of cyclotides using four simple physicochemical terms relevant to membrane contact. Specifically, surface areas of the cyclotides representing lipophilic and hydrogen bond donating properties were quantified and their distribution across the molecular surface was determined. The resulting quantitative structure-activity relation (QSAR) models suggest that the activity of the cyclotides is proportional to their lipophilic and positively charged surface areas, provided that the distribution of these surfaces is asymmetric. In addition, we qualitatively analyzed the physicochemical differences between the various cyclotide subfamilies and their effects on the cyclotides' orientation on the membrane and membrane activity.	[Park, Sungkyu; Stromstedt, Adam A.; Goransson, Ulf] Uppsala Univ, Div Pharmacognosy, Dept Med Chem, Uppsala, Sweden	Uppsala University	Goransson, U (corresponding author), Uppsala Univ, Div Pharmacognosy, Dept Med Chem, Uppsala, Sweden.	ulf.goransson@fkog.uu.se	Strömstedt, Adam/I-8820-2018	Strömstedt, Adam/0000-0001-9070-6944; Goransson, Ulf/0000-0002-5005-9612	Swedish Research Council [621-2007-5167]; Swedish Foundation for Strategic Research [F06-0058]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	U.G. is supported by the Swedish Research Council (#621-2007-5167) and the Swedish Foundation for Strategic Research (#F06-0058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboye TL, 2012, J MED CHEM, V55, P10729, DOI 10.1021/jm301468k; Accelrys Software Inc, 2007, DISC STUD MOD ENV; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Bhonsle JB, 2007, J MED CHEM, V50, P6545, DOI 10.1021/jm070884y; BLACK SD, 1991, ANAL BIOCHEM, V193, P72, DOI 10.1016/0003-2697(91)90045-U; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Burman R, 2011, BBA-BIOMEMBRANES, V1808, P2665, DOI 10.1016/j.bbamem.2011.07.004; Burman R, 2011, ORG BIOMOL CHEM, V9, P4306, DOI 10.1039/c0ob00966k; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Clark RJ, 2006, BIOCHEM J, V394, P85, DOI 10.1042/BJ20051691; Colgrave ML, 2008, CHEMBIOCHEM, V9, P1939, DOI 10.1002/cbic.200800174; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2004, CURR PROTEIN PEPT SC, V5, P297, DOI 10.2174/1389203043379512; Daly NL, 2006, BIOCHEM J, V393, P619, DOI 10.1042/BJ20051371; Daly NL, 1999, J MOL BIOL, V285, P333, DOI 10.1006/jmbi.1998.2276; de Planque MRR, 2003, BIOCHEMISTRY-US, V42, P5341, DOI 10.1021/bi027000r; Frecer V, 2006, BIOORGAN MED CHEM, V14, P6065, DOI 10.1016/j.bmc.2006.05.005; Gerlach SL, 2010, J NAT PROD, V73, P1207, DOI 10.1021/np9007365; Giang KTN, 2013, J BIOL CHEM, V288, P3370, DOI 10.1074/jbc.M112.415356; Goransson U, 2012, J BIOL CHEM, V287, P27001, DOI 10.1074/jbc.R111.300129; Goransson U, 2009, CHEMBIOCHEM, V10, P2354, DOI 10.1002/cbic.200900342; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; Hall L.H., 1991, REV COMPUTATIONAL CH, V2, P367, DOI DOI 10.1002/9780470125793.CH9; Hashempour H, 2013, AMINO ACIDS, V44, P581, DOI 10.1007/s00726-012-1376-x; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Herrmann A, 2006, CELL MOL LIFE SCI, V63, P235, DOI 10.1007/s00018-005-5486-4; Herrmann A, 2008, PHYTOCHEMISTRY, V69, P939, DOI 10.1016/j.phytochem.2007.10.023; Huang YH, 2010, J BIOL CHEM, V285, P10797, DOI 10.1074/jbc.M109.089854; Ireland DC, 2006, BIOCHEM J, V400, P1, DOI 10.1042/BJ20060627; Ireland DC, 2006, J MOL BIOL, V357, P1522, DOI 10.1016/j.jmb.2006.01.051; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Koehbach J, 2013, P NATL ACAD SCI USA, V110, P21183, DOI 10.1073/pnas.1311183110; Koltay A, 2005, INT J PEPT RES THER, V11, P99, DOI 10.1007/s10989-004-1722-2; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Labute P, 2010, J CHEM INF MODEL, V50, P792, DOI 10.1021/ci900508k; Langham AA, 2008, PEPTIDES, V29, P1085, DOI 10.1016/j.peptides.2008.03.018; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lindholm P, 2002, MOL CANCER THER, V1, P365; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Minitab IN, 2010, MINITAB 16 STAT SOFT; MOE, 2012, MOL OP ENV; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Mulvenna JR, 2005, STRUCTURE, V13, P691, DOI 10.1016/j.str.2005.02.013; Ostberg N, 2005, PEPTIDES, V26, P197, DOI 10.1016/j.peptides.2004.09.020; Ovesen RG, 2011, ENVIRON TOXICOL CHEM, V30, P1190, DOI 10.1002/etc.496; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Poth AG, 2012, J BIOL CHEM, V287, P27033, DOI 10.1074/jbc.M112.370841; Poth AG, 2011, ACS CHEM BIOL, V6, P345, DOI 10.1021/cb100388j; ROGERS D, 1994, J CHEM INF COMP SCI, V34, P854, DOI 10.1021/ci00020a020; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Stromstedt AA, 2010, CURR OPIN COLLOID IN, V15, P467, DOI 10.1016/j.cocis.2010.05.006; Svangard E, 2004, J NAT PROD, V67, P144, DOI 10.1021/np030101l; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Trabi M, 2004, PLANT CELL, V16, P2204, DOI 10.1105/tpc.104.021790; VANDEWATERBEEMD H, 1994, AMINO ACIDS, V7, P129, DOI 10.1007/BF00814156; Wang CK, 2009, BIOPHYS J, V97, P1471, DOI 10.1016/j.bpj.2009.06.032; Wang CK, 2009, J BIOL CHEM, V284, P10672, DOI 10.1074/jbc.M900021200; Wang CKL, 2011, BIOCHEMISTRY-US, V50, P4077, DOI 10.1021/bi2004153; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Yeshak MY, 2011, J NAT PROD, V74, P727, DOI 10.1021/np100790f	68	23	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e91430	10.1371/journal.pone.0091430	http://dx.doi.org/10.1371/journal.pone.0091430			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682019	Green Published, gold, Green Submitted			2022-12-27	WOS:000333678100003
J	Watanabe, K; Kazama, S; Omura, T; Monaghan, MT				Watanabe, Kozo; Kazama, So; Omura, Tatsuo; Monaghan, Michael T.			Adaptive Genetic Divergence along Narrow Environmental Gradients in Four Stream Insects	PLOS ONE			English	Article							NATURAL-SELECTION; LOCAL ADAPTATION; POPULATION-STRUCTURE; COLOR POLYMORPHISM; GENOME-SCAN; ECOLOGICAL SPECIALIZATION; REPRODUCTIVE ISOLATION; DOMINANT MARKERS; MIXED MODELS; DIFFERENTIATION	A central question linking ecology with evolutionary biology is how environmental heterogeneity can drive adaptive genetic divergence among populations. We examined adaptive divergence of four stream insects from six adjacent catchments in Japan by combining field measures of habitat and resource components with genome scans of non-neutral Amplified Fragment Length Polymorphism (AFLP) loci. Neutral genetic variation was used to measure gene flow and non-neutral genetic variation was used to test for adaptive divergence. We identified the environmental characteristics contributing to divergence by comparing genetic distances at non-neutral loci between sites with Euclidean distances for each of 15 environmental variables. Comparisons were made using partial Mantel tests to control for geographic distance. In all four species, we found strong evidence for non-neutral divergence along environmental gradients at between 6 and 21 loci per species. The relative contribution of these environmental variables to each species' ecological niche was quantified as the specialization index, S, based on ecological data. In each species, the variable most significantly correlated with genetic distance at non-neutral loci was the same variable along which each species was most narrowly distributed (i.e., highest S). These were gradients of elevation (two species), chlorophyll-a, and ammonia-nitrogen. This adaptive divergence occurred in the face of ongoing gene flow (F-st = 0.01-0.04), indicating that selection was strong enough to overcome homogenization at the landscape scale. Our results suggest that adaptive divergence is pronounced, occurs along different environmental gradients for different species, and may consistently occur along the narrowest components of species' niche.	[Watanabe, Kozo; Monaghan, Michael T.] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Berlin, Germany; [Kazama, So] Tohoku Univ, Dept Civil & Environm Engn, Sendai, Miyagi 980, Japan; [Omura, Tatsuo] Tohoku Univ, New Ind Creat Hatchery Ctr NIChe, Sendai, Miyagi 980, Japan	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Tohoku University; Tohoku University	Watanabe, K (corresponding author), Ehime Univ, Dept Civil & Environm Engn, Bunkyo Cho 3, Matsuyama, Ehime, Japan.	watanabe_kozo@cee.ehime-u.ac.jp	Monaghan, Michael T/A-2589-2009; Watanabe, Kozo/F-7388-2010; Kazama, So/T-2641-2019	Monaghan, Michael T/0000-0001-6200-2376; Watanabe, Kozo/0000-0002-7062-595X; 	Japan Society for the Promotion of Science (JSPS) [22360192, 25289172, 24254003, 25303020]; Ministry of Land, Infrastructure and Transport Japan [07052442]; European Commission [237026]; Grants-in-Aid for Scientific Research [25289172] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Land, Infrastructure and Transport Japan; European Commission(European CommissionEuropean Commission Joint Research Centre); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) (grant numbers 22360192, 25289172, 24254003 and 25303020), the Ministry of Land, Infrastructure and Transport Japan (grant number 07052442), and the European Commission (grant number 237026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JK, 2008, MOL ECOL, V17, P1597, DOI 10.1111/j.1365-294X.2007.03641.x; Ackermann M, 2004, EVOLUTION, V58, P2599; Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; Andres JA, 2000, EVOLUTION, V54, P2156, DOI 10.1111/j.0014-3820.2000.tb01258.x; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Antao T, 2011, BIOINFORMATICS, V27, P1717, DOI 10.1093/bioinformatics/btr253; ANTONOVICS J, 1976, ANN MO BOT GARD, V63, P224, DOI 10.2307/2395303; AOYA K, 1987, Japanese Journal of Limnology, V48, P41; Barton NH, 1999, GENET RES, V74, P223, DOI 10.1017/S001667239900422X; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2006, MOL BIOL EVOL, V23, P773, DOI 10.1093/molbev/msj087; Brittain J.E., 2003, ENCY INSECTS, P373; Caballero A, 2008, GENETICS, V179, P539, DOI 10.1534/genetics.107.083246; Carneiro M, 2011, MOL BIOL EVOL, V28, P1801, DOI 10.1093/molbev/msr003; COOK LM, 1992, HEREDITY, V69, P184, DOI 10.1038/hdy.1992.112; Counterman BA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000796; Cousyn C, 2001, P NATL ACAD SCI USA, V98, P6256, DOI 10.1073/pnas.111606798; Cox K, 2011, MOL ECOL, V20, P2724, DOI 10.1111/j.1365-294X.2011.05137.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fischer MC, 2011, MOL ECOL, V20, P1450, DOI 10.1111/j.1365-294X.2011.05015.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Frichot E, 2013, MOL BIOL EVOL, V30, P1687, DOI 10.1093/molbev/mst063; Gillespie RG, 1998, EVOLUTION, V52, P775, DOI [10.2307/2411271, 10.1111/j.1558-5646.1998.tb03701.x]; HALDANE JBS, 1956, PROC R SOC SER B-BIO, V145, P306, DOI 10.1098/rspb.1956.0039; Hauer F. R., 1996, METHODS STREAM ECOLO; Hawthorne DJ, 2001, NATURE, V412, P904, DOI 10.1038/35091062; Hendry AP, 2009, CAN J FISH AQUAT SCI, V66, P1383, DOI 10.1139/F09-074; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hughes JM, 2007, FRESHWATER BIOL, V52, P616, DOI 10.1111/j.1365-2427.2006.01722.x; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Li YF, 2008, EVOLUTION, V62, P2984, DOI 10.1111/j.1558-5646.2008.00486.x; Lynch M., 1998, GENETICS ANAL QUANTI; Manly BFJ, 1997, RANDOMIZATION BOOTST; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Narum SR, 2010, MOL ECOL, V19, P4622, DOI 10.1111/j.1365-294X.2010.04839.x; NEI M, 1975, GENETICS, V80, P395; Nosil P, 2005, EVOLUTION, V59, P705; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Perez-Figueroa A, 2010, J EVOLUTION BIOL, V23, P2267, DOI 10.1111/j.1420-9101.2010.02093.x; Poisot T, 2011, ECOL LETT, V14, P841, DOI 10.1111/j.1461-0248.2011.01645.x; Raufaste N, 2001, EVOLUTION, V55, P1703, DOI 10.1111/j.0014-3820.2001.tb00689.x; ROBERTSON A, 1975, GENETICS, V80, P396; Saint-Laurent R, 2003, MOL ECOL, V12, P315, DOI 10.1046/j.1365-294X.2003.01735.x; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Spichtig M, 2004, AM NAT, V164, P70, DOI 10.1086/421335; Tollenaere C, 2011, MOL ECOL, V20, P1026, DOI 10.1111/j.1365-294X.2010.04633.x; Van Strien MJ, 2012, MOL ECOL, V21, P4010, DOI 10.1111/j.1365-294X.2012.05687.x; Van VALEN LEIGH, 1965, AMER NATUR, V99, P377, DOI 10.1086/282379; VEKEMANS X, 2002, AFLP SURV VERSION 1; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Ward JV, 1992, AQUATIC INSECT ECOLO; Watanabe K, 2008, SCI TOTAL ENVIRON, V394, P57, DOI 10.1016/j.scitotenv.2008.01.006; Watanabe K, 2010, AQUAT CONSERV, V20, P574, DOI 10.1002/aqc.1124; Wilcock HR, 2007, FRESHWATER BIOL, V52, P1907, DOI 10.1111/j.1365-2427.2007.01818.x; Wong A, 2003, MOL ECOL, V12, P3505, DOI 10.1046/j.1365-294X.2003.02002.x; Yang RC, 2004, EVOLUTION, V58, P1839; Yeaman S, 2006, P ROY SOC B-BIOL SCI, V273, P1587, DOI 10.1098/rspb.2006.3498; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	70	20	20	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93055	10.1371/journal.pone.0093055	http://dx.doi.org/10.1371/journal.pone.0093055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681871	gold, Green Published, Green Submitted			2022-12-27	WOS:000333678100022
J	Grepin, R; Ambrosetti, D; Marsaud, A; Gastaud, L; Amiel, J; Pedeutour, F; Pages, G				Grepin, Renaud; Ambrosetti, Damien; Marsaud, Alexandre; Gastaud, Lauris; Amiel, Jean; Pedeutour, Florence; Pages, Gilles			The Relevance of Testing the Efficacy of Anti-Angiogenesis Treatments on Cells Derived from Primary Tumors: A New Method for the Personalized Treatment of Renal Cell Carcinoma	PLOS ONE			English	Article							CLEAR-CELL; TFE3 GENE; ANTITUMOR-ACTIVITY; GROWTH-FACTOR; C-MET; SORAFENIB; SUNITINIB; CANCER; FUSION; INHIBITION	Despite the numerous available drugs, the most appropriate treatments for patients affected by common or rare renal cell carcinomas (RCC), like those associated with the Xp11.2 translocation/transcription factor for immunoglobulin heavy-chain enhancer 3 (TFE3) gene fusion (TFE3 RCC), are not clearly defined. We aimed to make a parallel between the sensitivity to targeted therapies on living patients and on cells derived from the initial tumor. Three patients diagnosed with a metastatic RCC (one clear cell RCC [ccRCC], two TFE3 RCC) were treated with anti-angiogenesis drugs. The concentrations of the different drugs giving 50% inhibition of cell proliferation (IC50) were determined with the Thiazolyl Blue Tetrazolium Bromide (MTT) assay on cells from the primary tumors and a reference sensitive RCC cell line (786-O). We considered the cells to be sensitive if the IC50 was lower or equal to that in 786-O cells, and insensitive if the IC50 was higher to that in 786-O cells (IC 50 of 6 +/- 1 mu M for sunitinib, 10 +/- 1 mu M for everolimus and 661 mM for sorafenib). Based on this standard, the response in patients and in cells was equivalent. The efficacy of anti-angiogenesis therapies was also tested in cells obtained from five patients with non-metastatic ccRCC, and untreated as recommended by clinical practice in order to determine the best treatment in case of progression toward a metastatic grade. In vitro experiments may represent a method for evaluating the best first-line treatment for personalized management of ccRCC during the period following surgery.	[Grepin, Renaud] Univ Nice Sophia Antipolis, Principal Monaco, Ctr Sci Monaco, Biomed Res Unit, F-06189 Nice, France; [Ambrosetti, Damien] Univ Nice Sophia Antipolis, Nice Univ Hosp, IRCAN, UMR 7284,U1081, F-06189 Nice, France; [Marsaud, Alexandre] Univ Nice Sophia Antipolis, Dept Urol, Nice Univ Hosp, IRCAN UMR U1081 7284, F-06189 Nice, France; [Gastaud, Lauris] Ctr Antoine Lacassagne, Dept Med Oncol, F-06054 Nice, France; [Amiel, Jean] Univ Nice Sophia Antipolis, Dept Urol, Nice Univ Hosp, F-06189 Nice, France; [Pedeutour, Florence] Univ Nice Sophia Antipolis, Lab Solid Tumors Genet, Nice Univ Hosp, IRCAN,UMR U1081 7284, F-06189 Nice, France; [Pages, Gilles] Univ Nice Sophia Antipolis, IRCAN, UMR 7284, U1081, F-06189 Nice, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur	Pages, G (corresponding author), Univ Nice Sophia Antipolis, IRCAN, UMR 7284, U1081, F-06189 Nice, France.	gpages@unice.fr	Pages, Gilles/N-7135-2017; Ambrosetti, Damien/E-2131-2015	Ambrosetti, Damien/0000-0001-8665-0546	Institut National pour la Sante et la Recherche Medicale; Centre National de la Recherche Scientifique; Centre Scientifique de Monaco; National Institute of Cancer; Association for Cancer Research; Fondation de France; Fondation pour la Recherche Medicale; The "Association pour la Recherche sur les Tumeurs du Rein"	Institut National pour la Sante et la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Centre Scientifique de Monaco; National Institute of Cancer; Association for Cancer Research; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); The "Association pour la Recherche sur les Tumeurs du Rein"	This work was supported by institutional national fundings for research ("the Institut National pour la Sante et la Recherche Medicale", the "Centre National de la Recherche Scientifique", the "Centre Scientifique de Monaco", the National Institute of Cancer) and charities (the Association for Cancer Research, the "Fondation de France", the "Fondation pour la Recherche Medicale", The "Association pour la Recherche sur les Tumeurs du Rein"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argani P, 2003, AM J SURG PATHOL, V27, P750, DOI 10.1097/00000478-200306000-00005; Armah HB, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-15; AUERBACH R, 1978, CANCER RES, V38, P1739; Bockorny B, 2013, EXPERT OPIN BIOL TH, V13, P911, DOI 10.1517/14712598.2013.778970; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Burel-Vandenbos F, 2011, J NEURO-ONCOL, V102, P171, DOI 10.1007/s11060-010-0308-4; Cao Y, 2013, CANCER RES, V73, P4579, DOI 10.1158/0008-5472.CAN-13-0529; Cao Y, 2012, CANCER RES, V72, P3912, DOI 10.1158/0008-5472.CAN-11-4058; Choueiri TK, 2012, EUR UROL, V62, P917, DOI 10.1016/j.eururo.2012.05.051; Clark J, 1997, ONCOGENE, V15, P2233, DOI 10.1038/sj.onc.1201394; Davis IJ, 2010, CANCER RES, V70, P639, DOI 10.1158/0008-5472.CAN-09-1121; Escudier B, 2010, J CLIN ONCOL, V28, P2144, DOI 10.1200/JCO.2009.26.7849; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Giangrande PH, 2003, MOL CELL BIOL, V23, P3707, DOI 10.1128/MCB.23.11.3707-3720.2003; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Gotink KJ, 2011, CLIN CANCER RES, V17, P7337, DOI 10.1158/1078-0432.CCR-11-1667; Grepin R, 2012, ONCOGENE, V31, P1683, DOI 10.1038/onc.2011.360; Grepin R, 2013, CANC RES IN PRESS; Hammers HJ, 2010, MOL CANCER THER, V9, P1525, DOI 10.1158/1535-7163.MCT-09-1106; Heimann P, 2001, CANCER RES, V61, P4130; Huang D, 2010, CANCER RES, V70, P1063, DOI 10.1158/0008-5472.CAN-09-3965; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Kanellis J, 2000, AM J PHYSIOL-RENAL, V278, pF905, DOI 10.1152/ajprenal.2000.278.6.F905; Karam JA, 2011, EUR UROL, V59, P619, DOI 10.1016/j.eururo.2010.11.043; Kuroda N, 2012, HISTOL HISTOPATHOL, V27, P133, DOI 10.14670/HH-27.133; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malouf GG, 2010, ANN ONCOL, V21, P1834, DOI 10.1093/annonc/mdq029; McDermott DF, 2013, SEMIN ONCOL, V40, P492, DOI 10.1053/j.seminoncol.2013.05.008; Medendorp K, 2009, EXP CELL RES, V315, P2399, DOI 10.1016/j.yexcr.2009.04.022; Mestas J, 2005, J IMMUNOL, V175, P5351, DOI 10.4049/jimmunol.175.8.5351; Motzer RJ, 2013, J CLIN ONCOL, V31, P3791, DOI 10.1200/JCO.2012.47.4940; Motzer RJ, 2013, NEW ENGL J MED, V369, P722, DOI 10.1056/NEJMoa1303989; Motzer RJ, 2013, LANCET ONCOL, V14, P552, DOI 10.1016/S1470-2045(13)70093-7; Muller-Hocker J, 2008, PATHOL RES PRACT, V204, P589, DOI 10.1016/j.prp.2008.01.010; Pal SK, 2012, MOL CANCER THER, V11, P526, DOI 10.1158/1535-7163.MCT-11-0806; Ravaud A, 2011, ONCOLOGIST, V16, P32, DOI 10.1634/theoncologist.2011-S2-32; Riesterer O, 2004, ONCOGENE, V23, P4624, DOI 10.1038/sj.onc.1207596; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Ross H, 2012, ARCH PATHOL LAB MED, V136, P391, DOI 10.5858/arpa.2011-0479-RA; Sennino B, 2012, CANCER DISCOV, V2, P270, DOI 10.1158/2159-8290.CD-11-0240; Shiota M, 2010, INT J ONCOL, V37, P509, DOI 10.3892/ijo_00000700; Shiota M, 2010, INT J ONCOL, V36, P1521, DOI 10.3892/ijo_00000639; Sidhar SK, 1996, HUM MOL GENET, V5, P1333, DOI 10.1093/hmg/5.9.1333; Sivanand S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003643; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Wang B, 2006, CANCER RES, V66, P3071, DOI 10.1158/0008-5472.CAN-05-2871; Weterman MAJ, 2001, P NATL ACAD SCI USA, V98, P13808, DOI 10.1073/pnas.241304198; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yu K, 2010, CANCER RES, V70, P621, DOI 10.1158/0008-5472.CAN-09-2340; Zhang LB, 2009, NEOPLASIA, V11, P426, DOI 10.1593/neo.09166	52	18	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e89449	10.1371/journal.pone.0089449	http://dx.doi.org/10.1371/journal.pone.0089449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676409	gold, Green Submitted, Green Published			2022-12-27	WOS:000333677500004
J	Liu, ZF; Li, XR; Sun, N; Xu, Y; Meng, YQ; Yang, CX; Wang, YF; Zhang, KR				Liu, Zhifen; Li, Xinrong; Sun, Ning; Xu, Yong; Meng, Yaqin; Yang, Chunxia; Wang, Yanfang; Zhang, Kerang			Microarray Profiling and Co-Expression Network Analysis of Circulating IncRNAs and mRNAs Associated with Major Depressive Disorder	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LONG NONCODING RNAS; GENE-EXPRESSION; PREFRONTAL CORTEX; BIOLOGY; SUSCEPTIBILITY; MECHANISMS; BEHAVIOR; DISEASE; STRESS	LncRNAs, which represent one of the most highly expressed classes of ncRNAs in the brain, are becoming increasingly interesting with regard to brain functions and disorders. However, changes in the expression of regulatory IncRNAs in Major Depressive Disorder (MDD) have not yet been reported. Using microarrays, we profiled the expression of 34834 IncRNAs and 39224 mRNAs in peripheral blood sampled from MDD patients as well as demographically-matched controls. Among these, we found that 2007 IncRNAs and 1667 mRNAs were differentially expressed, 17 of which were documented as depression-related gene in previous studies. Gene Ontology (GO) and pathway analyses indicated that the biological functions of differentially expressed mRNAs were related to fundamental metabolic processes and neurodevelopment diseases. To investigate the potential regulatory roles of the differentially expressed IncRNAs on the mRNAs, we also constructed co-expression networks composed of the IncRNAs and mRNAs, which shows significant correlated patterns of expression. In the MDD-derived network, there were a greater number of nodes and connections than that in the control-derived network. The IncRNAs located at chr10:874695-874794, chr10:75873456-75873642, and chr3:47048304-47048512 may be important factors regulating the expression of mRNAs as they have previously been reported associations with MDD. This study is the first to explore genome-wide IncRNA expression and co-expression with mRNA patterns in MDD using microarray technology. We identified circulating IncRNAs that are aberrantly expressed in MDD and the results suggest that IncRNAs may contribute to the molecular pathogenesis of MDD.	[Liu, Zhifen; Li, Xinrong; Sun, Ning; Xu, Yong; Meng, Yaqin; Yang, Chunxia; Wang, Yanfang; Zhang, Kerang] Shanxi Med Univ, Hosp 1, Dept Psychiat, Taiyuan, Peoples R China	Shanxi Medical University	Zhang, KR (corresponding author), Shanxi Med Univ, Hosp 1, Dept Psychiat, Taiyuan, Peoples R China.	krangzhang_sxmu@vip.163.com	Sun, Ning/AAO-9421-2021	Sun, Ning/0000-0003-3844-2632	National Natural Science Foundation of China [30770770, 30971054, 81171290]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by grants from the National Natural Science Foundation of China. (Nos. 30770770, 30971054, and 81171290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge MS, 2007, CURR OPIN PHARMACOL, V7, P8, DOI 10.1016/j.coph.2006.11.006; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barry G, 2013, MOL PSYCHIATR, P1; Bhartiya D, 2012, EXPERT OPIN DRUG DIS, V7, P503, DOI 10.1517/17460441.2012.682055; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; Dong C, 2009, MOL PSYCHIATR, V14, P1105, DOI 10.1038/mp.2009.92; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Enache D, 2011, CURR OPIN PSYCHIATR, V24, P461, DOI 10.1097/YCO.0b013e32834bb9d4; FIRST MB, 1995, J PERS DISORD, V9, P92, DOI 10.1521/pedi.1995.9.2.92; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Hauser SR, 2011, PHARMACOL BIOCHEM BE, V100, P253, DOI 10.1016/j.pbb.2011.08.014; Henningsen K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016428; Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6; Lee GL, 2011, NAT REV UROL, V8, P123, DOI 10.1038/nrurol.2011.10; Lee PH, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.95; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Lewis CM, 2010, AM J PSYCHIAT, V167, P949, DOI 10.1176/appi.ajp.2010.09091380; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Lohoff FW, 2010, CURR PSYCHIAT REP, V12, P539, DOI 10.1007/s11920-010-0150-6; Lundh SH, 2013, HUM MOL GENET, V22, P3485, DOI 10.1093/hmg/ddt203; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Marsh L, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0409-5; Mehta D, 2010, CURR PSYCHIAT REP, V12, P135, DOI 10.1007/s11920-010-0100-3; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Mostafavi S., 2013, MOL PSYCHIAT; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Ng SY, 2013, TRENDS GENET, V29, P461, DOI 10.1016/j.tig.2013.03.002; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Sanchez Y, 2013, NUCLEIC ACID THER, V23, P15, DOI 10.1089/nat.2012.0414; Schlitt T, 2003, GENOME RES, V13, P2568, DOI 10.1101/gr.1111403; Schroeder M, 2012, CLIN PHARMACOL THER, V91, P310, DOI 10.1038/clpt.2011.282; Segman RH, 2010, MOL PSYCHIATR, V15, P93, DOI 10.1038/mp.2009.65; Seifuddin F, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-213; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Shyn SI, 2011, MOL PSYCHIATR, V16, P202, DOI 10.1038/mp.2009.125; Spadaro Paola A., 2012, Frontiers in Genetics, V3, P132, DOI 10.3389/fgene.2012.00132; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Teyssier JR, 2011, PSYCHIAT RES, V186, P244, DOI 10.1016/j.psychres.2010.07.030; Tiwary BK, 2012, INTEGR BIOL-UK, V4, P1096, DOI 10.1039/c2ib20066j; Tordera RM, 2011, EUR NEUROPSYCHOPHARM, V21, P23, DOI 10.1016/j.euroneuro.2010.06.016; Tsuang MT, 2004, J PSYCHIATR RES, V38, P3, DOI 10.1016/S0022-3956(03)00096-7; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vialou V, 2013, ANNU REV PHARMACOL, V53, P59, DOI 10.1146/annurev-pharmtox-010611-134540; Williams JM, 2009, AM J MED GENET A, V149A, P1758, DOI 10.1002/ajmg.a.32941; Wong ML, 2008, MOL PSYCHIATR, V13, P800, DOI 10.1038/mp.2008.59; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Wuwongse S, 2013, BBA-MOL BASIS DIS, V1832, P2245, DOI 10.1016/j.bbadis.2013.07.022; Xu WH, 2011, P NATL ACAD SCI USA, V108, P3707, DOI 10.1073/pnas.1019753108; Yamada S, 2003, J NEURAL TRANSM, V110, P671, DOI 10.1007/s00702-002-0810-8; Yi M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-30; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	62	82	89	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93388	10.1371/journal.pone.0093388	http://dx.doi.org/10.1371/journal.pone.0093388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676134	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677500118
J	Skaaby, T; Husemoen, LLN; Ahluwalia, TS; Rossing, P; Jorgensen, T; Thuesen, BH; Pisinger, C; Rasmussen, K; Linneberg, A				Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Ahluwalia, Tarunveer Singh; Rossing, Peter; Jorgensen, Torben; Thuesen, Betina Heinsbaek; Pisinger, Charlotta; Rasmussen, Knud; Linneberg, Allan			Cause-Specific Mortality According to Urine Albumin Creatinine Ratio in the General Population	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; BRAIN NATRIURETIC PEPTIDE; KIDNEY-DISEASE MEASURES; STAGE RENAL-DISEASE; COLLABORATIVE METAANALYSIS; SPOT URINE; MICROALBUMINURIA; RISK; ASSOCIATIONS; INDIVIDUALS	Background: Urine albumin creatinine ratio, UACR, is positively associated with all-cause mortality, cardiovascular disease and diabetes in observational studies. Whether a high UACR is also associated with other causes of death is unclear. We investigated the association between UACR and cause-specific mortality. Methods: We included a total of 9,125 individuals from two population-based studies, Monica10 and Inter99, conducted in 1993-94 and 1999-2001, respectively. Urine albumin creatinine ratio was measured from spot urine samples by standard methods. Information on causes of death was obtained from The Danish Register of Causes of Death until 31 December 2010. There were a total of 920 deaths, and the median follow-up was 11.3 years. Results: Multivariable Cox regression analyses with age as underlying time axis showed statistically significant positive associations between UACR status and risk of all-cause mortality, endocrine nutritional and metabolic diseases, mental and behavioural disorders, diseases of the circulatory system, and diseases of the respiratory system with hazard ratios 1.56, 6.98, 2.34, 2.03, and 1.91, for the fourth UACR compared with the first, respectively. Using UACR as a continuous variable, we also found a statistically significant positive association with risk of death caused by diseases of the digestive system with a hazard ratio of 1.02 per 10 mg/g higher UACR. Conclusion: We found statistically significant positive associations between baseline UACR and death from all-cause mortality, endocrine nutritional and metabolic diseases, and diseases of the circulatory system and possibly mental and behavioural disorders, and diseases of the respiratory and digestive system.	[Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Jorgensen, Torben; Thuesen, Betina Heinsbaek; Pisinger, Charlotta; Linneberg, Allan] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Ahluwalia, Tarunveer Singh] Univ Copenhagen, Sect Metab Genet, Copenhagen, Denmark; [Rossing, Peter] Steno Diabet Ctr, Gentofte, Denmark; [Rossing, Peter] Univ Copenhagen, Copenhagen, Denmark; [Rossing, Peter] Univ Aarhus, Aarhus, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Jorgensen, Torben] Aalborg Univ, Fac Med, Aalborg, Denmark; [Rasmussen, Knud] Roskilde Univ Hosp, Dept Med, Roskilde, Denmark; [Linneberg, Allan] Glostrup Univ Hosp, Dept Clin Expt Res, Glostrup, Denmark; [Linneberg, Allan] Univ Copenhagen, Dept Clin Med, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Steno Diabetes Center; University of Copenhagen; Aarhus University; University of Copenhagen; Aalborg University; University of Copenhagen; University of Copenhagen	Skaaby, T (corresponding author), Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark.	tea.skaaby.01@regionh.dk	Jørgensen, Torben/Z-1335-2018; rossing, peter/AAZ-3415-2021; rossing, peter/AAH-7879-2021; Ahluwalia, Tarunveer Singh/C-5549-2009	rossing, peter/0000-0002-1531-4294; Ahluwalia, Tarunveer Singh/0000-0002-7464-3354; Linneberg, Allan/0000-0002-0994-0184; Jorgensen, Torben/0000-0001-9453-2830; Pisinger, Charlotta/0000-0002-7970-3168; Skaaby, Tea/0000-0003-0031-5726; Thuesen, Betina/0000-0001-9772-4344				Aadahl M, 2009, PREV MED, V48, P326, DOI 10.1016/j.ypmed.2009.01.015; Aguilar MI, 2010, NEUROLOGY, V75, P1343, DOI 10.1212/WNL.0b013e3181f73638; Ambye L, 2005, DIABETES RES CLIN PR, V67, P175, DOI 10.1016/j.diabres.2004.06.013; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Babazono T, 2004, DIABETES CARE, V27, P1838, DOI 10.2337/diacare.27.7.1838; Bulcun E, 2013, COPD, V10, P186, DOI 10.3109/15412555.2012.735292; Casanova C, 2010, AM J RESP CRIT CARE, V182, P1004, DOI 10.1164/rccm.201003-0360OC; Cox AJ, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-68; de Borst MH, 2013, J AM SOC NEPHROL; de Zeeuw D, 2004, CIRCULATION, V110, P921, DOI 10.1161/01.CIR.0000139860.33974.28; Drivsholm T, 2001, DIABETIC MED, V18, P126, DOI 10.1046/j.1464-5491.2001.00417.x; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Fried L, 2012, CLIN J AM SOC NEPHRO, V7, P376, DOI 10.2215/CJN.00210112; Friedrich N, 2012, DIABETES CARE, V35, P768, DOI 10.2337/dc11-1833; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; Han TZ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/320560; Ibsen H, 2008, J NEPHROL, V21, P566; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Juel K, 1999, DAN MED BULL, V46, P354; Kovesdy CP, 2013, J AM COLL CARDIOL, V61, P1626, DOI 10.1016/j.jacc.2012.11.071; Mahmoodi BK, 2012, LANCET, V380, P1649, DOI 10.1016/S0140-6736(12)61272-0; Martin Helen, 2011, Clin Biochem Rev, V32, P97; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Menne J, 2012, J HYPERTENS, V30, P811, DOI 10.1097/HJH.0b013e328351856d; Olsen MH, 2005, HYPERTENSION, V46, P660, DOI 10.1161/01.HYP.0000179575.13739.72; Olsen MH, 2007, EUR HEART J, V28, P1374, DOI 10.1093/eurheartj/ehl448; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Ruggenenti P, 2012, J AM SOC NEPHROL; Sajjad I, 2012, CLIN J AM SOC NEPHRO, V7, P437, DOI 10.2215/CJN.05330611; Selvin E, 2013, AM J KIDNEY DIS, V61, P716, DOI 10.1053/j.ajkd.2012.11.048; Thyssen JP, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000062; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Wang CCL, 2012, AM J CARDIOL, V110, p58B, DOI 10.1016/j.amjcard.2012.08.036; Witte EC, 2009, J AM SOC NEPHROL, V20, P436, DOI 10.1681/ASN.2008030292	35	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93212	10.1371/journal.pone.0093212	http://dx.doi.org/10.1371/journal.pone.0093212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675825	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500092
J	Yu, L; Ding, GF; He, CZ; Sun, L; Jiang, YF; Zhu, LY				Yu, Lei; Ding, Guo-feng; He, Changzhi; Sun, Lei; Jiang, YanFang; Zhu, Liying			MicroRNA-424 Is Down-Regulated in Hepatocellular Carcinoma and Suppresses Cell Migration and Invasion through c-Myb	PLOS ONE			English	Article							DEREGULATED EXPRESSION; UP-REGULATION; CANCER; CATENIN	Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. MicroRNAs (miRNAs) are important regulators of multiple cellular processes, and the aberrant miRNAs expressions have been observed in different types of cancer including HCC. Their pathysiologic role and their relevance to tumorigenesis are still largely unknown. In this study, we demonstrated the down-regulation of miR-424 in HCC cell lines and tissues by quantitative RT-PCR analyses. Overexpression of miR-424 reduced the HCC cell prolifetation, migration, and invasion. Conversely, inhibiton of miR-424 expression significantly accelerated the cell proliferation, migration, and invasion. In addition, we further identified c-Myb as a functional downstream target of miR-424 by directly targeting the 3'UTR of c-Myb. Furthermore, overexpression of c-Myb impaired miR-424-induced inhibition of proliferation and invasion in HCC cells. Our results demonstrated that miR-424 was involved in tumorigenesis of HCC at least in part by suppression of c-Myb.	[Yu, Lei; Zhu, Liying] Harbin Med Univ, Hosp 4, Dept Infect Dis, Harbin, Heilongjiang, Peoples R China; [Ding, Guo-feng] Binzhou Med Univ Hosp, Dept Infect Dis, Binzhou, Shandong, Peoples R China; [He, Changzhi] Harbin Med Univ, Grad Sch, Harbin, Heilongjiang, Peoples R China; [Sun, Lei] Harbin Med Univ, Hosp 4, Dept Ophthalmol, Harbin, Heilongjiang, Peoples R China; [Jiang, YanFang] Jilin Univ, Inst Zoonosis, Key Lab Zoonosis Res, Minist Educ, Changchun, Jilin, Peoples R China; [Jiang, YanFang] Jilin Univ, Second Part First Hosp, Dept Cent Lab, Changchun, Jilin, Peoples R China	Harbin Medical University; Binzhou Medical University; Harbin Medical University; Harbin Medical University; Jilin University; Jilin University	Jiang, YF (corresponding author), Jilin Univ, Inst Zoonosis, Key Lab Zoonosis Res, Minist Educ, Changchun, Jilin, Peoples R China.	yanfangjiang@hotmail.com; zlyhmu@126.com		YU, LEI/0000-0002-8837-2022	Foundation of Department of Education of Heilongjiang Province [12521294]	Foundation of Department of Education of Heilongjiang Province	This work was supported by the Foundation of Department of Education of Heilongjiang Province (No. 12521294), http://www.hlje.net/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Cai W, 2013, CLIN TRANSL ONCOL, V15, P818, DOI 10.1007/s12094-013-1010-8; Chen RX, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-172; Chiu LY, 2013, J GASTROENTEROL; Faraoni I, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-26; Gonda TJ, 2008, EXPERT OPIN BIOL TH, V8, P713, DOI [10.1517/14712598.8.6.713, 10.1517/14712598.8.6.713 ]; Imig J, 2011, NUCLEIC ACIDS RES, V39, P1880, DOI 10.1093/nar/gkq1043; Ji JF, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-4; Karakatsanis A, 2013, MOL CARCINOGEN, V52, P297, DOI 10.1002/mc.21864; Li JP, 2009, HEPATOLOGY, V50, P2047, DOI 10.1002/hep.23356; Li R, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-169; Long XH, 2013, EXP THER MED, V5, P1048, DOI 10.3892/etm.2013.959; Lu H, 2013, CLIN TRANSL ONCOL, V15, P796, DOI 10.1007/s12094-013-1009-1; Minguez B, 2011, DIS MARKERS, V31, P181, DOI [10.1155/2011/310675, 10.3233/DMA-2011-0841]; Nakajima T, 2008, HEPATOL RES, V38, P886, DOI 10.1111/j.1872-034X.2008.00324.x; Nakashima T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014334; Nishida N, 2011, CURR GENOMICS, V12, P130, DOI 10.2174/138920211795564359; Pallasch CP, 2009, BLOOD, V114, P3255, DOI 10.1182/blood-2009-06-229898; Pattabiraman DR, 2013, LEUKEMIA, V27, P269, DOI 10.1038/leu.2012.225; Qiu X, 2013, ONCOGENE, V32, P3296, DOI 10.1038/onc.2013.150; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; ROUSSEL M, 1979, NATURE, V281, P452, DOI 10.1038/281452a0; Schwabe RF, 2011, CANCER CELL, V20, P698, DOI 10.1016/j.ccr.2011.11.021; Tahara H, 2013, JPN J CLIN ONCOL, V43, P579, DOI 10.1093/jjco/hyt037; Tang JT, 2009, MINI-REV MED CHEM, V9, P921, DOI 10.2174/138955709788681672; Volpe G, 2013, LEUKEMIA, V27, P1487, DOI 10.1038/leu.2013.23; Wang PR, 2012, P NATL ACAD SCI USA, V109, P11264, DOI 10.1073/pnas.1117032109; Wu WKK, 2010, ONCOGENE, V29, P5761, DOI 10.1038/onc.2010.352; Wu WKK, 2011, CARCINOGENESIS, V32, P247, DOI 10.1093/carcin/bgq243; Xu J, 2013, ONCOGENE, V32, P976, DOI 10.1038/onc.2012.121; Yang H, 2012, INT J ONCOL; Yang HP, 2001, FASEB J, V15, P1507, DOI 10.1096/fj.01-0040com; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Yates LA, 2013, CELL, V153, P516, DOI 10.1016/j.cell.2013.04.003; Yoon SO, 2011, HUM PATHOL, V42, P1391, DOI 10.1016/j.humpath.2010.12.010; Yu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083080; Yu XY, 2013, ONCOTARGETS THER, V6, P349, DOI 10.2147/OTT.S41343; Yuan QG, 2013, HEPATOLOGY, V57, P299, DOI 10.1002/hep.25984; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zucman-Rossi J, 2010, DIGEST LIVER DIS, V42, pS235, DOI 10.1016/S1590-8658(10)60511-7	40	78	81	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e91661	10.1371/journal.pone.0091661	http://dx.doi.org/10.1371/journal.pone.0091661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675898	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677500015
J	Zhang, KS; Liu, YJ; Kong, HJ; Cheng, WW; Shang, YJ; Tian, H; Zheng, HX; Guo, JH; Liu, XT				Zhang, Ke-Shan; Liu, Yong-Jie; Kong, Han-Jin; Cheng, Wei-Wei; Shang, You-Jun; Tian, Hong; Zheng, Hai-Xue; Guo, Jian-Hong; Liu, Xian-Tao			Identification and Analysis of Differential miRNAs in PK-15 Cells after Foot-and-Mouth Disease Virus Infection	PLOS ONE			English	Article							CELLULAR MICRORNAS; SMALL RNAS; BIOGENESIS; SUPPRESSES; EXPRESSION; GENOMICS; REVEALS; PCR	The alterations of MicroRNAs(miRNAs) in host cell after foot-and-mouth disease virus (FMDV) infection is still obscure. To increase our understanding of the pathogenesis of FMDV at the post-transcriptional regulation level, Solexa high-throu MicroRNAs (miRNAs) play an important role both in the post-transcriptional regulation of gene expression and host-virus interactions. Despite investigations of miRNA expression ghput sequencing and bioinformatic tools were used to identify differentially expressed miRNAs and analyze their functions during FMDV infection of PK-15cells. Results indicated that 9,165,674 and 9,230,378 clean reads were obtained, with 172 known and 72 novel miRNAs differently expressed in infected and uninfected groups respectively. Some of differently expressed miRNAs were validated using stem-loop real-time quantitative RT-PCR. The GO annotation and KEGG pathway analysis for target genes revealed that differently expressed miRNAs were involved in immune response and cell death pathways.	[Zhang, Ke-Shan; Liu, Yong-Jie; Kong, Han-Jin; Cheng, Wei-Wei; Shang, You-Jun; Tian, Hong; Zheng, Hai-Xue; Guo, Jian-Hong; Liu, Xian-Tao] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Liu, XT (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China.	hnxiangtao@hotmail.com		zheng, hai xue/0000-0001-6850-1379	The National Natural Science Foundation of China [31201914]; China Postdoctoral Science Foundation [2013M530683]; China Agriculture Research System [CARS-39]	The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); China Agriculture Research System	This work was supported by The National Natural Science Foundation of China (Grant No. 31201914), China Postdoctoral Science Foundation (2013M530683), and China Agriculture Research System (CARS-39). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boss IW, 2009, TRENDS MICROBIOL, V17, P544, DOI 10.1016/j.tim.2009.09.002; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Coll RC, 2010, J INNATE IMMUN, V2, P406, DOI 10.1159/000315469; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davies G, 2002, RES VET SCI, V73, P195, DOI 10.1016/S0034-5288(02)00105-4; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Ghosh Z, 2009, NUCLEIC ACIDS RES, V37, P1035, DOI 10.1093/nar/gkn1004; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Grinberg M, 2012, ARCH VIROL, V157, P1719, DOI 10.1007/s00705-012-1366-z; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Ho BC, 2011, CELL HOST MICROBE, V9, P58, DOI 10.1016/j.chom.2010.12.001; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Inoue Kunio, 2007, Tanpakushitsu Kakusan Koso, V52, P197; Ji ZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049463; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lerner M, 2011, CELL CYCLE, V10, P2172, DOI 10.4161/cc.10.13.16248; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li Y, 2010, J VIROL, V84, P3023, DOI 10.1128/JVI.02203-09; Li Y, 2012, NUCLEIC ACIDS RES, V40, P4298, DOI 10.1093/nar/gks043; Mahajan VS, 2009, TRENDS IMMUNOL, V30, P1, DOI 10.1016/j.it.2008.08.009; Matskevich AA, 2007, J GEN VIROL, V88, P2627, DOI 10.1099/vir.0.83103-0; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Reese TA, 2010, J VIROL, V84, P10344, DOI 10.1128/JVI.00707-10; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sellers R, 2008, VET J, V177, P159, DOI 10.1016/j.tvjl.2007.03.009; Singh CP, 2012, J VIROL, V86, P7867, DOI 10.1128/JVI.00064-12; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Sung TL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000263; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Wu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030988; Ye L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043741; Zhang R, 2008, NUCLEIC ACIDS RES, V36, P4621, DOI 10.1093/nar/gkn431; Zheng ZH, 2013, J VIROL, V87, P5645, DOI 10.1128/JVI.02655-12; Zhou Y, 2013, REPROD DOMEST ANIM, V48, P112, DOI 10.1111/j.1439-0531.2012.02040.x; Zuker M, 1998, RNA, V4, P669, DOI 10.1017/S1355838298980116; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	52	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e90865	10.1371/journal.pone.0090865	http://dx.doi.org/10.1371/journal.pone.0090865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675746	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500010
J	Dulebohn, DP; Hayes, BM; Rosa, PA				Dulebohn, Daniel P.; Hayes, Beth M.; Rosa, Patricia A.			Global Repression of Host-Associated Genes of the Lyme Disease Spirochete through Post-Transcriptional Modulation of the Alternative Sigma Factor RpoS	PLOS ONE			English	Article							OUTER-SURFACE PROTEIN; BORRELIA-BURGDORFERI OSPC; ESCHERICHIA-COLI; STRESS-RESPONSE; REGULATORY PATHWAY; MAMMALIAN HOST; IMMUNE EVASION; MESSENGER-RNA; FACTOR RSSB; LIFE-CYCLE	Borrelia burgdorferi, the agent of Lyme disease, is a vector-borne pathogen that transits between Ixodes ticks and vertebrate hosts. During the natural infectious cycle, spirochetes must globally adjust their transcriptome to survive in these dissimilar environments. One way B. burgdorferi accomplishes this is through the use of alternative sigma factors to direct transcription of specific genes. RpoS, one of only three sigma factors in B. burgdorferi, controls expression of genes required during tick-transmission and infection of the mammalian host. How spirochetes switch between different sigma factors during the infectious cycle has remained elusive. Here we establish a role for a novel protein, BBD18, in the regulation of the virulence-associated sigma factor RpoS. Constitutive expression of BBD18 repressed transcription of RpoS-dependent genes to levels equivalent to those observed in an rpoS mutant. Consistent with the global loss of RpoS-dependent transcripts, we were unable to detect RpoS protein. However, constitutive expression of BBD18 did not diminish the amount of rpoS transcript, indicating post-transcriptional regulation of RpoS by BBD18. Interestingly, BBD18-mediated repression of RpoS is independent of both the rpoS promoter and the 5' untranslated region, suggesting a mechanism of protein destabilization rather than translational control. We propose that BBD18 is a novel regulator of RpoS and its activity likely represents a first step in the transition from an RpoS-ON to an RpoS-OFF state, when spirochetes transition from the host to the tick vector.	[Dulebohn, Daniel P.; Hayes, Beth M.; Rosa, Patricia A.] NIAID, Lab Zoonot Pathogens, Rocky Mt Labs, Div Intramural Res,NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Dulebohn, DP (corresponding author), NIAID, Lab Zoonot Pathogens, Rocky Mt Labs, Div Intramural Res,NIH, Hamilton, MT USA.	dulebohnd@niaid.nih.gov		Hayes, Beth/0000-0001-6633-751X	Intramural Research Program of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000917] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades SE, 2008, CURR OPIN MICROBIOL, V11, P535, DOI 10.1016/j.mib.2008.10.004; Akins DR, 1998, J CLIN INVEST, V101, P2240, DOI 10.1172/JCI2325; Archambault L, 2013, BIOCHEM BIOPH RES CO, V433, P73, DOI 10.1016/j.bbrc.2013.02.063; Baker CS, 2002, MOL MICROBIOL, V44, P1599, DOI 10.1046/j.1365-2958.2002.02982.x; BARBOUR AG, 1986, MICROBIOL REV, V50, P381, DOI 10.1128/MMBR.50.4.381-400.1986; BARBOUR AG, 1986, INFECT IMMUN, V52, P549, DOI 10.1128/IAI.52.2.549-554.1986; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Battisti JM, 2008, INFECT IMMUN, V76, P5228, DOI 10.1128/IAI.00410-08; Bestor A, 2012, INFECT IMMUN, V80, P3501, DOI 10.1128/IAI.00521-12; Blevins JS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-82; Bono JL, 2000, J BACTERIOL, V182, P2445, DOI 10.1128/JB.182.9.2445-2452.2000; Bourret TJ, 2011, MOL MICROBIOL, V81, P259, DOI 10.1111/j.1365-2958.2011.07691.x; Boylan JA, 2003, P NATL ACAD SCI USA, V100, P11684, DOI 10.1073/pnas.2032956100; Boylan JA, 2008, MOL MICROBIOL, V68, P786, DOI 10.1111/j.1365-2958.2008.06204.x; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Burtnick MN, 2007, MOL MICROBIOL, V65, P277, DOI 10.1111/j.1365-2958.2007.05813.x; Caimano MJ, 2011, INFECT IMMUN, V79, P3117, DOI 10.1128/IAI.05136-11; Caimano MJ, 2005, J BACTERIOL, V187, P7845, DOI 10.1128/JB.187.22.7845-7852.2005; Caimano MJ, 2004, INFECT IMMUN, V72, P6433, DOI 10.1128/IAI.72.11.6433-6445.2004; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Carroll JA, 1999, INFECT IMMUN, V67, P3181, DOI 10.1128/IAI.67.7.3181-3187.1999; Casjens SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033280; Chen LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083276; Clifton DR, 2006, MOL MICROBIOL, V61, P243, DOI 10.1111/j.1365-2958.2006.05224.x; de Silva AM, 1998, J INFECT DIS, V177, P395, DOI 10.1086/514200; DeSilva AM, 1997, INFECT IMMUN, V65, P3146, DOI 10.1128/IAI.65.8.3146-3150.1997; Dong T, 2010, INFECT IMMUN, V78, P887, DOI 10.1128/IAI.00882-09; Dong T, 2009, INFECT IMMUN, V77, P501, DOI 10.1128/IAI.00850-08; Drecktrah D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068799; Dulebohn DP, 2011, INFECT IMMUN, V79, P3510, DOI 10.1128/IAI.05014-11; Dunham-Ems SM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002532; Elias AF, 2000, J BACTERIOL, V182, P2909, DOI 10.1128/JB.182.10.2909-2918.2000; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Fischer JR, 2003, P NATL ACAD SCI USA, V100, P7307, DOI 10.1073/pnas.1231043100; Fisher MA, 2005, P NATL ACAD SCI USA, V102, P5162, DOI 10.1073/pnas.0408536102; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gilmore RD, 2007, INFECT IMMUN, V75, P2753, DOI 10.1128/IAI.00037-07; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Hayes BM, 2010, APPL ENVIRON MICROB, V76, P7407, DOI 10.1128/AEM.01389-10; He M, 2008, MOL MICROBIOL, V70, P1453, DOI 10.1111/j.1365-2958.2008.06491.x; Hengge R, 2009, RES MICROBIOL, V160, P667, DOI 10.1016/j.resmic.2009.08.014; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Karna SLR, 2011, INFECT IMMUN, V79, P732, DOI 10.1128/IAI.00882-10; Kawabata H, 2004, INFECT IMMUN, V72, P7147, DOI 10.1128/IAI.72.12.7147-7154.2004; Kobryn K, 2000, MOL MICROBIOL, V37, P145, DOI 10.1046/j.1365-2958.2000.01981.x; LANE RS, 1991, ANNU REV ENTOMOL, V36, P587, DOI 10.1146/annurev.en.36.010191.003103; Lease RA, 2000, P NATL ACAD SCI USA, V97, P9919, DOI 10.1073/pnas.170281497; Lin T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047532; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Lybecker MC, 2010, MOL MICROBIOL, V78, P622, DOI 10.1111/j.1365-2958.2010.07374.x; MA Y, 1994, INFECT IMMUN, V62, P3663, DOI 10.1128/IAI.62.9.3663-3671.1994; MAGNARELLI LA, 1988, J CLIN MICROBIOL, V26, P1482, DOI 10.1128/JCM.26.8.1482-1486.1988; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; Manganelli R, 2004, J BACTERIOL, V186, P895, DOI 10.1128/JB.186.4.895-902.2004; Miller CL, 2013, MOL MICROBIOL, V88, P105, DOI 10.1111/mmi.12171; Montgomery RR, 2002, J INFECT DIS, V185, P1773, DOI 10.1086/340826; Mulay VB, 2009, J BACTERIOL, V191, P2783, DOI 10.1128/JB.01802-08; Ohnishi J, 2001, P NATL ACAD SCI USA, V98, P670, DOI 10.1073/pnas.98.2.670; Ojaimi C, 2003, INFECT IMMUN, V71, P1689, DOI 10.1128/IAI.71.4.1689-1705.2003; Osterberg S, 2011, ANNU REV MICROBIOL, V65, P37, DOI 10.1146/annurev.micro.112408.134219; Ouyang ZM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-44; Ouyang ZM, 2009, MOL MICROBIOL, V74, P1331, DOI 10.1111/j.1365-2958.2009.06945.x; Pappas CJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002102; Patton TG, 2013, INFECT IMMUN, V81, P2488, DOI 10.1128/IAI.00140-13; PIESMAN J, 1990, AM J TROP MED HYG, V42, P352, DOI 10.4269/ajtmh.1990.42.352; Pruteanu M, 2002, MOL MICROBIOL, V45, P1701, DOI 10.1046/j.1365-2958.2002.03123.x; Rego ROM, 2011, J BACTERIOL, V193, P1161, DOI 10.1128/JB.01176-10; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Rogers EA, 2009, MOL MICROBIOL, V71, P1551, DOI 10.1111/j.1365-2958.2009.06621.x; SADZIENE A, 1993, INFECT IMMUN, V61, P2192, DOI 10.1128/IAI.61.5.2192-2195.1993; Salman-Dilgimen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022168; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Sarkar A, 2011, J BACTERIOL, V193, P5365, DOI 10.1128/JB.01496-10; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; Seshu J, 2004, MOL MICROBIOL, V54, P1352, DOI 10.1111/j.1365-2958.2004.04352.x; Shi YL, 2008, INFECT IMMUN, V76, P1239, DOI 10.1128/IAI.00897-07; Smith AH, 2007, J BACTERIOL, V189, P2139, DOI 10.1128/JB.01653-06; STEERE AC, 1989, NEW ENGL J MED, V321, P586, DOI 10.1056/NEJM198908313210906; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; STEVENSON B, 1995, INFECT IMMUN, V63, P4535, DOI 10.1128/IAI.63.11.4535-4539.1995; Studemann A, 2003, EMBO J, V22, P4111, DOI 10.1093/emboj/cdg411; Sze CW, 2011, INFECT IMMUN, V79, P1270, DOI 10.1128/IAI.00871-10; Tilly K, 2007, INFECT IMMUN, V75, P1517, DOI 10.1128/IAI.01725-06; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Tokarz R, 2004, INFECT IMMUN, V72, P5419, DOI 10.1128/IAI.72.9.5419-5432.2004; Van Laar TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038171; Vytvytska O, 2000, GENE DEV, V14, P1109; Wang GQ, 2004, FEMS MICROBIOL LETT, V231, P219, DOI 10.1016/S0378-1097(03)00960-1; Weening EH, 2008, INFECT IMMUN, V76, P5694, DOI 10.1128/IAI.00690-08; WINTER RB, 1987, P NATL ACAD SCI USA, V84, P7822, DOI 10.1073/pnas.84.22.7822; Xu HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001104; Xu QL, 2008, MOL MICROBIOL, V69, P15, DOI 10.1111/j.1365-2958.2008.06264.x; Xu QL, 2007, MOL MICROBIOL, V64, P220, DOI 10.1111/j.1365-2958.2007.05636.x; Xu QL, 2006, INFECT IMMUN, V74, P5177, DOI 10.1128/IAI.00713-06; Xu QL, 2008, MICROB PATHOGENESIS, V45, P70, DOI 10.1016/j.micpath.2008.03.002; Xu Q, 2007, INFECT IMMUN, V75, P4272, DOI 10.1128/IAI.00560-07; Xu Q, 2008, MICROBIOL-SGM, V154, P3420, DOI 10.1099/mic.0.2008/019737-0; Yang XFF, 2005, J BACTERIOL, V187, P4822, DOI 10.1128/JB.187.14.4822-4829.2005; Yang XFF, 2004, J EXP MED, V199, P641, DOI 10.1084/jem.20031960; Yang XFF, 2003, P NATL ACAD SCI USA, V100, P11001, DOI 10.1073/pnas.1834315100; Young JC, 2003, CELL, V113, P1, DOI 10.1016/S0092-8674(03)00192-2; Zhiming OY, 2008, MICROBIOL-SGM, V154, P2641, DOI 10.1099/mic.0.2008/019992-0	104	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93141	10.1371/journal.pone.0093141	http://dx.doi.org/10.1371/journal.pone.0093141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671196	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000118
J	MacPherson, SE; Wagner, GP; Murphy, P; Bozzali, M; Cipolotti, L; Shallice, T				MacPherson, Sarah E.; Wagner, Gabriela Peretti; Murphy, Patrick; Bozzali, Marco; Cipolotti, Lisa; Shallice, Tim			Bringing the Cognitive Estimation Task into the 21st Century: Normative Data on Two New Parallel Forms	PLOS ONE			English	Article							PROBABLE ALZHEIMERS-DISEASE; FRONTAL-LOBE LESIONS; ABSTRACT DESIGNS; TEMPORAL-LOBE; TESTS; PERFORMANCE; DYSFUNCTION; FREQUENCY; JUDGMENTS; AMNESIA	The Cognitive Estimation Test (CET) is widely used by clinicians and researchers to assess the ability to produce reasonable cognitive estimates. Although several studies have published normative data for versions of the CET, many of the items are now outdated and parallel forms of the test do not exist to allow cognitive estimation abilities to be assessed on more than one occasion. In the present study, we devised two new 9-item parallel forms of the CET. These versions were administered to 184 healthy male and female participants aged 18-79 years with 9-22 years of education. Increasing age and years of education were found to be associated with successful CET performance as well as gender, intellect, naming, arithmetic and semantic memory abilities. To validate that the parallel forms of the CET were sensitive to frontal lobe damage, both versions were administered to 24 patients with frontal lobe lesions and 48 age-, gender-and education-matched controls. The frontal patients' error scores were significantly higher than the healthy controls on both versions of the task. This study provides normative data for parallel forms of the CET for adults which are also suitable for assessing frontal lobe dysfunction on more than one occasion without practice effects.	[MacPherson, Sarah E.; Shallice, Tim] UCL, Inst Cognit Neurosci, London, England; [MacPherson, Sarah E.; Murphy, Patrick; Cipolotti, Lisa] Natl Hosp Neurol & Neurosurg, Dept Neuropsychol, London WC1N 3BG, England; [Wagner, Gabriela Peretti] Univ Fed Ciencias Saude Porto Alegre UFCSPA, Dept Psychol, Porto Alegre, RS, Brazil; [Bozzali, Marco] UCL, Wellcome Dept Imaging Neurosci, London, England; [Bozzali, Marco] IRCCS, Santa Lucia Fdn, Neuroimaging Lab, Rome, Italy; [Cipolotti, Lisa] Univ Palermo, Dipartimento Psicol, Palermo, Italy; [Shallice, Tim] Int Sch Adv Studies SISSA, Trieste, Italy	University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Universidade Federal de Ciencias da Saude de Porto Alegre; University of London; University College London; IRCCS Santa Lucia; University of Palermo; International School for Advanced Studies (SISSA)	MacPherson, SE (corresponding author), UCL, Inst Cognit Neurosci, London, England.	sarah.macpherson@ed.ac.uk	Bozzali, Marco/AAC-1031-2022; MacPherson, Sarah E/G-8524-2013	MacPherson, Sarah E/0000-0001-8676-6514; Murphy, Patrick/0000-0001-8574-1470; Bozzali, Marco/0000-0002-0568-2026; Peretti Wagner, Gabriela/0000-0003-4260-6847; cipolotti, lisa/0000-0001-5838-3647	Wellcome Trust [066763]	Wellcome Trust(Wellcome Trust)	This work was supported by Wellcome Trust, grant number 066763. (http://www.wellcome.ac.uk/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAN AJ, 1995, NEUROPSYCHOLOGY, V9, P304; Appollonio IM, 2003, NEUROL SCI, V24, P153, DOI 10.1007/s10072-003-0105-3; Axelrod B.N., 1994, ASSESSMENT, V1, P269, DOI DOI 10.1177/107319119400100307; Barabassy A, 2010, PSYCHIAT RES, V176, P26, DOI 10.1016/j.psychres.2008.06.045; Billino J, 2008, INT J GERIATR PSYCH, V23, P982, DOI 10.1002/gps.1985; BOLLA KI, 1990, J CLIN PSYCHOL, V46, P623, DOI 10.1002/1097-4679(199009)46:5<623::AID-JCLP2270460513>3.0.CO;2-C; Brand M, 2002, SER BIOPHYS BIOCYBER, V12, P425, DOI 10.1142/9789812776563_0034; Brand M, 2003, J CLIN EXP NEUROPSYC, V25, P324, DOI 10.1076/jcen.25.3.324.13802; Brand M, 2003, NEUROPSYCHOLOGIA, V41, P575, DOI 10.1016/S0028-3932(02)00183-5; Bullard SE, 2004, ARCH CLIN NEUROPSYCH, V19, P835, DOI 10.1016/j.acn.2003.12.002; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Della Sala S, 2004, J NEUROL, V251, P156, DOI 10.1007/s00415-004-0292-8; Della Sala S, 2003, NEUROL SCI, V24, P10, DOI 10.1007/s100720300015; Freeman MR, 1995, INT J NEUROSCI, V83, P269, DOI 10.3109/00207459508986343; George D, 2003, SPSS WINDOWS STEP ST, V4th, DOI DOI 10.1080/13803395.2011.614598; Giaglis G, 2008, EUR J NEUROL, V15, P290; Gillespie DC, 2002, J CLIN EXP NEUROPSYC, V24, P286, DOI 10.1076/jcen.24.3.286.988; Goldstein FC, 1996, NEUROPSY NEUROPSY BE, V9, P35; GUTTMAN L., 1945, PSYCHOMETRIKA, V10, P255; Henry JD, 2006, AGING NEUROPSYCHOL C, V13, P529, DOI 10.1080/138255890969537; JACKSON M, 1986, CORTEX, V22, P611, DOI 10.1016/S0010-9452(86)80020-X; KOPELMAN MD, 1991, BRAIN, V114, P117; Kopelman MD, 1999, NEUROPSYCHOLOGIA, V37, P939, DOI 10.1016/S0028-3932(98)00143-2; Lamar M, 2004, NEUROBIOL AGING, V25, P553, DOI 10.1016/j.neurobiolaging.2003.06.005; LENG NRC, 1988, BRIT J CLIN PSYCHOL, V27, P359, DOI 10.1111/j.2044-8260.1988.tb00800.x; Levinoff EJ, 2006, NEUROPSYCHOLOGY, V20, P123, DOI 10.1037/0894-4105.20.1.123; Liss M, 2000, J AUTISM DEV DISORD, V30, P613, DOI 10.1023/A:1005699713072; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; McKenna P., 1983, GRADED NAMING TEST; Mell T, 2005, NEUROPSYCHOLOGIA, V43, P554, DOI 10.1016/j.neuropsychologia.2004.07.010; Mendez MF, 1998, J GERIATR PSYCH NEUR, V11, P2, DOI 10.1177/089198879801100102; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nelson H., 1991, NATL ADULT READING T; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; OCARROLL R, 1994, BRIT J CLIN PSYCHOL, V33, P193, DOI 10.1111/j.2044-8260.1994.tb01110.x; Raven J, 1998, SECTION 4 ADV PROGRE; SHALLICE T, 1978, CORTEX, V14, P294, DOI 10.1016/S0010-9452(78)80055-0; SHOQEIRAT MA, 1990, BRIT J CLIN PSYCHOL, V29, P401, DOI 10.1111/j.2044-8260.1990.tb00903.x; SMITH ML, 1984, NEUROPSYCHOLOGIA, V22, P697, DOI 10.1016/0028-3932(84)90096-4; SMITH ML, 1988, NEUROPSYCHOLOGIA, V26, P297, DOI 10.1016/0028-3932(88)90082-6; Spencer RJ, 2009, J CLIN EXP NEUROPSYC, V31, P373, DOI 10.1080/13803390802206398; Stanhope N, 1998, NEUROPSYCHOLOGIA, V36, P1387, DOI 10.1016/S0028-3932(98)00040-2; Strauss E, 2006, COMPENDIUM NEUROPSYC, DOI DOI 10.1212/WNL.41.11.1856-A; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; TAYLOR R, 1995, BRIT J CLIN PSYCHOL, V34, P223, DOI 10.1111/j.2044-8260.1995.tb01456.x; Wagner GP, 2011, NEUROL SCI, V32, P203, DOI 10.1007/s10072-010-0449-4; Wechsler D., 2010, WAIS 4 WECHSLER ADUL; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird	49	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92554	10.1371/journal.pone.0092554	http://dx.doi.org/10.1371/journal.pone.0092554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24671170	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000053
J	Wiedemar, N; Tetens, J; Jagannathan, V; Menoud, A; Neuenschwander, S; Bruggmann, R; Thaller, G; Drogemuller, C				Wiedemar, Natalie; Tetens, Jens; Jagannathan, Vidhya; Menoud, Annie; Neuenschwander, Samuel; Bruggmann, Remy; Thaller, Georg; Droegemueller, Cord			Independent Polled Mutations Leading to Complex Gene Expression Differences in Cattle	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; HORN; INHERITANCE; GENOME; LOCUS; ALIGNMENT; INSIGHTS; DELETION; REGION; MAPS	The molecular regulation of horn growth in ruminants is still poorly understood. To investigate this process, we collected 1019 hornless (polled) animals from different cattle breeds. High-density SNP genotyping confirmed the presence of two different polled associated haplotypes in Simmental and Holstein cattle co-localized on BTA 1. We refined the critical region of the Simmental polled mutation to 212 kb and identified an overlapping region of 932 kb containing the Holstein polled mutation. Subsequently, whole genome sequencing of polled Simmental and Holstein cows was used to determine polled associated genomic variants. By genotyping larger cohorts of animals with known horn status we found a single perfectly associated insertion/deletion variant in Simmental and other beef cattle confirming the recently published possible Celtic polled mutation. We identified a total of 182 sequence variants as candidate mutations for polledness in Holstein cattle, including an 80 kb genomic duplication and three SNPs reported before. For the first time we showed that hornless cattle with scurs are obligate heterozygous for one of the polled mutations. This is in contrast to published complex inheritance models for the bovine scurs phenotype. Studying differential expression of the annotated genes and loci within the mapped region on BTA 1 revealed a locus (LOC100848215), known in cow and buffalo only, which is higher expressed in fetal tissue of wildtype horn buds compared to tissue of polled fetuses. This implicates that the presence of this long noncoding RNA is a prerequisite for horn bud formation. In addition, both transcripts associated with polledness in goat and sheep (FOXL2 and RXFP2), show an overexpression in horn buds confirming their importance during horn development in cattle.	[Wiedemar, Natalie; Jagannathan, Vidhya; Menoud, Annie; Droegemueller, Cord] Univ Bern, Inst Genet, Bern, Switzerland; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany; [Neuenschwander, Samuel; Bruggmann, Remy] Univ Bern, Interfac Bioinformat Unit, Bern, Switzerland; [Neuenschwander, Samuel] Swiss Inst Bioinformat, Vital IT, Lausanne, Switzerland	University of Bern; University of Kiel; University of Bern; Swiss Institute of Bioinformatics	Drogemuller, C (corresponding author), Univ Bern, Inst Genet, Bern, Switzerland.	Cord.Droegemueller@vetsuisse.unibe.ch	Wiedemar, Natalie/AAR-3199-2021; Jagannathan, Vidhya/P-1055-2019	Wiedemar, Natalie/0000-0001-9470-4284; Jagannathan, Vidhya/0000-0002-8155-0041; Tetens, Jens/0000-0001-5352-464X; Bruggmann, Remy/0000-0001-5629-6363; Drogemuller, Cord/0000-0001-9773-522X; Neuenschwander, Samuel/0000-0002-4080-5546	Swiss National Science Foundation [31003A_141228]; Karl EiblStiftung, Neustadt, Germany; German Federal Ministry of Education and Research [0315134A]; KMSH (Kompetenzzentrum Milch-Schleswig-Holstein, Kiel, Germany)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Karl EiblStiftung, Neustadt, Germany; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); KMSH (Kompetenzzentrum Milch-Schleswig-Holstein, Kiel, Germany)	This study was funded by grant no. 31003A_141228 from the Swiss National Science Foundation. The authors further acknowledge the Karl EiblStiftung, Neustadt, Germany, for financial support, as well as the German Federal Ministry of Education and Research (project FUGATO-plus GENOTRACK, grant no. 0315134A), and the KMSH (Kompetenzzentrum Milch-Schleswig-Holstein, Kiel, Germany) for partly funding the genotyping. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allais-Bonnet A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063512; Asai M, 2004, ANIM GENET, V35, P34, DOI 10.1111/j.1365-2052.2003.01079.x; Brem G., 1982, Bayerisches Landwirtschaftliches Jahrbuch, V59, P688; Brenneman RA, 1996, J HERED, V87, P156, DOI 10.1093/oxfordjournals.jhered.a022975; Capitan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049084; Capitan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022242; Capitan A, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-33; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Drogemuller C, 2005, MAMM GENOME, V16, P613, DOI 10.1007/s00335-005-0016-0; Drogemuller C, 2005, COMP FUNCT GENOM, V6, P194, DOI 10.1002/cfg.476; Dyce KM., 2002, TXB VET ANATOMY, V3rd ed.; GEORGES M, 1993, NAT GENET, V4, P206, DOI 10.1038/ng0693-206; Glatzer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067992; Graf B, 1999, APPL ANIM BEHAV SCI, V62, P153, DOI 10.1016/S0168-1591(98)00218-4; Harlizius B, 1997, MAMM GENOME, V8, P255, DOI 10.1007/s003359900404; Johnston SE, 2010, HEREDITY, V104, P196, DOI 10.1038/hdy.2009.109; Johnston SE, 2011, MOL ECOL, V20, P2555, DOI 10.1111/j.1365-294X.2011.05076.x; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ligon KL, 2006, GLIA, V54, P1, DOI 10.1002/glia.20273; Liu WB, 2014, ANIM GENET, V45, P138, DOI 10.1111/age.12081; LONG CR, 1978, J HERED, V69, P395, DOI 10.1093/oxfordjournals.jhered.a108980; Mariasegaram M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-370; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Medugorac I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039477; Mei F, 2013, J NEUROSCI, V33, P8454, DOI 10.1523/JNEUROSCI.2453-12.2013; Niu JQ, 2012, GLIA, V60, P1427, DOI 10.1002/glia.22364; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; R?sse I., 1991, LEHRBUCH EMBRYOLOGIE; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHMUTZ SM, 1995, MAMM GENOME, V6, P710, DOI 10.1007/BF00354293; Schnorr B, 2011, EMBRYOLOGIE HAUSTIER; Seichter D, 2012, ANIM GENET, V43, P595, DOI 10.1111/j.1365-2052.2011.02302.x; Strouhal E., 1997, LIFE ANCIENT EGYPTIA; Vaiman D, 1999, GENOMICS, V56, P31, DOI 10.1006/geno.1998.5691; Weikard R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-789; White WT, 1936, J GENET, V32, P33, DOI 10.1007/BF02982500	38	49	55	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93435	10.1371/journal.pone.0093435	http://dx.doi.org/10.1371/journal.pone.0093435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671182	gold, Green Published			2022-12-27	WOS:000333677000145
J	Cerqueira, LB; de Francisco, TMG; Gasparetto, JC; Campos, FR; Pontarolo, R				Cerqueira, Leticia B.; de Francisco, Thais M. G.; Gasparetto, Joao C.; Campos, Francinete R.; Pontarolo, Roberto			Development and Validation of an HPLC-MS/MS Method for the Early Diagnosis of Aspergillosis	PLOS ONE			English	Article							INVASIVE ASPERGILLOSIS; FUNGAL-INFECTIONS; GALACTOMANNAN; GLIOTOXIN; PIPERACILLIN; ANTIGEN	Invasive aspergillosis is an opportunistic infection that is mainly caused by Aspergillus fumigatus, which is known to produce several secondary metabolites, including gliotoxin, the most abundant metabolite produced during hyphal growth. The diagnosis of invasive aspergillosis is often made late in the infection because of the lack of reliable and feasible diagnostic techniques; therefore, early detection is critical to begin treatment and avoid more serious complications. The present work reports the development and validation of an HPLC- MS/ MS method for the detection of gliotoxin in the serum of patients with suspected aspergillosis. Chromatographic separation was achieved using an XBridge C18 column ( 15062.1 mm id; 5 mm particle size) maintained at 25 degrees C with the corresponding guard column (XBridge C18, 10 X 2.1 mm id, 5 mm particle size). The mobile phase was composed of a gradient of water and acetonitrile/ water ( 95: 5 v/ v), both containing 1 mM ammonium formate with a flow rate of 0.45 mL min(-1). Data from the validation studies demonstrate that this new method is highly sensitive, selective, linear, precise, accurate and free from matrix interference. The developed method was successfully applied to samples from patients suspected of having aspergillosis. Therefore, the developed method has considerable potential as a diagnostic technique for aspergillosis	[Cerqueira, Leticia B.; de Francisco, Thais M. G.; Gasparetto, Joao C.; Campos, Francinete R.; Pontarolo, Roberto] Univ Fed Parana, Dept Pharm, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal do Parana	Pontarolo, R (corresponding author), Univ Fed Parana, Dept Pharm, BR-80060000 Curitiba, Parana, Brazil.	pontarolo@ufpr.br	Pontarolo, Roberto/G-6948-2014; Campos, Francinete/AAU-1346-2020; CERQUEIRA, LETICIA/H-5121-2016	Pontarolo, Roberto/0000-0002-7049-4363; CAMPOS, FRANCINETE/0000-0002-9688-2030	National Counsel of Technological and Scientific Development (CNPq); Coordination of Improvement of Higher Education Personnel (CAPES)	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination of Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The sources of founding were: 1) National Counsel of Technological and Scientific Development (CNPq) [http://www.cnpq.br/], 2) Coordination of Improvement of Higher Education Personnel (CAPES) [http://www.capes.gov.br/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorg R, 1997, MYCOSES, V40, P353, DOI 10.1111/j.1439-0507.1997.tb00249.x; Bondy GS, 2000, J TOXICOL ENV HEAL B, V3, P109, DOI 10.1080/109374000281113; *BRAS, 2012, DISP REQ MIN VAL MET; Food and D. Administration, 2001, BIOAN METH VAL GUID; Grovel O, 2006, J MICROBIOL METH, V66, P286, DOI 10.1016/j.mimet.2005.12.005; Herbrecht R, 2002, J CLIN ONCOL, V20, P1898, DOI 10.1200/JCO.2002.07.004; Jarque Isidro, 2003, Revista Iberoamericana de Micologia, V20, P116; Klont RR, 2004, CLIN INFECT DIS, V39, P1467, DOI 10.1086/425317; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lewis RE, 2005, INFECT IMMUN, V73, P635, DOI 10.1128/IAI.73.1.635-637.2005; Mennink-Kersten MASH, 2004, LANCET INFECT DIS, V4, P349, DOI 10.1016/S1473-3099(04)01045-X; Nucci M, 2010, CLIN INFECT DIS, V51, P561, DOI 10.1086/655683; PASQUALOTTO AC, 2005, EUR ONCOL REV, V11; Pazos Carmen, 2003, Revista Iberoamericana de Micologia, V20, P99; *PUBCHEM, 2014, COMP SUMM; Puri A, 2010, BIOMED CHROMATOGR, V24, P887, DOI 10.1002/bmc.1382; Stevens DA, 2002, J ANTIMICROB CHEMOTH, V49, P11, DOI 10.1093/jac/49.suppl_1.11; STYNEN D, 1995, J CLIN MICROBIOL, V33, P497, DOI 10.1128/JCM.33.2.497-500.1995; Sulahian A, 2003, NEW ENGL J MED, V349, P2366, DOI 10.1056/NEJM200312113492424; Sutton P, 1996, IMMUNOL CELL BIOL, V74, P318, DOI 10.1038/icb.1996.57; Viscoli C, 2004, CLIN INFECT DIS, V38, P913, DOI 10.1086/382224; Waring P, 1996, GEN PHARMACOL, V27, P1311, DOI 10.1016/S0306-3623(96)00083-3; Wheat LJ, 2008, EUR J CLIN MICROBIOL, V27, P245, DOI 10.1007/s10096-007-0437-7	23	16	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92851	10.1371/journal.pone.0092851	http://dx.doi.org/10.1371/journal.pone.0092851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690884	gold, Green Published, Green Submitted			2022-12-27	WOS:000334101100032
J	Choi, SS; Lee, HJ; Lim, I; Satoh, J; Kim, SU				Choi, Sung S.; Lee, Hong J.; Lim, Inja; Satoh, Jun-ichi; Kim, Seung U.			Human Astrocytes: Secretome Profiles of Cytokines and Chemokines	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; EXPRESSION; TRANSCRIPTION; RECEPTORS; INDUCTION; MICROGLIA; NEURONS; RANTES	Astrocytes play a key role in maintenance of neuronal functions in the central nervous system by producing various cytokines,chemokines, and growth factors, which act as a molecular coordinator of neuron-glia communication. At the site of neuroinflammation, astrocyte-derived cytokines and chemokines play both neuroprotective and neurotoxic roles in brain lesions of human neurological diseases. At present, the comprehensive profile of human astrocyte-derived cytokines and chemokines during inflammation remains to be fully characterized. We investigated the cytokine secretome profile of highly purified human astrocytes by using a protein microarray. Non-stimulated human astrocytes in culture expressed eight cytokines, including G-CSF, GM-CSF, GRO alpha (CXCL1), IL-6, IL-8 (CXCL8), MCP-1 (CCL2), MIF and Serpin E1. Following stimulation with IL-1 beta and TNF-alpha, activated astrocytes newly produced IL-1 beta, IL-1ra, TNF-alpha, IP-10 (CXCL10), MIP-1 alpha (CCL3) and RANTES (CCL5), in addition to the induction of sICAM-1 and complement component 5. Database search indicated that most of cytokines and chemokines produced by non-stimulated and activated astrocytes are direct targets of the transcription factor NF-kappa B. These results indicated that cultured human astrocytes express a distinct set of NF-kB-target cytokines and chemokines in resting and activated conditions, suggesting that the NF-kappa B signaling pathway differentially regulates gene expression of cytokines and chemokines in human astrocytes under physiological and inflammatory conditions.	[Choi, Sung S.; Lee, Hong J.; Kim, Seung U.] Chung Ang Univ, Coll Med, Med Res Inst, Seoul 156756, South Korea; [Lim, Inja] Chung Ang Univ, Coll Med, Dept Physiol, Seoul 156756, South Korea; [Satoh, Jun-ichi] Meiji Pharmaceut Univ, Dept Bioinformat & Mol Neuropathol, Kiyose, Japan; [Kim, Seung U.] Univ British Columbia, UBC Hosp, Dept Med, Div Neurol, Vancouver, BC, Canada	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital; Meiji Pharmaceutical University; University of British Columbia	Kim, SU (corresponding author), Chung Ang Univ, Coll Med, Med Res Inst, Seoul 156756, South Korea.	sukim@mail.ubc.ca			Korea Healthcare Technology RD Project [HI12C0167 (A120214)]; Canadian Myelin Research Initiative	Korea Healthcare Technology RD Project; Canadian Myelin Research Initiative	The present study was supported by the Korea Healthcare Technology R&D Project HI12C0167 (A120214) and Canadian Myelin Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOISI F, 1992, J IMMUNOL, V149, P2358; Bajetto A, 2002, J NEUROCHEM, V82, P1311, DOI 10.1046/j.1471-4159.2002.01091.x; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; CARNEY DF, 1991, J BIOL CHEM, V266, P18786; Chen LH, 2009, ATHEROSCLEROSIS, V207, P428, DOI 10.1016/j.atherosclerosis.2009.05.021; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Hua LWL, 2000, GLIA, V30, P74, DOI 10.1002/(SICI)1098-1136(200003)30:1<74::AID-GLIA8>3.0.CO;2-C; Kim MO, 2004, J NEUROCHEM, V90, P297, DOI 10.1111/j.1471-4159.2004.02487.x; KIM SU, 1986, J NEUROSCI RES, V15, P303, DOI 10.1002/jnr.490150303; Kitai R, 2000, J NEUROIMMUNOL, V110, P230, DOI 10.1016/S0165-5728(00)00315-5; LEE SC, 1993, J IMMUNOL, V150, P2659; Meeuwsen S, 2003, GLIA, V43, P243, DOI 10.1002/glia.10259; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; SATOH J, 1995, J NEUROPATH EXP NEUR, V54, P504, DOI 10.1097/00005072-199507000-00004; Satoh J, 2014, MULT SCLER RELAT DIS, V3, P94, DOI 10.1016/j.msard.2013.04.005; Schabitz WR, 2008, J CEREBR BLOOD F MET, V28, P29, DOI 10.1038/sj.jcbfm.9600496; Simpson JE, 1998, J NEUROIMMUNOL, V84, P238, DOI 10.1016/S0165-5728(97)00208-7; Skalnikova H, 2011, PROTEOMICS, V11, P691, DOI 10.1002/pmic.201000402; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sorensen TL, 1999, J CLIN INVEST, V103, P807, DOI 10.1172/JCI5150; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Tokami H, 2013, BRAIN RES, V1517, P122, DOI 10.1016/j.brainres.2013.04.022; UEDA A, 1994, J IMMUNOL, V153, P2052; Xia MQ, 2000, J NEUROIMMUNOL, V108, P227, DOI 10.1016/S0165-5728(00)00285-X	25	222	224	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92325	10.1371/journal.pone.0092325	http://dx.doi.org/10.1371/journal.pone.0092325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691121	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100019
J	He, F; Li, B; Zhao, ZX; Zhou, YM; Hu, GP; Zou, WF; Hong, W; Zou, YM; Jiang, CB; Zhao, DX; Ran, PX				He, Fang; Li, Bing; Zhao, Zhuxiang; Zhou, Yumin; Hu, Guoping; Zou, Weifeng; Hong, Wei; Zou, Yimin; Jiang, Changbin; Zhao, Dongxing; Ran, Pixin			The Pro-Proliferative Effects of Nicotine and Its Underlying Mechanism on Rat Airway Smooth Muscle Cells	PLOS ONE			English	Article							EPIDERMAL GROWTH-FACTOR; CIGARETTE-SMOKE; LIPOPOLYSACCHARIDE EXPOSURE; ACETYLCHOLINE-RECEPTORS; ACTIVATION; EXPRESSION; AKT; APOPTOSIS; PATHWAY; ANGIOGENESIS	Recent studies have shown that nicotine, a major component of cigarette smoke, can stimulate the proliferation of non-neuronal cells. Cigarette smoking can promote a variety of pulmonary and cardiovascular diseases, such as chronic obstructive pulmonary disease (COPD), atherosclerosis, and cancer. A predominant feature of COPD is airway remodeling, which includes increased airway smooth muscle (ASM) mass. The mechanisms underlying ASM remodeling in COPD have not yet been fully elucidated. Here, we show that nicotine induces a profound and time-dependent increase in DNA synthesis in rat airway smooth muscle cells (RASMCs) in vitro. Nicotine also significantly increased the number of RASMCs, which was associated with the increased expression of Cyclin D1, phosphorylation of the retinoblastoma protein (RB) and was dependent on the activation of Akt. The activation of Akt by nicotine occurred within minutes and depended upon the nicotinic acetylcholine receptors (nAchRs). Activated Akt increased the phosphorylation of downstream substrates such as GSK3 beta. Our data suggest that the binding of nicotine to the nAchRs on RASMCs can regulate cellular proliferation by activating the Akt pathway.	[He, Fang; Zhao, Zhuxiang; Zhou, Yumin; Hu, Guoping; Zou, Weifeng; Hong, Wei; Zou, Yimin; Jiang, Changbin; Zhao, Dongxing; Ran, Pixin] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China; [Li, Bing] Guangzhou Med Univ, Res Ctr Expt Med, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University	Li, B (corresponding author), Guangzhou Med Univ, Res Ctr Expt Med, Guangzhou, Guangdong, Peoples R China.	libing@gzhmc.edu.cn; pxran@vip.163.com		Zhao, Dongxing/0000-0002-4080-4754	National Natural Science Foundation of China [81170043]; National Natural Science Foundation of Guangdong [S2011020002789]; Ministry of Education of China [20104423110001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China (81170043), National Natural Science Foundation of Guangdong (S2011020002789), Doctoral Fund of Ministry of Education of China (20104423110001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE AK, 1975, BRIT MED J, V4, P313, DOI 10.1136/bmj.4.5992.313; Brass DM, 2003, AM J PHYSIOL-LUNG C, V285, pL755, DOI 10.1152/ajplung.00001.2003; Brognard J, 2001, CANCER RES, V61, P3986; Carlisle DL, 2007, PULM PHARMACOL THER, V20, P629, DOI 10.1016/j.pupt.2006.07.001; Churg A, 2007, THORAX, V62, P706, DOI 10.1136/thx.2006.068353; Clunes LA, 2008, J ANAL TOXICOL, V32, P201, DOI 10.1093/jat/32.3.201; CONTITRONCONI BM, 1994, CRIT REV BIOCHEM MOL, V29, P69, DOI 10.3109/10409239409086798; Cucina A, 2008, J SURG RES, V150, P227, DOI 10.1016/j.jss.2007.10.019; Dasgupta P, 2006, J CLIN INVEST, V116, P3083, DOI 10.1172/JCI28164C1; Dasgupta P, 2006, CELL CYCLE, V5, P2324, DOI 10.4161/cc.5.20.3366; Fu XW, 2011, AM J RESP CELL MOL, V44, P222, DOI 10.1165/rcmb.2010-0109OC; Grando SA, 1996, J INVEST DERMATOL, V107, P412, DOI 10.1111/1523-1747.ep12363399; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Lam DCL, 2007, CANCER RES, V67, P4638, DOI 10.1158/0008-5472.CAN-06-4628; Li XW, 2006, LIFE SCI, V78, P1863, DOI 10.1016/j.lfs.2005.08.031; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Limsirichaikul S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp023; LINDELL G, 1993, SCAND J GASTROENTERO, V28, P487, DOI 10.3109/00365529309098254; Lindstrom J, 1997, MOL NEUROBIOL, V15, P193, DOI 10.1007/BF02740634; MacNee W, 2007, CLIN CHEST MED, V28, P479, DOI 10.1016/j.ccm.2007.06.008; Minna JD, 2003, J CLIN INVEST, V111, P31, DOI 10.1172/JCI200317492; Morikawa-Futamatsu K, 2006, LIFE SCI, V79, P1380, DOI 10.1016/j.lfs.2006.04.005; Nakayama H, 2002, J NEUROCHEM, V83, P1372, DOI 10.1046/j.1471-4159.2002.01248.x; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Ouyang WM, 2007, J CELL BIOCHEM, V101, P969, DOI 10.1002/jcb.21279; Pera T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-48; RUSSELL MAH, 1980, BMJ-BRIT MED J, V280, P972, DOI 10.1136/bmj.280.6219.972; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; TARRONI P, 1992, FEBS LETT, V312, P66, DOI 10.1016/0014-5793(92)81411-E; Toward TJ, 2002, J PHARMACOL EXP THER, V302, P814, DOI 10.1124/jpet.102.033951; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; Vernooy JHJ, 2002, AM J RESP CELL MOL, V26, P152, DOI 10.1165/ajrcmb.26.1.4652; Wang F, 2012, J CELL BIOCHEM, V113, P2989, DOI 10.1002/jcb.24176; Wang R, 2012, J CELL BIOCHEM, V113, P349, DOI 10.1002/jcb.23361; Wang Y, 2001, MOL PHARMACOL, V60, P1201, DOI 10.1124/mol.60.6.1201; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wongtrakool C, 2012, AM J RESP CELL MOL, V46, P695, DOI 10.1165/rcmb.2011-0028OC; Wright JL, 2007, INHAL TOXICOL, V19, P915, DOI 10.1080/08958370701515563; Xu Y, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-13; Ye L, 2009, J EPITHELIAL BIOL PH, V2, P44; Yu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007040; Zevin S, 1998, CLIN DERMATOL, V16, P557, DOI 10.1016/S0738-081X(98)00038-8; Zhang WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031450; Zou WF, 2013, AM J PHYSIOL-LUNG C, V304, pL199, DOI 10.1152/ajplung.00094.2012	49	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93508	10.1371/journal.pone.0093508	http://dx.doi.org/10.1371/journal.pone.0093508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690900	Green Published, Green Submitted			2022-12-27	WOS:000334101100093
J	Reed, DM; Foldes, G; Gatheral, T; Paschalaki, KE; Lendvai, Z; Bagyura, Z; Nemeth, T; Skopal, J; Merkely, B; Telcian, AG; Gogsadze, L; Edwards, MR; Gough, PJ; Bertin, J; Johnston, SL; Harding, SE; Mitchell, JA				Reed, Daniel M.; Foldes, Gabor; Gatheral, Timothy; Paschalaki, Koralia E.; Lendvai, Zsuzsanna; Bagyura, Zsolt; Nemeth, Tamas; Skopal, Judit; Merkely, Bela; Telcian, Aurica G.; Gogsadze, Leila; Edwards, Michael R.; Gough, Peter J.; Bertin, John; Johnston, Sebastian L.; Harding, Sian E.; Mitchell, Jane A.			Pathogen Sensing Pathways in Human Embryonic Stem Cell Derived-Endothelial Cells: Role of NOD1 Receptors	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CORONARY-ARTERY-DISEASE; PROGENITOR CELLS; NITRIC-OXIDE; IN-VIVO; INFECTION; BLOOD; ATHEROSCLEROSIS; TRANSPLANTATION; ACTIVATION	Human embryonic stem cell-derived endothelial cells (hESC-EC), as well as other stem cell derived endothelial cells, have a range of applications in cardiovascular research and disease treatment. Endothelial cells sense Gram-negative bacteria via the pattern recognition receptors (PRR) Toll-like receptor (TLR)-4 and nucleotide-binding oligomerisation domain-containing protein (NOD)-1. These pathways are important in terms of sensing infection, but TLR4 is also associated with vascular inflammation and atherosclerosis. Here, we have compared TLR4 and NOD1 responses in hESC-EC with those of endothelial cells derived from other stem cells and with human umbilical vein endothelial cells (HUVEC). HUVEC, endothelial cells derived from blood progenitors (blood outgrowth endothelial cells; BOEC), and from induced pluripotent stem cells all displayed both a TLR4 and NOD1 response. However, hESC-EC had no TLR4 function, but did have functional NOD1 receptors. In vivo conditioning in nude rats did not confer TLR4 expression in hESC-EC. Despite having no TLR4 function, hESC-EC sensed Gram-negative bacteria, a response that was found to be mediated by NOD1 and the associated RIP2 signalling pathways. Thus, hESC-EC are TLR4 deficient but respond to bacteria via NOD1. This data suggests that hESC-EC may be protected from unwanted TLR4-mediated vascular inflammation, thus offering a potential therapeutic advantage.	[Reed, Daniel M.; Gatheral, Timothy; Mitchell, Jane A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Cardiothorac Pharmacol, London, England; [Foldes, Gabor; Harding, Sian E.] Univ London Imperial Coll Sci Technol & Med, Imperial Ctr Translat & Expt Med, Dept Cardiac Pharmacol, London, England; [Foldes, Gabor; Lendvai, Zsuzsanna; Bagyura, Zsolt; Nemeth, Tamas; Skopal, Judit] Semmelweis Univ, Heart & Vasc Ctr, H-1085 Budapest, Hungary; [Paschalaki, Koralia E.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Sect, London, England; [Telcian, Aurica G.; Gogsadze, Leila; Edwards, Michael R.; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, MRC, London, England; [Telcian, Aurica G.; Gogsadze, Leila; Edwards, Michael R.; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Asthma UK Ctr Allerg Mech Asthma, London, England; [Telcian, Aurica G.; Gogsadze, Leila; Edwards, Michael R.; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Ctr Resp Infect, Natl Heart & Lung Inst, London, England; [Gough, Peter J.; Bertin, John] GlaxoSmithKline, Pattern Recognit Receptor Discovery Performance U, Immuno Inflammat Therapeut Area, Philadelphia, PA USA	Imperial College London; Imperial College London; Semmelweis University; Imperial College London; Imperial College London; Imperial College London; University of London; King's College London; Imperial College London; GlaxoSmithKline	Mitchell, JA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Cardiothorac Pharmacol, London, England.	j.a.mitchell@imperial.ac.uk	Johnston, Sebastian Lennox/I-2423-2012; Paschalaki, Koralia/B-4465-2018	Johnston, Sebastian Lennox/0000-0003-3009-9200; Paschalaki, Koralia/0000-0002-4114-6140; Reed, Daniel/0000-0002-8326-5957; Gatheral, Timothy/0000-0003-2677-8729; Edwards, Michael Robert/0000-0001-6837-0532; Harding, Sian/0000-0002-3651-6354	Wellcome Trust [0852551Z108/Z]; British Heart Foundation [PG/09/078, FS/09/017/26810]; MRC studentship; Asthma UK [CH11SJ]; MRC Centre [G1000758]; ERC [233015]; Wellcome Trust; Hungarian Scientific Research Fund [MBOA 81237, 105555]; MRC [MR/L012618/1] Funding Source: UKRI; British Heart Foundation [PG/09/078/27985] Funding Source: researchfish; Medical Research Council [G1000758B, 1252436, G1000758, MR/L012618/1] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre, RF07/04] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); MRC studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asthma UK; MRC Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	This work was funded by a program grant from the Wellcome Trust (0852551Z108/Z; JAM) and the British Heart Foundation (PG/09/078 and FS/09/017/26810). DMR is funded by an MRC studentship. SLJ is a recipient of a Chair from Asthma UK (CH11SJ) and supported by an MRC Centre Grant G1000758, ERC FP7 Advanced grant 233015 (to SLJ) and the Wellcome Trust sponsored Centre for Respiratory Infection (CRI). GF and BM are recipients of funding from the Hungarian Scientific Research Fund (MBOA 81237, 105555). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andraws R, 2005, JAMA-J AM MED ASSOC, V293, P2641, DOI 10.1001/jama.293.21.2641; Brito-Martins M, 2008, BRIT J PHARMACOL, V153, P751, DOI 10.1038/sj.bjp.0707619; Cho SW, 2007, CIRCULATION, V116, P2409, DOI 10.1161/CIRCULATIONAHA.106.687038; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Ferreira LS, 2007, CIRC RES, V101, P286, DOI 10.1161/CIRCRESAHA.107.150201; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; Fishman JA, 2012, CLIN INFECT DIS, V55, P720, DOI 10.1093/cid/cis519; Fishman JA, 2010, INFECT DIS CLIN N AM, V24, P273, DOI 10.1016/j.idc.2010.01.005; Foldes G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010501; Gatheral T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042386; Hirano T, 2009, INT J PEDIATR OTORHI, V73, P1657, DOI 10.1016/j.ijporl.2009.08.015; Houliston RA, 2002, THROMB HAEMOSTASIS, V88, P321; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kobari L, 2012, HAEMATOL-HEMATOL J, V97, P1795, DOI 10.3324/haematol.2011.055566; Krull M, 1999, J IMMUNOL, V162, P4834; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; Libby P, 1997, CIRCULATION, V96, P4095; Martin-Ramirez J, 2012, NAT PROTOC, V7, P1709, DOI 10.1038/nprot.2012.093; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Michelsen KS, 2004, J IMMUNOL, V173, P5901, DOI 10.4049/jimmunol.173.10.5901; Mitchell JA, 2008, EXP PHYSIOL, V93, P141, DOI 10.1113/expphysiol.2007.038588; Mitchell JA, 2007, J ENDOCRINOL, V193, P323, DOI 10.1677/JOE-07-0067; Opitz B, 2007, THROMB HAEMOSTASIS, V98, P319, DOI 10.1160/TH06-12-0694; Opitz B, 2009, THROMB HAEMOSTASIS, V102, P1103, DOI 10.1160/TH09-05-0323; Paschalaki KE, 2013, STEM CELLS, V31, P2813, DOI 10.1002/stem.1488; Paul-Clark MJ, 2012, PHARM THER; Ratner AJ, 2007, CELL MICROBIOL, V9, P1343, DOI 10.1111/j.1462-5822.2006.00878.x; Reed DM, 2012, BR J CLIN PHARM; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6; Starke RD, 2010, BLOOD; Starke RD, 2013, BLOOD, V121, P2773, DOI 10.1182/blood-2012-06-435727; Thill M, 2008, INVEST OPHTH VIS SCI, V49, P2696, DOI 10.1167/iovs.07-0955; Ward MR, 2011, MOL THER, V19, P1323, DOI 10.1038/mt.2011.52; Zeuke S, 2002, CARDIOVASC RES, V56, P126, DOI 10.1016/S0008-6363(02)00512-6	35	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e91119	10.1371/journal.pone.0091119	http://dx.doi.org/10.1371/journal.pone.0091119			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690886	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100012
J	Willis, A; Rivers, P; Gray, LJ; Davies, M; Khunti, K				Willis, Andrew; Rivers, Peter; Gray, Laura J.; Davies, Melanie; Khunti, Kamlesh			The Effectiveness of Screening for Diabetes and Cardiovascular Disease Risk Factors in a Community Pharmacy Setting	PLOS ONE			English	Article							BLOOD-PRESSURE; PROGRAM; PREVALENCE; SERVICE; HEALTH; ADULTS	Risk factors for cardiovascular disease including diabetes have seen a large rise in prevalence in recent years. This has prompted interest in prevention through the identifying individuals at risk of both diabetes and cardiovascular disease and has seen increased investment in screening interventions taking place in primary care. Community pharmacies have become increasingly involved in the provision of such interventions and this systematic review and meta-analysis aims to gather and analyse the existing literature assessing community pharmacy based screening for risk factors for diabetes and those with a high cardiovascular disease risk. Methods: We conducted systematic searches of electronic databases using MeSH and free text terms from 1950 to March 2012. For our analysis two outcomes were assessed. They were the percentage of those screened who were referred for further assessment by primary care and the uptake of this referral. Results: Sixteen studies fulfilled our inclusion criteria comprising 108,414 participants screened. There was significant heterogeneity for all included outcomes. Consequently we have not presented summary statistics and present forest plots with I-2 and p values to describe heterogeneity. We found that all included studies suffered from high rates of attrition between pharmacy screening and follow up. We have also identified a strong trend towards higher rates for referral in more recent studies. Conclusions: Our results show that pharmacies are feasible sites for screening for diabetes and those at risk of cardiovascular disease. A significant number of previously unknown cases of cardiovascular disease risk factors such as hypertension, hypercholesterolemia and diabetes are identified, however a significant number of referred participants at high risk do not attend their practitioner for follow up. Research priorities should include methods of increasing uptake to follow up testing and early intervention, to maximise the efficacy of screening interventions based in community pharmacies.	[Willis, Andrew; Gray, Laura J.; Davies, Melanie; Khunti, Kamlesh] Univ Leicester, Diabet Res Unit, Leicester, Leics, England; [Rivers, Peter] DeMontford Univ, Leicester, Leics, England	University of Leicester; De Montfort University	Willis, A (corresponding author), Univ Leicester, Diabet Res Unit, Leicester, Leics, England.	aw187@le.ac.uk	/ABC-9527-2021	Davies, Melanie/0000-0002-9987-9371; Khunti, Kamlesh/0000-0003-2343-7099; Rivers, Peter/0000-0001-9409-3137; Willis, Andrew/0000-0002-9671-2162; Gray, Laura/0000-0002-9284-9321	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - East Midlands (NIHR CLAHRC - EM); Leicester Clinical Trials Unit; NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - East Midlands (NIHR CLAHRC - EM); Leicester Clinical Trials Unit; NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit	The authors acknowledge support from the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - East Midlands (NIHR CLAHRC - EM), the Leicester Clinical Trials Unit and the NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit which is a partnership between University Hospitals of Leicester NHS Trust, Loughborough University and the University of Leicester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Agency for Healthcare Research and Quality US Preventive Services Task Force Evidence Syntheses formerly Systematic Evidence Reviews, 2009, US PREV SERV TASK FO; Anderson C, 2000, PATIENT EDUC COUNS, V39, P285, DOI 10.1016/S0738-3991(99)00025-7; Blenkinsopp A, 2003, J PUBLIC HEALTH MED, V25, P144, DOI 10.1093/pubmed/fdg030; Buijsse B, 2011, EPIDEMIOL REV, V33, P46, DOI 10.1093/epirev/mxq019; Chamnan P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1693; Chatterjee R, 2010, DIABETES CARE, V33, P1484, DOI 10.2337/dc10-0054; Colagiuri S, 2012, DIABETES RES CLIN PR; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Donyai P, 2009, PHARM WORLD SCI, V31, P643, DOI 10.1007/s11096-009-9338-4; Earle KA, 2001, J HUM HYPERTENS, V15, P529, DOI 10.1038/sj.jhh.1001220; Edwards AGK, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001865.pub2; Edwards C, 1981, J R Coll Gen Pract, V31, P674; GARDNER SF, 1995, PHARMACOTHERAPY, V15, P292; Hersberger KE, 2006, PHARM WORLD SCI, V28, P171, DOI 10.1007/s11096-006-9034-6; Horgan JMP, 2010, J PUBLIC HEALTH-UK, V32, P110, DOI 10.1093/pubmed/fdp092; Hourihan Fleur, 2003, Aust J Rural Health, V11, P28, DOI 10.1046/j.1440-1584.2003.00468.x; Hunt BD, 2013, J PUBLIC HEALTH-UK, V35, P440, DOI 10.1093/pubmed/fdt017; HUTCHISON JC, 1979, ANGIOLOGY, V30, P568, DOI 10.1177/000331977903000807; International Diabetes Foundation, 2011, DIABETES ATLAS; Jafari M, 2001, PHARMACOTHERAPY, V21, P1403, DOI 10.1592/phco.21.17.1403.34416; Karwalajtys T, 2009, J HUM HYPERTENS, V23, P585, DOI 10.1038/jhh.2008.163; Krass I, 2007, DIABETES RES CLIN PR, V75, P339, DOI 10.1016/j.diabres.2006.06.022; Madejski R M, 1996, J Am Pharm Assoc (Wash), VNS36, P243; Mangum Stacy A, 2003, J Am Pharm Assoc (Wash), V43, P50, DOI 10.1331/10865800360467042; May AL, 2012, PEDIATRICS, V129, P1035, DOI 10.1542/peds.2011-1082; McElnay J, 1993, INT J PHARM PRACTICE, V2, P95; National Health and Medical Research Council, 2009, NAT EV BAS GUID CAS; Office for National Statistics, 2011, HLTH SURV ENGL; Olenak JL, 2010, J AM PHARM ASSOC, V50, P32, DOI 10.1331/JAPhA.2010.08104; Peterson GM, 2010, PHARM WORLD SCI, V32, P373, DOI 10.1007/s11096-010-9379-8; Pongwecharak J, 2010, PHARM WORLD SCI, V32, P329, DOI 10.1007/s11096-010-9373-1; Popham F, 2011, HEALTH PLACE, V17, P1132, DOI 10.1016/j.healthplace.2011.05.008; Sargeant LA, 2010, DIABETIC MED, V27, P995, DOI 10.1111/j.1464-5491.2010.03056.x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Teh R, 2001, INT J PHARM PRACT, V9, P261; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; World Health Organisation, 2011, GLOB ATL CARD DIS PR; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	39	70	71	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e91157	10.1371/journal.pone.0091157	http://dx.doi.org/10.1371/journal.pone.0091157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690919	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100014
J	Xu, ZF; Hansen, MA; Hansen, LH; Jacquiod, S; Sorensen, SJ				Xu, Zhuofei; Hansen, Martin Asser; Hansen, Lars H.; Jacquiod, Samuel; Sorensen, Soren J.			Bioinformatic Approaches Reveal Metagenomic Characterization of Soil Microbial Community	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; DIVERSITY; DISCOVERY; SEQUENCE; LIBRARIES; PATTERNS; SEARCH; SERVER; GENES	As is well known, soil is a complex ecosystem harboring the most prokaryotic biodiversity on the Earth. In recent years, the advent of high-throughput sequencing techniques has greatly facilitated the progress of soil ecological studies. However, how to effectively understand the underlying biological features of large-scale sequencing data is a new challenge. In the present study, we used 33 publicly available metagenomes from diverse soil sites (i.e. grassland, forest soil, desert, Arctic soil, and mangrove sediment) and integrated some state-of-the-art computational tools to explore the phylogenetic and functional characterizations of the microbial communities in soil. Microbial composition and metabolic potential in soils were comprehensively illustrated at the metagenomic level. A spectrum of metagenomic biomarkers containing 46 taxa and 33 metabolic modules were detected to be significantly differential that could be used as indicators to distinguish at least one of five soil communities. The co-occurrence associations between complex microbial compositions and functions were inferred by network-based approaches. Our results together with the established bioinformatic pipelines should provide a foundation for future research into the relation between soil biodiversity and ecosystem function.	[Xu, Zhuofei; Hansen, Martin Asser; Hansen, Lars H.; Jacquiod, Samuel; Sorensen, Soren J.] Univ Copenhagen, Dept Biol, Microbiol Sect, Copenhagen, Denmark	University of Copenhagen	Sorensen, SJ (corresponding author), Univ Copenhagen, Dept Biol, Microbiol Sect, Copenhagen, Denmark.	SJS@bio.ku.dk	Sørensen, Søren Johannes/N-2120-2019; Sørensen, Søren J/J-5015-2014; Jacquiod, Samuel/M-2259-2014	Sørensen, Søren Johannes/0000-0001-6227-9906; Sørensen, Søren J/0000-0001-6227-9906; Jacquiod, Samuel/0000-0002-0713-7996; Hestbjerg Hansen, Lars/0000-0003-0027-1524	EU ITN project TRAINBIODIVERSE; Center for Environmental and Agricultural Microbiology (CREAM); Villum Foundation	EU ITN project TRAINBIODIVERSE; Center for Environmental and Agricultural Microbiology (CREAM); Villum Foundation(Villum Fonden)	This work was partly funded by the EU ITN project TRAINBIODIVERSE and the Center for Environmental and Agricultural Microbiology (CREAM) funded by The Villum Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreote FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038600; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; DeAngelis KM, 2010, BIOENERG RES, V3, P146, DOI 10.1007/s12155-010-9089-z; Dedysh SN, 2009, MICROBIOLOGY+, V78, P655, DOI 10.1134/S0026261709060010; Dedysh SN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00184; Delmont TO, 2012, ISME J, V6, P1677, DOI 10.1038/ismej.2011.197; Delmont TO, 2011, APPL ENVIRON MICROB, V77, P1315, DOI 10.1128/AEM.01526-10; Desrosiers DC, 2007, MOL MICROBIOL, V65, P137, DOI 10.1111/j.1365-2958.2007.05771.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Empadinhas N, 2011, ENVIRON MICROBIOL, V13, P2056, DOI 10.1111/j.1462-2920.2010.02390.x; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Henne A, 1999, APPL ENVIRON MICROB, V65, P3901; Imhoff J. F., 2005, BERGEYS MANUAL SYSTE, V2, P41; Jang I, 2006, ECOL RES, V21, P849, DOI 10.1007/s11284-006-0041-9; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lau E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056993; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Maloney GS, 2010, PLANT PHYSIOL, V153, P925, DOI 10.1104/pp.110.154922; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mulkidjanian AY, 2006, P NATL ACAD SCI USA, V103, P13126, DOI 10.1073/pnas.0605709103; OJIMA DS, 1993, CHEMOSPHERE, V26, P675, DOI 10.1016/0045-6535(93)90452-B; Oksanen J., 2011, MULTIVARIATE ANAL EC, P1, DOI DOI 10.1016/0169-5347(88)90124-3; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; R Development Core Team, 2007, R LANG ENV STAT COMP; Rainey FA., 2005, BERGEYS MANUAL SYSTE, P988; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; Sarkar SK, 1997, J AM STAT ASSOC, V92, P1601, DOI 10.2307/2965431; Segata N, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.22; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stewart FJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r26; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Vogel TM, 2009, NAT REV MICROBIOL, V7, P252, DOI 10.1038/nrmicro2119; WOLOSIUK RA, 1993, FASEB J, V7, P622, DOI 10.1096/fasebj.7.8.8500687; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Ye YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000465; Yergeau E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030058	53	46	51	9	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93445	10.1371/journal.pone.0093445	http://dx.doi.org/10.1371/journal.pone.0093445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691166	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100082
J	Chen, M; Ye, TR; Krumholz, LR; Jiang, HL				Chen, Mo; Ye, Tian-Ran; Krumholz, Lee R.; Jiang, He-Long			Temperature and Cyanobacterial Bloom Biomass Influence Phosphorous Cycling in Eutrophic Lake Sediments	PLOS ONE			English	Article							FE(III) OXIDE REDUCTION; SOIL ORGANIC-MATTER; FRESH-WATER; SULFATE REDUCTION; PROFUNDAL SEDIMENTS; LARGE SHALLOW; IRON; SULFUR; PHOSPHATE; RELEASE	Cyanobacterial blooms frequently occur in freshwater lakes, subsequently, substantial amounts of decaying cyanobacterial bloom biomass (CBB) settles onto the lake sediments where anaerobic mineralization reactions prevail. Coupled Fe/S cycling processes can influence the mobilization of phosphorus (P) in sediments, with high releases often resulting in eutrophication. To better understand eutrophication in Lake Taihu (PRC), we investigated the effects of CBB and temperature on phosphorus cycling in lake sediments. Results indicated that added CBB not only enhanced sedimentary iron reduction, but also resulted in a change from net sulfur oxidation to sulfate reduction, which jointly resulted in a spike of soluble Fe(II) and the formation of FeS/FeS2. Phosphate release was also enhanced with CBB amendment along with increases in reduced sulfur. Further release of phosphate was associated with increases in incubation temperature. In addition, CBB amendment resulted in a shift in P from the Fe-adsorbed P and the relatively unreactive Residual-P pools to the more reactive Al-adsorbed P, Ca-bound P and organic-P pools. Phosphorus cycling rates increased on addition of CBB and were higher at elevated temperatures, resulting in increased phosphorus release from sediments. These findings suggest that settling of CBB into sediments will likely increase the extent of eutrophication in aquatic environments and these processes will be magnified at higher temperatures.	[Chen, Mo; Ye, Tian-Ran; Jiang, He-Long] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China; [Chen, Mo] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Krumholz, Lee R.] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Oklahoma System; University of Oklahoma - Norman	Jiang, HL (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China.	hljiang@niglas.ac.cn	Jiang, Helong/H-2709-2015	Jiang, He-Long/0000-0001-5528-423X	National Natural Science Foundation of China [51079139]; Innovation Program of the Chinese Academy of Sciences [KZCX2-EW-314]; 135 project of Nanjing Institute of Geography and Limnology, CAS [NIGLAS2012135008]; Chinese Academy of Sciences [2011T1Z37]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); 135 project of Nanjing Institute of Geography and Limnology, CAS; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National Natural Science Foundation of China (51079139), the Innovation Program of the Chinese Academy of Sciences (KZCX2-EW-314), 135 project of Nanjing Institute of Geography and Limnology, CAS (No. NIGLAS2012135008), and Chinese Academy of Sciences visiting professorship for senior international scientists (2011T1Z37). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen FO, 1999, HYDROBIOLOGIA, V408, P175, DOI 10.1023/A:1017027818233; Bai XL, 2009, ENVIRON POLLUT, V157, P2507, DOI 10.1016/j.envpol.2009.03.018; BAK F, 1991, FEMS MICROBIOL ECOL, V85, P31, DOI 10.1016/0378-1097(91)90629-O; Bullock AL, 2013, ESTUAR COAST, V36, P482, DOI 10.1007/s12237-012-9536-5; Carey CC, 2012, WATER RES, V46, P1394, DOI 10.1016/j.watres.2011.12.016; Chacon N, 2006, BIOGEOCHEMISTRY, V78, P67, DOI 10.1007/s10533-005-2343-3; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Conant RT, 2008, GLOBAL CHANGE BIOL, V14, P868, DOI 10.1111/j.1365-2486.2008.01541.x; Condron LM, 2011, J SOIL SEDIMENT, V11, P830, DOI 10.1007/s11368-011-0363-2; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Correll DL, 1998, J ENVIRON QUAL, V27, P261, DOI 10.2134/jeq1998.00472425002700020004x; Gachter R, 2003, LIMNOL OCEANOGR, V48, P929; GACHTER R, 1993, HYDROBIOLOGIA, V253, P103, DOI 10.1007/BF00050731; Genkai-Kato M, 2005, ECOLOGY, V86, P210, DOI 10.1890/03-0545; Gonsiorczyk T, 1998, WATER SCI TECHNOL, V37, P51, DOI 10.1016/S0273-1223(98)00055-9; Gunnars A, 1997, BIOGEOCHEMISTRY, V37, P203, DOI 10.1023/A:1005744610602; Handley KM, 2013, ISME J, V7, P800, DOI 10.1038/ismej.2012.148; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Holmer M, 2001, FRESHWATER BIOL, V46, P431, DOI 10.1046/j.1365-2427.2001.00687.x; Holmkvist L, 2011, GEOCHIM COSMOCHIM AC, V75, P3581, DOI 10.1016/j.gca.2011.03.033; Hsieh YP, 1997, CHEM GEOL, V137, P255, DOI 10.1016/S0009-2541(96)00159-3; Hu WP, 2006, ECOL MODEL, V190, P367, DOI 10.1016/j.ecolmodel.2005.02.024; INGVORSEN K, 1981, APPL ENVIRON MICROB, V42, P1029, DOI 10.1128/AEM.42.6.1029-1036.1981; Jiang X, 2008, WATER RES, V42, P2251, DOI 10.1016/j.watres.2007.12.003; Jilbert T, 2011, BIOGEOSCIENCES, V8, P1699, DOI 10.5194/bg-8-1699-2011; Jost G, 2010, FEMS MICROBIOL ECOL, V71, P226, DOI 10.1111/j.1574-6941.2009.00798.x; Karlson AML, 2008, LIMNOL OCEANOGR, V53, P2754, DOI 10.4319/lo.2008.53.6.2754; Kelton N, 2005, LAKE RESERV MANAGE, V21, P223, DOI 10.1080/07438140509354432; Kim LH, 2004, SCI TOTAL ENVIRON, V321, P115, DOI 10.1016/j.scitotenv.2003.08.018; Kraal P, 2013, ENVIRON SCI TECHNOL, V47, P3114, DOI 10.1021/es304868t; Li DP, 2010, ECOL ENG, V36, P958, DOI 10.1016/j.ecoleng.2010.04.014; Li JH, 1996, HYDROBIOLOGIA, V333, P201, DOI 10.1007/BF00013434; Li KY, 2010, WATER RES, V44, P1591, DOI 10.1016/j.watres.2009.11.007; LOVLEY DR, 1987, APPL ENVIRON MICROB, V53, P1536, DOI 10.1128/AEM.53.7.1536-1540.1987; MCLAUGHLIN JR, 1981, J SOIL SCI, V32, P365, DOI 10.1111/j.1365-2389.1981.tb01712.x; Michalak AM, 2013, P NATL ACAD SCI USA, V110, P6448, DOI 10.1073/pnas.1216006110; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; North RL, 2007, LIMNOL OCEANOGR, V52, P315, DOI 10.4319/lo.2007.52.1.0315; Pace Michael L., 2005, P103, DOI 10.1093/acprof:oso/9780198527084.003.0007; Peng JF, 2007, ECOL ENG, V31, P92, DOI 10.1016/j.ecoleng.2007.06.005; Pester M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00072; Qin BQ, 2010, ENVIRON MANAGE, V45, P105, DOI 10.1007/s00267-009-9393-6; Reddy KR, 1999, CRIT REV ENV SCI TEC, V29, P83, DOI 10.1080/10643389991259182; Robador A, 2009, ENVIRON MICROBIOL, V11, P1692, DOI 10.1111/j.1462-2920.2009.01896.x; Roden EE, 1997, ARCH HYDROBIOL, V139, P347; Roden EE, 1996, LIMNOL OCEANOGR, V41, P1733, DOI 10.4319/lo.1996.41.8.1733; Rozan TF, 2002, LIMNOL OCEANOGR, V47, P1346, DOI 10.4319/lo.2002.47.5.1346; Rydin E, 1998, WATER RES, V32, P2969, DOI 10.1016/S0043-1354(98)00055-4; Shao KQ, 2013, J BASIC MICROB, V53, P549, DOI 10.1002/jobm.201100532; Smith SJ, 2005, CLIMATIC CHANGE, V73, P267, DOI 10.1007/s10584-005-6887-y; Song N, 2013, HYDROBIOLOGIA, V714, P131, DOI 10.1007/s10750-013-1529-2; Spears BM, 2007, HYDROBIOLOGIA, V584, P37, DOI 10.1007/s10750-007-0610-0; Strosser Eduard, 2010, Journal of Agrobiology, V27, P49, DOI 10.2478/s10146-009-0008-x; Taillefert M, 2000, ENVIRON SCI TECHNOL, V34, P2169, DOI 10.1021/es990120a; Tang XM, 2009, MICROB ECOL, V58, P307, DOI 10.1007/s00248-008-9482-8; Ternan NG, 1998, WORLD J MICROB BIOT, V14, P635, DOI 10.1023/A:1008848401799; Turner AM, 2010, ECOL APPL, V20, P2089, DOI 10.1890/10-0208.1; Vahtera E, 2007, AMBIO, V36, P186, DOI 10.1579/0044-7447(2007)36[186:IEFENC]2.0.CO;2; VANCAPPELLEN P, 1988, AM J SCI, V288, P289, DOI 10.2475/ajs.288.4.289; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wilhelm S, 2008, FRESHWATER BIOL, V53, P226, DOI 10.1111/j.1365-2427.2007.01887.x; Zhu YR, 2013, ENVIRON SCI TECHNOL, V47, P7679, DOI 10.1021/es305277g	62	73	82	14	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93130	10.1371/journal.pone.0093130	http://dx.doi.org/10.1371/journal.pone.0093130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682039	Green Published, Green Submitted, gold			2022-12-27	WOS:000333678100026
J	Brown, AD; Sager, BW; Gorthi, A; Tonapi, SS; Brown, EJ; Bishop, AJR				Brown, Adam D.; Sager, Brian W.; Gorthi, Aparna; Tonapi, Sonal S.; Brown, Eric J.; Bishop, Alexander J. R.			ATR Suppresses Endogenous DNA Damage and Allows Completion of Homologous Recombination Repair	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; EARLY EMBRYONIC LETHALITY; S-PHASE CHECKPOINT; CELL-CYCLE; MAMMALIAN-CELLS; IN-VIVO; ATAXIA-TELANGIECTASIA; INCREASED FREQUENCY; REPLICATION FORKS; SECKEL-SYNDROME	DNA replication fork stalling or collapse that arises from endogenous damage poses a serious threat to genome stability, but cells invoke an intricate signaling cascade referred to as the DNA damage response (DDR) to prevent such damage. The gene product ataxia telangiectasia and Rad3-related (ATR) responds primarily to replication stress by regulating cell cycle checkpoint control, yet it's role in DNA repair, particularly homologous recombination (HR), remains unclear. This is of particular interest since HR is one way in which replication restart can occur in the presence of a stalled or collapsed fork. Hypomorphic mutations in human ATR cause the rare autosomal-recessive disease Seckel syndrome, and complete loss of Atr in mice leads to embryonic lethality. We recently adapted the in vivo murine pink-eyed unstable (p(un)) assay for measuring HR frequency to be able to investigate the role of essential genes on HR using a conditional Cre/loxP system. Our system allows for the unique opportunity to test the effect of ATR loss on HR in somatic cells under physiological conditions. Using this system, we provide evidence that retinal pigment epithelium (RPE) cells lacking ATR have decreased density with abnormal morphology, a decreased frequency of HR and an increased level of chromosomal damage.	[Brown, Adam D.; Sager, Brian W.; Gorthi, Aparna; Tonapi, Sonal S.; Bishop, Alexander J. R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Brown, Adam D.; Sager, Brian W.; Gorthi, Aparna; Tonapi, Sonal S.; Bishop, Alexander J. R.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Brown, Eric J.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; [Bishop, Alexander J. R.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Pennsylvania; Pennsylvania Medicine; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Bishop, AJR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.	bishopa@uthscsa.edu		Gorthi, Aparna/0000-0001-5935-4098; Bishop, Alexander/0000-0002-5742-4387	National Institute of Environmental Health Sciences [K22ES012264]; American Cancer Society Institutional Research Grant [ACS-IRG-00-173-04]; GCCRI Ambassador's Circle Research Support Award; National Institute of Aging [T32AG021890]; Medical Student Summer Research Program, School of Medicine, UTHSCSA; Cancer Prevention Research Institute of Texas [RP101491]; UT System Graduate Programs Initiative; National Cancer Institute [T32CA148724-2]; Greehey Children's Cancer Research Institute; NATIONAL CANCER INSTITUTE [T32CA148724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES012264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027376, T32AG021890] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Cancer Society Institutional Research Grant(American Cancer Society); GCCRI Ambassador's Circle Research Support Award; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Student Summer Research Program, School of Medicine, UTHSCSA; Cancer Prevention Research Institute of Texas; UT System Graduate Programs Initiative; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Greehey Children's Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Environmental Health Sciences [grant K22ES012264 to A.J.R.B.]; American Cancer Society Institutional Research Grant [ACS-IRG-00-173-04 to A.J.R.B.]; GCCRI Ambassador's Circle Research Support Award [to A.J.R.B.]; the National Institute of Aging [grant T32AG021890 to A. D. B.], the Medical Student Summer Research Program, School of Medicine, UTHSCSA [to B. W. S.], the Cancer Prevention Research Institute of Texas [grant RP101491 to A. G.], a Translational Science Training Across Disciplines Scholarship from the UT System Graduate Programs Initiative [to A. G.], a National Cancer Institute [grant T32CA148724-2 to SST] and Greehey Children's Cancer Research Institute endowment funds to defray the costs of publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton GK, 2004, HUM MOL GENET, V13, P3127, DOI 10.1093/hmg/ddh335; Bishop AJR, 2003, CANCER RES, V63, P5335; Bishop AJR, 2000, CANCER RES, V60, P395; Bishop AJR, 2001, CARCINOGENESIS, V22, P641, DOI 10.1093/carcin/22.4.641; BRILLIANT MH, 1991, SCIENCE, V252, P566, DOI 10.1126/science.1673574; Brilliant MH, 2001, PIGM CELL RES, V14, P86, DOI 10.1034/j.1600-0749.2001.140203.x; Brown AD, 2011, MOL CELL BIOL, V31, P3593, DOI 10.1128/MCB.00848-10; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Budzowska M, 2009, CELL BIOCHEM BIOPHYS, V53, P17, DOI 10.1007/s12013-008-9039-y; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Chanoux RA, 2009, J BIOL CHEM, V284, P5994, DOI 10.1074/jbc.M806739200; Claybon A, 2011, JOVE-J VIS EXP, DOI 10.3791/2563; Claybon A, 2010, NUCLEIC ACIDS RES, V38, P7538, DOI 10.1093/nar/gkq624; Davies SL, 2004, MOL CELL BIOL, V24, P1279, DOI 10.1128/MCB.24.3.1279-1291.2004; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Eykelenboom JK, 2013, CELL REP, V5, P1095, DOI 10.1016/j.celrep.2013.10.027; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Friedberg EC, 2006, DNA REPAIR, V5, P189, DOI 10.1016/j.dnarep.2005.09.009; GALLI A, 1995, MOL GEN GENET, V248, P301, DOI 10.1007/BF02191597; Garg R, 2004, MOL CANCER RES, V2, P362; Gunn A, 2011, J BIOL CHEM, V286, P42470, DOI 10.1074/jbc.M111.309252; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Hu BC, 2005, CANCER RES, V65, P8613, DOI 10.1158/0008-5472.CAN-05-1966; Karia B, 2013, DNA REPAIR AMST; Li WH, 2004, J CELL BIOL, V165, P801, DOI 10.1083/jcb.200402095; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Mori M, 2002, INVEST OPHTH VIS SCI, V43, P1384; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Oetting WS, 1999, HUM MUTAT, V13, P99, DOI 10.1002/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.3.CO;2-3; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Pichierri P, 2003, ONCOGENE, V22, P1491, DOI 10.1038/sj.onc.1206169; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Polo SE, 2012, MOL CELL, V45, P505, DOI 10.1016/j.molcel.2011.12.035; Reliene R, 2004, DNA REPAIR, V3, P103, DOI 10.1016/j.dnarep.2003.09.010; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Saleh-Gohari N, 2005, MOL CELL BIOL, V25, P7158, DOI 10.1128/MCB.25.16.7158-7169.2005; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Thanos A, 2012, AM J PATHOL, V180, P1917, DOI 10.1016/j.ajpath.2012.01.017; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Wang HY, 2004, CANCER RES, V64, P7139, DOI 10.1158/0008-5472.CAN-04-1289; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yeung PL, 2012, J CELL BIOCHEM, V113, P1787, DOI 10.1002/jcb.24050	47	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e91222	10.1371/journal.pone.0091222	http://dx.doi.org/10.1371/journal.pone.0091222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675793	gold, Green Submitted, Green Published			2022-12-27	WOS:000333677500012
J	Chen, L; Wu, JJ; Chen, XH; Cao, L; Wu, Y; Zhu, LJ; Lv, KT; Ji, CB; Guo, XR				Chen, Ling; Wu, Jing-Jing; Chen, Xiao-Hui; Cao, Li; Wu, Yun; Zhu, Li-Jun; Lv, Kang-Tai; Ji, Chen-Bo; Guo, Xi-Rong			Measurement of Fetal Abdominal and Subscapular Subcutaneous Tissue Thickness during Pregnancy to Predict Macrosomia: A Pilot Study	PLOS ONE			English	Article							GESTATIONAL-DIABETES-MELLITUS; BODY-COMPOSITION; NEWBORN-INFANTS; GROWTH; WEIGHT; ULTRASOUND; OUTCOMES; WOMEN; DELIVERY; RISK	This study assessed the growth trends and reference ranges of the ultrasound parameters, fetal abdominal subcutaneous tissue thickness (ASTT) and subscapular subcutaneous tissue thickness (SSTT), in the last two trimesters of normal pregnancy in a Chinese population. We recruited 744 healthy women with singleton pregnancies. The ASTT and SSTT were evaluated at different times between 21 and 36 weeks of gestation. The correlations between these parameters and fetal gestational weeks were assessed using linear regression analysis. Both ASTT and SSTT increased with gestation, and both parameters showed a strong correlation with gestation (ASTT vs. GA, R-2 = 0.792; P < 0.0001; SSTT vs. GA, R-2 = 0.302; P < 0.0001). Time-specific reference ranges, including 5th, 50th and 95th percentiles and means +/- SD, were constructed for ASTT and SSTT. These results provide a preliminary reference range to evaluate whether fetal development and maternal metabolic health is normal or not in a Chinese population.	[Chen, Ling; Wu, Jing-Jing; Chen, Xiao-Hui; Cao, Li; Wu, Yun; Zhu, Li-Jun; Lv, Kang-Tai; Ji, Chen-Bo; Guo, Xi-Rong] Nanjing Med Univ, Nanjing Maternal & Child Hlth Hosp, Nanjing, Jiangsu, Peoples R China; [Chen, Ling; Guo, Xi-Rong] Nanjing Med Univ, Inst Pediat, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Ji, CB (corresponding author), Nanjing Med Univ, Nanjing Maternal & Child Hlth Hosp, Nanjing, Jiangsu, Peoples R China.	chenboji@njmu.edu.cn; xrguo@njmu.edu.cn			National Key Basic Research Program of China [2013CB530604]; National Natural Science Foundation of China [81270928, 81200642]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Medical Innovation Team Project of Jiangsu province [LJ201108]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Medical Innovation Team Project of Jiangsu province	This work was supported by grants from the National Key Basic Research Program of China (2013CB530604), the National Natural Science Foundation of China (Grant Nos. 81270928 and 81200642), the Priority Academic Program Development of Jiangsu Higher Education Institutions, and the Medical Innovation Team Project of Jiangsu province (LJ201108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein IM, 1997, AM J OBSTET GYNECOL, V176, P28, DOI 10.1016/S0002-9378(97)80006-3; BERNSTEIN IM, 1994, OBSTET GYNECOL, V83, P462; Buchanan TA, 1999, DIABETES, V48, P2430, DOI 10.2337/diabetes.48.12.2430; Buhling KJ, 2012, ULTRASOUND OBST GYN, V39, P558, DOI 10.1002/uog.10092; CATALANO PM, 1992, OBSTET GYNECOL, V79, P46; Cetin I, 2008, SEMIN ULTRASOUND CT, V29, P136, DOI 10.1053/j.sult.2008.01.002; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Dashe JS, 2000, OBSTET GYNECOL, V96, P321, DOI 10.1016/S0029-7844(00)00943-1; de Groot LCPGM, 1999, NUTR REV, V57, P62; Edwards LE, 1996, OBSTET GYNECOL, V87, P389, DOI 10.1016/0029-7844(95)00446-7; Galan HL, 2001, AM J OBSTET GYNECOL, V185, P839, DOI 10.1067/mob.2001.117350; Gardosi J, 2006, HORM RES, V65, P15, DOI 10.1159/000091501; Gillmer MD, 1975, BRIT MED J, V3, P402; Gojnic M, 2012, CLIN EXP OBSTET GYN, V39, P512; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; Larciprete G, 2005, ULTRASOUND OBST GYN, V26, P258, DOI 10.1002/uog.1980; Larciprete G, 2003, ULTRASOUND OBST GYN, V22, P591, DOI 10.1002/uog.926; Li Shengli, 2004, PRENATAL ULTRASOUNDG; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; MINTZ MC, 1989, AM J PERINAT, V6, P240, DOI 10.1055/s-2007-999585; Rigano S, 2000, CROAT MED J, V41, P240; ROSATI P, 1992, ULTRASOUND OBST GYN, V2, P23, DOI 10.1046/j.1469-0705.1992.02010023.x; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; SHEPARD MJ, 1982, AM J OBSTET GYNECOL, V142, P47; WEN SW, 1990, AM J OBSTET GYNECOL, V162, P53; WHITELAW A, 1977, LANCET, V1, P15	27	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93077	10.1371/journal.pone.0093077	http://dx.doi.org/10.1371/journal.pone.0093077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675769	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677500070
J	Hamblin, J; Stefanova, K; Angessa, TT				Hamblin, John; Stefanova, Katia; Angessa, Tefera Tolera			Variation in Chlorophyll Content per Unit Leaf Area in Spring Wheat and Implications for Selection in Segregating Material	PLOS ONE			English	Article							PHOTOSYNTHESIS	Reduced levels of leaf chlorophyll content per unit leaf area in crops may be of advantage in the search for higher yields. Possible reasons include better light distribution in the crop canopy and less photochemical damage to leaves absorbing more light energy than required for maximum photosynthesis. Reduced chlorophyll may also reduce the heat load at the top of canopy, reducing water requirements to cool leaves. Chloroplasts are nutrient rich and reducing their number may increase available nutrients for growth and development. To determine whether this hypothesis has any validity in spring wheat requires an understanding of genotypic differences in leaf chlorophyll content per unit area in diverse germplasm. This was measured with a SPAD 502 as SPAD units. The study was conducted in series of environments involving up to 28 genotypes, mainly spring wheat. In general, substantial and repeatable genotypic variation was observed. Consistent SPAD readings were recorded for different sampling positions on leaves, between different leaves on single plant, between different plants of the same genotype, and between different genotypes grown in the same or different environments. Plant nutrition affected SPAD units in nutrient poor environments. Wheat genotypes DBW 10 and Transfer were identified as having consistent and contrasting high and low average SPAD readings of 52 and 32 units, respectively, and a methodology to allow selection in segregating populations has been developed.	[Hamblin, John; Stefanova, Katia] Univ Western Australia, Inst Agr, Crawley, WA, Australia; [Angessa, Tefera Tolera] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Hamblin, J (corresponding author), Univ Western Australia, Inst Agr, Crawley, WA, Australia.	hamway2@gmail.com	Angessa, Tefera/GLU-7090-2022	Angessa, Tefera Tolera/0000-0002-2400-1732	The University of Western Australia; SuperSeed Technologies Pty Ltd (SST)	The University of Western Australia(University of Melbourne); SuperSeed Technologies Pty Ltd (SST)	The University of Western Australia funded the salaries of Drs. Stefanove and Angessa. Dr. Hamblin is retired and self funded. The operating and publishing costs were supplied from SuperSeed Technologies Pty Ltd (SST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen X, 2007, PLANT SCI, V173, P397, DOI 10.1016/j.plantsci.2007.06.012; DONALD CM, 1976, ADV AGRON, V28, P361, DOI 10.1016/S0065-2113(08)60559-3; Giunta F, 2002, EUPHYTICA, V125, P197, DOI 10.1023/A:1015878719389; Li Y, 2013, J AGRON CROP SCI, V199, P49, DOI 10.1111/j.1439-037X.2012.00519.x; Murdock L, 2004, COMP USE CHLOROPHYLL; PETTIGREW WT, 1989, CROP SCI, V29, P1025, DOI 10.2135/cropsci1989.0011183X002900040040x; Robertson DW, 1937, GENETICS, V22, P104; USUDA H, 1984, AUST J PLANT PHYSIOL, V11, P509, DOI 10.1071/PP9840509; Zhang KP, 2009, J GENET, V88, P183, DOI 10.1007/s12041-009-0026-x; Zhao CJ, 2007, NEW ZEAL J AGR RES, V50, P735; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206	11	29	30	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92529	10.1371/journal.pone.0092529	http://dx.doi.org/10.1371/journal.pone.0092529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676338	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677500023
J	Hergueta-Redondo, M; Sarrio, D; Molina-Crespo, A; Megias, D; Mota, A; Rojo-Sebastian, A; Garcia-Sanz, P; Morales, S; Abril, S; Cano, A; Peinado, H; Moreno-Bueno, G				Hergueta-Redondo, Marta; Sarrio, David; Molina-Crespo, Angela; Megias, Diego; Mota, Alba; Rojo-Sebastian, Alejandro; Garcia-Sanz, Pablo; Morales, Saleta; Abril, Sandra; Cano, Amparo; Peinado, Hector; Moreno-Bueno, Gema			Gasdermin-B Promotes Invasion and Metastasis in Breast Cancer Cells	PLOS ONE			English	Article							MOUSE-CHROMOSOME 11; H LTR ELEMENT; MESENCHYMAL TRANSITION; GASTROINTESTINAL-TRACT; GASTRIC-CANCER; GSDML GENE; EXPRESSION; CARCINOMA; FAMILY; GROWTH	Gasdermin B (GSDMB) belongs to the Gasdermin protein family that comprises four members (GSDMA-D). Gasdermin B expression has been detected in some tumor types such as hepatocarcinomas, gastric and cervix cancers; and its overexpression has been related to tumor progression. At least four splicing isoforms of GSDMB have been identified, which may play differential roles in cancer. However, the implication of GSDMB in carcinogenesis and tumor progression is not well understood. Here, we uncover for the first time the functional implication of GSDMB in breast cancer. Our data shows that high levels of GSDMB expression is correlated with reduced survival and increased metastasis in breast cancer patients included in an expression dataset (>1,000 cases). We demonstrate that GSDMB is upregulated in breast carcinomas compared to normal breast tissue, being the isoform 2 (GSDMB-2) the most differentially expressed. In order to evaluate the functional role of GSDMB in breast cancer two GSDMB isoforms were studied (GSDMB-1 and GSDMB-2). The overexpression of both isoforms in the MCF7 breast carcinoma cell line promotes cell motility and invasion, while its silencing in HCC1954 breast carcinoma cells decreases the migratory and invasive phenotype. Importantly, we demonstrate that both isoforms have a differential role on the activation of Rac-1 and Cdc-42 Rho-GTPases. Moreover, our data support that GSMDB-2 induces a pro-tumorigenic and pro-metastatic behavior in mouse xenograft models as compared to GSDMB-1. Finally, we observed that although both GSDMB isoforms interact in vitro with the chaperone Hsp90, only the GSDMB-2 isoform relies on this chaperone for its stability. Taken together, our results provide for the first time evidences that GSDMB-2 induces invasion, tumor progression and metastasis in MCF7 cells and that GSDMB can be considered as a new potential prognostic marker in breast cancer.	[Hergueta-Redondo, Marta; Sarrio, David; Molina-Crespo, Angela; Mota, Alba; Morales, Saleta; Cano, Amparo; Moreno-Bueno, Gema] Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols,CSIC, IdiPAZ, Dept Bioquim, Madrid, Spain; [Megias, Diego; Abril, Sandra] CNIO, Madrid, Spain; [Abril, Sandra] Hosp MD Anderson Canc Ctr, Madrid, Spain; [Garcia-Sanz, Pablo; Moreno-Bueno, Gema] Fdn MD Anderson Internac, Madrid, Spain; [Peinado, Hector] Weill Cornell Med Coll, Dept Pediat, Dept Cell & Dev Biol, Childrens Canc & Blood Fdn Labs, New York, NY USA	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Centro Nacional de Investigaciones Oncologicas (CNIO); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Cornell University	Moreno-Bueno, G (corresponding author), Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols,CSIC, IdiPAZ, Dept Bioquim, Madrid, Spain.	gmoreno@iib.uam.es	SARRIO, DAVID/Y-8903-2019; Peinado, Hector/A-6417-2013; Jimenez, Alba Mota/M-5710-2014; Megías, Diego/L-6008-2014; Rojo, Alejandro/Y-9674-2019; Moreno-Bueno, Gema/K-9354-2016	Peinado, Hector/0000-0002-4256-3413; Jimenez, Alba Mota/0000-0001-9148-3965; Rojo, Alejandro/0000-0001-6439-3518; Moreno-Bueno, Gema/0000-0002-5030-6687; Megias, Diego/0000-0003-0755-0518; Sarrio, David/0000-0003-4886-8290	Spanish Ministry of Science and Innovation; MICINN [SAF2007-63075, SAF2010-20175]; AVON Foundation; Comunidad de Madrid [S2010/BMD-2302]; AECC network; Instituto de Salud Carlos III (ISCIII) [PI13_00132]; Breast Network from ISCIII [RD12036/0007]; AECC Scientific Foundation; MECD; ISCIII [RD12036/0007]; Melanoma Research Alliance; Pediatric Oncology Experimental Therapeutics Investigators Consortium; The Nancy C. and Daniel P. Paduano Foundation; The Manning Foundation; NCI [U01 CA169538, RO1 CA169416-01]; DoD [BC123187, BC121988];  [S2010/BMD23]; NATIONAL CANCER INSTITUTE [R01CA169416, U01CA169538] Funding Source: NIH RePORTER	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); AVON Foundation; Comunidad de Madrid(Comunidad de Madrid); AECC network; Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Breast Network from ISCIII; AECC Scientific Foundation; MECD; ISCIII(Instituto de Salud Carlos III); Melanoma Research Alliance; Pediatric Oncology Experimental Therapeutics Investigators Consortium; The Nancy C. and Daniel P. Paduano Foundation; The Manning Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DoD(United States Department of Defense); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Spanish Ministry of Science and Innovation, MICINN (SAF2007-63075 and SAF2010-20175), AVON Foundation 2012, Comunidad de Madrid (S2010/BMD-2302), AECC network 2011, Instituto de Salud Carlos III (ISCIII) (PI13_00132) to GMB and Breast Network from ISCIII RD12036/0007 to AC. MHR has been funded by a predoctoral contract associated to SAF2007-63075 and now has a postdoc contract from S2010/BMD23. DS and PGS are funded by postdoc contracts from the AECC Scientific Foundation, AM is funded by a predoctoral fellowship from MECD; ACM is funded by ISCIII RD12036/0007. Dr HP's work is supported by the Melanoma Research Alliance, Pediatric Oncology Experimental Therapeutics Investigators Consortium, The Nancy C. and Daniel P. Paduano Foundation, The Manning Foundation, NCI (U01 CA169538, RO1 CA169416-01) and the DoD (BC123187, BC121988). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carl-Mcgrath S, 2008, PATHOLOGY, V40, P13, DOI 10.1080/00313020701716250; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gimona M, 2006, INT J BIOCHEM CELL B, V38, P1875, DOI 10.1016/j.biocel.2006.05.003; Harrell JC, 2006, CANCER RES, V66, P9308, DOI 10.1158/0008-5472.CAN-06-1769; Huh JW, 2008, ARCH VIROL, V153, P1201, DOI 10.1007/s00705-008-0105-y; Iorns E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047995; Katoh M, 2004, INT J ONCOL, V24, P757; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Komiyama H, 2010, GENES GENET SYST, V85, P75, DOI 10.1266/ggs.85.75; KUREBAYASHI J, 1993, CANCER RES, V53, P2178; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Lunny DP, 2005, J INVEST DERMATOL, V124, P615, DOI 10.1111/j.0022-202X.2005.23623.x; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; Moreno-Bueno G, 2011, EMBO MOL MED, V3, P528, DOI 10.1002/emmm.201100156; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Nascimento CF, 2011, EXP CELL RES, V317, P2562, DOI 10.1016/j.yexcr.2011.08.022; Olmeda D, 2007, CANCER RES, V67, P11721, DOI 10.1158/0008-5472.CAN-07-2318; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Saeki N, 2007, ONCOGENE, V26, P6488, DOI 10.1038/sj.onc.1210475; Saeki N, 2000, MAMM GENOME, V11, P718, DOI 10.1007/s003350010138; Saeki N, 2009, GENE CHROMOSOME CANC, V48, P261, DOI 10.1002/gcc.20636; Sato H, 1998, MAMM GENOME, V9, P20, DOI 10.1007/s003359900673; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Sin HS, 2006, ARCH VIROL, V151, P1985, DOI 10.1007/s00705-006-0764-5; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sun Q, 2008, TRANSL ONCOL, V1, P73, DOI 10.1593/tlo.08112; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Tamura M, 2007, GENOMICS, V89, P618, DOI 10.1016/j.ygeno.2007.01.003; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; van Horssen R, 2006, J CELL BIOCHEM, V99, P1536, DOI 10.1002/jcb.20994; Wang HB, 2009, CLIN CHEM LAB MED, V47, P811, DOI 10.1515/CCLM.2009.186; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Watabe E, 2001, JPN J CANCER RES, V92, P140, DOI 10.1111/j.1349-7006.2001.tb01076.x; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; YONEDA T, 1994, BREAST CANCER RES TR, V32, P73, DOI 10.1007/BF00666208; Yu J, 2011, PEDIATR PULM, V46, P701, DOI 10.1002/ppul.21424	42	87	92	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e90099	10.1371/journal.pone.0090099	http://dx.doi.org/10.1371/journal.pone.0090099			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675552	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677500006
J	Hiilamo, H				Hiilamo, Heikki			Is Income Inequality 'Toxic for Mental Health'? An Ecological Study on Municipal Level Risk Factors for Depression	PLOS ONE			English	Article							SOCIOECONOMIC INEQUALITIES; POPULATION; SYMPTOMS	Most inequality research on the relationship between inequality and mental health has focused on cross-country variation. Findings from within-country data are mixed. We examined whether changes in municipal Gini index or in the share of people living in relative poverty were linked to changes in the use of antidepressants in several Finnish municipalities between 1995 and 2010. We found that more young adult females used antidepressants in municipalities where relative poverty had increased. Changes in municipal-level Gini index were not positively associated with changes in the use of antidepressants in the municipalities between 1995 and 2010. However, fewer elderly females used antidepressants in municipalities where the Gini index increased. In addition, more young adults used antidepressants in municipalities where the number of those not being educated or trained had also increased. An increase in the number of persons over 65 years of age living alone was positively associated with an increase in the use of antidepressants among elderly females.	Univ Helsinki, Dept Social Res, Helsinki, Finland	University of Helsinki	Hiilamo, H (corresponding author), Univ Helsinki, Dept Social Res, Helsinki, Finland.	heikki.hiilamo@helsinki.fi		Hiilamo, Heikki/0000-0003-4886-4935	Academy of Finland	Academy of Finland(Academy of Finland)	I acknowledge the invaluable help from Jenni Blomgren, Annemari Tuulio-Henriksson, Kathrin Komp, Jaana Martikainen and Jukka-Pekka Lauronen. Funding has been provided by the Academy of Finland.	Bambra C, 2012, CHANGING SOCIAL EQUALITY: THE NORDIC WELFARE MODEL IN THE 21ST CENTURY, P143; Belle D, 2003, PSYCHOL WOMEN QUART, V27, P101, DOI 10.1111/1471-6402.00090; Butterworth P, 2013, J AFFECT DISORDERS, V149, P75, DOI 10.1016/j.jad.2013.01.006; FRIEDLI L, 2009, MENTAL HTLH RESILIEN; Fritzell J, 2007, HLTH INEQUALITIES WE; Galea S, 2007, ANN EPIDEMIOL, V17, P171, DOI 10.1016/j.annepidem.2006.07.008; Hartikainen S, 2004, EUR J CLIN PHARMACOL, V59, P849, DOI 10.1007/s00228-003-0702-3; Henderson C, 2004, SOC SCI MED, V58, P565, DOI 10.1016/S0277-9536(03)00228-4; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Huber E, 2000, AM SOCIOL REV, V65, P323, DOI 10.2307/2657460; Kalela J., 2001, HEAVENS ASHES FINNIS; KAWACHI I, 2002, HLTH NATIONS WHY INE; Lahelma E, 2009, EUR J PUBLIC HEALTH, V19, P445, DOI 10.1093/eurpub/ckp120; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Lundberg O, 2008, LANCET, V372, P1633, DOI 10.1016/S0140-6736(08)61686-4; Lynch J, 2004, MILBANK Q, V82, P355, DOI 10.1111/j.0887-378X.2004.00312.x; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Marmot M., 2004, STATUS SYNDROME YOUR; Melchior M, 2010, PSYCHIAT RES, V177, P92, DOI 10.1016/j.psychres.2009.08.002; MESSIAS E, 2007, PSYCHIAT SERV, V62, P710; Muramatsu N, 2003, HEALTH SERV RES, V38, P1863, DOI 10.1111/j.1475-6773.2003.00206.x; OECD, 2008, GROW UN INC DISTR PO; Pickett KE, 2006, J EPIDEMIOL COMMUN H, V60, P646, DOI 10.1136/jech.2006.046631; Pirkola SP, 2005, SOC PSYCH PSYCH EPID, V40, P1, DOI 10.1007/s00127-005-0848-7; POP I, 2012, INEQUALITY WEALTH HL, DOI DOI 10.1007/S11205-012-0125-6; Rowlingson K., 2011, DOES INCOME INEQUALI; SANTIAGO CD, 2001, J ECON PSYCHOL, V32, P218; Sapolsky Robert, 1997, TROUBLE TESTOSTERONE; Shkolnikov VM, 2012, J EPIDEMIOL COMMUN H, V66, P372, DOI 10.1136/jech.2009.104786; Sihvo S, 2008, J AFFECT DISORDERS, V110, P94, DOI 10.1016/j.jad.2008.01.012; Steptoe A, 2007, INT J BEHAV MED, V14, P97, DOI 10.1007/BF03004175; TOWNSEND P, 2003, CHILD POVERTY DEV WO; Wilkinson R., 2009, SPIRIT LEVEL; Wilkinson RG, 2007, SOC SCI MED, V65, P1965, DOI 10.1016/j.socscimed.2007.05.041; Zheng H, 2009, SOC SCI MED, V69, P1333, DOI 10.1016/j.socscimed.2009.08.016	35	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92775	10.1371/journal.pone.0092775	http://dx.doi.org/10.1371/journal.pone.0092775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SW	24676058	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500038
J	Lehtonen, M; Harrer, G; Wande, E; Laine, M				Lehtonen, Minna; Harrer, Gabor; Wande, Erling; Laine, Matti			Testing the Stem Dominance Hypothesis: Meaning Analysis of Inflected Words and Prepositional Phrases	PLOS ONE			English	Article							MORPHOLOGICAL DECOMPOSITION; REPRESENTATION; RECOGNITION; ACCOUNTS; FINNISH; NOUNS	We tested the hypothesis that lexical-semantic access of inflected words is governed by the word stem. Object drawings overlaid with a dot/arrow marking position/movement were matched with corresponding linguistic expressions like "from the house". To test whether the stem dominates lexical-semantic access irrespective of its position, we used Swedish prepositional phrases (locative information via preposition immediately preceding the stem) or Finnish case-inflected words (locative information via suffix immediately following the stem). Both in monolingual Swedish and in bilingual Finnish-Swedish speakers, correct stems with incorrect prepositions/case-endings were hardest to reject. This finding supports the view that the stem is indeed the dominant unit in meaning access of inflected words.	[Lehtonen, Minna] Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland; [Lehtonen, Minna; Laine, Matti] Abo Akad Univ, Dept Psychol & Logoped, Turku, Finland; [Harrer, Gabor; Wande, Erling] Stockholm Univ, Dept Finnish, S-10691 Stockholm, Sweden	University of Helsinki; Abo Akademi University; Stockholm University	Lehtonen, M (corresponding author), Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland.	minna.h.lehtonen@helsinki.fi	Lehtonen, Minna/K-3672-2012; Lehtonen, Minna/AAN-8202-2020	Lehtonen, Minna/0000-0002-6137-8854; Lehtonen, Minna/0000-0002-6137-8854	Joint Committee of the Nordic Social Science Research Councils (NOS-S) [20010]	Joint Committee of the Nordic Social Science Research Councils (NOS-S)	This study was financially supported by a grant (#20010) from the Joint Committee of the Nordic Social Science Research Councils (NOS-S) to the last author (http://www.norden.org/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenta S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00232; Baayen RH, 2011, PSYCHOL REV, V118, P438, DOI 10.1037/a0023851; Baayen R. Harald, 1997, YB MORPHOLOGY 1996, V1996, P13, DOI [DOI 10.1007/978-94-017-3718-0_3, 10.1007/978-94-017-3718-0_3]; Bertram R, 1999, J PSYCHOLINGUIST RES, V28, P213, DOI 10.1023/A:1023200313787; Burani C., 2003, MORPHOLOGICAL STRUCT, P157, DOI DOI 10.1515/9783110910186.157; COLE P, 1989, J MEM LANG, V28, P1, DOI 10.1016/0749-596X(89)90025-9; Crepaldi D, 2010, J MEM LANG, V63, P83, DOI 10.1016/j.jml.2010.03.002; CUTLER A, 1985, LINGUISTICS, V23, P723, DOI 10.1515/ling.1985.23.5.723; Diependaele K, 2009, MEM COGNITION, V37, P895, DOI 10.3758/MC.37.6.895; Dunabeitia JA, 2008, LANG COGNITIVE PROC, V23, P1002, DOI 10.1080/01690960802164242; Dunabeitia JA, 2008, PSYCHON B REV, V15, P1072, DOI 10.3758/PBR.15.6.1072; Feldman LB, 2012, PSYCHON B REV, V19, P668, DOI 10.3758/s13423-012-0250-x; Feldman LB, 2009, PSYCHON B REV, V16, P684, DOI 10.3758/PBR.16.4.684; Giraudo H., 2003, MORPHOLOGICAL STRUCT, P209, DOI [DOI 10.1515/9783110910186.209, 10.1515/9783110910186.209]; Hawkins J.A., 1988, EXPLAINING LANGUAGE, P280; Hyona J, 2002, EUR J COGN PSYCHOL, V14, P417, DOI 10.1080/09541440143000131; HYONA J, 1995, STUD VIS INFORM PROC, V6, P445; Laine M, 1999, Q J EXP PSYCHOL-A, V52, P253, DOI 10.1080/027249899391313; Laine M, 1999, J MEM LANG, V40, P109, DOI 10.1006/jmla.1998.2615; LAINE M, 1994, CLIN LINGUIST PHONET, V8, P177, DOI 10.3109/02699209408985306; LAINE M, 1995, COGNITIVE NEUROPSYCH, V12, P457, DOI 10.1080/02643299508252005; Lehtonen M., 2003, BILING-LANG COGN, V6, P213, DOI [10.1017/S1366728903001147, DOI 10.1017/S1366728903001147]; Lehtonen M, 2007, BRAIN RES, V1148, P123, DOI 10.1016/j.brainres.2007.02.026; Lehtonen M, 2006, BRAIN LANG, V98, P182, DOI 10.1016/j.bandl.2006.04.011; MARSLENWILSON W, 1994, PSYCHOL REV, V101, P3, DOI 10.1037/0033-295X.101.1.3; Martin-Loeches M, 2006, BRAIN RES, V1093, P178, DOI 10.1016/j.brainres.2006.03.094; Meunier F, 2007, J MEM LANG, V56, P457, DOI 10.1016/j.jml.2006.11.005; NIEMI J, 1994, LANG COGNITIVE PROC, V9, P423, DOI 10.1080/01690969408402126; Rastle K, 2000, LANG COGNITIVE PROC, V15, P507, DOI 10.1080/01690960050119689; Rastle K, 2008, LANG COGNITIVE PROC, V23, P942, DOI 10.1080/01690960802069730; Schreuder R., 1995, MORPHOLOGICAL ASPECT, P131, DOI DOI 10.1002/0470018860.S00254; Taft M, 2010, LANG COGNITIVE PROC, V25, P277, DOI 10.1080/01690960903043261; Vartiainen J, 2009, NEUROIMAGE, V47, P2064, DOI 10.1016/j.neuroimage.2009.06.002	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93136	10.1371/journal.pone.0093136	http://dx.doi.org/10.1371/journal.pone.0093136			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SW	24676218	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500081
J	Burnett, WE; Heinze, J				Burnett, William E.; Heinze, Juergen			Sperm Bundles in the Seminal Vesicles of Sexually Mature Lasius Ant Males	PLOS ONE			English	Article							FIRE ANT; BEES HYMENOPTERA; ATTA-COLOMBICA; SOCIAL INSECTS; FORMICIDAE; ULTRASTRUCTURE; SPERMATOZOA; EVOLUTION; QUEENS; LENGTH	In many insects, sperm cells are produced in bundles with their heads being held together by a glycoprotein matrix secreted by a cyst cell. Mature sperm cells in the seminal vesicles are usually free, but in sawflies and several other insects, such structures (spermatodesmata) remain intact and sperm cells may be ejaculated as bundles. Here we report the occurrence of spermatodesmata in mature males of the ant Lasius pallitarsis. Microscopic investigations of the abdominal contents of males immediately prior to their nuptial flights showed that the anterior ends of numerous sperm cells were embedded in an oval-shaped 20 by 30 micrometer extracellular fibrous cap. Individual sperm ranged in length from 55 to 75 micrometers with an average overall length of 65 micrometers. The bulb-shaped heads of the sperm were relatively small, only about 1.5 micrometers in length and about 1.1 micrometers in diameter. The diameter of the sperm tails was approximately 1 micrometer. Observations of live preparations of the spermatodesmata showed increasingly active undulating wave-like movement of the sperm tails as the slide preparations aged. This appears to be the first case of sperm bundles being present in the seminal vesicles of mature ant males - males that are immediately poised to complete their nuptial mating flight.	[Burnett, William E.] Bitterroot Environm Serv Co, Hamilton, MT USA; [Heinze, Juergen] Univ Regensburg, D-93053 Regensburg, Germany	University of Regensburg	Burnett, WE (corresponding author), Bitterroot Environm Serv Co, Hamilton, MT USA.	cescoweb@aol.com						Baer B, 2005, APIDOLOGIE, V36, P187, DOI 10.1051/apido:2005013; Baer B, 2003, INSECT SOC, V50, P101, DOI 10.1007/s00040-003-0641-0; Baer B, 2009, BEHAV ECOL, V20, P38, DOI 10.1093/beheco/arn112; Baer B, 2006, J MORPHOL, V267, P1165, DOI 10.1002/jmor.10467; BARTELS PJ, 1985, AM MIDL NAT, V113, P190, DOI 10.2307/2425361; Boomsma JJ, 2005, ANNU REV ENTOMOL, V50, P395, DOI 10.1146/annurev.ento.50.071803.130416; Burnett WE, 2013, SPERM BUNDLES MALE A; den Boer SPA, 2008, BEHAV ECOL SOCIOBIOL, V62, P1843, DOI 10.1007/s00265-008-0613-5; den Boer SPA, 2010, SCIENCE, V327, P1506, DOI 10.1126/science.1184709; den Boer SPA, 2009, P ROY SOC B-BIOL SCI, V276, P3945, DOI 10.1098/rspb.2009.1184; Fjerdingstad EJ, 2003, J EVOLUTION BIOL, V16, P844, DOI 10.1046/j.1420-9101.2003.00589.x; Hayashi F, 1998, FUNCT ECOL, V12, P347, DOI 10.1046/j.1365-2435.1998.00205.x; Higginson DM, 2011, BIOL REV, V86, P249, DOI 10.1111/j.1469-185X.2010.00147.x; HOLLDOBLER B, 1985, EXPT BEHAV ECOLOGY S, P237; Lino-Neto J, 2002, TISSUE CELL, V34, P124, DOI 10.1016/S0040-8166(02)00026-5; Lino-Neto J, 2008, TISSUE CELL, V40, P185, DOI 10.1016/j.tice.2007.11.004; Moja J, 2007, ACTA ZOOLOGICA, V88, P181; Moreira Jane, 2004, Brazilian Journal of Morphological Sciences, V21, P185; Oppelt A, 2007, NATURWISSENSCHAFTEN, V94, P781, DOI 10.1007/s00114-007-0249-8; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P69, DOI 10.1016/B978-0-12-372568-4.00003-3; Pizzari T, 2008, PLOS BIOL, V6, P925, DOI 10.1371/journal.pbio.0060130; QUICKE DLJ, 1992, ZOOL SCR, V21, P381, DOI 10.1111/j.1463-6409.1992.tb00339.x; Schiff A, 2001, J HYMENOPT RES, V10, P119; THOMPSON TE, 1967, ANN ENTOMOL SOC AM, V60, P632, DOI 10.1093/aesa/60.3.632; TSCHINKEL WR, 1988, ANN ENTOMOL SOC AM, V81, P777, DOI 10.1093/aesa/81.5.777; VANDERHAVE TM, 1988, EVOLUTION, V42, P160, DOI 10.1111/j.1558-5646.1988.tb04116.x; WHEELER DE, 1990, J MORPHOL, V206, P343, DOI 10.1002/jmor.1052060311; WHEELER DE, 1992, J MORPHOL, V211, P307, DOI 10.1002/jmor.1052110308; Zama U, 2005, INSECT SOC, V52, P122, DOI 10.1007/s00040-005-0789-x; Zama U, 2004, TISSUE CELL, V36, P29, DOI 10.1016/j.tice.2003.08.003; Zama Uyra, 2001, Journal of Hymenoptera Research, V10, P261	31	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93383	10.1371/journal.pone.0093383	http://dx.doi.org/10.1371/journal.pone.0093383			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671307	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000138
J	da Silva, VM; Colussi, F; Neto, MD; Braz, ASK; Squina, FM; Oliveira, CLP; Garcia, W				da Silva, Viviam M.; Colussi, Francieli; Neto, Mario de Oliveira; Braz, Antonio S. K.; Squina, Fabio M.; Oliveira, Cristiano L. P.; Garcia, Wanius			Modular Hyperthermostable Bacterial Endo-beta-1, 4-Mannanase: Molecular Shape, Flexibility and Temperature-Dependent Conformational Changes	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; BIOLOGICAL MACROMOLECULES; STRUCTURE PREDICTION; SOLUTION SCATTERING; MANNANASES; RESOLUTION; SERVER	Endo-beta-1,4-mannanase from Thermotoga petrophila (TpMan) is a hyperthermostable enzyme that catalyzes the hydrolysis of beta-1,4-mannoside linkages in various mannan-containing polysaccharides. A recent study reported that TpMan is composed of a GH5 catalytic domain joined by a linker to a carbohydrate-binding domain. However, at this moment, there is no three-dimensional structure determined for TpMan. Little is known about the conformation of the TpMan as well as the role of the length and flexibility of the linker on the spatial arrangement of the constitutive domains. In this study, we report the first structural characterization of the entire TpMan by small-angle X-ray scattering combined with the three-dimensional structures of the individual domains in order to shed light on the low-resolution model, overall dimensions, and flexibility of this modular enzyme at different temperatures. The results are consistent with a linker with a compact structure and that occupies a small volume with respect to its large number of amino acids. Furthermore, at 20 degrees C the results are consistent with a model where TpMan is a molecule composed of three distinct domains and that presents some level of molecular flexibility in solution. Even though the full enzyme has some degree of molecular flexibility, there might be a preferable conformation, which could be described by the rigid-body modeling procedure. Finally, the results indicate that TpMan undergoes a temperature-driven transition between conformational states without a significant disruption of its secondary structure. Our results suggest that the linker can optimize the geometry between the other two domains with respect to the substrate at high temperatures. These studies should provide a useful basis for future biophysical studies of entire TpMan.	[da Silva, Viviam M.; Colussi, Francieli; Braz, Antonio S. K.; Garcia, Wanius] Univ Fed ABC UFABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil; [Neto, Mario de Oliveira] Univ Estadual Paulista, Inst Biociencias, Dept Fis & Biofis, Sao Paulo, Brazil; [Squina, Fabio M.] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Ciencia & Tecnol Bioetanol, Sao Paulo, Brazil; [Oliveira, Cristiano L. P.] Univ Sao Paulo, Inst Fis, BR-01498 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo	Garcia, W (corresponding author), Univ Fed ABC UFABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil.	wanius.garcia@ufabc.edu.br	Oliveira, Cristiano L P/B-4403-2008; Squina, Fabio/J-8130-2012; Silva, Wanius J. G./L-3948-2016; Neto, Mario Oliveira/F-2717-2013; Colussi, Francieli/J-9166-2016	Oliveira, Cristiano L P/0000-0002-3426-6507; Squina, Fabio/0000-0002-8154-7459; Colussi, Francieli/0000-0002-4392-767X; Oliveira Neto, Mario/0000-0002-6226-7419	Fundacao de Amparo a pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [2012/21054-9, 478900/2012-0, 2012/03503-0, 501037/2012-8]	Fundacao de Amparo a pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors would like to thank Fundacao de Amparo a pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for the financial support for this work via grants #2012/21054-9 and #478900/2012-0; and fellowships #2012/03503-0 (VMS) and #501037/2012-8 (FC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernado P, 2010, EUR BIOPHYS J BIOPHY, V39, P769, DOI 10.1007/s00249-009-0549-3; Boraston AB, 2003, STRUCTURE, V11, P665, DOI 10.1016/S0969-2126(03)00100-X; Brunecky R, 2012, ACTA CRYSTALLOGR D, V68, P292, DOI 10.1107/S0907444912001680; Chang MCY, 2007, CURR OPIN CHEM BIOL, V11, P677, DOI 10.1016/j.cbpa.2007.08.039; Cota J, 2011, BIOCHEM BIOPH RES CO, V406, P590, DOI 10.1016/j.bbrc.2011.02.098; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; dos Santos CR, 2011, BIOTECHNOL LETT, V33, P131, DOI 10.1007/s10529-010-0409-3; GILKES NR, 1991, MICROBIOL REV, V55, P303, DOI 10.1128/MMBR.55.2.303-315.1991; Girio FM, 2010, BIORESOURCE TECHNOL, V101, P4775, DOI 10.1016/j.biortech.2010.01.088; Hall M, 2011, J BIOTECHNOL, V155, P370, DOI 10.1016/j.jbiotec.2011.07.016; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Lima MA, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-75; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Montiel MD, 2002, APPL MICROBIOL BIOT, V58, P67, DOI 10.1007/s00253-001-0866-7; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Randall A, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-52; Rezende CA, 2011, BIOTECHNOL BIOFUELS, V4, P1, DOI 10.1186/1754-6834-4-54; Rost B, 1996, METHOD ENZYMOL, V266, P525; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANTOS CR, 2012, J STRUCT BIOL, V177, P469, DOI DOI 10.1016/J.JSB.2011.11.021; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takahata Y, 2001, INT J SYST EVOL MICR, V51, P1901, DOI 10.1099/00207713-51-5-1901; Tenkanen M, 1997, J BIOTECHNOL, V57, P191, DOI 10.1016/S0168-1656(97)00099-0; van Zyl WH, 2010, PROCESS BIOCHEM, V45, P1203, DOI 10.1016/j.procbio.2010.05.011; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268	42	6	6	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92996	10.1371/journal.pone.0092996	http://dx.doi.org/10.1371/journal.pone.0092996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671161	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000097
J	Hanson, AM; Gambill, J; Phomakay, V; Staten, CT; Kelley, MD				Hanson, Amanda M.; Gambill, Jessica; Phomakay, Venusa; Staten, C. Tyler; Kelley, Melissa D.			9-cis-Retinoic Acid and Troglitazone Impacts Cellular Adhesion, Proliferation, and Integrin Expression in K562 Cells	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; NF-KAPPA-B; RETINOIC ACID; ALL-TRANS; VITAMIN-A; EXTRACELLULAR-MATRIX; NUCLEAR RECEPTOR; T-CELLS; C-MYC; DIFFERENTIATION	Retinoids are established pleiotropic regulators of both adaptive and innate immune responses. Recently, troglitazone, a PPAR gamma agonist, has been demonstrated to have anti-inflammatory effects. Separately, retinoids and troglitazone are implicated in immune related processes; however, their combinatory role in cellular adhesion and proliferation has not been well established. In this study, the effect of 9-cis-retinoic acid (9-cis-RA) and troglitazone on K562 cellular adhesion and proliferation was investigated. Troglitazone exposure decreased K562 cellular adhesion to RGD containing extracellular matrix proteins fibronectin, FN-120, and vitronectin in a concentration and time-dependent manner. In the presence of troglitazone, 9-cis-retinoic acid restores cellular adhesion to levels comparable to vehicle treatment alone on fibronectin, FN-120, and vitronectin substrates within 72 hours. Due to the prominent role of integrins in attachment to extracellular matrix proteins, we evaluated the level of integrin alpha 5 subunit expression. Troglitazone treatment results in decrease in alpha 5 subunit expression on the cell surface. In the presence of both agonists, cell surface alpha 5 subunit expression was restored to levels comparable to vehicle treatment alone. Additionally, troglitazone and 9-cis-RA mediated cell adhesion was decreased in the presence of a function blocking integrin alpha 5 inhibitor. Further, through retinoid metabolic profiling and HPLC analysis, our study demonstrates that troglitazone augments retinoid availability in K562 cells. Finally, we demonstrate that troglitazone and 9-cis-retinoic acid synergistically dampen cellular proliferation in K562 cells. Our study is the first to report that the combination of troglitazone and 9-cis-retinoic acid restores cellular adhesion, alters retinoid availability, impacts integrin expression, and dampens cellular proliferation in K562 cells.	[Hanson, Amanda M.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA; [Gambill, Jessica; Phomakay, Venusa] Univ Arkansas Med Sci, Coll Med, Little Rock, AR USA; [Staten, C. Tyler] Harding Univ, Coll Pharm, Searcy, AR USA; [Kelley, Melissa D.] Univ Cent Arkansas, Dept Chem, Conway, AR 72035 USA	University of Arizona; University of Arkansas System; University of Arkansas Medical Sciences; University of Central Arkansas	Kelley, MD (corresponding author), Univ Cent Arkansas, Dept Chem, Conway, AR 72035 USA.	mkelley@uca.edu			National Center for Research Resources [5P20RR016460-11]; National Institute of General Medical Sciences from the National Institutes of Health [8 P20 GM103429-11]; National Science Foundation [0959209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103429] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The National Center for Research Resources (5P20RR016460-11) and the National Institute of General Medical Sciences (8 P20 GM103429-11) from the National Institutes of Health. The National Science Foundation Award ID 0959209. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baroni A, 2003, BRIT J DERMATOL, V148, P424, DOI 10.1046/j.1365-2133.2003.05165.x; Blomhoff HK, 2004, BIOCHEM SOC T, V32, P982, DOI 10.1042/BST0320982; BRAND N, 1988, NATURE, V332, P850, DOI 10.1038/332850a0; Bridges LC, 2008, BIOCHEMISTRY-US, V47, P4544, DOI 10.1021/bi702447u; Brown DC, 1999, BRIT J HAEMATOL, V107, P86, DOI 10.1046/j.1365-2141.1999.01671.x; Cariati R, 2000, INT J CANCER, V86, P375, DOI 10.1002/(SICI)1097-0215(20000501)86:3<375::AID-IJC12>3.0.CO;2-Z; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Clark RB, 2002, J LEUKOCYTE BIOL, V71, P388; Cooper JP, 2011, BRIT J PHARMACOL, V163, P1263, DOI 10.1111/j.1476-5381.2011.01310.x; DILLEHAY DL, 1987, CELL IMMUNOL, V107, P130, DOI 10.1016/0008-8749(87)90273-5; Ertesvag A, 2002, J IMMUNOL, V169, P5555, DOI 10.4049/jimmunol.169.10.5555; Ertesvag A, 2009, SEMIN IMMUNOL, V21, P36, DOI 10.1016/j.smim.2008.06.005; Escribese Maria M, 2007, BMC Nephrol, V8, P3, DOI 10.1186/1471-2369-8-3; FAULL RJ, 1993, J CELL BIOL, V121, P155, DOI 10.1083/jcb.121.1.155; Feng Y, 2001, J EXP CLIN CANC RES, V20, P429; Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785; Gardsvoll H, 2007, J BIOL CHEM, V282, P13561, DOI 10.1074/jbc.M610184200; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Gorrasi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086352; Gu XS, 2006, J BIOL CHEM, V281, P17882, DOI 10.1074/jbc.M601302200; Han SW, 2005, AM J RESP CELL MOL, V32, P350, DOI 10.1165/rcmb.2004-0345OC; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Idres N, 2001, CANCER RES, V61, P700; Ingber D, 1991, CURR OPIN CELL BIOL, V3, P841, DOI 10.1016/0955-0674(91)90058-7; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Iwata M, 2009, SEMIN IMMUNOL, V21, P8, DOI 10.1016/j.smim.2008.09.002; Iwata M, 2009, SEMIN IMMUNOL, V21, P1, DOI 10.1016/j.smim.2008.09.001; JARVINEN M, 1993, CELL BIOL INT, V17, P399, DOI 10.1006/cbir.1993.1078; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kinashi T, METHODS MOL BIOL, V757, P261; LEO MA, 1989, ARCH BIOCHEM BIOPHYS, V269, P305, DOI 10.1016/0003-9861(89)90112-4; Lerga A, 1999, CELL GROWTH DIFFER, V10, P639; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; Loi CM, 1999, CLIN PHARMACOKINET, V37, P91, DOI 10.2165/00003088-199937020-00001; Ludbrook SB, 2003, BIOCHEM J, V369, P311, DOI 10.1042/BJ20020809; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Marchetti MN, 1997, DRUG METAB DISPOS, V25, P637; MARTINI R, 1993, ARCH BIOCHEM BIOPHYS, V303, P57, DOI 10.1006/abbi.1993.1255; Massimi M, 2007, LIVER INT, V27, P128, DOI 10.1111/j.1478-3231.2006.01391.x; Medhora MM, 2000, AM J PHYSIOL-HEART C, V279, pH382, DOI 10.1152/ajpheart.2000.279.1.H382; Mellanby E, 1929, BMJ-BRIT MED J, V1929, P984; Molla A, 2000, CELL GROWTH DIFFER, V11, P83; Moore T, 1930, BIOCHEM J, V24, P692, DOI 10.1042/bj0240692; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Nakajima H, 1996, LEUKEMIA RES, V20, P665, DOI 10.1016/0145-2126(96)00020-3; Okazaki T, 2009, AM J PATHOL, V174, P2378, DOI 10.2353/ajpath.2009.080942; PASQUALINI R, 1993, J CELL SCI, V105, P101; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Pinaire JA, 2007, PPAR RES, V2007, DOI 10.1155/2007/94156; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Sahi J, 2003, DRUG METAB DISPOS, V31, P439, DOI 10.1124/dmd.31.4.439; Sasaki Makoto, 2005, BMC Physiol, V5, P3, DOI 10.1186/1472-6793-5-3; Schlezinger JJ, 2006, TOXICOL SCI, V92, P433, DOI 10.1093/toxsci/kfl003; Schlezinger JJ, 2004, J IMMUNOL, V173, P3165, DOI 10.4049/jimmunol.173.5.3165; Schlezinger JJ, 2002, J IMMUNOL, V169, P6831, DOI 10.4049/jimmunol.169.12.6831; Scrimshaw N S, 1968, Monogr Ser World Health Organ, V57, P3; Segara D, 2005, CLIN CANCER RES, V11, P3587, DOI 10.1158/1078-0432.CCR-04-1813; Semba RD, 1999, J NUTR, V129, P783, DOI 10.1093/jn/129.4.783; Semba RD, 1998, NUTR REV, V56, pS38, DOI 10.1111/j.1753-4887.1998.tb01643.x; Seta N, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/820827; Shirley MA, 1996, DRUG METAB DISPOS, V24, P293; SIDELL N, 1981, EXP CELL BIOL, V49, P239; Sonnenberg A, 1993, Curr Top Microbiol Immunol, V184, P7; Sporn M.B., 1994, RETINOIDS BIOL CHEM; Sun Z, 2008, AM J PHYSIOL-CELL PH, V295, pC268, DOI 10.1152/ajpcell.00516.2007; Svobodova H, 2009, PHYSIOL RES, V58, P701, DOI 10.33549/physiolres.931573; Tanaka R, 2009, J BIOL CHEM, V284, P19817, DOI 10.1074/jbc.M109.009860; Tarui T, 2003, J BIOL CHEM, V278, P29863, DOI 10.1074/jbc.M304694200; VARNER JA, 1995, MOL BIOL CELL, V6, P725, DOI 10.1091/mbc.6.6.725; Weber C, 1996, J CELL BIOL, V134, P1063, DOI 10.1083/jcb.134.4.1063; Whelan JT, J NUTR BIOCH, V24, P832; White JA, 1997, J BIOL CHEM, V272, P18538, DOI 10.1074/jbc.272.30.18538; WILLIAMS JB, 1985, P NATL ACAD SCI USA, V82, P4658, DOI 10.1073/pnas.82.14.4658; Worm M, 1998, BLOOD, V92, P1713, DOI 10.1182/blood.V92.5.1713.417k20_1713_1720; Wu Y, 2011, CELL IMMUNOL, V268, P68, DOI 10.1016/j.cellimm.2011.03.002; Zhang Y., IMMUNOLOGY, V135, P268	79	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93005	10.1371/journal.pone.0093005	http://dx.doi.org/10.1371/journal.pone.0093005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671180	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677000099
J	Anderson, LN; Briollais, L; Atkinson, HC; Marsh, JA; Xu, JX; Connor, KL; Matthews, SG; Pennell, CE; Lye, SJ				Anderson, Laura N.; Briollais, Laurent; Atkinson, Helen C.; Marsh, Julie A.; Xu, Jingxiong; Connor, Kristin L.; Matthews, Stephen G.; Pennell, Craig E.; Lye, Stephen J.			Investigation of Genetic Variants, Birthweight and Hypothalamic- Pituitary- Adrenal Axis Function Suggests a Genetic Variant in the SERPINA6 Gene Is Associated with Corticosteroid Binding Globulin in the Western Australia Pregnancy Cohort ( Raine) Study	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PLASMA-CORTISOL CONCENTRATIONS; SALIVARY CORTISOL; HPA AXIS; METABOLIC SYNDROME; STRESS RESPONSES; GENOME-WIDE; BODY-SIZE; CHILDREN; OBESITY	Background: The hypothalamic-pituitary-adrenal (HPA) axis regulates stress responses and HPA dysfunction has been associated with several chronic diseases. Low birthweight may be associated with HPA dysfunction in later life, yet human studies are inconclusive. The primary study aim was to identify genetic variants associated with HPA axis function. A secondary aim was to evaluate if these variants modify the association between birthweight and HPA axis function in adolescents. Methods: Morning fasted blood samples were collected from children of the Western Australia Pregnancy Cohort (Raine) at age 17 ( n =1077). Basal HPA axis function was assessed by total cortisol, corticosteroid binding globulin (CBG), and adrenocorticotropic hormone ( ACTH). The associations between 124 tag single nucleotide polymorphisms ( SNPs) within 16 HPA pathway candidate genes and each hormone were evaluated using multivariate linear regression and penalized linear regression analysis using the HyperLasso method. Results: The penalized regression analysis revealed one candidate gene SNP, rs11621961 in the CBG encoding gene ( SERPINA6), significantly associated with total cortisol and CBG. No other candidate gene SNPs were significant after applying the penalty or adjusting for multiple comparisons; however, several SNPs approached significance. For example, rs907621 (p=0.002) and rs3846326 (p=0.003) in the mineralocorticoid receptor gene ( NR3C2) were associated with ACTH and SERPINA6 SNPs rs941601 (p=0.004) and rs11622665 (p=0.008), were associated with CBG. To further investigate our findings for SERPINA6, rare and common SNPs in the gene were imputed from the 1,000 genomes data and 8 SNPs across the gene were significantly associated with CBG levels after adjustment for multiple comparisons. Birthweight was not associated with any HPA outcome, and none of the gene- birthweight interactions were significant after adjustment for multiple comparisons. Conclusions: Our study suggests that genetic variation in the SERPINA6 gene may be associated with altered CBG levels during	[Anderson, Laura N.; Briollais, Laurent; Xu, Jingxiong; Connor, Kristin L.; Lye, Stephen J.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Atkinson, Helen C.; Marsh, Julie A.; Pennell, Craig E.] Univ Western Australia, Sch Womens & Infants Hlth, Crawley, WA, Australia; [Matthews, Stephen G.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Lye, Stephen J.] Univ Toronto, Fraser Mustard Inst Human Dev, Toronto, ON, Canada; [Lye, Stephen J.] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Western Australia; University of Toronto; University of Toronto; University of Toronto	Anderson, LN (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.	Lye@lunenfeld.ca	Briollais, Laurent/A-2941-2013; Atkinson, Helen/B-9246-2015; Pennell, Craig/ABD-6902-2020; Study, Raine/G-9547-2015; Anderson, Laura/K-4707-2019; Lye, Stephen J/E-7269-2013; Matthews, Stephen G/N-7555-2018; Matthews, Stephen/R-5147-2019	Atkinson, Helen/0000-0002-2172-3780; Pennell, Craig/0000-0002-0937-6165; Anderson, Laura/0000-0002-6106-5073; Lye, Stephen J/0000-0002-3305-4406; Matthews, Stephen G/0000-0002-9654-9940; Matthews, Stephen/0000-0002-9654-9940; Marsh, Julie/0000-0001-8984-6907	National Health and Medical Research Council of Australia [353514, 572613, 403981]; Canadian Institutes of Health Research [MOP82893]; University of Western Australia (UWA); Raine Medical Research Foundation; Telethon Institute for Child Health Research; UWA Faculty of Medicine; Dentistry and Health Sciences; Women and Infants Research Foundation; Curtin University	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Western Australia (UWA); Raine Medical Research Foundation; Telethon Institute for Child Health Research; UWA Faculty of Medicine; Dentistry and Health Sciences; Women and Infants Research Foundation; Curtin University	This work was supported by funding for the 17-year follow-up and genotyping provided by the National Health and Medical Research Council of Australia (353514, 572613, 403981) and the Canadian Institutes of Health Research (MOP82893). Core funding for the Raine Study is provided by the University of Western Australia (UWA), Raine Medical Research Foundation, the Telethon Institute for Child Health Research, UWA Faculty of Medicine, Dentistry and Health Sciences, the Women and Infants Research Foundation and Curtin University. LNA and KLC are funded by Canadian Institutes of Health Research postdoctoral fellowship awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers KL, 2010, GENET EPIDEMIOL, V34, P879, DOI 10.1002/gepi.20543; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bose M, 2009, CURR OPIN ENDOCRINOL, V16, P340, DOI 10.1097/MED.0b013e32832fa137; COOLENS JL, 1987, J STEROID BIOCHEM, V26, P197, DOI 10.1016/0022-4731(87)90071-9; EDWARDS CRW, 1993, LANCET, V341, P355, DOI 10.1016/0140-6736(93)90148-A; Evans S, 1996, EARLY HUM DEV, V45, P203, DOI 10.1016/0378-3782(96)01728-8; Fall CH, 1995, BMJ-BRIT MED J, V210, P17; Fall CHD, 2002, J CLIN ENDOCR METAB, V87, P2001, DOI 10.1210/jc.87.5.2001; Gagliardi L, 2010, MOL CELL ENDOCRINOL, V316, P24, DOI 10.1016/j.mce.2009.07.015; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; HANNA CE, 1993, J CLIN ENDOCR METAB, V76, P384, DOI 10.1210/jc.76.2.384; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Hunter AL, 2011, STRESS, V14, P614, DOI 10.3109/10253890.2011.577848; Kajantie E, 2004, CLIN ENDOCRINOL, V60, P201, DOI 10.1046/j.1365-2265.2003.01965.x; Kajantie E, 2003, EUR J ENDOCRINOL, V149, P569, DOI 10.1530/eje.0.1490569; Kajantie E, 2007, J CLIN ENDOCR METAB, V92, P4094, DOI 10.1210/jc.2007-1539; Koupil I, 2005, CLIN ENDOCRINOL, V62, P661, DOI 10.1111/j.1365-2265.2005.02275.x; Kudielka BM, 2003, PSYCHOSOM MED, V65, P313, DOI 10.1097/01.PSY.0000058374.50240.BF; Lin HY, 2012, J CLIN ENDOCR METAB, V97, pE678, DOI 10.1210/jc.2011-3141; McMillen IC, 2009, ADV EXP MED BIOL, V646, P71, DOI 10.1007/978-1-4020-9173-5_8; Michels KB, 2003, J WOMEN HEALTH GEN-B, V12, P157, DOI 10.1089/154099903321576556; Moisan MP, 2010, MOL CELL ENDOCRINOL, V316, P35, DOI 10.1016/j.mce.2009.07.017; Mormede P, 2011, ANN NY ACAD SCI, V1220, P127, DOI 10.1111/j.1749-6632.2010.05902.x; NEWNHAM JP, 1993, LANCET, V342, P887, DOI 10.1016/0140-6736(93)91944-H; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Parmar PG, 2012, J DEV ORIGINS HLTH D; Pasquali R, 2006, ANN NY ACAD SCI, V1083, P111, DOI 10.1196/annals.1367.009; Phillips DIW, 1998, J CLIN ENDOCR METAB, V83, P757, DOI 10.1210/jc.83.3.757; Phillips DIW, 2000, HYPERTENSION, V35, P1301, DOI 10.1161/01.HYP.35.6.1301; Phillips DIW, 2006, J PHYSIOL-LONDON, V572, P45, DOI 10.1113/jphysiol.2005.104695; Rautanen A, 2006, J CLIN ENDOCR METAB, V91, P4544, DOI 10.1210/jc.2006-1065; Reynolds RM, 2010, J STEROID BIOCHEM, V122, P3, DOI 10.1016/j.jsbmb.2010.01.009; Reynolds RM, 2005, EUR J ENDOCRINOL, V152, P249, DOI 10.1530/eje.1.01846; Reynolds RM, 2012, PSYCHONEURO IN PRESS; Robinson M, 2010, BJOG-INT J OBSTET GY, V117, P1139, DOI 10.1111/j.1471-0528.2010.02596.x; Rosmalen JGM, 2005, PSYCHONEUROENDOCRINO, V30, P483, DOI 10.1016/j.psyneuen.2004.12.007; Rutters F, 2011, CLIN ENDOCRINOL, V74, P679, DOI 10.1111/j.1365-2265.2011.03985.x; van Leeuwen N, 2010, PSYCHONEUROENDOCRINO, V35, P339, DOI 10.1016/j.psyneuen.2009.07.006; Velders FP, 2011, PSYCHONEUROENDOCRINO, V36, P1053, DOI 10.1016/j.psyneuen.2011.01.003; Ward AMV, 2004, J CLIN ENDOCR METAB, V89, P1227, DOI 10.1210/jc.2003-030978; Williams LA, 1997, BRIT MED J, V314, P1864, DOI 10.1136/bmj.314.7098.1864	43	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92957	10.1371/journal.pone.0092957	http://dx.doi.org/10.1371/journal.pone.0092957			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691024	gold, Green Submitted, Green Published			2022-12-27	WOS:000334101100037
J	Chakravarti, LJ; Cotton, PA				Chakravarti, Leela J.; Cotton, Peter A.			The Effects of a Competitor on the Foraging Behaviour of the Shore Crab Carcinus maenas	PLOS ONE			English	Article							ENERGY MAXIMIZATION; FEEDING-BEHAVIOR; MYTILUS-EDULIS; PREDATION; RISK; PREY; DIET; CONSTRAINTS; SIZE; TIME	Optimal Diet Theory suggests that individuals make foraging decisions that maximise net energy intake. Many studies provide qualitative support for this, but factors such as digestive constraints, learning, predation-risk and competition can influence foraging behaviour and lead to departures from quantitative predictions. We examined the effects of intraspecific competition within a classic model of optimal diet - the common shore crab, Carcinus maenas, feeding on the mussel, Mytilus edulis. Unexpectedly, we found that breaking time (Tb), eating time (Te), and handling time (Th) all decreased significantly in the presence of a conspecific. Reduced handling time in the presence of a competitor resulted in an increased rate of energy intake, raising the question of why crabs do not always feed in such a way. We suggest that the costs of decreased shell breaking time may be increased risk of claw damage and that crabs may be trading-off the potential loss of food to a competitor with the potential to damage their claw whilst breaking the shell more rapidly. It is well documented that prey-size selection by crabs is influenced by both the risk of claw damage and competition. However, our results are the first to demonstrate similar effects on prey handling times. We suggest that crabs maximise their long-term rate of energy intake at a scale far greater than individual foraging events and that in order to minimise claw damage, they typically break shells at a rate below their maximum. In the presence of a competitor, crabs appear to become more risk-prone and handle their food more rapidly, minimising the risk of kleptoparasitism.	[Chakravarti, Leela J.; Cotton, Peter A.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England	University of Plymouth	Chakravarti, LJ (corresponding author), Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England.	leelajchakravarti@gmail.com		Cotton, Peter/0000-0002-4830-0868				ABELLO P, 1994, MAR BIOL, V121, P247, DOI 10.1007/BF00346732; ABRAMS P, 1983, ANNU REV ECOL SYST, V14, P359, DOI 10.1146/annurev.es.14.110183.002043; Atema J., 1980, P409; ATEMA J, 1986, CAN J FISH AQUAT SCI, V43, P2283, DOI 10.1139/f86-279; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; CUNNINGHAM PN, 1984, MAR ECOL PROG SER, V16, P21, DOI 10.3354/meps016021; DILL LM, 1984, BEHAV ECOL SOCIOBIOL, V16, P65, DOI 10.1007/BF00293105; Ellis JC, 2012, J EXP MAR BIOL ECOL, V416, P84, DOI 10.1016/j.jembe.2012.02.014; ELNER RW, 1978, OECOLOGIA, V36, P333, DOI 10.1007/BF00348059; ELNER RW, 1978, J ANIM ECOL, V47, P103, DOI 10.2307/3925; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; Gillette R, 2000, P NATL ACAD SCI USA, V97, P3585, DOI 10.1073/pnas.97.7.3585; Hartnoll R.G., 1982, P111; HAZLETT BA, 1986, CRUSTACEANA, V51, P107, DOI 10.1163/156854086X00124; HOLBROOK SJ, 1992, ECOLOGY, V73, P402, DOI 10.2307/1940748; HUBER ME, 1985, MAR BEHAV PHYSIOL, V12, P19, DOI 10.1080/10236248509378630; HUGHES RN, 1979, AM NAT, V113, P209, DOI 10.1086/283380; Innes DJ, 1999, MAR BIOL, V133, P691, DOI 10.1007/s002270050510; JUANES F, 1990, ECOLOGY, V71, P744, DOI 10.2307/1940327; LAWTON P, 1992, AM ZOOL, V32, P396; League-Pike PE, 2009, J CRUSTACEAN BIOL, V29, P350, DOI 10.1651/08-3066.1; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LUCAS JR, 1985, AM NAT, V126, P680, DOI 10.1086/284447; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MAGNHAGEN C, 1988, MAR ECOL PROG SER, V49, P21, DOI 10.3354/meps049021; Matheson K, 2012, J EXP MAR BIOL ECOL, V414, P6, DOI 10.1016/j.jembe.2012.01.006; MILINSKI M, 1982, BEHAV ECOL SOCIOBIOL, V11, P109, DOI 10.1007/BF00300099; MILINSKI M, 1978, NATURE, V275, P642, DOI 10.1038/275642a0; Milinski M, 1986, BEHAV TELEOST FISHES, P294; Mukherjee S, 2013, BIOL REV, V88, P550, DOI 10.1111/brv.12014; PARKER GA, 1990, NATURE, V348, P27, DOI 10.1038/348027a0; PULLIAM HR, 1974, AM NAT, V108, P59, DOI 10.1086/282885; Salmon M., 1983, P143; SEKKELSTEN GI, 1988, OIKOS, V51, P131, DOI 10.2307/3565635; SIH A, 1980, SCIENCE, V210, P1041, DOI 10.1126/science.210.4473.1041; Smallegange IM, 2003, J ANIM ECOL, V72, P599, DOI 10.1046/j.1365-2656.2003.00729.x; Smallegange IM, 2006, OIKOS, V113, P157, DOI 10.1111/j.0030-1299.2006.14172.x; Smallegange IM, 2007, BEHAV ECOL, V18, P215, DOI 10.1093/beheco/arl071; Smallegange IM, 2008, J EXP MAR BIOL ECOL, V367, P157, DOI 10.1016/j.jembe.2008.09.011; Spooner EH, 2007, MAR ECOL-EVOL PERSP, V28, P394, DOI 10.1111/j.1439-0485.2007.00186.x; VERLINDEN C, 1989, EVOL ECOL, V3, P264, DOI 10.1007/BF02270727; WALLACE JC, 1972, COMP BIOCHEM PHYSIOL, V41, P523, DOI 10.1016/0300-9629(72)90010-2; Whelan CJ, 2005, OIKOS, V110, P481, DOI 10.1111/j.0030-1299.2005.13387.x; Wirsing AJ, 2007, ANIM BEHAV, V74, P1085, DOI 10.1016/j.anbehav.2007.02.009; Wong BBM, 2005, BEHAV ECOL SOCIOBIOL, V58, P345, DOI 10.1007/s00265-005-0955-1	46	11	11	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93546	10.1371/journal.pone.0093546	http://dx.doi.org/10.1371/journal.pone.0093546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691360	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100102
J	Escudero, B; Lucas, D; Albo, C; Dhup, S; Bacher, JW; Sanchez-Munoz, A; Fernandez, M; Rivera-Torres, J; Carmona, RM; Fuster, E; Carreiro, C; Bernad, R; Gonzales, MA; Andres, V; Blanco, L; Roche, E; Fabregat, I; Samper, E; Bernad, A				Escudero, Beatriz; Lucas, Daniel; Albo, Carmen; Dhup, Suveera; Bacher, Jeff W.; Sanchez-Munoz, Aranzazu; Fernandez, Margarita; Rivera-Torres, Jose; Carmona, Rosa M.; Fuster, Encarnacio; Carreiro, Candelas; Bernad, Raquel; Gonzales, Manuel A.; Andres, Vicente; Blanco, Luis; Roche, Enrique; Fabregat, Isabel; Samper, Enrique; Bernad, Antonio			Pol mu Deficiency Increases Resistance to Oxidative Damage and Delays Liver Aging	PLOS ONE			English	Article							DNA-POLYMERASE-MU; STRAND BREAK REPAIR; PATHWAY; CANCER; CELLS; MECHANISMS; LONGEVITY; DEFINES; HEALTH; ROLES	pol mu an error- prone PoIX polymerase that contributes to classical NHEJ DNA repair. Mice lacking Pol mu (Pol mu (-/-)) show altered hematopoiesis homeostasis Pol mu 2/ 2 mice have increased learning capacity at old ages, suggesting delayed brain aging. Here we investigated the effect of Pol mu 2/ 2 deficiency on liver aging. We found that old Pol mu (-/-) mice (> 20 month) have greater liver regenerative capacity compared with wt animals. Old Pol mu (-/-) liver showed reduced genomic instability and increased apoptosis resistance. However, Pol mu (-/-) mice did not show an extended life span and other organs ( e. g., heart) aged normally. Our results suggest that Pol mu deficiency activates transcriptional networks that reduce constitutive apoptosis, leading to enhanced liver repair at old age.	[Escudero, Beatriz; Albo, Carmen; Dhup, Suveera; Carmona, Rosa M.; Carreiro, Candelas; Gonzales, Manuel A.; Samper, Enrique; Bernad, Antonio] CNIC, Dept Cardiol Regenerat, Madrid, Spain; [Escudero, Beatriz; Lucas, Daniel; Carmona, Rosa M.; Bernad, Raquel; Gonzales, Manuel A.; Samper, Enrique; Bernad, Antonio] Campus Univ Auto noma Madrid, CSIC, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, Madrid, Spain; [Bacher, Jeff W.] Promega Corp, Genet Anal Grp, Madison, WI USA; [Sanchez-Munoz, Aranzazu; Fernandez, Margarita] Univ Complutense, Dept Bioquim & Biol Mol 2, E-28040 Madrid, Spain; [Rivera-Torres, Jose; Andres, Vicente] Ctr Nacl Invest Cardiovasc, Dept Epidemiol Aterotrombosis & Imagen, Madrid, Spain; [Fuster, Encarnacio; Roche, Enrique] Miguel Hernandez Univ, Inst Bioengn, Elche, Alicante, Spain; [Blanco, Luis] CSIC, Ctr Biol Mol Severo Ochoa, Canto Blanco, Madrid, Spain; [Roche, Enrique] CIBERobn CB12 03 30038 Inst Salud Carlos, Madrid, Spain; [Fabregat, Isabel] Hosp Llobregat, Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Promega Corporation; Complutense University of Madrid; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Bernad, A (corresponding author), CNIC, Dept Cardiol Regenerat, Madrid, Spain.	abernad@cnic.es	Sánchez, Aránzazu/H-7810-2015; Dhup, Suveera/AAU-7630-2021; Rivera-Torres, José/P-2793-2015; Bernad, Antonio/P-8573-2017; Lucas, Daniel/ABB-6893-2021; Blanco, Luis/I-1848-2015; Fernández, Margarita/H-9077-2015; Andres, Vicente/I-6440-2014; Fabregat, Isabel/H-7038-2015; Roche, Enrique/V-5738-2017	Sánchez, Aránzazu/0000-0001-9145-6633; Rivera-Torres, José/0000-0003-0365-9604; Lucas, Daniel/0000-0002-0147-5425; Fernández, Margarita/0000-0001-7207-2028; Andres, Vicente/0000-0002-0125-7209; Fabregat, Isabel/0000-0003-0136-8440; Dhup, Suveera/0000-0002-6689-6597; Roche, Enrique/0000-0001-5128-1672; Bernad, Antonio/0000-0003-0620-9668	Ministry of Science and Innovation [SAF 2008-02099, PLE2009-0147, PSE-010000-2009-3]; Comunidad Autonoma de Madrid [S2010/BMD-2420]; European Commission [FP7-HEALTH-2009/CARE-MI]; Spanish Ministry of Economy and Competiveness; Pro-CNIC Foundation	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Economy and Competiveness(Spanish Government); Pro-CNIC Foundation	This work was supported by grants to AB from the Ministry of Science and Innovation (SAF 2008-02099; PLE2009-0147 and PSE-010000-2009-3), Comunidad Autonoma de Madrid (S2010/BMD-2420), and the European Commission (FP7-HEALTH-2009/CARE-MI. CC is supported by The Spanish Ministry of Economy and Competiveness and the Pro-CNIC Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade P, 2009, P NATL ACAD SCI USA, V106, P16203, DOI 10.1073/pnas.0908492106; Bacher JW, 2005, MOL CARCINOGEN, V44, P285, DOI 10.1002/mc.20146; Bertocci B, 2003, IMMUNITY, V19, P203, DOI 10.1016/S1074-7613(03)00203-6; Bokov AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026891; Brown-Borg HM, 2006, AGE, V28, P145, DOI 10.1007/s11357-006-9003-y; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chayot R, 2010, DNA REPAIR, V9, P1187, DOI 10.1016/j.dnarep.2010.09.001; Dominguez O, 2000, EMBO J, V19, P1731, DOI 10.1093/emboj/19.7.1731; Factor VM, 2010, PLOS ONE, V16, P5, DOI DOI 10.1371/J0URNAL.P0NE.0012739; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Holzenberger M, 2004, EXP GERONTOL, V39, P1761, DOI 10.1016/j.exger.2004.08.017; Huffman DM, 2010, INTERD T GERONT GERI, V37, P1, DOI 10.1159/000319991; Lapointe J, 2010, CELL MOL LIFE SCI, V67, P1, DOI 10.1007/s00018-009-0138-8; Li H, 2007, MOL CELL BIOL, V27, P8205, DOI 10.1128/MCB.00785-07; Lucas D, 2005, EUR J IMMUNOL, V35, P1601, DOI 10.1002/eji.200526015; Lucas D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053243; Lucas D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000389; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; McElhinny SAN, 2005, MOL CELL, V19, P357, DOI 10.1016/j.molcel.2005.06.012; Neal JA, 2011, MOL CELL BIOL, V31, P1719, DOI 10.1128/MCB.01298-10; Peterson MJ, 2010, METAB SYNDR RELAT D, V8, P317, DOI 10.1089/met.2009.0090; Ruiz JF, 2004, NUCLEIC ACIDS RES, V32, P5861, DOI 10.1093/nar/gkh929; Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161; Serrano M, 2007, NAT REV MOL CELL BIO, V8, P715, DOI 10.1038/nrm2242; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Yu QJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021770; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zhang LL, 2008, HEPATOLOGY, V48, P1598, DOI 10.1002/hep.22516	32	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93074	10.1371/journal.pone.0093074	http://dx.doi.org/10.1371/journal.pone.0093074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691161	Green Published, gold			2022-12-27	WOS:000334101100041
J	Konig, S; Nitzki, F; Uhmann, A; Dittmann, K; Theiss-Suennemann, J; Herrmann, M; Reichardt, HM; Schwendener, R; Pukrop, T; Schulz-Schaeffer, W; Hahn, H				Koenig, Simone; Nitzki, Frauke; Uhmann, Anja; Dittmann, Kai; Theiss-Suennemann, Jennifer; Herrmann, Markus; Reichardt, Holger M.; Schwendener, Reto; Pukrop, Tobias; Schulz-Schaeffer, Walter; Hahn, Heidi			Depletion of Cutaneous Macrophages and Dendritic Cells Promotes Growth of Basal Cell Carcinoma in Mice	PLOS ONE			English	Article							REGRESSION; CANCER; BISPHOSPHONATES; FIBROBLASTS; METASTASES; SPECTRUM	Basal cell carcinoma (BCC) belongs to the group of non-melanoma skin tumors and is the most common tumor in the western world. BCC arises due to mutations in the tumor suppressor gene Patched1 (Ptch). Analysis of the conditional Ptch knockout mouse model for BCC reveals that macrophages and dendritic cells (DC) of the skin play an important role in BCC growth restraining processes. This is based on the observation that a clodronate-liposome mediated depletion of these cells in the tumor-bearing skin results in significant BCC enlargement. The depletion of these cells does not modulate Ki67 or K10 expression, but is accompanied by a decrease in collagen-producing cells in the tumor stroma. Together, the data suggest that cutaneous macrophages and DC in the tumor microenvironment exert an antitumor effect on BCC.	[Koenig, Simone; Nitzki, Frauke; Uhmann, Anja; Hahn, Heidi] Genet Univ Med Ctr, Inst Human Genet, Gottingen, Germany; [Dittmann, Kai; Theiss-Suennemann, Jennifer; Reichardt, Holger M.] Univ Med Ctr, Inst Cellular & Mol Immunol, Gottingen, Germany; [Herrmann, Markus] Univ Med Ctr, Dept Radiat Oncol, Gottingen, Germany; [Schwendener, Reto] Univ Zurich, Inst Mol Canc Res, Zurich, Switzerland; [Pukrop, Tobias] Univ Med Ctr, Dept Hematol & Oncol, Gottingen, Germany; [Schulz-Schaeffer, Walter] Univ Med Ctr, Dept Neuropathol, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Zurich; University of Gottingen; University of Gottingen	Hahn, H (corresponding author), Genet Univ Med Ctr, Inst Human Genet, Gottingen, Germany.	hhahn@gwdg.de	Schwendener, Reto A/F-6373-2011; Reichardt, Holger/AAF-3048-2020	Reichardt, Holger/0000-0003-4647-057X	Deutsche Forschungsgemeinschaft [FOR942 HA 2197/5-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/; FOR942 HA 2197/5-2 to Heidi Hahn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Chow FY, 2004, NEPHROL DIAL TRANSPL, V19, P2987, DOI 10.1093/ndt/gfh441; CLAASSEN I, 1990, J IMMUNOL METHODS, V134, P153, DOI 10.1016/0022-1759(90)90376-7; CURSON C, 1979, J CUTAN PATHOL, V6, P432, DOI 10.1111/j.1600-0560.1979.tb01166.x; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Ferron M, 2005, GENESIS, V41, P138, DOI 10.1002/gene.20108; Fleming JM, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3215; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Ginhoux F, 2012, CURR TOP MICROBIOL, V351, P1, DOI 10.1007/82_2010_115; Gnant M, 2012, RECENT RESULTS CANC, V192, P65, DOI 10.1007/978-3-642-21892-7_3; GOLDNER JACQUES, 1938, AMER JOUR PATH, V14, P237; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Handoko HY, 2013, J INVEST DERMATOL, V133, P1803, DOI 10.1038/jid.2013.9; HUNT MJ, 1994, BRIT J DERMATOL, V130, P1, DOI 10.1111/j.1365-2133.1994.tb06873.x; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; Konig S, 2013, CANC IMMUNOL IMMUNOT; KURIMOTO I, 1994, IMMUNOLOGY, V83, P281; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Morgan G, 2010, SEMIN ONCOL, V37, pS30, DOI 10.1053/j.seminoncol.2010.10.005; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nestle FO, 1998, J INVEST DERMATOL, V110, P762, DOI 10.1046/j.1523-1747.1998.00189.x; Nitzki F, 2012, J SKIN CANCER, V2012, DOI 10.1155/2012/907543; Nitzki F, 2010, CANCER RES, V70, P2739, DOI 10.1158/0008-5472.CAN-09-3743; Rasmussen JW, 2006, INFECT IMMUN, V74, P6590, DOI 10.1128/IAI.00868-06; Romano E, 2011, CLIN CANCER RES, V17, P1984, DOI 10.1158/1078-0432.CCR-10-3421; Saarto T, 2001, J CLIN ONCOL, V19, P10, DOI 10.1200/JCO.2001.19.1.10; So PL, 2006, EXP DERMATOL, V15, P742, DOI 10.1111/j.1600-0625.2006.00465.x; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Uhmann A, 2007, BLOOD, V110, P1814, DOI 10.1182/blood-2007-02-075648; Urosevic M, 2003, ARCH DERMATOL, V139, P1325, DOI 10.1001/archderm.139.10.1325; Valladeau J, 2005, SEMIN IMMUNOL, V17, P273, DOI 10.1016/j.smim.2005.05.009; Walter C, 2010, CLIN ORAL INVEST, V14, P35, DOI 10.1007/s00784-009-0266-4; Wang HL, 2006, J CLIN INVEST, V116, P2105, DOI 10.1172/JCI27180; Ward NL, 2011, BRIT J DERMATOL, V164, P750, DOI 10.1111/j.1365-2133.2010.10129.x; Wong DA, 2000, BRIT J DERMATOL, V143, P91, DOI 10.1046/j.1365-2133.2000.03596.x; Wysowski DK, 2009, NEW ENGL J MED, V360, P89, DOI 10.1056/NEJMc0808738; Yanofsky VR, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/624123; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zibat A, 2009, CARCINOGENESIS, V30, P918, DOI 10.1093/carcin/bgp068	39	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93555	10.1371/journal.pone.0093555	http://dx.doi.org/10.1371/journal.pone.0093555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691432	Green Accepted, Green Published, gold			2022-12-27	WOS:000334101100104
J	Kuroda, N; Inoue, K; Ikeda, T; Hara, Y; Wake, K; Sato, T				Kuroda, Noriyuki; Inoue, Kouji; Ikeda, Tadayuki; Hara, Yaiko; Wake, Kenjiro; Sato, Tetsuji			Apoptotic Response through a High Mobility Box 1 Protein-Dependent Mechanism in LPS/GaIN-Induced Mouse Liver Failure and Glycyrrhizin-Mediated Inhibition	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; GLYCATION END-PRODUCTS; REPERFUSION INJURY; LIPOPOLYSACCHARIDE/D-GALACTOSAMINE; INTRAVENOUS GLYCYRRHIZIN; INFLAMMATORY RESPONSES; ISCHEMIA-REPERFUSION; EMBRYONIC LETHALITY; SIGNALING PATHWAYS; DENDRITIC CELLS	HMGB1 is a nuclear component involved in nucleosome stabilization and transcription regulation, but extracellularly it is able to serve as a potential late mediator of lethality. In the present study, we explored inflammation- promoting activity of HMGB1 and blockade of extracellular release of HMGB1 by glycyrrhizin ( GL) in LPS/ GaIN- triggered mouse liver injury. At 1 to 10 h after LPS/ GaIN- treatment, mice were anesthetized to collect blood from heart puncture, and serum transaminase and HMGB1 were evaluated. Administration of LPS/ GalN precipitated tissue injury associated with time- dependent alteration in HMGB1 serum levels. At 8 h nuclear immunoreactive products were remarkably reduced and extracellular HMGB1 expression was found exclusively in the pericentral foci. The treatment with GL significantly down- regulated the serum levels of ALT, AST, and HMGB1 in addition to the strong inhibition of tissue injury and extracellular immunoreactivity to HMGB1 and to acetylated- lysine. Furthermore, GL brought about a significant decrease in the number of apoptotic hepatocytes labeled with TUNEL- method. On the basis of these results, three apoptosis- associated genes were identified with microarray analysis and real- time PCR. The ChIP- assay revealed the binding of HMGB1 protein to Gsto1 promoter sequence in LPS/ GaIN- treated mice and the remarkable decrease in combined HMGB1 protein by GL. The current findings claim that a single injection of LPS/ GalN might stimulate apoptosis of hepatocytes through the binding of HMGB1 protein to Gsto1 promoter region and that GL- treatment might prevent the apoptosis and inflammatory infiltrates caused with LPS/ GaIN- injection by disturbing the binding of HMGB1 protein to Gsto1 promoter sequence.	[Kuroda, Noriyuki; Hara, Yaiko; Wake, Kenjiro; Sato, Tetsuji] Tsurumi Univ, Sch Dent Med, Dept Anat & Histocytol, Yokohama, Kanagawa, Japan; [Inoue, Kouji] Tsurumi Univ, Sch Dent Med, Res Ctr Electron Microscopy, Yokohama, Kanagawa, Japan; [Ikeda, Tadayuki] Tsurumi Univ, Sch Dent Med, Dept Geriatr Dent, Yokohama, Kanagawa, Japan; [Wake, Kenjiro] Minophagen Pharmaceut Co Ltd, Liver Res Unit, Tokyo, Japan	Tsurumi University; Tsurumi University; Tsurumi University	Sato, T (corresponding author), Tsurumi Univ, Sch Dent Med, Dept Anat & Histocytol, Yokohama, Kanagawa, Japan.	sato-t@tsurumi-u.ac.jp		KURODA, Noriyuki/0000-0002-4263-1367				Abe K, 2008, J PHARM PHARMACOL, V60, P91, DOI 10.1211/jpp.60.1.0012; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Arase Y, 1997, CANCER, V79, P1494, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-B; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; Board PG, 1997, BIOCHEM J, V328, P929; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; BUSTIN M, 1978, J BIOL CHEM, V253, P1694; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Chen GQ, 2004, J LEUKOCYTE BIOL, V76, P994, DOI 10.1189/jlb.0404242; Cinatl J, 2003, LANCET, V361, P2045, DOI 10.1016/S0140-6736(03)13615-X; Daemen MARC, 1999, J CLIN INVEST, V104, P541, DOI 10.1172/JCI6974; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Elenkov I, 2011, INT J BIOL SCI, V7, P691, DOI 10.7150/ijbs.7.691; Evankovich J, 2010, J BIOL CHEM, V285, P39888, DOI 10.1074/jbc.M110.128348; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Gujral JS, 2001, HEPATOLOGY, V33, P397, DOI 10.1053/jhep.2001.22002; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hoppe G, 2006, EXP CELL RES, V312, P3526, DOI 10.1016/j.yexcr.2006.07.020; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Ikeda K, 2006, DIGEST DIS SCI, V51, P603, DOI 10.1007/s10620-006-3177-0; Ikeda T, 2008, ARCH HISTOL CYTOL, V71, P163, DOI 10.1679/aohc.71.163; Ilmakunnas M, 2008, LIVER TRANSPLANT, V14, P1517, DOI 10.1002/lt.21573; Ito I, 2007, J BIOL CHEM, V282, P16336, DOI 10.1074/jbc.M608467200; Itokazu Y, 2000, J PHARM PHARMACOL, V52, P531, DOI 10.1211/0022357001774327; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; JOHNS EW, 1964, BIOCHEM J, V93, P161, DOI 10.1042/bj0930161; Kimura M, 2001, EUR J PHARMACOL, V431, P151, DOI 10.1016/S0014-2999(01)01424-8; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Kodym R, 1999, J BIOL CHEM, V274, P5131, DOI 10.1074/jbc.274.8.5131; Kubes P, 1999, HEPATO-GASTROENTEROL, V46, P1458; Liu PT, 1998, AM J PHYSIOL-HEART C, V275, pH2191, DOI 10.1152/ajpheart.1998.275.6.H2191; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Manns MP, 2012, J VIRAL HEPATITIS, V19, P537, DOI 10.1111/j.1365-2893.2011.01579.x; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; NAITO M, 1991, LAB INVEST, V64, P664; Nowak M, 2000, AM J PHYSIOL-REG I, V278, pR1202, DOI 10.1152/ajpregu.2000.278.5.R1202; OHUCHI K, 1981, PROSTAG LEUKOTR ESS, V7, P457, DOI 10.1016/0161-4630(81)90033-1; Okamoto T, 2000, EUR J PHARMACOL, V387, P229, DOI 10.1016/S0014-2999(99)00807-9; Okamoto T, 1999, INT J MOL MED, V4, P149; Oshima G, 2012, EUR SURG RES, V48, P154, DOI 10.1159/000338363; Piaggi S, 2010, CARCINOGENESIS, V31, P804, DOI 10.1093/carcin/bgq031; Ploeger B, 2001, DRUG METAB REV, V33, P125, DOI 10.1081/DMR-100104400; Rouhiainen A, 2004, BLOOD, V104, P1174, DOI 10.1182/blood-2003-10-3536; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Sass G, 2002, CYTOKINE, V19, P115, DOI 10.1006/cyto.2002.1948; Sato T, 1998, CELL TISSUE RES, V294, P503, DOI 10.1007/s004410051201; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Shin YW, 2007, PLANTA MED, V73, P257, DOI 10.1055/s-2007-967126; Smolarczyk R, 2012, ARCH IMMUNOL THER EX, V60, P391, DOI 10.1007/s00005-012-0183-0; STERNER R, 1979, J BIOL CHEM, V254, P1577; Sunden-Cullberg J, 2005, CRIT CARE MED, V33, P564, DOI [10.1097/01.CCM.0000155991.88802.4D, 10.1097/01.ccm.0000155991.88802.4D]; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Van Rossum TGJ, 1999, J GASTROEN HEPATOL, V14, P1093, DOI 10.1046/j.1440-1746.1999.02008.x; van Rossum TGJ, 1999, CLIN THER, V21, P2080, DOI 10.1016/S0149-2918(00)87239-2; van Rossum TGJ, 2001, AM J GASTROENTEROL, V96, P2432, DOI 10.1111/j.1572-0241.2001.04049.x; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang Y, 2001, CANCER RES, V61, P4112; Xu H, 2010, J IMMUNOL, V184, P1492, DOI 10.4049/jimmunol.0902660; Yadav SS, 1999, HEPATOLOGY, V29, P1494, DOI 10.1002/hep.510290505; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Yoshida T, 2007, EUR J PHARMACOL, V576, P136, DOI 10.1016/j.ejphar.2007.08.012; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889; Zeng S, 2004, HEPATOLOGY, V39, P422, DOI 10.1002/hep.20045; Zhang XH, 2008, J IMMUNOL, V181, P5015, DOI 10.4049/jimmunol.181.7.5015; Zwacka RM, 1997, J CLIN INVEST, V100, P279, DOI 10.1172/JCI119533	78	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92884	10.1371/journal.pone.0092884	http://dx.doi.org/10.1371/journal.pone.0092884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690901	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100034
J	Lai, YH; Beaver, JM; Lorente, K; Melo, J; Ramjagsingh, S; Agoulnik, IU; Zhang, ZZ; Liu, Y				Lai, Yanhao; Beaver, Jill M.; Lorente, Karla; Melo, Jonathan; Ramjagsingh, Shyama; Agoulnik, Irina U.; Zhang, Zunzhen; Liu, Yuan			Base Excision Repair of Chemotherapeutically-Induced Alkylated DNA Damage Predominantly Causes Contractions of Expanded GAA Repeats Associated with Friedreich's Ataxia	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; DOT-TTC REPEATS; TRIPLET-REPEAT; FRATAXIN GENE; EPIGENETIC CHANGES; OXIDATIVE STRESS; SOMATIC INSTABILITY; STICKY DNA; EXPANSION; TRANSCRIPTION	Expansion of GAA center dot TTC repeats within the first intron of the frataxin gene is the cause of Friedreich's ataxia (FRDA), an autosomal recessive neurodegenerative disorder. However, no effective treatment for the disease has been developed as yet. In this study, we explored a possibility of shortening expanded GAA repeats associated with FRDA through chemotherapeutically-induced DNA base lesions and subsequent base excision repair (BER). We provide the first evidence that alkylated DNA damage induced by temozolomide, a chemotherapeutic DNA damaging agent can induce massive GAA repeat contractions/deletions, but only limited expansions in FRDA patient lymphoblasts. We showed that temozolomide-induced GAA repeat instability was mediated by BER. Further characterization of BER of an abasic site in the context of (GAA)(20) repeats indicates that the lesion mainly resulted in a large deletion of 8 repeats along with small expansions. This was because temozolomide-induced single-stranded breaks initially led to DNA slippage and the formation of a small GAA repeat loop in the upstream region of the damaged strand and a small TTC loop on the template strand. This allowed limited pol beta DNA synthesis and the formation of a short 5'-GAA repeat flap that was cleaved by FEN1, thereby leading to small repeat expansions. At a later stage of BER, the small template loop expanded into a large template loop that resulted in the formation of a long 5'-GAA repeat flap. Pol beta then performed limited DNA synthesis to bypass the loop, and FEN1 removed the long repeat flap ultimately causing a large repeat deletion. Our study indicates that chemotherapeutically-induced alkylated DNA damage can induce large contractions/deletions of expanded GAA repeats through BER in FRDA patient cells. This further suggests the potential of developing chemotherapeutic alkylating agents to shorten expanded GAA repeats for treatment of FRDA.	[Lai, Yanhao; Zhang, Zunzhen] Sichuan Univ, West China Sch Publ Hlth, Dept Environm Hlth, Chengdu 610064, Sichuan, Peoples R China; [Lai, Yanhao; Beaver, Jill M.; Lorente, Karla; Melo, Jonathan; Ramjagsingh, Shyama; Liu, Yuan] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA; [Agoulnik, Irina U.] Florida Int Univ, Dept Cellular Biol & Pharmacol, Miami, FL 33199 USA	Sichuan University; State University System of Florida; Florida International University; State University System of Florida; Florida International University	Zhang, ZZ (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Dept Environm Hlth, Chengdu 610064, Sichuan, Peoples R China.	zhangzunzhen@163.com; yualiu@fiu.edu	Agoulnik, Irina/AAD-4687-2020; Lai, Yanhao/AAD-3392-2019	Agoulnik, Irina/0000-0003-4889-0324; 	National Institutes of Health [ES023569, ES017476]; National Natural Science Foundation of China [81172632]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES017476, R01ES023569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants ES023569 and ES017476 to Y.L. and was partially supported by the grant No. 81172632 from the National Natural Science Foundation of China to Z.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Armstrong JS, 2010, FASEB J, V24, P2152, DOI 10.1096/fj.09-143222; Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; Bourn RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047085; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Castaldo I, 2008, J MED GENET, V45, P808, DOI 10.1136/jmg.2008.058594; Chandok GS, 2012, NUCLEIC ACIDS RES, V40, P3964, DOI 10.1093/nar/gks021; Davies Peter A, 2002, Methods Mol Biol, V187, P51; De Biase I, 2007, GENOMICS, V90, P1, DOI 10.1016/j.ygeno.2007.04.001; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; De Blase I, 2007, ANN NEUROL, V61, P55, DOI 10.1002/ana.21052; De Michele G, 1998, HUM MOL GENET, V7, P1901, DOI 10.1093/hmg/7.12.1901; Dinnes J, 2002, BRIT J CANCER, V86, P501, DOI 10.1038/sj.bjc.6600135; Ditch S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000704; Du JT, 2012, J BIOL CHEM, V287, P29861, DOI 10.1074/jbc.M112.391961; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Emond M, 2000, NEUROLOGY, V55, P1752, DOI 10.1212/WNL.55.11.1752; Entezam A, 2010, HUM MUTAT, V31, P611, DOI 10.1002/humu.21237; Evans-Galea MV, 2012, ANN NEUROL, V71, P487, DOI 10.1002/ana.22671; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; Filla A, 1996, AM J HUM GENET, V59, P554; Follonier C, 2013, NAT STRUCT MOL BIOL, V20, P486, DOI 10.1038/nsmb.2520; Friedman HS, 2000, CLIN CANCER RES, V6, P2585; Gottesfeld JM, 2013, J NEUROCHEM, V126, P147, DOI 10.1111/jnc.12302; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P4930, DOI 10.1093/nar/28.24.4930; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Halabi A, 2012, J BIOL CHEM, V287, P29958, DOI 10.1074/jbc.M112.356758; Hashem VI, 2004, NUCLEIC ACIDS RES, V32, P6334, DOI 10.1093/nar/gkh976; Hashem VI, 2002, MUTAT RES-FUND MOL M, V508, P107, DOI 10.1016/S0027-5107(02)00190-2; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hick A, 2013, DIS MODEL MECH, V6, P608, DOI 10.1242/dmm.010900; Jain A, 2002, J BIOMOL STRUCT DYN, V19, P691, DOI 10.1080/07391102.2002.10506775; Jakupciak JP, 2000, IUBMB LIFE, V50, P355, DOI 10.1080/152165400300089358; KANG SM, 1995, J BIOL CHEM, V270, P27014, DOI 10.1074/jbc.270.45.27014; Kim HM, 2008, EMBO J, V27, P2896, DOI 10.1038/emboj.2008.205; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Krasilnikova MM, 2004, MOL CELL BIOL, V24, P2286, DOI 10.1128/MCB.24.6.2286-2295.2004; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; Lai YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056960; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; Liu Y, 2012, TRENDS BIOCHEM SCI, V37, P162, DOI 10.1016/j.tibs.2011.12.002; Liu Y, 2009, J BIOL CHEM, V284, P28352, DOI 10.1074/jbc.M109.050286; Mariappan SVS, 1999, J MOL BIOL, V285, P2035, DOI 10.1006/jmbi.1998.2435; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Monros E, 1997, AM J HUM GENET, V61, P101, DOI 10.1086/513887; Mrugala MM, 2008, NAT CLIN PRACT ONCOL, V5, P476, DOI 10.1038/ncponc1155; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; OLIVE PL, 1990, RADIAT RES, V122, P86, DOI 10.2307/3577587; OLIVE PL, 1995, EXP CELL RES, V221, P19, DOI 10.1006/excr.1995.1348; Oussatcheva EA, 2001, J BIOL CHEM, V276, P30878, DOI 10.1074/jbc.M104697200; Pastore A, 2013, J NEUROCHEM, V126, P43, DOI 10.1111/jnc.12220; Pianese L, 2004, J NEUROL NEUROSUR PS, V75, P1061, DOI 10.1136/jnnp.2003.028605; Pollard LM, 2008, NUCLEIC ACIDS RES, V36, P489, DOI 10.1093/nar/gkm1066; Punga T, 2010, EMBO MOL MED, V2, P120, DOI 10.1002/emmm.201000064; Richanison TE, 2013, BRAIN RES, V1514, P91, DOI 10.1016/j.brainres.2013.04.005; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Santos R, 2010, ANTIOXID REDOX SIGN, V13, P651, DOI 10.1089/ars.2009.3015; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Schulz JB, 2000, NEUROLOGY, V55, P1719, DOI 10.1212/WNL.55.11.1719; Schulz JB, 2009, NAT REV NEUROL, V5, P222, DOI 10.1038/nrneurol.2009.26; Shah KA, 2012, CELL REP, V2, P1088, DOI 10.1016/j.celrep.2012.10.006; Sharma R, 2002, HUM MOL GENET, V11, P2175, DOI 10.1093/hmg/11.18.2175; Sharma R, 2004, ANN NEUROL, V56, P898, DOI 10.1002/ana.20333; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Sobol RW, 2001, PROG NUCLEIC ACID RE, V68, P57; Soragni E, 2008, NUCLEIC ACIDS RES, V36, P6056, DOI 10.1093/nar/gkn604; Tang JB, 2011, NEURO-ONCOLOGY, V13, P471, DOI 10.1093/neuonc/nor011; Tang W, 2013, DNA REPAIR, V12, P10, DOI 10.1016/j.dnarep.2012.10.001; Trivedi RN, 2005, CANCER RES, V65, P6394, DOI 10.1158/0008-5472.CAN-05-0715; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Xu Meng, 2013, Nucleic Acids Res, V41, P1684, DOI 10.1093/nar/gks1306; Zouari M, 1998, NEUROMUSCULAR DISORD, V8, P416, DOI 10.1016/S0960-8966(98)00051-0	79	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93464	10.1371/journal.pone.0093464	http://dx.doi.org/10.1371/journal.pone.0093464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691413	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100085
J	Lu, LJ; Wang, RJ; Ran, L; Gan, L; Bai, Y; Jin, LB; Yao, ZX; Liu, SC; Ren, GS; Wu, KN; Li, HY; Kong, LQ				Lu, Lin-jie; Wang, Rui-jue; Ran, Liang; Gan, Lu; Bai, Yang; Jin, Liang-bin; Yao, Zi-xiang; Liu, Sheng-chun; Ren, Guo-sheng; Wu, Kai-nan; Li, Hong-yuan; Kong, Ling-quan			On the Status and Comparison of Glucose Intolerance in Female Breast Cancer Patients at Initial Diagnosis and during Chemotherapy through an Oral Glucose Tolerance Test	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; ADJUVANT CHEMOTHERAPY; LIFE-STYLE; IMPACT; RISK; PREVENTION	Aims: This study is to estimate the status and comparison of glucose intolerance in female breast cancer patients at initial diagnosis and during chemotherapy through an oral glucose tolerance test (OGTT), as well as to learn the effect of chemotherapy on the glucose metabolism of breast cancer patients. Methods: All the 79 breast cancer patients at initial diagnosis, with the mean age of 53.2 years, and 96 breast cancer patients before the 5th or 6th cycle of chemotherapy, with the mean age of 51.5 years, participated in the study from December 2012 to October 2013. After an overnight fast, participants underwent OGTT test, and fasting and 2-hour glucose levels were measured to identify undiagnosed diabetes and prediabetes (i.e., impaired fasting glucose or impaired glucose tolerance) in them. Previously diagnosed diabetes among the female breast cancer patients was determined on the self-report and the medical record. Results: The overall incidences of total normal glucose tolerance, prediabetes, diabetes in female breast cancer patients at initial diagnosis and during chemotherapy were 24.1% and 38.5% (p<0.05), 50.6% and 28.1% (p<0.05), and 25.3% and 33.3% (p>0.05), respectively, and the differences of normal glucose tolerance and prediabetes instead of diabetes between the two groups were statistically significant. About 84% of the total diabetes and prediabetes in the female breast cancer patients at initial diagnosis and 79.7% of those during chemotherapy need to be diagnosed with OGTT. Conclusions: Breast cancer patients have high incidences of diabetes and prediabetes. After chemotherapy even with steroids, some breast cancer patients with abnormal glucose metabolism may even become normal. Isolated hyperglycemia 2 hours after glucose loading is common, and OGTT should be made for breast cancer patients at initial diagnosis and during chemotherapy.	[Lu, Lin-jie; Wang, Rui-jue; Ran, Liang; Gan, Lu; Bai, Yang; Jin, Liang-bin; Yao, Zi-xiang; Liu, Sheng-chun; Ren, Guo-sheng; Wu, Kai-nan; Li, Hong-yuan; Kong, Ling-quan] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China	Chongqing Medical University	Wu, KN (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China.	wukainanwaiwu@126.com; hongy_li@hotmail.com; huihuikp@163.com		Kong, Ling-quan/0000-0001-5705-9001	National Natural Science Foundation of China (NSFC) [81372851]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (NSFC)(81372851) (Ling-quan Kong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2007, ARCH INTERN MED, V167, P2091, DOI 10.1001/archinte.167.19.2091; Arif JM, 2011, ASIAN PAC J CANCER P, V12, P589; Buysschaert M, 2013, DIABETES METAB SYND, V7, P247, DOI 10.1016/j.dsx.2013.08.001; Erickson K, 2011, J CLIN ONCOL, V29, P54, DOI 10.1200/JCO.2010.29.3183; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Furnary Anthony P, 2004, Endocr Pract, V10 Suppl 2, P21; Hickish T, 2009, J NATL CANCER I, V101, P537, DOI 10.1093/jnci/djp025; Ioannidis JPA, 2000, J CLIN ONCOL, V18, P3409, DOI 10.1200/JCO.2000.18.19.3409; Ji GY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0687-4; Jia WP, 2007, DIABETOLOGIA, V50, P286, DOI 10.1007/s00125-006-0503-1; Levitzky YS, 2008, J AM COLL CARDIOL, V51, P264, DOI 10.1016/j.jacc.2007.09.038; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lipscombe LL, 2008, BREAST CANCER RES TR, V109, P389, DOI 10.1007/s10549-007-9654-0; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Malek Mojtaba, 2013, ISRN Endocrinol, V2013, P636927, DOI 10.1155/2013/636927; Marble A, 1934, NEW ENGL J MED, V211, P339, DOI 10.1056/NEJM193408232110801; MUNCK A, 1971, PERSPECT BIOL MED, V14, P265; Norhammar A, 2013, DIABETOLOGIA, V56, P1, DOI 10.1007/s00125-012-2694-y; Oyer David S, 2006, J Support Oncol, V4, P479; Qiao Q, 2000, DIABETOLOGIA, V43, P1470, DOI 10.1007/s001250051557; Saydah SH, 2003, AM J EPIDEMIOL, V157, P1092, DOI 10.1093/aje/kwg100; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Schott S, 2010, EXP CLIN ENDOCR DIAB, V118, P673, DOI 10.1055/s-0030-1254116; Schrauder MG, 2011, J CANCER RES CLIN, V137, P975, DOI 10.1007/s00432-010-0960-2; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Srokowski TP, 2009, J CLIN ONCOL, V27, P2170, DOI 10.1200/JCO.2008.17.5935; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wolf I, 2005, LANCET ONCOL, V6, P103, DOI 10.1016/S1470-2045(05)01736-5; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yerrabothala S, 2013, PATHOL ONCOL RES; Zhang PH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-567	31	6	8	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93630	10.1371/journal.pone.0093630	http://dx.doi.org/10.1371/journal.pone.0093630			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690937	Green Submitted, Green Published, gold			2022-12-27	WOS:000334101100114
J	Verma, S; Rao, BJ				Verma, Shalini; Rao, Basuthkar J.			Uncovering the Basis of ATP Hydrolysis Activity in Purified Human p53 Protein: A Reinvestigation	PLOS ONE			English	Article							HUMAN RAD51 PROTEIN; DNA; BINDING; PURIFICATION; STABILITY; CLEAVAGE; ENZYMES; STRESS	p53 is one of the most well studied tumor suppressor proteins and regarded as the guardian of the genome. The protein mediates cell-cycle arrest, apoptosis in response to myriads of cellular stresses including DNA damage via its trascriptional as well as non-transcriptional roles. ATP binding/hydrolysis by p53 had been implicated in its DNA binding functions. However, till date, no ATP binding/hydrolysis domains have been mapped in p53. In the current study, we have reinvestigated the ATP hydrolysis activity associated with recombinant human p53 protein expressed and purified from E. coli. We confirmed the source of ATPase activity using various deletion constructs of p53 and an In-gel ATPase assay followed by LC-ESI-MS/MS analysis of the activity band. The activity was associated with Hsp70 homologue in E. coli, DnaK, a known interactor of p53. We clarify that wildtype human p53, expressed in E. coli BL21 (DE3) strain, carries no ATPase activity.	[Verma, Shalini; Rao, Basuthkar J.] Inst Fundamental Res, Dept Biol Sci, Bombay, Maharashtra, India		Rao, BJ (corresponding author), Inst Fundamental Res, Dept Biol Sci, Bombay, Maharashtra, India.	bjrao@tifr.res.in			Tata Institute of Fundamental Research (Department of Atomic Energy); Department of Science and Technology (JC Bose Award grant), India	Tata Institute of Fundamental Research (Department of Atomic Energy); Department of Science and Technology (JC Bose Award grant), India(Department of Science & Technology (India))	This work was supported by the Tata Institute of Fundamental Research (Department of Atomic Energy) and Department of Science and Technology (JC Bose Award grant), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDWELL JCA, 1984, P NATL ACAD SCI-BIOL, V81, P848, DOI 10.1073/pnas.81.3.848; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; BRAIN R, 1994, ONCOGENE, V9, P1775; Carvajal LA, 2013, EMBO REP, V14, P414, DOI 10.1038/embor.2013.25; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; CLARKE CF, 1988, MOL CELL BIOL, V8, P1206, DOI 10.1128/MCB.8.3.1206; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Kiianitsa K, 2003, ANAL BIOCHEM, V321, P266, DOI 10.1016/S0003-2697(03)00461-5; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Molinari M, 1996, ONCOGENE, V13, P2077; Okorokov AL, 1999, MOL CELL BIOL, V19, P7501; Okorokov AL, 1997, EMBO J, V16, P6008, DOI 10.1093/emboj/16.19.6008; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Verma S, 2013, J BIOCHEM, V154, P237, DOI 10.1093/jb/mvt040; Walerych D, 2009, ONCOGENE, V28, P4284, DOI 10.1038/onc.2009.281; Warnock LJ, 2004, CANCER BIOL THER, V3, P634, DOI 10.4161/cbt.3.7.915; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131; ZYLICZ M, 1983, P NATL ACAD SCI-BIOL, V80, P6431, DOI 10.1073/pnas.80.21.6431	27	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93652	10.1371/journal.pone.0093652	http://dx.doi.org/10.1371/journal.pone.0093652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691158	gold, Green Submitted, Green Published			2022-12-27	WOS:000334101100120
J	Zahn, D; Bitzek, E				Zahn, Dirk; Bitzek, Erik			Shearing in a Biomimetic Apatite-Protein Composite: Molecular Dynamics of Slip Zone Formation, Plastic Flow and Backcreep Mechanisms	PLOS ONE			English	Article								We report molecular dynamics simulations of shear in a biomimetic hydroxyapatite-collagen composite. Our model exhibits elastic properties fully dominated by the inorganic component. However, beyond the elastic regime the biomolecules along with the hierarchical nature of the composite account for the formation of structure-inherent slip zones. These accommodate shear without compromising the overall structure and lead to the sliding of intrinsically defined rods at roughly constant restoring force. Upon releasing load, rod displacement is reversible and backcreep is observed as gradual ionic rearrangement in the slip zone, subjected to an activation barrier.	[Zahn, Dirk] Univ Erlangen Nurnberg, Comp Chem Ctr, Lehrstuhl Theoret Chem, D-91054 Erlangen, Germany; [Bitzek, Erik] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Zahn, D (corresponding author), Univ Erlangen Nurnberg, Comp Chem Ctr, Lehrstuhl Theoret Chem, D-91054 Erlangen, Germany.	dirk.zahn@chemie.uni-erlangen.de; erik.bitzek@ww.uni-erlangen.de	Bitzek, Erik/F-5464-2015	Bitzek, Erik/0000-0001-7430-3694; Zahn, Dirk/0000-0002-4303-3422	DFG [ZA 420-7]; cluster of excellence 'engineering of advanced materials' [EXC 315]	DFG(German Research Foundation (DFG)); cluster of excellence 'engineering of advanced materials'	The authors gratefully acknowledge DFG grant ZA 420-7, and the cluster of excellence 'engineering of advanced materials' EXC 315. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Duchstein P, 2011, J MOL MODEL, V17, P73, DOI 10.1007/s00894-010-0707-7; He LH, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2450649; He LH, 2007, J DENT, V35, P431, DOI 10.1016/j.jdent.2006.12.002; He LH, 2009, J BIOMED MATER RES A, V91A, P352, DOI 10.1002/jbm.a.32223; Kawska A, 2008, ANGEW CHEM, V120, P5060; Kniep R, 2007, TOP CURR CHEM, V270, P73, DOI 10.1007/128_053; Maas MC, 1999, EVOL ANTHROPOL, V8, P133; Tlatlik H, 2006, ANGEW CHEM INT EDIT, V45, P1905, DOI 10.1002/anie.200503610; Zahn D, 2007, J MATER SCI, V42, P8966, DOI 10.1007/s10853-007-1586-x; Zahn D, 2010, ANGEW CHEM INT EDIT, V49, P9405, DOI 10.1002/anie.201002663	10	3	3	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93309	10.1371/journal.pone.0093309	http://dx.doi.org/10.1371/journal.pone.0093309			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691379	Green Submitted, Green Published, gold			2022-12-27	WOS:000334101100063
J	Galan-Moya, EM; Treps, L; Oliver, L; Chneiweiss, H; Vallette, FM; Bidere, N; Gavard, J				Galan-Moya, Eva Maria; Treps, Lucas; Oliver, Lisa; Chneiweiss, Herve; Vallette, Francois M.; Bidere, Nicolas; Gavard, Julie			Endothelial Secreted Factors Suppress Mitogen Deprivation-Induced Autophagy and Apoptosis in Glioblastoma Stem-Like Cells	PLOS ONE			English	Article							CANCER-CELLS; BECLIN 1; TUMORS; NICHE; INHIBITION; THERAPY; NETWORK; KINASE; GROWTH; DEATH	Rapidly growing and highly vascularized tumors, such as glioblastoma multiforme, contain heterogeneous areas within the tumor mass, some of which are inefficiently supplied with nutrients and oxygen. While the cell death rate is elevated in such zones, tumor cells are still suspected to grow and survive independently of extracellular growth factors. In line with this, glioblastoma stem-like cells (GSCs) are found closely associated with brain vasculature in situ, and as such are most likely in a protected microenvironment. However, the behavior of GSCs under deprived conditions has not been explored in detail. Using a panel of 14 patient-derived GSCs, we report that ex vivo mitogen deprivation impaired self-renewal capability, abolished constitutive activation of the mTor pathway, and impinged on GSC survival via the engagement of autophagic and apoptotic cascades. Moreover, pharmacological inhibition of the mTor pathway recapitulated the mitogen deprivation scenario. In contrast, blocking either apoptosis or autophagy, or culturing GSCs with endothelial-secreted factors partly restored mTor pathway activation and rescued GSC survival. Overall, our data suggest that GSCs are addicted to mTor, as their survival and self-renewal are profoundly dependent on this signaling axis. Thus, as mTor governs the fate of GSCs under both deprivation conditions and in the presence of endothelial factors, it could be a key target for therapeutic purposes.	[Galan-Moya, Eva Maria; Treps, Lucas; Gavard, Julie] Ctr Natl Rech Sci, UMR 8104, Paris, France; [Galan-Moya, Eva Maria; Treps, Lucas; Gavard, Julie] Inst Natl Sante & Rech Med, U1016, Paris, France; [Galan-Moya, Eva Maria; Treps, Lucas; Gavard, Julie] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Oliver, Lisa; Vallette, Francois M.] Inst Natl Sante & Rech Med, UMR 892, Nantes, France; [Oliver, Lisa; Vallette, Francois M.] Ctr Natl Rech Sci, UMR 6299, Nantes, France; [Oliver, Lisa; Vallette, Francois M.] Univ Nantes, Fac Med, Nantes, France; [Oliver, Lisa; Vallette, Francois M.] Inst Cancerol Ouest, Nantes, France; [Oliver, Lisa; Vallette, Francois M.; Bidere, Nicolas] Equipe Labellisee Ligue Canc, Paris, France; [Chneiweiss, Herve] Inst Natl Sante & Rech Med, Neurosci Paris Seine, UMRS 1130, Paris, France; [Chneiweiss, Herve] Ctr Natl Rech Sci, UMR 8246, Paris, France; [Chneiweiss, Herve] Univ Paris 06, UMCR18, Paris, France; [Bidere, Nicolas] Inst Natl Sante & Rech Med, UMR S1014, Villejuif, France; [Bidere, Nicolas] Univ Paris 11, Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Gavard, J (corresponding author), Ctr Natl Rech Sci, UMR 8104, Paris, France.	julie.gavard@inserm.fr	Oliver, Lisa J/L-3070-2015; Gavard, Julie/I-5487-2012; Treps, Lucas/AAF-2499-2020; Vallette, Francois/N-2361-2018; Bidère, Nicolas/K-8887-2015; Vallette, Francois M/K-9047-2015; Galan-Moya, Eva M/I-2912-2015; herve, chneiweiss/Q-6818-2019; Gavard, Julie/I-5487-2012	Oliver, Lisa J/0000-0002-5588-7564; Gavard, Julie/0000-0002-7985-9007; Treps, Lucas/0000-0003-0735-9000; Bidère, Nicolas/0000-0001-9177-0008; Vallette, Francois M/0000-0002-3296-8572; Galan-Moya, Eva M/0000-0001-5758-7592; herve, chneiweiss/0000-0001-7675-5061; Gavard, Julie/0000-0003-3107-2026; Vallette, Francois/0000-0003-0802-0519	Ligue Nationale Contre le Cancer; Association des NeuroOncologues d'Expression Francaise (ANOCEF); Fondation pour la Recherche Medicale (FRM); Fondation Association pour la Recherche sur le Cancer (ARC); Agence Nationale pour la Recherche Programme Jeunes Chercheuses-Jeunes Chercheurs (ANR JCJC); Institut National du Cancer [INCA 6508]; Marie Curie International Reintegration Grant within The Seventh Framework Program; Universite Paris Descartes	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Association des NeuroOncologues d'Expression Francaise (ANOCEF); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fondation Association pour la Recherche sur le Cancer (ARC); Agence Nationale pour la Recherche Programme Jeunes Chercheuses-Jeunes Chercheurs (ANR JCJC)(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France); Marie Curie International Reintegration Grant within The Seventh Framework Program; Universite Paris Descartes	This research was funded by Ligue Nationale Contre le Cancer, Association des NeuroOncologues d'Expression Francaise (ANOCEF), Fondation pour la Recherche Medicale (FRM), Fondation Association pour la Recherche sur le Cancer (ARC), Agence Nationale pour la Recherche Programme Jeunes Chercheuses-Jeunes Chercheurs (ANR JCJC), Institut National du Cancer (INCA 6508) and by a Marie Curie International Reintegration Grant within The Seventh Framework Program. EMGM is supported by a post-doctoral fellowship from Ligue Nationale contre le Cancer and LT is supported by doctoral fellowship from Universite Paris Descartes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Charles NA, 2012, GLIA, V60, P502, DOI 10.1002/glia.21264; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dwyer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045562; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Galan-Moya EM, 2011, CELL CYCLE, V10, P2403, DOI 10.4161/cc.10.15.16198; Galan-Moya EM, 2011, EMBO REP, V12, P470, DOI 10.1038/embor.2011.39; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; Jiang H, 2009, METHOD ENZYMOL, V453, P273, DOI 10.1016/S0076-6879(08)04013-5; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Le Guelte A, 2012, J CELL SCI; Lefranc Florence, 2006, Neurosurg Focus, V20, pE7, DOI 10.3171/foc.2006.20.4.4; Levine B, 2010, NATURE, V466, P38, DOI 10.1038/466038a; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Naik E, 2011, J EXP MED, V208, P1351, DOI 10.1084/jem.20100951; Oliver L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019820; Patru C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-66; Persano L, 2013, BIOCHEM PHARMACOL, V85, P612, DOI 10.1016/j.bcp.2012.10.001; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; Priault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008755; Selvakumaran M, 2013, CLIN CANCER RES, V19, P2995, DOI 10.1158/1078-0432.CCR-12-1542; Singh SK, 2003, CANCER RES, V63, P5821; Sini P, 2010, AUTOPHAGY, V6, P553, DOI 10.4161/auto.6.4.11671; Sneddon JB, 2009, METHODS MOL BIOL, V568, P217, DOI 10.1007/978-1-59745-280-9_14; Thirant C, 2012, STEM CELLS, V30, P845, DOI 10.1002/stem.1062; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014	33	12	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93505	10.1371/journal.pone.0093505	http://dx.doi.org/10.1371/journal.pone.0093505			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682219	Green Published, gold, Green Submitted			2022-12-27	WOS:000333678100050
J	Topper, SM; Aguilar, SC; Topper, VY; Elbel, E; Pierce-Shimomura, JT				Topper, Stephen M.; Aguilar, Sara C.; Topper, Viktoria Y.; Elbel, Erin; Pierce-Shimomura, Jonathan T.			Alcohol Disinhibition of Behaviors in C. elegans	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; RAT NUCLEUS-ACCUMBENS; CAENORHABDITIS-ELEGANS; DOPAMINE-RECEPTOR; ETHANOL; RELEASE; ANXIETY; RESPONSES; STRESS; SENSITIZATION	Alcohol has a wide variety of effects on physiology and behavior. One of the most well-recognized behavioral effects is disinhibition, where behaviors that are normally suppressed are displayed following intoxication. A large body of evidence has shown that alcohol-induced disinhibition in humans affects attention, verbal, sexual, and locomotor behaviors. Similar behavioral disinhibition is also seen in many animal models of ethanol response, from invertebrates to mammals and primates. Here we describe several examples of disinhibition in the nematode C. elegans. The nematode displays distinct behavioral states associated with locomotion (crawling on land and swimming in water) that are mediated by dopamine. On land, animals crawl and feed freely, but these behaviors are inhibited in water. We found that additional behaviors, including a variety of escape responses are also inhibited in water. Whereas alcohol non-specifically impaired locomotion, feeding, and escape responses in worms on land, alcohol specifically disinhibited these behaviors in worms immersed in water. Loss of dopamine signaling relieved disinhibition of feeding behavior, while loss of the D1-like dopamine receptor DOP-4 impaired the ethanol-induced disinhibition of crawling. The powerful genetics and simple nervous system of C. elegans may help uncover conserved molecular mechanisms that underlie alcohol-induced disinhibition of behaviors in higher animals.	[Topper, Stephen M.; Aguilar, Sara C.; Topper, Viktoria Y.; Elbel, Erin; Pierce-Shimomura, Jonathan T.] Univ Texas Austin, Dept Neurosci, Waggoner Ctr Alcohol & Addict Res Cell & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Pierce-Shimomura, JT (corresponding author), Univ Texas Austin, Dept Neurosci, Waggoner Ctr Alcohol & Addict Res Cell & Mol Biol, Austin, TX 78712 USA.	jonps@austin.utexas.edu			National Institutes of Health grants from NIAAA [R01AA020992]; NINDS, Waggoner Center for Alcohol and Addiction Research [R01NS075541]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020992] Funding Source: NIH RePORTER	National Institutes of Health grants from NIAAA; NINDS, Waggoner Center for Alcohol and Addiction Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding was provided by National Institutes of Health grants from NIAAA (R01AA020992) and NINDS (R01NS075541), Waggoner Center for Alcohol and Addiction Research (http://www.utexas.edu/research/wcaar/) to JTP as well as a Bruce Jones Fellowship to ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao KP, 2011, INT J NEUROPSYCHOPH, V14, P175, DOI 10.1017/S1461145710000441; AHLENIUS S, 1974, J NEURAL TRANSM, V35, P175, DOI 10.1007/BF01250743; Alaimo JT, 2012, ALCOHOL CLIN EXP RES, V36, P1840, DOI 10.1111/j.1530-0277.2012.01799.x; BABOR TF, 1983, PSYCHOPHARMACOLOGY, V80, P53, DOI 10.1007/BF00427496; Bahi A, 2012, BEHAV BRAIN RES, V226, P250, DOI 10.1016/j.bbr.2011.09.024; BRENNER S, 1974, GENETICS, V77, P71; Broadbent J, 2005, ALCOHOL, V35, P137, DOI 10.1016/j.alcohol.2005.03.006; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; COLOMBO G, 1995, PHYSIOL BEHAV, V57, P1181, DOI 10.1016/0031-9384(94)00382-F; Davies AG, 2004, NEURON, V42, P731, DOI 10.1016/j.neuron.2004.05.004; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; DEBOER MC, 1993, ADDICT BEHAV, V18, P117, DOI 10.1016/0306-4603(93)90041-7; DUNCAN HM, 1966, J BIOL CHEM, V241, P1694; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Gomez JL, 2012, ALCOHOL, V46, P499, DOI 10.1016/j.alcohol.2011.12.005; Gonzales RA, 2004, PHARMACOL THERAPEUT, V103, P121, DOI 10.1016/j.pharmthera.2004.06.002; HERWEIJER MA, 1985, BIOCHIM BIOPHYS ACTA, V809, P81, DOI 10.1016/0005-2728(85)90170-7; Hodge CW, 1997, ALCOHOL CLIN EXP RES, V21, P1083, DOI 10.1111/j.1530-0277.1997.tb04257.x; IMPERATO A, 1986, J PHARMACOL EXP THER, V239, P219; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Lee HG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001391; Lee J, 2009, GENES BRAIN BEHAV, V8, P578, DOI 10.1111/j.1601-183X.2009.00513.x; Marinkovic K, 2000, J STUD ALCOHOL, V61, P24, DOI 10.15288/jsa.2000.61.24; Melendez RI, 2002, ALCOHOL CLIN EXP RES, V26, P318; Mitchell PH, 2007, PHARMACOGENOMICS J, V7, P411, DOI 10.1038/sj.tpj.6500440; Mitchell P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010422; Moberg CA, 2009, J ABNORM PSYCHOL, V118, P335, DOI 10.1037/a0015636; Mongan NP, 2002, PROTEIN SCI, V11, P1162, DOI 10.1110/ps.3040102; Pandey SC, 2005, J CLIN INVEST, V115, P2762, DOI 10.1172/JCI24381; Pisu MG, 2011, EUR NEUROPSYCHOPHARM, V21, P414, DOI 10.1016/j.euroneuro.2010.07.006; Pohorecky LA, 2008, PHYSIOL BEHAV, V94, P432, DOI 10.1016/j.physbeh.2008.02.010; Prause N, 2011, ARCH SEX BEHAV, V40, P373, DOI 10.1007/s10508-010-9718-9; RASSNICK S, 1992, PSYCHOPHARMACOLOGY, V109, P92, DOI 10.1007/BF02245485; Rose AK, 2007, ALCOHOL ALCOHOLISM, V42, P544, DOI 10.1093/alcalc/agm073; SAMSON HH, 1993, BRAIN RES BULL, V30, P133, DOI 10.1016/0361-9230(93)90049-H; Sayette MA, 2012, PSYCHOL SCI, V23, P869, DOI 10.1177/0956797611435134; Sprengel R, 2001, TRENDS PHARMACOL SCI, V22, P7, DOI 10.1016/S0165-6147(00)01588-1; Stoner SA, 2007, AIDS BEHAV, V11, P227, DOI 10.1007/s10461-006-9137-z; Sugiura M, 2005, J NEUROCHEM, V94, P1146, DOI 10.1111/j.1471-4159.2005.03268.x; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; Suo S, 2003, J NEUROCHEM, V86, P869, DOI 10.1046/j.1471-4159.2003.01896.x; Suo S, 2002, NEUROSCI LETT, V319, P13, DOI 10.1016/S0304-3940(01)02477-6; Varlinskaya EI, 2012, PHARMACOL BIOCHEM BE, V100, P440, DOI 10.1016/j.pbb.2011.10.010; Vidal-Gadea A, 2011, P NATL ACAD SCI USA, V108, P17504, DOI 10.1073/pnas.1108673108; Vidal-Gadea Andres G, 2012, Worm, V1, P5; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; Weafer J, 2012, DRUG ALCOHOL DEPEN, V126, P176, DOI 10.1016/j.drugalcdep.2012.05.010; WEIGHT FF, 1992, ADV BIOCHEM PSYCHOPH, V47, P335; WEISS F, 1993, J PHARMACOL EXP THER, V267, P250; Wintle RF, 2001, PARKINSONISM RELAT D, V7, P177, DOI 10.1016/S1353-8020(00)00055-9; Yang YH, 1999, ALCOHOL CLIN EXP RES, V23, P983; Yassin L, 2001, MOL CELL NEUROSCI, V17, P589, DOI 10.1006/mcne.2000.0944; Yim HJ, 2000, ALCOHOL, V22, P107, DOI 10.1016/S0741-8329(00)00121-X	55	18	18	8	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92965	10.1371/journal.pone.0092965	http://dx.doi.org/10.1371/journal.pone.0092965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681782	Green Published, gold, Green Submitted			2022-12-27	WOS:000333678100020
J	Aquino, D; Di Stefano, AL; Scotti, A; Cuppini, L; Anghileri, E; Finocchiaro, G; Bruzzone, MG; Eoli, M				Aquino, Domenico; Di Stefano, Anna Luisa; Scotti, Alessandro; Cuppini, Lucia; Anghileri, Elena; Finocchiaro, Gaetano; Bruzzone, Maria Grazia; Eoli, Marica			Parametric Response Maps of Perfusion MRI May Identify Recurrent Glioblastomas Responsive to Bevacizumab and Irinotecan	PLOS ONE			English	Article							ANTI-ANGIOGENIC THERAPY; CEREBRAL BLOOD-VOLUME; HISTOGRAM ANALYSIS; BRAIN-TUMOR; GLIOMAS; SURVIVAL; GRADE; PROGRESSION; MULTIFORME; BIOMARKERS	Background: Perfusion weighted imaging (PWI) can be used to measure key aspects of tumor vascularity in vivo and recent studies suggest that perfusion imaging may be useful in the early assessment of response to angiogenesis inhibitors. Aim of this work is to compare Parametric Response Maps (PRMs) with the Region Of Interest (ROI) approach in the analysis of tumor changes induced by bevacizumab and irinotecan in recurrent glioblastomas (rGBM), and to evaluate if changes in tumor blood volume measured by perfusion MRI may predict clinical outcome. Methods: 42 rGBM patients with KPS >= 50 were treated until progression, as defined by MRI with RANO criteria. Relative cerebral blood volume (rCBV) variation after 8 weeks of treatment was calculated through semi-automatic ROI placement in the same anatomic region as in baseline. Alternatively, rCBV variations with respect to baseline were calculated into the evolving tumor region using a voxel-by-voxel difference. PRMs were created showing where rCBV significantly increased, decreased or remained unchanged. Results: An increased blood volume in PRM (PRMCBV+) higher than 18% (first quartile) after 8 weeks of treatment was associated with increased progression free survival (PFS; 24 versus 13 weeks, p = 0.045) and overall survival (OS; 38 versus 25 weeks, p = 0.016). After 8 weeks of treatment ROI analysis showed that mean rCBV remained elevated in non responsive patients (4.8 +/- 60.9 versus 5.1 +/- 1.2, p = 0.38), whereas decreased in responsive patients (4.2 +/- 1.3 versus 3.8 +/- 1.6 p = 0.04), and re-increased progressively when patients approached tumor progression. Conclusions: Our data suggest that PRMs can provide an early marker of response to antiangiogenic treatment and warrant further confirmation in a larger cohort of GBM patients.	[Aquino, Domenico; Scotti, Alessandro; Bruzzone, Maria Grazia] Fdn IRCCS Ist Neurol C Besta, Neuroradiol Unit, Milan, Italy; [Di Stefano, Anna Luisa] Fdn IRCCS Ist Neurol C Besta, Gen Neurol Unit, Milan, Italy; [Cuppini, Lucia; Anghileri, Elena; Finocchiaro, Gaetano; Eoli, Marica] Fdn IRCCS Ist Neurol C Besta, Mol Neurooncol Unit, Milan, Italy	IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta	Eoli, M (corresponding author), Fdn IRCCS Ist Neurol C Besta, Mol Neurooncol Unit, Milan, Italy.	eoli@istituto-besta.it	Aquino, Domenico/AAK-3047-2021; Bruzzone, Maria/AAM-4478-2021; Di Stefano, Anna Luisa/AAS-7836-2020; Finocchiaro, Gaetano/AAG-6791-2020; Eoli, Marica/K-7748-2016; Anghileri, Elena/AAK-4180-2021	Aquino, Domenico/0000-0002-1289-9573; Bruzzone, Maria/0000-0002-2786-1471; Di Stefano, Anna Luisa/0000-0003-1746-0647; Eoli, Marica/0000-0003-4744-9377; Anghileri, Elena/0000-0001-7383-3108; Finocchiaro, Gaetano/0000-0003-3583-4040	Italian Ministry of Health [RF-INN-2008-1142520]; MIUR [RBAP1183B5]	Italian Ministry of Health(Ministry of Health, Italy); MIUR(Ministry of Education, Universities and Research (MIUR))	This work was partially supported by a grant from the Italian Ministry of Health [RF-INN-2008-1142520 to GF]. Drugs were supplied by Roche S. p. A. (Monza, Italy) and Hospira (Napoli, Italy). This work was partially funded by MIUR, FIRB project "Materiali fluorurati nanostrutturati come mezzi di contrasto intelligenti in 19F-RMN (FLUORIMAGING)'' project no. RBAP1183B5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Barajas RF, 2012, PROG NEUROL SURG, V25, P55, DOI 10.1159/000331174; Batchelor TT, 2013, P NATL ACAD SCI USA, V110, P19059, DOI 10.1073/pnas.1318022110; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cha S, 2000, AM J NEURORADIOL, V21, P881; Chamberlain MC, 2011, J NEURO-ONCOL, V101, P319, DOI 10.1007/s11060-010-0251-4; Cuppini L, 2013, PLOS ONE IN PRESS; Galban CJ, 2011, CLIN CANCER RES, V17, P4751, DOI 10.1158/1078-0432.CCR-10-2098; Galban CJ, 2009, NAT MED, V15, P572, DOI 10.1038/nm.1919; Hashimoto M, 2004, ONCOGENE, V23, P3716, DOI 10.1038/sj.onc.1207418; Hu LS, 2012, AM J NEURORADIOL, V33, P69, DOI 10.3174/ajnr.A2743; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Law M, 2007, AM J NEURORADIOL, V28, P761; Law M, 2008, RADIOLOGY, V247, P490, DOI 10.1148/radiol.2472070898; Lu Kan V, 2013, CNS Oncol, V2, P49; Maier SE, 2010, NMR BIOMED, V23, P849, DOI 10.1002/nbm.1544; Maru D, 2013, CLIN CANCER RES, V19, P2824, DOI 10.1158/1078-0432.CCR-12-3409; McNamara MG, 2012, EXPERT REV ANTICANC, V12, P643, DOI [10.1586/ERA.12.35, 10.1586/era.12.35]; Mills SJ, 2010, AM J NEURORADIOL, V31, P726, DOI 10.3174/ajnr.A1925; Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102; Pope WB, 2011, AM J NEURORADIOL, V32, P882, DOI 10.3174/ajnr.A2385; Pope WB, 2012, J NEURO-ONCOL, V108, P491, DOI 10.1007/s11060-012-0847-y; Ratai EM, 2013, NEURO-ONCOLOGY, V15, P936, DOI 10.1093/neuonc/not044; Sawlani RN, 2010, RADIOLOGY, V255, P622, DOI 10.1148/radiol.10091341; Sorensen AG, 2012, CANCER RES, V72, P402, DOI 10.1158/0008-5472.CAN-11-2464; Specenier P, 2012, EXPERT REV ANTICANC, V12, P9, DOI [10.1586/ERA.11.179, 10.1586/era.11.179]; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sugahara T, 2000, AM J NEURORADIOL, V21, P901; Takano Shingo, 2013, Acta Neurochir Suppl, V118, P185, DOI 10.1007/978-3-7091-1434-6_34; Tsien C, 2010, J CLIN ONCOL, V28, P2293, DOI 10.1200/JCO.2009.25.3971; Van Meter MEM, 2010, CURR OPIN ONCOL, V22, P586, DOI 10.1097/CCO.0b013e32833edc0c; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Young R, 2007, J MAGN RESON IMAGING, V26, P1053, DOI 10.1002/jmri.21064; Zulfiqar M, 2013, AM J ROENTGENOL, V200, P624, DOI 10.2214/AJR.12.8679	33	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e90535	10.1371/journal.pone.0090535	http://dx.doi.org/10.1371/journal.pone.0090535			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675671	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677500008
J	Raghunath, S; Rajagopalan, S; Karwoski, RA; Maldonado, F; Peikert, T; Moua, T; Ryu, JH; Bartholmai, BJ; Robb, RA				Raghunath, Sushravya; Rajagopalan, Srinivasan; Karwoski, Ronald A.; Maldonado, Fabien; Peikert, Tobias; Moua, Teng; Ryu, Jay H.; Bartholmai, Brian J.; Robb, Richard A.			Quantitative Stratification of Diffuse Parenchymal Lung Diseases	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; NONSPECIFIC INTERSTITIAL PNEUMONIA; COMPUTED-TOMOGRAPHY; PREDICTS SURVIVAL; CLINICAL-TRIALS; EMPHYSEMA; CT; CLASSIFICATION; DIAGNOSIS; PATTERNS	Diffuse parenchymal lung diseases (DPLDs) are characterized by widespread pathological changes within the pulmonary tissue that impair the elasticity and gas exchange properties of the lungs. Clinical-radiological diagnosis of these diseases remains challenging and their clinical course is characterized by variable disease progression. These challenges have hindered the introduction of robust objective biomarkers for patient-specific prediction based on specific phenotypes in clinical practice for patients with DPLD. Therefore, strategies facilitating individualized clinical management, staging and identification of specific phenotypes linked to clinical disease outcomes or therapeutic responses are urgently needed. A classification schema consistently reflecting the radiological, clinical (lung function and clinical outcomes) and pathological features of a disease represents a critical need in modern pulmonary medicine. Herein, we report a quantitative stratification paradigm to identify subsets of DPLD patients with characteristic radiologic patterns in an unsupervised manner and demonstrate significant correlation of these self-organized disease groups with clinically accepted surrogate endpoints. The proposed consistent and reproducible technique could potentially transform diagnostic staging, clinical management and prognostication of DPLD patients as well as facilitate patient selection for clinical trials beyond the ability of current radiological tools. In addition, the sequential quantitative stratification of the type and extent of parenchymal process may allow standardized and objective monitoring of disease, early assessment of treatment response and mortality prediction for DPLD patients.	[Raghunath, Sushravya; Rajagopalan, Srinivasan; Karwoski, Ronald A.; Robb, Richard A.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Maldonado, Fabien; Peikert, Tobias; Moua, Teng; Ryu, Jay H.] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN USA; [Bartholmai, Brian J.] Mayo Clin, Dept Radiol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Robb, RA (corresponding author), Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.	robb.richard@mayo.edu	Moua, Teng/AAG-7445-2019	Bartholmai, Brian/0000-0001-7834-6579; Ryu, Jay/0000-0002-9576-2272	Mayo Graduate School, Mayo Clinic College of Medicine;  [HHSN268201100022C]; NATIONAL CANCER INSTITUTE [K23CA159391] Funding Source: NIH RePORTER	Mayo Graduate School, Mayo Clinic College of Medicine; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Brian J. Bartholmai is the PI of NIH/NHLBI Radiology core lab for LTRC (HHSN268201100022C) and was partially funded by this contract. Sushravya Raghunath was funded by Mayo Graduate School, Mayo Clinic College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study.	Akira M, 2009, RADIOLOGY, V251, P271, DOI 10.1148/radiol.2511080917; Bartholmai BJ, 2013, J THORAC IMAG, V28, P298, DOI 10.1097/RTI.0b013e3182a21969; Best AC, 2008, RADIOLOGY, V246, P935, DOI 10.1148/radiol.2463062200; Castaldi PJ, 2013, AM J RESP CRIT CARE, V188, P1083, DOI 10.1164/rccm.201305-0873OC; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Cesuroglu T, 2012, PERS MED, V9, P115, DOI 10.2217/pme.12.16; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Dirksen A, 2013, AM J RESP CRIT CARE, V188, P1045, DOI 10.1164/rccm.201309-1649ED; Flaherty KR, 2003, AM J RESP CRIT CARE, V168, P543, DOI 10.1164/rccm.200209-1112OC; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gietema HA, 2011, ACAD RADIOL, V18, P661, DOI 10.1016/j.acra.2011.01.011; Goldin JG, 2013, J THORAC IMAG, V28, P291, DOI 10.1097/RTI.0b013e3182a1d93d; Hansell DM, 2013, RADIOLOGY, V268, P628, DOI 10.1148/radiol.13120908; HAYHURST MD, 1984, LANCET, V2, P320; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Kim SS, 2013, RADIOLOGY, V266, P626, DOI 10.1148/radiol.12120385; Lederer DJ, 2013, EUROPEAN RESP J, V42, P1442; Ley B, 2012, ANN INTERN MED, V156, P684, DOI 10.7326/0003-4819-156-10-201205150-00004; Luppi F, 2012, CURR OPIN PULM MED, V18, P428, DOI 10.1097/MCP.0b013e3283567ff9; Lynch DA, 2005, AM J RESP CRIT CARE, V172, P488, DOI 10.1164/rccm.200412-1756OC; Lynch DA, 2005, RADIOLOGY, V236, P10, DOI 10.1148/radiol.2361031674; MacDonald SLS, 2001, RADIOLOGY, V221, P600, DOI 10.1148/radiol.2213010158; Maldonado F, 2014, EUR RESPIR J, V43, P204, DOI 10.1183/09031936.00071812; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mooney JJ, 2013, CHEST, V144, P586, DOI 10.1378/chest.12-2623; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Raghunath Sushravya, 2012, Stud Health Technol Inform, V173, P362; Ryerson CJ, 2013, CHEST, V144, P234, DOI 10.1378/chest.12-2403; Schuster DP, 2007, AM J RESP CRIT CARE, V176, P224, DOI 10.1164/rccm.200703-462PP; Sullivan DC, 2008, RADIOLOGY, V248, P328, DOI 10.1148/radiol.2482080242; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Trusheim MR, 2007, NAT REV DRUG DISCOV, V6, P287, DOI 10.1038/nrd2251; Uppaluri R, 1999, AM J RESP CRIT CARE, V159, P519, DOI 10.1164/ajrccm.159.2.9707145; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Xaubet A, 1998, AM J RESP CRIT CARE, V158, P431, DOI 10.1164/ajrccm.158.2.9709008; Xu Y, 2006, IEEE T MED IMAGING, V25, P464, DOI 10.1109/TMI.2006.870889	39	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93229	10.1371/journal.pone.0093229	http://dx.doi.org/10.1371/journal.pone.0093229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676019	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677500096
J	Ravetto, A; Wyss, HM; Anderson, PD; den Toonder, JMJ; Bouten, CVC				Ravetto, Agnese; Wyss, Hans M.; Anderson, Patrick D.; den Toonder, Jaap M. J.; Bouten, Carlijn V. C.			Monocytic Cells Become Less Compressible but More Deformable upon Activation	PLOS ONE			English	Article							POLYMORPHONUCLEAR LEUKOCYTES; MECHANICAL DEFORMATION; NARROW CHANNELS; NEUTROPHILS; CYTOSKELETON; RETENTION; CAPILLARIES	Aims: Monocytes play a significant role in the development of atherosclerosis. During the process of inflammation, circulating monocytes become activated in the blood stream. The consequent interactions of the activated monocytes with the blood flow and endothelial cells result in reorganization of cytoskeletal proteins, in particular of the microfilament structure, and concomitant changes in cell shape and mechanical behavior. Here we investigate the full elastic behavior of activated monocytes in relation to their cytoskeletal structure to obtain a better understanding of cell behavior during the progression of inflammatory diseases such as atherosclerosis. Methods and Results: The recently developed Capillary Micromechanics technique, based on exposing a cell to a pressure difference in a tapered glass microcapillary, was used to measure the deformation of activated and non-activated monocytic cells. Monitoring the elastic response of individual cells up to large deformations allowed us to obtain both the compressive and the shear modulus of a cell from a single experiment. Activation by inflammatory chemokines affected the cytoskeletal organization and increased the elastic compressive modulus of monocytes with 73-340%, while their resistance to shape deformation decreased, as indicated by a 25-88% drop in the cell's shear modulus. This decrease in deformability is particularly pronounced at high strains, such as those that occur during diapedesis through the vascular wall. Conclusion: Overall, monocytic cells become less compressible but more deformable upon activation. This change in mechanical response under different modes of deformation could be important in understanding the interplay between the mechanics and function of these cells. In addition, our data are of direct relevance for computational modeling and analysis of the distinct monocytic behavior in the circulation and the extravascular space. Lastly, an understanding of the changes of monocyte mechanical properties will be important in the development of diagnostic tools and therapies concentrating on circulating cells.	[Ravetto, Agnese; Bouten, Carlijn V. C.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Wyss, Hans M.; Anderson, Patrick D.; den Toonder, Jaap M. J.] Eindhoven Univ Technol, Dept Mech Engn, NL-5600 MB Eindhoven, Netherlands; [Wyss, Hans M.; Anderson, Patrick D.; den Toonder, Jaap M. J.] Eindhoven Univ Technol, Inst Complex Mol Syst, NL-5600 MB Eindhoven, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology; Eindhoven University of Technology	Ravetto, A (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, POB 513, NL-5600 MB Eindhoven, Netherlands.	a.ravetto@tue.nl	Bouten, Carlijn/AAT-5187-2020; Anderson, Patrick D/E-6046-2011; Wyss, Hans/A-9404-2008	Bouten, Carlijn/0000-0003-1035-5094; Wyss, Hans/0000-0001-6564-3398; den Toonder, Jaap/0000-0002-5923-4456; Anderson, Patrick/0000-0001-9157-0858	CTMM, the Center for Translational Molecular Medicine, project CIRCULATING CELLS [01C-102]; Dutch Heart Foundation	CTMM, the Center for Translational Molecular Medicine, project CIRCULATING CELLS; Dutch Heart Foundation(Netherlands Heart Foundation)	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project CIRCULATING CELLS (grant 01C-102), and supported by the Dutch Heart Foundation. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The manuscript had to be submitted to the funders for Clearance on IP issues.	BOYD AW, 1984, LEUKEMIA RES, V8, P27, DOI 10.1016/0145-2126(84)90029-8; BUTTRUM SM, 1994, J APPL PHYSIOL, V77, P1801, DOI 10.1152/jappl.1994.77.4.1801; CHIEN S, 1987, ANN NY ACAD SCI, V516, P333, DOI 10.1111/j.1749-6632.1987.tb33054.x; DOHERTY DE, 1994, J IMMUNOL, V153, P241; DOWNEY GP, 1990, J APPL PHYSIOL, V69, P1767, DOI 10.1152/jappl.1990.69.5.1767; DOWNEY GP, 1991, J CELL BIOL, V114, P1179, DOI 10.1083/jcb.114.6.1179; EVANS E, 1989, BIOPHYS J, V56, P151, DOI 10.1016/S0006-3495(89)82660-8; Gabriele S, 2009, BIOPHYS J, V96, P4308, DOI 10.1016/j.bpj.2009.02.037; Gossett DR, 2012, P NATL ACAD SCI USA, V109, P7630, DOI 10.1073/pnas.1200107109; Guo MY, 2011, MACROMOL MATER ENG, V296, P223, DOI 10.1002/mame.201000359; HOWARD TH, 1985, J CELL BIOL, V101, P1078, DOI 10.1083/jcb.101.3.1078; Kitagawa Y, 1997, J APPL PHYSIOL, V82, P1397, DOI 10.1152/jappl.1997.82.5.1397; NEEDHAM D, 1992, BIOPHYS J, V61, P1664, DOI 10.1016/S0006-3495(92)81970-7; Nishino M, 2005, J TRAUMA, V59, P1425, DOI 10.1097/01.ta.0000197356.83144.72; Nossal R, 1998, BIOPHYS J, V75, P1541, DOI 10.1016/S0006-3495(98)74073-1; Preira P, 2013, LAB CHIP, V13, P161, DOI [10.1039/c2lc40847c, 10.1039/c2lc40847]; Rinker KD, 2004, ATHEROSCLEROSIS, V177, P275, DOI 10.1016/j.atherosclerosis.2004.07.017; Rosenbluth MJ, 2006, BIOPHYS J, V90, P2994, DOI 10.1529/biophysj.105.067496; Sefah K, 2009, LEUKEMIA, V23, P235, DOI 10.1038/leu.2008.335; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Simon SI, 1999, J IMMUNOL, V163, P2891; Singh V, 2009, CURR VASC PHARMACOL, V7, P75, DOI 10.2174/157016109787354097; TSAI MA, 1993, BIOPHYS J, V65, P2078, DOI 10.1016/S0006-3495(93)81238-4; Tseng Y, 2004, J BIOL CHEM, V279, P1819, DOI 10.1074/jbc.M306090200; VERMES I, 1987, DIABETOLOGIA, V30, P434, DOI 10.1007/BF00292548; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; WORTHEN GS, 1989, SCIENCE, V245, P183, DOI 10.1126/science.2749255; Wyss HM, 2011, AM J PHYSIOL-CELL PH, V300, pC397, DOI 10.1152/ajpcell.00438.2010; Wyss HM, 2010, SOFT MATTER, V6, P4550, DOI 10.1039/c003344h; Yap B, 2005, J APPL PHYSIOL, V99, P2323, DOI 10.1152/japplphysiol.00503.2005; Yap B, 2005, J APPL PHYSIOL, V98, P1930, DOI 10.1152/japplphysiol.01226.2004	31	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92814	10.1371/journal.pone.0092814	http://dx.doi.org/10.1371/journal.pone.0092814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676335	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500043
J	Sun, W; Li, J; Han, PF; Yang, YH; Kang, XP; Li, YC; Li, JM; Zhang, Y; Wu, XY; Jiang, T; Qin, CF; Hu, Y; Zhu, QY				Sun, Wei; Li, Jing; Han, Pengfei; Yang, Yinhui; Kang, Xiaoping; Li, Yuchang; Li, Jiaming; Zhang, Yu; Wu, Xiaoyan; Jiang, Tao; Qin, Chengfeng; Hu, Yi; Zhu, Qingyu			U-4 at the 3 ' UTR of PB1 Segment of H5N1 Influenza Virus Promotes RNA Polymerase Activity and Contributes to Viral Pathogenicity	PLOS ONE			English	Article							MIGRATORY WATERFOWL; SECONDARY STRUCTURE; PANHANDLE RNA; HUMAN AIRWAY; REPLICATION; TRANSCRIPTION; NUCLEOTIDE; INFECTION; HEMAGGLUTININ; NUCLEOPROTEIN	The viral RNA-dependent RNA polymerase has been found to contribute to efficient replication in mammalian systems and to the high pathogenicity of H5N1 influenza A virus in humans and other mammals. The terminal untranslated regions of the viral segments perform functions such as polyadenylation and contain signals for genomic packaging and initiation of RNA synthesis. These sequences are highly conserved, apart from a U/C polymorphism at position 4 of the 39 end, most often seen in the polymerase gene segments. However, no study has yet tested whether the untranslated regions of H5N1 make any contribution to its high pathogenicity. Herein, the association of the fourth nucleotide at the 39 end of the untranslated region in segment 2 (PB1), of A/Vietnam/1194/2004 (H5N1), with pathogenicity was examined in mice. To this end, an RNA polymerase reporter system was constructed, and viruses with mutations at this site were rescued. Results showed the U-4 in PB1 was found to contribute to greater amounts of RNA-dependent RNA polymerase activity and differentially regulate genomic transcription and replication. Although a recombinant H5N1 virus with the rarer C-4 sequence in all eight segments was viable and replicated to high titers in vitro, replacing a single U-4 at the 39 termini of the PB1 gene segment enhanced viral reproduction and more pathogenesis. In this way, these data showed the importance of untranslated regions of H5N1 influenza virus to pathogenicity.	[Sun, Wei; Li, Jing; Han, Pengfei; Yang, Yinhui; Kang, Xiaoping; Li, Yuchang; Li, Jiaming; Zhang, Yu; Wu, Xiaoyan; Jiang, Tao; Qin, Chengfeng; Hu, Yi; Zhu, Qingyu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Hu, Y (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China.	qingyzh@aliyun.com; huyi-amms@163.com	Qin, Cheng-Feng/I-6839-2019; Li, Jing/AAE-6038-2019; Tao, Jiang/AAE-6623-2019	Qin, Cheng-Feng/0000-0002-0632-2807; Tao, Jiang/0000-0003-1908-2926	973 High-Tech Projects Plan [2011CB504706]; National Nature Science Foundation of China [31200119]; Major National Science and Technology Projects [2012ZX10004-502]	973 High-Tech Projects Plan(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major National Science and Technology Projects	This study was supported by the grant from the 973 High-Tech Projects Plan (No. 2011CB504706) (http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm), the grant from the National Nature Science Foundation of China (No. 31200119) (http://www.nsfc.gov.cn/Portal0/default166.htm) and the grant from Major National Science and Technology Projects (No. 2012ZX10004-502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; BOSCH FX, 1979, VIROLOGY, V95, P197, DOI 10.1016/0042-6822(79)90414-8; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Chen Y, 2013, LANCET, V6736, P3; Cheong HK, 1996, NUCLEIC ACIDS RES, V24, P4197, DOI 10.1093/nar/24.21.4197; Davis JM, 2008, AM J PHYSIOL-REG I, V295, pR505, DOI 10.1152/ajpregu.90319.2008; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; DESSELBERGER U, 1980, GENE, V8, P315, DOI 10.1016/0378-1119(80)90007-4; FODOR E, 1994, J VIROL, V68, P4092, DOI 10.1128/JVI.68.6.4092-4096.1994; Fujii K, 2005, J VIROL, V79, P3766, DOI 10.1128/JVI.79.6.3766-3774.2005; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jiang HB, 2010, VIROLOGY, V408, P190, DOI 10.1016/j.virol.2010.09.022; Kawakami E, 2011, J VIROL METHODS, V173, P1, DOI 10.1016/j.jviromet.2010.12.014; Klumpp K, 1997, EMBO J, V16, P1248, DOI 10.1093/emboj/16.6.1248; Lee KH, 1998, J GEN VIROL, V79, P1923, DOI 10.1099/0022-1317-79-8-1923; Lee MK, 2003, NUCLEIC ACIDS RES, V31, P1216, DOI 10.1093/nar/gkg214; Li J, 2011, J GEN VIROL, V92, P1435, DOI 10.1099/vir.0.030718-0; Li J, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-93; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Lutz A, 2005, J VIROL METHODS, V126, P13, DOI 10.1016/j.jviromet.2005.01.016; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Resa-Infante P, 2011, RNA BIOL, V8, P207, DOI 10.4161/rna.8.2.14513; ROBERTSON JS, 1979, NUCLEIC ACIDS RES, V6, P3745, DOI 10.1093/nar/6.12.3745; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Twu KY, 2007, J VIROL, V81, P8112, DOI 10.1128/JVI.00006-07; WEBSTER RG, 1987, CELL, V50, P665, DOI 10.1016/0092-8674(87)90321-7; Zheng HY, 1996, VIROLOGY, V217, P242, DOI 10.1006/viro.1996.0111	33	6	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93366	10.1371/journal.pone.0093366	http://dx.doi.org/10.1371/journal.pone.0093366			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676059	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677500117
J	Cruz-Ramirez, N; Acosta-Mesa, HG; Mezura-Montes, E; Guerra-Hernandez, A; Hoyos-Rivera, GD; Barrientos-Martinez, RE; Gutierrez-Fragoso, K; Nava-Fernandez, LA; Gonzalez-Gaspar, P; Novoa-del-Toro, EM; Aguilera-Rueda, VJ; Ameca-Alducin, MY				Cruz-Ramirez, Nicandro; Gabriel Acosta-Mesa, Hector; Mezura-Montes, Efren; Guerra-Hernandez, Alejandro; de Jesus Hoyos-Rivera, Guillermo; Erandi Barrientos-Martinez, Rocio; Gutierrez-Fragoso, Karina; Alonso Nava-Fernandez, Luis; Gonzalez-Gaspar, Patricia; Maria Novoa-del-Toro, Elva; Josue Aguilera-Rueda, Vicente; Yaneli Ameca-Alducin, Maria			How Good Is Crude MDL for Solving the Bias-Variance Dilemma? An Empirical Investigation Based on Bayesian Networks	PLOS ONE			English	Article							MODEL SELECTION; PROBABILISTIC NETWORKS; CLASSIFIERS; INFORMATION; DISCRETIZATION; DISTRIBUTIONS; ALGORITHMS; KNOWLEDGE; VARIABLES	The bias-variance dilemma is a well-known and important problem in Machine Learning. It basically relates the generalization capability (goodness of fit) of a learning method to its corresponding complexity. When we have enough data at hand, it is possible to use these data in such a way so as to minimize overfitting (the risk of selecting a complex model that generalizes poorly). Unfortunately, there are many situations where we simply do not have this required amount of data. Thus, we need to find methods capable of efficiently exploiting the available data while avoiding overfitting. Different metrics have been proposed to achieve this goal: the Minimum Description Length principle (MDL), Akaike's Information Criterion (AIC) and Bayesian Information Criterion (BIC), among others. In this paper, we focus on crude MDL and empirically evaluate its performance in selecting models with a good balance between goodness of fit and complexity: the so-called bias-variance dilemma, decomposition or tradeoff. Although the graphical interaction between these dimensions (bias and variance) is ubiquitous in the Machine Learning literature, few works present experimental evidence to recover such interaction. In our experiments, we argue that the resulting graphs allow us to gain insights that are difficult to unveil otherwise: that crude MDL naturally selects balanced models in terms of bias-variance, which not necessarily need be the gold-standard ones. We carry out these experiments using a specific model: a Bayesian network. In spite of these motivating results, we also should not overlook three other components that may significantly affect the final model selection: the search procedure, the noise rate and the sample size.	[Cruz-Ramirez, Nicandro; Gabriel Acosta-Mesa, Hector; Mezura-Montes, Efren; Guerra-Hernandez, Alejandro; de Jesus Hoyos-Rivera, Guillermo; Erandi Barrientos-Martinez, Rocio; Gonzalez-Gaspar, Patricia; Maria Novoa-del-Toro, Elva; Josue Aguilera-Rueda, Vicente; Yaneli Ameca-Alducin, Maria] Univ Veracruzana, Fac Fis & Inteligencia Artificial, Xalapa 91000, Veracruz, Mexico; [Gutierrez-Fragoso, Karina] Univ Veracruzana, Ctr Invest Biomed, Xalapa 91000, Veracruz, Mexico; [Alonso Nava-Fernandez, Luis] UNAM, Ctr Alta Tecnol Educ Distancia, Tlaxcala, Mexico	Universidad Veracruzana; Universidad Veracruzana; Universidad Nacional Autonoma de Mexico	Cruz-Ramirez, N (corresponding author), Univ Veracruzana, Fac Fis & Inteligencia Artificial, Xalapa 91000, Veracruz, Mexico.	ncruz@uv.mx	Acosta-Mesa, Hector Gabriel/GQP-3005-2022; Mezura-Montes, Efrén/R-3926-2019	Mezura-Montes, Efrén/0000-0002-1565-5267; Gonzalez-Gaspar, Patricia/0000-0003-2062-3697; Guerra-Hernandez, Alejandro/0000-0002-4856-4011	PROMEP (Programa de Mejoramiento del Profesorado) [PROMEP/103.5/06/0585]	PROMEP (Programa de Mejoramiento del Profesorado)	The first author thanks PROMEP (Programa de Mejoramiento del Profesorado), project number PROMEP/103.5/06/0585, for the economic support given for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acid S, 2013, DATA MIN KNOWL DISC, V26, P174, DOI 10.1007/s10618-011-0247-5; Allen T.V., 2000, P 17 INT C MACH LEAR, P1047; Alonso-Barba JI, 2011, SOFT COMPUT, V15, P1881, DOI 10.1007/s00500-010-0623-x; Bouckaert R. R., 1993, Symbolic and Quantitative Approaches to Reasoning and Uncertainty. European Conference ECSQARU '93 Proceedings, P41, DOI 10.1007/BFb0028180; Boulle M, 2007, J MACH LEARN RES, V8, P1659; Bozdogan H, 2000, J MATH PSYCHOL, V44, P62, DOI 10.1006/jmps.1999.1277; Buntine W, 1996, IEEE T KNOWL DATA EN, V8, P195, DOI 10.1109/69.494161; Carvalho AM, 2007, LECT NOTES COMPUT SC, V4830, P16; Castillo G, 2005, LECT NOTES COMPUT SC, V3735, P70; Cheng J, 2002, ARTIF INTELL, V137, P43, DOI 10.1016/S0004-3702(02)00191-1; Cheng J, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P101; Chickering D.M., 1996, LEARNING DATA ARTIFI, P121, DOI [DOI 10.1007/978-1-4612-2404-4_12, DOI 10.1007/978-1-4612-2404-412]; Chickering David Maxwell, 1997, P 13 C UNC ART INT P, P80; CHOW CK, 1968, IEEE T INFORM THEORY, V14, P462, DOI 10.1109/TIT.1968.1054142; Clarke EJ, 2000, INT J INTELL SYST, V15, P61, DOI 10.1002/(SICI)1098-111X(200001)15:1<61::AID-INT4>3.0.CO;2-O; Cooper GF, 1999, COMPUTATION, CAUSATION, AND DISCOVERY, P3; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; de Campos C.P., 2009, P 26 ANN INT C MACHI, P113; de Campos LM, 2006, J MACH LEARN RES, V7, P2149; Diez FJ, 1997, ARTIF INTELL MED, V10, P59, DOI 10.1016/S0933-3657(97)00384-9; Drugan MM, 2010, INT J APPROX REASON, V51, P695, DOI 10.1016/j.ijar.2010.02.001; Flores MJ, 2011, APPL INTELL, V34, P372, DOI 10.1007/s10489-011-0286-z; Francois OCH, 2008, EUR WORKSH PROB GRAP, V4, P121; Freno A, 2011, INTEL SYST REF LIBR, V15, P1, DOI 10.1007/978-3-642-20308-4; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Friedman JH, 1997, DATA MIN KNOWL DISC, V1, P55, DOI 10.1023/A:1009778005914; Friedman N, 1998, NATO ADV SCI I D-BEH, V89, P421; Friedman N., 1996, Machine Learning. Proceedings of the Thirteenth International Conference (ICML '96), P157; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Friedman N, 1996, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, P274; Friedman N, 1998, LEARNING BAYESIAN NE, V15; Geiger D, 1998, NATO ADV SCI I D-BEH, V89, P461; GEMAN S, 1992, NEURAL COMPUT, V4, P1, DOI 10.1162/neco.1992.4.1.1; Glymour C., 1999, COMPUTATION CAUSATIO; Grossman D., 2004, P 21 INT C MACH LEAR, P46; Grunwald P, 2000, J MATH PSYCHOL, V44, P133, DOI 10.1006/jmps.1999.1280; Grunwald P.D., 2005, ADV MINIMUM DESCRIPT; Grunwald P. D., 2007, MINIMUM DESCRIPTION; Heckerman D, 1998, NATO ADV SCI I D-BEH, V89, P301; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Ide JS, 2002, LECT NOTES ARTIF INT, V2507, P366; Isozaki T, 2012, NEW GENERAT COMPUT, V30, P17, DOI 10.1007/s00354-012-0103-1; Jing Y, 2005, P 22 INT C MACH LEAR, V22, P369; Jing YS, 2008, MACH LEARN, V73, P155, DOI 10.1007/s10994-008-5065-7; Flores MJ, 2011, ARTIF INTELL MED, V53, P181, DOI 10.1016/j.artmed.2011.08.004; Kearns M, 1997, MACH LEARN, V27, P7, DOI 10.1023/A:1007344726582; Kelner R, 2012, INT J APPROX REASON, V53, P248, DOI 10.1016/j.ijar.2011.10.006; Kleiner A., 2000, Artificial Intelligence and Soft Computing. Proceedings of the IASTED International Conference, P191; Kontkanen P, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P334; Kontkanen P, 2000, STAT COMPUT, V10, P39, DOI 10.1023/A:1008984400380; Langseth H, 2006, MACH LEARN, V63, P135, DOI 10.1007/s10994-006-6136-2; Larranaga P, 2013, INFORM SCIENCES, V233, P109, DOI 10.1016/j.ins.2012.12.051; Lee N, 2010, COMPUT STAT DATA AN, V54, P1247, DOI 10.1016/j.csda.2009.11.003; Lima CF, 2011, SOFT COMPUT, V15, P1351, DOI 10.1007/s00500-010-0675-y; Liu Y, 2010, FRONT BIOL, V5, P98; Madden M, 2003, P EUR C MACH LEARN W, V14, P59; Madden MG, 2002, LECT NOTES ARTIF INT, V2464, P203; Madden MG, 2009, KNOWL-BASED SYST, V22, P489, DOI 10.1016/j.knosys.2008.10.006; Myung IJ, 2000, J MATH PSYCHOL, V44, P190, DOI 10.1006/jmps.1999.1283; Neapolitan R.E., 1990, PROBABILISTIC REASON; Neapolitan R.E., 2004, LEARNING BAYESIAN NE; O'Donnell RT, 2006, LECT NOTES COMPUT SC, V4304, P192; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Press W. H., 1999, NUMERICAL RECIPES C; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Robinson RW., 1977, LECT NOTES MATH, P28, DOI DOI 10.1007/BFB0069178; Roos T, 2005, MACH LEARN, V59, P267; Russell S. J., 2010, ARTIF INTELL, V3rd; Sahin F, 2004, P SOC PHOTO-OPT INS, V5433, P88, DOI 10.1117/12.542371; Santos E., 2004, P 17 INT FLOR ART IN, P538; Silander T, 2010, INT J APPROX REASON, V51, P544, DOI 10.1016/j.ijar.2010.01.012; Spirtes P., 1995, KDD-95 Proceedings. First International Conference on Knowledge Discovery and Data Mining, P294; Spirtes P., 2000, CAUSATION PREDICTION, Vsecond; Su J., 2006, P 23 INT C MACH LEAR, P897, DOI DOI 10.1145/1143844.1143957; Suzuki J, 1999, IEICE T FUND ELECTR, VE82A, P2237; Suzuki J., 1996, Machine Learning. Proceedings of the Thirteenth International Conference (ICML '96), P462; Wai Lam, 1994, Computational Intelligence, V10, P269, DOI 10.1111/j.1467-8640.1994.tb00166.x; Wasserman L, 2000, J MATH PSYCHOL, V44, P92, DOI 10.1006/jmps.1999.1278; Whittaker J., 1990, GRAPHICAL MODELS APP; Wong ML, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P498, DOI 10.1109/ICDM.2002.1183994; Wong ML, 2002, GECCO, V2, P214; Yang Y, 2007, MACH LEARN, V69, P35, DOI 10.1007/s10994-007-5020-z; Yehezkel R, 2006, LECT NOTES COMPUT SC, V4109, P154; Zucchini W, 2000, J MATH PSYCHOL, V44, P41, DOI 10.1006/jmps.1999.1276	86	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92866	10.1371/journal.pone.0092866	http://dx.doi.org/10.1371/journal.pone.0092866			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671204	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677000087
J	Garfinkel, Y; Klimscha, F; Shalev, S; Rosenberg, D				Garfinkel, Yosef; Klimscha, Florian; Shalev, Sariel; Rosenberg, Danny			The Beginning of Metallurgy in the Southern Levant: A Late 6th Millennium CalBC Copper Awl from Tel Tsaf, Israel	PLOS ONE			English	Article							CHALCOLITHIC PERIOD	The beginning of metallurgy in the ancient Near East attracts much attention. The southern Levant, with the rich assemblage of copper artifacts from the Nahal Mishmar cave and the unique gold rings of the Nahal Qanah cave, is regarded as a main center of early metallurgy during the second half of the 5th millennium CalBC. However, a recently discovered copper awl from a Middle Chalcolithic burial at Tel Tsaf, Jordan Valley, Israel, suggests that cast metal technology was introduced to the region as early as the late 6th millennium CalBC. This paper examines the chemical composition of this item and reviews its context. The results indicate that it was exported from a distant source, probably in the Caucasus, and that the location where it was found is indicative of the social status of the buried individual. This rare finding indicates that metallurgy was first defused to the southern Levant through exchange networks and only centuries later involved local production. This copper awl, the earliest metal artifact found in the southern Levant, indicates that the elaborate Late Chalcolithic metallurgy developed from a more ancient tradition.	[Garfinkel, Yosef] Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel; [Klimscha, Florian] German Archaeol Inst, Eurasia Dept, Berlin, Germany; [Shalev, Sariel] Univ Haifa, Dept Maritime Civilizat, Dept Archaeol, IL-31999 Haifa, Israel; [Rosenberg, Danny] Univ Haifa, Zinman Inst Archaeol, Lab Groundstone Tools Res, IL-31999 Haifa, Israel	Hebrew University of Jerusalem; University of Haifa; University of Haifa	Garfinkel, Y (corresponding author), Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel.	drosenberg@research.haifa.ac.il	Garfinkel, Yosef/AAE-6626-2021; Rosenberg, Daniel/AAS-8006-2021	Rosenberg, Daniel/0000-0001-6991-4298; Garfinkel, Yosef/0000-0001-6685-9190; Klimscha, Florian/0000-0002-9875-6169	Philip and Muriel Berman Center for Biblical Archaeology at the Hebrew University of Jerusalem; Curtiss T. and Mary G. Brennan Foundation; Irene Sala CARE Foundation	Philip and Muriel Berman Center for Biblical Archaeology at the Hebrew University of Jerusalem; Curtiss T. and Mary G. Brennan Foundation; Irene Sala CARE Foundation	Tel Tsaf excavations were supported by the Philip and Muriel Berman Center for Biblical Archaeology at the Hebrew University of Jerusalem, The Curtiss T. and Mary G. Brennan Foundation and the Irene Sala CARE Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aardsma GE, 2001, RADIOCARBON, V43, P1247; Abramishvili M., 2010, MAJKOP BIS TRIALETI, P167; Bar-Adon P, 1980, CAVE TREASURE, P243; Bastert-Lamprichs K, 2012, BEGINN LANDWIRTSCHAF, P48; Ben-Shlomo D, 2009, J MEDITERR ARCHAEOL, V22, P129, DOI 10.1558/jmea.v22i2.129; Boric Dusan., 2009, METALS SOC STUDIES H, P191; Contenson H-de, 1992, RAS SHAMRA OUGARIT, V8, P283; Craddock P.T., 2000, PALEORIENT, P151, DOI DOI 10.3406/PALEO.2000.4716; Eluere C, 1991, CAYONU TEPESI EARLIE, P375; Esin U, 1999, ANSCHNITT, V9, P23; Gal Z., 1999, ATIQOT, V47, P16; Garfinkel Y., 2009, TRANSITIONS PREHISTO; Garfinkel Y, 2007, ISRAEL EXPLOR J, V57, P1; Garfinkel Y, 2009, ANTIQUITY, V83, P309, DOI 10.1017/S0003598X00098458; Garstang J, 1953, PREHISTORIC MERSIN, P271; Golden J, 2010, DAWN METAL AGE TECHN, P234; Gopher A., 1996, MONOGRAPH SERIES I A, V12, P91; Gophna R., 1988, TEL AVIV, V15-16, P3, DOI DOI 10.1179/TAV.1988.1988.1.3; Goren Y, 2008, GEOARCHAEOLOGY, V23, P374, DOI 10.1002/gea.20221; Hansen S., 2012, ALTERTUM, V57, P81; Hansen S, 2012, ARCHAOLOGISCHE FORSC, P64; Hauptmann A., 1993, RIVERS MOUNTAINS ARC, P541; Hole F, 1969, PREHISTORY HUMAN ECO, P427; Klimscha F., 2012, Z ORIENT ARCHAOLOGIE, V5, P188; Levy TE, 1993, BAR INT SERIES, V356, P418; Lichardus J, 1991, SAARBRUCKER BEITRAGE, V55; Lyonnet B., 2012, ARCHAOLOGISCHE MITTE, V44, P1; Mayer DEBY, 2008, P NATL ACAD SCI USA, V105, P8548, DOI 10.1073/pnas.0709931105; MOLIST M., 2009, PALEORIENT, V2, P33; Pernicka E., 1990, JB RO MISCH GERMANIS, V37, P21; Perrot J, 1968, DICT BIBLE S, V8, P286; Radivojevic M, 2011, 39 INT S ARCH 28 MAY, P64; Radivojevic M, 2010, J ARCHAEOL SCI, V37, P2775, DOI 10.1016/j.jas.2010.06.012; Rosenberg D, 2010, CURR ANTHROPOL, V51, P281, DOI 10.1086/650562; Rosenberg M, 1994, ANATOLICA, V20, P121; Rowan YM, 2009, J WORLD PREHIST, V22, P1, DOI 10.1007/s10963-009-9016-4; Schoop U., 2005, ANATOLISCHE CHALKOLI; SHALEV S, 1994, ANTIQUITY, V68, P630, DOI 10.1017/S0003598X00047153; Shalev S, 1991, DECOUVERTE METAL, P413; Shugar AN, 2001, THESIS U COLL LONDON, P255; Thornton CP, 2009, J WORLD PREHIST, V22, P301, DOI 10.1007/s10963-009-9019-1; Thornton CP, 2002, J ARCHAEOL SCI, V29, P1451, DOI 10.1006/jasc.2002.0809; Tobler AJ, 1950, EXCAVATIONS TEPE GAW, VII, P220; Tzori N., 1958, PALEST EXPLOR Q, V90, P44, DOI DOI 10.1179/PEQ.1958.90.1.44; uzdogan M., 1999, ANSCHNITT, P13; Wilde H, 2003, TECHNOLOGISCHE INNOV, P268; Yalcin U, 2000, ANATOLIAN METAL, P17; Yalcin U, 2000, ANATOLIAN METAL, P83	48	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92591	10.1371/journal.pone.0092591	http://dx.doi.org/10.1371/journal.pone.0092591			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AE0SR	24671185	gold, Green Published			2022-12-27	WOS:000333677000055
J	Russo, LM; Melton-Celsa, AR; Smith, MJ; O'Brien, AD				Russo, Lisa M.; Melton-Celsa, Angela R.; Smith, Michael J.; O'Brien, Alison D.			Comparisons of Native Shiga Toxins (Stxs) Type 1 and 2 with Chimeric Toxins Indicate that the Source of the Binding Subunit Dictates Degree of Toxicity	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; HEMOLYTIC-UREMIC SYNDROME; HYBRID TOXINS; UNITED-STATES; B-SUBUNIT; STRAINS; RNA; EPIDEMIOLOGY; DETERMINANTS; CYTOTOXICITY	Shiga toxin (Stx)-producing E. coli (STEC) cause food-borne outbreaks of hemorrhagic colitis. The main virulence factor expressed by STEC, Stx, is an AB(5) toxin that has two antigenically distinct forms, Stx1a and Stx2a. Although Stx1a and Stx2a bind to the same receptor, globotriaosylceramide (Gb3), Stx2a is more potent than Stx1a in mice, whereas Stx1a is more cytotoxic than Stx2a in cell culture. In this study, we used chimeric toxins to ask what the relative contribution of individual Stx subunits is to the differential toxicity of Stx1a and Stx2a in vitro and in vivo. Chimeric stx(1)/stx(2) operons were generated by PCR such that the coding regions for the A(2) and B subunits of one toxin were combined with the coding region for the A(1) subunit of the heterologous toxin. The toxicities of purified Stx1a, Stx2a, and the chimeric Stxs were determined on Vero and HCT-8 cell lines, while polarized HCT-8 cell monolayers grown on permeable supports were used to follow toxin translocation. In all in vitro assays, the activity of the chimeric toxin correlated with that of the parental toxin from which the B subunit originated. The origin of the native B subunit also dictated the 50% lethal dose of toxin after intraperitoneal intoxication of mice; however, the chimeric Stxs exhibited reduced oral toxicity and pH stability compared to Stx1a and Stx2a. Taken together, these data support the hypothesis that the differential toxicity of the chimeric toxins for cells and mice is determined by the origin of the B subunit.	[Russo, Lisa M.; Melton-Celsa, Angela R.; Smith, Michael J.; O'Brien, Alison D.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	O'Brien, AD (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA.	alison.obrien@usuhs.edu		O'Brien, Alison/0000-0002-1315-3204	National Institutes of Health [R37 AI020148, U54 AI057168]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020148, U54AI057168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants R37 AI020148 to ADO'B and U54 AI057168 to Dr. Myron Levine (subaward to ADO'B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULRAOUF UM, 1993, APPL ENVIRON MICROB, V59, P2364, DOI 10.1128/AEM.59.8.2364-2368.1993; ABDULRAOUF UM, 1993, APPL ENVIRON MICROB, V59, P1999, DOI 10.1128/AEM.59.7.1999-2006.1993; Armstrong GL, 1996, EPIDEMIOL REV, V18, P29, DOI 10.1093/oxfordjournals.epirev.a017914; AUSTIN PR, 1994, INFECT IMMUN, V62, P1768, DOI 10.1128/IAI.62.5.1768-1775.1994; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; BOYCE TG, 1995, NEW ENGL J MED, V333, P364, DOI 10.1056/NEJM199508103330608; Chark D, 2004, EUR J BIOCHEM, V271, P405, DOI 10.1046/j.1432-1033.2003.03941.x; DOWNES FP, 1988, INFECT IMMUN, V56, P1926, DOI 10.1128/IAI.56.8.1926-1933.1988; FRASER ME, 1994, NAT STRUCT BIOL, V1, P59, DOI 10.1038/nsb0194-59; Fraser ME, 2004, J BIOL CHEM, V279, P27511, DOI 10.1074/jbc.M401939200; GENTRY MK, 1980, J CLIN MICROBIOL, V12, P361, DOI 10.1128/JCM.12.3.361-366.1980; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; HEAD SC, 1991, J BIOL CHEM, V266, P3617; Hurley BP, 1999, INFECT IMMUN, V67, P6670; ITO H, 1990, MICROB PATHOGENESIS, V8, P47, DOI 10.1016/0882-4010(90)90007-D; ITO H, 1988, MICROB PATHOGENESIS, V5, P189, DOI 10.1016/0882-4010(88)90021-6; JEMAL C, 1995, J BACTERIOL, V177, P3128, DOI 10.1128/jb.177.11.3128-3132.1995; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; KARMALI MA, 1983, LANCET, V1, P619, DOI 10.1016/s0140-6736(83)91795-6; Kitova EN, 2009, BIOCHEMISTRY-US, V48, P5365, DOI 10.1021/bi9003155; KLEANTHOUS H, 1990, ARCH DIS CHILD, V65, P722, DOI 10.1136/adc.65.7.722; LINDGREN SW, 1993, INFECT IMMUN, V61, P3832, DOI 10.1128/IAI.61.9.3832-3842.1993; LINGWOOD CA, 1987, J BIOL CHEM, V262, P8834; Lingwood CA, 1996, TRENDS MICROBIOL, V4, P147, DOI 10.1016/0966-842X(96)10017-2; LOUISE CB, 1995, J INFECT DIS, V172, P1397, DOI 10.1093/infdis/172.5.1397; Marcato P, 2003, INFECT IMMUN, V71, P6075, DOI 10.1128/IAI.71.10.6075-6078.2003; Mayer CL, 2012, TOXINS, V4, P1261, DOI 10.3390/toxins4111261; Melton-Chelsa A.R., 1998, ESCHERICHIA COLI O15, P121; National Institutes of H, 1985, NAT I HLTH PUBL, V85-23; Neupane M, 2011, MICROB PATHOGENESIS, V51, P466, DOI 10.1016/j.micpath.2011.07.009; OGASAWARA T, 1988, MICROB PATHOGENESIS, V4, P127, DOI 10.1016/0882-4010(88)90054-X; Orth D, 2007, DIAGN MICR INFEC DIS, V59, P235, DOI 10.1016/j.diagmicrobio.2007.04.013; OSTROFF SM, 1989, J INFECT DIS, V160, P994, DOI 10.1093/infdis/160.6.994; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Russo LM, 2013, INFECT IMMUN; Rutjes NWP, 2002, KIDNEY INT, V62, P832, DOI 10.1046/j.1523-1755.2002.00502.x; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; SAXENA SK, 1989, J BIOL CHEM, V264, P596; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; SCHMITT CK, 1991, INFECT IMMUN, V59, P1065, DOI 10.1128/IAI.59.3.1065-1073.1991; Shimizu T, 2007, MICROB PATHOGENESIS, V43, P88, DOI 10.1016/j.micpath.2007.04.003; Smith MJ, 2006, VACCINE, V24, P4122, DOI 10.1016/j.vaccine.2006.02.035; Staples M, 2012, EVALUATION MERIDIAN; STROCKBINE NA, 1985, INFECT IMMUN, V50, P695, DOI 10.1128/IAI.50.3.695-700.1985; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993; TESH VL, 1991, J INFECT DIS, V164, P344, DOI 10.1093/infdis/164.2.344; Tilden J, 1996, AM J PUBLIC HEALTH, V86, P1142, DOI 10.2105/AJPH.86.8_Pt_1.1142; WADOLKOWSKI EA, 1990, INFECT IMMUN, V58, P3959, DOI 10.1128/IAI.58.12.3959-3965.1990; WEINSTEIN DL, 1989, INFECT IMMUN, V57, P3743, DOI 10.1128/IAI.57.12.3743-3750.1989; Zumbrun SD, 2010, INFECT IMMUN, V78, P4488, DOI 10.1128/IAI.00620-10	50	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93463	10.1371/journal.pone.0093463	http://dx.doi.org/10.1371/journal.pone.0093463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671194	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677000148
J	Barnes, C; Speroni, L; Quinn, KP; Montevil, M; Saetzler, K; Bode-Animashaun, G; McKerr, G; Georgakoudi, I; Downes, CS; Sonnenschein, C; Howard, CV; Soto, AM				Barnes, Clifford; Speroni, Lucia; Quinn, Kyle P.; Montevil, Mael; Saetzler, Kurt; Bode-Animashaun, Gbemisola; McKerr, George; Georgakoudi, Irene; Downes, C. Stephen; Sonnenschein, Carlos; Howard, C. Vyvyan; Soto, Ana M.			From Single Cells to Tissues: Interactions between the Matrix and Human Breast Cells in Real Time	PLOS ONE			English	Article							MAMMARY-GLAND DEVELOPMENT; CANCER; MORPHOGENESIS; ARCHITECTURE; MICROSCOPY; SURVIVAL; SCAFFOLD; MOTION; MODEL	Background: Mammary gland morphogenesis involves ductal elongation, branching, and budding. All of these processes are mediated by stroma - epithelium interactions. Biomechanical factors, such as matrix stiffness, have been established as important factors in these interactions. For example, epithelial cells fail to form normal acinar structures in vitro in 3D gels that exceed the stiffness of a normal mammary gland. Additionally, heterogeneity in the spatial distribution of acini and ducts within individual collagen gels suggests that local organization of the matrix may guide morphogenesis. Here, we quantified the effects of both bulk material stiffness and local collagen fiber arrangement on epithelial morphogenesis. Results: The formation of ducts and acini from single cells and the reorganization of the collagen fiber network were quantified using time-lapse confocal microscopy. MCF10A cells organized the surrounding collagen fibers during the first twelve hours after seeding. Collagen fiber density and alignment relative to the epithelial surface significantly increased within the first twelve hours and were a major influence in the shaping of the mammary epithelium. The addition of Matrigel to the collagen fiber network impaired cell-mediated reorganization of the matrix and increased the probability of spheroidal acini rather than branching ducts. The mechanical anisotropy created by regions of highly aligned collagen fibers facilitated elongation and branching, which was significantly correlated with fiber organization. In contrast, changes in bulk stiffness were not a strong predictor of this epithelial morphology. Conclusions: Localized regions of collagen fiber alignment are required for ductal elongation and branching suggesting the importance of local mechanical anisotropy in mammary epithelial morphogenesis. Similar principles may govern the morphology of branching and budding in other tissues and organs.	[Barnes, Clifford; Saetzler, Kurt; Bode-Animashaun, Gbemisola; McKerr, George; Downes, C. Stephen; Sonnenschein, Carlos; Howard, C. Vyvyan; Soto, Ana M.] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland; [Speroni, Lucia; Montevil, Mael; Sonnenschein, Carlos; Soto, Ana M.] Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Boston, MA 02111 USA; [Quinn, Kyle P.; Georgakoudi, Irene] Tufts Univ, Dept Biomed Engn, Boston, MA 02111 USA	Ulster University; Tufts University; Tufts University	Soto, AM (corresponding author), Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland.	ana.soto@tufts.edu	Montévil, Maël/S-2378-2017	Montévil, Maël/0000-0001-7177-5995; Speroni, Lucia/0000-0003-1567-8925; Howard, Charles Vyvyan/0000-0002-6151-3446	NC3R [94744]; Avon Foundation [02-2009-093, 02-2011-095]; Breast Cancer UK [13495]; NIAMS/NIH [F32AR061933]; American Cancer Society Research Scholar Grant [RSG-09-174-01-CCE]; NIH/NIBIB [R01EB007542]; Organix grant [1-202R-0463]; NIEHS/NIH [ES 08314]; Italian Space Agency; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR061933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008314] Funding Source: NIH RePORTER	NC3R; Avon Foundation; Breast Cancer UK; NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Cancer Society Research Scholar Grant(American Cancer Society); NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Organix grant; NIEHS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Italian Space Agency(Agenzia Spaziale Italiana (ASI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the NC3R Grant 94744 to CVH, and Avon Foundation Grants #02-2009-093 and 02-2011-095 to AMS. Additional support was provided by Breast Cancer UK 13495 to CB, NIAMS/NIH Grant F32AR061933 to KPQ, American Cancer Society Research Scholar Grant RSG-09-174-01-CCE and NIH/NIBIB grant R01EB007542 to IG, Organix grant 1-202R-0463 to CVH, NIEHS/NIH ES 08314 to AMS and the Italian Space Agency to CS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Environmental Health Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Dewitt DD, 2009, TISSUE ENG PT A, V15, P2785, DOI [10.1089/ten.tea.2008.0406, 10.1089/ten.TEA.2008.0406]; Dhimolea E, 2010, BIOMATERIALS, V31, P3622, DOI 10.1016/j.biomaterials.2010.01.077; Guo CL, 2012, P NATL ACAD SCI USA, V109, P5576, DOI 10.1073/pnas.1114781109; Howard BA, 2013, J MAMMARY GLAND BIOL, V18, P89, DOI 10.1007/s10911-013-9296-2; Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di; Keyes JT, 2011, MICROSC MICROANAL, V17, P167, DOI 10.1017/S1431927610094341; Kirkpatrick ND, 2007, AM J PHYSIOL-HEART C, V292, pH3198, DOI 10.1152/ajpheart.01234.2006; Krause S, 2008, TISSUE ENG PT C-METH, V14, P261, DOI 10.1089/ten.tec.2008.0030; Krause S, 2012, TISSUE ENG PT A, V18, P520, DOI [10.1089/ten.tea.2011.0317, 10.1089/ten.TEA.2011.0317]; Lee PF, 2009, EXP CELL RES, V315, P396, DOI 10.1016/j.yexcr.2008.10.040; Lenoir T., 1982, STRATEGY LIFE TELEOL; Longo G, 2012, PROG BIOPHYS MOL BIO, V109, P108, DOI 10.1016/j.pbiomolbio.2012.06.004; Maller O, 2013, J CELL SCI, V126, P4108, DOI 10.1242/jcs.121590; Manivannan S, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt133; McLeod C, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023984; National Cancer Institute, CELL CLASS BREAST CA; Niklason LE, 2010, P NATL ACAD SCI USA, V107, P3335, DOI 10.1073/pnas.0907813106; O'Loughlin A, 2013, DIABETES, V62, P2588, DOI 10.2337/db12-1822; Ollion J, 2013, BIOINFORMATICS, V29, P1840, DOI 10.1093/bioinformatics/btt276; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Perry SW, 2012, ANN BIOMED ENG, V40, P277, DOI 10.1007/s10439-012-0512-9; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Quinn KP, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046003; Quinn KP, 2008, J APPL PHYSIOL, V105, P1881, DOI 10.1152/japplphysiol.90792.2008; Sacks MS, 2003, J BIOMECH ENG-T ASME, V125, P280, DOI 10.1115/1.1544508; Sander EA, 2009, P NATL ACAD SCI USA, V106, P17675, DOI 10.1073/pnas.0903716106; Sieminski AL, 2002, TISSUE ENG, V8, P1057, DOI 10.1089/107632702320934155; Soto AM, 2013, J MAMMARY GLAND BIOL, V18, P199, DOI 10.1007/s10911-013-9293-5; Speroni L, 2014, TISSUE ENG PART C-ME, V20, P42, DOI [10.1089/ten.tec.2013.0054, 10.1089/ten.TEC.2013.0054]; Tanner K, 2012, P NATL ACAD SCI USA, V109, P1973, DOI 10.1073/pnas.1119578109; Thompson D.W, 1917, GROWTH FORM; Totonelli G, 2012, BIOMATERIALS, V33, P3401, DOI 10.1016/j.biomaterials.2012.01.012; Varner VD, 2013, INTEGR BIOL-UK, V5, P1162, DOI 10.1039/c3ib40080h; Wang H, 2013, P NATL ACAD SCI USA, V110, P163, DOI 10.1073/pnas.1201141110; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Xiang B, 2008, P NATL ACAD SCI USA, V105, P12463, DOI 10.1073/pnas.0805009105; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	40	34	36	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93325	10.1371/journal.pone.0093325	http://dx.doi.org/10.1371/journal.pone.0093325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691468	Green Published, gold			2022-12-27	WOS:000334101100066
J	Fagyas, M; Uri, K; Siket, IM; Darago, A; Boczan, J; Banyai, E; Edes, I; Papp, Z; Toth, A				Fagyas, Miklos; Uri, Katalin; Siket, Ivetta M.; Darago, Andrea; Boczan, Judit; Banyai, Emese; Edes, Istvan; Papp, Zoltan; Toth, Attila			New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) III: Endogenous Inhibition of Angiotensin Converting Enzyme (ACE) Provides Protection against Cardiovascular Diseases	PLOS ONE			English	Article							INSERTION DELETION POLYMORPHISM; LEFT-VENTRICULAR DYSFUNCTION; HUMAN-SERUM-ALBUMIN; TRYPTIC HYDROLYSATE; EUROPEAN-SOCIETY; TASK-FORCE; GENE POLYMORPHISM; DRAMATIC INCREASE; CARDIOLOGY ESC; GUIDELINES	ACE inhibitor drugs decrease mortality by up to one-fifth in cardiovascular patients. Surprisingly, there are reports dating back to 1979 suggesting the existence of endogenous ACE inhibitors. Here we investigated the clinical significance of this potential endogenous ACE inhibition. ACE concentration and activity was measured in patient's serum samples (n = 151). ACE concentration was found to be in a wide range ( 47-288 ng/ mL). ACE activity decreased with the increasing concentration of the serum albumin (HSA): ACE activity was 5661 U/L in the presence of 2.4 +/- 60.3 mg/mL HSA, compared to 3961 U/L in the presence of 1261 mg/mL HSA ( values are mean-SEM). Effects of the differences in ACE concentration were suppressed in human sera: patients with ACE DD genotype exhibited a 64% higher serum ACE concentration ( range, 74-288 ng/ mL, median, 155.2 ng/ mL, n = 52) compared to patients with II genotype ( range, 47-194 ng/ mL, median, 94.5 ng/ mL, n = 28) while the difference in ACE activities was only 32% ( range, 27.3-59.8 U/L, median, 43.11 U/L, and range 15.6-55.4 U/L, median, 32.74 U/L, respectively) in the presence of 1261 mg/mL HSA. No correlations were found between serum ACE concentration ( or genotype) and cardiovascular diseases, in accordance with the proposed suppressed physiological ACE activities by HSA ( concentration in the sera of these patients: 48 +/- 560.5 mg/mL) or other endogenous inhibitors. Main implications are that ( 1) physiological ACE activity can be stabilized at a low level by endogenous ACE inhibitors, such as HSA; ( 2) angiotensin II elimination may have a significant role in angiotensin II related pathologies.	[Fagyas, Miklos; Uri, Katalin; Siket, Ivetta M.; Darago, Andrea; Edes, Istvan; Papp, Zoltan; Toth, Attila] Univ Debrecen, Inst Cardiol, Div Clin Physiol, Debrecen, Hungary; [Boczan, Judit] Univ Debrecen, Dept Neurol, Debrecen, Hungary; [Banyai, Emese] Univ Debrecen, Inst Internal Med, Div Nephrol, Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen	Toth, A (corresponding author), Univ Debrecen, Inst Cardiol, Div Clin Physiol, Debrecen, Hungary.	atitoth@med.unideb.hu	Tóth, Attila/F-4859-2010; Fagyas, Miklós/AAQ-1013-2020	Tóth, Attila/0000-0001-6503-3653; Fagyas, Miklós/0000-0003-3262-884X	Hungarian Academy of Sciences OTKA [K84300]; Hungarian Ministry of Health [ETT 377/2009]; TAMOP [4.2.1./B-09/1/KONV-2010-0007, TAMOP-4.2.2, A-11/1/KONV 2012-0045, REG-EA-09-1-2009-0013]; European Social Fund; National Innovation Office of Hungary (Baross Gabor Project, EletMent); Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences	Hungarian Academy of Sciences OTKA(Hungarian Academy of SciencesOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Ministry of Health; TAMOP; European Social Fund(European Social Fund (ESF)); National Innovation Office of Hungary (Baross Gabor Project, EletMent); Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	The study was supported by the Hungarian Academy of Sciences OTKA (K84300 to AT) and by the Hungarian Ministry of Health (ETT 377/2009 to AT); the work is supported by the TAMOP 4.2.1./B-09/1/KONV-2010-0007 TAMOP-4.2.2. A-11/1/KONV 2012-0045, REG-EA-09-1-2009-0013 projects (to AT, IE and ZP); MSD Magyarorsag Kft, Pfier Magyararsag Kft also supported some of the research. The project is implemented through the New Hungary Development Plan, co-financed by the European Social Fund; and by the National Innovation Office of Hungary (Baross Gabor Project, EletMent). Finally, AT was supported by the Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm-Larsen B, 2000, ARTERIOSCL THROM VAS, V20, P484, DOI 10.1161/01.ATV.20.2.484; ALHENCGELAS F, 1983, J LAB CLIN MED, V101, P83; BENETEAU B, 1986, CLIN CHEM, V32, P884; Bien BY, 2010, J MANAGE CARE PHARM, V16, P671, DOI 10.18553/jmcp.2010.16.9.671; Brecher AS, 1996, ARCH INT PHARMACOD T, V331, P301; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; COLLINS R, 1995, LANCET, V345, P669; CORVOL P, 1995, J HYPERTENS, V13, pS3, DOI 10.1097/00004872-199509003-00002; Cuspidi C, 2002, J HYPERTENS, V20, P2293, DOI 10.1097/00004872-200211000-00030; Danilov S, 1996, J HYPERTENS, V14, P719, DOI 10.1097/00004872-199606000-00007; Danser AHJ, 2007, PHARMACOL THERAPEUT, V113, P607, DOI 10.1016/j.pharmthera.2006.12.001; Davidson NC, 1996, CIRCULATION, V93, P1155, DOI 10.1161/01.CIR.93.6.1155; DeVita C, 1996, J AM COLL CARDIOL, V27, P337; Eyries M, 2001, J BIOL CHEM, V276, P5525, DOI 10.1074/jbc.M007706200; Fagyas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087844; Fagyas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087843; Ferdinand KC, 2003, AM J HYPERTENS, V16, p50S, DOI 10.1016/S0895-7061(03)01069-0; Ferreira AJ, 2011, EXP PHYSIOL, V96, P287, DOI 10.1113/expphysiol.2010.055277; Fox KM, 2003, LANCET, V362, P782; GREENBERG B, 1995, CIRCULATION, V91, P2573, DOI 10.1161/01.CIR.91.10.2573; Guang C, 2009, J AGR FOOD CHEM, V57, P5113, DOI 10.1021/jf900494d; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hoogwerf BJ, 2000, CLEV CLIN J MED, V67, P287, DOI 10.3949/ccjm.67.4.287; Howard G, 2001, ANAESTH INTENS CARE, V29, P591, DOI 10.1177/0310057X0102900604; IKEMOTO F, 1989, BIOCHEM BIOPH RES CO, V159, P1093, DOI 10.1016/0006-291X(89)92221-3; Janitha PK, 2002, J AGR FOOD CHEM, V50, P6981, DOI 10.1021/jf025592e; KLAUSER RJ, 1979, HYPERTENSION, V1, P281, DOI 10.1161/01.HYP.1.3.281; Kramers C, 2001, CIRCULATION, V104, P1236, DOI 10.1161/hc3601.095932; Leon-Ruiz V, 2013, FOOD FUNCT, V4, P1617, DOI 10.1039/c3fo60221d; LIEBERMAN J, 1986, CHEST, V90, P869, DOI 10.1378/chest.90.6.869; LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103; Linnebank M, 2003, NEUROLOGY, V61, P1819, DOI 10.1212/01.WNL.0000098990.12845.DA; Luders S, 2008, J HYPERTENS, V26, P1487, DOI 10.1097/HJH.0b013e3282ff8864; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Muller BR, 2002, ANN CLIN BIOCHEM, V39, P436, DOI 10.1258/000456302320314449; Nakagomi K, 2000, FEBS LETT, V467, P235, DOI 10.1016/S0014-5793(00)01163-7; Nakagomi K, 1998, FEBS LETT, V438, P255, DOI 10.1016/S0014-5793(98)01311-8; Nakagomi K, 2000, BIOL PHARM BULL, V23, P879; Nesterovitch AB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008282; Oudit GY, 2010, DIABETES, V59, P529, DOI 10.2337/db09-1218; Persu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059537; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Rao SQ, 2012, FOOD CHEM, V135, P1245, DOI 10.1016/j.foodchem.2012.05.059; Rice GI, 2006, HYPERTENSION, V48, P914, DOI 10.1161/01.HYP.0000244543.91937.79; RIGAT B, 1992, NUCLEIC ACIDS RES, V20, P1433, DOI 10.1093/nar/20.6.1433-a; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; ROGERSON FM, 1989, NEUROPEPTIDES, V14, P213, DOI 10.1016/0143-4179(89)90048-6; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Ryan J W, 1979, Adv Exp Med Biol, V120B, P599; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Semmler A, 2006, CLIN CHEM LAB MED, V44, P1088, DOI 10.1515/CCLM.2006.200; SNYDER RA, 1986, BIOCHIM BIOPHYS ACTA, V871, P1, DOI 10.1016/0167-4838(86)90125-1; STEVENS J, 1990, J IMMUNOL METHODS, V132, P263, DOI 10.1016/0022-1759(90)90038-W; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Tauzin J, 2002, FEBS LETT, V531, P369, DOI 10.1016/S0014-5793(02)03576-7; Taylor J, 2012, EUR HEART J, V33, P1539, DOI 10.1093/eurheartj/ehs137; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; Thevananther S, 1999, CAN J PHYSIOL PHARM, V77, P216, DOI 10.1139/cjpp-77-3-216; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; TIRET L, 1992, AM J HUM GENET, V51, P197; Uri K, 2014, PLOS ONE; van Dijk MA, 2000, J CARDIOVASC PHARM, V35, P484, DOI 10.1097/00005344-200003000-00020; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419	63	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93719	10.1371/journal.pone.0093719	http://dx.doi.org/10.1371/journal.pone.0093719			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690767	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100130
J	Fullar, A; Baghy, K; Deak, F; Peterfia, B; Zsak, Y; Tatrai, P; Schaff, Z; Dudas, J; Kiss, I; Kovalszky, I				Fullar, Alexandra; Baghy, Kornelia; Deak, Ferenc; Peterfia, Balint; Zsak, Yvonne; Tatrai, Peter; Schaff, Zsuzsa; Dudas, Jozsef; Kiss, Ibolya; Kovalszky, Ilona			Lack of Matrilin-2 Favors Liver Tumor Development via Erk1/2 and GSK-3 beta Pathways In Vivo	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; EXTRACELLULAR-MATRIX; BETA-CATENIN; PROTEIN; EXPRESSION; INHIBITION; CELLS; P21(WAF1/CIP1); REGENERATION; ADHESION	Matrilin-2 (Matn2) is a multidomain adaptor protein which plays a role in the assembly of extracellular matrix (ECM). It is produced by oval cells during stem cell-driven liver regeneration. In our study, the impact of Matn2 on hepatocarcinogenesis was investigated in Matn2(-/-) mice comparing them with wild-type (WT) mice in a diethylnitrosamine (DEN) model. The liver tissue was analyzed macroscopically, histologically and immunohistochemically, at protein level by Proteome Profiler Arrays and Western blot analysis. Matn2(-/-) mice exhibited higher susceptibility to hepatocarcinogenesis compared to wild-type mice. In the liver of Matn2(-/-) mice, spontaneous microscopic tumor foci were detected without DEN treatment. After 15 mu g/g body weight DEN treatment, the liver of Matn2(-/-) mice contained macroscopic tumors of both larger number and size than the WT liver. In contrast with the WT liver, spontaneous phosphorylation of EGFR, Erk1/2 GSK-3 alpha/beta and retinoblastoma protein (p-Rb), decrease in p21/CIP1 level, and increase in beta-Catenin protein expression were detected in Matn2(-/-) livers. Focal Ki-67 positivity of these samples provided additional support to our presumption that the lack of Matn2 drives the liver into a pro-proliferatory state, making it prone to tumor development. This enhanced proliferative capacity was further increased in the tumor nodules of DEN-treated Matn2(-/-) livers. Our study suggests that Matn2 functions as a tumor suppressor in hepatocarcinogenesis, and in this process activation of EGFR together with that of Erk1/2, as well as inactivation of GSK-3 beta, play strategic roles.	[Fullar, Alexandra; Baghy, Kornelia; Peterfia, Balint; Tatrai, Peter; Kovalszky, Ilona] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Deak, Ferenc; Zsak, Yvonne; Kiss, Ibolya] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Schaff, Zsuzsa] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary; [Dudas, Jozsef] Med Univ Innsbruck, Dept Otorhinolaryngol, A-6020 Innsbruck, Austria	Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Semmelweis University; Medical University of Innsbruck	Kovalszky, I (corresponding author), Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary.	koval@korb1.sote.hu	Baghy, Kornélia/ABH-2549-2020; Schaff, Zsuzsa/K-5613-2017; Kovalszky, Ilona/ABH-2832-2020; Dudás, József/AAY-9352-2020; Tatrai, Peter/AAR-6014-2020	Baghy, Kornélia/0000-0002-5323-2775; Schaff, Zsuzsa/0000-0002-6429-8059; Kovalszky, Ilona/0000-0002-0179-3378; Dudás, József/0000-0002-9877-3399; Tatrai, Peter/0000-0001-9726-1992; Fullar, Alexandra/0000-0003-4368-1523	Hungarian Scientific Research Fund [OTKA 67925, 100904, OTKA T049608]; Anyos Jedlik Programme AVINOMID from the National Office for Research and Technology [OM-00087/2007]; Austrian-Hungarian Action Foundation [78ou1]; Austrian Science Fund [FWF P 22287-B13]; Austrian Science Fund (FWF) [P 25869] Funding Source: researchfish	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Anyos Jedlik Programme AVINOMID from the National Office for Research and Technology; Austrian-Hungarian Action Foundation; Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Hungarian Scientific Research Fund (OTKA 67925 and 100904 to I. Kovalszky, OTKA T049608 to I. Kiss); Anyos Jedlik Programme AVINOMID from the National Office for Research and Technology (OM-00087/2007 to PL and I. Kiss); Austrian-Hungarian Action Foundation (78ou1 to JD and I. Kovalszky); and Austrian Science Fund (FWF P 22287-B13 to JD). The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa T, 2010, BIOCHEM BIOPH RES CO, V392, P369, DOI 10.1016/j.bbrc.2010.01.027; Borgdorff V, 2010, ONCOGENE, V29, P2262, DOI 10.1038/onc.2009.497; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Deak F, 1999, MATRIX BIOL, V18, P55, DOI 10.1016/S0945-053X(98)00006-7; Deak F, 1997, J BIOL CHEM, V272, P9268; Densham RM, 2008, CELL SIGNAL, V20, P1986, DOI 10.1016/j.cellsig.2008.07.005; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Jin JL, 2009, MOL CELL BIOL, V29, P3867, DOI 10.1128/MCB.00456-09; Jung P, 2009, CELL CYCLE, V8, P982, DOI 10.4161/cc.8.7.7949; Klatt AR, 2011, INT J BIOCHEM CELL B, V43, P320, DOI 10.1016/j.biocel.2010.12.010; Mann HH, 2007, MATRIX BIOL, V26, P167, DOI 10.1016/j.matbio.2006.10.010; Mates L, 2004, MATRIX BIOL, V23, P195, DOI 10.1016/j.matbio.2004.05.003; Mates L, 2002, MATRIX BIOL, V21, P163, DOI 10.1016/S0945-053X(01)00194-9; Muratoglu S, 2000, CYTOGENET CELL GENET, V90, P323, DOI 10.1159/000056797; Pan OH, 1998, J BIOL CHEM, V273, P14205, DOI 10.1074/jbc.273.23.14205; Park DH, 2009, TOXICOL LETT, V191, P321, DOI 10.1016/j.toxlet.2009.09.016; Piecha D, 1999, J BIOL CHEM, V274, P13353, DOI 10.1074/jbc.274.19.13353; Sharma MK, 2006, NEUROLOGY, V66, P127, DOI 10.1212/01.wnl.0000188667.66646.1c; Szabo E, 2008, PATHOL ONCOL RES, V14, P15, DOI 10.1007/s12253-008-9005-4; Szabo E, 2007, MATRIX BIOL, V26, P554, DOI 10.1016/j.matbio.2007.04.007; Wagener R, 2005, FEBS LETT, V579, P3323, DOI 10.1016/j.febslet.2005.03.018; Wang Q, 2006, ONCOGENE, V25, P43, DOI 10.1038/sj.onc.1209004; Wiberg C, 2002, BIOCH J, V367, P715	28	9	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93469	10.1371/journal.pone.0093469	http://dx.doi.org/10.1371/journal.pone.0093469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691449	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100086
J	Islam, MZ; Musekiwa, A; Islam, K; Ahmed, S; Chowdhury, S; Ahad, A; Biswas, PK				Islam, Md Zohorul; Musekiwa, Alfred; Islam, Kamrul; Ahmed, Shahana; Chowdhury, Sharmin; Ahad, Abdul; Biswas, Paritosh Kumar			Regional Variation in the Prevalence of E. coli O157 in Cattle: A Meta-Analysis and Meta-Regression	PLOS ONE			English	Article							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; FOOD-PRODUCING ANIMALS; HEALTHY DAIRY-CATTLE; BEEF-CATTLE; FEEDLOT CATTLE; FECAL SAMPLES; BOVINE FECES; VIRULENCE GENES; CARCASS CONTAMINATION; SLAUGHTERED CATTLE	Background: Escherichia coli O157 (EcO157) infection has been recognized as an important global public health concern. But information on the prevalence of EcO157 in cattle at the global and at the wider geographical levels is limited, if not absent. This is the first meta-analysis to investigate the point prevalence of EcO157 in cattle at the global level and to explore the factors contributing to variation in prevalence estimates. Methods: Seven electronic databases-CAB Abstracts, PubMed, Biosis Citation Index, Medline, Web of Knowledge, Scirus and Scopus were searched for relevant publications from 1980 to 2012. A random effect meta-analysis model was used to produce the pooled estimates. The potential sources of between study heterogeneity were identified using meta-regression. Principal findings: A total of 140 studies consisting 220,427 cattle were included in the meta-analysis. The prevalence estimate of EcO157 in cattle at the global level was 5.68% (95% CI, 5.16-6.20). The random effects pooled prevalence estimates in Africa, Northern America, Oceania, Europe, Asia and Latin America-Caribbean were 31.20% (95% CI, 12.35-50.04), 7.35% (95% CI, 6.44-8.26), 6.85% (95% CI, 2.41-11.29), 5.15% (95% CI, 4.21-6.09), 4.69% (95% CI, 3.05-6.33) and 1.65% (95% CI, 0.77-2.53), respectively. Between studies heterogeneity was evidenced in most regions. World region (p<0.001), type of cattle (p<0.001) and to some extent, specimens (p = 0.074) as well as method of pre-enrichment (p = 0.110), were identified as factors for variation in the prevalence estimates of EcO157 in cattle. Conclusion: The prevalence of the organism seems to be higher in the African and Northern American regions. The important factors that might have influence in the estimates of EcO157 are type of cattle and kind of screening specimen. Their roles need to be determined and they should be properly handled in any survey to estimate the true prevalence of EcO157.	[Islam, Md Zohorul; Islam, Kamrul; Ahad, Abdul; Biswas, Paritosh Kumar] Chittagong Vet & Anim Sci Univ, Dept Microbiol, Chittagong, Bangladesh; [Musekiwa, Alfred] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Pietermaritzburg, South Africa; [Ahmed, Shahana] Chittagong Vet Lab, Chittagong, Bangladesh; [Chowdhury, Sharmin] Chittagong Vet & Anim Sci Univ, Dept Pathol & Parasitol, Chittagong, Bangladesh	University of Kwazulu Natal	Islam, MZ (corresponding author), Chittagong Vet & Anim Sci Univ, Dept Microbiol, Chittagong, Bangladesh.	zahir_vet@yahoo.com	Islam, Zohorul/T-4023-2019	Islam, Zohorul/0000-0002-2015-5195; Islam, Kamrul/0000-0002-5968-7068; Musekiwa, Alfred/0000-0001-5880-3680; Ahmed, Shahana/0000-0002-4399-7774				Akanbi BO, 2011, LETT APPL MICROBIOL, V53, P336, DOI 10.1111/j.1472-765X.2011.03113.x; Al-Saigh H, 2004, J FOOD PROTECT, V67, P679, DOI 10.4315/0362-028X-67.4.679; Alam MJ, 2006, J FOOD PROTECT, V69, P3018, DOI 10.4315/0362-028X-69.12.3018; Albihn A, 2003, ACTA VET SCAND, V44, P43, DOI 10.1186/1751-0147-44-43; Albonetti S, 2004, VET RES COMMUN, V28, P249, DOI 10.1023/B:VERC.0000045418.58737.0a; Alonso S, 2007, INT MICROBIOL, V10, P109, DOI 10.2436/20.1501.01.16; Andral B, 2004, VET REC, V155, P365, DOI 10.1136/vr.155.12.365; Armstrong GL, 1996, EPIDEMIOL REV, V18, P29, DOI 10.1093/oxfordjournals.epirev.a017914; Arthur TM, 2009, APPL ENVIRON MICROB, V75, P6515, DOI 10.1128/AEM.00081-09; Aslantas O, 2006, INT J FOOD MICROBIOL, V106, P338, DOI 10.1016/j.ijfoodmicro.2005.08.005; Ateba CN, 2008, S AFR J SCI, V104, P7; Ateba CN, 2011, RES MICROBIOL, V162, P240, DOI 10.1016/j.resmic.2010.11.008; Barlow RS, 2010, FOODBORNE PATHOG DIS, V7, P1239, DOI 10.1089/fpd.2010.0574; Besser TE, 1997, J INFECT DIS, V175, P726, DOI 10.1093/infdis/175.3.726; Blanco M, 1996, EPIDEMIOL INFECT, V117, P251, DOI 10.1017/S0950268800001424; Bonardi S, 2004, MICROBIOLOGICA, V27, P255; Bonardi S, 1999, VET MICROBIOL, V67, P203, DOI 10.1016/S0378-1135(99)00039-5; Bonardi S, 2001, INT J FOOD MICROBIOL, V66, P47, DOI 10.1016/S0168-1605(00)00491-8; Boqvist S, 2009, J FOOD PROTECT, V72, P1709, DOI 10.4315/0362-028X-72.8.1709; Borie CF, 1997, J VET MED B, V44, P273, DOI 10.1111/j.1439-0450.1997.tb00973.x; Brichta-Harhay DM, 2007, J APPL MICROBIOL, V103, P1657, DOI 10.1111/j.1365-2672.2007.03405.x; Cabalar M, 2001, TURK J VET ANIM SCI, V25, P191; Callaway TR, 2006, FOODBORNE PATHOG DIS, V3, P234, DOI 10.1089/fpd.2006.3.234; Callaway TR, 2004, J FOOD PROTECT, V67, P2274, DOI 10.4315/0362-028X-67.10.2274; Canada Canadian Medical Association., 2000, Canada Communicable Disease Report, V26, P170; Cernicchiaro N, 2012, ZOONOSES PUBLIC HLTH, V59, P320, DOI 10.1111/j.1863-2378.2012.01457.x; Cernicchiaro N, 2009, PREV VET MED, V92, P106, DOI 10.1016/j.prevetmed.2009.07.004; Cerqueira AMF, 1999, VET MICROBIOL, V70, P111, DOI 10.1016/S0378-1135(99)00123-6; Chapman PA, 1997, EPIDEMIOL INFECT, V119, P245, DOI 10.1017/S0950268897007826; CHAPMAN PA, 1993, EPIDEMIOL INFECT, V111, P439, DOI 10.1017/S0950268800057162; Chattopadhyay UK, 2001, INT J ENVIRON HEAL R, V11, P107, DOI 10.1080/09603120020019692; Chinen I, 2003, RES VET SCI, V74, P283, DOI 10.1016/S0034-5288(02)00192-3; Cho S, 2006, J FOOD PROTECT, V69, P252, DOI 10.4315/0362-028X-69.2.252; Cizek A, 1999, LETT APPL MICROBIOL, V28, P435, DOI 10.1046/j.1365-2672.1999.00549.x; Cobbold R, 2000, VET MICROBIOL, V71, P125, DOI 10.1016/S0378-1135(99)00173-X; Cobeljic M, 2005, EPIDEMIOL INFECT, V133, P359, DOI 10.1017/S0950268804003334; Conedera G, 2001, INT J FOOD MICROBIOL, V66, P85, DOI 10.1016/S0168-1605(00)00489-X; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Cristancho L, 2008, VET MICROBIOL, V126, P200, DOI 10.1016/j.vetmic.2007.06.012; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dodson K, 2005, J FOOD PROTECT, V68, P927, DOI 10.4315/0362-028X-68.5.927; DORN CR, 1991, J CLIN MICROBIOL, V29, P1225, DOI 10.1128/JCM.29.6.1225-1231.1991; Dunn JR, 2004, J FOOD PROTECT, V67, P2391, DOI 10.4315/0362-028X-67.11.2391; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; Ennis C, 2012, J APPL MICROBIOL, V113, P1238, DOI 10.1111/j.1365-2672.2012.05421.x; Ezawa A, 2004, J VET MED SCI, V66, P779, DOI 10.1292/jvms.66.779; Faith NG, 1996, GEN M AM SOC MICR 95, V95, P384; Fegan N, 2004, J APPL MICROBIOL, V97, P362, DOI 10.1111/j.1365-2672.2004.02300.x; Fegan N, 2009, FOODBORNE PATHOG DIS, V6, P1113, DOI 10.1089/fpd.2009.0338; Fernandez D, 2010, LETT APPL MICROBIOL, V51, P377, DOI 10.1111/j.1472-765X.2010.02904.x; Fey PD, 2000, EMERG INFECT DIS, V6, P530, DOI 10.3201/eid0605.000513; Foster G, 2003, J APPL MICROBIOL, V95, P155, DOI 10.1046/j.1365-2672.2003.01955.x; Fox JT, 2008, J FOOD PROTECT, V71, P1761, DOI 10.4315/0362-028X-71.9.1761; Fox JT, 2008, FOODBORNE PATHOG DIS, V5, P69, DOI 10.1089/fpd.2008.0042; Fremaux B, 2006, VET MICROBIOL, V117, P180, DOI 10.1016/j.vetmic.2006.04.030; Fukushima H, 2004, FEMS MICROBIOL LETT, V238, P189, DOI 10.1016/j.femsle.2004.07.035; Garber L, 1999, J FOOD PROTECT, V62, P307, DOI 10.4315/0362-028X-62.4.307; Greenquist MA, 2005, APPL ENVIRON MICROB, V71, P6431, DOI 10.1128/AEM.71.10.6431-6433.2005; Gunn GJ, 2007, VET J, V174, P554, DOI 10.1016/j.tvjl.2007.08.024; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Hancock DD, 1997, J FOOD PROTECT, V60, P363, DOI 10.4315/0362-028X-60.4.363; Hancock DD, 1998, PREV VET MED, V35, P11, DOI 10.1016/S0167-5877(98)00050-6; HANCOCK DD, 1994, EPIDEMIOL INFECT, V113, P199, DOI 10.1017/S0950268800051633; Hancock DD, 1997, EPIDEMIOL INFECT, V118, P193, DOI 10.1017/S0950268896007212; Heuvelink A, 1996, TIJDSCHR DIERGENEESK, V121, P642; Heuvelink AE, 1998, J CLIN MICROBIOL, V36, P3480, DOI 10.1128/JCM.36.12.3480-3487.1998; Heuvelink AE, 1998, J CLIN MICROBIOL, V36, P878, DOI 10.1128/JCM.36.4.878-882.1998; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hussein HS, 2005, J FOOD PROTECT, V68, P2224, DOI 10.4315/0362-028X-68.10.2224; Hyatt DR, 2001, J VET DIAGN INVEST, V13, P71, DOI 10.1177/104063870101300114; Irino K, 2005, VET MICROBIOL, V105, P29, DOI 10.1016/j.vetmic.2004.08.007; Islam MA, 2008, APPL ENVIRON MICROB, V74, P5414, DOI 10.1128/AEM.00854-08; Jacob ME, 2011, J FOOD PROTECT, V74, P1186, DOI 10.4315/0362-028X.JFP-11-022; Jacob ME, 2010, J FOOD PROTECT, V73, P1030, DOI 10.4315/0362-028X-73.6.1030; Jeon SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055728; Jo MY, 2004, INT J FOOD MICROBIOL, V95, P41, DOI 10.1016/j.ijfoodmicro.2004.01.016; Johnsen G, 2001, INT J FOOD MICROBIOL, V65, P193, DOI 10.1016/S0168-1605(00)00518-3; Kang SJ, 2004, VET MICROBIOL, V98, P323, DOI 10.1016/j.vetmic.2003.11.004; KARMALI MA, 1989, CLIN MICROBIOL REV, V2, P15, DOI 10.1128/CMR.2.1.15-38.1989; Keen JE, 2007, APPL ENVIRON MICROB, V73, P362, DOI 10.1128/AEM.01563-06; Keen JE, 2006, EMERG INFECT DIS, V12, P780; Kerr P, 2001, J APPL MICROBIOL, V91, P933, DOI 10.1046/j.1365-2672.2001.01459.x; Kijima-Tanaka M, 2005, J VET MED B, V52, P230, DOI 10.1111/j.1439-0450.2005.00852.x; Kobayashi H, 2003, APPL ENVIRON MICROB, V69, P5690, DOI 10.1128/AEM.69.9.5690-5692.2003; Kuhnert P, 2005, VET MICROBIOL, V109, P37, DOI 10.1016/j.vetmic.2005.02.015; Laegreid WW, 1999, EPIDEMIOL INFECT, V123, P291, DOI 10.1017/S0950268899002757; Lahti E, 2001, VET MICROBIOL, V79, P239, DOI 10.1016/S0378-1135(00)00355-2; Laven RA, 2003, VET J, V165, P78, DOI 10.1016/S1090-0233(02)00162-4; LeJeune JT, 2006, INT J FOOD MICROBIOL, V109, P19, DOI 10.1016/j.ijfoodmicro.2006.01.005; LeJeune JT, 2005, APPL ENVIRON MICROB, V71, P326, DOI 10.1128/AEM.71.1.326-330.2005; LeJeune JT, 2004, APPL ENVIRON MICROB, V70, P377, DOI 10.1128/AEM.70.1.377-384.2004; Leung PHM, 2001, EPIDEMIOL INFECT, V126, P173, DOI 10.1017/S0950268801005210; Lin Yen-Lan, 2001, Journal of Microbiology Immunology and Infection, V34, P17; Low JC, 2005, APPL ENVIRON MICROB, V71, P93, DOI 10.1128/AEM.71.1.93-97.2005; Lynch MJ, 2012, ZOONOSES PUBLIC HLTH, V59, P264, DOI 10.1111/j.1863-2378.2011.01443.x; Madden RH, 2007, LETT APPL MICROBIOL, V44, P115, DOI 10.1111/j.1472-765X.2006.02064.x; Manna SK, 2006, LETT APPL MICROBIOL, V43, P405, DOI 10.1111/j.1472-765X.2006.01975.x; Masana MO, 2010, J FOOD PROTECT, V73, P649, DOI 10.4315/0362-028X-73.4.649; McDonough PL, 2000, J CLIN MICROBIOL, V38, P318; McEvoy JM, 2003, J APPL MICROBIOL, V95, P256, DOI 10.1046/j.1365-2672.2003.01981.x; Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7; Mechie SC, 1997, EPIDEMIOL INFECT, V118, P17, DOI 10.1017/S0950268896007194; Meichtri L, 2004, INT J FOOD MICROBIOL, V96, P189, DOI 10.1016/j.ijfoodmicro.2004.03.018; Milnes AS, 2008, EPIDEMIOL INFECT, V136, P739, DOI 10.1017/S0950268807009223; Minihan D, 2003, J VET MED B, V50, P378, DOI 10.1046/j.1439-0450.2003.00674.x; Miyao Y, 1998, VET MICROBIOL, V61, P137, DOI 10.1016/S0378-1135(98)00165-5; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; MONTENEGRO MA, 1990, J CLIN MICROBIOL, V28, P1417, DOI 10.1128/JCM.28.6.1417-1421.1990; Moreira CN, 2003, VET MICROBIOL, V93, P179, DOI 10.1016/S0378-1135(03)00041-5; Murinda S E, 2004, Foodborne Pathog Dis, V1, P97, DOI 10.1089/153531404323143611; Murinda SE, 2002, J FOOD PROTECT, V65, P752, DOI 10.4315/0362-028X-65.5.752; Narvaez-Bravo CA, 2007, REV CIENT-FAC CIEN V, V17, P239; Nastasijevic I, 2009, MEAT SCI, V82, P101, DOI 10.1016/j.meatsci.2008.12.007; Nielsen EM, 2002, VET MICROBIOL, V88, P245, DOI 10.1016/S0378-1135(02)00108-6; Ogden ID, 2004, FEMS MICROBIOL LETT, V233, P297, DOI 10.1111/j.1574-6968.2004.tb09495.x; Ojo OE, 2010, INT J FOOD MICROBIOL, V142, P214, DOI 10.1016/j.ijfoodmicro.2010.06.030; Omisakin F, 2003, APPL ENVIRON MICROB, V69, P2444, DOI 10.1128/AEM.69.5.2444-2447.2003; Ongor H, 2007, VET REC, V161, P392, DOI 10.1136/vr.161.11.392; Oot RA, 2007, LETT APPL MICROBIOL, V45, P445, DOI 10.1111/j.1472-765X.2007.02211.x; Osaili TM, 2013, MEAT SCI, V93, P463, DOI 10.1016/j.meatsci.2012.11.023; Paiba GA, 2003, VET REC, V153, P347, DOI 10.1136/vr.153.12.347; Paiba GA, 2002, VET REC, V150, P593, DOI 10.1136/vr.150.19.593; Panutdaporn N, 2004, J INFECTION, V48, P149, DOI 10.1016/j.jinf.2003.08.011; Pearce MC, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-276; Pennington H, 2010, LANCET, V376, P1428, DOI 10.1016/S0140-6736(10)60963-4; Pradel N, 2000, J CLIN MICROBIOL, V38, P1023, DOI 10.1128/JCM.38.3.1023-1031.2000; Ransom JR, 2002, J FOOD PROTECT, V65, P621, DOI 10.4315/0362-028X-65.4.621; Reinstein S, 2009, APPL ENVIRON MICROB, V75, P5421, DOI 10.1128/AEM.00459-09; Renter DG, 2004, AM J VET RES, V65, P1367, DOI 10.2460/ajvr.2004.65.1367; Richards MS, 1998, EPIDEMIOL INFECT, V120, P187, DOI 10.1017/S0950268897008583; Rivera FP, 2012, J DAIRY SCI, V95, P1166, DOI 10.3168/jds.2011-4662; Sanchez S, 2010, RES VET SCI, V88, P208, DOI 10.1016/j.rvsc.2009.07.014; Sargeant JM, 2007, ZOONOSES PUBLIC HLTH, V54, P260, DOI 10.1111/j.1863-2378.2007.01059.x; Sargeant JM, 2003, PREV VET MED, V61, P127, DOI 10.1016/S0167-5877(03)00166-1; Sasaki Y, 2011, VET MICROBIOL, V150, P140, DOI 10.1016/j.vetmic.2010.12.024; Schurman RD, 2000, J FOOD PROTECT, V63, P1583, DOI 10.4315/0362-028X-63.11.1583; Shinagawa K, 2000, VET MICROBIOL, V76, P305, DOI 10.1016/S0378-1135(00)00246-7; Sisti M, 2004, INT J HYG ENVIR HEAL, V207, P577, DOI 10.1078/1438-4639-00330; Smith D, 2001, J FOOD PROTECT, V64, P1899, DOI 10.4315/0362-028X-64.12.1899; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tahamtan Y, 2010, IRAN J MICROBIOL, V2, P9; Nguyen TD, 2011, J VET SCI, V12, P159, DOI 10.4142/jvs.2011.12.2.159; Tanaro JD, 2010, FOODBORNE PATHOG DIS, V7, P475, DOI 10.1089/fpd.2009.0431; Thomas KM, 2012, INT J FOOD MICROBIOL, V153, P288, DOI 10.1016/j.ijfoodmicro.2011.11.012; Toth I, 2009, APPL ENVIRON MICROB, V75, P6282, DOI 10.1128/AEM.00873-09; Tutenel AV, 2002, EPIDEMIOL INFECT, V129, P41, DOI 10.1017/S0950268802007197; Untimanon O., 2005, Current Issues in Intestinal Microbiology, V6, P25; Van Donkersgoed J, 1999, CAN VET J, V40, P332; Vernozy-Rozand C, 2000, LETT APPL MICROBIOL, V30, P217, DOI [10.1046/j.1472-765x.2000.00702.x, 10.1046/j.1472-765X.2000.00702.x]; Vidovic S, 2006, APPL ENVIRON MICROB, V72, P4347, DOI 10.1128/AEM.02791-05; Vold L, 1998, EPIDEMIOL INFECT, V120, P21, DOI 10.1017/S0950268897008364; Vuddhakul V, 2000, FEMS MICROBIOL LETT, V182, P343, DOI 10.1111/j.1574-6968.2000.tb08919.x; Walker C, 2010, FOODBORNE PATHOG DIS, V7, P249, DOI 10.1089/fpd.2009.0410; Wani SA, 2003, LETT APPL MICROBIOL, V37, P121, DOI 10.1046/j.1472-765X.2003.01364.x; WELLS JG, 1991, J CLIN MICROBIOL, V29, P985, DOI 10.1128/JCM.29.5.985-989.1991; Widiasih DA, 2004, EPIDEMIOL INFECT, V132, P67, DOI 10.1017/S0950268803001468; Woerner DR, 2006, J FOOD PROTECT, V69, P2824, DOI 10.4315/0362-028X-69.12.2824; Yilmaz A, 2002, J FOOD PROTECT, V65, P1637, DOI 10.4315/0362-028X-65.10.1637; Zhou ZJ, 2002, J VET MED SCI, V64, P1041, DOI 10.1292/jvms.64.1041	160	20	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93299	10.1371/journal.pone.0093299	http://dx.doi.org/10.1371/journal.pone.0093299			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691253	gold, Green Published, Green Submitted			2022-12-27	WOS:000334101100062
J	Koon, YL; Koh, CG; Chiam, KH				Koon, Yen Ling; Koh, Cheng Gee; Chiam, Keng-Hwee			Computational Modeling Reveals Optimal Strategy for Kinase Transport by Microtubules to Nerve Terminals	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; SIGNAL-TRANSDUCTION; SCAFFOLD PROTEINS; AXONAL-TRANSPORT; MAP KINASE; INTERACTING PROTEIN-1; MOLECULAR MOTORS; KINESIN; JNK; TAU	Intracellular transport of proteins by motors along cytoskeletal filaments is crucial to the proper functioning of many eukaryotic cells. Since most proteins are synthesized at the cell body, mechanisms are required to deliver them to the growing periphery. In this article, we use computational modeling to study the strategies of protein transport in the context of JNK (c-JUN NH2-terminal kinase) transport along microtubules to the terminals of neuronal cells. One such strategy for protein transport is for the proteins of the JNK signaling cascade to bind to scaffolds, and to have the whole protein-scaffold cargo transported by kinesin motors along microtubules. We show how this strategy outperforms protein transport by diffusion alone, using metrics such as signaling rate and signal amplification. We find that there exists a range of scaffold concentrations for which JNK transport is optimal. Increase in scaffold concentration increases signaling rate and signal amplification but an excess of scaffolds results in the dilution of reactants. Similarly, there exists a range of kinesin motor speeds for which JNK transport is optimal. Signaling rate and signal amplification increases with kinesin motor speed until the speed of motor translocation becomes faster than kinase/scaffold-motor binding. Finally, we suggest experiments that can be performed to validate whether, in physiological conditions, neuronal cells do indeed adopt such an optimal strategy. Understanding cytoskeletal-assisted protein transport is crucial since axonal and cell body accumulation of organelles and proteins is a histological feature in many human neurodegenerative diseases. In this paper, we have shown that axonal transport performance changes with altered transport component concentrations and transport speeds wherein these aspects can be modulated to improve axonal efficiency and prevent or slowdown axonal deterioration.	[Koon, Yen Ling; Koh, Cheng Gee; Chiam, Keng-Hwee] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Koon, Yen Ling] Nanyang Technol Univ, Interdisciplinary Grad Sch, Singapore 639798, Singapore; [Koh, Cheng Gee] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Chiam, Keng-Hwee] ASTAR, Bioinformat Inst, Singapore, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII)	Chiam, KH (corresponding author), Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore.	chiamkh@bii.a-star.edu.sg	Koh, Cheng Gee/A-2215-2011; Koh, C. G./H-1122-2015	Koh, Cheng Gee/0000-0003-1905-8010; Koh, C. G./0000-0002-4779-2207	Seed Fund of the Mechanobiology Institute, Research Centre of Excellence; National Research Foundation of Singapore; Singapore Ministry of Education; Agency of Science, Technology and Research (A*STAR) of Singapore; A*STAR Graduate Scholarship	Seed Fund of the Mechanobiology Institute, Research Centre of Excellence; National Research Foundation of Singapore(National Research Foundation, Singapore); Singapore Ministry of Education(Ministry of Education, Singapore); Agency of Science, Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); A*STAR Graduate Scholarship(Agency for Science Technology & Research (A*STAR))	This work was supported by the Seed Fund of the Mechanobiology Institute, Research Centre of Excellence financed by the National Research Foundation of Singapore and the Singapore Ministry of Education, as well as the Agency of Science, Technology and Research (A*STAR) of Singapore. YLK is supported by the A*STAR Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; Banks GA, 2003, GENE THER, V10, P1766, DOI 10.1038/sj.gt.3302076; Blacque OE, 2008, FRONT BIOSCI-LANDMRK, V13, P2633, DOI 10.2741/2871; Blasius TL, 2007, J CELL BIOL, V176, P11, DOI 10.1083/jcb.200605099; Bray D, 1998, ANNU REV BIOPH BIOM, V27, P59, DOI 10.1146/annurev.biophys.27.1.59; Brown A, 2003, J CELL BIOL, V160, P817, DOI 10.1083/jcb.200212017; Bulinski JC, 2007, CURR BIOL, V17, P18; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Chapman SA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.73; Chiam KH, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.051910; Chiu JW, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.056708; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Dorner C, 1999, J BIOL CHEM, V274, P33654, DOI 10.1074/jbc.274.47.33654; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Farzan SF, 2008, CURR BIOL, V18, P1215, DOI 10.1016/j.cub.2008.07.026; Gallant PE, 2000, J NEUROCYTOL, V29, P779, DOI 10.1023/A:1010961022455; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Haugh JM, 2009, BIOPHYS J, V97, P435, DOI 10.1016/j.bpj.2009.05.014; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Horiuchi D, 2007, CURR BIOL, V17, P1313, DOI 10.1016/j.cub.2007.06.062; Inomata H, 2003, J BIOL CHEM, V278, P22946, DOI 10.1074/jbc.M212160200; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Kholodenko BN, 2003, J EXP BIOL, V206, P2073, DOI 10.1242/jeb.00298; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Klann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029645; Klipp E, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S10; Klopfenstein DR, 2000, CELL, V103, P537, DOI 10.1016/S0092-8674(00)00144-6; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Matsuda S, 2001, J NEUROSCI, V21, P6597; Meyer D, 1999, J BIOL CHEM, V274, P35113, DOI 10.1074/jbc.274.49.35113; Moran U, 2010, CELL, V141, P1262, DOI 10.1016/j.cell.2010.06.019; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Neri I, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/8/085005; Neri I, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.098102; Pellet JB, 2000, EUR J NEUROSCI, V12, P621, DOI 10.1046/j.1460-9568.2000.00945.x; Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x; Sakamoto R, 2005, MOL BIOL CELL, V16, P483, DOI 10.1091/mbc.E04-07-0553; Schnapp BJ, 2003, J CELL SCI, V116, P2125, DOI 10.1242/jcs.00488; SCHNAPP BJ, 1989, P NATL ACAD SCI USA, V86, P1548, DOI 10.1073/pnas.86.5.1548; Seitz A, 2002, EMBO J, V21, P4896, DOI 10.1093/emboj/cdf503; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Stagi M, 2006, FASEB J, V20, P2573, DOI 10.1096/fj.06-6679fje; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Taru H, 2002, J BIOL CHEM, V277, P20070, DOI 10.1074/jbc.M108372200; Trinczek B, 1999, J CELL SCI, V112, P2355; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Whitmarsh AJ, 2001, GENE DEV, V15, P2421, DOI 10.1101/gad.922801; Willoughby EA, 2003, J BIOL CHEM, V278, P10731, DOI 10.1074/jbc.M207324200; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Yuste SB, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.061123; Zhang WS, 2005, DEV CELL, V8, P267, DOI 10.1016/j.devcel.2005.01.001; Zhou J, 2005, INVEST OPHTH VIS SCI, V46, P3403, DOI 10.1167/iovs.04-1064	72	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92437	10.1371/journal.pone.0092437	http://dx.doi.org/10.1371/journal.pone.0092437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691408	gold, Green Published			2022-12-27	WOS:000334101100024
J	Lee, JP; Kim, DH; Yang, SH; Hwang, JH; An, JN; Sang, IM; Ha, J; Oh, YK; Kim, YS; Lim, CS				Lee, Jung Pyo; Kim, Do Hyoung; Yang, Seung Hee; Hwang, Jin Ho; An, Jung Nam; Min, Sang Il; Ha, Jongwon; Oh, Yun Kyu; Kim, Yon Su; Lim, Chun Soo			Serum Bilirubin Affects Graft Outcomes through UDP-Glucuronosyltransferase Sequence Variation in Kidney Transplantation	PLOS ONE			English	Article							HEME OXYGENASE-1 GENE; CORONARY-ARTERY-DISEASE; OXIDATIVE STRESS; MICROSATELLITE POLYMORPHISM; PROMOTER POLYMORPHISM; INDUCE TOLERANCE; HEART-DISEASE; ASSOCIATION; SUSCEPTIBILITY; GENOTYPE	Background: Oxidative stress is a major mediator of adverse outcome after kidney transplantation. Bilirubin is produced by heme oxygenase-1 (HO-1), catalyzed by UDP-glucuronosyltransferase (UGT1A1), and has potential as an antioxidant. In this study, we investigated the effects of HO-1 and UGT1A1 sequence variations on kidney allograft outcomes. Methods: Clinical data were collected from 429 Korean recipients who underwent kidney transplantation from 1990-2008. Genotyping for UGT1A1*28 and HO-1 (A-413T) was performed. Acute rejection and graft survival were monitored as end-points. Results: Serum levels of total bilirubin were significantly increased after transplantation (0.41 +/- 0.19 mg/dL to 0.80 +/- 0.33 mg/dL, P<0.001). Post-transplant 1-year bilirubin level was higher in 6/7 or 7/7 carriers compared with 6/6 homozygotes in terms of the UGT1A1*28 polymorphism (6/6 vs. 6/7 vs. 7/7: 0.71 +/- 0.27 vs. 1.06 +/- 0.36 vs. 1.10 +/- 0.45 mg/dL, P<0.001). According to an additive model of genotype analysis, the 7-allele genotype had a protective effect on the development of acute rejection compared with the 6-allele (odds ratio 0.43, 95% CI 0.25-0.73, P for trend = 0.006). Multivariate Cox regression analysis revealed that individuals carrying the 7-allele had a decreased risk of graft loss, by a factor of 0.36 (95% CI 0.15-0.85, P = 0.019). The HO-1 (A-413T) polymorphism had no effect on serum bilirubin levels or graft outcomes. Conclusions: The UGT1A1*28 polymorphism is associated with changes in serum bilirubin and with graft outcome after kidney transplantation.	[Lee, Jung Pyo; Oh, Yun Kyu; Lim, Chun Soo] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Kim, Do Hyoung; Hwang, Jin Ho] Chung Ang Univ Hosp, Dept Internal Med, Seoul, South Korea; [Yang, Seung Hee; An, Jung Nam; Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Yang, Seung Hee; Kim, Yon Su] Seoul Natl Univ, Coll Med, Kidney Res Inst, Seoul, South Korea; [Min, Sang Il; Ha, Jongwon] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lim, CS (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea.	cslimjy@snu.ac.kr	Kim, Do Hyoung/AAE-7557-2022; Oh, Yun Kyu/J-5542-2012; Hwang, Jin Ho/E-7203-2015	Kim, Do Hyoung/0000-0002-8664-8830; Hwang, Jin Ho/0000-0003-0829-0922	Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center [03-2012-4]; Korean Society of Nephrology [H-1112-003-0387]	Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center; Korean Society of Nephrology	This work was supported by a clinical research grant-in-aid from the Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center (03-2012-4) and by a grant from the Korean Society of Nephrology (H-1112-003-0387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2009, AM J PHYSIOL-RENAL, V297, pF1137, DOI 10.1152/ajprenal.90449.2008; Adin CA, 2005, AM J PHYSIOL-RENAL, V288, pF778, DOI 10.1152/ajprenal.00215.2004; Antolini F, 2004, CLIN NEPHROL, V62, P131; Baan C, 2004, AM J TRANSPLANT, V4, P811, DOI 10.1111/j.1600-6143.2004.00420.x; Bulmer AC, 2008, ATHEROSCLEROSIS, V199, P390, DOI 10.1016/j.atherosclerosis.2007.11.022; Campise M, 2003, TRANSPLANTATION, V76, P1474, DOI 10.1097/01.TP.0000090344.61975.F0; Chen YH, 2002, HUM GENET, V111, P1, DOI 10.1007/s00439-002-0769-4; Chen YH, 2008, DIABETES CARE, V31, P1615, DOI 10.2337/dc07-2126; Chen YH, 2011, CLIN J AM SOC NEPHRO, V6, P567, DOI 10.2215/CJN.06130710; Chin HJ, 2009, J KOREAN MED SCI, V24, pS30, DOI 10.3346/jkms.2009.24.S1.S30; Chin HJ, 2009, J KOREAN MED SCI, V24, pS22, DOI 10.3346/jkms.2009.24.S1.S22; Courtney AE, 2007, AM J TRANSPLANT, V7, P908, DOI 10.1111/j.1600-6143.2006.01726.x; Cristol JP, 1998, TRANSPLANTATION, V65, P1322, DOI 10.1097/00007890-199805270-00007; Denschlag D, 2004, MOL HUM REPROD, V10, P211, DOI 10.1093/molehr/gah024; Endler G, 2004, THROMB HAEMOSTASIS, V91, P155, DOI 10.1160/TH03-05-0291; Exner M, 2004, TRANSPLANTATION, V77, P538, DOI 10.1097/01.TP.0000113467.36269.F8; Guenegou A, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039743; Hasegawa T, 2009, AM J PHYSIOL-HEART C, V296, pH1007, DOI 10.1152/ajpheart.00498.2008; Hribova P, 2008, AM J TRANSPLANT, V8, P1077, DOI 10.1111/j.1600-6143.2008.02207.x; Ikushiro S, 1997, BIOCHEMISTRY-US, V36, P7154, DOI 10.1021/bi9702344; Joo DJ, 2010, TRANSPL P, V42, P729, DOI 10.1016/j.transproceed.2010.02.033; Kim SY, 2003, NEPHROLOGY, V8, pS2, DOI 10.1046/j.1440-1797.8.s.5.x; Kimpara T, 1997, HUM GENET, V100, P145, DOI 10.1007/s004390050480; Lee SS, 2007, FASEB J, V21, P3450, DOI 10.1096/fj.07-8472com; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; LLESUY SF, 1994, BBA-MOL CELL RES, V1223, P9, DOI 10.1016/0167-4889(94)90067-1; Morena Marion, 2005, Hemodial Int, V9, P37, DOI 10.1111/j.1492-7535.2005.01116.x; NAKAGAMI T, 1993, BIOCHIM BIOPHYS ACTA, V1158, P189, DOI 10.1016/0304-4165(93)90013-X; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Pileggi A, 2001, DIABETES, V50, P1983, DOI 10.2337/diabetes.50.9.1983; Ribeiro MM, 2003, BIOCHEM BIOPH RES CO, V305, P876, DOI 10.1016/S0006-291X(03)00856-8; Rocuts F, 2010, CELL TRANSPLANT, V19, P443, DOI 10.3727/096368909X484680; Schillinger M, 2004, J AM COLL CARDIOL, V43, P950, DOI 10.1016/j.jacc.2003.09.058; STOCKER R, 1987, P NATL ACAD SCI USA, V84, P5918, DOI 10.1073/pnas.84.16.5918; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Sun K, 2004, TRANSPLANTATION, V77, P1683, DOI 10.1097/01.TP.0000131169.29553.B1; Turpeinen H, 2007, INT J IMMUNOGENET, V34, P253, DOI 10.1111/j.1744-313X.2007.00688.x; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; Vostalova J, 2012, RENAL FAILURE, V34, P413, DOI 10.3109/0886022X.2011.649658; Wang HJ, 2006, ENDOCRINOLOGY, V147, P762, DOI 10.1210/en.2005-0632; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729; Zahmatkesh M, 2010, EXP CLIN TRANSPLANT, V8, P38	42	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93633	10.1371/journal.pone.0093633	http://dx.doi.org/10.1371/journal.pone.0093633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690955	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100115
J	Ryoo, IG; Ha, H; Kwak, MK				Ryoo, In-geun; Ha, Hunjoo; Kwak, Mi-Kyoung			Inhibitory Role of the KEAP1-NRF2 Pathway in TGF beta 1-Stimulated Renal Epithelial Transition to Fibroblastic Cells: A Modulatory Effect on SMAD Signaling	PLOS ONE			English	Article							UNILATERAL URETERAL OBSTRUCTION; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; TGF-BETA; MESENCHYMAL TRANSITION; OXIDATIVE STRESS; MOLECULAR-MECHANISMS; TUBULOINTERSTITIAL FIBROSIS; NRF2-KEAP1 PATHWAY; GENE-EXPRESSION	Transforming growth factor beta 1 (TGF beta 1) is a potent stimulator of epithelial-to-mesenchymal transition (EMT) and has been associated with chronic kidney diseases by activating profibrotic gene expression. In this study, we investigated the role of the KEAP1-NRF2 pathway, which is a master regulator of the cellular antioxidant system, in TGF beta 1-stimulated EMT gene changes using human renal tubular epithelial HK2. Treatment with TGF beta 1 enhanced the levels of reactive oxygen species (ROS) and TGF beta 1-stimulated EMT gene changes, including an increase in profibrotic fibronectin-1 and collagen 1A1, were diminished by the antioxidant N-acetylcysteine. In HK2, TGF beta 1 suppressed NRF2 activity and thereby reduced the expression of GSH synthesizing enzyme through the elevation of ATF3 level. Therefore, the activation of NRF2 signaling with sulforaphane effectively attenuated the TGF beta 1-stimulated increase in fibronectin-1 and collagen 1A1. Conversely, the TGF beta 1-EMT gene changes were further enhanced by NRF2 knockdown compared to the control cells. The relationship of NRF2 signaling and TGF beta 1-EMT changes was further confirmed in a stable KEAP1-knockdown HK2, which is a model of pure activation of NRF2. The TGF beta 1-mediated increase of collagen 1A1 and fibronectin-1 in KEAP1 knockdown HK2 was suppressed. In particular, TGF beta 1-SMAD signaling was modulated in KEAP1 knockdown HK2: the TGF beta 1-stimulated SMAD2/3 phosphorylation and SMAD transcriptional activity were repressed. Additionally, the protein level of SMAD7, an inhibitor of SMAD signaling, was elevated and the level of SMURF1, an E3 ubiquitin ligase for SMAD7 protein, was diminished in KEAP1 knockdown HK2. Finally, the inhibition of SMAD7 expression in KEAP1 knockdown HK2 restored TGF beta 1 response, indicating that SMURF1-SMAD7 may be a molecular signaling linking the NRF2-GSH pathway to TGF beta 1-EMT changes. Collectively, these results indicate that the KEAP1-NRF2 antioxidant system can be an effective modulator of TGF beta 1-stimulated renal epithelial transition to fibroblastic cells through the SMUR1-SMAD7 signaling, and further implies the beneficial role of NRF2 in chronic renal diseases.	[Ryoo, In-geun; Kwak, Mi-Kyoung] Catholic Univ Korea, Coll Pharm, Puchon, Gyeonggi Do, South Korea; [Ha, Hunjoo] Ewha Womans Univ, Coll Pharm, Seoul, South Korea	Catholic University of Korea; Ewha Womans University	Kwak, MK (corresponding author), Catholic Univ Korea, Coll Pharm, Puchon, Gyeonggi Do, South Korea.	mkwak@catholic.ac.kr		Ha, Hunjoo/0000-0002-5601-1265	Bio & Medical Technology Development Program of the National Research Foundation (NRF) [NRF-2013M3A9B5075839]; Ministry of Science, ICT & Future Planning; Basic Science Research Program of the NRF [2011-0003619]; Ministry of Education, Science and Technology; Research Fund of The Catholic University of Korea	Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Basic Science Research Program of the NRF(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Research Fund of The Catholic University of Korea	This research was supported by the Bio & Medical Technology Development Program (NRF-2013M3A9B5075839) of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning, and the Basic Science Research Program (2011-0003619) of the NRF funded by the Ministry of Education, Science and Technology. This work was also supported by the Research Fund, 2011 of The Catholic University of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminzadeh MA, 2013, NEPHROL DIAL TRANSPL, V28, P2038, DOI 10.1093/ndt/gft022; Artaud-Macari E, 2013, ANTIOXID REDOX SIGN, V18, P66, DOI 10.1089/ars.2011.4240; Bakin AV, 2005, FREE RADICAL BIO MED, V38, P375, DOI 10.1016/j.freeradbiomed.2004.10.033; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Biswas SK, 2009, MOL ASPECTS MED, V30, P60, DOI 10.1016/j.mam.2008.07.001; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Brown SL, 2008, CANCER RES, V68, P364, DOI 10.1158/0008-5472.CAN-07-2170; Burns WC, 2010, AM J PHYSIOL-RENAL, V299, pF585, DOI 10.1152/ajprenal.00538.2009; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Choi HK, 2009, TOXICOL APPL PHARM, V240, P377, DOI 10.1016/j.taap.2009.07.030; Chung ACK, 2009, NEPHROL DIAL TRANSPL, V24, P1443, DOI 10.1093/ndt/gfn699; Cui WP, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/821936; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Franklin CC, 2003, FASEB J, V17, P1535, DOI 10.1096/fj.02-0867fje; Hackett TL, 2009, AM J RESP CRIT CARE, V180, P122, DOI 10.1164/rccm.200811-1730OC; Hertig A, 2006, AM J TRANSPLANT, V6, P2937, DOI 10.1111/j.1600-6143.2006.01559.x; Hu TS, 2005, AM J PHYSIOL-RENAL, V289, pF816, DOI 10.1152/ajprenal.00024.2005; Hwang M, 2006, EXP MOL PATHOL, V81, P48, DOI 10.1016/j.yexmp.2005.11.005; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jardine H, 2002, J BIOL CHEM, V277, P21158, DOI 10.1074/jbc.M112145200; Jung KA, 2013, TOXICOL LETT, V218, P39, DOI 10.1016/j.toxlet.2012.12.026; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kashihara N, 2010, CURR MED CHEM, V17, P4256, DOI 10.2174/092986710793348581; Kim HJ, 2010, AM J PHYSIOL-RENAL, V298, pF662, DOI 10.1152/ajprenal.00421.2009; Kim TH, 2011, CANCER RES, V71, P2260, DOI 10.1158/0008-5472.CAN-10-3007; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lewerenz J, 2011, ANTIOXID REDOX SIGN, V14, P1449, DOI 10.1089/ars.2010.3600; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Liu RM, 2010, FREE RADICAL BIO MED, V48, P1, DOI 10.1016/j.freeradbiomed.2009.09.026; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Margetts PJ, 2005, J AM SOC NEPHROL, V16, P425, DOI 10.1681/ASN.2004060436; Meurer SK, 2005, BIOCHEM PHARMACOL, V70, P1026, DOI 10.1016/j.bcp.2005.07.001; Michaeloudes C, 2011, AM J RESP CRIT CARE, V184, P894, DOI 10.1164/rccm.201011-1780OC; Miyata T, 2013, KIDNEY INT, V84, P693, DOI 10.1038/ki.2013.74; Monteleone G, 2008, MUCOSAL IMMUNOL, V1, pS50, DOI 10.1038/mi.2008.55; Nakamura T, 2011, AM J RESP CELL MOL, V44, P614, DOI 10.1165/rcmb.2010-0338OC; Oh CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045870; Oh CJ, 2012, FREE RADICAL BIO MED, V52, P671, DOI 10.1016/j.freeradbiomed.2011.11.012; Pat B, 2005, KIDNEY INT, V67, P931, DOI 10.1111/j.1523-1755.2005.00157.x; Ping Z, 2010, BRAIN RES, V1343, P178, DOI 10.1016/j.brainres.2010.04.036; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Priya DKD, 2011, PULM PHARMACOL THER, V24, P110, DOI 10.1016/j.pupt.2010.09.002; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Rhyu DY, 2012, TRANSPL P, V44, P625, DOI 10.1016/j.transproceed.2011.12.054; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Simonson MS, 2007, KIDNEY INT, V71, P846, DOI 10.1038/sj.ki.5002180; Soetikno V, 2013, MOL NUTR FOOD RES, V57, P1649, DOI 10.1002/mnfr.201200540; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang M, 2009, LUNG, V187, P187, DOI 10.1007/s00408-009-9139-5; Zhu H, 2008, CARDIOVASC TOXICOL, V8, P71, DOI 10.1007/s12012-008-9016-0	69	50	54	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93265	10.1371/journal.pone.0093265	http://dx.doi.org/10.1371/journal.pone.0093265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691097	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100058
J	van Houten, EEW				van Houten, Elijah E. W.			Parameter Identification in a Generalized Time- Harmonic Rayleigh Damping Model for Elastography	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; VISCOELASTIC SHEAR PROPERTIES; MR ELASTOGRAPHY; BRAIN; LIVER	The identifiability of the two damping components of a Generalized Rayleigh Damping model is investigated through analysis of the continuum equilibrium equations as well as a simple spring- mass system. Generalized Rayleigh Damping provides a more diversified attenuation model than pure Viscoelasticity, with two parameters to describe attenuation effects and account for the complex damping behavior found in biological tissue. For heterogeneous Rayleigh Damped materials, there is no equivalent Viscoelastic system to describe the observed motions. For homogeneous systems, the inverse problem to determine the two Rayleigh Damping components is seen to be uniquely posed, in the sense that the inverse matrix for parameter identification is full rank, with certain conditions: when either multi- frequency data is available or when both shear and dilatational wave propagation is taken into account. For the multi- frequency case, the frequency dependency of the elastic parameters adds a level of complexity to the reconstruction problem that must be addressed for reasonable solutions. For the dilatational wave case, the accuracy of compressional wave measurement in fluid saturated soft tissues becomes an issue for qualitative parameter identification. These issues can be addressed with reasonable assumptions on the negligible damping levels of dilatational waves in soft tissue. In general, the parameters of a Generalized Rayleigh Damping model are identifiable for the elastography inverse problem, although with more complex conditions than the simpler Viscoelastic damping model. The value of this approach is the additional structural information provided by the Generalized Rayleigh Damping model, which can be linked to tissue composition as well as rheological interpretations.	Univ Sherbrooke, Dept Genie Mecan, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	van Houten, EEW (corresponding author), Univ Sherbrooke, Dept Genie Mecan, Sherbrooke, PQ J1K 2R1, Canada.	eew.vanhouten@usherbrooke.ca						Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Clayton EH, 2011, PHYS MED BIOL, V56, P2391, DOI 10.1088/0031-9155/56/8/005; Cook R.D., 2002, CONCEPTS APPL FINITE; Doyley MM, 2010, MED PHYS, V37, P3970, DOI 10.1118/1.3454738; Eskandari H, 2008, IEEE T ULTRASON FERR, V55, P1611, DOI 10.1109/TUFFC.2008.839; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Huwart L, 2007, RADIOLOGY, V245, P458, DOI 10.1148/radiol.2452061673; Klatt D, 2007, PHYS MED BIOL, V52, P7281, DOI 10.1088/0031-9155/52/24/006; Klatt D, 2006, INVEST RADIOL, V41, P841, DOI 10.1097/01.rli.0000244341.16372.08; Klatt D, 2010, BIORHEOLOGY, V47, P133, DOI 10.3233/BIR-2010-0565; Leclerc G, 2012, J BIOMECH, V45, P252; McGarry MDJ, 2012, MED PHYS, V39, P6388, DOI 10.1118/1.4754649; McGarry MDJ, 2008, MED BIOL ENG COMPUT, V46, P759, DOI 10.1007/s11517-008-0356-5; Murphy MC, 2012, MAGN RESON IMAGING, V30, P535, DOI 10.1016/j.mri.2011.12.019; Papazoglou S, 2012, PHYS MED BIOL, V57, P2329, DOI 10.1088/0031-9155/57/8/2329; Rouviere O, 2006, RADIOLOGY, V240, P440, DOI 10.1148/radiol.2402050606; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Semblat JF, 2011, INT J NUMER METH ENG, V85, P1543, DOI 10.1002/nme.3035; Semblat JF, 1997, J SOUND VIB, V206, P741, DOI 10.1006/jsvi.1997.1067; Sinkus R, 2005, MAGN RESON IMAGING, V23, P159, DOI 10.1016/j.mri.2004.11.060; Van Houten EEW, 2012, P 20 ANN M ISMRM MEL, P2520; Van Houtena EEW, 2011, MED PHYS, V38, P1993, DOI 10.1118/1.3557469; Vappou J, 2006, J RHEOL, V50, P531, DOI 10.1122/1.2207187; Venkatesh SK, 2013, J MAGN RESON IMAGING, V37, P544, DOI 10.1002/jmri.23731; Wuerfel J, 2010, NEUROIMAGE, V49, P2520, DOI 10.1016/j.neuroimage.2009.06.018; Zhang J, 2011, J BIOMECH, V44, P1909, DOI 10.1016/j.jbiomech.2011.04.034	26	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93080	10.1371/journal.pone.0093080	http://dx.doi.org/10.1371/journal.pone.0093080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691213	Green Published, gold			2022-12-27	WOS:000334101100042
J	Kim, A; Rivera, S; Shprung, D; Limbrick, D; Gabayan, V; Nemeth, E; Ganz, T				Kim, Airie; Rivera, Seth; Shprung, Dana; Limbrick, Donald; Gabayan, Victoria; Nemeth, Elizabeta; Ganz, Tomas			Mouse Models of Anemia of Cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; EPOETIN ALPHA; HEPCIDIN; CHEMOTHERAPY; INFLAMMATION; PREVALENCE; MANAGEMENT; ONCOLOGY; SURVIVAL; OUTCOMES	Anemia of cancer (AC) may contribute to cancer-related fatigue and impair quality of life. Improved understanding of the pathogenesis of AC could facilitate better treatment, but animal models to study AC are lacking. We characterized four syngeneic C57BL/6 mouse cancers that cause AC. Mice with two different rapidly-growing metastatic lung cancers developed the characteristic findings of anemia of inflammation (AI), with dramatically different degrees of anemia. Mice with rapidly-growing metastatic melanoma also developed a severe anemia by 14 days, with hematologic and inflammatory parameters similar to AI. Mice with a slow-growing peritoneal ovarian cancer developed an iron-deficiency anemia, likely secondary to chronically impaired nutrition and bleeding into the peritoneal cavity. Of the four models, hepcidin mRNA levels were increased only in the milder lung cancer model. Unlike in our model of systemic inflammation induced by heat-killed Brucella abortus, ablation of hepcidin in the ovarian cancer and the milder lung cancer mouse models did not affect the severity of anemia. Hepcidin-independent mechanisms play an important role in these murine models of AC.	[Kim, Airie; Rivera, Seth; Shprung, Dana; Limbrick, Donald; Gabayan, Victoria; Nemeth, Elizabeta; Ganz, Tomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Ganz, Tomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kim, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	airiekim@mednet.ucla.edu	Ganz, Tomas/AAN-3308-2020; Ganz, Tomas/D-4567-2009	Nemeth, Elizabeta/0000-0002-3477-2397; Ganz, Tomas/0000-0002-2830-5469	NIH [HL072752]; Roche Foundation for Anemia Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072752] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roche Foundation for Anemia Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH Pulmonary & Critical Care Institutional Training Grant T32 (HL072752) to AK, 09/2008 - 06/2011; and Roche Foundation for Anemia Research to TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapro M, 2009, ONCOLOGIST, V14, P6, DOI 10.1634/theoncologist.2009-S1-6; Adamson John W, 2008, Hematology Am Soc Hematol Educ Program, P159, DOI 10.1182/asheducation-2008.1.159; Butterfield AM, 2010, CLIN CHEM, V56, P1725, DOI 10.1373/clinchem.2010.151522; Caro JJ, 2001, CANCER-AM CANCER SOC, V91, P2214, DOI 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P; Crawford J, 2002, CANCER-AM CANCER SOC, V95, P888, DOI 10.1002/cncr.10763; Demetri GD, 1998, J CLIN ONCOL, V16, P3412, DOI 10.1200/JCO.1998.16.10.3412; Demetri GD, 2001, BRIT J CANCER, V84, P31, DOI 10.1054/bjoc.2001.1750; Dicato M, 2010, ANN ONCOL, V21, P167, DOI 10.1093/annonc/mdq284; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Glaspy J, 1997, J CLIN ONCOL, V15, P1218, DOI 10.1200/JCO.1997.15.3.1218; Goodnough JB, 2012, HEPATOLOGY, V56, P291, DOI 10.1002/hep.25615; Hagihara K, 2004, BIOCHEM BIOPH RES CO, V314, P363, DOI 10.1016/j.bbrc.2003.12.096; Kim A, 2014, BLOOD, V123, P1129, DOI 10.1182/blood-2013-08-521419; Knight K, 2004, AM J MED, V116, P11, DOI 10.1016/j.amjmed.2003.12.008; Kosmidis P, 2005, LUNG CANCER, V50, P401, DOI 10.1016/j.lungcan.2005.08.004; Lesbordes-Brion JC, 2006, BLOOD, V108, P1402, DOI 10.1182/blood-2006-02-003376; Ludwig H, 2004, EUR J CANCER, V40, P2293, DOI 10.1016/j.ejca.2004.06.019; Lynch EC, 1990, CLIN METHODS HIST PH; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Pak M, 2006, BLOOD, V108, P3730, DOI 10.1182/blood-2006-06-028787; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pietrangelo A, 2007, GASTROENTEROLOGY, V132, P294, DOI 10.1053/j.gastro.2006.10.018; Ramos E, 2012, BLOOD, V120, P3829, DOI 10.1182/blood-2012-07-440743; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Sasu BJ, 2010, BLOOD CELL MOL DIS, V45, P238, DOI 10.1016/j.bcmd.2010.07.013; Sharma S, 2008, CLIN CANCER RES, V14, P3262, DOI 10.1158/1078-0432.CCR-07-4153; Songur N, 2004, TUMORI J, V90, P196, DOI 10.1177/030089160409000207; Spivak JL, 2009, ONCOLOGIST, V14, P43, DOI 10.1634/theoncologist.2009-S1-43; Stasi R, 2003, CANCER-AM CANCER SOC, V98, P1786, DOI 10.1002/cncr.11742; Ukarma L, 2009, CLIN CHEM, V55, P1354, DOI 10.1373/clinchem.2008.121285; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Wong SS, 1996, CLIN CHIM ACTA, V244, P91; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Zakrzewska I, 2001, Pol Merkur Lekarski, V11, P210; Zhang ZZ, 2012, HEPATOLOGY, V56, P961, DOI 10.1002/hep.25746	38	15	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93283	10.1371/journal.pone.0093283	http://dx.doi.org/10.1371/journal.pone.0093283			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681760	Green Published, gold, Green Submitted			2022-12-27	WOS:000333678100039
J	Weeda, S; Zhang, N; Zhao, XL; Ndip, G; Guo, YD; Buck, GA; Fu, CG; Ren, SX				Weeda, Sarah; Zhang, Na; Zhao, Xiaolei; Ndip, Grace; Guo, Yangdong; Buck, Gregory A.; Fu, Conggui; Ren, Shuxin			Arabidopsis Transcriptome Analysis Reveals Key Roles of Melatonin in Plant Defense Systems	PLOS ONE			English	Article							GROWTH-STIMULATING COMPOUND; PV. TOMATO DC3000; REACTIVE OXYGEN; EXOGENOUS MELATONIN; PEROXIDASE-ACTIVITY; TRANSGENIC RICE; SIGNAL-TRANSDUCTION; ROOT REGENERATION; OXIDATIVE STRESS; RESISTANCE	Melatonin is a ubiquitous molecule and exists across kingdoms including plant species. Studies on melatonin in plants have mainly focused on its physiological influence on growth and development, and on its biosynthesis. Much less attention has been drawn to its affect on genome-wide gene expression. To comprehensively investigate the role(s) of melatonin at the genomics level, we utilized mRNA-seq technology to analyze Arabidopsis plants subjected to a 16-hour 100 pM (low) and 1 mM (high) melatonin treatment. The expression profiles were analyzed to identify differentially expressed genes. 100 pM melatonin treatment significantly affected the expression of only 81 genes with 51 down-regulated and 30 up-regulated. However, 1 mM melatonin significantly altered 1308 genes with 566 up-regulated and 742 down-regulated. Not all genes altered by low melatonin were affected by high melatonin, indicating different roles of melatonin in regulation of plant growth and development under low and high concentrations. Furthermore, a large number of genes altered by melatonin were involved in plant stress defense. Transcript levels for many stress receptors, kinases, and stress-associated calcium signals were up-regulated. The majority of transcription factors identified were also involved in plant stress defense. Additionally, most identified genes in ABA, ET, SA and JA pathways were up-regulated, while genes pertaining to auxin responses and signaling, peroxidases, and those associated with cell wall synthesis and modifications were mostly down-regulated. Our results indicate critical roles of melatonin in plant defense against various environmental stresses, and provide a framework for functional analysis of genes in melatonin-mediated signaling pathways.	[Weeda, Sarah; Ren, Shuxin] Virginia State Univ, ARS, Petersburg, VA 23806 USA; [Zhang, Na; Guo, Yangdong] China Agr Univ, Coll Agr & Biotechnol, Beijing 100094, Peoples R China; [Zhao, Xiaolei; Fu, Conggui] Tianjin Acad Agr Sci, Tianjin Crop Sci Inst, Tianjin, Peoples R China; [Ndip, Grace] Virginia State Univ, Dept Chem, Petersburg, VA 23806 USA; [Buck, Gregory A.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA	Virginia State University; China Agricultural University; Virginia State University; Virginia Commonwealth University	Guo, YD (corresponding author), China Agr Univ, Coll Agr & Biotechnol, Beijing 100094, Peoples R China.	yaguo@cau.edu.cn; sren@vsu.edu	zhang, na/M-6968-2016		USDA Evans Allen Fund	USDA Evans Allen Fund	This work is partially supported by USDA Evans Allen Fund. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afreen F, 2006, J PINEAL RES, V41, P108, DOI 10.1111/j.1600-079X.2006.00337.x; Arnao MB, 2009, J PINEAL RES, V46, P58, DOI 10.1111/j.1600-079X.2008.00625.x; Arnao MB, 2007, J PINEAL RES, V42, P147, DOI 10.1111/j.1600-079X.2006.00396.x; Arnao MB, 2006, PLANT SIGNAL BEHAV, V1, P89, DOI 10.4161/psb.1.3.2640; Arnao MB, 2013, J PINEAL RES, V55, P149, DOI 10.1111/jpi.12055; Arnao MB, 2009, J PINEAL RES, V46, P295, DOI 10.1111/j.1600-079X.2008.00660.x; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Banas AK, 2011, PLANT PHYSIOL, V157, P1497, DOI 10.1104/pp.111.185504; Arnao MB, 2013, FOOD CHEM, V138, P1212, DOI 10.1016/j.foodchem.2012.10.077; Boccalandro HE, 2011, J PINEAL RES, V51, P226, DOI 10.1111/j.1600-079X.2011.00884.x; Brunskill EW, 2012, DEV BIOL, V368, P4, DOI 10.1016/j.ydbio.2012.05.030; Byeon Y, 2013, J PINEAL RES, V55, P357, DOI 10.1111/jpi.12077; Byeon Y, 2012, J PINEAL RES, V53, P107, DOI 10.1111/j.1600-079X.2012.00976.x; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Carrillo-Vico A, 2005, ENDOCRINE, V27, P189, DOI 10.1385/ENDO:27:2:189; Cartieaux F, 2008, MOL PLANT MICROBE IN, V21, P244, DOI 10.1094/MPMI-21-2-0244; Catinot J, 2008, FEBS LETT, V582, P473, DOI 10.1016/j.febslet.2007.12.039; Chen Q, 2009, J PLANT PHYSIOL, V166, P324, DOI 10.1016/j.jplph.2008.06.002; Cuypers A, 2001, PLANT PHYSIOL BIOCH, V39, P657, DOI 10.1016/S0981-9428(01)01276-1; Danquah A, 2014, BIOTECHNOL ADV, V32, P40, DOI 10.1016/j.biotechadv.2013.09.006; DUBBELS R, 1995, J PINEAL RES, V18, P28, DOI 10.1111/j.1600-079X.1995.tb00136.x; ECKER JR, 1995, SCIENCE, V268, P667, DOI 10.1126/science.7732375; EDGERTON MD, 1994, PHYTOCHEMISTRY, V35, P1111, DOI 10.1016/S0031-9422(00)94807-6; Ellis C, 2002, PLANT CELL, V14, P1557, DOI 10.1105/tpc.002022; Espino J, 2010, J MEMBRANE BIOL, V233, P105, DOI 10.1007/s00232-010-9230-0; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; Hamann T, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00077; Hardeland R, 1999, REPROD NUTR DEV, V39, P399, DOI 10.1051/rnd:19990311; HATTORI A, 1995, BIOCHEM MOL BIOL INT, V35, P627; Hernandez-Ruiz J, 2008, J AGR FOOD CHEM, V56, P10567, DOI 10.1021/jf8022063; Hernandez-Ruiz J, 2005, J PINEAL RES, V39, P137, DOI 10.1111/j.1600-079X.2005.00226.x; Hernandez-Ruiz J, 2004, PLANTA, V220, P140, DOI 10.1007/s00425-004-1317-3; Hernandez-Ruiz J, 2008, PLANT GROWTH REGUL, V55, P29, DOI 10.1007/s10725-008-9254-y; Iglesias MJ, 2011, PLANT SIGNAL BEHAV, V6, P452, DOI 10.4161/psb.6.3.14676; Jung JH, 2011, PLANT SIGNAL BEHAV, V6, P1198, DOI 10.4161/psb.6.8.15792; Kang K, 2010, J PINEAL RES, V49, P176, DOI 10.1111/j.1600-079X.2010.00783.x; Kedziora-Kornatowska K, 2007, J PINEAL RES, V42, P153, DOI 10.1111/j.1600-079X.2006.00394.x; Kolar J, 1997, PHYTOCHEMISTRY, V44, P1407, DOI 10.1016/S0031-9422(96)00568-7; Kolar J, 2003, PHYSIOL PLANTARUM, V118, P605, DOI 10.1034/j.1399-3054.2003.00114.x; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kwak JM, 2006, PLANT PHYSIOL, V141, P323, DOI 10.1104/pp.106.079004; Lei XY, 2004, J PINEAL RES, V36, P126, DOI 10.1046/j.1600-079X.2003.00106.x; LERNER AB, 1958, J AM CHEM SOC, V80, P2587, DOI 10.1021/ja01543a060; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig-Muller J, 2011, J EXP BOT, V62, P1757, DOI 10.1093/jxb/erq412; Ma SS, 2006, J EXP BOT, V57, P1097, DOI 10.1093/jxb/erj098; Manchester LC, 1995, CELL MOL BIOL RES, V41, P391; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; McMullan CJ, 2013, JAMA-J AM MED ASSOC, V309, P1388, DOI 10.1001/jama.2013.2710; Melchiorri D, 1996, BIOCHEM PHARMACOL, V51, P1095, DOI 10.1016/0006-2952(96)00055-X; MELCHIORRI D, 1994, LIFE SCI, V56, P83, DOI 10.1016/0024-3205(94)00928-7; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Murch SJ, 2002, NATURWISSENSCHAFTEN, V89, P555, DOI 10.1007/s00114-002-0376-1; Murch SJ, 2000, PLANT CELL REP, V19, P698, DOI 10.1007/s002990000206; Nickkholgh A, 2011, J PINEAL RES, V50, P381, DOI 10.1111/j.1600-079X.2011.00854.x; Nishida S, 2005, ENDOCRINE, V27, P131, DOI 10.1385/ENDO:27:2:131; Paredes SD, 2009, J EXP BOT, V60, P57, DOI 10.1093/jxb/ern284; Park S, 2012, J PINEAL RES, V52, P211, DOI [10.1111/j.1600-079X.2011.00930.x, 10.1111/j.1600-079X.2012.01029.x]; Park S, 2013, J PINEAL RES, V55, P40, DOI 10.1111/jpi.12021; Park S, 2012, J PINEAL RES, V53, P385, DOI 10.1111/j.1600-079X.2012.01008.x; Park WJ, 2011, J PLANT BIOL, V54, P143, DOI 10.1007/s12374-011-9159-6; Pelagio-Flores R, 2012, J PINEAL RES, V53, P279, DOI 10.1111/j.1600-079X.2012.00996.x; Perez-Ruiz JM, 2006, PLANT CELL, V18, P2356, DOI 10.1105/tpc.106.041541; Peters JL, 2005, J COMP NEUROL, V493, P370, DOI 10.1002/cne.20779; POEGGELER B, 1993, J PINEAL RES, V14, P151, DOI 10.1111/j.1600-079X.1993.tb00498.x; Posmyk MM, 2008, J PINEAL RES, V45, P24, DOI 10.1111/j.1600-079X.2007.00552.x; Posmyk MM, 2009, J PINEAL RES, V46, P214, DOI 10.1111/j.1600-079X.2008.00652.x; Raghavan Chitra, 2006, Functional & Integrative Genomics, V6, P60, DOI 10.1007/s10142-005-0012-1; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; REITER RJ, 1993, EXPERIENTIA, V49, P654, DOI 10.1007/BF01923947; Reiter RJ, 2001, CELL BIOCHEM BIOPHYS, V34, P237, DOI 10.1385/CBB:34:2:237; Ren S. X., 2012, Journal of Biotech Research, V4, P80; REUVENI R, 1992, PHYTOPATHOLOGY, V82, P749, DOI 10.1094/Phyto-82-749; REUVENI R, 1985, PHYTOPATHOL Z, V112, P193; REUVENI R, 1985, PHYTOPATHOL Z, V114, P260; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Rodriguez C, 2013, INT J MOL SCI, V14, P6597, DOI 10.3390/ijms14046597; Sarropoulou V, 2012, PLANT PHYSIOL BIOCH, V61, P162, DOI 10.1016/j.plaphy.2012.10.001; Sasidharan R, 2011, CRIT REV PLANT SCI, V30, P548, DOI 10.1080/07352689.2011.615706; Singhal NK, 2011, J PINEAL RES, V50, P97, DOI 10.1111/j.1600-079X.2010.00819.x; Sjoblom M, 2003, AM J PHYSIOL-GASTR L, V284, pG1034, DOI 10.1152/ajpgi.00500.2002; Tal O, 2011, J EXP BOT, V62, P1903, DOI 10.1093/jxb/erq378; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Tan DX, 2007, FASEB J, V21, P1724, DOI 10.1096/fj.06-7745com; Tan Dun-Xian, 2002, Current Topics in Medicinal Chemistry, V2, P181, DOI 10.2174/1568026023394443; Tan DX, 2012, J EXP BOT, V63, P577, DOI 10.1093/jxb/err256; Tan DX, 2007, PLANT SIGNAL BEHAV, V2, P514, DOI 10.4161/psb.2.6.4639; Tena G, 2001, CURR OPIN PLANT BIOL, V4, P392, DOI 10.1016/S1369-5266(00)00191-6; Tettamanti C., 2000, ACTA PHYTOTHERAPEUTI, V3, P2000; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsutsui T, 2009, J PLANT RES, V122, P633, DOI 10.1007/s10265-009-0252-6; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P79, DOI 10.4161/psb.2.2.4176; Vadassery J, 2012, PLANT PHYSIOL, V159, P1159, DOI 10.1104/pp.112.198150; Valerio L, 2004, PHYTOCHEMISTRY, V65, P1331, DOI 10.1016/j.phytochem.2004.04.017; Van Tassel DL, 2001, J PINEAL RES, V31, P8, DOI 10.1034/j.1600-079X.2001.310102.x; Wang P, 2013, J PINEAL RES, V54, P292, DOI [10.1111/j.1600-079X.2012.00999.x, 10.1111/jpi.12017]; Wang P, 2012, J PINEAL RES, V53, P11, DOI 10.1111/j.1600-079X.2011.00966.x; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Yin LH, 2013, J PINEAL RES, V54, P426, DOI 10.1111/jpi.12038; Yoo SD, 2008, PLANT SIGNAL BEHAV, V3, P848, DOI 10.4161/psb.3.10.5995; Zhang JH, 2006, FIELD CROP RES, V97, P111, DOI 10.1016/j.fcr.2005.08.018; Zhang L, 2012, PLOS ONE, DOI [10.1371/journal.pone.0031229, DOI 10.1371/J0URNAL.P0NE.0031229]; Zhang LJ, 2012, IN VITRO CELL DEV-PL, V48, P275, DOI 10.1007/s11627-011-9413-0; Zhang N, 2014, J PINEAL RES, V56, P39, DOI 10.1111/jpi.12095; Zhang N, 2013, J PINEAL RES, V54, P15, DOI 10.1111/j.1600-079X.2012.01015.x; Zhao Y, 2013, J PINEAL RES, V55, P79, DOI 10.1111/jpi.12044	110	193	202	7	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93462	10.1371/journal.pone.0093462	http://dx.doi.org/10.1371/journal.pone.0093462			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682084	Green Published, Green Submitted, gold			2022-12-27	WOS:000333678100047
J	Wu, J; Uchino, M; Sastry, SM; Schaumberg, DA				Wu, Juan; Uchino, Miki; Sastry, Srinivas M.; Schaumberg, Debra A.			Age-Related Macular Degeneration and the Incidence of Cardiovascular Disease: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							MYOCARDIAL-INFARCTION; RISK-FACTORS; APOLIPOPROTEIN-E; EYE DISEASE; MACULOPATHY; MORTALITY; GENOTYPES; STROKE; GENE	Importance: Research has indicated some shared pathogenic mechanisms between age-related macular degeneration (AMD) and cardiovascular disease (CVD). However, results from prior epidemiologic studies have been inconsistent as to whether AMD is predictive of future CVD risk. Objective: To systematically review population-based cohort studies of the association between AMD and risk of total CVD and CVD subtypes, coronary heart disease (CHD) and stroke. Data Sources: A systematic search of the PubMed and EMBASE databases and reference lists of key retrieved articles up to December 20, 2012 without language restriction. Data Extraction: Two reviewers independently extracted data on baseline AMD status, risk estimates of CVD and methods used to assess AMD and CVD. We pooled relative risks using random or fixed effects models as appropriate. Results: Thirteen cohort studies (8 prospective and 5 retrospective studies) with a total of 1,593,390 participants with 155,500 CVD events (92,039 stroke and 62,737 CHD) were included in this meta-analysis. Among all studies, early AMD was associated with a 15% (95% CI, 1.08-1.22) increased risk of total CVD. The relative risk was similar but not significant for late AMD (RR, 1.17; 95% CI, 0.98-1.40). In analyses restricted to the subset of prospective studies, the risk associated with early AMD did not appreciably change; however, there was a marked 66% (95% CI, 1.31-2.10) increased risk of CVD among those with late AMD. Conclusion: Whereas the results from all cohort studies suggest that both early and late AMD are predictive of a small increase in risk of future CVD, subgroup analyses limited to prospective studies demonstrate a markedly increased risk of CVD among people with late AMD. Retrospective studies using healthcare databases may have inherent methodological limitations that obscure such association. Additional prospective studies are needed to further elucidate the associations between AMD and specific CVD outcomes.	[Wu, Juan] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Uchino, Miki] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Sastry, Srinivas M.] Suburban Hosp, Bethesda, MD USA; [Schaumberg, Debra A.] Harvard Univ, Div Prevent Med, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Schaumberg, Debra A.] Univ Utah, Sch Med, Dept Ophthalmol & Visual Sci, Moran Ctr Translat Med,John A Moran Eye Ctr, Salt Lake City, UT USA; [Schaumberg, Debra A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Schaumberg, Debra A.] Schepens Eye Res Inst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Keio University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Utah System of Higher Education; University of Utah; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Schepens Eye Research Institute	Wu, J (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	juan.wu@mail.harvard.edu	Uchino, Miki/T-9102-2019		National Eye Institute [EY021900, EY017362]; Research to Prevent Blindness, Inc., New York, NY; NATIONAL EYE INSTITUTE [R01EY021900, R01EY017362] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness, Inc., New York, NY(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by EY021900, and EY017362 from the National Eye Institute (Dr. Schaumberg); and by an Unrestricted Grant from Research to Prevent Blindness, Inc., New York, NY, to the Department of Ophthalmology & Visual Sciences, University of Utah (Dr. Schaumberg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Clemons TE, 2004, ARCH OPHTHALMOL-CHIC, V122, P716; Curcio CA, 2001, INVEST OPHTH VIS SCI, V42, P265; Duan YK, 2007, OPHTHALMOLOGY, V114, P732, DOI 10.1016/j.ophtha.2006.07.045; Fernandez AB, 2012, OPHTHALMOLOGY, V119, P765, DOI 10.1016/j.ophtha.2011.09.044; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Friedman E, 2000, AM J OPHTHALMOL, V130, P658, DOI 10.1016/S0002-9394(00)00643-7; Golan S, 2011, GRAEF ARCH CLIN EXP, V249, P179, DOI 10.1007/s00417-010-1489-4; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hogg RE, 2008, OPHTHALMOLOGY, V115, P1046, DOI 10.1016/j.ophtha.2007.07.031; Hu CC, 2010, STROKE, V41, P613, DOI 10.1161/STROKEAHA.109.571000; Ikram MK, 2012, STROKE, V43, P1681, DOI 10.1161/STROKEAHA.112.654632; Kardys I, 2006, J AM COLL CARDIOL, V47, P1568, DOI 10.1016/j.jacc.2005.11.076; Klaver CCW, 1998, AM J HUM GENET, V63, P200, DOI 10.1086/301901; Klein B E, 2001, Ophthalmic Epidemiol, V8, P251, DOI 10.1076/opep.8.4.251.1612; Klein R, 2002, OPHTHALMOLOGY, V109, P1767, DOI 10.1016/S0161-6420(02)01146-6; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein Ronald, 2003, Ophthalmology, V110, P1273, DOI 10.1016/S0161-6420(03)00599-2; Knudtson MD, 2006, ARCH OPHTHALMOL-CHIC, V124, P243, DOI 10.1001/archopht.124.2.243; Liao DP, 2008, OPEN OPHTHALMOL J, V2, P37, DOI 10.2174/1874364100802010037; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Mitchell P, 2002, ARCH OPHTHALMOL-CHIC, V120, P1357, DOI 10.1001/archopht.120.10.1357; Mitta VP, 2013, JAMA OPHTHALMOL, P1; Nguyen-Khoa BA, 2008, ARCH OPHTHALMOL-CHIC, V126, P1280, DOI 10.1001/archopht.126.9.1280; Schaumberg DA, 2007, ARCH OPHTHALMOL-CHIC, V125, P300, DOI 10.1001/archopht.125.3.300; Shaw PX, 2012, P NATL ACAD SCI USA, V109, P13757, DOI 10.1073/pnas.1121309109; Snow K K, 1999, Ophthalmic Epidemiol, V6, P125, DOI 10.1076/opep.6.2.125.1558; Sofat R, 2010, ATHEROSCLEROSIS, V213, P184, DOI 10.1016/j.atherosclerosis.2010.07.021; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sun C, 2009, OPHTHALMOLOGY, V116, P1913, DOI 10.1016/j.ophtha.2009.03.046; Tan JSL, 2008, BRIT J OPHTHALMOL, V92, P509, DOI 10.1136/bjo.2007.131706; Tan JSL, 2007, OPHTHALMOLOGY, V114, P1143, DOI 10.1016/j.ophtha.2006.09.033; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; Wieberdink RG, 2011, STROKE, V42, P2138, DOI 10.1161/STROKEAHA.111.616359; Wong TY, 2007, OPHTHALMOLOGY, V114, P86, DOI 10.1016/j.ophtha.2006.06.039	42	55	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e89600	10.1371/journal.pone.0089600	http://dx.doi.org/10.1371/journal.pone.0089600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681973	Green Published, Green Submitted, gold			2022-12-27	WOS:000333678100002
J	Fichtner, D; Lorenz, B; Engin, S; Deichmann, C; Oelkers, M; Janshoff, A; Menke, A; Wedlich, D; Franz, CM				Fichtner, Dagmar; Lorenz, Baerbel; Engin, Sinem; Deichmann, Christina; Oelkers, Marieelen; Janshoff, Andreas; Menke, Andre; Wedlich, Doris; Franz, Clemens M.			Covalent and Density-Controlled Surface Immobilization of E-Cadherin for Adhesion Force Spectroscopy	PLOS ONE			English	Article							CELL-CELL ADHESION; SELF-ASSEMBLED MONOLAYERS; MEMBRANE TETHERS; FUSION PROTEINS; STEM-CELLS; BINDING; COOPERATIVITY; BENZYLGUANINE; ACTIVATION; MECHANISMS	E-cadherin is a key cell-cell adhesion molecule but the impact of receptor density and the precise contribution of individual cadherin ectodomains in promoting cell adhesion are only incompletely understood. Investigating these mechanisms would benefit from artificial adhesion substrates carrying different cadherin ectodomains at defined surface density. We therefore developed a quantitative E-cadherin surface immobilization protocol based on the SNAP-tag technique. Extracellular (EC) fragments of E-cadherin fused to the SNAP-tag were covalently bound to self-assembled monolayers (SAM) of thiols carrying benzylguanine (BG) head groups. The adhesive functionality of the different E-cadherin surfaces was then assessed using cell spreading assays and single-cell (SCSF) and single-molecule (SMSF) force spectroscopy. We demonstrate that an E-cadherin construct containing only the first and second outmost EC domain (E1-2) is not sufficient for mediating cell adhesion and yields only low single cadherin-cadherin adhesion forces. In contrast, a construct containing all five EC domains (E1-5) efficiently promotes cell spreading and generates strong single cadherin and cell adhesion forces. By varying the concentration of BG head groups within the SAM we determined a lateral distance of 5-11 nm for optimal E-cadherin functionality. Integrating the results from SCMS and SMSF experiments furthermore demonstrated that the dissolution of E-cadherin adhesion contacts involves a sequential unbinding of individual cadherin receptors rather than the sudden rupture of larger cadherin receptor clusters. Our method of covalent, oriented and density-controlled E-cadherin immobilization thus provides a novel and versatile platform to study molecular mechanisms underlying cadherin-mediated cell adhesion under defined experimental conditions.	[Fichtner, Dagmar; Engin, Sinem; Deichmann, Christina; Wedlich, Doris; Franz, Clemens M.] Karlsruhe Inst Technol, DFG Ctr Funct Nanostruct, D-76021 Karlsruhe, Germany; [Lorenz, Baerbel; Oelkers, Marieelen; Janshoff, Andreas] Univ Gottingen, Inst Phys Chem, D-37073 Gottingen, Germany; [Menke, Andre] Univ Giessen, D-35390 Giessen, Germany	German Research Foundation (DFG); Helmholtz Association; Karlsruhe Institute of Technology; University of Gottingen; Justus Liebig University Giessen	Franz, CM (corresponding author), Karlsruhe Inst Technol, DFG Ctr Funct Nanostruct, D-76021 Karlsruhe, Germany.	clemens.franz@kit.edu		Franz, Clemens/0000-0003-0104-4841; Janshoff, Andreas/0000-0002-0773-2963	DFG-Center for Functional Nanostructures [E2.2, E2.4]; DFG [FOR 1756]; Open Access Publishing Fund of Karlsruhe Institute of Technology	DFG-Center for Functional Nanostructures(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Open Access Publishing Fund of Karlsruhe Institute of Technology	This study is partially supported by grants E2.2 and E2.4 from the DFG-Center for Functional Nanostructures. Andreas Janshoff and Clemens Franz gratefully acknowledge further financial support from DFG (FOR 1756). The authors also acknowledge support from the Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697; Bayas MV, 2006, BIOPHYS J, V90, P1385, DOI 10.1529/biophysj.105.069583; Becker SF, 2012, ARCH BIOCHEM BIOPHYS, V524, P30, DOI 10.1016/j.abb.2012.02.013; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Bruns M, 2012, SURF INTERFACE ANAL, V44, P909, DOI 10.1002/sia.4876; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Chien YH, 2008, J BIOL CHEM, V283, P1848, DOI 10.1074/jbc.M708044200; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; del Valle I, 2013, DEVELOPMENT, V140, P1684, DOI 10.1242/dev.088690; Engin S, 2010, LANGMUIR, V26, P6097, DOI 10.1021/la904829y; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; Franz CM, 2007, SCI STKE, V2007, P15; FRANZ CM, 2007, SCI STKE, pPL5; Franz CM, 2012, AFM BASED SINGLE CEL, P307; Friedrichs J, 2010, NAT PROTOC, V5, P1353, DOI 10.1038/nprot.2010.89; Ganz A, 2006, BIOL CELL, V98, P721, DOI 10.1042/BC20060039; Gavard J, 2004, J CELL SCI, V117, P257, DOI 10.1242/jcs.00857; Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Karpowicz P, 2009, J NEUROSCI, V29, P3885, DOI 10.1523/JNEUROSCI.0037-09.2009; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kindermann M, 2003, J AM CHEM SOC, V125, P7810, DOI 10.1021/ja034145s; Korner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054749; Kraft B, 2012, J CELL BIOL, V198, P695, DOI 10.1083/jcb.201110076; Lambert M, 2002, J CELL BIOL, V157, P469, DOI 10.1083/jcb.200107104; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Leckband D, 2012, CURR OPIN CELL BIOL, V24, P620, DOI 10.1016/j.ceb.2012.05.014; MCNEILL H, 1993, J CELL BIOL, V120, P1217, DOI 10.1083/jcb.120.5.1217; Muller MA, 2013, J MOL BIOL, V425, P2988, DOI 10.1016/j.jmb.2013.05.020; Niessen CM, 2011, PHYSIOL REV, V91, P691, DOI 10.1152/physrev.00004.2010; Niessen CM, 2002, J CELL BIOL, V156, P389, DOI 10.1083/jcb.200108040; OZAWA M, 1990, CELL, V63, P1033, DOI 10.1016/0092-8674(90)90506-A; OZAWA M, 1990, J CELL BIOL, V111, P1645, DOI 10.1083/jcb.111.4.1645; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x; Puech PH, 2006, ULTRAMICROSCOPY, V106, P637, DOI 10.1016/j.ultramic.2005.08.003; Raucher D, 1999, BIOPHYS J, V77, P1992, DOI 10.1016/S0006-3495(99)77040-2; Richter B, 2013, ADV MAT; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; Sako Y, 1998, J CELL BIOL, V140, P1227, DOI 10.1083/jcb.140.5.1227; Schmitz J, 2008, BIOPHYS J, V95, P1448, DOI 10.1529/biophysj.107.124289; Selhuber-Unkel C, 2008, BIOPHYS J, V95, P5424, DOI 10.1529/biophysj.108.139584; Stemmler MP, 2008, MOL BIOSYST, V4, P835, DOI 10.1039/b719215k; Sun MZ, 2005, BIOPHYS J, V89, P4320, DOI 10.1529/biophysj.104.058180; Taubenberger A, 2007, MOL BIOL CELL, V18, P1634, DOI 10.1091/mbc.E06-09-0777; Thie M, 1998, HUM REPROD, V13, P3211, DOI 10.1093/humrep/13.11.3211; Thiery JP, 2012, CURR OPIN CELL BIOL, V24, P614, DOI 10.1016/j.ceb.2012.06.007; Weber GF, 2012, DEV CELL, V22, P104, DOI 10.1016/j.devcel.2011.10.013; Wu YH, 2011, NATURE, V475, P510, DOI 10.1038/nature10183; Wu YH, 2010, P NATL ACAD SCI USA, V107, P17592, DOI 10.1073/pnas.1011247107; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P109, DOI 10.1073/pnas.0811350106	56	30	30	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93123	10.1371/journal.pone.0093123	http://dx.doi.org/10.1371/journal.pone.0093123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675966	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677500075
J	Hidalgo-Tenorio, C; Rivero-Rodriguez, M; Gil-Anguita, C; De Hierro, ML; Palma, P; Ramirez-Taboada, J; Esquivias, J; Lopez-Ruz, MA; Javier-Martinez, R; Pasquau-Liano, J				Hidalgo-Tenorio, Carmen; Rivero-Rodriguez, Mar; Gil-Anguita, Concepcion; Lopez De Hierro, Mercedes; Palma, Pablo; Ramirez-Taboada, Jessica; Esquivias, Javier; Angel Lopez-Ruz, Miguel; Javier-Martinez, Rosario; Pasquau-Liano, Juan			Antiretroviral Therapy as a Factor Protective against Anal Dysplasia in HIV-Infected Males Who Have Sex with Males	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; AIDS-DEFINING CANCERS; NATURAL-HISTORY; RISK; MEN; LESIONS; HPV; EPIDEMIOLOGY; TERMINOLOGY; GUIDELINES	Objectives: Chronic infection with oncogenic HPV genotype is associated with the development of anal dysplasia. Antiretroviral therapy (ART) has been shown to decrease the incidence of cervical carcinoma in women with HIV. We sought to: 1) describe the prevalence and grade of anal dysplasia and HPV infection in our study subjects; 2) analyze the grade of correlation between anal cytology, PCR of high-risk HPV, and histology; 3) identify the factors associated with the appearance of >= AIN2 lesions. Design: Cross-sectional, prospective study. Methods: A cohort of HIV-positive males (n = 140, mean age = 37 years) who have sex with males (MSM) had epidemiological, clinical and analytical data collected. Anal mucosa samples were taken for cytology, HPV PCR genotyping, and anoscopy for histological analysis. Results: Within the cohort, 77.1% were being treated with ART, 8.5% anoscopy findings were AIN2, and 11.4% carcinoma in situ; 74.2% had high-risk (HR), 59.7% low-risk (LR) HPV genotypes and 46.8% had both. The combination of cytology with PCR identifying HR-HPV better predicts the histology findings than either of these factors alone. Logistic regression highlighted ART as a protective factor against >= AIN2 lesions (OR: 0.214; 95% CI: 0.054-0.84). Anal/genital condylomas (OR: 4.26; 95% CI: 1.27-14.3), and HPV68 genotype (OR: 10.6; 95% CI: 1.23-91.47) were identified as risk factors. Conclusions: In our cohort, ART has a protective effect against dysplastic anal lesions. Anal/genital warts and HPV68 genotype are predictors of >= AIN2 lesions. Introducing PCR HPV genotype evaluation improves screening success over that of cytology alone.	[Hidalgo-Tenorio, Carmen; Rivero-Rodriguez, Mar; Gil-Anguita, Concepcion; Ramirez-Taboada, Jessica; Angel Lopez-Ruz, Miguel; Javier-Martinez, Rosario; Pasquau-Liano, Juan] Univ Hosp Virgen Nieves, Infect Dis Unit, Granada, Spain; [Lopez De Hierro, Mercedes] Univ Hosp Virgen Nieves, Gastroenterol Serv, Granada, Spain; [Palma, Pablo] Univ Hosp Virgen Nieves, Gen Surg Serv, Granada, Spain; [Esquivias, Javier] Univ Hosp Virgen Nieves, Pathol Serv, Granada, Spain	Hospital Universitario Virgen de las Nieves; Hospital Universitario Virgen de las Nieves; Hospital Universitario Virgen de las Nieves; Hospital Universitario Virgen de las Nieves	Hidalgo-Tenorio, C (corresponding author), Univ Hosp Virgen Nieves, Infect Dis Unit, Granada, Spain.	chidalgo72@hotmail.com		Palma, Pablo/0000-0003-1084-5982				Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Andres AM, 2005, STAT METHODS MED RES, V14, P473, DOI 10.1191/0962280205sm412oa; Blitz S, 2013, J INFECT DIS, V208, P454, DOI 10.1093/infdis/jit181; CHAN SY, 1992, J VIROL, V66, P5714, DOI 10.1128/JVI.66.10.5714-5725.1992; D'Souza G, 2008, JAIDS-J ACQ IMM DEF, V48, P491, DOI 10.1097/QAI.0b013e31817aebfe; Darragh TM, 2012, J LOW GENIT TRACT DI, V16, P205, DOI 10.1097/PGP.0b013e31826916c7; Darwich L, 2013, DIS COLON RECTUM, V56, P1043, DOI 10.1097/DCR.0b013e31829c654f; de Pokomandy A, 2011, CLIN INFECT DIS, V52, P1174, DOI 10.1093/cid/cir064; Diamond C, 2005, SEX TRANSM DIS, V32, P314, DOI 10.1097/01.olq.0000162366.60245.02; Franceschi S, 2010, BRIT J CANCER, V103, P416, DOI 10.1038/sj.bjc.6605756; Freeman D, 1987, APPL CATEGORICAL DAT; GESIDA & PNS, 2011, ENFERM INFEC MICR CL, V29, P286, DOI 10.1016/j.eimc.2010.10.002; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Heard I, 2005, MED MALADIES INFECT, V35, P302, DOI 10.1016/j.medmal.2005.02.008; Tenorio CH, 2013, MED CLIN-BARCELONA, V140, P193, DOI 10.1016/j.medcli.2012.05.044; Hleyhel M, 2013, CLIN INFECT DIS, V57, P1638, DOI 10.1093/cid/cit497; Kojic EM, 2011, SEX TRANSM DIS, V38, P253, DOI 10.1097/OLQ.0b013e3181f70253; Kutlubay Z, 2013, CLIN DERMATOL, V31, P362, DOI 10.1016/j.clindermatol.2013.01.003; Mooij SH, 2013, CANCER EPIDEM BIOMAR, V22, P1698, DOI 10.1158/1055-9965.EPI-13-0460; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Oon SF, 2010, J MED SCREEN, V17, P44, DOI 10.1258/jms.2009.009058; Palefsky JM, 2009, OBSTET GYN CLIN N AM, V36, P187, DOI 10.1016/j.ogc.2009.02.003; Piketty C, 2008, AIDS, V22, P1203, DOI 10.1097/QAD.0b013e3283023f78; Pinzone MR, 2012, EUR REV MED PHARMACO, V16, P1377; Salati SA, 2012, INT J HEALTH SCI-IJH, V6, P206, DOI 10.12816/0006000; Scholefield JH, 2011, COLORECTAL DIS, V13, P3, DOI 10.1111/j.1463-1318.2010.02494.x; Schwartz LM, 2013, J INFECT DIS, V208, P1768, DOI 10.1093/infdis/jit374; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Silverberg MJ, 2012, CLIN INFECT DIS, V54, P1026, DOI 10.1093/cid/cir1012; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; van der Snoek EM, 2012, SEX TRANSM DIS, V39, P495, DOI 10.1097/OLQ.0b013e31825aa764; Videla S, 2013, SEX TRANSM DIS, V40, P3, DOI 10.1097/OLQ.0b013e31827e87bd; Yang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035983	33	15	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92376	10.1371/journal.pone.0092376	http://dx.doi.org/10.1371/journal.pone.0092376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676139	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500020
J	Pickering, AJ; Blum, AG; Breiman, RF; Ram, PK; Davis, J				Pickering, Amy J.; Blum, Annalise G.; Breiman, Robert F.; Ram, Pavani K.; Davis, Jennifer			Video Surveillance Captures Student Hand Hygiene Behavior, Reactivity to Observation, and Peer Influence in Kenyan Primary Schools	PLOS ONE			English	Article							QUESTIONNAIRES; SOAP	Background: In-person structured observation is considered the best approach for measuring hand hygiene behavior, yet is expensive, time consuming, and may alter behavior. Video surveillance could be a useful tool for objectively monitoring hand hygiene behavior if validated against current methods. Methods: Student hand cleaning behavior was monitored with video surveillance and in-person structured observation, both simultaneously and separately, at four primary schools in urban Kenya over a study period of 8 weeks. Findings: Video surveillance and in-person observation captured similar rates of hand cleaning (absolute difference <5%, p = 0.74). Video surveillance documented higher hand cleaning rates (71%) when at least one other person was present at the hand cleaning station, compared to when a student was alone (48%; rate ratio = 1.14 [95% CI 1.01-1.28]). Students increased hand cleaning rates during simultaneous video and in-person monitoring as compared to single-method monitoring, suggesting reactivity to each method of monitoring. This trend was documented at schools receiving a handwashing with soap intervention, but not at schools receiving a sanitizer intervention. Conclusion: Video surveillance of hand hygiene behavior yields results comparable to in-person observation among schools in a resource-constrained setting. Video surveillance also has certain advantages over in-person observation, including rapid data processing and the capability to capture new behavioral insights. Peer influence can significantly improve student hand cleaning behavior and, when possible, should be exploited in the design and implementation of school hand hygiene programs.	[Pickering, Amy J.; Davis, Jennifer] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Pickering, Amy J.; Blum, Annalise G.; Davis, Jennifer] Stanford Univ, Stanford, CA 94305 USA; [Breiman, Robert F.] Ctr Dis Control & Prevent, Kenya Off, Global Dis Detect Program, Nairobi, Kenya; [Ram, Pavani K.] SUNY Buffalo, Buffalo, NY 14260 USA; [Breiman, Robert F.] Ctr Dis Control & Prevent, Global Dis Detect Branch, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA	Stanford University; Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Centers for Disease Control & Prevention - USA	Pickering, AJ (corresponding author), Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA.	amyjanel@stanford.edu			CDC-Kenya/KEMRI; Freeman Spogli Institute for International Studies at Stanford University	CDC-Kenya/KEMRI; Freeman Spogli Institute for International Studies at Stanford University	This study was funded by CDC-Kenya/KEMRI (http://www.cdc.gov/globalhealth/countries/kenya/), and the Freeman Spogli Institute for International Studies at Stanford University (http://fsi.stanford.edu/). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MEC, 2012, EPIDEMIOL INFECT, V140, P182, DOI 10.1017/S095026881100029X; Armellino D, 2012, CLIN INFECT DIS, V54, P1, DOI 10.1093/cid/cir773; Brown J, 1996, PEDIATR INFECT DIS J, V15, P908, DOI 10.1097/00006454-199610000-00016; Cousens S, 1996, SOC SCI MED, V43, P1299, DOI 10.1016/0277-9536(95)00380-0; Curtis VA, 2009, HEALTH EDUC RES, V24, P655, DOI 10.1093/her/cyp002; Drankiewicz D, 2003, AM J INFECT CONTROL, V31, P67, DOI 10.1067/mic.2003.6; Gittelsohn J, 1997, HUM ORGAN, V56, P182, DOI 10.17730/humo.56.2.c7x0532q2u86m207; Jay LS, 1999, J FOOD PROTECT, V62, P1285, DOI 10.4315/0362-028X-62.11.1285; Luby SP, 2009, AM J TROP MED HYG, V81, P882, DOI 10.4269/ajtmh.2009.09-0031; ManunEbo M, 1997, TROP MED INT HEALTH, V2, P1015, DOI 10.1046/j.1365-3156.1997.d01-180.x; Maury E, 2006, INTENS CARE MED, V32, P2088, DOI 10.1007/s00134-006-0398-9; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; Nishimura S, 1999, AM J INFECT CONTROL, V27, P367, DOI 10.1016/S0196-6553(99)70058-1; O'Reilly CE, 2007, EPIDEMIOL INFECT; Pan SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053746; PEDERSEN DM, 1986, PERCEPT MOTOR SKILL, V62, P169, DOI 10.2466/pms.1986.62.1.169; Pickering AJ, 2013, AM J TROP MED HYG, V89, P411, DOI 10.4269/ajtmh.13-0008; Ram P, 2013, PRACTICAL GUIDANCE M; Ram PK, 2010, AM J TROP MED HYG, V83, P1070, DOI 10.4269/ajtmh.2010.09-0763; RUSSELL A, 1992, MERRILL PALMER QUART, V38, P263; STANTON BF, 1987, B WORLD HEALTH ORGAN, V65, P217; Zhang L, 2009, CHINESE J NOSOCOMIOL	22	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92571	10.1371/journal.pone.0092571	http://dx.doi.org/10.1371/journal.pone.0092571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SW	24676389	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677500025
J	Wang, YH; Pang, BB; Ghosh, S; Zhou, X; Shintani, T; Urushibara, N; Song, YW; He, MY; Liu, MQ; Tang, WF; Peng, JS; Hu, Q; Zhou, DJ; Kobayashi, N				Wang, Yuan-Hong; Pang, Bei-Bei; Ghosh, Souvik; Zhou, Xuan; Shintani, Tsuzumi; Urushibara, Noriko; Song, Yu-Wei; He, Ming-Yang; Liu, Man-Qing; Tang, Wei-Feng; Peng, Jin-Song; Hu, Quan; Zhou, Dun-Jin; Kobayashi, Nobumichi			Molecular Epidemiology and Genetic Evolution of the Whole Genome of G3P[8] Human Rotavirus in Wuhan, China, from 2000 through 2013	PLOS ONE			English	Article							GROUP-A ROTAVIRUS; REPUBLIC-OF-CHINA; ACUTE GASTROENTERITIS; PEDIATRIC-PATIENTS; CHILDREN; STRAINS; G3; DIARRHEA; PROTEIN; VP7	Background: Rotaviruses are a major etiologic agent of gastroenteritis in infants and young children worldwide. Since the latter of the 1990s, G3 human rotaviruses referred to as "new variant G3'' have emerged and spread in China, being a dominant genotype until 2010, although their genomic evolution has not yet been well investigated. Methods: The complete genomes of 33 G3P[8] human rotavirus strains detected in Wuhan, China, from 2000 through 2013 were analyzed. Phylogenetic trees of concatenated sequences of all the RNA segments and individual genes were constructed together with published rotavirus sequences. Results: Genotypes of 11 gene segments of all the 33 strains were assigned to G3-P[8]-I1-R1-C1-M1-A1-N1-T1-E1-H1, belonging to Wa genogroup. Phylogenetic analysis of the concatenated full genome sequences indicated that all the modern G3P[8] strains were assigned to Cluster 2 containing only one clade of G3P[8] strains in the US detected in the 1970s, which was distinct from Cluster 1 comprising most of old G3P[8] strains. While main lineages of all the 11 gene segments persisted during the study period, different lineages appeared occasionally in RNA segments encoding VP1, VP4, VP6, and NSP1-NSP5, exhibiting various allele constellations. In contrast, only a single lineage was detected for VP7, VP2, and VP3 genes. Remarkable lineage shift was observed for NSP1 gene; lineage A1-2 emerged in 2007 and became dominant in 2008-2009 epidemic season, while lineage A1-1 persisted throughout the study period. Conclusion: Chinese G3P[8] rotavirus strains have evolved since 2000 by intra-genogroup reassortment with co-circulating strains, accumulating more reassorted genes over the years. This is the first large-scale whole genome-based study to assess the long-term evolution of common human rotaviruses (G3P[8]) in an Asian country.	[Wang, Yuan-Hong; Pang, Bei-Bei; Zhou, Xuan; Liu, Man-Qing; Tang, Wei-Feng; Peng, Jin-Song; Hu, Quan; Zhou, Dun-Jin] Wuhan Ctr Dis Prevent & Control, Virol Sect, Wuhan, Hubei Province, Peoples R China; [Ghosh, Souvik; Shintani, Tsuzumi; Urushibara, Noriko; Kobayashi, Nobumichi] Sapporo Med Univ, Sch Med, Dept Hyg, Sapporo, Hokkaido, Japan; [Song, Yu-Wei; He, Ming-Yang] Cent China Normal Univ, Coll Life Sci, Wuhan, Hubei Province, Peoples R China	Sapporo Medical University; Central China Normal University	Wang, YH (corresponding author), Wuhan Ctr Dis Prevent & Control, Virol Sect, Wuhan, Hubei Province, Peoples R China.	wyhhyc@163.com; nkobayas@sapmed.ac.jp	Liu, Man-Qing/M-9598-2014; Urushibara, Noriko/AAQ-9883-2021	Liu, Man-Qing/0000-0002-9754-3102; Urushibara, Noriko/0000-0003-0363-567X; Ghosh, Souvik/0000-0001-7581-1033	National Natural Science Foundation of China [81071352]; Japan Society for the Promotion of Science [25305022]; Ministry of Health, Labour and Welfare, Japan [H25-shinkou-ippan-005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	The work was funded by the National Natural Science Foundation of China (Grant no. 81071352), and the fund for experts of Wuhan municipality to Yuan-Hong Wang, and the Grant-in-Aid for Scientific Research (Grant no. 25305022) from the Japan Society for the Promotion of Science, and the Grant-in-Aid for Research on Emerging and Re-emerging Infectious Diseases (grant H25-shinkou-ippan-005) by the Ministry of Health, Labour and Welfare, Japan to NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed K, 2010, ARCH VIROL, V155, P71, DOI 10.1007/s00705-009-0552-0; [Anonymous], 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002907; Aoki ST, 2009, SCIENCE, V324, P1444, DOI 10.1126/science.1170481; Arnold MM, 2011, J VIROL, V85, P1970, DOI 10.1128/JVI.01801-10; Bagchi P, 2010, J VIROL, V84, P6834, DOI 10.1128/JVI.00225-10; Barro M, 2005, P NATL ACAD SCI USA, V102, P4114, DOI 10.1073/pnas.0408376102; Barro M, 2007, J VIROL, V81, P4473, DOI 10.1128/JVI.02498-06; Bucardo F, 2012, INFECT GENET EVOL, V12, P1282, DOI 10.1016/j.meegid.2012.03.007; Chaimongkol N, 2012, INFECT GENET EVOL, V12, P1381, DOI 10.1016/j.meegid.2012.04.015; Chan-It W, 2011, INFECT GENET EVOL, V11, P415, DOI 10.1016/j.meegid.2010.11.018; Chen Y, 2013, PEDIATR INFECT DIS J, V32, pE285, DOI 10.1097/INF.0b013e31828c3de4; Chen YD, 2008, VIROLOGY, V375, P361, DOI 10.1016/j.virol.2008.01.003; Dong HJ, 2013, INFECT GENET EVOL, V20, P155, DOI 10.1016/j.meegid.2013.08.024; Dormitzer PR, 2004, NATURE, V430, P1053, DOI 10.1038/nature02836; Duan ZJ, 2009, J INFECT DIS, V200, pS167, DOI 10.1086/605039; Estes MK, 2007, FIELDS VIROLOGY, P1917; Fang ZY, 2005, J INFECT DIS, V192, pS94, DOI 10.1086/431505; Fang ZY, 2002, J CLIN MICROBIOL, V40, P1875, DOI 10.1128/JCM.40.5.1875-1878.2002; Feng N, 2009, J VIROL, V83, P6987, DOI 10.1128/JVI.00585-09; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; Gentsch JR, 1996, J INFECT DIS, V174, pS30, DOI 10.1093/infdis/174.Supplement_1.S30; Ghosh S, 2011, FUTURE MICROBIOL, V6, P1049, DOI [10.2217/FMB.11.90, 10.2217/fmb.11.90]; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990; Graff JW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000280; Han TH, 2010, ARCH VIROL, V155, P1663, DOI 10.1007/s00705-010-0752-7; Heiman EM, 2008, J VIROL, V82, P11106, DOI 10.1128/JVI.01402-08; HUA J, 1993, VIROLOGY, V196, P372, DOI 10.1006/viro.1993.1492; Iturriza-Gomara M, 2004, J CLIN VIROL, V31, P259, DOI 10.1016/j.jcv.2004.04.009; Kawai K, 2012, VACCINE, V30, P1244, DOI 10.1016/j.vaccine.2011.12.092; Khamrin P, 2006, J MED VIROL, V78, P273, DOI 10.1002/jmv.20536; KOBAYASHI N, 1989, ARCH VIROL, V109, P11, DOI 10.1007/BF01310514; Lai HC, 2005, J CLIN VIROL, V32, P199, DOI 10.1016/j.jcv.2004.07.009; Lennon G, 2008, J MED VIROL, V80, P524, DOI 10.1002/jmv.21084; Li RC, 2014, HUM VACC IMMUNOTHER, V10, P11, DOI 10.4161/hv.26319; Martinez-Laso J, 2009, J GEN VIROL, V90, P935, DOI 10.1099/vir.0.007807-0; Matthijnssens J, 2012, EXPERT REV VACCINES, V11, P1347, DOI [10.1586/ERV.12.105, 10.1586/erv.12.105]; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; McDonald SM, 2012, J VIROL, V86, P9148, DOI 10.1128/JVI.01105-12; McDonald SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000634; Meiji-Soe-Aung, 2010, SE ASIAN J TROP MED, V41, P1393; Min BS, 2004, J CLIN MICROBIOL, V42, P4297, DOI 10.1128/JCM.42.9.4297-4299.2004; Mitui MT, 2011, J CLIN VIROL, V50, P325, DOI 10.1016/j.jcv.2011.01.008; Nagashima S, 2010, JPN J INFECT DIS, V63, P208; Nakagomi T, 2002, ARCH VIROL, V147, P2187, DOI 10.1007/s00705-002-0861-z; Ngo TC, 2009, VACCINE, V27, pF75, DOI 10.1016/j.vaccine.2009.08.074; Orenstein EW, 2007, VACCINE, V25, P406, DOI 10.1016/j.vaccine.2006.07.054; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Phan TG, 2007, CLIN LAB, V53, P41; Pietsch C, 2011, J CLIN VIROL, V50, P136, DOI 10.1016/j.jcv.2010.10.013; Sanchez-Fauquier A, 2006, EMERG INFECT DIS, V12, P1536, DOI 10.3201/eid1210.060384; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Seheri LM, 2010, J INFECT DIS, V202, pS139, DOI 10.1086/653559; Shintani T, 2012, VIRUSES-BASEL, V4, P1289, DOI 10.3390/v4081289; Stupka JA, 2009, INFECT GENET EVOL, V9, P1225, DOI 10.1016/j.meegid.2009.07.002; Tamura T, 2010, JPN J INFECT DIS, V63, P405; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Thongprachum A, 2013, INFECT GENET EVOL, V13, P168, DOI 10.1016/j.meegid.2012.09.010; Trinh QD, 2007, J MED VIROL, V79, P1611, DOI 10.1002/jmv.20931; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; Varshney B, 2002, ARCH VIROL, V147, P143, DOI 10.1007/s705-002-8308-z; Wang YH, 2007, ARCH VIROL, V152, P669, DOI 10.1007/s00705-006-0904-y; Wang YH, 2013, INFECT GENET EVOL, V16, P103, DOI 10.1016/j.meegid.2013.01.016; Wang YH, 2011, ARCH VIROL, V156, P2221, DOI 10.1007/s00705-011-1122-9; Wang YH, 2010, J MED VIROL, V82, P1094, DOI 10.1002/jmv.21760; Wang YH, 2009, J MED VIROL, V81, P382, DOI 10.1002/jmv.21387; WANG Z, 2009, ZHONGGUO WEI SHENG J, V0019; Ward P, 2013, J APPL MICROBIOL, V114, P1435, DOI 10.1111/jam.12165; Wen L, 1997, ARCH VIROL, V142, P1481, DOI 10.1007/s007050050174; Zeller M, 2012, J CLIN MICROBIOL, V50, P966, DOI 10.1128/JCM.05590-11; Zhang Xian-E, 2012, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V26, P5	70	28	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e88850	10.1371/journal.pone.0088850	http://dx.doi.org/10.1371/journal.pone.0088850			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676363	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500003
J	Wen, YX; Wu, WR				Wen, Yongxian; Wu, Weiren			Mapping of Imprinted Quantitative Trait Loci Using Immortalized F-2 Populations	PLOS ONE			English	Article							BODY-COMPOSITION; MATERNAL CONTROL; GENE; CROSSES; PIGS; QTL; ARABIDOPSIS; PHENOTYPE; ENDOSPERM; GROWTH	Mapping of imprinted quantitative trait loci (iQTLs) is helpful for understanding the effects of genomic imprinting on complex traits in animals and plants. At present, the experimental designs and corresponding statistical methods having been proposed for iQTL mapping are all based on temporary populations including F-2 and BC1, which can be used only once and suffer some other shortcomings respectively. In this paper, we propose a framework for iQTL mapping, including methods of interval mapping (IM) and composite interval mapping (CIM) based on conventional low-density genetic maps and point mapping (PM) and composite point mapping (CPM) based on ultrahigh-density genetic maps, using an immortalized F-2 (imF(2)) population generated by random crosses between recombinant inbred lines or doubled haploid lines. We demonstrate by simulations that imF(2) populations are very desirable and the proposed statistical methods (especially CIM and CPM) are very powerful for iQTL mapping, with which the imprinting effects as well as the additive and dominance effects of iQTLs can be unbiasedly estimated.	[Wen, Yongxian; Wu, Weiren] Fujian Agr & Forestry Univ, Key Lab Educ, Minist Genet Breeding & Multiple Utilizat Crops, Fuzhou, Fujian, Peoples R China; [Wen, Yongxian] Fujian Agr & Forestry Univ, Sch Comp & Informat Sci, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Wu, WR (corresponding author), Fujian Agr & Forestry Univ, Key Lab Educ, Minist Genet Breeding & Multiple Utilizat Crops, Fuzhou, Fujian, Peoples R China.	wuwr@fafu.edu.cn			National Natural Science Foundation of China [31171448]; Natural Science Foundation of Fujian Province [2012J01069]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This work was supported by the National Natural Science Foundation of China ( project no.: 31171448) and the Natural Science Foundation of Fujian Province (project no. 2012J01069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Chen W, 2007, THEOR APPL GENET, V115, P849, DOI 10.1007/s00122-007-0613-2; Cheverud JM, 2008, P NATL ACAD SCI USA, V105, P4253, DOI 10.1073/pnas.0706562105; CHURCHILL GA, 1994, GENETICS, V138, P963; Cruz-Correa M, 2004, GASTROENTEROLOGY, V126, P964, DOI 10.1053/j.gastro.2003.12.051; Cui YH, 2006, GENOMICS, V87, P543, DOI 10.1016/j.ygeno.2005.11.021; Cui YH, 2007, GENETICA, V130, P227, DOI 10.1007/s10709-006-9101-x; Cui YH, 2007, J THEOR BIOL, V244, P115, DOI 10.1016/j.jtbi.2006.07.009; Cui YH, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-6; de Koning DJ, 2002, GENETICS, V161, P931; de Koning DJ, 2000, P NATL ACAD SCI USA, V97, P7947, DOI 10.1073/pnas.140216397; Dilkes BP, 2002, GENETICS, V160, P1163; Falls JG, 1999, AM J PATHOL, V154, P635, DOI 10.1016/S0002-9440(10)65309-6; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HALEY CS, 1994, GENETICS, V136, P1195; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Kelsey G, 1997, BIOESSAYS, V19, P361, DOI 10.1002/bies.950190502; KERMICLE JL, 1970, GENETICS, V66, P69; Kinoshita T, 1999, PLANT CELL, V11, P1945, DOI 10.1105/tpc.11.10.1945; Knott SA, 1998, GENETICS, V149, P1069; Lawson HA, 2013, NAT REV GENET, V14, P608, DOI 10.1038/nrg3543; Li ZK, 2010, J GENET, V89, P409, DOI 10.1007/s12041-010-0059-1; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Nezer C, 1999, NAT GENET, V21, P155, DOI 10.1038/5935; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; SAPIENZA C, 1995, DEV GENET, V17, P185, DOI 10.1002/dvg.1020170302; Tang JH, 2010, THEOR APPL GENET, V120, P333, DOI 10.1007/s00122-009-1213-0; Threadgill DW, 2011, ILAR J, V52, P24, DOI 10.1093/ilar.52.1.24; Wang CG, 2012, BRIEF BIOINFORM, V13, P34, DOI 10.1093/bib/bbr023; Waters AJ, 2011, PLANT CELL, V23, P4221, DOI 10.1105/tpc.111.092668; Wolf JB, 2008, EPIGENETICS-US, V3, P295, DOI 10.4161/epi.3.6.7257; Wu RL, 2002, GENET RES, V79, P85, DOI 10.1017/S0016672301005389; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; ZENG ZB, 1994, GENETICS, V136, P1457; Zou F, 2005, GENETICS, V170, P1299, DOI 10.1534/genetics.104.035709	38	1	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92989	10.1371/journal.pone.0092989	http://dx.doi.org/10.1371/journal.pone.0092989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676330	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500063
J	Ainalem, ML; Bartles, A; Muck, J; Dias, RS; Carnerup, AM; Zink, D; Nylander, T				Ainalem, Marie-Louise; Bartles, Andrew; Muck, Joscha; Dias, Rita S.; Carnerup, Anna M.; Zink, Daniele; Nylander, Tommy			DNA Compaction Induced by a Cationic Polymer or Surfactant Impact Gene Expression and DNA Degradation	PLOS ONE			English	Article							COIL-GLOBULE TRANSITION; TRANSCRIPTIONAL ACTIVITY; PAMAM DENDRIMERS; ETHIDIUM-BROMIDE; LIGHT-SCATTERING; PHASE-BEHAVIOR; CHROMATIN; PEPTIDE; CONDENSATION; ACTIVATION	There is an increasing interest in achieving gene regulation in biotechnological and biomedical applications by using synthetic DNA-binding agents. Most studies have so far focused on synthetic sequence-specific DNA-binding agents. Such approaches are relatively complicated and cost intensive and their level of sophistication is not always required, in particular for biotechnological application. Our study is inspired by in vivo data that suggest that DNA compaction might contribute to gene regulation. This study exploits the potential of using synthetic DNA compacting agents that are not sequence-specific to achieve gene regulation for in vitro systems. The semi-synthetic in vitro system we use include common cationic DNA-compacting agents, poly(amido amine) (PAMAM) dendrimers and the surfactant hexadecyltrimethylammonium bromide (CTAB), which we apply to linearized plasmid DNA encoding for the luciferase reporter gene. We show that complexing the DNA with either of the cationic agents leads to gene expression inhibition in a manner that depends on the extent of compaction. This is demonstrated by using a coupled in vitro transcription-translation system. We show that compaction can also protect DNA against degradation in a dose-dependent manner. Furthermore, our study shows that these effects are reversible and DNA can be released from the complexes. Release of DNA leads to restoration of gene expression and makes the DNA susceptible to degradation by Dnase. A highly charged polyelectrolyte, heparin, is needed to release DNA from dendrimers, while DNA complexed with CTAB dissociates with the non-ionic surfactant C12E5. Our results demonstrate the relation between DNA compaction by non-specific DNA-binding agents and gene expression and gene regulation can be achieved in vitro systems in a reliable dose-dependent and reversible manner.	[Ainalem, Marie-Louise; Bartles, Andrew; Dias, Rita S.; Carnerup, Anna M.; Nylander, Tommy] Lund Univ, Ctr Chem & Chem Engn, S-22100 Lund, Sweden; [Muck, Joscha; Zink, Daniele] Univ Munich, Dept Biol 2, Planegg Martinsried, Germany	Lund University; University of Munich	Ainalem, ML (corresponding author), Lund Univ, Ctr Chem & Chem Engn, S-22100 Lund, Sweden.	marie-louise.ainalem@esss.se	de Sousa Dias, Rita/C-2224-2008; Zink, Daniele/A-8181-2015	de Sousa Dias, Rita/0000-0001-9600-0934; Nylander, Tommy/0000-0001-9420-2217	EU [12967]; Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BPD/24203/2005]	EU(European Commission); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	The sixth EU framework program is greatly acknowledged for funding this work as being a part of a EU-STREP project with NEST program (NEONUCLEI, Contract no. 12967). RD acknowledges the Fundacao para a Ciencia e a Tecnologia, Portugal (SFRH/BPD/24203/2005 and the programme Ciencia 2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainalem ML, 2011, SOFT MATTER, V7, P4577, DOI 10.1039/c0sm01171a; Ainalem ML, 2009, SOFT MATTER, V5, P2310, DOI 10.1039/b821629k; Bednarski D, 2006, CHEMBIOCHEM, V7, P1715, DOI 10.1002/cbic.200600141; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; BELLARE JR, 1988, J ELECTRON MICR TECH, V10, P87, DOI 10.1002/jemt.1060100111; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Besch R, 2004, J INVEST DERMATOL, V122, P1114, DOI 10.1111/j.0022-202X.2004.22521.x; Bielinska A, 1996, NUCLEIC ACIDS RES, V24, P2176, DOI 10.1093/nar/24.11.2176; Bielinska AU, 1997, BBA-GENE STRUCT EXPR, V1353, P180, DOI 10.1016/S0167-4781(97)00069-9; Bitton R, 2005, LANGMUIR, V21, P11888, DOI 10.1021/la051811p; Blagbrough IS, 2003, BIOCHEM SOC T, V31, P397, DOI 10.1042/BST0310397; Cakara D, 2003, MACROMOLECULES, V36, P4201, DOI 10.1021/ma0300241; Cardenas M, 2008, INTERACTION DNA SURF, P291; Carlson ED, 2012, BIOTECHNOL ADV, V30, P1185, DOI 10.1016/j.biotechadv.2011.09.016; Carnerup AM, 2009, LANGMUIR, V25, P12466, DOI 10.1021/la903068v; Carnerup AM, 2011, SOFT MATTER, V7, P760, DOI 10.1039/c0sm00644k; Chen W, 2000, LANGMUIR, V16, P15, DOI 10.1021/la981429v; Cogoi S, 2005, BIOCHEMISTRY-US, V44, P10510, DOI 10.1021/bi0505215; Corbyn CP, 2009, PHYS CHEM CHEM PHYS, V11, P11568, DOI 10.1039/b916116c; Corsi J, 2008, CHEM COMMUN, P2307, DOI 10.1039/b801199k; Dexter AF, 2008, IND ENG CHEM RES, V47, P6391, DOI 10.1021/ie800127f; Dias R, 2000, LANGMUIR, V16, P9577, DOI 10.1021/la000640f; Dias R.S., 2008, DNA INTERACT POLYM S, P89, DOI DOI 10.1002/9780470286364.CH4; Dias RS, 2005, ELECTROPHORESIS, V26, P2908, DOI 10.1002/elps.200400182; Dias RS, 2005, J PHYS CHEM B, V109, P10458, DOI 10.1021/jp0444464; Dufes C, 2005, ADV DRUG DELIVER REV, V57, P2177, DOI 10.1016/j.addr.2005.09.017; El-Sayed M, 2001, PHARM RES-DORDR, V18, P23, DOI 10.1023/A:1011066408283; Fant K, 2008, BIOCHEMISTRY-US, V47, P1732, DOI 10.1021/bi7017199; Fox KR, 2000, CURR MED CHEM, V7, P17, DOI 10.2174/0929867003375506; Ghosh MK, 2005, MOL CELL BIOCHEM, V278, P147, DOI 10.1007/s11010-005-7283-7; GODDARD ED, 1977, J AM OIL CHEM SOC, V54, P561, DOI 10.1007/BF03027636; Gonzalez-Perez A, 2008, BIOMACROMOLECULES, V9, P772, DOI 10.1021/bm7012907; Graslund T, 2005, J BIOL CHEM, V280, P3707, DOI 10.1074/jbc.M406809200; HAENSLER J, 1993, BIOCONJUGATE CHEM, V4, P372, DOI 10.1021/bc00023a012; Hedman J, 2013, BIOSECUR BIOTERROR, V11, pS87, DOI 10.1089/bsp.2012.0090; Holmberg K., 2003, SURFACTANTS POLYM AQ, P39; Izumrudov VA, 2002, LANGMUIR, V18, P10348, DOI 10.1021/la020592u; Janowski BA, 2005, NAT CHEM BIOL, V1, P210, DOI 10.1038/nchembio724; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jorge AF, 2012, BIOMACROMOLECULES, V13, P3151, DOI 10.1021/bm300934p; Joseph J, 1997, NUCLEIC ACIDS RES, V25, P2182, DOI 10.1093/nar/25.11.2182; Klug A, 2005, FEBS LETT, V579, P892, DOI 10.1016/j.febslet.2004.10.104; KukowskaLatallo JF, 1996, P NATL ACAD SCI USA, V93, P4897, DOI 10.1073/pnas.93.10.4897; Lai YM, 2005, J PHARMACOL EXP THER, V315, P571, DOI 10.1124/jpet.105.089086; Leal C, 2004, J PHYS CHEM B, V108, P3044, DOI 10.1021/jp030850b; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lindemose S, 2005, NUCLEIC ACIDS RES, V33, P1790, DOI 10.1093/nar/gki319; Liu ZH, 2010, PROG POLYM SCI, V35, P1144, DOI 10.1016/j.progpolymsci.2010.04.007; Lleres D, 2002, LANGMUIR, V18, P10340, DOI 10.1021/la025845y; Lu YJ, 2001, BIOPOLYMERS, V61, P261, DOI 10.1002/bip.10151; Mapp AK, 2000, P NATL ACAD SCI USA, V97, P3930, DOI 10.1073/pnas.97.8.3930; Milhem OM, 2000, INT J PHARM, V197, P239, DOI 10.1016/S0378-5173(99)00463-9; MOLLEGAARD NE, 1994, P NATL ACAD SCI USA, V91, P3892, DOI 10.1073/pnas.91.9.3892; Orberg ML, 2007, BIOMACROMOLECULES, V8, P1557, DOI 10.1021/bm061194z; Page C., 2013, ISRN PHARM, V2013, P1, DOI [DOI 10.1155/2013/910743, 10.1155/2013/910743]; Pavlov G, 2003, EUR BIOPHYS J BIOPHY, V32, P437, DOI 10.1007/s00249-003-0316-9; Piculell L, 1998, SURF SCI SERIES, V77, P65; Potschke D, 2000, MACROMOL CHEM PHYS, V201, P330; Prasad TK, 2003, BBA-GEN SUBJECTS, V1619, P59, DOI 10.1016/S0304-4165(02)00442-7; Qamhieh K, 2009, BIOMACROMOLECULES, V10, P1720, DOI 10.1021/bm9000662; Raspaud E, 2005, BIOPHYS J, V88, P392, DOI 10.1529/biophysj.104.040113; Ritchie S, 2000, J BIOL CHEM, V275, P847, DOI 10.1074/jbc.275.2.847; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Ronsin G, 2001, CHEM COMMUN, P2234, DOI 10.1039/b105936j; Rosenfeldt S, 2002, MACROMOL CHEM PHYS, V203, P1995, DOI 10.1002/1521-3935(200209)203:13<1995::AID-MACP1995>3.0.CO;2-6; Ryan AJ, 2004, BIOCHEM J, V382, P741, DOI 10.1042/BJ20040105; Santoso SS, 2002, CURR OPIN COLLOID IN, V7, P262, DOI 10.1016/S1359-0294(02)00072-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Takahashi M, 1997, J PHYS CHEM B, V101, P9396, DOI 10.1021/jp9716391; Tsumoto K, 2003, BIOPHYS CHEM, V106, P23, DOI 10.1016/S0301-4622(03)00138-8; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; Wang XH, 1999, MACROMOLECULES, V32, P4299, DOI 10.1021/ma9902450; Waterhouse JE, 2005, CHEMBIOCHEM, V6, P1212, DOI 10.1002/cbic.200400408; Xu YH, 1996, BIOCHEMISTRY-US, V35, P5616, DOI 10.1021/bi9602019; Yoshikawa Y, 2013, ANGEW CHEM INT EDIT, V52, P3712, DOI 10.1002/anie.201209144	76	31	31	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92692	10.1371/journal.pone.0092692	http://dx.doi.org/10.1371/journal.pone.0092692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671109	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000064
J	Aydin, U; Vorwerk, J; Kupper, P; Heers, M; Kugel, H; Galka, A; Hamid, L; Wellmer, J; Kellinghaus, C; Rampp, S; Wolters, CH				Aydin, Uemit; Vorwerk, Johannes; Kuepper, Philipp; Heers, Marcel; Kugel, Harald; Galka, Andreas; Hamid, Laith; Wellmer, Joerg; Kellinghaus, Christoph; Rampp, Stefan; Wolters, Carsten Hermann			Combining EEG and MEG for the Reconstruction of Epileptic Activity Using a Calibrated Realistic Volume Conductor Model	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; FOCAL CORTICAL DYSPLASIA; ELEMENT HEAD MODEL; SOURCE LOCALIZATION; HUMAN BRAIN; HUMAN SKULL; IN-VIVO; INTRINSIC EPILEPTOGENICITY; PRESURGICAL EVALUATION; EQUIVALENT DIPOLE	To increase the reliability for the non-invasive determination of the irritative zone in presurgical epilepsy diagnosis, we introduce here a new experimental and methodological source analysis pipeline that combines the complementary information in EEG and MEG, and apply it to data from a patient, suffering from refractory focal epilepsy. Skull conductivity parameters in a six compartment finite element head model with brain anisotropy, constructed from individual MRI data, are estimated in a calibration procedure using somatosensory evoked potential (SEP) and field (SEF) data. These data are measured in a single run before acquisition of further runs of spontaneous epileptic activity. Our results show that even for single interictal spikes, volume conduction effects dominate over noise and need to be taken into account for accurate source analysis. While cerebrospinal fluid and brain anisotropy influence both modalities, only EEG is sensitive to skull conductivity and conductivity calibration significantly reduces the difference in especially depth localization of both modalities, emphasizing its importance for combining EEG and MEG source analysis. On the other hand, localization differences which are due to the distinct sensitivity profiles of EEG and MEG persist. In case of a moderate error in skull conductivity, combined source analysis results can still profit from the different sensitivity profiles of EEG and MEG to accurately determine location, orientation and strength of the underlying sources. On the other side, significant errors in skull modeling are reflected in EEG reconstruction errors and could reduce the goodness of fit to combined datasets. For combined EEG and MEG source analysis, we therefore recommend calibrating skull conductivity using additionally acquired SEP/SEF data.	[Aydin, Uemit; Vorwerk, Johannes; Kuepper, Philipp; Wolters, Carsten Hermann] Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany; [Kuepper, Philipp; Kellinghaus, Christoph] Klinikum Osnabruck, Dept Neurol, Osnabruck, Germany; [Heers, Marcel; Wellmer, Joerg] Univ Klinikum Knappschaftskrankenhaus Bochum, Ruhr Epileptol Dept Neurol, Bochum, Germany; [Kugel, Harald] Univ Klinikum Munster, Dept Clin Radiol, Munster, Germany; [Galka, Andreas; Hamid, Laith] Univ Klinikum Schleswig Holstein, Dept Neuropediat, Kiel, Germany; [Rampp, Stefan] Univ Klinikum Erlangen, Dept Neurol, Epilepsy Ctr, Erlangen, Germany	University of Munster; Ruhr University Bochum; University of Munster; University of Kiel; Schleswig Holstein University Hospital; University of Erlangen Nuremberg	Aydin, U (corresponding author), Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany.	umitaydin@ieee.org	Heers, Marcel/AAF-9364-2019; Heers, Marcel/GRS-2648-2022; Wolters, Carsten H/R-4234-2016; Rampp, Stefan/J-9386-2019; Aydin, Ümit/HII-7669-2022	Heers, Marcel/0000-0001-5545-7014; Wolters, Carsten H/0000-0001-6233-424X; Rampp, Stefan/0000-0002-4826-1520; Kugel, Harald/0000-0002-4349-1984; Aydin, Umit/0000-0002-6327-7811; Vorwerk, Johannes/0000-0003-3597-4203	German Research Foundation (DFG) [WO1425/2-1, STE380/14-1, SFB 855]; Medical Faculty, Ruhr University Bochum; FoRUM research grant [K062-11]	German Research Foundation (DFG)(German Research Foundation (DFG)); Medical Faculty, Ruhr University Bochum; FoRUM research grant	This research has been supported by the German Research Foundation (DFG) through projects WO1425/2-1, STE380/14-1 and SFB 855 (http://dfg.de), and by the Medical Faculty, Ruhr University Bochum, by a FoRUM research grant (K062-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar ZA, 2013, BRAIN TOPOGR, V26, P378, DOI 10.1007/s10548-012-0274-6; Akhtari M, 2000, BRAIN TOPOGR, V13, P29, DOI 10.1023/A:1007882102297; Akhtari M, 2002, BRAIN TOPOGR, V14, P151, DOI 10.1023/A:1014590923185; Baillet S, 1999, IEEE T BIO-MED ENG, V46, P522, DOI 10.1109/10.759053; Barkley GL, 2003, J CLIN NEUROPHYSIOL, V20, P163, DOI 10.1097/00004691-200305000-00002; Bast T, 2004, EPILEPSIA, V45, P621, DOI 10.1111/j.0013-9580.2004.56503.x; Bast T, 2006, J CLIN NEUROPHYSIOL, V23, P487, DOI 10.1097/01.wnp.0000232208.14060.c7; BAUMGARTNER C, 1995, NEUROLOGY, V45, P118, DOI 10.1212/WNL.45.1.118; Baysal U, 2004, PHYSIOL MEAS, V25, P737, DOI 10.1088/0967-3334/25/3/013; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bertrand O, 1991, 3D FINITE ELEMENT ME, P154; Boon P, 2002, J CLIN NEUROPHYSIOL, V19, P461, DOI 10.1097/00004691-200210000-00009; Buchner H, 1997, ELECTROEN CLIN NEURO, V102, P267, DOI 10.1016/S0013-4694(96)95698-9; Buchner Helmut, 1994, Brain Topography, V6, P299, DOI 10.1007/BF01211175; Camacho DLA, 1997, J BIOMECH, V30, P1067, DOI 10.1016/S0021-9290(97)00073-0; Chitoku S, 2003, BRAIN DEV-JPN, V25, P14, DOI 10.1016/S0387-7604(02)00104-3; COHEN D, 1987, PHYS MED BIOL, V32, P85, DOI 10.1088/0031-9155/32/1/013; Dannhauer M, 2011, HUM BRAIN MAPP, V32, P1383, DOI 10.1002/hbm.21114; DASILVA FHL, 1991, BRAIN TOPOGR, V4, P133; Dassios G, 2007, INVERSE PROBL, V23, P2541, DOI 10.1088/0266-5611/23/6/016; Degen R, 2003, ACTA NEUROL SCAND, V108, P309, DOI 10.1034/j.1600-0404.2003.00153.x; Ebersole JS, 2010, J CLIN NEUROPHYSIOL, V27, P360, DOI 10.1097/WNP.0b013e318201ffc4; Ebersole JS, 1999, EEG CL N SU, V50, P167; Fuchs M, 1998, ELECTROEN CLIN NEURO, V107, P93, DOI 10.1016/S0013-4694(98)00046-7; Gavaret M, 2004, J CLIN NEUROPHYSIOL, V21, P267, DOI 10.1097/01.WNP.0000139929.06455.82; Goncalves S, 2003, IEEE T BIO-MED ENG, V50, P1124, DOI 10.1109/TBME.2003.816072; Goncalves S, 2000, PHYSIOL MEAS, V21, P379, DOI 10.1088/0967-3334/21/3/304; Gullmar D, 2010, NEUROIMAGE, V51, P145, DOI 10.1016/j.neuroimage.2010.02.014; Hallez H, 2008, PHYS MED BIOL, V53, P1877, DOI 10.1088/0031-9155/53/7/005; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1989, IEEE T BIO-MED ENG, V36, P165, DOI 10.1109/10.16463; Heers M, 2011, SEIZURE, V21, P128; Hoekema R, 2003, BRAIN TOPOGR, V16, P29, DOI 10.1023/A:1025606415858; HOMMA S, 1995, NEUROSCI RES, V22, P51, DOI 10.1016/0168-0102(95)00880-3; Huang MX, 2007, NEUROIMAGE, V37, P731, DOI 10.1016/j.neuroimage.2007.06.002; Huiskamp G, 1999, IEEE T BIO-MED ENG, V46, P1281, DOI 10.1109/10.797987; Iwasaki M, 2005, EPILEPSIA, V46, P59, DOI 10.1111/j.0013-9580.2005.21104.x; Janszky J, 2000, NEUROLOGY, V54, P1470, DOI 10.1212/WNL.54.7.1470; Jenkinson M, 2005, BET2 MR BASED ESTIMA; Jerbi K, 2004, NEUROIMAGE, V22, P779, DOI 10.1016/j.neuroimage.2004.02.010; Knake S, 2006, EPILEPSY RES, V69, P80, DOI 10.1016/j.eplepsyres.2006.01.001; Kohling R, 2000, J NEUROPHYSIOL, V84, P2161, DOI 10.1152/jn.2000.84.4.2161; Kupper P, 2012, THESIS BEUTH HOCHSCH; Lai Y, 2005, CLIN NEUROPHYSIOL, V116, P456, DOI 10.1016/j.clinph.2004.08.017; Lanfer B, 2012, NEUROIMAGE, V62, P418, DOI 10.1016/j.neuroimage.2012.05.006; Lanfer B, 2013, BRAIN TOPOGR, V26, P212, DOI 10.1007/s10548-012-0251-0; Lantz G, 2003, J CLIN NEUROPHYSIOL, V20, P311, DOI 10.1097/00004691-200309000-00003; Lau S., 2011, INT J BIOELECTROMAGN, V13, P228; Lee SK, 2005, ANN NEUROL, V58, P525, DOI 10.1002/ana.20569; Lew S, 2009, HUM BRAIN MAPP, V30, P2862, DOI 10.1002/hbm.20714; Liu AK, 2002, HUM BRAIN MAPP, V16, P47, DOI 10.1002/hbm.10024; Luders HO, 2006, EPILEPTIC DISORD, V8, pS1; Meno FM, 1997, IEEE T BIOMED ENG, V3, P220, DOI DOI 10.1109/10.554770; Montes-Restrepo V, 2014, BRAIN TOPOGR, V27, P95, DOI 10.1007/s10548-013-0313-y; Morioka T, 1999, EPILEPSY RES, V33, P177, DOI 10.1016/S0920-1211(98)00096-5; Munck JCD, 2012, EEG MEG FORWARD MODE, P192; Ollikainen JO, 1999, MED ENG PHYS, V21, P143, DOI 10.1016/S1350-4533(99)00038-7; Oozeer M, 2005, MED BIOL ENG COMPUT, V43, P608, DOI 10.1007/BF02351034; Ossenblok P, 2007, EPILEPSIA, V48, P2139, DOI 10.1111/j.1528-1167.2007.01223.x; Otsubo H, 2001, EPILEPSIA, V42, P1523, DOI 10.1046/j.1528-1157.2001.16701.x; Pataraia E, 2005, NEUROIMAGE, V24, P607, DOI 10.1016/j.neuroimage.2004.09.031; Ramon C, 2004, BRAIN TOPOGR, V16, P245; Ramon C., 2012, INT J BIOELECTROMAGN, V14, P27; Rampp S, 2007, EXPERT REV MED DEVIC, V4, P335, DOI 10.1586/17434440.4.3.335; Rice JK, 2013, NEUROIMAGE, V64, P476, DOI 10.1016/j.neuroimage.2012.09.041; Rullmann M, 2009, NEUROIMAGE, V44, P399, DOI 10.1016/j.neuroimage.2008.09.009; Ruthotto L, 2012, PHYS MED BIOL, V57, P5715, DOI 10.1088/0031-9155/57/18/5715; Salayev KA, 2006, CLIN NEUROPHYSIOL, V117, P1836, DOI 10.1016/j.clinph.2006.05.003; Scherg M, 2002, J CLIN NEUROPHYSIOL, V19, P91, DOI 10.1097/00004691-200203000-00001; Schimpf PH, 2002, IEEE T BIO-MED ENG, V49, P409, DOI 10.1109/10.995679; Slutzky MW, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026004; Speckmann EJ, 2012, NIEDERMEYERS ELECTRO; Stefan H, 2003, BRAIN, V126, P2396, DOI 10.1093/brain/awg239; Sutherling WW, 2008, NEUROLOGY, V71, P990, DOI 10.1212/01.wnl.0000326591.29858.1a; Tuch DS, 2001, P NATL ACAD SCI USA, V98, P11697, DOI 10.1073/pnas.171473898; Van't Ent D, 2003, CLIN NEUROPHYSIOL, V114, P1948, DOI 10.1016/S1388-2457(03)00156-1; Vorwerk J, 2012, BIOMED ENG TECH; Weinstein D, 2000, ANN BIOMED ENG, V28, P1059, DOI 10.1114/1.1310220; Wendel K, 2008, IEEE T BIO-MED ENG, V55, P1454, DOI 10.1109/TBME.2007.912427; Wennberg R, 2014, CLIN NEUROPHYSIOL, V125, P903, DOI 10.1016/j.clinph.2013.08.032; Wennberg R, 2011, CLIN NEUROPHYSIOL, V122, P1295, DOI 10.1016/j.clinph.2010.11.019; Wolters C.H., 2010, BIOMED TECHNIK BIOME, V55, P64; Wolters CH, 2007, IEEE T BIO-MED ENG, V54, P1446, DOI 10.1109/TBME.2007.890736; Wolters CH, 2006, NEUROIMAGE, V30, P813, DOI 10.1016/j.neuroimage.2005.10.014; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	85	58	58	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93154	10.1371/journal.pone.0093154	http://dx.doi.org/10.1371/journal.pone.0093154			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671208	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000121
J	Dias, T; Clemente, A; Martins-Loucao, MA; Sheppard, L; Bobbink, R; Cruz, C				Dias, Teresa; Clemente, Adelaide; Martins-Loucao, Maria Amelia; Sheppard, Lucy; Bobbink, Roland; Cruz, Cristina			Ammonium as a Driving Force of Plant Diversity and Ecosystem Functioning: Observations Based on 5 Years' Manipulation of N Dose and Form in a Mediterranean Ecosystem	PLOS ONE			English	Article							ATMOSPHERIC NITROGEN DEPOSITION; SPECIES RICHNESS; BIODIVERSITY HOTSPOTS; BIOMASS PRODUCTION; SOIL; PRODUCTIVITY; HETEROGENEITY; DECOMPOSITION; VARIABILITY; SATURATION	Enhanced nitrogen (N) availability is one of the main drivers of biodiversity loss and degradation of ecosystem functions. However, in very nutrient-poor ecosystems, enhanced N input can, in the short-term, promote diversity. Mediterranean Basin ecosystems are nutrient-limited biodiversity hotspots, but no information is available on their medium-or long-term responses to enhanced N input. Since 2007, we have been manipulating the form and dose of available N in a Mediterranean Basin maquis in south-western Europe that has low ambient N deposition (<4 kg N ha(-1) yr(-1)) and low soil N content (0.1%). N availability was modified by the addition of 40 kg N ha(-1) yr(-1) as a 1: 1 NH4Cl to (NH4)(2)SO4 mixture, and 40 and 80 kg N ha(-1) yr(-1) as NH4NO3. Over the following 5 years, the impacts on plant composition and diversity (richness and evenness) and some ecosystem characteristics (soil extractable N and organic matter, aboveground biomass and % of bare soil) were assessed. Plant species richness increased with enhanced N input and was more related to ammonium than to nitrate. Exposure to 40 kg NH4+-N ha(-1) yr(-1) (alone and with nitrate) enhanced plant richness, but did not increase aboveground biomass; soil extractable N even increased under 80 kg NH4NO3-N ha(-1) yr(-1) and the % of bare soil increased under 40 kg NH4(+)-N ha(-1) yr(-1). The treatment containing less ammonium, 40 kg NH4NO3-N ha(-1) yr(-1), did not enhance plant diversity but promoted aboveground biomass and reduced the % of bare soil. Data suggest that enhanced NHy availability affects the structure of the maquis, which may promote soil erosion and N leakage, whereas enhanced NOx availability leads to biomass accumulation which may increase the fire risk. These observations are relevant for land use management in biodiverse and fragmented ecosystems such as the maquis, especially in conservation areas.	[Dias, Teresa; Clemente, Adelaide; Martins-Loucao, Maria Amelia; Cruz, Cristina] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal; [Clemente, Adelaide] Museu Nacl Histo Nat & Ciencia, Lisbon, Portugal; [Sheppard, Lucy] Ctr Ecol & Hydrol, Edinburgh, Midlothian, Scotland; [Martins-Loucao, Maria Amelia] Radboud Univ Nijmegen, B Ware Res Ctr, NL-6525 ED Nijmegen, Netherlands	Universidade de Lisboa; UK Centre for Ecology & Hydrology (UKCEH); Radboud University Nijmegen	Dias, T (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal.	mtdias@fc.ul.pt	Dias, Teresa/E-8816-2015; Martins-Loução, Maria Amélia/H-1994-2011; Cruz, Cristina/F-2643-2011	Dias, Teresa/0000-0002-5421-4763; Martins-Loução, Maria Amélia/0000-0002-5883-2462; Bobbink, Roland/0000-0003-1994-6085; Clemente, Adelaide/0000-0002-8961-4791; Cruz, Cristina/0000-0003-3100-463X	Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/BIA-BEC/099323/2008, PTDC/BIA-ECS/122214/2010]; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by the Fundacao para a Ciencia e Tecnologia (FCT) through the projects PTDC/BIA-BEC/099323/2008 and PTDC/BIA-ECS/122214/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EB, 2005, AIR POLLUTION VEGETA; Allen EB, 2007, THESCIENTIFICWORLDJO, V7, P247, DOI 10.1100/tsw.2007.72; Blondel J., 1999, Biology and wildlife of the Mediterranean region.; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Bobbink R., 2011, REV REVISION EMPIRIC; Bonanomi G, 2006, ACTA OECOL, V30, P419, DOI 10.1016/j.actao.2006.06.007; Bonet A, 2004, PLANT ECOL, V174, P257, DOI 10.1023/B:VEGE.0000049106.96330.9c; Caldeira MC, 2005, OIKOS, V110, P115, DOI 10.1111/j.0030-1299.2005.13873.x; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Casals P, 2005, BIOGEOCHEMISTRY, V76, P477, DOI 10.1007/s10533-005-8659-1; Clemente AS, 2005, ACTA OECOL, V27, P233, DOI 10.1016/j.actao.2005.01.005; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Cruz C, 2008, ENVIRON POLLUT, V154, P414, DOI 10.1016/j.envpol.2007.12.007; De Schrijver A, 2008, NATURE, V451, pE1, DOI 10.1038/nature06578; De Schrijver A, 2011, GLOBAL ECOL BIOGEOGR, V20, P803, DOI 10.1111/j.1466-8238.2011.00652.x; Dias T, 2012, BIOGEOSCIENCES, V9, P193, DOI 10.5194/bg-9-193-2012; Dias T, 2013, SOIL BIOL BIOCHEM, V58, P163, DOI 10.1016/j.soilbio.2012.10.027; Dias T, 2011, PLANT SOIL, V347, P363, DOI 10.1007/s11104-011-0856-1; Dias T, 2011, PLANT SOIL, V341, P125, DOI 10.1007/s11104-010-0628-3; Fanelli G, 2008, PLANT ECOL, V194, P231, DOI 10.1007/s11258-007-9287-8; Fenn ME, 2010, J ENVIRON MANAGE, V91, P2404, DOI 10.1016/j.jenvman.2010.07.034; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Isbell F, 2013, P NATL ACAD SCI USA, V110, P11911, DOI 10.1073/pnas.1310880110; Jiang L, 2009, J ECOL, V97, P603, DOI 10.1111/j.1365-2745.2009.01503.x; Jones A, 2012, STATE SOIL EUROPE; Klausmeyer KR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006392; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Krebs C.J., 2014, ECOLOGICAL METHODOLO; LAVOREL S, 1994, OIKOS, V71, P75, DOI 10.2307/3546174; LAVOREL S, 1994, OIKOS, V70, P455, DOI 10.2307/3545786; Lavorel S., 1999, DIVERS DISTRIB, V5, P3, DOI [10.1046/j.1472-4642.1999.00033.x, DOI 10.1046/J.1472-4642.1999.00033.X]; Lopez-Bermudez F, 2006, NATO SCI PEACE SECUR, V3, P401; MacDougall AS, 2013, NATURE, V494, P86, DOI 10.1038/nature11869; Martins-Loucao M. A, 2000, DETERMINATION AMMONI; Matsumura S, 1999, SOIL SCI PLANT NUTR, V45, P231, DOI 10.1080/00380768.1999.10409338; Meixner T, 2006, ENVIRON SCI TECHNOL, V40, P2887, DOI 10.1021/es051268z; Meixner T, 2004, BIOGEOCHEMISTRY, V70, P331, DOI 10.1007/s10533-003-4106-3; Michalet R, 2006, ECOL LETT, V9, P767, DOI 10.1111/j.1461-0248.2006.00935.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nilsson J., 1988, CRITICAL LOADS SULPH; Ochoa-Hueso R, 2011, EFECTOS DEPOSICION A; Ochoa-Hueso R, 2011, ENVIRON POLLUT, V159, P2265, DOI 10.1016/j.envpol.2010.12.019; Padgett PE, 1999, ATMOS ENVIRON, V33, P769, DOI 10.1016/S1352-2310(98)00214-3; Phoenix GK, 2012, GLOBAL CHANGE BIOL, V18, P1197, DOI 10.1111/j.1365-2486.2011.02590.x; Phoenix GK, 2006, GLOBAL CHANGE BIOL, V12, P470, DOI 10.1111/j.1365-2486.2006.01104.x; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; RIGGAN PJ, 1988, ECOL MONOGR, V58, P155, DOI 10.2307/2937023; Rivas-Martinez S., 2004, BIOBLIMATIC MAP EURO; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sardans J, 2008, GLOBAL CHANGE BIOL, V14, P2304, DOI 10.1111/j.1365-2486.2008.01656.x; Schultz J, 1995, ECOZONES WORLD ECOLO, Vi-x, P1; Southon GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059031; SPECHT RL, 1988, MEDITERRANEAN TYPE E; Stevens CJ, 2011, ENVIRON MANAGE, V48, P885, DOI 10.1007/s00267-011-9745-x; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Thompson JD., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Trabaud L., 1994, ROLE FIRE MEDITERRAN, P1, DOI DOI 10.1007/978-1-4613-8395-6_1; Trabaud L, 1987, ECOLOGIA MEDITERRANE, V13, P25, DOI DOI 10.3406/ECMED.1987.1186; Tylianakis JM, 2008, PLOS BIOL, V6, P947, DOI 10.1371/journal.pbio.0060122; Vourlitis GL, 2009, ECOSYSTEMS, V12, P473, DOI 10.1007/s10021-009-9236-6; [No title captured]	65	18	18	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92517	10.1371/journal.pone.0092517	http://dx.doi.org/10.1371/journal.pone.0092517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695101	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000334103000020
J	Hassan, NZA; Mokhtar, NM; Sin, TK; Rose, IM; Sagap, I; Harun, R; Jamal, R				Hassan, Nur Zarina Ali; Mokhtar, Norfilza Mohd; Sin, Teow Kok; Rose, Isa Mohamed; Sagap, Ismail; Harun, Roslan; Jamal, Rahman			Integrated Analysis of Copy Number Variation and Genome-Wide Expression Profiling in Colorectal Cancer Tissues	PLOS ONE			English	Article							CELL-CYCLE; GENE-EXPRESSION; ARRAY-CGH; CDC25B PHOSPHATASE; PROGRESSION; REVEALS; ACTIVATION; CARCINOMA; PATTERNS; SURVIVAL	Integrative analyses of multiple genomic datasets for selected samples can provide better insight into the overall data and can enhance our knowledge of cancer. The objective of this study was to elucidate the association between copy number variation (CNV) and gene expression in colorectal cancer (CRC) samples and their corresponding non-cancerous tissues. Sixty-four paired CRC samples from the same patients were subjected to CNV profiling using the Illumina HumanOmni1-Quad assay, and validation was performed using multiplex ligation probe amplification method. Genome-wide expression profiling was performed on 15 paired samples from the same group of patients using the Affymetrix Human Gene 1.0 ST array. Significant genes obtained from both array results were then overlapped. To identify molecular pathways, the data were mapped to the KEGG database. Whole genome CNV analysis that compared primary tumor and non-cancerous epithelium revealed gains in 1638 genes and losses in 36 genes. Significant gains were mostly found in chromosome 20 at position 20q12 with a frequency of 45.31% in tumor samples. Examples of genes that were associated at this cytoband were PTPRT, EMILIN3 and CHD6. The highest number of losses was detected at chromosome 8, position 8p23.2 with 17.19% occurrence in all tumor samples. Among the genes found at this cytoband were CSMD1 and DLC1. Genome-wide expression profiling showed 709 genes to be up-regulated and 699 genes to be down-regulated in CRC compared to non-cancerous samples. Integration of these two datasets identified 56 overlapping genes, which were located in chromosomes 8, 20 and 22. MLPA confirmed that the CRC samples had the highest gains in chromosome 20 compared to the reference samples. Interpretation of the CNV data in the context of the transcriptome via integrative analyses may provide more in-depth knowledge of the genomic landscape of CRC.	[Hassan, Nur Zarina Ali; Mokhtar, Norfilza Mohd; Sin, Teow Kok; Harun, Roslan; Jamal, Rahman] Univ Kebangsaan Malaysia, Med Mol Biol Inst, Kuala Lumpur, Malaysia; [Rose, Isa Mohamed] Univ Kebangsaan Malaysia, Fac Med, Dept Pathol, Kuala Lumpur, Malaysia; [Sagap, Ismail] Univ Kebangsaan Malaysia, Fac Med, Dept Surg, Kuala Lumpur, Malaysia; [Mokhtar, Norfilza Mohd] Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia; [Harun, Roslan] Univ Kebangsaan Malaysia, Fac Med, Dept Med, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Mokhtar, NM (corresponding author), Univ Kebangsaan Malaysia, Med Mol Biol Inst, Kuala Lumpur, Malaysia.	norfilza@ppukm.ukm.edu.my; rahmanj@ppukm.ukm.edu	Mokhtar, Norfilza Mohd/AAK-8196-2020	Mokhtar, Norfilza Mohd/0000-0002-4863-100X	Ministry of Science, Technology Innovation [07-05-MGI-GMB016]; Higher Institution Centre of Excellence grant from the Ministry of Higher Education	Ministry of Science, Technology Innovation(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Higher Institution Centre of Excellence grant from the Ministry of Higher Education	The project was funded by the the Ministry of Science, Technology & Innovation (07-05-MGI-GMB016) and Higher Institution Centre of Excellence grant from the Ministry of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock HE, 2003, GENE CHROMOSOME CANC, V37, P369, DOI 10.1002/gcc.10201; Aressy B, 2008, CELL CYCLE, V7, P2234, DOI 10.4161/cc.7.14.6305; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bugler B, 2006, MOL CANCER THER, V5, P1446, DOI 10.1158/1535-7163.MCT-06-0099; Camps J, 2009, GENE CHROMOSOME CANC, V48, P1002, DOI 10.1002/gcc.20699; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [10.1038/nature11252, DOI 10.1038/NATURE11252]; Carvalho B, 2009, GUT, V58, P79, DOI 10.1136/gut.2007.143065; Chaignat E, 2011, GENOME RES, V21, P106, DOI 10.1101/gr.112748.110; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Goldstone S, 2001, ONCOGENE, V20, P921, DOI 10.1038/sj.onc.1204177; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Hawthorn L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-460; Henley SA, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-10; Huang V, 2012, NUCLEIC ACIDS RES, V40, P1695, DOI 10.1093/nar/gkr934; Issa JP, 2008, CLIN CANCER RES, V14, P5939, DOI 10.1158/1078-0432.CCR-08-1596; Jasmine F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031968; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jia DS, 2011, HEPATOLOGY, V54, P1227, DOI 10.1002/hep.24495; Jones AM, 2005, ONCOGENE, V24, P118, DOI 10.1038/sj.onc.1208194; Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374; Kamal M, 2010, BREAST CANCER RES TR, V121, P555, DOI 10.1007/s10549-009-0500-4; Kimura Y, 2004, MODERN PATHOL, V17, P1328, DOI 10.1038/modpathol.3800180; Kotliarov Y, 2009, CANCER RES, V69, P1596, DOI 10.1158/0008-5472.CAN-08-2496; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Lagerstedt KK, 2007, CANCER INFORM, V3, P341; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Lindqvist A, 2004, J CELL SCI, V117, P4979, DOI 10.1242/jcs.01395; Lipska L, 2007, ANTICANCER RES, V27, P1901; Loffler H, 2006, CELL CYCLE, V5, P2543, DOI 10.4161/cc.5.21.3435; Lu TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024829; Ma CQ, 2009, CANCER BIOL THER, V8, P907, DOI 10.4161/cbt.8.10.8132; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Nakao M, 2009, CANCER GENET CYTOGEN, V188, P70, DOI 10.1016/j.cancergencyto.2008.09.013; Platzer P, 2002, CANCER RES, V62, P1134; Poptsova M, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-19; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rodel F, 2010, AM J PATHOL, V177, P918, DOI 10.2353/ajpath.2010.100040; Romer MU, 2013, MOL ONCOL, V7, P101, DOI 10.1016/j.molonc.2012.09.001; Senapati S, 2010, J CLIN PATHOL, V63, P702, DOI 10.1136/jcp.2010.078717; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Smith DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060613; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Strzalka W, 2011, ANN BOT-LONDON, V107, P1127, DOI 10.1093/aob/mcq243; Takemasa I, 2000, CANCER RES, V60, P3043; Tan DSP, 2011, CLIN CANCER RES, V17, P1521, DOI 10.1158/1078-0432.CCR-10-1688; Tang XB, 2008, CANCER INVEST, V26, P178, DOI 10.1080/07357900701560786; Thomas SM, 2003, CANCER RES, V63, P5629; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Walworth NC, 2000, CURR OPIN CELL BIOL, V12, P697, DOI 10.1016/S0955-0674(00)00154-X; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wells A, 2003, CLIN EXP METASTAS, V20, P285, DOI 10.1023/A:1024088922957; Woodwark C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014814; Wu XD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-707; Xie T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042001, 10.1371/journal.pone.0047577]; Zainal Ariffin O, 2011, NATL CANC REGISTRY R	57	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92553	10.1371/journal.pone.0092553	http://dx.doi.org/10.1371/journal.pone.0092553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24694993	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000021
J	Chen, YP; Ye, Y				Chen, Yaping; Ye, Yong			Effects of Salinity and Nutrient Addition on Mangrove Excoecaria agallocha	PLOS ONE			English	Article							VS. PHOSPHORUS LIMITATION; AVICENNIA-MARINA; KANDELIA-CANDEL; SALT TOLERANCE; SPARTINA-ALTERNIFLORA; RHIZOPHORA-STYLOSA; LEAF DEMOGRAPHY; SODIUM-CHLORIDE; GROWTH; RESPONSES	Effects of salinity on seed germination and growth of young (1 month old) and old (2-year old) seedlings of Excoecaria agallocha were investigated. Combined effects of salinity and nutrient level were also examined on old seedlings. Seed germination was best at 0 and 5 psu salinity. 15 psu salinity significantly delayed root initiation and decreased final establishment rate. All seeds failed to establish at 25 psu salinity. Young seedlings performed best at 0 and 5 psu, but growth was stunned at 15 psu, and all seedlings died within 90 days at 25 psu. Old seedlings grew best at salinities below 5 psu and they survived the whole cultivation at 25 psu. This indicated that E. agallocha increased salt tolerance over time. Gas exchange was significantly compromised by salinities above 15 psu but evidently promoted by high nutrient. Proline accumulated considerably at high nutrient, and its contents increased from 0 to 15 psu but decreased at 25 psu salinity. Lipid peroxidation was aggravated by increasing salinity beyond 15 psu but markedly alleviated by nutrient addition. These responses indicated that E. agallocha was intolerant to high salinity but it can be greatly enhanced by nutrient addition.	[Chen, Yaping; Ye, Yong] Xiamen Univ, Coll Environm & Ecol, Minist Educ Coastal & Wetland Ecosyst, Key Lab, Xiamen, Fujian, Peoples R China	Xiamen University	Ye, Y (corresponding author), Xiamen Univ, Coll Environm & Ecol, Minist Educ Coastal & Wetland Ecosyst, Key Lab, Xiamen, Fujian, Peoples R China.	yeyong@xmu.edu.cn			National Natural Science Foundation of China [41276077, 41076049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by projects funded by National Natural Science Foundation of China (Grant No. 41276077 and 41076049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abari A. K., 2011, African Journal of Plant Science, V5, P52; AEBI H, 1984, METHOD ENZYMOL, V105, P121; BALL MC, 1995, FUNCT ECOL, V9, P77, DOI 10.2307/2390093; BALL MC, 1984, PLANT PHYSIOL, V74, P1, DOI 10.1104/pp.74.1.1; Ball MC, 1999, PHYSIOLOGICAL PLANT ECOLOGY, P331; BALL MC, 1986, AUST J PLANT PHYSIOL, V13, P689, DOI 10.1071/PP9860689; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Benabderrahim MA, 2011, SPAN J AGRIC RES, V9, P135; CAVALIERI AJ, 1981, OECOLOGIA, V49, P224, DOI 10.1007/BF00349192; Chandrasekaran M, 2009, WORLD J MICROB BIOT, V25, P155, DOI 10.1007/s11274-008-9869-1; Chen YP, 2013, MAR ECOL PROG SER, V482, P107, DOI 10.3354/meps10274; Cheng H, 2012, ENVIRON POLLUT, V164, P110, DOI 10.1016/j.envpol.2012.01.034; CHOW WS, 1990, AUST J PLANT PHYSIOL, V17, P563, DOI 10.1071/PP9900563; CLOUGH BF, 1989, OECOLOGIA, V79, P38, DOI 10.1007/BF00378237; CLOUGH BF, 1984, AUST J PLANT PHYSIOL, V11, P419, DOI 10.1071/PP9840419; Dasgupta N, 2012, TREES-STRUCT FUNCT, V26, P377, DOI 10.1007/s00468-011-0599-x; Dasgupta N, 2011, ACTA PHYSIOL PLANT, V33, P803, DOI 10.1007/s11738-010-0605-8; Dasgupta N, 2010, J PLANT INTERACT, V5, P211, DOI 10.1080/17429140903438076; Ellison AM, 1997, OECOLOGIA, V112, P435, DOI 10.1007/s004420050330; FEIGIN A, 1985, PLANT SOIL, V89, P285, DOI 10.1007/BF02182248; Feller IC, 2003, BIOGEOCHEMISTRY, V62, P145, DOI 10.1023/A:1021166010892; Feller IC, 1999, ECOLOGY, V80, P2193, DOI 10.1890/0012-9658(1999)080[2193:EONEOW]2.0.CO;2; FLOWERS TJ, 1977, ANNU REV PLANT PHYS, V28, P89, DOI 10.1146/annurev.pp.28.060177.000513; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; [何奋琳 He Fenlin], 2004, [环境科学与技术, Enuivonmental science and technology], V27, P81; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; Hunt R., 1978, Plant growth analysis.; Kao WY, 2001, J PLANT PHYSIOL, V158, P841, DOI 10.1078/0176-1617-00248; Khan MA, 2003, AM J BOT, V90, P131, DOI 10.3732/ajb.90.1.131; Khan MA, 2000, J ARID ENVIRON, V45, P73, DOI 10.1006/jare.1999.0617; Krauss KW, 2003, FOREST ECOL MANAG, V176, P49, DOI 10.1016/S0378-1127(02)00219-0; Leblebici Z, 2011, WATER AIR SOIL POLL, V214, P175, DOI 10.1007/s11270-010-0413-1; Li MY, 2009, NAT PROD REP, V26, P281, DOI 10.1039/b816245j; Li NY, 2008, AQUAT BOT, V88, P303, DOI 10.1016/j.aquabot.2007.12.003; Lin CC, 2010, J HAZARD MATER, V174, P202, DOI 10.1016/j.jhazmat.2009.09.137; Lovelock CE, 2006, PLANT CELL ENVIRON, V29, P793, DOI 10.1111/j.1365-3040.2005.01446.x; Lovelock CE, 2004, FUNCT ECOL, V18, P25, DOI 10.1046/j.0269-8463.2004.00805.x; Lovelock CE, 2003, OECOLOGIA, V134, P455, DOI 10.1007/s00442-002-1118-y; Macfarlane GR, 2001, MAR POLLUT BULL, V42, P233, DOI 10.1016/S0025-326X(00)00147-8; McKee KL, 2002, ECOLOGY, V83, P1065, DOI 10.2307/3071914; Medina E, 1997, ESTUAR COAST SHELF S, V45, P337, DOI 10.1006/ecss.1996.0188; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; Mimura T, 2003, PLANTA, V216, P397, DOI 10.1007/s00425-002-0878-2; MUNNS R, 1986, AUST J PLANT PHYSIOL, V13, P143, DOI 10.1071/PP9860143; Naidoo G, 2006, ANN BOT-LONDON, V97, P1095, DOI 10.1093/aob/mcl064; NAIDOO G, 1992, AM J BOT, V79, P765, DOI 10.2307/2444942; NAIDOO G, 1987, NEW PHYTOL, V107, P317, DOI 10.1111/j.1469-8137.1987.tb00183.x; Naidoo G, 2011, FLORA, V206, P814, DOI 10.1016/j.flora.2011.04.009; Nandy (Datta) Paramita, 2007, Wetlands Ecology and Management, V15, P347, DOI 10.1007/s11273-007-9036-8; Nandy (Datta) Paramita, 2009, Physiology and Molecular Biology of Plants, V15, P151, DOI 10.1007/s12298-009-0017-7; Nandy Paramita, 2005, Acta Botanica Croatica, V64, P331; Nardini A, 2000, TREES-STRUCT FUNCT, V15, P14, DOI 10.1007/s004680000071; Nemati SH., 2011, J BIOL ENV SCI, V5, P159, DOI DOI 10.1007/S12298-011-0097-Z; Parida AK, 2004, J PLANT PHYSIOL, V161, P921, DOI 10.1016/j.jplph.2003.11.006; Parida AK, 2004, TREES-STRUCT FUNCT, V18, P167, DOI 10.1007/s00468-003-0293-8; Patel NT, 2010, AQUAT BOT, V93, P9, DOI 10.1016/j.aquabot.2010.02.002; Popp M, 1996, J EXP BOT, V47, P1469, DOI 10.1093/jxb/47.10.1469; POPP M, 1985, VEGETATIO, V61, P247; POPP M, 1984, Z PFLANZENPHYSIOL, V113, P395, DOI 10.1016/S0044-328X(84)80096-3; Prochazkova D, 2007, BIOL PLANTARUM, V51, P401, DOI 10.1007/s10535-007-0088-7; Prochazkova D, 2001, PLANT SCI, V161, P765, DOI 10.1016/S0168-9452(01)00462-9; RAWSON HM, 1984, PLANT CELL ENVIRON, V7, P207; Reef R, 2010, TREE PHYSIOL, V30, P1148, DOI 10.1093/treephys/tpq048; Rehman S, 1997, SEED SCI TECHNOL, V25, P45; Satyan RS, 2010, BIOTECH HISTOCHEM, V85, P285, DOI [10.3109/10520290903202478, 10.1080/10520290903202478]; Shi GR, 2010, PLANT GROWTH REGUL, V61, P45, DOI 10.1007/s10725-010-9447-z; SRIVASTAVA DS, 1995, J ECOL, V83, P421, DOI 10.2307/2261595; Suarez N, 2005, TREES-STRUCT FUNCT, V19, P721, DOI 10.1007/s00468-005-0001-y; Tam NFY, 1998, WATER AIR SOIL POLL, V103, P245, DOI 10.1023/A:1004925700931; Tanaka Y, 1999, PLANT SCI, V148, P131, DOI 10.1016/S0168-9452(99)00133-8; Warwick NWM, 1998, AQUAT BOT, V62, P19, DOI 10.1016/S0304-3770(98)00082-5; WERNER JE, 1995, PHYSIOL PLANTARUM, V93, P659, DOI 10.1111/j.1399-3054.1995.tb05114.x; Whigham DF, 2009, ESTUAR COAST, V32, P926, DOI 10.1007/s12237-009-9184-6; Yates EJ, 2002, TREES-STRUCT FUNCT, V16, P120, DOI 10.1007/s00468-001-0145-3; Ye Y, 2005, AQUAT BOT, V83, P193, DOI 10.1016/j.aquabot.2005.06.006; Ye Y, 2005, HYDROBIOLOGIA, V539, P109, DOI 10.1007/s10750-004-3404-7; Ye Y, 2004, ACTA BOT SIN, V46, P896; [Zhang Yubin 张瑜斌], 2008, [生态学报, Acta Ecologica Sinica], V28, P1287; Zhang ZH, 2008, AQUAT BOT, V89, P57, DOI 10.1016/j.aquabot.2008.03.002	79	29	31	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93337	10.1371/journal.pone.0093337	http://dx.doi.org/10.1371/journal.pone.0093337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691495	Green Submitted, Green Published, gold			2022-12-27	WOS:000334101100067
J	Fagyas, M; Uri, K; Siket, IM; Darago, A; Boczan, J; Banyai, E; Edes, I; Papp, Z; Toth, A				Fagyas, Miklos; Uri, Katalin; Siket, Ivetta M.; Darago, Andrea; Boczan, Judit; Banyai, Emese; Edes, Istvan; Papp, Zoltan; Toth, Attila			New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) I: Endogenous Angiotensin Converting Enzyme (ACE) Inhibition	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; TRYPTIC HYDROLYSATE; EUROPEAN-SOCIETY; HUMAN-SERUM; TASK-FORCE; CARDIOVASCULAR-DISEASE; DRAMATIC INCREASE; CARDIOLOGY ESC; GUIDELINES; ASSOCIATION	Angiotensin-converting enzyme (ACE) inhibitors represent the fifth most often prescribed drugs. ACE inhibitors decrease 5-year mortality by approximately one-fifth in cardiovascular patients. Surprisingly, there are reports dating back to 1979 suggesting the existence of endogenous ACE inhibitors, which endogenous inhibitory effects are much less characterized than that for the clinically administered ACE inhibitors. Here we aimed to investigate this endogenous ACE inhibition in human sera. It was hypothesized that ACE activity is masked by an endogenous inhibitor, which dissociates from the ACE when its concentration decreases upon dilution. ACE activity was measured by FAPGG hydrolysis first. The specific (dilution corrected) enzyme activities significantly increased by dilution of human serum samples (23.2 +/- 0.7 U/L at 4-fold dilution, 51.4 +/- 0.3 U/L at 32-fold dilution, n = 3, p = 0.001), suggesting the presence of an endogenous inhibitor. In accordance, specific enzyme activities did not changed by dilution when purified renal ACE was used, where no endogenous inhibitor was present (655 +/- 145 U/L, 605 = 42 U/L, n = 3, p = 0.715, respectively). FAPGG conversion strongly correlated with angiotensin I conversion suggesting that this feature is not related to the artificial substrate. Serum samples were ultrafiltered to separate ACE (MW: 180 kDa) and the hypothesized inhibitor. Filtering through 50 kDa filters was without effect, while filtering through 100 kDa filters eliminated the inhibiting factor (ACE activity after <100 kDa filtering: 56.4 +/- 2.4 U/L, n = 4, control: 26.4 +/- 0.7 U/L, n = 4, p<0.001). Lineweaver-Burk plot indicated non-competitive inhibition of ACE by this endogenous factor. The endogenous inhibitor had higher potency on the C-terminal active site than N-terminal active site of ACE. Finally, this endogenous ACE inhibition was also present in mouse, donkey, goat, bovine sera besides men (increasing of specific ACE activity from 4-fold to 32-fold dilution: 2.8-fold, 1.7-fold, 1.5-fold, 1.8-fold, 2.6-fold, respectively). We report here the existence of an evolutionary conserved mechanism suppressing circulating ACE activity, in vivo, similarly to ACE inhibitory drugs.	[Fagyas, Miklos; Uri, Katalin; Siket, Ivetta M.; Darago, Andrea; Edes, Istvan; Papp, Zoltan; Toth, Attila] Univ Debrecen, Inst Cardiol, Div Clin Physiol, H-4012 Debrecen, Hungary; [Boczan, Judit] Univ Debrecen, Dept Neurol, H-4012 Debrecen, Hungary; [Banyai, Emese] Univ Debrecen, Div Nephrol, Inst Internal Med, H-4012 Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen	Toth, A (corresponding author), Univ Debrecen, Inst Cardiol, Div Clin Physiol, H-4012 Debrecen, Hungary.	atitoth@med.unideb.hu	Tóth, Attila/F-4859-2010; Fagyas, Miklós/AAQ-1013-2020	Tóth, Attila/0000-0001-6503-3653; Fagyas, Miklós/0000-0003-3262-884X	Hungarian Academy of Sciences OTKA [K84300]; Hungarian Ministry of Health [ETT 377/2009]; MSD Magyarorszag Kft; Pfizer Magyarorszag Kft; European Social Fund; National Innovation Office of Hungary; Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences;  [TAMOP 4.2.1./B-09/1/KONV-2010-0007];  [TAMOP-4.2.2.A-11/1/KONV 2012-0045];  [REG-EA 09-1-2009-0013]	Hungarian Academy of Sciences OTKA(Hungarian Academy of SciencesOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Ministry of Health; MSD Magyarorszag Kft; Pfizer Magyarorszag Kft; European Social Fund(European Social Fund (ESF)); National Innovation Office of Hungary; Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); ; ; 	The study was supported by the Hungarian Academy of Sciences OTKA (K84300 to AT) and by the Hungarian Ministry of Health (ETT 377/2009 to AT); the work is supported by the TAMOP 4.2.1./B-09/1/KONV-2010-0007 TAMOP-4.2.2.A-11/1/KONV 2012-0045, REG-EA 09-1-2009-0013 projects (to AT, IE and ZP); MSD Magyarorszag Kft, Pfizer Magyarorszag Kft also supported some of the research. The project is implemented through the New Hungary Development Plan, co-financed by the European Social Fund; and by the National Innovation Office of Hungary (Baross Gabor Project, EletMent). Finally, AT was supported by the Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences. The authors thank David Durham for reading and language editing the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm-Larsen B, 2000, ARTERIOSCL THROM VAS, V20, P484, DOI 10.1161/01.ATV.20.2.484; [Anonymous], 1996, J Am Coll Cardiol, V27, P337; BENETEAU B, 1986, CLIN CHEM, V32, P884; Bien BY, 2010, J MANAGE CARE PHARM, V16, P671, DOI 10.18553/jmcp.2010.16.9.671; Brecher AS, 1996, ARCH INT PHARMACOD T, V331, P301; Carmona AK, 2006, NAT PROTOC, V1, P1971, DOI 10.1038/nprot.2006.306; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; COLLINS R, 1995, LANCET, V345, P669; CORVOL P, 1995, J HYPERTENS, V13, pS3, DOI 10.1097/00004872-199509003-00002; Cuspidi C, 2002, J HYPERTENS, V20, P2293, DOI 10.1097/00004872-200211000-00030; Danilov S, 1996, J HYPERTENS, V14, P719, DOI 10.1097/00004872-199606000-00007; Danser AHJ, 2007, PHARMACOL THERAPEUT, V113, P607, DOI 10.1016/j.pharmthera.2006.12.001; Davidson NC, 1996, CIRCULATION, V93, P1155, DOI 10.1161/01.CIR.93.6.1155; Dzau VJ, 2001, AM J CARDIOL, V88, p1L; Fagyas M, 2014, PLOS ONE; Fagyas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087844; Fox KM, 2003, LANCET, V362, P782; GREENBERG B, 1995, CIRCULATION, V91, P2573, DOI 10.1161/01.CIR.91.10.2573; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hoogwerf BJ, 2000, CLEV CLIN J MED, V67, P287, DOI 10.3949/ccjm.67.4.287; IKEMOTO F, 1989, BIOCHEM BIOPH RES CO, V159, P1093, DOI 10.1016/0006-291X(89)92221-3; KLAUSER RJ, 1979, HYPERTENSION, V1, P281, DOI 10.1161/01.HYP.1.3.281; Kramers C, 2001, CIRCULATION, V104, P1236, DOI 10.1161/hc3601.095932; Leon-Ruiz V, 2013, FOOD FUNCT, V4, P1617, DOI 10.1039/c3fo60221d; LIEBERMAN J, 1986, CHEST, V90, P869, DOI 10.1378/chest.90.6.869; Luders S, 2008, J HYPERTENS, V26, P1487, DOI 10.1097/HJH.0b013e3282ff8864; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Nakagomi K, 2000, FEBS LETT, V467, P235, DOI 10.1016/S0014-5793(00)01163-7; Nakagomi K, 1998, FEBS LETT, V438, P255, DOI 10.1016/S0014-5793(98)01311-8; Nakagomi K, 2000, BIOL PHARM BULL, V23, P879; Nesterovitch AB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008282; ONDETTI MA, 1977, SCIENCE, V196, P441, DOI 10.1126/science.191908; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Rice GI, 2006, HYPERTENSION, V48, P914, DOI 10.1161/01.HYP.0000244543.91937.79; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; ROGERSON FM, 1989, NEUROPEPTIDES, V14, P213, DOI 10.1016/0143-4179(89)90048-6; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Ryan J W, 1979, Adv Exp Med Biol, V120B, P599; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; SNYDER RA, 1986, BIOCHIM BIOPHYS ACTA, V871, P1, DOI 10.1016/0167-4838(86)90125-1; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Tauzin J, 2002, FEBS LETT, V531, P369, DOI 10.1016/S0014-5793(02)03576-7; Taylor J, 2012, EUR HEART J, V33, P1539, DOI 10.1093/eurheartj/ehs137; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; Thevananther S, 1999, CAN J PHYSIOL PHARM, V77, P216, DOI 10.1139/cjpp-77-3-216; TIRET L, 1992, AM J HUM GENET, V51, P197; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419	47	19	19	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e87843	10.1371/journal.pone.0087843	http://dx.doi.org/10.1371/journal.pone.0087843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691160	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100002
J	Ker, YB; Peng, CC; Chang, WL; Chyau, CC; Peng, RY				Ker, Yaw-Bee; Peng, Chiung-Chi; Chang, Wan-Lin; Chyau, Charng-Cherng; Peng, Robert Y.			Hepatoprotective Bioactivity of the Glycoprotein, Antrodan, Isolated from Antrodia cinnamomea Mycelia	PLOS ONE			English	Article							PROTEIN-BOUND POLYSACCHARIDE; OXIDATIVE STRESS; NITRIC-OXIDE; BETA-GLUCANS; CANCER; BASIDIOMYCETE; ACTIVATION; RESISTANCE; MECHANISM; MUSHROOM	Antrodan, a protein- bound polysaccharide isolated from Antrodia cinnamomea mycelia, was demonstrated to exhibit significant anti- inflammatory bioactivity in vitro. However, its role in hepatic injury in vivo still remains unclear. We hypothesized that antrodan may have beneficial hepatoprotective effects. To verify this, a lipopolysaccharide ( LPS)- SpragueDawley rat model was used. Antrodan protected against liver damage by suppressing LPS- stimulated serum glutamineoxaloacetic transaminase ( GOT), glutamic- pyruvic transaminase ( GPT), interleukin ( IL)- 6, hepatic thiobarbituric acid reactive substances ( TBARS), nitric oxide ( NO), inducible NO synthase ( iNOS) and nuclear factor ( NF)- kappa B, and by effectively alleviating the downregulated hepatic superoxide dismutase ( SOD), catalase, and glutathione peroxidase ( GSH- Px). Hematoxylin- eosin staining revealed that antrodan at a dosage of 40 mg/ kg was able to alleviate LPS- induced liver damage to a normal status. In addition, we identified the partial main architectural backbone of antrodan to have a 1 -> 3 linear beta- glycosidic backbone of mannan linked by b- 1 -> 3 glucosidic branches. Conclusively, antrodan can potentially ameliorate liver damage in vivo by suppressing oxidative stress induced by LPS.	[Ker, Yaw-Bee] Hungkuang Univ, Dept Appl Food Technol, Taichung, Taiwan; [Peng, Chiung-Chi] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Peng, Chiung-Chi; Chang, Wan-Lin; Chyau, Charng-Cherng; Peng, Robert Y.] Hungkuang Univ, Biotechnol Res Inst, Taichung, Taiwan	Hungkuang University; Taipei Medical University; Hungkuang University	Ker, YB (corresponding author), Hungkuang Univ, Dept Appl Food Technol, Taichung, Taiwan.	ybker@sunrise.hk.edu.tw; ccchyau@sunrise.hk.edu.tw			National Science Council, Taiwan ROC [NSC-102-2313-B-241-003]	National Science Council, Taiwan ROC(Ministry of Science and Technology, Taiwan)	Financial support by the National Science Council (NSC-102-2313-B-241-003), Taiwan ROC is gratefully acknowledged. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Akagi J, 2010, INT J CLIN ONCOL, V15, P145, DOI 10.1007/s10147-010-0033-1; AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; Bohn JA, 1995, CARBOHYD POLYM, V28, P3, DOI 10.1016/0144-8617(95)00076-3; Boveris A, 2002, FREE RADICAL BIO MED, V33, P1186, DOI 10.1016/S0891-5849(02)01009-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buege J A, 1978, Methods Enzymol, V52, P302; Carbonero ER, 2002, FEMS MICROBIOL LETT, V206, P175, DOI 10.1111/j.1574-6968.2002.tb11005.x; Chan GCF, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-25; Chen CJ, 2011, FUNGAL SCI, V16, P65; Chen HX, 2004, J AGR FOOD CHEM, V52, P3333, DOI 10.1021/jf0349679; Chen JZ, 2008, VASC HEALTH RISK MAN, V4, P1265, DOI 10.2147/VHRM.S3803; Chen JZ, 2007, MYCOL RES, V111, P635, DOI 10.1016/j.mycres.2007.02.011; Chen Y, 2008, FOOD CHEM, V107, P231, DOI 10.1016/j.foodchem.2007.08.021; Chiu CH, 2014, MOLECULES, V19, P22, DOI 10.3390/molecules19010022; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; Dennis JW, 2002, BBA-GEN SUBJECTS, V1573, P414, DOI 10.1016/S0304-4165(02)00411-7; Fujimiya Y, 1998, CANCER IMMUNOL IMMUN, V46, P147, DOI 10.1007/s002620050473; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gao B, 2012, J GASTROEN HEPATOL, V27, P89, DOI 10.1111/j.1440-1746.2011.07003.x; Geethangili M, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep108; GREEN SJ, 1994, IMMUNOL LETT, V43, P87, DOI 10.1016/0165-2478(94)00158-8; Hong F, 2004, J IMMUNOL, V173, P797, DOI 10.4049/jimmunol.173.2.797; Jedinak A, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-52; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Lee SB, 2003, BIOMATERIALS, V24, P2503, DOI 10.1016/S0142-9612(03)00003-6; Lindequist U, 2005, EVID-BASED COMPL ALT, V2, P285, DOI 10.1093/ecam/neh107; Liu F, 1997, LIFE SCI, V60, P763, DOI 10.1016/S0024-3205(97)00004-0; Maehara Y, 2012, SURG TODAY, V42, P8, DOI 10.1007/s00595-011-0075-7; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Mizuno T., 1999, International Journal of Medicinal Mushrooms, V1, P105; Mohamadin Ahmed M, 2011, Pathophysiology, V18, P235, DOI 10.1016/j.pathophys.2011.02.003; Moradali MF, 2007, INT IMMUNOPHARMACOL, V7, P701, DOI 10.1016/j.intimp.2007.01.008; Mungrue Imran N, 2002, Heart Fail Rev, V7, P407, DOI 10.1023/A:1020762401408; Neveu WA, 2011, AM J RESP CELL MOL, V45, P1133, DOI 10.1165/rcmb.2011-0054OC; Sebai H, 2010, ECOTOX ENVIRON SAFE, V73, P1078, DOI 10.1016/j.ecoenv.2009.12.031; Song KS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-307; Takimoto F, 2004, BIOL PHARM BULL, V27, P404; Torkelson Carolyn J, 2012, ISRN Oncol, V2012, P251632, DOI 10.5402/2012/251632; Tsuboi S, 2012, TRENDS MOL MED, V18, P224, DOI 10.1016/j.molmed.2012.02.001; TSUKAGOSHI S, 1984, CANCER TREAT REV, V11, P131, DOI 10.1016/0305-7372(84)90005-7; Wang CL, 2011, BIOTECHNOL LETT, V33, P2271, DOI 10.1007/s10529-011-0697-2; Yazar E, 2010, FREE RADICAL RES, V44, P397, DOI 10.3109/10715760903513025; Yokoyama H, 1998, ALCOHOL CLIN EXP RES, V22, p133S, DOI 10.1111/acer.1998.22.s3_part1.133s; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754; Yun CH, 2003, FEMS IMMUNOL MED MIC, V35, P67, DOI 10.1016/S0928-8244(02)00460-1	47	21	30	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93191	10.1371/journal.pone.0093191	http://dx.doi.org/10.1371/journal.pone.0093191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690763	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100050
J	Kiss, A; Horvath, P; Rothballer, A; Kutay, U; Csucs, G				Kiss, Alexa; Horvath, Peter; Rothballer, Andrea; Kutay, Ulrike; Csucs, Gabor			Nuclear Motility in Glioma Cells Reveals a Cell-Line Dependent Role of Various Cytoskeletal Components	PLOS ONE			English	Article							NEURONAL MIGRATION DEFECTS; CYTOPLASMIC DYNEIN; FISSION YEAST; ACTIN FLOW; MYOSIN-II; CENTROSOME; ENVELOPE; MOVEMENT; MICROTUBULES; LIS1	Nuclear migration is a general term for the movement of the nucleus towards a specific site in the cell. These movements are involved in a number of fundamental biological processes, such as fertilization, cell division, and embryonic development. Despite of its importance, the mechanism of nuclear migration is still poorly understood in mammalian cells. In order to shed light on the mechanical processes underlying nuclear movements, we adapted a micro-patterning based assay. C6 rat and U87 human glioma cells seeded on fibronectin patterns - thereby forced into a bipolar morphology displayed oscillatory movements of the nucleus or the whole cell, respectively. We found that both the actomyosin system and microtubules are involved in the nuclear/cellular movements of both cell lines, but their contributions are cell-/migration-type specific. Dynein activity was necessary for nuclear migration of C6 cells but active myosin-II was dispensable. On the other hand, coupled nuclear and cellular movements of U87 cells were driven by actomyosin contraction. We explain these cell-line dependent effects by the intrinsic differences in the overall mechanical tension due to the various cytoskeletal elements inside the cell. Our observations showed that the movements of the nucleus and the centrosome are strongly correlated and display large variation, indicating a tight but flexible coupling between them. The data also indicate that the forces responsible for nuclear movements are not acting directly via the centrosome. Based on our observations, we propose a new model for nuclear oscillations in C6 cells in which dynein and microtubule dynamics are the main drivers of nuclear movements. This mechanism is similar to the meiotic nuclear oscillations of Schizosaccharomyces pombe and may be evolutionary conserved.	[Kiss, Alexa; Horvath, Peter; Rothballer, Andrea; Kutay, Ulrike; Csucs, Gabor] Swiss Fed Inst Technol, Inst Biochem, Zurich, Switzerland; [Kiss, Alexa; Horvath, Peter; Csucs, Gabor] Swiss Fed Inst Technol, Light Microscopy & Screening Ctr, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Csucs, G (corresponding author), Swiss Fed Inst Technol, Inst Biochem, Zurich, Switzerland.	csucs@lmsc.ethz.ch		Kiss, Alexa/0000-0003-4384-4396	ETH Zurich	ETH Zurich(ETH Zurich)	The work was funded by ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abal M, 2002, J CELL BIOL, V159, P731, DOI 10.1083/jcb.200207076; BAKER J, 1993, J CELL BIOL, V122, P113, DOI 10.1083/jcb.122.1.113; Barnhart EL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001059; Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; BROWN SS, 1981, J CELL BIOL, V88, P487, DOI 10.1083/jcb.88.3.487; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3; Chen CS, 1999, OSTEOARTHR CARTILAGE, V7, P81, DOI 10.1053/joca.1998.0164; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Csucs G, 2003, BIOMATERIALS, V24, P1713, DOI 10.1016/S0142-9612(02)00568-9; Daga RR, 2006, CURR BIOL, V16, P1544, DOI 10.1016/j.cub.2006.06.026; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Demeter K, 2005, NEUROSCI RES, V53, P331, DOI 10.1016/j.neures.2005.08.003; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; Ding DQ, 1998, J CELL SCI, V111, P701; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Dupin I, 2011, INT J BIOCHEM CELL B, V43, P1698, DOI 10.1016/j.biocel.2011.09.004; Dupin I, 2011, J CELL SCI, V124, P865, DOI 10.1242/jcs.076356; Dupin I, 2009, J CELL BIOL, V185, P779, DOI 10.1083/jcb.200812034; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Fridolfsson HN, 2010, J CELL BIOL, V191, P115, DOI 10.1083/jcb.201004118; Gerashchenko MV, 2009, CELL BIOL INT, V33, P1057, DOI 10.1016/j.cellbi.2009.06.020; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Grosse AS, 2011, DEVELOPMENT, V138, P4423, DOI 10.1242/dev.065789; Hale CM, 2008, BIOPHYS J, V95, P5462, DOI 10.1529/biophysj.108.139428; Hale CM, 2011, J CELL SCI, V124, P4267, DOI 10.1242/jcs.091231; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Hu DJK, 2013, CELL, V154, P1300, DOI 10.1016/j.cell.2013.08.024; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Kim D, 2012, INT J MOL MED, V29, P440, DOI 10.3892/ijmm.2011.867; Kobayashi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007827; Kosodo Y, 2011, EMBO J, V30, P1690, DOI 10.1038/emboj.2011.81; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Lavelin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073549; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Levy JR, 2008, J CELL SCI, V121, P3187, DOI 10.1242/jcs.033878; Lombardi ML, 2011, J BIOL CHEM, V286, P26743, DOI 10.1074/jbc.M111.233700; Luxton GWG, 2011, CURR OPIN CELL BIOL, V23, P579, DOI 10.1016/j.ceb.2011.08.001; Luxton GWG, 2010, SCIENCE, V329, P956, DOI 10.1126/science.1189072; Malone CJ, 1999, DEVELOPMENT, V126, P3171; Martini FJ, 2010, J NEUROSCI, V30, P8660, DOI 10.1523/JNEUROSCI.1962-10.2010; Mellad JA, 2011, CURR OPIN CELL BIOL, V23, P47, DOI 10.1016/j.ceb.2010.11.006; MESSIER PE, 1978, EXPERIENTIA, V34, P289, DOI 10.1007/BF01922992; Mih JD, 2012, J CELL SCI, V125, P5974, DOI 10.1242/jcs.108886; Moore JK, 2009, P NATL ACAD SCI USA, V106, P5147, DOI 10.1073/pnas.0810828106; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; NAGELE RG, 1979, J EXP ZOOL, V210, P89, DOI 10.1002/jez.1402100110; NEMERE I, 1985, CELL MOTIL CYTOSKEL, V5, P17, DOI 10.1002/cm.970050103; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Pelham RJ, 1999, MOL BIOL CELL, V10, P935, DOI 10.1091/mbc.10.4.935; PENNINGROTH SM, 1982, BIOCHEM BIOPH RES CO, V104, P234, DOI 10.1016/0006-291X(82)91964-7; Poole K, 2005, J MOL BIOL, V349, P380, DOI 10.1016/j.jmb.2005.03.064; Pouthas F, 2008, J CELL SCI, V121, P2406, DOI 10.1242/jcs.026849; Reinsch S, 1998, J CELL SCI, V111, P2283; Said HM, 2007, J NEURO-ONCOL, V81, P27, DOI 10.1007/s11060-006-9205-2; Sasaki S, 2005, MOL CELL BIOL, V25, P7812, DOI 10.1128/MCB.25.17.7812-7827.2005; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Starr DA, 2003, J CELL SCI, V116, P211, DOI 10.1242/jcs.00248; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Starr DA, 2009, J CELL SCI, V122, P577, DOI 10.1242/jcs.037622; Stearns T, 1997, J CELL BIOL, V138, P957, DOI 10.1083/jcb.138.5.957; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; Suelmann R, 2000, RES MICROBIOL, V151, P247, DOI 10.1016/S0923-2508(00)00151-0; Szabo B, 2004, CELL MOTIL CYTOSKEL, V59, P38, DOI 10.1002/cm.20022; Szabo B, 2011, CYTOSKELETON, V68, P325, DOI 10.1002/cm.20515; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; Tran PT, 1999, BIOL BULL, V197, P262, DOI 10.2307/1542640; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Umeshima H, 2007, P NATL ACAD SCI USA, V104, P16182, DOI 10.1073/pnas.0708047104; Versaevel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1668; Vogel SK, 2009, PLOS BIOL, V7, P918, DOI 10.1371/journal.pbio.1000087; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018; Zhu J, 2010, MOL BIOL CELL, V21, P4418, DOI 10.1091/mbc.E10-07-0627	88	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93431	10.1371/journal.pone.0093431	http://dx.doi.org/10.1371/journal.pone.0093431			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691067	gold, Green Submitted, Green Published			2022-12-27	WOS:000334101100079
J	Steel, E; Murray, VL; Liu, AP				Steel, Elisabeth; Murray, Victoria L.; Liu, Allen P.			Multiplex Detection of Homo- and Heterodimerization of G Protein-Coupled Receptors by Proximity Biotinylation	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; BETA(2)-ADRENERGIC RECEPTOR; GPCR OLIGOMERIZATION; CRYSTAL-STRUCTURE; CXCR4; DIMERIZATION; CCR5; LIGAND; CELLS; REVEALS	Dimerization of G protein-coupled receptors (GPCRs) represents a potential mechanism by which GPCR functions are regulated. Several resonance energy transfer (RET)-based methods have revealed GPCR homo- and heterodimerization. However, interpretation of an increase in FRET efficiency could be attributed to either dimerization/oligomerization events or conformational changes within an already dimerized/oligomerized receptor complex. Furthermore, RET-based methods can only measure pairwise dimerization, and cannot easily achieve multiplex detection. In this study, we applied proximity-based biotinylation for detecting receptor dimerization by utilizing a specific enzyme-substrate pair that are fused to GPCRs. The biotin ligase BirA is fused to CXCR4 and site-specifically biotinylates an acceptor peptide (AP) in the presence of biotin. As a test case for our newly developed assay, we have characterized the homo-dimerization of chemokine receptor CXCR4 and heterodimerization of CXCR4 with CCR2 or CCR5. The degree of biotinylation varies with the amount of GPCR-AP as well as biotinylation time. Using enzyme/substrate receptor pairs and measuring receptor biotinylation, we demonstrate that CXCR4 can homo-dimerize and hetero-dimerize with CCR2 and CCR5. The effect of CXCL12, agonist for CXCR4, was found to decrease surface biotinylation of CXCR4-AP. This effect is due to a combination of CXCR4 endocytosis and stabilization of CXCR4 homodimers. Finally, when CXCR4-AP, CCR2-AP, and CCR5-AP were expressed together, we observed CXCR4-CXCR4 homodimers and CXCR4-CCR2 and CXCR4-CCR5 heterodimers. The newly developed assay opens new opportunity for multiplex detection for GPCR homo- and heterodimerization within the same cellular context.	[Steel, Elisabeth; Murray, Victoria L.; Liu, Allen P.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Liu, Allen P.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Liu, Allen P.] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Liu, Allen P.] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Liu, AP (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	allenliu@umich.edu	Liu, Allen P/A-1704-2011	Liu, Allen P/0000-0002-0309-7018; Steel, Elisabeth/0000-0001-6693-4285	National Institutes of Health [DP2 HL117748-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [DP2HL117748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	AL is supported by National Institutes of Health Director's New Innovator Award DP2 HL117748-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Choi WT, 2012, BIOCHEMISTRY-US, V51, P7078, DOI 10.1021/bi2016712; Clapp AR, 2005, J AM CHEM SOC, V127, P18212, DOI 10.1021/ja054630i; Fernandez-Suarez M, 2008, J AM CHEM SOC, V130, P9251, DOI 10.1021/ja801445p; Ferre S, 2010, CURR OPIN PHARMACOL, V10, P1, DOI 10.1016/j.coph.2009.11.002; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Hammad MM, 2010, J BIOL CHEM, V285, P34653, DOI 10.1074/jbc.M110.106591; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; Isik N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003424; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; LaRocca TJ, 2010, J CARDIOVASC PHARM, V56, P548, DOI 10.1097/FJC.0b013e3181f713fe; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; Lin H, 2013, NAT METHODS, V10, P140, DOI [10.1038/NMETH.2324, 10.1038/nmeth.2324]; Liu AP, 2010, J CELL BIOL, V191, P1381, DOI 10.1083/jcb.201008117; Liu DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052823; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; Munoz LM, 2012, IMMUNOL LETT, V145, P23, DOI 10.1016/j.imlet.2012.04.012; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Mellado M, 1999, NATURE, V400, P723, DOI 10.1038/23382; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Reiner S, 2010, J BIOL CHEM, V285, P36188, DOI 10.1074/jbc.M110.175604; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Singer II, 2001, J VIROL, V75, P3779, DOI 10.1128/JVI.75.8.3779-3790.2001; SMYTHE E, 1992, METHOD ENZYMOL, V219, P223; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Vischer HF, 2011, BRIT J PHARMACOL, V163, P246, DOI 10.1111/j.1476-5381.2011.01229.x; Wang JH, 2004, J CELL BIOCHEM, V93, P753, DOI 10.1002/jcb.20161; Wang YX, 2008, ANNU REV BIOMED ENG, V10, P1, DOI 10.1146/annurev.bioeng.010308.161731; Ward RJ, 2013, METHOD ENZYMOL, V521, P69, DOI 10.1016/B978-0-12-391862-8.00004-1; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; WILSON KP, 1992, P NATL ACAD SCI USA, V89, P9257, DOI 10.1073/pnas.89.19.9257; Zou P, 2011, ACS CHEM BIOL, V6, P308, DOI 10.1021/cb100361k	41	16	16	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93646	10.1371/journal.pone.0093646	http://dx.doi.org/10.1371/journal.pone.0093646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691126	Green Submitted, gold, Green Published			2022-12-27	WOS:000334101100119
J	Xu, Y; Zeng, FF; He, LP; Ling, WH; Chen, WQ; Chen, YM				Xu, Ying; Zeng, Fang-fang; He, Li-ping; Ling, Wen-hua; Chen, Wei-qing; Chen, Yu-ming			Comparison of Predictive Value of Cardiometabolic Indices for Subclinical Atherosclerosis in Chinese Adults	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; EARLY CAROTID ATHEROSCLEROSIS; CARDIOVASCULAR RISK-FACTORS; INSULIN-RESISTANCE SYNDROME; INTIMA MEDIA THICKNESS; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; FOLLOW-UP; BLOOD-PRESSURE; JAPANESE MEN	Objectives: Metabolic disturbances are well-known risk factors for atherosclerosis, but it remains unclear which cardiometabolic components are the predominant determinants. This study aimed to compare and identify the key determinants of carotid atherosclerosis in asymptomatic middle-aged and elderly Chinese. Methods: A community-based cross-sectional study including 3,162 apparently healthy residents aged 37-75 years was performed from July 2008 to June 2010 in Guangzhou, China. Carotid artery intima-media thickness (IMT) was assessed by B-mode ultrasound, and increased IMT was defined as IMT>1.00 mm. Obesity indices, blood pressure, fasting blood lipids, glucose and uric acid levels were determined. Principal components factor analysis was used to extract common factors underlying 11 metabolic factors. Results: Four common factors, defined as "adiposity,'' "blood lipids,'' "triglycerides/uric acid (TG/UA)'' (in men) or "triglycerides/uric acid/glucose (TG/UA/Glu)'' (in women), and "blood pressure,'' were retained for both sexes. After adjustment for potential covariates, the "adiposity'' factor showed the strongest positive association with increased IMT in men. Comparing the extreme quartiles, ORs (95% CI) of increased IMT were 4.64 (2.04-10.59) at the CCA and 2.37 (1.54-3.64) at the BIF), followed by "blood pressure'', the corresponding OR (95% CI) was 2.85 (1.37-5.90) at the CCA. Whereas, the four common factors showed comparable and weak relationship with increased IMTs, the ORs for quartile 4 vs. quartile 1 varied from 0.89 to 3.59 in women. Conclusions: Among the metabolic factors, "adiposity'' and "blood pressure'' play predominant roles in the presence of carotid atherosclerosis in men, but no key factor is identified in women.	[Xu, Ying; Zeng, Fang-fang; He, Li-ping; Ling, Wen-hua; Chen, Wei-qing; Chen, Yu-ming] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Ying] Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guangzhou, Guangdong, Peoples R China; [He, Li-ping] Guangzhou Panyu Cent Hosp, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangdong Pharmaceutical University	Chen, YM (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food, Guangzhou 510275, Guangdong, Peoples R China.	chenyum@mail.sysu.edu.cn	Chen, Yi/HIR-2608-2022; Chen, Yu/Y-3292-2019	chen, Yu-ming/0000-0003-1658-5528	Sun Yat-sen University, Guangzhou, China [2007032]; State Key Program of National Natural Science of China [81130052]	Sun Yat-sen University, Guangzhou, China; State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC))	This study was jointly supported by the 5010 Program for Clinical Researches by Sun Yat-sen University, Guangzhou, China (No. 2007032) and the State Key Program of National Natural Science of China (No. 81130052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison MA, 2008, AM J EPIDEMIOL, V167, P962, DOI 10.1093/aje/kwm402; Child D, 2006, ESSENTIALS FACTOR AN, V3rd; Cremer P, 1997, ATHEROSCLEROSIS, V129, P221, DOI 10.1016/S0021-9150(96)06030-3; De Bacquer D, 2003, EUR J CARDIOV PREV R, V10, P289, DOI 10.1097/00149831-200308000-00012; Ebrahim S, 1999, STROKE, V30, P841, DOI 10.1161/01.STR.30.4.841; Fan AZ, 2006, J ATHEROSCLER THROMB, V13, P46, DOI 10.5551/jat.13.46; Fang XH, 2001, CEREBROVASC DIS, V11, P225, DOI 10.1159/000047643; Fujii K, 2003, HYPERTENS RES, V26, P465, DOI 10.1291/hypres.26.465; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Perez-Larraya JG, 2012, J CLIN ULTRASOUND, V40, P479, DOI 10.1002/jcu.21916; HAHEIM LL, 1993, J INTERN MED, V234, P17, DOI 10.1111/j.1365-2796.1993.tb00699.x; Haring R, 2010, EXP CLIN ENDOCR DIAB, V118, P685, DOI 10.1055/s-0030-1261876; Howard BV, 2003, METABOLISM, V52, P362, DOI 10.1053/meta.2003.50057; Hwang IC, 2012, KOREAN J FAM MED, V33, P229, DOI 10.4082/kjfm.2012.33.4.229; Jonsdottir LS, 2002, J CARDIOVASC RISK, V9, P67, DOI 10.1097/00043798-200204000-00001; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Kawamoto R, 2007, J ATHEROSCLER THROMB, V14, P36, DOI 10.5551/jat.14.36; MARMOT MG, 1975, AM J EPIDEMIOL, V102, P514, DOI 10.1093/oxfordjournals.aje.a112189; Meigs JB, 2000, AM J EPIDEMIOL, V152, P908, DOI 10.1093/aje/152.10.908; Menotti A, 1996, J Cardiovasc Risk, V3, P69, DOI 10.1097/00043798-199602000-00010; Moran A, 2010, CIRC-CARDIOVASC QUAL, V3, P243, DOI 10.1161/CIRCOUTCOMES.109.910711; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Qian JC, 2010, B WORLD HEALTH ORGAN, V88, P769, DOI 10.2471/BLT.09.064709; Qizilbash N, 1995, LANCET, V346, P1647; SALONEN JT, 1982, STROKE, V13, P327, DOI 10.1161/01.STR.13.3.327; SEEMAN T, 1993, AM J EPIDEMIOL, V138, P1037, DOI 10.1093/oxfordjournals.aje.a116822; Stevens J, 1986, APPL MULTIVARIATE ST, P337; Suzuki M, 1996, HYPERTENSION, V28, P593, DOI 10.1161/01.HYP.28.4.593; Touboul PJ, 2012, EUR J PREV CARDIOL, V19, P18, DOI 10.1177/2047487312448990; Tzou Wendy S, 2007, Prev Cardiol, V10, P181, DOI 10.1111/j.1520-037X.2007.06450.x; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; Wang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032736; WONG ND, 1991, ANN INTERN MED, V115, P687, DOI 10.7326/0003-4819-115-9-687; Yang Y, 2011, CHINESE MED J-PEKING, V124, P3702, DOI 10.3760/cma.j.issn.0366-6999.2011.22.018; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205; YANO K, 1988, AM J EPIDEMIOL, V127, P476, DOI 10.1093/oxfordjournals.aje.a114824; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	38	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93538	10.1371/journal.pone.0093538	http://dx.doi.org/10.1371/journal.pone.0093538			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691185	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100100
J	Ersahin, T; Carkacioglu, L; Can, T; Konu, O; Atalay, V; Cetin-Atalay, R				Ersahin, Tulin; Carkacioglu, Levent; Can, Tolga; Konu, Ozlen; Atalay, Volkan; Cetin-Atalay, Rengul			Identification of Novel Reference Genes Based on MeSH Categories	PLOS ONE			English	Article							SUITABLE REFERENCE GENES; REAL-TIME PCR; HEPATOCELLULAR-CARCINOMA; HOUSEKEEPING GENES; EXPRESSION; NORMALIZATION; VARIANCE; MODEL	Transcriptome experiments are performed to assess protein abundance through mRNA expression analysis. Expression levels of genes vary depending on the experimental conditions and the cell response. Transcriptome data must be diverse and yet comparable in reference to stably expressed genes, even if they are generated from different experiments on the same biological context from various laboratories. In this study, expression patterns of 9090 microarray samples grouped into 381 NCBI-GEO datasets were investigated to identify novel candidate reference genes using randomizations and Receiver Operating Characteristic (ROC) curves. The analysis demonstrated that cell type specific reference gene sets display less variability than a united set for all tissues. Therefore, constitutively and stably expressed, origin specific novel reference gene sets were identified based on their coefficient of variation and percentage of occurrence in all GEO datasets, which were classified using Medical Subject Headings (MeSH). A large number of MeSH grouped reference gene lists are presented as novel tissue specific reference gene lists. The most commonly observed 17 genes in these sets were compared for their expression in 8 hepatocellular, 5 breast and 3 colon carcinoma cells by RT-qPCR to verify tissue specificity. Indeed, commonly used housekeeping genes GAPDH, Actin and EEF2 had tissue specific variations, whereas several ribosomal genes were among the most stably expressed genes in vitro. Our results confirm that two or more reference genes should be used in combination for differential expression analysis of large-scale data obtained from microarray or next generation sequencing studies. Therefore context dependent reference gene sets, as presented in this study, are required for normalization of expression data from diverse technological backgrounds.	[Ersahin, Tulin; Konu, Ozlen; Cetin-Atalay, Rengul] Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey; [Carkacioglu, Levent; Can, Tolga; Atalay, Volkan] Middle E Tech Univ, Dept Comp Engn, TR-06531 Ankara, Turkey	Ihsan Dogramaci Bilkent University; Middle East Technical University	Cetin-Atalay, R (corresponding author), Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey.	rengul@bilkent.edu.tr	Can, Tolga/D-1395-2010; Cetin-Atalay, Rengul/F-5780-2013; Cetin-Atalay, Rengul/O-9826-2014; Atalay, Volkan/M-2256-2016	Can, Tolga/0000-0002-5532-0154; Cetin-Atalay, Rengul/0000-0003-2408-6606; Cetin-Atalay, Rengul/0000-0003-2408-6606; Atalay, Volkan/0000-0001-7850-0601	Scientific and Technical Research Council of Turkey, (TUBITAK) [110S338]; Bilkent University; Middle East Technical University	Scientific and Technical Research Council of Turkey, (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Bilkent University(Ihsan Dogramaci Bilkent University); Middle East Technical University(Middle East Technical University)	This work was supported by grants from The Scientific and Technical Research Council of Turkey, (TUBITAK-project #110S338), Bilkent University and Middle East Technical University local funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carkacioglu L, 2010, INT J DATA MIN BIOIN, V4, P701, DOI 10.1504/IJDMB.2010.037548; CHANG C, 2011, FILM COMMENT, V47, P6, DOI DOI 10.1371/J0URNAL.P0NE.0022859; Chen ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054082; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Eisenberg E, 2013, TRENDS GENET, P1; Fu LY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-49; Gao Q, 2008, J CANCER RES CLIN, V134, P979, DOI 10.1007/s00432-008-0369-3; HE L, 1984, IN VITRO CELL DEV B, V20, P493, DOI 10.1007/BF02619623; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Jin P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-55; Jung M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-47; Lee S, 2007, J BIOCHEM MOL BIOL, V40, P226; OEFINGER PE, 1981, J GEN VIROL, V53, P105, DOI 10.1099/0022-1317-53-1-105; Ohl F, 2005, J MOL MED, V83, P1014, DOI 10.1007/s00109-005-0703-z; Popovici V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-42; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Sikand K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047510; Srivastava S, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq670; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041659; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Valenti MT, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-49; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Waxman S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-243; Zimonjic DB, 2009, J CELL MOL MED, V13, P3985, DOI 10.1111/j.1582-4934.2009.00769.x	36	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93341	10.1371/journal.pone.0093341	http://dx.doi.org/10.1371/journal.pone.0093341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682035	Green Published, gold, Green Submitted			2022-12-27	WOS:000333678100045
J	Doi, H; Heeren, A; Maurage, P				Doi, Hideyuki; Heeren, Alexandre; Maurage, Pierre			Scientific Activity Is a Better Predictor of Nobel Award Chances than Dietary Habits and Economic Factors	PLOS ONE			English	Article							CHOCOLATE CONSUMPTION; CONSERVATION BIOLOGY; REGRESSION; ECOLOGY	Several recent studies have described a strong correlation between nutritional or economic data and the number of Nobel awards obtained across a large range of countries. This sheds new light on the intriguing question of the key predictors of Nobel awards chances. However, all these studies have been focused on a single predictor and were only based on simple correlation and/or linear model analysis. The main aim of the present study was thus to clarify this debate by simultaneously exploring the influence of food consumption (cacao, milk, and wine), economic variables (gross domestic product) and scientific activity (number of publications and research expenditure) on Nobel awards. An innovative statistical analysis, hierarchical partitioning, has been used because it enables us to reduce collinearity problems by determining and comparing the independent contribution of each factor. Our results clearly indicate that a country's number of Nobel awards can be mainly predicted by its scientific achievements such as number of publications and research expenditure. Conversely, dietary habits and the global economy variable are only minor predictors; this finding contradicts the conclusions of previous studies. Dedicating a large proportion of the GDP to research and to the publication of a high number of scientific papers would thus create fertile ground for obtaining Nobel awards.	[Doi, Hideyuki] Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 724, Japan; [Heeren, Alexandre; Maurage, Pierre] Catholic Univ Louvain, Psychol Sci Res Inst, Lab Expt Psychopathol, B-1348 Louvain, Belgium	Hiroshima University; Universite Catholique Louvain	Doi, H (corresponding author), Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 724, Japan.	doih@hiroshima-u.ac.jp	Doi, Hideyuki/D-2012-2010; Heeren, Alexandre/U-9748-2019	Doi, Hideyuki/0000-0002-2701-3982; Heeren, Alexandre/0000-0003-0553-6149; Maurage, Pierre/0000-0003-0197-0810	Belgian Fund for Scientific Research (F.R.S.-FNRS, Belgium)	Belgian Fund for Scientific Research (F.R.S.-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS)	Alexandre Heeren (Post-doctoral Research Fellow) and Pierre Maurage (Research Associate) are funded by the Belgian Fund for Scientific Research (F.R.S.-FNRS, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Golomb BA, 2013, NATURE, V499, P409, DOI 10.1038/499409a; Kayser Manfred, 2012, Investig Genet, V3, P26, DOI 10.1186/2041-2223-3-26; Li J, 2013, PRACT NEURO IN PRESS; Lintwaithe S, 2012, PRACT NEUROL, V13, P63; Loney Tom, 2013, Evid Based Med, V18, P120, DOI 10.1136/eb-2013-101288; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; Maurage P, 2013, J NUTR, V143, P931, DOI 10.3945/jn.113.174813; Messerli FH, 2012, NEW ENGL J MED, V367, P1562, DOI 10.1056/NEJMon1211064; Olea PP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011698; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Shulman T, 2012, PED ANN, V41, P486; Walsh C, 2013, HIER PART HIER PART; [No title captured]	15	7	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92612	10.1371/journal.pone.0092612	http://dx.doi.org/10.1371/journal.pone.0092612			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675712	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677500028
J	Goren, A; Annunziata, K; Schnoll, RA; Suaya, JA				Goren, Amir; Annunziata, Kathy; Schnoll, Robert A.; Suaya, Jose A.			Smoking Cessation and Attempted Cessation among Adults in the United States	PLOS ONE			English	Article							QUALITY-OF-LIFE; QUIT ATTEMPTS; MENTAL-ILLNESS; PREDICTORS; ABSTINENCE; SMOKERS; PRODUCTIVITY; GENDER; RATES	Aims: With growing recognition of stagnant rates of attempted cigarette smoking cessation, the current study examined demographic and psychometric characteristics associated with successful and attempted smoking cessation in a nationally representative sample. This additional understanding may help target tobacco cessation treatments toward sub-groups of smokers in order to increase attempts to quit smoking. Design, setting, and participants: Data were used from the 2011 U.S. National Health and Wellness Survey (n = 50,000). Measurements: Current smoking status and demographics, health characteristics, comorbidities, and health behaviors. Findings: In 2011, 18%, 29%, and 52% of U.S. adults were current, former, or never smokers, respectively. Over one quarter (27%) of current smokers were attempting to quit. Current smokers (vs. others) were significantly more likely to be poorer, non-Hispanic White, less educated, ages 45-64, and uninsured, and they had fewer health-conscious behaviors (e. g., influenza vaccination, exercise). Attempting quitters vs. current smokers were significantly less likely to be non-Hispanic White and more likely to be younger, educated, insured, non-obese, with family history of chronic obstructive pulmonary disease, and they had more health-conscious behaviors. Conclusions: Smokers, attempting quitters, and successful quitters differ on characteristics that may be useful for targeting and personalizing interventions aiming to increase cessation attempts, likelihood, and sustainability.	[Goren, Amir] Kantar Hlth, Hlth Outcomes Practice, New York, NY 10010 USA; [Annunziata, Kathy] Kantar Hlth, Hlth Outcomes Practice, Princeton, NJ USA; [Schnoll, Robert A.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Suaya, Jose A.] GlaxoSmithKline Vaccines, Philadelphia, PA USA	University of Pennsylvania; GlaxoSmithKline	Goren, A (corresponding author), Kantar Hlth, Hlth Outcomes Practice, New York, NY 10010 USA.	Amir.Goren@kantarhealth.com			GlaxoSmithKline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support for this study was provided by GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaku Israel, 2012, Morbidity and Mortality Weekly Report, V61, P889; Augustson EM, 2008, AM J PUBLIC HEALTH, V98, P549, DOI 10.2105/AJPH.2005.084137; Bolge SC, 2009, QUAL LIFE RES, V18, P415, DOI 10.1007/s11136-009-9462-6; Bunn WB, 2006, J OCCUP ENVIRON MED, V48, P1099, DOI 10.1097/01.jom.0000243406.08419.74; Carpenter MJ, 2011, ARCH INTERN MED, V171, P1901, DOI 10.1001/archinternmed.2011.492; Carpenter MJ, 2010, CLIN TRIALS, V7, P157, DOI 10.1177/1740774510361533; Davila Evelyn P, 2009, Tob Induc Dis, V5, P10, DOI 10.1186/1617-9625-5-10; DiBonaventura Marco DaCosta, 2010, J Med Econ, V13, P709, DOI 10.3111/13696998.2010.535576; DICLEMENTE CC, 1985, COGNITIVE THER RES, V9, P181, DOI 10.1007/BF01204849; Dube S. R., 2010, Morbidity and Mortality Weekly Report, V59, P1135; Fagan P, 2007, J HEALTH CARE POOR U, V18, P52, DOI 10.1353/hpu.2007.0119; Fiore MC, 2008, TREATING TOBACCO USE; Fiore MC, 2008, TREATING TOBACCO USE; Fishman PA, 2003, HEALTH SERV RES, V38, P733, DOI 10.1111/1475-6773.00142; FLEGAL KM, 1995, NEW ENGL J MED, V333, P1165, DOI 10.1056/NEJM199511023331801; Giovino Gary A., 1994, Morbidity and Mortality Weekly Report, V43, P1; HAUSWALD M, 1989, AM J EMERG MED, V7, P187, DOI 10.1016/0735-6757(89)90136-8; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Heikkinen H, 2008, NICOTINE TOB RES, V10, P1199, DOI 10.1080/14622200802163142; Hickman NJ, 2010, NICOTINE TOB RES, V12, P1125, DOI 10.1093/ntr/ntq160; HORVITZ DG, 1952, J AM STAT ASSOC, V47, P663, DOI 10.2307/2280784; Hymowitz N, 1997, Tob Control, V6 Suppl 2, pS57, DOI 10.1136/tc.6.suppl_2.S57; Jardin BF, 2012, NICOTINE TOB RES, V14, P1197, DOI 10.1093/ntr/nts015; Kenney BA, 2009, ADDICT BEHAV, V34, P548, DOI 10.1016/j.addbeh.2009.03.020; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Maarcher Ann, 2011, Morbidity and Mortality Weekly Report, V60, P1513; Messer K, 2008, AM J PUBLIC HEALTH, V98, P317, DOI 10.2105/AJPH.2007.112060; Monso E, 2001, TOB CONTROL, V10, P165, DOI 10.1136/tc.10.2.165; Piper ME, 2010, NICOTINE TOB RES, V12, P647, DOI 10.1093/ntr/ntq067; Pratt Laura A, 2010, NCHS Data Brief, P1; Rafful C, 2013, ADDICT BEHAV, V38, P1920, DOI 10.1016/j.addbeh.2012.12.019; Ramo DE, 2011, HEALTH PSYCHOL, V30, P693, DOI 10.1037/a0023443; Rosal MC, 1998, HEALTH PSYCHOL, V17, P476, DOI 10.1037/0278-6133.17.5.476; Scharf D, 2004, ADDICTION, V99, P1462, DOI 10.1111/j.1360-0443.2004.00845.x; Schiller JS, 2012, VITAL HLTH STAT, V10, P1; Shiffman S, 2008, AM J PREV MED, V34, P102, DOI 10.1016/j.amepre.2007.09.033; Siegel MB, 2011, AM J PREV MED, V40, P472, DOI 10.1016/j.amepre.2010.12.006; Thieleke Jessica, 2005, WMJ, V104, P41; Twardella D, 2006, J CLIN EPIDEMIOL, V59, P82, DOI 10.1016/j.jclinepi.2005.05.003; U.S. Department of Health and Human Services, 2004, HLTH CONS SMOK REP S; US Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; US Department of Health and Human Services [Internet], 1990, HLTH BEN SMOK CESS R	42	22	22	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93014	10.1371/journal.pone.0093014	http://dx.doi.org/10.1371/journal.pone.0093014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SW	24676348	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677500064
J	He, JH; Lai, HF; Engle, M; Gorlatov, S; Gruber, C; Steinkellner, H; Diamond, MS; Chen, Q				He, Junyun; Lai, Huafang; Engle, Michael; Gorlatov, Sergey; Gruber, Clemens; Steinkellner, Herta; Diamond, Michael S.; Chen, Qiang			Generation and Analysis of Novel Plant-Derived Antibody-Based Therapeutic Molecules against West Nile Virus	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; DEPENDENT ENHANCEMENT; N-GLYCOSYLATION; INFECTION; EXPRESSION; VECTORS; PARTICLES; INDUCTION; DISEASE; SYSTEM	Previously, our group engineered a plant-derived monoclonal antibody (MAb) (pHu-E16) that efficiently treated West Nile virus (WNV) infection in mice. In this study, we developed several pHu-E16 variants to improve its efficacy. These variants included a single-chain variable fragment (scFv) of pHu-E16 fused to the heavy chain (HC) constant domains (C-H(1-3)) of human IgG (pHu-E16scFv-C-H(1-3)) and a tetravalent molecule (Tetra pHu-E16) assembled from pHu-E16scFv-C-H(1-3) with a second pHu-E16scFv fused to the light chain (LC) constant region. pHu-E16scFv-C-H(1-3) and Tetra pHu-E16 were efficiently expressed and assembled in plants. To assess the impact of differences in N-linked glycosylation on pHu-E16 variant assembly and function, we expressed additional pHu-E16 variants with various combinations of HC and LC components. Our study revealed that proper pairing of HC and LC was essential for the complete N-glycan processing of antibodies in both plant and animal cells. Associated with their distinct N-glycoforms, pHu-E16, pHu-E16scFv-C-H(1-3) and Tetra pHu-E16 exhibited differential binding to C1q and specific Fc gamma receptors (Fc gamma R). Notably, none of the plant-derived Hu-E16 variants showed antibody-dependent enhancement (ADE) activity in CD32A(+) human cells, suggesting the potential of plant-produced antibodies to minimize the adverse effect of ADE. Importantly, all plant-derived MAb variants exhibited at least equivalent in vitro neutralization and in vivo protection in mice compared to mammalian cell-produced Hu-E16. This study demonstrates the capacity of plants to express and assemble a large, complex and functional IgG-like tetravalent mAb variant and also provides insight into the relationship between MAb N-glycosylation, Fc gamma R and C1q binding, and ADE. These new insights may allow the development of safer and cost effective MAb-based therapeutics for flaviviruses, and possibly other pathogens.	[He, Junyun; Lai, Huafang; Chen, Qiang] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Chen, Qiang] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Engle, Michael; Diamond, Michael S.] Arizona State Univ, Coll Technol & Innovat, Mesa, AZ USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Gruber, Clemens] Univ Nat Resources & Appl Life Sci, Dept Chem, Vienna, Austria; [Steinkellner, Herta] Univ Nat Resources & Appl Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria; [Gorlatov, Sergey] MacroGenics Inc, Rockville, MD USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Chen, Q (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA.	qiang.chen.4@asu.edu	Diamond, Michael/AAH-1733-2019; he, junyun/H-6461-2011; Steinkellner, Herta/N-4267-2016	Diamond, Michael/0000-0002-8791-3165; Steinkellner, Herta/0000-0003-4823-1505; Grunwald-Gruber, Clemens/0000-0002-6097-8348; chen, qiang/0000-0003-1498-7013	NIAID [U01 AI075549, R21 AI101329]; Laura Bassi Centers of Expertise PlantBioP [822757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI075549, R21AI101329, R33AI101329] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Laura Bassi Centers of Expertise PlantBioP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID grants number U01 AI075549 and R21 AI101329 to Q. C., and by a Laura Bassi Centers of Expertise PlantBioP grant number 822757 to H. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; Bendandi M, 2010, ANN ONCOL, V21, P2420, DOI 10.1093/annonc/mdq256; Boado RJ, 2007, BIOTECHNOL BIOENG, V96, P381, DOI 10.1002/bit.21120; Bode AV, 2006, CLIN INFECT DIS, V42, P1234, DOI 10.1086/503038; Bosch D, 2013, CURR PHARM DESIGN, V19, P5503, DOI 10.2174/1381612811319310006; Chen Q., 2013, MOL VACCINES, V1, P153, DOI [10.1007/978-3-7091-1419-3_8, DOI 10.1007/978-3-7091-1419-3_8]; Chen Q., 2008, BIOL ENG, V1, P291, DOI DOI 10.13031/201326854; Chen Qiang, 2013, Adv Tech Biol Med, V1; Chen Q, 2011, TRANSGENIC HORTICULTURAL CROPS: CHALLENGES AND OPPORTUNITIES, P83; Chen Q, 2011, HUM VACCINES, V7, P331, DOI 10.4161/hv.7.3.14262; De Muynck B, 2010, PLANT BIOTECHNOL J, V8, P529, DOI 10.1111/j.1467-7652.2009.00494.x; Diamond MS, 2006, TRENDS MICROBIOL, V14, P287, DOI 10.1016/j.tim.2006.05.004; Engle MJ, 2003, J VIROL, V77, P12941, DOI 10.1128/JVI.77.24.12941-12949.2003; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Fuchs A, 2011, VIROLOGY, V412, P101, DOI 10.1016/j.virol.2011.01.003; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; Gomord V, 2010, PLANT BIOTECHNOL J, V8, P564, DOI 10.1111/j.1467-7652.2009.00497.x; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; He J, 2014, BIOMED RES IN PRESS; He JY, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/106783; HIATT A, 1989, NATURE, V342, P76, DOI 10.1038/342076a0; Houde D, 2010, MOL CELL PROTEOMICS, V9, P1716, DOI 10.1074/mcp.M900540-MCP200; Huang Z, 2010, BIOTECHNOL BIOENG, V106, P9, DOI 10.1002/bit.22652; Huang Z, 2009, BIOTECHNOL BIOENG, V103, P706, DOI 10.1002/bit.22299; Huisman W, 2009, VACCINE, V27, P505, DOI 10.1016/j.vaccine.2008.10.087; Lai HF, 2012, PLANT CELL REP, V31, P573, DOI 10.1007/s00299-011-1196-6; Lai HF, 2012, PLANT BIOTECHNOL J, V10, P95, DOI 10.1111/j.1467-7652.2011.00649.x; Lai HF, 2010, P NATL ACAD SCI USA, V107, P2419, DOI 10.1073/pnas.0914503107; Lee YK, 1999, MOL BIOL CELL, V10, P2209, DOI 10.1091/mbc.10.7.2209; Leuzinger K, 2013, JOVE-J VIS EXP, DOI 10.3791/50521; Lico C, 2008, J CELL PHYSIOL, V216, P366, DOI 10.1002/jcp.21423; Lim JK, 2008, J INFECT DIS, V197, P262, DOI 10.1086/524691; Loos A, 2012, ARCH BIOCHEM BIOPHYS, V526, P167, DOI 10.1016/j.abb.2012.05.011; Loos A, 2011, PLANT PHYSIOL, V155, P2036, DOI 10.1104/pp.110.171330; Mehlhop E, 2007, CELL HOST MICROBE, V2, P417, DOI 10.1016/j.chom.2007.09.015; MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07; Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042; Phoolcharoen W, 2011, P NATL ACAD SCI USA, V108, P20695, DOI 10.1073/pnas.1117715108; Phoolcharoen W, 2011, PLANT BIOTECHNOL J, V9, P807, DOI 10.1111/j.1467-7652.2011.00593.x; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; Santi L, 2008, VACCINE, V26, P1846, DOI 10.1016/j.vaccine.2008.01.053; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Williams KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003157; Zeitlin L, 2011, P NATL ACAD SCI USA, V108, P20690, DOI 10.1073/pnas.1108360108	48	44	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93541	10.1371/journal.pone.0093541	http://dx.doi.org/10.1371/journal.pone.0093541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675995	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500136
J	Kelly, ER; Plat, J; Haenen, GRMM; Kijlstra, A; Berendschot, TTJM				Kelly, Elton R.; Plat, Jogchum; Haenen, Guido R. M. M.; Kijlstra, Aize; Berendschot, Tos T. J. M.			The Effect of Modified Eggs and an Egg-Yolk Based Beverage on Serum Lutein and Zeaxanthin Concentrations and Macular Pigment Optical Density: Results from a Randomized Trial	PLOS ONE			English	Article							AGE-RELATED MACULOPATHY; LIPOPROTEIN CHOLESTEROL; BETA-CAROTENE; VITAMIN-E; SUPPLEMENTATION; DEGENERATION; INCREASES; BIOAVAILABILITY; ANTIOXIDANTS; TOXICITY	Increasing evidence suggests a beneficial effect of lutein and zeaxanthin on the progression of age-related macular degeneration. The aim of this study was to investigate the effect of lutein or zeaxanthin enriched eggs or a lutein enriched egg-yolk based buttermilk beverage on serum lutein and zeaxanthin concentrations and macular pigment levels. Naturally enriched eggs were made by increasing the levels of the xanthophylls lutein and zeaxanthin in the feed given to laying hens. One hundred healthy volunteers were recruited and randomized into 5 groups for 90 days. Group one added one normal egg to their daily diet and group two received a lutein enriched egg-yolk based beverage. Group three added one lutein enriched egg and group four one zeaxanthin enriched egg to their diet. Group five was the control group and individuals in this group did not modify their daily diet. Serum lutein and zeaxanthin concentrations and macular pigment densities were obtained at baseline, day 45 and day 90. Macular pigment density was measured by heterochromatic flicker photometry. Serum lutein concentration in the lutein enriched egg and egg yolk-based beverage groups increased significantly (p<0.001, 76% and 77%). A strong increase in the serum zeaxanthin concentration was observed in individuals receiving zeaxanthin enriched eggs (P<0.001, 430%). No changes were observed in macular pigment density in the various groups tested. The results indicate that daily consumption of lutein or zeaxanthin enriched egg yolks as well as an egg yolk-based beverage show increases in serum lutein and zeaxanthin levels that are comparable with a daily use of 5 mg supplements.	[Kelly, Elton R.; Kijlstra, Aize; Berendschot, Tos T. J. M.] Maastricht Univ, Univ Eye Clin Maastricht, Maastricht, Netherlands; [Plat, Jogchum] Maastricht Univ, Dept Human Biol, Maastricht, Netherlands; [Haenen, Guido R. M. M.] Maastricht Univ, Dept Pharmacol & Toxicol, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University	Berendschot, TTJM (corresponding author), Maastricht Univ, Univ Eye Clin Maastricht, Maastricht, Netherlands.	t.berendschot@maastrichtuniversity.nl	Berendschot, Tos TJM/M-8509-2016	Berendschot, Tos TJM/0000-0002-8101-939X; Haenen, Guido/0000-0001-6986-290X	Newtricious (Oirlo, The Netherlands); OP-Zuid grant	Newtricious (Oirlo, The Netherlands)(Netherlands Government); OP-Zuid grant	The study was financially supported by Newtricious (Oirlo, The Netherlands) and an OP-Zuid grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Age-Related Eye Disease Research Group, 2013, JAMA-J AM MED ASSOC, P1; Applegate E, 2000, J AM COLL NUTR, V19, p495S, DOI 10.1080/07315724.2000.10718971; Baumgartner S, 2013, NUTRITION, V29, P1237, DOI 10.1016/j.nut.2013.03.020; Berendschot TTJM, 2000, INVEST OPHTH VIS SCI, V41, P3322; Berrow EJ, 2013, BRIT J NUTR, V109, P2008, DOI 10.1017/S0007114512004187; Bone RA, 2010, ARCH BIOCHEM BIOPHYS, V504, P50, DOI 10.1016/j.abb.2010.06.019; Chung HY, 2004, J NUTR, V134, P1887, DOI 10.1093/jn/134.8.1887; Clark RM, 2006, J NUTR, V136, P601, DOI 10.1093/jn/136.3.601; Connolly EE, 2011, INVEST OPHTH VIS SCI, V52, P9207, DOI 10.1167/iovs.11-8025; Dupont WD, 1997, CONTROL CLIN TRIALS, V18, P274, DOI 10.1016/S0197-2456(97)00074-3; Falsini B, 2003, OPHTHALMOLOGY, V110, P51, DOI 10.1016/S0161-6420(02)01547-6; Goodrow EF, 2006, J NUTR, V136, P2519, DOI 10.1093/jn/136.10.2519; Hammond BR, 1997, INVEST OPHTH VIS SCI, V38, P1795; Handelman GJ, 1999, AM J CLIN NUTR, V70, P247; Hesterberg K, 2012, J BIOPHOTONICS, V5, P33, DOI 10.1002/jbio.201100036; HYMAN L, 1987, EYE, V1, P330, DOI 10.1038/eye.1987.53; Izumi-Nagai K, 2007, ARTERIOSCL THROM VAS, V27, P2555, DOI 10.1161/ATVBAHA.107.151431; Junghans A, 2001, ARCH BIOCHEM BIOPHYS, V391, P160, DOI 10.1006/abbi.2001.2411; KAHN HA, 1977, AM J EPIDEMIOL, V106, P17, DOI 10.1093/oxfordjournals.aje.a112428; Kijlstra A, 2012, PROG RETIN EYE RES, V31, P303, DOI 10.1016/j.preteyeres.2012.03.002; Landrum JT, 1997, EXP EYE RES, V65, P57, DOI 10.1006/exer.1997.0309; Ma L, 2012, AM J OPHTHALMOL, V154, P625, DOI 10.1016/j.ajo.2012.04.014; Nidhi B, 2013, J FOOD SCI, V78, pT1636, DOI 10.1111/1750-3841.12256; Obana A, 2008, OPHTHALMOLOGY, V115, P147, DOI 10.1016/j.ophtha.2007.02.028; Parisi V, 2008, OPHTHALMOLOGY, V115, P324, DOI 10.1016/j.ophtha.2007.05.029; Preethi KC, 2008, INT J TOXICOL, V27, P1, DOI 10.1080/10915810701876265; Ravikrishnan R, 2011, FOOD CHEM TOXICOL, V49, P2841, DOI 10.1016/j.fct.2011.08.011; Roodenburg AJC, 2000, AM J CLIN NUTR, V71, P1187; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P1225, DOI 10.1001/archopht.125.9.1225; Schlatterer J, 2006, J AGR FOOD CHEM, V54, P2267, DOI 10.1021/jf053204d; SNODDERLY DM, 1984, INVEST OPHTH VIS SCI, V25, P674; Stahl W, 2003, MOL ASPECTS MED, V24, P345, DOI 10.1016/S0098-2997(03)00030-X; Sujak A, 1999, ARCH BIOCHEM BIOPHYS, V371, P301, DOI 10.1006/abbi.1999.1437; Surai PF, 2000, EUR J CLIN NUTR, V54, P298, DOI 10.1038/sj.ejcn.1600939; Tan JSL, 2008, OPHTHALMOLOGY, V115, P334, DOI 10.1016/j.ophtha.2007.03.083; Thompson AK, 2006, J DAIRY SCI, V89, P410, DOI 10.3168/jds.S0022-0302(06)72105-1; Trieschmann M, 2007, EXP EYE RES, V84, P718, DOI 10.1016/j.exer.2006.12.010; Urbaniak G., 2007, RES RANDOMIZER; Vaisman N, 2006, CLIN NUTR, V25, P897, DOI 10.1016/j.clnu.2006.06.002; van der Veen RLP, 2009, OPHTHAL PHYSL OPT, V29, P127, DOI 10.1111/j.1475-1313.2008.00618.x; Vishwanathan R, 2009, AM J CLIN NUTR, V90, P1272, DOI 10.3945/ajcn.2009.28013; Weggemans RM, 2001, AM J CLIN NUTR, V73, P885; Wenzel AJ, 2006, J NUTR, V136, P2568, DOI 10.1093/jn/136.10.2568	43	34	37	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92659	10.1371/journal.pone.0092659	http://dx.doi.org/10.1371/journal.pone.0092659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675775	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677500031
J	Reimers, AK; Wagner, M; Alvanides, S; Steinmayr, A; Reiner, M; Schmidt, S; Woll, A				Reimers, Anne K.; Wagner, Matthias; Alvanides, Seraphim; Steinmayr, Andreas; Reiner, Miriam; Schmidt, Steffen; Woll, Alexander			Proximity to Sports Facilities and Sports Participation for Adolescents in Germany	PLOS ONE			English	Article							PHYSICAL-ACTIVITY LEVELS; HEALTH INTERVIEW; SOCIOECONOMIC-STATUS; BUILT ENVIRONMENT; CHILDREN; AVAILABILITY; KIGGS; ASSOCIATIONS; BEHAVIORS; YOUTH	Objectives: To assess the relationship between proximity to specific sports facilities and participation in the corresponding sports activities for adolescents in Germany. Methods: A sample of 1,768 adolescents aged 11-17 years old and living in 161 German communities was examined. Distances to the nearest sports facilities were calculated as an indicator of proximity to sports facilities using Geographic Information Systems (GIS). Participation in specific leisure-time sports activities in sports clubs was assessed using a self-report questionnaire and individual-level socio-demographic variables were derived from a parent questionnaire. Community-level socio-demographics as covariates were selected from the INKAR database, in particular from indicators and maps on land development. Logistic regression analyses were conducted to examine associations between proximity to the nearest sports facilities and participation in the corresponding sports activities. Results: The logisitic regression analyses showed that girls residing longer distances from the nearest gym were less likely to engage in indoor sports activities; a significant interaction between distances to gyms and level of urbanization was identified. Decomposition of the interaction term showed that for adolescent girls living in rural areas participation in indoor sports activities was positively associated with gym proximity. Proximity to tennis courts and indoor pools was not associated with participation in tennis or water sports, respectively. Conclusions: Improved proximity to gyms is likely to be more important for female adolescents living in rural areas.	[Reimers, Anne K.; Wagner, Matthias] Univ Konstanz, Dept Sport Sci, Constance, Germany; [Reimers, Anne K.; Reiner, Miriam; Schmidt, Steffen; Woll, Alexander] Karlsruhe Inst Technol, Inst Sport & Sport Sci, D-76021 Karlsruhe, Germany; [Steinmayr, Andreas] Northumbria Univ, Dept Geog & Built Environm, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Steinmayr, Andreas] Univ St Gallen, Swiss Inst Empir Econ Res SEW, St Gallen, Switzerland	University of Konstanz; Helmholtz Association; Karlsruhe Institute of Technology; Northumbria University; University of St Gallen	Reimers, AK (corresponding author), Univ Konstanz, Dept Sport Sci, Constance, Germany.	anne.reimers@uni-konstanz.de	Reimers, Anne/AAH-5735-2021; Steinmayr, Andreas/AAF-4741-2019; Reimers, Anne/M-8519-2018; Alvanides, S./H-1057-2019	Steinmayr, Andreas/0000-0002-2491-5032; Reimers, Anne/0000-0003-4053-1378; Alvanides, S./0000-0003-4905-4109	German Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research); German Bundesministerium fur Gesundheit (Federal Ministry of Health) [01ER0810]; Brigitte Schlieben-Lange-Programm from the Ministry of Science of the German State of Baden-Wurttemberg; Economic and Social Research Council [ES/I035206/1] Funding Source: researchfish; ESRC [ES/I035206/1] Funding Source: UKRI	German Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); German Bundesministerium fur Gesundheit (Federal Ministry of Health); Brigitte Schlieben-Lange-Programm from the Ministry of Science of the German State of Baden-Wurttemberg; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was funded by a project grant from the German Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research) and by the German Bundesministerium fur Gesundheit (Federal Ministry of Health) (grant number: 01ER0810). The content of this article reflects only the authors' views and the funders were not liable for any use that may be made of the information contained therein. The contribution of AKR was funded by a grant scholarship of the Brigitte Schlieben-Lange-Programm from the Ministry of Science of the German State of Baden-Wurttemberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, ADJUSTMENT SOCIAL CL; Ball K, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-33; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; BIK Aschpurwis und Behrens GmbH, 2001, BIK REG BALL STADTR; Brettschneider W-D, 2001, EUR J SPORT SCI, V1, P1, DOI DOI 10.1080/17461390100071201; Brug J, 2012, PEDIATR OBES, V7, P399, DOI 10.1111/j.2047-6310.2012.00067.x; Burgoine T, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-33; Davison KK, 2009, MED SCI SPORT EXER, V41, P1816, DOI 10.1249/MSS.0b013e3181a278e2; Federal Office for Building and Regional Planning, 2012, INF FORSCH BBSR; Giles-Corti B, 2005, EXERC SPORT SCI REV, V33, P175, DOI 10.1097/00003677-200510000-00005; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Gordon-Larsen P, 2006, PEDIATRICS, V117, P417, DOI 10.1542/peds.2005-0058; Grow HM, 2008, MED SCI SPORT EXER, V40, P2071, DOI 10.1249/MSS.0b013e3181817baa; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hanson MD, 2007, J BEHAV MED, V30, P263, DOI 10.1007/s10865-007-9098-3; Hayes, 2012, CISC VIS NETW IND GL; Brodersen NH, 2007, BRIT J SPORT MED, V41, P140, DOI 10.1136/bjsm.2006.031138; Holling H, 2007, BUNDESGESUNDHEITSBLA, V50, P557, DOI 10.1007/s00103-007-0216-8; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Jekauc D, 2014, INT J EPIDE IN PRESS; Jekauc D, 2013, J PUBLIC HEALTH-HEID, V21, P505, DOI 10.1007/s10389-013-0579-2; Jekauc D, 2013, DIAGNOSTICA, V59, P100, DOI 10.1026/0012-1924/a000083; Jekauc D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-714; Jones A, 2010, OBESOGENIC ENV, P41; Kamtsiuris P, 2007, BUNDESGESUNDHEITSBLA, V50, P547, DOI 10.1007/s00103-007-0215-9; Kurth BM, 2007, BUNDESGESUNDHEITSBLA, V50, P533, DOI 10.1007/s00103-007-0214-x; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Lampert T, 2002, GESUNDHEITSWESEN, V64, pS48; Macintyre S, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-32; Moore JB, 2010, HEALTH EDUC RES, V25, P355, DOI 10.1093/her/cyq004; Niclasen B, 2012, SCAND J PUBLIC HEALT, V40, P614, DOI 10.1177/1403494812459815; Owen CG, 2009, INT J EPIDEMIOL, V38, P1082, DOI 10.1093/ije/dyp176; Owen N, 2000, Exerc Sport Sci Rev, V28, P153; Pikora T, 2003, SOC SCI MED, V56, P1693, DOI 10.1016/S0277-9536(02)00163-6; Powell LM, 2007, AM J PREV MED, V33, pS292, DOI 10.1016/j.amepre.2007.07.002; Prins RG, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-90; Prins RG, 2010, HEALTH EDUC RES, V25, P489, DOI 10.1093/her/cyq024; Prins RG, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-70; Prins RG, 2011, HEALTH PLACE, V17, P1228, DOI 10.1016/j.healthplace.2011.07.012; Roux AVD, 2007, AM J PUBLIC HEALTH, V97, P493, DOI 10.2105/AJPH.2006.087734; Sagatun A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-419; Sallis JF, 2008, HLTH BEHAV HLTH ED T, V260, P465; Schenk L, 2007, BUNDESGESUNDHEITSBLA, V50, P590, DOI 10.1007/s00103-007-0220-z; Spence JC, 2003, PSYCHOL SPORT EXERC, V4, P7, DOI 10.1016/S1469-0292(02)00014-6; Steinmayr A, 2011, EUR REV AGING PHYS A, V8, P67, DOI 10.1007/s11556-011-0090-0; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; Telama R, 2009, PEDIATR EXERC SCI, V21, P462, DOI 10.1123/pes.21.4.462; Thornton Lukar E, 2011, Int J Behav Nutr Phys Act, V8, P71, DOI 10.1186/1479-5868-8-71; Woll A, 2011, EUR J PEDIATR, V170, P1129, DOI 10.1007/s00431-010-1391-4; Wong BYM, 2010, INT J PEDIATR OBES, V5, P169, DOI 10.3109/17477160903159432; Xiaolin Yang, 1996, International Review for the Sociology of Sport, V31, P273	51	30	30	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93059	10.1371/journal.pone.0093059	http://dx.doi.org/10.1371/journal.pone.0093059			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SW	24675689	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000333677500067
J	Weldearegawi, B; Spigt, M; Berhane, Y; Dinant, GJ				Weldearegawi, Berhe; Spigt, Mark; Berhane, Yemane; Dinant, GeertJan			Mortality Level and Predictors in a Rural Ethiopian Population: Community Based Longitudinal Study	PLOS ONE			English	Article							MARITAL-STATUS; BUTAJIRA; HEALTH; TRANSITION; PROFILE; GENDER; DEATH; MEN	Background: Over the last fifty years the world has seen enormous decline in mortality rates. However, in low-income countries, where vital registration systems are absent, mortality statistics are not easily available. The recent economic growth of Ethiopia and the parallel large scale healthcare investments make investigating mortality figures worthwhile. Methods: Longitudinal health and demographic surveillance data collected from September 11, 2009 to September 10, 2012 were analysed. We computed incidence of mortality, overall and stratified by background variables. Poisson regression was used to test for a linear trend in the standardized mortality rates. Cox-regression analysis was used to identify predictors of mortality. Households located at <2300 meter and >= 2300 meter altitude were defined to be midland and highland, respectively. Results: An open cohort, with a baseline population of 66,438 individuals, was followed for three years to generate 194,083 person-years of observation. The crude mortality rate was 4.04 (95% CI: 3.77, 4.34) per 1,000 person-years. During the follow-up period, incidence of mortality significantly declined among under five (P<0.001) and 5-14 years old (P<0.001), whereas it increased among 65 years and above (P<0.001). Adjusted for other covariates, mortality was higher in males (hazard ratio (HR) = 1.42, 95% CI: 1.22, 1.66), rural population (HR = 1.74, 95% CI: 1.32, 2.31), highland (HR = 1.20, 95% CI: 1.03, 1.40) and among those widowed (HR = 2.25, 95% CI: 1.81, 2.80) and divorced (HR = 1.80, 95% CI: 1.30, 2.48). Conclusions: Overall mortality rate was low. The level and patterns of mortality indicate changes in the epidemiology of major causes of death. Certain population groups had significantly higher mortality rates and further research is warranted to identify causes of higher mortality in those groups.	[Weldearegawi, Berhe; Spigt, Mark] Mekelle Univ, Coll Hlth Sci, Dept Publ Hlth, Mekelle, Ethiopia; [Weldearegawi, Berhe; Spigt, Mark; Dinant, GeertJan] Maastricht Univ, Sch Publ Hlth & Primary Care, CAPHRI, Maastricht, Netherlands; [Berhane, Yemane] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia	Mekelle University; Maastricht University; Addis Continental Institute of Public Health	Weldearegawi, B (corresponding author), Mekelle Univ, Coll Hlth Sci, Dept Publ Hlth, Mekelle, Ethiopia.	berheph@gmail.com	Berhane, Yemane/ABB-8154-2020	Berhane, Yemane/0000-0002-2527-1339; Sahle, Berhe W/0000-0003-3243-9176	Centers for Disease Control and Prevention (CDC) through Ethiopian Public Health Association (EPHA) [5U22/PS022179_05]; Mekelle University	Centers for Disease Control and Prevention (CDC) through Ethiopian Public Health Association (EPHA)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Mekelle University	The study was Funded by Centers for Disease Control and Prevention (CDC) through Ethiopian Public Health Association (EPHA) in accordance with the EPHA-CDC Cooperative Agreement No. 5U22/PS022179_05 and Mekelle University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abrahams Z, 2011, BMC PUBLIC HEALTH, V11, P1471; [Anonymous], 2006, COUNTRY PASTURE FORA; Berhane Y, 2002, B WHO, V80; Berhane Y., 1999, ETHIOP J HEALTH DEV, V13, P1; Berhane Y, 2008, SCAND J PUBLIC HEALT, V36, P436, DOI 10.1177/1403494808089064; Bradley E, 2011, GRAND STRATEGY GLOBA; Bradshow D, 2006, DIS MORTALITY SUBSAH; Byass P, 2008, PAEDIATR PERINAT EP, V22, P569, DOI 10.1111/j.1365-3016.2008.00974.x; Byass P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000155; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Fantahun M, 2009, PUBLIC HEALTH, V123, P326, DOI 10.1016/j.puhe.2008.10.019; Fantahun M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-268; Federal Ministry of Health, 2010, HLTH SECT DEV PROGR; Fottrell E, 2010, EPIDEMIOL REV, V32, P38, DOI 10.1093/epirev/mxq003; Fottrell E, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-13; Hill K, 2006, DIS MORTALITY SUBSAH; HU YR, 1990, DEMOGRAPHY, V27, P233, DOI 10.2307/2061451; Ikeda A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-73; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Kalediene R, 2007, PUBLIC HEALTH, V121, P385, DOI 10.1016/j.puhe.2006.09.026; Kamugisha M L, 2007, Tanzan Health Res Bull, V9, P32; Kaneko S, 2012, J EPIDEMIOL, V22, P276, DOI 10.2188/jea.JE20110078; Kassa N, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-1; Liu H, 2009, J MARRIAGE FAM, V71, P1158, DOI 10.1111/j.1741-3737.2009.00661.x; Misganaw A, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110142; MoFED. Ministry of Finance and Economic Development (MOFED), 2006, PLAN ACC SUST DEV EN, VI; Molla M., 2008, Ethiopian Journal of Health Development, V22, P218; Mudenda SS, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-40; Oduro AR, 2012, INT J EPIDEMIOL, V41, P968, DOI 10.1093/ije/dys111; Onarheim KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041521; Pati RN, 2008, FAMILY PLANNING, P217; Preston SH, 1980, POPULATION EC CHANGE, P289; Sankoh OA, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P75; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; Singh-Manoux A, 2008, AM J PUBLIC HEALTH, V98, P2251, DOI 10.2105/AJPH.2006.107912; Tesfaye F, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-39; The World Bank, 2013, GLOB IND; Tigray Regional Health Bureau, 2013, ANN PROF 2012 13; Van de Poel E, 2009, DEMOGRAPHY, V46, P827, DOI 10.1353/dem.0.0074; Weldearegawi B, 2013, HEALTH POLICY PLANN, V28, P891, DOI 10.1093/heapol/czs135; World Health Organization, 2008, GLOB BURD DIS 2004 U	41	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93099	10.1371/journal.pone.0093099	http://dx.doi.org/10.1371/journal.pone.0093099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SW	24675840	Green Published, gold			2022-12-27	WOS:000333677500073
J	Sun, L; Qiang, R; Yang, Y; Jiang, ZL; Wang, GH; Zhao, GW; Ren, TJ; Jiang, R; Xu, LH				Sun, Li; Qiang, Ren; Yang, Yao; Jiang, Zheng-Lin; Wang, Guo-Hua; Zhao, Guang-Wei; Ren, Tao-Jie; Jiang, Rui; Xu, Li-Hua			L-Serine Treatment May Improve Neurorestoration of Rats after Permanent Focal Cerebral Ischemia Potentially Through Improvement of Neurorepair	PLOS ONE			English	Article							NEURAL STEM-CELLS; PROMOTES NEURITE OUTGROWTH; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; TENASCIN-C; NEURONAL MIGRATION; NOGO-A; STROKE; MECHANISMS; GDNF	The present study was conducted to clarify whether treatment with L-serine can improve the brain repair and neurorestoration of rats after permanent middle cerebral artery occlusion (pMCAO). After pMCAO, the neurological functions, brain lesion volume, and cortical injury were determined. GDNF, NGF, NCAM L1, tenascin-C, and Nogo-A levels were measured. Proliferation and differentiation of the neural stem cells (NSCs) and proliferation of the microvessels in the ischemic boundary zone of the cortex were evaluated. Treatment with L-serine (168 mg/kg body weight, i.p.) began 3 h after pMCAO and was repeated every 12 h for 7 days or until the end of the experiment. L-Serine treatment: 1) reduced the lesion volume and neuronal loss; 2) improved the recovery of neurological functions; 3) elevated the expression of nerve growth-related factors; and 4) facilitated the proliferation of endogenous NSCs and microvessels activated after pMCAO and increased the number of new-born neurons. 5) D-cycloserine, an inhibitor of serine hydroxymethyltransferase, blunted the effects of L-serine on NSC proliferation, differentiation, microvascular proliferation. In conclusions, L-serine treatment in pMCAO rats can reduce brain injury and facilitate neurorestoration which is partly associated with the improvement of proliferation of NSCs and microvessels, reconstruction of neurovascular units and resultant neurorepair. The effects of L-serine on endogenous NSC proliferation and microvascular proliferation are partly mediated by the action of L-serine as a substrate for the production of one-carbon groups used for purine and pyrimidine synthesis and modulation of the expression of some nerve growth-related factors.	[Sun, Li; Yang, Yao; Jiang, Zheng-Lin; Wang, Guo-Hua; Zhao, Guang-Wei; Ren, Tao-Jie; Jiang, Rui; Xu, Li-Hua] Nantong Univ, Dept Neuropharmacol, Inst Naut Med, Nantong, Jiangsu, Peoples R China; [Qiang, Ren] Third Peoples Hosp Nantong, Dept Infect Dis, Nantong, Jiangsu, Peoples R China; [Jiang, Zheng-Lin; Zhao, Guang-Wei; Ren, Tao-Jie] Nantong Univ, Dept Neurol, Affiliated Hosp, Nantong, Jiangsu, Peoples R China	Nantong University; Nantong University	Yang, Y (corresponding author), Nantong Univ, Dept Neuropharmacol, Inst Naut Med, Nantong, Jiangsu, Peoples R China.	jsyangyao@126.com; jiangzl@ntu.edu.cn	Wang, Guohua/AAD-8992-2022	Wang, Guohua/0000-0002-4810-8534	National Natural Science Foundation of China [81000497, 81071614, 81372131]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Nantong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Nantong University	This work was supported partly by grants from the National Natural Science Foundation of China (81000497, 81071614 and 81372131), by project funding from the Priority Academic Program Development of Jiangsu Higher Education Institutions, and by the Project for Innovation Development of Graduate Student of Nantong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaskharoun M, 2010, ASN NEURO, V2, DOI 10.1042/AN20100001; Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Andrews MR, 2009, J NEUROSCI, V29, P5546, DOI 10.1523/JNEUROSCI.0759-09.2009; Bednar MM, 2012, NEUROL RES, V34, P129, DOI 10.1179/1743132811Y.0000000069; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Chen B, 2009, BRAIN RES, V1284, P1, DOI 10.1016/j.brainres.2009.05.100; Chen J, 2005, J NEUROTRAUM, V22, P896, DOI 10.1089/neu.2005.22.896; Chen JA, 2010, MOL THER, V18, P1769, DOI 10.1038/mt.2010.133; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chiu SC, 2009, J MOL MED, V87, P1179, DOI 10.1007/s00109-009-0528-2; Cui YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017126; de Koning TJ, 2004, CURR OPIN NEUROL, V17, P197, DOI 10.1097/00019052-200404000-00019; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; Duan SR, 2010, NEUROL RES, V32, P835, DOI 10.1179/016164109X12581096870159; Duarte EP, 2012, GROWTH FACTORS, V30, P242, DOI 10.3109/08977194.2012.691478; GERMANO AF, 1994, J NEUROTRAUM, V11, P345, DOI 10.1089/neu.1994.11.345; Gogel S, 2011, GENE THER, V18, P1, DOI 10.1038/gt.2010.130; He XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046223; Ichim G, 2012, EXP CELL RES, V318, P1221, DOI 10.1016/j.yexcr.2012.03.006; Jablonska A, 2011, ACTA NEUROBIOL EXP, V71, P74; Joester A, 2001, MATRIX BIOL, V20, P13, DOI 10.1016/S0945-053X(00)00136-0; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; Joshi CN, 2004, BRAIN RES PROTOC, V13, P11, DOI 10.1016/j.brainresprot.2003.12.001; Kameda M, 2007, EUR J NEUROSCI, V26, P1462, DOI 10.1111/j.1460-9568.2007.05776.x; Kramer M, 2010, J NEUROSCI METH, V187, P84, DOI 10.1016/j.jneumeth.2009.12.020; Leker RR, 2009, EXPERT OPIN BIOL TH, V9, P1117, DOI 10.1517/14712590903130558; Macrae IM, 2011, BRIT J PHARMACOL, V164, P1062, DOI 10.1111/j.1476-5381.2011.01398.x; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; MANOHAR R, 1984, BIOCHEMISTRY-US, V23, P4116, DOI 10.1021/bi00313a016; Meiners S, 1999, J NEUROSCI, V19, P8443; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Pandya Rachna S., 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P81; Pernet V, 2012, CELL DEATH DIFFER, V19, P1096, DOI 10.1038/cdd.2011.191; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; RAMESH KS, 1980, BIOCHEM J, V187, P623, DOI 10.1042/bj1870623; Ren TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067044; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Rigato F, 2002, J NEUROSCI, V22, P6596; Sahota P, 2011, NEUROTHERAPEUTICS, V8, P434, DOI 10.1007/s13311-011-0040-6; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Schulz F, 2013, NANOSCALE, V5, P10605, DOI 10.1039/c3nr02707d; Seo JH, 2012, YONSEI MED J, V53, P1059, DOI 10.3349/ymj.2012.53.6.1059; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Stout RW, 2001, COMPARATIVE MED, V51, P524; Sun CR, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-77; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Vaquero J, 2011, PROG NEUROBIOL, V93, P341, DOI 10.1016/j.pneurobio.2010.12.002; Wang GH, 2010, J NEUROSCI RES, V88, P2035, DOI 10.1002/jnr.22365; Wang T, 2012, BRAIN RES BULL, V87, P499, DOI 10.1016/j.brainresbull.2012.02.011; Wang XK, 2004, MOL PHARMACOL, V65, P890, DOI 10.1124/mol.65.4.890; Xiong Y, 2010, DISCOV MED, V10, P434; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yoneyama M, 2011, J PHARMACOL SCI, V115, P425, DOI 10.1254/jphs.11R02CP	54	15	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93405	10.1371/journal.pone.0093405	http://dx.doi.org/10.1371/journal.pone.0093405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671106	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677000140
J	Adam, C; Baeurle, A; Brodsky, JL; Wipf, P; Schrama, D; Becker, JC; Houben, R				Adam, Christian; Baeurle, Anne; Brodsky, Jeffrey L.; Wipf, Peter; Schrama, David; Becker, Jurgen Christian; Houben, Roland			The HSP70 Modulator MAL3-101 Inhibits Merkel Cell Carcinoma	PLOS ONE			English	Article							LARGE T-ANTIGEN; SV40 LARGE T; HEAT-SHOCK PROTEINS; J DOMAIN; TUMOR-SUPPRESSOR; HEAT-SHOCK-PROTEIN-70; CANCER; APOPTOSIS; MOLECULES; GROWTH	Merkel Cell Carcinoma (MCC) is a rare and highly aggressive neuroendocrine skin cancer for which no effective treatment is available. MCC represents a human cancer with the best experimental evidence for a causal role of a polyoma virus. Large T antigens (LTA) encoded by polyoma viruses are oncoproteins, which are thought to require support of cellular heat shock protein 70 (HSP70) to exert their transforming activity. Here we evaluated the capability of MAL3- 101, a synthetic HSP70 inhibitor, to limit proliferation and survival of various MCC cell lines. Remarkably, MAL3-101 treatment resulted in considerable apoptosis in 5 out of 7 MCC cell lines. While this effect was not associated with the viral status of the MCC cells, quantitative mRNA expression analysis of the known HSP70 isoforms revealed a significant correlation between MAL3- 101 sensitivity and HSC70 expression, the most prominent isoform in all cell lines. Moreover, MAL3- 101 also exhibited in vivo antitumor activity in an MCC xenograft model suggesting that this substance or related compounds are potential therapeutics for the treatment of MCC in the future.	[Adam, Christian; Baeurle, Anne; Houben, Roland] Univ Hosp Wurzberg, Dept Dermatol, Wurzburg, Germany; [Brodsky, Jeffrey L.; Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Brodsky, Jeffrey L.; Wipf, Peter] Univ Pittsburgh, Dept Biol, Pittsburgh, PA USA; [Schrama, David; Becker, Jurgen Christian] Med Univ Graz, Div Gen Dermatol, Graz, Austria	University of Wurzburg; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical University of Graz	Adam, C (corresponding author), Univ Hosp Wurzberg, Dept Dermatol, Wurzburg, Germany.	Adam_C@ukw.de	Wipf, Peter/AAG-1771-2021	Wipf, Peter/0000-0001-7693-5863; Houben, Roland/0000-0003-4538-2324; Schrama, David/0000-0002-6931-8194; Adam, Christian/0000-0001-7721-4144	Wilhelm-Sander-Stiftung [2007.057.3]; German Research Foundation (DFG); University of Wurzburg	Wilhelm-Sander-Stiftung; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg	This study was supported by the Wilhelm-Sander-Stiftung (grant number: 2007.057.3) (http://www.wilhelm-sander-stiftung.de). This publication was funded by the German Research Foundation (DFG) and the University of Wurzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelli M, 2010, CURR PROB CANCER, V34, P14, DOI 10.1016/j.currproblcancer.2010.01.001; Albores-Saavedra J, 2010, J CUTAN PATHOL, V37, P20, DOI 10.1111/j.1600-0560.2009.01370.x; Arora R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003713; Bakker ABH, 1998, J IMMUNOL, V160, P5239; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Braunstein MJ, 2011, J ONCOL, V2011, DOI 10.1155/2011/232037; Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19; Campbell KS, 1997, GENE DEV, V11, P1098, DOI 10.1101/gad.11.9.1098; Cheng JW, 2013, J VIROL, V87, P6118, DOI 10.1128/JVI.00385-13; Daily K, 2013, J INVEST DERMATOL, V133, pS71; Davids M, 2009, J CLIN ONCOL, V27, pE97, DOI 10.1200/JCO.2009.21.8149; DeCaprio JA, 1999, BIOLOGICALS, V27, P23, DOI 10.1006/biol.1998.0173; Duprat JP, 2011, CLINICS, V66, P1817, DOI 10.1590/S1807-59322011001000023; Fakiha M, 2010, J CANCER RES THER, V6, P382, DOI 10.4103/0973-1482.73352; Fewell SW, 2004, J BIOL CHEM, V279, P51131, DOI 10.1074/jbc.M404857200; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Gewirtz DA, 2001, ARCH BIOCHEM BIOPHYS, V388, P243, DOI 10.1006/abbi.2000.2278; GILLIS S, 1980, J EXP MED, V152, P1709, DOI 10.1084/jem.152.6.1709; GREEN D, 1971, BLOOD-J HEMATOL, V37, P47, DOI 10.1182/blood.V37.1.47.47; Gurbuxani S, 2003, ONCOGENE, V22, P6669, DOI 10.1038/sj.onc.1206794; Houben R, 2013, J INVEST DERMATOL, V133, P2453, DOI 10.1038/jid.2013.169; Houben R, 2012, INT J CANCER, V130, P847, DOI 10.1002/ijc.26076; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; Howard RA, 2006, CANCER EPIDEM BIOMAR, V15, P1545, DOI 10.1158/1055-9965.EPI-05-0895; Kim HY, 2001, EMBO J, V20, P295, DOI 10.1093/emboj/20.1.295; Kwun HJ, 2009, J VIROL, V83, P12118, DOI 10.1128/JVI.01336-09; Liu T, 2012, PHARMACOL THERAPEUT, V136, P354, DOI 10.1016/j.pharmthera.2012.08.014; Meier G, 2004, ONCOLOGY-BASEL, V66, P160, DOI 10.1159/000077443; Miller NJ, 2013, CURR TREAT OPTION ON, V14, P249, DOI 10.1007/s11864-013-0225-9; Moens U, 2007, CELL MOL LIFE SCI, V64, P1656, DOI 10.1007/s00018-007-7020-3; Myung Jae-Kyung, 2004, Proteome Sci, V2, P8, DOI 10.1186/1477-5956-2-8; Nylandsted J, 2000, ANN NY ACAD SCI, V926, P122; Pincelli C, 1997, J INVEST DERMATOL, V109, P757, DOI 10.1111/1523-1747.ep12340768; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Rodig SJ, 2012, J CLIN INVEST; Rodina A, 2007, NAT CHEM BIOL, V3, P498, DOI 10.1038/nchembio.2007.10; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; RONAN SG, 1993, J AM ACAD DERMATOL, V29, P715, DOI 10.1016/0190-9622(93)70236-M; Samlowski WE, 2010, AM J CLIN ONCOL-CANC, V33, P495, DOI 10.1097/COC.0b013e3181b9cf04; SAWAI ET, 1989, J VIROL, V63, P3961, DOI 10.1128/JVI.63.9.3961-3973.1989; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Schmitt E, 2006, CANCER RES, V66, P4191, DOI 10.1158/0008-5472.CAN-05-3778; Schrama D, 2012, CURR OPIN ONCOL, V24, P141, DOI 10.1097/CCO.0b013e32834fc9fe; Sheng Q, 1997, J VIROL, V71, P9410, DOI 10.1128/JVI.71.12.9410-9416.1997; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Shuda M, 2011, J CLIN INVEST, V121, P3623, DOI 10.1172/JCI46323; Sullivan CS, 2000, MOL CELL BIOL, V20, P6233, DOI 10.1128/MCB.20.17.6233-6243.2000; Sullivan CS, 2000, MOL CELL BIOL, V20, P5749, DOI 10.1128/MCB.20.15.5749-5757.2000; Tai PTH, 2000, J CLIN ONCOL, V18, P2493, DOI 10.1200/JCO.2000.18.12.2493; Tutar Yusuf, 2011, Recent Pat DNA Gene Seq, V5, P214; Van Gele M, 2002, INT J CANCER, V101, P137, DOI 10.1002/ijc.10591; Wang RE, 2011, CURR MED CHEM, V18, P4250; Wieland U, 2011, CURR OPIN ONCOL, V23, P488, DOI 10.1097/CCO.0b013e3283495a5b; Willmes C, 2012, CANCER RES, V72, P2120, DOI 10.1158/0008-5472.CAN-11-2651; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zalvide J, 1998, MOL CELL BIOL, V18, P1408, DOI 10.1128/MCB.18.3.1408	56	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92041	10.1371/journal.pone.0092041	http://dx.doi.org/10.1371/journal.pone.0092041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24694787	Green Published, Green Accepted, gold			2022-12-27	WOS:000334103000014
J	Lee, JC; Gutell, RR				Lee, Jung C.; Gutell, Robin R.			Helix Capping in RNA Structure	PLOS ONE			English	Article							NUCLEAR MAGNETIC-RESONANCE; DANGLING END STACKING; UNUSUALLY STABLE RNA; RIBOSOMAL-RNA; TERMINAL MISMATCHES; INTERNAL LOOP; D-APTPGPCPAPT; FREE-ENERGY; BASE-PAIRS; STABILITY	Helices are an essential element in defining the three-dimensional architecture of structured RNAs. While internal basepairs in a canonical helix stack on both sides, the ends of the helix stack on only one side and are exposed to the loop side, thus susceptible to fraying unless they are protected. While coaxial stacking has long been known to stabilize helix ends by directly stacking two canonical helices coaxially, based on analysis of helix-loop junctions in RNA crystal structures, herein we describe helix capping, topological stacking of a helix end with a basepair or an unpaired nucleotide from the loop side, which in turn protects helix ends. Beyond the topological protection of helix ends against fraying, helix capping should confer greater stability onto the resulting composite helices. Our analysis also reveals that this general motif is associated with the formation of tertiary structure interactions. Greater knowledge about the dynamics at the helix-junctions in the secondary structure should enhance the prediction of RNA secondary structure with a richer set of energetic rules and help better understand the folding of a secondary structure into its three-dimensional structure. These together suggest that helix capping likely play a fundamental role in driving RNA folding.	[Lee, Jung C.] Milwaukee Sch Engn, Dept Chem & Phys, BioMol Engn Program, Milwaukee, WI 53202 USA; [Gutell, Robin R.] Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Gutell, Robin R.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	Milwaukee School Engineering; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Lee, JC (corresponding author), Milwaukee Sch Engn, Dept Chem & Phys, BioMol Engn Program, Milwaukee, WI 53202 USA.	lee@msoe.edu; robin.gutell@mail.utexas.edu			National Institutes of Health [GM067317, GM085337]; Microsoft Research Technical Computing Initiative [UTA08-531]; Welch Foundation [F-1427]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085337, R01GM067317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Microsoft Research Technical Computing Initiative(Microsoft); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health(GM067317 and GM085337), Microsoft Research Technical Computing Initiative grant (UTA08-531), and Welch Foundation (F-1427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkafi M, 1998, BIOCHEMISTRY-US, V37, P7878, DOI 10.1021/bi980011t; ALKEMA D, 1981, FEBS LETT, V136, P70, DOI 10.1016/0014-5793(81)81215-X; Andreatta D, 2006, J AM CHEM SOC, V128, P6885, DOI 10.1021/ja0582105; ANTAO VP, 1991, NUCLEIC ACIDS RES, V19, P5901, DOI 10.1093/nar/19.21.5901; AURORA R, 1994, SCIENCE, V264, P1126, DOI 10.1126/science.8178170; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borovinskaya MA, 2007, NAT STRUCT MOL BIOL, V14, P727, DOI 10.1038/nsmb1271; BOYLE J, 1980, J MOL BIOL, V139, P601, DOI 10.1016/0022-2836(80)90051-0; CARAFA YD, 1990, J MOL BIOL, V216, P835, DOI 10.1016/S0022-2836(99)80005-9; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; Chai DG, 2008, PROG NUCLEIC ACID RE, V82, P71, DOI 10.1016/S0079-6603(08)00003-2; Chen G, 2005, BIOCHEMISTRY-US, V44, P2845, DOI 10.1021/bi048079y; CHEONG CJ, 1990, NATURE, V346, P680, DOI 10.1038/346680a0; CROTHERS DM, 1974, J MOL BIOL, V87, P63, DOI 10.1016/0022-2836(74)90560-9; CROTHERS DM, 1964, J MOL BIOL, V9, P1, DOI 10.1016/S0022-2836(64)80086-3; Draper DE, 2004, RNA, V10, P335, DOI 10.1261/rna.5205404; Elgavish T, 2001, J MOL BIOL, V310, P735, DOI 10.1006/jmbi.2001.4807; FREIER SM, 1983, BIOCHEMISTRY-US, V22, P6198, DOI 10.1021/bi00295a025; FREIER SM, 1986, BIOCHEMISTRY-US, V25, P3214, DOI 10.1021/bi00359a020; FREIER SM, 1985, BIOCHEMISTRY-US, V24, P4533, DOI 10.1021/bi00338a008; FREIER SM, 1986, BIOCHEMISTRY-US, V25, P3209, DOI 10.1021/bi00359a019; Gutell RR, 2002, CURR OPIN STRUC BIOL, V12, P301, DOI 10.1016/S0959-440X(02)00339-1; Gutell RR, 2000, J MOL BIOL, V304, P335, DOI 10.1006/jmbi.2000.4172; HICKEY DR, 1985, BIOCHEMISTRY-US, V24, P3987, DOI 10.1021/bi00336a028; KIM SH, 1974, SCIENCE, V185, P435, DOI 10.1126/science.185.4149.435; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Lee JC, 2004, J MOL BIOL, V344, P1225, DOI 10.1016/j.jmb.2004.09.072; Lee JC, 2003, J MOL BIOL, V325, P65, DOI 10.1016/S0022-2836(02)01106-3; Lee JC, 2003, THESIS U TEXAS AUSTI; Lee JC, 2006, J MOL BIOL, V360, P978, DOI 10.1016/j.jmb.2006.05.066; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; PATEL DJ, 1975, BIOCHEMISTRY-US, V14, P2651, DOI 10.1021/bi00683a014; PATEL DJ, 1974, BIOCHEMISTRY-US, V13, P2396, DOI 10.1021/bi00708a025; PETERSHEIM M, 1983, BIOCHEMISTRY-US, V22, P256, DOI 10.1021/bi00271a004; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; ROMANIUK PJ, 1978, J AM CHEM SOC, V100, P3971, DOI 10.1021/ja00480a076; SANTALUCIA J, 1991, J AM CHEM SOC, V113, P4313, DOI 10.1021/ja00011a039; SERRANO L, 1989, NATURE, V342, P296, DOI 10.1038/342296a0; SINCLAIR A, 1984, BIOCHEMISTRY-US, V23, P2656, DOI 10.1021/bi00307a018; SUGIMOTO N, 1987, BIOCHEMISTRY-US, V26, P4554, DOI 10.1021/bi00388a058; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Tucker BJ, 2005, CURR OPIN STRUC BIOL, V15, P342, DOI 10.1016/j.sbi.2005.05.003; TUERK C, 1988, P NATL ACAD SCI USA, V85, P1364, DOI 10.1073/pnas.85.5.1364; WIMBERLY B, 1993, BIOCHEMISTRY-US, V32, P1078, DOI 10.1021/bi00055a013; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P8467, DOI 10.1073/pnas.87.21.8467; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	48	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93664	10.1371/journal.pone.0093664	http://dx.doi.org/10.1371/journal.pone.0093664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691270	Green Submitted, Green Published, gold			2022-12-27	WOS:000334101100122
J	Sharma, S; Padmaja, KL; Gupta, V; Paritosh, K; Pradhan, AK; Pental, D				Sharma, Sarita; Padmaja, K. Lakshmi; Gupta, Vibha; Paritosh, Kumar; Pradhan, Akshay K.; Pental, Deepak			Two Plastid DNA Lineages-Rapa/Oleracea and Nigra-within the Tribe Brassiceae Can Be Best Explained by Reciprocal Crosses at Hexaploidy: Evidence from Divergence Times of the Plastid Genomes and R-Block Genes of the A and B Genomes of Brassica juncea	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; MOLECULAR SYSTEMATICS; KARYOTYPE EVOLUTION; CHROMOSOME-NUMBER; NAPUS GENOME; PHYLOGENY; CHLOROPLAST; SEQUENCE; POLYPLOIDY; PATTERNS	Brassica species (tribe Brassiceae) belonging to U's triangle-B. rapa (AA), B. nigra (BB), B. oleracea (CC), B. juncea (AABB), B. napus (AACC) and B. carinata (BBCC)-originated via two polyploidization rounds: a U event producing the three allopolyploids, and a more ancient b genome-triplication event giving rise to the A-, B-, and C-genome diploid species. Molecular mapping studies, in situ hybridization, and genome sequencing of B. rapa support the genome triplication origin of tribe Brassiceae, and suggest that these three diploid species diversified from a common hexaploid ancestor. Analysis of plastid DNA has revealed two distinct lineages-Rapa/Oleracea and Nigra-that conflict with hexaploidization as a single event defining the tribe Brassiceae. We analysed an R-block region of A. thaliana present in six copies in B. juncea (AABB), three copies each on A- and B-genomes to study gene fractionation pattern and synonymous base substitution rates (Ks values). Divergence time of paralogues within the A and B genomes and homoeologues between the A and B genomes was estimated. Homoeologous R blocks of the A and B genomes exhibited high gene collinearity and a conserved gene fractionation pattern. The three progenitors of diploid Brassicas were estimated to have diverged approximately 12 mya. Divergence of B. rapa and B. nigra, calculated from plastid gene sequences, was estimated to have occurred approximately 12 mya, coinciding with the divergence of the three genomes participating in the b event. Divergence of B. juncea A and B genome homoeologues was estimated to have taken place around 7 mya. Based on divergence time estimates and the presence of distinct plastid lineages in tribe Brassiceae, it is concluded that at least two independent triplication events involving reciprocal crosses at the time of the b event have given rise to Rapa/Oleracea and Nigra lineages.	[Sharma, Sarita; Padmaja, K. Lakshmi; Gupta, Vibha; Paritosh, Kumar; Pradhan, Akshay K.; Pental, Deepak] Univ Delhi South Campus, Ctr Genet Manipulat Crop Plants, New Delhi, India; [Pradhan, Akshay K.; Pental, Deepak] Univ Delhi South Campus, Dept Genet, New Delhi, India	University of Delhi; University of Delhi	Pental, D (corresponding author), Univ Delhi South Campus, Ctr Genet Manipulat Crop Plants, South Campus, New Delhi, India.	dpental@gmail.com			National Dairy Development Board (NDDB); Centre of Excellence on Mustard Breeding by the Department of Biotechnology (DBT), Government of India; Department of Science and Technology (DST), Government of India	National Dairy Development Board (NDDB); Centre of Excellence on Mustard Breeding by the Department of Biotechnology (DBT), Government of India; Department of Science and Technology (DST), Government of India(Department of Science & Technology (India))	This work was funded by the National Dairy Development Board (NDDB) and Centre of Excellence on Mustard Breeding by the Department of Biotechnology (DBT), Government of India. DP acknowledges a J.C. Bose Fellowship from the Department of Science and Technology (DST), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Al-Shehbaz IA, 2012, TAXON, V61, P931, DOI 10.1002/tax.615002; Allender CJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-54; Arias T, 2012, TAXON, V61, P980, DOI 10.1002/tax.615005; Bailey CD, 2006, MOL BIOL EVOL, V23, P2142, DOI 10.1093/molbev/msl087; Cheng F, 2013, PLANT CELL, V25, P1541, DOI 10.1105/tpc.113.110486; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Cho K, 2010, PLANT J, V61, P591, DOI 10.1111/j.1365-313X.2009.04084.x; Cifuentes M, 2010, PLANT CELL, V22, P2265, DOI 10.1105/tpc.109.072991; ERICKSON LR, 1983, THEOR APPL GENET, V65, P201, DOI 10.1007/BF00308066; Hall JC, 2011, AM J BOT, V98, P1989, DOI 10.3732/ajb.1100203; Harberd D. J., 1980, Brassica crops and wild allies. [I]., P65; Inaba R, 2002, THEOR APPL GENET, V105, P1159, DOI 10.1007/s00122-002-0968-3; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Johnston JS, 2005, ANN BOT-LONDON, V95, P229, DOI 10.1093/aob/mci016; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Lagercrantz U, 1998, GENETICS, V150, P1217; Lagercrantz U, 1996, GENETICS, V144, P1903; Liu ZQ, 2006, GENETICS, V174, P1583, DOI 10.1534/genetics.106.064071; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Lysak MA, 2007, PLANT PHYSIOL, V145, P402, DOI 10.1104/pp.107.104380; Lysak MA, 2011, PLANT GENET GENOMICS, V9, P1, DOI 10.1007/978-1-4419-7118-0_1; Mandakova T, 2008, PLANT CELL, V20, P2559, DOI 10.1105/tpc.108.062166; Marhold K, 2006, PLANT SYST EVOL, V259, P143, DOI 10.1007/s00606-006-0417-x; McBreen K, 2006, TRENDS PLANT SCI, V11, P398, DOI 10.1016/j.tplants.2006.06.004; Mizushima U., 1980, Brassica crops and wild allies. [I]., P89; Mun JH, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r94; Navabi ZK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-250; NEI M, 1986, MOL BIOL EVOL, V3, P418; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Pradhan AK, 2003, THEOR APPL GENET, V106, P607, DOI 10.1007/s00122-002-1083-1; PRADHAN AK, 1992, THEOR APPL GENET, V85, P331, DOI 10.1007/BF00222878; Prakash S, 1999, DEV PL GEN, V4, P59; Ramchiary N, 2007, THEOR APPL GENET, V115, P807, DOI 10.1007/s00122-007-0610-5; Sambrook J., 2001, MOL CLONING LAB MANU; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Schulz O.E., 1936, NATURLICHEN PFLANZEN, V17B, P227; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Srivastava A, 2001, THEOR APPL GENET, V102, P193, DOI 10.1007/s001220051635; Takahata Y., 1983, Tohoku Journal of Agricultural Research, V33, P111; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00172; Tang HB, 2012, GENETICS, V190, P1563, DOI 10.1534/genetics.111.137349; U. N., 1935, Japanese Journal of Botany, V7, P389; Wang J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-271; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Warwick SI, 2006, PLANT SYST EVOL, V259, P237, DOI 10.1007/s00606-006-0421-1; Warwick SI, 2005, CAN J BOT, V83, P467, DOI [10.1139/B05-021, 10.1139/b05-021]; WARWICK SI, 1991, THEOR APPL GENET, V82, P81, DOI 10.1007/BF00231281; Yadava SK, 2012, THEOR APPL GENET, V125, P1553, DOI 10.1007/s00122-012-1934-3; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Yang YW, 1999, J MOL EVOL, V48, P597, DOI 10.1007/PL00006502	56	10	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93260	10.1371/journal.pone.0093260	http://dx.doi.org/10.1371/journal.pone.0093260			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691069	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100057
J	Pessoa, R; Watanabe, JT; Nukui, Y; Pereira, J; Kasseb, J; de Oliveira, ACP; Segurado, AC; Sanabani, SS				Pessoa, Rodrigo; Watanabe, Jaqueline Tomoko; Nukui, Youko; Pereira, Juliana; Kasseb, Jorge; Penalva de Oliveira, Augusto Cesar; Segurado, Aluisio Cotrim; Sanabani, Sabri Saeed			Molecular Characterization of Human T-Cell Lymphotropic Virus Type 1 Full and Partial Genomes by Illumina Massively Parallel Sequencing Technology	PLOS ONE			English	Article							I HTLV-I; LEUKEMIA-VIRUS; BLOOD-DONORS; STRAINS; AFRICAN; BRAZIL; SOUTH; IDENTIFICATION; EPIDEMIOLOGY; RETROVIRUS	Background: Here, we report on the partial and full-length genomic (FLG) variability of HTLV-1 sequences from 90 well-characterized subjects, including 48 HTLV-1 asymptomatic carriers (ACs), 35 HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and 7 adult T-cell leukemia/lymphoma (ATLL) patients, using an Illumina paired-end protocol. Methods: Blood samples were collected from 90 individuals, and DNA was extracted from the PBMCs to measure the proviral load and to amplify the HTLV-1 FLG from two overlapping fragments. The amplified PCR products were subjected to deep sequencing. The sequencing data were assembled, aligned, and mapped against the HTLV-1 genome with sufficient genetic resemblance and utilized for further phylogenetic analysis. Results: A high-throughput sequencing-by-synthesis instrument was used to obtain an average of 3210-and 5200-fold coverage of the partial (n = 14) and FLG (n = 76) data from the HTLV-1 strains, respectively. The results based on the phylogenetic trees of consensus sequences from partial and FLGs revealed that 86 (95.5%) individuals were infected with the transcontinental sub-subtypes of the cosmopolitan subtype (aA) and that 4 individuals (4.5%) were infected with the Japanese sub-subtypes (aB). A comparison of the nucleotide and amino acids of the FLG between the three clinical settings yielded no correlation between the sequenced genotype and clinical outcomes. The evolutionary relationships among the HTLV sequences were inferred from nucleotide sequence, and the results are consistent with the hypothesis that there were multiple introductions of the transcontinental subtype in Brazil. Conclusions: This study has increased the number of subtype aA full-length genomes from 8 to 81 and HTLV-1 aB from 2 to 5 sequences. The overall data confirmed that the cosmopolitan transcontinental sub-subtypes were the most prevalent in the Brazilian population. It is hoped that this valuable genomic data will add to our current understanding of the evolutionary history of this medically important virus.	[Pessoa, Rodrigo; Watanabe, Jaqueline Tomoko] Sao Paulo Inst Trop Med, Dept Virol, Sao Paulo, Brazil; [Nukui, Youko; Pereira, Juliana] Univ Sao Paulo, Fac Med, Dept Hematol, Sao Paulo, Brazil; [Kasseb, Jorge; Penalva de Oliveira, Augusto Cesar] Inst Infectol Emilio Ribas, Dept Neurol, Sao Paulo, Brazil; [Segurado, Aluisio Cotrim] Univ Sao Paulo, Fac Med, Dept Infect Dis, Sao Paulo, Brazil; [Sanabani, Sabri Saeed] Univ Sao Paulo, Sch Med, Hosp Clin, Clin Lab,Dept Pathol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Sanabani, SS (corresponding author), Univ Sao Paulo, Sch Med, Hosp Clin, Clin Lab,Dept Pathol, Sao Paulo, Brazil.	sabyem_63@yahoo.com	PEREIRA, JULIANA/C-2742-2014; Segurado, Aluisio C/K-2229-2012; Pessôa, Rodrigo/B-7206-2018; Sanabani, Sabri Saeed/F-5600-2012	PEREIRA, JULIANA/0000-0002-0655-2821; Segurado, Aluisio C/0000-0002-6311-8036; Sanabani, Sabri Saeed/0000-0002-8876-8262	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/12297-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported with funding from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2011/12297-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara LCJ, 2006, AIDS, V20, P780, DOI 10.1097/01.aids.0000216383.14808.13; Mota ACA, 2007, AIDS RES HUM RETROV, V23, P503, DOI 10.1089/aid.2006.0203; Balcazar N, 2003, MEM I OSWALDO CRUZ, V98, P641, DOI 10.1590/S0074-02762003000500010; Bimber BN, 2010, J VIROL, V84, P12087, DOI 10.1128/JVI.01378-10; Bimber BN, 2009, J VIROL, V83, P8247, DOI 10.1128/JVI.00897-09; Carneiro-Proietti ABF, 2012, AIDS RES HUM RETROV, V28, P1265, DOI 10.1089/aid.2011.0143; Catalan-Soares Bernadette, 2005, Cad. Saúde Pública, V21, P926, DOI 10.1590/S0102-311X2005000300027; Da--Costa AC, 2011, VIROL J, V8, P535; Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013; Dudley DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036494; Edlich RF, 2000, J EMERG MED, V18, P109, DOI 10.1016/S0736-4679(99)00173-0; Eirin ME, 2008, AIDS RES HUM RETROV, V24, P1237, DOI 10.1089/aid.2008.0024; Franchini G, 2003, INT J HEMATOL, V78, P280, DOI 10.1007/BF02983552; Furukawa Y, 2000, J INFECT DIS, V182, P1343, DOI 10.1086/315897; GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x; GESSAIN A, 1985, LANCET, V2, P407; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; HENEINE W, 1992, J CLIN MICROBIOL, V30, P1605, DOI 10.1128/JCM.30.6.1605-1607.1992; HUANG YQ, 1992, LANCET, V339, P1110; Kashima S, 2006, AIDS RES HUM RETROV, V22, P953, DOI 10.1089/aid.2006.22.953; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KOMURIAN F, 1991, J VIROL, V65, P3770, DOI 10.1128/JVI.65.7.3770-3778.1991; LEITNER T, 2002, MOL EPIDEMIOLOGY HUM; LONGO DL, 1984, NATURE, V310, P505, DOI 10.1038/310505a0; Magri MC, 2012, AIDS RES HUM RETROV, V28, P110, DOI [10.1089/AID.2011.0117, 10.1089/aid.2011.0117]; Mahieux R, 1997, J VIROL, V71, P1317, DOI 10.1128/JVI.71.2.1317-1333.1997; Matsuoka M, 2003, ONCOGENE, V22, P5131, DOI 10.1038/sj.onc.1206551; Naderi M, 2012, J CLIN VIROL, V53, P302, DOI 10.1016/j.jcv.2011.12.033; NISHIOKA K, 1989, LANCET, V1, P441; OSAME M, 1986, LANCET, V1, P1031; OSAME M, 1990, HUMAN RETROVIROLOGY : HTLV, P191; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Segurado AAC, 2002, MEM I OSWALDO CRUZ, V97, P329, DOI 10.1590/S0074-02762002000300009; SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618; SONG KJ, 1995, AM J TROP MED HYG, V52, P101, DOI 10.4269/ajtmh.1995.52.101; SUGIMOTO M, 1987, LANCET, V2, P1220; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Dooren S, 1998, J GEN VIROL, V79, P2695, DOI 10.1099/0022-1317-79-11-2695; Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6; VIDAL AU, 1994, J GEN VIROL, V75, P3655, DOI 10.1099/0022-1317-75-12-3655; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Willerth SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013564; Yamashita M, 2001, AIDS RES HUM RETROV, V17, P783, DOI 10.1089/088922201750237068; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031	47	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93374	10.1371/journal.pone.0093374	http://dx.doi.org/10.1371/journal.pone.0093374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686382	Green Published, gold, Green Submitted			2022-12-27	WOS:000340842300010
J	Wierenga, ATJ; Vellenga, E; Schuringa, JJ				Wierenga, Albertus T. J.; Vellenga, Edo; Schuringa, Jan Jacob			Convergence of Hypoxia and TGF beta Pathways on Cell Cycle Regulation in Human Hematopoietic Stem/Progenitor Cells	PLOS ONE			English	Article							BONE-MARROW NICHE; STEM-CELLS; INDUCIBLE FACTORS; TRANSCRIPTION FACTOR; SELF-RENEWAL; OXYGEN; PROLIFERATION; NRF2; STRESS; LOCALIZATION	Although it has been shown that HIF1 and 2 fulfill essential roles within the hematopoietic system and in the regulation of HSC fate, little is currently known about the specific mechanisms that are involved. We identified transcriptome changes induced by hypoxia, constitutively active HIF1((P402/564)) and HIF2((P405/531)) in human cord blood CD34(+) cells. Thus, we were able to identify common hypoxia-HIF1-HIF2 gene signatures, but we also identified specific target genes that were exclusively regulated by HIF1, HIF2 or hypoxia. Geneset enrichment analysis (GSEA) revealed that, besides known pathways associated with "hypoxia-induced signaling'', also significant enrichment for the Transforming Growth Factor beta (TGF beta) pathway was observed within the hypoxia/HIF1/HIF2 transcriptomes. One of the most significantly upregulated genes in both gene sets was the cyclin dependent kinase inhibitor CDKN1C (p57kip2). Combined hypoxia treatment or HIF overexpression together with TGF beta stimulation resulted in enhanced expression of CDKN1C and enhanced cell cycle arrest within the CD34(+)/CD38(-) stem cell compartment. Interestingly, we observed that CD34(+) cells cultured under hypoxic conditions secreted high levels of latent TGF beta, suggesting an auto-or paracrine role of TGF beta in the regulation of quiescence of these cells. However, knockdown of SMAD4 could not rescue the hypoxia induced cell cycle arrest, arguing against direct effects of hypoxia-induced secreted TGF beta. Finally, the Ga-coupled receptor GTPase RGS1 was identified as a HIF-dependent hypoxia target that dampens SDF1-induced migration and signal transduction in human CD34(+) stem/progenitor cells.	[Wierenga, Albertus T. J.; Vellenga, Edo; Schuringa, Jan Jacob] Univ Groningen, Univ Med Ctr Groningen, Dept Expt Hematol, Groningen, Netherlands; [Wierenga, Albertus T. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands	University of Groningen; University of Groningen	Schuringa, JJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Expt Hematol, Groningen, Netherlands.	j.j.schuringa@umcg.nl			UMCG	UMCG	These studies were supported by internal funds from the UMCG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; ALLALUNISTURNER MJ, 1987, INT J CELL CLONING, V5, P315, DOI 10.1002/stem.5530050406; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Argiropoulos B, 2008, EXP HEMATOL, V36, P845, DOI 10.1016/j.exphem.2008.02.011; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; BRADLEY TR, 1978, J CELL PHYSIOL, V97, P517, DOI 10.1002/jcp.1040970327; Cao YA, 2008, BLOOD, V112, P4494, DOI 10.1182/blood-2007-12-127621; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Eliasson P, 2010, EXP HEMATOL, V38, P301, DOI 10.1016/j.exphem.2010.01.005; Fahling M, 2009, J CELL MOL MED, V13, P2770, DOI 10.1111/j.1582-4934.2009.00875.x; Forristal CE, 2013, BLOOD, V121, P759, DOI 10.1182/blood-2012-02-408419; Guitart AV, 2013, BLOOD, V122, P1741, DOI 10.1182/blood-2013-02-484923; Haase VH, 2013, BLOOD REV, V27, P41, DOI 10.1016/j.blre.2012.12.003; Han JI, 2006, J LEUKOCYTE BIOL, V79, P1357, DOI 10.1189/jlb.1105693; Ivanovic Z, 2000, TRANSFUSION, V40, P1482, DOI 10.1046/j.1537-2995.2000.40121482.x; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karlsson G, 2007, J EXP MED, V204, P467, DOI 10.1084/jem.20060465; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253; Krause DS, 2013, CYTOM PART B-CLIN CY, V84B, P7, DOI 10.1002/cyto.b.21066; Kuang LH, 2013, INT J BIOL SCI, V9, P656, DOI 10.7150/ijbs.5887; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Moratz C, 2004, MOL CELL BIOL, V24, P5767, DOI 10.1128/MCB.24.13.5767-5775.2004; Nakamura-Ishizu A, 2013, BBA-GEN SUBJECTS, V1830, P2404, DOI 10.1016/j.bbagen.2012.08.023; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Rouault-Pierre K, 2013, CELL STEM CELL, V13, P549, DOI 10.1016/j.stem.2013.08.011; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Smirnova NA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1108, DOI 10.1134/S0006297912100033; Smith JNP, 2013, STEM CELLS, V31, P1044, DOI 10.1002/stem.1370; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tsai JJ, 2013, NAT CELL BIOL, V15, P309, DOI 10.1038/ncb2699; Wierenga ATJ, 2008, MOL CELL BIOL, V28, P6668, DOI 10.1128/MCB.01025-08; Wierenga ATJ, 2006, BLOOD, V107, P4326, DOI 10.1182/blood-2005-11-4608; Wierenga ATJ, 2010, BLOOD, V115, P4367, DOI 10.1182/blood-2009-10-250894; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480	48	37	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93494	10.1371/journal.pone.0093494	http://dx.doi.org/10.1371/journal.pone.0093494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686421	Green Published, Green Submitted, gold			2022-12-27	WOS:000340842300014
J	He, ZG; Qian, DH; Hua, J; Gong, J; Lin, SP; Song, ZS				He, Zhigang; Qian, Daohai; Hua, Jie; Gong, Jian; Lin, Shengping; Song, Zhenshun			Clinical Comparison of Distal Pancreatectomy with or without Splenectomy: A Meta-Analysis	PLOS ONE			English	Article							SPLENIC PRESERVATION; SPLEEN; CANCER; CONSERVATION; WORTHWHILE; RESECTIONS; FISTULA	Objective: A distal pancreatectomy has routinely been used for removing benign/borderline malignant tumors of the body and tail of the pancreas; however, controversy exists whether or not the spleen should be saved. Therefore, we conducted this meta-analysis for comparing the clinical outcomes of patients who underwent distal pancreatectomy with or without splenectomy. Methods: A literature research from the databases of Medline, Embase, and Cochrane library was performed to evaluate and compare the clinical outcomes between spleen-preserving distal pancreatectomy (SPDP) and distal pancreatectomy with splenectomy (DPS). Pooled odds ratio (OR) and weighted mean difference (WMD) with 95% confidence interval (95% CI) were calculated using fixed-effects or random-effects models. Results: Eleven non-randomized controlled studies involving 897 patients were selected to satisfy the inclusion criteria; 355 patients underwent SPDP and 542 patients underwent DPS. Compared with DPS, SPDP required a shorter hospital stay (WMD = 1.16, 95% CI = -2.00 to -0.31, P = 0.007), and had a lower incidence of intra-abdominal abscesses (OR = 0.48, 95% CI = 0.27 to 0.83, P = 0.009). In addition, spleen infarctions occurred in SPDP, most of which involved use of the Warshaw method for preserving the spleen. There were no differences between the SPDP and DPS groups with respect to operative time, operative blood loss, requirement for blood transfusion, pancreatic fistulas, thromboses, post-operative bleeding, wound infections and re-operation rates. Conclusion: SPDP should be performed due to the benefits of the immune system and quick post-operative recovery. It is also essential to preserve the splenic artery and vein. Large randomized controlled trials are further needed to verify the results of this meta-analysis.	[He, Zhigang; Qian, Daohai; Hua, Jie; Gong, Jian; Lin, Shengping; Song, Zhenshun] Tongji Univ Med, Shanghai Peoples Hosp 10, Dept Gen Surg, Shanghai, Peoples R China	Tongji University	Song, ZS (corresponding author), Tongji Univ Med, Shanghai Peoples Hosp 10, Dept Gen Surg, Shanghai, Peoples R China.	zs_song@hotmail.com			National Natural Science Foundation of China [60171009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China (Grant No. 60171009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Benoist S, 1999, J AM COLL SURGEONS, V188, P255, DOI 10.1016/S1072-7515(98)00299-3; BONENKAMP JJ, 1995, LANCET, V345, P745, DOI 10.1016/S0140-6736(95)90637-1; Carrere N, 2007, WORLD J SURG, V31, P375, DOI 10.1007/s00268-006-0425-6; Choi SH, 2012, SURG ENDOSC, V26, P3149, DOI 10.1007/s00464-012-2306-4; COOPER MJ, 1985, BRIT J SURG, V72, P801, DOI 10.1002/bjs.1800721009; DELAITRE B, 1992, SURG ENDOSC-ULTRAS, V6, P305, DOI 10.1007/BF02498866; Dulucq JL, 2005, SURG ENDOSC, V19, P1028, DOI 10.1007/s00464-004-2182-7; Edwin B, 2004, SURG ENDOSC, V18, P407, DOI 10.1007/s00464-003-9007-y; Espat N., 2003, JAMA-J AM MED ASSOC, V289, P1862; Feng W, 2013, HEPATOGASTROENTEROLO, V60; Khanna A, 2005, J GASTROINTEST SURG, V9, P733, DOI 10.1016/j.gassur.2004.07.006; Laxa BU, 2008, AM SURGEON, V74, P481; Lee SE, 2008, J KOREAN MED SCI, V23, P1011, DOI 10.3346/jkms.2008.23.6.1011; Lynch AM, 1996, INFECT DIS CLIN N AM, V10, P693, DOI 10.1016/S0891-5520(05)70322-6; Ma JP, 2011, CHINESE MED J-PEKING, V124, P1217, DOI 10.3760/cma.j.issn.0366-6999.2011.08.018; Mabrut JY, 2005, SURGERY, V137, P597, DOI 10.1016/j.surg.2005.02.002; Mallet-Guy P., 1943, PANCREATITES CHRONIQ; MARTIN FM, 1989, ARCH SURG-CHICAGO, V124, P571; McGory ML, 2007, ARCH SURG-CHICAGO, V142, P668, DOI 10.1001/archsurg.142.7.668; Mekeel KL, 2011, SURG LAPARO ENDO PER, V21, P362, DOI 10.1097/SLE.0b013e31822e0ea8; Mellemkjaer L, 1995, Ugeskr Laeger, V157, P5097; MELLEMKJAER L, 1995, CANCER, V75, P577, DOI 10.1002/1097-0142(19950115)75:2<577::AID-CNCR2820750222>3.0.CO;2-K; Melotti G, 2007, ANN SURG, V246, P77, DOI 10.1097/01.sla.0000258607.17194.2b; MONTORSI M, 1995, SURGERY, V117, P26, DOI 10.1016/S0039-6060(05)80225-9; Norman M, 2012, J PANCREATIC DISORDE; RICHARDSON DQ, 1989, AM SURGEON, V55, P21; Rodriguez JR, 2007, SURGERY, V141, P619, DOI 10.1016/j.surg.2006.09.020; Shoup M, 2002, ARCH SURG-CHICAGO, V137, P164, DOI 10.1001/archsurg.137.2.164; Tsiouris A, 2011, HPB, V13, P738, DOI 10.1111/j.1477-2574.2011.00369.x; WARSHAW AL, 1988, ARCH SURG-CHICAGO, V123, P550; Yamaguchi K, 2001, INT SURG, V86, P162; Zhao YP, 2012, HEPATOB PANCREAT DIS, V11, P536, DOI 10.1016/S1499-3872(12)60220-3	33	18	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e91593	10.1371/journal.pone.0091593	http://dx.doi.org/10.1371/journal.pone.0091593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682038	Green Published, gold, Green Submitted			2022-12-27	WOS:000333678100004
J	Shin, HM; McKone, TE; Sohn, MD; Bennett, DH				Shin, Hyeong-Moo; McKone, Thomas E.; Sohn, Michael D.; Bennett, Deborah H.			Tracking Contributions to Human Body Burden of Environmental Chemicals by Correlating Environmental Measurements with Biomarkers	PLOS ONE			English	Article							ORGANOPHOSPHATE PESTICIDE EXPOSURE; IN-HOUSE DUST; SERUM; CHILDREN; PBDES; CHARACTERIZE; ASSOCIATIONS; VARIABILITY; HANDWIPES; URINE	The work addresses current knowledge gaps regarding causes for correlations between environmental and biomarker measurements and explores the underappreciated role of variability in disaggregating exposure attributes that contribute to biomarker levels. Our simulation-based study considers variability in environmental and food measurements, the relative contribution of various exposure sources (indoors and food), and the biological half-life of a compound, on the resulting correlations between biomarker and environmental measurements. For two hypothetical compounds whose half-lives are on the order of days for one and years for the other, we generate synthetic daily environmental concentrations and food exposures with different day-to-day and population variability as well as different amounts of home-and food-based exposure. Assuming that the total intake results only from home-based exposure and food ingestion, we estimate time-dependent biomarker concentrations using a one-compartment pharmacokinetic model. Box plots of modeled R-2 values indicate that although the R-2 correlation between wipe and biological (e. g., serum) measurements is within the same range for the two compounds, the relative contribution of the home exposure to the total exposure could differ by up to 20%, thus providing the relative indication of their contribution to body burden. The novel method introduced in this paper provides insights for evaluating scenarios or experiments where sample, exposure, and compound variability must be weighed in order to interpret associations between exposure data.	[Shin, Hyeong-Moo; Bennett, Deborah H.] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [McKone, Thomas E.; Sohn, Michael D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Environm Energy Technol Div, Berkeley, CA 94720 USA; [McKone, Thomas E.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Shin, HM (corresponding author), Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA.	hmshin@ucdavis.edu	Shin, Hyeong-Moo/T-2127-2017; Shin, Hyeong-Moo/AAI-5229-2021; Sohn, Michael/HHM-5790-2022	Shin, Hyeong-Moo/0000-0002-7001-2555; 	American Chemistry Council [3-DBACC01]	American Chemistry Council	This research is funded by the American Chemistry Council (Grant#: 3-DBACC01, http://www.americanchemistry.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartell S, 2003, STAT METHODS NONSTEA; Bradman A, 2007, J EXPO SCI ENV EPID, V17, P331, DOI 10.1038/sj.jes.7500507; Centers for Disease Control and Prevention, 2009, 4 CDCP; Centers for Disease Control and Prevention (CDC), 2005, 3 CDC; Chen CC, 2004, STOCH ENV RES RISK A, V18, P377, DOI 10.1007/s00477-004-0208-2; Coronado GD, 2006, ENVIRON HEALTH PERSP, V114, P999, DOI 10.1289/ehp.8620; Curwin BD, 2007, ANN OCCUP HYG, V51, P53, DOI [10.1093/annhug/mel062, 10.1093/annhyg/mel062]; Fraser AJ, 2012, ENVIRON SCI TECHNOL, V46, P1209, DOI 10.1021/es2038257; Geens T, 2012, FOOD CHEM TOXICOL, V50, P3725, DOI 10.1016/j.fct.2012.07.059; Griffith W, 2011, ENVIRON RES, V111, P751, DOI 10.1016/j.envres.2011.05.008; Hubal EAC, 2000, ENVIRON HEALTH PERSP, V108, P475, DOI 10.2307/3454607; Johnson PI, 2010, ENVIRON SCI TECHNOL, V44, P5627, DOI 10.1021/es100697q; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Loomis D, 2004, AM J IND MED, V45, P113, DOI 10.1002/ajim.10324; Lorber M, 2011, ENVIRON SCI TECHNOL, V45, P8006, DOI 10.1021/es103718h; Quiros-Alcala L, 2012, J EXPO SCI ENV EPID, V22, P559, DOI 10.1038/jes.2012.46; Ramaswami A, 2005, INTEGRATED ENV MODEL; RAPPAPORT SM, 1995, ENVIRON HEALTH PERSP, V103, P49, DOI 10.2307/3432560; Rothlein J, 2006, ENVIRON HEALTH PERSP, V114, P691, DOI 10.1289/ehp.8182; Shin HM, 2013, ATMOS ENVIRON, V69, P148, DOI 10.1016/j.atmosenv.2012.12.027; Shin HM, 2013, ENVIRON SCI TECHNOL, V47, P859, DOI 10.1021/es303316d; Shin HM, 2012, ENVIRON SCI TECHNOL, V46, P10063, DOI 10.1021/es3018286; Shin HM, 2011, ENVIRON HEALTH PERSP, V119, P1760, DOI 10.1289/ehp.1103729; Stapleton HM, 2012, ENVIRON HEALTH PERSP, V120, P1049, DOI 10.1289/ehp.1104802; Watkins DJ, 2012, ENVIRON SCI TECHNOL, V46, P1192, DOI 10.1021/es203314e; Watkins DJ, 2011, ENVIRON HEALTH PERSP, V119, P1247, DOI 10.1289/ehp.1003271; Weschler CJ, 2012, INDOOR AIR, V22, P356, DOI 10.1111/j.1600-0668.2012.00772.x; Wu N, 2007, ENVIRON SCI TECHNOL, V41, P1584, DOI 10.1021/es0620282; Xu ZL, 2013, SCI TOTAL ENVIRON, V443, P485, DOI 10.1016/j.scitotenv.2012.10.089	29	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93678	10.1371/journal.pone.0093678	http://dx.doi.org/10.1371/journal.pone.0093678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681626	gold, Green Submitted, Green Published			2022-12-27	WOS:000333678100054
J	Wasserberg, G; Bailes, N; Davis, C; Yeoman, K				Wasserberg, Gideon; Bailes, Nicholas; Davis, Christopher; Yeoman, Kim			Hump-Shaped Density-Dependent Regulation of Mosquito Oviposition Site-Selection by Conspecific Immature Stages: Theory, Field Test with Aedes albopictus, and a Meta-Analysis	PLOS ONE			English	Article							CULEX-QUINQUEFASCIATUS DIPTERA; ANOPHELES-GAMBIAE; EGG RAFTS; ATROPALPUS DIPTERA; CULISETA-LONGIAREOLATA; HABITAT SELECTION; CHEMICAL ECOLOGY; AEGYPTI DIPTERA; PREDATION RISK; SAY DIPTERA	Oviposition site selection by gravid females is an important determinant of the distribution, abundance, and dynamics of dipteran hematophagous insects. The presence of conspecific immature stages in a potential oviposition site could, on the one hand, indicate the suitability of that site but on the other hand could indicate the potential for intraspecific competition. In this paper, we present a graphic model suggesting that the trade-off between these two opposing forces could result in a hump-shaped density-dependent relationship between oviposition rate and conspecific immature stage density (hereafter, the "Hump-shaped regulation model'') with positive effects of aggregation prevailing at low densities and negative effect of intraspecific competition prevailing at higher densities. We field-tested the predictions of this model at both the egg-and the larval levels with Aedes albopictus and evaluated if and how these relationships are affected by resource enrichment. We found support for the hump-shaped regulation model at both the larval and the egg levels. Using oviposition cups containing varying numbers of conspecific larvae, we showed that the oviposition activity of Ae. albopictus first increases and then decreases with larvae number. Medium enrichment resulted in higher hatching rate, and demonstrated linear relations for the no-enrichment treatment where larvae density range was low and hump-shaped relationship for the enriched medium that had a wider larvae density range. Using pairs of oviposition cups, we showed that at low egg densities mosquitoes laid more eggs on substrates containing pre-existing eggs. However, at higher egg densities, mosquitoes laid more eggs on a virgin substrate. Based on our results and on a meta-analysis, we suggest that due to study design or methodological shortcomings the hump-shaped regulation model is often left undetected and that it is likely to be more common than currently thought.	[Wasserberg, Gideon; Yeoman, Kim] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA; [Bailes, Nicholas] Villanova Univ, Inst Global Interdisciplinary Studies, Villanova, PA 19085 USA; [Davis, Christopher] Messiah Univ, Dept Biol, Mechanicsburg, PA USA	University of North Carolina; University of North Carolina Greensboro; Villanova University	Wasserberg, G (corresponding author), Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA.	g_wasser@uncg.edu			UNC-Greensboro Office of Undergraduate Research; Biology Department; NSF [DMS 0850465]	UNC-Greensboro Office of Undergraduate Research; Biology Department; NSF(National Science Foundation (NSF))	The authors thank the UNC-Greensboro Office of Undergraduate Research and the Biology Department for providing support for this study. The research was partially supported by NSF grant DMS 0850465 "Research Experiences for Undergraduates (REU)." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 2002, ECOL ENTOMOL, V27, P396, DOI 10.1046/j.1365-2311.2002.00430.x; AHMADI A, 1983, MOSQ NEWS, V43, P343; Allan SA, 1998, J MED ENTOMOL, V35, P943, DOI 10.1093/jmedent/35.6.943; Allee W.C, 1931, ANIMAL AGGREGATION S; Armistead JS, 2008, J VECTOR ECOL, V33, P238, DOI 10.3376/1081-1710-33.2.238; Barbosa RMR, 2007, MEM I OSWALDO CRUZ, V102, P523, DOI 10.1590/S0074-02762007005000058; BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153; BENTLEY MD, 1976, J MED ENTOMOL, V13, P112, DOI 10.1093/jmedent/13.1.112; BENZON GL, 1988, J MED ENTOMOL, V25, P158, DOI 10.1093/jmedent/25.3.158; BLACKWELL A, 1993, PHYSIOL ENTOMOL, V18, P343, DOI 10.1111/j.1365-3032.1993.tb00607.x; Blaustein L, 1999, EVOLUTIONARY THEORY AND PROCESSES: MODERN PERSPECTIVES, P441; Blaustein L, 2010, ISR J ECOL EVOL, V56, P251, DOI 10.1560/IJEE.56.3-4.251; BOUSKILA A, 1992, AM NAT, V139, P161, DOI 10.1086/285318; Braks MAH, 2007, J CHEM ECOL, V33, P567, DOI 10.1007/s10886-006-9223-8; Brodin T, 2006, FRESHWATER BIOL, V51, P1277, DOI 10.1111/j.1365-2427.2006.01563.x; BRUNO DW, 1979, J MED ENTOMOL, V16, P300, DOI 10.1093/jmedent/16.4.300; CHADEE DD, 1990, ENTOMOL EXP APPL, V57, P295, DOI 10.1007/BF00355029; Chaves LF, 2011, J APPL ENTOMOL, V135, P611, DOI 10.1111/j.1439-0418.2010.01580.x; Chaves LF, 2009, J MED ENTOMOL, V46, P220, DOI 10.1603/033.046.0206; DADD RH, 1974, ENVIRON ENTOMOL, V3, P21, DOI 10.1093/ee/3.1.21; Dhileepan K, 1997, ENVIRON ENTOMOL, V26, P318, DOI 10.1093/ee/26.2.318; Dougherty M, 1997, J CHEM ECOL, V23, P2657, DOI 10.1023/A:1022598523803; Edgerly JS, 1998, J ANIM ECOL, V67, P805, DOI 10.1046/j.1365-2656.1998.00243.x; EDGERLY JS, 1992, J ANIM ECOL, V61, P139, DOI 10.2307/5517; Ellis AM, 2008, J ANIM ECOL, V77, P247, DOI 10.1111/j.1365-2656.2007.01345.x; Ellis AM, 2008, J ANIM ECOL, V77, P156, DOI 10.1111/j.1365-2656.2007.01319.x; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Ganesan K, 2006, AUST J ENTOMOL, V45, P75, DOI 10.1111/j.1440-6055.2006.00513.x; Glos J, 2008, BIOTROPICA, V40, P646, DOI 10.1111/j.1744-7429.2008.00411.x; HEARD SB, 1994, EVOL ECOL, V8, P493, DOI 10.1007/BF01238254; KALPAGE K S P, 1973, Environmental Entomology, V2, P729, DOI 10.1093/ee/2.5.729; Kershenbaum A, 2012, EVOL ECOL, V26, P955, DOI 10.1007/s10682-011-9548-9; Kiflawi M, 2003, ECOL ENTOMOL, V28, P168, DOI 10.1046/j.1365-2311.2003.00505.x; KITRON UD, 1989, J MED ENTOMOL, V26, P462, DOI 10.1093/jmedent/26.5.462; LAURENCE BR, 1985, B ENTOMOL RES, V75, P283, DOI 10.1017/S0007485300014371; MAIRE A, 1985, J MED ENTOMOL, V22, P111, DOI 10.1093/jmedent/22.1.111; Mboera LEG, 2000, J MED ENTOMOL, V37, P172, DOI 10.1603/0022-2585-37.1.172; McCall PJ, 1997, B ENTOMOL RES, V87, P609, DOI 10.1017/S0007485300038700; MCCRAE AWR, 1984, ANN TROP MED PARASIT, V78, P307, DOI 10.1080/00034983.1984.11811821; McCulagh P, 1989, GEN LINEAR MODELS, V2nd; Mokany A, 2003, AUSTRAL ECOL, V28, P33, DOI 10.1046/j.1442-9993.2003.01239.x; Munga S, 2006, J MED ENTOMOL, V43, P221, DOI 10.1603/0022-2585(2006)043[0221:EOLCAP]2.0.CO;2; Nakamura H., 1978, Japanese Journal of Sanitary Zoology, V29, P117; Navarro-Silva MA, 2009, REV BRAS ENTOMOL, V53, P1, DOI 10.1590/S0085-56262009000100002; Nguyen AT, 2012, J MED ENTOMOL, V49, P1328, DOI 10.1603/ME12090; Onyabe DY, 1997, CAN ENTOMOL, V129, P1173, DOI 10.4039/Ent1291173-6; OSGOOD CE, 1971, J ECON ENTOMOL, V64, P1038, DOI 10.1093/jee/64.5.1038; OTIENO WA, 1988, B ENTOMOL RES, V78, P463, DOI 10.1017/S0007485300013213; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; Pavlovich SG, 2000, GREAT LAKES ENTOMOL, V33, P141; Pickett JA, 2010, J CHEM ECOL, V36, P113, DOI 10.1007/s10886-010-9739-9; Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105; Ponnusamy L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024409; REISEN WK, 1990, J AM MOSQUITO CONTR, V6, P244; Reiskind MH, 2004, J MED ENTOMOL, V41, P179, DOI 10.1603/0022-2585-41.2.179; RESETARITS WJ, 1989, ECOLOGY, V70, P220, DOI 10.2307/1938428; Rova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014628; Spencer M, 2002, ECOLOGY, V83, P669, DOI 10.1890/0012-9658(2002)083[0669:OHSBMC]2.0.CO;2; Sumba LA, 2008, J CHEM ECOL, V34, P1430, DOI 10.1007/s10886-008-9549-5; THOMPSON JN, 1991, ANNU REV ENTOMOL, V36, P65, DOI 10.1146/annurev.en.36.010191.000433; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; VALLADARES G, 1991, J ANIM ECOL, V60, P227, DOI 10.2307/5456; Vonesh JR, 2010, ISR J ECOL EVOL, V56, P263, DOI 10.1560/IJEE.56.3-4.263; Wachira SW, 2010, MED VET ENTOMOL, V24, P369, DOI 10.1111/j.1365-2915.2010.00913.x; Wasserberg G, 2013, J MED ENTOMOL, V50, P1159, DOI 10.1603/ME12275; Williams CR, 2008, TROP BIOMED, V25, P140; Wisenden BD, 2000, PHILOS T ROY SOC B, V355, P1205, DOI 10.1098/rstb.2000.0668; Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015; Yoshioka M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-225; Zahiri N, 1998, J MED ENTOMOL, V35, P782, DOI 10.1093/jmedent/35.5.782; Zahiri N, 1997, J MED ENTOMOL, V34, P565, DOI 10.1093/jmedent/34.5.565	72	16	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92658	10.1371/journal.pone.0092658	http://dx.doi.org/10.1371/journal.pone.0092658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681526	Green Published, gold, Green Submitted			2022-12-27	WOS:000333678100012
J	Xi, B; Li, SS; Liu, ZL; Tian, H; Yin, XX; Huai, PC; Tang, WH; Zhou, DH; Steffen, LM				Xi, Bo; Li, Shuangshuang; Liu, Zhaolu; Tian, Huan; Yin, Xiuxiu; Huai, Pengcheng; Tang, Weihong; Zhou, Donghao; Steffen, Lyn M.			Intake of Fruit Juice and Incidence of Type 2 Diabetes: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							SUGAR-SWEETENED BEVERAGES; SOFT DRINK; RISK; CONSUMPTION; MELLITUS; VEGETABLES	Background: Several prospective studies have been conducted to examine the relationship between fruit juice intake and risk of incident type 2 diabetes, but results have been mixed. In the present study, we aimed to estimate the association between fruit juice intake and risk of type 2 diabetes. Methods: PubMed and Embase databases were searched up to December 2013. All prospective cohort studies of fruit juice intake with risk of type 2 diabetes were included. The pooled relative risks (RRs) with 95% confidence intervals (CIs) for highest vs. lowest category of fruit juice intake were estimated using a random-effects model. Results: A total of four studies (191,686 participants, including 12,375 with type 2 diabetes) investigated the association between sugar-sweetened fruit juice and risk of incident type 2 diabetes, and four studies (137,663 participants and 4,906 cases) investigated the association between 100% fruit juice and risk of incident type 2 diabetes. A higher intake of sugar-sweetened fruit juice was significantly associated with risk of type 2 diabetes (RR = 1.28, 95%CI = 1.04-1.59, p = 0.02), while intake of 100% fruit juice was not associated with risk of developing type 2 diabetes (RR = 1.03, 95%CI = 0.91-1.18, p = 0.62). Conclusions: Our findings support dietary recommendations to limit sugar-sweetened beverages, such as fruit juice with added sugar, to prevent the development of type 2 diabetes.	[Xi, Bo; Li, Shuangshuang; Liu, Zhaolu; Tian, Huan; Yin, Xiuxiu] Shandong Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Jinan 250100, Peoples R China; [Huai, Pengcheng] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Peoples R China; [Tang, Weihong; Steffen, Lyn M.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Zhou, Donghao] Linyi Peoples Hosp, Dept Endocrinol, Linyi, Peoples R China	Shandong University; Shandong University; University of Minnesota System; University of Minnesota Twin Cities	Zhou, DH (corresponding author), Linyi Peoples Hosp, Dept Endocrinol, Linyi, Peoples R China.	donghaozhou@163.com; steffen@umn.edu		Steffen, Lyn M/0000-0002-4053-6729				Bazzano LA, 2008, DIABETES CARE, V31, P1311, DOI 10.2337/dc08-0080; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Carter P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4229; Davis MM, 2007, PEDIATRICS, V120, pS229, DOI 10.1542/peds.2007-2329E; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eshak ES, 2013, CLIN NUTR, V32, P300, DOI 10.1016/j.clnu.2012.08.003; Fagherazzi G, 2013, AM J CLIN NUTR, V97, P517, DOI 10.3945/ajcn.112.050997; Hamer M, 2007, J HYPERTENS, V25, P2361, DOI 10.1097/HJH.0b013e3282efc214; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kaiser KA, 2013, OBES REV, V14, P620, DOI 10.1111/obr.12048; Kit BK, 2013, AM J CLIN NUTR, V98, P180, DOI 10.3945/ajcn.112.057943; Livesey G, 2013, AM J CLIN NUTR, V97, P584, DOI 10.3945/ajcn.112.041467; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; MANTEL N, 1959, J NATL CANCER I, V22, P719; Montonen J, 2007, J NUTR, V137, P1447, DOI 10.1093/jn/137.6.1447; Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001; Mursu J, 2013, AM J CLIN NUTR; O'Neil CE, 2008, AM J LIFESTYLE MED, V2, P315, DOI 10.1177/1559827608317277; Odegaard AO, 2010, AM J EPIDEMIOL, V171, P701, DOI 10.1093/aje/kwp452; Palmer JR, 2008, ARCH INTERN MED, V168, P1487, DOI 10.1001/archinte.168.14.1487; Paynter NP, 2006, AM J EPIDEMIOL, V164, P1075, DOI 10.1093/aje/kwj323; Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Wells G.A., NEWCASTLE OTTAWA SCA; Zenith International, 2008, REP GLOB SOFT DRINKS	26	93	98	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93471	10.1371/journal.pone.0093471	http://dx.doi.org/10.1371/journal.pone.0093471			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682091	Green Published, gold, Green Submitted			2022-12-27	WOS:000333678100048
J	Barstow, CK; Ngabo, F; Rosa, G; Majorin, F; Boisson, S; Clasen, T; Thomas, EA				Barstow, Christina K.; Ngabo, Fidele; Rosa, Ghislaine; Majorin, Fiona; Boisson, Sophie; Clasen, Thomas; Thomas, Evan A.			Designing and Piloting a Program to Provide Water Filters and Improved Cookstoves in Rwanda	PLOS ONE			English	Article							INDOOR AIR-POLLUTION; DEVELOPING-COUNTRIES; RESPIRATORY-INFECTIONS; CHILDREN; QUALITY; KENYA; MODEL	Background: In environmental health interventions addressing water and indoor air quality, multiple determinants contribute to adoption. These may include technology selection, technology distribution and education methods, community engagement with behavior change, and duration and magnitude of implementer engagement. In Rwanda, while the country has the fastest annual reduction in child mortality in the world, the population is still exposed to a disease burden associated with environmental health challenges. Rwanda relies both on direct donor funding and coordination of programs managed by international non-profits and health sector businesses working on these challenges. Methods and Findings: This paper describes the design, implementation and outcomes of a pilot program in 1,943 households across 15 villages in the western province of Rwanda to distribute and monitor the use of household water filters and improved cookstoves. Three key program design criteria include a.) an investment in behavior change messaging and monitoring through community health workers, b.) free distributions to encourage community-wide engagement, and c.) a private-public partnership incentivized by a business model designed to encourage "pay for performance''. Over a 5-month period of rigorous monitoring, reported uptake was maintained at greater than 90% for both technologies, although exclusive use of the stove was reported in only 28.5% of households and reported water volume was 1.27 liters per person per day. On-going qualitative monitoring suggest maintenance of comparable adoption rates through at least 16 months after the intervention. Conclusion: High uptake and sustained adoption of a water filter and improved cookstove was measured over a five-month period with indications of continued comparable adoption 16 months after the intervention. The design attributes applied by the implementers may be sufficient in a longer term. In particular, sustained and comprehensive engagement by the program implementer is enabled by a pay-for-performance business model that rewards sustained behavior change.	[Barstow, Christina K.] Univ Colorado, Boulder, CO 80309 USA; [Ngabo, Fidele] Minist Hlth, Kigali, Rwanda; [Rosa, Ghislaine; Majorin, Fiona; Boisson, Sophie; Clasen, Thomas] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; [Clasen, Thomas] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA; [Thomas, Evan A.] Portland State Univ, Portland, OR 97207 USA	University of Colorado System; University of Colorado Boulder; University of London; London School of Hygiene & Tropical Medicine; Emory University; Rollins School Public Health; Portland State University	Thomas, EA (corresponding author), Portland State Univ, Portland, OR 97207 USA.	evan.thomas@pdx.edu		Majorin, Fiona/0000-0002-4697-2679; Thomas, Evan/0000-0003-3095-8407	DelAgua Health Limited; London School of Hygiene and Tropical Medicine	DelAgua Health Limited; London School of Hygiene and Tropical Medicine	All funding for this study was provided by DelAgua Health Limited www.delaguahealth.com) through a sponsored research grant to Portland State University and the London School of Hygiene and Tropical Medicine. The DelAgua Health Board and CEO had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All such responsibility was devolved to Author Thomas.	Aboud FE, 2012, SOC SCI MED, V75, P589, DOI 10.1016/j.socscimed.2012.04.009; Albert J, 2010, ENVIRON SCI TECHNOL, V44, P4426, DOI 10.1021/es1000566; [Anonymous], 1974, Health Education Monograph, V2, P324; *APR RES CTR, 2012, RES WAT BIOL TEST 41; Bensch G., 2012, RECIPE SUCCESS RANDO; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Boisson S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012613; BROWN J, 2012, PLOS ONE, DOI DOI 10.1371/J0URNAL.-P0NE.0036735; CLASEN T, 2007, BMJ, V334; Clasen T, 2009, AM J TROP MED HYG, V80, P819, DOI 10.4269/ajtmh.2009.80.819; ENGER KS, 2013, WATER RES, DOI DOI 10.1016/J.WA-TRES.2012.11.034; *EUR UN EN IN, 2009, BIOM EN STRAT BEST R, V3; Ezzati M, 2001, LANCET, V358, P619, DOI 10.1016/S0140-6736(01)05777-4; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; FIEBELKORN P, 2012, SOC SCI MED, DOI DOI 10.1016/J.S0CSCIMED.2012.02.011; Figueroa ME, 2010, CTR PUBLICATION HCI; Geary CW, 2012, FIELD ASSESSMENT ADO; Gundry S, 2004, J WATER HEALTH, V2, P1; Hunter PR, 2009, ENVIRON SCI TECHNOL, V43, P8991, DOI 10.1021/es9028217; *JAM POV ACT LAB, 2011, PRIC IS WRONG CHARG; Johnson MA, 2013, ENERGY SUSTAIN DEV, V17, P403, DOI 10.1016/j.esd.2013.04.004; Kirby M, 2013, WATER QUALITY UNPUB; KREMER M, 2008, INNOVATIONS POVERTY; Lewis JJ, 2012, ENVIRON HEALTH PERSP, V120, P637, DOI 10.1289/ehp.1104194; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Masera O, 2007, ENERGY SUSTAIN DEV, V11, P45, DOI DOI 10.1016/S0973-0826(08)60399-3; Masera OR, 2000, WORLD DEV, V28, P2083, DOI 10.1016/S0305-750X(00)00076-0; Narajo J, 2011, ASSESSMENT LIFESTRAW; Onda K, 2012, INT J ENV RES PUB HE, V9, P880, DOI 10.3390/ijerph9030880; PELETZ R, 2012, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0046548; REDMAN A, 2011, EHOS C 2011 KIRKL; *REP RWAND, 2011, RWAND DEM HLTH SURV; Roden CA, 2009, ATMOS ENVIRON, V43, P1170, DOI 10.1016/j.atmosenv.2008.05.041; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Rosa G, 2012, WATER QUALITY UNPUB; ROSA G, 2014, PLOS ONE IN PRESS; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Ruiz-Mercado I, 2011, ENERG POLICY, V39, P7557, DOI 10.1016/j.enpol.2011.03.028; *RWAND BUR STAND, 2011, 4352009 RS; Rwanda Ministry of Health, 2012, 3 HLTH SECT STRAT PL; *SHELL FDN, 2007, KITCH PERF TEST; Smith KR, 2000, THORAX, V55, P518, DOI 10.1136/thorax.55.6.518; Thomas E, 2012, LEVERAGING CARBON FI; Thomas EA, 2013, ENVIRON SCI TECHNOL, V47, P13602, DOI 10.1021/es403412x; *UN CLEAN DEV MECH, 2013, DELAGUA PUBL HLTH PR; UNICEF, 2015, COMMITTING CHILD SUR; WHO, 2011, EV HOUS WAT TREATM O; WHO(WorldHealthOrganization), 1997, GUID DRINK WAT QUAL; Williams M, 2013, ENVIRON LAW, V43, P517; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x	51	25	26	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92403	10.1371/journal.pone.0092403	http://dx.doi.org/10.1371/journal.pone.0092403			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676210	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000333677500021
J	Koslik, HJ; Hamilton, G; Golomb, BA				Koslik, Hayley J.; Hamilton, Gavin; Golomb, Beatrice A.			Mitochondrial Dysfunction in Gulf War Illness Revealed by 31Phosphorus Magnetic Resonance Spectroscopy: A Case-Control Study	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; OXIDATIVE STRESS; VETERANS; ASSOCIATION; SYMPTOMS; QUANTIFICATION; RECOVERY; EXERCISE; SPECTRA; BRAIN	Background: Approximately 1/3 of 1990-1 Gulf War veterans developed chronic multisymptom health problems. Implicated exposures bear mechanisms that adversely affect mitochondria. Symptoms emphasize fatigue, cognition and muscle (brain and muscle are aerobically demanding); with protean additional domains affected, compatible with mitochondrial impairment. Recent evidence supports treatments targeting cell bioenergetics (coenzyme10) to benefit Gulf War illness symptoms. However, no evidence has directly documented mitochondrial or bioenergetic impairment in Gulf War illness. Objective: We sought to objectively assess for mitochondrial dysfunction, examining post-exercise phosphocreatine-recovery time constant (PCr-R) using (31)Phosphorus Magnetic Resonance Spectroscopy (P-31-MRS), in Gulf War veterans with Gulf War illness compared to matched healthy controls. PCr-R has been described as a "robust and practical" index of mitochondrial status. Design and Participants: Case-control study from 2012-2013. Fourteen community-dwelling Gulf War veterans and matched controls from the San Diego area comprised 7 men meeting CDC and Kansas criteria for Gulf War illness, and 7 non-deployed healthy controls matched 1: 1 to cases on age, sex, and ethnicity. Outcome Measure: Calf muscle phosphocreatine was evaluated by P-31-MRS at rest, through 5 minutes of foot pedal depression exercise, and in recovery, to assess PCr-R. Paired t-tests compared cases to matched controls. Results: PCr-R was significantly prolonged in Gulf War illness cases vs their matched controls: control values, mean +/- SD, 29.0 +/- 8.7 seconds; case values 46.1 +/- 18.0 seconds; difference 17.1 +/- 14.9 seconds; p = 0.023. PCr-R was longer for cases relative to their matched controls for all but one pair; moreover while values clustered under 31 seconds for all but one control, they exceeded 35 seconds (with a spread up to 70 seconds) for all but one case. Discussion: These data provide the first direct evidence supporting mitochondrial dysfunction in Gulf War illness. Findings merit replication in a larger study and/or corroboration with additional mitochondrial assessment tools.	[Koslik, Hayley J.; Golomb, Beatrice A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Hamilton, Gavin] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Golomb, Beatrice A.] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Golomb, BA (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	bgolomb@ucsd.edu		Hamilton, Gavin/0000-0001-9302-5546	University of California, San Diego, Academic Senate Award [MED126M]; Department of Defense Congressionally Directed Medical Research Program [GW120071]	University of California, San Diego, Academic Senate Award; Department of Defense Congressionally Directed Medical Research Program(United States Department of Defense)	This study was funded by a University of California, San Diego, Academic Senate Award (MED126M) and the Department of Defense Congressionally Directed Medical Research Program (GW120071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouDonia MB, 1996, FUND APPL TOXICOL, V34, P201, DOI 10.1006/faat.1996.0190; Binns J., 2004, SCI PROGR UNDERSTAND; Binns JH, 2008, GULF WARE ILLNESS HL; Broderick G, 2013, BRAIN BEHAV IMMUN, V28, P159, DOI 10.1016/j.bbi.2012.11.007; Cecchine G., 2000, REV SCI LIT PERTAINS, V8; Chan JYH, 2006, NEUROPHARMACOLOGY, V51, P1109, DOI 10.1016/j.neuropharm.2006.06.024; Coffman CJ, 2005, NEUROEPIDEMIOLOGY, V24, P141, DOI 10.1159/000083297; Department of Defense, 2003, ENV EXP REP PEST; Fricker RD, 2000, MR101812OSD RAND, V12; General Accounting Office, 2004, GAO04159; Genova ML, 2004, ANN NY ACAD SCI, V1011, P86, DOI 10.1196/annals.1293.010; Gillert DJ, 1997, DOD SAYS 98910 EXPOS; GOLOMB B, 1999, REV SCI LIT PERTAINS, V2; Golomb B, 2012, OXIDATIVE STRESS MIT; Golomb BA, 2014, NEURAL COMP IN PRESS; Golomb BA, 2013, J CHILD NEUROL; Golomb BA, 2009, DRUG SAFETY, V32, P649, DOI 10.2165/00002018-200932080-00004; Golomb BA, 2008, P NATL ACAD SCI USA, V105, P4295, DOI 10.1073/pnas.0711986105; Haley RW, 2003, NEUROLOGY, V61, P750, DOI 10.1212/WNL.61.6.750; Hamilton G, 2006, J MAGN RESON IMAGING, V23, P459, DOI 10.1002/jmri.20524; Hamilton G, 2003, NMR BIOMED, V16, P168, DOI 10.1002/nbm.821; Horner RD, 2003, NEUROLOGY, V61, P742, DOI 10.1212/01.WNL.0000069922.32557.CA; Hotopf M, 2003, BRIT MED J, V327, P1370, DOI 10.1136/bmj.327.7428.1370; KEMP GJ, 1993, NMR BIOMED, V6, P66, DOI 10.1002/nbm.1940060111; Kroenke K, 1998, J OCCUP ENVIRON MED, V40, P520, DOI 10.1097/00043764-199806000-00004; Lee HC, 1997, J BIOMED SCI, V4, P319, DOI 10.1007/BF02258357; Milatovic D, 2006, THESCIENTIFICWORLDJO, V6, P295, DOI 10.1100/tsw.2006.38; MURPHY EJ, 1989, MAGNET RESON MED, V12, P282, DOI 10.1002/mrm.1910120218; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Ozakinci G, 2006, ENVIRON HEALTH PERSP, V114, P1553, DOI 10.1289/ehp.9251; Pena-Llopis S, 2003, DIS AQUAT ORGAN, V55, P237, DOI 10.3354/dao055237; Pena-Llopis S, 2003, AQUAT TOXICOL, V65, P337, DOI 10.1016/S0166-445X(03)00148-6; Rayhan RU, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058493, 10.1371/journal.pone.0063903]; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; THOMPSON CH, 1995, J APPL PHYSIOL, V78, P2131, DOI 10.1152/jappl.1995.78.6.2131; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Wei YH, 1998, P SOC EXP BIOL MED, V217, P53; Whistler T, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-12	38	59	61	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92887	10.1371/journal.pone.0092887	http://dx.doi.org/10.1371/journal.pone.0092887			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675771	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677500050
J	Lorent, N; Choun, K; Thai, S; Kim, T; Huy, S; Pe, R; van Griensven, J; Buyze, J; Colebunders, R; Rigouts, L; Lynen, L				Lorent, Natalie; Choun, Kimcheng; Thai, Sopheak; Kim, Tharin; Huy, Sopheaktra; Pe, Reaksmey; van Griensven, Johan; Buyze, Jozefien; Colebunders, Robert; Rigouts, Leen; Lynen, Lutgarde			Community-Based Active Tuberculosis Case Finding in Poor Urban Settlements of Phnom Penh, Cambodia: A Feasible and Effective Strategy	PLOS ONE			English	Article							TREATMENT SUCCESS; DIAGNOSIS; TB	Background: In light of the limitations of the current case finding strategies and the global urgency to improve tuberculosis (TB) case-detection, a renewed interest in active case finding (ACF) has risen. The WHO calls for more evidence on innovative ways of TB screening, especially from low-income countries, to inform global guideline development. We aimed to assess the feasibility of community-based ACF for TB among the urban poor in Cambodia and determine its impact on case detection, treatment uptake and outcome. Methods: Between 9/2/2012-31/3/2013 the Sihanouk Hospital Center of HOPE conducted a door-to-door survey for TB in deprived communities of Phnom Penh. TB workers and community health volunteers performed symptom screening, collected sputum and facilitated specimen transport to the laboratories. Fluorescence microscopy was introduced at three referral hospitals. The GeneXpert MTB/RIF assay (Xpert) was performed at tertiary level for individuals at increased risk of HIV-associated, drug-resistant or smear-negative TB. Mobile phone/short message system (SMS) was used for same-day issuing of positive results. TB workers contacted diagnosed patients and referred them for care at their local health centre. Results: In 14 months, we screened 315.874 individuals; we identified 12.201 aged >= 15 years with symptoms suggestive of TB; 84% provided sputum. We diagnosed 783, including 737 bacteriologically confirmed, TB cases. Xpert testing yielded 41% and 48% additional diagnoses among presumptive HIV-associated and multidrug-resistant TB cases, respectively. The median time from sputum collection to notification (by SMS) of the first positive (microscopy or Xpert) result was 3 days (IQR 2-6). Over 94% commenced TB treatment and 81% successfully completed it. Conclusion: Our findings suggest that among the urban poor ACF for TB, using a sensitive symptom screen followed by smear-microscopy and targeted Xpert, contributed to improved case detection of drug-susceptible and drug-resistant TB, shortening the diagnostic delay, and successfully bringing patients into care.	[Lorent, Natalie; Choun, Kimcheng; Thai, Sopheak; Huy, Sopheaktra; Pe, Reaksmey; van Griensven, Johan] Sihanouk Hosp, Ctr HOPE, Dept Infect Dis, Phnom Penh, Cambodia; [Kim, Tharin] Sihanouk Hosp, Ctr HOPE, Mycobacteriol Lab, Phnom Penh, Cambodia; [Rigouts, Leen] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium; [Lorent, Natalie; van Griensven, Johan; Buyze, Jozefien; Colebunders, Robert; Lynen, Lutgarde] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Colebunders, Robert] Univ Antwerp, B-2020 Antwerp, Belgium; [Rigouts, Leen] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); University of Antwerp; University of Antwerp	Lorent, N (corresponding author), Sihanouk Hosp, Ctr HOPE, Dept Infect Dis, Phnom Penh, Cambodia.	nlorent@itg.be	Lynen, Lutgarde/AAT-9180-2020; Lynen, Lutgarde/A-1212-2014; Buyze, Jozefien/B-8550-2014	Lynen, Lutgarde/0000-0001-7183-4895; Lynen, Lutgarde/0000-0001-7183-4895; Buyze, Jozefien/0000-0001-6780-380X; Colebunders, Robert/0000-0002-1919-1340	TB REACH Initiative (wave 2) of the Stop TB partnership [T9-370-114CAM]; Directorate General for Development Cooperation, Belgium, through the Institute of Tropical Medicine, Belgium [FA3/II 2.08]; Research Foundation - Flanders [G.0322.10]	TB REACH Initiative (wave 2) of the Stop TB partnership; Directorate General for Development Cooperation, Belgium, through the Institute of Tropical Medicine, Belgium; Research Foundation - Flanders(FWO)	The study was funded by the TB REACH Initiative (wave 2) of the Stop TB partnership, grant number: T9-370-114CAM (http://www.stoptb.org/global/awards/tbreach/wave2.asp); the Directorate General for Development Cooperation, Belgium, through the Institute of Tropical Medicine, Belgium, grant number: FA3/II 2.08 (http://diplomatie.belgium.be/en/policy/development_cooperation/partnerships/non_governmental/scientific_cooperation/); and the Research Foundation - Flanders, programme grant G.0322.10 (http://www.fwo.be/Default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Darraji HAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073717; Ayles H, 2013, LANCET; Chadha VK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042625; Claassens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058689; Cobelens F, 2012, J INFECT DIS, V205, pS191, DOI 10.1093/infdis/jis188; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; Den Boon S, 2008, EPIDEMIOL INFECT, V136, P1342, DOI 10.1017/S0950268807000106; Dorman SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043307; Dowdy DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070485; Dowdy DW, 2012, P NATL ACAD SCI USA, V109, P9557, DOI 10.1073/pnas.1203517109; Eang MT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-469; Getahun H, 2010, LANCET, V376, P1205, DOI 10.1016/S0140-6736(10)61503-6; Golub JE, 2013, INT J TUBERC LUNG D, V17, P856, DOI 10.5588/ijtld.13.0059; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Hossain S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044980; Khan MS, 2007, LANCET, V369, P1955, DOI 10.1016/S0140-6736(07)60916-7; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Kranzer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001281; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Long Q, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-202; McCord GC, 2013, B WORLD HEALTH ORGAN, V91, P244, DOI 10.2471/BLT.12.109660; Miller AC, 2010, INT J TUBERC LUNG D, V14, P720; National Centre for Tuberculosis and Leprosy Control C Ministry of Health, 2013, SECOND NATIONAL TUBE; National Institute of Statistics DGfHaIM2, 2013, CAMBODIA DEMOGRAPHIC; National Tuberculosis and Leprosy Control Programme C, 2012, NATIONAL REPORT ON T; National Tuberculosis and Leprosy Control Programme C, 2013, NATIONAL REPORT ON T; National Tuberculosis and leprosy Programme C, 2011, NATIONAL REPORT ON T; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Ntinginya EN, 2012, INT J TUBERC LUNG D, V16, P1468, DOI 10.5588/ijtld.12.0127; Obermeyer Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001721; Raviglione M, 2013, LANCET; Santha T, 2003, INT J TUBERC LUNG D, V7, P258; Schuurman MWE, 1996, TUBERCLE LUNG DIS, V77, P549, DOI 10.1016/S0962-8479(96)90054-4; Sekandi JN, 2009, INT J TUBERC LUNG D, V13, P508; Shapiro AE, 2012, AM J RESP CRIT CARE, V185, P1110, DOI 10.1164/rccm.201111-1941OC; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2011, TECHNICAL AND OPERAT; WHO, 2010, TREATMENT FOR TUBERC; WHO, 2013, PRINCIPLES AND RECOM; Williams Virginia, 2013, Int J Tuberc Lung Dis, V17, P1, DOI 10.5588/ijtld.13.0447; World Health Organization, 2013, DEFINITIONS REPORTIN; Yassin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063174; Zachariah R, 2012, INT J TUBERC LUNG D, V16, P714, DOI 10.5588/ijtld.11.0635	47	71	71	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92754	10.1371/journal.pone.0092754	http://dx.doi.org/10.1371/journal.pone.0092754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675985	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677500036
J	Hermes, R; Goritz, F; Saragusty, J; Stoops, MA; Hildebrandt, TB				Hermes, Robert; Goeritz, Frank; Saragusty, Joseph; Stoops, Monica A.; Hildebrandt, Thomas B.			Reproductive Tract Tumours: The Scourge of Woman Reproduction Ails Indian Rhinoceroses	PLOS ONE			English	Article							ARTIFICIAL-INSEMINATION; UTERINE LEIOMYOMA; FIBROIDS; PREGNANCY; WOMEN; SIMUM; ULTRASONOGRAPHY; EMBOLIZATION	In Indian rhinoceros, extensive leiomyoma, a benign smooth muscle tumour, was sporadically diagnosed post mortem and commonly thought of as contributing factor for reduced fecundity of this species in captivity. However, to date, the prevalence of reproductive tract tumours and their relevance for fecundity are unknown. Our analysis of the international studbook now reveals that females cease reproducing at the age of 18.1 +/- 1.2 years; equivalent to a reproductive lifespan of just 9.5 +/- 1.3 years. This short reproductive life is in sharp contrast to their longevity in captivity of over 40 years. Here we show, after examining 42% of the captive female population, that age-related genital tract tumours are highly prevalent in this endangered species. Growth and development of these tumours was found to be age-related, starting from the age of 10 years. All females older than 12 years had developed genital tumours, just 7-9 years past maturity. Tumour sizes ranged from 1.5-10 cm. With age, tumours became more numerous, sometimes merging into one large diffuse tumour mass. These tumours, primarily vaginal and cervical, presumably cause widespread young-age infertility by the age of 18 years. In few cases, tumour necrosis suggested possible malignancy of tumours. Possible consequences of such genital tract tumour infestation are hindered intromission, pain during mating, hampered sperm passage, risk of ascending infection during pregnancy, dystocia, or chronic vaginal bleeding. In humans, leiomyoma affect up to 80% of pre-menopause women. While a leading cause for infertility, pregnancy is known to reduce the risk of tumour development. However, different from human, surgical intervention is not a viable treatment option in rhinoceroses. Thus, in analogy to humans, we suggest early onset and seamless consecutive pregnancies to help reduce prevalence of this disease, better maintain a self-sustained captive population and improve animal welfare.	[Hermes, Robert; Goeritz, Frank; Saragusty, Joseph; Hildebrandt, Thomas B.] Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany; [Stoops, Monica A.] Cincinnati Zoo & Bot Garden, Ctr Conservat & Res Endangered Wildlife, Cincinnati, OH USA	Leibniz Institut fur Zoo und Wildtierforschung	Hermes, R (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany.	hermes@izw-berlin.de	Saragusty, Joseph/M-5030-2016	Saragusty, Joseph/0000-0002-9274-7800				Aballi Neninger OL, 2002, ANN C AM ASS ZOO VET, P428; Aupperle H, 2008, J ZOO WILDLIFE MED, V39, P107, DOI 10.1638/2006-0045.1; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Burek KA, 2000, ANN C AM ASS ZOO VET, P468; Burns R., 2006, P AM ASS ZOO VET, P154; Cook H, 2010, Minerva Ginecol, V62, P225; Cooper NP, 2005, OBSTET GYNECOL SURV, V60, P132, DOI 10.1097/01.ogx.0000154688.02423.68; CRAMER SF, 1990, AM J CLIN PATHOL, V94, P435, DOI 10.1093/ajcp/94.4.435; Dejuste de Paula C, 2002, ANN C AM ASS ZOO VET, P435; Dinerstein E., 2003, RETURN UNICORNS NATU; Foose Thomas J., 1997, pi; Ford E.W., 1986, American Association of Zoo Veterinarians Annual Proceedings, V1986, P155; Galateanu G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068493; Gamble KC, 2004, ANN C AM ASS ZOO VET, P561; Goldberg J, 2006, CURR OPIN OBSTET GYN, V18, P402, DOI 10.1097/01.gco.0000233934.13684.cb; Goltenboth R., 1995, P209; Guldenschuh G, 2002, HUSBANDRY MANUAL GRE; Hermes R, 2006, THERIOGENOLOGY, V65, P1492, DOI 10.1016/j.theriogenology.2005.09.002; Hermes R, 2004, ANIM REPROD SCI, V82-3, P49, DOI 10.1016/j.anireprosci.2004.05.015; Hermes R, 2009, THERIOGENOLOGY, V72, P959, DOI 10.1016/j.theriogenology.2009.06.014; Hermes Robert, 2012, P546; Hernandez-Lopez L, 2007, THERIOGENOLOGY, V67, P399, DOI 10.1016/j.theriogenology.2006.06.016; Hildebrandt TB, 2007, THERIOGENOLOGY, V67, P1473, DOI 10.1016/j.theriogenology.2007.03.005; Hildebrandt TB, 2000, ZOO BIOL, V19, P321, DOI 10.1002/1098-2361(2000)19:5&lt;321::AID-ZOO4&gt;3.0.CO;2-K; Hlavacek G, 2002, INT STUDBOOK GREATER; IUCN, 2013, AFR RHIN WONT HOLD O; JONES ML, 1977, ZOO ANVERS, V42, P124; King NW, 1973, UTERUS, P548; Klein LV, 1997, ANN C AM ASS ZOO VET, P127; Kroon B, 2011, AUST NZ J OBSTET GYN, V51, P289, DOI 10.1111/j.1479-828X.2011.01300.x; Lueders I, 2010, REPROD FERT DEVELOP, V22, P1159, DOI 10.1071/RD09305; Mikaelian I, 2000, J VET DIAGN INVEST, V12, P371, DOI 10.1177/104063870001200414; Montali RJ, 1982, INT S ERKRANKUNGEN Z, V24, P117; Montali RJ, 1997, INT S ERKRANKUNGEN Z, P253; MYLNICZENKO ND, 2008, P AM ASS ZOO VET, P149; Okolo S, 2008, BEST PRACT RES CL OB, V22, P571, DOI 10.1016/j.bpobgyn.2008.04.002; Owston MA, 2005, ANN C AM ASS ZOO VET, P100; Parazzini F, 1996, EPIDEMIOLOGY, V7, P440, DOI 10.1097/00001648-199607000-00018; PARAZZINI F, 1988, OBSTET GYNECOL, V72, P853, DOI 10.1097/00006250-198812000-00008; Pashov BN, 1990, ANN C AM ASS ZOO VET, P53; Rachlow JL, 1998, ANIM CONSERV, V1, P101, DOI 10.1111/j.1469-1795.1998.tb00017.x; Radcliffe RM, 2000, J ZOO WILDLIFE MED, V31, P201, DOI 10.1638/1042-7260(2000)031[0201:SLGUBI]2.0.CO;2; Radcliffe Robin W., 2007, P543, DOI 10.1002/9780470376478.ch48; Roberts J., 1986, American Association of Zoo Veterinarians Annual Proceedings, V1986, P173; Sabry M, 2012, REPROD SCI, V19, P339, DOI 10.1177/1933719111432867; Sapundzhiev E, 2007, J VET MED A, V54, P499, DOI 10.1111/j.1439-0442.2007.00949.x; Schaffer N.E. M., 2001, INT EL RHIN RES S 7; SCHAFFER NE, 1994, J ZOO WILDLIFE MED, V25, P337; Steck B, 2012, EUR ASS ZOOS AQ ANN; Steck B, 2010, EUR ASS ZOOS AQ ANN; Stoops MA, 2004, REPRODUCTION, V128, P843, DOI 10.1530/rep.1.00328; Viswanathan Meera, 2007, Evid Rep Technol Assess (Full Rep), P1; von Houwald F, 2012, GREATER ONE HORNED I; von Houwald FF, 2001, FOOT PROBLEMS INDIAN; Walker WJ, 2002, BJOG-INT J OBSTET GY, V109, P1262, DOI 10.1046/j.1471-0528.2002.01449.x; Wilson M, 2010, J ZOO WILDLIFE MED, V41, P111, DOI 10.1638/2009-0128.1; World Health Organization, 2003, TUMOURS BREAST FEMAL; WWF, 2010, JAV RHIN FOUND DEAD; Young LA, 1996, J ZOO WILDLIFE MED, V27, P96; Zimmermann A, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-6; Zschokke Samuel, 1998, IZN (International Zoo News), V45, P261	61	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92595	10.1371/journal.pone.0092595	http://dx.doi.org/10.1371/journal.pone.0092595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671211	Green Published, gold			2022-12-27	WOS:000333677000057
J	Magnhagen, C; Wacker, S; Forsgren, E; Myhre, LC; Espy, E; Amundsen, T				Magnhagen, Carin; Wacker, Sebastian; Forsgren, Elisabet; Myhre, Lise Cats; Espy, Elizabeth; Amundsen, Trond			Context Consistency and Seasonal Variation in Boldness of Male Two-Spotted Gobies	PLOS ONE			English	Article							STICKLEBACKS GASTEROSTEUS-ACULEATUS; GOBIUSCULUS-FLAVESCENS FABRICIUS; FALSE DISCOVERY RATE; ANIMAL PERSONALITY; PREDATION RISK; POECILIA-RETICULATA; PUMPKINSEED SUNFISH; BEHAVIORAL SYNDROME; NATURAL-SELECTION; TRADE-OFF	In order to attribute the behaviour of an animal to its personality it is important to study whether certain behavioural traits show up consistently across a variety of contexts. The aim of this study was to investigate whether breeding state males of the two-spotted goby, Gobiusculus flavescens, showed consistent degree of boldness when tested in four different behaviour assays. We also wanted to investigate whether boldness varied over the breeding season in accordance with changes in male-male competition for matings. We used two standard assays (the emergence test and the open field test), and two simple assays related to threat response. Repeated runs of each of the tests were highly correlated, and we found significant correlations between all four assays. Thus, we have documented both a within and a between-context consistency in risk-taking behaviour. Furthermore, we found that goby males studied during the middle of the breeding season were bolder than males studied at the end of the season. Since male two-spotted gobies face strongly decreasing male-male competition as the season progresses, the benefit of being bold for the mating success of the males may differ over the time of the breeding season. The difference in behaviour found over the season thus corresponds well with the sexual dynamics of this model species.	[Magnhagen, Carin] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden; [Wacker, Sebastian; Myhre, Lise Cats; Espy, Elizabeth; Amundsen, Trond] Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway; [Forsgren, Elisabet] Norwegian Inst Nat Res NINA, Trondheim, Norway	Swedish University of Agricultural Sciences; Norwegian University of Science & Technology (NTNU); Norwegian Institute Nature Research	Magnhagen, C (corresponding author), Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden.	carin.magnhagen@slu.se	Magnhagen, Carin/ABA-4968-2021	Amundsen, Trond/0000-0003-4261-0555	Royal Swedish Academy of Science, ASSEMBLE [227799]; Nordic Marine Academy; German Academic Exchange Service (DAAD)	Royal Swedish Academy of Science, ASSEMBLE; Nordic Marine Academy; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The study was financially supported by the Royal Swedish Academy of Science, ASSEMBLE (grant agreement no. 227799), Nordic Marine Academy (grants to LCM and SW), and the German Academic Exchange Service (DAAD; grant to SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens B, 2013, ECOL LETT, V16, P47, DOI 10.1111/ele.12011; Amundsen T, 2001, P NATL ACAD SCI USA, V98, P13155, DOI 10.1073/pnas.211439298; Beckmann C, 2013, ETHOLOGY, V119, P937, DOI 10.1111/eth.12137; Bell AM, 2012, BEHAVIOUR, V149, P1339, DOI 10.1163/1568539X-00003019; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjelvenmark J, 2003, BEHAVIOUR, V140, P55, DOI 10.1163/156853903763999890; Brown C, 2004, ANIM BEHAV, V68, P1325, DOI 10.1016/j.anbehav.2004.04.004; Brown C, 2007, BEHAV ECOL SOCIOBIOL, V62, P237, DOI 10.1007/s00265-007-0458-3; Burns JG, 2008, J COMP PSYCHOL, V122, P344, DOI 10.1037/0735-7036.122.4.344; Candolin U, 1998, P ROY SOC B-BIOL SCI, V265, P1171, DOI 10.1098/rspb.1998.0415; Carter AJ, 2013, BIOL REV, V88, P465, DOI 10.1111/brv.12007; Carter AJ, 2012, ANIM BEHAV, V83, P1051, DOI 10.1016/j.anbehav.2012.01.033; Castanheira MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062037; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Dammhahn M, 2012, P ROY SOC B-BIOL SCI, V279, P2645, DOI 10.1098/rspb.2012.0212; De Jong K., 2011, THESIS NORWEGIAN U S; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Dingemanse NJ, 2003, P ROY SOC B-BIOL SCI, V270, P741, DOI 10.1098/rspb.2002.2300; Forsgren E, 2004, NATURE, V429, P551, DOI 10.1038/nature02562; Garamszegi LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002647; Godin JGJ, 1996, P NATL ACAD SCI USA, V93, P10262, DOI 10.1073/pnas.93.19.10262; GORDON JCD, 1983, OPHELIA, V22, P173, DOI 10.1080/00785326.1983.10426593; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; King AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081116; Kortet R, 2007, EVOL ECOL RES, V9, P185; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; MAGNHAGEN C, 1991, BEHAV ECOL, V2, P351, DOI 10.1093/beheco/2.4.351; Miller KA, 2006, ANIM BEHAV, V71, P1323, DOI 10.1016/j.anbehav.2005.08.018; Mobley KB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-6; Montiglio PO, 2012, ANIM BEHAV, V84, P1071, DOI 10.1016/j.anbehav.2012.08.010; Myhre LC, 2012, AM NAT, V179, P741, DOI 10.1086/665651; Nicolaus M, 2012, P ROY SOC B-BIOL SCI, V279, P4885, DOI 10.1098/rspb.2012.1936; Nyqvist MJ, 2013, ETHOLOGY, V119, P156, DOI 10.1111/eth.12049; Oosten JE, 2010, BEHAV ECOL SOCIOBIOL, V64, P793, DOI 10.1007/s00265-009-0896-1; Pelabon C, 2003, BEHAV ECOL, V14, P787, DOI 10.1093/beheco/arg074; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; SALVANES AGV, 1993, SARSIA, V78, P221, DOI 10.1080/00364827.1993.10413536; Schuett W, 2011, ETHOLOGY, V117, P908, DOI 10.1111/j.1439-0310.2011.01945.x; Schuett W, 2010, BIOL REV, V85, P217, DOI 10.1111/j.1469-185X.2009.00101.x; Skolbekken R, 2001, J EXP MAR BIOL ECOL, V261, P137, DOI 10.1016/S0022-0981(01)00249-0; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Stamps JA, 2012, ANIM BEHAV, V83, P1325, DOI 10.1016/j.anbehav.2012.02.017; UTNE ACW, 1993, J EXP MAR BIOL ECOL, V166, P203, DOI 10.1016/0022-0981(93)90219-E; Waite TA, 2006, ECOSCIENCE, V13, P439, DOI 10.2980/1195-6860(2006)13[439:CTFDRA]2.0.CO;2; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; Wheeler A.C., 1969, FISHES BRIT ISLES N; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilson AJW, 2005, MARINERS MIRROR, V91, P111; WILSON DS, 1993, J COMP PSYCHOL, V107, P250, DOI 10.1037/0735-7036.107.3.250; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wolf M, 2008, P NATL ACAD SCI USA, V105, P15825, DOI 10.1073/pnas.0805473105; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835	54	11	11	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93354	10.1371/journal.pone.0093354	http://dx.doi.org/10.1371/journal.pone.0093354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671255	gold, Green Published			2022-12-27	WOS:000333677000135
J	Zhu, YJ; Bu, QX; Liu, XY; Hu, WH; Wang, YY				Zhu, Yuanjun; Bu, Qixin; Liu, Xiaoyan; Hu, Wenhui; Wang, Yinye			Neuroprotective Effect of TAT-14-3-3 epsilon Fusion Protein against Cerebral Ischemia/Reperfusion Injury in Rats	PLOS ONE			English	Article							ISCHEMIC BRAIN-INJURY; TRANSDUCED TAT-DJ-1 PROTEIN; TAT-MEDIATED DELIVERY; CELL-DEATH; REPERFUSION INJURY; FUTURE PERSPECTIVES; OXIDATIVE STRESS; NEURON DEATH; AUTOPHAGY; STROKE	Stroke is the major cause of death and disability worldwide, and the thrombolytic therapy currently available was unsatisfactory. 14-3-3 epsilon is a well characterized member of 14-3-3 family, and has been reported to protect neurons against apoptosis in cerebral ischemia. However, it cannot transverse blood brain barrier (BBB) due to its large size. A protein transduction domain (PTD) of HIV TAT protein, is capable of delivering a large variety of proteins into the brain. In this study, we generated a fusion protein TAT-14-3-3 epsilon, and evaluated its potential neuroprotective effect in rat focal ischemia/reperfusion (I/R) model. Western blot analysis validated the efficient transduction of TAT-14-3-3 epsilon fusion protein into brain via a route of intravenous injection. TAT-14-3-3 epsilon pre-treatment 2 h before ischemia significantly reduced cerebral infarction volume and improved neurologic score, while post-treatment 2 h after ischemia was less effective. Importantly, pre- or post-ischemic treatment with TAT-14-3-3 epsilon significantly increased the number of surviving neurons as determined by Nissl staining, and attenuated I/R-induced neuronal apoptosis as showed by the decrease in apoptotic cell numbers and the inhibition of caspase-3 activity. Moreover, the introduction of 14-3-3 epsilon into brain by TAT-mediated delivering reduced the formation of autophagosome, attenuated LC3B-II upregulation and reversed p62 downregulation induced by ischemic injury. Such inhibition of autophagy was reversed by treatment with an autophagy inducer rapamycin (RAP), which also attenuated the neuroprotective effect of TAT-14-3-3 epsilon. Conversely, autophagy inhibitor 3-methyladenine (3-MA) inhibited I/R-induced the increase in autophagic activity, and attenuated I/R-induced brain infarct. These results suggest that TAT-14-3-3 epsilon can be efficiently transduced into brain and exert significantly protective effect against brain ischemic injury through inhibiting neuronal apoptosis and autophagic activation.	[Zhu, Yuanjun; Bu, Qixin; Liu, Xiaoyan; Wang, Yinye] Peking Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Beijing 100871, Peoples R China; [Hu, Wenhui] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA	Peking University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Wang, YY (corresponding author), Peking Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Beijing 100871, Peoples R China.	wangyinye@bjmu.edu.cn			Natural Science Foundation of China [61071002, 81302763]; Beijing Natural Science Foundation [7144218]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the Natural Science Foundation of China (61071002 and 81302763) and Beijing Natural Science Foundation (7144218). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami F, 2007, AUTOPHAGY, V3, P42, DOI 10.4161/auto.3412; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Asoh S, 2008, ADV DRUG DELIVER REV, V60, P499, DOI 10.1016/j.addr.2007.09.011; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Cai B, 2011, EXP NEUROL, V227, P224, DOI 10.1016/j.expneurol.2010.11.009; Cao GD, 2002, J NEUROSCI, V22, P5423; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Chen RL, 2010, NAT REV NEUROL, V6, P256, DOI 10.1038/nrneurol.2010.36; Denicourt C, 2003, TRENDS PHARMACOL SCI, V24, P216, DOI 10.1016/S0165-6147(03)00074-9; Doeppner TR, 2010, NEUROBIOL DIS, V40, P265, DOI 10.1016/j.nbd.2010.05.033; Duncan PW, 2005, STROKE, V36, pE100, DOI 10.1161/01.STR.0000180861.54180.FF; Fujimura M, 1999, J NEUROSCI, V19, P3414; Gao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046092; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Gou XC, 2011, J DRUG TARGET, V19, P86, DOI 10.3109/10611861003733961; Grotta J, 2007, SURG NEUROL, V68, pS12, DOI 10.1016/j.surneu.2007.07.079; Guegan C, 2006, NEUROBIOL DIS, V22, P177, DOI 10.1016/j.nbd.2005.10.014; Hartmann A, 2000, P NATL ACAD SCI USA, V97, P2875, DOI 10.1073/pnas.040556597; Hata R, 1999, METAB BRAIN DIS, V14, P117, DOI 10.1023/A:1020709814456; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Hu XM, 2006, J PROTEOME RES, V5, P2396, DOI 10.1021/pr060209x; Hu ZY, 2013, BRAIN RES, V1491, P204, DOI 10.1016/j.brainres.2012.11.004; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Jeong HJ, 2012, EXP MOL MED, V44, P586, DOI 10.3858/emm.2012.44.10.067; Jeong HJ, 2012, MOL CELLS, V33, P471, DOI 10.1007/s10059-012-2255-8; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kilic E, 2006, FRONT BIOSCI-LANDMRK, V11, P1716, DOI 10.2741/1917; Kilic U, 2003, STROKE, V34, P1304, DOI 10.1161/01.STR.0000066869.45310.50; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Lai Y, 2005, J NEUROCHEM, V94, P360, DOI 10.1111/j.1471-4159.2005.03212.x; Li WL, 2013, NEUROSCIENCE; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Love S, 2000, NEUROPATH APPL NEURO, V26, P55, DOI 10.1046/j.1365-2990.2000.00218.x; Love S, 2003, PROG NEURO-PSYCHOPH, V27, P267, DOI 10.1016/S0278-5846(03)00022-8; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Minnerup J, 2012, INT J MOL SCI, V13, P11753, DOI 10.3390/ijms130911753; Misra A, 2003, J PHARM PHARM SCI, V6, P252; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Nijboer CH, 2008, STROKE, V39, P2578, DOI 10.1161/STROKEAHA.108.516401; Pan J, 2007, NEURORADIOLOGY, V49, P93, DOI 10.1007/s00234-006-0183-z; Parsadanian AS, 1998, J NEUROSCI, V18, P1009; Pozuelo-Rubio M, 2011, AUTOPHAGY, V7, P240, DOI 10.4161/auto.7.2.14286; Qin AP, 2010, AUTOPHAGY, V6, P738, DOI 10.4161/auto.6.6.12573; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Rojas JI, 2007, EUR J NEUROL, V14, P895, DOI 10.1111/j.1468-1331.2007.01841.x; Rosenquist M, 2003, BRAZ J MED BIOL RES, V36, P403, DOI 10.1590/S0100-879X2003000400001; Sairanen T, 2006, BRAIN, V129, P189, DOI 10.1093/brain/awh645; Schulz JB, 1999, ANN NEUROL, V45, P421, DOI 10.1002/1531-8249(199904)45:4<421::AID-ANA2>3.0.CO;2-Q; Sheng R, 2010, AUTOPHAGY, V6, P482, DOI 10.4161/auto.6.4.11737; Shi RY, 2012, CNS NEUROSCI THER, V18, P250, DOI 10.1111/j.1755-5949.2012.00295.x; Smrcka M, 2003, PHYSIOL RES, V52, P117; Soane L, 2005, J NEUROCHEM, V95, P230, DOI 10.1111/j.1471-4159.2005.03359.x; Steinacker P, 2011, SEMIN CELL DEV BIOL, V22, P696, DOI 10.1016/j.semcdb.2011.08.005; Sugawara Taku, 2004, NeuroRx, V1, P17, DOI 10.1602/neurorx.1.1.17; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; van der Kooij MA, 2010, NEUROBIOL DIS, V38, P266, DOI 10.1016/j.nbd.2010.01.016; Wang JY, 2011, J NEUROPATH EXP NEUR, V70, P314, DOI 10.1097/NEN.0b013e31821352bd; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048247; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Won J, 2003, J BIOL CHEM, V278, P19347, DOI 10.1074/jbc.M213098200; Wu JS, 2009, CIRCULATION, V119, P1124, DOI 10.1161/CIRCULATIONAHA.108.812537; Xu F, 2012, NEUROSCI BULL, V28, P658, DOI 10.1007/s12264-012-1268-9; Ye NH, 2011, LIFE SCI, V89, P868, DOI 10.1016/j.lfs.2011.09.015; Yin W, 2006, NEUROBIOL DIS, V21, P358, DOI 10.1016/j.nbd.2005.07.015; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhong JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039378	70	37	41	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93334	10.1371/journal.pone.0093334	http://dx.doi.org/10.1371/journal.pone.0093334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671253	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677000134
J	Chatterjee, P; Bhattacharyya, M; Bandyopadhyay, S; Roy, D				Chatterjee, Paulami; Bhattacharyya, Malay; Bandyopadhyay, Sanghamitra; Roy, Debjani			Studying the System-Level Involvement of MicroRNAs in Parkinson's Disease	PLOS ONE			English	Article							THERAPEUTIC TARGET; EXPRESSION PROFILE; PANCREATIC-CANCER; MIRNA-200 FAMILY; CELL INVASION; NETWORK; GENES; TOOL; IDENTIFICATION; MOLECULES	Background : Parkinson's Disease (PD) is a progressive neurologic disorder that affects movement and balance. Recent studies have revealed the importance of microRNA (miR) in PD. However, the detailed role of miR and its regulation by Transcription Factor (TF) remain unexplored. In this work for the first time we have studied TF-miR-mRNA regulatory network as well as miR co-expression network in PD. Result: We compared the 204 differentially expressed miRs from microarray data with 73 PD related miRs obtained from literature, Human MicroRNA Disease Database and found a significant overlap of 47 PD related miRs ( p-value, 0.05). Functional enrichment analyses of these 47 common (Group1) miRs and the remaining 157 (Group2) miRs revealed similar kinds of over-representative GO Biological Processes and KEGG pathways. This strengthens the possibility that some of the Group 2 miRs can have functional roles in PD progression, hitherto unidentified in any study. In order to explore the cross talk between TF, miR and target mRNA, regulatory networks were constructed. Study of these networks resulted in 14 InterRegulatory hub miRs whereas miR co-expression network revealed 18 co-expressed hub miRs. Of these 32 hub miRs, 23 miRs were previously unidentified with respect to their association with PD. Hierarchical clustering analysis further strengthens the roles of these novel miRs in different PD pathways. Furthermore hsa-miR-92a appeared as novel hub miR in both regulatory and co-expression network indicating its strong functional role in PD. High conservation patterns were observed for most of these 23 novel hub miRs across different species including human. Thus these 23 novel hub miRs can be considered as potential biomarkers for PD. Conclusion: Our study identified 23 novel miR markers which can open up new avenues for future studies and shed lights on potential therapeutic targets for PD.	[Chatterjee, Paulami; Roy, Debjani] Bose Inst, Dept Biophys, Kolkata, India; [Bhattacharyya, Malay] Univ Kalyani, Dept CSE, Kalyani 741235, W Bengal, India; [Bandyopadhyay, Sanghamitra] Indian Stat Inst, Machine Intelligence Unit, Kolkata, India	Department of Science & Technology (India); Bose Institute; Kalyani University; Indian Statistical Institute; Indian Statistical Institute Kolkata	Roy, D (corresponding author), Bose Inst, Dept Biophys, Acharya JC Bose Centenary Bldg, Kolkata, India.	drdebjani@yahoo.com	Bandyopadhyay, Sanghamitra/AAP-4578-2020; Bhattacharyya, Malay/AAF-5036-2020; Bandyopadhyay, Sanghamitra/AAO-7010-2020; Bandyopadhyay, Sanghamitra/A-6597-2010	Bandyopadhyay, Sanghamitra/0000-0001-6370-2083; Bhattacharyya, Malay/0000-0001-7781-1264; Chatterjee, Paulami/0000-0002-2204-5459	Department of Biophysics, Bose Institute, Kalyani University; Indian Statistical Institute (ISI)	Department of Biophysics, Bose Institute, Kalyani University; Indian Statistical Institute (ISI)	The authors would like to thank the Department of Biophysics, Bose Institute, Kalyani University and the Indian Statistical Institute (ISI) for their co-operation and support.	Ab Mutalib NS, 2011, INT J MOL MED, V28, P327, DOI 10.3892/ijmm.2011.714; Abe M, 2013, TRENDS CELL BIOL, V23, P30, DOI 10.1016/j.tcb.2012.08.013; Aguda BD, 2013, ADV EXP MED BIOL, V774, P149, DOI 10.1007/978-94-007-5590-1_9; Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Artzi S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-39; Bandyopadhyay S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-163; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bockmeyer CL, 2012, J HEART LUNG TRANSPL, V31, P764, DOI 10.1016/j.healun.2012.03.010; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Chen ZL, 2014, GENE, V533, P456, DOI 10.1016/j.gene.2013.09.067; Chiang YP, 2012, PATHOL ONCOL RES, V18, P585, DOI 10.1007/s12253-011-9480-x; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Delfino KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058608; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Du ZW, 2013, DEVELOPMENT, V140, P2611, DOI 10.1242/dev.092809; Esposito E, 2010, CURR MED CHEM, V17, P2764, DOI 10.2174/092986710791859324; Fitzgerald JC, 2008, FEBS J, V275, P5758, DOI 10.1111/j.1742-4658.2008.06708.x; FOWLKES EB, 1983, J AM STAT ASSOC, V78, P553, DOI 10.2307/2288117; Gaughwin PM, 2011, HUM MOL GENET, V20, P2225, DOI 10.1093/hmg/ddr111; Goh KI, 2002, P NATL ACAD SCI USA, V99, P12583, DOI 10.1073/pnas.202301299; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Gubian S, 2012, EXIMIR FUNCTIONS NOR; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; Hsu J, 2012, CIRC-CARDIOVASC GENE, V5, P327, DOI 10.1161/CIRCGENETICS.111.961631; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khoo SK, 2012, J PARKINSON DIS, V2, P321, DOI 10.3233/JPD-012144; Kiezun Adam, 2012, BMC Res Notes, V5, P92, DOI 10.1186/1756-0500-5-92; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kisby GE, 2013, JAMA NEUROL, V70, P414, DOI 10.1001/jamaneurol.2013.1283; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee JW, 2011, GYNECOL ONCOL, V120, P56, DOI 10.1016/j.ygyno.2010.09.022; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Liu SG, 2013, ONCOL LETT, V5, P1639, DOI 10.3892/ol.2013.1251; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Lu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006159; Ma D, 2012, CHINESE MED J-PEKING, V125, P4270, DOI 10.3760/cma.j.issn.0366-6999.2012.23.020; Martins M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025443; Matsumoto S, 2013, CIRC RES, V113, P322, DOI 10.1161/CIRCRESAHA.113.301209; Mongroo Perry S, 2010, Cancer Biol Ther, V10, P219; Ohyagi-Hara C, 2013, AM J PATHOL, V182, P1876, DOI 10.1016/j.ajpath.2013.01.039; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Ruan JH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-8; Satoh J, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-17; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Sengupta D, 2013, MOL BIOSYST, V9, P1360, DOI 10.1039/c3mb25518b; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi WY, 2014, EUR REV MED PHARMACO, V18, P217; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Slaby O, 2013, MED HYPOTHESES, V80, P325, DOI 10.1016/j.mehy.2012.11.033; Song H, 2013, GENET MOL RES, V12, P4934, DOI 10.4238/2013.October.24.4; Su HF, 2014, CELL BIOL INT, V38, P318, DOI 10.1002/cbin.10202; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Sutherland GT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004955; Taguchi YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066714; Taurino C, 2010, CLIN SCI, V119, P335, DOI 10.1042/CS20100043; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uhlmann S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.100; Vaishnavi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056781; Vergoulis T, 2012, NUCLEIC ACIDS RES, V14, P9; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wee EJH, 2012, ONCOGENE, V31, P4182, DOI 10.1038/onc.2011.584; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Xie P, 2012, J HUAZHONG U SCI-MED, V32, P576, DOI 10.1007/s11596-012-0099-2; Xie YF, 2011, INT J ORAL SCI, V3, P125, DOI 10.4248/IJOS11046; Xu LJ, 2014, INT J ONCOL, V44, P459, DOI 10.3892/ijo.2013.2189; Xue Q, 2014, JPN J CLIN ONCOL, V44, P13, DOI 10.1093/jjco/hyt181; Yang N, 2008, CANCER RES, V68, P10307, DOI 10.1158/0008-5472.CAN-08-1954; Yip KY, 2006, BIOINFORMATICS, V22, P2968, DOI 10.1093/bioinformatics/btl488; Yu J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-169; Yu T, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-64; Yuan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081524; Zanetti R, 2007, CANCER EPIDEM BIOMAR, V16, P1081, DOI 10.1158/1055-9965.EPI-07-0377; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang N, 2013, FEBS LETT, V587, P3661, DOI 10.1016/j.febslet.2013.09.018; Zovoilis A, 2011, EMBO J, V30, P4299, DOI 10.1038/emboj.2011.327	81	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93751	10.1371/journal.pone.0093751	http://dx.doi.org/10.1371/journal.pone.0093751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690883	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100132
J	Chen, S; Liu, HJ; You, YL; Mullens, E; Hu, JJ; Yuan, Y; Huang, MY; He, L; Luo, YM; Zeng, XJ; Tang, GQ; Hong, Y				Chen, Sheng; Liu, Huijuan; You, Yalei; Mullens, Esther; Hu, Junjun; Yuan, Ye; Huang, Mengyu; He, Li; Luo, Yongming; Zeng, Xingji; Tang, Guoqiang; Hong, Yang			Evaluation of High-Resolution Precipitation Estimates from Satellites during July 2012 Beijing Flood Event Using Dense Rain Gauge Observations	PLOS ONE			English	Article							PASSIVE MICROWAVE; PRODUCTS; SYSTEM; TRMM; RADAR	Satellite-based precipitation estimates products, CMORPH and PERSIANN-CCS, were evaluated with a dense rain gauge network over Beijing and adjacent regions for an extremely heavy precipitation event on July 21 2012. CMORPH and PEERSIANN-CSS misplaced the region of greatest rainfall accumulation, and failed to capture the spatial pattern of precipitation, evidenced by a low spatial correlation coefficient ( CC). CMORPH overestimated the daily accumulated rainfall by 22.84% while PERSIANN-CCS underestimated by 72.75%. In the rainfall center, both CMORPH and PERSIANN-CCS failed to capture the temporal variation of the rainfall, and underestimated rainfall amounts by 43.43% and 87.26%, respectively. Based on our results, caution should be exercised when using CMORPH and PERSIANN-CCS as input for monitoring and forecasting floods in Beijing urban areas, and the potential for landslides in the mountainous zones west and north of Beijing.	[Chen, Sheng; Hong, Yang] Univ Oklahoma, Sch Civil Engn & Environm Sci, Norman, OK 73019 USA; [Chen, Sheng; Hong, Yang] Natl Weather Ctr, Adv Radar Res Ctr, Norman, OK USA; [Liu, Huijuan; Yuan, Ye] Anhui Weather Modificat Off, Hefei, Peoples R China; [You, Yalei] Florida State Univ, Dept Earth Sci, Tallahassee, FL 32306 USA; [You, Yalei] Florida State Univ, Dept Ocean Sci, Tallahassee, FL 32306 USA; [You, Yalei] Florida State Univ, Dept Atmospher Sci, Tallahassee, FL 32306 USA; [Mullens, Esther] Univ Oklahoma, Cooperat Inst Mesoscale Meteorol Studies, Norman, OK 73019 USA; [Mullens, Esther] Univ Oklahoma, Sch Meteorol, Norman, OK 73019 USA; [Hu, Junjun] Univ Oklahoma, Sch Comp Sci, Norman, OK 73019 USA; [Huang, Mengyu] Beijing Weather Modificat Off, Beijing, Peoples R China; [He, Li; Luo, Yongming] Natl Satellite Ctr, Remote Sensing Applicat Test Base, Gaugnxi, Peoples R China; [He, Li; Luo, Yongming] Guangxi Meteorol Bur, Disaster Mitigat Inst, Nanning, Gaugnxi, Peoples R China; [Zeng, Xingji] Guangxi Meteorol Bur, Meteorol Informat Ctr, Nanning, Gaugnxi, Peoples R China; [Tang, Guoqiang] Tsinghua Univ, Dept Hydraul Engn, Beijing 100084, Peoples R China	University of Oklahoma System; University of Oklahoma - Norman; National Oceanic Atmospheric Admin (NOAA) - USA; State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; Tsinghua University	Liu, HJ (corresponding author), Anhui Weather Modificat Off, Hefei, Peoples R China.	64230038@qq.com	Hong, Yang/D-5132-2009; Tang, Guoqiang/P-3802-2018	Hong, Yang/0000-0001-8720-242X; Tang, Guoqiang/0000-0002-0923-583X	R & D Special Foundation for Public Welfare Industry (meteorology) of China [GYHY201306040]; National Natural Science Foundation of China [40905019, 41105098, 41275030]; State Key Laboratory of Severe Weather Open Fund [2013LASW-A09]	R & D Special Foundation for Public Welfare Industry (meteorology) of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Severe Weather Open Fund	This work was supported by the R & D Special Foundation for Public Welfare Industry (meteorology) of China under Grant No. GYHY201306040; the National Natural Science Foundation of China with Grant No. 40905019, 41105098, 41275030; the State Key Laboratory of Severe Weather Open Fund 2013LASW-A09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Barrett E., 1994, REMOTE SENS REV, V11, P23, DOI [10.1080/02757259409532257, DOI 10.1080/02757259409532257]; Change IPOC, 2007, AGENDA; Chen S, 2012, J HYDROLOGY; Chiu LS, 2006, ADV ATMOS SCI, V23, P1, DOI 10.1007/s00376-006-0001-x; Chokngamwong R, 2008, J HYDROMETEOROL, V9, P256, DOI 10.1175/2007JHM876.1; Creutin JD, 2003, HYDROL PROCESS, V17, P1453, DOI 10.1002/hyp.5122; Dinku T, 2010, COMP CMORPH TRMM 3B4; Gourley JJ, 2010, J APPL METEOROL CLIM, V49, P437, DOI 10.1175/2009JAMC2302.1; Grumm R. H., 2012, BEIJING FLOOD 21 JUL; Hirpa FA, 2010, J APPL METEOROL CLIM, V49, P1044, DOI 10.1175/2009JAMC2298.1; Hong Y, 2007, INT J REMOTE SENS, V28, P3713, DOI 10.1080/01431160701311242; Hong Y, 2004, J APPL METEOROL, V43, P1834, DOI 10.1175/JAM2173.1; Hong Y, 2007, NAT HAZARDS, V43, P285, DOI 10.1007/s11069-006-9106-x; Hong Y, 2007, IEEE T GEOSCI REMOTE, V45, P1671, DOI 10.1109/TGRS.2006.888436; Hsu KL, 1997, J APPL METEOROL, V36, P1176, DOI 10.1175/1520-0450(1997)036<1176:PEFRSI>2.0.CO;2; Huffman GJ, 2007, TRMM OTHER DATA PREC; Joyce RJ, 2004, J HYDROMETEOROL, V5, P487, DOI 10.1175/1525-7541(2004)005<0487:CAMTPG>2.0.CO;2; Kay AL, 2009, CLIMATIC CHANGE, V92, P41, DOI 10.1007/s10584-008-9471-4; Kummerow C, 1996, IEEE T GEOSCI REMOTE, V34, P1213, DOI 10.1109/36.536538; Li L, 2012, COMP GLOBAL TRMM WFD; McMillan HK, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR005995; NEGRI AJ, 1993, J APPL METEOROL, V32, P357, DOI 10.1175/1520-0450(1993)032<0357:AIOTSI>2.0.CO;2; Nicholson SE, 2003, J APPL METEOROL, V42, P1355, DOI 10.1175/1520-0450(2003)042&lt;1355:VOTAOR&gt;2.0.CO;2; [任芝花 Ren Zhihua], 2003, [气象学报, Acta Meteorologica Sinica], V61, P621; Sang YF, 2012, NAT HAZARDS, P1; Sorooshian S, 2000, B AM METEOROL SOC, V81, P2035, DOI 10.1175/1520-0477(2000)081<2035:EOPSSE>2.3.CO;2; Tian YD, 2010, J HYDROMETEOROL, V11, P566, DOI 10.1175/2009JHM1190.1; Tuttle JD, 2008, J APPL METEOROL CLIM, V47, P3264, DOI 10.1175/2008JAMC2000.1; Wang JH, 2011, HYDROLOG SCI J, V56, P84, DOI 10.1080/02626667.2010.543087; Wang K, 2013, NAT HAZARDS, P1; You YL, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015345; Zhang D-L, 2013, GEOPHYS RES LETT; Zhang X, 2012, USING NWP ANAL SATEL	34	38	41	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e89681	10.1371/journal.pone.0089681	http://dx.doi.org/10.1371/journal.pone.0089681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691358	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100005
J	Evans, JA; Shim, JM; Ioannidis, JPA				Evans, James A.; Shim, Jae-Mahn; Ioannidis, John P. A.			Attention to Local Health Burden and the Global Disparity of Health Research	PLOS ONE			English	Article							QUALITY-OF-CARE; RACIAL DISPARITIES; CANCER; ASSOCIATION; KNOWLEDGE; MORTALITY; DISEASE; TRIALS; TRENDS; STATES	Most studies on global health inequality consider unequal health care and socio-economic conditions but neglect inequality in the production of health knowledge relevant to addressing disease burden. We demonstrate this inequality and identify likely causes. Using disability-adjusted life years (DALYs) for 111 prominent medical conditions, assessed globally and nationally by the World Health Organization, we linked DALYs with MEDLINE articles for each condition to assess the influence of DALY-based global disease burden, compared to the global market for treatment, on the production of relevant MEDLINE articles, systematic reviews, clinical trials and research using animal models vs. humans. We then explored how DALYs, wealth, and the production of research within countries correlate with this global pattern. We show that global DALYs for each condition had a small, significant negative relationship with the production of each type of MEDLINE articles for that condition. Local processes of health research appear to be behind this. Clinical trials and animal studies but not systematic reviews produced within countries were strongly guided by local DALYs. More and less developed countries had very different disease profiles and rich countries publish much more than poor countries. Accordingly, conditions common to developed countries garnered more clinical research than those common to less developed countries. Many of the health needs in less developed countries do not attract attention among developed country researchers who produce the vast majority of global health knowledge - including clinical trials - in response to their own local needs. This raises concern about the amount of knowledge relevant to poor populations deficient in their own research infrastructure. We recommend measures to address this critical dimension of global health inequality.	[Evans, James A.] Univ Chicago, Dept Sociol, Computat Inst, Chicago, IL 60637 USA; [Evans, James A.] Univ Chicago, Ctr Hlth & Social Sci, Chicago, IL 60637 USA; [Shim, Jae-Mahn] Univ Seoul, Dept Sociol, Seoul, South Korea; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Stanford Prevent Res Ctr, Stanford, CA 94305 USA	University of Chicago; University of Chicago; University of Seoul; Stanford University; Stanford University; Stanford University	Evans, JA (corresponding author), Univ Chicago, Dept Sociol, Computat Inst, Chicago, IL 60637 USA.	jevans@uchicago.edu	Ioannidis, John P. A./G-9836-2011; Shim, Jae-Mahn/B-7392-2014	Shim, Jae-Mahn/0000-0002-7752-8204	Center for Health Administration; University of Chicago; SBE Off Of Multidisciplinary Activities [1158803] Funding Source: National Science Foundation	Center for Health Administration; University of Chicago(University of Chicago); SBE Off Of Multidisciplinary Activities(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This study was funded by a health and health policy research for disadvantaged populations seed grant, Center for Health Administration, and by a Research Opportunity Seed grant, both from the University of Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer A, 2010, NATL BUREAU EC RES W, V15840; Albain KS, 2009, JNCI-J NATL CANCER I, V101, P984, DOI 10.1093/jnci/djp175; [Anonymous], 2002, JAMA-J AM MED ASSOC, V288, P155; [Anonymous], 1996, GLOBAL BURDEN DIS CO; [Anonymous], 2011, ECONOMIST; Bartlett C, 2002, BRIT MED J, V325, P81, DOI 10.1136/bmj.325.7355.81; Bendavid E, 2010, JAMA-J AM MED ASSOC, V304, P791, DOI 10.1001/jama.2010.1189; Boerma J. T., 2008, GLOB BURD DIS 2004 U, pvii; Boseley S., 2011, GUARDIAN; Bunker CH, 2002, CANCER EPIDEM BIOMAR, V11, P726; Buscher AL, 2010, JAMA-J AM MED ASSOC, V304, P340, DOI 10.1001/jama.2010.870; Chartier K, 2010, ALCOHOL RES HEALTH, V33, P152; CTP RTSS, 2011, NEW ENGLAND J MED; Epstein S, 2007, INCLUSION POLITICS D, pix; Grant WB, 2010, J AM MED DIR ASSOC, V11, P617, DOI 10.1016/j.jamda.2010.03.013; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; HENSCHKE UK, 1973, CANCER-AM CANCER SOC, V31, P763, DOI 10.1002/1097-0142(197304)31:4<763::AID-CNCR2820310401>3.0.CO;2-S; Holmboe ES, 2008, JAMA-J AM MED ASSOC, V299, P338, DOI 10.1001/jama.299.3.338; Ioannidis JPA, 2004, BMJ-BRIT MED J, V329, P789; Isaakidis P, 2002, BRIT MED J, V324, P702, DOI 10.1136/bmj.324.7339.702; Jha AK, 2005, NEW ENGL J MED, V353, P683, DOI 10.1056/NEJMsa050672; Lipscomb CE, 2000, B MED LIBR ASSOC, V88, P265; Lurie N, 2005, NEW ENGL J MED, V353, P727, DOI 10.1056/NEJMe058143; Maitland K, 2011, NEW ENGLAND J MED; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Medicine Io, 2003, UNEQUAL TREATMENT CO; Rogers FB, 2000, B MED LIB ASS, V88, P114; ROSSER R, 1978, INT J EPIDEMIOL, V7, P347, DOI 10.1093/ije/7.4.347; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Swingler GH, 2005, B WORLD HEALTH ORGAN, V83, P511; Swingler GH, 2003, BRIT MED J, V327, P1083, DOI 10.1136/bmj.327.7423.1083; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; Vaccarino V, 2005, NEW ENGL J MED, V353, P671, DOI 10.1056/NEJMsa032214; Wallace TA, 2011, CARCINOGENESIS, V32, P1107, DOI 10.1093/carcin/bgr066; World Bank, WORLD DEV IND	37	43	45	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e90147	10.1371/journal.pone.0090147	http://dx.doi.org/10.1371/journal.pone.0090147			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691431	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100007
J	Ganan-Gomez, I; Wei, Y; Yang, H; Pierce, S; Bueso-Ramos, C; Calin, G; Boyano-Adanez, MD; Garcia-Manero, G				Ganan-Gomez, Irene; Wei, Yue; Yang, Hui; Pierce, Sherry; Bueso-Ramos, Carlos; Calin, George; del Carmen Boyano-Adanez, Maria; Garcia-Manero, Guillermo			Overexpression of miR-125a in Myelodysplastic Syndrome CD34(+) Cells Modulates NF-kappa B Activation and Enhances Erythroid Differentiation Arrest	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; PATTERN-RECOGNITION RECEPTORS; ACUTE MYELOID-LEUKEMIA; SINGLE-STRANDED RNA; TOLL-LIKE RECEPTORS; MICRORNA EXPRESSION; BONE-MARROW; CIRCULATING MICRORNAS; MYELOGENOUS LEUKEMIA; PROGENITOR CELLS	Myelodysplastic syndromes (MDS) are characterized by impaired proliferation and differentiation of hematopoietic stem cells. The participation of toll-like receptor (TLR)-mediated signaling in MDS is well documented. Increased TLR signaling leads to the constitutive activation of NF-kappa B, which mediates inflammation, cell proliferation and apoptosis. In addition, the TLR pathway induces the expression of miRNAs which participate in the fine-tuning of the inflammatory response. miRNAs also regulate other biological processes, including hematopoiesis. miR-125a and miR-125b are known modulators of hematopoiesis and are abnormally expressed in several hematologic malignancies. However, little is known about their role in MDS. NF-kappa B-activating ability has been described for both miRNAs. We studied the role of miR-125a/miR-125b in MDS and their relationship with TLR signaling and hematopoietic differentiation. Our results indicate that miR-125a is significantly overexpressed in MDS patients and correlates negatively with patient survival. Expression of miR-99b, which is clustered with miR-125a, is also directly correlated with prognosis of MDS. Both miR-125a and miR-99b activated NF-kappa B in vitro; however, we observed a negative correlation between miR-99b expression and the levels of TLR2, TLR7 and two downstream genes, suggesting that NF-kappa B activation by the miRNA cluster occurs in the absence of TLR signaling. We also show that TLR7 is negatively correlated with patient survival in MDS. In addition, our data suggest that miR-125a may act as an NF-kappa B inhibitor upon TLR stimulation. These results indicate that miR-125a is involved in the fine-tuning of NF-kappa B activity and that its effects may depend on the status of the TLR pathway. Furthermore, we observed that miR-125a inhibits erythroid differentiation in leukemia and MDS cell lines. Therefore, this miRNA could serve as a prognostic marker and a potential therapeutic target in MDS.	[Ganan-Gomez, Irene; del Carmen Boyano-Adanez, Maria] Univ Alcala De Henares, Dept Syst Biol, Madrid, Spain; [Wei, Yue; Yang, Hui; Pierce, Sherry; Garcia-Manero, Guillermo] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Bueso-Ramos, Carlos] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Calin, George] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Div Canc Med, Houston, TX 77030 USA	Universidad de Alcala; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ganan-Gomez, I (corresponding author), Univ Alcala De Henares, Dept Syst Biol, Madrid, Spain.	irene.ganan@edu.uah.es; ggarciam@mdanderson.org	Calin, George/E-9390-2011; Ganan-Gomez, Irene/GRF-3018-2022	Ganan-Gomez, Irene/0000-0001-8354-3139; Calin, George/0000-0001-6704-5615; Calin, George/0000-0002-7427-0578	Ruth and Ken Arnold Leukemia Fund; Edward P. Evans Foundation; MD Anderson Cancer Center Support Grant (CCSG) [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Ruth and Ken Arnold Leukemia Fund; Edward P. Evans Foundation; MD Anderson Cancer Center Support Grant (CCSG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Ruth and Ken Arnold Leukemia Fund, the Edward P. Evans Foundation, the generous philanthropic contributions to The University of Texas MD Anderson Moon Shots Program and the MD Anderson Cancer Center Support Grant (CCSG) CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bousquet M, 2008, J EXP MED, V205, P2499, DOI 10.1084/jem.20080285; Bousquet M, 2012, HAEMATOL-HEMATOL J, V97, P1713, DOI 10.3324/haematol.2011.061515; Chapiro E, 2010, LEUKEMIA, V24, P1362, DOI 10.1038/leu.2010.93; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; CHEN W, 1989, LEUKEMIA, V3, P264; Cherfils-Vicini J, 2010, J CLIN INVEST, V120, P1285, DOI 10.1172/JCI36551; COOPER MC, 1974, P NATL ACAD SCI USA, V71, P1677, DOI 10.1073/pnas.71.5.1677; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; De Luca K, 2009, LEUKEMIA, V23, P2063, DOI 10.1038/leu.2009.155; Dimicoli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071120; Erdogan B, 2011, EXP HEMATOL, V39, P915, DOI 10.1016/j.exphem.2011.06.002; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; GALLAGHER R, 1979, BLOOD, V54, P713; Garofalo M, 2011, ANNU REV PHARMACOL, V51, P25, DOI 10.1146/annurev-pharmtox-010510-100517; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Gerrits A, 2012, BLOOD, V119, P377, DOI 10.1182/blood-2011-01-331686; Guiducci C, 2010, NATURE, V465, P937, DOI 10.1038/nature09102; Guo SQ, 2012, P NATL ACAD SCI USA, V109, P16636, DOI 10.1073/pnas.1213196109; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Gupta G, 2010, J BLOOD MED, V1, P171, DOI 10.2147/JBM.S12257; Haferlach T, 2012, LEUKEMIA RES, V36, P1459, DOI 10.1016/j.leukres.2012.08.009; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Horwich MD, 2008, NAT PROTOC, V3, P1537, DOI 10.1038/nprot.2008.145; Huang JJ, 2012, MED ONCOL, V29, P2402, DOI 10.1007/s12032-012-0210-3; Hussein K, 2010, LEUKEMIA RES, V34, P1169, DOI 10.1016/j.leukres.2010.04.012; Jongen-Lavrencic M, 2008, BLOOD, V111, P5078, DOI 10.1182/blood-2008-01-133355; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; KOEFFLER HP, 1978, SCIENCE, V200, P1153, DOI 10.1126/science.306682; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kuninaka N, 2010, EXP MOL PATHOL, V88, P293, DOI 10.1016/j.yexmp.2010.01.009; Lee J, 2009, BIOCHEM J, V421, P301, DOI 10.1042/BJ20090013; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lionetti M, 2009, BLOOD, V114, pE20, DOI 10.1182/blood-2009-08-237495; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; LUISIDELUCA C, 1984, J CLIN INVEST, V74, P821, DOI 10.1172/JCI111498; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maratheftis CI, 2007, CLIN CANCER RES, V13, P1154, DOI 10.1158/1078-0432.CCR-06-2108; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Nakamura S, 2000, CYTOKINES CELL MOL T, V6, P61, DOI 10.1080/13684730050515787; Nimer SD, 2008, BLOOD, V111, P4841, DOI 10.1182/blood-2007-08-078139; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; OGURA M, 1985, BLOOD, V66, P1384; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pons A, 2009, LEUKEMIA LYMPHOMA, V50, P1854, DOI 10.3109/10428190903147645; San Jose-Eneriz E, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-69; Sawanobori M, 2003, LEUKEMIA RES, V27, P583, DOI 10.1016/S0145-2126(02)00095-4; Schepers H, 2006, HAEMATOLOGICA, V91, P1710; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Seca H, 2010, EUR J CANCER, V46, P1520, DOI 10.1016/j.ejca.2010.03.031; Shaham L, 2012, LEUKEMIA, V26, P2011, DOI 10.1038/leu.2012.90; Sioud M, 2006, J MOL BIOL, V364, P945, DOI 10.1016/j.jmb.2006.09.054; Sokol L, 2011, BRIT J HAEMATOL, V153, P24, DOI 10.1111/j.1365-2141.2011.08581.x; Starczynowski DT, 2010, HEMATOL ONCOL CLIN N, V24, P343, DOI 10.1016/j.hoc.2010.02.008; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tan GY, 2012, J BIOL CHEM, V287, P33036, DOI 10.1074/jbc.M112.383273; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Vasilatou D, 2013, LEUKEMIA RES, V37, P251, DOI 10.1016/j.leukres.2012.11.011; Votavova H, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-1; Wang HL, 2012, TRANSL RES, V160, P198, DOI 10.1016/j.trsl.2012.04.002; Wei Y, 2013, LEUKEMIA, V27, P2177, DOI 10.1038/leu.2013.91; Whitehead Institute for Biomedical Research, 2012, TARGETSCAN HUM 6 2 P; Wieser R, 2010, GENE CHROMOSOME CANC, V49, P193, DOI 10.1002/gcc.20740; Yu S, 2012, J CLIN ENDOCR METAB, V97, P2084, DOI 10.1210/jc.2011-3059; Zhang YL, 2008, MOL IMMUNOL, V45, P1184, DOI 10.1016/j.molimm.2007.07.014; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681; Zimmerman EI, 2010, MOL PHARMACOL, V78, P811, DOI 10.1124/mol.110.066258	79	37	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93404	10.1371/journal.pone.0093404	http://dx.doi.org/10.1371/journal.pone.0093404			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690917	gold, Green Submitted, Green Published			2022-12-27	WOS:000334101100075
J	Harsch, MA; McGlone, MS; Wilmshurst, JM				Harsch, Melanie A.; McGlone, Matt S.; Wilmshurst, Janet M.			Winter Climate Limits Subantarctic Low Forest Growth and Establishment	PLOS ONE			English	Article							WARMING EVENTS; NEW-ZEALAND; TEMPERATURE VARIABILITY; PINUS-SYLVESTRIS; VEGETATION; TREELINE; IMPACTS; HISTORY; TRENDS; SPREAD	Campbell Island, an isolated island 600 km south of New Zealand mainland (52 degrees S, 169 degrees E) is oceanic (Conrad Index of Continentality = -5) with small differences between mean summer and winter temperatures. Previous work established the unexpected result that a mean annual climate warming of c. 0.6 degrees C since the 1940's has not led to upward movement of the forest limit. Here we explore the relative importance of summer and winter climatic conditions on growth and age-class structure of the treeline forming species, Dracophyllum longifolium and Dracophyllum scoparium over the second half of the 20th century. The relationship between climate and growth and establishment were evaluated using standard dendroecological methods and local climate data from a meteorological station on the island. Growth and establishment were correlated against climate variables and further evaluated within hierarchical regression models to take into account the effect of plot level variables. Winter climatic conditions exerted a greater effect on growth and establishment than summer climatic conditions. Establishment is maximized under warm (mean winter temperatures >7 degrees C), dry winters (total winter precipitation <400 mm). Growth, on the other hand, is adversely affected by wide winter temperature ranges and increased rainfall. The contrasting effect of winter warmth on growth and establishment suggests that winter temperature affects growth and establishment through differing mechanisms. We propose that milder winters enhance survival of seedlings and, therefore, recruitment, but increases metabolic stress on established plants, resulting in lower growth rates. Future winter warming may therefore have complex effects on plant growth and establishment globally.	[Harsch, Melanie A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [McGlone, Matt S.; Wilmshurst, Janet M.] Landcare Res, Ecosyst & Global Change, Lincoln, NE USA	University of Washington; University of Washington Seattle	Harsch, MA (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	harsch.melanie@gmail.com	Wilmshurst, Janet/O-8611-2019; Wilmshurst, Janet M/C-2209-2009	Wilmshurst, Janet/0000-0002-4474-8569; Wilmshurst, Janet M/0000-0002-4474-8569	New Zealand Ministry of Business, Innovation and Employment's Science and Innovation Group; Direct For Biological Sciences [1103734] Funding Source: National Science Foundation	New Zealand Ministry of Business, Innovation and Employment's Science and Innovation Group(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded Core funding for Crown Research Institutes from the New Zealand Ministry of Business, Innovation and Employment's Science and Innovation Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1968, TREE RING DATING; Balling RC, 1998, CLIMATE RES, V9, P175, DOI 10.3354/cr009175; Batllori E, 2009, J VEG SCI, V20, P814, DOI 10.1111/j.1654-1103.2009.01085.x; Bestic KL, 2005, NEW ZEAL J ECOL, V29, P291; Bestic KL, 2002, DRACOPHYLLUM SCRUB E; Bjerke JW, 2011, J ECOL, V99, P1481, DOI 10.1111/j.1365-2745.2011.01859.x; Bokhorst S, 2011, GLOBAL CHANGE BIOL, V17, P2817, DOI 10.1111/j.1365-2486.2011.02424.x; Bokhorst S, 2010, PHYSIOL PLANTARUM, V140, P128, DOI 10.1111/j.1399-3054.2010.01386.x; Bokhorst SF, 2009, J ECOL, V97, P1408, DOI 10.1111/j.1365-2745.2009.01554.x; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Bunn A, 2010, DENDROCHRONOLOGY PRO; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cook E.R., 2013, METHODS DENDROCHRONO; COUTTS MP, 1990, FORESTRY, V63, P143, DOI 10.1093/forestry/63.2.143; Crawford RMM, 2003, ANN BOT-LONDON, V91, P213, DOI 10.1093/aob/mcf185; Crawford RMM, 2000, NEW PHYTOL, V147, P257, DOI 10.1046/j.1469-8137.2000.00705.x; CRAWFORD RMM, 1981, FLORA, V171, P338; Crawford RMM, 1996, FOLIA GEOBOT PHYTOTX, V31, P7, DOI 10.1007/BF02803990; Crawford RMM, 2005, P ROY IRISH ACAD, V105B, P129; Crawford RMM, 2005, ENV CHALLENGES ARCTI, P85; D'Arrigo RD, 1998, CLIM DYNAM, V14, P191, DOI 10.1007/s003820050217; Diffenbaugh NS, 2013, NAT CLIM CHANGE, V3, P379, DOI [10.1038/nclimate1732, 10.1038/NCLIMATE1732]; Dullinger S, 2004, J ECOL, V92, P241, DOI 10.1111/j.0022-0477.2004.00872.x; Fritter AH, 1999, OECOLOGIA, V120, P575; Gelman A., 2007, DATA ANAL USING REGR; Giesecke T, 2010, J BIOGEOGR, V37, P1394, DOI 10.1111/j.1365-2699.2010.02296.x; Grace J, 1977, PLANT RESPONSES WIND; Harsch MA, 2011, GLOBAL ECOL BIOGEOGR, V20, P582, DOI 10.1111/j.1466-8238.2010.00622.x; Harsch MA, 2009, ECOL LETT, V12, P1040, DOI 10.1111/j.1461-0248.2009.01355.x; Juntunen V, 2002, ARCTIC, V55, P348, DOI 10.14430/arctic719; Kirchhefer AJ, 2001, HOLOCENE, V11, P41, DOI 10.1191/095968301670181592; Kreyling J, 2010, ECOLOGY, V91, P1939, DOI 10.1890/09-1160.1; Kullman L, 2007, J ECOL, V95, P41, DOI 10.1111/j.1365-2745.2006.01190.x; LAVOIE C, 1992, ARCTIC ALPINE RES, V24, P40, DOI 10.2307/1551318; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877; McDowell NG, 2011, PLANT PHYSIOL, V155, P1051, DOI 10.1104/pp.110.170704; McGlone M, 2007, EARTH ENV SCI T R SO, V98, P71, DOI 10.1017/S1755691007000060; McGlone MS, 2002, QUATERNARY SCI REV, V21, P683, DOI 10.1016/S0277-3791(01)00044-0; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Nicoll BC, 1998, TREES-STRUCT FUNCT, V12, P241, DOI 10.1007/s004680050147; Niessner A, 2013, STEM GROWTH DYNAMICS; NIWA, 2009, CLIFLO NIWAS NAT CLI; Ogren E, 1996, FUNCT ECOL, V10, P724, DOI 10.2307/2390507; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Salinger MJ, 2001, INT J CLIMATOL, V21, P1437, DOI 10.1002/joc.694; Skre O, 2008, ENVIRON EXP BOT, V62, P254, DOI 10.1016/j.envexpbot.2007.09.005; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Wilmshurst JM, 2004, J BIOGEOGR, V31, P401, DOI 10.1046/j.0305-0270.2003.01029.x; Zuur Alain F., 2009, P1	51	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93241	10.1371/journal.pone.0093241	http://dx.doi.org/10.1371/journal.pone.0093241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691026	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100056
J	Kadra, G; Dean, K; Hotopf, M; Hatch, SL				Kadra, Giouliana; Dean, Kimberlie; Hotopf, Matthew; Hatch, Stephani L.			Investigating Exposure to Violence and Mental Health in a Diverse Urban Community Sample: Data from the South East London Community Health (SELCoH) Survey	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; INTERPERSONAL VIOLENCE; STANDARDIZED ASSESSMENT; PSYCHIATRIC-DISORDER; RISK-FACTORS; LIFE EVENTS; VICTIMIZATION; POPULATION; GENDER; PREVALENCE	Background: General population surveys have seldom examined violence as a multidimensional concept and in relation to an array of mental disorders. Methods: Data from the South East London Community Health Study was used to examine the prevalence, overlap and distribution of proximal witnessed, victimised and perpetrated violence and their association with current mental disorders. We further investigated the cumulative effect of lifetime exposure to violence on current mental disorders. Unadjusted and adjusted (for confounders and violence) models were examined. Results: In the last twelve months, 7.4% reported witnessing violence, 6.3% victimisation and 3.2% perpetration of violence. There was a significant overlap across violence types, with some shared correlates across the groups such as being younger and male. Witnessing violence in the past year was associated with current common mental disorders (CMD) and posttraumatic stress disorder (PTSD) symptoms. Proximal perpetration was associated with current CMD, PTSD symptoms and past 12 months drug use; whereas proximal victimisation was associated with lifetime and past 12 months drug use. Lifetime exposure to two or more types of violence was associated with increased risk for all mental health outcomes, suggesting a cumulative effect. Conclusion: Exposure to violence needs to be examined in a multi-faceted manner: i) as discrete distal and proximal events, which may have distinct patterns of association with mental health and ii) as a concept with different but overlapping dimensions, thus also accounting for possible cumulative effects.	[Kadra, Giouliana] Kings Coll London, Biomed Res Ctr Nucleus, Inst Psychiat, Dept Psychol Med, London, England; [Dean, Kimberlie] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Dean, Kimberlie] Justice Hlth & Forens Mental Hlth Network, Sydney, NSW, Australia; [Hotopf, Matthew; Hatch, Stephani L.] Kings Coll London, Inst Psychiat, Dept Psychol Med, London, England	University of London; King's College London; University of New South Wales Sydney; University of London; King's College London	Kadra, G (corresponding author), Kings Coll London, Biomed Res Ctr Nucleus, Inst Psychiat, Dept Psychol Med, London, England.	giouliana.kadra@kcl.ac.uk	Hatch, Stephani L/B-4235-2010; Hotopf, Matthew/E-4971-2010; Kadra, Giouliana/G-8346-2017	Kadra, Giouliana/0000-0003-3182-905X; Hatch, Stephani/0000-0001-9103-2427; Hotopf, Matthew/0000-0002-3980-4466	Biomedical Research Nucleus data management and informatics facility at South London and Maudsley NHS Foundation Trust; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; King's College London; Guy's and St Thomas' Charity; Maudsley Charity; Justice Health AMP; Forensic Mental Health Network, New South Wales, Australia	Biomedical Research Nucleus data management and informatics facility at South London and Maudsley NHS Foundation Trust; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; King's College London; Guy's and St Thomas' Charity; Maudsley Charity; Justice Health AMP; Forensic Mental Health Network, New South Wales, Australia	This research was supported by the Biomedical Research Nucleus data management and informatics facility at South London and Maudsley NHS Foundation Trust, which is funded by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London and a joint infrastructure grant from Guy's and St Thomas' Charity and the Maudsley Charity. G Kadra, SL Hatch and M Hotopf receive salary support from the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. K Dean receives salary support from the Justice Health & Forensic Mental Health Network, New South Wales, Australia. The funders did not have a role in the study design; collection, analysis or interpretation of data; the writing of the manuscript; or in the decision to submit the manuscript for publication.	Acierno R, 1997, BEHAV MED, V23, P53, DOI 10.1080/08964289709596729; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andrade LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031879; Barrett EL, 2011, ADDICT BEHAV, V36, P721, DOI 10.1016/j.addbeh.2011.02.005; Boden JM, 2012, DRUG ALCOHOL DEPEN, V122, P135, DOI 10.1016/j.drugalcdep.2011.09.023; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Breslau N, 1999, AM J PSYCHIAT, V156, P902, DOI 10.1176/ajp.156.6.902; Budd T., 2005, OFFENDING ENGLAND WA; Chaplin R, 2011, HOME OFFICE STAT B; Choe JY, 2008, PSYCHIAT SERV, V59, P153, DOI 10.1176/ps.2008.59.2.153; Clark C, 2008, J URBAN HEALTH, V85, P22, DOI 10.1007/s11524-007-9229-8; Colbert SJ, 2009, HEALTH EDUC BEHAV, V36, P259, DOI 10.1177/1090198107303310; DoH, 2012, HLTH PROF LAMB 2012; DoH, 2012, HLTH PROF SOUTHW 201; Dunn EC, 2012, DEPRESS ANXIETY, V29, P392, DOI 10.1002/da.21916; Duque LF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-628; Faergemann C, 2010, SCAND J PUBLIC HEALT, V38, P524, DOI 10.1177/1403494810370234; Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120; Fergusson DM, 2000, ADDICTION, V95, P1525, DOI 10.1046/j.1360-0443.2000.951015257.x; Fok M, 2013, J PERS DISORD, V27, P119; Goldmann E, 2011, J TRAUMA STRESS, V24, P747, DOI 10.1002/jts.20705; Hart C, 2012, SOC PSYCH PSYCH EPID, V47, P1581, DOI 10.1007/s00127-011-0464-7; Hatch SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048012; Hatch SL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-861; Hedtke KA, 2008, J CONSULT CLIN PSYCH, V76, P633, DOI 10.1037/0022-006X.76.4.633; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P10, DOI 10.1177/1403494810380774; Hiday VA, 2001, INT J LAW PSYCHIAT, V24, P559, DOI 10.1016/S0160-2527(01)00091-7; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Holman EA, 2000, ARCH FAM MED, V9, P802, DOI 10.1001/archfami.9.9.802; Khalifeh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055952; Khalifeh H, 2010, INT REV PSYCHIATR, V22, P535, DOI 10.3109/09540261.2010.506185; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Lipsky S, 2011, SOC PSYCH PSYCH EPID, V46, P843, DOI 10.1007/s00127-010-0258-3; McDonald CC, 2008, J PSYCHIATR MENT HLT, V15, P833, DOI 10.1111/j.1365-2850.2008.01321.x; McGruder-Johnson AK, 2000, J INTERPERS VIOLENCE, V15, P205, DOI 10.1177/088626000015002006; Monahan J, 2005, PSYCHIAT SERV, V56, P810, DOI 10.1176/appi.ps.56.7.810; Moran P, 2003, BRIT J PSYCHIAT, V183, P228, DOI 10.1192/bjp.183.3.228; Mulvey EP, 1997, VIOLENT BEHAV MENTAL, P14; ONS, 2011, CENS 2011 ETHN GROUP; Porcerelli JH, 2003, J AM BOARD FAM PRACT, V16, P32, DOI 10.3122/jabfm.16.1.32; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Ribeiro WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063545; Scarpa A, 2001, J INTERPERS VIOLENCE, V16, P36, DOI 10.1177/088626001016001003; Sharp C, 2003, CRIME JUSTICE SURVEY; Silove D, 1997, BRIT J PSYCHIAT, V170, P351, DOI 10.1192/bjp.170.4.351; Silver E, 2005, AM J PUBLIC HEALTH, V95, P2015, DOI 10.2105/AJPH.2003.021436; Slopen N, 2012, SOC PSYCH PSYCH EPID, V47, P1591, DOI 10.1007/s00127-011-0466-5; StataCorp, 2021, STATA STAT SOFTWARE; Sundaram V, 2004, J EPIDEMIOL COMMUN H, V58, P65, DOI 10.1136/jech.58.1.65; Sundquist J, 2000, J NERV MENT DIS, V188, P357, DOI 10.1097/00005053-200006000-00006; Tarling R., 2000, VICTIM WITNESS INTIM, V124; ten Have M, 2014, PSYCHOL MED, V44, P1485, DOI 10.1017/S0033291713002262; Turner RJ, 1995, J HEALTH SOC BEHAV, V36, P360, DOI 10.2307/2137325; Turner RJ, 2004, ARCH GEN PSYCHIAT, V61, P481, DOI 10.1001/archpsyc.61.5.481; Walsh E, 2003, BRIT J PSYCHIAT, V183, P233, DOI 10.1192/bjp.183.3.233; Whiting JB, 2009, J FAM VIOLENCE, V24, P639, DOI 10.1007/s10896-009-9262-3	58	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93660	10.1371/journal.pone.0093660	http://dx.doi.org/10.1371/journal.pone.0093660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6KM	24691206	Green Published, gold			2022-12-27	WOS:000334101100121
J	Yi, X; Long, L; Yang, CZ; Lu, YY; Cheng, ML				Yi, Xu; Long, Li; Yang, Chunzhang; Lu, Yingying; Cheng, Mingliang			Maotai Ameliorates Diethylnitrosamine-Initiated Hepatocellular Carcinoma Formation in Mice	PLOS ONE			English	Article							GLUTAMATE-CYSTEINE LIGASE; OXIDATIVE STRESS; DIAGNOSTIC-VALUE; GLYPICAN-3 EXPRESSION; ALCOHOL-CONSUMPTION; 2-RELATED FACTOR-2; GENE-EXPRESSION; LIVER FIBROSIS; METALLOTHIONEIN; NRF2	Consumption of alcohol is closely related to liver disease, such as hepatic fibrosis or even hepatocellular carcinoma (HCC). However, epidemiological and experimental studies indicated that consumption of Maotai, one of the famous liquors in China, exhibits no significant correlation with hepatic fibrosis or cirrhosis as other beverage sources do. This study detected the relationship of Maotai consumption and HCC development in a diethylnitrosamine (DEN)-initiated HCC animal model. DEN was given to mice at a dose of 100 mg/kg, ip, and 50 mg/kg, ip in the following week. Mice were simultaneously given Maotai or an equal amount of ethanol (53%, 5 ml/kg/day, 5days/week for up to 35weeks). At 3-week and 35-week of the experiment, serum and livers were collected for biochemical and histopathological examination of liver injury and incidence of HCC. Real-time RT-PCR, immunohistochemistry and Western blotting were used to examine the expression of metallothionein-1/2 (MT-1/2), NF-E2-related factor 2 (Nrf2), glutamate-cysteine ligase catalytic subunit (GCLC) and modified subunit (GCLM). We identified tissue damage and dysfunction of liver in ethanol + DEN-treated mice, whereas the extent of injury was reduced in Maotai+ DEN-treated mice. Significant Glypican-3(GPC3) expression and precancerous injury or HCC were seen in approximately 50% of mice with ethanol+ DEN, but barely be seen in Maotai + DEN-treated mice. A higher expression of MT-1/2, Nrf2 and GCLC could be seen in Maotai + DEN-treated mice. Thus, Maotai liquor ameliorates the formation of DEN-induced HCC in mice, and the protection mechanism is possibly related with the activation of anti-oxidation factors, such as MTs, Nrf2 and GCLC.	[Yi, Xu; Long, Li; Cheng, Mingliang] Guiyang Med Coll Hosp, Guiyang, Guizhou, Peoples R China; [Yang, Chunzhang] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Lu, Yingying] Beijing 302 Hosp, Ctr Therapeut Res Hepatocellular Carcinoma, Beijing, Peoples R China	Guizhou Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Fifth Medical Center of Chinese PLA General Hospital	Cheng, ML (corresponding author), Guiyang Med Coll Hosp, Guiyang, Guizhou, Peoples R China.	mlcheng@yeah.net			project 973, Department of Science and Technology, Government of China [2011CB512114]	project 973, Department of Science and Technology, Government of China	Supported by a grant from the project 973, Department of Science and Technology, Government of China (2011CB512114). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Basra S, 2011, WORLD J HEPATOL, V3, P108, DOI 10.4254/wjh.v3.i5.108; Bataille AM, 2012, CLIN PHARMACOL THER, V92, P340, DOI 10.1038/clpt.2012.110; Bishayee A, 2010, CANCER PREV RES, V3, P753, DOI 10.1158/1940-6207.CAPR-09-0171; Brandon-Warner E, 2012, ALCOHOL CLIN EXP RES, V36, P641, DOI 10.1111/j.1530-0277.2011.01660.x; Cheng Ming-Liang, 2004, Hepatobiliary Pancreat Dis Int, V3, P93; Cheng ML, 2002, WORLD J GASTROENTERO, V8, P520, DOI 10.3748/wjg.v8.i3.520; Dayoub R, 2013, MOL MED, V19, P237, DOI 10.2119/molmed.2013.00027; Di Tommaso L, 2007, HEPATOLOGY, V45, P725, DOI 10.1002/hep.21531; Diaz-Hernandez JI, 2005, J BIOL CHEM, V280, P38992, DOI 10.1074/jbc.M507065200; Dong H, 2005, WORLD J GASTROENTERO, V11, P1339, DOI 10.3748/wjg.v11.i9.1339; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ghoshal K, 2000, J BIOL CHEM, V275, P539, DOI 10.1074/jbc.275.1.539; Gordillo-Bastidas D, 2013, WORLD J GASTROENTERO, V19, P9020, DOI 10.3748/wjg.v19.i47.9020; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087930; Kaplan MM, 1979, PROBLEMS LIVER DISEA, P79; Kubo S, 2005, HEPATOL RES, V31, P73, DOI 10.1016/j.hepres.2004.09.008; Lamle J, 2008, GASTROENTEROLOGY, V134, P1159, DOI 10.1053/j.gastro.2008.01.011; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Libbrecht L, 2006, AM J SURG PATHOL, V30, P1405, DOI 10.1097/01.pas.0000213323.97294.9a; Liu H, 2010, WORLD J GASTROENTERO, V16, P4410, DOI 10.3748/wjg.v16.i35.4410; Liu J, 2006, EXP BIOL MED, V231, P1535, DOI 10.1177/153537020623100913; Liu J, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/305861; Majumder S, 2010, CANCER RES, V70, P10265, DOI 10.1158/0008-5472.CAN-10-2839; Markovic D, 2013, BRAZ J MED BIOL RES, V46, P1014, DOI 10.1590/1414-431X20132814; McKillop IH, 2009, SEMIN LIVER DIS, V29, P222, DOI 10.1055/s-0029-1214377; MOHR U, 1997, IRAC SCI PUBLICATION, V122; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Okada K, 2013, J GASTROENTEROL, V48, P620, DOI 10.1007/s00535-012-0659-z; Orr WC, 2005, J BIOL CHEM, V280, P37331, DOI 10.1074/jbc.M508272200; PEGG AE, 1990, CANCER RES, V50, P6119; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Ruttkay-Nedecky B, 2013, INT J MOL SCI, V14, P6044, DOI 10.3390/ijms14036044; SCHARL A, 1990, ARCH GYNECOL OBSTET, V247, P63, DOI 10.1007/BF02390663; Shimozono R, 2013, MOL PHARMACOL, V84, P62, DOI 10.1124/mol.112.084269; Shin SM, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/763257; Singal AK, 2007, J CLIN GASTROENTEROL, V41, P761, DOI 10.1097/MCG.0b013e3180381584; Singal AK, 2011, EUR J GASTROEN HEPAT, V23, P204, DOI 10.1097/MEG.0b013e328343b085; Sookoian S, 2014, GUT, V63, P530, DOI 10.1136/gutjnl-2013-305718; Stampfer MJ, 2005, NEW ENGL J MED, V352, P245, DOI 10.1056/NEJMoa041152; Tao X, 2007, HEPATOL RES, V37, P820, DOI 10.1111/j.1872-034X.2007.00113.x; Teoh NC, 2008, HEPATOLOGY, V47, P2078, DOI 10.1002/hep.22194; Thirumoorthy N, 2007, WORLD J GASTROENTERO, V13, P993, DOI 10.3748/wjg.v13.i7.993; Voigt Michael D, 2005, Clin Liver Dis, V9, P151, DOI 10.1016/j.cld.2004.10.003; Wang XY, 2006, HUM PATHOL, V37, P1435, DOI 10.1016/j.humpath.2006.05.016; Wu J, 2002, WORLD J GASTROENTERO, V8, P571, DOI 10.3748/wjg.v8.i3.571; Xu WH, 2008, LAB INVEST, V88, P1068, DOI 10.1038/labinvest.2008.75; Yang JJ, 2013, FOOD CHEM TOXICOL, V59, P421, DOI 10.1016/j.fct.2013.06.018; Zhang DY, 2006, MOL CELL BIOCHEM, V293, P161, DOI 10.1007/s11010-006-9238-z; Zhang YKJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059122; Zhou ZX, 2002, EXP BIOL MED, V227, P214, DOI 10.1177/153537020222700310; Zima T, 2001, J BIOMED SCI, V8, P59, DOI 10.1159/000054014	54	16	18	4	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93599	10.1371/journal.pone.0093599	http://dx.doi.org/10.1371/journal.pone.0093599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690765	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100110
J	Vo, N; Taga, A; Inaba, Y; Yoshida, H; Cotterill, S; Yamaguchi, M				Vo, Nicole; Taga, Ayano; Inaba, Yasuhiro; Yoshida, Hideki; Cotterill, Sue; Yamaguchi, Masamitsu			Drosophila Mcm10 Is Required for DNA Replication and Differentiation in the Compound Eye	PLOS ONE			English	Article							POLYMERASE-ALPHA; SACCHAROMYCES-CEREVISIAE; CHROMATIN ASSOCIATION; CATALYTIC SUBUNIT; FISSION YEAST; BINDING; MELANOGASTER; EXPRESSION; INITIATION; COMPLEX	Mini chromosome maintenance 10 (Mcm10) is an essential protein, which is conserved from S. cerevisiae to Drosophila and human, and is required for the initiation of DNA replication. Knockdown of Drosophila Mcm10 (dMcm10) by RNA interference in eye imaginal discs induces abnormal eye morphology (rough eye phenotype), and the number of ommatidia is decreased in adult eyes. We also observed a delay in the S phase and M phase in eye discs of dMcm10 knockdown fly lines. These results show important roles for dMcm10 in the progression of S and M phases. Furthermore, genome damage and apoptosis were induced by dMcm10 knockdown in eye imaginal discs. Surprisingly, when we used deadpan-lacZ and klingon-lacZ enhancer trap lines to monitor the photoreceptor cells in eye discs, knockdown of dMcm10 by the GMR-GAL4 driver reduced the signals of R7 photoreceptor cells. These data suggest an involvement of dMcm10 in R7 cell differentiation. This involvement appears to be independent of the apoptosis induced by dMcm10 knockdown. Together, these results suggest that dMcm10 knockdown has an effect on DNA replication and R7 cell differentiation.	[Vo, Nicole; Taga, Ayano; Inaba, Yasuhiro; Yoshida, Hideki; Yamaguchi, Masamitsu] Kyoto Inst Technol, Dept Appl Biol, Kyoto 606, Japan; [Vo, Nicole; Taga, Ayano; Inaba, Yasuhiro; Yoshida, Hideki; Yamaguchi, Masamitsu] Kyoto Inst Technol, Insect Biomed Res Ctr, Kyoto 606, Japan; [Cotterill, Sue] St Georges Univ London, Dept Basic Med Sci, London, England	Kyoto Institute of Technology; Kyoto Institute of Technology; St Georges University London	Yamaguchi, M (corresponding author), Kyoto Inst Technol, Dept Appl Biol, Kyoto 606, Japan.	myamaguc@kit.ac.jp		Yamaguchi, Masamitsu/0000-0002-6321-9750	JSPS; Ministry of Education, Culture, Sports, Science and Technology of Japan	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-Aid from JSPS and the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Apger J, 2010, GENETICS, V185, P1151, DOI 10.1534/genetics.110.117234; Chattopadhyay S, 2007, MOL BIOL CELL, V18, P4085, DOI 10.1091/mbc.E06-12-1148; Christensen TW, 2003, MOL BIOL CELL, V14, P2206, DOI 10.1091/mbc.E02-11-0706; Cook CR, 2003, J BIOL CHEM, V278, P36051, DOI 10.1074/jbc.M306049200; Douglas NL, 2005, MOL BIOL REP, V32, P197, DOI 10.1007/s11033-005-2312-x; Du Wenyue, 2012, Subcell Biochem, V62, P197, DOI 10.1007/978-94-007-4572-8_11; Du WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070518; Gregan J, 2003, MOL BIOL CELL, V14, P3876, DOI 10.1091/mbc.E03-02-0090; Hayashi Y, 2006, BBA-GENE STRUCT EXPR, V1759, P359, DOI 10.1016/j.bbaexp.2006.07.002; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Hirose F, 2001, MOL CELL BIOL, V21, P7231, DOI 10.1128/MCB.21.21.7231-7242.2001; Izumi M, 2004, J BIOL CHEM, V279, P32569, DOI 10.1074/jbc.M314017200; Kanke M, 2012, EMBO J, V31, P2182, DOI 10.1038/emboj.2012.68; Knott SRV, 2009, GENE DEV, V23, P1077, DOI 10.1101/gad.1784309; Liachko I, 2005, GENETICS, V171, P503, DOI 10.1534/genetics.105.042333; Liachko I, 2009, GENETICS, V181, P379, DOI 10.1534/genetics.108.099101; Reichhart JM, 2002, GENESIS, V34, P160, DOI 10.1002/gene.10122; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Ricke RM, 2006, J BIOL CHEM, V281, P18414, DOI 10.1074/jbc.M513551200; ROBERTSON HM, 1988, GENETICS, V118, P461; Robertson PD, 2008, J BIOL CHEM, V283, P3338, DOI 10.1074/jbc.M706267200; Robertson PD, 2010, J BIOL CHEM, V285, P22942, DOI 10.1074/jbc.M110.131276; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; Sun JT, 1999, MOL CELL BIOL, V19, P216; Thu YM, 2013, TRENDS BIOCHEM SCI, V38, P184, DOI 10.1016/j.tibs.2012.12.003; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Warren EM, 2008, STRUCTURE, V16, P1892, DOI 10.1016/j.str.2008.10.005; Warren EM, 2009, J BIOL CHEM, V284, P24662, DOI 10.1074/jbc.M109.020438; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Wolff Tanya, 1993, P1277; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; Yamaguchi M, 1995, BIOL CELL, V85, P147, DOI 10.1016/0248-4900(96)85275-0; Yang XW, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-13; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	35	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93450	10.1371/journal.pone.0093450	http://dx.doi.org/10.1371/journal.pone.0093450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686397	Green Published, gold, Green Submitted			2022-12-27	WOS:000340842300011
J	Shen, JH; Nair, A; Saxena, R; Zhang, CC; Borrelli, J; Tang, LP				Shen, Jinhui; Nair, Ashwin; Saxena, Ramesh; Zhang, Cheng Cheng; Borrelli, Joseph, Jr.; Tang, Liping			Tissue Engineering Bone Using Autologous Progenitor Cells in the Peritoneum	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ACUTE INFLAMMATORY RESPONSES; IN-VIVO; OSTEOGENIC DIFFERENTIATION; MORPHOGENETIC PROTEIN-2; GROWTH-FACTOR; SCAFFOLDS; REGENERATION; RECRUITMENT; ADHESION	Despite intensive research efforts, there remains a need for novel methods to improve the ossification of scaffolds for bone tissue engineering. Based on a common phenomenon and known pathological conditions of peritoneal membrane ossification following peritoneal dialysis, we have explored the possibility of regenerating ossified tissue in the peritoneum. Interestingly, in addition to inflammatory cells, we discovered a large number of multipotent mesenchymal stem cells (MSCs) in the peritoneal lavage fluid from mice with peritoneal catheter implants. The osteogenic potential of these peritoneal progenitor cells was demonstrated by their ability to easily infiltrate decalcified bone implants, produce osteocalcin and form mineralized bone in 8 weeks. Additionally, when poly(l-lactic acid) scaffolds loaded with bone morphogenetic protein-2 (a known osteogenic differentiation agent) were implanted into the peritoneum, signs of osteogenesis were seen within 8 weeks of implantation. The results of this investigation support the concept that scaffolds containing BMP-2 can stimulate the formation of bone in the peritoneum via directed autologous stem and progenitor cell responses.	[Shen, Jinhui; Nair, Ashwin; Tang, Liping] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA; [Saxena, Ramesh] Univ Texas SW Med Ctr Dallas, Div Nephrol, Dallas, TX 75390 USA; [Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Borrelli, Joseph, Jr.] Texas Hlth Arlington Mem Hosp, Texas Hlth Phys Grp, Arlington, TX USA; [Tang, Liping] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan	University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Kaohsiung Medical University	Tang, LP (corresponding author), Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.	ltang@uta.edu	Zhang, Cheng/GRS-8698-2022; Nair, Ashwin/B-8307-2011	Nair, Ashwin/0000-0002-7334-3114	National Institutes of Health [EB007271, CA172268]; NATIONAL CANCER INSTITUTE [R01CA172268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This works was supported by National Institutes of Health grants EB007271 and CA172268. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2004, AM J ROENTGENOL, V182, P441, DOI 10.2214/ajr.182.2.1820441; Arpornmaeklong P, 2009, STEM CELLS DEV, V18, P955, DOI 10.1089/scd.2008.0310; Bellon JM, 2002, AM J SURG, V184, P154, DOI 10.1016/S0002-9610(02)00907-8; Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P1, DOI 10.1002/term.63; Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Campbell GR, 2008, J TISSUE ENG REGEN M, V2, P50, DOI 10.1002/term.66; Campbell JH, 2000, ANN NY ACAD SCI, V902, P224; Cao Y, 2008, J BIOMED MATER RES A, V87A, P719, DOI 10.1002/jbm.a.31781; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chartoff EH, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/586586; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Chue WL, 2004, J VASC SURG, V39, P859, DOI 10.1016/j.jvs.2003.03.003; Crisostomo PR, 2006, SHOCK, V26, P575, DOI 10.1097/01.shk.0000235087.45798.93; Di Paolo N, 2004, PERITON DIALYSIS INT, V24, P471; Diao HJ, 2009, TISSUE ENG PT A, V15, P2687, DOI [10.1089/ten.tea.2008.0621, 10.1089/ten.TEA.2008.0621]; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dudek AZ, 2003, BLOOD, V101, P4687, DOI 10.1182/blood-2002-08-2363; Fadare O, 2002, MODERN PATHOL, V15, P777, DOI 10.1097/01.MP.0000017565.19341.63; GANDHI VC, 1980, ARCH INTERN MED, V140, P1201, DOI 10.1001/archinte.140.9.1201; Garosi G, 2001, PERITON DIALYSIS INT, V21, P417; Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008; GUO W, 1993, INT J ARTIF ORGANS, V16, P276, DOI 10.1177/039139889301600508; Gupta B, 2007, PROG POLYM SCI, V32, P455, DOI 10.1016/j.progpolymsci.2007.01.005; Hakki SS, 2014, J BIOMED MATER RES B, V102, P119, DOI 10.1002/jbm.b.32988; Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6; Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019; Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009; Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231; Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226; Ikada Y, 2006, J R SOC INTERFACE, V3, P589, DOI 10.1098/rsif.2006.0124; Ioannidis O, 2012, J RES MED SCI, V17, P92; King RD, 2010, NEUROIMAGE, V53, P471, DOI 10.1016/j.neuroimage.2010.06.050; Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093; Le SJ, 2010, DIFFERENTIATION, V79, P232, DOI 10.1016/j.diff.2010.03.001; Libetta C, 1996, KIDNEY INT, V49, P506, DOI 10.1038/ki.1996.72; LORD BI, 1995, BLOOD, V85, P3412, DOI 10.1182/blood.V85.12.3412.bloodjournal85123412; Matthews BD, 2005, J SURG RES, V123, P227, DOI 10.1016/j.jss.2004.08.012; Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4; Mizutani H, 1996, Nagoya J Med Sci, V59, P37; Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063; Nair A, 2011, ACTA BIOMATER, V7, P3887, DOI 10.1016/j.actbio.2011.06.050; Nair AM, 2013, BIOMATERIALS, V34, P7364, DOI 10.1016/j.biomaterials.2013.06.031; Najman S, 2004, BIO-MED MATER ENG, V14, P61; Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L; Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019; Pelus LM, 2006, EXP HEMATOL, V34, P1010, DOI 10.1016/j.exphem.2006.04.004; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; Riser BL, 2011, NEPHROL DIAL TRANSPL, V26, P3349, DOI 10.1093/ndt/gfr039; SAMPATH TK, 1992, J BIOL CHEM, V267, P20352; Shen JH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00067; Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Song I, 2011, BIOCHEM BIOPH RES CO, V408, P126, DOI 10.1016/j.bbrc.2011.03.135; Spinella-Jaegle S, 2001, BONE, V29, P323, DOI 10.1016/S8756-3282(01)00580-4; Stocum DL, 2008, DEV DYNAM, V237, P3648, DOI 10.1002/dvdy.21774; Takahashi S, 1987, Nihon Seikeigeka Gakkai Zasshi, V61, P197; TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147; Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549; Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841; Thevenot P, 2008, TISSUE ENG PART C-ME, V14, P319, DOI 10.1089/ten.tec.2008.0221; Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144; TULI SM, 1978, J BONE JOINT SURG BR, V60, P116, DOI 10.1302/0301-620X.60B1.342532; URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601; Vranken I, 2008, BIOMATERIALS, V29, P797, DOI 10.1016/j.biomaterials.2007.10.041; Wayne JS, 2005, TISSUE ENG, V11, P953, DOI 10.1089/ten.2005.11.953; WLODARSKI KH, 1991, CLIN ORTHOP RELAT R, P8; Yaccoby S, 2007, BLOOD, V109, P2106, DOI 10.1182/blood-2006-09-047712; Zhang F, 2009, J BIOL CHEM, V284, P17564, DOI 10.1074/jbc.M109.013987; Zhang J, 2004, LEUKEMIA RES, V28, P631, DOI 10.1016/j.leukres.2003.10.028; Zheng JK, 2012, NATURE, V485, P656, DOI 10.1038/nature11095	71	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93514	10.1371/journal.pone.0093514	http://dx.doi.org/10.1371/journal.pone.0093514			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681529	Green Published, Green Submitted, gold			2022-12-27	WOS:000333678100051
J	Dia, N; Sarr, FD; Thiam, D; Sarr, TF; Espie, E; OmarBa, I; Coly, M; Niang, M; Richard, V				Dia, Ndongo; Sarr, Fatoumata Diene; Thiam, Diamilatou; Sarr, Tening Faye; Espie, Emmanuelle; OmarBa, Ibrahim; Coly, Malang; Niang, Mbayame; Richard, Vincent		4S Network Grp	Influenza-Like Illnesses in Senegal: Not Only Focus on Influenza Viruses	PLOS ONE			English	Article							SENTINEL SURVEILLANCE; VIRAL ETIOLOGY; MADAGASCAR	Influenza surveillance in African countries was initially restricted to the identification of circulating strains. In Senegal, the network has recently been enhanced (i) to include epidemiological data from Dakar and other regions and (ii) to extend virological surveillance to other respiratory viruses. Epidemiological data from the sentinel sites is transmitted daily by mobile phone. The data include those for other febrile syndromes similar to influenza- like illnesses (ILI), corresponding to integrated approach. Also, clinical samples are randomly selected and analyzed for influenza and other respiratory viruses. There were 101,640 declared visits to the 11 sentinel sites between week 11-2012 and week 35-2013; 22% of the visits were for fever syndromes and 23% of the cases of fever syndrome were ILI. Influenza viruses were the second most frequent cause of ILI (20%), after adenoviruses (21%) and before rhinoviruses (18%) and enteroviruses (15%). Co-circulation and co-infection were frequent and were responsible for ILI peaks. The first months of implementation of the enhanced surveillance system confirmed that viruses other the influenza make large contributions to influenza- like illnesses. It is therefore important to consider these etiologies in the development of strategies to reduce respiratory infections. More informative tools and research studies are required to assess the burden of respiratory infections in developing countries.	[Dia, Ndongo; Niang, Mbayame] Pasteur Inst Dakar, Virol Unit, Dakar, Senegal; [Sarr, Fatoumata Diene; Thiam, Diamilatou; Sarr, Tening Faye; Espie, Emmanuelle; Richard, Vincent] Pasteur Inst Dakar, Epidemiol Unit, Dakar, Senegal; [OmarBa, Ibrahim] Minist Hlth, Dakar, Senegal; [Coly, Malang] World Hlth Org, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; World Health Organization	Richard, V (corresponding author), Pasteur Inst Dakar, Epidemiol Unit, Dakar, Senegal.	vrichard@pasteur.sn		Vincent, RICHARD/0000-0002-6961-1753	Department of Health and Human Service via the International Network of Pasteur Institutes [IDSEP 110011-01-00]	Department of Health and Human Service via the International Network of Pasteur Institutes	This network was supported by the Department of Health and Human Service (Grant Number: IDSEP 110011-01-00) via the International Network of Pasteur Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dosseh A, 2000, AM J TROP MED HYG, V62, P639, DOI 10.4269/ajtmh.2000.62.639; El Moussi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074064; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Heraud JM, 2012, J INFECT DIS, V206, pS5, DOI 10.1093/infdis/jis541; Kebede S, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-22; Kim HK, 2013, J CLIN MICROBIOL, V51, P1137, DOI 10.1128/JCM.02958-12; Lipsitch M, 2009, NEW ENGL J MED, V361, P112, DOI 10.1056/NEJMp0904380; Monto AS, 2004, INT CONGR SER, V1263, P3, DOI 10.1016/j.ics.2004.02.049; Niang MN, 2012, J INFECT DIS, V206, pS129, DOI 10.1093/infdis/jis576; Niang MN, 2010, J MED VIROL, V82, P866, DOI 10.1002/jmv.21665; Njouom R, 2012, J INFECT DIS, V206, pS29, DOI 10.1093/infdis/jis573; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Rajatonirina S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072839; Rajatonirina S, 2012, B WORLD HEALTH ORGAN, V90, P385, DOI 10.2471/BLT.11.097816; Randrianasolo L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-31; Razanajatovo NH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017579; Schoub Barry D, 2010, Expert Rev Respir Med, V4, P167, DOI 10.1586/ers.10.10; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Yazdanbakhsh M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000182	19	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93227	10.1371/journal.pone.0093227	http://dx.doi.org/10.1371/journal.pone.0093227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675982	Green Published, gold			2022-12-27	WOS:000333677500095
J	Guo, ZN; Liu, J; Xing, YQ; Yan, S; Lv, CL; Jin, H; Yang, Y				Guo, Zhen-Ni; Liu, Jia; Xing, Yingqi; Yan, Shuo; Lv, Cunling; Jin, Hang; Yang, Yi			Dynamic Cerebral Autoregulation Is Heterogeneous in Different Subtypes of Acute Ischemic Stroke	PLOS ONE			English	Article							CAROTID-ARTERY STENOSIS; SMALL VESSEL DISEASE; MULTICENTER; RISK	Background and Purpose: Stroke of large-artery atherosclerosis and small-artery occlusion are two main subtypes of stroke according to TOAST classification. The underlying mechanisms of how these two subtypes affect dynamic cerebral autoregulation (dCA) might be heterogeneous, resulting in varied clinical conditions and outcomes. We therefore studied the pattern of dCA in these two subtypes. Methods: Forty-one patients with acute unilateral middle cerebral artery (MCA) territory stroke (15 with ipsilateral large-artery atherosclerosis and 26 with small-artery occlusion) and 20 healthy volunteers were enrolled. Non-invasive continuous cerebral blood flow velocity and arterial blood pressure were recorded simultaneously from each subject in supine position using transcranial Doppler on MCA bilaterally and servo-controlled plethysmograph on the middle finger, respectively. Transfer function analysis was applied to derive autoregulatory parameters, gain, phase difference (PD), and slope of step response. Results: In the large-artery atherosclerosis group, PD in affected hemisphere was 42.9 +/- 18.5 degree, which is significantly lower than the unaffected hemisphere (72.4 +/- 29.9 degree, P < 0.01), and the healthy group (P < 0.01). However, PD is similar in the unaffected hemisphere and healthy group (P > 0.1). In the small-artery occlusion group, PD in the affected hemisphere was similar to that in the contralateral hemisphere (33.8 +/- 17.9 vs. 32.6 +/- 21.1 degree, P > 0.1), both sides were significantly lower than the healthy group (all P < 0.001). The results of the slope of step response agree with the findings in PD. Conclusions: DCA in different subtypes of acute ischemic stroke is heterogeneous, which might be attributed to the varied pathologic changes of cerebral blood vessels.	[Guo, Zhen-Ni; Yan, Shuo; Lv, Cunling; Jin, Hang; Yang, Yi] Jilin Univ, Dept Neurol, Neurosci Ctr, Norman Bethune Hosp 1, Changchun 130023, Peoples R China; [Liu, Jia] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Xing, Yingqi] Jilin Univ, Ctr Neurovasc Ultrasound, Norman Bethune Hosp 1, Changchun 130023, Peoples R China	Jilin University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Jilin University	Yang, Y (corresponding author), Jilin Univ, Dept Neurol, Neurosci Ctr, Norman Bethune Hosp 1, Changchun 130023, Peoples R China.	doctor_yangyi@hotmail.com		Xing, Yingqi/0000-0002-7403-5789; Yang, Yi/0000-0002-9729-8522				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Caplan LR, 1998, ARCH NEUROL-CHICAGO, V55, P1475, DOI 10.1001/archneur.55.11.1475; Dawson SL, 2003, CEREBROVASC DIS, V16, P69, DOI 10.1159/000070118; Diehl Rolf R, 2002, Eur J Ultrasound, V16, P31, DOI 10.1016/S0929-8266(02)00048-4; Eames PJ, 2002, J NEUROL NEUROSUR PS, V72, P467; Gong XP, 2006, NEUROL RES, V28, P76, DOI 10.1179/016164106X91915; Haubrich C, 2004, STROKE, V35, P848, DOI 10.1161/01.STR.0000120729.99039.B6; Henderson RD, 2000, STROKE, V31, P128, DOI 10.1161/01.STR.31.1.128; Immink RV, 2005, STROKE, V36, P2595, DOI 10.1161/01.STR.0000189624.06836.03; Khan U, 2007, J NEUROL NEUROSUR PS, V78, P702, DOI 10.1136/jnnp.2006.103549; KLEISER B, 1992, STROKE, V23, P171, DOI 10.1161/01.STR.23.2.171; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Liu Y, 2003, MED ENG PHYS, V25, P647, DOI 10.1016/S1350-4533(03)00015-8; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Reinhard M, 2005, STROKE, V36, P1684, DOI 10.1161/01.STR.0000173183.36331.ee; Reinhard M, 2004, STROKE, V35, P1381, DOI 10.1161/01.STR.0000127533.46914.31; Reinhard M, 2012, ACTA NEUROL SCAND, V125, P156, DOI 10.1111/j.1600-0404.2011.01515.x; Saeed NP, 2013, CEREBROVASC DIS, V35, P257, DOI 10.1159/000347075; White RP, 1997, STROKE, V28, P1340, DOI 10.1161/01.STR.28.7.1340; Wijnhoud AD, 2008, ULTRASOUND MED BIOL, V34, P923, DOI 10.1016/j.ultrasmedbio.2007.11.022; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233; Zhao LM, 2011, STROKE, V42, P3429, DOI 10.1161/STROKEAHA.111.621235	22	34	37	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93213	10.1371/journal.pone.0093213	http://dx.doi.org/10.1371/journal.pone.0093213			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671155	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677000128
J	Jagielski, AC; Brown, A; Hosseini-Araghi, M; Thomas, GN; Taheri, S				Jagielski, Alison C.; Brown, Adrian; Hosseini-Araghi, Marzieh; Thomas, G. Neil; Taheri, Shahrad			The Association between Adiposity, Mental Well-Being, and Quality of Life in Extreme Obesity	PLOS ONE			English	Article							BODY-MASS INDEX; HOSPITAL ANXIETY; HEALTH-STATUS; DEPRESSION; POPULATION; DISORDERS; EUROQOL; SCALE; MOOD	Objectives: To explore the cross-sectional association between adiposity, mental well-being, and quality of life in extreme obese individuals entering a UK specialist weight management service prior to treatment commencement. Methods: The sample comprised 263 extreme obese individuals who were referred to the service as a result of having a body mass index (BMI) >= 40 kg/m(2) or >= 35 kg/m(2) with a co-morbid health condition. In a retrospective analysis, routinely collected baseline clinical examination data and self-report questionnaires (Impact of Weight on Quality of Life: IWQOL-Lite, EQ5D-3L, and Hospital Anxiety and Depression Scale: HADS) were analysed to examine the cross-sectional association between adiposity and quality of life. Results: The sample was predominantly female (74.8%) with mean BMI 47.0 +/- 7.9 kg/m(2). Increasing adiposity was significantly negatively associated with quality of life, with an increase of 1 BMI unit associated with decreases of 1.93 in physical function (95% CI -2.86 + -1.00, p<0.001), 1.62 in self-esteem (95% CI -2.67 + -0.57, p<0.05), 2.69 in public distress (95% CI -3.75 + -1.62, p<0.001), 1.33 in work (95% CI -2.63 + -0.02, p<0.05), and 1.79 in total IWQOL-Lite scores (95% CI -2.65 + -0.93, p<0.001). Adiposity was associated with significantly increased risk of problems in mobility (OR = 3.44, 95% CI 1.4728.05), and performing usual activities (OR = 2.45, 95% CI 1.10-5.46) in highest relative to lowest BMI tertile. The prevalence of experience of symptoms of anxiety (70.3%) and depression (66.2%) as measured by HADS was consistently high. Conclusions: We identified a high prevalence of psychological co-morbidity, including widespread experience of symptoms of anxiety and depressive disorders and reduced quality of life among these extreme obese individuals seeking weight management treatment. Clinical implications include the need for the incorporation of strategies to improve mental wellbeing into multi-disciplinary weight management interventions.	[Jagielski, Alison C.; Hosseini-Araghi, Marzieh; Thomas, G. Neil; Taheri, Shahrad] Birmingham & Black Country NIHR CLAHRC, Birmingham, W Midlands, England; [Brown, Adrian; Taheri, Shahrad] Heart England NHS Fdn Trust, Specialist Weight Management Serv, Birmingham, W Midlands, England; [Thomas, G. Neil] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Thomas, G. Neil] Heidelberg Univ, Mannheim Med Fac, Inst Publ Hlth Social & Prevent Med, Mannheim, Germany; [Taheri, Shahrad] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Taheri, Shahrad] Kings Coll London, Dept Med, London, England	Heart of England NHS Foundation Trust; University of Birmingham; Ruprecht Karls University Heidelberg; Cornell University; University of London; King's College London	Thomas, GN (corresponding author), Birmingham & Black Country NIHR CLAHRC, Birmingham, W Midlands, England.	gneilthomas@yahoo.co.uk; staheri@me.com	Taheri, Shahrad/O-9721-2016; Thomas, G. Neil/A-1879-2013	Taheri, Shahrad/0000-0001-8314-1500; Thomas, G. Neil/0000-0002-2777-1847	National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme	National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme(National Institute for Health Research (NIHR))	AJ, MHA and ST were supported by the National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme. NIHR disclaimer: This paper presents independent work supported by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atlantis E, 2008, INT J OBESITY, V32, P881, DOI 10.1038/ijo.2008.54; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Bruffaerts R, 2008, CAN J PSYCHIAT, V53, P679, DOI 10.1177/070674370805301007; Butler GS, 1999, INT J OBESITY, V23, P505, DOI 10.1038/sj.ijo.0800850; Cox TL, 2012, APPL RES QUAL LIFE, V7, P309, DOI 10.1007/s11482-011-9160-8; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Dixon JB, 2002, OBES SURG, V12, P65, DOI 10.1381/096089202321144612; Doll HA, 2000, OBES RES, V8, P160, DOI 10.1038/oby.2000.17; Fabricatore AN, 2005, OBES SURG, V15, P304, DOI 10.1381/0960892053576578; Fettich KC, 2012, OBESITY, V20, P1118, DOI 10.1038/oby.2012.12; FITZGIBBON ML, 1993, HEALTH PSYCHOL, V12, P342, DOI 10.1037/0278-6133.12.5.342; Fontaine KR, 1996, J FAM PRACTICE, V43, P265; Gariepy G, 2010, INT J OBESITY, V34, P407, DOI 10.1038/ijo.2009.252; Health and Social Care Information Centre, 2012, HLTH SURV ENGL 2012; Health and Social Care Information Centre, 2012, HLTH SURV ENGL 2011; Heo M, 2003, OBES RES, V11, P209, DOI 10.1038/oby.2003.33; Jia HM, 2005, J PUBLIC HEALTH-UK, V27, P156, DOI 10.1093/pubmed/fdi025; Karlsson J, 2007, INT J OBESITY, V31, P1248, DOI 10.1038/sj.ijo.0803573; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Kolotkin RL, 2002, OBES RES, V10, P748, DOI 10.1038/oby.2002.102; Kolotkin RL, 2001, OBES RES, V9, P564, DOI 10.1038/oby.2001.73; Kolotkin RL, 2001, OBES RES, V9, P102, DOI 10.1038/oby.2001.13; Kolotkin RL, 2006, OBESITY, V14, P472, DOI 10.1038/oby.2006.62; Korhonen PE, 2014, QUAL LIFE RES, V23, P67, DOI 10.1007/s11136-013-0433-6; Mannucci E, 1999, ADDICT BEHAV, V24, P345, DOI 10.1016/S0306-4603(98)00055-0; McElroy SL, 2004, J CLIN PSYCHIAT, V65, P634; Murphy JM, 2009, INT J OBESITY, V33, P335, DOI 10.1038/ijo.2008.273; National Patient Safety Agency, 2009, DEF RES NRES GUID HE; Onyike CU, 2003, AM J EPIDEMIOL, V158, P1139, DOI 10.1093/aje/kwg275; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; Sach TH, 2007, INT J OBESITY, V31, P189, DOI 10.1038/sj.ijo.0803365; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Sturm R, 2013, INT J OBESITY, V37, P889, DOI 10.1038/ijo.2012.159; Tessier A, 2011, QUAL LIFE RES, V20, P467, DOI 10.1007/s11136-010-9787-1; Thomas DM, 2013, OBESITY, DOI [10.1002/oby.20520, DOI 10.1002/0BY.20520]; WADDEN TA, 1985, ANN INTERN MED, V103, P1062, DOI 10.7326/0003-4819-103-6-1062; Zhao G, 2009, INT J OBESITY, V33, P257, DOI 10.1038/ijo.2008.268; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	39	38	38	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92859	10.1371/journal.pone.0092859	http://dx.doi.org/10.1371/journal.pone.0092859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24671197	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000086
J	Muller-Nordhorn, J; Muckelbauer, R; Englert, H; Grittner, U; Berger, H; Sonntag, F; Voller, H; Prugger, C; Wegscheider, K; Katus, HA; Willich, SN				Mueller-Nordhorn, Jacqueline; Muckelbauer, Rebecca; Englert, Heike; Grittner, Ulrike; Berger, Hendrike; Sonntag, Frank; Voeller, Heinz; Prugger, Christof; Wegscheider, Karl; Katus, Hugo A.; Willich, Stefan N.			Longitudinal Association between Body Mass Index and Health-Related Quality of Life	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; OLDER-ADULTS; US POPULATION; WEIGHT-LOSS; PHYSICAL-ACTIVITY; CHRONIC ILLNESS; HEART-FAILURE; WHITEHALL II; PRIMARY-CARE; OBESITY	Objective: Health-related quality of life (HRQoL) is an important outcome in individuals with a high risk for cardiovascular diseases. We investigated the association of HRQoL and body mass index (BMI) as an indicator for obesity. Design: Secondary longitudinal analysis of the ORBITAL study, an intervention study which included high-risk cardiovascular primary care patients with hypercholesterolemia and an indication for statin therapy. Methods: HRQoL was determined with the generic Short Form (SF)-12 health status instrument. Body weight and height were assessed at baseline and at months 6, 12, 18, 24, 30, and 36. We used a linear and a linear mixed-effects regression model to investigate the association between BMI and SF-12 summary scores at baseline as well as between change in BMI and SF-12 summary scores over 3 years. We adjusted for age, sex, smoking status, and in the longitudinal analysis also for the study arm and its interaction term with time. Results: Of the 7640 participants who completed the baseline questionnaire, 6726 participants (mean age: 61 years) were analyzed. The baseline BMI was inversely associated with physical and mental SF-12 summary scores (beta [95% CI] per 1 kg/ m(2) : -0.36 [-0.41; -0.30] and -0.05 [-0.11; -0.00], respectively). A significant association between the change in BMI and physical SF-12 summary scores over time was only present in women (-0.18 [-0.27; -0.09]) and only in obese participants (-0.19 [-0.29; -0.10]). A change in BMI was directly associated with mental SF-12 summary scores (0.12 [0.06; 0.19]) in the total population. Conclusion: Increases in BMI were associated with decreases in physical HRQoL, particularly in obese individuals and in women. In contrast, the mental HRQoL seemed to increase with increasing BMI over time. Thus, body weight management with respect to the HRQoL should be evaluated differentially by sex and body weight status.	[Mueller-Nordhorn, Jacqueline; Willich, Stefan N.] Charite, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany; [Mueller-Nordhorn, Jacqueline; Muckelbauer, Rebecca] Charite, Berlin Sch Publ Hlth, D-13353 Berlin, Germany; [Englert, Heike] Univ Appl Sci, Munster, Germany; [Grittner, Ulrike] Charite, Dept Biostat & Clin Epidemiol, D-13353 Berlin, Germany; [Berger, Hendrike] Univ Appl Sci, Osnabruck, Germany; [Voeller, Heinz] Univ Potsdam, Rehabil Res Ctr, Potsdam, Germany; [Prugger, Christof] Univ Paris 05, Sorbonne Paris Cite, Paris Cardiovasc Res Ctr, UMR S970, Paris, France; [Wegscheider, Karl] Univ Hamburg, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Katus, Hugo A.] Heidelberg Univ, Dept Cardiol Angiol & Pneumol, Heidelberg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Applied Sciences, Muenster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Potsdam; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Hamburg; Ruprecht Karls University Heidelberg	Muller-Nordhorn, J (corresponding author), Charite, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany.	jacqueline.mueller-nordhorn@charite.de	Grittner, Ulrike/I-2026-2019	Grittner, Ulrike/0000-0003-2595-0224; Prugger, Christof/0000-0003-1845-0950; Muckelbauer, Rebecca/0000-0001-5979-2469	AstraZeneca	AstraZeneca(AstraZeneca)	The original intervention study was supported by an unconditional grant from AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The present analysis was supported exclusively by the Berlin School of Public Health, Charite University Medical Center Berlin.	ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Aranceta J, 2009, NUTR REV, V67, pS83, DOI 10.1111/j.1753-4887.2009.00166.x; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bottone FG, 2013, J NUTR HEALTH AGING, V17, P495, DOI 10.1007/s12603-013-0022-y; Brown WJ, 1998, INT J OBESITY, V22, P520, DOI 10.1038/sj.ijo.0800617; Brown WJ, 2000, INT J OBESITY, V24, P1360, DOI 10.1038/sj.ijo.0801384; BULLINGER M., 1998, HDB DEUTSCHSPRACHIGE; Cameron AJ, 2012, INT J OBESITY, V36, P295, DOI 10.1038/ijo.2011.103; Zuluaga MC, 2010, EUR J HEART FAIL, V12, P1372, DOI 10.1093/eurjhf/hfq163; Doll HA, 2000, OBES RES, V8, P160, DOI 10.1038/oby.2000.17; Fine JT, 1999, JAMA-J AM MED ASSOC, V282, P2136, DOI 10.1001/jama.282.22.2136; Finkelstein MM, 2000, J FAM PRACTICE, V49, P734; Flegal KM, 2007, AM J EPIDEMIOL, V166, P975, DOI 10.1093/aje/kwm152; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Ford ES, 2001, OBES RES, V9, P21, DOI 10.1038/oby.2001.4; Franco OH, 2012, EUR J EPIDEMIOL, V27, P255, DOI 10.1007/s10654-012-9664-z; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Groessl EJ, 2004, AM J PREV MED, V26, P126, DOI 10.1016/j.amepre.2003.10.007; Han TS, 1998, AM J PUBLIC HEALTH, V88, P1814, DOI 10.2105/AJPH.88.12.1814; Hassan MK, 2003, INT J OBESITY, V27, P1227, DOI 10.1038/sj.ijo.0802396; Heo M, 2003, OBES RES, V11, P209, DOI 10.1038/oby.2003.33; Herman KM, 2012, MED SCI SPORT EXER, V44, P625, DOI 10.1249/MSS.0b013e31823a90ae; Hernandez JL, 2003, AM J MED, V114, P631, DOI 10.1016/S0002-9343(03)00115-3; Huang IC, 2006, INT J OBESITY, V30, P1250, DOI 10.1038/sj.ijo.0803250; Hunger M, 2012, J DIABETES COMPLICAT, V26, P413, DOI 10.1016/j.jdiacomp.2012.05.008; Jia HM, 2005, J PUBLIC HEALTH-UK, V27, P156, DOI 10.1093/pubmed/fdi025; Kato N, 2011, CIRC J, V75, P1661, DOI 10.1253/circj.CJ-10-1308; Katz DA, 2000, J GEN INTERN MED, V15, P789, DOI 10.1046/j.1525-1497.2000.90906.x; Kinge JM, 2010, SOC SCI MED, V71, P1864, DOI 10.1016/j.socscimed.2010.09.001; Kocalevent RD, 2013, GEN HOSP PSYCHIAT; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Landman GWD, 2010, DIABETES CARE, V33, P2378, DOI 10.2337/dc10-0979; Larsson U, 2002, INT J OBESITY, V26, P417, DOI 10.1038/sj.ijo.0801919; Le Pen C, 1998, J EPIDEMIOL COMMUN H, V52, P445, DOI 10.1136/jech.52.7.445; Lean MEJ, 1999, ARCH INTERN MED, V159, P837, DOI 10.1001/archinte.159.8.837; Lean MEJ, 1998, LANCET, V351, P853, DOI 10.1016/S0140-6736(97)10004-6; Lenz M, 2009, DTSCH ARZTEBL INT, V106, P641, DOI 10.3238/arztebl.2009.0641; Maatouk I, 2012, J HYPERTENS, V30, P1364, DOI 10.1097/HJH.0b013e328353d81b; Maatouk I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031088; Maciejewski ML, 2005, J CLIN EPIDEMIOL, V58, P568, DOI 10.1016/j.jclinepi.2004.10.015; McMinn J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1732; Moriel G, 2010, ARQ BRAS CARDIOL, V95, P691, DOI 10.1590/S0066-782X2010001600004; Myint PK, 2007, NEUROLOGY, V69, P2243, DOI 10.1212/01.wnl.0000296010.21252.78; Onyike CU, 2003, AM J EPIDEMIOL, V158, P1139, DOI 10.1093/aje/kwg275; Osthus TBH, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-46; Osthus TBH, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-78; Sach TH, 2007, INT J OBESITY, V31, P189, DOI 10.1038/sj.ijo.0803365; Stafford M, 1998, INT J OBESITY, V22, P23, DOI 10.1038/sj.ijo.0800539; Tapp R, 2010, DIABETES CARE, V33, P757, DOI 10.2337/dc09-1107; ter Horst R, 2012, INTERACT CARDIOV TH, V15, P651, DOI 10.1093/icvts/ivs184; Ul-Haq Z, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-143; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wee HL, 2008, VALUE HEALTH, V11, pS105, DOI 10.1111/j.1524-4733.2008.00374.x; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Willich SN, 2004, AM HEART J, V148, P1060, DOI 10.1016/j.ahj.2004.05.032; Willich SN, 2009, EUR J CARDIOV PREV R, V16, P180, DOI 10.1097/HJR.0b013e3283262ac3; World Health Organization, 2000, OB PREV MAN GLOB EP, pi; Yan LJL, 2004, OBES RES, V12, P69, DOI 10.1038/oby.2004.10; Yancy WS, 2002, OBES RES, V10, P1057, DOI 10.1038/oby.2002.143	60	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93071	10.1371/journal.pone.0093071	http://dx.doi.org/10.1371/journal.pone.0093071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24671104	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000110
J	Moores, G; Shakarian, P; Macdonald, B; Howard, N				Moores, Geoffrey; Shakarian, Paulo; Macdonald, Brian; Howard, Nicholas			Finding Near-Optimal Groups of Epidemic Spreaders in a Complex Network	PLOS ONE			English	Article								In this paper, we present algorithms to find near-optimal sets of epidemic spreaders in complex networks. We extend the notion of local-centrality, a centrality measure previously shown to correspond with a node's ability to spread an epidemic, to sets of nodes by introducing combinatorial local centrality. Though we prove that finding a set of nodes that maximizes this new measure is NP-hard, good approximations are available. We show that a strictly greedy approach obtains the best approximation ratio unless P = NP and then formulate a modified version of this approach that leverages qualities of the network to achieve a faster runtime while maintaining this theoretical guarantee. We perform an experimental evaluation on samples from several different network structures which demonstrate that our algorithm maximizes combinatorial local centrality and consistently chooses the most effective set of nodes to spread infection under the SIR model, relative to selecting the top nodes using many common centrality measures. We also demonstrate that the optimized algorithm we develop scales effectively.	[Moores, Geoffrey; Shakarian, Paulo] US Mil Acad, Elect Engn & Comp Sci Dept, West Point, NY 10996 USA; [Macdonald, Brian; Howard, Nicholas] US Mil Acad, Dept Math Sci, West Point, NY 10996 USA; [Moores, Geoffrey; Shakarian, Paulo; Macdonald, Brian; Howard, Nicholas] US Mil Acad, Network Sci Ctr, West Point, NY 10996 USA	United States Department of Defense; United States Army; United States Military Academy; United States Department of Defense; United States Army; United States Military Academy; United States Department of Defense; United States Army; United States Military Academy	Shakarian, P (corresponding author), US Mil Acad, Elect Engn & Comp Sci Dept, West Point, NY 10996 USA.	paulo@shakarian.net	Shakarian, Paulo/GPK-6176-2022; Macdonald, Brian/AAY-5603-2021	Shakarian, Paulo/0000-0002-3159-4660; Macdonald, Brian/0000-0003-4229-9752	Army Research Office	Army Research Office	This work is funded by the Army Research Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Arenas A., 2009, JAZZ MUSICIANS NETWO; Barabasi AL, 2007, NETWORK DATABASES; Borgatti S. P., 2006, Computational & Mathematical Organization Theory, V12, P21, DOI 10.1007/s10588-006-7084-x; Borge-Holthoefer J, 2011, PHYS SOC; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Castellano, 2012, SCI REPORTS; Chen DB, 2012, PHYSICA A, V391, P1777, DOI 10.1016/j.physa.2011.09.017; Chen W, 2010, P 16 ACM SIGKDD INT, P1029, DOI DOI 10.1145/1835804.1835934; Easley D, 2010, NETWORKS CROWDS MARK; Feige U, 1998, J ACM, V45, P634, DOI 10.1145/285055.285059; Garey M.R., 1979, COMPUTERS INTRACTABI; Gleeson JP, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056103; Kang C, 2012, P 2012 IEEE ACM INT; Kempe D, 2003, P 9 ACM SIGKDD INT C, V2003, P137, DOI DOI 10.1145/956750.956769; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Klemm K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00292; Leskovec J., 2012, STANFORD NETWORK ANA; Leskovec J, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P420; NEMHAUSER GL, 1978, MATH PROGRAM, V14, P265, DOI 10.1007/BF01588971; Ortiz-Arroyo D, 2008, LECT NOTES COMPUT SC, V5376, P15, DOI 10.1007/978-3-540-89900-6_5; Rocha LEC, 2010, P NATL ACAD SCI; Swart P, 2013, NETWORKX; Zafarani R., 2009, SOCIAL COMPUTING DAT; Zafarani R, 2009, SOCIAL COMPUTING REP	25	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e90303	10.1371/journal.pone.0090303	http://dx.doi.org/10.1371/journal.pone.0090303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24694693	Green Published, gold			2022-12-27	WOS:000334103000007
J	Dawson, TF; Boone, AN; Senatore, A; Piticaru, J; Thiyagalingam, S; Jackson, D; Davison, A; Spafford, JD				Dawson, Taylor F.; Boone, Adrienne N.; Senatore, Adriano; Piticaru, Joshua; Thiyagalingam, Shano; Jackson, Daniel; Davison, Angus; Spafford, J. David			Gene Splicing of an Invertebrate Beta Subunit ( LCav beta) in the N-Terminal and HOOK Domains and Its Regulation of LCav1 and LCav2 Calcium Channels	PLOS ONE			English	Article							T-TYPE; PHYLOGENETIC ANALYSIS; CA2+ CHANNELS; MODULATION; INACTIVATION; EXPRESSION; IDENTIFICATION; MECHANISM; DEPLETION; COMPLEX	The accessory beta subunit ( Ca-v beta) of calcium channels first appear in the same genome as Ca(v)1 L- type calcium channels in single-celled coanoflagellates. The complexity of this relationship expanded in vertebrates to include four different possible Ca-v beta subunits ( beta 1, beta 2, beta 3, beta 4) which associate with four Ca(v)1 channel isoforms (Ca(v)1.1 to Ca(v)1.4) and three Ca-v channel isoforms ( Cav2.1 to Cav2.3). Here we assess the fundamentally- shared features of the Ca-v beta subunit in an invertebrate model ( pond snail Lymnaea stagnalis) that bears only three homologous genes: ( LCa(v)1, LCa(v)2, and LCav beta). Invertebrate Ca-v beta subunits ( in flatworms, snails, squid and honeybees) slow the inactivation kinetics of Ca(v)2 channels, and they do so with variable N- termini and lacking the canonical palmitoylation residues of the vertebrate b2a subunit. Alternative splicing of exon 7 of the HOOK domain is a primary determinant of a slow inactivation kinetics imparted by the invertebrate LCav beta subunit. LCav beta will also slow the inactivation kinetics of LCav beta T- type channels, but this is likely not physiologically relevant in vivo. Variable N- termini have little influence on the voltage- dependent inactivation kinetics of differing invertebrate Cavb subunits, but the expression pattern of N- terminal splice isoforms appears to be highly tissue specific. Molluscan LCav beta subunits have an N- terminal "A'' isoform (coded by exons: 1a and 1b) that structurally resembles the muscle specific variant of vertebrate b1a subunit, and has a broad mRNA expression profile in brain, heart, muscle and glands. A more variable "B'' N- terminus ( exon 2) in the exon position of mammalian b3 and has a more brain- centric mRNA expression pattern. Lastly, we suggest that the facilitation of closed- state inactivation ( e. g. observed in Ca(v)2.2 and Ca-v beta 3 subunit combinations) is a specialization in vertebrates, because neither snail subunit ( LCa(v)2 nor LCavCa beta) appears to be compatible with this observed property.	[Dawson, Taylor F.; Boone, Adrienne N.; Senatore, Adriano; Piticaru, Joshua; Thiyagalingam, Shano; Spafford, J. David] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Jackson, Daniel; Davison, Angus] Univ Nottingham, Sch Biol, Inst Genet, Nottingham NG7 2RD, England	University of Waterloo; University of Nottingham	Spafford, JD (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	spafford@uwaterloo.ca	Jackson, Daniel J./J-5158-2012; Davison, Angus/C-3156-2009	Jackson, Daniel J./0000-0001-9045-381X; Davison, Angus/0000-0003-2554-8585	Heart and Stroke Foundation of Canada; NSERC; NSERC Canada Graduate Scholarship; Ontario Graduate Scholarship award; Biotechnology and Biological Sciences Research Council [BB/F018940/1] Funding Source: researchfish; BBSRC [BB/F018940/1] Funding Source: UKRI	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship award(Ontario Graduate Scholarship); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded through a Heart and Stroke Foundation of Canada Grant-In-Aid and NSERC Discovery Grant to J.D.S. and an NSERC Canada Graduate Scholarship and Ontario Graduate Scholarship award to A. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagor L, 2012, J NEUROSCI, V32, P7602, DOI 10.1523/JNEUROSCI.5727-11.2012; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Arias JM, 2005, FEBS LETT, V579, P3907, DOI 10.1016/j.febslet.2005.06.008; Bae J, 2010, MOL CELLS, V30, P185, DOI 10.1007/s10059-010-0106-z; Berjukow S, 1996, BRIT J PHARMACOL, V118, P748, DOI 10.1111/j.1476-5381.1996.tb15463.x; Buraei Z, 2012, BIOCH BIOPHYS ACTA; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Canti C, 2001, BIOPHYS J, V81, P1439, DOI 10.1016/S0006-3495(01)75799-2; Cens T, 2013, PFLUG ARCH EUR J PHY, V465, P985, DOI 10.1007/s00424-013-1223-2; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Christel C, 2012, BBA-GEN SUBJECTS, V1820, P1243, DOI 10.1016/j.bbagen.2011.12.012; Cohen RM, 2005, AM J PHYSIOL-HEART C, V288, pH2363, DOI 10.1152/ajpheart.00348.2004; Currie KPM, 2010, CHANNELS, V4, P497, DOI 10.4161/chan.4.6.12871; de Mendoza A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-93; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DEWAARD M, 1995, J BIOL CHEM, V270, P12056, DOI 10.1074/jbc.270.20.12056; Dolphin AC, 2012, BIOCH BIOPHYS ACTA; Dolphin AC, 2012, NAT REV NEUROSCI, V13, P542, DOI 10.1038/nrn3311; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Dubel SJ, 2004, J BIOL CHEM, V279, P29263, DOI 10.1074/jbc.M313450200; Ebert AM, 2008, PHYSIOL GENOMICS, V35, P133, DOI 10.1152/physiolgenomics.90264.2008; Ebert AM, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-38; Fang K, 2011, J PHYSIOL-LONDON, V589, P4437, DOI 10.1113/jphysiol.2011.214247; Foell JD, 2004, PHYSIOL GENOMICS, V17, P183, DOI 10.1152/physiolgenomics.00207.2003; Fux J, ACCESSORY BETA SUBUN; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; Hanlon MR, 2002, BIOCHEMISTRY-US, V41, P2886, DOI 10.1021/bi0119565; Harry JB, 2004, J BIOL CHEM, V279, P46367, DOI 10.1074/jbc.M409523200; Herzig S, 2007, FASEB J, V21, P1527, DOI 10.1096/fj.06-7377com; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; Huang X, 2010, J EXP BIOL, V213, P2094, DOI 10.1242/jeb.042242; Jangsangthong W, 2010, PFLUG ARCH EUR J PHY, V459, P399, DOI 10.1007/s00424-009-0738-z; Kimura T, 2003, NEUROSCI RES, V46, P105, DOI 10.1016/S0168-0102(03)00038-5; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; LACERDA AE, 1994, BIOPHYS J, V66, P1833, DOI 10.1016/S0006-3495(94)80977-4; Lambert RC, 1997, J NEUROSCI, V17, P6621; Leuranguer V, 1998, NEUROPHARMACOLOGY, V37, P701, DOI 10.1016/S0028-3908(98)00060-4; Li J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-337; Ly CV, 2008, J CELL BIOL, V181, P157, DOI 10.1083/jcb.200712152; Mangubat EZ, 2003, J MOL MICROB BIOTECH, V5, P216, DOI 10.1159/000071073; Miranda-Laferte E, 2012, J BIOL CHEM, V287, P32588, DOI 10.1074/jbc.M112.362509; Murakami M, 2007, BRAIN RES, V1160, P102, DOI 10.1016/j.brainres.2007.05.041; Obermair GJ, 2008, CURR OPIN PHARMACOL, V8, P311, DOI 10.1016/j.coph.2008.01.008; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Patil PG, 1998, NEURON, V20, P1027, DOI 10.1016/S0896-6273(00)80483-3; Patino GA, 2010, NEUROSCI LETT, V486, P53, DOI 10.1016/j.neulet.2010.06.050; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Restituito S, 2000, J NEUROSCI, V20, P9046; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richards MW, 2007, CHANNELS, V1, P92, DOI 10.4161/chan.4145; Rougier JS, 2011, J BIOL CHEM, V286, P8829, DOI 10.1074/jbc.M110.166520; Sadamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042546; Salvador-Recatala Vicenta, 2008, BMC Physiology, V8, P6, DOI 10.1186/1472-6793-8-6; Schredelseker J, 2005, P NATL ACAD SCI USA, V102, P17219, DOI 10.1073/pnas.0508710102; Senatore A., 2012, WIRES MEMBR TRANSP S, V1, P467, DOI DOI 10.1002/WMTS.41; Senatore A, 2013, CHANNELS AUSTIN, P7; Senatore A, 2014, J BIOL CHEM; Senatore A, 2011, JOVE-J VIS EXP, DOI 10.3791/2314; Senatore A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037409; Senatore A, 2011, CHANNELS, V5, P173, DOI 10.4161/chan.5.2.15141; Senatore A, 2010, J BIOL CHEM, V285, P7447, DOI 10.1074/jbc.M109.090753; Shepard S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007853; Spafford JD, 2006, J NEUROPHYSIOL, V95, P42, DOI 10.1152/jn.00658.2005; Spafford JD, 2004, J BIOL CHEM, V279, P41157, DOI 10.1074/jbc.M403781200; Spafford JD, 2003, J BIOL CHEM, V278, P21178, DOI 10.1074/jbc.M302212200; Subramanyam P, 2009, CHANNELS, V3, P343, DOI 10.4161/chan.3.5.9696; Taiakina V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061765; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; Tseng TT, 2007, J MOL MICROB BIOTECH, V12, P249, DOI 10.1159/000099646; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Velthuis AJWT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-129; Vitko I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003560; Waithe D, 2011, J BIOL CHEM, V286, P9598, DOI 10.1074/jbc.M110.195909; WITCHER DR, 1993, SCIENCE, V261, P486, DOI 10.1126/science.8392754; Xu XF, 2011, J BIOL CHEM, V286, P9677, DOI 10.1074/jbc.M110.187864; Yasuda T, 2004, J GEN PHYSIOL, V123, P401, DOI 10.1085/jgp.200308967; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; Zhang Y, 2010, J BIOL CHEM, V285, P2527, DOI 10.1074/jbc.M109.022236; Zhang Y, 2008, J NEUROSCI, V28, P14176, DOI 10.1523/JNEUROSCI.1350-08.2008	81	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92941	10.1371/journal.pone.0092941	http://dx.doi.org/10.1371/journal.pone.0092941			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690951	gold, Green Published, Green Submitted			2022-12-27	WOS:000334101100036
J	Herrera, M; Salva, S; Villena, J; Barbieri, N; Marranzino, G; Alvarez, S				Herrera, Matias; Salva, Susana; Villena, Julio; Barbieri, Natalia; Marranzino, Gabriela; Alvarez, Susana			Dietary Supplementation with Lactobacilli Improves Emergency Granulopoiesis in Protein-Malnourished Mice and Enhances Respiratory Innate Immune Response	PLOS ONE			English	Article							BONE-MARROW; STREPTOCOCCUS-PNEUMONIAE; INFECTION; CASEI; MOBILIZATION; INFLAMMATION; GRANULOCYTE; EXPRESSION; CHEMOKINES; MOLECULES	This work studied the effect of protein malnutrition on the hemato-immune response to the respiratory challenge with Streptococcus pneumoniae and evaluated whether the dietary recovery with a probiotic strain has a beneficial effect in that response. Three important conclusions can be inferred from the results presented in this work: a) protein-malnutrition significantly impairs the emergency myelopoiesis induced by the generation of the innate immune response against pneumococcal infection; b) repletion of malnourished mice with treatments including nasally or orally administered Lactobacillus rhamnosus CRL1505 are able to significantly accelerate the recovery of granulopoiesis and improve innate immunity and; c) the immunological mechanisms involved in the protective effect of immunobiotics vary according to the route of administration. The study demonstrated that dietary recovery of malnourished mice with oral or nasal administration of L. rhamnosus CRL1505 improves emergency granulopoiesis and that CXCR4/CXCR12 signaling would be involved in this effect. Then, the results summarized here are a starting point for future research and open up broad prospects for future applications of probiotics in the recovery of immunocompromised malnourished hosts.	[Herrera, Matias; Salva, Susana; Villena, Julio; Barbieri, Natalia; Marranzino, Gabriela; Alvarez, Susana] Reference Ctr Lactobacilli CERELA CONICET, Immunobiot Res Grp, San Miguel De Tucuman, Argentina; [Herrera, Matias; Salva, Susana; Villena, Julio; Barbieri, Natalia; Alvarez, Susana] Reference Ctr Lactobacilli CERELA CONICET, Lab Immunobiotechnol, San Miguel De Tucuman, Argentina; [Alvarez, Susana] Tucuman Univ, Inst Appl Biochem, San Miguel De Tucuman, Argentina; [Marranzino, Gabriela] Natl Univ Tucuman, INSIBIO CONICET, San Miguel De Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman	Alvarez, S (corresponding author), Reference Ctr Lactobacilli CERELA CONICET, Immunobiot Res Grp, San Miguel De Tucuman, Argentina.	salvarez@cerela.org.ar		Salva, Susana/0000-0001-9571-1259	PIP [632-2009]; CIUNT [26 D/403]; PICT [1381]	PIP; CIUNT; PICT(ANPCyT)	This work was supported by grants from PIP 632-2009, CIUNT 26 D/403 and PICT 2010 No 1381. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero G, 2006, NUTRITION, V22, P810, DOI 10.1016/j.nut.2006.03.013; Alvarez S., 2009, RES ADV INFECT IMMUN, P1; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Barbieri N, 2013, J NUTR, V143, P227, DOI 10.3945/jn.112.165811; Benguigui Yehuda, 2006, Semin Pediatr Infect Dis, V17, P80, DOI 10.1053/j.spid.2006.04.006; Cain DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019957; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Czerkinsky C, 1999, IMMUNOL REV, V170, P197, DOI 10.1111/j.1600-065X.1999.tb01339.x; Czerkinsky C, 2012, CURR TOP MICROBIOL, V354, P1, DOI 10.1007/82_2010_112; Delano MJ, 2011, J IMMUNOL, V187, P911, DOI 10.4049/jimmunol.1100588; Dominis-Kramaric M, 2011, INFLAMMATION, V34, P471, DOI 10.1007/s10753-010-9255-7; Fillion I, 2001, J IMMUNOL, V166, P7353, DOI 10.4049/jimmunol.166.12.7353; Granick JL, 2012, BONE MARROW RES, DOI 10.1155/2012/165107; Kaushansky K, 2006, CYTOKINE GROWTH F R, V17, P423, DOI 10.1016/j.cytogfr.2006.09.005; Kim HK, 2006, BLOOD, V108, P812, DOI 10.1182/blood-2005-10-4162; Kirby AC, 2009, J IMMUNOL, V183, P1983, DOI 10.4049/jimmunol.0901089; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Link DC, 2005, IMMUNOL RES, V32, P169, DOI 10.1385/IR:32:1-3:169; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Mestecky J, 2010, J REPROD IMMUNOL, V85, P81, DOI 10.1016/j.jri.2010.02.003; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Nie L, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-82; Okuno Y, 2002, P NATL ACAD SCI USA, V99, P6246, DOI 10.1073/pnas.092027799; Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; Racedo S, 2006, MICROBES INFECT, V8, P2359, DOI 10.1016/j.micinf.2006.04.022; Rodriguez L, 2011, J NEUROSCI REV, V31, P8373; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Salva S, 2008, FOOD AGR IMMUNOL, V19, P195, DOI 10.1080/09540100802247243; Salva S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031171; Salva S, 2011, J SCI FOOD AGR, V91, P2355, DOI 10.1002/jsfa.4467; Salva S, 2010, INT J FOOD MICROBIOL, V141, P82, DOI 10.1016/j.ijfoodmicro.2010.03.013; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Ueda Y, 2009, J IMMUNOL, V182, P6477, DOI 10.4049/jimmunol.0803961; Villena J, 2006, BRIT J NUTR, V95, P591, DOI 10.1079/BJN20051663; Villena J, 2005, J NUTR, V135, P1462, DOI 10.1093/jn/135.6.1462; Villena J., 2012, International Journal of Biotechnology for Wellness Industries, V1, P189; Villena J, 2011, INT IMMUNOPHARMACOL, V11, P1633, DOI 10.1016/j.intimp.2011.06.004; Vinderola G, 2006, CYTOKINE, V36, P254, DOI 10.1016/j.cyto.2007.01.003; Vituri CL, 2000, BRAZ J MED BIOL RES, V33, P889, DOI 10.1590/S0100-879X2000000800004; Wang EJ, 2001, INFECT IMMUN, V69, P5294, DOI 10.1128/IAI.69.9.5294-5304.2001; Yankelevich M, 2008, EXP HEMATOL, V36, P9, DOI 10.1016/j.exphem.2007.08.019; Zhang Z, 2003, EMBO J, V22, P4759, DOI 10.1093/emboj/cdg464; Zhu J, 2004, BIOESSAYS, V26, P595, DOI 10.1002/bies.20052	45	17	17	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e90227	10.1371/journal.pone.0090227	http://dx.doi.org/10.1371/journal.pone.0090227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691464	Green Submitted, Green Published, gold			2022-12-27	WOS:000334101100008
J	Lu, DF; Wang, Y; Su, ZZ; Zeng, ZH; Xing, XW; He, ZY; Zhang, CX				Lu, Dong-feng; Wang, Ying; Su, Zi-zhuo; Zeng, Zhao-hua; Xing, Xiao-wen; He, Zhi-yu; Zhang, Chunxiang			Knockdown of the HDAC1 Promotes the Directed Differentiation of Bone Mesenchymal Stem Cells into Cardiomyocytes	PLOS ONE			English	Article								Failure of the directed differentiation of the transplanted stem cells into cardiomyocytes is still a major challenge of cardiac regeneration therapy. Our recent study has demonstrated that the expression of histone deacetylase 1 (HDAC1) is decreased in bone mesenchymal stem cells (BMSCs) during their differentiation into cardiomyocytes. However, the potential roles of HDAC1 in cardiac cell differentiation of BMSCs, as well as the mechanisms involved are still unclear. In current study, the expression of HDAC1 in cultured rat BMSCs is knocked down by lentiviral vectors expressing HDAC1-RNAi. The directed differentiation of BMSCs into cardiomyocytes is evaluated by the expression levels of cardiomyocyte-related genes such as GATA-binding protein 4 (GATA-4), Nirenberg, Kim gene 2 homeobox 5 (Nkx2.5), cardiac troponin T (CTnT), myosin heavy chain (MHC), and connexin-43. Compared with that in control BMSCs, the expression of these cardiomyocyte-related genes is significantly increased in these HDAC1 deficient stem cells. The results suggest that HDAC1 is involved in the cardiomyocyte differentiation of BMSCs. Knockdown of the HDAC1 may promote the directed differentiation of BMSCs into cardiomyocytes.	[Lu, Dong-feng; Wang, Ying; Su, Zi-zhuo; Zeng, Zhao-hua; Xing, Xiao-wen; He, Zhi-yu] Guangzhou Med Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Zhang, Chunxiang] Rush Univ, Dept Pharmacol, Rush Med Coll, Chicago, IL 60612 USA; [Zhang, Chunxiang] Rush Univ, Cardiovasc Res Ctr, Rush Med Coll, Chicago, IL 60612 USA	Guangzhou Medical University; Rush University; Rush University	Lu, DF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Guangdong, Peoples R China.	497440817@qq.com; chunxiang_zhang@rush.edu	zhang, xiang chun/HCH-7063-2022	zhang, xiang chun/0000-0001-8303-6495	Scientific Foundation of Guangdong, China [2009B030801358, 10151009504000008, 2012A030400028, 7003080]	Scientific Foundation of Guangdong, China	This research was supported by the Scientific Foundation of Guangdong, China (No. 2009B030801358; No. 10151009504000008; No. 2012A030400028; No. 7003080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.		0	11	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e92179	10.1371/journal.pone.0092179	http://dx.doi.org/10.1371/journal.pone.0092179			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TJ	24686813	gold, Green Submitted, Green Published			2022-12-27	WOS:000333678800002
J	Hu, KZ; Du, K; Tang, GH; Yao, SB; Wang, HL; Liang, X; Yao, BG; Huang, TT; Zang, LQ				Hu, Kongzhen; Du, Kan; Tang, Ganghua; Yao, Shaobo; Wang, Hongliang; Liang, Xiang; Yao, Baoguo; Huang, Tingting; Zang, Linquan			Radiosynthesis and Biological Evaluation of N-[F-18]Labeled Glutamic Acid as a Tumor Metabolic Imaging Tracer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; X(C)(-) TRANSPORTER ACTIVITY; PET; GLUTAMINOLYSIS; CARCINOMA; FDG	We have previously reported that N-(2-[F-18]fluoropropionyl)-L-methionine ([F-18]FPMET) selectively accumulates in tumors. However, due to the poor pharmacokinetics of [F-18]FPMET in vivo, the potential clinical translation of this observation is hampered. In this study, we rationally designed and synthesized [F-18] or [C-11]labeled N-position L-glutamic acid analogues for tumor imaging. N-(2-[F-18]fluoropropionyl)-L-glutamic acid ([F-18]FPGLU) was synthesized with a 30 +/- 10% (n = 10, decay-corrected) overall radiochemical yield and a specific activity of 40 +/- 25 GBq/mu mol (n = 10) after 130 min of radiosynthesis. In vitro cell experiments showed that [F-18]FPGLU was primarily transported through the X-AG system and was not incorporated into protein. [F-18]FPGLU was stable in urine, tumor tissues, and blood. We were able to use [F-18]FPGLU in PET imaging and obtained high tumor to background ratios when visualizing tumors tissues in animal models.	[Hu, Kongzhen; Tang, Ganghua; Yao, Shaobo; Wang, Hongliang; Liang, Xiang; Yao, Baoguo; Huang, Tingting] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nucl Med, PET CT Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Du, Kan; Zang, Linquan] Guangdong Pharmaceut Univ, Sch Pharm, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangdong Pharmaceutical University	Tang, GH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nucl Med, PET CT Ctr, Guangzhou 510275, Guangdong, Peoples R China.	gtang0224@126.com	Yao, Shaobo/AAR-3740-2021	Yao, Shaobo/0000-0003-2245-871X; Hu, Kongzhen/0000-0002-7889-9576	National High Technology Research and Development Program of China (863 Program) [2008AA02Z430, 81371584]; National Natural Science Foundation [81371584, 30970856]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [[2010]609]; Science and Technology Planning Project of Guangzhou [2011J5200025]; Sun Yat-Sen University [80000-3126132]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Science and Technology Planning Project of Guangzhou; Sun Yat-Sen University	National High Technology Research and Development Program of China (863 Program, No. 2008AA02Z430, NO. 81371584), the National Natural Science Foundation (No. 30970856, No. 81371584), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry ([2010]609), Science and Technology Planning Project of Guangzhou (2011J5200025), and Sun Yat-Sen University (No. 80000-3126132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek S, 2013, J NUCL MED, V54, P117, DOI 10.2967/jnumed.112.108704; Bourdier T, 2011, J MED CHEM, V54, P1860, DOI 10.1021/jm101513q; DALLASTA V, 1983, J BIOL CHEM, V258, P6371; Deng HF, 2011, J NUCL MED, V52, P287, DOI 10.2967/jnumed.110.081349; Dimitrakopoulou-Strauss A, 2001, J NUCL MED, V42, P248; Hautzel H, 2002, UROLOGE A, V41, P569, DOI 10.1007/s00120-002-0244-9; Hu KZ, 2014, J RADIOANAL NUCL CH, V299, P271, DOI 10.1007/s10967-013-2736-z; Hu KZ, 2013, NUCL MED BIOL, V40, P926, DOI 10.1016/j.nucmedbio.2013.06.006; Hughes AB, 2000, AUST J CHEM, V53, P237, DOI 10.1071/CH99182; Hultsch C, 2005, AMINO ACIDS, V29, P405, DOI 10.1007/s00726-005-0204-y; Ide M, 2006, Q J NUCL MED MOL IM, V50, P23; Kanai Yoshikatsu, 2003, J Toxicol Sci, V28, P1, DOI 10.2131/jts.28.1; Kansal Vinod K., 2000, Indian Journal of Experimental Biology, V38, P1097; Koglin N, 2011, CLIN CANCER RES, V17, P6000, DOI 10.1158/1078-0432.CCR-11-0687; Krasikova RN, 2011, J MED CHEM, V54, P406, DOI 10.1021/jm101068q; Lang LX, 2011, BIOCONJUGATE CHEM, V22, P2415, DOI 10.1021/bc200197h; Langen KJ, 2002, NUCL MED BIOL, V29, P685, DOI 10.1016/S0969-8051(02)00327-X; Lieberman BP, 2011, J NUCL MED, V52, P1947, DOI 10.2967/jnumed.111.093815; Machtens S, 2004, UROLOGE A, V43, P1397, DOI 10.1007/s00120-004-0714-3; Nagren K, 2000, J LABELLED COMPD RAD, V43, P1013, DOI 10.1002/1099-1344(200009)43:10<1013::AID-JLCR387>3.0.CO;2-H; Pekkala S, 2009, BIOCHEM J, V424, P211, DOI 10.1042/BJ20090888; Pillarsetty NV, 2009, J NUCL MED, V50, P1709, DOI 10.2967/jnumed.109.064212; Ploessl K, 2012, J NUCL MED, V53, P1616, DOI 10.2967/jnumed.111.101279; Prenant C, 1996, NUCL MED BIOL, V23, P359, DOI 10.1016/0969-8051(96)00016-9; Rajagopalan KN, 2011, J NUCL MED, V52, P1005, DOI 10.2967/jnumed.110.084244; Shanware NP, 2011, J MOL MED, V89, P229, DOI 10.1007/s00109-011-0731-9; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Tang Ganghua, 2006, Nuclear Techniques, V29, P531; Wang XL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053938, 10.1371/journal.pone.0050627]; Weber WA, 2000, EUR J NUCL MED, V27, P542, DOI 10.1007/s002590050541; Wester HJ, 1999, J NUCL MED, V40, P205; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wu SF, 1980, SCI CHINA, P913	33	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93262	10.1371/journal.pone.0093262	http://dx.doi.org/10.1371/journal.pone.0093262			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681642	Green Published, Green Submitted, gold			2022-12-27	WOS:000333678100036
J	Lauten, A; Gerhard-Garcia, A; Suhr, F; Fischer, JH; Figulla, HR; Bloch, W				Lauten, Alexander; Gerhard-Garcia, Alexandra; Suhr, Frank; Fischer, Juergen H.; Figulla, Hans R.; Bloch, Wilhelm			Impact of Ischemia-Reperfusion on Extracellular Matrix Processing and Structure of the Basement Membrane of the Heart	PLOS ONE			English	Article							ANGIOGENESIS; METALLOPROTEINASES; ENDOSTATIN; INFARCTION; CONDUCTION; ENDOREPELLIN; PROTEOLYSIS; INHIBITION; TUMSTATIN; FRAGMENT	Purpose: Acute ischemic injury is a strong inductor of cardiac remodelling, resulting in structural changes of the extracellular matrix (ECM) and basement membrane (BM). In a large animal model of ischemia-reperfusion (I/R) we investigated the post-ischemic liberation of the collagen-IV-fragments Tumstatin (TUM; 28 kDa-fragment of collagen-IV-alpha-3), Arresten (ARR; 26 kDa-fragment of collagen-IV-alpha-1) and Endorepellin (LG3, 85 kDa-fragment of perlecan) which are biologically active in angiogenesis and vascularization in the post-ischemic myocardium. Methods and Results: In this blinded study, 30 pigs were randomized to 60 min of global I/R at either 4 degrees C or 32 degrees C or served as control. Three transmyocardial tissue samples were collected prior to ischemia and within 30 min and 150 min of reperfusion. Tissue content of TUM, ARR and LG3 was analyzed by western blotting and immunostaining. Within 150 min of mild hypothermic I/R a significantly increased tissue content of ARR (0.17+/-0.14 vs. 0.56+/-0.56; p = 0.001) and LG3 (1.13+/-0.34 vs. 2.51+/-1.71, p<0.001) was observed. In contrast, deep hypothermic I/R was not associated with a significant release of cleavage products. Cleavage of TUM remained unchanged irrespective of temperature. Increased matrix processing following mild hypothermia I/R is further supported by a>11 fold elevation of creatine kinase (2075+/-2595 U/l vs. 23248+/-6551 U/l; p<0.001) in the coronary sinus plasma samples. Immunostaining demonstrated no changes for ARR and LG3 presentation irrespective of temperature. In contrast, TUM significantly decreased in the BM surrounding cardiomyocytes and capillaries after mild and deep hypothermic I/R, thus representing structural alterations of the BM in these groups. Conclusion: The study demonstrates an early temperature-dependent processing of Col-IV as major component of the BM of cardiomyocytes and vascular endothelium. These observations support the protective effects of deep hypothermia during I/R. Furthermore, the results suggest an increased structural remodelling of the myocardial basement membrane with potential functional impairment during mild hypothermic I/R which may contribute to the progression to post-ischemic heart failure.	[Lauten, Alexander; Figulla, Hans R.] Univ Jena, Dept Internal Med Cardiol Angiol Pneumol 1, Jena, Germany; [Lauten, Alexander; Gerhard-Garcia, Alexandra; Suhr, Frank; Bloch, Wilhelm] German Sports Univ, Inst Cardiovasc Res & Sports Med, Cologne, Germany; [Fischer, Juergen H.] Univ Cologne, Inst Expt Med, D-50931 Cologne, Germany	Friedrich Schiller University of Jena; German Sport University Cologne; University of Cologne	Lauten, A (corresponding author), Univ Jena, Dept Internal Med Cardiol Angiol Pneumol 1, Jena, Germany.	alexander.lauten@med.uni-jena.de	Lauten, Alexander/GLT-9500-2022; Suhr, Frank/AAU-5080-2021	Suhr, Frank/0000-0002-9013-3944				Bendrik C, 2010, CANCER LETT, V292, P32, DOI 10.1016/j.canlet.2009.11.002; Cailhier JF, 2008, J BIOL CHEM, V283, P27220, DOI 10.1074/jbc.M801164200; Cleutjens JPM, 1996, CARDIOVASC RES, V32, P816; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Falk V, 2002, EUR J CARDIO-THORAC, V22, P53, DOI 10.1016/S1010-7940(02)00207-5; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; He KJ, 2004, CARDIOVASC RES, V64, P72, DOI 10.1016/j.cardiores.2004.06.007; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x; Laplante P, 2006, J BIOL CHEM, V281, P30383, DOI 10.1074/jbc.M606412200; Lauten A, 2009, CATHETER CARDIO INTE, V74, P514, DOI 10.1002/ccd.22093; Lauten A, 2009, BASIC RES CARDIOL, V104, P559, DOI 10.1007/s00395-009-0013-7; LERMAN RH, 1983, CIRC RES, V53, P378, DOI 10.1161/01.RES.53.3.378; Maeshima Y, 2000, J BIOL CHEM, V275, P23745, DOI 10.1074/jbc.C000186200; Malan D, 2009, STEM CELLS, V27, P88, DOI 10.1634/stemcells.2008-0335; MARAGOUDAKIS ME, 1995, MICROVASC RES, V50, P215, DOI 10.1006/mvre.1995.1054; MARAGOUDAKIS ME, 1993, KIDNEY INT, V43, P147, DOI 10.1038/ki.1993.24; Mellon MJ, 2008, HUM GENE THER, V19, P487, DOI 10.1089/hum.2007.135; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Morley GE, 1999, J CARDIOVASC ELECTR, V10, P1361, DOI 10.1111/j.1540-8167.1999.tb00192.x; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Raymond MA, 2004, FASEB J, V18, P705, DOI 10.1096/fj.03-0573fje; Roell W, 2002, CIRCULATION, V105, P2435, DOI 10.1161/01.CIR.0000016063.66513.BB; Sabbah HN, 2003, CIRC RES, V93, P1095, DOI 10.1161/01.RES.0000101932.70443.FE; Sasse P, 2008, CARDIOVASC RES, V80, P435, DOI 10.1093/cvr/cvn225; Schmidt A, 2004, DEV DYNAM, V230, P468, DOI 10.1002/dvdy.20072; Schrickel JW, 2007, CARDIOVASC RES, V76, P257, DOI 10.1016/j.cardiores.2007.07.001; Shamhart PE, 2010, J MOL CELL CARDIOL, V48, P530, DOI 10.1016/j.yjmcc.2009.06.017; Spinale FG, 2008, CIRCULATION, V118, pS16, DOI 10.1161/CIRCULATIONAHA.108.786640; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Suhr F, 2009, SCAND J MED SCI SPOR; TAKAHASHI S, 1990, BIOCHEM J, V265, P233, DOI 10.1042/bj2650233; van Rijen HVM, 2004, CIRCULATION, V109, P1048, DOI 10.1161/01.CIR.0000117402.70689.75; Wenzel D, 2006, CIRC RES, V98, P1203, DOI 10.1161/01.RES.0000219899.93384.ed	34	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92833	10.1371/journal.pone.0092833	http://dx.doi.org/10.1371/journal.pone.0092833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681713	gold, Green Published, Green Submitted			2022-12-27	WOS:000333678100018
J	Arner, E; Forrest, ARR; Ehrlund, A; Mejhert, N; Itoh, M; Kawaji, H; Lassmann, T; Laurencikiene, J; Ryden, M; Arner, P				Arner, Erik; Forrest, Alistair R. R.; Ehrlund, Anna; Mejhert, Niklas; Itoh, Masayoshi; Kawaji, Hideya; Lassmann, Timo; Laurencikiene, Jurga; Ryden, Mikael; Arner, Peter		Fantom Consortium	Ceruloplasmin Is a Novel Adipokine Which Is Overexpressed in Adipose Tissue of Obese Subjects and in Obesity-Associated Cancer Cells	PLOS ONE			English	Article							BODY-WATER; ADIPOCYTES	Obesity confers an increased risk of developing specific cancer forms. Although the mechanisms are unclear, increased fat cell secretion of specific proteins (adipokines) may promote/facilitate development of malignant tumors in obesity via cross-talk between adipose tissue(s) and the tissues prone to develop cancer among obese. We searched for novel adipokines that were overexpressed in adipose tissue of obese subjects as well as in tumor cells derived from cancers commonly associated with obesity. For this purpose expression data from human adipose tissue of obese and non-obese as well as from a large panel of human cancer cell lines and corresponding primary cells and tissues were explored. We found expression of ceruloplasmin to be the most enriched in obesity-associated cancer cells. This gene was also significantly up-regulated in adipose tissue of obese subjects. Ceruloplasmin is the body's main copper carrier and is involved in angiogenesis. We demonstrate that ceruloplasmin is a novel adipokine, which is produced and secreted at increased rates in obesity. In the obese state, adipose tissue contributed markedly (up to 22%) to the total circulating protein level. In summary, we have through bioinformatic screening identified ceruloplasmin as a novel adipokine with increased expression in adipose tissue of obese subjects as well as in cells from obesity-associated cancers. Whether there is a causal relationship between adipose overexpression of ceruloplasmin and cancer development in obesity cannot be answered by these cross-sectional comparisons.	[Arner, Erik; Forrest, Alistair R. R.; Itoh, Masayoshi; Kawaji, Hideya; Lassmann, Timo] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan; [Arner, Erik; Ehrlund, Anna; Mejhert, Niklas; Laurencikiene, Jurga; Ryden, Mikael; Arner, Peter] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Huddinge, Sweden; [Itoh, Masayoshi; Kawaji, Hideya] RIKEN Prevent Med & Diag Innovat Program, Wako, Saitama, Japan; [Arner, Erik; Forrest, Alistair R. R.; Itoh, Masayoshi; Kawaji, Hideya; Lassmann, Timo] RIKEN Om Sci Ctr, Yokohama, Kanagawa, Japan	RIKEN; Karolinska Institutet; Karolinska University Hospital; RIKEN; RIKEN	Arner, E (corresponding author), RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan.	arner@gsc.riken.jp; peter.arner@ki.se	Lassmann, Timo/HCH-4313-2022; Ohno, Hiroshi/L-7899-2014; Ravasi, Timothy/B-8777-2008; Mackay-Sim, Alan/C-3431-2008; Kawaji, Hideya/N-5116-2015; Arner, Erik/A-1895-2010; Daub, Carsten O/A-7436-2010; Itoh, Masayoshi/N-5363-2015; Kere, Juha/A-9179-2008; Hide, Winston A/V-2727-2017; Hide, Winston Hide/C-7217-2009; Hide, Winston/R-3815-2019; Kenna, Tony/A-6035-2011; Bodega, Beatrice/I-4644-2018; Katayama, Shintaro/F-2958-2010; Wolvetang, Ernst jurgen/D-6644-2017; Lassmann, Timo/A-8271-2008; Wells, Christine/A-5071-2010	Lassmann, Timo/0000-0002-0138-2691; Ohno, Hiroshi/0000-0001-8776-9661; Mackay-Sim, Alan/0000-0003-4446-5371; Kawaji, Hideya/0000-0002-0575-0308; Arner, Erik/0000-0003-1225-4908; Daub, Carsten O/0000-0002-3295-8729; Itoh, Masayoshi/0000-0002-1772-318X; Kere, Juha/0000-0003-1974-0271; Hide, Winston A/0000-0002-8621-3271; Hide, Winston Hide/0000-0002-8621-3271; Hide, Winston/0000-0002-8621-3271; Bodega, Beatrice/0000-0003-0527-9234; Katayama, Shintaro/0000-0001-7581-5157; Wolvetang, Ernst jurgen/0000-0002-2146-6614; Lassmann, Timo/0000-0002-0138-2691; Valen, Eivind/0000-0003-1840-6108; Moro, Kazuyo/0000-0002-7377-1303; Burroughs, A. Max/0000-0002-2229-8771; Knox, Alan/0000-0002-5906-4143; Wasserman, Wyeth/0000-0001-6098-6412; Wells, Christine/0000-0003-3133-3628; Heutink, Peter/0000-0001-5218-1737; Sajantila, Antti/0000-0003-4117-5248; Lenhard, Boris/0000-0002-1114-1509; Arner, Peter/0000-0002-6208-6220; IIDA, Kei/0000-0001-7130-8705; Forrest, Alistair/0000-0003-4543-1675; Winteringham, Louise/0000-0002-8117-5069; Mejhert, Niklas/0000-0003-1785-833X; Fisher, Malcolm/0000-0003-1074-8103; , Jurga/0000-0002-7032-2924; Meehan, Terrence/0000-0003-1980-3228; Ekwall, Karl/0000-0002-3029-4041	MEXT; MEXT, Japan; Swedish Research Council; Swedish Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA076674] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF12OC1016371, NNF14OC0010187] Funding Source: researchfish	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Novo Nordisk Fonden(Novo Nordisk Foundation)	FANTOM5 was made possible by a Research Grant for RIKEN Omics Science Center from MEXT to Yoshihide Hayashizaki and a Grant of the Research Program of Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from MEXT, Japan to Yoshihide Hayashizaki. This study was also supported by grants from the Swedish Research Council and the Swedish Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner E, 2012, DIABETES, V61, P1986, DOI 10.2337/db11-1508; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen J, 2011, OBES REV, V12, P1063, DOI 10.1111/j.1467-789X.2011.00917.x; Cignarelli M, 1996, INT J OBESITY, V20, P809; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Healy J, 2007, J NEURAL TRANSM, V114, P777, DOI 10.1007/s00702-007-0687-7; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Kim OY, 2011, CLIN BIOCHEM, V44, P351, DOI 10.1016/j.clinbiochem.2011.01.014; Laurencikiene J, 2011, J CLIN ENDOCR METAB, V96, pE2045, DOI 10.1210/jc.2011-1702; Lehr S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010504; Lonnqvist F, 1997, J CLIN INVEST, V99, P2398, DOI 10.1172/JCI119422; Mayi TH, 2012, J BIOL CHEM, V287, P21904, DOI 10.1074/jbc.M111.315200; Park J, 2011, ENDOCR REV, V32, P550, DOI 10.1210/er.2010-0030; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; RAISON J, 1983, AM J CARDIOL, V51, P165, DOI 10.1016/S0002-9149(83)80030-7; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Ribeiro R, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-108; Ritz P, 2008, CLIN NUTR, V27, P740, DOI 10.1016/j.clnu.2008.07.010; WCRF/ AICR, 2007, FOOD NUTR PHYS ACT P; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595; Zhang Y, 2012, CANCER RES, V72, P5198, DOI 10.1158/0008-5472.CAN-12-0294	23	39	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e80274	10.1371/journal.pone.0080274	http://dx.doi.org/10.1371/journal.pone.0080274			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676332	gold, Green Published, Green Accepted			2022-12-27	WOS:000333677500001
J	Idziak, D; Hazuka, I; Poliwczak, B; Wiszynska, A; Wolny, E; Hasterok, R				Idziak, Dominika; Hazuka, Iwona; Poliwczak, Beata; Wiszynska, Anna; Wolny, Elzbieta; Hasterok, Robert			Insight into the Karyotype Evolution of Brachypodium Species Using Comparative Chromosome Barcoding	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; GENOME EVOLUTION; NUMBER REDUCTION; DISTACHYON; TOMATO; RECONSTRUCTION; GRASSES; FISH; REARRANGEMENTS; BRASSICACEAE	Paleogenomic studies based on bioinformatic analyses of DNA sequences have enabled unprecedented insight into the evolution of grass genomes. They have revealed that nested chromosome fusions played an important role in the divergence of modern grasses. Nowadays, studies on karyotype evolution based on the sequence analysis can also be effectively complemented by the fine-scale cytomolecular approach. In this work, we studied the karyotype evolution of small genome grasses using BAC-FISH based comparative chromosome barcoding in four Brachypodium species: diploid B. distachyon (2n = 10) and B. sylvaticum (2n = 18), diploid (2n = 18) and allopolyploid (2n = 28) B. pinnatum as well as B. phoenicoides (2n = 28). Using BAC clones derived from the B. distachyon genomic libraries for the chromosomes Bd2 and Bd3, we identified the descending dysploidy events that were common for diploids with x = 9 and B. distachyon as well as two nested chromosome fusions that were specific only for B. distachyon. We suggest that dysploidy events that are shared by different lineages of the genus had already appeared in their common ancestor. We also show that additional structural rearrangements, such as translocations and duplications, contributed to increasing genome diversification in the species analysed. No chromosomes structured exactly like Bd2 and Bd3 were found in B. pinnatum (2n = 28) and B. phoenicoides. The structure of Bd2 and Bd3 homeologues belonging to the two genomes in the allopolyploids resembled the structure of their counterparts in the 2n = 18 diploids. These findings reinforce the hypothesis which excludes B. distachyon as a potential parent for Eurasian perennial Brachypodium allopolyploids. Our cytomolecular data elucidate some mechanisms of the descending dysploidy in monocots and enable reconstructions of the evolutionary events which shaped the extant karyotypes in both the genus Brachypodium and in grasses as a whole.	[Idziak, Dominika; Hazuka, Iwona; Poliwczak, Beata; Wiszynska, Anna; Wolny, Elzbieta; Hasterok, Robert] Univ Silesia Katowice, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland	University of Silesia in Katowice	Hasterok, R (corresponding author), Univ Silesia Katowice, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland.	robert.hasterok@us.edu.pl	Hasterok, Robert/A-1629-2008	Idziak-Helmcke, Dominika/0000-0002-0713-2466; Hasterok, Robert/0000-0001-6667-2721; Wolny, Elzbieta/0000-0001-7588-4830	Polish National Science Centre [2012/04/A/NZ3/00572]	Polish National Science Centre	The authors acknowledge financial support from the Polish National Science Centre (grant no. 2012/04/A/NZ3/00572). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrouk M, 2010, TRENDS PLANT SCI, V15, P479, DOI 10.1016/j.tplants.2010.06.001; Bolot S, 2009, CURR OPIN PLANT BIOL, V12, P119, DOI 10.1016/j.pbi.2008.10.011; Catalan P, 2000, PLANT SYST EVOL, V220, P1, DOI 10.1007/BF00985367; Catalan P, 2012, ANN BOT-LONDON, V109, P385, DOI 10.1093/aob/mcr294; Devos KM, 2005, CURR OPIN PLANT BIOL, V8, P155, DOI 10.1016/j.pbi.2005.01.005; Farrar K, 2007, NAT PROTOC, V2, P1661, DOI 10.1038/nprot.2007.204; Febrer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013461; Guerra M, 2008, CYTOGENET GENOME RES, V120, P339, DOI 10.1159/000121083; Hasterok R, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-20; Hasterok R, 2006, GENETICS, V173, P349, DOI 10.1534/genetics.105.049726; Idziak D, 2011, CHROMOSOMA, V120, P469, DOI 10.1007/s00412-011-0326-9; Iovene M, 2008, GENETICS, V180, P1307, DOI 10.1534/genetics.108.093179; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jenkins G, 2007, NAT PROTOC, V2, P88, DOI 10.1038/nprot.2006.490; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Khan MA, 1999, NORD J BOT, V19, P257, DOI 10.1111/j.1756-1051.1999.tb01108.x; Larkin DM, 2009, GENOME RES, V19, P770, DOI 10.1101/gr.086546.108; Leitch I.J., 2013, PHYS STRUCTURE BEHAV, V2, P307, DOI [DOI 10.1007/978-3-7091-1160-4_19, DOI 10.1007/978-3-7091-1160-4_]; Lou QF, 2010, CHROMOSOMA, V119, P435, DOI 10.1007/s00412-010-0269-6; Luo MC, 2009, P NATL ACAD SCI USA, V106, P15780, DOI 10.1073/pnas.0908195106; LYSAK M. A., 2013, PLANT GENOME DIVERSI, V2, P137, DOI [10.1007/978-3-7091-1160-4_9, DOI 10.1007/978-3-7091-1160-4_9]; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Lysak MA, 2006, P NATL ACAD SCI USA, V103, P5224, DOI 10.1073/pnas.0510791103; Mandakova T, 2008, PLANT CELL, V20, P2559, DOI 10.1105/tpc.108.062166; Mandakova T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-367; Mandakova T, 2010, PLANT CELL, V22, P2277, DOI 10.1105/tpc.110.074526; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; Murat F, 2010, GENOME RES, V20, P1545, DOI 10.1101/gr.109744.110; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; ROBERTSON IH, 1981, GENETICA, V56, P55, DOI 10.1007/BF00126930; Salse J, 2012, CURR OPIN PLANT BIOL, V15, P122, DOI 10.1016/j.pbi.2012.01.001; Salse J, 2009, P NATL ACAD SCI USA, V106, P14908, DOI 10.1073/pnas.0902350106; Schibler L, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-194; Schubert I, 2011, TRENDS GENET, V27, P207, DOI 10.1016/j.tig.2011.03.004; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Szinay D, 2010, CYTOGENET GENOME RES, V129, P199, DOI 10.1159/000313502; Szinay D, 2008, PLANT J, V56, P627, DOI 10.1111/j.1365-313X.2008.03626.x; Tang XM, 2008, GENETICS, V180, P1319, DOI 10.1534/genetics.108.093211; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Weiss-Schneeweiss H., 2013, PHYS STRUCTURE BEHAV, V2, P209, DOI DOI 10.1007/978-3-7091-1160-4_13; Wolny E, 2011, CHROMOSOMA, V120, P199, DOI 10.1007/s00412-010-0303-8; Wolny E, 2009, ANN BOT-LONDON, V104, P873, DOI 10.1093/aob/mcp179; Zhang J, 1999, GENETICS, V153, P1403	44	28	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93503	10.1371/journal.pone.0093503	http://dx.doi.org/10.1371/journal.pone.0093503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675822	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677500132
J	Perez-Granda, MJ; Barrio, JM; Munoz, P; Hortal, J; Rincon, C; Rabadan, PM; Pernia, MS; Bouza, E				Jesus Perez-Granda, Maria; Maria Barrio, Jose; Munoz, Patricia; Hortal, Javier; Rincon, Cristina; Martin Rabadan, Pablo; Sagrario Pernia, Maria; Bouza, Emilio			Ethanol Lock Therapy (E-Lock) in the Prevention of Catheter-Related Bloodstream Infections (CR-BSI) after Major Heart Surgery (MHS): A Randomized Clinical Trial	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; PARENTERAL-NUTRITION PATIENTS; HEMODIALYSIS-PATIENTS; NOSOCOMIAL INFECTIONS; BACTEREMIA; RISK; ICU; MICROBIOLOGY; INTERVENTION; COLONIZATION	Background: Lock-therapy with antimicrobials has been used for the treatment and prevention of catheter-related bloodstream infections (CR-BSI). Experiences with Ethanol-Locks (E-locks) have included therapeutic interventions with variable results. Patients undergoing Major Heart Surgery (MHS) are a high-risk population for CR-BSI. The aim of this study was to assess the efficacy and tolerance to E-Locks in the prevention of CR-BSI of patients undergoing MHS. Methods and Findings: This is an academic, prospective, randomized, non-blinded and controlled clinical trial assessing the incidence of CR-BSI of patients with E-locks (E-lock) and the tolerance to the procedure in comparison with patients receiving conventional catheter-care (CCC). Patients undergoing MHS with intravascular catheters for more than 48 hours were randomly assigned into treatment or control group by a computer-generated list of randomly assigned numbers. In the treatment group, all their catheter lumens were locked with an ethanol solution at 70% for two hours, every three days (E-Locks). The control group received conventional catheter-care (CCC). Overall, 200 patients with 323 catheters were included in the study, which was stopped after 10 months due to adverse events. Of them, 179 catheters (113 patients) had E-Locks and 144 catheters (87 patients) were CCC. Euroscore Surgical Risk in both groups was 4.04 vs 4.07 p = 0.94 respectively. The results for the E-Locks and CCC were as follows: Incidence of CR-BSI/1000 days of exposure 2.1 vs 5.2 (p = 0.33), catheter tip colonization 14 (7.8%) vs 6 (4.2%) patients (p = 0.17), median length of hospital stay, 15 vs 16 days (p = 0.77). Seven patients (6.19%), all in the ethanol branch, had to discontinue the trial due to intolerance or adverse events. Conclusions: We do not recommend prophylaxis of CR-BSI with ethanol-lock on a routine basis in patients undergoing Major Heart Surgery.	[Jesus Perez-Granda, Maria; Maria Barrio, Jose; Hortal, Javier; Rincon, Cristina] Univ Complutense, Sch Med, Dept Anesthesiol, E-28040 Madrid, Spain; [Munoz, Patricia; Martin Rabadan, Pablo; Bouza, Emilio] Univ Complutense, Sch Med, Dept Clin Microbiol & Infect Dis, E-28040 Madrid, Spain; [Sagrario Pernia, Maria] Univ Gregorio Maranon, Gen Hosp, Dept Pharm, Madrid, Spain; [Munoz, Patricia; Martin Rabadan, Pablo; Bouza, Emilio] Univ Complutense, Sch Med, Dept Med, E-28040 Madrid, Spain; [Jesus Perez-Granda, Maria; Maria Barrio, Jose; Munoz, Patricia; Hortal, Javier; Martin Rabadan, Pablo; Bouza, Emilio] Inst Invest Biomed Gregorio Maranon, Madrid, Spain; [Jesus Perez-Granda, Maria; Maria Barrio, Jose; Munoz, Patricia; Hortal, Javier; Martin Rabadan, Pablo; Bouza, Emilio] CIBER Enfermedades Resp CIBERES, CB06 06 0058, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid; General University Gregorio Maranon Hospital; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Perez-Granda, MJ (corresponding author), Univ Complutense, Sch Med, Dept Anesthesiol, E-28040 Madrid, Spain.	massus@hotmail.es; pmunoz@micro.hggm.es	Muñoz, Patricia/E-9431-2017; Bouza, Emilio/D-8661-2014; GRANDA, MARIA JESUS mjpg PEREZ/L-3040-2015	Muñoz, Patricia/0000-0001-5706-5583; Bouza, Emilio/0000-0001-6967-9267; GRANDA, MARIA JESUS mjpg PEREZ/0000-0002-0613-2122; Martin-Rabadan, Pablo/0000-0003-0621-9970	Fondo de Investigacion Sanitaria, FIS [EC07/90653]; Rafael del Pino Foundation	Fondo de Investigacion Sanitaria, FIS; Rafael del Pino Foundation	This study was partially supported by a grant from Fondo de Investigacion Sanitaria, FIS EC07/90653 (Instituto de Salud Carlos III) and by the Rafael del Pino Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berenholtz SM, 2004, CRIT CARE MED, V32, P2014, DOI 10.1097/01.CCM.0000142399.70913.2F; Betjes MGH, 2011, NAT REV NEPHROL, V7, P257, DOI 10.1038/nrneph.2011.28; Blackwood RA, 2011, PEDIATR INFECT DIS J, V30, P1105, DOI 10.1097/INF.0b013e31822c84a4; Bouza E, 2004, CLIN MICROBIOL INFEC, V10, P838, DOI 10.1111/j.1469-0691.2004.00936.x; Bouza E, 2005, CRIT CARE MED, V33, P1953, DOI 10.1097/01.CCM.0000171842.63887.C1; Broom J, 2008, SCAND J INFECT DIS, V40, P399, DOI 10.1080/00365540701756953; Broom JK, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-146; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Ghannoum MA, 2011, ANTIMICROB AGENTS CH, V55, P4430, DOI 10.1128/AAC.00677-11; Heng AE, 2011, CLIN NEPHROL, V75, P534, DOI 10.5414/CN106559; Huang EY, 2011, J PEDIATR SURG, V46, P2000, DOI 10.1016/j.jpedsurg.2011.06.017; John BK, 2011, JPEN J PARENTER ENTE; Kim EY, 2010, MT SINAI J MED, V77, P549, DOI 10.1002/msj.20213; Kim JS, 2011, AM J INFECT CONTROL, V39, P640, DOI 10.1016/j.ajic.2010.11.005; Kollef MH, 1997, CHEST, V112, P666, DOI 10.1378/chest.112.3.666; Landry DL, 2010, CLIN J AM SOC NEPHRO, V5, P1799, DOI 10.2215/CJN.01270210; Le Guillou V, 2011, J HOSP INFECT, V79, P236, DOI 10.1016/j.jhin.2011.07.004; MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; McGrath EJ, 2011, CLIN PEDIATR, V50, P943, DOI 10.1177/0009922811409568; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003; Oliveira C, 2012, PEDIATRICS; Onder AM, 2010, NEPHROL DIAL TRANSPL, V25, P3686, DOI 10.1093/ndt/gfq276; Opilla MT, 2007, JPEN-PARENTER ENTER, V31, P302, DOI 10.1177/0148607107031004302; Martinez MP, 2010, MED INTENSIVA, V34, P581, DOI 10.1016/j.medin.2010.07.005; Patil HV, 2011, INDIAN J CRIT CARE M, V15, P213, DOI 10.4103/0972-5229.92074; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Raad I, 2007, ANTIMICROB AGENTS CH, V51, P78, DOI 10.1128/AAC.00154-06; Rajpurkar M, 2009, HAEMOPHILIA, V15, P1267, DOI 10.1111/j.1365-2516.2009.02075.x; Rebollo MH, 1996, J THORAC CARDIOV SUR, V112, P908, DOI 10.1016/S0022-5223(96)70090-9; Rodriguez-Creixems M, 2013, CLIN MICROBIOL INFEC, V19, P845, DOI 10.1111/1469-0691.12050; Shenep LE, 2011, J HOSP INFECT, V79, P317, DOI 10.1016/j.jhin.2011.07.010; Slobbe L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010840; Valentine KM, 2011, PEDIATR CRIT CARE ME, V12, pE292, DOI 10.1097/PCC.0b013e318219267c; van der Kooi TII, 2012, J HOSP INFECT, V80, P238, DOI 10.1016/j.jhin.2011.11.012; Venditto M, 2010, BLOOD PURIFICAT, V29, P268, DOI 10.1159/000274461; Wales PW, 2011, J PEDIATR SURG, V46, P951, DOI 10.1016/j.jpedsurg.2011.02.036; Weller C, 2010, J WOUND CARE, V19, P347, DOI 10.12968/jowc.2010.19.8.77713; Wong T, 2011, JPEN J PARENTER ENTE; Yahav D, 2008, CLIN INFECT DIS, V47, P83, DOI 10.1086/588667; Zack J., 2008, AM J INFECT CONTROL, V36	42	22	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e91838	10.1371/journal.pone.0091838	http://dx.doi.org/10.1371/journal.pone.0091838			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675993	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500017
J	Tanaka, Y; Tiest, WMB; Kappers, AML; Sano, A				Tanaka, Yoshihiro; Tiest, Wouter M. Bergmann; Kappers, Astrid M. L.; Sano, Akihito			Contact Force and Scanning Velocity during Active Roughness Perception	PLOS ONE			English	Article							TACTILE ROUGHNESS; GROOVED SURFACES; TEMPORAL CUES	Haptic perception is bidirectionally related to exploratory movements, which means that exploration influences perception, but perception also influences exploration. We can optimize or change exploratory movements according to the perception and/or the task, consciously or unconsciously. This paper presents a psychophysical experiment on active roughness perception to investigate movement changes as the haptic task changes. Exerted normal force and scanning velocity are measured in different perceptual tasks (discrimination or identification) using rough and smooth stimuli. The results show that humans use a greater variation in contact force for the smooth stimuli than for the rough stimuli. Moreover, they use higher scanning velocities and shorter break times between stimuli in the discrimination task than in the identification task. Thus, in roughness perception humans spontaneously use different strategies that seem effective for the perceptual task and the stimuli. A control task, in which the participants just explore the stimuli without any perceptual objective, shows that humans use a smaller contact force and a lower scanning velocity for the rough stimuli than for the smooth stimuli. Possibly, these strategies are related to aversiveness while exploring stimuli.	[Tanaka, Yoshihiro; Sano, Akihito] Nagoya Inst Technol, Grad Sch Engn, Dept Engn Phys Elect & Mech, Nagoya, Aichi, Japan; [Tiest, Wouter M. Bergmann; Kappers, Astrid M. L.] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands	Nagoya Institute of Technology; Utrecht University	Tanaka, Y (corresponding author), Nagoya Inst Technol, Grad Sch Engn, Dept Engn Phys Elect & Mech, Nagoya, Aichi, Japan.	tanaka.yoshihiro@nitech.ac.jp		Kappers, Astrid/0000-0003-4101-7717	Netherlands Organisation for Scientific Research (NWO); European Commission [248587, FP7-ICT-2009-4-2-1]; JSPS [22686026, 25289060]; Grants-in-Aid for Scientific Research [25289060] Funding Source: KAKEN	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Commission(European CommissionEuropean Commission Joint Research Centre); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded in part by grants from the Netherlands Organisation for Scientific Research (NWO), the European Commission with the Collaborative Project no. 248587, "THE Hand Embodied'', within the FP7-ICT-2009-4-2-1 program "Cognitive Systems and Robotics'', the JSPS Institutional Program for Young Researcher Overseas Visits, the JSPS Grant-in-Aid for Young Scientists (A) (No. 22686026), and the JSPS Grant-in-Aid for Scientific Research (B) (No. 25289060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros S, 2009, WORLD HAPTICS 2009: THIRD JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P166, DOI 10.1109/WHC.2009.4810901; Cascio CJ, 2001, J NEUROSCI, V21, P5289, DOI 10.1523/JNEUROSCI.21-14-05289.2001; Coren S, 1992, LEFT HANDER SYNDROME; Drewing K., 2011, 2011 IEEE World Haptics Conference (WHC 2011), P215, DOI 10.1109/WHC.2011.5945488; EKMAN G, 1965, J EXP PSYCHOL, V70, P18, DOI 10.1037/h0021985; Gamzu E, 2001, J NEUROSCI, V21, P7416, DOI 10.1523/JNEUROSCI.21-18-07416.2001; Hollins M, 2000, PERCEPT PSYCHOPHYS, V62, P695, DOI 10.3758/BF03206916; Hollins M, 2002, BEHAV BRAIN RES, V135, P51, DOI 10.1016/S0166-4328(02)00154-7; Hollins M, 2000, PERCEPT PSYCHOPHYS, V62, P1534, DOI 10.3758/BF03212154; Hollins M, 2007, CAN J EXP PSYCHOL, V61, P184, DOI 10.1037/cjep2007020; JOHANSSON RS, 1990, ATTENTION PERFORM, V8, P677; Kaim LR, 2009, WORLD HAPTICS 2009: THIRD JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P565, DOI 10.1109/WHC.2009.4810830; Kitada R, 2005, NEUROIMAGE, V25, P90, DOI 10.1016/j.neuroimage.2004.11.026; LEDERMAN SJ, 1981, B PSYCHONOMIC SOC, V18, P253; LEDERMAN SJ, 1974, PERCEPT PSYCHOPHYS, V16, P385, DOI 10.3758/BF03203958; LEDERMAN SJ, 1972, PERCEPT PSYCHOPHYS, V12, P401, DOI 10.3758/BF03205850; LEDERMAN SJ, 1982, PERCEPT PSYCHOPHYS, V32, P109, DOI 10.3758/BF03204270; Lederman SJ, 1998, CLIN DEV MED, P16; Meftah E, 2000, EXP BRAIN RES, V132, P351, DOI 10.1007/s002210000348; MORLEY JW, 1983, EXP BRAIN RES, V49, P291; Roland PE, 1998, P NATL ACAD SCI USA, V95, P3295, DOI 10.1073/pnas.95.6.3295; Sinapov J, 2011, IEEE T ROBOT, V27, P488, DOI 10.1109/TRO.2011.2127130; Smith AM, 2002, EXP BRAIN RES, V144, P211, DOI 10.1007/s00221-002-1015-y; Smith AM, 2002, EXP BRAIN RES, V147, P209, DOI 10.1007/s00221-002-1240-4; Smith AM, 1996, J NEUROPHYSIOL, V75, P1957, DOI 10.1152/jn.1996.75.5.1957; STEVENS SS, 1962, J EXP PSYCHOL, V64, P489, DOI 10.1037/h0042621; Tanaka Yoshihiro, 2012, Haptics: Perception, Devices, Mobility, and Communication. Proceedings International Conference (EuroHaptics 2012), P169, DOI 10.1007/978-3-642-31404-9_29; Tanaka Yoshihiro, 2012, Haptics: Perception, Devices, Mobility, and Communication. Proceedings International Conference (EuroHaptics 2012), P163, DOI 10.1007/978-3-642-31404-9_28; Tanaka Y., 2011, 2011 IEEE World Haptics Conference (WHC 2011), P621, DOI 10.1109/WHC.2011.5945557; TAYLOR MM, 1975, PERCEPT PSYCHOPHYS, V17, P23, DOI 10.3758/BF03203993	30	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93363	10.1371/journal.pone.0093363	http://dx.doi.org/10.1371/journal.pone.0093363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676036	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500116
J	Chiu, HC; Hannemann, H; Heesom, KJ; Matthews, DA; Davidson, AD				Chiu, Han-Chen; Hannemann, Holger; Heesom, Kate J.; Matthews, David A.; Davidson, Andrew D.			High-Throughput Quantitative Proteomic Analysis of Dengue Virus Type 2 Infected A549 Cells	PLOS ONE			English	Article							GENE TRANSCRIPT ABUNDANCE; WEST-NILE-VIRUS; NF-KAPPA-B; NUCLEAR-LOCALIZATION; PERIPHERAL-BLOOD; HOST RESPONSES; CYCLE ARREST; WILD-TYPE; PROTEIN; EXPRESSION	Disease caused by dengue virus is a global health concern with up to 390 million individuals infected annually worldwide. There are no vaccines or antiviral compounds available to either prevent or treat dengue disease which may be fatal. To increase our understanding of the interaction of dengue virus with the host cell, we analyzed changes in the proteome of human A549 cells in response to dengue virus type 2 infection using stable isotope labelling in cell culture (SILAC) in combination with high-throughput mass spectrometry (MS). Mock and infected A549 cells were fractionated into nuclear and cytoplasmic extracts before analysis to identify proteins that redistribute between cellular compartments during infection and reduce the complexity of the analysis. We identified and quantified 3098 and 2115 proteins in the cytoplasmic and nuclear fractions respectively. Proteins that showed a significant alteration in amount during infection were examined using gene enrichment, pathway and network analysis tools. The analyses revealed that dengue virus infection modulated the amounts of proteins involved in the interferon and unfolded protein responses, lipid metabolism and the cell cycle. The SILAC-MS results were validated for a select number of proteins over a time course of infection by Western blotting and immunofluorescence microscopy. Our study demonstrates for the first time the power of SILAC-MS for identifying and quantifying novel changes in cellular protein amounts in response to dengue virus infection.	[Chiu, Han-Chen; Hannemann, Holger; Matthews, David A.; Davidson, Andrew D.] Univ Bristol, Sch Cellular & Mol Med, Fac Med & Vet Sci, Bristol, Avon, England; [Heesom, Kate J.] Univ Bristol, Prote Facil, Fac Med & Vet Sci, Bristol, Avon, England	University of Bristol; University of Bristol	Davidson, AD (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Fac Med & Vet Sci, Bristol, Avon, England.	andrew.davidson@bristol.ac.uk		Matthews, David/0000-0003-4611-8795	Medical Research Council, UK [G0801973]; Medical Research Council [G0801973] Funding Source: researchfish; MRC [G0801973] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council, UK (www.mrc.ac.uk) Grant G0801973 to ADD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque LM, 2009, J PROTEOME RES, V8, P5431, DOI 10.1021/pr900236f; Altindis E, 2013, CURR TOP MED CHEM; Arrington DD, 2008, AM J PHYSIOL-CELL PH, V294, pC641, DOI 10.1152/ajpcell.00400.2007; Balas C, 2011, J INFECT DIS, V203, P103, DOI 10.1093/infdis/jiq022; Behera B, 2010, J INFECT DEV COUNTR, V4, P48, DOI 10.3855/jidc.535; Bhatia VN, 2009, ANAL CHEM, V81, P9819, DOI 10.1021/ac901335x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brasier AR, 2012, CTS-CLIN TRANSL SCI, V5, P8, DOI 10.1111/j.1752-8062.2011.00377.x; Bunyaratvej A, 1997, Southeast Asian J Trop Med Public Health, V28 Suppl 3, P32; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Chukkapalli V, 2012, CURR OPIN MICROBIOL, V15, P512, DOI 10.1016/j.mib.2012.05.013; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Davy C, 2007, VIROLOGY, V368, P219, DOI 10.1016/j.virol.2007.05.043; De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407; Devignot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011671; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Fehr AR, 2013, J VIROL; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; Fischl W, 2011, CURR OPIN MICROBIOL; Fo CS, 2006, GENE, V371, P154, DOI 10.1016/j.gene.2005.12.009; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Grigoriev I, 2011, CURR BIOL, V21, P967, DOI 10.1016/j.cub.2011.04.030; Gualano RC, 1998, J GEN VIROL, V79, P437, DOI 10.1099/0022-1317-79-3-437; Hannemann H, 2013, J BIOL CHEM; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Helt AM, 2005, J VIROL, V79, P13218, DOI 10.1128/JVI.79.21.13218-13230.2005; Hoang LT, 2010, J VIROL; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005; Kanlaya R, 2010, J PROTEOME RES; Kanlaya R, 2009, J PROTEOME RES, V8, P2551, DOI 10.1021/pr900060g; Kannan RP, 2011, J VIROL, V85, P7989, DOI 10.1128/JVI.00280-11; Khadka S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.012187-1, 10.1074/mcp.M111.012187]; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kroschewski H, 2008, J BIOL CHEM, V283, P19410, DOI 10.1074/jbc.M800613200; Le Breton M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-234; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Loke P, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000710; Long HT, 2009, J INFECT DIS, V199, P537, DOI 10.1086/596507; Mairiang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053535; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Marianneau P, 1997, J VIROL, V71, P3244, DOI 10.1128/JVI.71.4.3244-3249.1997; Mason DA, 2009, J MOL EVOL, V68, P351, DOI 10.1007/s00239-009-9215-8; Munday DC, 2012, PROTEOMICS; Munday DC, 2010, MOL CELL PROTEOMICS, V9, P2438, DOI 10.1074/mcp.M110.001859; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Munoz-Jordan JL, 2010, FRONTIERS IN DENGUE VIRUS RESEARCH, P121; Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007892; Onoguchi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001012; Paradkar PN, 2010, BIOSCI REP; Pastorino B, 2009, MOL CELL PROTEOMICS; Patramool S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-138; Pattanakitsakul S, 2007, J PROTEOME RES, V6, P4592, DOI 10.1021/pr070366b; Pattanakitsakul SN, 2010, J PROTEOME RES, V9, P4640, DOI 10.1021/pr100357f; Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584; Pettersson M, 2000, GENOMICS, V68, P351, DOI 10.1006/geno.2000.6278; Phoolcharoen W, 2004, J MED VIROL, V74, P434, DOI 10.1002/jmv.20195; Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x; Rasmussen AL, 2011, J VIROL, V85, P11646, DOI 10.1128/JVI.05605-11; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Rothwell C, 2009, VIROLOGY; Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0; Sanson M, 2008, CELL DEATH DIFFER, V15, P1255, DOI 10.1038/cdd.2008.36; Schussek S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077811; Schweneker M, 2005, FEBS LETT, V579, P1751, DOI 10.1016/j.febslet.2005.02.037; Sessions OM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002107; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; Silveira GF, 2011, J VIROL, V85, P5374, DOI 10.1128/JVI.01915-10; Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Tanabe K, 2013, PARASITOL INT; Tchankouo-Nguetcheu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013149; Tolfvenstam T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-209; Ubol S, 2008, J INFECT DIS, V197, P1459, DOI 10.1086/587699; Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05; Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0; Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91; Vento MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015636; Wacher C, 2007, J VIROL, V81, P860, DOI 10.1128/JVI.01167-06; Walther TC, 2010, J CELL BIOL, V190, P491, DOI 10.1083/jcb.201004052; Warke RV, 2008, J VIROL, V82, P555, DOI 10.1128/JVI.01694-06; Warke RV, 2003, J VIROL, V77, P11822, DOI 10.1128/JVI.77.21.11822-11832.2003; Wati S, 2009, J VIROL, V83, P12871, DOI 10.1128/JVI.01419-09; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; World Health Organization, 2009, DENGUE GUIDELINES DI; Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06; Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780; Zhang LK, 2013, J PROTEOME RES, V12, P2666, DOI 10.1021/pr400011k	100	55	57	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93305	10.1371/journal.pone.0093305	http://dx.doi.org/10.1371/journal.pone.0093305			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671231	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677000133
J	Wang, XH; Xia, Y; Wen, XH; Yang, YF; Zhou, JZ				Wang, Xiaohui; Xia, Yu; Wen, Xianghua; Yang, Yunfeng; Zhou, Jizhong			Microbial Community Functional Structures in Wastewater Treatment Plants as Characterized by GeoChip	PLOS ONE			English	Article							ACTIVATED-SLUDGE; BACTERIAL COMMUNITY; GENE DIVERSITY; DYNAMICS; TEMPERATURE; NITRIFICATION; INSTABILITY; BIOREACTOR; REMOVAL; REVEALS	Background: Biological WWTPs must be functionally stable to continuously and steadily remove contaminants which rely upon the activity of complex microbial communities. However, knowledge is still lacking in regard to microbial community functional structures and their linkages to environmental variables. Aims: To investigate microbial community functional structures of activated sludge in wastewater treatment plants (WWTPs) and to understand the effects of environmental factors on their structure. Methods: 12 activated sludge samples were collected from four WWTPs in Beijing. A comprehensive functional gene array named GeoChip 4.2 was used to determine the microbial functional genes involved in a variety of biogeochemical processes such as carbon, nitrogen, phosphorous and sulfur cycles, metal resistance, antibiotic resistance and organic contaminant degradation. Results: High similarities of the microbial community functional structures were found among activated sludge samples from the four WWTPs, as shown by both diversity indices and the overlapped genes. For individual gene category, such as egl, amyA, lip, nirS, nirK, nosZ, ureC, ppx, ppk, aprA, dsrA, sox and benAB, there were a number of microorganisms shared by all 12 samples. Canonical correspondence analysis (CCA) showed that the microbial functional patterns were highly correlated with water temperature, dissolved oxygen (DO), ammonia concentrations and loading rate of chemical oxygen demand (COD). Based on the variance partitioning analyses (VPA), a total of 53% of microbial community variation from GeoChip data can be explained by wastewater characteristics (25%) and operational parameters (23%), respectively. Conclusions: This study provided an overall picture of microbial community functional structures of activated sludge in WWTPs and discerned the linkages between microbial communities and environmental variables in WWTPs.	[Wang, Xiaohui; Xia, Yu; Wen, Xianghua; Yang, Yunfeng; Zhou, Jizhong] Tsinghua Univ, Sch Environm, Environm Simulat & Pollut Control State Key Joint, Beijing 100084, Peoples R China; [Wang, Xiaohui] Beijing Univ Chem Technol, Dept Environm Sci & Engn, Beijing 100029, Peoples R China; [Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA; [Zhou, Jizhong] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Zhou, Jizhong] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA	Tsinghua University; Beijing University of Chemical Technology; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Wen, XH (corresponding author), Tsinghua Univ, Sch Environm, Environm Simulat & Pollut Control State Key Joint, Beijing 100084, Peoples R China.	xhwen@tsinghua.edu.cn	Yang, Yunfeng/H-9853-2013; 吴, 昊/AAB-1620-2020; wen, xianghua/A-7551-2015	Yang, Yunfeng/0000-0001-8274-6196; 	National Natural Science Foundation of China [51078207, 51178239]; special fund of State Key Joint Laboratory of Environment Simulation and Pollution Control [12L03ESPC]; ENIGMA-Ecosystems; Networks Integrated with Genes and Molecular Assemblies through the Office of Science, Office of Biological and Environmental Research; U.S. Department of Energy [DE-AC02-05CH11231]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special fund of State Key Joint Laboratory of Environment Simulation and Pollution Control; ENIGMA-Ecosystems; Networks Integrated with Genes and Molecular Assemblies through the Office of Science, Office of Biological and Environmental Research; U.S. Department of Energy(United States Department of Energy (DOE))	This study was supported by National Natural Science Foundation of China funds (51078207 and 51178239) and the special fund of State Key Joint Laboratory of Environment Simulation and Pollution Control (12L03ESPC). This study made use of the GeoChip and associated computational pipelines funded by ENIGMA-Ecosystems and Networks Integrated with Genes and Molecular Assemblies through the Office of Science, Office of Biological and Environmental Research, the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsubasi AT, 2009, ENVIRON SCI TECHNOL, V43, P2950, DOI 10.1021/es8026488; Association AAPH, 2012, STANDARD METHODS EXA; Bergaust L, 2011, BIOCHEM SOC T, V39, P207, DOI 10.1042/BST0390207; Briones A, 2003, CURR OPIN BIOTECH, V14, P270, DOI 10.1016/S0958-1669(03)00065-X; Curtis TP, 2006, WATER SCI TECHNOL, V54, P227, DOI 10.2166/wst.2006.391; Dytczak MA, 2008, WATER RES, V42, P2320, DOI 10.1016/j.watres.2007.12.018; Ebie Y, 2002, WATER SCI TECHNOL, V46, P105, DOI 10.2166/wst.2002.0724; Ebrahimi S, 2010, APPL MICROBIOL BIOT, V87, P1555, DOI 10.1007/s00253-010-2621-4; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gentile ME, 2007, APPL ENVIRON MICROB, V73, P680, DOI 10.1128/AEM.01519-06; Graham DW, 2007, ISME J, V1, P385, DOI 10.1038/ismej.2007.45; Gregory SP, 2010, ECOL ENG, V36, P1485, DOI 10.1016/j.ecoleng.2010.06.031; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; He ZL, 2010, ECOL LETT, V13, P564, DOI 10.1111/j.1461-0248.2010.01453.x; Hemme CL, 2010, ISME J, V4, P660, DOI 10.1038/ismej.2009.154; Huang ZH, 2010, WATER RES, V44, P4351, DOI 10.1016/j.watres.2010.05.037; Kunin V, 2008, GENOME RES, V18, P293, DOI 10.1101/gr.6835308; Li TL, 2012, BIORESOURCE TECHNOL, V108, P28, DOI 10.1016/j.biortech.2011.12.141; Lopez-Vazquez CM, 2008, WATER RES, V42, P2349, DOI 10.1016/j.watres.2008.01.001; Lu ZM, 2012, ISME J, V6, P451, DOI 10.1038/ismej.2011.91; Lydmark P, 2007, ENVIRON MICROBIOL, V9, P2220, DOI 10.1111/j.1462-2920.2007.01336.x; Miura Y, 2007, WATER RES, V41, P627, DOI 10.1016/j.watres.2006.11.005; Nogales B, 2001, APPL ENVIRON MICROB, V67, P1874, DOI 10.1128/AEM.67.4.1874-1884.2001; Ofiteru ID, 2010, P NATL ACAD SCI USA, V107, P15345, DOI 10.1073/pnas.1000604107; Park HD, 2004, WATER RES, V38, P3275, DOI 10.1016/j.watres.2004.04.047; Petropoulos P, 2005, CAN J MICROBIOL, V51, P791, DOI [10.1139/W05-069, 10.1139/w05-069]; Pholchan MK, 2010, WATER RES, V44, P1341, DOI 10.1016/j.watres.2009.11.005; Rittmann BE, 2006, ENVIRON SCI TECHNOL, V40, P1096, DOI 10.1021/es062631k; Sanapareddy N, 2009, APPL ENVIRON MICROB, V75, P1688, DOI 10.1128/AEM.01210-08; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; Szukics U, 2010, FEMS MICROBIOL ECOL, V72, P395, DOI 10.1111/j.1574-6941.2010.00853.x; ter B, 2002, CANOCO REFERENCE MAN; Urakawa H, 2008, APPL ENVIRON MICROB, V74, P894, DOI 10.1128/AEM.01529-07; Van Nostrand JD, 2011, APPL ENVIRON MICROB, V77, P3860, DOI 10.1128/AEM.01981-10; Wang FP, 2009, P NATL ACAD SCI USA, V106, P4840, DOI 10.1073/pnas.0810418106; Wang XH, 2012, APPL ENVIRON MICROB, V78, P7042, DOI 10.1128/AEM.01617-12; Wang XH, 2011, FRONT ENVIRON SCI EN, V5, P92, DOI 10.1007/s11783-010-0254-6; Wang XH, 2011, BIORESOURCE TECHNOL, V102, P2352, DOI 10.1016/j.biortech.2010.10.095; Wang XH, 2010, J ENVIRON SCI-CHINA, V22, P627, DOI 10.1016/S1001-0742(09)60155-8; Wells GF, 2009, ENVIRON MICROBIOL, V11, P2310, DOI 10.1111/j.1462-2920.2009.01958.x; Wu L, 2008, APPL ENVIRON MICROB, V74, P4516, DOI 10.1128/AEM.02751-07; Xia SQ, 2010, ENVIRON SCI TECHNOL, V44, P7391, DOI 10.1021/es101554m; Xie JP, 2011, APPL ENVIRON MICROB, V77, P991, DOI 10.1128/AEM.01798-10; Ye L, 2012, ENVIRON SCI TECHNOL, V46, P13244, DOI 10.1021/es303454k; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188; Zhou JZ, 2008, P NATL ACAD SCI USA, V105, P7768, DOI 10.1073/pnas.0709016105; Zhou JZ, 2002, APPL ENVIRON MICROB, V68, P326, DOI 10.1128/AEM.68.1.326-334.2002; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	49	34	36	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93422	10.1371/journal.pone.0093422	http://dx.doi.org/10.1371/journal.pone.0093422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671164	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677000143
J	Li, TJ; Wang, S; Meng, XS; Bao, YR; Guan, SS; Liu, B; Chen, L; Wang, L; Ran, XR				Li Tianjiao; Wang Shuai; Meng Xiansheng; Bao Yongrui; Guan Shanshan; Liu Bo; Chen Lu; Wang Lei; Ran Xiaorong			Metabolomics Coupled with Multivariate Data and Pathway Analysis on Potential Biomarkers in Gastric Ulcer and Intervention Effects of Corydalis yanhusuo Alkaloid	PLOS ONE			English	Article							MASS-SPECTROMETRY; CHINESE; METABONOMICS; RECOGNITION; MEDICINE; SURFACE; PLASMA	Metabolomics, the systematic analysis of potential metabolites in a biological specimen, has been increasingly applied to discovering biomarkers, identifying perturbed pathways, measuring therapeutic targets, and discovering new drugs. By analyzing and verifying the significant difference in metabolic profiles and changes of metabolite biomarkers, metabolomics enables us to better understand substance metabolic pathways which can clarify the mechanism of Traditional Chinese Medicines (TCM). Corydalis yanhusuo alkaloid (CA) is a major component of Qizhiweitong (QZWT) prescription which has been used for treating gastric ulcer for centuries and its mechanism remains unclear completely. Metabolite profiling was performed by high-performance liquid chromatography combined with time-of-flight mass spectrometry (HPLC/ESI-TOF-MS) and in conjunction with multivariate data analysis and pathway analysis. The statistic software Mass Profiller Prossional (MPP) and statistic method including ANOVA and principal component analysis (PCA) were used for discovering novel potential biomarkers to clarify mechanism of CA in treating acid injected rats with gastric ulcer. The changes in metabolic profiling were restored to their base-line values after CA treatment according to the PCA score plots. Ten different potential biomarkers and seven key metabolic pathways contributing to the treatment of gastric ulcer were discovered and identified. Among the pathways, sphingophospholipid metabolism and fatty acid metabolism related network were acutely perturbed. Quantitative real time polymerase chain reaction (RT-PCR) analysis were performed to evaluate the expression of genes related to the two pathways for verifying the above results. The results show that changed biomarkers and pathways may provide evidence to insight into drug action mechanisms and enable us to increase research productivity toward metabolomics drug discovery.	[Li Tianjiao; Wang Shuai; Meng Xiansheng; Bao Yongrui; Guan Shanshan; Liu Bo; Chen Lu] Liaoning Univ Tradit Chinese Med, Dalian, Peoples R China; [Wang Lei; Ran Xiaorong] Agilent Technol Co Ltd, Beijing, Peoples R China; [Wang Shuai; Meng Xiansheng; Wang Lei; Ran Xiaorong] Liaoning Univ Tradit Chinese Med, Agilent Technol Modern TCM & Multiom Res Collabor, Dalian, Peoples R China	Liaoning University of Traditional Chinese Medicine; Agilent Technologies; Liaoning University of Traditional Chinese Medicine	Meng, XS (corresponding author), Liaoning Univ Tradit Chinese Med, Dalian, Peoples R China.	mxsvvv@163.com; xiaorong-ran@aglient.com			Natural Science Foundation of the State [81241111]	Natural Science Foundation of the State	This work was supported by grants from the Key Program of the Natural Science Foundation of the State (No. 81241111). The Aglient and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2008, DIGEST DIS SCI, V53, P933, DOI 10.1007/s10620-007-9965-3; Cheng Xing-ye, 2009, Yaoxue Xuebao, V44, P167; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Eamlamnam K, 2006, WORLD J GASTROENTERO, V12, P2034, DOI 10.3748/wjg.v12.i13.2034; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Gao W, 2012, J CHROMATOGR A, V1245, P109, DOI 10.1016/j.chroma.2012.05.027; Griffin JL, 2006, PHILOS T R SOC B, V361, P147, DOI 10.1098/rstb.2005.1734; HAKOMORI S, 1995, J BIOCHEM, V118, P1091, DOI 10.1093/oxfordjournals.jbchem.a124992; Idle JR, 2007, CELL METAB, V6, P348, DOI 10.1016/j.cmet.2007.10.005; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; Ji CX, 2012, EUR J PHARMACOL, V691, P46, DOI 10.1016/j.ejphar.2012.06.041; Konturek PC, 2012, J PHYSIOL PHARMACOL, V50, P211; Lavie Y, 1996, J BIOL CHEM, V271, P19530, DOI 10.1074/jbc.271.32.19530; Lee TH, 2010, BIOL PHARM BULL, V33, P958, DOI 10.1248/bpb.33.958; Lee U, 2012, XENOBIOTICA, V42, P310, DOI 10.3109/00498254.2011.619014; Li Y, 2005, J ETHNOPHARMACOL, V98, P329, DOI 10.1016/j.jep.2005.01.020; Lin G, 2012, J NUTR, V142, P990, DOI 10.3945/jn.111.153411; Liu JL, 2011, BIOL PHARM BULL, V34, P871, DOI 10.1248/bpb.34.871; Murata K, 2012, PHYTOTHER RES, V26, P1126, DOI 10.1002/ptr.3681; Nakashita M, 2013, DIGEST DIS SCI, V58, P354, DOI 10.1007/s10620-012-2350-x; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Nie HG, 2010, J LIPID RES, V51, P2833, DOI 10.1194/jlr.D007567; Normile D, 2003, SCIENCE, V299, P188, DOI 10.1126/science.299.5604.188; OKABE S, 1971, AM J DIG DIS, V16, P277, DOI 10.1007/BF02235252; OKABE S, 1972, AM J DIG DIS, V17, P619, DOI 10.1007/BF02231748; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Sacca R, 1997, CURR OPIN IMMUNOL, V9, P851, DOI 10.1016/S0952-7915(97)80189-6; Shu MH, 2013, BMC COMPLEM ALTERN M, V13, P1; Soji Y, 1969, Nihon Yakurigaku Zasshi, V65, P196; Stone R, 2008, SCIENCE, V319, P709, DOI 10.1126/science.319.5864.709; Sun H, 2012, PHYTOTHER RES, V26, P1466, DOI 10.1002/ptr.4613; Suzuki H, 2000, J GASTROEN HEPATOL, V15, pD46; UCHIDA M, 1990, DIGEST DIS SCI, V35, P80, DOI 10.1007/BF01537227; Wang XJ, 2012, J PROTEOME RES, V11, P1284, DOI 10.1021/pr200963e; Zhang AH, 2012, ANALYST, V137, P293, DOI 10.1039/c1an15605e; Zhang QH, 2013, INT WOUND J, V10, P221, DOI 10.1111/j.1742-481X.2012.00969.x	38	38	45	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e82499	10.1371/journal.pone.0082499	http://dx.doi.org/10.1371/journal.pone.0082499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24671209	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100005
J	Pugno, NM				Pugno, Nicola M.			The "Egg of Columbus" for Making the World's Toughest Fibres	PLOS ONE			English	Article							CARBON-NANOTUBE FIBERS; COMPOSITE FIBERS; GRAPHENE OXIDE; SINGLE; KNOTS; TRANSPARENT; PROTEINS; YARNS	In this letter we present the "Egg of Columbus" for making fibres with unprecedented toughness: a slider, in the simplest form just a knot, is introduced as frictional element to dissipate additional energy and thus demonstrating the existence of a previously "hidden" toughness. The proof of concept is experimentally realized making the world's toughest fibre, increasing the toughness modulus of a commercial Endumax macroscopic fibre from 44 J/g up to 1070 J/g ( and of a zylon microfiber from 20 J/g up to 1400 J/g). The ideal upperbound toughness is expected for graphene, with a theoretical value of similar to 10(5) J/g. This new concept, able of maximizing ( one fold increment) the structural robustness, could explain the mysterious abundance of knot formations, in spite of their incremental energy cost and topological difficulty, in biological evolved structures, such as DNA strands and proteins.	[Pugno, Nicola M.] Univ Trento, Dept Civil Environm & Mech Engn, Lab Bioinspired & Graphene Nanomech, Trento, Italy; [Pugno, Nicola M.] Fdn Bruno Kessler, Ctr Mat & Microsyst, Povo, Trento, Italy; [Pugno, Nicola M.] Queen Marys Univ Hosp, Sch Engn & Mat Sci, London, England	University of Trento; Fondazione Bruno Kessler; FBK-CMM - Centre for Materials & Microsystems; University of London; Queen Mary University London	Pugno, NM (corresponding author), Univ Trento, Dept Civil Environm & Mech Engn, Lab Bioinspired & Graphene Nanomech, Trento, Italy.	nicola.pugno@unitn.it			European Research Council (ERC); European Commission under the Graphene Flagship	European Research Council (ERC)(European Research Council (ERC)); European Commission under the Graphene Flagship	NMP is supported by the European Research Council (ERC) thanks to the following 3 projects: ERC Starting Grant 2011 BIHSNAM on "Bio-inspired hierarchical super nano materials''; ERC Proof of Concept 2013-1 REPLICA2 on "Large-area replication of biological anti-adhesive nano surfaces''; ERC Proof of Concept 2013-2 KNOTOUGH on "Super-tough knotted fibers; and by the European Commission under the Graphene Flagship. The author particularly thanks the support on this specific idea just received from the ERC. The initial version of this paper was posted in the archive and commented by the MIT Technology Review at: http://www.technologyreview.com/view/514316/simple-trick-turns-commercial-polymer-into-worlds-toughest-fiber/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234; Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; BUCK D, 2008, P S APPL MATH, V66; Cranford SW, 2012, NATURE, V482, P72, DOI 10.1038/nature10739; Dalton AB, 2003, NATURE, V423, P703, DOI 10.1038/423703a; Delbruck M., 1962, P S APPL MATH, V14, P55; Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016; Endo M, 2005, NATURE, V433, P476, DOI 10.1038/433476a; Ericson LM, 2004, SCIENCE, V305, P1447, DOI 10.1126/science.1101398; Jiang KL, 2002, NATURE, V419, P801, DOI 10.1038/419801a; King NP, 2007, J MOL BIOL, V373, P153, DOI 10.1016/j.jmb.2007.07.042; Koziol K, 2007, SCIENCE, V318, P1892, DOI 10.1126/science.1147635; Li YL, 2004, SCIENCE, V304, P276, DOI 10.1126/science.1094982; Lua RC, 2006, PLOS COMPUT BIOL, V2, P350, DOI 10.1371/journal.pcbi.0020045; MANSFIELD ML, 1994, NAT STRUCT BIOL, V1, P213, DOI 10.1038/nsb0494-213; Miaudet P, 2005, NANO LETT, V5, P2212, DOI 10.1021/nl051419w; Micheletti C, 2008, BIOPHYS J, V95, P3591, DOI [10.1529/biophysj.108.137653, 10.1529/biophysj.l08.137653]; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Pugno NM, 2010, J MECH PHYS SOLIDS, V58, P1397, DOI 10.1016/j.jmps.2010.05.007; RYBENKOV VV, 1993, P NATL ACAD SCI USA, V90, P5307, DOI 10.1073/pnas.90.11.5307; Shin MK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1661; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Sulkowska JI, 2009, P NATL ACAD SCI USA, V106, P3119, DOI 10.1073/pnas.0811147106; Sulkowska JI, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.058106; Sulkowska JI, 2008, P NATL ACAD SCI USA, V105, P19714, DOI 10.1073/pnas.0805468105; Vilatela JJ, 2010, ADV MATER, V22, P4959, DOI 10.1002/adma.201002131; Virnau P, 2006, PLOS COMPUT BIOL, V2, P1074, DOI 10.1371/journal.pcbi.0020122; Wang SR, 2007, ADV MATER, V19, P1257, DOI 10.1002/adma.200602140; Wu JY, 2013, SMALL, V9, P3561, DOI 10.1002/smll.201202830; Wu JY, 2013, J AM CHEM SOC, V135, P13775, DOI 10.1021/ja404330q; Wu ZC, 2004, SCIENCE, V305, P1273, DOI 10.1126/science.1101243; Zhang M, 2005, SCIENCE, V309, P1215, DOI 10.1126/science.1115311; Zhang M, 2004, SCIENCE, V306, P1358, DOI 10.1126/science.1104276; Zhu HW, 2002, SCIENCE, V296, P884, DOI 10.1126/science.1066996	35	19	19	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93079	10.1371/journal.pone.0093079	http://dx.doi.org/10.1371/journal.pone.0093079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695084	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000334103000038
J	Tran, B; Falster, MO; Douglas, K; Blyth, F; Jorm, LR				Bich Tran; Falster, Michael O.; Douglas, Kirsty; Blyth, Fiona; Jorm, Louisa R.			Health Behaviours and Potentially Preventable Hospitalisation: A Prospective Study of Older Australian Adults	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; CARE SENSITIVE CONDITIONS; LIFE-STYLE FACTORS; MEDITERRANEAN DIET; RISK-FACTORS; AVOIDABLE HOSPITALIZATION; ALCOHOL-CONSUMPTION; PROSPECTIVE COHORT; PHYSICAL-ACTIVITY; COMBINED IMPACT	Objective : Several Studies have demonstrated the effetcs of health behaviors on risk of chronic diseases and mortality , but none have investigated their contribution to potentially preventable hospitalisation (PPH). We aimed to quantify the effects on risk of PPH of six health behaviours: smoking; alcohol consumption; physical activity; fruit and vegetables consumption; sitting time; and sleeping time. Design/ Setting: Prospective observational study in New South Wales, Australia. Subjects: 267,006 men and women aged 45 years and over. Outcome Measures: PPH admissions and mortality during follow- up according to individual positive health behaviours ( non- smoking < 14 alcoholic drinks per week, >= 2.5 hours of physical activity per week, >= 2 servings of fruit and 5 servings of vegetables per day < 8 hours sitting and >= 7 hours sleeping per day) and the total number of these behaviours. Results: During an average of 3 years follow- up, 20971 ( 8%) participants had at least one PPH admission. After adjusting for potential confounders, participants who reported all six positive health behaviours at baseline had 46% lower risk of PPH admission ( 95% CI 0.48-0.61), compared to those who reported having only one of these behaviours. Based on these risk estimates, approximately 29% of PPH admissions in Australians aged 45 years and over were attributable to not adhering to the six health behaviours. Estimates were similar for acute, chronic and vaccine- preventable categories of PPH admissions. Conclusions: Individual and combined positive health behaviours were associated with lower risk of PPH admission. These findings suggest that there is a significant opportunity to reduce PPH by promoting healthy behaviours.	[Bich Tran; Falster, Michael O.; Jorm, Louisa R.] Univ Western Sydney, Sch Med, Ctr Hlth Res, Campbelltown, NSW, Australia; [Douglas, Kirsty] Australian Natl Univ, Canberra, ACT, Australia; [Blyth, Fiona] Sax Inst, Haymarket, NSW, Australia; [Blyth, Fiona] Univ Sydney, Concord Clin Sch, Sydney, NSW, Australia	Western Sydney University; Australian National University; University of Sydney; University of Sydney	Tran, B (corresponding author), Univ Western Sydney, Sch Med, Ctr Hlth Res, Campbelltown, NSW, Australia.	b.tran@uws.edu.au	Douglas, Kirsty/E-3083-2017; Jorm, Louisa/AAN-6874-2020; Falster, Michael/X-7118-2019	Douglas, Kirsty/0000-0003-0174-782X; Jorm, Louisa/0000-0003-0390-661X; Falster, Michael/0000-0001-6444-7272; Blyth, Fiona/0000-0003-1128-6756	National Health and Medical Research Council [1036858]; Australian Commission on Safety and Quality in Health Care; Agency for Clinical Innovation; NSW Bureau of Health Information	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Commission on Safety and Quality in Health Care; Agency for Clinical Innovation; NSW Bureau of Health Information	The study was funded by a National Health and Medical Research Council Partnership Project Grant (#1036858) and by partner agencies the Australian Commission on Safety and Quality in Health Care, the Agency for Clinical Innovation and the NSW Bureau of Health Information. The funders play no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NATIONAL HEALTHCARE; Ansari Z, 2007, AUST J PRIM HEALTH, V13, P91, DOI 10.1071/PY07043; Australian Government, 2005, PHYSICAL ACTIVITY GU; Australian Health Survey, 2011, AUSTRALIAN HEALTH SU; Australian Institute of Health and Welfare, 2004, RURAL REGIONAL AND R; Australian Institute of Health and Welfare, 2003, THE ACTIVE AUSTRALIA; Babitsch B, 2012, RE REVISITING ANDERS, V9, pDoc11; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; Buckland G, 2008, OBES REV, V9, P582, DOI 10.1111/j.1467-789X.2008.00503.x; Calderon-Larranaga A, 2011, THORAX, V66, P191, DOI 10.1136/thx.2010.147058; Callaway LK, 2006, MED J AUSTRALIA, V184, P56, DOI 10.5694/j.1326-5377.2006.tb00115.x; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Daly LE, 1998, AM J EPIDEMIOL, V147, P783; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; Feldman C, 2013, J INFECTION, V67, P169, DOI 10.1016/j.jinf.2013.05.004; Ford ES, 2011, AM J PUBLIC HEALTH, V101, P1922, DOI [10.2105/AJPH.2011.300167, 10.2105//AJPH.2011.300167]; Forey BA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-36; George ES, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-20; Hanley JA, 2001, J EPIDEMIOL COMMUN H, V55, P508, DOI 10.1136/jech.55.7.508; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Jackson G, 2001, AUST NZ J PUBL HEAL, V25, P212, DOI 10.1111/j.1467-842X.2001.tb00565.x; Jorm LR, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-002344; Katteri R, 2013, PHC RIS POLICY ISSUE; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Korda RJ, 2013, INT J OBESITY, V37, P790, DOI 10.1038/ijo.2012.155; Kornum JB, 2010, EUR RESPIR J, V36, P1330, DOI 10.1183/09031936.00184209; Kubo A, 2009, GASTROENTEROLOGY, V136, P806, DOI 10.1053/j.gastro.2008.11.042; Kvaavik E, 2010, ARCH INTERN MED, V170, P711, DOI 10.1001/archinternmed.2010.76; Magee CA, 2013, SLEEP MED, V14, P591, DOI 10.1016/j.sleep.2013.02.002; Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26; Muenchberger H, 2010, J PUBLIC HEALTH POL, V31, P150, DOI 10.1057/jphp.2010.3; National Health and Medical Research Council, 2013, AUSTRALIAN DIETARY G; National Health and Medical Research Council (NHMRC), 2009, AUSTRALIAN GUIDELINE; Niti M, 2003, J EPIDEMIOL COMMUN H, V57, P17, DOI 10.1136/jech.57.1.17; Northcote J, 2011, ALCOHOL ALCOHOLISM, V46, P709, DOI 10.1093/alcalc/agr138; Pavey TG, 2012, BRIT J SPORT MED, V0, P1, DOI DOI 10.1136/BJSP0RTS-2012-091676; Pelegrino NRG, 2013, AM J MED SCI, V345, P440, DOI 10.1097/MAJ.0b013e31825f32a7; POIKOLAINEN K, 1985, BRIT J ADDICT, V80, P215; Ponsonby AL, 1996, AUST NZ J PUBL HEAL, V20, P54, DOI 10.1111/j.1467-842X.1996.tb01336.x; Reid MC, 2003, AM J ADDICTION, V12, P211, DOI 10.1111/j.1521-0391.2003.tb00649.x; Roos LL, 2005, HEALTH SERV RES, V40, P1167, DOI 10.1111/j.1475-6773.2005.00407.x; Rosano A, 2013, EUR J PUBLIC HEALTH, V23, P356, DOI 10.1093/eurpub/cks053; Strasser B, 2013, ANN NY ACAD SCI, V1281, P141, DOI 10.1111/j.1749-6632.2012.06785.x; Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; Thrift AP, 2011, AM J GASTROENTEROL, V106, P1220, DOI 10.1038/ajg.2011.89; Tomlin AM, 2008, DIABETES RES CLIN PR, V80, P244, DOI 10.1016/j.diabres.2007.12.017; van Dam RM, 2008, BRIT MED J, V337, pa1440, DOI [DOI 10.1136/BMJ.A1440, 10.1136/bmj.a1440]; van den Brandt PA, 2011, AM J CLIN NUTR, V94, P913, DOI 10.3945/ajcn.110.008250; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Veugelers PJ, 2006, DIS ESOPHAGUS, V19, P321, DOI 10.1111/j.1442-2050.2006.00602.x; Vgontzas AN, 2010, SLEEP, V33, P1159, DOI 10.1093/sleep/33.9.1159; Zheng XY, 2012, CURR MED RES OPIN, V28, P1791, DOI 10.1185/03007995.2012.722991	55	16	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93111	10.1371/journal.pone.0093111	http://dx.doi.org/10.1371/journal.pone.0093111			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6KM	24691471	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100046
J	Engel, J; Blanchet, L; Engelke, UFH; Wevers, RA; Buydens, LMC				Engel, Jasper; Blanchet, Lionel; Engelke, Udo F. H.; Wevers, Ron A.; Buydens, Lutgarde M. C.			Towards the Disease Biomarker in an Individual Patient Using Statistical Health Monitoring	PLOS ONE			English	Article							METABONOMICS; CHEMOMETRICS	In metabolomics, identification of complex diseases is often based on application of ( multivariate) statistical techniques to the data. Commonly, each disease requires its own specific diagnostic model, separating healthy and diseased individuals, which is not very practical in a diagnostic setting. Additionally, for orphan diseases such models cannot be constructed due to a lack of available data. An alternative approach adapted from industrial process control is proposed in this study: statistical health monitoring ( SHM). In SHM the metabolic profile of an individual is compared to that of healthy people in a multivariate manner. Abnormal metabolite concentrations, or abnormal patterns of concentrations, are indicated by the method. Subsequently, this biomarker can be used for diagnosis. A tremendous advantage here is that only data of healthy people is required to construct the model. The method is applicable in current- population based - clinical practice as well as in personalized health applications. In this study, SHM was successfully applied for diagnosis of several orphan diseases as well as detection of metabotypic abnormalities related to diet and drug intake.	[Engel, Jasper; Blanchet, Lionel; Buydens, Lutgarde M. C.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands; [Engelke, Udo F. H.; Wevers, Ron A.] Radboud Univ Nijmegen Med Ctr, Dept Lab Med, Lab Genet Endocrine & Metab Dis, Nijmegen, Netherlands; [Blanchet, Lionel] Radboud Univ Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Engel, J (corresponding author), Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands.	j.engel@science.ru.nl	Blanchet, Lionel/H-3150-2019; Engelke, U.F.H./L-4293-2015; Blanchet, Lionel/C-8829-2011; Buydens, Lutgarde M.C./D-4338-2012; Wevers, Ron A./H-8116-2014	Blanchet, Lionel/0000-0003-2284-8101; Blanchet, Lionel/0000-0003-2284-8101; Wevers, Ron A./0000-0003-2278-9746; Engel, Jasper/0000-0001-6087-1711	Radboud University Nijmegen; Radboud University Medical Centre	Radboud University Nijmegen; Radboud University Medical Centre	The research was funded by the Radboud University Nijmegen and the Radboud University Medical Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala CF, 2011, J PROCESS CONTR, V21, P322, DOI 10.1016/j.jprocont.2010.10.005; Bersimis S, 2007, QUAL RELIAB ENG INT, V23, P517, DOI 10.1002/qre.829; Chen T., 2013, EVID-BASED COMPL ALT, V2013, P11; Dunn WB, 2005, ANALYST, V130, P606, DOI 10.1039/b418288j; Engelke U, 2007, HDB 1H NMR SPECTROSC; Henry RC, 1999, CHEMOMETR INTELL LAB, V48, P91, DOI 10.1016/S0169-7439(99)00015-5; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; KENNARD RW, 1969, TECHNOMETRICS, V11, P137, DOI 10.2307/1266770; Lenz EM, 2007, J PROTEOME RES, V6, P443, DOI 10.1021/pr0605217; Lindon J. C., 2007, HDB METABONOMICS MET; Lindon JC, 2007, FEBS J, V274, P1140, DOI 10.1111/j.1742-4658.2007.05673.x; Louwerse DJ, 2000, CHEM ENG SCI, V55, P1225, DOI 10.1016/S0009-2509(99)00408-X; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; Melnikova I, 2012, NAT REV DRUG DISCOV, V11, P267, DOI 10.1038/nrd3654; Nicholson JK, 2012, NATURE, V491, P384, DOI 10.1038/nature11708; Qin SJ, 2003, J CHEMOMETR, V17, P480, DOI 10.1002/cem.800; Smolinska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038163; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Wise B., 1992, PLS TOOLBOX USE MATL	19	12	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92452	10.1371/journal.pone.0092452	http://dx.doi.org/10.1371/journal.pone.0092452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691487	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100026
J	Fan, XT; Zhang, Q; You, C; Qian, YX; Gao, J; Liu, P; Chen, HQ; Song, HF; Chen, Y; Chen, KP; Zhou, YJ				Fan, Xiaoting; Zhang, Qian; You, Chao; Qian, Yuanxia; Gao, Jing; Liu, Peng; Chen, Huiqing; Song, Huifang; Chen, Yan; Chen, Keping; Zhou, Yajing			Proteolysis of the Human DNA Polymerase Delta Smallest Subunit p12 by mu-Calpain in Calcium-Triggered Apoptotic HeLa Cells	PLOS ONE			English	Article							DAMAGE; ACTIVATION; CLEAVAGE; PROTEIN; REPAIR; PCNA; PROTEASES; ENZYME; DEATH; PHOSPHORYLATION	Degradation of p12 subunit of human DNA polymerase delta (Pol delta) that results in an interconversion between Pol delta 4 and Pol delta 3 forms plays a significant role in response to replication stress or genotoxic agents triggered DNA damage. Also, the p12 is readily degraded by human calpain in vitro. However, little has been done for the investigation of its degree of participation in any of the more common apoptosis. Here, we first report that the p12 subunit is a substrate of mu-calpain. In calcium-triggered apoptotic HeLa cells, the p12 is degraded at 12 hours post-induction (hpi), restored thereafter by 24 hpi, and then depleted again after 36 hpi in a time-dependent manner while the other three subunits are not affected. It suggests a dual function of Pol delta by its interconversion between Pol delta 4 and Pol delta 3 that is involved in a novel unknown apoptosis mechanism. The proteolysis of p12 could be efficiently blocked by both calpain inhibitor ALLN and proteasome inhibitor MG132. In vitro pull down and co-immunoprecipitation assays show that the mu-calpain binds to p12 through the interaction of mu-calpain with Pol delta other three subunits, not p12 itself, and PCNA, implying that the proteolysis of p12 by mu-calpain might be through a Pol delta 4/PCNA complex. The p12 cleavage sites by mu-calpain are further determined as the location within a 16-amino acids peptide 28-43 by in vitro cleavage assays. Thus, the p12/Pol delta is a target as a nuclear substrate of mu-calpain in a calcium-triggered apoptosis and appears to be a potential marker in the study of the chemotherapy of cancer therapies.	[Fan, Xiaoting; Zhang, Qian; You, Chao; Liu, Peng; Chen, Huiqing; Song, Huifang; Chen, Yan; Chen, Keping; Zhou, Yajing] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China; [Qian, Yuanxia; Gao, Jing] Jiangsu Univ, Sch Pharm, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Zhou, YJ (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China.	yajingzhou@ujs.edu.cn			National Natural Science Foundation of China [31370790, 30970612, 31100118]; Natural Science Foundation of Jiangsu Province [BK2011495]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (31370790, 30970612, 31100118), and Natural Science Foundation of Jiangsu Province (BK2011495). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An B, 1996, CANCER RES, V56, P438; Andersen PL, 2011, MOL BIOL CELL, V22, P2373, DOI 10.1091/mbc.E10-12-0938; BANIK NL, 1994, J NEUROSCI RES, V37, P489, DOI 10.1002/jnr.490370408; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Camins A, 2006, CNS DRUG REV, V12, P135, DOI 10.1111/j.1527-3458.2006.00135.x; Chea J, 2012, CELL CYCLE, V11, P2885, DOI 10.4161/cc.21280; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; duVerle DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019035; Friedrich P, 2005, BIOL CHEM, V386, P609, DOI 10.1515/BC.2005.071; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Harwood SM, 2005, ANN CLIN BIOCHEM, V42, P415, DOI 10.1258/000456305774538238; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Johnson DE, 2000, LEUKEMIA, V14, P1695, DOI 10.1038/sj.leu.2401879; Kaina B, 2003, BIOCHEM PHARMACOL, V66, P1547, DOI 10.1016/S0006-2952(03)00510-0; Kannouche P, 2006, METHOD ENZYMOL, V408, P407, DOI 10.1016/S0076-6879(06)08025-6; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kidd VJ, 2000, SEMIN CELL DEV BIOL, V11, P191, DOI 10.1006/scdb.2000.0165; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P9870, DOI 10.1073/pnas.152336999; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lakshmikuttyamma A, 2004, CANCER EPIDEM BIOMAR, V13, P1604; LAZEBNIK YA, 1995, P NATL ACAD SCI USA, V92, P9042, DOI 10.1073/pnas.92.20.9042; Li H, 2006, J BIOL CHEM, V281, P14748, DOI 10.1074/jbc.M600322200; Liu W, 2000, NUCLEIC ACIDS RES, V28, P4180, DOI 10.1093/nar/28.21.4180; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Mani SK, 2009, AM J PHYSIOL-HEART C, V297, pH1744, DOI 10.1152/ajpheart.00338.2009; Meng X, 2010, BIOCHEMISTRY-US, V49, P3545, DOI 10.1021/bi100042b; Meng X, 2009, NUCLEIC ACIDS RES, V37, P647, DOI 10.1093/nar/gkn1000; Michetti M, 1996, FEBS LETT, V392, P11, DOI 10.1016/0014-5793(96)00775-2; Momeni HR, 2011, CELL J, V13, P65; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Podust VN, 2002, J BIOL CHEM, V277, P3894, DOI 10.1074/jbc.M109684200; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; Rahmeh AA, 2012, BIOCHEMISTRY-US, V51, P416, DOI 10.1021/bi201638e; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Wang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027092; Xiao TT, 2013, FOOD CHEM TOXICOL, V53, P364, DOI 10.1016/j.fct.2012.12.022; Zhang SF, 2007, J BIOL CHEM, V282, P15330, DOI 10.1074/jbc.M610356200; Zhang SF, 2013, J BIOL CHEM, V288, P29550, DOI 10.1074/jbc.M113.490466; Zhang SF, 2013, J BIOL CHEM, V288, P2941, DOI 10.1074/jbc.M112.423392; Zhang WW, 2011, FEBS LETT, V585, P2786, DOI 10.1016/j.febslet.2011.04.044; Zhang ZT, 2012, CELL CYCLE, V11, P2128, DOI 10.4161/cc.20595; Zhou YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039156; Zhou YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022224	55	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93642	10.1371/journal.pone.0093642	http://dx.doi.org/10.1371/journal.pone.0093642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691096	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100118
J	Hong, EJ; Park, JS; Kim, Y; Lee, HS				Hong, Eun-Ji; Park, Joon-Song; Kim, Younhee; Lee, Heung-Shick			Role of Corynebacterium glutamicum sprA Encoding a Serine Protease in glxR-Mediated Global Gene Regulation	PLOS ONE			English	Article							DNA-BINDING SITES; ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATOR; ACETATE METABOLISM; ISOCITRATE DEHYDROGENASE; ENZYMATIC-SYNTHESIS; BACILLUS-SUBTILIS; GENOME SEQUENCE; AMINO-ACIDS; IN-VITRO	The global regulator glxR of Corynebacterium glutamicum is involved in many cellular activities. Considering its role, the GlxR protein likely interacts with other proteins to obtain, maintain, and control its activity. To isolate proteins interacting with GlxR, we used a two-hybrid system with GlxR as the bait. Subsequently, the partner, a subtilisin-like serine protease, was isolated from a C. glutamicum genomic library. Unlike glxR, which showed constitutive expression, the expression of sprA, encoding a serine protease, was maximal in the log phase. Purified His(6)-SprA protein underwent self-proteolysis and proteolyzed purified GlxR. The proteolytic action of SprA on GlxR was not observed in the presence of cyclic adenosine monophosphate, which modulates GlxR activity. The C. glutamicum sprA deletion mutant (Delta sprA) and sprA-overexpressing (P-180-sprA) strains showed reduced growth. The activity of isocitrate dehydrogenase (a tricarboxylic acid cycle enzyme) in these strains decreased to 30-50% of that in the wild-type strain. In the P-180-sprA strain, proteins involved in diverse cellular functions such as energy and carbon metabolism (NCgl2809), nitrogen metabolism (NCgl0049), methylation reactions (NCgl0719), and peptidoglycan biosynthesis (NCgl1267), as well as stress, starvation, and survival (NCgl0938) were affected and showed decreased transcription. Taken together, these data suggest that SprA, as a serine protease, performs a novel regulatory role not only in glxR-mediated gene expression but also in other areas of cell physiology. In addition, the tight control of SprA and GlxR availability may indicate their importance in global gene regulation.	[Hong, Eun-Ji; Park, Joon-Song; Lee, Heung-Shick] Korea Univ, Dept Biotechnol & Bioinformat, Sejong Si, South Korea; [Kim, Younhee] Semyung Univ, Dept Oriental Med, Checheon, Chungbuk, South Korea	Korea University; Semyung University	Lee, HS (corresponding author), Korea Univ, Dept Biotechnol & Bioinformat, Sejong Si, South Korea.	hlee@korea.ac.kr	Kim, Younhee/A-2143-2015		National Research Foundation of Korea (NRF); Ministry of Education [NRF-2013R1A1A4A01004556]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A4A01004556) (URL: http://nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auchter M, 2011, J BIOTECHNOL, V154, P126, DOI 10.1016/j.jbiotec.2010.07.001; Barzantny H, 2012, J BIOTECHNOL, V159, P235, DOI 10.1016/j.jbiotec.2012.01.021; Becker J, 2009, APPL ENVIRON MICROB, V75, P7866, DOI 10.1128/AEM.01942-09; Bonnet M, 2013, FEBS LETT, V587, P88, DOI 10.1016/j.febslet.2012.11.014; Brown GD, 2000, GENE, V254, P147, DOI 10.1016/S0378-1119(00)00277-8; Bussmann M, 2009, J BIOTECHNOL, V143, P173, DOI 10.1016/j.jbiotec.2009.06.025; Chao GL, 1997, J BACTERIOL, V179, P4299, DOI 10.1128/jb.179.13.4299-4304.1997; Chen X, 2012, APPL ENVIRON MICROB, V78, P5796, DOI 10.1128/AEM.01588-12; Cramer A, 2006, J BACTERIOL, V188, P2554, DOI 10.1128/JB.188.7.2554-2567.2006; DELAHABA G, 1959, J BIOL CHEM, V234, P603; EIKMANNS BJ, 1995, J BACTERIOL, V177, P774, DOI 10.1128/jb.177.3.774-782.1995; Engels S, 2004, MOL MICROBIOL, V52, P285, DOI 10.1111/j.1365-2958.2003.03979.x; FOLLETTIE MT, 1993, J BACTERIOL, V175, P4096, DOI 10.1128/JB.175.13.4096-4103.1993; Fuhrer T, 2007, J BACTERIOL, V189, P8073, DOI 10.1128/JB.01027-07; GARNAK M, 1979, J BIOL CHEM, V254, P7915; Gerstmeir R, 2004, J BACTERIOL, V186, P2798, DOI 10.1128/JB.186.9.2798-2809.2004; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Han SO, 2008, MICROBIOLOGY; Han SO, 2007, MICROBIOL-SGM, V153, P2190, DOI 10.1099/mic.0.2006/004366-0; Ikeda M, 2003, APPL MICROBIOL BIOT, V62, P99, DOI 10.1007/s00253-003-1328-1; Jenal U, 2003, CURR OPIN MICROBIOL, V6, P163, DOI 10.1016/S1369-5274(03)00029-8; JETTEN MSM, 1994, APPL ENVIRON MICROB, V60, P2501, DOI 10.1128/AEM.60.7.2501-2507.1994; Jungwirth B, 2008, FEMS MICROBIOL LETT, V281, P190, DOI 10.1111/j.1574-6968.2008.01098.x; Jungwirth B, 2013, MICROBIOL-SGM, V159, P12, DOI 10.1099/mic.0.062059-0; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; KANEKO R, 1989, J BACTERIOL, V171, P5232, DOI 10.1128/jb.171.9.5232-5236.1989; Kim HJ, 2004, J BACTERIOL, V186, P3453, DOI 10.1128/JB.186.11.3453-3460.2004; Kohl TA, 2008, J BIOTECHNOL, V135, P340, DOI 10.1016/j.jbiotec.2008.05.011; Kohl TA, 2009, J BIOTECHNOL, V143, P239, DOI 10.1016/j.jbiotec.2009.08.005; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Lee JY, 2012, FEMS MICROBIOL LETT, V327, P103, DOI 10.1111/j.1574-6968.2011.02463.x; Letek M, 2006, J BACTERIOL, V188, P409, DOI 10.1128/JB.188.2.409-423.2006; Leuchtenberger W, 2005, APPL MICROBIOL BIOT, V69, P1, DOI 10.1007/s00253-005-0155-y; Ludke A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-6; Mettert EL, 2005, J MOL BIOL, V354, P220, DOI 10.1016/j.jmb.2005.09.066; Nakano S, 2002, J BACTERIOL, V184, P3664, DOI 10.1128/JB.184.13.3664-3670.2002; NEUHAUS FC, 1962, J BIOL CHEM, V237, P3128; Nishimura T, 2011, MICROBIOL-SGM, V157, P21, DOI 10.1099/mic.0.044552-0; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; Pan Q, 2012, BIOCHEMISTRY-US, V51, P5061, DOI 10.1021/bi2018688; Panhorst M, 2011, J BIOTECHNOL, V154, P149, DOI 10.1016/j.jbiotec.2010.07.015; Park JS, 2012, FEMS MICROBIOL LETT, V331, P63, DOI 10.1111/j.1574-6968.2012.02554.x; Park JS, 2011, FEMS MICROBIOL LETT, V322, P8, DOI 10.1111/j.1574-6968.2011.02318.x; Park SD, 2004, J MICROBIOL BIOTECHN, V14, P789; Park SD, 2008, MICROBIOL-SGM, V154, P915, DOI 10.1099/mic.0.2007/012690-0; PARK SS, 1989, J BACTERIOL, V171, P2657, DOI 10.1128/jb.171.5.2657-2665.1989; Park SY, 2010, FEMS MICROBIOL LETT, V304, P107, DOI 10.1111/j.1574-6968.2009.01884.x; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; Prost JF, 1999, J BACTERIOL, V181, P893, DOI 10.1128/JB.181.3.893-898.1999; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schroder J, 2010, FEMS MICROBIOL REV, V34, P685, DOI 10.1111/j.1574-6976.2010.00228.x; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Strosser J, 2004, MOL MICROBIOL, V54, P132, DOI 10.1111/j.1365-2958.2004.04247.x; Teramoto H, 2011, J BIOTECHNOL, V154, P114, DOI 10.1016/j.jbiotec.2011.01.016; Toyoda K, 2011, J BACTERIOL, V193, P4123, DOI 10.1128/JB.00384-11; Toyoda K, 2009, J BACTERIOL, V191, P968, DOI 10.1128/JB.01425-08; Tripathi LP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-549; van Ooyen J, 2011, J BIOTECHNOL, V154, P140, DOI 10.1016/j.jbiotec.2010.07.004; VONDEROSTEN CH, 1989, J AM CHEM SOC, V111, P3924, DOI 10.1021/ja00193a025; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Xu QP, 2012, J BACTERIOL, V194, P2987, DOI 10.1128/JB.00038-12; Yukawa H, 2007, MICROBIOL-SGM, V153, P1042, DOI 10.1099/mic.0.2006/003657-0	62	7	7	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93587	10.1371/journal.pone.0093587	http://dx.doi.org/10.1371/journal.pone.0093587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691519	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100107
J	Kasinski, A; Dong, X; Khuri, FR; Boss, J; Fu, HA				Kasinski, Andrea; Dong, Xueyuan; Khuri, Fadlo R.; Boss, Jeremy; Fu, Haian			Transcriptional Regulation of YWHAZ, the Gene Encoding 14-3-3 zeta	PLOS ONE			English	Article							HUMAN-MELANOMA CELLS; GENOME-WIDE ANALYSIS; NF-KAPPA-B; LUNG-CANCER; IN-VIVO; KINASE-ACTIVITY; BREAST-CANCER; TUMOR-GROWTH; PROTEINS; BINDING	Aberrant expression of oncogenic 14-3-3 proteins is correlated with poor survival of cancer patients. While the underlying mechanism of the abnormal expression in tumors remains elusive for the six oncogenic 14-3-3 isoforms; the potential involvement of a transcriptional component has been suggested. Unfortunately, little experimental data has been reported to support this hypothesis. In this study we describe the genetic structure of YWHAZ, the gene encoding 14-3-3 zeta, including the identification of previously unreported transcript variants. In total, five transcript variants were revealed and their expressions confirmed in a panel of cell lines. Expressed sequence tag (EST) database mining and in vitro rapid-amplification of cDNA ends (RACE) confirmed that one variant, 1c, represents >80% of the expressed transcripts, which is also the most efficiently translated. An analysis of the proximal promoter of this variant revealed a functional Cyclic-AMP Response Element (CRE). Factors that bound to the CRE element were recognized through fractionation and subsequent EMSAs. This analysis identified CREB and ATF-1 as the trans-interacting factors. Cell-based assays confirm that ATF-1, and to a lesser extent CREB, bind the endogenous YWHAZ promoter especially under TNF-alpha stimulating conditions. In support of a role of ATF-1 in the regulation of YWHAZ, silencing of ATF-1 resulted in a marked reduction in two of the five YWHAZ transcripts. These data suggest a novel mechanism for the transcriptional regulation of a major pro-survival gene, YWHAZ, by ATF-1.	[Kasinski, Andrea] Emory Univ, Program Genet & Mol Biol, Atlanta, GA 30322 USA; [Kasinski, Andrea; Dong, Xueyuan; Fu, Haian] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [Boss, Jeremy] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Khuri, Fadlo R.] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Fu, HA (corresponding author), Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA.	hfu@emory.edu	Khuri, Fadlo R./AAU-4942-2020; Kasinski, Andrea L/E-7951-2014; Kasinski, Andrea/AAF-3864-2021	Khuri, Fadlo R./0000-0002-8638-7618; Kasinski, Andrea/0000-0002-9602-7827	US National Institutes of Health [P01 CA116676, RO1 GM47310]; Georgia Cancer Coalition; Georgia Research Alliance; NATIONAL CANCER INSTITUTE [P01CA116676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047310] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition; Georgia Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in authors' laboratories was supported in part by the US National Institutes of Health grants P01 CA116676 (to F.R.K. and H.F.) and RO1 GM47310 (to J.M.B.), Georgia Cancer Coalition (to F.R.K. and H.F.), and Georgia Research Alliance (H.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjappala BS, 2009, J IMMUNOL, V182, P1050, DOI 10.4049/jimmunol.182.2.1050; Beresford GW, 2001, NAT IMMUNOL, V2, P652, DOI 10.1038/89810; BRASELMANN S, 1995, EMBO J, V14, P4839, DOI 10.1002/j.1460-2075.1995.tb00165.x; Cao L, 2008, NEUROSCI LETT, V432, P94, DOI 10.1016/j.neulet.2007.11.071; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Fan T, 2007, CANCER RES, V67, P7901, DOI 10.1158/0008-5472.CAN-07-0090; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Jean D, 2000, MOL CELL BIOCHEM, V212, P19, DOI 10.1023/A:1007128101751; Jean D, 1998, J BIOL CHEM, V273, P24884, DOI 10.1074/jbc.273.38.24884; Jean D, 2001, CRIT REV IMMUNOL, V21, P275; Jornot L, 1997, FEBS LETT, V416, P381, DOI 10.1016/S0014-5793(97)01244-1; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kasinski A, 2011, 14 3 3 ZETA AFCS NAT; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee J, 2001, MOL BIOL CELL, V12, P551, DOI 10.1091/mbc.12.3.551; Leonard MO, 2008, AM J RESP CRIT CARE, V178, P977, DOI 10.1164/rccm.200712-1890OC; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Matta A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-169; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Murata T, 2012, CLIN CANCER RES, V18, P5617, DOI 10.1158/1078-0432.CCR-12-0281; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Neal CL, 2009, CANCER RES, V69, P3425, DOI 10.1158/0008-5472.CAN-08-2765; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Powell DW, 2003, MOL CELL BIOL, V23, P5376, DOI 10.1128/MCB.23.15.5376-5387.2003; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Qi WQ, 2005, INT J CANCER, V113, P359, DOI 10.1002/ijc.20492; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; vanHeusden GPH, 1996, FEBS LETT, V391, P252, DOI 10.1016/0014-5793(96)00746-6; Vincenz C, 1996, J BIOL CHEM, V271, P20029, DOI 10.1074/jbc.271.33.20029; Woodcock JM, 2003, J BIOL CHEM, V278, P36323, DOI 10.1074/jbc.M304689200; Xie SH, 1997, ONCOGENE, V15, P2069, DOI 10.1038/sj.onc.1201358; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; Yang YM, 1996, ONCOGENE, V12, P2223; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	45	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93480	10.1371/journal.pone.0093480	http://dx.doi.org/10.1371/journal.pone.0093480			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690670	Green Submitted, Green Published, gold			2022-12-27	WOS:000334101100089
J	Li, XF; Zhang, X; Chen, Y; Zhang, KL; Liu, XJ; Li, JP				Li, Xiao-Feng; Zhang, Xu; Chen, Yang; Zhang, Kun-Lian; Liu, Xiang-Jun; Li, Jian-Ping			An Analysis of HLA- A, - B, and-DRB1 Allele and Haplotype Frequencies of 21,918 Residents Living in Liaoning, China	PLOS ONE			English	Article							HAN POPULATION; CLASS-I; POLYMORPHISM; GENE; DRB1	HLA-A,-B and - DRB1 allele frequencies and their haplotype frequencies in 21,918 Chinese residents living in Liaoning Province, who were registered as volunteer donors of China Marrow Donor Registry, were investigated. They are composed of 93.37% Han Chinese, 5.1% Manchus, 0.57% Mongols, 0.46% Hui persons, 0.29% Koreans and 0.14% Xibe ethnic group. In total eighteen different HLA-A alleles, forty- eight different HLA- B alleles and fourteen different HLA- DRB1 alleles have been identified. Their frequencies are in agreement with the Hardy- Weinberg equilibrium. For Han Chinese in Liaoning, 1,534 different HLA- A- B- DRB1 haplotypes were identified, with a frequency of higher than 0.01%. A* 30- B* 13- DRB1* 07, A* 02- B* 46DRB1* 09 and A* 02- B* 13- DRB1* 12 are the most frequent haplotypes among Liaoning Han. While Liaoning Han, Liaoning Manchu, Liaoning Mongol, Liaoning Hui and Liaoning Korean share the northern Han characteristic haplotypes, all minority ethnic groups with the exception of Liaoning Manchu have developed their own unique HLA profiles. This dataset characterizes the HLA allele and haplotype frequencies in the Liaoning area and suggests that it is different from those in other parts of China and ethnic groups, which implicates transplant donor searching strategies and studies on population genetics.	[Li, Xiao-Feng; Zhang, Xu; Chen, Yang; Zhang, Kun-Lian; Li, Jian-Ping] HLA Lab, Liaoning Blood Ctr, Shenyang, Liaoning, Peoples R China; [Li, Xiao-Feng; Zhang, Xu; Chen, Yang; Zhang, Kun-Lian; Li, Jian-Ping] Liaoning Key Lab Blood Safety Res, Shenyang, Liaoning, Peoples R China; [Liu, Xiang-Jun] BFR Diagnost LTD, Beijing, Peoples R China; [Li, Jian-Ping] Shenyang Res Ctr Stem Cell Clin Applicat, Shenyang, Liaoning, Peoples R China		Li, JP (corresponding author), HLA Lab, Liaoning Blood Ctr, Shenyang, Liaoning, Peoples R China.	ljp_63@163.com		Li, Xiaofeng/0000-0002-3888-6359; Li, Jianping/0000-0002-5392-0471	Shenyang Science and Technology Foundation [F10-206-1-00]; China marrow donor program (CMDP)	Shenyang Science and Technology Foundation; China marrow donor program (CMDP)	This study was supported in part by a grant from Shenyang Science and Technology Foundation (F10-206-1-00), and China marrow donor program (CMDP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen R, 1993, Yi Chuan Xue Bao, V20, P389; Chen Yang, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P461; [程良红 CHENG Lianghong], 2009, [中国输血杂志, Chinese Journal of Blood Transfusion], V22, P196; Danzer M, 2007, HUM IMMUNOL, V68, P915, DOI 10.1016/j.humimm.2007.10.005; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HASHIMOTO M, 1994, TISSUE ANTIGENS, V44, P166, DOI 10.1111/j.1399-0039.1994.tb02375.x; HATTEMER HH, 1982, THEOR APPL GENET, V62, P219, DOI 10.1007/BF00276242; Hong WG, 2007, HUM IMMUNOL, V68, P439, DOI 10.1016/j.humimm.2007.01.020; Jiang B, 2006, FORENSIC SCI INT, V162, P66, DOI 10.1016/j.forsciint.2006.06.041; [金士正 JIN Shixheng], 2006, [广东医学, Guangdong Medical Journal], V27, P1289; Kupatawintu P, 2010, TISSUE ANTIGENS, V75, P730, DOI 10.1111/j.1399-0039.2010.01450.x; LO YMD, 1992, NUCLEIC ACIDS RES, V20, P1005, DOI 10.1093/nar/20.5.1005; Miao KR, 2007, INT J IMMUNOGENET, V34, P419, DOI 10.1111/j.1744-313X.2007.00713.x; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NIJENHUIS LE, 1985, TISSUE ANTIGENS, V26, P215, DOI 10.1111/j.1399-0039.1985.tb00963.x; PETERSDORF EW, 1991, TISSUE ANTIGENS, V38, P169, DOI 10.1111/j.1399-0039.1991.tb01891.x; Qu Zhe, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P349; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANTAMARIA P, 1993, HUM IMMUNOL, V37, P39, DOI 10.1016/0198-8859(93)90141-M; Shaw CK, 1999, TISSUE ANTIGENS, V53, P51, DOI 10.1034/j.1399-0039.1999.530106.x; Shen Chun-Mei, 2008, Yichuan, V30, P164, DOI 10.3724/SP.J.1005.2008.00164; Shen CM, 2008, CROAT MED J, V49, P476, DOI 10.3325/cmj.2008.4.476; Trachtenberg E, 2007, TISSUE ANTIGENS, V70, P455, DOI 10.1111/j.1399-0039.2007.00932.x; Wang C.Q., 2009, J MOL DIAGN THER, V1, P165; Wu Qiang-Ju, 2007, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V15, P357; Yao Y, 2009, TISSUE ANTIGENS, V73, P561, DOI 10.1111/j.1399-0039.2009.01237.x; Yoon JH, 2010, TISSUE ANTIGENS, V75, P170, DOI 10.1111/j.1399-0039.2009.01418.x; Zeng J, 2005, CHIN J BLOOD TRANSFU, V18, P384; ZETTERQUIST H, 1992, HUM IMMUNOL, V34, P64, DOI 10.1016/0198-8859(92)90086-3; Zhu BF, 2010, J ZHEJIANG UNIV-SC B, V11, P127, DOI 10.1631/jzus.B0900232; 曲喆, 2005, [中国法医学杂志, Chinese Journal of Forensic Medicine], V20, P355	34	10	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93082	10.1371/journal.pone.0093082	http://dx.doi.org/10.1371/journal.pone.0093082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691290	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100043
J	Qi, JP; Zhang, Q; Zhu, Y; Qi, J				Qi, Jin-Peng; Zhang, Qing; Zhu, Ying; Qi, Jie			A Novel Method for Fast Change-Point Detection on Simulated Time Series and Electrocardiogram Data	PLOS ONE			English	Article								Although Kolmogorov-Smirnov (KS) statistic is a widely used method, some weaknesses exist in investigating abrupt Change Point (CP) problems, e. g. it is time-consuming and invalid sometimes. To detect abrupt change from time series fast, a novel method is proposed based on Haar Wavelet (HW) and KS statistic (HWKS). First, the two Binary Search Trees (BSTs), termed TcA and TcD, are constructed by multi-level HW from a diagnosed time series; the framework of HWKS method is implemented by introducing a modified KS statistic and two search rules based on the two BSTs; and then fast CP detection is implemented by two HWKS-based algorithms. Second, the performance of HWKS is evaluated by simulated time series dataset. The simulations show that HWKS is faster, more sensitive and efficient than KS, HW, and T methods. Last, HWKS is applied to analyze the electrocardiogram (ECG) time series, the experiment results show that the proposed method can find abrupt change from ECG segment with maximal data fluctuation more quickly and efficiently, and it is very helpful to inspect and diagnose the different state of health from a patient's ECG signal.	[Qi, Jin-Peng; Qi, Jie] Donghua Univ, Coll Informat Sci & Technol, Shanghai, Peoples R China; [Qi, Jin-Peng; Zhang, Qing] CSIRO, Australia E Hlth Res Ctr, Brisbane, Qld, Australia; [Zhu, Ying] Royal N Shore Hosp, Hunter New England Hlth, St Leonards, NSW, Australia	Donghua University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Royal North Shore Hospital	Qi, JP (corresponding author), Donghua Univ, Coll Informat Sci & Technol, Shanghai, Peoples R China.	qipengkai@dhu.edu.cn	Qi, Jinpeng/HDL-6725-2022		National Natural Science Foundation of China [61104154]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This paper is supported by National Natural Science Foundation of China (No. 61104154), and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1998, MAGNET RESON MED, V39, P500, DOI 10.1002/mrm.1910390322; Alarcon-Aquino V, 2001, IEE P-COMMUN, V148, P355, DOI 10.1049/ip-com:20010659; Alarcon-Aquino V, 2009, LAT AM APPL RES, V39, P145; Bolton RJ, 2002, STAT SCI, V17, P235; Brodsky BE, 1993, NONPARAMETRIC METHOD; Brown JR, 2008, J STAT SOFTW, V26, P1; Darkhovski B. S., 1994, IMS LECT NOTES MONOG, V23, P99; Fell J, 2000, ACTA NEUROBIOL EXP, V60, P87; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Greenwald S. D, 1986, DEV ANAL VENTRICULAR; Gustafsson F, 1996, IEEE T AUTOMAT CONTR, V41, P66, DOI 10.1109/9.481608; Gustafsson F., 2000, ADAPTIVE FILTERING C; Hall LD, 2004, MECH SYST SIGNAL PR, V18, P849, DOI 10.1016/S0888-3270(03)00050-5; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Hordle WK., 2004, NONPARAMETRIC SEMIPA; Ide T., 2004, P 10 ACM SIGKDD INT; Kawahara Y, 2007, DAT MIN 2007 ICDM 20; Khalil M, 1999, SIGNAL PROCESS, V75, P239, DOI 10.1016/S0165-1684(98)00236-9; Kifer Daniel, 2004, VLDB, DOI DOI 10.1016/B978-012088469-8/50019-X; Kobayashi M, 2001, NONLINEAR ANAL-THEOR, V47, P1749, DOI 10.1016/S0362-546X(01)00307-8; Lin HD, 2007, IMAGE VISION COMPUT, V25, P1785, DOI 10.1016/j.imavis.2007.02.002; Marsaglia G., 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i14, DOI 10.18637/JSS.V008.I18, 10.18637/jss.v008.i18]; Meagher M, 2007, IEEE INT CONF INF VI, P601; MOODY G, 1984, COMPUT CARDIOL, V0011; Murad U, 1999, LECT NOTES ARTIF INT, V1704, P251; Percival D.B., 2006, WAVELET METHODS TIME; Percival D.B., 2008, NONLINEAR TIME SERIE, DOI DOI 10.1007/978-3-540-78938-3_4; Qi JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022228; Raimondo M, 2004, STAT SINICA, V14, P395; Salam M, 2008, INT J COMPUTER SCI S, V2, P23; Sharifzadeh M, 2005, LECT NOTES COMPUT SC, V3633, P127; Simard R, 2011, J STAT SOFTW, V39, P1, DOI 10.18637/jss.v039.i11; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; Tseng VS, 2006, DAT MIN WORKSH 2006; Walker J.S., 2002, PRIMER WAVELETS THEI; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020060; Yamanishi K, 2004, DATA MIN KNOWL DISC, V8, P275, DOI 10.1023/B:DAMI.0000023676.72185.7c; Yamanishi K, 2002, P 8 ACM SIGKDD INT C	40	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93365	10.1371/journal.pone.0093365	http://dx.doi.org/10.1371/journal.pone.0093365			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690633	Green Submitted, Green Published, gold			2022-12-27	WOS:000334101100069
J	N'Dilimabaka, N; Taoufiq, Z; Zougbede, S; Bonnefoy, S; Lorthiois, A; Couraud, PO; Rebollo, A; Snounou, G; Mazier, D; Sabater, AM				N'Dilimabaka, Nadine; Taoufiq, Zacharie; Zougbede, Sergine; Bonnefoy, Serge; Lorthiois, Audrey; Couraud, Pierre Oliver; Rebollo, Angelita; Snounou, Georges; Mazier, Dominique; Sabater, Alicia Moreno			P-falciparum Isolate-Specific Distinct Patterns of Induced Apoptosis in Pulmonary and Brain Endothelial Cells	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; HUMAN CEREBRAL MALARIA; INFECTED ERYTHROCYTES; MODEL; CYTOADHERENCE; TRANSCRIPTION; PATHOGENESIS; DYSFUNCTION; ACTIVATION; EXPRESSION	The factors implicated in the transition from uncomplicated to severe clinical malaria such as pulmonary oedema and cerebral malaria remain unclear. It is known that alterations in vascular integrity due to endothelial cell (EC) activation and death occur during severe malaria. In this study, we assessed the ability of different P. falciparum clinical isolates to induce apoptosis in ECs derived from human lung and brain. We observed that induction of EC apoptosis was sensitive to the environmental pH and required direct contact between the parasite and the cell, though it was not correlated to the ability of the parasite to cytoadhere. Moreover, the extent of induced apoptosis in the two EC types varied with the isolate. Analysis of parasite genes transcript led us to propose that the activation of different pathways, such as Plasmodium apoptosis-linked pathogenicity factors (PALPF), PALPF-2, PALPF-5 and PF11_0521, could be implied in EC death. These observations provide an experimental framework to decipher the molecular mechanism implicated in the genesis of severe malaria.	[N'Dilimabaka, Nadine; Taoufiq, Zacharie; Zougbede, Sergine; Lorthiois, Audrey; Rebollo, Angelita; Snounou, Georges; Mazier, Dominique; Sabater, Alicia Moreno] Univ Paris 06, UMRS 945, Paris, France; [N'Dilimabaka, Nadine; Taoufiq, Zacharie; Zougbede, Sergine; Lorthiois, Audrey; Rebollo, Angelita; Snounou, Georges; Mazier, Dominique; Sabater, Alicia Moreno] INSERM, UMRS 945, Paris, France; [Bonnefoy, Serge] Inst Pasteur, CNRS, URA 2581, Unite Immunol Mol Parasites, Paris, France; [Couraud, Pierre Oliver] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Couraud, Pierre Oliver] CNRS, UMR8104, Paris, France; [Couraud, Pierre Oliver] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Mazier, Dominique] Hop La Pitie Salpetriere, AP HP, Lab Parasitol Mycol, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Sabater, AM (corresponding author), Univ Paris 06, UMRS 945, Paris, France.	alicia.moreno-sabater@upmc.fr	Rebollo, Angelita/P-2118-2017; Bonnefoy, Serge/B-2466-2014; Snounou, Georges/F-3352-2011; Moreno Sabater, Alicia/P-3536-2017	Bonnefoy, Serge/0000-0001-9148-0123; Taoufiq, Zacharie/0000-0003-4893-0322; Snounou, Georges/0000-0002-6133-6398; Moreno Sabater, Alicia/0000-0002-7571-9533; Rebollo, Angelita/0000-0002-1293-9686	Ministere des Affaires Etrangeres through the Ambassade de France at Libreville, Gabon	Ministere des Affaires Etrangeres through the Ambassade de France at Libreville, Gabon	NN was supported by a fellowship from the Ministere des Affaires Etrangeres through the Ambassade de France at Libreville, Gabon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; [Anonymous], LANCET; Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; Chakravorty SJ, 2007, INT J PARASITOL, V37, P975, DOI 10.1016/j.ijpara.2007.02.006; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; CLARK IA, 1994, PARASITOL TODAY, V10, P410, DOI 10.1016/0169-4758(94)90237-2; Combes V, 2004, JAMA-J AM MED ASSOC, V291, P2542, DOI 10.1001/jama.291.21.2542-b; Craig A, 2001, MOL BIOCHEM PARASIT, V115, P129, DOI 10.1016/S0166-6851(01)00275-4; Day NPJ, 2000, CRIT CARE MED, V28, P1833, DOI 10.1097/00003246-200006000-00025; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Elias RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044004; Gardner JP, 1996, P NATL ACAD SCI USA, V93, P3503, DOI 10.1073/pnas.93.8.3503; Gerardin P, 2002, AM J TROP MED HYG, V66, P686, DOI 10.4269/ajtmh.2002.66.686; Gillrie MR, 2007, BLOOD, V110, P3426, DOI 10.1182/blood-2007-04-084582; Gillrie MR, 2012, AM J PATHOL, V180, P1028, DOI 10.1016/j.ajpath.2011.11.037; GOODYER ID, 1994, ANN TROP MED PARASIT, V88, P209, DOI 10.1080/00034983.1994.11812859; GRAU GE, 1994, PARASITOL TODAY, V10, P408, DOI 10.1016/0169-4758(94)90236-4; Hanson J, 2012, J INFECT DIS, V206, P571, DOI 10.1093/infdis/jis400; Hemmer CJ, 2011, TROP MED INT HEALTH, V16, P906, DOI 10.1111/j.1365-3156.2011.02788.x; Hemmer CJ, 2005, INFECT IMMUN, V73, P1764, DOI 10.1128/IAI.73.3.1764-1770.2005; HEMMER CJ, 1991, AM J MED, V91, P37, DOI 10.1016/0002-9343(91)90071-5; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Jambou R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001021; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Marchiafava E, 1894, 2 MONOGRAPHS MALARIA; McKenzie FE, 2008, ADV PARASIT, V66, P1, DOI 10.1016/S0065-308X(08)00201-7; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mita-Mendoza NK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054481; Montgomery J, 2007, MOL MICROBIOL, V65, P959, DOI 10.1111/j.1365-2958.2007.05837.x; Muanza K, 1996, RES IMMUNOL, V147, P149, DOI 10.1016/0923-2494(96)83167-1; Peters JM, 2007, J INFECT DIS, V195, P748, DOI 10.1086/511436; Pino P, 2003, ANN NY ACAD SCI, V1010, P582, DOI 10.1196/annals.1299.109; Prato M, 2011, CELL MICROBIOL, V13, P1275, DOI 10.1111/j.1462-5822.2011.01620.x; Punsawad C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-260; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Schofield L, 2002, NATURE, V418, P785, DOI 10.1038/nature00937; Schofield L, 1996, J IMMUNOL, V156, P1886; Siau A, 2007, J INFECT DIS, V196, P1603, DOI 10.1086/522012; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Taoufiq Z, 2008, J INFECT DIS, V197, P1062, DOI 10.1086/528988; Taoufiq Z, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-52; Taylor WRJ, 2012, CHEST, V142, P492, DOI 10.1378/chest.11-2655; Toure FS, 2008, PARASITE IMMUNOL, V30, P47; Tripathi AK, 2007, J INFECT DIS, V195, P942, DOI 10.1086/512083; Tripathi AK, 2009, BLOOD, V114, P4243, DOI 10.1182/blood-2009-06-226415; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Wassmer SC, 2006, INFECT IMMUN, V74, P645, DOI 10.1128/IAI.74.1.645-653.2006; Wassmer SC, 2006, J IMMUNOL, V176, P1180, DOI 10.4049/jimmunol.176.2.1180; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; White NJ, 2013, J INFECT DIS, V208, P192, DOI 10.1093/infdis/jit116; WHO, 2000, T R SOC TROP MED HYG, P94; Zang-Edou ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013221; Zougbede S, 2011, J CEREBR BLOOD F MET, V31, P514, DOI 10.1038/jcbfm.2010.121	57	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e90692	10.1371/journal.pone.0090692	http://dx.doi.org/10.1371/journal.pone.0090692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TJ	24686750	gold, Green Published, Green Submitted			2022-12-27	WOS:000333678800001
J	DuVal, MG; Oel, AP; Allison, WT				DuVal, Michele G.; Oel, A. Phillip; Allison, W. Ted			gdf6a Is Required for Cone Photoreceptor Subtype Differentiation and for the Actions of tbx2b in Determining Rod Versus Cone Photoreceptor Fate	PLOS ONE			English	Article							RETINAL DEVELOPMENT; ZEBRAFISH BRAIN; PRECURSOR CELLS; OPTIC-NERVE; OPSIN GENE; REGENERATION; EXPRESSION; TRANSPLANTATION; DEGENERATION; GOLDFISH	Functional vision restoration is within reach via stem cell therapy, but one of the largest obstacles is the derivation of colour-sensitive cone photoreceptors that are required for high-acuity daytime vision. To enhance progress made using nocturnal murine models, we instead utilize cone-rich zebrafish and herein investigate relationships between gdf6a and tbx2b in cone photoreceptor development. Growth/differentiation factor 6a (gdf6a), a bone morphogenetic protein family ligand, is an emerging factor in photoreceptor degenerative diseases. The T-box transcription factor tbx2b is required to specify UV cone photoreceptor fate instead of rod photoreceptor fate. Interactions between these factors in cone development would be unanticipated, considering the discrete phenotypes in their respective mutants. However, gdf6a positively modulates the abundance of tbx2b transcript during early eye morphogenesis, and we extended this conclusion to later stages of retinal development comprising the times when photoreceptors differentiate. Despite this, gdf6a(-/-) larvae possess a normal relative number of UV cones and instead present with a low abundance of blue cone photoreceptors, approximately half that of siblings (p<0.001), supporting a differential role for gdf6a amongst the spectral subtypes of cone photoreceptors. Further, gdf6a(-/-) larvae from breeding of compound heterozygous gdf6a(+/-); tbx2b(+/-) mutants exhibit the recessive lots-of-rods phenotype (which also shows a paucity of UV cones) at significantly elevated rates (44% or 48% for each of two tbx2b alleles, chi(2) p <= 0.007 for each compared to expected Mendelian 25%). Thus the gdf6a(-/-) background sensitizes fish such that the recessive lots-of-rods phenotype can appear in heterozygous tbx2b(+/-) fish. Overall, this work establishes a novel link between tbx2b and gdf6a in determining photoreceptor fates, defining the nexus of an intricate pathway influencing the abundance of cone spectral subtypes and specifying rod vs. cone photoreceptors. Understanding this interaction is a necessary step in the refinement of stem cell-based restoration of daytime vision in humans.	[DuVal, Michele G.; Oel, A. Phillip; Allison, W. Ted] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Allison, W. Ted] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Allison, W. Ted] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Allison, WT (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	ted.allison@ualberta.ca	Allison, W. Ted/A-2612-2014; Allison, W. Ted/K-5228-2012	Allison, W. Ted/0000-0002-8461-4864; DuVal, Michele/0000-0001-6975-8117	NSERC; CIHR	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR))	The work was funded by NSERC (www.nserc-crsng.gc.ca) Discovery Grant to WTA, CGSM Studentship from NSERC to APO, and MD/PhD Studentship from CIHR (www.cihr-irsc.gc.ca) to MGD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison WT, 2006, J COMP NEUROL, V499, P702, DOI 10.1002/cne.21164; Allison WT, 2006, MOL VIS, V12, P655; Allison WT, 2010, J COMP NEUROL, V518, P4182, DOI 10.1002/cne.22447; Allison WT, 2004, VISUAL NEUROSCI, V21, P945, DOI 10.1017/S0952523804216145; Allison WT, 2003, J COMP NEUROL, V461, P294, DOI 10.1002/cne.10682; Allison WT, 2004, THESIS U VICTORIA VI; Alvarez-Delfin K, 2009, P NATL ACAD SCI USA, V106, P2023, DOI 10.1073/pnas.0809439106; Asai-Coakwell M, 2007, AM J HUM GENET, V80, P306, DOI 10.1086/511280; Asai-Coakwell M, 2013, HUM MOL GENET, V22, P1432, DOI 10.1093/hmg/dds560; Asai-Coakwell M, 2009, HUM MOL GENET, V18, P1110, DOI 10.1093/hmg/ddp008; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Becker T, 1998, J NEUROSCI, V18, P5789; Behesti H, 2009, DEV BIOL, V333, P360, DOI 10.1016/j.ydbio.2009.06.026; Bilican B, 2006, EXP CELL RES, V312, P2358, DOI 10.1016/j.yexcr.2006.03.033; BROWMAN HI, 1994, J EXP BIOL, V193, P191; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Clanton JA, 2013, DEVELOPMENT, V140, P323, DOI 10.1242/dev.083709; Dann SG, 2004, J MOL EVOL, V58, P400, DOI 10.1007/s00239-003-2562-y; den Hollander AI, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-102; DuVal MG, 2013, PLOS ONE, V9, DOI [10.1371/journal.pone.0089183, DOI 10.1371/J0URNAL.P0NE.0089183]; Duval MG, 2013, MOL VIS, V19, P1082; Easter SS, 2000, NEUROSCIENTIST, V6, P454, DOI 10.1177/107385840000600608; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fleisch VC, 2011, BBA-MOL BASIS DIS, V1812, P364, DOI 10.1016/j.bbadis.2010.10.012; Fraser B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055410; French CR, 2010, THESIS U ALBERTA EDM; French CR, 2013, INVEST OPHTH VIS SCI, V54, P4636, DOI 10.1167/iovs.13-11674; French CR, 2009, DEV BIOL, V333, P37, DOI 10.1016/j.ydbio.2009.06.018; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; Goldshmit Y, 2012, J NEUROSCI, V32, P7477, DOI 10.1523/JNEUROSCI.0758-12.2012; Gonzalez-Rodriguez J, 2010, BRIT J OPHTHALMOL, V94, P1100, DOI 10.1136/bjo.2009.173500; Gosse NJ, 2009, P NATL ACAD SCI USA, V106, P2236, DOI 10.1073/pnas.0803202106; Gross JM, 2005, P NATL ACAD SCI USA, V102, P4371, DOI 10.1073/pnas.0501061102; Hanel ML, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-43; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Lakowski J, 2011, STEM CELLS, V29, P1391, DOI 10.1002/stem.694; Lakowski J, 2010, HUM MOL GENET, V19, P4545, DOI 10.1093/hmg/ddq378; Lamba D, 2008, CELL STEM CELL, V2, P538, DOI 10.1016/j.stem.2008.05.002; Lenkowski JR, 2013, GLIA, V61, P1687, DOI 10.1002/glia.22549; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Mansergh FC, 2010, EXP EYE RES, V91, P500, DOI 10.1016/j.exer.2010.07.003; Martin N, 2012, EMBO J, V31, P95, DOI 10.1038/emboj.2011.370; Matsukawa T, 2004, BIOL PHARM BULL, V27, P445, DOI 10.1248/bpb.27.445; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Milam AH, 2002, P NATL ACAD SCI USA, V99, P473, DOI 10.1073/pnas.022533099; Morris AC, 2005, INVEST OPHTH VIS SCI, V46, P4762, DOI 10.1167/iovs.05-0797; Ng L, 2001, HUM MOL GENET, V10, P2701, DOI 10.1093/hmg/10.23.2701; Ng L, 2011, J NEUROSCI, V31, P11118, DOI 10.1523/JNEUROSCI.1709-11.2011; Okada I, 2011, AM J HUM GENET, V88, P30, DOI 10.1016/j.ajhg.2010.11.012; RAYMOND PA, 1993, NEURON, V10, P1161, DOI 10.1016/0896-6273(93)90064-X; Raymond PA, 2004, INT J DEV BIOL, V48, P935, DOI 10.1387/ijdb.041873pr; RAYMOND PA, 1995, J COMP NEUROL, V359, P537, DOI 10.1002/cne.903590403; Roberts MR, 2005, INVEST OPHTH VIS SCI, V46, P2897, DOI 10.1167/iovs.05-0093; Satoh S, 2009, J NEUROSCI, V29, P12401, DOI 10.1523/JNEUROSCI.0951-09.2009; Seko Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035611; Senut MC, 2004, J NEUROSCI, V24, P7663, DOI 10.1523/JNEUROSCI.2281-04.2004; Sharon D, 2003, ARCH OPHTHALMOL-CHIC, V121, P1316, DOI 10.1001/archopht.121.9.1316; Snelson CD, 2008, DEVELOPMENT, V135, P1693, DOI 10.1242/dev.016576; Srinivas M, 2006, MOL ENDOCRINOL, V20, P1728, DOI 10.1210/me.2005-0505; Stenkamp DL, 1997, J COMP NEUROL, V382, P272, DOI 10.1002/(SICI)1096-9861(19970602)382:2<272::AID-CNE10>3.0.CO;2-U; Stenkamp DL, 1996, INVEST OPHTH VIS SCI, V37, P363; Suzuki SC, 2013, P NATL ACAD SCI USA, V110, P15109, DOI 10.1073/pnas.1303551110; Takechi M, 2005, J EXP BIOL, V208, P1337, DOI 10.1242/jeb.01532; Takechi M, 2003, FEBS LETT, V553, P90, DOI 10.1016/S0014-5793(03)00977-3; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Veldhoen K, 2006, VISUAL NEUROSCI, V23, P169, DOI 10.1017/S0952523806232139; Vihtelic TS, 1999, VISUAL NEUROSCI, V16, P571, DOI 10.1017/S0952523899163168; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Zhang L, 2012, J BIOL CHEM, V287, P1520, DOI 10.1074/jbc.M111.275990	72	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92991	10.1371/journal.pone.0092991	http://dx.doi.org/10.1371/journal.pone.0092991			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681822	Green Published, gold, Green Submitted			2022-12-27	WOS:000333678100021
J	Lohse, KR; Hilderman, CGE; Cheung, KL; Tatla, S; Van der Loos, HFM				Lohse, Keith R.; Hilderman, Courtney G. E.; Cheung, Katharine L.; Tatla, Sandy; Van der Loos, H. F. Machiel			Virtual Reality Therapy for Adults Post-Stroke: A Systematic Review and Meta-Analysis Exploring Virtual Environments and Commercial Games in Therapy	PLOS ONE			English	Review							RANDOMIZED CLINICAL-TRIAL; CHRONIC STROKE; MOTOR RECOVERY; MOVEMENT REPRESENTATIONS; UPPER EXTREMITIES; IMPROVE BALANCE; DOUBLE-BLIND; UPPER-LIMB; REHABILITATION; INDIVIDUALS	Background: The objective of this analysis was to systematically review the evidence for virtual reality (VR) therapy in an adult post-stroke population in both custom built virtual environments (VE) and commercially available gaming systems (CG). Methods: MEDLINE, CINAHL, EMBASE, ERIC, PSYCInfo, DARE, PEDro, Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews were systematically searched from the earliest available date until April 4, 2013. Controlled trials that compared VR to conventional therapy were included. Population criteria included adults (>18) post-stroke, excluding children, cerebral palsy, and other neurological disorders. Included studies were reported in English. Quality of studies was assessed with the Physiotherapy Evidence Database Scale (PEDro). Results: Twenty-six studies met the inclusion criteria. For body function outcomes, there was a significant benefit of VR therapy compared to conventional therapy controls, G = 0.48, 95% CI = [ 0.27, 0.70], and no significant difference between VE and CG interventions (P = 0.38). For activity outcomes, there was a significant benefit of VR therapy, G = 0.58, 95% CI = [ 0.32, 0.85], and no significant difference between VE and CG interventions (P = 0.66). For participation outcomes, the overall effect size was G = 0.56, 95% CI = [ 0.02, 1.10]. All participation outcomes came from VE studies. Discussion: VR rehabilitation moderately improves outcomes compared to conventional therapy in adults post-stroke. Current CG interventions have been too few and too small to assess potential benefits of CG. Future research in this area should aim to clearly define conventional therapy, report on participation measures, consider motivational components of therapy, and investigate commercially available systems in larger RCTs.	[Lohse, Keith R.] Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA; [Lohse, Keith R.] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada; [Hilderman, Courtney G. E.; Cheung, Katharine L.] Univ British Columbia, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada; [Tatla, Sandy] Univ British Columbia, Dept Occupat Sci & Occupat Therapy, Vancouver, BC V5Z 1M9, Canada; [Van der Loos, H. F. Machiel] Univ British Columbia, Dept Mech Engn, Vancouver, BC V6T 1W5, Canada	Auburn University System; Auburn University; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Lohse, KR (corresponding author), Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA.	kelopelli@gmail.com	Tatla, Sandy/V-6805-2019	Lohse, Keith/0000-0002-7643-3887; Van der Loos, H.F. Machiel/0000-0003-1355-980X; Tatla, Sandy/0000-0001-5708-2666; Hilderman, Courtney G E/0000-0003-0209-4939	Peter Wall Solutions Initiative at the University of British Columbia [11-079]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007357, K24DK085446] Funding Source: NIH RePORTER	Peter Wall Solutions Initiative at the University of British Columbia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by #11-079 from the Peter Wall Solutions Initiative at the University of British Columbia awarded to H. F. M. Van der Loos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovich SV, 2009, NEUROREHABILITATION, V25, P29, DOI 10.3233/NRE-2009-0497; Agmon M, 2011, J GERIATR PHYS THER, V34, P161, DOI 10.1519/JPT.0b013e3182191d98; Bailey BW, 2001, ARCH PEDIAT ADOLESC, V165, P597; Borenstein M., 2011, INTRO METAANALYSIS, P450; Broeren J, 2008, CEREBROVASC DIS, V26, P289, DOI 10.1159/000149576; Burke JW, 2009, VISUAL COMPUT, V25, P1085, DOI 10.1007/s00371-009-0387-4; Cho KH, 2013, AM J PHYS MED REHAB, V92, P371, DOI 10.1097/PHM.0b013e31828cd5d3; Cikajlo I, 2012, DISABIL REHABIL, V34, P13, DOI 10.3109/09638288.2011.583308; Crosbie JH, 2012, CLIN REHABIL, V26, P798, DOI 10.1177/0269215511434575; Crosbie J.H., 2008, SCREEN, V229, P235; Cameirao MDS, 2011, RESTOR NEUROL NEUROS, V29, P287, DOI 10.3233/RNN-2011-0599; Deutsch JE, 2004, RESTOR NEUROL NEUROS, V22, P371; Deutsch JE, 2011, TOP STROKE REHABIL, V18, P701, DOI 10.1310/tsr1806-701; Flaghouse. ca, GEST TEK IREX SYST; Foley Norine C, 2003, Top Stroke Rehabil, V10, P1; Gil-Gomez JA, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-30; Harding J, 2009, CAN J OCCUP THER, V76, P133, DOI 10.1177/000841740907600302; Henderson A, 2007, TOP STROKE REHABIL, V14, P52, DOI 10.1310/tsr1402-52; Housman SJ, 2009, NEUROREHAB NEURAL RE, V23, P505, DOI 10.1177/1545968308331148; In TS, 2012, J PHYS THER SCI, V24, P339, DOI 10.1589/jpts.24.339; Jo K, 2012, J PHYS THER SCI, V24, P1205; Jung J, 2012, J PHYS THER SCI, V24, P1133, DOI 10.1589/jpts.24.1133; Katz N, 2005, DISABIL REHABIL, V27, P1235, DOI 10.1080/09638280500076079; Kim EK, 2012, J PHYS THER SCI, V24, P901, DOI 10.1589/jpts.24.901; Kim JH, 2009, AM J PHYS MED REHAB, V88, P693, DOI 10.1097/PHM.0b013e3181b33350; Kiper P, 2011, NEUROL NEUROCHIR POL, V45, P436; Kwakkel G, 2006, DISABIL REHABIL, V28, P823, DOI 10.1080/09638280500534861; Kwon JS, 2012, NEUROREHABILITATION, V31, P379, DOI 10.3233/NRE-2012-00807; Lam YS, 2006, NEUROREHABILITATION, V21, P245; Lang CE, 2009, ARCH PHYS MED REHAB, V90, P1692, DOI 10.1016/j.apmr.2009.04.005; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub2, 10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4]; Lohse K, 2013, J NEUROL PHYS THER, V37, P166, DOI 10.1097/NPT.0000000000000017; Majnemer A, 2008, DEV MED CHILD NEUROL, V50, P751, DOI 10.1111/j.1469-8749.2008.03068.x; Mang CS, 2013, PHYS THER; Mirelman A, 2010, GAIT POSTURE, V31, P433, DOI 10.1016/j.gaitpost.2010.01.016; Mirelman A, 2009, STROKE, V40, P169, DOI 10.1161/STROKEAHA.108.516328; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Nichols-Larsen DS, 2005, STROKE, V36, P1480, DOI 10.1161/01.STR.0000170706.13595.4f; Nintendo Co. Ltd, CONS SAL TRANS REG; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144, DOI 10.1152/jn.1996.75.5.2144; Patton J, 2006, ASSIST TECHNOL, V18, P181, DOI 10.1080/10400435.2006.10131917; Piron L, 2007, VIRTUAL REHABILITATI, P121; Piron L, 2010, NEUROREHAB NEURAL RE, V24, P501, DOI 10.1177/1545968310362672; Piron L, 2009, J REHABIL MED, V41, P1016, DOI 10.2340/16501977-0459; Plautz EJ, 2000, NEUROBIOL LEARN MEM, V74, P27, DOI 10.1006/nlme.1999.3934; Saposnik G, 2011, STROKE, V42, P1380, DOI 10.1161/STROKEAHA.110.605451; Saposnik G, 2010, STROKE, V41, P1477, DOI 10.1161/STROKEAHA.110.584979; Shirzad N, 2012, P ANN INT C IEEE ENG; Subramanian SK, 2013, NEUROREHAB NEURAL RE, V27, P13, DOI 10.1177/1545968312449695; Sullivan KJ, 2011, PHYS THER, V91, P1892, DOI 10.2522/ptj.20110003; Taylor MJD, 2011, J REHABIL RES DEV, V48, P1171, DOI 10.1682/JRRD.2010.09.0171; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; World Health Organization, 2002, COMM LANG FUNCT DIS; Yang SW, 2011, AM J PHYS MED REHAB, V90, P969, DOI 10.1097/PHM.0b013e3182389fae; Yang YR, 2008, GAIT POSTURE, V28, P201, DOI 10.1016/j.gaitpost.2007.11.007; Yavuzer G, 2008, EUR J PHYS REHAB MED, V44, P237; You SH, 2005, STROKE, V36, P1166, DOI 10.1161/01.STR.0000162715.43417.91	58	250	258	4	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93318	10.1371/journal.pone.0093318	http://dx.doi.org/10.1371/journal.pone.0093318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0TC	24681826	Green Published, gold, Green Submitted			2022-12-27	WOS:000333678100041
J	Usselman, RJ; Hill, I; Singel, DJ; Martino, CF				Usselman, Robert J.; Hill, Iain; Singel, David J.; Martino, Carlos F.			Spin Biochemistry Modulates Reactive Oxygen Species (ROS) Production by Radio Frequency Magnetic Fields	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; PAIR MECHANISM; NADPH OXIDASES; SMOOTH-MUSCLE; MAGNETORECEPTION; SUPEROXIDE; ACTIVATION; BIOLOGY	The effects of weak magnetic fields on the biological production of reactive oxygen species (ROS) from intracellular superoxide (O-2(center dot-)) and extracellular hydrogen peroxide (H2O2) were investigated in vitro with rat pulmonary arterial smooth muscle cells (rPASMC). A decrease in O-2(center dot-) and an increase in H2O2 concentrations were observed in the presence of a 7 MHz radio frequency (RF) at 10 mu T-RMS and static 45 mu T magnetic fields. We propose that O-2(center dot-) and H2O2 production in some metabolic processes occur through singlet-triplet modulation of semiquinone flavin (FADH(center dot)) enzymes and O-2(center dot-) spin-correlated radical pairs. Spin-radical pair products are modulated by the 7 MHz RF magnetic fields that presumably decouple flavin hyperfine interactions during spin coherence. RF flavin hyperfine decoupling results in an increase of H2O2 singlet state products, which creates cellular oxidative stress and acts as a secondary messenger that affects cellular proliferation. This study demonstrates the interplay between O-2(center dot-) and H2O2 production when influenced by RF magnetic fields and underscores the subtle effects of low-frequency magnetic fields on oxidative metabolism, ROS signaling, and cellular growth.	[Usselman, Robert J.] NIST, Electromagnet Div, Boulder, CO 80309 USA; [Singel, David J.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Hill, Iain; Martino, Carlos F.] Univ Nevada, Dept Mech Engn, Reno, NV 89557 USA	National Institute of Standards & Technology (NIST) - USA; Montana State University System; Montana State University Bozeman; Nevada System of Higher Education (NSHE); University of Nevada Reno	Usselman, RJ (corresponding author), NIST, Electromagnet Div, Boulder, CO 80309 USA.	robert.usselman@gmail.com; cmartino@unr.edu	Martino, Carlos F/C-6597-2016	Martino, Carlos F/0000-0002-0560-2604	United States government	United States government	This work was partially supported by the United States government but is not protected by US copyright. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair RK, 1999, BIOELECTROMAGNETICS, V20, P255, DOI 10.1002/(SICI)1521-186X(1999)20:4<255::AID-BEM6>3.0.CO;2-W; [Anonymous], 2005, C951 IEEE; Ball P, 2011, NATURE, V474, P272, DOI 10.1038/474272a; Barnes F. S., 2006, HDB BIOL EFFECTS ELE, P67; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BLANKENSHIP RE, 1977, BIOCHIM BIOPHYS ACTA, V461, P297, DOI 10.1016/0005-2728(77)90179-7; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Bucci M, 2010, NAT CHEM BIOL, V6, P847, DOI 10.1038/nchembio.489; Buchachenko AL, 2005, P NATL ACAD SCI USA, V102, P10793, DOI 10.1073/pnas.0504876102; Buetler TM, 2004, NEWS PHYSIOL SCI, V19, P120, DOI 10.1152/nips.01514.2003; CANFIELD JM, 1994, CHEM PHYS, V182, P1, DOI 10.1016/0301-0104(93)E0442-X; Cespedes O, 2010, BIOELECTROMAGNETICS, V31, P311, DOI 10.1002/bem.20564; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Challis LJ, 2005, BIOELECTROMAGNETICS, pS98, DOI 10.1002/bem.20119; Chen K, 2009, ANTIOXID REDOX SIGN, V11, P2467, DOI [10.1089/ars.2009.2594, 10.1089/ARS.2009.2594]; Cintolesi F, 2003, CHEM PHYS, V294, P385, DOI 10.1016/S0301-0104(03)00320-3; Cohen AE, 2009, J PHYS CHEM A, V113, P11084, DOI 10.1021/jp907113p; Crotty D, 2012, P NATL ACAD SCI USA, V109, P1437, DOI 10.1073/pnas.1117840108; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013; Dikalov SI, 2011, FREE RADICAL RES, V45, P417, DOI 10.3109/10715762.2010.540242; Engstrom S, 2006, HDB BIOL EFFECTS ELE, P157; Fisher AB, 2009, ANTIOXID REDOX SIGN, V11, P1349, DOI [10.1089/ars.2008.2378, 10.1089/ARS.2008.2378]; Forrest AS, 2012, AM J PHYSIOL-CELL PH, V303, pC1229, DOI 10.1152/ajpcell.00044.2012; FRIX WM, 1994, IEEE T POWER DELIVER, V9, P100, DOI 10.1109/61.277684; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; GRISSOM CB, 1995, CHEM REV, V95, P3, DOI 10.1021/cr00033a001; HOFF AJ, 1977, BIOCHIM BIOPHYS ACTA, V460, P547, DOI 10.1016/0005-2728(77)90094-9; Hogben HJ, 2009, CHEM PHYS LETT, V480, P118, DOI 10.1016/j.cplett.2009.08.051; Hore PJ, 2012, P NATL ACAD SCI USA, V109, P1357, DOI 10.1073/pnas.1120531109; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; Jones AR, 2009, J AM CHEM SOC, V131, P17246, DOI 10.1021/ja9059238; Kominis IK, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056115; Lacy-Hulbert A, 1998, FASEB J, V12, P395, DOI 10.1096/fasebj.12.6.395; Lambert N, 2013, NAT PHYS, V9, P10, DOI [10.1038/nphys2474, 10.1038/NPHYS2474]; Leszczynski D, 2002, DIFFERENTIATION, V70, P120, DOI 10.1046/j.1432-0436.2002.700207.x; Maeda K, 2008, NATURE, V453, P387, DOI 10.1038/nature06834; Martino CF, 2010, BIOELECTROMAGNETICS, V31, P296, DOI 10.1002/bem.20565; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mates JM, 2008, ARCH TOXICOL, V82, P273, DOI 10.1007/s00204-008-0304-z; MCLAUCHLAN K, 1992, PHYS WORLD, V5, P41; Miller RL, 2007, BRAIN RES, V1167, P129, DOI 10.1016/j.brainres.2007.06.046; Minaev B. F., 2008, UKR BIOORG ACTA, V2, P56; Minaev BF, 2012, HDB COMPUTATIONAL CH, P1067; Niessner C, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0638; Okano H, 2008, FRONT BIOSCI-LANDMRK, V13, P6106, DOI 10.2741/3141; OKAZAKI M, 1987, J CHEM PHYS, V86, P6792, DOI 10.1063/1.452378; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Portelli LA, 2013, BIOELECTROMAGNETICS, V34, P337, DOI 10.1002/bem.21787; Prabhakar R, 2002, J PHYS CHEM B, V106, P3742, DOI 10.1021/jp014013q; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; Schleicher E, 2010, APPL MAGN RESON, V37, P339, DOI 10.1007/s00723-009-0101-8; SCHULTEN K, 1978, J CHEM PHYS, V68, P3292, DOI 10.1063/1.436135; Solov'yov IA, 2009, BIOPHYS J, V96, P4804, DOI 10.1016/j.bpj.2009.03.048; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005; Swanson MA, 2008, BIOCHEMISTRY-US, V47, P8894, DOI 10.1021/bi800507p; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P808, DOI 10.1001/jama.2011.186; Vorst A. V., 2006, RF MICROWAVE INTERAC; Wedge CJ, 2013, PHYS CHEM CHEM PHYS, V15, P16043, DOI 10.1039/c3cp52019f; Yakunin IN, 2010, RUSS J PHYS CHEM B+, V4, P210, DOI 10.1134/S1990793110020053; Yu YB, 2008, CELL RES, V18, P1233, DOI 10.1038/cr.2008.306	68	50	51	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93065	10.1371/journal.pone.0093065	http://dx.doi.org/10.1371/journal.pone.0093065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681944	Green Published, Green Submitted, gold			2022-12-27	WOS:000333678100023
J	Zhang, JB; An, M; Wu, HW; Liu, DL; Stanton, R				Zhang, Jinbiao; An, Min; Wu, Hanwen; Liu, De Li; Stanton, Rex			Phytotoxic Activity and Chemical Composition of Aqueous Volatile Fractions from Eucalyptus Species	PLOS ONE			English	Article							ESSENTIAL OIL; MONOTERPENES	The essential oils from four Eucalyptus species (E. spathulata, E. salubris, E. brockwayii and E. dundasii) have been previously confirmed to have stronger inhibitory effects on germination and seedling growth of silverleaf nightshade (Solanum elaeagnifolium Cav.). The aqueous volatile fractions (AVFs) were the water soluble volatile fractions produced together with the essential oils (water insoluble fractions) during the steam distillation process. The aim of this study was to further assess the phytotoxicity of AVFs from the four Eucalyptus species and their chemical composition. The fresh leaves of the four Eucalyptus species were used for the extraction of AVFs. The AVFs were tested for their phytotoxic effects on the perennial weed, silverleaf nightshade under laboratory conditions. The chemical compositions of the AVFs were determined by gas chromatograph-mass spectrometry (GC-MS). Our results showed that the AVFs had strong inhibition on the germination and seedling growth of silverleaf nightshade. The inhibition index increased with the increasing concentrations of AVFs. The inhibitory effects of the AVFs varied between different Eucalyptus species. The AVF from E. salubris demonstrated the highest inhibitory activity on the weed tested, with complete inhibition on germination and seedling growth at a concentration of 75%. The GC-MS analysis revealed that 1,8-cineole, isopentyl isovalerate, isomenthol, pinocarvone, trans-pinocarveol, alpha-terpineol and globulol were the main compounds in the AVFs. These results indicated that all AVFs tested had differential inhibition on the germination and seedling growth of silverleaf nightshade, which could be due to the joint effects of compounds present in the AVFs as these compounds were present in different quantities and ratio between Eucalyptus species.	[Zhang, Jinbiao] Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China; [Zhang, Jinbiao] Fujian Agr & Forestry Univ, Sch Life Sci, Fuzhou, Peoples R China; [An, Min] Charles Sturt Univ, Fac Sci, Environm & Analyt Labs, Wagga Wagga, NSW, Australia; [Wu, Hanwen; Liu, De Li; Stanton, Rex] Wagga Wagga Agr Inst, EH Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Charles Sturt University	Zhang, JB (corresponding author), Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China.	jbzhangfj@yahoo.com	Wu, Hanwen/B-7901-2010; , De Li Liu/Y-4656-2019	Wu, Hanwen/0000-0001-5157-4977; Liu, De Li/0000-0003-2574-1908	Meat and Livestock of Australia	Meat and Livestock of Australia	This work was supported by Meat and Livestock of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P., 1995, IDENTIFICATION ESSEN; An Min, 2005, Nonlinearity in Biology Toxicology and Medicine, V3, P245, DOI 10.2201/nonlin.003.02.006; Anonymous, 2007, Bulletin OEPP, V37, P236, DOI 10.1111/j.1365-2338.2007.01112.x; AWC (Australian Weeds Committee), 2012, WEEDS NAT SIGN; Babu RC, 1997, J AGRON CROP SCI, V179, P123, DOI 10.1111/j.1439-037X.1997.tb00507.x; Batish DR, 2006, Z NATURFORSCH C, V61, P52; Baum SF, 1998, J PLANT GROWTH REGUL, V17, P107, DOI 10.1007/PL00007015; Cuevas-Glory LF, 2007, FOOD CHEM, V103, P1032, DOI 10.1016/j.foodchem.2006.07.068; DELMORAL R, 1978, AUST J BOT, V26, P203; Deng CH, 2004, J CHROMATOGR A, V1059, P149, DOI 10.1016/j.chroma.2004.10.005; Kaur S, 2011, J PLANT INTERACT, V6, P297, DOI 10.1080/17429145.2010.539709; Khan M. A., 2008, Pakistan Journal of Weed Science Research, V14, P201; Li XF, 2011, PLANT SOIL, V341, P383, DOI 10.1007/s11104-010-0652-3; Liu DL, 2007, ALLELOPATHY J, V19, P203; Martins C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061233; Romagni JG, 2000, J CHEM ECOL, V26, P303, DOI 10.1023/A:1005414216848; Setia N, 2007, J ENVIRON BIOL, V28, P63; Singh HP, 2005, ANN APPL BIOL, V146, P89, DOI 10.1111/j.1744-7348.2005.04018.x; Singh HP, 2002, CROP PROT, V21, P347, DOI 10.1016/S0261-2194(01)00096-5; Stanton R, 2008, P 16 AUSTR WEEDS C C, P330; Stanton R, 2012, WEED SCI, V60, P42, DOI 10.1614/WS-D-11-00105.1; USDA-NRCS, 2005, PLANTS DAT VERS 35; Van Vuuren SF, 2007, FLAVOUR FRAG J, V22, P540, DOI 10.1002/ffj.1843; VAUGHN SF, 1993, WEED SCI, V41, P114, DOI 10.1017/S0043174500057672; Wu H, 1999, WEED RES, V39, P171, DOI 10.1046/j.1365-3180.1999.00136.x; Wu HW, 2011, ALLELOPATHY J, V28, P87; Zhang JB, 2012, PLANT GROWTH REGUL, V68, P231, DOI 10.1007/s10725-012-9711-5; Zhang JB, 2010, ALLELOPATHY J, V25, P313	28	30	32	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93189	10.1371/journal.pone.0093189	http://dx.doi.org/10.1371/journal.pone.0093189			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681490	Green Published, Green Submitted, gold			2022-12-27	WOS:000333678100031
J	Bergamini, A; Chimenti, MS; Baffari, E; Guarino, MD; Gigliucci, G; Perricone, C; Perricone, R				Bergamini, Alberto; Chimenti, Maria Sole; Baffari, Eleonora; Guarino, Maria Domenica; Gigliucci, Gianfranco; Perricone, Carlo; Perricone, Roberto			Downregulation of Immunoglobulin-Like Transcript-4 (ILT4) in Patients with Psoriatic Arthritis	PLOS ONE			English	Article							INHIBITORY RECEPTOR ILT4; DENDRITIC CELLS; T-CELLS; ENDOTHELIAL-CELLS; DIFFERENTIAL EXPRESSION; RHEUMATOID-ARTHRITIS; PERIPHERAL-BLOOD; SYNOVIAL-FLUID; UP-REGULATION; KAPPA-B	Objective: The immunoglobulin-like transcript-4 (ILT4) is an inhibitory receptor that modulates the activity of innate immune agents. We determined the expression of ILT4 and analysed the relationship with the expression of costimulatory proteins and tumor necrosis factor-alpha (TNF-alpha) production in monocytes from patients with psoriatic arthritis (PsA) starting anti-TNF treatment. Methods: Peripheral blood monocytes from 15 healthy controls and from 16 patients with PsA were activated in vitro by CD40 ligand (CD40L) and analyzed for ILT4, CD40, CD80 and CD86 expression, and spontaneous lipopolysaccharide (LPS)-induced TNF-alpha production by flow cytometry, before and after treatment with adalimumab. Results: The percentage of ILT4-negative monocytes was greater in PsA patients compared to controls and negatively correlated with DAS44. Normal monocytes treated with sera of PsA patients showed a reduced expression of ILT4 compared with monocytes exposed to sera from controls. CD40, CD80 and CD86 expression was higher in patients compared to controls. Both spontaneous and LPS-induced TNF-alpha production was restricted to ILT4-negative monocytes and was greater in PsA patients compared to controls. Finally, twelve weeks-treatment with adalimumab resulted in a significant increase of ILT4 expression and a decrease of costimulatory molecules expression in PsA patients, compared to pre-therapy levels. Conclusions: These data support the possibility that changes in the immunophenotype of monocytes play a role in the pathogenesis of PSA. Thus, modulation of the expression of ILT4 may represent an enticing new therapeutic target.	[Bergamini, Alberto; Chimenti, Maria Sole; Baffari, Eleonora; Guarino, Maria Domenica; Gigliucci, Gianfranco; Perricone, Roberto] Univ Roma Tor Vergata, Dept Internal Med, Rheumatol Unit, Rome, Italy; [Perricone, Carlo] Sapienza Univ Roma, Dipartimento Med Interna & Specialita Med, Rome, Italy	University of Rome Tor Vergata; Sapienza University Rome	Perricone, C (corresponding author), Sapienza Univ Roma, Dipartimento Med Interna & Specialita Med, Rome, Italy.	carlo.perricone@gmail.com	Chimenti, Maria Sole/ABG-3165-2020	Chimenti, Maria Sole/0000-0002-1343-1729; Perricone, Carlo/0000-0003-4771-6981; Perricone, Roberto/0000-0002-2368-9766				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ALDERSON MR, 1993, J EXP MED, V178, P669, DOI 10.1084/jem.178.2.669; Allen RL, 2004, CURR MOL MED, V4, P59, DOI 10.2174/1566524043479329; Baffari E, 2013, HUM IMMUNOL, V74, P1244, DOI 10.1016/j.humimm.2013.07.012; Borghi A, 2008, ARCH DERMATOL RES, V300, P551, DOI 10.1007/s00403-008-0886-6; Brossart P, 1998, BLOOD, V92, P4238, DOI 10.1182/blood.V92.11.4238.423k16_4238_4247; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Chang CC, 2009, J IMMUNOL, V182, P5208, DOI 10.4049/jimmunol.0804048; Chimenti MS, 2013, AUTOIMMUN REV, V12, P599, DOI 10.1016/j.autrev.2012.10.002; Christophers E, 2001, CLIN EXP DERMATOL, V26, P314, DOI 10.1046/j.1365-2230.2001.00832.x; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Contini C, 2011, RHEUMATOL INT, V31, P1307, DOI 10.1007/s00296-010-1460-z; Cortesini NSF, 2004, TRANSPL IMMUNOL, V13, P73, DOI 10.1016/j.trim.2004.06.001; Curran SA, 2004, J IMMUNOL, V172, P1935, DOI 10.4049/jimmunol.172.3.1935; Danning CL, 2000, ARTHRITIS RHEUM-US, V43, P1244, DOI 10.1002/1529-0131(200006)43:6<1244::AID-ANR7>3.0.CO;2-2; Daoussis D, 2007, RHEUMATOLOGY, V46, P227, DOI 10.1093/rheumatology/kel229; Dietrich J, 2001, J IMMUNOL, V166, P2514, DOI 10.4049/jimmunol.166.4.2514; Dulphy N, 2002, INT IMMUNOL, V14, P471, DOI 10.1093/intimm/14.5.471; GRAF D, 1992, EUR J IMMUNOL, V22, P3191, DOI 10.1002/eji.1830221226; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; HELLIWELL P, 1991, BRIT J RHEUMATOL, V30, P339; Huynh OA, 2007, RHEUMATOLOGY, V46, P742, DOI 10.1093/rheumatology/kel405; Iannone F, 2012, J RHEUMATOL, V39, P100, DOI 10.3899/jrheum.120257; KIENER PA, 1995, J IMMUNOL, V155, P4917; Kollnberger S, 2002, ARTHRITIS RHEUM, V46, P2972, DOI 10.1002/art.10605; Konig A, 1997, RHEUMATOL INT, V17, P159, DOI 10.1007/s002960050028; Lehtonen A, 2005, J IMMUNOL, V175, P6570, DOI 10.4049/jimmunol.175.10.6570; Merlo A, 2001, INFECT IMMUN, V69, P6022, DOI 10.1128/IAI.69.10.6022-6029.2001; Moen K, 2006, CLIN EXP RHEUMATOL, V24, P656; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; Murakami K, 1999, J IMMUNOL, V163, P2667; Nakajima H, 2003, J IMMUNOL, V171, P6611, DOI 10.4049/jimmunol.171.12.6611; Neumann M, 2000, BLOOD, V95, P277; O'Sullivan B, 2003, CRIT REV IMMUNOL, V23, P83, DOI 10.1615/CritRevImmunol.v23.i12.50; PICKER LJ, 1995, BLOOD, V86, P1408, DOI 10.1182/blood.V86.4.1408.bloodjournal8641408; Placido R, 1997, J PATHOL, V181, P31, DOI 10.1002/(SICI)1096-9896(199701)181:1<31::AID-PATH722>3.0.CO;2-G; Prigione I, 2011, RHEUMATOLOGY, V50, P966, DOI 10.1093/rheumatology/keq418; Ristich V, 2005, EUR J IMMUNOL, V35, P1133, DOI 10.1002/eji.200425741; Ritchlin C, 1998, J RHEUMATOL, V25, P1544; Ritchlin CT, 2009, ANN RHEUM DIS, V68, P1387, DOI 10.1136/ard.2008.094946; Rojas D, 2010, IMMUNOL LETT, V132, P31, DOI 10.1016/j.imlet.2010.05.003; Samaridis J, 1997, EUR J IMMUNOL, V27, P660, DOI 10.1002/eji.1830270313; Seitz Michael, 1999, Current Opinion in Rheumatology, V11, P226, DOI 10.1097/00002281-199905000-00012; Stuber E, 1996, J EXP MED, V183, P693, DOI 10.1084/jem.183.2.693; Svajger U, 2010, IMMUNOLOGY, V129, P525, DOI 10.1111/j.1365-2567.2009.03205.x; Tassiulas I, 1999, HUM IMMUNOL, V60, P479, DOI 10.1016/S0198-8859(99)00034-8; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; van Kuijk AWR, 2006, ANN RHEUM DIS, V65, P1551, DOI 10.1136/ard.2005.050963; VANDERHEIJDE DMFM, 1993, J RHEUMATOL, V20, P579; Vlad G, 2003, HUM IMMUNOL, V64, P483, DOI 10.1016/S0198-8859(03)00040-5; Wang QM, 1999, ARTHRITIS RHEUM, V42, P2055, DOI 10.1002/1529-0131(199910)42:10<2055::AID-ANR5>3.0.CO;2-A; Wijngaarden S, 2005, RHEUMATOLOGY, V44, P729, DOI 10.1093/rheumatology/keh583; YELLIN MJ, 1995, J EXP MED, V182, P1857, DOI 10.1084/jem.182.6.1857; Young NT, 2008, BLOOD, V111, P3090, DOI 10.1182/blood-2007-05-089771	55	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92018	10.1371/journal.pone.0092018	http://dx.doi.org/10.1371/journal.pone.0092018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676037	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677500018
J	Mei, LL; Xue, G; Lu, ZL; He, QH; Zhang, MX; Wei, M; Xue, F; Chen, CS; Dong, Q				Mei, Leilei; Xue, Gui; Lu, Zhong-Lin; He, Qinghua; Zhang, Mingxia; Wei, Miao; Xue, Feng; Chen, Chuansheng; Dong, Qi			Artificial Language Training Reveals the Neural Substrates Underlying Addressed and Assembled Phonologies	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; READING ALOUD; DUAL-ROUTE; KANA WORDS; FUNCTIONAL-ANATOMY; CEREBRAL-CORTEX; BRAIN; FMRI; PSEUDOWORDS; METAANALYSIS	Although behavioral and neuropsychological studies have suggested two distinct routes of phonological access, their neural substrates have not been clearly elucidated. Here, we designed an artificial language (based on Korean Hangul) that can be read either through addressed (i.e., whole word mapping) or assembled (i.e., grapheme-to-phoneme mapping) phonology. Two matched groups of native English-speaking participants were trained in one of the two conditions, one hour per day for eight days. Behavioral results showed that both groups correctly named more than 90% of the trained words after training. At the neural level, we found a clear dissociation of the neural pathways for addressed and assembled phonologies: There was greater involvement of the anterior cingulate cortex, posterior cingulate cortex, right orbital frontal cortex, angular gyrus and middle temporal gyrus for addressed phonology, but stronger activation in the left precentral gyrus/inferior frontal gyrus and supramarginal gyrus for assembled phonology. Furthermore, we found evidence supporting the strategy-shift hypothesis, which postulates that, with practice, reading strategy shifts from assembled to addressed phonology. Specifically, compared to untrained words, trained words in the assembled phonology group showed stronger activation in the addressed phonology network and less activation in the assembled phonology network. Our results provide clear brain-imaging evidence for the dual-route models of reading.	[Mei, Leilei] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Mei, Leilei] Univ Calif Irvine, Sch Psychol, Irvine, CA USA; [Mei, Leilei; Chen, Chuansheng] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA 92697 USA; [Zhang, Mingxia; Dong, Qi] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhang, Mingxia; Dong, Qi] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Lu, Zhong-Lin] Ohio State Univ, Ctr Cognit & Behav Brain Imaging, Columbus, OH 43210 USA; [Lu, Zhong-Lin] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [He, Qinghua; Wei, Miao; Xue, Feng] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA	South China Normal University; University of California System; University of California Irvine; University of California System; University of California Irvine; Beijing Normal University; Beijing Normal University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Southern California	Chen, CS (corresponding author), Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA 92697 USA.	cschen@uci.edu; dongqi@bnu.edu.cn	Xue, Feng/B-2304-2010; Xue, Gui/A-1762-2009; He, Qinghua/B-2573-2008	Xue, Feng/0000-0001-8286-3552; Xue, Gui/0000-0001-7891-8151; He, Qinghua/0000-0001-6396-6273; Chen, Chuansheng/0000-0002-8224-1005; Lu, Zhong-Lin/0000-0002-7295-727X; zhang, ming xia/0000-0003-1512-2513	National Natural Science Foundation of China [31130025, 31221003]; National Science Foundation [BCS 0823624, BCS 0823495]; National Institute of Health [HD057884-01A2]; 111 Project [B0700]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057884] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 111 Project(Ministry of Education, China - 111 Project); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Natural Science Foundation of China (31130025, 31221003), National Science Foundation (grant numbers BCS 0823624 and BCS 0823495), the National Institute of Health (grant number HD057884-01A2), and the 111 Project (B0700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, WOODCOCK READING MAS; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Binder JR, 2005, NEUROIMAGE, V27, P677, DOI 10.1016/j.neuroimage.2005.04.029; Bolger DJ, 2005, HUM BRAIN MAPP, V25, P92, DOI 10.1002/hbm.20124; Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; Burton H, 2003, J NEUROPHYSIOL, V90, P1965, DOI 10.1152/jn.00279.2003; Carreiras M, 2007, J COGNITIVE NEUROSCI, V19, P433, DOI 10.1162/jocn.2007.19.3.433; Cattinelli I, 2013, J NEUROLINGUIST, V26, P214, DOI 10.1016/j.jneuroling.2012.08.001; Chen CS, 2007, NEUROPSYCHOLOGIA, V45, P741, DOI 10.1016/j.neuropsychologia.2006.08.018; Chen CS, 2009, PROG BRAIN RES, V178, P159, DOI 10.1016/S0079-6123(09)17811-1; Chen YP, 2002, J COGNITIVE NEUROSCI, V14, P1088, DOI 10.1162/089892902320474535; Church JA, 2008, CEREB CORTEX, V18, P2054, DOI 10.1093/cercor/bhm228; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; COLTHEART M, 1993, PSYCHOL REV, V100, P589, DOI 10.1037/0033-295X.100.4.589; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Fiebach CJ, 2002, J COGNITIVE NEUROSCI, V14, P11, DOI 10.1162/089892902317205285; Fiez JA, 1999, NEURON, V24, P205, DOI 10.1016/S0896-6273(00)80833-8; Fu SM, 2002, NEUROIMAGE, V17, P1538, DOI 10.1006/nimg.2002.1155; Graves WW, 2010, CEREB CORTEX, V20, P1799, DOI 10.1093/cercor/bhp245; Hagoort P, 1999, J COGNITIVE NEUROSCI, V11, P383, DOI 10.1162/089892999563490; Hartwigsen G, 2010, P NATL ACAD SCI USA, V107, P16494, DOI 10.1073/pnas.1008121107; Heim S, 2005, COGNITIVE BRAIN RES, V25, P982, DOI 10.1016/j.cogbrainres.2005.09.022; Herbster AN, 1997, HUM BRAIN MAPP, V5, P84, DOI 10.1002/(SICI)1097-0193(1997)5:2<84::AID-HBM2>3.0.CO;2-I; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Joubert S, 2004, BRAIN LANG, V89, P9, DOI 10.1016/S0093-934X(03)00403-6; Lee H, 2007, J NEUROSCI, V27, P1184, DOI 10.1523/JNEUROSCI.4442-06.2007; Levy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006675; Maloney E, 2009, Q J EXP PSYCHOL, V62, P858, DOI 10.1080/17470210802578385; MARSHALL JC, 1973, J PSYCHOLINGUIST RES, V2, P175, DOI 10.1007/BF01067101; McDermott KB, 2003, NEUROPSYCHOLOGIA, V41, P293, DOI 10.1016/S0028-3932(02)00162-8; Mechelli A, 2005, J COGNITIVE NEUROSCI, V17, P1753, DOI 10.1162/089892905774589190; Mechelli A, 2003, J COGNITIVE NEUROSCI, V15, P260, DOI 10.1162/089892903321208196; Mumford J., 2007, GUIDE CALCULAT UNPUB; Nakamura K, 2005, J COGNITIVE NEUROSCI, V17, P954, DOI 10.1162/0898929054021166; Nosarti C, 2010, CEREB CORTEX, V20, P315, DOI 10.1093/cercor/bhp101; PAAP KR, 1991, PSYCHOL RES-PSYCH FO, V53, P13, DOI 10.1007/BF00867328; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; Perry C, 2007, NESTED INCREMENTAL M; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Price CJ, 1998, TRENDS COGN SCI, V2, P281, DOI 10.1016/S1364-6613(98)01201-7; Pugh KR, 2001, J COMMUN DISORD, V34, P479, DOI 10.1016/S0021-9924(01)00060-0; Rastle K, 2002, Q J EXP PSYCHOL-A, V55, P1339, DOI 10.1080/02724980244000099; Raven J.C, 1990, ADV PROGR MATRICES S; Richlan F, 2009, HUM BRAIN MAPP, V30, P3299, DOI 10.1002/hbm.20752; Sakurai Y, 2000, COGNITIVE BRAIN RES, V9, P111, DOI 10.1016/S0926-6410(99)00052-X; Seghier ML, 2010, J NEUROSCI, V30, P16809, DOI 10.1523/JNEUROSCI.3377-10.2010; SEIDENBERG MS, 1984, J VERB LEARN VERB BE, V23, P383, DOI 10.1016/S0022-5371(84)90270-6; SHALLICE T, 1975, Q J EXP PSYCHOL, V27, P187, DOI 10.1080/14640747508400479; Simos PG, 2002, CEREB CORTEX, V12, P297, DOI 10.1093/cercor/12.3.297; SNYDER PJ, 1993, CORTEX, V29, P115, DOI 10.1016/S0010-9452(13)80216-X; Tagamets MA, 2000, J COGNITIVE NEUROSCI, V12, P281, DOI 10.1162/089892900562101; Tan LH, 2005, HUM BRAIN MAPP, V25, P83, DOI 10.1002/hbm.20134; TARABAN R, 1987, J MEM LANG, V26, P608, DOI 10.1016/0749-596X(87)90105-7; Thuy DHD, 2004, NEUROIMAGE, V23, P878, DOI 10.1016/j.neuroimage.2004.07.059; Tohka J, 2008, NEUROIMAGE, V39, P1227, DOI 10.1016/j.neuroimage.2007.10.013; Torgesen J.K., 1999, TOWRE TEST WORD READ; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Van Essen DC, 2002, CURR OPIN NEUROBIOL, V12, P574, DOI 10.1016/S0959-4388(02)00361-6; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Xu B, 2001, CEREB CORTEX, V11, P267, DOI 10.1093/cercor/11.3.267; Xue G, 2006, NEUROIMAGE, V31, P1315, DOI 10.1016/j.neuroimage.2005.11.055; Zorzi M, 1998, J EXP PSYCHOL HUMAN, V24, P1131, DOI 10.1037/0096-1523.24.4.1131	69	22	22	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93548	10.1371/journal.pone.0093548	http://dx.doi.org/10.1371/journal.pone.0093548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SW	24676060	Green Published, gold			2022-12-27	WOS:000333677500138
J	Plischke, M; Kohl, M; Bankir, L; Shayganfar, S; Handisurya, A; Heinze, G; Haas, M				Plischke, Max; Kohl, Maria; Bankir, Lise; Shayganfar, Sascha; Handisurya, Ammon; Heinze, Georg; Haas, Martin			Urine Osmolarity and Risk of Dialysis Initiation in a Chronic Kidney Disease Cohort - a Possible Titration Target?	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; WATER-INTAKE; RECEPTOR ANTAGONISM; ANTIDIURETIC ACTION; COMPETING RISK; VASOPRESSIN; RATS; PROGRESSION; VOLUME; PROTEIN	Background: Increasing evidence is linking fluid intake, vasopressin suppression and osmotic control with chronic kidney disease progression. Interestingly, the association between urine volume, urine osmolarity and risk of dialysis initiation has not been studied in chronic kidney disease patients before. Objective: To study the relationship between urine volume, urine osmolarity and the risk of initiating dialysis in chronic kidney disease. Design: In a retrospective cohort analysis of 273 patients with chronic kidney disease stage 1-4 we assessed the association between urine volume, urine osmolarity and the risk of dialysis by a multivariate proportional sub-distribution hazards model for competing risk data according to Fine and Gray. Co-variables were selected via the purposeful selection algorithm. Results: Dialysis was reached in 105 patients over a median follow-up period of 92 months. After adjustment for age, baseline creatinine clearance, other risk factors and diuretics, a higher risk for initiation of dialysis was found in patients with higher urine osmolarity. The adjusted sub-distribution hazard ratio for initiation of dialysis was 2.04 ( 95% confidence interval, 1.06 to 3.92) for each doubling of urine osmolarity. After 72 months, the estimated adjusted cumulative incidence probabilities of dialysis were 15%, 24%, and 34% in patients with a baseline urine osmolarity of 315, 510, and 775 mosm/ L, respectively. Conclusions: We conclude that higher urine osmolarity is associated with a higher risk of initiating dialysis. As urine osmolarity is a potentially modifiable risk factor, it thus deserves further, prospective research as a potential target in chronic kidney disease progression.	[Plischke, Max; Handisurya, Ammon; Haas, Martin] Med Univ Vienna, Dept Internal Med 3, Div Nephrol & Dialysis, Vienna, Austria; [Kohl, Maria; Heinze, Georg] Med Univ Vienna, Sect Clin Biometr, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Bankir, Lise] Ctr Rech Cordeliers, INSERM UMRS 1138, Equipe 2, Paris, France; [Shayganfar, Sascha] Univ Hosp Dusseldorf, Fac Med, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany	Medical University of Vienna; Medical University of Vienna; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Haas, M (corresponding author), Med Univ Vienna, Dept Internal Med 3, Div Nephrol & Dialysis, Vienna, Austria.	martin.haas@meduniwien.ac.at	BANKIR, Lise/AAK-2733-2020	BANKIR, Lise/0000-0002-3321-0819; Heinze, Georg/0000-0003-1147-8491; Plischke, Max/0000-0002-7410-2611	European Community [241544]	European Community(European Commission)	Maria Kohl (statistician) was supported by the European Community's Seventh Framework Programme, grant number 241544. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Maria Kohl was involved in study design, analysis, and preparation of the manuscript. Mortality data, obtained via Statistics Austria, was payed for using the authors' departments (Department of Internal Med. III, Division of Nephrology and Dialysis, Medical University Vienna) research budget, which is not tied to any external funding institution. As this was a retrospective study, other expenses (laboratory, etc) were fully covered by routine patient care at the authors' outpatient department.	Anastasio P, 2001, KIDNEY INT, V60, P748, DOI 10.1046/j.1523-1755.2001.060002748.x; Bankir L, 2001, CARDIOVASC RES, V51, P372, DOI 10.1016/S0008-6363(01)00328-5; BANKIR L, 1991, AM J KIDNEY DIS, V17, P661, DOI 10.1016/S0272-6386(12)80346-5; Bankir L, 2013, NAT REV NEPHROL, V9, P223, DOI 10.1038/nrneph.2013.22; Bardoux P, 2003, NEPHROL DIAL TRANSPL, V18, P1755, DOI 10.1093/ndt/gfg277; Bouby N, 1996, J AM SOC NEPHROL, V7, P842; Bouby N, 2003, EUR J CLIN NUTR, V57, pS39, DOI 10.1038/sj.ejcn.1601900; BOUBY N, 1990, AM J PHYSIOL, V258, pF973, DOI 10.1152/ajprenal.1990.258.4.F973; Clark WF, 2011, CLIN J AM SOC NEPHRO, V6, P2634, DOI 10.2215/CJN.01990211; FEINFELD DA, 1987, AM J KIDNEY DIS, V10, P231, DOI 10.1016/S0272-6386(87)80179-8; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GELLAI M, 1984, AM J PHYSIOL, V246, pF819, DOI 10.1152/ajprenal.1984.246.6.F819; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hebert LA, 2003, AM J KIDNEY DIS, V41, P962, DOI 10.1016/S0272-6386(03)00193-8; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; LUFT FC, 1983, J LAB CLIN MED, V101, P605; Meijer E, 2010, KIDNEY INT, V77, P29, DOI 10.1038/ki.2009.397; Meijer E, 2009, TRANSPLANTATION, V88, P561, DOI 10.1097/TP.0b013e3181b11ae4; Nagao S, 2006, J AM SOC NEPHROL, V17, P2220, DOI 10.1681/ASN.2006030251; Perico N, 2009, KIDNEY INT, V76, P960, DOI 10.1038/ki.2009.267; Perucca J, 2007, AM J PHYSIOL-REG I, V292, pR700, DOI 10.1152/ajpregu.00500.2006; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Strippoli GFM, 2011, NEPHROLOGY, V16, P326, DOI 10.1111/j.1440-1797.2010.01415.x; Sugiura T, 1999, KIDNEY INT, V55, P1800, DOI 10.1046/j.1523-1755.1999.00443.x; Thomas MC, 2011, DIABETES CARE, V34, P861, DOI 10.2337/dc10-1722; Torres VE, 2011, CLIN J AM SOC NEPHRO, V6, P640, DOI 10.2215/CJN.03250410; Wang CJ, 2013, KIDNEY INT, V84, P45, DOI 10.1038/ki.2013.23; Wang CJ, 2011, CLIN J AM SOC NEPHRO, V6, P192, DOI 10.2215/CJN.03950510; Wang XL, 2006, J AM SOC NEPHROL, V17, P2900, DOI 10.1681/ASN.2005101106	29	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93226	10.1371/journal.pone.0093226	http://dx.doi.org/10.1371/journal.pone.0093226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675963	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500094
J	Yamashita, H; Kotani, T; Park, JH; Murata, Y; Okazawa, H; Ohnishi, H; Ku, Y; Matozaki, T				Yamashita, Hironori; Kotani, Takenori; Park, Jung-ha; Murata, Yoji; Okazawa, Hideki; Ohnishi, Hiroshi; Ku, Yonson; Matozaki, Takashi			Role of the Protein Tyrosine Phosphatase Shp2 in Homeostasis of the Intestinal Epithelium	PLOS ONE			English	Article							STEM-CELLS; EXPRESSION; DIFFERENTIATION; ALPHA; CRYPT; RAS; PROLIFERATION; INFLAMMATION; PROGRESSION; DEFENSINS	Protein tyrosine phosphorylation is thought to be important for regulation of the proliferation, differentiation, and rapid turnover of intestinal epithelial cells (IECs). The role of protein tyrosine phosphatases in such homeostatic regulation of IECs has remained largely unknown, however. Src homology 2-containing protein tyrosine phosphatase (Shp2) is a ubiquitously expressed cytoplasmic protein tyrosine phosphatase that functions as a positive regulator of the Ras-mitogen-activated protein kinase (MAPK) signaling pathway operative downstream of the receptors for various growth factors and cytokines, and it is thereby thought to contribute to the regulation of cell proliferation and differentiation. We now show that mice lacking Shp2 specifically in IECs (Shp2 CKO mice) develop severe colitis and die as early as 3 to 4 weeks after birth. The number of goblet cells in both the small intestine and colon of Shp2 CKO mice was markedly reduced compared with that for control mice. Furthermore, Shp2 CKO mice showed marked impairment of both IEC migration along the crypt-villus axis in the small intestine and the development of intestinal organoids from isolated crypts. The colitis as well as the reduction in the number of goblet cells apparent in Shp2 CKO mice were normalized by expression of an activated form of K-Ras in IECs. Our results thus suggest that Shp2 regulates IEC homeostasis through activation of Ras and thereby protects against the development of colitis.	[Yamashita, Hironori; Kotani, Takenori; Park, Jung-ha; Murata, Yoji; Okazawa, Hideki; Matozaki, Takashi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Signaling, Kobe, Hyogo 657, Japan; [Yamashita, Hironori; Ku, Yonson] Kobe Univ, Grad Sch Med, Dept Surg, Div Hepato Biliary Pancreat Surg, Kobe, Hyogo 657, Japan; [Ohnishi, Hiroshi] Gunma Univ, Grad Sch Hlth Sci, Dept Lab Sci, Maebashi, Gunma, Japan; [Matozaki, Takashi] Gunma Univ, Inst Mol & Cellular Regulat, Lab Biosignal Sci, Maebashi, Gunma, Japan	Kobe University; Kobe University; Gunma University; Gunma University	Kotani, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Signaling, Kobe, Hyogo 657, Japan.	kotani@med.kobe-u.ac.jp; matozaki@med.kobe-u.ac.jp		Kotani, Takenori/0000-0001-8571-4210; Murata, Yoji/0000-0002-9576-7030	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23370061, 25114709]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (B) (23370061) and a Grant-in-Aid for Scientific Research on Innovative Area (25114709) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N., 2010, CURR PROTOC STEM CEL; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Coulombe G, 2013, MOL CELL BIOL, V33, P2275, DOI 10.1128/MCB.00043-13; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; Feng Y, 2011, GASTROENTEROLOGY, V141, P1003, DOI 10.1053/j.gastro.2011.05.007; Fornaro M, 2006, J CELL BIOL, V175, P87, DOI 10.1083/jcb.200602029; Grossmann KS, 2009, P NATL ACAD SCI USA, V106, P16704, DOI 10.1073/pnas.0904336106; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; HALL PA, 1994, J CELL SCI, V107, P3569; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Kanazawa Y, 2010, GENES CELLS, V15, P1189, DOI 10.1111/j.1365-2443.2010.01453.x; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Matozaki T, 2009, CANCER SCI, V100, P1786, DOI 10.1111/j.1349-7006.2009.01257.x; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Murata Y, 2010, GENES CELLS, V15, P513, DOI 10.1111/j.1365-2443.2010.01398.x; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; Noguchi T, 2001, J BIOL CHEM, V276, P15216, DOI 10.1074/jbc.M007208200; Ouellette AJ, 2005, SPRINGER SEMIN IMMUN, V27, P133, DOI 10.1007/s00281-005-0202-x; Sadakata H, 2009, GENES CELLS, V14, P295, DOI 10.1111/j.1365-2443.2008.01270.x; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Schoenwaelder SM, 2000, CURR BIOL, V10, P1523, DOI 10.1016/S0960-9822(00)00831-9; Shi JS, 2007, INFLAMM BOWEL DIS, V13, P1284, DOI 10.1002/ibd.20197; Siegmund B, 2004, J LEUKOCYTE BIOL, V76, P782, DOI 10.1189/jlb.0404239; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Takahashi A, 2011, MOL CELL, V43, P45, DOI 10.1016/j.molcel.2011.05.014; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581	37	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92904	10.1371/journal.pone.0092904	http://dx.doi.org/10.1371/journal.pone.0092904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675817	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677500053
J	Zhang, Q; Liu, L; Zhu, F; Ning, ZH; Hincke, MT; Yang, N; Hou, ZC				Zhang, Quan; Liu, Long; Zhu, Feng; Ning, ZhongHua; Hincke, Maxwell T.; Yang, Ning; Hou, ZhuoCheng			Integrating De Novo Transcriptome Assembly and Cloning to Obtain Chicken Ovocleidin-17 Full-Length cDNA	PLOS ONE			English	Article							LECTIN-LIKE PROTEINS; EGG-WHITE PROTEOME; MATRIX PROTEINS; RNA-SEQ; EGGSHELL MATRIX; SEQUENCE; BIOMINERALIZATION; MINERALIZATION; ALIGNMENT	Efficiently obtaining full-length cDNA for a target gene is the key step for functional studies and probing genetic variations. However, almost all sequenced domestic animal genomes are not 'finished'. Many functionally important genes are located in these gapped regions. It can be difficult to obtain full-length cDNA for which only partial amino acid/EST sequences exist. In this study we report a general pipeline to obtain full-length cDNA, and illustrate this approach for one important gene (Ovocleidin-17, OC-17) that is associated with chicken eggshell biomineralization. Chicken OC-17 is one of the best candidates to control and regulate the deposition of calcium carbonate in the calcified eggshell layer. OC-17 protein has been purified, sequenced, and has had its three-dimensional structure solved. However, researchers still cannot conduct OC-17 mRNA related studies because the mRNA sequence is unknown and the gene is absent from the current chicken genome. We used RNA-Seq to obtain the entire transcriptome of the adult hen uterus, and then conducted de novo transcriptome assembling with bioinformatics analysis to obtain candidate OC-17 transcripts. Based on this sequence, we used RACE and PCR cloning methods to successfully obtain the full-length OC-17 cDNA. Temporal and spatial OC-17 mRNA expression analyses were also performed to demonstrate that OC-17 is predominantly expressed in the adult hen uterus during the laying cycle and barely at immature developmental stages. Differential uterine expression of OC-17 was observed in hens laying eggs with weak versus strong eggshell, confirming its important role in the regulation of eggshell mineralization and providing a new tool for genetic selection for eggshell quality parameters. This study is the first one to report the full-length OC-17 cDNA sequence, and builds a foundation for OC-17 mRNA related studies. We provide a general method for biologists experiencing difficulty in obtaining candidate gene full-length cDNA sequences.	[Zhang, Quan; Liu, Long; Ning, ZhongHua; Yang, Ning; Hou, ZhuoCheng] China Agr Univ, Dept Anim Genet & Breeding, Natl Engn Lab Anim Breeding, Beijing 100094, Peoples R China; [Zhang, Quan; Liu, Long; Ning, ZhongHua; Yang, Ning; Hou, ZhuoCheng] China Agr Univ, Dept Anim Genet & Breeding, MOA Key Lab Anim Genet & Breeding, Beijing 100094, Peoples R China; [Zhu, Feng] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Peoples R China; [Hincke, Maxwell T.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada	China Agricultural University; China Agricultural University; Sichuan Agricultural University; University of Ottawa	Hou, ZC (corresponding author), China Agr Univ, Dept Anim Genet & Breeding, Natl Engn Lab Anim Breeding, Beijing 100094, Peoples R China.	zchou@cau.edu.cn		Zhang, Quan/0000-0002-6123-9512; Yang, Ning/0000-0001-5772-3320	Chinese Agricultural Research System [CARS-41]; Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]; Fundamental Research Funds for the Central Universities [2011JS003]; National Scientific Supporting Projects of China [2011BAD28B03]; Natural Sciences and Engineering Research Council of Canada (NSERC) [210015]	Chinese Agricultural Research System; Program for Changjiang Scholar and Innovation Research Team in University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Scientific Supporting Projects of China; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by the Chinese Agricultural Research System (CARS-41), and the Program for Changjiang Scholar and Innovation Research Team in University (IRT1191) to NY, the Fundamental Research Funds for the Central Universities (2011JS003) and the National Scientific Supporting Projects of China (2011BAD28B03) to ZCH, Natural Sciences and Engineering Research Council of Canada (NSERC, 210015) to MTH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Colfen H, 2010, NAT MATER, V9, P960, DOI 10.1038/nmat2911; D'Ambrosio C, 2008, J PROTEOME RES, V7, P3461, DOI 10.1021/pr800193y; English AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047768; Freeman CL, 2012, PHYS CHEM CHEM PHYS, V14, P7287, DOI 10.1039/c2cp23987f; Garg R, 2013, METHODS MOL BIOL, V1069, P43, DOI 10.1007/978-1-62703-613-9_4; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hincke MT, 2012, FRONT BIOSCI-LANDMRK, V17, P1266, DOI 10.2741/3985; HINCKE MT, 1995, CALCIFIED TISSUE INT, V56, P578, DOI 10.1007/BF00298593; Hoeijmakers Wieteke A M, 2013, Methods Mol Biol, V923, P221; Hou Z, 2009, GENOMICS, V93, P33, DOI 10.1016/j.ygeno.2008.09.005; Koren S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r101; Lakshminarayanan R, 2002, P NATL ACAD SCI USA, V99, P5155, DOI 10.1073/pnas.072658899; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li CQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-552; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mann K, 2006, COMP BIOCHEM PHYS B, V143, P160, DOI 10.1016/j.cbpb.2005.11.003; Mann K, 2004, BBA-PROTEINS PROTEOM, V1696, P41, DOI 10.1016/j.bbapap.2003.09.006; Mann K, 2008, PROTEOMICS, V8, P2322, DOI 10.1002/pmic.200800032; Mann K, 2008, PROTEOMICS, V8, P178, DOI 10.1002/pmic.200700790; Mann K, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-7; MANN S, 1993, SCIENCE, V261, P1286, DOI 10.1126/science.261.5126.1286; Nys Y, 2004, CR PALEVOL, V3, P549, DOI 10.1016/j.crpv.2004.08.002; Panheleux M, 2000, POULTRY SCI, V79, P580, DOI 10.1093/ps/79.4.580; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Reyes-Grajeda JP, 2004, J BIOL CHEM, V279, P40876, DOI 10.1074/jbc.M406033200; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Rose MLH, 2009, CELL MOL LIFE SCI, V66, P2707, DOI 10.1007/s00018-009-0046-y; Zhang Y, 2011, POULTRY SCI, V90, P2718, DOI 10.3382/ps.2011-01751	30	13	14	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93452	10.1371/journal.pone.0093452	http://dx.doi.org/10.1371/journal.pone.0093452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676480	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500125
J	Wang, HH; Xu, SY; Sun, LY; Pan, XD; Yang, SW; Wang, LY				Wang, Haihong; Xu, Shengyuan; Sun, Liyuan; Pan, Xiaodong; Yang, Shiwei; Wang, Luya			Functional Characterization of Two Low-Density Lipoprotein Receptor Gene Mutations in Two Chinese Patients with Familial Hypercholesterolemia	PLOS ONE			English	Article							DOMAIN; PREVALENCE; DIAGNOSIS; PROTEINS; DATABASE; BINDING; DISEASE; VARIANT; UPDATE	Background: Familial hypercholesterolemia (FH) is an autosomal dominant disease that primarily results from mutations in the low-density lipoprotein receptor (LDLR) gene. We investigated two unrelated Chinese FH patients using gene screening and functional analysis to reveal the pathogenicity and the mechanism by which these mutations cause FH. Methods: First, the LDLR gene was sequenced in these patients. Then, mutant receptors were transfected into human embryo kidney 293(HEK-293) cells, and a confocal laser-scanning microscope was used to observe the localization of mutant proteins. Further, the expression and the internalization activity were analyzed by flow cytometry. Finally, LDLR protein expression and stability was detected by western blot. Results: Two different LDLR class 2B mutations were detected in two patients. The C201F mutation is a known mutation. However, the G615V mutation is novel. Flow cytometry showed that the expression and internalization activity of the mutant LDLRs were reduced to 73.6% and 82.6% for G615V and 33.2% and 33.5% for C201F, respectively. Conclusions: This study identified two LDLR mutations in Chinese patients with FH and analyzed the relationship between the genotype and phenotype of these patients. We found that these mutant LDLRs were defective in transport, which led to a reduction in cholesterol clearance. These results increase our understanding of the mutational spectrum of FH in the Chinese population.	[Wang, Haihong; Xu, Shengyuan; Sun, Liyuan; Pan, Xiaodong; Yang, Shiwei; Wang, Luya] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Atherosclerosis, Beijing, Peoples R China	Capital Medical University	Wang, LY (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Atherosclerosis, Beijing, Peoples R China.	wangluya@126.com			National Natural Science Foundation of China [81170810, 81271923]; Beijing Natural Science Foundation [7112022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by grants from the National Natural Science Foundation of China (81170810, 81271923) and the Beijing Natural Science Foundation (7112022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin MA, 2004, AM J EPIDEMIOL, V160, P407, DOI 10.1093/aje/kwh236; Benn M, 2012, J CLIN ENDOCR METAB, V97, P3956, DOI 10.1210/jc.2012-1563; Beuret N, 2004, J BIOL CHEM, V279, P20242, DOI 10.1074/jbc.M310613200; Civeira F, 2008, AM J CARDIOL, V102, P1187, DOI 10.1016/j.amjcard.2008.06.056; ESSER V, 1988, J BIOL CHEM, V263, P13282; Fouchier SW, 2001, HUM GENET, V109, P602, DOI 10.1007/s00439-001-0628-8; Gent J, 2004, CELL MOL LIFE SCI, V61, P2461, DOI 10.1007/s00018-004-4090-3; Goldstein J.L, 2001, METABOLIC MOL BASES, V3, P2863; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Leigh SEA, 2008, ANN HUM GENET, V72, P485, DOI 10.1111/j.1469-1809.2008.00436.x; Leren TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016721; Lin J, 2008, CHINESE MED J-PEKING, V121, P776, DOI 10.1097/00029330-200805010-00002; Marais A David, 2004, Clin Biochem Rev, V25, P49; MOORJANI S, 1989, ARTERIOSCLEROSIS, V9, P211, DOI 10.1161/01.ATV.9.2.211; Naoumova RP, 2004, ATHEROSCLEROSIS, V174, P67, DOI 10.1016/j.atherosclerosis.2004.01.001; Nordestgaard BG, 2013, EUR HEART J; Palacios L, 2012, ATHEROSCLEROSIS, V221, P137, DOI 10.1016/j.atherosclerosis.2011.12.021; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; Rudenko G, 2003, CURR OPIN STRUC BIOL, V13, P683, DOI 10.1016/j.sbi.2003.10.001; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Silva S, 2012, ATHEROSCLEROSIS, V225, P128, DOI 10.1016/j.atherosclerosis.2012.08.017; Sorensen S, 2006, J BIOL CHEM, V281, P468, DOI 10.1074/jbc.M507071200; Soutar AK, 2007, NAT CLIN PRACT CARD, V4, P214, DOI 10.1038/ncpcardio0836; Usifo E, 2012, ANN HUM GENET, V76, P387, DOI 10.1111/j.1469-1809.2012.00724.x; Wang L, 2009, NUTR METAB CARDIOVAS, V19, P391, DOI 10.1016/j.numecd.2008.07.011	29	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92703	10.1371/journal.pone.0092703	http://dx.doi.org/10.1371/journal.pone.0092703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671153	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000066
J	Arbyn, M; Fabri, V; Temmerman, M; Simoens, C				Arbyn, Marc; Fabri, Valerie; Temmerman, Marleen; Simoens, Cindy			Attendance at Cervical Cancer Screening and Use of Diagnostic and Therapeutic Procedures on the Uterine Cervix Assessed from Individual Health Insurance Data ( Belgium, 2002-2006)	PLOS ONE			English	Article							EUROPEAN GUIDELINES; QUALITY-ASSURANCE; MORTALITY; VALIDITY; OUTCOMES; ACCURACY; HISTORY; LESIONS	Objective: To assess the coverage for cervical cancer screening as well as the use of cervical cytology, colposcopy and other diagnostic and therapeutic interventions on the uterine cervix in Belgium, using individual health insurance data. Methods: The Intermutualistic Agency compiled a database containing 14 million records from reimbursement claims for Pap smears, colposcopies, cervical biopsies and surgery, performed between 2002 and 2006. Cervical cancer screening coverage was defined as the proportion of women aged 25-64 that had a Pap smear within the last 3 years. Results: Cervical cancer screening coverage was 61% at national level, for the target population of women between 25 and 64 years old, in the period 2004- 2006. Differences between the 3 regions were small, but varied more substantially between provinces. Coverage was 70% for 25-34 year old women, 67% for those aged 35-39 years, and decreased to 44% in the age group of 60-64 years. The median screening interval was 13 months. The screening coverage varied substantially by social category: 40% and 64%, in women categorised as beneficiary or not- beneficiary of increased reimbursement from social insurance, respectively. In the 3- year period 2004-2006, 3.2 million screen tests were done in the target group consisting of 2.8 million women. However, only 1.7 million women got one or more smears and 1.1 million women had no smears, corresponding to an average of 1.88 smears per woman in three years of time. Colposcopy was excessively used (number of Pap smears over colposcopies =3.2). The proportion of women with a history of conisation or hysterectomy, before the age of 65, was 7% and 19%, respectively. Conclusion: The screening coverage increased slightly from 59% in 2000 to 61% in 2006. The screening intensity remained at a high level, and the number of cytological examinations was theoretically sufficient to cover more than the whole target population.	[Arbyn, Marc; Simoens, Cindy] Sci Inst Publ Hlth, Canc Epidemiol Unit, Brussels, Belgium; [Fabri, Valerie] AIM, Intermutualist Agcy IMA, Brussels, Belgium; [Temmerman, Marleen] Univ Ghent, Dept Obstet & Gynaecol, B-9000 Ghent, Belgium; [Temmerman, Marleen] WHO, CH-1211 Geneva, Switzerland; [Simoens, Cindy] Univ Antwerp, Lab Cell Biol & Histol, B-2020 Antwerp, Belgium	Ghent University; World Health Organization; University of Antwerp	Arbyn, M (corresponding author), Sci Inst Publ Hlth, Canc Epidemiol Unit, Brussels, Belgium.	Marc.Arbyn@wiv-isp.be			Belgian Cancer Foundation (Brussels, Belgium); 7th Framework Programme of DG Research of the European Commission (CoheaHr Project) [603019]; FNRS (le Fonds National de la Recherche Scientific), through TELEVIE, Brussels, Belgium [7.4523.11.F]; Belgian Cancer Centre	Belgian Cancer Foundation (Brussels, Belgium); 7th Framework Programme of DG Research of the European Commission (CoheaHr Project); FNRS (le Fonds National de la Recherche Scientific), through TELEVIE, Brussels, Belgium(Fonds de la Recherche Scientifique - FNRS); Belgian Cancer Centre	Financial support was received from (1) the Belgian Cancer Foundation (Brussels, Belgium); (2) the 7th Framework Programme of DG Research of the European Commission (CoheaHr Project, coordinated by the Vrije Universiteit Amsterdam, the Netherlands, Grant number: 603019); (3) FNRS (le Fonds National de la Recherche Scientific), through TELEVIE, Brussels, Belgium (ref 7.4523.11.F); and (4) the Belgian Cancer Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, OFF J EUR UNION L, VL327, P34; ANTTILA A, 2008, EUROPEAN GUIDELINES, P11; Arbyn M, 1997, EUR J CANCER PREV, V6, P389, DOI 10.1097/00008469-199708000-00012; Arbyn M, 2000, EUR J CANCER, V36, P2191, DOI 10.1016/S0959-8049(00)00308-7; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Arbyn M., 2002, Archives of Public Health, V60, P73; Arbyn M, 2002, INT J CANCER, V102, P649, DOI 10.1002/ijc.10761; Arbyn M, 2010, ANN ONCOL, V21, P448, DOI 10.1093/annonc/mdp471; Arbyn M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1284; Arbyn M, 2011, IPH EPI REPORTS; Arbyn M, 1999, EUR J HLTH LAW, V6, P401; Arbyn M, 2011, EUR J CANCER PREV, V20, P18, DOI 10.1097/CEJ.0b013e32833ecbc6; Arbyn M, 2009, EUR J CANCER, V45, P2640, DOI 10.1016/j.ejca.2009.07.018; Arbyn M, 2009, PREV MED, V48, P438, DOI 10.1016/j.ypmed.2009.02.021; Bowman JA, 1997, SOC SCI MED, V44, P969, DOI 10.1016/S0277-9536(96)00222-5; Caplan LS, 2003, CANCER EPIDEM BIOMAR, V12, P1182; Centre for Operational Research in Public Health, 2006, STAND PROC MORT AN V; COLEMAN D, 1993, EUR J CANCER, V29A, pS1; Demarest S, 2006, HLTH INTERVIEW SURVE, P1; Desai MM, 2001, AM J EPIDEMIOL, V153, P299, DOI 10.1093/aje/153.3.299; European Commission. Directorate-General for Health and Consumer Protection. & International Agency for Research on Cancer, 2008, EUROPEAN GUIDELINES; FRUCHTER RG, 1992, NEW YORK STATE J MED, V92, P421; Habbema D, 2012, MILBANK Q, V90, P5, DOI 10.1111/j.1468-0009.2011.00652.x; International Agency for Research on Cancer (IARC), 2005, IARC HDB CANC PREV, V10, P45; Jordan J, 2008, CYTOPATHOLOGY, V19, P342, DOI 10.1111/j.1365-2303.2008.00623.x; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Klungsoyr O, 2009, J MED SCREEN, V16, P91, DOI 10.1258/jms.2009.008087; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; LAARA E, 1987, LANCET, V1, P1247; Miller AB, 2002, EUR J CANCER, V38, P321, DOI 10.1016/S0959-8049(01)00374-4; MONTANO DE, 1995, AM J PUBLIC HEALTH, V85, P795, DOI 10.2105/AJPH.85.6.795; Noehr B, 2009, OBSTET GYNECOL, V114, P1232, DOI 10.1097/AOG.0b013e3181bf1ef2; Nygard JF, 2002, J MED SCREEN, V9, P86, DOI 10.1136/jms.9.2.86; Onkelinx L, 2013, KONINKLIJK BESLUIT V, P11882; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Quinn M, 1999, BRIT MED J, V318, P904, DOI 10.1136/bmj.318.7188.904; Racey CS, 2013, CAN J PUBLIC HEALTH, V104, pE159, DOI 10.1007/BF03405681; Simoens C, 2012, BJOG-INT J OBSTET GY, V119, P1247, DOI 10.1111/j.1471-0528.2012.03429.x; Sirovich BE, 2004, JAMA-J AM MED ASSOC, V291, P2990, DOI 10.1001/jama.291.24.2990; Tjalma W, 2005, TIJDSCHR GENEESKUNDE, V61, P108; van der Aa MA, 2008, EUR J OBSTET GYN R B, V139, P204, DOI 10.1016/j.ejogrb.2007.10.017; Weyers S, 2005, TIJDSCHR GENEESKUNDE, V61, P129	42	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92615	10.1371/journal.pone.0092615	http://dx.doi.org/10.1371/journal.pone.0092615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6KM	24690620	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100029
J	Doron, R; Lotan, D; Versano, Z; Benatav, L; Franko, M; Armoza, S; Kately, N; Rehavi, M				Doron, Ravid; Lotan, Dafna; Versano, Ziv; Benatav, Layla; Franko, Motty; Armoza, Shir; Kately, Nadav; Rehavi, Moshe			Escitalopram or Novel Herbal Mixture Treatments during or following Exposure to Stress Reduce Anxiety-Like Behavior through Corticosterone and BDNF Modifications	PLOS ONE			English	Article							NEUROTROPHIC FACTOR EXPRESSION; NEONATAL MATERNAL SEPARATION; LONG-LASTING CHANGES; MOOD DISORDERS; ANIMAL-MODELS; MILD STRESS; DEPRESSION; BRAIN; MICE; MOUSE	Anxiety disorders are a major public health concern worldwide. Studies indicate that repeated exposure to adverse experiences early in life can lead to anxiety disorders in adulthood. Current treatments for anxiety disorders are characterized by a low success rate and are associated with a wide variety of side effects. The aim of the present study was to evaluate the anxiolytic effects of a novel herbal treatment, in comparison to treatment with the selective serotonin reuptake inhibitor escitalopram. We recently demonstrated the anxiolytic effects of these treatments in BALB mice previously exposed to one week of stress. In the present study, ICR mice were exposed to post natal maternal separation and to 4 weeks of unpredictable chronic mild stress in adolescence, and treated during or following exposure to stress with the novel herbal treatment or with escitalopram. Anxiety-like behavior was evaluated in the elevated plus maze. Blood corticosterone levels were evaluated using radioimmunoassay. Brain derived neurotrophic factor levels in the hippocampus were evaluated using enzyme-linked immunosorbent assay. We found that (1) exposure to stress in childhood and adolescence increased anxiety-like behavior in adulthood; (2) the herbal treatment reduced anxiety-like behavior, both when treated during or following exposure to stress; (3) blood corticosterone levels were reduced following treatment with the herbal treatment or escitalopram, when treated during or following exposure to stress; (4) brain derived neurotrophic factor levels in the hippocampus of mice treated with the herbal treatment or escitalopram were increased, when treated either during or following exposure to stress. This study expands our previous findings and further points to the proposed herbal compound's potential to be highly efficacious in treating anxiety disorders in humans.	[Doron, Ravid; Versano, Ziv; Benatav, Layla; Franko, Motty; Armoza, Shir] Acad Coll Tel Aviv Yaffo, Sch Behav Sci, Tel Aviv, Israel; [Doron, Ravid; Lotan, Dafna] Open Univ Israel, Dept Educ & Psychol, Raanana, Israel; [Doron, Ravid] Hadassah Acad Coll, Sch Hlth & Life Sci, Jerusalem, Israel; [Lotan, Dafna] Sch Psychol Sci, Tel Aviv, Israel; [Lotan, Dafna] Sagol Sch Neurosci, Tel Aviv, Israel; [Kately, Nadav] Tel Aviv Univ, IL-69978 Tel Aviv, Israel; [Versano, Ziv; Armoza, Shir; Rehavi, Moshe] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Rehavi, Moshe] Tel Aviv Univ, Sackler Fac Med, Dr Miriam & Sheldon G Adelson Chair Biol Addict D, IL-69978 Tel Aviv, Israel	Open University Israel; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Doron, R (corresponding author), Acad Coll Tel Aviv Yaffo, Sch Behav Sci, Tel Aviv, Israel.	raviddor@mta.ac.il			Israel Science Foundation [ISF 738/11]; National Institute for Psychobiology in Israel [NIPI-7-2011-12]; Open University foundation	Israel Science Foundation(Israel Science Foundation); National Institute for Psychobiology in Israel; Open University foundation	This work was funded by the Israel Science Foundation (http://www.isf.org.il/english/ [ISF 738/11]), by the National Institute for Psychobiology in Israel (http://www.psychobiology.org.il/ [NIPI-7-2011-12]), and by the Open University foundation. No individuals employed or contracted by the funders (other than the named authors) played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avital A, 2005, INT J NEUROPSYCHOPH, V8, P163, DOI 10.1017/S1461145704004808; Avitsur R, 2006, BRAIN BEHAV IMMUN, V20, P339, DOI 10.1016/j.bbi.2005.09.006; Baker-Herman TL, 2004, NAT NEUROSCI, V7, P48, DOI 10.1038/nn1166; Baldwin DS, 2011, INT J NEUROPSYCHOPH, V14, P697, DOI 10.1017/S1461145710001434; Barbui C, 2009, EVID-BASED MENT HEAL, V12, P79, DOI 10.1136/ebmh.12.3.79; Buhl ES, 2010, AM J PHYSIOL-ENDOC M, V298, pE920, DOI 10.1152/ajpendo.00606.2009; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Culpepper L, 2002, J CLIN PSYCHIAT, V63, P35; De Bellis MD, 2005, CHILD ADOL PSYCH CL, V14, P745, DOI 10.1016/j.chc.2005.05.006; Dording Christina M, 2002, Ann Clin Psychiatry, V14, P143, DOI 10.1023/A:1021137118956; Doron R, 2014, LIFE SCI, V94, P151, DOI 10.1016/j.lfs.2013.10.025; Doron R, 2012, LIFE SCI, V90, P995, DOI 10.1016/j.lfs.2012.05.014; Ducottet C, 2004, PHYSIOL BEHAV, V81, P417, DOI 10.1016/j.physbeh.2004.01.013; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Dwivedi Y, 2006, NEUROSCIENCE, V139, P1017, DOI 10.1016/j.neuroscience.2005.12.058; File SE, 2001, BEHAV BRAIN RES, V125, P151, DOI 10.1016/S0166-4328(01)00292-3; Frielingsdorf H, 2010, ANN NY ACAD SCI, V1208, P150, DOI 10.1111/j.1749-6632.2010.05722.x; Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Heim C, 1997, ANN NY ACAD SCI, V821, P194, DOI 10.1111/j.1749-6632.1997.tb48279.x; Ihne JL, 2012, NEUROPHARMACOLOGY, V62, P464, DOI 10.1016/j.neuropharm.2011.08.045; Kalinichev M, 2002, PHARMACOL BIOCHEM BE, V73, P131, DOI 10.1016/S0091-3057(02)00781-5; Katzman MA, 2009, CNS DRUGS, V23, P103, DOI 10.2165/00023210-200923020-00002; Lang UE, 2005, PSYCHOPHARMACOLOGY, V180, P95, DOI 10.1007/s00213-004-2137-7; Larsen MH, 2010, J PSYCHIATR RES, V44, P808, DOI 10.1016/j.jpsychires.2010.01.005; Lee TTY, 2012, NEUROSCIENCE, V204, P17, DOI 10.1016/j.neuroscience.2011.10.006; Lenze EJ, 2011, AM J GERIAT PSYCHIAT, V19, P482, DOI 10.1097/JGP.0b013e3181ec806c; Linde K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000448.pub3; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Maayan R, 2006, EUR NEUROPSYCHOPHARM, V16, P329, DOI 10.1016/j.euroneuro.2005.10.002; Mantella RC, 2008, PSYCHONEUROENDOCRINO, V33, P773, DOI 10.1016/j.psyneuen.2008.03.002; Marco EM, 2012, NEUROPHARMACOLOGY; Middeldorp CM, 2010, GENES BRAIN BEHAV, V9, P808, DOI 10.1111/j.1601-183X.2010.00619.x; Millstein RA, 2007, NEUROSCI BIOBEHAV R, V31, P3, DOI 10.1016/j.neubiorev.2006.05.003; Muller WE, 1997, PHARMACOPSYCHIATRY, V30, P102, DOI 10.1055/s-2007-979528; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Panossian A, 1999, PHYTOMEDICINE, V6, P147, DOI 10.1016/S0944-7113(99)80002-6; Reinhold JA, 2011, EXPERT OPIN PHARMACO, V12, P2457, DOI 10.1517/14656566.2011.618496; Roceri M, 2004, BIOL PSYCHIAT, V55, P708, DOI 10.1016/j.biopsych.2003.12.011; Romeo RD, 2003, HORM BEHAV, V43, P561, DOI 10.1016/S0018-506X(03)00063-1; Sanchez C, 2003, PSYCHOPHARMACOLOGY, V167, P353, DOI 10.1007/s00213-002-1364-z; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Sarris J, 2009, J ALTERN COMPLEM MED, V15, P827, DOI 10.1089/acm.2009.0066; Scheid Volker, 2009, CHINESE HERBAL MED F, V2nd; Schmidt MV, 2007, PSYCHONEUROENDOCRINO, V32, P417, DOI 10.1016/j.psyneuen.2007.02.011; Simmen U, 1999, J RECEPT SIGNAL TR R, V19, P59, DOI 10.3109/10799899909036637; Slotten HA, 2006, BRAIN RES, V1097, P123, DOI 10.1016/j.brainres.2006.04.066; Tamaji A, 2012, HUM PSYCHOPHARM CLIN, V27, P329, DOI 10.1002/hup.2220; Thase ME, 2006, EXPERT OPIN PHARMACO, V7, P429, DOI 10.1517/14656566.7.4.429; Tsoory M, 2007, EUR NEUROPSYCHOPHARM, V17, P245, DOI 10.1016/j.euroneuro.2006.06.007; Vermetten E, 2006, ANN NY ACAD SCI, V1071, P184, DOI 10.1196/annals.1364.014; Vreeburg SA, 2010, PSYCHOSOM MED, V72, P340, DOI 10.1097/PSY.0b013e3181d2f0c8; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Witte S, 2005, PHYTOTHER RES, V19, P183, DOI 10.1002/ptr.1609	56	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e91455	10.1371/journal.pone.0091455	http://dx.doi.org/10.1371/journal.pone.0091455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690945	Green Submitted, Green Published, gold			2022-12-27	WOS:000334101100015
J	Hansen, DS; Ryg-Cornejo, V; Ioannidis, LJ; Chiu, CY; Ly, A; Nie, CQ; Scalzo, AA; Schofield, L				Hansen, Diana S.; Ryg-Cornejo, Victoria; Ioannidis, Lisa J.; Chiu, Chris Y.; Ly, Ann; Nie, Catherine Q.; Scalzo, Anthony A.; Schofield, Louis			The Contribution of Natural Killer Complex Loci to the Development of Experimental Cerebral Malaria	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; TUMOR-NECROSIS-FACTOR; ENHANCED VASCULAR-PERMEABILITY; NK CELL ACTIVATION; IFN-GAMMA; T-CELLS; GENE-COMPLEX; INFECTED ERYTHROCYTES; INTERFERON-GAMMA; DENDRITIC CELLS	Background: The Natural Killer Complex (NKC) is a genetic region of highly linked genes encoding several receptors involved in the control of NK cell function. The NKC is highly polymorphic and allelic variability of various NKC loci has been demonstrated in inbred mice, providing evidence for NKC haplotypes. Using BALB.B6-Cmv1(r) congenic mice, in which NKC genes from C57BL/6 mice were introduced into the BALB/c background, we have previously shown that the NKC is a genetic determinant of malarial pathogenesis. C57BL/6 alleles are associated with increased disease-susceptibility as BALB.B6-Cmv1(r) congenic mice had increased cerebral pathology and death rates during P. berghei ANKA infection than cerebral malaria-resistant BALB/c controls. Methods: To investigate which regions of the NKC are involved in susceptibility to experimental cerebral malaria (ECM), intra-NKC congenic mice generated by backcrossing recombinant F2 progeny from a (BALB/c x BALB.B6-Cmv1(r)) F1 intercross to BALB/c mice were infected with P. berghei ANKA. Results: Our results revealed that C57BL/6 alleles at two locations in the NKC contribute to the development of ECM. The increased severity to severe disease in intra-NKC congenic mice was not associated with higher parasite burdens but correlated with a significantly enhanced systemic IFN-gamma response to infection and an increased recruitment of CD8(+) T cells to the brain of infected animals. Conclusions: Polymorphisms within the NKC modulate malarial pathogenesis and acquired immune responses to infection.	[Hansen, Diana S.; Ryg-Cornejo, Victoria; Ioannidis, Lisa J.; Chiu, Chris Y.; Ly, Ann; Schofield, Louis] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Nie, Catherine Q.] Burnet Inst, Melbourne, Vic, Australia; [Ryg-Cornejo, Victoria; Chiu, Chris Y.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Scalzo, Anthony A.] Lions Eye Inst, Ctr Expt Immunol, Nedlands, WA, Australia; [Scalzo, Anthony A.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Nedlands, WA 6009, Australia; [Schofield, Louis] James Cook Univ, Australian Inst Trop Hlth & Med, Douglas, Qld, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Burnet Institute; University of Melbourne; Lions Eye Institute; University of Western Australia; University of Western Australia; James Cook University	Hansen, DS (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	hansen@wehi.edu.au		Chiu, Yu Ho Chris/0000-0002-5380-1114	 [1031212]		This work was made possible through Victorian State Government Operational Infrastructure Support, Australian Government National Health and Medical Research Council IRIISS, and Project Grant 1031212. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amani V, 2000, EUR J IMMUNOL, V30, P1646, DOI 10.1002/1521-4141(200006)30:6&lt;1646::AID-IMMU1646&gt;3.0.CO;2-0; Arase H, 1996, J EXP MED, V183, P2391, DOI 10.1084/jem.183.5.2391; Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Artavanis-Tsakonas K, 2003, J IMMUNOL, V171, P5396, DOI 10.4049/jimmunol.171.10.5396; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Baratin M, 2005, P NATL ACAD SCI USA, V102, P14747, DOI 10.1073/pnas.0507355102; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Brown MG, 2001, IMMUNOGENETICS, V53, P584, DOI 10.1007/s002510100365; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; D'Ombrain MC, 2007, EUR J IMMUNOL, V37, P1864, DOI 10.1002/eji.200636889; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; El-Assaad F, 2013, INFECT IMMUN, V81, P3984, DOI 10.1128/IAI.00428-13; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; GRAU GE, 1989, P NATL ACAD SCI USA, V86, P5572, DOI 10.1073/pnas.86.14.5572; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; Hansen DS, 2007, CURR OPIN IMMUNOL, V19, P416, DOI 10.1016/j.coi.2007.07.011; Hansen DS, 2007, J IMMUNOL, V178, P5779, DOI 10.4049/jimmunol.178.9.5779; Hansen DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003045; Hansen DS, 2003, IMMUNITY, V18, P391, DOI 10.1016/S1074-7613(03)00052-9; Hansen DS, 2005, INFECT IMMUN, V73, P2288, DOI 10.1128/IAI.73.4.2288-2297.2005; Ho EL, 2002, J IMMUNOL, V169, P3667, DOI 10.4049/jimmunol.169.7.3667; HO M, 1995, J INFECT DIS, V172, P838, DOI 10.1093/infdis/172.3.838; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Ing R, 2009, INFECT IMMUN, V77, P770, DOI 10.1128/IAI.00994-08; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; Koch O, 2002, J INFECT DIS, V185, P1684, DOI 10.1086/340516; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; Ma NL, 1996, AM J PATHOL, V149, P1745; Mason LH, 2000, J IMMUNOL, V164, P603, DOI 10.4049/jimmunol.164.2.603; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Miu J, 2008, J IMMUNOL, V180, P1217, DOI 10.4049/jimmunol.180.2.1217; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nie CQ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000369; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; Ochiel DO, 2005, INFECT IMMUN, V73, P4190, DOI 10.1128/IAI.73.7.4190-4197.2005; PATNAIK JK, 1994, AM J TROP MED HYG, V51, P642, DOI 10.4269/ajtmh.1994.51.642; PORTA J, 1993, CLIN NEUROPATHOL, V12, P142; RINGWALD P, 1991, J CLIN MICROBIOL, V29, P2076, DOI 10.1128/JCM.29.9.2076-2078.1991; Ryg-Cornejo V, 2013, IMMUNOBIOLOGY, V218, P263, DOI 10.1016/j.imbio.2012.05.018; Scalzo AA, 1999, IMMUNOGENETICS, V49, P238, DOI 10.1007/s002510050486; SCALZO AA, 1995, GENOMICS, V27, P435, DOI 10.1006/geno.1995.1074; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Trowsdale J, 2001, IMMUNITY, V15, P363, DOI 10.1016/S1074-7613(01)00197-2; WHITE NJ, 1992, ADV PARASIT, V31, P83, DOI 10.1016/S0065-308X(08)60021-4; Yanez DM, 1996, J IMMUNOL, V157, P1620; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055	49	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93268	10.1371/journal.pone.0093268	http://dx.doi.org/10.1371/journal.pone.0093268			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691125	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100059
J	Wang, XL; Wang, YJ; Huang, H; Chen, BY; Chen, XJ; Hu, JD; Chang, T; Lin, RJ; Yee, JK				Wang, Xiaoling; Wang, Yingjia; Huang, He; Chen, Buyuan; Chen, Xinji; Hu, Jianda; Chang, Tammy; Lin, Ren-Jang; Yee, Jiing-Kuan			Precise Gene Modification Mediated by TALEN and Single-Stranded Oligodeoxynucleotides in Human Cells	PLOS ONE			English	Article							DNA-BINDING SPECIFICITY; EFFECTOR NUCLEASES; HUMAN HEPATOCYTES; STEM-CELLS; OLIGONUCLEOTIDES; REPAIR; DIFFERENTIATION; RECOMBINATION; RECOGNITION; DISRUPTION	The development of human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) facilitates in vitro studies of human disease mechanisms, speeds up the process of drug screening, and raises the feasibility of using cell replacement therapy in clinics. However, the study of genotype-phenotype relationships in ESCs or iPSCs is hampered by the low efficiency of site-specific gene editing. Transcription activator-like effector nucleases (TALENs) spurred interest due to the ease of assembly, high efficiency and faithful gene targeting. In this study, we optimized the TALEN design to maximize its genomic cutting efficiency. We showed that using optimized TALENs in conjunction with single-strand oligodeoxynucleotide (ssODN) allowed efficient gene editing in human cells. Gene mutations and gene deletions for up to 7.8 kb can be accomplished at high efficiencies. We established human tumor cell lines and H9 ESC lines with homozygous deletion of the microRNA-21 (miR-21) gene and miR-9-2 gene. These cell lines provide a robust platform to dissect the roles these genes play during cell differentiation and tumorigenesis. We also observed that the endogenous homologous chromosome can serve as a donor template for gene editing. Overall, our studies demonstrate the versatility of using ssODN and TALEN to establish genetically modified cells for research and therapeutic application.	[Wang, Xiaoling; Wang, Yingjia; Chang, Tammy; Yee, Jiing-Kuan] Beckman Res Inst City Hope, Dept Virol, Duarte, CA 91010 USA; [Chen, Buyuan; Chen, Xinji; Lin, Ren-Jang] Beckman Res Inst City Hope, Dept Mol & Cellular Biol, Duarte, CA USA; [Wang, Yingjia; Huang, He] Zhejiang Univ, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Buyuan; Chen, Xinji; Hu, Jianda] Fujian Med Univ, Union Hosp, Dept Hematol, Fuzhou, Fujian, Peoples R China	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Zhejiang University; Fujian Medical University	Yee, JK (corresponding author), Beckman Res Inst City Hope, Dept Virol, Duarte, CA 91010 USA.	JYee@coh.org	Lin, Ren-Jang/G-2052-2014	Lin, Ren-Jang/0000-0002-2738-2438	California Institute of Regenerative Medicine [RB3-02161]; Nesvig Foundation; Beckman Research Institute Excellence Award; National Natural Science Foundation of China; Zhejiang Provincial Natural Science Foundation of China; Zhejiang Provincial Major Science and Technology Project; China Scholarship Council; P.R.C. National and Fujian Provincial Key Clinical Specialty Discipline Construction Program	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Nesvig Foundation; Beckman Research Institute Excellence Award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Major Science and Technology Project; China Scholarship Council(China Scholarship Council); P.R.C. National and Fujian Provincial Key Clinical Specialty Discipline Construction Program	This work is supported by grant RB3-02161 from California Institute of Regenerative Medicine to JKY, grants from Nesvig Foundation and Beckman Research Institute Excellence Award to RJL. YJW was supported by grants from National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China, Zhejiang Provincial Major Science and Technology Project and China Scholarship Council. BC and XC were supported in part by the P.R.C. National and Fujian Provincial Key Clinical Specialty Discipline Construction Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2010, NUCLEIC ACIDS RES, V38, P6956, DOI 10.1093/nar/gkq589; Andrieu-Soler C, 2005, NUCLEIC ACIDS RES, V33, P3733, DOI 10.1093/nar/gki686; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; CAMPBELL C R, 1989, New Biologist, V1, P223; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Chen SJ, 2013, NUCLEIC ACIDS RES, V41, P2769, DOI 10.1093/nar/gks1356; Cho S. W., 2013, GENOME RES; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Dajas-Bailador F, 2012, NAT NEUROSCI, V15, P697, DOI 10.1038/nn.3082; De Preter K, 2002, MODERN PATHOL, V15, P159, DOI 10.1038/modpathol.3880508; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Dvorak Z, 2003, MOL PHARMACOL, V64, P160, DOI 10.1124/mol.64.1.160; Fine E.J., 2013, NUCL ACIDS RES; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gandhi M, 2012, P NATL ACAD SCI USA, V109, P9454, DOI 10.1073/pnas.1205759109; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hu RZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063074; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Igoucheva O, 2006, OLIGONUCLEOTIDES, V16, P94, DOI 10.1089/oli.2006.16.94; Igoucheva O, 2008, OLIGONUCLEOTIDES, V18, P111, DOI 10.1089/oli.2008.0120; Laneve P, 2010, NUCLEIC ACIDS RES, V38, P6895, DOI 10.1093/nar/gkq604; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Papaioannou I, 2009, J GENE MED, V11, P267, DOI 10.1002/jgm.1296; Park J, 2013, NAT STRUCT MOL BIOL; Radecke S, 2006, J GENE MED, V8, P217, DOI 10.1002/jgm.828; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Shibata M, 2008, J NEUROSCI, V28, P10415, DOI 10.1523/JNEUROSCI.3219-08.2008; Shibata M, 2011, J NEUROSCI, V31, P3407, DOI 10.1523/JNEUROSCI.5085-10.2011; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Takada S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076004; Tong C, 2012, J GENET GENOMICS, V39, P275, DOI 10.1016/j.jgg.2012.04.004; Uchida N, 2010, CELL STEM CELL, V6, P294, DOI 10.1016/j.stem.2010.03.010; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wefers B, 2013, P NATL ACAD SCI USA, V110, P3782, DOI 10.1073/pnas.1218721110; Yuva-Aydemir Y, 2011, RNA BIOL, V8, P557, DOI 10.4161/rna.8.4.16019	62	52	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93575	10.1371/journal.pone.0093575	http://dx.doi.org/10.1371/journal.pone.0093575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691488	gold, Green Published			2022-12-27	WOS:000334101100106
J	Cavaco-Silva, J; Abecasis, A; Miranda, AC; Pocas, J; Narciso, J; Aguas, MJ; Maltez, F; Almeida, I; Germano, I; Diniz, A; Goncalves, MDF; Gomes, P; Cunha, C; Camacho, RJ				Cavaco-Silva, Joana; Abecasis, Ana; Miranda, Ana Claudia; Pocas, Jose; Narciso, Jorge; Aguas, Maria Joao; Maltez, Fernando; Almeida, Isabel; Germano, Isabel; Diniz, Antonio; de Fatima Goncalves, Maria; Gomes, Perpetua; Cunha, Celso; Camacho, Ricardo Jorge		Portuguese HIV-2 Resistance Study	HIV-2 Integrase Polymorphisms and Longitudinal Genotypic Analysis of HIV-2 Infected Patients Failing a Raltegravir-Containing Regimen	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VITRO PHENOTYPIC SUSCEPTIBILITY; MULTIPLE SEQUENCE ALIGNMENT; CARBOXYL-TERMINAL DOMAINS; DNA-BINDING REGION; RESISTANCE MUTATIONS; DRUG-RESISTANCE; VIRAL FITNESS; CORE DOMAIN; PROTEIN	To characterize the HIV-2 integrase gene polymorphisms and the pathways to resistance of HIV-2 patients failing a raltegravir-containing regimen, we studied 63 integrase strand transfer inhibitors (INSTI)-naive patients, and 10 heavily pretreated patients exhibiting virological failure while receiving a salvage raltegravir-containing regimen. All patients were infected by HIV-2 group A. 61.4% of the integrase residues were conserved, including the catalytic motif residues. No INSTI-major resistance mutations were detected in the virus population from naive patients, but two amino acids that are secondary resistance mutations to INSTIs in HIV-1 were observed. The 10 raltegravir-experienced patients exhibited resistance mutations via three main genetic pathways: N155H, Q148R, and eventually E92Q - T97A. The 155 pathway was preferentially used (7/10 patients). Other mutations associated to raltegravir resistance in HIV-1 were also observed in our HIV-2 population (V151I and D232N), along with several novel mutations previously unreported. Data retrieved from this study should help build a more robust HIV-2-specific algorithm for the genotypic interpretation of raltegravir resistance, and contribute to improve the clinical monitoring of HIV-2-infected patients.	[Cavaco-Silva, Joana; Cunha, Celso] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol Med, Ctr Malaria & Outras Doencas Tropicais, P-1200 Lisbon, Portugal; [Abecasis, Ana] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Saude Publ Int & Bioestat, Ctr Malaria & Outras Doencas Tropicais, P-1200 Lisbon, Portugal; [Miranda, Ana Claudia] Ctr Hosp Lisboa Ocidental, Serv Doencas Infecciosas, Lisbon, Portugal; [Pocas, Jose] Ctr Hosp Setubal, Hosp Sao Bernardo, Setubal, Portugal; [Narciso, Jorge] Hosp SAMS, Lisbon, Portugal; [Aguas, Maria Joao] Hosp Garcia de Orta, Almada, Portugal; [Maltez, Fernando] Ctr Hosp Lisboa Cent, Hosp Curry Cabral, Lisbon, Portugal; [Almeida, Isabel] Ctr Hosp Porto, Hosp Santo Antonio, Oporto, Portugal; [Germano, Isabel] Ctr Hosp Lisboa Cent, Hosp Sao Jose, Lisbon, Portugal; [Diniz, Antonio] Ctr Hosp Lisboa Norte, Hosp Pulido Valente, Lisbon, Portugal; [de Fatima Goncalves, Maria; Gomes, Perpetua] Ctr Hosp Lisboa Ocidental, Serv Patol Clin SPC, Lab Microbiol Clin & Biol Mol, Lisbon, Portugal; [Gomes, Perpetua; Camacho, Ricardo Jorge] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Tropicais, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal; [Gomes, Perpetua] Inst Super Ciencias Saude Sul, Ctr Invest Interdisciplinar Egas Moniz CiiEM, Caparica, Portugal; [Camacho, Ricardo Jorge] Katholieke Univ Leuven KU Leuven, Rega Inst Med Res, Leuven, Belgium	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Centro Hospitalar de Lisboa Ocidental, EPE; Universidade de Lisboa; Hospital Garcia de Orta; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; Universidade de Lisboa; Centro Hospitalar de Lisboa Ocidental, EPE; Universidade de Lisboa; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Instituto Superior de Ciencias da Saude Egas Moniz; KU Leuven	Cavaco-Silva, J (corresponding author), Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol Med, Ctr Malaria & Outras Doencas Tropicais, P-1200 Lisbon, Portugal.	jo.cvsilva@gmail.com	Abecasis, Ana/B-6295-2009; Cunha, Celso/I-2371-2012; Abecasis, Ana/ABF-6657-2020; Gomes, Perpetua/I-5652-2012; Camacho, Ricardo J/I-7629-2012	Abecasis, Ana/0000-0002-3903-5265; Cunha, Celso/0000-0003-4745-3819; Abecasis, Ana/0000-0002-3903-5265; Gomes, Perpetua/0000-0003-3271-8255; Camacho, Ricardo J/0000-0002-9129-3237; Almeida, Isabel/0000-0002-8867-1540; Vasconcelos, Carlos/0000-0002-8073-5028	Merck & Co., Inc., Whitehouse Station, N.J., USA; European Commission [223131]; Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/61141/2009]	Merck & Co., Inc., Whitehouse Station, N.J., USA(Merck & Company); European Commission(European CommissionEuropean Commission Joint Research Centre); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by a research grant from Merck & Co., Inc., Whitehouse Station, N.J., USA, and by the European Commission's Seventh Framework Programme (FP7/2007-2013) under the project "Collaborative HIV and Anti-HIV Drug Resistance Network" (CHAIN, grant 223131). J.C.-S. was supported by Fundacao para a Ciencia e Tecnologia (FCT) with a PhD grant no. SFRH/BD/61141/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram ME, 2013, ANTIMICROB AGENTS CH, V57, P2654, DOI 10.1128/AAC.02568-12; Appa RS, 2001, J BIOL CHEM, V276, P45848, DOI 10.1074/jbc.M107365200; Armstrong-James D, 2010, ANTIVIR RES, V86, P224, DOI 10.1016/j.antiviral.2010.02.324; Bercoff DP, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-98; Borrego P, 2012, ANTIVIR THER, V17, P565, DOI 10.3851/IMP1996; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; Buzon MJ, 2008, ANTIVIR THER, V13, P881; Ceccherini-Silberstein F, 2010, J ANTIMICROB CHEMOTH, V65, P2305, DOI 10.1093/jac/dkq326; Ceccherini-Silberstein F, 2009, AIDS REV, V11, P17; Charpentier C, 2011, ANTIVIR THER, V16, P937, DOI 10.3851/IMP1826; Charpentier C, 2011, ANTIMICROB AGENTS CH, V55, P1293, DOI 10.1128/AAC.00942-10; Charpentier C, 2010, AIDS, V24, P2753, DOI 10.1097/QAD.0b013e32833f9e36; Colson P, 2004, J CLIN MICROBIOL, V42, P570, DOI 10.1128/JCM.42.2.570-577.2004; Damond F, 2008, AIDS, V22, P665, DOI 10.1097/QAD.0b013e3282f51203; Dar MJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-94; de Silva TI, 2008, TRENDS MICROBIOL, V16, P588, DOI 10.1016/j.tim.2008.09.003; DeAnda F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077448; Departamento de Doencas Infecciosas do INSA. Unidade de Referencia e Vigilancia Laboratorial Epidemiologica. Nucleo de Vigilancia Laboratorial de Doencas Infecciosas, 2013, 144 SIDA DEP DOENC I; Desbois D, 2008, ANTIMICROB AGENTS CH, V52, P1545, DOI 10.1128/AAC.01284-07; DRELICH M, 1992, VIROLOGY, V188, P459, DOI 10.1016/0042-6822(92)90499-F; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ENGELMAN A, 1994, J VIROL, V68, P5911, DOI 10.1128/JVI.68.9.5911-5917.1994; ENGELMAN A, 1992, J VIROL, V66, P6361, DOI 10.1128/JVI.66.11.6361-6369.1992; Eron JJ, 2013, J INFECT DIS, V207, P740, DOI 10.1093/infdis/jis750; Esposito D, 1999, ADV VIRUS RES, V52, P319, DOI 10.1016/S0065-3527(08)60304-8; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Fransen S, 2009, ANTIMICROB AGENTS CH, V53, P4522, DOI 10.1128/AAC.00651-09; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Garrett N, 2008, AIDS, V22, P1091, DOI 10.1097/QAD.0b013e3282f9b165; Gerton JL, 1997, J BIOL CHEM, V272, P25809, DOI 10.1074/jbc.272.41.25809; Gomes P, 2009, ALGORITHM INTERPRETA; Gottlieb GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022204; Hansmann A, 2005, JAIDS-J ACQ IMM DEF, V38, P335; Harper AL, 2001, J VIROL, V75, P7756, DOI 10.1128/JVI.75.16.7756-7762.2001; HICKMAN AB, 1994, J BIOL CHEM, V269, P29279; Hu ZX, 2010, JAIDS-J ACQ IMM DEF, V55, P148, DOI 10.1097/QAI.0b013e3181e9a87a; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Buzon MJ, 2010, AIDS, V24, P17, DOI 10.1097/QAD.0b013e328331c81e; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; Lataillade M, 2007, ANTIVIR THER, V12, P563; Lee SP, 1997, BIOCHEMISTRY-US, V36, P173, DOI 10.1021/bi961849o; Low A, 2009, ANTIMICROB AGENTS CH, V53, P4275, DOI 10.1128/AAC.00397-09; Malet I, 2008, ANTIMICROB AGENTS CH, V52, P1351, DOI 10.1128/AAC.01228-07; Malet I, 2009, J ANTIMICROB CHEMOTH, V63, P795, DOI 10.1093/jac/dkp014; Matheron S, 2006, AIDS, V20, P459, DOI 10.1097/01.aids.0000199829.57112.2f; McColl DJ, 2007, ANTIVIR THER, V12, pS11; Mesplede T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-22; Ni XJ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-68; Ntemgwa M, 2007, ANTIMICROB AGENTS CH, V51, P604, DOI 10.1128/AAC.00870-06; Poveda E, 2004, AIDS RES HUM RETROV, V20, P347, DOI 10.1089/088922204322996590; Quashie PK, 2012, J VIROL, V86, P2696, DOI 10.1128/JVI.06591-11; Rodes B, 2006, J ANTIMICROB CHEMOTH, V57, P709, DOI 10.1093/jac/dkl034; Rodes B, 2006, AIDS, V20, P127, DOI 10.1097/01.aids.0000196171.35056.6c; Roquebert B, 2008, J ANTIMICROB CHEMOTH, V62, P914, DOI 10.1093/jac/dkn335; Roquebert B, 2008, AIDS, V22, P2045, DOI 10.1097/QAD.0b013e32830f4c7d; Salgado M, 2009, J CLIN VIROL, V46, P173, DOI 10.1016/j.jcv.2009.06.020; Smith RA, 2011, AIDS, V25, P2235, DOI 10.1097/QAD.0b013e32834d8e52; Smith RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045372; Smith RA, 2009, J INFECT DIS, V199, P1323, DOI 10.1086/597802; Trevino A, 2011, J ANTIMICROB CHEMOTH, V66, P1484, DOI 10.1093/jac/dkr164; Tuaillon E, 2004, JAIDS-J ACQ IMM DEF, V37, P1543, DOI 10.1097/00126334-200412150-00001; *UNAIDS, 2006, AIDS EP UPD DEC 2006; van Rossum Guido, 2011, PYTHON LANGUAGE WEBS; VANGENT DC, 1992, P NATL ACAD SCI USA, V89, P9598, DOI 10.1073/pnas.89.20.9598; VINK C, 1993, NUCLEIC ACIDS RES, V21, P1419, DOI 10.1093/nar/21.6.1419; Wandeler G, 2011, AIDS, V25, P2306, DOI 10.1097/QAD.0b013e32834cdb89; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Witvrouw M, 2004, ANTIVIR THER, V9, P57; WOERNER AM, 1993, NUCLEIC ACIDS RES, V21, P3507, DOI 10.1093/nar/21.15.3507; Xu L, 2008, AIDS RES HUM RETROV, V24, P1003, DOI 10.1089/aid.2007.0303; Xu L, 2009, AIDS RES HUM RETROV, V25, P843, DOI 10.1089/aid.2009.0039; Zheng RL, 1996, P NATL ACAD SCI USA, V93, P13659, DOI 10.1073/pnas.93.24.13659	75	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92747	10.1371/journal.pone.0092747	http://dx.doi.org/10.1371/journal.pone.0092747			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681625	Green Published, gold, Green Submitted			2022-12-27	WOS:000333678100015
J	Furubayashi, M; Ikezumi, M; Kajiwara, J; Iwasaki, M; Fujii, A; Li, L; Saito, K; Umeno, D				Furubayashi, Maiko; Ikezumi, Mayu; Kajiwara, Jun; Iwasaki, Miki; Fujii, Akira; Li, Ling; Saito, Kyoichi; Umeno, Daisuke			A High-Throughput Colorimetric Screening Assay for Terpene Synthase Activity Based on Substrate Consumption	PLOS ONE			English	Article							SESQUITERPENE CYCLASE; DIRECTED MUTAGENESIS; DIPHOSPHATE SYNTHASE; TAXADIENE SYNTHASE; PSEUDOMATURE FORM; ESCHERICHIA-COLI; GENE FAMILY; BIOSYNTHESIS; EXPRESSION; EVOLUTION	Terpene synthases catalyze the formation of a variety of terpene chemical structures. Systematic mutagenesis studies have been effective in providing insights into the characteristic and complex mechanisms of C-C bond formations and in exploring the enzymatic potential for inventing new chemical structures. In addition, there is growing demand to increase terpene synthase activity in heterologous hosts, given the maturation of metabolic engineering and host breeding for terpenoid synthesis. We have developed a simple screening method for the cellular activities of terpene synthases by scoring their substrate consumption based on the color loss of the cell harboring carotenoid pathways. We demonstrate that this method can be used to detect activities of various terpene synthase or prenyltransferase genes in a high-throughput manner, irrespective of the product type, enabling the mutation analysis and directed evolution of terpene synthases. We also report the possibility for substrate-specific screening system of terpene synthases by taking advantage of the substrate-size specificity of C-30 and C-40 carotenoid pathways.	[Furubayashi, Maiko; Ikezumi, Mayu; Kajiwara, Jun; Iwasaki, Miki; Fujii, Akira; Li, Ling; Saito, Kyoichi; Umeno, Daisuke] Chiba Univ, Dept Appl Chem & Biotechnol, Chiba, Japan; [Umeno, Daisuke] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan	Chiba University; Japan Science & Technology Agency (JST)	Umeno, D (corresponding author), Chiba Univ, Dept Appl Chem & Biotechnol, Chiba, Japan.	umeno@faculty.chiba-u.jp	Furubayashi, Maiko/E-1457-2011; Li, Ling/F-9769-2018	Furubayashi, Maiko/0000-0001-5215-523X; Li, Ling/0000-0003-2192-4678	JSPS; PRESTO (JST); MEXT/JSPS [23108507]; Mishima-Kaiun Memorial Foundation; Futaba Electronics Memorial Foundation; Shorai Foundation for Science and Technology	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); PRESTO (JST)(Japan Science & Technology Agency (JST)); MEXT/JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mishima-Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Futaba Electronics Memorial Foundation; Shorai Foundation for Science and Technology	M.F. is supported by a JSPS fellowship for young scientists. D.U. is supported by the PRESTO (JST) and the MEXT/JSPS Grant-in-Aid for Scientific Research on Innovative Areas 23108507, Biosynthetic Machinery. This work have been financially supported by the Mishima-Kaiun Memorial Foundation, the Futaba Electronics Memorial Foundation, and the Shorai Foundation for Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony JR, 2009, METAB ENG, V11, P13, DOI 10.1016/j.ymben.2008.07.007; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Austin MB, 2008, NAT CHEM BIOL, V4, P217, DOI 10.1038/nchembio0408-217; Bar-Even A, 2013, CURR OPIN BIOTECH, V24, P310, DOI 10.1016/j.copbio.2012.10.006; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Burke C, 2002, ARCH BIOCHEM BIOPHYS, V405, P130, DOI 10.1016/S0003-9861(02)00335-1; Cane D.E., 1999, COMPR NAT PROD CHEM, V2, P155, DOI [10.1016/B978-0-08-091283-7.00039-4, DOI 10.1016/B978-0-08-091283-7.00039-4]; Cane DE, 2000, ARCH BIOCHEM BIOPHYS, V376, P354, DOI 10.1006/abbi.2000.1734; Chen APC, 2005, BIOCHEM J, V386, P169, DOI 10.1042/BJ20040785; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Christianson DW, 2008, CURR OPIN CHEM BIOL, V12, P141, DOI 10.1016/j.cbpa.2007.12.008; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; CUNNINGHAM FX, 1994, PLANT CELL, V6, P1107, DOI 10.1105/tpc.6.8.1107; Diaz JE, 2011, PROTEIN SCI, V20, P1597, DOI 10.1002/pro.691; Dudareva N, 2003, PLANT CELL, V15, P1227, DOI 10.1105/tpc.011015; Dumelin CE, 2012, NAT CHEM BIOL, V8, P913, DOI [10.1038/nchembio.1070, 10.1038/NCHEMBIO.1070]; FACCHINI PJ, 1992, P NATL ACAD SCI USA, V89, P11088, DOI 10.1073/pnas.89.22.11088; Furubayashi M, 2014, FEBS LETT, V588, P436, DOI 10.1016/j.febslet.2013.12.003; Huang QL, 2000, TETRAHEDRON LETT, V41, P9701, DOI 10.1016/S0040-4039(00)01733-0; Iijima Y, 2004, PLANT PHYSIOL, V134, P370, DOI 10.1104/pp.103.032946; Kirby J, 2009, ANNU REV PLANT BIOL, V60, P335, DOI 10.1146/annurev.arplant.043008.091955; Kotera I, 2008, J BIOTECHNOL, V137, P1, DOI 10.1016/j.jbiotec.2008.07.1816; Lange BM, 2013, PLANT BIOTECHNOL J, V11, P169, DOI 10.1111/pbi.12022; Lauchli R, 2013, ANGEW CHEM INT EDIT, V52, P5571, DOI 10.1002/anie.201301362; Little DB, 2002, ARCH BIOCHEM BIOPHYS, V402, P120, DOI 10.1016/S0003-9861(02)00068-1; Marienhagen J, 2013, J BIOTECHNOL, V163, P166, DOI 10.1016/j.jbiotec.2012.06.001; Martin DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-226; Martin VJJ, 2001, BIOTECHNOL BIOENG, V75, P497, DOI 10.1002/bit.10037; McAndrew RP, 2011, STRUCTURE, V19, P1876, DOI 10.1016/j.str.2011.09.013; McCaskill D, 1997, Adv Biochem Eng Biotechnol, V55, P107; Misawa N, 2011, CURR OPIN BIOTECH, V22, P627, DOI 10.1016/j.copbio.2011.01.002; Nieuwenhuizen NJ, 2009, J EXP BOT, V60, P3203, DOI 10.1093/jxb/erp162; O'Maille PE, 2008, NAT CHEM BIOL, V4, P617, DOI 10.1038/nchembio.113; Ohnuma S, 1996, J BIOL CHEM, V271, P30748, DOI 10.1074/jbc.271.48.30748; Pelz A, 2005, J BIOL CHEM, V280, P32493, DOI 10.1074/jbc.M505070200; Reiling KK, 2004, BIOTECHNOL BIOENG, V87, P200, DOI 10.1002/bit.20128; Salis HM, 2011, METHOD ENZYMOL, V498, P19, DOI 10.1016/B978-0-12-385120-8.00002-4; Seemann M, 2002, J AM CHEM SOC, V124, P7681, DOI 10.1021/ja026058q; Segura MJR, 2003, NAT PROD REP, V20, P304, DOI 10.1039/b008338k; Soll J, 2004, NAT REV MOL CELL BIO, V5, P198, DOI 10.1038/nrm1333; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; Tarshis LC, 1996, P NATL ACAD SCI USA, V93, P15018, DOI 10.1073/pnas.93.26.15018; Umeno D, 2004, J BACTERIOL, V186, P1531, DOI 10.1128/JB.186.5.1531-1536.2004; Umeno D, 2002, J BACTERIOL, V184, P6690, DOI 10.1128/JB.184.23.6690-6699.2002; Vedula LS, 2008, ARCH BIOCHEM BIOPHYS, V469, P184, DOI 10.1016/j.abb.2007.10.015; VOGELI U, 1990, PLANT PHYSIOL, V93, P182, DOI 10.1104/pp.93.1.182; WHITEHEAD IM, 1989, PHYTOCHEMISTRY, V28, P775, DOI 10.1016/0031-9422(89)80114-1; WIELAND B, 1994, J BACTERIOL, V176, P7719, DOI 10.1128/JB.176.24.7719-7726.1994; Wildung MR, 1996, J BIOL CHEM, V271, P9201, DOI 10.1074/jbc.271.16.9201; Williams DC, 2000, ARCH BIOCHEM BIOPHYS, V379, P137, DOI 10.1006/abbi.2000.1865; Williams DC, 1998, BIOCHEMISTRY-US, V37, P12213, DOI 10.1021/bi980854k; Wise M. L., 1999, COMPREHENSIVE NATURA, P97, DOI DOI 10.1016/B978-0-08-091283-7.00038-2; Withers ST, 2007, APPL ENVIRON MICROB, V73, P6277, DOI 10.1128/AEM.00861-07; Yoshikuni Y, 2006, CHEM BIOL, V13, P91, DOI 10.1016/j.chembiol.2005.10.016	54	35	38	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93317	10.1371/journal.pone.0093317	http://dx.doi.org/10.1371/journal.pone.0093317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681801	gold, Green Published, Green Submitted			2022-12-27	WOS:000333678100040
J	Cao, PH; Wang, X; Fang, SS; Cheng, XW; Chan, KP; Wang, XL; Lu, X; Wu, CL; Tang, XJ; Zhang, RL; Ma, HW; Cheng, JQ; Wong, CM; Yang, L				Cao, Pei-Hua; Wang, Xin; Fang, Shi-Song; Cheng, Xiao-Wen; Chan, King-Pan; Wang, Xi-Ling; Lu, Xing; Wu, Chun-Li; Tang, Xiu-Juan; Zhang, Ren-Li; Ma, Han-Wu; Cheng, Jin-Quan; Wong, Chit-Ming; Yang, Lin			Forecasting Influenza Epidemics from Multi-Stream Surveillance Data in a Subtropical City of China	PLOS ONE			English	Article							OUTBREAK DETECTION	Background: Influenza has been associated with heavy burden of mortality and morbidity in subtropical regions. However, timely forecast of influenza epidemic in these regions has been hindered by unclear seasonality of influenza viruses. In this study, we developed a forecasting model by integrating multiple sentinel surveillance data to predict influenza epidemics in a subtropical city Shenzhen, China. Methods: Dynamic linear models with the predictors of single or multiple surveillance data for influenza-like illness (ILI) were adopted to forecast influenza epidemics from 2006 to 2012 in Shenzhen. Temporal coherence of these surveillance data with laboratory-confirmed influenza cases was evaluated by wavelet analysis and only the coherent data streams were entered into the model. Timeliness, sensitivity and specificity of these models were also evaluated to compare their performance. Results: Both influenza virology data and ILI consultation rates in Shenzhen demonstrated a significant annual seasonal cycle (p < 0.05) during the entire study period, with occasional deviations observed in some data streams. The forecasting models that combined multi-stream ILI surveillance data generally outperformed the models with single-stream ILI data, by providing more timely, sensitive and specific alerts. Conclusions: Forecasting models that combine multiple sentinel surveillance data can be considered to generate timely alerts for influenza epidemics in subtropical regions like Shenzhen.	[Cao, Pei-Hua; Chan, King-Pan; Wang, Xi-Ling; Wong, Chit-Ming; Yang, Lin] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Wang, Xin; Fang, Shi-Song; Cheng, Xiao-Wen; Wu, Chun-Li; Tang, Xiu-Juan; Zhang, Ren-Li; Ma, Han-Wu; Cheng, Jin-Quan] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Yang, Lin] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Shenzhen Center for Disease Control & Prevention (SZCDC); Hong Kong Polytechnic University	Cheng, JQ (corresponding author), Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China.	Cjinquan@vip.sohu.com; hrmrwcm@hku.hk	Cao, Peihua/GYU-4280-2022; YANG, Lin/F-9601-2014	YANG, Lin/0000-0002-5964-3233				Alonso WJ, 2007, AM J EPIDEMIOL, V165, P9; [Anonymous], 2002, Wkly Epidemiol Rec, V77, P191; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Centers for Disease Control and Prevention (CDC), 2012, OV INFL SURV US; Cheng XW, 2013, J INFECT DIS, V207, P106, DOI 10.1093/infdis/jis526; Chowell G, 2010, P ROY SOC B-BIOL SCI, V277, P1857, DOI 10.1098/rspb.2009.1897; COSTAGLIOLA D, 1991, AM J PUBLIC HEALTH, V81, P97, DOI 10.2105/AJPH.81.1.97; Cowling BJ, 2006, INT J EPIDEMIOL, V35, P1314, DOI 10.1093/ije/dyl162; Hutwagner LC, 1997, EMERG INFECT DIS, V3, P395, DOI 10.3201/eid0303.970322; Kleinman KP, 2006, STAT METHODS MED RES, V15, P445, DOI 10.1177/0962280206071641; Lau EHY, 2008, EMERG INFECT DIS, V14, P1154, DOI 10.3201/eid1407.080060; Li J, 2010, J ROY STAT SOC, V59, P20; Maraun D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016707; Monto AS, 2000, ARCH INTERN MED, V160, P5; OBrien SJ, 1997, PUBLIC HEALTH, V111, P255, DOI 10.1016/S0033-3506(97)00044-9; Peiris G, 2010, J STAT SOFTW, V36, P16; Petris G, 2009, USE R, P1, DOI 10.1007/b135794_1; Petris G, 2011, J STAT SOFTW, V41, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Stern L, 1999, EPIDEMIOL INFECT, V122, P103, DOI 10.1017/S0950268898001939; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tusell F, 2011, J STAT SOFTW, V39, P1; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Wang X, 2011, EPIDEMIOL INFECT, V139, P1551, DOI 10.1017/S0950268810002694; Widdowson MA, 2003, EMERG INFECT DIS, V9, P1046; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315	28	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92945	10.1371/journal.pone.0092945	http://dx.doi.org/10.1371/journal.pone.0092945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676091	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500059
J	Victorio, CBL; Xu, YS; Ng, Q; Chow, VTK; Chua, KB				Victorio, Carla Bianca Luena; Xu, Yishi; Ng, Qimei; Chow, Vincent T. K.; Chua, Kaw Bing			Phenotypic and Genotypic Characteristics of Novel Mouse Cell Line (NIH/3T3)-Adapted Human Enterovirus 71 Strains (EV71:TLLm and EV71:TLLmv)	PLOS ONE			English	Article							NEUROGENIC PULMONARY-EDEMA; POLIOMYELITIS-LIKE DISEASE; MOUTH-DISEASE; SWISS-MODEL; INFECTION; OUTBREAK; FOOT; EPIDEMIC; HAND; VIRUS	Since its identification in 1969, Enterovirus 71 (EV71) has been causing periodic outbreaks of infection in children worldwide and most prominently in the Asia-Pacific Region. Understanding the pathogenesis of Enterovirus 71 (EV71) is hampered by the virus's inability to infect small animals and replicate in their derived in vitro cultured cells. This manuscript describes the phenotypic and genotypic characteristics of two selected EV71 strains (EV71:TLLm and EV71:TLLmv), which have been adapted to replicate in mouse-derived NIH/3T3 cells, in contrast to the original parental virus which is only able to replicate in primate cell lines. The EV71: TLLm strain exhibited productive infection in all primate and rodent cell lines tested, while EV71: TLLmv exhibited greater preference for mouse cell lines. EV71: TLLmv displayed higher degree of adaptation and temperature adaptability in NIH/3T3 cells than in Vero cells, suggesting much higher fitness in NIH/3T3 cells. In comparison with the parental EV71:BS strain, the adapted strains accumulated multiple adaptive mutations in the genome resulting in amino acid substitutions, most notably in the capsid-encoding region (P1) and viral RNA-dependent RNA polymerase (3D). Two mutations, E167D and L169F, were mapped to the VP1 canyon that binds the SCARB2 receptor on host cells. Another two mutations, S135T and K140I, were located in the VP2 neutralization epitope spanning amino acids 136-150. This is the first report of human EV71 with the ability to productively infect rodent cell lines in vitro.	[Victorio, Carla Bianca Luena; Xu, Yishi; Ng, Qimei; Chua, Kaw Bing] Natl Univ Singapore, Temasek Lifesci Lab, Singapore 117548, Singapore; [Victorio, Carla Bianca Luena; Xu, Yishi; Chow, Vincent T. K.] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Host & Pathogen Interact Lab,Dept Microbiol, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Chua, KB (corresponding author), Natl Univ Singapore, Temasek Lifesci Lab, 1 Res Link, Singapore 117548, Singapore.	chuakb@tll.org.sg	Victorio, Bianca/AAF-5227-2021	Victorio, Bianca/0000-0002-1161-5006; Chow, Vincent/0000-0003-2634-6213	Temasek LifeSciences Laboratory (TLL)	Temasek LifeSciences Laboratory (TLL)	The research was fully funded by Temasek LifeSciences Laboratory (TLL). The funder had no role in study design, data collection and analysis, or preparation of the manuscript. The authors have obtained permission from the institute to publish these results.	ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Arita M, 2005, J GEN VIROL, V86, P1391, DOI 10.1099/vir.0.80784-0; Arita M, 2008, J VIROL, V82, P1787, DOI 10.1128/JVI.01798-07; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bible JM, 2008, J CLIN MICROBIOL, V46, P3192, DOI 10.1128/JCM.00628-08; Biebricher CK, 2006, CURR TOP MICROBIOL, V299, P1; BLOMBERG J, 1974, LANCET, V2, P112; BORREGO B, 1993, J VIROL, V67, P6071, DOI 10.1128/JVI.67.10.6071-6079.1993; Burch CL, 1999, GENETICS, V151, P921; Chang LY, 1998, LANCET, V352, P367, DOI 10.1016/S0140-6736(98)24031-1; Chen P, 2012, J BIOL CHEM, V287, P6406, DOI 10.1074/jbc.M111.301622; Chen YC, 2004, J GEN VIROL, V85, P69, DOI 10.1099/vir.0.19423-0; CHONMAITREE T, 1981, PEDIATRICS, V67, P489; Chua BH, 2008, J GEN VIROL, V89, P1622, DOI 10.1099/vir.0.83676-0; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; DEIBEL R, 1975, P SOC EXP BIOL MED, V148, P203, DOI 10.3181/00379727-148-38506; Domingo E, 2002, J VIROL, V76, P463, DOI 10.1128/JVI.76.1.463-465.2002; Domingo E, 1997, REV MED VIROL, V7, P87, DOI 10.1002/(SICI)1099-1654(199707)7:2<87::AID-RMV188>3.0.CO;2-0; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; EIGEN M, 1993, GENE, V135, P37, DOI 10.1016/0378-1119(93)90047-7; Eigen M., 1988, RNA GENETICS, V3, P211; GILBERT GL, 1988, PEDIATR INFECT DIS J, V7, P484, DOI 10.1097/00006454-198807000-00007; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAGIWARA A, 1978, INTERVIROLOGY, V9, P60, DOI 10.1159/000148922; HAGIWARA A, 1983, J GEN VIROL, V64, P491, DOI 10.1099/0022-1317-64-2-499; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HAYWARD JC, 1989, PEDIATR INFECT DIS J, V8, P611, DOI 10.1097/00006454-198909000-00009; ISHIMARU Y, 1980, ARCH DIS CHILD, V55, P583, DOI 10.1136/adc.55.8.583; KENNETT ML, 1974, B WORLD HEALTH ORGAN, V51, P609; Khong WX, 2012, J VIROL, V86, P2121, DOI 10.1128/JVI.06103-11; Lin JY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-103; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Lum LCS, 1998, LANCET, V352, P1391, DOI 10.1016/S0140-6736(05)60789-1; Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6; Melnick J.L., 1996, FIELDS VIROLOGY, Vthird, P655; Miyamura K, 2011, J GEN VIROL, V92, P287, DOI 10.1099/vir.0.022418-0; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; REED L. J., 1938, AMER JOUR HYG, V27, P493; SAMUDA GM, 1987, PEDIATR INFECT DIS J, V6, P206, DOI 10.1097/00006454-198702000-00013; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; SHINDAROV LM, 1979, J HYG EPID MICROB IM, V23, P284; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; STEINHAUER DA, 1992, GENE, V122, P281, DOI 10.1016/0378-1119(92)90216-C; TAGAYA I, 1981, JPN J MED SCI BIOL, V34, P191, DOI 10.7883/yoken1952.34.191; The Central People's Government of the People's Republic of China, 2008, HAND FOOT MOUTH DIS; Wang JR, 2000, J CLIN VIROL, V17, P91, DOI 10.1016/S1386-6532(00)00079-2; Wang W, 2011, MICROBES INFECT, V13, P862, DOI 10.1016/j.micinf.2011.04.004; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Yamayoshi S, 2013, J VIROL, V87, P3335, DOI 10.1128/JVI.02070-12; Yamayoshi S, 2011, J VIROL, V85, P4937, DOI 10.1128/JVI.02358-10; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yan JJ, 2000, J CLIN VIROL, V17, P13, DOI 10.1016/S1386-6532(00)00067-6; Yang F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-508; Yao PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051996; Zaini Z, 2012, J GEN VIROL, V93, P1935, DOI 10.1099/vir.0.043893-0; Zaini Z, 2012, VIRUS RES, V167, P86, DOI 10.1016/j.virusres.2012.04.009; Zaini Z, 2012, VIRUS RES, V165, P151, DOI 10.1016/j.virusres.2012.02.009; Zeng M, 2012, J CLIN VIROL, V53, P285, DOI 10.1016/j.jcv.2011.12.025; Zhang Y, 2011, LAB INVEST, V91, P1337, DOI 10.1038/labinvest.2011.82	64	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92719	10.1371/journal.pone.0092719	http://dx.doi.org/10.1371/journal.pone.0092719			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671184	gold, Green Submitted, Green Published			2022-12-27	WOS:000333677000069
J	Huang, MZ; Tang, SN; Upadhyay, G; Marsh, JL; Jackman, CP; Shankar, S; Srivastava, RK				Huang, Minzhao; Tang, Su-Ni; Upadhyay, Ghanshyam; Marsh, Justin L.; Jackman, Christopher P.; Shankar, Sharmila; Srivastava, Rakesh K.			Embelin Suppresses Growth of Human Pancreatic Cancer Xenografts, and Pancreatic Cancer Cells Isolated from Kras(G12D) Mice by Inhibiting Akt and Sonic Hedgehog Pathways	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROLIFERATION; METASTASIS; APOPTOSIS; FAMILY; DEATH; IL-8	Pancreatic cancer is a deadly disease, and therefore effective treatment and/or prevention strategies are urgently needed. The objectives of this study were to examine the molecular mechanisms by which embelin inhibited human pancreatic cancer cell growth in vitro, and xenografts in Balb C nude mice, and pancreatic cancer cell growth isolated from Kras(G12D) transgenic mice. XTT assays were performed to measure cell viability. AsPC-1 cells were injected subcutaneously into Balb c nude mice and treated with embelin. Cell proliferation and apoptosis were measured by Ki67 and TUNEL staining, respectively. The expression of Akt, and Sonic Hedgehog (Shh) and their target gene products were measured by the immunohistochemistry, and Western blot analysis. The effects of embelin on pancreatic cancer cells isolated from 10months old Kras(G12D) mice were also examined. Embelin inhibited cell viability in pancreatic cancer AsPC-1, PANC-1, MIA PaCa-2 and Hs 766T cell lines, and these inhibitory effects were blocked either by constitutively active Akt or Shh protein. Embelin-treated mice showed significant inhibition in tumor growth which was associated with reduced expression of markers of cell proliferation (Ki67, PCNA and Bcl-2) and cell cycle (cyclin D1, CDK2, and CDK6), and induction of apoptosis (activation of caspase-3 and cleavage of PARP, and increased expression of Bax). In addition, embelin inhibited the expression of markers of angiogenesis (COX-2, VEGF, VEGFR, and IL-8), and metastasis (MMP-2 and MMP-9) in tumor tissues. Antitumor activity of embelin was associated with inhibition of Akt and Shh pathways in xenografts, and pancreatic cancer cells isolated from Kras(G12D) mice. Furthermore, embelin also inhibited epithelial-to-mesenchymal transition (EMT) by upregulating E-cadherin and inhibiting the expression of Snail, Slug, and ZEB1. These data suggest that embelin can inhibit pancreatic cancer growth, angiogenesis and metastasis by suppressing Akt and Shh pathways, and can be developed for the treatment and/or prevention of pancreatic cancer.	[Huang, Minzhao; Tang, Su-Ni; Upadhyay, Ghanshyam; Srivastava, Rakesh K.] Univ Kansas, Med Ctr, Ctr Canc, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Marsh, Justin L.; Jackman, Christopher P.] Univ Texas Hlth Ctr Tyler, Dept Biochem, Tyler, TX 75710 USA; [Shankar, Sharmila] Univ Kansas, Med Ctr, Ctr Canc, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Kansas; University of Kansas Medical Center	Shankar, S (corresponding author), Univ Kansas, Med Ctr, Ctr Canc, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	sshankar@kumc.edu; rsrivastava@kumc.edu		Srivastava, Rakesh/0000-0002-0065-4069; Srivastava, Rakesh/0000-0003-3112-4252	NCI NIH HHS [R01 CA114469] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA114469] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Basanez G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001399; Choy SW, 2012, VITAM HORM, V88, P1, DOI 10.1016/B978-0-12-394622-5.00001-8; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; Folkman J, 2003, J THROMB HAEMOST, V1, P1681, DOI 10.1046/j.1538-7836.2003.00344.x; Fu JS, 2013, CANCER LETT, V330, P22, DOI 10.1016/j.canlet.2012.11.018; Gold E B, 1998, Surg Oncol Clin N Am, V7, P67; Hao K, 2013, ONCOL REP, V29, P1124, DOI 10.3892/or.2012.2210; Harada Hisashi, 2003, Rev Clin Exp Hematol, V7, P117; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; Heo JY, 2011, CANCER LETT, V308, P71, DOI 10.1016/j.canlet.2011.04.015; Hill R, 2012, MOL CANCER THER, V11, P2127, DOI 10.1158/1535-7163.MCT-12-0342; Hill R, 2010, CANCER RES, V70, P7114, DOI 10.1158/0008-5472.CAN-10-1649; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hu R, 2011, MED ONCOL, V28, P1584, DOI 10.1007/s12032-010-9601-5; Huang YX, 2012, BIOCONJUGATE CHEM, V23, P1443, DOI 10.1021/bc3000468; Jaffee EM, 2002, CANCER CELL, V2, P25, DOI 10.1016/S1535-6108(02)00093-4; Jenkins D, 2009, CELL SIGNAL, V21, P1023, DOI 10.1016/j.cellsig.2009.01.033; Kennedy Alyssa L, 2011, Small GTPases, V2, P264; Kim SW, 2013, PROSTATE, V73, P296, DOI 10.1002/pros.22574; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; Li DH, 2001, CANCER J, V7, P259; Li J, 2010, AAPS J, V12, P223, DOI 10.1208/s12248-010-9181-5; Li SH, 2013, MOL CELL BIOCHEM, V373, P217, DOI 10.1007/s11010-012-1493-6; Magee CJ, 2002, BEST PRACT RES CL GA, V16, P435, DOI 10.1053/bega.2002.0317; Maitra A, 2005, CANCER CELL, V8, P171, DOI 10.1016/j.ccr.2005.08.007; Marsh JL, 2014, FRONT BIOSCI-LANDMRK, V19, P113, DOI 10.2741/4198; Nikolovska-Coleska Z, 2004, J MED CHEM, V47, P2430, DOI 10.1021/jm030420+; Palena C, 2012, FUTURE ONCOL, V8, P713, DOI [10.2217/FON.12.59, 10.2217/fon.12.59]; Pavelic SK, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-22; Segura PP, 2012, CLIN TRANSL ONCOL, V14, P553, DOI 10.1007/s12094-012-0840-0; Rodova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046083; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Roy Sanjit K, 2010, J Mol Signal, V5, P10, DOI 10.1186/1750-2187-5-10; Saqui-Salces M, 2010, BBA-MOL CELL RES, V1803, P786, DOI 10.1016/j.bbamcr.2010.03.008; Shankar S, 2005, INT J MOL MED, V16, P1125; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegelin MD, 2009, NEUROCHEM INT, V55, P423, DOI 10.1016/j.neuint.2009.04.011; Singh BN, 2012, BIOCHEM PHARMACOL, V84, P1154, DOI 10.1016/j.bcp.2012.08.007; Singh BN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027306; Srivastava Rakesh K, 2011, Front Biosci (Elite Ed), V3, P515, DOI 10.2741/e266; Srivastava Rakesh K., 2000, Molecular Cell Biology Research Communications, V4, P67, DOI 10.1006/mcbr.2001.0265; Srivastava RK, 2001, NEOPLASIA, V3, P535, DOI 10.1038/sj.neo.7900203; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tang SN, 2012, INT J CANCER, V131, P30, DOI 10.1002/ijc.26323; Tang Su-Ni, 2010, J Mol Signal, V5, P14, DOI 10.1186/1750-2187-5-14; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang ZW, 2011, NAT REV GASTRO HEPAT, V8, P27, DOI 10.1038/nrgastro.2010.188; Xu MJ, 2005, PLANTA MED, V71, P944, DOI 10.1055/s-2005-871250; Zhao M, 2013, CANCER LETT, V337, P210, DOI 10.1016/j.canlet.2013.05.009	52	41	43	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92161	10.1371/journal.pone.0092161	http://dx.doi.org/10.1371/journal.pone.0092161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24694877	Green Submitted, gold, Green Published			2022-12-27	WOS:000334103000015
J	Brett, M; McPherson, J; Zang, ZJ; Lai, A; Tan, ES; Ng, I; Ong, LC; Cham, B; Tan, P; Rozen, S; Tan, EC				Brett, Maggie; McPherson, John; Zang, Zhi Jiang; Lai, Angeline; Tan, Ee-Shien; Ng, Ivy; Ong, Lai-Choo; Cham, Breana; Tan, Patrick; Rozen, Steve; Tan, Ene-Choo			Massively Parallel Sequencing of Patients with Intellectual Disability, Congenital Anomalies and/or Autism Spectrum Disorders with a Targeted Gene Panel	PLOS ONE			English	Article							DE-NOVO MUTATIONS; PERIVENTRICULAR NODULAR HETEROTOPIA; THALASSEMIA-MENTAL-RETARDATION; IDENTIFICATION; ENZYME; FOXP1; AHI1	Developmental delay and/or intellectual disability (DD/ID) affects 1-3% of all children. At least half of these are thought to have a genetic etiology. Recent studies have shown that massively parallel sequencing (MPS) using a targeted gene panel is particularly suited for diagnostic testing for genetically heterogeneous conditions. We report on our experiences with using massively parallel sequencing of a targeted gene panel of 355 genes for investigating the genetic etiology of eight patients with a wide range of phenotypes including DD/ID, congenital anomalies and/or autism spectrum disorder. Targeted sequence enrichment was performed using the Agilent SureSelect Target Enrichment Kit and sequenced on the Illumina HiSeq2000 using paired-end reads. For all eight patients, 81-84% of the targeted regions achieved read depths of at least 20x, with average read depths overlapping targets ranging from 322x to 798x. Causative variants were successfully identified in two of the eight patients: a nonsense mutation in the ATRX gene and a canonical splice site mutation in the L1CAM gene. In a third patient, a canonical splice site variant in the USP9X gene could likely explain all or some of her clinical phenotypes. These results confirm the value of targeted MPS for investigating DD/ID in children for diagnostic purposes. However, targeted gene MPS was less likely to provide a genetic diagnosis for children whose phenotype includes autism.	[Brett, Maggie; Tan, Ene-Choo] KK Womens & Childrens Hosp, KK Res Ctr, Singapore, Singapore; [McPherson, John; Tan, Patrick; Rozen, Steve] Duke NUS Grad Med Sch, Singapore, Singapore; [Zang, Zhi Jiang; Tan, Patrick] Natl Canc Ctr, Singapore, Singapore; [Lai, Angeline; Tan, Ee-Shien; Ng, Ivy; Cham, Breana] KK Womens & Childrens Hosp, Genet Serv, Singapore, Singapore; [Ong, Lai-Choo] Univ Malaya Med Ctr, Petaling Jaya, Malaysia	KK Women's & Children's Hospital; National University of Singapore; National Cancer Centre Singapore (NCCS); KK Women's & Children's Hospital; Universiti Malaya	Tan, EC (corresponding author), KK Womens & Childrens Hosp, KK Res Ctr, Singapore, Singapore.	tanec@bigfoot.com	Ong, Lai Choo/G-6439-2011; Tan, EC/W-6304-2019; McPherson, John D/D-2633-2017; Rozen, Steven G./J-5939-2013	Ong, Lai Choo/0000-0003-3903-9343; McPherson, John D/0000-0001-8049-9347; Rozen, Steven G./0000-0002-4288-0056	Agency for Science and Technology and Research [BMRC 06/1/50/19/485]; National Medical Research Council, Ministry of Health, Republic of Singapore [NMRC/PPG/KKH12010-Theme3]	Agency for Science and Technology and Research(Agency for Science Technology & Research (A*STAR)); National Medical Research Council, Ministry of Health, Republic of Singapore(Ministry of Health-SingaporeNational Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study is funded by Grant number BMRC 06/1/50/19/485 from the Agency for Science and Technology and Research; and NMRC/PPG/KKH12010-Theme3 from the National Medical Research Council, Ministry of Health, Republic of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Retuerto AI, 2008, HUM MOL GENET, V17, P3887, DOI 10.1093/hmg/ddn291; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Brownstein Z, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r89; Carter MT, 2013, CLIN GENET, V83, P399, DOI 10.1111/cge.12101; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Coe BP, 2012, AM J MED GENET C, V160C, P118, DOI 10.1002/ajmg.c.31327; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Finckh U, 2000, AM J MED GENET, V92, P40, DOI 10.1002/(SICI)1096-8628(20000501)92:1<40::AID-AJMG7>3.0.CO;2-R; Gibbons R, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-15; Gibbons RJ, 2008, HUM MUTAT, V29, P796, DOI 10.1002/humu.20734; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Hamdan FF, 2010, AM J HUM GENET, V87, P671, DOI 10.1016/j.ajhg.2010.09.017; Horn D, 2010, HUM MUTAT, V31, pE1851, DOI 10.1002/humu.21362; Jolly LA, 2009, MOL BIOL CELL, V20, P2015, DOI 10.1091/mbc.E08-06-0596; Jones MH, 1996, HUM MOL GENET, V5, P1695, DOI 10.1093/hmg/5.11.1695; Kakita A, 2002, ACTA NEUROPATHOL, V104, P649, DOI 10.1007/s00401-002-0594-9; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Kroes HY, 2008, EUR J MED GENET, V51, P24, DOI 10.1016/j.ejmg.2007.10.001; Kunishima S, 2010, J HUM GENET, V55, P844, DOI 10.1038/jhg.2010.114; Latiff ZA, 2013, J PEDIATR NEUROL, V11, P67, DOI 10.3233/JPN-120598; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Matsunami N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052239; Meder B, 2011, CIRC-CARDIOVASC GENE, V4, P110, DOI 10.1161/CIRCGENETICS.110.958322; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Pantaleon M, 2001, MECH DEVELOP, V109, P151, DOI 10.1016/S0925-4773(01)00551-2; Rehnberg M, 2011, AM J MED GENET A, V155A, P439, DOI 10.1002/ajmg.a.33803; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sultana R, 2002, GENOMICS, V80, P129, DOI 10.1006/geno.2002.6810; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367	34	29	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93409	10.1371/journal.pone.0093409	http://dx.doi.org/10.1371/journal.pone.0093409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690944	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100076
J	Crimi, A; Commowick, O; Maarouf, A; Ferre, JC; Bannier, E; Tourbah, A; Berry, I; Ranjeva, JP; Edan, G; Barillot, C				Crimi, Alessandro; Commowick, Olivier; Maarouf, Adil; Ferre, Jean-Christophe; Bannier, Elise; Tourbah, Ayman; Berry, Isabelle; Ranjeva, Jean-Philippe; Edan, Gilles; Barillot, Christian			Predictive Value of Imaging Markers at Multiple Sclerosis Disease Onset Based on Gadolinium- and USPIO-Enhanced MRI and Machine Learning	PLOS ONE			English	Article							CLINICALLY ISOLATED SYNDROMES; SPIN-ECHO MRI; HYPOINTENSE LESIONS; IRON-OXIDE; DIAGNOSTIC-CRITERIA; AXONAL INJURY; DISABILITY; PROGRESSION; DEMYELINATION; PATHOLOGY	Objectives : A novel characterization of Clinically Isolated Syndrome (CIS) patients according to lesion patterns is proposed. More specifically, patients are classified according to the nature of inflammatory lesions patterns. It is expected that this characterization can infer new prospective figures from the earliest imaging signs of Multiple Sclerosis (MS), since it can provide a classification of different types of lesions across patients. Methods: The method is based on a two- tiered classification. Initially, the spatio- temporal lesion patterns are classified. The discovered lesion patterns are then used to characterize groups of patients. The patient groups are validated using statistical measures and by correlations at 24- month follow- up with hypointense lesion loads. Results: The methodology identified 3 statistically significantly different clusters of lesion patterns showing p- values smaller than 0.01. Moreover, these patterns defined at baseline correlated with chronic hypointense lesion volumes by follow-up with an R-2 score of 0.90. Conclusions: The proposed methodology is capable of identifying three major different lesion patterns that are heterogeneously present in patients, allowing a patient classification using only two MRI scans. This finding may lead to more accurate prognosis and thus to more suitable treatments at early stage of MS.	[Crimi, Alessandro; Commowick, Olivier; Barillot, Christian] INRIA Atlantique, Rennes, France; [Maarouf, Adil; Ranjeva, Jean-Philippe] Aix Marseille Univ, CNRS, CRMBM, Marseille, France; [Ferre, Jean-Christophe; Bannier, Elise; Edan, Gilles] CHU Rennes, Rennes, France; [Maarouf, Adil; Tourbah, Ayman] CHU Reims, Reims, France; [Berry, Isabelle] CHU Toulouse, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CHU Rennes; CHU de Reims; CHU de Toulouse	Crimi, A (corresponding author), INRIA Atlantique, Campus Beaulieu, Rennes, France.	alecrimi@alice.it	Edan, Gilles/AAI-5944-2020; Crimi, Alessandro/Y-3535-2019	Crimi, Alessandro/0000-0001-5397-6363; Ferre, Jean-Christophe/0000-0003-3911-1800; Bannier, Elise/0000-0002-8942-7486; Ranjeva, Jean-Philippe/0000-0001-8073-102X; BERRY, Isabelle/0000-0002-0886-3252	ARSEP (Foundation pour l'Aide a la Recherche sur la Scelerose en Plaques); ERCIM (European Research Consortium for Informatics and Mathematics)	ARSEP (Foundation pour l'Aide a la Recherche sur la Scelerose en Plaques); ERCIM (European Research Consortium for Informatics and Mathematics)	The study was supported by ARSEP (Foundation pour l'Aide a la Recherche sur la Scelerose en Plaques). The scholarship of Dr. Crimi has been financed by ERCIM (European Research Consortium for Informatics and Mathematics). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Enein F, 2006, ACTA NEUROPATHOL, V111, P539, DOI 10.1007/s00401-006-0047-y; Anderson VM, 2006, J MAGN RESON IMAGING, V23, P605, DOI 10.1002/jmri.20550; Barkhof F, 2001, BRAIN, V124, P1396, DOI 10.1093/brain/124.7.1396; BARTLETT MS, 1954, J ROY STAT SOC B, V16, P296; Bezdek JC, 1998, IEEE T SYST MAN CY B, V28, P301, DOI 10.1109/3477.678624; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Brex PA, 2002, NEW ENGL J MED, V346, P158, DOI 10.1056/NEJMoa011341; Brex PA, 2001, J NEUROL NEUROSUR PS, V70, P390, DOI 10.1136/jnnp.70.3.390; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Confavreux C, 2003, BRAIN, V126, P770, DOI 10.1093/brain/awg081; Dousset V, 2006, AM J NEURORADIOL, V27, P1000; Dousset V, 2002, ACAD RADIOL, V9, pS156, DOI 10.1016/S1076-6332(03)80426-9; Duda R.O., 2000, PATTERN CLASSIFICATI; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; FILIPPI M, 1994, NEUROLOGY, V44, P635, DOI 10.1212/WNL.44.4.635; Fox E, 2006, NEUROLOGY, V28; Gokcay E, 2002, IEEE T PATTERN ANAL, V24, P158, DOI 10.1109/34.982897; Haermae V., 2010, PLOS ONE, V5, P245; INRIA, 2013, MED SOFTW PAG; Kornek B, 1999, BRAIN PATHOL, V9, P651; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lassmann H, 2010, EXP NEUROL, V225, P2, DOI 10.1016/j.expneurol.2009.10.009; Leray E, 2010, BRAIN, V133, P1900, DOI 10.1093/brain/awq076; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Marriott J, 2010, NEUROLOGY, V74; Maulik U, 2002, IEEE T PATTERN ANAL, V24, P1650, DOI 10.1109/TPAMI.2002.1114856; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Miller D, 2005, LANCET NEUROL, V4, P341, DOI 10.1016/S1474-4422(05)70095-8; Molyneux PD, 1998, ANN NEUROL, V43, P332, DOI 10.1002/ana.410430311; Ng A, 2001, NIPS, V14, P224; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Redford EJ, 1997, BRAIN, V120, P2149, DOI 10.1093/brain/120.12.2149; Reuter M, 2006, COMPUT AIDED DESIGN, V38, P342, DOI 10.1016/j.cad.2005.10.011; Scalfari A, 2010, BRAIN, V133, P1914, DOI 10.1093/brain/awq118; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Smith KJ, 2001, ANN NEUROL, V49, P470; SMITH ME, 1993, ANN NEUROL, V33, P480, DOI 10.1002/ana.410330511; Steel R, 1960, PRINCIPLES PROCEDURE, V70, P187; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tourdias T, 2012, RADIOLOGY, V264, P225, DOI 10.1148/radiol.12111416; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Truyen L, 1996, NEUROLOGY, V47, P1469, DOI 10.1212/WNL.47.6.1469; van Walderveen M, 1995, NEUROLOGY, V454; van Walderveen MAA, 1998, NEUROLOGY, V50, P1282, DOI 10.1212/WNL.50.5.1282; Vellinga MM, 2008, BRAIN, V131, P800, DOI 10.1093/brain/awn009; Zelnik-Manor L, 2004, NIPS, V17	49	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93024	10.1371/journal.pone.0093024	http://dx.doi.org/10.1371/journal.pone.0093024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691080	gold, Green Published, Green Submitted			2022-12-27	WOS:000334101100039
J	Gallardo-Escarate, C; Valenzuela-Munoz, V; Nunez-Acuna, G				Gallardo-Escarate, Cristian; Valenzuela-Munoz, Valentina; Nunez-Acuna, Gustavo			RNA-Seq Analysis Using De Novo Transcriptome Assembly as a Reference for the Salmon Louse Caligus rogercresseyi	PLOS ONE			English	Article							CALANUS-FINMARCHICUS CRUSTACEA; LEPEOPHTHEIRUS-SALMONIS; ATLANTIC SALMON; SALAR L.; EMAMECTIN BENZOATE; MOLECULAR CHARACTERIZATION; REDUCED SENSITIVITY; BRITISH-COLUMBIA; SNP DISCOVERY; LICE	Despite the economic and environmental impacts that sea lice infestations have on salmon farming worldwide, genomic data generated by high-throughput transcriptome sequencing for different developmental stages, sexes, and strains of sea lice is still limited or unknown. In this study, RNA-seq analysis was performed using de novo transcriptome assembly as a reference for evidenced transcriptional changes from six developmental stages of the salmon louse Caligus rogercresseyi. EST-datasets were generated from the nauplius I, nauplius II, copepodid and chalimus stages and from female and male adults using MiSeq Illumina sequencing. A total of 151,788,682 transcripts were yielded, which were assembled into 83,444 high quality contigs and subsequently annotated into roughly 24,000 genes based on known proteins. To identify differential transcription patterns among salmon louse stages, cluster analyses were performed using normalized gene expression values. Herein, four clusters were differentially expressed between nauplius I-II and copepodid stages (604 transcripts), five clusters between copepodid and chalimus stages (2,426 transcripts), and six clusters between female and male adults (2,478 transcripts). Gene ontology analysis revealed that the nauplius I-II, copepodid and chalimus stages are mainly annotated to aminoacid transfer/repair/breakdown, metabolism, molting cycle, and nervous system development. Additionally, genes showing differential transcription in female and male adults were highly related to cytoskeletal and contractile elements, reproduction, cell development, morphogenesis, and transcription-translation processes. The data presented in this study provides the most comprehensive transcriptome resource available for C. rogercresseyi, which should be used for future genomic studies linked to host-parasite interactions.	[Gallardo-Escarate, Cristian; Valenzuela-Munoz, Valentina; Nunez-Acuna, Gustavo] Univ Concepcion, Interdisciplinary Ctr Aquaculture Res INCAR, Lab Biotechnol & Aquat Genom, Concepcion, Chile	Universidad de Concepcion	Gallardo-Escarate, C (corresponding author), Univ Concepcion, Interdisciplinary Ctr Aquaculture Res INCAR, Lab Biotechnol & Aquat Genom, Concepcion, Chile.	crisgallardo@udec.cl	Gallardo-Escárate, Cristian/AAE-8980-2022	Gallardo-Escárate, Cristian/0000-0002-7094-6702; Nunez-Acuna, Gustavo/0000-0003-2568-0332; Valenzuela-Munoz, Valentina/0000-0002-9402-6695	FONDAP [15110027]; CONICYT-Chile	FONDAP; CONICYT-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This study was supported by the FONDAP (15110027) project granted by CONICYT-Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarseth KA, 1999, MAR ECOL PROG SER, V186, P211, DOI 10.3354/meps186211; Belles X, 2005, INVERTEBR REPROD DEV, V47, P23, DOI 10.1080/07924259.2005.9652144; Bellin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-555; Bowers JM, 2000, J FISH DIS, V23, P165, DOI 10.1046/j.1365-2761.2000.00225.x; BRANDAL PO, 1976, NORW J ZOOL, V24, P341; Bravo S, 2010, AQUACULTURE, V303, P22, DOI 10.1016/j.aquaculture.2010.03.007; Bravo S, 2008, AQUACULTURE, V282, P7, DOI 10.1016/j.aquaculture.2008.06.011; Bravo S, 2013, AQUACULTURE, V404, P55, DOI 10.1016/j.aquaculture.2013.04.002; Bravo S, 2010, EXP PARASITOL, V125, P51, DOI 10.1016/j.exppara.2009.12.001; Brooks KM, 2005, REV FISH SCI, V13, P177, DOI 10.1080/10641260500207109; Carmichael SN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-408; Christie AE, 2008, GEN COMP ENDOCR, V155, P526, DOI 10.1016/j.ygcen.2007.09.002; Christie AE, 2013, COMP BIOCHEM PHYS D, V8, P165, DOI 10.1016/j.cbd.2013.04.002; Christie AE, 2013, GEN COMP ENDOCR, V187, P117, DOI 10.1016/j.ygcen.2013.03.018; Christie AE, 2013, COMP BIOCHEM PHYS D, V8, P45, DOI 10.1016/j.cbd.2012.11.002; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dalvin S, 2011, DIS AQUAT ORGAN, V94, P211, DOI 10.3354/dao02331; Duston J, 2002, AQUACULTURE, V207, P1, DOI 10.1016/S0044-8486(01)00734-7; Eichner C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-126; Everett MV, 2011, MOL ECOL RESOUR, V11, P93, DOI 10.1111/j.1755-0998.2010.02969.x; Fast MD, 2003, J PARASITOL, V89, P7, DOI 10.1645/0022-3395(2003)089[0007:ERFLSI]2.0.CO;2; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Firth KJ, 2000, J PARASITOL, V86, P1199, DOI 10.1645/0022-3395(2000)086[1199:COPITS]2.0.CO;2; Gonzalez L, 2003, AQUACULTURE, V220, P101, DOI 10.1016/S0044-8486(02)00512-4; Hamre LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073539; He LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047195; Hergarden AC, 2012, P NATL ACAD SCI USA, V109, P3967, DOI 10.1073/pnas.1200778109; JONES MW, 1992, J FISH DIS, V15, P197, DOI 10.1111/j.1365-2761.1992.tb00654.x; Jones SRM, 2012, J EUKARYOT MICROBIOL, V59, P206, DOI 10.1111/j.1550-7408.2011.00614.x; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kristoffersen AB, 2013, PREV VET MED, V111, P165, DOI 10.1016/j.prevetmed.2013.03.015; Kvamme BO, 2005, GENE, V352, P63, DOI 10.1016/j.gene.2005.03.011; Kvamme BO, 2004, INT J PARASITOL, V34, P823, DOI 10.1016/j.ijpara.2004.02.004; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Mordue AJ, 2009, J FISH DIS, V32, P3, DOI 10.1111/j.1365-2761.2008.01004.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neira-Oviedo M, 2011, INSECT MOL BIOL, V20, P141, DOI 10.1111/j.1365-2583.2010.01053.x; Porter ML, 2007, MOL BIOL EVOL, V24, P253, DOI 10.1093/molbev/msl152; Ritdachyeng E, 2013, PHYSIOL ENTOMOL, V38, P183, DOI 10.1111/phen.12010; Rodriguez EM, 2007, COMP BIOCHEM PHYS A, V146, P661, DOI 10.1016/j.cbpa.2006.04.030; Roth M, 1996, AQUACULTURE, V140, P217, DOI 10.1016/0044-8486(95)01181-1; Sahasrabudhe PV, 1998, PROTEINS, V33, P558, DOI 10.1002/(SICI)1097-0134(19981201)33:4<558::AID-PROT8>3.3.CO;2-Q; Saksida SM, 2013, J FISH DIS, V36, P515, DOI 10.1111/jfd.12018; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Sekhon BS, 2010, RES REP BIOL, V1, P1, DOI 10.2147/RRB.S12043; Sevatdal S, 2003, AQUACULTURE, V218, P21, DOI 10.1016/S0044-8486(02)00339-3; Skilbrei OT, 2013, J FISH DIS, V36, P249, DOI 10.1111/jfd.12052; Sutherland BJG, 2012, MOL ECOL, V21, P6000, DOI 10.1111/mec.12072; Tadiso TM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-141; Gonzalez MT, 2012, AQUAC RES, V43, P853, DOI 10.1111/j.1365-2109.2011.02900.x; Torrissen O, 2013, J FISH DIS, V36, P171, DOI 10.1111/jfd.12061; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Wilson CH, 2011, J COMP NEUROL, V519, P3259, DOI 10.1002/cne.22695; Wilstermann A, 2013, J PEST SCI, V86, P419, DOI 10.1007/s10340-013-0496-8; Yasuike M, 2012, MAR BIOTECHNOL, V14, P155, DOI 10.1007/s10126-011-9398-z	59	54	56	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92239	10.1371/journal.pone.0092239	http://dx.doi.org/10.1371/journal.pone.0092239			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691066	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100017
J	Matsunaga, M; Isowa, T; Yamakawa, K; Fukuyama, S; Shinoda, J; Yamada, J; Ohira, H				Matsunaga, Masahiro; Isowa, Tokiko; Yamakawa, Kaori; Fukuyama, Seisuke; Shinoda, Jun; Yamada, Jitsuhiro; Ohira, Hideki			Genetic Variations in the Human Cannabinoid Receptor Gene Are Associated with Happiness	PLOS ONE			English	Article							PREFRONTAL CORTEX; ENDOCANNABINOID SYSTEM; NUCLEUS-ACCUMBENS; REWARD SYSTEM; CNR1 GENE; LONG-TERM; ANANDAMIDE; BRAIN; VALIDATION; PATHWAYS	Happiness has been viewed as a temporary emotional state (e. g., pleasure) and a relatively stable state of being happy (subjective happiness level). As previous studies demonstrated that individuals with high subjective happiness level rated their current affective states more positively when they experience positive events, these two aspects of happiness are interrelated. According to a recent neuroimaging study, the cytosine to thymine single-nucleotide polymorphism of the human cannabinoid receptor 1 gene is associated with sensitivity to positive emotional stimuli. Thus, we hypothesized that our genetic traits, such as the human cannabinoid receptor 1 genotypes, are closely related to the two aspects of happiness. In Experiment 1, 198 healthy volunteers were used to compare the subjective happiness level between cytosine allele carriers and thymine-thymine carriers of the human cannabinoid receptor 1 gene. In Experiment 2, we used positron emission tomography with 20 healthy participants to compare the brain responses to positive emotional stimuli of cytosine allele carriers to that of thymine-thymine carriers. Compared to thymine-thymine carriers, cytosine allele carriers have a higher subjective happiness level. Regression analysis indicated that the cytosine allele is significantly associated with subjective happiness level. The positive mood after watching a positive film was significantly higher for the cytosine allele carriers compared to the thymine-thymine carriers. Positive emotion-related brain region such as the medial prefrontal cortex was significantly activated when the cytosine allele carriers watched the positive film compared to the thyminethymine carriers. Thus, the human cannabinoid receptor 1 genotypes are closely related to two aspects of happiness. Compared to thymine-thymine carriers, the cytosine allele carriers of the human cannabinoid receptor 1 gene, who are sensitive to positive emotional stimuli, exhibited greater magnitude positive emotions when they experienced positive events and had a higher subjective happiness level.	[Matsunaga, Masahiro] Aichi Med Univ, Sch Med, Dept Hlth & Psychosocial Med, Aichi, Japan; [Isowa, Tokiko] Mie Univ, Fac Med, Dept Gerontol Nursing, Tsu, Mie, Japan; [Yamakawa, Kaori; Ohira, Hideki] Nagoya Univ, Grad Sch Environm Studies, Dept Psychol, Aichi, Japan; [Fukuyama, Seisuke; Shinoda, Jun; Yamada, Jitsuhiro] Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, Gifu, Japan	Aichi Medical University; Mie University; Nagoya University	Matsunaga, M (corresponding author), Aichi Med Univ, Sch Med, Dept Hlth & Psychosocial Med, Aichi, Japan.	matsunag@aichi-med-u.ac.jp	YAMAKAWA, Kaori/ABC-8782-2020		Japan Society for the Promotion of Science [25750354]; Grants-in-Aid for Scientific Research [25284003] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (25750354 to MM). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study.	Berridge KC, 2011, PSYCHOL WELL-BEING, V1, DOI 10.1186/2211-1522-1-3; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Carlson JM, 2011, NEUROIMAGE, V57, P1608, DOI 10.1016/j.neuroimage.2011.05.037; Chakrabarti B, 2006, EUR J NEUROSCI, V23, P1944, DOI 10.1111/j.1460-9568.2006.04697.x; DEVANE WA, 1994, P NATL ACAD SCI USA, V91, P6698, DOI 10.1073/pnas.91.14.6698; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Hoffman AF, 2003, EUR J NEUROSCI, V18, P524, DOI 10.1046/j.1460-9568.2003.02773.x; Katona I, 2001, J NEUROSCI, V21, P9506, DOI 10.1523/JNEUROSCI.21-23-09506.2001; KOZMA A, 1983, J GERONTOL, V38, P626, DOI 10.1093/geronj/38.5.626; KOZMA A, 1990, SOC INDIC RES, V22, P119, DOI 10.1007/BF00354836; Krueger F, 2009, TRENDS COGN SCI, V13, P103, DOI 10.1016/j.tics.2008.12.005; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; Mahler SV, 2007, NEUROPSYCHOPHARMACOL, V32, P2267, DOI 10.1038/sj.npp.1301376; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Matsunaga M, 2011, NAT SCI, V3, P723, DOI DOI 10.4236/NS.2011.38095; Matsunaga M, 2008, BRAIN BEHAV IMMUN, V22, P408, DOI 10.1016/j.bbi.2007.09.008; Matsunaga M, 2011, NEUROENDOCRINOL LETT, V32, P458; Mitjans M, 2013, PSYCHOPHARMACOLOGY, V227, P509, DOI 10.1007/s00213-013-2995-y; Moreira FA, 2008, ADDICT BIOL, V13, P196, DOI 10.1111/j.1369-1600.2008.00104.x; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Okamoto Y, 2007, CHEM BIODIVERS, V4, P1842, DOI 10.1002/cbdv.200790155; Otake Keiko, 2006, J Happiness Stud, V7, P361, DOI 10.1007/s10902-005-3650-z; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; Roy M, 2012, TRENDS COGN SCI, V16, P147, DOI 10.1016/j.tics.2012.01.005; Schimmack U., 2008, SCI SUBJECTIVE WELL, P97, DOI DOI 10.5860/CHOICE.45-5867; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Shimai Satoshi, 2004, Nihon Koshu Eisei Zasshi, V51, P845; Sperlagh B, 2009, NEUROCHEM INT, V54, P452, DOI 10.1016/j.neuint.2009.01.017; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Stones MJ, 1995, SOC INDIC RES, V36, P129, DOI 10.1007/BF01079722; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Bos W, 2012, CEREB CORTEX, V22, P1247, DOI 10.1093/cercor/bhr198; van der Stelt M, 2003, EUR J PHARMACOL, V480, P133, DOI 10.1016/j.ejphar.2003.08.101; Waterman AS, 2008, J HAPPINESS STUD, V9, P41, DOI 10.1007/s10902-006-9020-7; Zhang PW, 2004, MOL PSYCHIATR, V9, P916, DOI 10.1038/sj.mp.4001560	38	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93771	10.1371/journal.pone.0093771	http://dx.doi.org/10.1371/journal.pone.0093771			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690898	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100133
J	Mozaffar, H; Williams, R; Cresswell, K; Morison, Z; Slee, A; Sheikh, A				Mozaffar, Hajar; Williams, Robin; Cresswell, Kathrin; Morison, Zoe; Slee, Ann; Sheikh, Aziz		ePrescribing Programme Team	Product Diversity and Spectrum of Choice in Hospital ePrescribing Systems in England	PLOS ONE			English	Article							PHYSICIAN ORDER ENTRY; ERP	Background: ePrescribing systems have considerable potential for improving healthcare quality and safety. With growing expectations about the benefits of such systems, there is evidence of widespread plans to implement these systems in hospitals in England where hitherto they have had a low uptake. Given the international drive away from developing homegrown to systems to procuring commercial applications, we aimed to identify available ePrescribing systems in England and to use the findings to develop a taxonomy of the systems offered by suppliers. Methods and Findings: We undertook a scoping review of the published and grey literature, and conducted expert interviews with vendors, healthcare organisations and national ePrescribing experts in order to identify the spectrum of available systems, identify and map their key features, and then iteratively develop and validate a taxonomy of commercial ePrescribing systems available to English hospitals. There is a wide range of available systems including 13 hospital- wide applications and a range of specialty systems. These commercial applications can be grouped into four sub- categories: standalone systems, modules within integrated systems, functionalities spread over several modules, and specialty systems. The findings also reveal that apart from four packaged applications ( two of which are specialty systems), all other systems have none or less than two live implementations across England. Conclusions: The wide range of products developed in the last few years by different national and international suppliers, and the low uptake of these products by English hospitals indicate that the English ePrescribing market is still in its infancy. This market is undergoing rapid cycles of change, both with respect to the number of suppliers and their diversity of offerings. Constant renewal of knowledge is needed on the status of this evolving market, encompassing the products development and adoption, to assist implementation decisions and facilitate market maturity.	[Mozaffar, Hajar; Morison, Zoe; Slee, Ann; Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, eHlth Res Grp, Edinburgh, Midlothian, Scotland; [Williams, Robin] Univ Edinburgh, Inst Study Sci Technol & Innovat, Edinburgh, Midlothian, Scotland; [Cresswell, Kathrin] Univ Edinburgh, Sch Hlth Social Sci, Edinburgh, Midlothian, Scotland; [Sheikh, Aziz] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gen Internal Med & Primary Care, Boston, MA 02115 USA	University of Edinburgh; University of Edinburgh; University of Edinburgh; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Mozaffar, H (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, eHlth Res Grp, Edinburgh, Midlothian, Scotland.	h.mozaffar@ed.ac.uk	Chuter, Antony/GNO-9976-2022	Chuter, Antony/0000-0002-0646-5939; Sheikh, Aziz/0000-0001-7022-3056; Williams, Robin/0000-0002-9044-4611; Lilford, Richard/0000-0002-0634-984X; Slight, Sarah P/0000-0002-0339-846X; Coleman, Jamie/0000-0002-7512-5153	National Institute for Health Research (NIHR) [RP-PG-1209-10099]; National Institute for Health Research [RP-PG-1209-10099] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research funded by the National Institute for Health Research (NIHR) under the Programme Grants for Applied Research programme (RP-PG-1209-10099). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammenwerth E, 2008, J AM MED INFORM ASSN, V15, P585, DOI 10.1197/jamia.M2667; Barber N, 2006, SAFER FASTER BETTER; Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Brodie M., 1995, MIGRATING LEGACY SYS; Campbell-Kelly M, 1995, BUS EC HIST, V24; CampbellKelly M, 2003, HIST COMPUT-MIT PRES, P1; Corley Sarah T, 2003, Top Health Inf Manage, V24, P29; Cresswell KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079394; Cresswell KM, 2013, J AM MED INFORM ASSN, V20, pE9, DOI 10.1136/amiajnl-2013-001684; Crowe Sarah, 2010, JRSM Short Rep, V1, P33, DOI 10.1258/shorts.2010.010040; Davenport TH, 1998, HARVARD BUS REV, V76, P121; eHealth Innitiative, 2004, EL PRESCR MAX VAL RA; Huckvale C, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.038497; James D, 2012, BUYING INFORM SYSTEM; Kaushal R, 2003, ARCH INTERN MED, V163, P1409, DOI 10.1001/archinte.163.12.1409; Kaushal R, 2001, MAKING HLTH CARE SAF, P63; Kelly S, 1999, AMCIS 1999 P; Liamputtong P., 2009, QUALITATIVE RES METH; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Morton NA, 2008, INT J INFORM MANAGE, V28, P391, DOI 10.1016/j.ijinfomgt.2008.01.008; NHS Connecting for Health, 2009, EL PRESCR HOSP CHALL; NHS Connecting for Health, 2007, EPRESCRIBING FUNCT S, P2007; NHS ENGLAND, 2013, SAF HOSP SAF WARDS A; Patton M. Q., 2005, QUALITATIVE RES; Pollock Neil, 2009, SOFTWARE ORG BIOGRAP; Reckmann MH, 2009, J AM MED INFORM ASSN, V16, P613, DOI 10.1197/jamia.M3050; Robertson A, 2011, J ROY SOC MED, V104, P434, DOI 10.1258/jrsm.2011.11k039; Sawyer S, 2000, EUR J INFORM SYST, V9, P47, DOI 10.1057/palgrave.ejis.3000345; Shamliyan TA, 2008, HEALTH SERV RES, V43, P32, DOI 10.1111/j.1475-6773.2007.00751.x; Sheikh A., 2011, IMPACT EHEALTH QUALI; Simon SR, 2006, J AM GERIATR SOC, V54, P963, DOI 10.1111/j.1532-5415.2006.00734.x; Soh C, 2004, J STRATEGIC INF SYST, V13, P375, DOI 10.1016/j.jsis.2004.11.001; Westbrook JI, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001164	33	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92516	10.1371/journal.pone.0092516	http://dx.doi.org/10.1371/journal.pone.0092516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6KM	24691517	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100027
J	Yamanaka, T; Hosoi, H; Murai, T; Kobayashi, T; Inada, Y; Nakamura, T				Yamanaka, Toshiaki; Hosoi, Hiroshi; Murai, Takayuki; Kobayashi, Takehiko; Inada, Yuji; Nakamura, Tatsuo			Regeneration of the Nerves in the Aerial Cavity with an Artificial Nerve Conduit -Reconstruction of Chorda Tympani Nerve Gaps-	PLOS ONE			English	Article							ACID-COLLAGEN TUBE; TASTE; ELECTROGUSTOMETRY; RELIABILITY; SURGERY; ANATOMY; INJURY; REPAIR	Objectives/Hypothesis: Due to its anatomical features, the chorda tympani nerve (CTN) is sometimes sacrificed during middle ear surgery, resulting in taste dysfunction. We examined the effect of placing an artificial nerve conduit, a polyglycolic acid (PGA)-collagen tube, across the gap in the section of the resected chorda tympani nerve (CTN) running through the tympanic cavity. Methods: The CTN was reconstructed with a PGA-collagen tube in three patients with taste disturbance who underwent CTN resection. To evaluate the effect of the reconstruction procedure on the patients' gustatory function, we measured the patients' electrogustometry (EGM) thresholds. The patients were followed-up for at least two years. Results: Gustatory function was completely restored in all of the patients after the reconstruction. The patients' EGM thresholds exhibited early improvements within one to two weeks and had returned to their normal ranges within three months. They subsequently remained stable throughout the two-year follow-up period. In a patient who underwent a second surgical procedure, it was found that the PGA-collagen tube used in the first surgical procedure had been absorbed and replaced by new CTN fibers with blood vessels on their surfaces. Conclusion: These results suggest that reconstruction of the CTN with an artificial nerve conduit, a PGA-collagen tube, allows functional and morphological regeneration of the nerve and facilitates the recovery of taste function. PGA-collagen tubes might be useful for repairing CTNs that are resected during middle ear surgery. Further research is required to confirm these preliminary results although this is the first report to describe the successful regeneration of a nerve running through an aerial space.	[Yamanaka, Toshiaki; Hosoi, Hiroshi; Murai, Takayuki; Kobayashi, Takehiko] Nara Med Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Nara, Japan; [Inada, Yuji] Inada Hosp, Dept Orthoped Surg, Nara, Japan; [Nakamura, Tatsuo] Kyoto Univ, Inst Frontier Med Sci, Dept Bioartificial Organs, Kyoto, Japan	Nara Medical University; Kyoto University	Yamanaka, T (corresponding author), Nara Med Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Nara, Japan.	toshya@naramed-u.ac.jp						ANSON BJ, 1972, ANN OTO RHINOL LARYN, V81, P616, DOI 10.1177/000348947208100502; Boyd KU, 2011, CLIN PLAST SURG, V38, P643, DOI 10.1016/j.cps.2011.07.008; Horie RT, 2010, LARYNGOSCOPE, V120, P377, DOI 10.1002/lary.20713; Ichihara S, 2008, INJURY, V39, pS29, DOI 10.1016/j.injury.2008.08.029; Inada Y, 2005, PAIN, V117, P251, DOI 10.1016/j.pain.2005.05.033; Inada Y, 2004, NEUROSURGERY, V55, P640, DOI 10.1227/01.NEU.0000134388.86603.11; Kannan RY, 2005, BIOTECHNOL APPL BIOC, V41, P193, DOI 10.1042/BA20040137; Kiverniti E, 2012, J LARYNGOL OTOL, V126, P34, DOI 10.1017/S0022215111002623; Kiyotani T, 1996, BRAIN RES, V740, P66, DOI 10.1016/S0006-8993(96)00848-7; KVETON JF, 1994, LARYNGOSCOPE, V104, P25; Leung RM, 2009, LARYNGOSCOPE, V119, P2061, DOI 10.1002/lary.20588; Lobb B, 2000, CLIN OTOLARYNGOL, V25, P531, DOI 10.1046/j.1365-2273.2000.00392.x; MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015; Mahendran S, 2005, EUR ARCH OTO-RHINO-L, V262, P482, DOI 10.1007/s00405-004-0854-5; McManus LJ, 2012, J LARYNGOL OTOL, V126, P8, DOI 10.1017/S0022215111002039; McManus LJ, 2011, J LARYNGOL OTOL, V125, P1101, DOI 10.1017/S0022215111001873; MURPHY C, 1995, CHEM SENSES, V20, P499, DOI 10.1093/chemse/20.5.499; Nakamura T, 2004, BRAIN RES, V1027, P18, DOI 10.1016/j.brainres.2004.08.040; Nectow AR, 2012, TISSUE ENG PART B-RE, V18, P40, DOI [10.1089/ten.teb.2011.0240, 10.1089/ten.TEB.2011.0240]; Nin T, 2006, AURIS NASUS LARYNX, V33, P13, DOI 10.1016/j.anl.2005.07.015; Pfister Bryan J., 2011, Critical Reviews in Biomedical Engineering, V39, P81, DOI 10.1615/CritRevBiomedEng.v39.i2.20; Saito T, 2001, LARYNGOSCOPE, V111, P2064, DOI 10.1097/00005537-200111000-00037; Sakagami M, 2005, CHEM SENSES, V30, pI220, DOI 10.1093/chemse/bjh193; Seddon HJ, 1943, J PHYSIOL-LONDON, V102, P191, DOI 10.1113/jphysiol.1943.sp004027; Toba T, 2001, J BIOMED MATER RES, V58, P622, DOI 10.1002/jbm.1061	25	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92258	10.1371/journal.pone.0092258	http://dx.doi.org/10.1371/journal.pone.0092258			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691095	gold, Green Published, Green Submitted			2022-12-27	WOS:000334101100018
J	Zhang, JC; Pu, RL; Yuan, L; Wang, JH; Huang, WJ; Yang, GJ				Zhang, Jingcheng; Pu, Ruiliang; Yuan, Lin; Wang, Jihua; Huang, Wenjiang; Yang, Guijun			Monitoring Powdery Mildew of Winter Wheat by Using Moderate Resolution Multi- Temporal Satellite Imagery	PLOS ONE			English	Article							LEAST-SQUARES REGRESSION; YELLOW RUST; REFLECTANCE MEASUREMENTS; SPECTRAL REFLECTANCE; VEGETATION INDEXES; AREA INDEX; DISEASE; INFESTATION; PINE; SENSITIVITY	Powdery mildew is one of the most serious diseases that have a significant impact on the production of winter wheat. As an effective alternative to traditional sampling methods, remote sensing can be a useful tool in disease detection. This study attempted to use multi- temporal moderate resolution satellite- based data of surface reflectances in blue ( B), green ( G), red ( R) and near infrared (NIR) bands from HJ-CCD ( CCD sensor on Huanjing satellite) to monitor disease at a regional scale. In a suburban area in Beijing, China, an extensive field campaign for disease intensity survey was conducted at key growth stages of winter wheat in 2010. Meanwhile, corresponding time series of HJ- CCD images were acquired over the study area. In this study, a number of single- stage and multi- stage spectral features, which were sensitive to powdery mildew, were selected by using an independent t- test. With the selected spectral features, four advanced methods: mahalanobis distance, maximum likelihood classifier, partial least square regression and mixture tuned matched filtering were tested and evaluated for their performances in disease mapping. The experimental results showed that all four algorithms could generate disease maps with a generally correct distribution pattern of powdery mildew at the grain filling stage ( Zadoks 72). However, by comparing these disease maps with ground survey data ( validation samples), all of the four algorithms also produced a variable degree of error in estimating the disease occurrence and severity. Further, we found that the integration of MTMF and PLSR algorithms could result in a significant accuracy improvement of identifying and determining the disease intensity ( overall accuracy of 72% increased to 78% and kappa coefficient of 0.49 increased to 0.59). The experimental results also demonstrated that the multi- temporal satellite images have a great potential in crop diseases mapping at a regional scale.	[Zhang, Jingcheng; Yuan, Lin; Wang, Jihua; Huang, Wenjiang; Yang, Guijun] Beijing Acad Agr & Forestry Sci, Beijing Res Ctr Informat Technol Agr, Beijing, Peoples R China; [Zhang, Jingcheng; Pu, Ruiliang] Univ S Florida, Sch Geosci, Tampa, FL USA; [Zhang, Jingcheng; Yuan, Lin; Wang, Jihua] Zhejiang Univ, Inst Agr Remote Sensing & Informat Syst Applicat, Hangzhou 310003, Zhejiang, Peoples R China; [Huang, Wenjiang] Chinese Acad Sci, Ctr Earth Observat & Digital Earth, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry; State University System of Florida; University of South Florida; Zhejiang University; Chinese Academy of Sciences	Yang, GJ (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Res Ctr Informat Technol Agr, Beijing, Peoples R China.	yanggj@nercita.org.cn	huang, wenjiang/AAM-6844-2021	Yang, Guijun/0000-0002-6425-8321	National Natural Science Foundation of China [41301476, 41271412]; Beijing Natural Science Foundation [4132029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was subsidized by National Natural Science Foundation of China (41301476, 41271412), and Beijing Natural Science Foundation (4132029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew ME, 2008, REMOTE SENS ENVIRON, V112, P4301, DOI 10.1016/j.rse.2008.07.016; Bauriegel E, 2011, COMPUT ELECTRON AGR, V75, P304, DOI 10.1016/j.compag.2010.12.006; BOARDMAN JW, 1998, P 5 JPL GEOSC WORKSH; Cao XR, 2013, CROP PROT, V45, P124, DOI 10.1016/j.cropro.2012.12.002; Chen X, 2007, INT J REMOTE SENS, V28, P5183, DOI 10.1080/01431160701620683; Christou P, 2004, NUTR RES REV, V17, P23, DOI 10.1079/NRR200373; Cooke BM, 2006, EPIDEMIOLOGY PLANT D; Coops NC, 2006, REMOTE SENS ENVIRON, V105, P83, DOI 10.1016/j.rse.2006.06.007; Devadas R, 2009, PRECIS AGRIC, V10, P459, DOI 10.1007/s11119-008-9100-2; Eklundh L, 2009, REMOTE SENS ENVIRON, V113, P1566, DOI 10.1016/j.rse.2009.03.008; Faber NM, 2007, ANAL CHIM ACTA, V595, P98, DOI 10.1016/j.aca.2007.05.030; Franke J, 2007, PRECIS AGRIC, V8, P161, DOI 10.1007/s11119-007-9036-y; Gonsamo A, 2012, ISPRS J PHOTOGRAMM, V70, P15, DOI 10.1016/j.isprsjprs.2012.03.009; Goodwin NR, 2008, REMOTE SENS ENVIRON, V112, P3680, DOI 10.1016/j.rse.2008.05.005; Hahn F, 2009, ALGORITHMS, V2, P301, DOI 10.3390/a2010301; Huang W, 2007, PRECIS AGRIC, V8, P187, DOI 10.1007/s11119-007-9038-9; Jones CD, 2010, COMPUT ELECTRON AGR, V74, P329, DOI 10.1016/j.compag.2010.09.008; Kennedy RE, 2009, REMOTE SENS ENVIRON, V113, P1382, DOI 10.1016/j.rse.2008.07.018; Li BB, 2002, CHEMOMETR INTELL LAB, V64, P79, DOI 10.1016/S0169-7439(02)00051-5; Li G.B., 1989, INTEGRATED MANAGEMEN; Liang SL, 2001, IEEE T GEOSCI REMOTE, V39, P2490, DOI 10.1109/36.964986; Liu DS, 2006, REMOTE SENS ENVIRON, V101, P167, DOI 10.1016/j.rse.2005.12.012; LORENZEN B, 1989, REMOTE SENS ENVIRON, V27, P201, DOI 10.1016/0034-4257(89)90018-7; Lu D, 2004, INT J REMOTE SENS, V25, P2365, DOI 10.1080/0143116031000139863; Mitchell JJ, 2009, INT J REMOTE SENS, V30, P6099, DOI 10.1080/01431160902810620; Moshou D, 2004, COMPUT ELECTRON AGR, V44, P173, DOI 10.1016/j.compag.2004.04.003; Muhammed HH, 2005, BIOSYST ENG, V91, P9, DOI 10.1016/j.biosystemseng.2005.02.007; Naidu RA, 2009, COMPUT ELECTRON AGR, V66, P38, DOI 10.1016/j.compag.2008.11.007; NILSSON HE, 1995, CAN J PLANT PATHOL, V17, P154, DOI 10.1080/07060669509500707; Nofal MA, 2006, CROP PROT, V25, P480, DOI 10.1016/j.cropro.2005.08.003; Olsen M, 2003, CROP PROT, V22, P679, DOI 10.1016/S0261-2194(02)00245-4; Pu RL, 2012, REMOTE SENS ENVIRON, V124, P516, DOI 10.1016/j.rse.2012.06.011; Pu RL, 2012, GISCI REMOTE SENS, V49, P92, DOI 10.2747/1548-1603.49.1.92; Qin ZH, 2005, INT J APPL EARTH OBS, V7, P115, DOI 10.1016/j.jag.2005.03.004; RABBINGE R, 1985, NETH J PLANT PATHOL, V91, P235, DOI 10.1007/BF01997967; Remus-Borel W, 2005, PHYSIOL MOL PLANT P, V66, P108, DOI 10.1016/j.pmpp.2005.05.006; Richards J.A., 2006, REMOTE SENSING DIGIT; Sankaran S, 2010, COMPUT ELECTRON AGR, V72, P1, DOI 10.1016/j.compag.2010.02.007; Sharma AK, 2004, CROP PROT, V23, P249, DOI 10.1016/j.cropro.2003.08.009; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; Skakun RS, 2003, REMOTE SENS ENVIRON, V86, P433, DOI 10.1016/S0034-4257(03)00112-3; Song SL, 2011, ISPRS J PHOTOGRAMM, V66, P672, DOI 10.1016/j.isprsjprs.2011.05.002; Stohlgren TJ, 2005, N AM WEED MANAGEMENT; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Townshend JRG, 1992, IEEE T GEOSCI REMOTE, V30, P1056; Veraverbeke S, 2012, ISPRS J PHOTOGRAMM, V68, P28, DOI 10.1016/j.isprsjprs.2011.12.007; West JS, 2003, ANNU REV PHYTOPATHOL, V41, P593, DOI 10.1146/annurev.phyto.41.121702.103726; Yang CM, 2007, CROP SCI, V47, P329, DOI 10.2135/cropsci2006.05.0335; Zhang J., 2012, THESIS ZHEJIANG U; Zhang JC, 2012, COMPUT ELECTRON AGR, V85, P13, DOI 10.1016/j.compag.2012.03.006; Zhang JC, 2011, INTELL AUTOM SOFT CO, V17, P531; Zhang JC, 2011, PRECIS AGRIC, V12, P716, DOI 10.1007/s11119-010-9214-1; Zhang M., 2003, INT J APPL EARTH OBS, V4, P295, DOI 10.1016/S0303-2434(03)00008-4; Zhang Minghua, 2005, Precision Agriculture, V6, P489, DOI 10.1007/s11119-005-5640-x; Zhao CJ, 2004, INT GEOSCI REMOTE SE, P4318	55	23	30	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93107	10.1371/journal.pone.0093107	http://dx.doi.org/10.1371/journal.pone.0093107			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691435	Green Submitted, Green Published, gold			2022-12-27	WOS:000334101100045
J	Ma, Y; Kang, XN; Ding, WB; Yang, HZ; Wang, Y; Zhang, J; Huang, YR; Dai, HL				Ma, Yi; Kang, Xiao-Nan; Ding, Wen-Bin; Yang, Hao-Zheng; Wang, Ye; Zhang, Jin; Huang, Yi-Ran; Dai, Hui-Li			Renal Tissue Thawed for 30 Minutes Is Still Suitable for Gene Expression Analysis	PLOS ONE			English	Article							FRESH-FROZEN TISSUE; RNA INTEGRITY; WARM ISCHEMIA; IMPACT; TIME; QUALITY; DEGRADATION; MICROARRAYS; STABILITY	Some biosamples obtained from biobanks may go through thawing before processing. We aim to evaluate the effects of thawing at room temperature for different time periods on gene expression analysis. A time course study with four time points was conducted to investigate the expression profiling on 10 thawed normal mice renal tissue samples through Affymetrix GeneChip mouse gene 2.0 st array. Microarray results were validated by quantitative real time polymerase chain reactions (qPCR) on 6 candidate reference genes and 11 target genes. Additionally, we used geNorm plus and NormFinder to identify the most stably expressed reference genes over time. The results showed RNA degraded more after longer incubation at room temperature. However, microarray results showed only 240 genes (0.91%) altered significantly in response to thawing at room temperature. The signal of majority altered probe sets decreased with thawing time, and the crossing point (Cp) values of all candidate reference genes correlated positively with the thawing time (p < 0.05). The combination of B2M, ACTB and PPIA was identified as the best choice for qPCR normalization. We found most target genes were stable by using this normalization method. However, serious gene quantification errors were resulted from improper reference genes. In conclusion, thirty minutes of thawing at room temperature has a limited impact on microarray and qPCR analysis, gene expression variations due to RNA degradation in early period after thawing can be largely reduced by proper normalization.	[Ma, Yi; Kang, Xiao-Nan; Ding, Wen-Bin; Wang, Ye; Dai, Hui-Li] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Biobank, Shanghai 200030, Peoples R China; [Ma, Yi; Zhang, Jin; Huang, Yi-Ran] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Urol, Shanghai 200030, Peoples R China; [Yang, Hao-Zheng] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Cent Lab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Huang, YR (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Urol, Shanghai 200030, Peoples R China.	dr_yrh@126.com; dr_dhl@126.com			Science and Technology Commission of Shanghai Municipality [124119a1300, 12DZ2295005]; Shanghai JiaoTong University School of Medicine [12XJ10014, YBKL2013004]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai JiaoTong University School of Medicine	This work was supported by Science and Technology Commission of Shanghai Municipality (124119a1300; 12DZ2295005) and Shanghai JiaoTong University School of Medicine (12XJ10014; YBKL2013004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah-Sayani A, 2006, NAT CLIN PRACT ONCOL, V3, P501, DOI 10.1038/ncponc0587; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Antonov J, 2005, LAB INVEST, V85, P1040, DOI 10.1038/labinvest.3700303; Auer H, 2003, NAT GENET, V35, P292, DOI 10.1038/ng1203-292; Barry WT, 2010, J CLIN ONCOL, V28, P2198, DOI 10.1200/JCO.2009.26.7245; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; Blackhall FH, 2004, NEOPLASIA, V6, P761, DOI 10.1593/neo.04301; Botling J, 2009, DIAGN MOL PATHOL, V18, P44, DOI 10.1097/PDM.0b013e3181857e92; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dash A, 2002, AM J PATHOL, V161, P1743, DOI 10.1016/S0002-9440(10)64451-3; De Cecco L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-409; Elger BS, 2006, EMBO REP, V7, P661, DOI 10.1038/sj.embor.7400740; Ellis M, 2002, CLIN CANCER RES, V8, P1155; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Hatzis C, 2011, JNCI-J NATL CANCER I, V103, P1871, DOI 10.1093/jnci/djr438; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Ioannidis JPA, 2007, ONCOLOGIST, V12, P301, DOI 10.1634/theoncologist.12-3-301; Lin DW, 2006, J CLIN ONCOL, V24, P3763, DOI 10.1200/JCO.2005.05.1458; Ma Y, 2012, DIAGN MOL PATHOL, V21, P157, DOI 10.1097/PDM.0b013e31824d3435; Ma Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036050; Ma Y, 2012, ANAL BIOCHEM, V423, P229, DOI 10.1016/j.ab.2012.02.003; Mager SR, 2007, EUR J CANCER, V43, P828, DOI 10.1016/j.ejca.2007.01.002; Micke P, 2006, LAB INVEST, V86, P202, DOI 10.1038/labinvest.3700372; Mutter GL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-88; Perez-Novo CA, 2005, BIOTECHNIQUES, V39, P52; Rudloff U, 2010, ANN SURG ONCOL, V17, P2229, DOI 10.1245/s10434-010-0959-6; Schlomm T, 2008, EUR UROL, V53, P333, DOI 10.1016/j.eururo.2007.03.075; Schoor O, 2003, BIOTECHNIQUES, V35, P1192, DOI 10.2144/03356rr01; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Thompson KL, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-57; Vermeulen J, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr065	31	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93175	10.1371/journal.pone.0093175	http://dx.doi.org/10.1371/journal.pone.0093175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24687048	gold, Green Submitted, Green Published			2022-12-27	WOS:000340842300005
J	Dotterl, S; Gluck, U; Jurgens, A; Woodring, J; Aas, G				Doetterl, Stefan; Glueck, Ulrike; Juergens, Andreas; Woodring, Joseph; Aas, Gregor			Floral Reward, Advertisement and Attractiveness to Honey Bees in Dioecious Salix caprea	PLOS ONE			English	Article							POLLEN LIMITATION; REPRODUCTIVE SUCCESS; POLLINATOR SELECTIVITY; PLANT REPRODUCTION; NECTAR PRODUCTION; CHEMICAL ECOLOGY; WIND POLLINATION; SEX-DIFFERENCES; FEMALE FLOWERS; OLFACTORY CUES	In dioecious, zoophilous plants potential pollinators have to be attracted to both sexes and switch between individuals of both sexes for pollination to occur. It often has been suggested that males and females require different numbers of visits for maximum reproductive success because male fertility is more likely limited by access to mates, whereas female fertility is rather limited by resource availability. According to sexual selection theory, males therefore should invest more in pollinator attraction (advertisement, reward) than females. However, our knowledge on the sex specific investment in floral rewards and advertisement, and its effects on pollinator behaviour is limited. Here, we use an approach that includes chemical, spectrophotometric, and behavioural studies i) to elucidate differences in floral nectar reward and advertisement (visual, olfactory cues) in dioecious sallow, Salix caprea, ii) to determine the relative importance of visual and olfactory floral cues in attracting honey bee pollinators, and iii) to test for differential attractiveness of female and male inflorescence cues to honey bees. Nectar amount and sugar concentration are comparable, but sugar composition varies between the sexes. Olfactory sallow cues are more attractive to honey bees than visual cues; however, a combination of both cues elicits the strongest behavioural responses in bees. Male flowers are due to the yellow pollen more colourful and emit a higher amount of scent than females. Honey bees prefer the visual but not the olfactory display of males over those of females. In all, the data of our multifaceted study are consistent with the sexual selection theory and provide novel insights on how the model organism honey bee uses visual and olfactory floral cues for locating host plants.	[Doetterl, Stefan] Univ Bayreuth, Dept Plant Systemat, Bayreuth, Germany; [Glueck, Ulrike; Aas, Gregor] Univ Bayreuth, Ecol Bot Garden, Bayreuth, Germany; [Juergens, Andreas] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Pietermaritzburg, South Africa; [Woodring, Joseph] Univ Bayreuth, Dept Anim Ecol, Bayreuth, Germany	University of Bayreuth; University of Bayreuth; University of Kwazulu Natal; University of Bayreuth	Dotterl, S (corresponding author), Salzburg Univ, A-5020 Salzburg, Austria.	stefan.doetterl@sbg.ac.at	Juergens, Andreas/E-9479-2010	Juergens, Andreas/0000-0002-5288-0498; Dotterl, Stefan/0000-0001-5228-1332	German Research Foundation (Research Training Group 678) [C5]	German Research Foundation (Research Training Group 678)	This work was supported by German Research Foundation (Research Training Group 678, Project C5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN J, 1986, OECOLOGIA, V70, P332, DOI 10.1007/BF00379493; Amirav A, 1997, EUR MASS SPECTROM, V3, P105, DOI 10.1255/ejms.27; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Armstrong JE, 1997, AM J BOT, V84, P1266, DOI 10.2307/2446051; Ashman TL, 2009, FUNCT ECOL, V23, P852, DOI 10.1111/j.1365-2435.2009.01590.x; Ashman TL, 2000, OIKOS, V90, P347, DOI 10.1034/j.1600-0706.2000.900216.x; Ashman TL, 2005, ECOLOGY, V86, P2099, DOI 10.1890/04-1161; Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; Ashman TL, 2000, ECOLOGY, V81, P2577, DOI 10.1890/0012-9658(2000)081[2577:PSAIIF]2.0.CO;2; Balkenius A, 2006, J COMP PHYSIOL A, V192, P431, DOI 10.1007/s00359-005-0081-6; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BAWA KS, 1980, ANNU REV ECOL SYST, V11, P15, DOI 10.1146/annurev.es.11.110180.000311; BAWA KS, 1980, EVOLUTION, V34, P467, DOI 10.1111/j.1558-5646.1980.tb04836.x; BAWA KS, 1975, EVOLUTION, V29, P167, DOI [10.2307/2407150, 10.1111/j.1558-5646.1975.tb00824.x]; BIERZYCHUDEK P, 1987, ECOLOGY, V68, P444, DOI 10.2307/1939276; Blair AC, 2007, CAN J BOT, V85, P414, DOI 10.1139/B07-025; BURD M, 1994, BOT REV, V60, P83, DOI 10.1007/BF02856594; Burger H, 2010, FUNCT ECOL, V24, P1234, DOI 10.1111/j.1365-2435.2010.01744.x; BUTLER CG, 1951, PROC R SOC SER B-BIO, V138, P403, DOI 10.1098/rspb.1951.0032; CHARLESWORTH D, 1993, AM NAT, V141, P481, DOI 10.1086/285485; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; Chittka L., 2005, PRACTICAL POLLINATIO, P157; Clarke KR, 2006, PRIMER V6 USER MANUA, P1; COLLISON CH, 1979, J APICULT RES, V18, P184, DOI 10.1080/00218839.1979.11099965; Costich DE, 2001, BIOL J LINN SOC, V74, P475, DOI 10.1111/j.1095-8312.2001.tb01406.x; Delph LF, 2006, INTEGR COMP BIOL, V46, P465, DOI 10.1093/icb/icj038; Dotterl S, 2010, CAN J ZOOL, V88, P668, DOI 10.1139/Z10-031; Dotterl S, 2011, J COMP PHYSIOL A, V197, P1119, DOI 10.1007/s00359-011-0673-2; Dotterl S, 2005, PHYTOCHEMISTRY, V66, P203, DOI 10.1016/j.phytochem.2004.12.002; Dotterl S, 2005, J CHEM ECOL, V31, P2993, DOI 10.1007/s10886-005-9152-y; Dyer AG, 2004, J COMP PHYSIOL A, V190, P105, DOI 10.1007/s00359-003-0475-2; FOX JF, 1992, OECOLOGIA, V90, P283, DOI 10.1007/BF00317187; Fussel U, 2007, J CHEM ECOL, V33, P749, DOI 10.1007/s10886-007-9257-6; Fussel U., 2007, THESIS U BAYREUTH BA; GALEN C, 1980, AM MIDL NAT, V104, P281, DOI 10.2307/2424867; GIURFA M, 1995, J COMP PHYSIOL A, V177, P247; Golonka AM, 2013, AM MIDL NAT, V169, P235, DOI 10.1674/0003-0031-169.2.235; Goukon K, 1976, SAISHU TO SHIIKU, V38, P111; Greco CF, 1996, CAN ENTOMOL, V128, P355, DOI 10.4039/Ent128355-3; HARDER LD, 1994, EVOL ECOL, V8, P542, DOI 10.1007/BF01238257; HEINRICH B, 1977, BEHAV ECOL SOCIOBIOL, V2, P247, DOI 10.1007/BF00299738; Herrera CM, 2008, ECOLOGY, V89, P2369, DOI 10.1890/08-0241.1; Heuschen B, 2005, PLANT SYST EVOL, V252, P121, DOI 10.1007/s00606-004-0249-5; Howe Henry F., 1997, P262; Johnson SD, 2009, AM J BOT; Jurgens A, 2004, AM J BOT, V91, P1969, DOI 10.3732/ajb.91.12.1969; Karrenberg S, 2002, PLANT SYST EVOL, V235, P181, DOI 10.1007/s00606-002-0231-z; KATOH N, 1985, Science Reports of the Tohoku University Fourth Series (Biology), V39, P45; KAY QON, 1984, NEW PHYTOL, V98, P515, DOI 10.1111/j.1469-8137.1984.tb04145.x; KEVAN PG, 1972, J ECOL, V60, P831, DOI 10.2307/2258569; Laporte MM, 1996, OECOLOGIA, V106, P63, DOI 10.1007/BF00334408; LEPAGE M, 1968, LIPIDS, V3, P530, DOI 10.1007/BF02530897; LUNAU K, 1992, CAN J ZOOL, V70, P2139, DOI 10.1139/z92-288; Lunau K, 2000, PLANT SYST EVOL, V222, P89, DOI 10.1007/BF00984097; Lunau K, 2007, BOT JB SYSTEMATIK PF, V127, P13; Menzel R, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P21, DOI 10.1017/CBO9780511542268.003; Milet-Pinheiro P, 2012, BEHAV ECOL, V23, P531, DOI 10.1093/beheco/arr219; Nepi M, 1996, ACTA BOT NEERL, V45, P41; Omura H, 2005, OECOLOGIA, V142, P588, DOI 10.1007/s00442-004-1761-6; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; PERCIVAL MARY S., 1961, NEW PHYTOL, V60, P235, DOI 10.1111/j.1469-8137.1961.tb06255.x; PICHERSKY E, 1994, PLANT PHYSIOL, V106, P1533, DOI 10.1104/pp.106.4.1533; Pohl M, 2008, BEHAV ECOL SOCIOBIOL, V63, P295, DOI 10.1007/s00265-008-0661-x; Raguso RA, 2005, ANIM BEHAV, V69, P407, DOI 10.1016/j.anbehav.2004.04.015; Raguso RA, 2002, ANIM BEHAV, V64, P685, DOI 10.1006/anbe.2002.4010; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; RIBBANDS CR, 1949, J ANIM ECOL, V18, P47, DOI 10.2307/1581; Richard A.J, 1997, PLANT BREEDING SYSTE; Roy BA, 1997, OECOLOGIA, V109, P414, DOI 10.1007/s004420050101; Schaffler I, 2011, APIDOLOGIE, V42, P409, DOI 10.1007/s13592-011-0010-3; Shykoff JA, 1997, CAN J BOT, V75, P1407, DOI 10.1139/b97-855; Skvortsov A.K., 1999, FACULTY MATH NATURAL; Soler CCL, 2012, ECOL LETT, V15, P978, DOI 10.1111/j.1461-0248.2012.01818.x; STANTON ML, 1986, SCIENCE, V232, P1625, DOI 10.1126/science.232.4758.1625; StatSoft Inc, 2008, STAT DAT AN SOFTW SY; Svensson GP, 2010, NEW PHYTOL, V186, P995, DOI 10.1111/j.1469-8137.2010.03227.x; Theis N, 2007, INT J PLANT SCI, V168, P587, DOI 10.1086/513481; TOLLSTEN L, 1992, PLANT SYST EVOL, V182, P229, DOI 10.1007/BF00939189; Totland O, 2001, AM J BOT, V88, P1011, DOI 10.2307/2657082; Urban Claudia, 2004, Senckenbergiana Biologica, V84, P81; van der Werf F, 1982, BEITR BIOL PFLANZ, V56, P105; Vaughton G, 1998, OECOLOGIA, V115, P93, DOI 10.1007/s004420050495; von Frisch Karl, 1919, ZOOL JB, V37, P1; VROEGE PW, 1990, ISRAEL J BOT, V39, P125; Waelti MO, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-190; WILSON P, 1994, AM NAT, V143, P283, DOI 10.1086/285604; Wright GA, 2005, J COMP PHYSIOL A, V191, P105, DOI 10.1007/s00359-004-0576-6; WYKES GR, 1952, J EXP BIOL, V29, P511; Zhen-Fu F., 1987, J SYST EVOL, V25, P307	90	52	56	3	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93421	10.1371/journal.pone.0093421	http://dx.doi.org/10.1371/journal.pone.0093421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676333	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677500121
J	Dostal, A; Gagnon, M; Chassard, C; Zimmermann, MB; O'Mahony, L; Lacroix, C				Dostal, Alexandra; Gagnon, Melanie; Chassard, Christophe; Zimmermann, Michael Bruce; O'Mahony, Liam; Lacroix, Christophe			Salmonella Adhesion, Invasion and Cellular Immune Responses Are Differentially Affected by Iron Concentrations in a Combined In Vitro Gut Fermentation-Cell Model	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; LACTIC-ACID BACTERIA; KAPPA-B ACTIVATION; COCULTURE MODEL; CACO-2; RESISTANCE; EXPRESSION; MICROBIOTA; INFECTION; GROWTH	In regions with a high infectious disease burden, concerns have been raised about the safety of iron supplementation because higher iron concentrations in the gut lumen may increase risk of enteropathogen infection. The aim of this study was to investigate interactions of the enteropathogen Salmonella enterica ssp. enterica Typhimurium with intestinal cells under different iron concentrations encountered in the gut lumen during iron deficiency and supplementation using an in vitro colonic fermentation system inoculated with immobilized child gut microbiota combined with Caco-2/HT29-MTX co-culture monolayers. Colonic fermentation effluents obtained during normal, low (chelation by 2,2'-dipyridyl) and high iron (26.5 mg iron/L) fermentation conditions containing Salmonella or pure Salmonella cultures with similar iron conditions were applied to cellular monolayers. Salmonella adhesion and invasion capacity, cellular integrity and immune response were assessed. Under high iron conditions in pure culture, Salmonella adhesion was 8-fold increased compared to normal iron conditions while invasion was not affected leading to decreased invasion efficiency (-86%). Moreover, cellular cytokines IL-1 beta, IL-6, IL-8 and TNF-alpha secretion as well as NF-kappa B activation in THP-1 cells were attenuated under high iron conditions. Low iron conditions in pure culture increased Salmonella invasion correlating with an increase in IL-8 release. In fermentation effluents, Salmonella adhesion was 12-fold and invasion was 428-fold reduced compared to pure culture. Salmonella in high iron fermentation effluents had decreased invasion efficiency (-77.1%) and cellular TNF-alpha release compared to normal iron effluent. The presence of commensal microbiota and bacterial metabolites in fermentation effluents reduced adhesion and invasion of Salmonella compared to pure culture highlighting the importance of the gut microbiota as a barrier during pathogen invasion. High iron concentrations as encountered in the gut lumen during iron supplementation attenuated Salmonella invasion efficiency and cellular immune response suggesting that high iron concentrations alone may not lead to an increased Salmonella invasion.	[Dostal, Alexandra; Gagnon, Melanie; Chassard, Christophe; Lacroix, Christophe] ETH, Inst Food Nutr & Hlth, Lab Food Biotechnol, Zurich, Switzerland; [Zimmermann, Michael Bruce] ETH, Inst Food Nutr & Hlth, Human Nutr Lab, Zurich, Switzerland; [O'Mahony, Liam] Univ Zurich, Swiss Inst Allergy & Asthma Res, Davos, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Allergy & Asthma Research; University of Zurich	Lacroix, C (corresponding author), ETH, Inst Food Nutr & Hlth, Lab Food Biotechnol, Zurich, Switzerland.	christophe.lacroix@hest.ethz.ch	Lacroix, Christophe/B-5139-2016; O'Mahony, Liam/AAG-5838-2019; Zimmermann, Michael B/C-3062-2016	Lacroix, Christophe/0000-0003-4360-2020; O'Mahony, Liam/0000-0003-4705-3583; 	Swiss National Science Foundation, Bern, Switzerland [310030_127272]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01HD0 64921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD064921] Funding Source: NIH RePORTER	Swiss National Science Foundation, Bern, Switzerland(Swiss National Science Foundation (SNSF)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the Swiss National Science Foundation (project number: 310030_127272, Bern, Switzerland) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (award number: U01HD0 64921). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrami B, 2011, J APPL MICROBIOL, V110, P353, DOI 10.1111/j.1365-2672.2010.04889.x; Bahrami B, 2011, APPL ENVIRON MICROB, V77, P2934, DOI 10.1128/AEM.02244-10; Bermudez-Brito M, 2013, BRIT J NUTR, V109, pS27, DOI 10.1017/S0007114512004023; Bjarnason J, 2003, J BACTERIOL, V185, P4973, DOI 10.1128/JB.185.16.4973-4982.2003; Burkholder KM, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-14; Chen CY, 2012, POULTRY SCI, V91, P2139, DOI 10.3382/ps.2012-02237; Collado MC, 2007, CURR MICROBIOL, V55, P260, DOI 10.1007/s00284-007-0144-8; Collins HL, 2008, EUR J IMMUNOL, V38, P1803, DOI 10.1002/eji.200838505; Collins HL, 2003, IMMUNOL LETT, V85, P193, DOI 10.1016/S0165-2478(02)00229-8; Collins HL, 2002, J IMMUNOL, V168, P3458, DOI 10.4049/jimmunol.168.7.3458; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Dostal A, 2013, FEMS MICROBIOL ECOL, V83, P161, DOI 10.1111/j.1574-6941.2012.01461.x; Dostal A, 2012, J NUTR, V142, P271, DOI 10.3945/jn.111.148643; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Fang HW, 2010, J MED MICROBIOL, V59, P573, DOI 10.1099/jmm.0.009662-0; Ferreira RBR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020338; Foster SL, 2001, J NUTR, V131, P1452, DOI 10.1093/jn/131.5.1452; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gagnon M, 2013, J MICROBIOL METH, V94, P274, DOI 10.1016/j.mimet.2013.06.027; Gantois I, 2006, APPL ENVIRON MICROB, V72, P946, DOI 10.1128/AEM.72.1.946-949.2006; Gera T, 2002, BMJ-BRIT MED J, V325, P1142, DOI 10.1136/bmj.325.7373.1142; Haller D, 2004, IMMUNOLOGY, V112, P310, DOI 10.1111/j.1365-2567.2004.01874.x; Haller D, 2000, GUT, V47, P79, DOI 10.1136/gut.47.1.79; Iannotti LL, 2006, AM J CLIN NUTR, V84, P1261, DOI 10.1093/ajcn/84.6.1261; Janakiraman A, 2000, MOL MICROBIOL, V35, P1146, DOI 10.1046/j.1365-2958.2000.01783.x; Kortman GAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029968; Lakhdari O, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/282356; Laparra JM, 2009, LETT APPL MICROBIOL, V49, P695, DOI 10.1111/j.1472-765X.2009.02729.x; Laparra JM, 2009, CELL BIOL INT, V33, P971, DOI 10.1016/j.cellbi.2009.06.001; Layton AN, 2010, FEMS MICROBIOL LETT, V302, P114, DOI 10.1111/j.1574-6968.2009.01847.x; Lee SH, 2008, BIOL TRACE ELEM RES, V126, pS57, DOI 10.1007/s12011-008-8209-5; LESUFFLEUR T, 1990, CANCER RES, V50, P6334; Mahler GJ, 2009, J NUTR BIOCHEM, V20, P494, DOI 10.1016/j.jnutbio.2008.05.006; Nairz M, 2008, EUR J IMMUNOL, V38, P1923, DOI 10.1002/eji.200738056; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; O'Mahony D, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-63; Parlesak A, 2004, SCAND J IMMUNOL, V60, P477, DOI 10.1111/j.0300-9475.2004.01495.x; Pieracci Fredric M, 2005, Surg Infect (Larchmt), V6 Suppl 1, pS41, DOI 10.1089/sur.2005.6.s1-41; PUSCHMANN M, 1977, INFECT IMMUN, V17, P663, DOI 10.1128/IAI.17.3.663-664.1977; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Simovich M, 2003, AM J HEMATOL, V74, P32, DOI 10.1002/ajh.10383; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Stoidis CN, 2010, NUTR RES REV, P1; Teixido L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019711; Tsai CC, 2011, FEMS IMMUNOL MED MIC, V63, P44, DOI 10.1111/j.1574-695X.2011.00826.x; Van Immerseel F, 2004, POULTRY SCI, V83, P69, DOI 10.1093/ps/83.1.69; Van Immerseel F, 2003, INT J FOOD MICROBIOL, V85, P237, DOI 10.1016/S0168-1605(02)00542-1; Viswanathan VK, 2009, NAT REV MICROBIOL, V7, P110, DOI 10.1038/nrmicro2053; Wang LJ, 2008, J IMMUNOL, V181, P2723, DOI 10.4049/jimmunol.181.4.2723; Wang LJ, 2009, J CLIN INVEST, V119, P3322, DOI 10.1172/JCI39939; Zaharik ML, 2002, P NATL ACAD SCI USA, V99, P15705, DOI 10.1073/pnas.252415599; Zihler A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-264; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5; Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564	57	38	38	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93549	10.1371/journal.pone.0093549	http://dx.doi.org/10.1371/journal.pone.0093549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676135	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000333677500139
J	Lu, KL; Xu, WN; Wang, LN; Zhang, DD; Zhang, CN; Liu, WB				Lu, Kang-Le; Xu, Wei-Na; Wang, Li-Na; Zhang, Ding-Dong; Zhang, Chun-Nuan; Liu, Wen-Bin			Hepatic beta-Oxidation and Regulation of Carnitine Palmitoyltransferase (CPT) I in Blunt Snout Bream Megalobrama amblycephala Fed a High Fat Diet	PLOS ONE			English	Article							CARP CTENOPHARYNGODON-IDELLA; SALMON SALMO-SALAR; GENE-EXPRESSION; LIPID-COMPOSITION; MITOCHONDRIAL DYSFUNCTION; GROWTH-PERFORMANCE; LIVER HISTOLOGY; PRACTICAL DIETS; INDUCED OBESITY; ACID OXIDATION	High-fat diets may promote growth, partly through their protein-sparing effects. However, high-fat diets often lead to excessive fat deposition, which may have a negative impact on fish such as poor growth and suppressive immune. Therefore, this study investigated the effects of a fat-rich diet on the mechanisms of fat deposition in the liver. Three-hundred blunt snout bream (Megalobrama amblycephala) juveniles (initial mass 18.00 +/- 0.05 g) were fed with one of two diets (5% or 15% fat) for 8 weeks. beta-Oxidation capacity and regulation of rate-limiting enzymes were assessed. Large fat droplets were present in hepatocytes of fish fed the high-fat diet. This observation is thought to be largely owing to the reduced capacity for mitochondrial and peroxisomal beta-oxidation in the livers of fish fed the high-fat diet, as well as the decreased activities of carnitine palmitoyltransferase (CPT) I and acyl-CoA oxidase (ACO), which are enzymes involved in fatty-acid metabolism. Study of CPT I kinetics showed that CPT I had a low affinity for its substrates and a low catalytic efficiency in fish fed the high-fat diet. Expression of both CPT I and ACO was significantly down-regulated in fish fed the high-fat diet. Moreover, the fatty-acid composition of the mitochondrial membrane varied between the two groups. In conclusion, the attenuated beta-oxidation capacity observed in fish fed a high-fat diet is proposed to be owing to decreased activity and/or catalytic efficiency of the rate-limiting enzymes CPT I and ACO, via both genetic and non-genetic mechanisms.	[Lu, Kang-Le; Xu, Wei-Na; Wang, Li-Na; Zhang, Ding-Dong; Zhang, Chun-Nuan; Liu, Wen-Bin] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Liu, WB (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	wbliu@njau.edu.cn	Lu, Kang-le/I-6284-2019	Lu, Kang-le/0000-0002-6548-4291	National Natural Science Foundation of China [31172418, 31202005]; China Agriculture Research System [CARS-46-20]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System	The project was supported by the National Natural Science Foundation of China (31172418 and 31202005) and China Agriculture Research System (CARS-46-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIEBER LL, 1986, METHOD ENZYMOL, V123, P276; Blanchard G, 2008, BRIT J NUTR, V100, P317, DOI 10.1017/S0007114508926532; Bolla S, 2011, AQUACULTURE, V312, P117, DOI 10.1016/j.aquaculture.2010.12.019; Caballero MJ, 1999, AQUACULTURE, V179, P277, DOI 10.1016/S0044-8486(99)00165-9; Colquhoun A, 2002, BBA-MOL CELL BIOL L, V1583, P74, DOI 10.1016/S1388-1981(02)00162-2; DEMOZ A, 1995, J CHROMATOGR B, V667, P148, DOI 10.1016/0378-4347(94)00595-V; Du ZY, 2008, AQUACULT NUTR, V14, P77, DOI 10.1111/j.1365-2095.2007.00507.x; Du ZY, 2006, BRIT J NUTR, V95, P905, DOI 10.1079/BJN20061733; Du ZY, 2012, BIOCHIM BIOPHYS ACTA, V1831, P291; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fraser F, 2001, J BIOL CHEM, V276, P20182, DOI 10.1074/jbc.M101078200; Froyland L, 1995, J LIPID RES, V36, P2529; Froyland L, 2000, AQUACULT NUTR, V6, P85; Grove TJ, 2004, COMP BIOCHEM PHYS B, V139, P53, DOI 10.1016/j.cbpc.2004.06.005; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Hansen JO, 2008, AQUACULTURE, V284, P159, DOI 10.1016/j.aquaculture.2008.07.043; HOFSTEE BHJ, 1952, SCIENCE, V116, P329, DOI 10.1126/science.116.3013.329; Kennedy SR, 2007, AQUACULTURE, V272, P489, DOI 10.1016/j.aquaculture.2007.06.033; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; KIESSLING KH, 1993, CAN J ZOOL, V71, P248, DOI 10.1139/z93-035; Kim JH, 2005, J PHARMACOL SCI, V97, P124, DOI 10.1254/jphs.FP0040184; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Kjaer MA, 2008, LIPIDS, V43, P813, DOI 10.1007/s11745-008-3208-z; Kjaer MA, 2009, AQUACULTURE, V288, P325, DOI 10.1016/j.aquaculture.2008.12.022; KOLODZIEJ MP, 1990, BIOCHEM J, V272, P421, DOI 10.1042/bj2720421; Leaver MJ, 2007, J MOL ENDOCRINOL, V38, P391, DOI 10.1677/JME-06-0043; Leaver MJ, 2005, ENDOCRINOLOGY, V146, P3150, DOI 10.1210/en.2004-1638; Li XF, 2012, FISH SHELLFISH IMMUN, V33, P316, DOI 10.1016/j.fsi.2012.05.007; Li XF, 2010, AQUACULTURE, V303, P65, DOI 10.1016/j.aquaculture.2010.03.014; Li XF, 2012, FISH PHYSIOL BIOCHEM, V38, P529, DOI 10.1007/s10695-011-9533-9; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu KL, 2013, AQUACULTURE, V408, P160, DOI 10.1016/j.aquaculture.2013.06.003; Lu KL, 2013, FISHERIES SCI, V79, P661, DOI 10.1007/s12562-013-0635-4; MCCORMICK SD, 1995, J COMP PHYSIOL B, V165, P245, DOI 10.1007/BF00367308; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Morais S, 2001, AQUACULTURE, V203, P101, DOI 10.1016/S0044-8486(01)00618-4; Morais S, 2007, PHYSIOL GENOMICS, V28, P239, DOI 10.1152/physiolgenomics.00136.2006; Morash AJ, 2008, BBA-BIOMEMBRANES, V1778, P1382, DOI 10.1016/j.bbamem.2008.02.013; Morash AJ, 2009, COMP BIOCHEM PHYS B, V152, P85, DOI 10.1016/j.cbpb.2008.10.005; MURTHY MSR, 1987, P NATL ACAD SCI USA, V84, P378, DOI 10.1073/pnas.84.2.378; NAKANO M, 1990, METHOD ENZYMOL, V186, P227; Nanton DA, 2006, AQUACULT NUTR, V12, P363, DOI 10.1111/j.1365-2095.2006.00435.x; Nanton DA, 2003, COMP BIOCHEM PHYS B, V135, P95, DOI 10.1016/S1096-4959(03)0002-6; PHILIP GH, 1995, ECOTOX ENVIRON SAFE, V31, P173, DOI 10.1006/eesa.1995.1059; Power GW, 1997, LIPIDS, V32, P31, DOI 10.1007/s11745-997-0005-4; Price PT, 2000, CURR OPIN LIPIDOL, V11, P3, DOI 10.1097/00041433-200002000-00002; Rasmussen BB, 1999, ANNU REV NUTR, V19, P463, DOI 10.1146/annurev.nutr.19.1.463; Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030; Reddy JK, 2001, AM J PHYSIOL-GASTR L, V281, pG1333, DOI 10.1152/ajpgi.2001.281.6.G1333; Richards JG, 2002, AM J PHYSIOL-REG I, V282, pR89, DOI 10.1152/ajpregu.00238.2001; Roberts R. J, 1989, FISH PATHOLOGY; Robinson-Rechavi M, 2001, GENOME RES, V11, P781, DOI 10.1101/gr.165601; Rueda-Jasso R, 2004, AQUACULTURE, V231, P417, DOI 10.1016/S0044-8486(03)00537-4; Ruyter B, 2006, AQUACULTURE, V252, P441, DOI 10.1016/j.aquaculture.2005.07.014; Sargent J, 1999, AQUACULTURE, V177, P191, DOI 10.1016/S0044-8486(99)00083-6; SUAREZ RK, 1981, J COMP PHYSIOL, V143, P269; Tan XY, 2013, LIPIDS, V48, P505, DOI 10.1007/s11745-013-3759-5; Torstensen BE, 2009, AQUACULT NUTR, V15, P440, DOI 10.1111/j.1365-2095.2008.00609.x; Turchini GM, 2003, AQUACULTURE, V225, P251, DOI 10.1016/S0044-8486(03)00294-1; Walczak R, 2002, J LIPID RES, V43, P177; Watanabe T, 2002, FISHERIES SCI, V68, P242, DOI 10.1046/j.1444-2906.2002.00418.x; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004; Zheng JL, 2013, CHEMOSPHERE, V92, P616, DOI 10.1016/j.chemosphere.2013.04.013; Zheng JL, 2013, GENOMICS, V101, P195, DOI 10.1016/j.ygeno.2012.12.002; Zhou Z, 2008, AQUACULT NUTR, V14, P153, DOI 10.1111/j.1365-2095.2007.00515.x	66	116	119	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93135	10.1371/journal.pone.0093135	http://dx.doi.org/10.1371/journal.pone.0093135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676148	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677500080
J	Peng, HC; Kaloshian, I				Peng, Hsuan-Chieh; Kaloshian, Isgouhi			The Tomato Leucine-Rich Repeat Receptor-Like Kinases SlSERK3A and SlSERK3B Have Overlapping Functions in Bacterial and Nematode Innate Immunity	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; PAMP-TRIGGERED IMMUNITY; CELL-DEATH; MI-1-MEDIATED RESISTANCE; DEFENSE RESPONSES; EFFECTORS TARGET; STRUCTURAL BASIS; EARLY EVENTS; ARABIDOPSIS; BAK1	The Somatic Embryogenesis Receptor Kinase 3 (SERK3)/Brassinosteroid (BR) Insensitive 1-Associated Kinase 1 (BAK1) is required for pattern-triggered immunity (PTI) in Arabidopsis thaliana and Nicotiana benthamiana. Tomato (Solanum lycopersicum) has three SlSERK members. Two of them exhibit particularly high levels of sequence similarity to AtSERK3 and, therefore, were named SlSERK3A and SlSERK3B. To characterize a role for SlSERK3A and SlSERK3B in defense, we suppressed each gene individually or co-silenced both using virus-induced gene silencing (VIGS) in the tomato cv. Moneymaker. Co-silencing SlSERK3A and SlSERK3B resulted in spontaneous necrotic lesions and reduced sensitivity to exogenous BR treatment. Silencing either SlSERK3A or SlSERK3B resulted in enhanced susceptibility to root knot-nematode and to nonpathogenic Pseudomonas syringae pv. tomato (Pst) DC3000 hrcC indicating that both SlSERK3s are positive regulators of defense. Interestingly, silencing SlSERK3B, but not SlSERK3A, resulted in enhanced susceptibility to the pathogenic strain Pst DC3000 indicating distinct roles for these two SlSERK3 paralogs. SlSERK3A and SlSERK3B are active kinases, localized to the plasma membrane, and interact in vivo with the Flagellin Sensing 2 receptor in a flg22-dependent manner. Complementation of the Atserk3/bak1-4 mutant with either SlSERK3A or SlSERK3B partially rescued the mutant phenotype. Thus, SlSERK3A and SlSERK3B are likely to constitute tomato orthologs of BAK1.	[Peng, Hsuan-Chieh; Kaloshian, Isgouhi] Univ Calif Riverside, Ctr Plant Cell Biol, Dept Nematol, Grad Program Bot & Plant Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside	Kaloshian, I (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Dept Nematol, Grad Program Bot & Plant Sci, Riverside, CA 92521 USA.	Isgouhi.kaloshian@ucr.edu			University of California Agricultural Experiment Station	University of California Agricultural Experiment Station(University of California System)	This research was supported by the University of California Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2008, PLANT PHYSIOL, V148, P611, DOI 10.1104/pp.108.123216; Allemandou F, 2003, J BIOMED BIOTECHNOL, P202; Anderson JC, 2006, PLANT CELL, V18, P502, DOI 10.1105/tpc.105.036590; Bajwa VS, 2013, PLANT PHYSIOL, V163, P30, DOI 10.1104/pp.113.221465; Bar M, 2010, PLANT J, V63, P791, DOI 10.1111/j.1365-313X.2010.04282.x; Bhattarai KK, 2007, PLANT PHYSIOL, V144, P312, DOI 10.1104/pp.107.097246; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bucherl CA, 2013, PLANT PHYSIOL, V162, P1911, DOI 10.1104/pp.113.220152; Chaparro-Garcia A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016608; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davis EL, 2008, CURR OPIN PLANT BIOL, V11, P360, DOI 10.1016/j.pbi.2008.04.003; de Ilarduya OM, 2003, MOL PLANT MICROBE IN, V16, P699, DOI 10.1094/MPMI.2003.16.8.699; de Ilarduya OM, 2001, PLANT J, V27, P417, DOI 10.1046/j.1365-313X.2001.01112.x; Fradin EF, 2011, PLANT PHYSIOL, V156, P2255, DOI 10.1104/pp.111.180067; Fradin EF, 2009, PLANT PHYSIOL, V150, P320, DOI 10.1104/pp.109.136762; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Gou XP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002452; Haegeman A, 2012, GENE, V492, P19, DOI 10.1016/j.gene.2011.10.040; Hann DR, 2007, PLANT J, V49, P607, DOI 10.1111/j.1365-313X.2006.02981.x; He K, 2007, CURR BIOL, V17, P1109, DOI 10.1016/j.cub.2007.05.036; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaloshian I, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P309, DOI 10.1007/978-94-007-0434-3_15; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; Karlova R, 2009, PROTEOMICS, V9, P368, DOI 10.1002/pmic.200701059; Kemmerling B, 2007, CURR BIOL, V17, P1116, DOI 10.1016/j.cub.2007.05.046; Kim JG, 2009, PLANT CELL, V21, P1305, DOI 10.1105/tpc.108.063123; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; LIANG XW, 1992, P NATL ACAD SCI USA, V89, P11046, DOI 10.1073/pnas.89.22.11046; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Mantelin S, 2011, PLANT J, V67, P459, DOI 10.1111/j.1365-313X.2011.04609.x; Mathur J, 1998, PLANT J, V14, P593, DOI 10.1046/j.1365-313X.1998.00158.x; Millet YA, 2010, PLANT CELL, V22, P973, DOI 10.1105/tpc.109.069658; Monaghan J, 2012, CURR OPIN PLANT BIOL, V15, P349, DOI 10.1016/j.pbi.2012.05.006; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nguyen HP, 2010, MOL PLANT MICROBE IN, V23, P991, DOI 10.1094/MPMI-23-8-0991; Ntoukakis V, 2011, PLANT CELL, V23, P3871, DOI 10.1105/tpc.111.090779; Quentin M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00053; Robatzek S, 2007, PLANT MOL BIOL, V64, P539, DOI 10.1007/s11103-007-9173-8; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Sakamoto T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-229; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; Shah H, 2001, J MOL BIOL, V309, P641, DOI 10.1006/jmbi.2001.4706; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Smant G, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P273, DOI 10.1007/978-94-007-0434-3_13; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Torii KU, 2004, INT REV CYTOL, V234, P1, DOI 10.1016/S0074-7696(04)34001-5; Tornero P, 1997, MOL PLANT MICROBE IN, V10, P624, DOI 10.1094/MPMI.1997.10.5.624; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang Z, 2011, PLANT J, V67, P1081, DOI 10.1111/j.1365-313X.2011.04659.x; Williamson VM, 2006, TRENDS GENET, V22, P396, DOI 10.1016/j.tig.2006.05.003; Yang DH, 2011, J EXP BOT, V62, P641, DOI 10.1093/jxb/erq298; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003	65	40	42	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93302	10.1371/journal.pone.0093302	http://dx.doi.org/10.1371/journal.pone.0093302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675749	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677500108
J	Puig, I; Calvet, X; Baylina, M; Isava, A; Sort, P; Llaoo, J; Porta, F; Vida, F				Puig, Ignasi; Calvet, Xavier; Baylina, Mireia; Isava, Alvaro; Sort, Pau; Llao, Jordina; Porta, Francesc; Vida, Francesc			How and When Should NSAIDs Be Used for Preventing Post-ERCP Pancreatitis? A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RECTAL INDOMETHACIN; INFLAMMATORY MEDIATORS; RANDOMIZED-TRIALS; RISK-FACTORS; DOUBLE-BLIND; DICLOFENAC; EFFICACY; SEVERITY	Background: Non-steroidal anti-inflammatory drugs (NSAIDs) have been shown to be efficacious to prevent pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP). However, the target patients, the type of NSAID, the route of administration and the time of drug delivery remain unclear, as well as the potential efficacy in reducing the severity of pancreatitis, length of hospital stay and mortality. The objective of the study was to evaluate these questions by performing a systematic review and meta-analysis. Methods: Multiple searches were performed in the main databases. Randomized controlled trials (RCTs) comparing NSAIDs vs. placebo in the prevention of post-ERCP pancreatitis were included. Primary endpoint of the study was the efficacy for pancreatitis prevention. Sub-analyses were performed to determine the risk reduction in high and low risk patients, and to define optimal time, route of administration, and type of NSAID. Secondary endpoints were safety, moderate to severe pancreatitis prevention and reduction of hospital stay and mortality. Results: Nine RCTs enrolling 2133 patients were included. The risk of pancreatitis was lower in the NSAID group than in the placebo group (RR 0.51; 95% CI 0.39-0.66). The number needed to treat was 14. The risk of moderate to severe pancreatitis was also lower in the NSAID group. (RR 0.46; 95% CI 0.28-0.76). No adverse events related to NSAID use were reported. NSAIDs were effective in both high-risk and unselected patients (RR 0.53; 95% CI 0.30-0.93 and RR 0.57; 95% CI 0.37-0.88). In the subanalyses, only rectal administration of either indomethacin (RR 0.54; 95% CI 0.38-0.75) or diclofenac (RR 0.42; 95% CI 0.21-0.84) was shown to be effective. There were not enough data to perform a meta-analysis in hospital stay reduction. No deaths occurred. Conclusion: A single rectal dose of indomethacin or diclofenac before or immediately after ERCP is safe and prevents procedure-related pancreatitis both in high risk and in unselected patients.	[Puig, Ignasi; Isava, Alvaro; Sort, Pau; Llao, Jordina; Porta, Francesc; Vida, Francesc] Althaia Xarxa Assistencial Univ Manresa, Digest Dis Dept, Barcelona, Spain; [Puig, Ignasi; Isava, Alvaro; Sort, Pau; Llao, Jordina; Porta, Francesc; Vida, Francesc] Univ Int Catalunya, Barcelona, Spain; [Puig, Ignasi; Calvet, Xavier; Baylina, Mireia] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain; [Calvet, Xavier] Corp Sanitaria Parc Tauli, Digest Dis Dept, Barcelona, Spain; [Calvet, Xavier] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain; [Baylina, Mireia] Corp Sanitaria Parc Tauli, Dept Internal Med, Barcelona, Spain	Universitat Internacional de Catalunya (UIC); Autonomous University of Barcelona; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Autonomous University of Barcelona; Parc Tauli Hospital Universitari	Puig, I (corresponding author), Althaia Xarxa Assistencial Univ Manresa, Digest Dis Dept, Barcelona, Spain.	ignasipuig@gmail.com	Puig, Ignasi/N-1208-2014; Calvet, Xavier/H-3288-2019	Puig, Ignasi/0000-0002-9059-8602; Calvet, Xavier/0000-0002-6278-9663; Calvet, Xavier/0000-0002-4413-4209	Centro de Investigacion Biomedica en Red de enfermedades hepaticas y digestivas (CIBERehd); Instituto de Salud Carlos III	Centro de Investigacion Biomedica en Red de enfermedades hepaticas y digestivas (CIBERehd); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	The Centro de Investigacion Biomedica en Red de enfermedades hepaticas y digestivas (CIBERehd) is funded by the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, REV MAN REVMAN; Bhatia M, 2000, J PATHOL, V190, P117; Bhatia V, 2011, J CLIN GASTROENTEROL, V45, P170, DOI 10.1097/MCG.0b013e3181eb600e; Cheng CL, 2006, AM J GASTROENTEROL, V101, P139, DOI 10.1111/j.1572-0241.2006.00380.x; Cheon YK, 2007, GASTROINTEST ENDOSC, V66, P1126, DOI 10.1016/j.gie.2007.04.012; Cheon YK, 2007, GASTROINTEST ENDOSC, V65, P385, DOI 10.1016/j.gie.2006.10.021; Choi CW, 2009, GASTROINTEST ENDOSC, V69, pE11, DOI 10.1016/j.gie.2008.10.046; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Dai HF, 2009, HEPATOB PANCREAT DIS, V8, P11; Ding XW, 2012, GASTROINTEST ENDOSC, V76, P1152, DOI 10.1016/j.gie.2012.08.021; Doebroente Zoltan, 2012, Orvosi Hetilap, V153, P990, DOI 10.1556/OH.2012.29403; Dumonceau JM, 2010, ENDOSCOPY, V42, P503, DOI 10.1055/s-0029-1244208; Dumonceau JM, 2010, GASTROINTEST ENDOSC, V71, P934, DOI 10.1016/j.gie.2009.10.055; Elmunzer BJ, 2008, GUT, V57, P1262, DOI 10.1136/gut.2007.140756; Elmunzer BJ, 2013, AM J GASTROENTEROL, V108, P410, DOI 10.1038/ajg.2012.442; Elmunzer BJ, 2012, NEW ENGL J MED, V366, P1414, DOI 10.1056/NEJMoa1111103; Freeman ML, 1996, NEW ENGL J MED, V335, P909, DOI 10.1056/NEJM199609263351301; Freeman ML, 2004, GASTROINTEST ENDOSC, V59, P8, DOI 10.1016/S0016-5107(03)02530-6; GROSS V, 1993, HEPATO-GASTROENTEROL, V40, P522; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Karne S, 1999, SURG CLIN N AM, V79, P699, DOI 10.1016/S0039-6109(05)70036-0; Katsinelos P, 2012, ENDOSCOPY, V44, P53, DOI 10.1055/s-0031-1291440; Khoshbaten M, 2008, J GASTROEN HEPATOL, V23, pE11, DOI 10.1111/j.1440-1746.2007.05096.x; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; KOZAREK RA, 1990, GASTROINTEST ENDOSC, V36, P93, DOI 10.1016/S0016-5107(90)70958-3; Lee KT, 2008, PANCREAS, V37, P445, DOI 10.1097/MPA.0b013e3181733721; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Loza AM, 2007, REV ESP ENFERM DIG, V99, P330; Makela A, 1997, SCAND J CLIN LAB INV, V57, P401, DOI 10.3109/00365519709084587; Masci E, 2003, ENDOSCOPY, V35, P830; Masci E, 2001, AM J GASTROENTEROL, V96, P417; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Montano Loza Alejandro, 2006, Rev Gastroenterol Mex, V71, P262; Murray B, 2003, GASTROENTEROLOGY, V124, P1786, DOI 10.1016/S0016-5085(03)00384-6; Otsuka T, 2012, J GASTROENTEROL, V47, P912, DOI 10.1007/s00535-012-0554-7; Senol A, 2009, WORLD J GASTROENTERO, V15, P3999, DOI 10.3748/wjg.15.3999; Sotoudehmanesh R, 2007, AM J GASTROENTEROL, V102, P978, DOI 10.1111/j.1572-0241.2007.01165.x; Zheng MH, 2008, GUT, V57, P1632, DOI 10.1136/gut.2008.153866	39	51	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92922	10.1371/journal.pone.0092922	http://dx.doi.org/10.1371/journal.pone.0092922			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675922	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677500055
J	Volis, S				Volis, Sergei			Dormancy-Related Seed Positional Effect in Two Populations of an Annual Grass from Locations of Contrasting Aridity	PLOS ONE			English	Article							OATS AVENA-FATUA; PURE LINES; GERMINATION; DEMOGRAPHY; CONSEQUENCES; TEMPERATURE; DYNAMICS; BANKING; WINTER; TIME	In grasses, variation in seed size and dormancy often results from a seed's position within a dispersal unit. In this paper, I asked whether seed positional effect within a spikelet contributes to ecotypic differentiation between two populations of Avena sterilis having different species range position and associated aridity. I created experimental seed banks in which germination of seeds (florets) having different positions within a spikelet was examined over three years. In addition, two germination tests were conducted under controlled conditions. The two populations were found to have a short-living soil seed bank due to sequential germination of the florets. Although positional seed dormancy effect in A. sterilis does not appear to be a specific desert adaptation against unpredictability of rainfall events, this trait does contribute to ecotypic differentiation between desert and Mediterranean populations. Consistent with bet hedging buffering against rainfall unpredictability, germination fractions in the first year were higher in the Mediterranean than in the desert population, while seeds of the desert origin had stronger dormancy and more sequential germination of florets.	Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Volis, S (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming, Peoples R China.	volis@mail.kib.ac.cn	Volis, Sergei/GLU-5848-2022					ADKINS SW, 1988, PHYSIOL PLANTARUM, V73, P15, DOI 10.1111/j.1399-3054.1988.tb09186.x; ADKINS SW, 1987, WEED SCI, V35, P169; ADKINS SW, 1986, WEED SCI, V34, P859; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; BEATLEY JC, 1967, ECOLOGY, V48, P745, DOI 10.2307/1933732; CAMPBELL CS, 1983, ANNU REV ECOL SYST, V14, P411, DOI 10.1146/annurev.es.14.110183.002211; Childs DZ, 2010, P ROY SOC B-BIOL SCI, V277, P3055, DOI 10.1098/rspb.2010.0707; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; DelArco MJS, 1995, WEED RES, V35, P477, DOI 10.1111/j.1365-3180.1995.tb01645.x; Dyer AR, 2004, PLANT ECOL, V172, P211, DOI 10.1023/B:VEGE.0000026339.61069.33; Evans MEK, 2007, AM NAT, V169, P184, DOI 10.1086/510599; Evans MEK, 2005, Q REV BIOL, V80, P431, DOI 10.1086/498282; FREAS KE, 1983, J ECOL, V71, P211, DOI 10.2307/2259973; GOSLING PG, 1981, J EXP BOT, V32, P621, DOI 10.1093/jxb/32.3.621; Gutterman Y, 1998, PLANT SOIL, V204, P223, DOI 10.1023/A:1004314017674; Horovitz A, 1998, CENTRAL RES I FIELD, P185; Imbert E, 2002, PERSPECT PLANT ECOL, V5, P13, DOI 10.1078/1433-8319-00021; Inouye R., 1991, ECOLOGY DESERT COMMU, P27; JOHNSON L. P. V., 1935, CANADIAN JOUR RES SEC C BOT SCI, V13, P283; KALISZ S, 1992, ECOLOGY, V73, P1082, DOI 10.2307/1940182; ORZACK SH, 1989, AM NAT, V133, P901, DOI 10.1086/284959; Pake CE, 1996, ECOLOGY, V77, P1427, DOI 10.2307/2265540; PHANEENDRANATH BR, 1978, CROP SCI, V18, P683, DOI 10.2135/cropsci1978.0011183X001800040040x; PITT MD, 1978, ECOLOGY, V59, P336, DOI 10.2307/1936378; Polis GA, 1995, ECOLOGY DESERT COMMU, P1; Schwendiman Alvin, 1943, JOUR AMER SOC AGRON, V35, P681; Simpson G. M., 1990, SEED DORMANCY GRASSE; *STATSOFT INC, 2004, STATISTICA DAT AN SO; Stocklin J, 1999, OECOLOGIA, V120, P539, DOI 10.1007/s004420050888; Sugawara S, 1959, B FACULTY AGR NIIGAT, V11, P9; TEVIS L, 1958, ECOLOGY, V39, P681, DOI 10.2307/1931608; Tuljapurkar S, 2000, ECOL MODEL, V133, P143, DOI 10.1016/S0304-3800(00)00288-X; Valleriani A, 2006, THEOR POPUL BIOL, V70, P255, DOI 10.1016/j.tpb.2006.07.008; van der Aart P.J.M., 1988, PLANT FORM VEGETATIO, P211; Venable D. Lawrence, 1999, P115; Volis S, 2004, BASIC APPL ECOL, V5, P53, DOI 10.1078/1439-1791-00192; Volis S, 2012, PERSPECT PLANT ECOL, V14, P335, DOI 10.1016/j.ppees.2012.07.002; Wang AB, 2010, ANN BOT-LONDON, V106, P95, DOI 10.1093/aob/mcq089; WURZBURGER J, 1976, PLANT PHYSIOL, V57, P670, DOI 10.1104/pp.57.4.670; ZOHARY D, 1983, ISRAEL J BOT, V32, P97	40	6	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93061	10.1371/journal.pone.0093061	http://dx.doi.org/10.1371/journal.pone.0093061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675719	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500068
J	Wu, J; Xu, YQ; Mo, DP; Huang, PJ; Sun, RH; Huang, L; Pan, SY; Xu, J				Wu, Jing; Xu, Yuqiao; Mo, Dongping; Huang, Peijun; Sun, Ruihong; Huang, Lei; Pan, Shiyang; Xu, Jian			Kaposi's Sarcoma-Associated Herpesvirus (KSHV) vIL-6 Promotes Cell Proliferation and Migration by Upregulating DNMT1 via STAT3 Activation	PLOS ONE			English	Article							VIRUS-X PROTEIN; DNA METHYLTRANSFERASE-1; GENE; EXPRESSION; GROWTH; CANCER; METHYLATION; SEQUENCES; HOMOLOG	Kaposi's sarcoma-associated herpesvirus (KSHV) is etiologically associated with Kaposi's sarcoma (KS), the most common AIDS-related malignancy. KSHV vIL-6 promotes KS development, but the exact mechanisms remain unclear. Here, we reported that KSHV vIL-6 enhanced the expression of DNA methyltransferase 1 (DNMT1) in endothelial cells, increased the global genomic DNA methylation, and promoted cell proliferation and migration. And this effect could be blocked by the DNA methyltransferase inhibitor, 5-azadeoxycytidine. We also showed that vIL-6 induced up-regulation of DNMT1 was dependent on STAT3 activation. Therefore, the present study suggests that vIL-6 plays a role in KS tumorigenesis partly by activating DNMT1 and inducing aberrant DNA methylation, and it might be a potential target for KS therapy.	[Wu, Jing] Nanjing Chest Hosp, Dept Resp Med, Nanjing, Jiangsu, Peoples R China; [Xu, Yuqiao; Mo, Dongping; Huang, Peijun; Sun, Ruihong; Huang, Lei; Pan, Shiyang; Xu, Jian] Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanjing, Jiangsu, Peoples R China; [Huang, Peijun; Pan, Shiyang; Xu, Jian] Natl Key Clin Dept Lab Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Pan, SY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanjing, Jiangsu, Peoples R China.	sypan@njmu.edu.cn; xu_jian79@163.com			National Natural Science Foundation of China [30901262, 81371894]; Key Laboratory for Laboratory Medicine of Jiangsu Province of China [XK201114]; Medical Science and Technology Development Foundation, Nanjing Department of Health [QYK11143]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory for Laboratory Medicine of Jiangsu Province of China; Medical Science and Technology Development Foundation, Nanjing Department of Health; Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by National Natural Science Foundation of China (No. 30901262, 81371894), Key Laboratory for Laboratory Medicine of Jiangsu Province of China (No. XK201114), Medical Science and Technology Development Foundation, Nanjing Department of Health (No. QYK11143), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 1999, BLOOD, V93, P4034, DOI 10.1182/blood.V93.12.4034.412k38_4034_4043; Bigey P, 2000, GENE, V242, P407, DOI 10.1016/S0378-1119(99)00501-6; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Detich N, 2001, J BIOL CHEM, V276, P24881, DOI 10.1074/jbc.M103056200; Dhe-Paganon Sirano, 2011, Int J Biochem Mol Biol, V2, P58; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Flanagan JM, 2007, BRIT J CANCER, V96, P183, DOI 10.1038/sj.bjc.6603516; Foran E, 2010, MOL CANCER RES, V8, P471, DOI 10.1158/1541-7786.MCR-09-0496; Gasche JA, 2011, INT J CANCER, V129, P1053, DOI 10.1002/ijc.25764; Hodge David R., 2007, Cancer Genomics & Proteomics, V4, P387; Hodge DR, 2005, CANCER RES, V65, P4673, DOI 10.1158/0008-5472.CAN-04-3589; Hodge DR, 2001, J BIOL CHEM, V276, P39508, DOI 10.1074/jbc.C100343200; Jenner RG, 2002, BBA-REV CANCER, V1602, P1, DOI 10.1016/S0304-419X(01)00040-3; Jin BL, 2013, ADV EXP MED BIOL, V754, P3, DOI 10.1007/978-1-4419-9967-2_1; Jung JK, 2007, CANCER RES, V67, P5771, DOI 10.1158/0008-5472.CAN-07-0529; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; Lee JO, 2005, ONCOGENE, V24, P6617, DOI 10.1038/sj.onc.1208827; Marshall V, 2007, J INFECT DIS, V195, P645, DOI 10.1086/511434; McLemore ML, 2001, IMMUNITY, V14, P193, DOI 10.1016/S1074-7613(01)00101-7; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Moody R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003857; Morris VA, 2012, VIROLOGY, V428, P112, DOI 10.1016/j.virol.2012.03.013; Neipel F, 1997, J VIROL, V71, P839, DOI 10.1128/JVI.71.1.839-842.1997; Pan SY, 2009, BIOMED PHARMACOTHER, V63, P463, DOI 10.1016/j.biopha.2008.09.006; RIEBER AJ, 1993, THROMB HAEMOSTASIS, V69, P476; Sakakibara S, 2011, J INTERF CYTOK RES, V31, P791, DOI 10.1089/jir.2011.0043; Shamay M, 2006, P NATL ACAD SCI USA, V103, P14554, DOI 10.1073/pnas.0604469103; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Suthaus J, 2011, EUR J CELL BIOL, V90, P495, DOI 10.1016/j.ejcb.2010.10.016; Tsai CL, 2006, CANCER RES, V66, P11668, DOI 10.1158/0008-5472.CAN-06-2194; Wan XY, 1999, J VIROL, V73, P8268, DOI 10.1128/JVI.73.10.8268-8278.1999; Wehbe H, 2006, CANCER RES, V66, P10517, DOI 10.1158/0008-5472.CAN-06-2130; WU JJ, 1993, P NATL ACAD SCI USA, V90, P8891, DOI 10.1073/pnas.90.19.8891; Yeung CLA, 2010, ONCOL REP, V24, P1599, DOI 10.3892/or_00001023; Zhang Q, 2006, BLOOD, V108, P1058, DOI 10.1182/blood-2005-08-007377; Zhu X, 2014, ONCOGENE, V33, P1986, DOI 10.1038/onc.2013.136	38	25	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93478	10.1371/journal.pone.0093478	http://dx.doi.org/10.1371/journal.pone.0093478			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675762	gold, Green Submitted, Green Published			2022-12-27	WOS:000333677500129
J	Chisholm, JD; Chapman, CS; Amm, M; Bischof, WF; Smilek, D; Kingstone, A				Chisholm, Joseph D.; Chapman, Craig S.; Amm, Marvin; Bischof, Walter F.; Smilek, Dan; Kingstone, Alan			A Cognitive Ethology Study of First- and Third-Person Perspectives	PLOS ONE			English	Article							EYE-MOVEMENTS; CONCEPTUAL PERSPECTIVE; VANTAGE POINT; ATTENTION; SELF; REPRESENTATIONS; INFORMATION; ANXIETY	The aim of the present study was to test the cognitive ethology approach, which seeks to link cognitions and behaviours as they operate in everyday life with those studied in controlled lab-based investigations. Our test bed was the understanding of first-person and third-person perspectives, which in lab-based investigations have been defined in a diverse and multifaceted manner. We hypothesized that because these lab-based investigations seek to connect with how first-and third-person perspective operates in everyday life, then either some of the divergent lab-based definitions are missing their mark or the everyday conceptualization of first-and third-person perspective is multi-faceted. Our investigation revealed the latter. By applying a cognitive ethology approach we were able to determine that a) peoples' everyday understanding of perspective is diverse yet reliable, and b) a lab-based investigation that applies these diverse understandings in a controlled setting can accurately predict how people will perform. These findings provide a 'proof of concept' for the cognitive ethology approach. Moreover, the present data demonstrate that previous lab-based studies, that often had very different understandings of first-and third-person perspective, were each in and of themselves valid. That is, each is capturing part of a broader understanding of perspective in everyday life. Our results also revealed a novel social factor not included in traditional conceptualizations of first-person third-perspective, that of eye gaze, i.e., eye contact is equated strongly with first-person perspective and the lack of eye-contact with third-person perspective.	[Chisholm, Joseph D.; Kingstone, Alan] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Chapman, Craig S.] Univ Alberta, Fac Phys Educ & Recreat, Edmonton, AB, Canada; [Amm, Marvin] Univ Aberdeen, Sch Psychol, Aberdeen, Scotland; [Bischof, Walter F.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Smilek, Dan] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada	University of British Columbia; University of Alberta; University of Aberdeen; University of Alberta; University of Waterloo	Chisholm, JD (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	jchisholm@psych.ubc.ca	Bischof, Walter/AAB-9343-2020	Bischof, Walter/0000-0001-5508-0421	Natural Sciences and Engineering Council of Canada	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The present investigation was funded by a grant awarded to AK by the Natural Sciences and Engineering Council of Canada. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	BALLARD DH, 1995, J COGNITIVE NEUROSCI, V7, P66, DOI 10.1162/jocn.1995.7.1.66; Baron-Cohen S., 2000, UNDERSTANDING OTHER, V2, P102, DOI DOI 10.1093/ACPROF:OSO/9780199692972.001.0001; Birmingham E, 2008, Q J EXP PSYCHOL, V61, P986, DOI 10.1080/17470210701410375; Birmingham E, 2008, VIS COGN, V16, P341, DOI 10.1080/13506280701434532; BORKE H, 1975, DEV PSYCHOL, V11, P240, DOI 10.1037/h0076459; BROADBENT DE, 1993, ATTENTION PERFORM, V14, P863; Clark D. M., 1995, SOCIALPHOBIA DIAGNOS, P69, DOI DOI 10.1017/S1352465808004487; Coles ME, 2001, BEHAV RES THER, V39, P651, DOI 10.1016/S0005-7967(00)00035-8; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; David N, 2006, J COGNITIVE NEUROSCI, V18, P898, DOI 10.1162/jocn.2006.18.6.898; Enns JT, 2008, TRENDS COGN SCI, V12, P327, DOI 10.1016/j.tics.2008.06.001; Epley N, 2004, J EXP SOC PSYCHOL, V40, P760, DOI 10.1016/j.jesp.2004.02.002; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Foulsham T, 2011, VISION RES, V51, P1920, DOI 10.1016/j.visres.2011.07.002; Gallup AC, 2012, BIOL LETTERS, V8, P520, DOI 10.1098/rsbl.2012.0160; Gallup AC, 2012, P NATL ACAD SCI USA, V109, P7245, DOI 10.1073/pnas.1116141109; Giesbrecht B, 2003, J EXP PSYCHOL HUMAN, V29, P238, DOI 10.1037/0096-1523.29.1.238; Glenberg AM, 2010, WIRES COGN SCI, V1, P586, DOI 10.1002/wcs.55; GODDEN D, 1980, BRIT J PSYCHOL, V71, P99, DOI 10.1111/j.2044-8295.1980.tb02735.x; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Hollan J., 2000, ACM Transactions on Computer-Human Interaction, V7, P174, DOI 10.1145/353485.353487; HUTCHINS E., 1995, COGNITION WILD; Itier RJ, 2007, NEUROPSYCHOLOGIA, V45, P1019, DOI 10.1016/j.neuropsychologia.2006.09.004; Jackson PL, 2006, NEUROIMAGE, V31, P429, DOI 10.1016/j.neuroimage.2005.11.026; Killeen PR, 2010, COMP COGN BEHAV REV, V5, P59, DOI 10.3819/ccbr.2010.50003; Kingstone A, 2003, CURR DIR PSYCHOL SCI, V12, P176, DOI 10.1111/1467-8721.01255; Kingstone A, 2008, BRIT J PSYCHOL, V99, P317, DOI 10.1348/000712607X251243; Kingstone A, 2009, CURR OPIN NEUROBIOL, V19, P52, DOI 10.1016/j.conb.2009.05.004; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Laidlaw KEW, 2011, P NATL ACAD SCI USA, V108, P5548, DOI 10.1073/pnas.1017022108; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Lang PJ, 1995, INT AFFECTIVE PICTUR; Levy J, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0850; MARVIN RS, 1976, CHILD DEV, V47, P511, DOI 10.2307/1128810; McIsaac HK, 2004, PSYCHOL SCI, V15, P248, DOI 10.1111/j.0956-7976.2004.00660.x; McIsaac HK, 2002, PSYCHON B REV, V9, P146, DOI 10.3758/BF03196271; McNamara P, 2005, J NERV MENT DIS, V193, P53, DOI 10.1097/01.nmd.0000149219.04841.f5; MOSSLER DG, 1976, DEV PSYCHOL, V12, P85; Neisser U., 1976, COGNITION REALITY; NIGRO G, 1983, COGNITIVE PSYCHOL, V15, P467, DOI 10.1016/0010-0285(83)90016-6; Piaget J., 1956, CHILDS CONCEPTION SP; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Robinson J A, 1993, Memory, V1, P169; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Smilek D, 2006, BRAIN RES, V1080, P101, DOI 10.1016/j.brainres.2005.12.090; Spurr JM, 2003, BEHAV RES THER, V41, P1009, DOI 10.1016/S0005-7967(02)00177-8; Tabachnick B.G., 2007, USING MULTIVARIATE S, V5; Tatler BW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0066; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322	54	10	10	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92696	10.1371/journal.pone.0092696	http://dx.doi.org/10.1371/journal.pone.0092696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24671136	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000065
J	Delgado, MM; Nicholas, M; Petrie, DJ; Jacobs, LF				Delgado, Mikel M.; Nicholas, Molly; Petrie, Daniel J.; Jacobs, Lucia F.			Fox Squirrels Match Food Assessment and Cache Effort to Value and Scarcity	PLOS ONE			English	Article							GREY SQUIRRELS; SEX-DIFFERENCES; FUTURE VALUE; SCIURUS; HIPPOCAMPUS; EVOLUTION; BEHAVIOR; HABITS; MODEL; NUTS	Scatter hoarders must allocate time to assess items for caching, and to carry and bury each cache. Such decisions should be driven by economic variables, such as the value of the individual food items, the scarcity of these items, competition for food items and risk of pilferage by conspecifics. The fox squirrel, an obligate scatter-hoarder, assesses cacheable food items using two overt movements, head flicks and paw manipulations. These behaviors allow an examination of squirrel decision processes when storing food for winter survival. We measured wild squirrels' time allocations and frequencies of assessment and investment behaviors during periods of food scarcity (summer) and abundance (fall), giving the squirrels a series of 15 items (alternating five hazelnuts and five peanuts). Assessment and investment per cache increased when resource value was higher (hazelnuts) or resources were scarcer (summer), but decreased as scarcity declined (end of sessions). This is the first study to show that assessment behaviors change in response to factors that indicate daily and seasonal resource abundance, and that these factors may interact in complex ways to affect food storing decisions. Food-storing tree squirrels may be a useful and important model species to understand the complex economic decisions made under natural conditions.	[Delgado, Mikel M.; Nicholas, Molly; Petrie, Daniel J.; Jacobs, Lucia F.] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Delgado, MM (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	mikeldelgado@berkeley.edu		Delgado, Mikel/0000-0002-3252-2618	University of California at Berkeley Chancellor's Fellowship; National Science Foundation Graduate Research Fellowship; National Science Foundation Electrical, Communications and Cyber Systems [1028319]	University of California at Berkeley Chancellor's Fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation Electrical, Communications and Cyber Systems	This work was funded by the University of California at Berkeley Chancellor's Fellowship and the National Science Foundation Graduate Research Fellowship to MD and the National Science Foundation Electrical, Communications and Cyber Systems Grant 1028319 to LJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON M, 1978, ANIM BEHAV, V26, P707, DOI 10.1016/0003-3472(78)90137-9; [Anonymous], 2012, USDA NAT NUTR DAT ST; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brown J. S., 1992, ANN ZOOL FENN, V29, P1; Burger DK, 2013, BEHAV BRAIN RES, V236, P131, DOI 10.1016/j.bbr.2012.08.044; COCKRELL R. A., 1976, TREES BERKELEY CAMPU; Coxe S, 2009, J PERS ASSESS, V91, P121, DOI 10.1080/00223890802634175; Eibl-Eibesfeldt I., 1963, Zeitschrift fuer Tierpsychologie, V20, P705; Fowells HA, 1956, 1150 USDA; Gerber LR, 2004, ECOL MODEL, V175, P77, DOI 10.1016/j.ecolmodel.2003.10.022; GOODRUM PD, 1972, J WILDLIFE MANAGE, V36, P159, DOI 10.2307/3799203; HadjChikh LZ, 1996, ANIM BEHAV, V52, P941, DOI 10.1006/anbe.1996.0242; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Hopewell LJ, 2008, ETHOLOGY, V114, P1061, DOI 10.1111/j.1439-0310.2008.01554.x; HORWICH R H, 1972, P103; Jacobs LF, 1999, J COMP PSYCHOL, V113, P116, DOI 10.1037/0735-7036.113.2.116; Kislalioglu M., 1976, Journal of exp mar Biol Ecol, V25, P151, DOI 10.1016/0022-0981(76)90016-2; Koenig WD, 2008, CALIFORNIA ACORN SUR; Kotler BP, 1999, AM MIDL NAT, V142, P77, DOI 10.1674/0003-0031(1999)142[0077:FSATFB]2.0.CO;2; KRAUS B, 1983, ECOLOGY, V64, P608, DOI 10.2307/1939982; Langen TA, 1998, ANIM BEHAV, V55, P1245, DOI 10.1016/S0003-3472(98)90000-8; Langen Tom A., 1999, Animal Cognition, V2, P223, DOI 10.1007/s100710050043; Lavenex P, 2000, J COMP NEUROL, V425, P152; Leaver LA, 2007, ANIM COGN, V10, P23, DOI 10.1007/s10071-006-0026-7; LEWIS AR, 1982, AM MIDL NAT, V107, P250, DOI 10.2307/2425376; Lichti N. I., 2012, THESIS; LIGON JD, 1974, ANIM BEHAV, V22, P421, DOI 10.1016/S0003-3472(74)80040-0; LOEWENSTEIN G, 1987, ECON J, V97, P666, DOI 10.2307/2232929; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; McDonald PM, 1969, SILVICAL CHARACTERIS, V53; MCQUADE DB, 1986, ETHOLOGY, V72, P22; Melin AD, 2009, INT J PRIMATOL, V30, P753, DOI 10.1007/s10764-009-9383-9; Moore JE, 2007, ECOLOGY, V88, P2529, DOI 10.1890/07-0247.1; MUUL I, 1969, J MAMMAL, V50, P542, DOI 10.2307/1378781; NIXON CM, 1991, AM MIDL NAT, V125, P168, DOI 10.2307/2426380; NIXON CM, 1968, J WILDLIFE MANAGE, V32, P294, DOI 10.2307/3798974; Preston SD, 2009, J MAMMAL, V90, P787, DOI 10.1644/08-MAMM-A-254.1; Rockwell C, 2013, ANIM BEHAV, V86, P783, DOI 10.1016/j.anbehav.2013.07.018; Schmidt KA, 2008, AM NAT, V171, P386, DOI 10.1086/527497; SHORT HL, 1971, J WILDLIFE MANAGE, V35, P435, DOI 10.2307/3799694; Skaug H., 2006, GLMMADMB GEN LINEAR; SMITH CC, 1984, ANNU REV ECOL SYST, V15, P329, DOI 10.1146/annurev.es.15.110184.001553; STAPANIAN MA, 1978, ECOLOGY, V59, P884, DOI 10.2307/1938541; STAPANIAN MA, 1984, ECOLOGY, V65, P1387, DOI 10.2307/1939119; Steele MA, 2008, ANIM BEHAV, V75, P705, DOI 10.1016/j.anbehav.2007.07.026; Steele MA, 2014, BEHAV ECOL, V25, P206, DOI 10.1093/beheco/art107; Stephens D.W., 1986, pi; THOMPSON DC, 1980, CAN J ZOOL, V58, P701, DOI 10.1139/z80-101; Valone TJ, 2006, OIKOS, V112, P252; Vander Wall SB, 1990, FOOD HOARDING ANIMAL, P453; Waisman AS, 2008, ANIM COGN, V11, P625, DOI 10.1007/s10071-008-0152-5; Waisman AS, 2011, P 33 ANN C COGN SCI; Wang B, 2013, OIKOS, V122, P1027, DOI 10.1111/j.1600-0706.2012.20823.x; Wood M, 1998, J ECON PSYCHOL, V19, P295, DOI 10.1016/S0167-4870(98)00009-9	55	9	9	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92892	10.1371/journal.pone.0092892	http://dx.doi.org/10.1371/journal.pone.0092892			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671221	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000089
J	Huber, A; Lui, F; Duzzi, D; Pagnoni, G; Porro, CA				Huber, Alexa; Lui, Fausta; Duzzi, Davide; Pagnoni, Giuseppe; Porro, Carlo Adolfo			Structural and Functional Cerebral Correlates of Hypnotic Suggestibility	PLOS ONE			English	Article							RESTING-STATE FMRI; HUMAN BRAIN; COGNITIVE CONTROL; HYPNOTIZABILITY; HYPNOSIS; SUSCEPTIBILITY; CONFLICT; PAIN; INTEGRATION; ABSORPTION	Little is known about the neural bases of hypnotic suggestibility, a cognitive trait referring to the tendency to respond to hypnotic suggestions. In the present magnetic resonance imaging study, we performed regression analyses to assess hypnotic suggestibility-related differences in local gray matter volume, using voxel-based morphometry, and in waking resting state functional connectivity of 10 resting state networks, in 37 healthy women. Hypnotic suggestibility was positively correlated with gray matter volume in portions of the left superior and medial frontal gyri, roughly overlapping with the supplementary and pre-supplementary motor area, and negatively correlated with gray matter volume in the left superior temporal gyrus and insula. In the functional connectivity analysis, hypnotic suggestibility was positively correlated with functional connectivity between medial posterior areas, including bilateral posterior cingulate cortex and precuneus, and both the lateral visual network and the left fronto-parietal network; a positive correlation was also found with functional connectivity between the executive-control network and a right postcentral/parietal area. In contrast, hypnotic suggestibility was negatively correlated with functional connectivity between the right fronto-parietal network and the right lateral thalamus. These findings demonstrate for the first time a correlation between hypnotic suggestibility, the structural features of specific cortical regions, and the functional connectivity during the normal resting state of brain structures involved in imagery and self-monitoring activity.	[Huber, Alexa; Lui, Fausta; Duzzi, Davide; Pagnoni, Giuseppe; Porro, Carlo Adolfo] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy	Universita di Modena e Reggio Emilia	Porro, CA (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy.	carlo.porro@unimore.it	Porro, Carlo Adolfo/N-2580-2015; Lui, Fausta/P-3816-2015; Pagnoni, Giuseppe/F-3398-2015	Porro, Carlo Adolfo/0000-0003-2345-5852; Lui, Fausta/0000-0001-6577-059X; Pagnoni, Giuseppe/0000-0002-8272-8091; Mullner-Huber, Alexa/0000-0003-2372-7942	Fondazione Cassa di Risparmio di Modena (FCRM); FCRM International grant [A0FF-0AAB-9711-FA30]	Fondazione Cassa di Risparmio di Modena (FCRM); FCRM International grant	The authors thank the Fondazione Cassa di Risparmio di Modena (FCRM) for its financial support to the Modena MR center. A. H. is supported by a FCRM International grant 2010 (code: A0FF-0AAB-9711-FA30) to C. A. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Carli G., 2008, CONT HYPNOSIS, V25, P65, DOI [DOI 10.1002/CH.356, 10.1002/ch.v25:210.1002/ch.356, DOI 10.1002/CH.V25:210.1002/CH.356]; Carli G, 2008, COGN NEUROPSYCHOL, V25, P1065, DOI 10.1080/02643290801913712; Castellani E, 2011, INT J CLIN EXP HYP, V59, P250, DOI 10.1080/00207144.2011.546269; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; De Pascalis V, 2000, INT J CLIN EXP HYP, V48, P315, DOI 10.1080/00207140008415249; De Pascalis V, 2008, PAIN, V134, P197, DOI 10.1016/j.pain.2007.09.005; Dienes Z, 2013, CORTEX, V49, P386, DOI 10.1016/j.cortex.2012.07.009; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Egner T, 2005, NEUROIMAGE, V27, P969, DOI 10.1016/j.neuroimage.2005.05.002; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Garcia-Larrea L, 2012, NEUROPHYSIOL CLIN, V42, P299, DOI 10.1016/j.neucli.2012.06.001; GLISKY ML, 1995, INT J CLIN EXP HYP, V43, P34, DOI 10.1080/00207149508409374; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Gotts SJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00356; Green JP, 2011, INT J CLIN EXP HYP, V59, P103, DOI 10.1080/00207144.2011.522914; Gruzelier J, 2010, CONT HYPNOSIS, V28, P116; Hoeft F, 2012, ARCH GEN PSYCHIAT, V69, P1064, DOI 10.1001/archgenpsychiatry.2011.2190; Horton JE, 2004, BRAIN, V127, P1741, DOI 10.1093/brain/awh196; Huber A, 2013, PAIN, V154, P1509, DOI 10.1016/j.pain.2013.03.031; Aguilar EJ, 2008, EUR J RADIOL, V67, P434, DOI 10.1016/j.ejrad.2008.02.046; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Kirsch I, 2001, CURR DIR PSYCHOL SCI, V10, P57, DOI 10.1111/1467-8721.00115; LYNN SJ, 1986, J PERS SOC PSYCHOL, V51, P404, DOI 10.1037/0022-3514.51.2.404; Maquet P, 1999, BIOL PSYCHIAT, V45, P327, DOI 10.1016/S0006-3223(97)00546-5; McGeown WJ, 2012, CONSCIOUS COGN, V21, P100, DOI 10.1016/j.concog.2011.10.015; McGeown WJ, 2009, CONSCIOUS COGN, V18, P848, DOI 10.1016/j.concog.2009.09.001; Menzocchi M, 2010, INT J CLIN EXP HYP, V58, P122, DOI 10.1080/00207140903316169; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Molinari E, 2013, CEREB CORTEX, V23, P178, DOI 10.1093/cercor/bhr393; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Oakley DA, 2013, NAT REV NEUROSCI, V14, P565, DOI 10.1038/nrn3538; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pedrabissi L, 1989, INVENTARIO ANSIA STA; PICCIONE C, 1989, J PERS SOC PSYCHOL, V56, P289, DOI 10.1037/0022-3514.56.2.289; Pochon JB, 2008, J NEUROSCI, V28, P3468, DOI 10.1523/JNEUROSCI.4195-07.2008; Preacher KJ, 2005, PSYCHOL METHODS, V10, P178, DOI 10.1037/1082-989X.10.2.178; Pyka M, 2011, NEUROIMAGE, V56, P2173, DOI 10.1016/j.neuroimage.2011.03.078; Raz A, 2005, P NATL ACAD SCI USA, V102, P9978, DOI 10.1073/pnas.0503064102; Raz A, 2008, INT J CLIN EXP HYP, V56, P99, DOI 10.1080/00207140701506482; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; Terhune DB, 2011, PSYCHOPHYSIOLOGY, V48, P1444, DOI 10.1111/j.1469-8986.2011.01211.x; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Weitzenhoffer A., 1959, STANFORD HYPNOTIC SU; Whittingstall K, 2013, STRUCTURAL NETWORK U; Woody EZ, 2005, PSYCHOL ASSESSMENT, V17, P200, DOI 10.1037/1040-3590.17.2.200; Wylie KP, 2010, SCHIZOPHR RES, V123, P93, DOI 10.1016/j.schres.2010.08.027	52	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93187	10.1371/journal.pone.0093187	http://dx.doi.org/10.1371/journal.pone.0093187			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671130	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677000126
J	Paredes, R; Orben, RA; Suryan, RM; Irons, DB; Roby, DD; Harding, AMA; Young, RC; Benoit-Bird, K; Ladd, C; Renner, H; Heppell, S; Phillips, RA; Kitaysky, A				Paredes, Rosana; Orben, Rachael A.; Suryan, Robert M.; Irons, David B.; Roby, Daniel D.; Harding, Ann M. A.; Young, Rebecca C.; Benoit-Bird, Kelly; Ladd, Carol; Renner, Heather; Heppell, Scott; Phillips, Richard A.; Kitaysky, Alexander			Foraging Responses of Black-Legged Kittiwakes to Prolonged Food-Shortages around Colonies on the Bering Sea Shelf	PLOS ONE			English	Article							POLLOCK THERAGRA-CHALCOGRAMMA; DIEL VERTICAL MIGRATION; PRIBILOF ISLANDS; PISCIVOROUS SEABIRDS; POPULATION PROCESSES; MYCTOPHID FISHES; EL-NINO; PREY; AVAILABILITY; STRESS	We hypothesized that changes in southeastern Bering Sea foraging conditions for black-legged kittiwakes (Rissa tridactyla) have caused shifts in habitat use with direct implications for population trends. To test this, we compared at-sea distribution, breeding performance, and nutritional stress of kittiwakes in three years (2008-2010) at two sites in the Pribilof Islands, where the population has either declined (St. Paul) or remained stable (St. George). Foraging conditions were assessed from changes in (1) bird diets, (2) the biomass and distribution of juvenile pollock (Theragra chalcogramma) in 2008 and 2009, and (3) eddy kinetic energy (EKE; considered to be a proxy for oceanic prey availability). In years when biomass of juvenile pollock was low and patchily distributed in shelf regions, kittiwake diets included little or no neritic prey and a much higher occurrence of oceanic prey (e.g. myctophids). Birds from both islands foraged on the nearby shelves, or made substantially longer-distance trips overnight to the basin. Here, feeding was more nocturnal and crepuscular than on the shelf, and often occurred near anticyclonic, or inside cyclonic eddies. As expected from colony location, birds from St. Paul used neritic waters more frequently, whereas birds from St. George typically foraged in oceanic waters. Despite these distinctive foraging patterns, there were no significant differences between colonies in chick feeding rates or fledging success. High EKE in 2010 coincided with a 63% increase in use of the basin by birds from St. Paul compared with 2008 when EKE was low. Nonetheless, adult nutritional stress, which was relatively high across years at both colonies, peaked in birds from St. Paul in 2010. Diminishing food resources in nearby shelf habitats may have contributed to kittiwake population declines at St Paul, possibly driven by increased adult mortality or breeding desertion due to high foraging effort and nutritional stress.	[Paredes, Rosana; Heppell, Scott] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Orben, Rachael A.] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Suryan, Robert M.] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Newport, OR 97365 USA; [Irons, David B.] US Fish & Wildlife Serv, Anchorage, AK USA; [Roby, Daniel D.] Oregon State Univ, US Geol Survey, Oregon Cooperat Fish & Wildlife Res Unit, Corvallis, OR 97331 USA; [Harding, Ann M. A.] Alaska Pacific Univ, Dept Environm Sci, Anchorage, AK USA; [Young, Rebecca C.; Kitaysky, Alexander] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Benoit-Bird, Kelly] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Ladd, Carol] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; [Renner, Heather] US Fish & Wildlife Serv, Alaska Maritime Natl Wildlife Refuge, Homer, AK USA; [Phillips, Richard A.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England	Oregon State University; University of California System; University of California Santa Cruz; Oregon State University; United States Department of the Interior; US Fish & Wildlife Service; Oregon State University; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; US Fish & Wildlife Service; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Paredes, R (corresponding author), Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA.	rparedes.insley@gmail.com	Orben, Rachael A./H-9460-2019; Ladd, Carol/M-6159-2014	Orben, Rachael A./0000-0002-0802-407X; Ladd, Carol/0000-0003-1065-430X; Suryan, Robert/0000-0003-0755-8317	North Pacific Research Board as part of the Bering Sea Project; Oregon State University; Natural Environment Research Council [bas0100025] Funding Source: researchfish; NERC [bas0100025] Funding Source: UKRI	North Pacific Research Board as part of the Bering Sea Project; Oregon State University; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by the North Pacific Research Board as part of the Bering Sea Project [http://bsierp.nprb.org/1, Fish and Wildlife Service (http:// alaska;fws.gov/) and Oregon State University (http://fw.oregonstate.edu/). BSIERP projects were granted to David Irons and Daniel Roby (B63 and B77), Heather Renner (B77), Alexander Kitaysky (B77), and to Scott Heppell and Kelly Benoit-Bird (B67 and B77). The funders facilitated indersciplinary partnerships as part of the program but had no role in the specifics of the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley DG, 2003, ECOLOGY, V84, P709, DOI 10.1890/0012-9658(2003)084[0709:PRCAGS]2.0.CO;2; ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Atwood E, 2010, FISH OCEANOGR, V19, P493, DOI 10.1111/j.1365-2419.2010.00559.x; Beamish RJ, 1999, PROG OCEANOGR, V43, P399, DOI 10.1016/S0079-6611(99)00017-8; Benoit-Bird KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053348; Benoit-Bird KJ, 2011, MAR ECOL PROG SER, V443, P217, DOI 10.3354/meps09408; Benowitz-Fredericks ZM, 2008, DEEP-SEA RES PT II, V55, P1868, DOI 10.1016/j.dsr2.2008.04.007; Bertrand S, 2012, J APPL ECOL, V49, P1168, DOI 10.1111/j.1365-2664.2012.02190.x; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; BRAUN BM, 1983, AUK, V100, P469, DOI 10.1093/auk/100.2.469; Burger AE, 2008, AUK, V125, P253, DOI 10.1525/auk.2008.1408; Byrd GV, 2008, DEEP-SEA RES PT II, V55, P1846, DOI 10.1016/j.dsr2.2008.04.004; CHAURAND T, 1994, J ANIM ECOL, V63, P275, DOI 10.2307/5546; Chelton DB, 2011, PROG OCEANOGR, V91, P167, DOI 10.1016/j.pocean.2011.01.002; CLARK CW, 1990, EVOL ECOL, V4, P21, DOI 10.1007/BF02270712; Cotte C, 2007, P R SOC B, V274, P2385, DOI 10.1098/rspb.2007.0775; Coyle KO, 2011, FISH OCEANOGR, V20, P139, DOI 10.1111/j.1365-2419.2011.00574.x; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Dell J, 2011, FISH OCEANOGR, V20, P383, DOI 10.1111/j.1365-2419.2011.00591.x; Dias MP, 2012, MAR ECOL PROG SER, V467, P245, DOI 10.3354/meps09966; Drazen JC, 2011, DEEP-SEA RES PT I, V58, P557, DOI 10.1016/j.dsr.2011.03.002; DRENT RH, 1980, ARDEA, V68, P225; Ducet N, 2000, J GEOPHYS RES-OCEANS, V105, P19477, DOI 10.1029/2000JC900063; Elliott KH, 2009, AUK, V126, P613, DOI 10.1525/auk.2009.08245; Erikstad KE, 1998, ECOLOGY, V79, P1781; Erikstad KE, 2009, ECOLOGY, V90, P3197, DOI 10.1890/08-1778.1; Frederiksen M, 2004, J APPL ECOL, V41, P1129, DOI 10.1111/j.0021-8901.2004.00966.x; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Furuhashi M, 1989, P NIPR S POLAR BIOL, V2, P94; Garthe S, 2007, MAR BIOL, V151, P687, DOI 10.1007/s00227-006-0523-x; Godo OR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030161; Golet GH, 1998, J ANIM ECOL, V67, P827, DOI 10.1046/j.1365-2656.1998.00233.x; Gonzalez-Solis J, 2007, AQUAT CONSERV, V17, pS22, DOI 10.1002/aqc.911; Gonzalez-Solis J, 2009, MAR ECOL PROG SER, V391, P117, DOI 10.3354/meps08282; Goutte A, 2010, GEN COMP ENDOCR, V167, P246, DOI 10.1016/j.ygcen.2010.03.018; Gremillet D, 2004, FUNCT ECOL, V18, P793, DOI 10.1111/j.0269-8463.2004.00914.x; Harding AMA, 2009, FUNCT ECOL, V23, P348, DOI 10.1111/j.1365-2435.2008.01488.x; Hatch SA, 2013, MAR ECOL PROG SER, V477, P271, DOI 10.3354/meps10161; Haynes Trevor B., 2011, Marine Ornithology, V39, P151; HAYS C, 1986, BIOL CONSERV, V36, P169, DOI 10.1016/0006-3207(86)90005-4; Hollowed AB, 2012, DEEP-SEA RES PT II, V65-70, P230, DOI 10.1016/j.dsr2.2012.02.008; Hunt GL, 2011, ICES J MAR SCI, V68, P1230, DOI 10.1093/icesjms/fsr036; HUNT GL, 1986, AUK, V103, P306, DOI 10.1093/auk/103.2.306; Irons DB, 2008, GLOBAL CHANGE BIOL, V14, P1455, DOI 10.1111/j.1365-2486.2008.01581.x; Jahncke J, 2008, DEEP-SEA RES PT II, V55, P1809, DOI 10.1016/j.dsr2.2008.04.003; Jodice PGR, 2000, WATERBIRDS, V23, P405, DOI 10.2307/1522177; Karpouzi VS, 2007, MAR ECOL PROG SER, V343, P87, DOI 10.3354/meps06860; Kitaysky AS, 2007, MAR ECOL PROG SER, V352, P245, DOI 10.3354/meps07074; Kitaysky AS, 2010, FUNCT ECOL, V24, P625, DOI 10.1111/j.1365-2435.2009.01679.x; Kitaysky AS, 1999, FUNCT ECOL, V13, P577, DOI 10.1046/j.1365-2435.1999.00352.x; Klostermann MR, 2013, 201308 AMNWR US FISH; Kotzerka J, 2010, J ORNITHOL, V151, P459, DOI 10.1007/s10336-009-0479-y; Ladd C, 2012, DEEP-SEA RES PT I, V66, P67, DOI 10.1016/j.dsr.2012.04.003; Lewis S, 2001, NATURE, V412, P816, DOI 10.1038/35090566; LOBEL PS, 1988, J PLANKTON RES, V10, P1209, DOI 10.1093/plankt/10.6.1209; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Mizobata K, 2002, PROG OCEANOGR, V55, P65, DOI 10.1016/S0079-6611(02)00070-8; Mueter FJ, 2011, ICES J MAR SCI, V68, P1284, DOI 10.1093/icesjms/fsr022; Muhling BA, 2007, DEEP-SEA RES PT II, V54, P1113, DOI 10.1016/j.dsr2.2006.05.045; Navarro J, 2007, OECOLOGIA, V151, P150, DOI 10.1007/s00442-006-0559-0; Navarro J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062897; Nel DC, 2001, MAR ECOL PROG SER, V217, P15, DOI 10.3354/meps217015; Nordstrom CA, 2013, DEEP-SEA RES PT II, V88-89, P78, DOI 10.1016/j.dsr2.2012.07.010; Orians G.H., 1979, P155; Oro D, 2002, ECOLOGY, V83, P2516; Paredes R, 2012, MAR ECOL PROG SER, V471, P253, DOI 10.3354/meps10034; REID WV, 1987, OECOLOGIA, V74, P458, DOI 10.1007/BF00378945; Renner HM, 2012, DEEP-SEA RES PT II, V65-70, P273, DOI 10.1016/j.dsr2.2012.02.014; RICKLEFS RE, 1987, AUK, V104, P750, DOI 10.1093/auk/104.4.750; RICKLEFS RE, 1991, ACT 20 ORN C TRUST B, P992; Romero LM, 2001, P NATL ACAD SCI USA, V98, P7366, DOI 10.1073/pnas.131091498; Romero LM, 2000, GEN COMP ENDOCR, V118, P113, DOI 10.1006/gcen.1999.7446; Sassa C, 2004, MAR BIOL, V144, P417, DOI 10.1007/s00227-003-1214-5; Satterthwaite WH, 2012, MAR ECOL PROG SER, V454, P221, DOI 10.3354/meps09539; Satterthwaite WH, 2010, EVOL ECOL RES, V12, P779; Schabetsberger R, 2000, ICES J MAR SCI, V57, P1283, DOI 10.1006/jmsc.2000.0814; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; Schumacher J.D., 1994, Fisheries Oceanography, V3, P182, DOI 10.1111/j.1365-2419.1994.tb00095.x; Sigler MF, 2012, DEEP-SEA RES PT II, V65-70, P292, DOI 10.1016/j.dsr2.2012.02.017; Sinclair EH, 2008, DEEP-SEA RES PT II, V55, P1897, DOI 10.1016/j.dsr2.2008.04.031; Stabeno PJ, 2012, DEEP-SEA RES PT II, V65-70, P31, DOI 10.1016/j.dsr2.2012.02.020; Sterling J.T., 2009, NO SEAL FORAGING BEH; Suryan RM, 2002, MAR ECOL PROG SER, V236, P273, DOI 10.3354/meps236273; Suryan RM, 2000, CONDOR, V102, P374, DOI 10.1650/0010-5422(2000)102[0374:PSAVFS]2.0.CO;2; Suryan RM, 2012, MAR ECOL PROG SER, V451, P213, DOI 10.3354/meps09597; Thomson G, 2013, 201310 AMNWR US FISH; Traynor JJ, 1996, ICES J MAR SCI, V53, P253, DOI 10.1006/jmsc.1996.0031; Vacquie-Garcia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043565; Wakefield ED, 2013, SCIENCE, V341, P68, DOI 10.1126/science.1236077; Watanabe H, 1999, FISH OCEANOGR, V8, P115, DOI 10.1046/j.1365-2419.1999.00103.x; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Weimerskirch H, 2012, MAR ECOL PROG SER, V458, P231, DOI 10.3354/meps09752; Whitman L, 2010, THESIS OREGON STATE; Wingfield JC, 2002, INTEGR COMP BIOL, V42, P600, DOI 10.1093/icb/42.3.600; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191; Zainuddin M, 2006, DEEP-SEA RES PT II, V53, P419, DOI 10.1016/j.dsr2.2006.01.007; Zavalaga CB, 2007, MAR ECOL PROG SER, V336, P291, DOI 10.3354/meps336291	97	39	40	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							c92520	10.1371/journal.pone.0092520	http://dx.doi.org/10.1371/journal.pone.0092520			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671108	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000333677000050
J	Restrepo, BI; Twahirwa, M; Rahbar, MH; Schlesinger, LS				Restrepo, Blanca I.; Twahirwa, Marcel; Rahbar, Mohammad H.; Schlesinger, Larry S.			Phagocytosis via Complement or Fc-Gamma Receptors Is Compromised in Monocytes from Type 2 Diabetes Patients with Chronic Hyperglycemia	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RISK; MACROPHAGES; INCREASES; MICE	Type 2 diabetes patients (DM2) have a higher risk of tuberculosis (TB) that may be attributed to functional defects in their mononuclear phagocytes given the critical role of these cells in Mycobacterium tuberculosis containment. Our previous findings suggest that monocytes from DM2 have reduced association with serum-opsonized M. tuberculosis. To determine if this alteration is due to defects in phagocytosis via complement or Fc-gamma receptors (Fc gamma Rs), in this study we evaluated the uptake of sheep red blood cells coated with IgG or complement, respectively, by monocytes from individuals with and without DM2. We found that chronic hyperglycemia was significantly associated with reduced phagocytosis via either receptor by univariable and multivariable analyses. This defect was independent of host serum opsonins and flow cytometry data indicated this was not attributed to reduced expression of these phagocytic receptors on DM2 monocytes. The positive correlation between both pathways (R = 0.64; p = 0.003) indicate that monocytes from individuals with chronic hyperglycemia have a defect in the two predominant phagocytic pathways of these cells. Given that phagocytosis is linked to activation of effector mechanisms for bacterial killing, it is likely that this defect is one factor contributing to the higher susceptibility of DM2 patients to pathogens like M. tuberculosis.	[Restrepo, Blanca I.] UTHlth Houston, Sch Publ Hlth Brownsville, Div Epidemiol, Brownsville, TX USA; [Twahirwa, Marcel] Joslin Diabet Ctr Doctors Hosp Renaissance, Edinburg, TX USA; [Rahbar, Mohammad H.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Internal Med, Div Clin & Translat Sci, Houston, TX 77030 USA; [Schlesinger, Larry S.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Schlesinger, Larry S.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	University of Texas System; University of Texas Health Science Center Houston; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Restrepo, BI (corresponding author), UTHlth Houston, Sch Publ Hlth Brownsville, Div Epidemiol, Brownsville, TX USA.	blanca.i.restrepo@uth.tmc.edu		Restrepo, Blanca I/0000-0002-3743-9098	National Institute of Allergy and Infectious Diseases at the National Institutes of Health [R21AI079624-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079624] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (grant number R21AI079624-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; CHANG FY, 1995, DIABETES RES CLIN PR, V28, P137, DOI 10.1016/0168-8227(95)00168-8; COOPER NR, 1991, IMMUNOL TODAY, V12, P327, DOI 10.1016/0167-5699(91)90010-Q; Dai SP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003114; Dandona P, 2007, CURR OPIN CLIN NUTR, V10, P511, DOI 10.1097/MCO.0b013e3281e38774; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Feng B, 2011, BBA-MOL BASIS DIS, V1812, P1130, DOI 10.1016/j.bbadis.2011.05.007; GEISLER C, 1982, ACTA PATH MICRO IM C, V90, P33; Gomez DI, 2013, TUBERCULOSIS, V93, P192, DOI 10.1016/j.tube.2012.10.003; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Guirado E, 2013, SEMIN IMMUNOPATHOL, V35, P563, DOI 10.1007/s00281-013-0388-2; Hair PS, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-35; Harries AD, 2011, INT J TUBERC LUNG D, V15, P1436, DOI 10.5588/ijtld.11.0503; Hodgson KA, 2011, MICROBES INFECT, V13, P1177, DOI 10.1016/j.micinf.2011.07.008; HORWITZ MA, 1980, J CLIN INVEST, V65, P82, DOI 10.1172/JCI109663; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; KATZ S, 1983, DIABETES CARE, V6, P479, DOI 10.2337/diacare.6.5.479; Labuzek K, 2010, N-S ARCH PHARMACOL, V381, P171, DOI 10.1007/s00210-009-0477-x; Liu BF, 1999, DIABETES, V48, P2074, DOI 10.2337/diabetes.48.10.2074; LOIKE JD, 1979, J BIOL CHEM, V254, P9558; Martens GW, 2007, AM J RESP CELL MOL, V37, P518, DOI 10.1165/rcmb.2006-0478OC; Mathews CE, 2012, CLIN VACCINE IMMUNOL, V19, P1360, DOI 10.1128/CVI.00268-12; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; Rajaram MVS, 2010, J IMMUNOL, V185, P929, DOI 10.4049/jimmunol.1000866; Restrepo BI, 2008, CLIN INFECT DIS, V47, P634, DOI 10.1086/590565; Restrepo BI, 2013, TUBERCULOSIS, V93, pS10, DOI 10.1016/S1472-9792(13)70004-0; Restrepo BI, 2011, B WORLD HEALTH ORGAN, V89, P352, DOI 10.2471/BLT.10.085738; Schlesinger LS, 1996, CURR TOP MICROBIOL, V215, P71; SCHLESINGER LS, 1990, J IMMUNOL, V144, P2771; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Stalenhoef JE, 2008, EUR J CLIN MICROBIOL, V27, P97, DOI 10.1007/s10096-007-0395-0; Stevenson CR, 2007, CHRONIC ILLN, V3, P228, DOI 10.1177/1742395307081502; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Vallerskog T, 2010, J IMMUNOL, V184, P6275, DOI 10.4049/jimmunol.1000304; Walsh MC, 2011, INT J TUBERC LUNG D, V15, P179; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; ZIEGLERHEITBROCK HWL, 1993, EUR J IMMUNOL, V23, P2053, DOI 10.1002/eji.1830230902; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	41	52	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92977	10.1371/journal.pone.0092977	http://dx.doi.org/10.1371/journal.pone.0092977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671137	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000096
J	Zhao, Q; Zhang, W; Ning, ZF; Zhuang, XF; Lu, HZ; Liang, J; Li, J; Zhang, Y; Dong, Y; Zhang, YH; Zhang, SR; Liu, SM; Liu, BL				Zhao, Qian; Zhang, Wen; Ning, Zhifeng; Zhuang, Xiufen; Lu, Haizhen; Liang, Jing; Li, Jie; Zhang, Yu; Dong, Ying; Zhang, Youhui; Zhang, Shuren; Liu, Shangmei; Liu, Binlei			A Novel Oncolytic Herpes Simplex Virus Type 2 Has Potent Anti-Tumor Activity	PLOS ONE			English	Article							OVARIAN-CANCER; TUMOR CELLS; DOXORUBICIN; REPLICATION; IMMUNITY; THERAPY; DEATH; CHEMOTHERAPY; INDUCTION; CARCINOMA	Oncolytic viruses are promising treatments for many kinds of solid tumors. In this study, we constructed a novel oncolytic herpes simplex virus type 2: oHSV2. We investigated the cytopathic effects of oHSV2 in vitro and tested its antitumor efficacy in a 4T1 breast cancer model. We compared its effect on the cell cycle and its immunologic impact with the traditional chemotherapeutic agent doxorubicin. In vitro data showed that oHSV2 infected most of the human and murine tumor cell lines and was highly oncolytic. oHSV2 infected and killed 4T1 tumor cells independent of their cell cycle phase, whereas doxorubicin mainly blocked cells that were in S and G2/M phase. In vivo study showed that both oHSV2 and doxorubicin had an antitumor effect, though the former was less toxic. oHSV2 treatment alone not only slowed down the growth of tumors without causing weight loss but also induced an elevation of NK cells and mild decrease of Tregs in spleen. In addition, combination therapy of doxorubicin followed by oHSV2 increased survival with weight loss than oHSV2 alone. The data showed that the oncolytic activity of oHSV2 was similar to oHSV1 in cell lines examined and in vivo. Therefore, we concluded that our virus is a safe and effective therapeutic agent for 4T1 breast cancer and that the sequential use of doxorubicin followed by oHSV2 could improve antitumor activity without enhancing doxorubicin's toxicity.	[Zhao, Qian; Lu, Haizhen; Liang, Jing; Liu, Shangmei] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Pathol, Beijing 100730, Peoples R China; [Zhao, Qian; Zhang, Wen; Zhuang, Xiufen; Lu, Haizhen; Liang, Jing; Li, Jie; Zhang, Yu; Dong, Ying; Zhang, Youhui; Zhang, Shuren; Liu, Shangmei; Liu, Binlei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Wen; Zhuang, Xiufen; Li, Jie; Zhang, Yu; Dong, Ying; Zhang, Youhui; Zhang, Shuren; Liu, Binlei] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Immunol, Beijing 100730, Peoples R China; [Ning, Zhifeng; Liu, Binlei] Hubei Univ Sci & Technol, Sch Pharmacol, Xianning, Hubei, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Hubei University of Science & Technology	Liu, SM (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, Dept Pathol, Beijing 100730, Peoples R China.	liu_shangmei@sina.com; liubinlei@cicams.ac.cn	Zhang, Wen/AAX-4530-2021; Zhang, Wen/ABE-6422-2021	Zhang, Wen/0000-0003-3150-2751; Zhang, Wen/0000-0003-3150-2751; Liu, Binlei/0000-0002-2852-600X	National Basic Research Program of China (973 Program) [2012CB917100]; National Natural Sciene Foundation of China [81172160]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Sciene Foundation of China	This work was supported by grants from the National Basic Research Program of China (973 Program) granted (No. 2012CB917100) and National Natural Sciene Foundation of China (No. 81172160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagalkot V, 2009, MOL PHARMACEUT, V6, P1019, DOI 10.1021/mp800177f; Betaman AR, 2002, CANCER RES, V62, P6566; Chernajovsky Y, 2006, BRIT MED J, V332, P170, DOI 10.1136/bmj.332.7534.170; Colunga AG, 2010, GENE THER, V17, P315, DOI 10.1038/gt.2009.126; Cross D, 2006, CLIN MED RES, V4, P218, DOI 10.3121/cmr.4.3.218; Davydova J, 2010, CANCER SCI, V101, P474, DOI 10.1111/j.1349-7006.2009.01407.x; FORNARI FA, 1994, MOL PHARMACOL, V45, P649; Fu X, 2007, CANCER GENE THER, V14, P480, DOI 10.1038/sj.cgt.7701033; Fu XP, 2007, INT J ONCOL, V30, P1561; Fu XP, 2006, MOL THER, V13, P882, DOI 10.1016/j.ymthe.2006.02.007; Fu XP, 2002, CANCER RES, V62, P2306; Hardcastle J, 2010, MOL THER, V18, P285, DOI 10.1038/mt.2009.232; Hu JCC, 2006, CLIN CANCER RES, V12, P6737, DOI 10.1158/1078-0432.CCR-06-0759; Huszthy PC, 2010, GENE THER, V17, P202, DOI 10.1038/gt.2009.130; Ishida D, 2010, CANCER LETT, V288, P17, DOI 10.1016/j.canlet.2009.06.014; Israyelyan A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-68; Jennings VA, 2014, INT J CANCER, V134, P1091, DOI 10.1002/ijc.28450; Kaufman HL, 2010, ANN SURG ONCOL, V17, P718, DOI 10.1245/s10434-009-0809-6; Laginha KM, 2005, CLIN CANCER RES, V11, P6944, DOI 10.1158/1078-0432.CCR-05-0343; Li C, 2012, MOL MED REP, V6, P977, DOI 10.3892/mmr.2012.1066; Li HT, 2007, J GENE MED, V9, P161, DOI 10.1002/jgm.1005; Loudon PT, 2003, J GENE MED, V5, P407, DOI 10.1002/jgm.354; MOMPARLER RL, 1976, CANCER RES, V36, P2891; Nagano S, 2008, CANCER RES, V68, P3795, DOI 10.1158/0008-5472.CAN-07-6193; Nakamori M, 2004, MOL THER, V9, P658, DOI 10.1016/j.ymthe.2004.02.019; Nowak R, 2013, J PHARM PHARMACOL, V65, P855, DOI 10.1111/jphp.12042; Prados J, 2012, ANTI-CANCER AGENT ME, V12, P1058, DOI 10.2174/187152012803529646; Sheridan C, 2013, NAT BIOTECHNOL, V31, P471, DOI 10.1038/nbt0613-471; Smith KD, 2006, J VIROL, V80, P1110, DOI 10.1128/JVI.80.3.1110-1120.2006; THOMAS D, 2003, MANAGE TODAY     JAN, P8; Toda M, 1999, HUM GENE THER, V10, P385, DOI 10.1089/10430349950018832; Wong HH, 2008, PANCREATOLOGY, V8, P431, DOI 10.1159/000151536; Zhuang Xiu-fen, 2012, Zhonghua Zhong Liu Za Zhi, V34, P187, DOI 10.3760/cma.j.issn.0253-3766.2012.03.006; Zhuang XF, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-549; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	35	26	29	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93103	10.1371/journal.pone.0093103	http://dx.doi.org/10.1371/journal.pone.0093103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671154	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000113
J	Jaganathan, H; Mitra, S; Srinivasan, S; Dave, B; Godin, B				Jaganathan, Hamsa; Mitra, Sucharita; Srinivasan, Srimeenakshi; Dave, Bhuvanesh; Godin, Biana			Design and In Vitro Evaluation of Layer by Layer siRNA Nanovectors Targeting Breast Tumor Initiating Cells	PLOS ONE			English	Article							COATED GOLD NANOPARTICLES; CANCER CELLS; STEM-CELLS; DELIVERY; THERAPY; CHEMOTHERAPY; EXPRESSION; EFFICIENT; STAT3	Efficient therapeutics and early detection has helped to increase breast cancer survival rates over the years. However, the recurrence of breast cancer remains to be a problem and this may be due to the presence of a small population of cells, called tumor initiating cells (TICs). Breast TICs are resistant to drugs, difficult to detect, and exhibit high self-renewal capabilities. In this study, layer by layer (LBL) small interfering RNA (siRNA) nanovectors (SNVs) were designed to target breast TICs. SNVs were fabricated using alternating layers of poly-L-lysine and siRNA molecules on gold (Au) nanoparticle (NP) surfaces. The stability, cell uptake, and release profile for SNVs were examined. In addition, SNVs reduced TIC-related STAT3 expression levels, CD44(+)/CD24(-)/EpCAM(+) surface marker levels and the number of mammospheres formed compared to the standard transfection agent. The data from this study show, for the first time, that SNVs in LBL assembly effectively delivers STAT3 siRNA and inhibit the growth of breast TICs in vitro.	[Jaganathan, Hamsa; Srinivasan, Srimeenakshi; Godin, Biana] Houston Methodist Res Inst, Dept Nanomed, Houston, TX 77030 USA; [Mitra, Sucharita; Dave, Bhuvanesh] Houston Methodist Res Inst, Canc Ctr Excellence, Houston, TX USA	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston	Godin, B (corresponding author), Houston Methodist Res Inst, Dept Nanomed, Houston, TX 77030 USA.	BGodin@houstonmethodist.org	Godin, Biana/AAB-3190-2020; Dave, Bhuvanesh/ABF-8334-2020	Dave, Bhuvanesh/0000-0001-6741-1363; Godin, Biana/0000-0001-6089-6695	Susan G. Komen Postdoctoral Fellowship [PDF12229449]; Houston Methodist Cancer Center of Excellence startup funds; NIH [U54CA143837]; DOD [W81XWH-11-02-0168];  [DODW81XWH-09-1-0212]; NATIONAL CANCER INSTITUTE [U54CA151668, U54CA143837] Funding Source: NIH RePORTER	Susan G. Komen Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); Houston Methodist Cancer Center of Excellence startup funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Susan G. Komen Postdoctoral Fellowship (PDF12229449), Houston Methodist Cancer Center of Excellence startup funds, NIH U54CA143837 (CTO, PS-OC), DODW81XWH-09-1-0212 and DOD W81XWH-11-02-0168. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Zaid Siddiquee K, CELL RES, V18, P254; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Caruso F, 2001, ADV MATER, V13, P11, DOI 10.1002/1521-4095(200101)13:1<11::AID-ADMA11>3.0.CO;2-N; Choi SY, 2012, TOXICOL IN VITRO, V26, P229, DOI 10.1016/j.tiv.2011.11.016; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Daka A, 2012, ADV DRUG DELIVER REV, V64, P1508, DOI 10.1016/j.addr.2012.08.014; Dave B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030207; Dave B, 2009, J MAMMARY GLAND BIOL, V14, P79, DOI 10.1007/s10911-009-9117-9; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Dontu G, 2005, STEM CELL REV, V1, P207, DOI 10.1385/SCR:1:3:207; Elbakry A, 2009, NANO LETT, V9, P2059, DOI 10.1021/nl9003865; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Guo ST, 2010, ACS NANO, V4, P5505, DOI 10.1021/nn101638u; Han L, 2012, ACS NANO, V6, P7340, DOI 10.1021/nn3024688; Jeong JH, 2011, PHARM RES-DORDR, V28, P2072, DOI 10.1007/s11095-011-0412-y; Kong WH, 2012, PHARM RES-DORDR, V29, P362, DOI 10.1007/s11095-011-0554-y; Lee MY, 2011, ACS NANO, V5, P6138, DOI 10.1021/nn2017793; Lee SK, 2011, SMALL, V7, P364, DOI 10.1002/smll.201001314; Lee SH, 2008, INT J PHARMACEUT, V364, P94, DOI 10.1016/j.ijpharm.2008.07.027; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lvov Y, 1997, LANGMUIR, V13, P6195, DOI 10.1021/la970517x; Malikova N, 2002, LANGMUIR, V18, P3694, DOI 10.1021/la025563y; Meyer M, 2008, J AM CHEM SOC, V130, P3272, DOI 10.1021/ja710344v; Moghimi SM, 2005, MOL THER, V11, P990, DOI 10.1016/j.ymthe.2005.02.010; Rodriguez-Pinilla SM, 2006, CLIN CANCER RES, V12, P1533, DOI 10.1158/1078-0432.CCR-05-2281; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Song H, 2004, ONCOGENE, V23, P8301, DOI 10.1038/sj.onc.1208026; Song WJ, 2010, SMALL, V6, P239, DOI 10.1002/smll.200901513; Tan SJ, 2011, SMALL, V7, P841, DOI 10.1002/smll.201001389; Tanaka T, 2010, CANCER RES, V70, P3687, DOI 10.1158/0008-5472.CAN-09-3931; Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wallgren A, 2003, J CLIN ONCOL, V21, P1205, DOI 10.1200/JCO.2003.03.130; Wang Y, 2008, CHEM MATER, V20, P848, DOI 10.1021/cm7024813; Ware M, 2014, CATIONIC POLYM REGEN; Yessine MA, 2003, BBA-BIOMEMBRANES, V1613, P28, DOI 10.1016/S0005-2736(03)00137-8; Zhang X, 2010, BIOMATERIALS, V31, P6013, DOI 10.1016/j.biomaterials.2010.04.024; Zhao EY, 2012, NANOSCALE, V4, P5102, DOI 10.1039/c2nr31290e	41	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e91986	10.1371/journal.pone.0091986	http://dx.doi.org/10.1371/journal.pone.0091986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24694753	Green Submitted, Green Published, gold			2022-12-27	WOS:000334103000012
J	Collares, RVA; Salgado, W; Tirapelli, DPD; dos Santos, JS				Collares, Renata Viesti A.; Salgado, Wilson, Jr.; da Cunha Tirapelli, Daniela Pretti; dos Santos, Jose Sebastiao			The Expression of LEP, LEPR, IGF1 and IL10 in Obesity and the Relationship with microRNAs	PLOS ONE			English	Article							METABOLIC SYNDROME; ADIPOSE-TISSUE; INSULIN-RESISTANCE; GENE-EXPRESSION; SERUM LEPTIN; INTERLEUKIN-10; FAT; ADIPOCYTOKINES; ASSOCIATION; ACTIVATION	Obesity is a multifactorial disease, with epigenetic alterations. Have been described modifications in the expression of some microRNAs, and some proteins related to obesity. The objective was to determine and correlate, in obese patients, the gene expression of LEP, LEPR, IGF1, IL10 and of miR-27a, miR-27b, miR-143 and miR-145. RNA was extracted from biopsies of subcutaneous fat, liver and visceral fat of 15 obese subjects submitted to bariatric surgery and of 15 non-obese subjects submitted to cholecystectomy for cDNA synthesis and for RT-PCR. The microRNAs were chosen using the TargetScan software. An increased expression of LEP and IGF1 was detected in the subcutaneous fat of the obese group compared to control, while the expression of IGF1 was higher in the control group than in the obese one. MiRNA-27a had a higher expression in the omentum of the obese patients and there was also a correlation in the expression of miRNA-145 and LEPR in the omentum of this group.	[Collares, Renata Viesti A.; Salgado, Wilson, Jr.; da Cunha Tirapelli, Daniela Pretti; dos Santos, Jose Sebastiao] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Surg & Anat, BR-14049 Ribeirao Preto, SP, Brazil; [da Cunha Tirapelli, Daniela Pretti] Mol Biol Lab, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Salgado, W (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Surg & Anat, BR-14049 Ribeirao Preto, SP, Brazil.	wsalgado@fmrp.usp.br	Salgado, Wilson/L-1470-2016; Santos, José Sebastião/A-2179-2008; Tirapelli, Daniela PC/F-9230-2012	Santos, José Sebastião/0000-0001-5118-0361; Tirapelli, Daniela PC/0000-0002-1886-4988	Fundacao Waldemar Barnsley Pessoa, Ribeirao Preto, SP, Brazil	Fundacao Waldemar Barnsley Pessoa, Ribeirao Preto, SP, Brazil	Research supported by Fundacao Waldemar Barnsley Pessoa, Ribeirao Preto, SP, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bassols J, 2010, OBESITY, V18, P611, DOI 10.1038/oby.2009.313; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Buchwald H, 2004, OBES SURG, V14, P1157, DOI 10.1381/0960892042387057; Carmina E, 2008, FERTIL STERIL, V89, P642, DOI 10.1016/j.fertnstert.2007.03.085; Cleveland-Donovan K, 2010, ENDOCRINOLOGY, V151, P3752, DOI 10.1210/en.2010-0043; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dusserre E, 2000, BBA-MOL BASIS DIS, V1500, P88, DOI 10.1016/S0925-4439(99)00091-5; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Esposito K, 2003, J CLIN ENDOCR METAB, V88, P1055, DOI 10.1210/jc.2002-021437; Esteghamati A, 2011, ARCH MED RES, V42, P244, DOI 10.1016/j.arcmed.2011.05.005; Fain JN, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/513948; Funahashi T, 1999, INTERNAL MED, V38, P202, DOI 10.2169/internalmedicine.38.202; Gautron L, 2011, J CLIN INVEST, V121, P2087, DOI 10.1172/JCI45888; Gnacinska M, 2009, ADV MED SCI-POLAND, V54, P150, DOI 10.2478/v10039-009-0035-2; Gomez JM, 2004, GROWTH HORM IGF RES, V14, P91, DOI 10.1016/j.ghir.2003.11.004; Heneghan HM, 2010, OBES REV, V11, P354, DOI 10.1111/j.1467-789X.2009.00659.x; Jackson Richard J, 2007, Sci STKE, V2007, pre1, DOI 10.1126/stke.3672007re1; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; La Rocca G, 2011, EXP CELL RES, V317, P488, DOI 10.1016/j.yexcr.2010.11.010; Lowery AJ, 2008, CLIN CANCER RES, V14, P360, DOI 10.1158/1078-0432.CCR-07-0992; Martins IS, 2003, REV SAUDE PUBL, V37, P760, DOI 10.1590/S0034-89102003000600011; Matsuzawa Y, 2002, J DIABETES COMPLICAT, V16, P17, DOI 10.1016/S1056-8727(01)00194-5; Mehta R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-39; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moses AGW, 2001, BRIT J SURG, V88, P588, DOI 10.1046/j.1365-2168.2001.01743.x; Nam SY, 1997, INT J OBESITY, V21, P355, DOI 10.1038/sj.ijo.0800412; Nyomba BLG, 1999, METABOLISM, V48, P840, DOI 10.1016/S0026-0495(99)90215-9; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Owecki M, 2010, HORM METAB RES, V42, P585, DOI 10.1055/s-0030-1253422; Pardina E, 2010, OBES SURG, V20, P623, DOI 10.1007/s11695-010-0103-5; Ramis JM, 2005, J NUTR BIOCHEM, V16, P279, DOI 10.1016/j.jnutbio.2004.12.009; Romero Carla Eduarda Machado, 2006, Rev. Nutr., V19, P85, DOI 10.1590/S1415-52732006000100009; Russell CD, 2001, AM J PHYSIOL-ENDOC M, V280, pE399, DOI 10.1152/ajpendo.2001.280.3.E399; Scarpelli D, 2006, DIABETES, V55, P1529, DOI 10.2337/db06-0047; Schoof E, 2004, EUR J ENDOCRINOL, V150, P579, DOI 10.1530/eje.0.1500579; Seron K, 2006, BIOCHEM BIOPH RES CO, V348, P1232, DOI 10.1016/j.bbrc.2006.07.068; Siegmund B, 2004, J LEUKOCYTE BIOL, V76, P782, DOI 10.1189/jlb.0404239; Takanabe R, 2008, BIOCHEM BIOPH RES CO, V376, P728, DOI 10.1016/j.bbrc.2008.09.050; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; van Exel E, 2002, DIABETES, V51, P1088, DOI 10.2337/diabetes.51.4.1088; Vettor R, 2005, ALIMENT PHARM THER, V22, P3, DOI 10.1111/j.1365-2036.2005.02587.x; Wajchenberg BL, 2000, ARQUIVOS BRASILEIROS, V44, P13; Yang Weining, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P140	50	29	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93512	10.1371/journal.pone.0093512	http://dx.doi.org/10.1371/journal.pone.0093512			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690978	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100095
J	Nov, O; Arazy, O; Anderson, D				Nov, Oded; Arazy, Ofer; Anderson, David			Scientists@Home: What Drives the Quantity and Quality of Online Citizen Science Participation?	PLOS ONE			English	Article							OPEN SOURCE SOFTWARE; COLLECTIVE IDENTIFICATION; VIRTUAL COMMUNITIES; EMPIRICAL-ANALYSIS; MOTIVATIONS; KNOWLEDGE; DEVELOPERS; REPOSITORIES; CONTEXT; TASK	Online citizen science offers a low-cost way to strengthen the infrastructure for scientific research and engage members of the public in science. As the sustainability of online citizen science projects depends on volunteers who contribute their skills, time, and energy, the objective of this study is to investigate effects of motivational factors on the quantity and quality of citizen scientists' contribution. Building on the social movement participation model, findings from a longitudinal empirical study in three different citizen science projects reveal that quantity of contribution is determined by collective motives, norm-oriented motives, reputation, and intrinsic motives. Contribution quality, on the other hand, is positively affected only by collective motives and reputation. We discuss implications for research on the motivation for participation in technology-mediated social participation and for the practice of citizen science.	[Nov, Oded] NYU, New York, NY 10012 USA; [Arazy, Ofer] Univ Alberta, Edmonton, AB, Canada; [Arazy, Ofer; Anderson, David] Univ Calif Berkeley, Berkeley, CA 94720 USA	New York University; University of Alberta; University of California System; University of California Berkeley	Nov, O (corresponding author), NYU, New York, NY 10012 USA.	onov@nyu.edu	Anderson, David/ABC-6011-2021		National Science Foundation [IIS-1149745]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a National Science Foundation grant IIS-1149745. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 1998, INFORM SYST RES, V9, P204, DOI 10.1287/isre.9.2.204; Amichai-Hamburger Y, 2008, COMPUT HUM BEHAV, V24, P544, DOI 10.1016/j.chb.2007.02.004; Amichai-Hamburger Y, 2010, COMPUT HUM BEHAV, V26, P1289, DOI 10.1016/j.chb.2010.03.018; Baytiyeh H, 2010, COMPUT HUM BEHAV, V26, P1345, DOI 10.1016/j.chb.2010.04.008; Beale AV, 1984, EXPLORING CAREERS VO; BENKLER Y, 2006, WEALTH NETWORKS; Bierstedt R., 1964, EXCHANGE POWER SOCIA; Bryant S. L., 2005, P 2005 INT ACM SIGGR, P1, DOI DOI 10.1145/1099203.1099205; Burke M, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P945; Butler B., 2002, LEADERSHIP DISTANCE, V54, P346; Butler BS, 2001, INFORM SYST RES, V12, P346, DOI 10.1287/isre.12.4.346.9703; Cassel C, 1999, J APPL STAT, V26, P435, DOI 10.1080/02664769922322; Cheshire C, 2008, J COMPUT-MEDIAT COMM, V13, P705, DOI 10.1111/j.1083-6101.2008.00416.x; Chin WW, 1998, QUANT METH SER, P295; Chiu CM, 2006, DECIS SUPPORT SYST, V42, P1872, DOI 10.1016/j.dss.2006.04.001; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; EREZ M, 1990, S APPL PSYC, P53; Farzan R, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P563; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Frey B, 1997, NOT JUST MONEY; Frey BS, 1997, AM ECON REV, V87, P746; Frey BS, 2001, J ECON SURV, V15, P589, DOI 10.1111/1467-6419.00150; Gidron B, 1978, Volunt Adm, V11, P18; GILLILAND SW, 1992, J APPL PSYCHOL, V77, P672, DOI 10.1037/0021-9010.77.5.672; Gu B, 2007, INFORM SYST RES, V18, P68, DOI 10.1287/isre.1070.0114; Hand E, 2010, NATURE, V465, P673, DOI 10.1038/465673a; Hars A, 2002, INT J ELECTRON COMM, V6, P25; Hertel G, 2003, RES POLICY, V32, P1159, DOI 10.1016/S0048-7333(03)00047-7; Holohan A, 2005, J COMPUT-MEDIAT COMM, V10; Houle BJ, 2005, BASIC APPL SOC PSYCH, V27, P337, DOI 10.1207/s15324834basp2704_6; HOWELL WC, 1963, J EXP PSYCHOL, V65, P39, DOI 10.1037/h0038982; Jones C, 1997, ACAD MANAGE REV, V22, P911, DOI 10.5465/AMR.1997.9711022109; Joreskog K. G., 2006, LISREL 8 80; Kankanhalli A, 2005, MIS QUART, V29, P113, DOI 10.2307/25148670; Kittur A, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1495; Klandermans B., 1997, SOCIAL PSYCHOL PROTE; Klandermans B., 2003, OXFORD HDB POLITICAL, P670; Knispel B, 2010, SCIENCE, V329, P1305, DOI 10.1126/science.1195253; Lakhani K.R., 2005, PERSPECTIVES FREE OP, DOI 10.2139/ssrn.443040; Ling K, 2005, J COMPUT-MEDIAT COMM, V10; LOCKE EA, 1994, J MANAGE, V20, P67, DOI 10.1177/014920639402000104; Nov O, 2011, DUSTING SCI MOTIVATI; Nov O, 2010, VOLUNTEER COMPUTING, P741; Nov O, 2009, AM C INF SYST AMCIS; Nov O, 2007, COMMUN ACM, V50, P60, DOI 10.1145/1297797.1297798; Nov O, 2010, J AM SOC INF SCI TEC, V61, P555, DOI 10.1002/asi.21278; Oreg S, 2008, COMPUT HUM BEHAV, V24, P2055, DOI 10.1016/j.chb.2007.09.007; Osterloh M, 2000, ORGAN SCI, V11, P538, DOI 10.1287/orsc.11.5.538.15204; Osterloh M., 2002, INT J ECON BUS, V9, P61, DOI DOI 10.1080/13571510110102976; Osterloh M., 2001, J MANAGEMENT GOVERNA, V5, P231, DOI DOI 10.1023/A:1014084019816; Parameswaran M, 2007, J ASSOC INF SYST, V8, P336, DOI 10.17705/1jais.00132; Pavlou PA, 2006, MIS QUART, V30, P115; Peddibhotla NB, 2007, ORGAN STUD, V28, P327, DOI 10.1177/0170840607076002; Piliavin J. A., 1984, DEV MAINTENANCE PROS, P471; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Porta Della., 2006, SOCIAL MOVEMENTS INT, V2; Preece J., 2009, ASS INFORM SYSTEMS T, V1, P13, DOI DOI 10.17705/1THCI.00005; Qureshi I, 2009, MIS QUART, V33, P197; Raddick M. Jordan, 2010, Astronomy Education Review, V9, DOI 10.3847/AER2009036; Ranganathan C, 2002, INFORM MANAGE-AMSTER, V39, P457, DOI 10.1016/S0378-7206(01)00112-4; Ribar DC, 2002, J POLIT ECON, V110, P425, DOI 10.1086/338750; Ringle C.M., 2005, SMARTPLS 2 0 M3 BETA; Roberts JA, 2006, MANAGE SCI, V52, P984, DOI 10.1287/mnsc.1060.0554; Schroer J, 2009, MEDIA PSYCHOL, V12, P96, DOI 10.1080/15213260802669466; Simon B, 1998, J PERS SOC PSYCHOL, V74, P646, DOI 10.1037/0022-3514.74.3.646; Snyder M., 2000, COOPERATION MODERN S, P127; Sohn DY, 2007, J COMMUN, V57, P435, DOI 10.1111/j.1460-2466.2007.00351.x; Stewart KJ, 2006, MIS QUART, V30, P291; Sturmer S, 2004, PERS SOC PSYCHOL B, V30, P263, DOI 10.1177/0146167203256690; Toch H., 1965, SOCIAL PSYCHOL SOCIA; Wang EST, 2012, COMPUT HUM BEHAV, V28, P570, DOI 10.1016/j.chb.2011.11.002; Wasko MM, 2005, MIS QUART, V29, P35, DOI 10.2307/25148667; Wiggins A, 2012, GOALS TASKS 2 TYPOLO, P3426; Wiggins Andrea, 2011, P HICSS, P1, DOI DOI 10.1109/HICSS.2011.207; Wilson J, 2000, ANNU REV SOCIOL, V26, P215, DOI 10.1146/annurev.soc.26.1.215; Wu CG, 2007, INFORM MANAGE-AMSTER, V44, P253, DOI 10.1016/j.im.2006.12.006; Wuthnow R., 1993, ACTS COMPASSION CARI; Yang HL, 2010, COMPUT HUM BEHAV, V26, P1377, DOI 10.1016/j.chb.2010.04.011	80	125	128	1	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e90375	10.1371/journal.pone.0090375	http://dx.doi.org/10.1371/journal.pone.0090375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6KM	24690612	gold, Green Published, Green Submitted			2022-12-27	WOS:000334101100009
J	Eichstaedt, CA; Antao, T; Pagani, L; Cardona, A; Kivisild, T; Mormina, M				Eichstaedt, Christina A.; Antao, Tiago; Pagani, Luca; Cardona, Alexia; Kivisild, Toomas; Mormina, Maru			The Andean Adaptive Toolkit to Counteract High Altitude Maladaptation: Genome-Wide and Phenotypic Analysis of the Collas	PLOS ONE			English	Article							ARTERIAL OXYGEN-SATURATION; RECENT POSITIVE SELECTION; GRAN-CHACO POPULATIONS; HUMAN ADAPTATION; HEMOGLOBIN CONCENTRATION; GENETIC ADAPTATION; GROWTH-FACTOR; NITRIC-OXIDE; TIBETAN; MOUNTAIN	During their migrations out of Africa, humans successfully colonised and adapted to a wide range of habitats, including extreme high altitude environments, where reduced atmospheric oxygen (hypoxia) imposes a number of physiological challenges. This study evaluates genetic and phenotypic variation in the Colla population living in the Argentinean Andes above 3500 m and compares it to the nearby lowland Wichi group in an attempt to pinpoint evolutionary mechanisms underlying adaptation to high altitude hypoxia. We genotyped 730,525 SNPs in 25 individuals from each population. In genome-wide scans of extended haplotype homozygosity Collas showed the strongest signal around VEGFB, which plays an essential role in the ischemic heart, and ELTD1, another gene crucial for heart development and prevention of cardiac hypertrophy. Moreover, pathway enrichment analysis showed an overrepresentation of pathways associated with cardiac morphology. Taken together, these findings suggest that Colla highlanders may have evolved a toolkit of adaptative mechanisms resulting in cardiac reinforcement, most likely to counteract the adverse effects of the permanently increased haematocrit and associated shear forces that characterise the Andean response to hypoxia. Regulation of cerebral vascular flow also appears to be part of the adaptive response in Collas. These findings are not only relevant to understand the evolution of hypoxia protection in high altitude populations but may also suggest new avenues for medical research into conditions where hypoxia constitutes a detrimental factor.	[Eichstaedt, Christina A.; Pagani, Luca; Cardona, Alexia; Kivisild, Toomas; Mormina, Maru] Univ Cambridge, Div Biol Anthropol, Cambridge, England; [Antao, Tiago] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Pagani, Luca] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Mormina, Maru] Univ E Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England	University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute; University of East Anglia	Eichstaedt, CA (corresponding author), Univ Cambridge, Div Biol Anthropol, Cambridge, England.	cae31@cam.ac.uk; mem50@cam.ac.uk	Kivisild, Toomas/P-5889-2017; Antao, Tiago/C-3615-2009; Mormina, Maru/HGC-2853-2022; Pagani, Luca/G-8511-2017	Kivisild, Toomas/0000-0002-6297-7808; Antao, Tiago/0000-0002-7269-5513; Pagani, Luca/0000-0002-6639-524X; Mormina, Maru/0000-0002-5836-8989; Cardona, Alexia/0000-0002-7877-5565	European Research Council [FP7-261213]; University of East Anglia [RC-158]; National Geographic Society [8900-11]	European Research Council(European Research Council (ERC)European Commission); University of East Anglia; National Geographic Society(National Geographic Society)	This work was supported by European Research Council Starting Investigator grant http://erc.europa.eu/starting-grants (FP7-261213, TK), a starting investigator grant from the University of East Anglia (RC-158, MM) and the Young Explorers Grant from the National Geographic Society http://www.nationalgeographic.co.uk/explorers/grants-programs/young-explorers/ (8900-11, CE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acreche N, 2004, CUADERNOS FHYCS UNJU, V22, P171; Albeza MV, 2002, CHUNGARA, V34, P119; Aldashev AA, 2005, THORAX, V60, P683, DOI 10.1136/thx.2005.041954; Aldenderfer MS, 2003, AM SCI, V91, P542; Alexander DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-246; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Alkorta-Aranburu G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003110; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Bauer M, 2010, J PSYCHIATR RES, V44, P1170, DOI 10.1016/j.jpsychires.2010.04.009; Beall CM, 2006, INTEGR COMP BIOL, V46, P18, DOI 10.1093/icb/icj004; Beall CM, 1997, AM J PHYS ANTHROPOL, V104, P427, DOI 10.1002/(SICI)1096-8644(199712)104:4<427::AID-AJPA1>3.0.CO;2-P; Beall CM, 2001, NATURE, V414, P411, DOI 10.1038/35106641; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Bigham AW, 2008, HIGH ALT MED BIOL, V9, P167, DOI 10.1089/ham.2007.1066; Bigham Abigail W., 2009, Human Genomics, V4, P79; Bigham AW, 2013, AM J HUM BIOL; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; Braunstein J, 2001, PEOPLES GRAN CHACO; Brutsaert TD, 2000, AM J PHYS ANTHROPOL, V113, P169, DOI 10.1002/1096-8644(200010)113:2<169::AID-AJPA3>3.3.CO;2-0; Brutsaert TD, 1999, AM J HUM BIOL, V11, P383, DOI 10.1002/(SICI)1520-6300(1999)11:3<383::AID-AJHB9>3.0.CO;2-X; Cabana GS, 2006, AM J PHYS ANTHROPOL, V131, P108, DOI 10.1002/ajpa.20410; Cameron N, 1981, PRACTICAL HUMAN BIOL, P27; Center for International Earth Science Information Network (CIESIN)/Columbia University, 2012, NAT AGGR GEOSP DAT P; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Corach D, 2010, ANN HUM GENET, V74, P65, DOI 10.1111/j.1469-1809.2009.00556.x; de Simone G, 1999, HYPERTENSION, V33, P800, DOI 10.1161/01.HYP.33.3.800; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Demarchi DA, 2004, HUM BIOL, V76, P413, DOI 10.1353/hub.2004.0043; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dorward DA, 2007, RESP MED, V101, P587, DOI 10.1016/j.rmed.2006.06.014; Egan JR, 2008, J THORAC CARDIOV SUR, V136, P1265, DOI 10.1016/j.jtcvs.2008.04.002; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Frank S., 2008, PUEBLOS ORIGINARIOS; Fransen M, 2012, BBA-MOL BASIS DIS, V1822, P1363, DOI 10.1016/j.bbadis.2011.12.001; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FRISANCHO AR, 1975, HUM BIOL, V47, P233; Frisancho AR, 2008, ANTHROPOMETRIC STAND, pviii; Gaya-Vidal M, 2011, AM J PHYS ANTHROPOL, V145, P215, DOI 10.1002/ajpa.21487; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Giussani DA, 2001, PEDIATR RES, V49, P490, DOI 10.1203/00006450-200104000-00009; Hawks J, 2007, P NATL ACAD SCI USA, V104, P20753, DOI 10.1073/pnas.0707650104; Heath D, 1995, HIGH ALTITUDE MED PA, px; Heggarty P, 2010, CURR ANTHR, V51; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huerta-Sanchez E, 2013, MOL BIOL EVOL, V30, P1877, DOI 10.1093/molbev/mst089; Igwe EI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-408; Jansen GFA, 2011, J CEREBR BLOOD F MET, V31, P706, DOI 10.1038/jcbfm.2010.150; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Levett DZ, 2012, FASEB J, V26, P1431, DOI 10.1096/fj.11-197772; Levett DZH, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-98; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Li X, 2008, ARTERIOSCL THROM VAS, V28, P1614, DOI 10.1161/ATVBAHA.107.158725; Lundby C, 2004, AM J PHYSIOL-REG I, V287, pR1202, DOI 10.1152/ajpregu.00725.2003; Mao XY, 2007, AM J HUM GENET, V80, P1171, DOI 10.1086/518564; Martin D, 2008, POSTGRAD MED J, V84, P622, DOI 10.1136/pgmj.2008.068296; Monge C, 1982, HYPOXIA MAN ALTITUDE, P51; Moore LG, 2001, HIGH ALT MED BIOL, V2, P257, DOI 10.1089/152702901750265341; Morikawa T, 2012, P NATL ACAD SCI USA, V109, P1293, DOI 10.1073/pnas.1119658109; Nechiporuk T, 2001, J BIOL CHEM, V276, P4150, DOI 10.1074/jbc.M004814200; Nei M., 1987, MOL EVOLUTIONARY GEN; Nordstrom DK, 2002, SCIENCE, V296, P2143, DOI 10.1126/science.1072375; Pagani L, 2012, HUM GENET, V131, P423, DOI 10.1007/s00439-011-1084-8; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Penaloza D, 2007, CIRCULATION, V115, P1132, DOI 10.1161/CIRCULATIONAHA.106.624544; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinque D, 2006, ANAL BIOCHEM, V353, P272, DOI 10.1016/j.ab.2006.03.021; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; ROTHHAMMER F, 1989, AM J PHYS ANTHROPOL, V78, P403, DOI 10.1002/ajpa.1330780308; Rothhammer F, 2001, LAT AM ANTIQ, V12, P59, DOI 10.2307/971757; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rupert JL, 2001, J EXP BIOL, V204, P3151; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sala A, 1998, HUM BIOL, V70, P937; Scheinfeldt LB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r1; Sevini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064054; Shriver MD, 2004, HUM GENOMICS, V1, P274; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Simonson TS, 2010, SCIENCE; SYKES B, 1995, AM J HUM GENET, V57, P1463; TAJIMA F, 1983, GENETICS, V105, P437; Tajima N, 2006, J PHYSIOL-LONDON, V571, P349, DOI 10.1113/jphysiol.2005.096818; Tarazona-Santos E, 2000, AM J PHYS ANTHROPOL, V111, P165, DOI 10.1002/(SICI)1096-8644(200002)111:2<165::AID-AJPA3>3.3.CO;2-7; Thornton KR, 2007, GENETICS, V175, P737, DOI 10.1534/genetics.106.064642; U.S. Department of Agriculture, 2008, USDA FOOD SEARCH REL; Villafuerte FC, 2004, J APPL PHYSIOL, V96, P1581, DOI 10.1152/japplphysiol.00328.2003; Virues-Ortega J, 2006, DEVELOPMENTAL SCI, V9, P400, DOI 10.1111/j.1467-7687.2006.00505.x; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017002; West JB, 2007, HIGH ALTITUDE MED PH, pxii; Xing GQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002342; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhou D, 2013, AM J HUM GENET	106	46	48	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93314	10.1371/journal.pone.0093314	http://dx.doi.org/10.1371/journal.pone.0093314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686296	gold, Green Submitted, Green Published			2022-12-27	WOS:000340842300008
J	Zhou, YB; Wang, QX; Liang, S; Gong, YH; Yang, MX; Nie, SJ; Nan, L; Yang, AH; Liao, Q; Yang, Y; Song, XX; Jiang, QW				Zhou, Yi-Biao; Wang, Qi-Xing; Liang, Song; Gong, Yu-Han; Yang, Mei-xia; Nie, Shi-Jiao; Nan, Lei; Yang, Ai-Hui; Liao, Qiang; Yang, Yang; Song, Xiu-Xia; Jiang, Qing-Wu			HIV-, HCV-, and Co- Infections and Associated Risk Factors among Drug Users in Southwestern China: A Township-Level Ecological Study Incorporating Spatial Regression	PLOS ONE			English	Article							HEPATITIS-C; SICHUAN PROVINCE; PREVALENCE; COINFECTION; METHADONE; VIRUS; SEX; EPIDEMIOLOGY; BEHAVIORS; COMMUNITY	Background: The human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are major public health problems. Many studies have been performed to investigate the association between demographic and behavioral factors and HIV or HCV infection. However, some of the results of these studies have been in conflict. Methodology/Principal Findings: The data of all entrants in the 11 national methadone clinics in the Yi Autonomous Prefecture from March 2004 to December 2012 were collected from the national database. Several spatial regression models were used to analyze specific community characteristics associated with the prevalence of HIV and HCV infection at the township level. The study enrolled 6,417 adult patients. The prevalence of HIV infection, HCV infection and co-infection was 25.4%, 30.9%, and 11.0%, respectively. Prevalence exhibited stark geographical variations in the area studied. The four regression models showed Yi ethnicity to be associated with both the prevalence of HIV and of HIV/HCV co-infection. The male drug users in some northwestern counties had greater odds of being infected with HIV than female drug users, but the opposite was observed in some eastern counties. The 'being in drug rehabilitation variable was found to be positively associated with prevalence of HCV infection in some southern townships, however, it was found to be negatively associated with it in some northern townships. Conclusions/Significance: The spatial modeling creates better representations of data such that public health interventions must focus on areas with high frequency of HIV/HCV to prevent further transmission of both HIV and HCV.	[Zhou, Yi-Biao; Nie, Shi-Jiao; Yang, Ai-Hui; Song, Xiu-Xia; Jiang, Qing-Wu] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China; [Zhou, Yi-Biao; Nie, Shi-Jiao; Yang, Ai-Hui; Song, Xiu-Xia; Jiang, Qing-Wu] Fudan Univ, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China; [Zhou, Yi-Biao; Nie, Shi-Jiao; Yang, Ai-Hui; Song, Xiu-Xia; Jiang, Qing-Wu] Fudan Univ, Trop Dis Res Ctr, Shanghai 200433, Peoples R China; [Wang, Qi-Xing; Gong, Yu-Han; Nan, Lei; Liao, Qiang] Ctr Dis Prevent & Control Liangshan Prefecture, Chengdu, Sichuan, Peoples R China; [Liang, Song; Yang, Yang] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA; [Liang, Song] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Yang, Mei-xia] Xuhui Ctr Dis Prevent & Control, Shanghai, Peoples R China; [Yang, Yang] Univ Florida, Dept Biostat, Gainesville, FL USA	Fudan University; Fudan University; Fudan University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Zhou, YB (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China.	ybzhou@fudan.edu.cn; jiangqw@fudan.edu.cn		Jiang, Qingwu/0000-0001-8921-3317				Aceijas C, 2007, INT J DRUG POLICY, V18, P352, DOI 10.1016/j.drugpo.2007.04.004; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Anselin LY, 2004, J GEOGRAPHICAL SYSTE, V6, P197, DOI DOI 10.1007/S10109-004-0132-5; Arraiz I, 2010, J REGIONAL SCI, V50, P592, DOI 10.1111/j.1467-9787.2009.00618.x; Bivand R, 2006, GEOGR ANAL, V38, P23, DOI 10.1111/j.0016-7363.2005.00672.x; Booth RE, 2011, AIDS BEHAV, V15, P30, DOI 10.1007/s10461-010-9751-7; Buse K, 2008, J ROY SOC MED, V101, P572, DOI 10.1258/jrsm.2008.08k036; Chen HT, 2013, AIDS EDUC PREV, V25, P336, DOI 10.1521/aeap.2013.25.4.336; Choi SYP, 2006, SOC SCI MED, V62, P1672, DOI 10.1016/j.socscimed.2005.08.046; Conley JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-20; Cuadros DF, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-28; Dai SY, 2012, J MED VIROL, V84, P1, DOI 10.1002/jmv.22214; Davies AG, 1996, AIDS CARE, V8, P517, DOI 10.1080/09540129650125489; De Cock KM, 2012, AIDS, V26, P1205, DOI 10.1097/QAD.0b013e328354622a; Du WJ, 2008, DRUG ALCOHOL DEPEN, V94, P158, DOI 10.1016/j.drugalcdep.2007.11.009; Fang YX, 2006, ACTA PHARMACOL SIN, V27, P140, DOI 10.1111/j.1745-7254.2006.00270.x; Gaskin, 2000, Int J Drug Policy, V11, P423, DOI 10.1016/S0955-3959(00)00069-4; Hu ZY, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-26; Karim SSA, 2009, INT J EPIDEMIOL, V38, P1016, DOI 10.1093/ije/dyp201; Kelejian HH, 2007, J ECONOMETRICS, V140, P131, DOI 10.1016/j.jeconom.2006.09.005; Kelejian HH, 1999, INT ECON REV, V40, P509, DOI 10.1111/1468-2354.00027; Kelejian HH, 1998, J REAL ESTATE FINANC, V17, P99, DOI 10.1023/A:1007707430416; Kim AY, 2013, J INFECT DIS, V207, pS1, DOI 10.1093/infdis/jis927; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Kretzschmar M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-108; Maier I, 2002, WORLD J GASTROENTERO, V8, P577, DOI 10.3748/wjg.v8.i4.577; Messina JP, 2010, SOC SCI MED, V71, P1428, DOI 10.1016/j.socscimed.2010.07.025; Pang L, AIDS S8, V21, pS103; Qian HZ, 2008, J SUBST ABUSE TREAT, V34, P391, DOI 10.1016/j.jsat.2007.07.002; Rey SJ, 2006, GEOGR ANAL, V38, P67, DOI 10.1111/j.0016-7363.2005.00675.x; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; Strader DB, 2005, CLIN INFECT DIS, V41, pS7, DOI 10.1086/429489; Strathdee SA, 2001, ARCH INTERN MED, V161, P1281, DOI 10.1001/archinte.161.10.1281; SUSSER M, 1994, AM J PUBLIC HEALTH, V84, P825, DOI 10.2105/AJPH.84.5.825; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148; Weidmann C, 2012, VOX SANG, V102, P47, DOI 10.1111/j.1423-0410.2011.01501.x; Wilson D, 2008, LANCET, V372, P423, DOI 10.1016/S0140-6736(08)60883-1; Yang Y, 2012, ASIAN J ANDROL, V14, P758, DOI 10.1038/aja.2012.25; Yen YF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1066; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210; Zhuang X, 2012, DRUG ALCOHOL DEPEN, V126, P286, DOI 10.1016/j.drugalcdep.2012.05.028	42	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93157	10.1371/journal.pone.0093157	http://dx.doi.org/10.1371/journal.pone.0093157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24687006	Green Published, Green Submitted, gold			2022-12-27	WOS:000340842300004
J	van der Voet, H; de Boer, WJ; Souverein, OW; Doets, EL; van't Veer, P				van der Voet, Hilko; de Boer, Waldo J.; Souverein, Olga W.; Doets, Esmee L.; van't Veer, Pieter			A Statistical Method to Base Nutrient Recommendations on Meta-Analysis of Intake and Health-Related Status Biomarkers	PLOS ONE			English	Article							INTAKE VALUES; VITAMIN-B-12; BIOAVAILABILITY; POPULATION; PREVALENCE; MODELS; ADULTS; NIVS	Nutrient recommendations in use today are often derived from relatively old data of few studies with few individuals. However, for many nutrients, including vitamin B-12, extensive data have now become available from both observational studies and randomized controlled trials, addressing the relation between intake and health-related status biomarkers. The purpose of this article is to provide new methodology for dietary planning based on dose-response data and meta-analysis. The methodology builds on existing work, and is consistent with current methodology and measurement error models for dietary assessment. The detailed purposes of this paper are twofold. Firstly, to define a Population Nutrient Level (PNL) for dietary planning in groups. Secondly, to show how data from different sources can be combined in an extended meta-analysis of intake-status datasets for estimating PNL as well as other nutrient intake values, such as the Average Nutrient Requirement (ANR) and the Individual Nutrient Level (INL). For this, a computational method is presented for comparing a bivariate lognormal distribution to a health criterion value. Procedures to meta-analyse available data in different ways are described. Example calculations on vitamin B-12 requirements were made for four models, assuming different ways of estimating the dose-response relation, and different values of the health criterion. Resulting estimates of ANRs and less so for INLs were found to be sensitive to model assumptions, whereas estimates of PNLs were much less sensitive to these assumptions as they were closer to the average nutrient intake in the available data.	[van der Voet, Hilko; de Boer, Waldo J.] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [Souverein, Olga W.; Doets, Esmee L.; van't Veer, Pieter] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	van der Voet, H (corresponding author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.	hilko.vandervoet@wur.nl	van der Voet, Hilko/W-8531-2019; van der Voet, Hilko/A-4073-2013	van der Voet, Hilko/0000-0003-0802-7382; van der Voet, Hilko/0000-0003-0802-7382	European Community's Sixth RTD Framework Program, within the EURRECA Network of Excellence [036196]	European Community's Sixth RTD Framework Program, within the EURRECA Network of Excellence	This work was supported by the European Community's Sixth RTD Framework Program, contract 036196, within the EURRECA Network of Excellence (www.eurreca.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LH, 2010, INT J VITAM NUTR RES, V80, P330, DOI 10.1024/0300-9831/a000041; Beaton G.H, 1994, CRITERIA ADEQUATE DI, P1491; Bor MV, 2010, AM J CLIN NUTR, V91, P571, DOI 10.3945/ajcn.2009.28082; Carriquiry AL, 1999, PUBLIC HEALTH NUTR, V2, P23, DOI 10.1017/S1368980099000038; DARBY WJ, 1958, AM J MED, V25, P726, DOI 10.1016/0002-9343(58)90010-X; de Boer EJ, 2011, EUR J CLIN NUTR, V65, pS102, DOI 10.1038/ejcn.2011.94; de Boer WJ, 2009, FOOD ADDIT CONTAM A, V26, P1433, DOI 10.1080/02652030903161606; de Lauzon B, 2004, PUBLIC HEALTH NUTR, V7, P893, DOI 10.1079/PHN2004616; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dodd KW, 2006, J AM DIET ASSOC, V106, P1640, DOI 10.1016/j.jada.2006.07.011; Doets EL, 2013, ANN NUTR METAB, V62, P311, DOI 10.1159/000346968; Doets EL, 2012, PUBLIC HEALTH NUTR, V15, P906, DOI 10.1017/S1368980011002643; Dullemeijer C, 2013, AM J CLIN NUTR, V97, P390, DOI 10.3945/ajcn.112.033951; EFSA, 2010, SCI OP PRINC DER APP; Gezondheidsraad, 2003, VOED VIT B6 FOL VIT; Goedhart P.W, 2012, COMP SIMULATION DIFF; Hoffmann K, 2002, EUR J CLIN NUTR, V56, pS53, DOI 10.1038/sj.ejcn.1601429; Institute of Medicine (IOM), 2000, DIET REF INT APPL DI; IOM, 1998, DIET REF INT THIAM R; IOM, 2003, DIET REF INT APPL DI, P248; Jackson D, 2010, J STAT PLAN INFER, V140, P961, DOI 10.1016/j.jspi.2009.09.017; King JC, 2007, FOOD NUTR BULL, V28, pS16, DOI 10.1177/15648265070281S103; Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091; McKinley MC, 2001, CLIN CHEM, V47, P1430; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; Murphy SP, 2007, FOOD NUTR BULL, V28, pS51, DOI 10.1177/15648265070281S106; NEVO, 2006, NEVO TAB NED VOED; Roodenburg AJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072378; Smith AD, 2012, J INTERN MED, V271, P179, DOI 10.1111/j.1365-2796.2011.02485.x; Souverein OW, 2011, EUR J CLIN NUTR, V65, pS92, DOI 10.1038/ejcn.2011.93; Souverein OW, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-57; VANROSSUM CTM, 2011, 3500500062011 RIVM; Vogiatzoglou A, 2009, AM J CLIN NUTR, V89, P1078, DOI 10.3945/ajcn.2008.26598; Yetley EA, 2011, AM J CLIN NUTR, V94, p313S, DOI 10.3945/ajcn.111.013243	34	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93171	10.1371/journal.pone.0093171	http://dx.doi.org/10.1371/journal.pone.0093171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682145	Green Submitted, gold, Green Published			2022-12-27	WOS:000333678100029
J	Vanni, T; Mesa-Frias, M; Sanchez-Garcia, R; Roesler, R; Schwartsmann, G; Goldani, MZ; Foss, AM				Vanni, Tazio; Mesa-Frias, Marco; Sanchez-Garcia, Ruben; Roesler, Rafael; Schwartsmann, Gilberto; Goldani, Marcelo Z.; Foss, Anna M.			International Scientific Collaboration in HIV and HPV: A Network Analysis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS TYPES; WOMEN; AIDS; LESIONS; CANCER; PREVALENCE; INFECTION; NEOPLASIA; CERVIX	Research endeavours require the collaborative effort of an increasing number of individuals. International scientific collaborations are particularly important for HIV and HPV co-infection studies, since the burden of disease is rising in developing countries, but most experts and research funds are found in developed countries, where the prevalence of HIV is low. The objective of our study was to investigate patterns of international scientific collaboration in HIV and HPV research using social network analysis. Through a systematic review of the literature, we obtained epidemiological data, as well as data on countries and authors involved in co-infection studies. The collaboration network was analysed in respect to the following: centrality, density, modularity, connected components, distance, clustering and spectral clustering. We observed that for many low-and middle-income countries there were no epidemiological estimates of HPV infection of the cervix among HIV-infected individuals. Most studies found only involved researchers from the same country (64%). Studies derived from international collaborations including high-income countries and either low-or middle-income countries had on average three times larger sample sizes than those including only high-income countries or low-income countries. The high global clustering coefficient (0.9) coupled with a short average distance between researchers (4.34) suggests a "small-world phenomenon.'' Researchers from high-income countries seem to have higher degree centrality and tend to cluster together in densely connected communities. We found a large well-connected community, which encompasses 70% of researchers, and 49 other small isolated communities. Our findings suggest that in the field of HIV and HPV, there seems to be both room and incentives for researchers to engage in collaborations between countries of different income-level. Through international collaboration resources available to researchers in high-income countries can be efficiently used to enroll more participants in low-and middle-income countries.	[Vanni, Tazio; Roesler, Rafael; Foss, Anna M.] Hosp Clin Porto Alegre, Natl Inst Sci & Technol Translat Med, Porto Alegre, RS, Brazil; [Vanni, Tazio; Mesa-Frias, Marco] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1, England; [Sanchez-Garcia, Ruben] Univ Southhampton, Southampton, England; [Roesler, Rafael] Univ Fed Rio Grande do Sul, Dept Pharmacol, Inst Basic Hlth Sci, Lab Neuropharmacol & Neural Tumor Biol, Porto Alegre, RS, Brazil; [Roesler, Rafael; Schwartsmann, Gilberto] Univ Fed Rio Grande do Sul, Univ Hosp Res Ctr CPE HCPA, Canc Res Lab, Porto Alegre, RS, Brazil; [Goldani, Marcelo Z.] Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, Brazil; [Goldani, Marcelo Z.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Foss, Anna M.] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Social & Math Epidemiol Res Grp, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of Southampton; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; University of London; London School of Hygiene & Tropical Medicine	Vanni, T (corresponding author), Hosp Clin Porto Alegre, Natl Inst Sci & Technol Translat Med, Porto Alegre, RS, Brazil.	taziovanni@gmail.com	Sanchez-Garcia, Ruben J/AAI-5391-2021; Schwartsmann, Gilberto/G-4256-2016; Goldani, Marcelo Zubaran/U-8596-2019; Vanni, Tazio P./B-7925-2018; Roesler, Rafael/U-9261-2019	Schwartsmann, Gilberto/0000-0002-7850-1644; Sanchez-Garcia, Ruben/0000-0001-6479-3028; Roesler, Rafael/0000-0001-6016-2261				Ambos TC, 2009, J INT MANAG, V15, P1, DOI 10.1016/j.intman.2008.02.002; [Anonymous], 2009, INT AAAI C WEBL SOC; [Anonymous], 6 DEGREES SEPARATION; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; BIERBAUM EG, 1995, J AM SOC INFORM SCI, V46, P530, DOI 10.1002/(SICI)1097-4571(199508)46:7<530::AID-ASI6>3.0.CO;2-C; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Breschi S, 2010, RES POLICY, V39, P14, DOI 10.1016/j.respol.2009.11.004; Burt RS, 2004, AM J SOCIOL, V110, P349, DOI 10.1086/421787; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; De Cock KM, 2012, AIDS, V26, P1205, DOI 10.1097/QAD.0b013e328354622a; De Nooy W., 2011, EXPLORATORY SOCIAL N, V2; De Vuyst H, 2012, BRIT J CANCER, V107, P1624, DOI 10.1038/bjc.2012.441; De Vuyst H, 2008, EUR J CANCER PREV, V17, P545, DOI 10.1097/CEJ.0b013e3282f75ea1; Denny LA, 2012, VACCINE, V30, pF168, DOI 10.1016/j.vaccine.2012.06.045; Easley D, 2010, NETWORKS CROWDS MARK; Falagas ME, 2006, AIDS RES HUM RETROV, V22, P1199, DOI 10.1089/aid.2006.22.1199; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Guan P, 2013, INT J CANCER, V132, P248, DOI 10.1002/ijc.27663; Latapy M, 2008, THEOR COMPUT SCI, V407, P458, DOI 10.1016/j.tcs.2008.07.017; Long JC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001434; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Moodley JR, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-135; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Onyancha OB, 2004, LIBR INFORM SCI RES, V26, P434, DOI 10.1016/j.lisr.2004.04.005; Page L, 1999, PAGERANK CITATION RA, DOI DOI 10.1109/IISWC.2012.6402911; Palefsky JM, 2003, CURR OPIN ONCOL, V15, P382, DOI 10.1097/00001622-200309000-00007; Rochon PA, 2004, CAN MED ASSOC J, V170, P1673, DOI 10.1503/cmaj.1031006; Rosas SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017428; SENGUPTA IN, 1991, SCIENTOMETRICS, V20, P297, DOI 10.1007/BF02018160; SMALL H, 1994, SCIENTOMETRICS, V30, P229, DOI 10.1007/BF02017225; SMALL H, 1989, COMMUN RES, V16, P642, DOI 10.1177/009365089016005006; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Tarjan R., 1972, SIAM Journal on Computing, V1, P146, DOI 10.1137/0201010; The Royal Society, 2011, KNOWL NETW NAT GLOB; Thijs J, 2010, SOCIOL EDUC, V83, P333, DOI 10.1177/0038040710383521; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; Uddin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057546; Vanni T, 2012, INT J CANCER, V131, pE96, DOI 10.1002/ijc.26472; Vasconcellos AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045569; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Yu Q, 2013, INT J CARDIOL, V167, P631, DOI 10.1016/j.ijcard.2012.09.134	45	34	36	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93376	10.1371/journal.pone.0093376	http://dx.doi.org/10.1371/journal.pone.0093376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0TC	24682041	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000333678100046
J	Benelli, G; Benvenuti, S; Desneux, N; Canale, A				Benelli, Giovanni; Benvenuti, Stefano; Desneux, Nicolas; Canale, Angelo			Cephalaria transsylvanica-Based Flower Strips as Potential Food Source for Bees during Dry Periods in European Mediterranean Basin Countries	PLOS ONE			English	Article							SOWN WILDFLOWER STRIPS; SOIL TEXTURE; NATIVE BEES; POLLINATION; CONSERVATION; HABITAT; WEED; BIODIVERSITY; ENHANCEMENT; DIVERSITY	The introduction of sown wildflower strips favours the establishment of pollinator communities, with special reference to social Apoidea. Here, we evaluated the late summer flowering Cephalaria transsylvanica as suitable species for strips providing food for pollinators in paucity periods. C. transsylvanica showed no particular requirements in terms of seed germination and growth during summer. This plant had an excellent potential of self-seeding and competitiveness towards weed competitors. C. transsylvanica prevented from entomophilous pollination showed inbreeding depression, with a decrease in seed-set and accumulation of seed energy reserves. However, C. transsylvanica did not appear to be vulnerable in terms of pollination biology since it had a wide range of pollinators including bees, hoverflies and Lepidoptera. C. transsylvanica was visited mainly by honeybees and bumblebees and these latter pollinators increased their visits on C. transsylvanica flowers during early autumn. This plant may be useful as an abundant source of pollen during food paucity periods, such as autumn. We proposed C. transsylvanica for incorporation into flower strips to be planted in non-cropped farmlands in intensively managed agricultural areas as well as in proximity of beehives. The latter option may facilitate the honeybees collecting pollen and nectar for the colony, thereby ensuring robustness to overcome the winter season.	[Benelli, Giovanni; Canale, Angelo] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Pisa, Italy; [Benvenuti, Stefano] Univ Pisa, Dept Agr Food & Environm, Agron & Agroecosyst Management Sect, Pisa, Italy; [Desneux, Nicolas] French Natl Inst Agr Res INRA, Sophia Antipolis, France	University of Pisa; University of Pisa; INRAE	Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Pisa, Italy.	g.benelli@sssup.it; angelo.canale@unipi.it	Desneux, Nicolas/J-6262-2013; Benelli, Giovanni/A-9100-2013	Benelli, Giovanni/0000-0001-8971-6010	Italian Ministry of Education, University and Research (MIUR)	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	Funds were achieved by the Italian Ministry of Education, University and Research (MIUR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; [Anonymous], 1973, GEOBOTANICAL FDN MID; Aviron S, 2011, RESTOR ECOL, V19, P500, DOI 10.1111/j.1526-100X.2010.00649.x; Baker HG, 1983, POLLEN BIOL IMPLICAT, P43; Basteri G, 2010, ACTA HORTIC, V881, P585; Benedek P, 1969, Z ANG ENTOMOL, V63, P186; Benvenuti S, 2003, AGRON J, V95, P191, DOI 10.2134/agronj2003.0191; Benvenuti S, 2007, SEED SCI RES, V17, P211, DOI 10.1017/S0960258507782752; Blake RJ, 2011, PEST MANAG SCI, V67, P377, DOI 10.1002/ps.2136; Bosch J, 1997, OECOLOGIA, V109, P583, DOI 10.1007/s004420050120; Bretzel F, 2009, ACTA OECOL, V35, P657, DOI 10.1016/j.actao.2009.06.008; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Canale A, 2014, PLANT BIOSYST, V148, P889, DOI 10.1080/11263504.2013.863810; Canale A, 2010, REDIA, V93, P95; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; Corbet SA, 2003, APIDOLOGIE, V34, P1, DOI 10.1051/apido:2002049; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Decourtye A, 2010, APIDOLOGIE, V41, P264, DOI 10.1051/apido/2010024; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Fabian Y, 2013, J ANIM ECOL, V82, P1203, DOI 10.1111/1365-2656.12103; Freitas BM, 2009, APIDOLOGIE, V40, P332, DOI 10.1051/apido/2009012; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Graves SD, 2003, BIOL CONSERV, V110, P413, DOI 10.1016/S0006-3207(02)00233-1; Haaland C, 2011, IMPORTANCE OF BIOLOGICAL INTERACTIONS IN THE STUDY OF BIODIVERSITY, P155; Haaland C, 2011, J INSECT CONSERV, V15, P301, DOI 10.1007/s10841-010-9353-8; Haaland C, 2011, INSECT CONSERV DIVER, V4, P60, DOI 10.1111/j.1752-4598.2010.00098.x; HEDRICK PW, 1992, ECOL APPL, V2, P30, DOI 10.2307/1941887; Hitchmough J, 2004, LANDSCAPE URBAN PLAN, V66, P75, DOI 10.1016/S0169-2046(03)00096-3; ISTA, 1999, SEED SCI TECHNOL, V31, P1; Jacobs JH, 2009, ANN BOT-LONDON, V104, P1397, DOI 10.1093/aob/mcp236; JENNERSTEN O, 1984, OECOLOGIA, V63, P80, DOI 10.1007/BF00379789; Jennings JA, 2002, AGRON J, V94, P1104, DOI 10.2134/agronj2002.1104; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; Katzourakis A, 2001, J EVOLUTION BIOL, V14, P219, DOI 10.1046/j.1420-9101.2001.00278.x; Kayce P, 2010, REC NAT PROD, V4, P141; KIRMIZIGUL S, 1995, PHYTOCHEMISTRY, V39, P1171, DOI 10.1016/0031-9422(95)00106-H; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Korpela EL, 2011, AGR ECOSYST ENVIRON, V179, P18; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Ma MH, 2002, AGR ECOSYST ENVIRON, V89, P137, DOI 10.1016/S0167-8809(01)00325-5; MARSHALL EJP, 1995, LANDSCAPE URBAN PLAN, V31, P205, DOI 10.1016/0169-2046(94)01047-C; Nicholls CI, 2013, AGRON SUSTAIN DEV, V33, P257, DOI 10.1007/s13593-012-0092-y; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Ollerton J, 2003, ANN BOT-LONDON, V92, P807, DOI 10.1093/aob/mcg206; Ollerton J, 2007, TAXON, V56, P717, DOI 10.2307/25065856; Ozkok Tuylu A, 2007, HACETTEPE J BIOL CHE, V35, P31; Pesson P., 1984, P97; Pignatti S., 1982, FLORA DITALIA, VVolume I; Pisciotta S, 2011, PLANT BIOSYST, V145, P141, DOI 10.1080/11263504.2010.540779; POTTS S, 2010, STRAD, V121, P25; Ricciardelli G., 2000, FIORI API FLORA VISI; SCHUHMACHER H, 1982, ENTOMOL GEN, V7, P327; Steffan-Dewenter I, 1997, OECOLOGIA, V109, P294, DOI 10.1007/s004420050087; Vange V, 2002, BIOL CONSERV, V108, P59, DOI 10.1016/S0006-3207(02)00090-3; VANTREUREN R, 1994, J EVOLUTION BIOL, V7, P287, DOI 10.1046/j.1420-9101.1994.7030287.x; Wratten SD, 2012, AGR ECOSYST ENVIRON, V159, P112, DOI 10.1016/j.agee.2012.06.020	58	22	22	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93153	10.1371/journal.pone.0093153	http://dx.doi.org/10.1371/journal.pone.0093153			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676345	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677500083
J	Browne, S; Macdonald, S; May, CR; Macleod, U; Mair, FS				Browne, Susan; Macdonald, Sara; May, Carl R.; Macleod, Una; Mair, Frances S.			Patient, Carer and Professional Perspectives on Barriers and Facilitators to Quality Care in Advanced Heart Failure	PLOS ONE			English	Article							NORMALIZATION PROCESS THEORY; PALLIATIVE CARE; EUROPEAN-SOCIETY; COMMUNITY; PEOPLE; CANCER; ASSOCIATION; PREVALENCE; DIAGNOSIS; SURVIVAL	Background: Those with advanced heart failure (HF) experience high levels of morbidity and mortality, similar to common cancers. However, there remains evidence of inequity of access to palliative care services compared to people with cancer. This study examines patient, carer, and professional perspectives on current management of advanced HF and barriers and facilitators to improved care. Methods: Qualitative study involving semi-structured interviews and focus groups with advanced HF patients (n = 30), carers (n = 20), and professionals (n = 65). Data analysed using Normalisation Process Theory (NPT) as the underpinning conceptual framework. Findings: Uncertainty is ubiquitous in accounts from advanced HF patients and their caregivers. This uncertainty relates to understanding of the implications of their diagnosis, appropriate treatments, and when and how to seek effective help. Health professionals agree this is a major problem but feel they lack knowledge, opportunities, or adequate support to improve the situation. Fragmented care with lack of coordination and poor communication makes life difficult. Poor understanding of the condition extends to the wider circle of carers and means that requests for help may not be perceived as legitimate, and those with advanced HF are not prioritised for social and financial supports. Patient and caregiver accounts of emergency care are uniformly poor. Managing polypharmacy and enduring concomitant side effects is a major burden, and the potential for rationalisation exists. This study has potential limitations because it was undertaken within a single geographical location within the United Kingdom. Conclusions: Little progress is being made to improve care experiences for those with advanced HF. Even in the terminal stages, patients and caregivers are heavily and unnecessarily burdened by health care services that are poorly coordinated and offer fragmented care. There is evidence that these poor experiences could be improved to a large extent by simple organisational rather than complex clinical mechanisms.	[Browne, Susan; Macdonald, Sara; Mair, Frances S.] Univ Glasgow, Inst Hlth & Wellbeing MVLS, Gen Practice & Primary Care, Glasgow, Lanark, Scotland; [May, Carl R.] Univ Southampton, Fac Hlth Sci, Southampton, Hants, England; [Macleod, Una] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England	University of Glasgow; University of Southampton; University of Hull; University of York - UK	Mair, FS (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing MVLS, Gen Practice & Primary Care, Glasgow, Lanark, Scotland.	Frances.Mair@glasgow.ac.uk	Macdonald, Sara/D-3340-2018; Morris, Josephine D./F-3366-2018	Macdonald, Sara/0000-0002-5380-6943; Morris, Josephine D./0000-0001-9404-5602; Browne, Susan/0000-0003-1785-1429; Mair, Frances/0000-0001-9780-1135; May, Carl/0000-0002-0451-2690	Marie Curie Cancer Care; British Heart Foundation; NHS Greater Glasgow and Clyde	Marie Curie Cancer Care; British Heart Foundation(British Heart Foundation); NHS Greater Glasgow and Clyde	This work was funded by the Caring Together programme (http://www.mariecurie.org.uk/caring), a partnership between Marie Curie Cancer Care, British Heart Foundation, and NHS Greater Glasgow and Clyde. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler ED, 2009, CIRCULATION, V120, P2597, DOI 10.1161/CIRCULATIONAHA.109.869123; Allen LA, 2012, CIRCULATION, V125, P1928, DOI 10.1161/CIR.0b013e31824f2173; Barclay S., 2011, BRITISH JOURNAL OF G, V61, P582; Barnes S, 2006, J PAIN SYMPTOM MANAG, V32, P208, DOI 10.1016/j.jpainsymman.2006.04.005; Beattie JM, 2007, IMPLANTABLE CARDIOVE; Dev S, 2012, AM HEART J, V164, P313, DOI 10.1016/j.ahj.2012.05.023; Gadoud A, 2013, PALLIATIVE MED, V27, P822, DOI 10.1177/0269216313494960; Gallacher K, 2011, ANN FAM MED, V9, P235, DOI 10.1370/afm.1249; Haga K, 2012, HEART, V98, P579, DOI 10.1136/heartjnl-2011-301021; Hogg KJ, 2012, HEART, V98, P523, DOI 10.1136/heartjnl-2012-301753; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Jaarsma T, 2009, EUR J HEART FAIL, V11, P433, DOI 10.1093/eurjhf/hfp041; Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172; LeMond L, 2011, PROG CARDIOVASC DIS, V54, P168, DOI 10.1016/j.pcad.2011.03.012; Low J, 2011, J CARD FAIL, V17, P231, DOI 10.1016/j.cardfail.2010.10.003; May C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2803; May C, 2009, SOCIOLOGY, V43, P535, DOI 10.1177/0038038509103208; May CR, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-29; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Metzger M, 2013, HEART LUNG, V42, P112, DOI 10.1016/j.hrtlng.2012.11.002; Momen Natalie C, 2011, Curr Opin Support Palliat Care, V5, P312, DOI 10.1097/SPC.0b013e32834b8c4d; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Nordgren Lena, 2003, Eur J Cardiovasc Nurs, V2, P213; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Rogers AE, 2000, BMJ-BRIT MED J, V321, P605, DOI 10.1136/bmj.321.7261.605; Shah AB, 2013, REV CARDIOVASC MED, V14, P41, DOI 10.3909/ricm0635; SIGN, 2007, GUID 95 MAN CHRON HE; Solano JP, 2006, J PAIN SYMPTOM MANAG, V31, P58, DOI 10.1016/j.jpainsymman.2005.06.007; Stewart S, 2001, EUR J HEART FAIL, V3, P315, DOI 10.1016/S1388-9842(00)00141-0; Stuart B, 2007, J PALLIAT MED, V10, P210, DOI 10.1089/jpm.2006.9988; Walke LM, 2006, J PAIN SYMPTOM MANAG, V31, P31, DOI 10.1016/j.jpainsymman.2005.05.014	32	64	66	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93288	10.1371/journal.pone.0093288	http://dx.doi.org/10.1371/journal.pone.0093288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676421	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000333677500104
J	Markey, FB; Ruezinsky, W; Tyagi, S; Batish, M				Markey, Fatu Badiane; Ruezinsky, William; Tyagi, Sanjay; Batish, Mona			Fusion FISH Imaging: Single-Molecule Detection of Gene Fusion Transcripts In Situ	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; NEUROECTODERMAL TUMOR; RNA DETECTION; HUMAN CANCER; CHROMOSOME; FAMILY; CELLS; TRANSLOCATIONS; ABERRATIONS; EXPRESSION	Double-stranded DNA breaks occur on a regular basis in the human genome as a consequence of genotoxic stress and errors during replication. Usually these breaks are rapidly and faithfully repaired, but occasionally different chromosomes, or different regions of the same chromosome, are fused to each other. Some of these aberrant chromosomal translocations yield functional recombinant genes, which have been implicated as the cause of a number of lymphomas, leukemias, sarcomas, and solid tumors. Reliable methods are needed for the in situ detection of the transcripts encoded by these recombinant genes. We have developed just such a method, utilizing single-molecule fluorescence in situ hybridization (sm-FISH), in which approximately 50 short fluorescent probes bind to adjacent sites on the same mRNA molecule, rendering each target mRNA molecule visible as a diffraction-limited spot in a fluorescence microscope. Utilizing this method, gene fusion transcripts are detected with two differently colored probe sets, each specific for one of the two recombinant segments of a target mRNA; enabling the fusion transcripts to be seen in the microscope as distinct spots that fluoresce in both colors. We demonstrate this method by detecting the BCR-ABL fusion transcripts that occur in chronic myeloid leukemia cells, and by detecting the EWSR1-FLI1 fusion transcripts that occur in Ewing's sarcoma cells. This technology should pave the way for accurate in situ typing of many cancers that are associated with, or caused by, fusion transcripts.	[Markey, Fatu Badiane; Ruezinsky, William; Batish, Mona] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07102 USA; [Tyagi, Sanjay] Rutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Batish, M (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07102 USA.	batishmo@njms.rutgers.edu	Batish, Mona/AAG-8296-2019	Batish, Mona/0000-0001-9039-6149; Tyagi, Sanjay/0000-0001-7303-5827	US National Institutes of Health (NIH) [5DP5OD-0121605]; NIH [AI-106036]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106036] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012160] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Rutgers University receives royalties from the sale of pre-labeled single-molecule FISH probes by Biosearch Technologies Inc., which markets them as Stellaris probes. A fraction of these proceeds is distributed to Sanjay Tyagi's laboratory for research and to him personally. Funding for this study was provided from the US National Institutes of Health (NIH) Director's Early Independence Award (5DP5OD-0121605) to MB, and from NIH grant AI-106036 to ST. The funders had no role in study design, data collection and analysis, decision to publish, or in preparation of the manuscript.	Batish M, 2012, P NATL ACAD SCI USA, V109, P4645, DOI 10.1073/pnas.1111226109; Batish M, 2011, METHODS MOL BIOL, V714, P3, DOI 10.1007/978-1-61779-005-8_1; Battich N, 2013, NAT METHODS, V10, P1127, DOI 10.1038/nmeth.2657; Branford S, 2006, METH MOLEC MED, V125, P69; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Chinnaiyan AM, 2010, PROG MOL BIOL TRANSL, V95, P55, DOI 10.1016/B978-0-12-385071-3.00004-6; Drexler HG, 2000, LEUKEMIA, V14, P1533, DOI 10.1038/sj.leu.2401878; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Evans CH, 2012, CLIN CANCER RES, V18, P5341, DOI 10.1158/1078-0432.CCR-12-1985; Folpe AL, 2000, AM J SURG PATHOL, V24, P1657, DOI 10.1097/00000478-200012000-00010; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gamberi G, 2011, J MOL DIAGN, V13, P313, DOI 10.1016/j.jmoldx.2011.01.004; Jabbour E, 2007, CANCER-AM CANCER SOC, V109, P2171, DOI 10.1002/cncr.22661; Le Deley MC, 2010, J CLIN ONCOL, V28, P1982, DOI 10.1200/JCO.2009.23.3585; Leiserson MDM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003054; Lyubimova A, 2013, NAT PROTOC, V8, P1743, DOI 10.1038/nprot.2013.109; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Rabbitts TH, 2009, CELL, V137, P391, DOI 10.1016/j.cell.2009.04.034; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Semrau S, 2014, CELL REP, V6, P18, DOI 10.1016/j.celrep.2013.12.002; Shaffer SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075120; Sinnamon JR, 2014, RNA, V20, P260, DOI 10.1261/rna.041905.113; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Steine EJ, 2011, J CLIN INVEST, V121, P1748, DOI 10.1172/JCI43169; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2011, SCI TRANSL MED, V3; Tsugita M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077416; Vargas DY, 2011, CELL, V147, P1054, DOI 10.1016/j.cell.2011.10.024	35	26	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93488	10.1371/journal.pone.0093488	http://dx.doi.org/10.1371/journal.pone.0093488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675777	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500130
J	Meng, HW; Pagano, JM; White, BS; Toyoda, Y; Min, IM; Craighead, HG; Shalloway, D; Lis, JT; Xiao, K; Jin, MM				Meng, Hsien-Wei; Pagano, John M.; White, Brian S.; Toyoda, Yoshiko; Min, Irene M.; Craighead, Harold G.; Shalloway, David; Lis, John T.; Xiao, Kai; Jin, Moonsoo M.			Discovering Aptamers by Cell-SELEX against Human Soluble Growth Factors Ectopically Expressed on Yeast Cell Surface	PLOS ONE			English	Article							HEPARIN-BINDING DOMAIN; DNA APTAMERS; RNA; VEGF; SELECTION; DISEASE; CANCER; RECEPTORS; THERAPY; ANTIBODIES	SELEX, the process of selecting aptamers, is often hampered by the difficulty of preparing target molecules in their native forms and by a lack of a simple yet quantitative assay for monitoring enrichment and affinity of reactive aptamers. In this study, we sought to discover DNA aptamers against human serum markers for potential therapeutic and diagnostic applications. To circumvent soluble expression and immobilization for performing SELEX, we ectopically expressed soluble growth factors on the surface of yeast cells to enable cell-SELEX and devised a flow cytometry-based method to quantitatively monitor progressive enrichment of specific aptamers. High-throughput sequencing of selected pools revealed that the emergence of highly enriched sequences concurred with the increase in the percentage of reactive aptamers shown by flow cytometry. Particularly, selected DNA aptamers against VEGF were specific and of high affinity (K-D = similar to 1 nM) and demonstrated a potent inhibition of capillary tube formation of endothelial cells, comparable to the effect of a clinically approved anti-VEGF antibody drug, bevacizumab. Considering the fact that many mammalian secretory proteins have been functionally expressed in yeast, the strategy of implementing cell-SELEX and quantitative binding assay can be extended to discover aptamers against a broad array of soluble antigens.	[Meng, Hsien-Wei; Toyoda, Yoshiko; Jin, Moonsoo M.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA; [Meng, Hsien-Wei] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Pagano, John M.; White, Brian S.; Shalloway, David; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Craighead, Harold G.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Xiao, Kai; Jin, Moonsoo M.] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Min, Irene M.] Dongguk Univ, Dept Biomed Engn, Seoul, South Korea	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Dongguk University	Jin, MM (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.	moj2005@med.cornell.edu	Toyoda, Yoshiko/AAP-8180-2021; Min, Irene/AAQ-4186-2021	Min, Irene/0000-0002-1057-4804	National Institutes of Health [R01 GM090320]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM090320. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027051; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Avci-Adali M, 2010, MOLECULES, V15, P1, DOI 10.3390/molecules15010001; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Cho M, 2010, P NATL ACAD SCI USA, V107, P15373, DOI 10.1073/pnas.1009331107; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Gu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030680; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hasegawa H, 2008, BIOTECHNOL LETT, V30, P829, DOI 10.1007/s10529-007-9629-6; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Hu XB, 2010, P NATL ACAD SCI USA, V107, P6252, DOI 10.1073/pnas.0914358107; JENISON RD, 1994, SCIENCE, V263, P1425, DOI 10.1126/science.7510417; Kaur H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031196; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Krilleke D, 2007, J BIOL CHEM, V282, P28045, DOI 10.1074/jbc.M700319200; Krilleke D, 2009, BIOCHEM SOC T, V37, P1201, DOI 10.1042/BST0371201; KRUEGER JG, 1990, J INVEST DERMATOL, V94, pS135, DOI 10.1111/1523-1747.ep12876121; Latuhppe DR, 2013, ANAL GHEM; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Ordas I, 2012, CLIN PHARMACOL THER, V91, P635, DOI 10.1038/clpt.2011.328; Ozer A, 2013, NUCL ACIDS RES; Pagano JM, 2011, RNA, V17, P14, DOI 10.1261/rna.2428111; Patel DJ, 1997, J MOL BIOL, V272, P645, DOI 10.1006/jmbi.1997.1281; Potty ASR, 2009, BIOPOLYMERS, V91, P145, DOI 10.1002/bip.21097; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Trikha M, 2003, CLIN CANCER RES, V9, P4653; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wecker M, 1996, RNA, V2, P982; Ye S, 2001, BIOCHEMISTRY-US, V40, P14429, DOI 10.1021/bi011000u; Zearfoss N Ruth, 2012, Methods Mol Biol, V941, P181, DOI 10.1007/978-1-62703-113-4_14	38	3	3	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93052	10.1371/journal.pone.0093052	http://dx.doi.org/10.1371/journal.pone.0093052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675636	gold, Green Submitted, Green Published			2022-12-27	WOS:000333677500066
J	Mitchell, SN; Rigden, DJ; Dowd, AJ; Lu, F; Wilding, CS; Weetman, D; Dadzie, S; Jenkins, AM; Regna, K; Boko, P; Djogbenou, L; Muskavitch, MAT; Ranson, H; Paine, MJI; Mayans, O; Donnelly, MJ				Mitchell, Sara N.; Rigden, Daniel J.; Dowd, Andrew J.; Lu, Fang; Wilding, Craig S.; Weetman, David; Dadzie, Samuel; Jenkins, Adam M.; Regna, Kimberly; Boko, Pelagie; Djogbenou, Luc; Muskavitch, Marc A. T.; Ranson, Hilary; Paine, Mark J. I.; Mayans, Olga; Donnelly, Martin J.			Metabolic and Target-Site Mechanisms Combine to Confer Strong DDT Resistance in Anopheles gambiae	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; PROTEIN STABILITY CHANGES; AMINO-ACID SUBSTITUTION; INSECTICIDE RESISTANCE; MALARIA VECTOR; KDR MUTATION; WEB SERVER; IDENTIFICATION; POPULATIONS; INHIBITION	The development of resistance to insecticides has become a classic exemplar of evolution occurring within human time scales. In this study we demonstrate how resistance to DDT in the major African malaria vector Anopheles gambiae is a result of both target-site resistance mechanisms that have introgressed between incipient species (the M-and S-molecular forms) and allelic variants in a DDT-detoxifying enzyme. Sequencing of the detoxification enzyme, Gste2, from DDT resistant and susceptible strains of An. gambiae, revealed a non-synonymous polymorphism (I114T), proximal to the DDT binding domain, which segregated with strain phenotype. Recombinant protein expression and DDT metabolism analysis revealed that the proteins from the susceptible strain lost activity at higher DDT concentrations, characteristic of substrate inhibition. The effect of I114T on GSTE2 protein structure was explored through X-ray crystallography. The amino acid exchange in the DDT-resistant strain introduced a hydroxyl group nearby the hydrophobic DDT-binding region. The exchange does not result in structural alterations but is predicted to facilitate local dynamics and enzyme activity. Expression of both wild-type and 114T alleles the allele in Drosophila conferred an increase in DDT tolerance. The 114T mutation was significantly associated with DDT resistance in wild caught M-form populations and acts in concert with target-site mutations in the voltage gated sodium channel (Vgsc-1575Y and Vgsc-1014F) to confer extreme levels of DDT resistance in wild caught An. gambiae.	[Mitchell, Sara N.; Dowd, Andrew J.; Wilding, Craig S.; Weetman, David; Dadzie, Samuel; Boko, Pelagie; Ranson, Hilary; Paine, Mark J. I.; Donnelly, Martin J.] Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England; [Rigden, Daniel J.; Lu, Fang; Mayans, Olga] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Dadzie, Samuel] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; [Jenkins, Adam M.; Regna, Kimberly; Muskavitch, Marc A. T.] Boston Coll, Chestnut Hill, MA 02167 USA; [Djogbenou, Luc] Univ Dabomey Calavi, Inst Reg Sante Publ Ouidah, Cotonou, Benin; [Muskavitch, Marc A. T.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Donnelly, Martin J.] Wellcome Trust Sanger Inst, Malaria Programme, Cambridge, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool; University of Ghana; Boston College; University of Abomey Calavi; Harvard University; Harvard T.H. Chan School of Public Health; Wellcome Trust Sanger Institute	Mayans, O (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	olga.mayans@liv.ac.uk; m.j.donnelly@liv.ac.uk	Paine, Mark John Ingraham/O-7450-2019; Weetman, David/M-1261-2014; Mitchell, Sara/AAB-5536-2020; Wilding, Craig S/C-5500-2012; Mitchell, Sara/I-3104-2014	Paine, Mark John Ingraham/0000-0003-2061-7713; Weetman, David/0000-0002-5820-1388; Wilding, Craig S/0000-0001-5818-2706; Dowd, Andrew/0000-0001-7936-7531; Donnelly, Martin/0000-0001-5218-1497; DJOGBENOU, Salako Luc/0000-0002-7381-6321; Dadzie, Dr Samuel Kweku/0000-0002-4105-1010; Rigden, Daniel/0000-0002-7565-8937; Ranson, Hilary/0000-0003-2332-8247; Mitchell, Sara/0000-0002-7926-1881; Mayans, Olga/0000-0001-6876-8532	Biotechnology and Biological Sciences Research Council; Innovative Vector Control Consortium; National Institute of Allergy and Infectious Diseases [R01AI082734]; UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR) [A70588]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082734] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Innovative Vector Control Consortium; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR)(World Health Organization); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a Biotechnology and Biological Sciences Research Council studentship (to S.N.M.), by the Innovative Vector Control Consortium and the National Institute of Allergy and Infectious Diseases Grant R01AI082734. Funding for the mosquito collections from Burkina Faso was provided by UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR), Grant A70588. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amenya DA, 2008, INSECT MOL BIOL, V17, P19, DOI 10.1111/j.1365-2583.2008.00776.x; Badolo A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-232; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Claudianos C, 1999, INSECT BIOCHEM MOLEC, V29, P675, DOI 10.1016/S0965-1748(99)00035-1; Daborn PJ, 2012, INSECT BIOCHEM MOLEC, V42, P918, DOI 10.1016/j.ibmb.2012.09.003; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Ding YC, 2005, BIOCHEM J, V387, P879, DOI 10.1042/BJ20041850; Ding YC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-35; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Donnelly MJ, 2000, INSECT MOL BIOL, V9, P357, DOI 10.1046/j.1365-2583.2000.00197.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hood G.M., 2010, POPTOOLS VERSION 3 2; JAENICKE R, 1991, EUR J BIOCHEM, V202, P715, DOI 10.1111/j.1432-1033.1991.tb16426.x; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Le Goff G, 2003, INSECT BIOCHEM MOLEC, V33, P701, DOI 10.1016/S0965-1748(03)00064-X; Lin Y, 2001, DRUG METAB DISPOS, V29, P368; Lones C, 2012, P NATL ACAD SCI USA, V109, P6614; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; McCoy AJ, 2007, J APPL CRYSTALLOGRAP, V40; Merz A, 2000, BIOCHEMISTRY-US, V39, P880, DOI 10.1021/bi992333i; Mitchell SN, 2012, P NATL ACAD SCI USA, V109, P6147, DOI 10.1073/pnas.1203452109; Mosca R, 2008, NUCLEIC ACIDS RES, V36, pW42, DOI 10.1093/nar/gkn197; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; PRAPANTHADARA L, 1995, B ENTOMOL RES, V85, P267, DOI 10.1017/S0007485300034350; PRAPANTHADARA LA, 1993, PESTIC BIOCHEM PHYS, V47, P119, DOI 10.1006/pest.1993.1070; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; R Core Team, 2012, R LANG ENV STAT COMP; Ranson H, 2000, INSECT MOL BIOL, V9, P499, DOI 10.1046/j.1365-2583.2000.00214.x; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Reimer L, 2008, J MED ENTOMOL, V45, P260, DOI 10.1603/0022-2585(2008)45[260:RBKMAR]2.0.CO;2; Schlee S, 2009, BIOCHEMISTRY-US, V48, P5199, DOI 10.1021/bi802335s; Smith DT, 2011, J EVOLUTION BIOL, V24, P1351, DOI 10.1111/j.1420-9101.2011.02271.x; Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Vincent F, 2005, J BIOL CHEM, V280, P19649, DOI 10.1074/jbc.M502131200; Wang YJ, 2008, J STRUCT BIOL, V164, P228, DOI 10.1016/j.jsb.2008.08.003; Weetman D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013140; Weill M, 2000, INSECT MOL BIOL, V9, P451, DOI 10.1046/j.1365-2583.2000.00206.x; WHO, 2012, TEST PROC INS RES MO; Wilkins EE, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-91	51	64	65	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92662	10.1371/journal.pone.0092662	http://dx.doi.org/10.1371/journal.pone.0092662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675797	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000333677500032
J	Newman, MR; Sykes, PJ; Blyth, BJ; Bezak, E; Lawrence, MD; Morel, KL; Ormsby, RJ				Newman, Michelle R.; Sykes, Pamela J.; Blyth, Benjamin J.; Bezak, Eva; Lawrence, Mark D.; Morel, Katherine L.; Ormsby, Rebecca J.			A Single Whole-Body Low Dose X-Irradiation Does Not Affect L1, B1 and IAP Repeat Element DNA Methylation Longitudinally	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITOR CELLS; ADAPTIVE RESPONSE; LINE-1 HYPOMETHYLATION; GENE-EXPRESSION; NEOPLASTIC TRANSFORMATION; CHROMOSOMAL INVERSIONS; EPIGENETIC VARIATIONS; HISTONE MODIFICATIONS; IONIZING-RADIATION; POSSIBLE MECHANISM	The low dose radioadaptive response has been shown to be protective against high doses of radiation as well as aging-induced genomic instability. We hypothesised that a single whole-body exposure of low dose radiation would induce a radioadaptive response thereby reducing or abrogating aging-related changes in repeat element DNA methylation in mice. Following sham or 10 mGy X-irradiation, serial peripheral blood sampling was performed and differences in Long Interspersed Nucleic Element 1 (L1), B1 and Intracisternal-A-Particle (IAP) repeat element methylation between samples were assessed using high resolution melt analysis of PCR amplicons. By 420 days post-irradiation, neither radiation-or aging-related changes in the methylation of peripheral blood, spleen or liver L1, B1 and IAP elements were observed. Analysis of the spleen and liver tissues of cohorts of untreated aging mice showed that the 17-19 month age group exhibited higher repeat element methylation than younger or older mice, with no overall decline in methylation detected with age. This is the first temporal analysis of the effect of low dose radiation on repeat element methylation in mouse peripheral blood and the first to examine the long term effect of this dose on repeat element methylation in a radiosensitive tissue (spleen) and a tissue fundamental to the aging process (liver). Our data indicate that the methylation of murine DNA repeat elements can fluctuate with age, but unlike human studies, do not demonstrate an overall aging-related decline. Furthermore, our results indicate that a low dose of ionising radiation does not induce detectable changes to murine repeat element DNA methylation in the tissues and at the time-points examined in this study. This radiation dose is relevant to human diagnostic radiation exposures and suggests that a dose of 10 mGy X-rays, unlike high dose radiation, does not cause significant short or long term changes to repeat element or global DNA methylation.	[Newman, Michelle R.; Sykes, Pamela J.; Blyth, Benjamin J.; Lawrence, Mark D.; Morel, Katherine L.; Ormsby, Rebecca J.] Flinders Univ & Med Ctr, Flinders Ctr Innovat Canc, Bedford Pk, SA, Australia; [Bezak, Eva] Royal Adelaide Hosp, Dept Med Phys, Adelaide, SA 5000, Australia	Flinders University South Australia; Royal Adelaide Hospital	Sykes, PJ (corresponding author), Flinders Univ & Med Ctr, Flinders Ctr Innovat Canc, Bedford Pk, SA, Australia.	pam.sykes@flinders.edu.au	Bezak, Eva/Q-6309-2017; Bezak, Eva/S-4231-2019	Bezak, Eva/0000-0002-1315-1735; Bezak, Eva/0000-0002-1315-1735; Lawrence, Mark/0000-0003-4078-8691; Sykes, Pam/0000-0001-9239-7639; Ormsby, Rebecca/0000-0002-4256-7481; Morel, Katherine/0000-0002-7968-4032; Blyth, Benjamin/0000-0003-4754-6249	Low Dose Radiation Research Program, Biological and Environmental Research, U.S. Department of Energy [DE-FG02-05ER64104]; Flinders Medical Centre/Flinders Centre for Innovation in Cancer Research Grant; Flinders Medical Centre Foundation; BHP Billiton Low Dose Radiation Research Scholarship	Low Dose Radiation Research Program, Biological and Environmental Research, U.S. Department of Energy(United States Department of Energy (DOE)); Flinders Medical Centre/Flinders Centre for Innovation in Cancer Research Grant; Flinders Medical Centre Foundation; BHP Billiton Low Dose Radiation Research Scholarship	This work was supported by the Low Dose Radiation Research Program, Biological and Environmental Research, U.S. Department of Energy (DE-FG02-05ER64104); the Flinders Medical Centre/Flinders Centre for Innovation in Cancer Research Grant; and the Flinders Medical Centre Foundation and BHP Billiton Low Dose Radiation Research Scholarship (to M.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalsteinsson BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046705; Akagi K, 2008, GENOME RES, V18, P869, DOI 10.1101/gr.075770.107; Aukett R J, 2005, Phys Med Biol, V50, P2739, DOI 10.1088/0031-9155/50/12/001; Azzam EI, 1996, RADIAT RES, V146, P369, DOI 10.2307/3579298; AZZAM EI, 1994, RADIAT RES, V138, pS28, DOI 10.2307/3578755; Baccarelli A, 2010, EPIDEMIOLOGY, V21, P819, DOI 10.1097/EDE.0b013e3181f20457; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Barbot W, 2002, NUCLEIC ACIDS RES, V30, P2365, DOI 10.1093/nar/30.11.2365; Beetstra S, 2005, MUTAT RES-FUND MOL M, V578, P317, DOI 10.1016/j.mrfmmm.2005.05.012; Belgnaoui SM, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-13; Bollati V, 2011, BRAIN BEHAV IMMUN, V25, P1078, DOI 10.1016/j.bbi.2011.01.017; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Broome EJ, 2002, RADIAT RES, V158, P181, DOI 10.1667/0033-7587(2002)158[0181:DRFATL]2.0.CO;2; Calvanese V, 2009, AGEING RES REV, V8, P268, DOI 10.1016/j.arr.2009.03.004; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; CovielloMcLaughlin GM, 1997, NUCLEIC ACIDS RES, V25, P3051, DOI 10.1093/nar/25.15.3051; Danam RP, 1999, MOL CARCINOGEN, V24, P85, DOI 10.1002/(SICI)1098-2744(199902)24:2<85::AID-MC2>3.0.CO;2-C; Daskalos A, 2009, INT J CANCER, V124, P81, DOI 10.1002/ijc.23849; Day TK, 2007, INT J RADIAT BIOL, V83, P523, DOI 10.1080/09553000701420582; Day TK, 2007, RADIAT RES, V167, P682, DOI 10.1667/RR0764.1; Day TK, 2006, RADIAT RES, V166, P757, DOI 10.1667/RR0689.1; de Andrade A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-617; Drissi R, 2011, CANCER PREV RES, V4, P1973, DOI 10.1158/1940-6207.CAPR-11-0069; Edwards LJ, 2000, PEDIATR PULM, V30, P330, DOI 10.1002/1099-0496(200010)30:4<330::AID-PPUL10>3.0.CO;2-D; Ekram MB, 2012, EPIGENETICS-US, V7, P370, DOI 10.4161/epi.19462; El-Maarri O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016252; Elmore E, 2008, RADIAT RES, V169, P311, DOI 10.1667/RR1199.1; Fahrner JA, 2002, CANCER RES, V62, P7213; Feinendegen LE, 1999, HUM EXP TOXICOL, V18, P426, DOI 10.1191/096032799678840309; Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104; Filkowski JN, 2010, CARCINOGENESIS, V31, P1110, DOI 10.1093/carcin/bgp300; Gadhia PK, 1998, MUTAGENESIS, V13, P151; GAUBATZ JW, 1991, MECH AGEING DEV, V57, P71, DOI 10.1016/0047-6374(91)90025-U; Gentilini D, 2013, AGE, V35, P1961, DOI 10.1007/s11357-012-9463-1; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Giotopoulos G, 2006, EXP HEMATOL, V34, P1462, DOI 10.1016/j.exphem.2006.06.008; Goetz W, 2011, RADIAT RES, V175, P575, DOI 10.1667/RR2390.1; Gonzalo S, 2010, J APPL PHYSIOL, V109, P586, DOI 10.1152/japplphysiol.00238.2010; Hagan CR, 2003, NAT GENET, V35, P219, DOI 10.1038/ng1259; Hashimoto S, 1999, RADIAT RES, V151, P717, DOI 10.2307/3580211; Hooker AM, 2004, RADIAT RES, V162, P447, DOI 10.1667/RR3228; Horie K, 2002, J RADIAT RES, V43, P353, DOI 10.1269/jrr.43.353; Hunter Richard G, 2013, Mob Genet Elements, V3, pe24555; Hunter RG, 2009, P NATL ACAD SCI USA, V106, P20912, DOI 10.1073/pnas.0911143106; Igarashi S, 2010, CLIN CANCER RES, V16, P5114, DOI 10.1158/1078-0432.CCR-10-0581; Ina Y, 2005, RADIAT RES, V163, P153, DOI 10.1667/RR3289; Iyer R, 2002, RADIAT RES, V157, P3, DOI 10.1667/0033-7587(2002)157[0003:APIIIT]2.0.CO;2; Jintaridth P, 2010, PHYSIOL GENOMICS, V41, P194, DOI 10.1152/physiolgenomics.00146.2009; Johansson A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067378; Kato K, 2011, J RADIAT RES, V52, P293, DOI 10.1269/jrr.10142; Kim K-c, 2010, BR J NUTR, V104, P1; Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692; Klevenhagen SC, 1996, PHYS MED BIOL, V41, P2605, DOI 10.1088/0031-9155/41/12/002; Koturbash I, 2005, BIOCHEM BIOPH RES CO, V337, P526, DOI 10.1016/j.bbrc.2005.09.084; Kovalchuk O, 2004, MUTAT RES-FUND MOL M, V550, P59, DOI 10.1016/j.mrfmmm.2004.02.007; Kovalchuk O, 2004, MUTAT RES-FUND MOL M, V548, P75, DOI 10.1016/j.mrfmmm.2003.12.016; Kumar A, 2011, INT J RADIAT BIOL, V87, P1086, DOI 10.3109/09553002.2011.605417; Lange NE, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001231; Li W, 2004, EXP HEMATOL, V32, P1088, DOI 10.1016/j.exphem.2004.07.015; Lin CH, 2001, CANCER RES, V61, P4238; LINDOP PJ, 1962, BRIT J RADIOL, V35, P23, DOI 10.1259/0007-1285-35-409-23; Liu L, 2011, CLIN EPIGENETICS, V2, P349, DOI 10.1007/s13148-011-0042-6; LORENZ E, 1955, J NATL CANCER I, V15, P1049; MAYSHOOPES L, 1986, DEV GENET, V7, P65, DOI 10.1002/dvg.1020070202; Meischl C, 2000, EUR J HUM GENET, V8, P697, DOI 10.1038/sj.ejhg.5200523; Mitchel REJ, 2008, RADIAT RES, V170, P765, DOI 10.1667/RR1414.1; Mitchel REJ, 2004, RADIAT RES, V162, P20, DOI 10.1667/RR3190; Mitchel REJ, 2003, RADIAT RES, V159, P320, DOI 10.1667/0033-7587(2003)159[0320:LDORIT]2.0.CO;2; Mizugaki M, 1997, CLIN EXP IMMUNOL, V110, P265; Nakagawachi T, 2003, ONCOGENE, V22, P8835, DOI 10.1038/sj.onc.1207183; Newman MR, 2012, EPIGENETICS-US, V7, P92, DOI 10.4161/epi.7.1.18815; Nomura T, 2013, RADIAT RES, V179, P717, DOI 10.1667/RR2977.1; Ogino S, 2008, INT J CANCER, V122, P2767, DOI 10.1002/ijc.23470; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Pogribny I, 2004, BIOCHEM BIOPH RES CO, V320, P1253, DOI 10.1016/j.bbrc.2004.06.081; Pogribny IP, 2010, EPIGENETICS OF AGING, P11, DOI 10.1007/978-1-4419-0639-7_2; Pogrlbny I, 2005, MOL CANCER RES, V3, P553, DOI 10.1158/1541-7786.MCR-05-0074; Raiche J, 2004, BIOCHEM BIOPH RES CO, V325, P39, DOI 10.1016/j.bbrc.2004.10.002; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Saito K, 2010, CLIN CANCER RES, V16, P2418, DOI 10.1158/1078-0432.CCR-09-2819; Sakai Kazuo, 2006, Dose-Response, V4, P327, DOI 10.2203/dose-response.06-115.Sakai; SASAKI S, 1991, J RADIAT RES, V32, P73, DOI 10.1269/jrr.32.SUPPLEMENT2_73; SHADLEY JD, 1987, MUTAGENESIS, V2, P95, DOI 10.1093/mutage/2.2.95; Shuryak I, 2010, JNCI-J NATL CANCER I, V102, P1628, DOI 10.1093/jnci/djq346; SILINI G, 1974, EXP GERONTOL, V9, P99, DOI 10.1016/0531-5565(74)90038-2; SINGHAL RP, 1987, MECH AGEING DEV, V41, P199, DOI 10.1016/0047-6374(87)90040-6; St Laurent G, 2010, MECH AGEING DEV, V131, P299, DOI 10.1016/j.mad.2010.03.008; Stach D, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng002; Steegenga WT, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-38; Stoilov LM, 2007, MUTAGENESIS, V22, P117, DOI 10.1093/mutage/gel061; Tawa R, 1998, J RADIAT RES, V39, P271, DOI 10.1269/jrr.39.271; Ugwu A, 2009, J BIOMED RES, V1, P61; Wang GJ, 2000, TOXICOL SCI, V53, P369, DOI 10.1093/toxsci/53.2.369; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; WILSON VL, 1987, J BIOL CHEM, V262, P9948; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917; WOLFF S, 1988, INT J RADIAT BIOL, V53, P39, DOI 10.1080/09553008814550401; Wolff S, 1998, ENVIRON HEALTH PERSP, V106, P277, DOI 10.2307/3433927; Wu HC, 2012, CANCER EPIDEM BIOMAR, V21, P1314, DOI 10.1158/1055-9965.EPI-12-0300; Wu HC, 2011, EPIGENETICS-US, V6, P76, DOI 10.4161/epi.6.1.13391; YOSHIDA N, 1993, J RADIAT RES, V34, P269, DOI 10.1269/jrr.34.269; Zaichkina S. I., 2006, International Journal of Low Radiation, V2, P1, DOI 10.1504/IJLR.2006.007890; Zeng GX, 2006, MUTAT RES-FUND MOL M, V602, P65, DOI 10.1016/j.mrfmmm.2006.08.002	106	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93016	10.1371/journal.pone.0093016	http://dx.doi.org/10.1371/journal.pone.0093016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676381	Green Published, Green Accepted, gold			2022-12-27	WOS:000333677500065
J	Ristau, T; Paun, C; Ersoy, L; Hahn, M; Lechanteur, Y; Hoyng, C; de Jong, EK; Daha, MR; Kirchhof, B; den Hollander, AI; Fauser, S				Ristau, Tina; Paun, Constantin; Ersoy, Lebriz; Hahn, Moritz; Lechanteur, Yara; Hoyng, Carel; de Jong, Eiko K.; Daha, Mohamed R.; Kirchhof, Bernd; den Hollander, Anneke I.; Fauser, Sascha			Impact of the Common Genetic Associations of Age-Related Macular Degeneration upon Systemic Complement Component C3d Levels	PLOS ONE			English	Article							FACTOR-H POLYMORPHISM; ALTERNATIVE PATHWAY; HAPLOTYPE RECONSTRUCTION; RISK; VARIANT; ACTIVATION; RECOGNITION; DRUSEN	Age-related macular degeneration (AMD) is a common condition that leads to severe vision loss and dysregulation of the complement system is thought to be associated with the disease. To investigate associations of polymorphisms in AMD susceptibility genes with systemic complement activation, 2655 individuals were genotyped for 32 single nucleotide polymorphisms (SNPs) in or near 23 AMD associated risk genes. Component 3 (C3) and its catabolic fragment C3d were measured in serum and AMD staging was performed using multimodal imaging. The C3d/C3 ratio was calculated and associations with environmental factors, SNPs and various haplotypes of complement factor H (CFH) genes and complement factor B (CFB) genes were analyzed. Linear models were built to measure the influence of genetic variants on the C3d/C3 ratio. The study cohort included 1387 patients with AMD and 1268 controls. Higher C3d/C3 ratios were found for current smoker (p = 0.002), higher age (p = 1.56x10(-7)), AMD phenotype (p = 1.15x10(-11)) and the two SNPs in the C3 gene rs6795735 (p = 0.04) and rs2230199 (p = 0.04). Lower C3d/C3 ratios were found for diabetes (p = 2.87x10(-6)), higher body mass index (p = 1.00x10(-13)), the SNPs rs1410996 (p = 0.0001), rs800292 (p = 0.003), rs12144939 (p = 4.60x10(-6)) in CFH, rs4151667 (p = 1.01x10(-5)) in CFB and individual haplotypes in CFH and CFB. The linear model revealed a corrected R-square of 0.063 including age, smoking status, gender, and genetic polymorphisms explaining 6.3% of the C3d/C3 ratio. After adding the AMD status the corrected R-square was 0.067. In conclusion, none of the evaluated genetic polymorphisms showed an association with increased systemic complement activation apart from two SNPs in the C3 gene. Major genetic and non-genetic factors for AMD were not associated with systemic complement activation.	[Ristau, Tina; Ersoy, Lebriz; Kirchhof, Bernd; Fauser, Sascha] Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany; [Paun, Constantin; Lechanteur, Yara; Hoyng, Carel; de Jong, Eiko K.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Hahn, Moritz] Univ Cologne, Inst Med Stat Informat & Epidemiol, D-50931 Cologne, Germany; [Daha, Mohamed R.] Leiden Univ Nijmegen, Med Ctr, Dept Nephrol, Leiden, Netherlands	University of Cologne; Radboud University Nijmegen; University of Cologne	Fauser, S (corresponding author), Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany.	sascha.fauser@uk-koeln.de	Hollander, Anneke den/N-4911-2014; Lechanteur, Yara/ABB-6875-2020; de Jong, Eiko/P-3407-2015; Lehtimäki, Terho/AAD-1094-2022; Hoyng, C.B./H-8050-2014	Lechanteur, Yara/0000-0003-0951-4625; de Jong, Eiko/0000-0001-6520-0407; Lehtimäki, Terho/0000-0002-2555-4427; 	Retinovit Foundation, Germany	Retinovit Foundation, Germany	This work was supported by the Retinovit Foundation, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hawkins JR, 2002, HUM MUTAT, V19, P543, DOI 10.1002/humu.10060; Hecker LA, 2010, HUM MOL GENET, V19, P209, DOI 10.1093/hmg/ddp472; Johnson PT, 2006, P NATL ACAD SCI USA, V103, P17456, DOI 10.1073/pnas.0606234103; Khandhadia S, 2012, IMMUNOBIOLOGY, V217, P127, DOI 10.1016/j.imbio.2011.07.019; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; SCHREIBER RD, 1978, P NATL ACAD SCI USA, V75, P3948, DOI 10.1073/pnas.75.8.3948; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Smailhodzic D, 2012, OPHTHALMOLOGY, V119, P339, DOI 10.1016/j.ophtha.2011.07.056; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; van de Ven JPH, 2013, NAT GENET, V45, P813, DOI 10.1038/ng.2640; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zipfel PF, 2008, VACCINE, V26, pI67, DOI 10.1016/j.vaccine.2008.11.015	22	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93459	10.1371/journal.pone.0093459	http://dx.doi.org/10.1371/journal.pone.0093459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675670	gold, Green Submitted, Green Published			2022-12-27	WOS:000333677500126
J	Bhaskaracharya, A; Phuong, DU; Jalilian, I; Spildrejorde, M; Skarratt, KK; Fuller, SJ; Sluyter, R; Stokes, L				Bhaskaracharya, Archana; Phuong Dao-Ung; Jalilian, Iman; Spildrejorde, Mari; Skarratt, Kristen K.; Fuller, Stephen J.; Sluyter, Ronald; Stokes, Leanne			Probenecid Blocks Human P2X7 Receptor-Induced Dye Uptake via a Pannexin-1 Independent Mechanism	PLOS ONE			English	Article							HUMAN P2X(7) RECEPTOR; INTERLEUKIN-1-BETA RELEASE; INFLAMMASOME ACTIVATION; HUMAN MONOCYTES; ATP RELEASE; POLYMORPHISM; MACROPHAGES; SECRETION; TRANSPORT; IL-1-BETA	P2X7 is a ligand-gated ion channel which is activated by ATP and displays secondary permeability characteristics. The mechanism of development of the secondary permeability pathway is currently unclear, although a role for the hemichannel protein pannexin-1 has been suggested. In this study we investigated the role of pannexin-1 in P2X7-induced dye uptake and ATP-induced IL-1 beta secretion from human monocytes. We found no pharmacological evidence for involvement of pannexin-1 in P2X7-mediated dye uptake in transfected HEK-293 cells with no inhibition seen for carbenoxolone and the pannexin-1 mimetic inhibitory peptide, (10)Panx1. However, we found that probenecid inhibited P2X7-induced cationic and anionic dye uptake in stably transfected human P2X7 HEK-293 cells. An IC50 value of 203 mM was calculated for blockade of ATP-induced responses at human P2X7. Probenecid also reduced dye uptake and IL-1 beta secretion from human CD14(+) monocytes whereas carbenoxolone and (10)Panx1 showed no inhibitory effect. Patch clamp and calcium indicator experiments revealed that probenecid directly blocks the human P2X7 receptor.	[Bhaskaracharya, Archana; Phuong Dao-Ung; Skarratt, Kristen K.; Fuller, Stephen J.; Stokes, Leanne] Univ Sydney, Nepean Hosp, Sydney Med Sch Nepean, Penrith, NSW, Australia; [Jalilian, Iman; Spildrejorde, Mari; Sluyter, Ronald] Univ Wollongong, Sch Biol Sci, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Stokes, Leanne] RMIT Univ, Sch Med Sci, Hlth Innovat Res Inst, Melbourne, Vic, Australia	Nepean Hospital; University of Sydney; University of Wollongong; Royal Melbourne Institute of Technology (RMIT)	Stokes, L (corresponding author), Univ Sydney, Nepean Hosp, Sydney Med Sch Nepean, Penrith, NSW, Australia.	leanne.stokes@rmit.edu.au	Skarratt, Kristy/AAN-1479-2020; Fuller, Stephen/W-6646-2019; Sluyter, Ronald/B-5798-2009	Fuller, Stephen/0000-0003-4637-7391; Sluyter, Ronald/0000-0003-4909-686X; Spildrejorde, Mari/0000-0002-3890-9477; Skarratt, Kristy/0000-0003-4971-2773; Stokes, Leanne/0000-0003-4013-6781	National Health and Medical Research Council of Australia [ID632687]; Nepean Medical Research Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Nepean Medical Research Foundation	This work was supported by a project grant from the National Health and Medical Research Council of Australia (LS, ID632687) and the Nepean Medical Research Foundation (LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto AVP, 2013, N-S ARCH PHARMACOL, V386, P775, DOI 10.1007/s00210-013-0868-x; Bang SS, 2007, NEUROSCI LETT, V425, P120, DOI 10.1016/j.neulet.2007.08.035; Bartlett R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/271813; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; DIVIRGILIO F, 1988, J IMMUNOL, V140, P915; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Gadeock S, 2012, PURINERG SIGNAL, V8, P669, DOI 10.1007/s11302-012-9320-9; Greene TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020123; Hanley PJ, 2012, J BIOL CHEM, V287, P10650, DOI 10.1074/jbc.M111.332676; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Kingsbury SR, 2011, J INFLAMM RES, V4, P39, DOI 10.2147/JIR.S11330; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; Marques-Da-Silva C, 2011, BRIT J PHARMACOL, V163, P912, DOI 10.1111/j.1476-5381.2011.01254.x; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2010, IMMUNOL REV, V233, P218, DOI 10.1111/j.0105-2896.2009.00860.x; McClenaghan C, 2012, ASSAY DRUG DEV TECHN, V10, P533, DOI 10.1089/adt.2012.447; Michel AD, 2006, BRIT J PHARMACOL, V149, P948, DOI 10.1038/sj.bjp.0706938; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Pupovac A, 2013, PURINERG SIGNAL, V9, P609, DOI 10.1007/s11302-013-9371-6; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Riteau N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.144; RochRamel F, 1997, J PHARMACOL EXP THER, V280, P839; Schachter J, 2008, J CELL SCI, V121, P3261, DOI 10.1242/jcs.029991; Shemon AN, 2004, BRIT J PHARMACOL, V142, P1015, DOI 10.1038/sj.bjp.0705868; Shemon AN, 2008, BIOCHEM BIOPH RES CO, V365, P515, DOI 10.1016/j.bbrc.2007.11.008; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Sluyter R, 2004, GENES IMMUN, V5, P588, DOI 10.1038/sj.gene.6364127; Sluyter R, 2004, J IMMUNOL, V172, P3399, DOI 10.4049/jimmunol.172.6.3399; STEINBERG TH, 1987, J CELL BIOL, V105, P2695, DOI 10.1083/jcb.105.6.2695; Stokes L, 2010, FASEB J, V24, P2916, DOI 10.1096/fj.09-150862; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Tao JH, 2013, SEMIN ARTHRITIS RHEU, V43, P376, DOI 10.1016/j.semarthrit.2013.04.007; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x	37	56	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93058	10.1371/journal.pone.0093058	http://dx.doi.org/10.1371/journal.pone.0093058			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671093	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000333677000109
J	De Cao, E; Melegaro, A; Klok, R; Postma, M				De Cao, Elisabetta; Melegaro, Alessia; Klok, Rogier; Postma, Maarten			Optimising Assessments of the Epidemiological Impact in the Netherlands of Paediatric Immunisation with 13-Valent Pneumococcal Conjugate Vaccine Using Dynamic Transmission Modelling	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; COST-EFFECTIVENESS; NASOPHARYNGEAL CARRIAGE; SEROTYPE REPLACEMENT; DISEASE; CHILDREN; INFANTS; PROGRAM; ENGLAND; TRENDS	This work is the first attempt to quantify the overall effects of a 13-valent pneumococcal conjugate vaccine (PCV13) vaccination programme in the Dutch population taking into account all the direct and indirect effects of the vaccine on invasive pneumococcal disease. Using available Dutch data, a dynamic transmission model for the spread of pneumococci and potential subsequent invasive pneumococcal disease has been adapted to the Dutch setting. Overall, invasive pneumococcal disease cases in the Netherlands are predicted to decrease from a pre-vaccination level of 2623 cases annually to 2475, 2289, 2185, 2179, and 2178 cases annually 5-, 10-, 20-, 30-, and 40- years, respectively, post-vaccination. Therefore, vaccination with PCV13 in the Netherlands is predicted to lower invasive pneumococcal disease cases per year by up to 445 cases in the medium- to long-term. The results are quite robust for the sensitivity analyses performed on the parameters that regulate herd immunity and competition between vaccine and non-vaccine types.	[De Cao, Elisabetta; Postma, Maarten] Univ Groningen, Dept Pharm, Groningen, Netherlands; [De Cao, Elisabetta] Univ Groningen, Dept Econ Econometr & Finance, Groningen, Netherlands; [Melegaro, Alessia] Bocconi Univ, Policy Anal & Publ Management Dept, Milan, Italy; [Melegaro, Alessia] Bocconi Univ, Dondena Ctr Res Social Dynam, Milan, Italy	University of Groningen; University of Groningen; Bocconi University; Bocconi University	Postma, M (corresponding author), Univ Groningen, Dept Pharm, Groningen, Netherlands.	m.j.postma@rug.nl		De Cao, Elisabetta/0000-0002-7769-486X; Melegaro, Alessia/0000-0003-2221-8898; Postma, Maarten/0000-0002-6306-3653	Pfizer Inc.	Pfizer Inc.(Pfizer)	This study was funded by Pfizer Inc. The role of Pfizer Inc included study design, decision to publish, and preparation of the manuscript. Pfizer Inc had no role in data collection and analysis.	Bingen E, 2008, EUR J CLIN MICROBIOL, V27, P191, DOI 10.1007/s10096-007-0417-y; Black S, 2004, PEDIATR INFECT DIS J, V23, P485, DOI 10.1097/01.inf.0000129685.04847.94; Cauchemez S, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-14; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Choi YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026190; Cox CM, 2012, 1 NAT IMM C ONL MARC; Dagan R, 1996, J INFECT DIS, V174, P1271, DOI 10.1093/infdis/174.6.1271; de Vries R, 2008, VALUE HEALTH, V11, P272, DOI 10.1111/j.1524-4733.2007.00225.x; de Vries R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013392; Dery Mark Alain, 2007, Curr Infect Dis Rep, V9, P301, DOI 10.1007/s11908-007-0047-7; Farkouh RA, 2012, EXPERT REV VACCINES, V11, P1235, DOI [10.1586/erv.12.99, 10.1586/ERV.12.99]; Fedson DS, 1999, VACCINE, V17, pS11, DOI 10.1016/S0264-410X(99)00122-X; Givon-Lavi N, 2003, PEDIATR INFECT DIS J, V22, P524, DOI 10.1097/00006454-200306000-00008; Hammitt LL, 2012, 8 INT S PNEUM PNEUM; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Klein JO, 2007, CLIN INFECT DIS, V45, P2, DOI 10.1086/520068; Klugman K P, 2001, Lancet Infect Dis, V1, P85, DOI 10.1016/S1473-3099(01)00063-9; Koshy E, 2010, THORAX, V65, P770, DOI 10.1136/thx.2010.137802; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Link-Gelles R, 2013, VACCINE, V31, P2572, DOI 10.1016/j.vaccine.2013.03.049; MACLEOD CM, 1945, J EXP MED, V82, P445, DOI 10.1084/jem.82.6.445; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; Melegaro A, 2007, AM J EPIDEMIOL, V166, P228, DOI 10.1093/aje/kwm076; Melegaro A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-90; Miller E, 2011, VACCINE, V29, P9127, DOI 10.1016/j.vaccine.2011.09.112; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Moore M, 2012, IDWEEK 2012 OCT 17 2; Moore MR, 2004, J INFECT DIS, V190, P2031, DOI 10.1086/425422; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Obaro SK, 1996, LANCET, V348, P271, DOI 10.1016/S0140-6736(05)65585-7; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Prymula R, 2013, VACCINE, V31, P2080, DOI 10.1016/j.vaccine.2013.01.044; Prymula R, 2011, VACCINE, V29, P1959, DOI 10.1016/j.vaccine.2010.12.086; Prymula R, 2009, LANCET, V374, P1339, DOI 10.1016/S0140-6736(09)61208-3; Public Health England, PNEUM DIS; Roche PW, 2008, COMMUN DIS INTELL, V32, P18; Rozenbaum MH, 2012, VACCINE, V30, P7327, DOI 10.1016/j.vaccine.2012.06.026; Rozenbaum MH, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2509; Rozenbaum MH, 2010, VACCINE, V28, P2367, DOI 10.1016/j.vaccine.2010.01.005; Spijkerman J, 2011, EMERG INFECT DIS, V17, P584, DOI 10.3201/eid1704.101115; Talbot TR, 2004, PEDIATR INFECT DIS J, V23, P726, DOI 10.1097/01.inf.0000133046.60555.de; van Deursen AMM, 2012, EMERG INFECT DIS, V18, P1729, DOI 10.3201/eid1811.120329; van Gils EJM, 2009, JAMA-J AM MED ASSOC, V302, P159, DOI 10.1001/jama.2009.975; van Hoek AJ, 2012, VACCINE, V30, P7205, DOI 10.1016/j.vaccine.2012.10.017; van Lier EA, 2013, 150202001 RIVM; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	47	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e89415	10.1371/journal.pone.0089415	http://dx.doi.org/10.1371/journal.pone.0089415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24694656	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000334103000006
J	Elfes, CT; Longo, C; Halpern, BS; Hardy, D; Scarborough, C; Best, BD; Pinheiro, T; Dutra, GF				Elfes, Cristiane T.; Longo, Catherine; Halpern, Benjamin S.; Hardy, Darren; Scarborough, Courtney; Best, Benjamin D.; Pinheiro, Tiago; Dutra, Guilherme F.			A Regional-Scale Ocean Health Index for Brazil	PLOS ONE			English	Article								Brazil has one of the largest and fastest growing economies and one of the largest coastlines in the world, making human use and enjoyment of coastal and marine resources of fundamental importance to the country. Integrated assessments of ocean health are needed to understand the condition of a range of benefits that humans derive from marine systems and to evaluate where attention should be focused to improve the health of these systems. Here we describe the first such assessment for Brazil at both national and state levels. We applied the Ocean Health Index framework, which evaluates ten public goals for healthy oceans. Despite refinements of input data and model formulations, the national score of 60 (out of 100) was highly congruent with the previous global assessment for Brazil of 62. Variability in scores among coastal states was most striking for goals related to mariculture, protected areas, tourism, and clean waters. Extractive goals, including Food Provision, received low scores relative to habitat-related goals, such as Biodiversity. This study demonstrates the applicability of the Ocean Health Index at a regional scale, and its usefulness in highlighting existing data and knowledge gaps and identifying key policy and management recommendations. To improve Brazil's ocean health, this study suggests that future actions should focus on: enhancing fisheries management, expanding marine protected areas, and monitoring coastal habitats.	[Elfes, Cristiane T.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Longo, Catherine; Halpern, Benjamin S.; Hardy, Darren; Scarborough, Courtney; Best, Benjamin D.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA; [Halpern, Benjamin S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Halpern, Benjamin S.] Univ London Imperial Coll Sci Technol & Med, London, Berks, England; [Hardy, Darren] Stanford Univ, Stanford, CA 94305 USA; [Pinheiro, Tiago] Conservat Int Brazil, Atlantic Forest Program, Belo Horizonte, MG, Brazil; [Dutra, Guilherme F.] Conservat Int Brazil, Marine Program, Rio De Janeiro, RJ, Brazil	University of California System; University of California Santa Barbara; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Imperial College London; Stanford University	Elfes, CT (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	cristiane.elfes@lifesci.ucsb.edu		Scarborough, Courtney/0000-0001-7270-9228	Thomas W. Haas Fund of the New Hampshire Charitable Foundation; Oak Foundation; Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation; Darden Restaurants Inc.; Foundation, Conservation International, New England Aquarium, National Geographic; National Center for Ecological Analysis and Synthesis	Thomas W. Haas Fund of the New Hampshire Charitable Foundation; Oak Foundation; Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation; Darden Restaurants Inc.; Foundation, Conservation International, New England Aquarium, National Geographic; National Center for Ecological Analysis and Synthesis	Beau and Heather Wrigley provided the founding grant for the original Ocean Health Index work and the Pacific Life Foundation is the Founding Presenting Sponsor. Additional financial and in-kind support was provided by the Thomas W. Haas Fund of the New Hampshire Charitable Foundation, the Oak Foundation, Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation, Darden Restaurants Inc. Foundation, Conservation International, New England Aquarium, National Geographic, and the National Center for Ecological Analysis and Synthesis, which supported the Ecosystem Health Working Group as part of the Science of Ecosystem-Based Management project funded by the David and Lucile Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035171; [Anonymous], 2010, COP OUT BIOD LOSS RI; Guimaraes AS, 2005, MONOGRAPH FEDERAL U; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2013, MAR POLICY, V42, P68, DOI 10.1016/j.marpol.2013.01.019; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; IMF (International Monetary Fund), 2013, REP SEL COUNTR SUBJ; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; Marone E, 2012, BIOMAS BRASILEIROS R; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; MMA, 2006, REL EX PROGR REVIZEE; Peres M.B., 2012, 6 WORLD FISH C 7 11, P21; PEREZ J. A. A., 2003, DINAMICA FROTAS PESQ, P117; Polette M, 2003, J COASTAL RES, P94; Rapport DJ, 1999, ECOSYST HEALTH, V5, P82, DOI 10.1046/j.1526-0992.1999.09913.x; Samhouri JF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00366.1; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; TOBEY J, 1998, MAINTAINING BALANCE; Valenti, 2008, 2008 REV IUCN RED LI	19	41	46	5	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92589	10.1371/journal.pone.0092589	http://dx.doi.org/10.1371/journal.pone.0092589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695103	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000023
J	Vidigal, PG; Musken, M; Becker, KA; Haussler, S; Wingender, J; Steinmann, E; Kehrmann, J; Gulbins, E; Buer, J; Rath, PM; Steinmann, J				Vidigal, Pedrina G.; Muesken, Mathias; Becker, Katrin A.; Haeussler, Susanne; Wingender, Jost; Steinmann, Eike; Kehrmann, Jan; Gulbins, Erich; Buer, Jan; Rath, Peter Michael; Steinmann, Joerg			Effects of Green Tea Compound Epigallocatechin-3-Gallate against Stenotrophomonas maltophilia Infection and Biofilm	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE EGCG; PSEUDOMONAS-AERUGINOSA; CANDIDA-ALBICANS; GALLATE; PATHOGENS; CATECHIN; STAPHYLOCOCCI; TOBRAMYCIN; TOXICITY	We investigated the in vitro and in vivo activities of epigallocatechin- 3- gallate ( EGCg), a green tea component, against Stenotrophomonas maltophilia ( Sm) isolates from cystic fibrosis ( CF) patients. In vitro effects of EGCg and the antibiotic colistin ( COL) on growth inhibition, survival, and also against young and mature biofilms of S. maltophilia were determined. Qualitative and quantitative changes on the biofilms were assessed by confocal laser scanning microscopy ( CLSM). Further, in vivo effects of nebulized EGCg in C57BL/ 6 and Cftr mutant mice during acute Sm lung infection were evaluated. Subinhibitory concentrations of EGCg significantly reduced not only biofilm formation, but also the quantity of viable cells in young and mature biofilms. CLSM showed that EGCg- exposed biofilms exhibited either a change in total biofilm biovolume or an increase of the fraction of dead cells contained within the biofilm in a dose depended manner. Sm infected wild- type and Cftr mutant mice treated with 1,024 mg/ L EGCg by inhalation exhibited significantly lower bacterial counts than those undergoing no treatment or treated with COL. EGCg displayed promising inhibitory and anti- biofilm properties against CF Sm isolates in vitro and significantly reduced Sm bacterial counts in an acute infection model with wild type and CF mice. This natural compound may represent a novel therapeutic agent against Sm infection in CF.	[Vidigal, Pedrina G.; Kehrmann, Jan; Buer, Jan; Rath, Peter Michael; Steinmann, Joerg] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, Essen, Germany; [Muesken, Mathias; Haeussler, Susanne] Ctr Expt & Clin Infect Res, TWINCORE, Inst Mol Bacteriol, Hannover, Germany; [Muesken, Mathias; Haeussler, Susanne] Helmholtz Ctr Infect Res, Dept Mol Bacteriol, Braunschweig, Germany; [Becker, Katrin A.; Gulbins, Erich] Univ Duisburg Essen, Inst Mol Biol, Essen, Germany; [Wingender, Jost] Univ Duisburg Essen, Fac Chem, Dept Aquat Microbiol, Biofilm Ctr, Essen, Germany; [Steinmann, Eike] Ctr Expt & Clin Infect Res, TWINCORE, Div Expt Virol, Hannover, Germany	University of Duisburg Essen; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; University of Duisburg Essen; University of Duisburg Essen; Helmholtz Association; Helmholtz-Center for Infection Research	Steinmann, J (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, Essen, Germany.	Joerg.Steinmann@uk-essen.de	Gulbins, Erich/L-6989-2014; Pohl, Sarah/B-3102-2016; Häussler, Susanne/I-2605-2014	Gulbins, Erich/0000-0002-3117-1342; Pohl, Sarah/0000-0003-2655-7037; Häussler, Susanne/0000-0001-6141-9102; Musken, Mathias/0000-0002-5624-1378; Buer, Jan/0000-0002-7602-1698; Steinmann, Eike/0000-0002-3654-9965	Mercator Stiftung	Mercator Stiftung	Pedrina Goncalves Vidigal holds a scholarship from the Mercator Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 2004, BIOL PHARM BULL, V27, P277, DOI 10.1248/bpb.27.277; Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031; Benelli R, 2002, BIOL CHEM, V383, P101, DOI 10.1515/BC.2002.010; Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Chernish RN, 2003, CURR OPIN PULM MED, V9, P509, DOI 10.1097/00063198-200311000-00011; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cui Y, 2012, FOOD MICROBIOL, V29, P80, DOI 10.1016/j.fm.2011.08.019; de Vrankrijker AMM, 2010, PAEDIATR RESPIR REV, V11, P246, DOI 10.1016/j.prrv.2010.07.003; Di Bonaventura G, 2007, FOLIA MICROBIOL, V52, P86, DOI 10.1007/BF02932144; Di Bonaventura G, 2004, ANTIMICROB AGENTS CH, V48, P151, DOI 10.1128/AAC.48.1.151-160.2004; Evensen NA, 2009, CAN J MICROBIOL, V55, P1033, DOI [10.1139/W09-058, 10.1139/w09-058]; Gales AC, 2001, CLIN INFECT DIS, V32, pS104, DOI 10.1086/320183; Gordon NC, 2010, INT J ANTIMICROB AG, V36, P129, DOI 10.1016/j.ijantimicag.2010.03.025; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Herrmann G, 2010, J INFECT DIS, V202, P1585, DOI 10.1086/656788; Hirasawa M, 2004, J ANTIMICROB CHEMOTH, V53, P225, DOI 10.1093/jac/dkh046; Hoiby Niels, 2002, J Cyst Fibros, V1, P249, DOI 10.1016/S1569-1993(02)00104-2; Isbrucker RA, 2006, FOOD CHEM TOXICOL, V44, P636, DOI 10.1016/j.fct.2005.11.003; Isbrucker RA, 2006, FOOD CHEM TOXICOL, V44, P626, DOI 10.1016/j.fct.2005.07.005; Lechtzin N, 2006, RESPIRATION, V73, P27, DOI 10.1159/000087686; McCaughey G, 2012, J CYST FIBROS, V11, P163, DOI 10.1016/j.jcf.2011.11.003; Musken M, 2010, NAT PROTOC, V5, P1460, DOI 10.1038/nprot.2010.110; Navarro-Martinez MD, 2005, ANTIMICROB AGENTS CH, V49, P2914, DOI 10.1128/AAC.49.7.2914-2920.2005; O'Connell OJ, 2011, RESP CARE, V56, P771, DOI 10.4187/respcare.00866; Osterburg A, 2009, CLIN MICROBIOL INFEC, V15, P341, DOI 10.1111/j.1469-0691.2009.02710.x; Pompilio A, 2011, PEPTIDES, V32, P1807, DOI 10.1016/j.peptides.2011.08.002; Pompilio A, 2010, J MED MICROBIOL, V59, P76, DOI 10.1099/jmm.0.011981-0; Pompilio A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-159; Pompilio A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-102; Rayamajhi M., 2011, JOVE-J VIS EXP, V51, P2702; Roccaro AS, 2004, ANTIMICROB AGENTS CH, V48, P1968, DOI 10.1128/AAC.48.6.1968-1973.2004; Steinmann J, 2013, BRIT J PHARMACOL, V168, P1059, DOI 10.1111/bph.12009; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; UK Cystic Fibrosis Trust Antibiotic Working Group, 2009, ANT TREATM CYST FIBR; Waters V, 2013, J CYST FIBROS, V12, P482, DOI 10.1016/j.jcf.2012.12.006; Waters V, 2011, AM J RESP CRIT CARE, V183, P635, DOI 10.1164/rccm.201009-1392OC; Wolfensohn S., 1999, HUMANE ENDPOINTS ANI, P48; Wu F, 2012, TOXICOL APPL PHARM, V258, P166, DOI 10.1016/j.taap.2011.10.018; Xu X, 2011, ANTIMICROB AGENTS CH, V55, P1229, DOI 10.1128/AAC.01016-10; Yamada H, 2006, J AM MED DIR ASSOC, V7, P79, DOI 10.1016/j.jamda.2005.06.002; Yoda Yoshiyuki, 2004, Journal of Infection and Chemotherapy, V10, P55, DOI 10.1007/s10156-003-0284-0; Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006	45	23	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92876	10.1371/journal.pone.0092876	http://dx.doi.org/10.1371/journal.pone.0092876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690894	gold, Green Published			2022-12-27	WOS:000334101100033
J	Zhong, HJ; Liu, LJ; Chong, CM; Lu, LH; Wang, MD; Chan, DSH; Chan, PWH; Lee, SMY; Ma, DL; Leung, CH				Zhong, Hai-Jing; Liu, Li-Juan; Chong, Cheong-Meng; Lu, Lihua; Wang, Modi; Chan, Daniel Shiu-Hin; Chan, Philip Wai Hong; Lee, Simon Ming-Yuen; Ma, Dik-Lung; Leung, Chung-Hang			Discovery of a Natural Product-Like iNOS Inhibitor by Molecular Docking with Potential Neuroprotective Effects In Vivo	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; DRUG DISCOVERY; SELECTIVE INHIBITOR; PARKINSONS-DISEASE; MPTP; ZEBRAFISH; LIGAND; IDENTIFICATION; INFLAMMATION; SUPPRESSION	In this study, we applied structure- based virtual screening techniques to identify natural product or natural product- like inhibitors of iNOS. The iNOS inhibitory activity of the hit compounds was characterized using cellular assays and an in vivo zebrafish larvae model. The natural product- like compound 1 inhibited NO production in LPS- stimulated Raw264.7 macrophages, without exerting cytotoxic effects on the cells. Significantly, compound 1 was able to reverse MPTP-induced locomotion deficiency and neurotoxicity in an in vivo zebrafish larval model. Hence, compound 1 could be considered as a scaffold for the further development of iNOS inhibitors for potential anti- inflammatory or anti- neurodegenerative applications.	[Zhong, Hai-Jing; Liu, Li-Juan; Chong, Cheong-Meng; Lee, Simon Ming-Yuen; Leung, Chung-Hang] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macao, Peoples R China; [Lu, Lihua; Wang, Modi; Chan, Daniel Shiu-Hin; Ma, Dik-Lung] Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China; [Chan, Philip Wai Hong] Nanyang Technol Univ, Sch Phys & Math Sci, Div Chem & Biol Chem, Singapore 639798, Singapore	University of Macau; Hong Kong Baptist University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ma, DL (corresponding author), Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China.	edmondma@hkbu.edu.hk; duncanleung@umac.mo	Wang, Modi/ABG-9659-2021	Zhong, Hai-Jing/0000-0002-1247-3150; Ma, Dik-Lung/0000-0002-9515-340X	Hong Kong Baptist University [FRG2/12-13/021]; Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU); Health and Medical Research Fund [HMRF/13121482]; Research Grants Council [HKBU/201811, HKBU/204612, HKBU/201913]; French National Research Agency/Research Grants Council Joint Research Scheme [A-HKBU201/12]; Science and Technology Development Fund, Macao SAR [001/2012/A, 103/2012/A3]; University of Macau [MYRG091(Y2-L2)-ICMS12-LCH, MYRG121(Y2-L2)-ICMS12-LCH, MRG023/LCH/2013/ICMS]	Hong Kong Baptist University; Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU); Health and Medical Research Fund; Research Grants Council(Hong Kong Research Grants Council); French National Research Agency/Research Grants Council Joint Research Scheme(French National Research Agency (ANR)); Science and Technology Development Fund, Macao SAR; University of Macau	This work is supported by Hong Kong Baptist University (FRG2/12-13/021), Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU), the Health and Medical Research Fund (HMRF/13121482), the Research Grants Council (HKBU/201811, HKBU/204612 and HKBU/201913), the French National Research Agency/Research Grants Council Joint Research Scheme (A-HKBU201/12), the Science and Technology Development Fund, Macao SAR (001/2012/A and 103/2012/A3) and the University of Macau (MYRG091(Y2-L2)-ICMS12-LCH, MYRG121(Y2-L2)-ICMS12-LCH and MRG023/LCH/2013/ICMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abagyan AR, 2009, ICM MANUAL 3 0; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Ando K, 2008, PSYCHOPHARMACOLOGY, V195, P509, DOI 10.1007/s00213-007-0929-2; Anichtchik OV, 2004, J NEUROCHEM, V88, P443, DOI 10.1046/j.1471-4159.2003.02190.x; Arias-Salvatierra D, 2011, CELL SIGNAL, V23, P425, DOI 10.1016/j.cellsig.2010.10.017; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Butler MS, 2004, J NAT PROD, V67, P2141, DOI 10.1021/np040106y; Chan DSH, 2010, ANGEW CHEM INT EDIT, V49, P2860, DOI 10.1002/anie.200907360; Cheshire DR, 2011, BIOORG MED CHEM LETT, V21, P2468, DOI 10.1016/j.bmcl.2011.02.061; Coleman JW, 2001, INT IMMUNOPHARMACOL, V1, P1397, DOI 10.1016/S1567-5769(01)00086-8; CONNOR JR, 1995, EUR J PHARMACOL, V273, P15, DOI 10.1016/0014-2999(94)00672-T; Davey DD, 2007, J MED CHEM, V50, P1146, DOI 10.1021/jm061319i; Dehmer T, 2000, J NEUROCHEM, V74, P2213, DOI 10.1046/j.1471-4159.2000.0742213.x; Forstermann U, 1998, FASEB J, V12, P773; Gasparotto J, 2013, CELL BIOL TOXICOL, V29, P175, DOI 10.1007/s10565-013-9245-2; Gradler U, 2011, BIOORG MED CHEM LETT, V21, P4228, DOI 10.1016/j.bmcl.2011.05.073; Hansel TT, 2003, FASEB J, V17, P1298, DOI 10.1096/fj.02-0633fje; Hemmens B, 2000, J BIOL CHEM, V275, P35786, DOI 10.1074/jbc.M005976200; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; JONES RSG, 1982, PROG NEUROBIOL, V19, P117, DOI 10.1016/0301-0082(82)90023-5; Lam CS, 2005, EUR J NEUROSCI, V21, P1758, DOI 10.1111/j.1460-9568.2005.03988.x; Lassiani L, 2009, BIOORGAN MED CHEM, V17, P2336, DOI 10.1016/j.bmc.2009.02.012; Lee HM, 2010, CHEM COMMUN, V46, P4680, DOI 10.1039/b926359d; Leung CH, 2011, CHEM COMMUN, V47, P2511, DOI 10.1039/c0cc04927a; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Liberatore GT, 1999, NAT MED, V5, P1403; Luiking YC, 2010, CURR OPIN CLIN NUTR, V13, P97, DOI 10.1097/MCO.0b013e328332f99d; Ma DL, 2011, CHEM SCI, V2, P1656, DOI 10.1039/c1sc00152c; McKinley ET, 2005, MOL BRAIN RES, V141, P128, DOI 10.1016/j.molbrainres.2005.08.014; McMillan K, 2000, P NATL ACAD SCI USA, V97, P1506, DOI 10.1073/pnas.97.4.1506; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; MOORE WM, 1994, J MED CHEM, V37, P3886, DOI 10.1021/jm00049a007; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nosal R, 2010, NEUROENDOCRINOL LETT, V31, P69; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Rollinger Judith M., 2008, V65; Rosenfeld RJ, 2002, BIOCHEMISTRY-US, V41, P13915, DOI 10.1021/bi026313j; Schapira M, 1999, J MOL RECOGNIT, V12, P177, DOI 10.1002/(SICI)1099-1352(199905/06)12:3<177::AID-JMR451>3.0.CO;2-Z; Schuster D, 2010, CURR PHARM DESIGN, V16, P1666, DOI 10.2174/138161210791164072; Suaifan GARY, 2012, J MOL GRAPH MODEL, V37, P1, DOI 10.1016/j.jmgm.2012.04.001; Tanrikulu Y, 2013, DRUG DISCOV TODAY, V18, P358, DOI 10.1016/j.drudis.2013.01.007; Tinker AC, 2003, J MED CHEM, V46, P913, DOI 10.1021/jm0255926; Totrov M, 1997, PROTEINS, P215; Zhang ZJ, 2011, INT J MOL MED, V27, P195, DOI 10.3892/ijmm.2010.571; Zhong HJ, 2012, BIOCHIMIE, V94, P2457, DOI 10.1016/j.biochi.2012.06.004; Zhu YZ, 2012, CNS NEUROL DISORD-DR, V11, P350, DOI 10.2174/187152712800792901	48	29	29	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92905	10.1371/journal.pone.0092905	http://dx.doi.org/10.1371/journal.pone.0092905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690920	gold, Green Published			2022-12-27	WOS:000334101100035
J	An, X; Gong, HL; McLoughlin, N; Yang, YP; Wang, W				An, Xu; Gong, Hongliang; McLoughlin, Niall; Yang, Yupeng; Wang, Wei			The Mechanism for Processing Random-Dot Motion at Various Speeds in Early Visual Cortices	PLOS ONE			English	Article							SPATIAL-FREQUENCY SELECTIVITY; COMPLEX CELLS; RECEPTIVE-FIELDS; FUNCTIONAL ARCHITECTURE; DIRECTION SELECTIVITY; CONTRAST SENSITIVITY; STRIATE CORTEX; ORIENTATION SELECTIVITY; AREAS 17; CAT	All moving objects generate sequential retinotopic activations representing a series of discrete locations in space and time (motion trajectory). How direction-selective neurons in mammalian early visual cortices process motion trajectory remains to be clarified. Using single-cell recording and optical imaging of intrinsic signals along with mathematical simulation, we studied response properties of cat visual areas 17 and 18 to random dots moving at various speeds. We found that, the motion trajectory at low speed was encoded primarily as a direction signal by groups of neurons preferring that motion direction. Above certain transition speeds, the motion trajectory is perceived as a spatial orientation representing the motion axis of the moving dots. In both areas studied, above these speeds, other groups of direction-selective neurons with perpendicular direction preferences were activated to encode the motion trajectory as motion-axis information. This applied to both simple and complex neurons. The average transition speed for switching between encoding motion direction and axis was about 31 degrees/s in area 18 and 15 degrees/s in area 17. A spatio-temporal energy model predicted the transition speeds accurately in both areas, but not the direction-selective indexes to random-dot stimuli in area 18. In addition, above transition speeds, the change of direction preferences of population responses recorded by optical imaging can be revealed using vector maximum but not vector summation method. Together, this combined processing of motion direction and axis by neurons with orthogonal direction preferences associated with speed may serve as a common principle of early visual motion processing.	[An, Xu; Yang, Yupeng] Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Sch Life Sci, Hefei 230026, Peoples R China; [An, Xu; Gong, Hongliang; Wang, Wei] Chinese Acad Sci, Inst Neurosci, Shanghai, Peoples R China; [An, Xu; Gong, Hongliang; Wang, Wei] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai, Peoples R China; [McLoughlin, Niall] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Manchester	Yang, YP (corresponding author), Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Sch Life Sci, Hefei 230026, Peoples R China.	yangyp@ustc.edu.cn; w.wang@ion.ac.cn	An, Xu/HIK-2020-2022; Yang, Yupeng/G-5107-2018	An, Xu/0000-0003-3386-5521; Yang, Yupeng/0000-0002-9473-9994; McLoughlin, Niall/0000-0002-0138-4312	National '973' Program [2011CBA00400, 2009CB941303]; Fundamental Research Funds for the Central Universities [WK2070000007]	National '973' Program(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National '973' Program 2011CBA00400, 2009CB941303, and the Fundamental Research Funds for the Central Universities (WK2070000007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; An X, 2012, J NEUROSCI, V32, P13363, DOI 10.1523/JNEUROSCI.1900-12.2012; Apthorp D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2339; Bair W, 2005, CURR OPIN NEUROBIOL, V15, P459, DOI 10.1016/j.conb.2005.07.006; Baker TI, 2005, J NEUROPHYSIOL, V94, P775, DOI 10.1152/jn.01093.2004; Basole A, 2003, NATURE, V423, P986, DOI 10.1038/nature01721; Basole A, 2006, PROG BRAIN RES, V154, P121, DOI 10.1016/S0079-6123(06)54006-3; BISTI S, 1974, J PHYSIOL-LONDON, V241, P201, DOI 10.1113/jphysiol.1974.sp010649; BISTI S, 1985, J PHYSIOL-LONDON, V359, P259, DOI 10.1113/jphysiol.1985.sp015584; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bonhoeffer Tobias, 1996, P55; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Borst A, 2011, NEURON, V71, P974, DOI 10.1016/j.neuron.2011.08.031; BRADDICK OJ, 1980, PHILOS T ROY SOC B, V290, P137, DOI 10.1098/rstb.1980.0087; Bradley DC, 2008, NAT REV NEUROSCI, V9, P686, DOI 10.1038/nrn2472; Burr D, 2011, VISION RES, V51, P1431, DOI 10.1016/j.visres.2011.02.008; Burr DC, 2002, J NEUROSCI, V22, P8661; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V198, P237, DOI 10.1113/jphysiol.1968.sp008604; CAMPBELL FW, 1973, J PHYSIOL-LONDON, V229, P719, DOI 10.1113/jphysiol.1973.sp010163; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; CASANOVA C, 1995, J NEUROPHYSIOL, V74, P1271, DOI 10.1152/jn.1995.74.3.1271; Chance FS, 1998, J NEUROSCI, V18, P4785; Chen Y, 2009, J VISION, V9, DOI 10.1167/9.9.12; CROOK JM, 1990, EXP BRAIN RES, V80, P545; De Valois RL, 2000, VISION RES, V40, P3685, DOI 10.1016/S0042-6989(00)00210-8; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; Dreher B, 1996, CEREB CORTEX, V6, P585, DOI 10.1093/cercor/6.4.585; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Felsen G, 2005, NAT NEUROSCI, V8, P1643, DOI 10.1038/nn1608; FERSTER D, 1990, VISUAL NEUROSCI, V4, P115, DOI 10.1017/S0952523800002285; Fournier J, 2011, NAT NEUROSCI, V14, P1053, DOI 10.1038/nn.2861; FREUND TF, 1985, J COMP NEUROL, V242, P263, DOI 10.1002/cne.902420208; Gardner JL, 1999, VISUAL NEUROSCI, V16, P1115, DOI 10.1017/S0952523899166112; Geisler WS, 1999, NATURE, V400, P65, DOI 10.1038/21886; Geisler WS, 2001, VISUAL NEUROSCI, V18, P501, DOI 10.1017/S0952523801184014; Grabska-Barwinska A, 2012, J NEUROSCI METH, V203, P1, DOI 10.1016/j.jneumeth.2011.08.026; Gur M, 2005, CEREB CORTEX, V15, P1207, DOI 10.1093/cercor/bhi003; HAMMOND P, 1978, EXP BRAIN RES, V31, P341; HAMMOND P, 1983, J PHYSIOL-LONDON, V342, P35, DOI 10.1113/jphysiol.1983.sp014838; HAMMOND P, 1980, NEUROSCI LETT, V19, P309, DOI 10.1016/0304-3940(80)90279-7; HAMMOND P, 1978, J PHYSIOL-LONDON, V285, P479, DOI 10.1113/jphysiol.1978.sp012584; Hedges JH, 2011, CURR BIOL, V21, P2023, DOI 10.1016/j.cub.2011.10.049; HEGGELUND P, 1978, EXP BRAIN RES, V32, P197; Hua TM, 2006, NEUROBIOL AGING, V27, P155, DOI 10.1016/j.neurobiolaging.2004.11.012; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUMPHREY AL, 1985, J COMP NEUROL, V233, P190, DOI 10.1002/cne.902330204; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; Jancke D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-14-j0005.2000; Kisvarday ZF, 2001, CEREB CORTEX, V11, P636, DOI 10.1093/cercor/11.7.636; Kourtzi Z, 2008, TRENDS COGN SCI, V12, P230, DOI 10.1016/j.tics.2008.02.013; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; Lu HDD, 2010, NEURON, V68, P1002, DOI 10.1016/j.neuron.2010.11.020; Mante V, 2005, J NEUROPHYSIOL, V94, P788, DOI 10.1152/jn.01094.2004; MARR D, 1981, PROC R SOC SER B-BIO, V211, P151, DOI 10.1098/rspb.1981.0001; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; MORRONE MC, 1986, J NEUROPHYSIOL, V56, P969, DOI 10.1152/jn.1986.56.4.969; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; NAKAYAMA K, 1985, PERCEPTION, V14, P225, DOI 10.1068/p140225; NAKAYAMA K, 1981, VISION RES, V21, P427, DOI 10.1016/0042-6989(81)90089-4; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Pan YX, 2012, J NEUROSCI, V32, P6760, DOI 10.1523/JNEUROSCI.6140-11.2012; PAYNE BR, 1993, CEREB CORTEX, V3, P1, DOI 10.1093/cercor/3.1.1; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; RAMACHANDRAN VS, 1986, SCI AM, V254, P102, DOI 10.1038/scientificamerican0686-102; Rao SC, 1997, J COMP NEUROL, V387, P358; Reichardt W., 1961, S PRINC SENS COMM, P303; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; ROSE D, 1974, EXP BRAIN RES, V20, P1; SAUL AB, 1992, VISUAL NEUROSCI, V8, P365, DOI 10.1017/S0952523800005101; SCANNELL JW, 1995, J NEUROSCI, V15, P1463; Schiessl I, 2008, NEUROIMAGE, V39, P634, DOI 10.1016/j.neuroimage.2007.09.022; Schmolesky MT, 2000, NAT NEUROSCI, V3, P384, DOI 10.1038/73957; Shmuel A, 1996, J NEUROSCI, V16, P6945; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Sincich LC, 2005, ANNU REV NEUROSCI, V28, P303, DOI 10.1146/annurev.neuro.28.061604.135731; SKOTTUN BC, 1988, J NEUROPHYSIOL, V59, P1719, DOI 10.1152/jn.1988.59.6.1719; SKOTTUN BC, 1991, VISION RES, V31, P43, DOI 10.1016/0042-6989(91)90071-C; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; SKOTTUN BC, 1994, VISUAL NEUROSCI, V11, P885, DOI 10.1017/S0952523800003849; STONE J, 1973, J NEUROPHYSIOL, V36, P551, DOI 10.1152/jn.1973.36.3.551; Swindale NV, 2003, CEREB CORTEX, V13, P225, DOI 10.1093/cercor/13.3.225; Tani T, 2012, EUR J NEUROSCI, V35, P44, DOI 10.1111/j.1460-9568.2011.07954.x; TOLHURST DJ, 1981, PROC R SOC SER B-BIO, V213, P183, DOI 10.1098/rspb.1981.0061; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; TUSA RJ, 1978, J COMP NEUROL, V177, P213, DOI 10.1002/cne.901770204; VANESSEN DC, 1994, NEURON, V13, P1, DOI 10.1016/0896-6273(94)90455-3; WATKINS DW, 1974, EXP BRAIN RES, V19, P433; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0; WORGOTTER F, 1991, EXP BRAIN RES, V83, P665; WORGOTTER F, 1989, EXP BRAIN RES, V76, P307; WORGOTTER F, 1991, EXP BRAIN RES, V83, P656; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452; Zhan CA, 2008, CEREB CORTEX, V18, P1029, DOI 10.1093/cercor/bhm139; Zhan CA, 2006, CEREB CORTEX, V16, P896, DOI 10.1093/cercor/bhj033; Zhang J, 2004, SOC NEUROSCI, V648, P6	104	13	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93115	10.1371/journal.pone.0093115	http://dx.doi.org/10.1371/journal.pone.0093115			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682033	gold, Green Published, Green Submitted			2022-12-27	WOS:000333678100025
J	Burlaud-Gaillard, J; Sellin, C; Georgeault, S; Uzbekov, R; Lebos, C; Guillaume, JM; Roingeard, P				Burlaud-Gaillard, Julien; Sellin, Caroline; Georgeault, Sonia; Uzbekov, Rustem; Lebos, Claude; Guillaume, Jean-Marc; Roingeard, Philippe			Correlative Scanning-Transmission Electron Microscopy Reveals that a Chimeric Flavivirus Is Released as Individual Particles in Secretory Vesicles	PLOS ONE			English	Article							INFECTED-CELLS; DENGUE VIRUS; REPLICATION; LIGHT	The intracellular morphogenesis of flaviviruses has been well described, but flavivirus release from the host cell remains poorly documented. We took advantage of the optimized production of an attenuated chimeric yellow fever/dengue virus for vaccine purposes to study this phenomenon by microscopic approaches. Scanning electron microscopy (SEM) showed the release of numerous viral particles at the cell surface through a short-lived process. For transmission electron microscopy (TEM) studies of the intracellular ultrastructure of the small number of cells releasing viral particles at a given time, we developed a new correlative microscopy method: CSEMTEM (for correlative scanning electron microscopy transmission electron microscopy). CSEMTEM analysis suggested that chimeric flavivirus particles were released as individual particles, in small exocytosis vesicles, via a regulated secretory pathway. Our morphological findings provide new insight into interactions between flaviviruses and cells and demonstrate that CSEMTEM is a useful new method, complementary to SEM observations of biological events by intracellular TEM investigations.	[Burlaud-Gaillard, Julien; Georgeault, Sonia; Uzbekov, Rustem; Lebos, Claude; Roingeard, Philippe] Univ Tours, PPF ASB, Plate Forme RIO Microscopies, Tours, France; [Burlaud-Gaillard, Julien; Georgeault, Sonia; Uzbekov, Rustem; Lebos, Claude; Roingeard, Philippe] CHRU Tours, Tours, France; [Sellin, Caroline; Guillaume, Jean-Marc] Sanofi Pasteur, Dept Bioproc, Upstream Platform, Marcy Letoile, France; [Roingeard, Philippe] Univ Tours, INSERM, U966, Tours, France	Universite de Tours; CHU Tours; Sanofi-Aventis; Sanofi France; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Roingeard, P (corresponding author), Univ Tours, PPF ASB, Plate Forme RIO Microscopies, Tours, France.	roingeard@med.univ-tours.fr			Francois Rabelais University, Loire Valley, France	Francois Rabelais University, Loire Valley, France	This work was supported by the Francois Rabelais University, Loire Valley, France. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTH OM, 1992, MEM I OSWALDO CRUZ, V87, P565, DOI 10.1590/S0074-02761992000400017; Barth OM, 2000, ATLAS DENGUE VIRUSES; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blanchard E, 2002, J VIROL, V76, P4073, DOI 10.1128/JVI.76.8.4073-4079.2002; Chen ZN, 2011, MICROBES INFECT, V13, P143, DOI 10.1016/j.micinf.2010.10.011; Chu JJH, 2002, J GEN VIROL, V83, P2427, DOI 10.1099/0022-1317-83-10-2427; Depla M, 2010, CELL MOL LIFE SCI, V67, P3151, DOI 10.1007/s00018-010-0373-z; DEUBEL V, 1981, AM J TROP MED HYG, V30, P1071, DOI 10.4269/ajtmh.1981.30.1071; Ferraris P, 2013, CELL MOL LIFE SCI, V70, P1297, DOI 10.1007/s00018-012-1213-0; Ferraris P, 2010, J GEN VIROL, V91, P2230, DOI 10.1099/vir.0.022186-0; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; GRAY EW, 1987, J GEN VIROL, V68, P2339, DOI 10.1099/0022-1317-68-9-2339; Guizetti J, 2010, METHOD CELL BIOL, V96, P591, DOI 10.1016/S0091-679X(10)96024-X; Guy B, 2010, HUM VACCINES, V6, P696, DOI [10.4161/hv.6.9.12739, 10.4161.hv.6.9.12739]; HASE T, 1987, ARCH VIROL, V92, P273, DOI 10.1007/BF01317484; KO KK, 1979, ARCH VIROL, V62, P41, DOI 10.1007/BF01314902; Kolotuev I, 2010, BIOL CELL, V102, P121, DOI 10.1042/BC20090096; Macovei A, 2006, BIOCHEM BIOPH RES CO, V346, P1083, DOI 10.1016/j.bbrc.2006.06.023; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Mironov AA, 2012, METHOD ENZYMOL, V504, P201, DOI 10.1016/B978-0-12-391857-4.00010-0; Muller-Reichert T, 2007, METHOD CELL BIOL, V79, P101, DOI 10.1016/S0091-679X(06)79004-5; Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264	27	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93573	10.1371/journal.pone.0093573	http://dx.doi.org/10.1371/journal.pone.0093573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681578	Green Published, Green Submitted, gold			2022-12-27	WOS:000333678100053
J	Coyan, FC; Abderemane-Ali, F; Amarouch, MY; Piron, J; Mordel, J; Nicolas, CS; Steenman, M; Merot, J; Marionneau, C; Thomas, A; Brasseur, R; Baro, I; Loussouarn, G				Coyan, Fabien C.; Abderemane-Ali, Fayal; Amarouch, Mohamed Yassine; Piron, Julien; Mordel, Jerome; Nicolas, Celine S.; Steenman, Marja; Merot, Jean; Marionneau, Celine; Thomas, Annick; Brasseur, Robert; Baro, Isabelle; Loussouarn, Gildas			A Long QT Mutation Substitutes Cholesterol for Phosphatidylinositol-4,5-Bisphosphate in KCNQ1 Channel Regulation	PLOS ONE			English	Article							PROTEIN-KINASE-A; K+ CHANNEL; ION CHANNELS; POTASSIUM CHANNELS; I-KS; MEMBRANE CHOLESTEROL; VOLTAGE-SENSOR; PIP2; 4,5-BISPHOSPHATE; ATP	Introduction: Phosphatidylinositol-4,5-bisphosphate (PIP2) is a cofactor necessary for the activity of KCNQ1 channels. Some Long QT mutations of KCNQ1, including R243H, R539W and R555C have been shown to decrease KCNQ1 interaction with PIP2. A previous study suggested that R539W is paradoxically less sensitive to intracellular magnesium inhibition than the WT channel, despite a decreased interaction with PIP2. In the present study, we confirm this peculiar behavior of R539W and suggest a molecular mechanism underlying it. Methods and Results: COS-7 cells were transfected with WT or mutated KCNE1-KCNQ1 channel, and patch-clamp recordings were performed in giant-patch, permeabilized-patch or ruptured-patch configuration. Similar to other channels with a decreased PIP2 affinity, we observed that the R243H and R555C mutations lead to an accelerated current rundown when membrane PIP2 levels are decreasing. As opposed to R243H and R555C mutants, R539W is not more but rather less sensitive to PIP2 decrease than the WT channel. A molecular model of a fragment of the KCNQ1 C-terminus and the membrane bilayer suggested that a potential novel interaction of R539W with cholesterol stabilizes the channel opening and hence prevents rundown upon PIP2 depletion. We then carried out the same rundown experiments under cholesterol depletion and observed an accelerated R539W rundown that is consistent with this model. Conclusions: We show for the first time that a mutation may shift the channel interaction with PIP2 to a preference for cholesterol. This de novo interaction wanes the sensitivity to PIP2 variations, showing that a mutated channel with a decreased affinity to PIP2 could paradoxically present a slowed current rundown compared to the WT channel. This suggests that caution is required when using measurements of current rundown as an indicator to compare WT and mutant channel PIP2 sensitivity.	[Coyan, Fabien C.; Abderemane-Ali, Fayal; Amarouch, Mohamed Yassine; Piron, Julien; Mordel, Jerome; Nicolas, Celine S.; Steenman, Marja; Merot, Jean; Marionneau, Celine; Baro, Isabelle; Loussouarn, Gildas] Inst Natl Sante & Rech Med, Inst Thorax, Nantes, France; [Coyan, Fabien C.; Abderemane-Ali, Fayal; Amarouch, Mohamed Yassine; Piron, Julien; Mordel, Jerome; Nicolas, Celine S.; Steenman, Marja; Merot, Jean; Marionneau, Celine; Baro, Isabelle; Loussouarn, Gildas] Ctr Natl Rech Sci, Unite Mixte Rech 6291, Nantes, France; [Coyan, Fabien C.; Abderemane-Ali, Fayal; Amarouch, Mohamed Yassine; Piron, Julien; Mordel, Jerome; Nicolas, Celine S.; Merot, Jean; Marionneau, Celine; Baro, Isabelle; Loussouarn, Gildas] Univ Nantes, Unite Format & Rech Med, Nantes, France; [Thomas, Annick] Ctr Natl Rech Sci, Inst Pharmacol & Biol Struct, Toulouse, France; [Brasseur, Robert] Univ Liege, Ctr Biophys Mol Numer, Gembloux, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Nantes Universite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Liege	Loussouarn, G (corresponding author), Inst Natl Sante & Rech Med, Inst Thorax, Nantes, France.	gildas.loussouarn@inserm.fr	MEROT, Jean/D-5741-2015; Baró, Isabelle/ABH-5667-2020; Marionneau, Céline/D-4011-2015; Loussouarn, Gildas/ABH-6043-2020; Steenman, Marja/S-8433-2019; Baró, Isabelle/D-3604-2015; Steenman, Marja/D-3618-2015; Loussouarn, Gildas/D-3590-2015	Baró, Isabelle/0000-0003-4850-4171; Marionneau, Céline/0000-0003-0962-9756; Loussouarn, Gildas/0000-0001-8007-5931; Steenman, Marja/0000-0003-4547-4448; Baró, Isabelle/0000-0003-4850-4171; Steenman, Marja/0000-0003-4547-4448; Loussouarn, Gildas/0000-0001-8007-5931; Nicolas, Celine/0000-0002-5285-5946; Amarouch, Mohamed Yassine/0000-0002-0523-1348	Agence Nationale de la Recherche [ANR-05-JCJC-0160-01]; AFMTelethon; Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme; Fondation d'entreprise Genavie; Association Francaise contre les Myopathies; INSERM (poste d'accueil); French Ministere de la Recherche	Agence Nationale de la Recherche(French National Research Agency (ANR)); AFMTelethon(Association Francaise contre les Myopathies); Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme; Fondation d'entreprise Genavie; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); INSERM (poste d'accueil)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ministere de la Recherche(Ministry of Research, France)	This work was supported by the Agence Nationale de la Recherche (ANR-05-JCJC-0160-01), the AFMTelethon, and a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (GL). FCC and FA-A were recipients of a grant from the French Ministere de la Recherche. FA-A was supported by the Fondation d'entreprise Genavie. JP was supported by the Association Francaise contre les Myopathies. CSN was supported by the INSERM (poste d'accueil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderemane-Ali F, 2012, J BIOL CHEM, V287, P36158, DOI 10.1074/jbc.M112.382085; Atger VM, 1997, J CLIN INVEST, V99, P773, DOI 10.1172/JCI119223; Balijepalli RC, 2007, CHANNELS, V1, P263, DOI 10.4161/chan.4946; Bian JS, 2001, CIRC RES, V89, P1168, DOI 10.1161/hh2401.101375; BRASSEUR R, 1991, J BIOL CHEM, V266, P16120; Bukiya AN, 2011, J GEN PHYSIOL, V137, P93, DOI 10.1085/jgp.201010519; Carozzi AJ, 2002, J BIOL CHEM, V277, P17944, DOI 10.1074/jbc.M110879200; Chouabe C, 2000, CARDIOVASC RES, V45, P971, DOI 10.1016/S0008-6363(99)00411-3; Coyan FC, 2013, CHANNELS, V7, P415, DOI 10.4161/chan.26683; Donger C, 1997, CIRCULATION, V96, P2778, DOI 10.1161/01.CIR.96.9.2778; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Ducarme P, 1998, PROTEINS, V30, P357, DOI 10.1002/(SICI)1097-0134(19980301)30:4<357::AID-PROT3>3.0.CO;2-G; Epshtein Y, 2009, P NATL ACAD SCI USA, V106, P8055, DOI 10.1073/pnas.0809847106; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Gasque G, 2005, FEBS LETT, V579, P5129, DOI 10.1016/j.febslet.2005.08.022; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hibino H, 2007, EUR J NEUROSCI, V26, P2539, DOI 10.1111/j.1460-9568.2007.05876.x; Hihara T, 2013, HUM EXP TOXICOL, V32, P1028, DOI 10.1177/0960327112474848; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Jalili T, 1999, CARDIOVASC RES, V44, P5, DOI 10.1016/S0008-6363(99)00211-4; Levitan I, 2010, SUBCELL BIOCHEM, V51, P509, DOI 10.1007/978-90-481-8622-8_19; Li Y, 2013, P NATL ACAD SCI USA, V110, P18922, DOI 10.1073/pnas.1315649110; Li Y, 2011, P NATL ACAD SCI USA, V108, P9095, DOI 10.1073/pnas.1100872108; Liou HH, 1999, P NATL ACAD SCI USA, V96, P5820, DOI 10.1073/pnas.96.10.5820; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Logothetis DE, 2010, PFLUG ARCH EUR J PHY, V460, P321, DOI 10.1007/s00424-010-0828-y; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lopes CMB, 2007, CHANNELS, V1, P124, DOI 10.4161/chan.4322; Loussouarn G, 2003, EMBO J, V22, P5412, DOI 10.1093/emboj/cdg526; Loussouarn G, 2001, J BIOL CHEM, V276, P29098, DOI 10.1074/jbc.M102365200; Loussouarn Gildas, 2006, V337, P167; Matavel A, 2010, CHANNELS, V4, P3, DOI 10.4161/chan.4.1.10227; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Nakajo K, 2010, P NATL ACAD SCI USA, V107, P18862, DOI 10.1073/pnas.1010354107; Nakamura H, 2007, CIRCULATION, V116, P2913, DOI 10.1161/CIRCULATIONAHA.107.702407; Napolitano C, INHERITED ARRHYTHMIA; Nicolas CS, 2008, CARDIOVASC RES, V79, P427, DOI 10.1093/cvr/cvn085; Park KH, 2005, CIRC RES, V96, P730, DOI 10.1161/01.RES.0000161451.04649.a8; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; Piron J, 2010, J PHYSIOL-LONDON, V588, P3471, DOI 10.1113/jphysiol.2010.195313; Rodriguez N, 2010, BIOPHYS J, V99, P1110, DOI 10.1016/j.bpj.2010.06.013; Rodriguez-Menchaca AA, 2012, P NATL ACAD SCI USA, V109, pE2399, DOI 10.1073/pnas.1207901109; Rohacs T, 2002, METHOD ENZYMOL, V345, P71; Roura-Ferrer M, 2010, J CELL PHYSIOL, V225, P692, DOI 10.1002/jcp.22265; Santiago J, 2001, J BIOL CHEM, V276, P46523, DOI 10.1074/jbc.M104563200; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Sillen L, 1964, STABILITY CONSTANTS; Singh DK, 2009, J BIOL CHEM, V284, P30727, DOI 10.1074/jbc.M109.011221; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Taniguchi T, 2012, J CARDIOVASC PHARM, V59, P377, DOI 10.1097/FJC.0b013e318245e0c5; Thomas A, 2006, PROTEINS, V65, P889, DOI 10.1002/prot.21151; Varga A, 2007, EUR J PHARMACOL, V562, P130, DOI 10.1016/j.ejphar.2007.02.003; WALSH KB, 1988, SCIENCE, V242, P67, DOI 10.1126/science.2845575; Wang WY, 1998, J BIOL CHEM, V273, P34069, DOI 10.1074/jbc.273.51.34069; Wiener R, 2008, J BIOL CHEM, V283, P5815, DOI 10.1074/jbc.M707541200; Xia FZ, 2004, J BIOL CHEM, V279, P24685, DOI 10.1074/jbc.M314314200; Yarbrough TL, 2002, CIRC RES, V90, P443, DOI 10.1161/hh0402.105177; Yasuda Y, 2005, BRIT J PHARMACOL, V145, P156, DOI 10.1038/sj.bjp.0706191; YAZAWA K, 1990, J PHYSIOL-LONDON, V421, P135, DOI 10.1113/jphysiol.1990.sp017937; Zaydman MA, 2013, P NATL ACAD SCI USA, V110, P13180, DOI 10.1073/pnas.1305167110; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	61	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93255	10.1371/journal.pone.0093255	http://dx.doi.org/10.1371/journal.pone.0093255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681627	gold, Green Published, Green Submitted			2022-12-27	WOS:000333678100035
J	Liang, GX; Malmuthuge, N; McFadden, TB; Bao, H; Griebel, PJ; Stothard, P; Guan, LL				Liang, Guanxiang; Malmuthuge, Nilusha; McFadden, Thomas B.; Bao, Hua; Griebel, Philip J.; Stothard, Paul; Guan, Le Luo			Potential Regulatory Role of MicroRNAs in the Development of Bovine Gastrointestinal Tract during Early Life	PLOS ONE			English	Article							GUT MICROBIOTA; IMMUNE-SYSTEM; MAST-CELLS; EXPRESSION; BACTERIA; TISSUES; EPITHELIUM; PHENOTYPE; INTESTINE; TARGETS	This study aimed to investigate the potential regulatory role of miRNAs in the development of gastrointestinal tract (GIT) during the early life of dairy calves. Rumen and small intestinal (mid-jejunum and ileum) tissue samples were collected from newborn (30 min after birth; n = 3), 7-day-old (n = 6), 21-day-old (n = 6), and 42-day-old (n = 6) dairy calves. The miRNA profiling was performed using Illumina RNA-sequencing and the temporal and regional differentially expressed miRNAs were further validated using qRT-PCR. Analysis of 16S rRNA gene copy numbers was used to quantify total bacteria, Bifidobacterium and Lactobacillus species. The expression of miR-143 was abundant in all three gut regions, at all time points and it targets genes involved primarily in the proliferation of connective tissue cells and muscle cells, suggesting a role in regulating rapid tissue development during the early life of calves. The expression of miR-146, miR-191, miR-33, miR-7, miR-99/100, miR-486, miR-145, miR-196 and miR-211 displayed significant temporal differences (FDR <0.05), while miR-192/215, miR-194, miR-196, miR-205 and miR-31 revealed significant regional differences (FDR <0.05). The expression levels of miR-15/16, miR-29 and miR-196 were positively correlated with the copy numbers of 16S rRNA gene of Bifidobacterium or Lactobacillus species or both (P<0.05). Functional analysis using Ingenuity Pathway Analysis identified the above mentioned differentially expressed miRNAs as potential regulators of gut tissue cell proliferation and differentiation. The bacterial density-associated miRNAs were identified as modulators of the development of lymphoid tissues (miR-196), maturation of dendritic cells (miR-29) and development of immune cells (miR-15/16). The present study revealed temporal and regional changes in miRNA expression and a correlation between miRNA expression and microbial population in the GIT during the early life, which provides further evidence for another mechanism by which host-microbial interactions play a role in regulating gut development.	[Liang, Guanxiang; Malmuthuge, Nilusha; Bao, Hua; Stothard, Paul; Guan, Le Luo] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [McFadden, Thomas B.] Univ Missouri, Div Anim Sci, Columbia, MO USA; [Griebel, Philip J.] Univ Saskatchewan, Saskatoon, SK, Canada; [Griebel, Philip J.] Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK, Canada	University of Alberta; University of Missouri System; University of Missouri Columbia; University of Saskatchewan; University of Saskatchewan	Guan, LL (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	lguan@ualberta.ca	Liang, Guanxiang/C-7108-2018; Liang, Guanxiang/CAG-8838-2022; Malmuthuge, Nilusha/N-2215-2019	Liang, Guanxiang/0000-0002-7367-2516; 	Alberta Livestock and Meat Agency (Edmonton, Alberta, Canada) [2011F129R]	Alberta Livestock and Meat Agency (Edmonton, Alberta, Canada)	This project was funded by Alberta Livestock and Meat Agency (Edmonton, Alberta, Canada) (2011F129R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bao H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-609; Benjamini Y, 1995, J R STAT SOC B, V57; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Chew R, 2008, GASTROINTESTINAL SYS; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Cristino AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019350; Dalmasso G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019293, 10.1371/journal.pone.0023806]; De Winter BY, 2012, BBA-MOL BASIS DIS, V1822, P66, DOI 10.1016/j.bbadis.2011.03.016; Enright AJ, 2004, GENOME BIOL, V5; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Groschwitz KR, 2009, P NATL ACAD SCI USA, V106, P22381, DOI 10.1073/pnas.0906372106; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Hart AL, 2004, GUT, V53, P1602, DOI 10.1136/gut.2003.037325; Hausser J, 2013, GENOME RES; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huang JM, 2011, INT J BIOL SCI, V7, P1016, DOI 10.7150/ijbs.7.1016; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jin WW, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-90; Jost T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044595; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li M, 2009, J APPL MICROBIOL, V107, P1924, DOI 10.1111/j.1365-2672.2009.04376.x; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Macfarlane S, 2007, J APPL MICROBIOL, V102, P1187, DOI 10.1111/j.1365-2672.2007.03287.x; Malmuthuge N, 2012, FEMS MICROBIOL ECOL, V79, P337, DOI 10.1111/j.1574-6941.2011.01220.x; Masotti A, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00137; McLeod KR, 2007, J ANIM SCI, V85, P2256, DOI 10.2527/jas.2006-359; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; North TE, 2004, STEM CELLS, V22, P158, DOI 10.1634/stemcells.22-2-158; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Playford RJ, 2000, AM J CLIN NUTR, V72, P5; Popovic R, 2009, BLOOD, V113, P3314, DOI 10.1182/blood-2008-04-154310; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SHELDRAKE RF, 1985, J DAIRY RES, V52, P599, DOI 10.1017/S0022029900024560; Song Lin, 2006, Birth Defects Research, V78, P140, DOI 10.1002/bdrc.20070; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; van Baarlen P, 2013, TRENDS IMMUNOL, V34, P208, DOI 10.1016/j.it.2013.01.005; Walter J, 2001, APPL ENVIRON MICROB, V67, P7; Wang XB, 2010, J BIOL CHEM, V285, P23239, DOI 10.1074/jbc.M109.084673; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhou R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002702	60	71	77	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92592	10.1371/journal.pone.0092592	http://dx.doi.org/10.1371/journal.pone.0092592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682221	gold, Green Published, Green Submitted			2022-12-27	WOS:000333678100010
J	Zhu, Q; Gu, LW; Wang, YM; Jia, L; Zhao, ZM; Peng, SQ; Lei, LS				Zhu, Qing; Gu, Liwei; Wang, Yimei; Jia, Li; Zhao, Zengming; Peng, Shuangqing; Lei, Linsheng			The Role of Alpha-1 and Alpha-2 Adrenoceptors in Restraint Stress-Induced Liver Injury in Mice	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; IMMOBILIZATION STRESS; INDUCED ELEVATION; OXIDATIVE STRESS; ANTIOXIDANT; DISEASE; RATS; APOPTOSIS; BLOCKADE; HEPATOTOXICITY	Acute stress affects cellular integrity in many tissues including the liver, but its underlying mechanism is still unclear. The aim of the present study was to investigate the potential involvement of catecholamines and adrenoceptors in the regulation of acute restraint stress-induced liver injury. Restraint was achieved by placing mice in restraint tubes. Mice were treated with either an alpha-l antagonist, prazosin, an alpha-2 antagonist, yohimbine, a beta-l antagonist, betaxolol, a beta-2 antagonist, ICI 118551, or a central and peripheral catecholamine depleting agent, reserpine, and followed by restraint stress. Assessment of liver injury (serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), hepatic total GSH, GSSG and GSH/GSSG ratio), histopathology and of apoptosis, by TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling) assay and western blotting, was performed. Three hours of restraint stress resulted in liver injury, as indexed by elevated serum transaminase levels, decreased hepatic total GSH levels and GSH/GSSG ratio, increased hepatic GSSG levels as well as enhanced hepatocytes apoptosis. Either reserpine or prazosin or yohimbine was found to attenuate liver injury. Furthermore, prazosin and yohimbine protected against restraint-induced hepatocytes apoptosis through attenuating the activation of caspases-9 and -3 and reducing the Bax/Bcl-2 ratio. These results suggest that alpha-1 and alpha-2 adrenoceptors mediate restraint-induced liver oxidative injury through caspase-9 and Bcl-2 family of apoptotic regulatory proteins.	[Zhu, Qing; Lei, Linsheng] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Zhu, Qing; Wang, Yimei; Jia, Li; Zhao, Zengming; Peng, Shuangqing] Acad Mil Med Sci, Evaluat & Res Ctr Toxicol, Inst Dis Control & Prevent, Beijing, Peoples R China; [Gu, Liwei] China Acad Chinese Med Sci, Inst Chinese Mat Med, Qinghaosu Artemisinin Res Ctr, Beijing, Peoples R China	Southern Medical University - China; Academy of Military Medical Sciences - China; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS	Peng, SQ (corresponding author), Acad Mil Med Sci, Evaluat & Res Ctr Toxicol, Inst Dis Control & Prevent, Beijing, Peoples R China.	pengsq@hotmail.com; lls@smu.edu.cn			National Natural Science Foundation of China [81273602]; National Key Research and Development Programs on Fundamental Sciences (973 Project) [2011CB503803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Programs on Fundamental Sciences (973 Project)(National Basic Research Program of China)	This project was supported by the National Natural Science Foundation of China (No. 81273602) and the National Key Research and Development Programs on Fundamental Sciences (973 Project) (No. 2011CB503803). The funders who supported this project had a role in data collection.	Adamekova E, 2003, NEOPLASMA, V50, P428; Ahmet I, 2004, CIRCULATION, V110, P1083, DOI 10.1161/01.CIR.0000139844.15045.F9; Bemeur C, 2010, METAB BRAIN DIS, V25, P23, DOI 10.1007/s11011-010-9186-x; Black PH, 2002, BRAIN BEHAV IMMUN, V16, P622, DOI 10.1016/S0889-1591(02)00021-1; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Castrejon-Sosa M, 2002, LIFE SCI, V71, P2469, DOI 10.1016/S0024-3205(02)02041-6; Chida Y, 2004, NEUROIMMUNOMODULAT, V11, P419, DOI 10.1159/000080153; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; FELDMAN S, 1995, NEUROSCI BIOBEHAV R, V19, P235, DOI 10.1016/0149-7634(94)00062-6; Fernandez G, 2000, CELL STRESS CHAPERON, V5, P306, DOI 10.1379/1466-1268(2000)005<0306:ISICFA>2.0.CO;2; Forray MI, 2004, BRAIN RES REV, V47, P145, DOI 10.1016/j.brainresrev.2004.07.011; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Kvetnansky R, 1995, ANN NY ACAD SCI, V771, P131, DOI 10.1111/j.1749-6632.1995.tb44676.x; Kwak HB, 2006, FASEB J, V20, P791, DOI 10.1096/fj.05-5116fje; Ma S, 2005, J NEUROENDOCRINOL, V17, P22, DOI 10.1111/j.1365-2826.2005.01279.x; Martini D, 2011, J NEUROCHEM, V119, P1317, DOI 10.1111/j.1471-4159.2011.07530.x; Mastorakos G, 2005, HORM METAB RES, V37, P577, DOI 10.1055/s-2005-870426; Mastorakos George, 2005, Hormones (Athens), V4, P73; Nichols WG, 2008, ANTIMICROB AGENTS CH, V52, P858, DOI 10.1128/AAC.00821-07; Nukina H, 1998, NEUROIMMUNOMODULAT, V5, P323, DOI 10.1159/000026352; Ohta Y, 2007, REDOX REP, V12, P139, DOI 10.1179/135100007X200218; Oishi K, 2002, SCAND J CLIN LAB INV, V62, P115, DOI 10.1080/003655102753611735; Olfe Jakob, 2010, BMC Physiology, V10, P2, DOI 10.1186/1472-6793-10-2; Panuganti SD, 2006, J PHARMACOL EXP THER, V318, P26, DOI 10.1124/jpet.106.100933; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Reyes TM, 1997, BRAIN RES, V769, P29, DOI 10.1016/S0006-8993(97)00687-2; Rogoz Z, 2010, PHARMACOL REP, V62, P1191; Sahin E, 2007, COMP BIOCHEM PHYS C, V144, P342, DOI 10.1016/j.cbpc.2006.10.009; SALAS M, 1980, PATHOL RES PRACT, V167, P217, DOI 10.1016/S0344-0338(80)80052-5; Salim SA-R, 2012, AFRICAN J PHARM PHAR, V6; Sanchez O, 2002, CELL STRESS CHAPERON, V7, P36, DOI 10.1379/1466-1268(2002)007<0036:ASITII>2.0.CO;2; Sanchez O, 2007, AM J PHYSIOL-REG I, V293, pR1908, DOI 10.1152/ajpregu.00113.2007; Stojanovich L, 2008, AUTOIMMUN REV, V7, P209, DOI 10.1016/j.autrev.2007.11.007; Stone EA, 1996, PHARMACOL BIOCHEM BE, V55, P215, DOI 10.1016/S0091-3057(96)00070-6; SWAROOP A, 1983, BIOCHEM J, V214, P745, DOI 10.1042/bj2140745; von Montfort C, 2008, AM J PHYSIOL-GASTR L, V294, pG1227, DOI 10.1152/ajpgi.00050.2008; Wang P, 2000, BBA-MOL BASIS DIS, V1535, P36, DOI 10.1016/S0925-4439(00)00080-6; Weng D, 2007, TOXICOLOGY, V232, P15, DOI 10.1016/j.tox.2006.12.010; Yang LJ, 2012, NEUROSCI LETT, V511, P95, DOI 10.1016/j.neulet.2012.01.046; Zaidi S M Kashif R, 2005, Drugs R D, V6, P157, DOI 10.2165/00126839-200506030-00004; Zaidi SMKR, 2003, J NUTR BIOCHEM, V14, P633, DOI 10.1016/S0955-2863(03)00117-7; Zhu RZ, 2012, HEPATOL RES, V42, P741, DOI 10.1111/j.1872-034X.2012.00996.x; Zubidat AE, 2008, PHYSIOL BEHAV, V93, P243, DOI 10.1016/j.physbeh.2007.08.024	44	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92125	10.1371/journal.pone.0092125	http://dx.doi.org/10.1371/journal.pone.0092125			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682087	Green Published, Green Submitted, gold			2022-12-27	WOS:000333678100006
J	Hyung, D; Lee, C; Kim, JH; Yoo, D; Seo, YS; Jeong, SC; Lee, JH; Chung, Y; Jung, KH; Cook, DR; Choi, HK				Hyung, Daejin; Lee, Chaeyoung; Kim, Jin-Hyun; Yoo, Dongwoon; Seo, Young-Su; Jeong, Soon-Chun; Lee, Jai-Heon; Chung, Youngsoo; Jung, Ki-Hong; Cook, Douglas R.; Choi, Hong-Kyu			Cross-Family Translational Genomics of Abiotic Stress-Responsive Genes between Arabidopsis and Medicago truncatula	PLOS ONE			English	Article							2C PROTEIN PHOSPHATASES; ABSCISIC-ACID; KINASE SOS2; LEGUME; EXPRESSION; ABA; IDENTIFICATION; EVOLUTION; NETWORK; SALT	Cross-species translation of genomic information may play a pivotal role in applying biological knowledge gained from relatively simple model system to other less studied, but related, genomes. The information of abiotic stress (ABS)-responsive genes in Arabidopsis was identified and translated into the legume model system, Medicago truncatula. Various data resources, such as TAIR/AtGI DB, expression profiles and literatures, were used to build a genome-wide list of ABS genes. tBlastX/BlastP similarity search tools and manual inspection of alignments were used to identify orthologous genes between the two genomes. A total of 1,377 genes were finally collected and classified into 18 functional criteria of gene ontology (GO). The data analysis according to the expression cues showed that there was substantial level of interaction among three major types (i.e., drought, salinity and cold stress) of abiotic stresses. In an attempt to translate the ABS genes between these two species, genomic locations for each gene were mapped using an in-house-developed comparative analysis platform. The comparative analysis revealed that fragmental colinearity, represented by only 37 synteny blocks, existed between Arabidopsis and M. truncatula. Based on the combination of E-value and alignment remarks, estimated translation rate was 60.2% for this cross-family translation. As a prelude of the functional comparative genomic approaches, in-silico gene network/interactome analyses were conducted to predict key components in the ABS responses, and one of the sub-networks was integrated with corresponding comparative map. The results demonstrated that core members of the sub-network were well aligned with previously reported ABS regulatory networks. Taken together, the results indicate that network-based integrative approaches of comparative and functional genomics are important to interpret and translate genomic information for complex traits such as abiotic stresses.	[Hyung, Daejin] Dong A Univ, Dept Comp Sci, Pusan, South Korea; [Lee, Chaeyoung; Kim, Jin-Hyun] Dong A Univ, Dept Med Biosci, Pusan, South Korea; [Yoo, Dongwoon; Lee, Jai-Heon; Chung, Youngsoo; Choi, Hong-Kyu] Dong A Univ, Dept Genet Engn, Pusan, South Korea; [Seo, Young-Su] Busan Natl Univ, Dept Microbiol, Pusan, South Korea; [Jeong, Soon-Chun] Korea Res Inst Biosci & Biotechnol, Bioevaluat Ctr, Cheongwon, South Korea; [Jung, Ki-Hong] Kyung Hee Univ, Dept Plant Mol Syst Biotechnol, Yongin, South Korea; [Jung, Ki-Hong] Kyung Hee Univ, Grad Sch Biotechnol, Yongin, South Korea; [Cook, Douglas R.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	Dong A University; Dong A University; Dong A University; Pusan National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Kyung Hee University; Kyung Hee University; University of California System; University of California Davis	Choi, HK (corresponding author), Dong A Univ, Dept Genet Engn, Pusan, South Korea.	hkchoi@dau.ac.kr	Jung, Ki Hong/L-5570-2019	Jung, Ki Hong/0000-0003-0427-5901; Jeong, Soon-Chun/0000-0003-0223-1155	Next-Generation BioGreen21 Program, Rural Development Administration [PJ009089, PJ008124]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology, Republic of Korea [NRF-2010-0023585]	Next-Generation BioGreen21 Program, Rural Development Administration; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was conducted within the framework of the Next-Generation BioGreen21 Program (PJ009089, PJ008124), Rural Development Administration and the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (NRF-2010-0023585), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Abrouk M, 2010, TRENDS PLANT SCI, V15, P479, DOI 10.1016/j.tplants.2010.06.001; Berardini TZ, 2004, PLANT PHYSIOL, V135, P745, DOI 10.1104/pp.104.040071; Bies-Etheve N, 1999, PLANT MOL BIOL, V40, P1045, DOI 10.1023/A:1006252512202; Bordat A, 2011, G3-GENES GENOM GENET, V1, P93, DOI 10.1534/g3.111.000349; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Brendel V, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews1005; Cannon SB, 2009, PLANT PHYSIOL, V151, P970, DOI 10.1104/pp.109.144659; Cheong YH, 2003, PLANT CELL, V15, P1833, DOI 10.1105/tpc.012393; Cheong YH, 2007, PLANT J, V52, P223, DOI 10.1111/j.1365-313X.2007.03236.x; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Choi HI, 2005, PLANT PHYSIOL, V139, P1750, DOI 10.1104/pp.105.069757; Choi HK, 2004, P NATL ACAD SCI USA, V101, P15289, DOI 10.1073/pnas.0402251101; Choi HK, 2006, MOL GENET GENOMICS, V276, P56, DOI 10.1007/s00438-006-0118-8; Choi HK, 2013, MOL PLANT MICROBE IN, V26, P643, DOI 10.1094/MPMI-09-12-0217-R; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Conte MG, 2008, NUCLEIC ACIDS RES, V36, pD991, DOI 10.1093/nar/gkm934; Doyle JJ, 2003, PLANT PHYSIOL, V131, P900, DOI 10.1104/pp.102.018150; FINKELSTEIN RR, 1994, PLANT J, V5, P765, DOI 10.1046/j.1365-313X.1994.5060765.x; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Gale MD, 1998, SCIENCE, V282, P656, DOI 10.1126/science.282.5389.656; Garcia ME, 2008, PLANT MOL BIOL, V67, P643, DOI 10.1007/s11103-008-9344-2; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guo Y, 2001, PLANT CELL, V13, P1383, DOI 10.1105/tpc.13.6.1383; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Hirsch AM, 2001, PLANT PHYSIOL, V127, P1484, DOI 10.1104/pp.010866; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jensen MK, 2010, BIOCHEM J, V426, P183, DOI 10.1042/BJ20091234; Juul T, 2010, J BIOL CHEM, V285, P21411, DOI 10.1074/jbc.M110.103564; Kim W, 2013, PLANT CELL PHYSIOL, V54, P555, DOI 10.1093/pcp/pct017; Krysan PJ, 1996, P NATL ACAD SCI USA, V93, P8145, DOI 10.1073/pnas.93.15.8145; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Liu H, 2001, GENOME RES, V11, P2020, DOI 10.1101/gr.194501; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Michard E, 2005, PLANT J, V44, P783, DOI 10.1111/j.1365-313X.2005.02566.x; Movahedi S, 2011, PLANT PHYSIOL, V156, P1316, DOI 10.1104/pp.111.177865; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Ohta M, 2003, P NATL ACAD SCI USA, V100, P11771, DOI 10.1073/pnas.2034853100; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Queval G, 2007, PLANT J, V52, P640, DOI 10.1111/j.1365-313X.2007.03263.x; Ramon M, 2007, PLANT MOL BIOL, V63, P195, DOI 10.1007/s11103-006-9082-2; Ren XL, 2013, PLANT J, V74, P258, DOI 10.1111/tpj.12123; Rohde A, 2000, PLANT CELL, V12, P35, DOI 10.1105/tpc.12.1.35; Sanchez DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017094; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Tripathi V, 2009, PLANT J, V58, P778, DOI 10.1111/j.1365-313X.2009.03812.x; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Verslues PE, 2006, J EXP BOT, V57, P201, DOI 10.1093/jxb/erj026; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Vlad F, 2009, PLANT CELL, V21, P3170, DOI 10.1105/tpc.109.069179; Wang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-101; Wang Y, 2013, ANNU REV PLANT BIOL, V64, P451, DOI 10.1146/annurev-arplant-050312-120153; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Young ND, 2009, CURR OPIN PLANT BIOL, V12, P193, DOI 10.1016/j.pbi.2008.11.005; Zhang WX, 2005, BIOINFORMATICS, V21, P3074, DOI 10.1093/bioinformatics/bti490; Zhu HY, 2003, PLANT PHYSIOL, V131, P1018, DOI 10.1104/pp.102.016436; Zhu HY, 2002, MOL PLANT MICROBE IN, V15, P529, DOI 10.1094/MPMI.2002.15.6.529	66	14	15	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e91721	10.1371/journal.pone.0091721	http://dx.doi.org/10.1371/journal.pone.0091721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675968	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500016
J	Kim, MH; Kim, SH; Yang, WM				Kim, Mi Hye; Kim, Sung-Hoon; Yang, Woong Mo			Beneficial Effects of Astragaloside IV for Hair Loss via Inhibition of Fas/Fas L-Mediated Apoptotic Signaling	PLOS ONE			English	Article							CELL-DEATH; GROWTH; KERATINOCYTES; PROTEINS	Apoptosis with premature termination of hair follicle growth induces several types of hair loss and is one of the crucial factors of hair loss. Astragaloside IV, which is a major component of Astragalus membranaceus, is a cycloartane triterpene saponin. Although an anti-apoptotic effect of Astragaloside IV has been reported, its effects against hair loss have not been investigated. To explore the underlying mechanisms of Astragaloside IV on apoptotic signaling in hair follicle, the dorsal skin of depilated C57BL/6 mice was topically treated with 1 and 100 mu M Astragaloside IV for 14 days. In Astragaloside IV-treated group, TUNEL-positive cells were reduced. We found that Astragaloside IV blocked the procaspase-8, resulting in the inhibition of caspase-3 and procaspase-9 activities. The changes were accompanied with down-regulation of Bax and p53, and up-regulation of Bcl-2 and Bcl-(xL) by Astragaloside IV treatment. In addition, activation of NF-kappa B and phosphorylation of IkB-alpha were inhibited, along with decreases in three MAPKs: ERK, SAPK/JNK and p38 by Astragaloside IV. The expressions of KGF, p21, TNF-alpha and IL-1 beta, which are keratinocyte terminal differentiation markers associated with catagen, were modulated by treatment with Astragaloside IV. These results demonstrated that Astragaloside IV is concerned with blocking the Fas/Fas L-mediated apoptotic pathway, which would be an alternative therapy for hair loss.	[Kim, Mi Hye; Yang, Woong Mo] Kyung Hee Univ, Coll Korean Med, Seoul, South Korea; [Kim, Mi Hye; Yang, Woong Mo] Kyung Hee Univ, Inst Korean Med, Seoul, South Korea; [Kim, Sung-Hoon] Kyung Hee Univ, Coll Korean Med, Canc Prevent Mat Dev Res Ctr, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University	Yang, WM (corresponding author), Kyung Hee Univ, Coll Korean Med, Seoul, South Korea.	wmyang@khu.ac.kr	Yang, Woong Mo/AAH-9185-2020	kim, sunghoon/0000-0002-1570-3230; Yang, Woong Mo/0000-0001-5308-2386	National Research Foundation of Korea; Korea government [MEST] [2012 0005755]	National Research Foundation of Korea(National Research Foundation of Korea); Korea government [MEST](Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea grant funded by the Korea government [MEST] (No. 2012-0005755). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botchkarev VA, 2001, AM J PATHOL, V158, P1913, DOI 10.1016/S0002-9440(10)64659-7; Botchkareva NV, 2006, J INVEST DERMATOL, V126, P258, DOI 10.1038/sj.jid.5700007; Cho YS, 2008, BBA-MOL CELL RES, V1783, P323, DOI 10.1016/j.bbamcr.2007.11.017; Gafter-Gvili A, 2003, AM J PHYSIOL-CELL PH, V284, pC1593, DOI 10.1152/ajpcell.00537.2002; Gui DK, 2013, APOPTOSIS, V18, P409, DOI 10.1007/s10495-013-0801-2; Gui DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039824; Ipaktchi K, 2006, SHOCK, V26, P201, DOI 10.1097/01.shk.0000225739.13796.f2; Kim SH, 2009, TOXICOL IN VITRO, V23, P1215, DOI 10.1016/j.tiv.2009.07.036; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Luanpitpong S, 2011, APOPTOSIS, V16, P769, DOI 10.1007/s10495-011-0609-x; Martin SS, 2004, BBA-MOL CELL RES, V1692, P145, DOI 10.1016/j.bbamcr.2004.02.008; Park S, 2011, J ETHNOPHARMACOL, V138, P340, DOI 10.1016/j.jep.2011.08.013; Philpott MP, 1996, BRIT J DERMATOL, V135, P942, DOI 10.1046/j.1365-2133.1996.d01-1099.x; Qi WW, 2014, CELL STRESS CHAPERON, V19, P105, DOI 10.1007/s12192-013-0438-7; Saxena N, 2013, TOXICOL SCI, V135, P103, DOI 10.1093/toxsci/kft139; Schultz DR, 2003, SEMIN ARTHRITIS RHEU, V32, P345, DOI 10.1053/sarh.2003.50005; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Sredni B, 2003, FASEB J, V17, P400, DOI 10.1096/fj.03-0552fje; Van Neste D, 2004, MICRON, V35, P193, DOI 10.1016/j.micron.2003.11.006; Zhang ZG, 2012, MOL CELL BIOCHEM, V364, P209, DOI 10.1007/s11010-011-1219-1; Zhao MM, 2013, BIOL PHARM BULL, V36, P515, DOI 10.1248/bpb.b12-00655	21	22	29	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92984	10.1371/journal.pone.0092984	http://dx.doi.org/10.1371/journal.pone.0092984			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676213	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677500061
J	Lee, KY; Chan, KYY; Tsang, KS; Chen, YC; Kung, HF; Ng, PC; Li, CK; Leung, KT; Li, K				Lee, King Yiu; Chan, Kathy Yuen Yee; Tsang, Kam Sze; Chen, Yang Chao; Kung, Hsiang-fu; Pak Cheung Ng; Li, Chi Kong; Kam Tong Leung; Li, Karen			Ubiquitous Expression of MAKORIN-2 in Normal and Malignant Hematopoietic Cells and Its Growth Promoting Activity	PLOS ONE			English	Article							STEM/PROGENITOR CELLS; ANTISENSE; GENES; RING; IDENTIFICATION; TRANSCRIPTION; DOWNSTREAM; PROTEINS; CLONING; MKRN1	Makorin-2 (MKRN2) is a highly conserved protein and yet its functions are largely unknown. We investigated the expression levels of MKRN2 and RAF1 in normal and malignant hematopoietic cells, and leukemia cell lines. We also attempted to delineate the role of MKRN2 in umbilical cord blood CD34(+) stem/progenitor cells and K562 cell line by over-expression and inhibition of MKRN2 through lentivirus transduction and shRNA nucleofection, respectively. Our results provided the first evidence on the ubiquitous expression of MKRN2 in normal hematopoietic cells, embryonic stem cell lines, primary leukemia and leukemic cell lines of myeloid, lymphoid, erythroid and megakaryocytic lineages. The expression levels of MKRN2 were generally higher in primary leukemia samples compared with those in age-matched normal BM cells. In all leukemia subtypes, there was no significant correlation between expression levels of MKRN2 and RAF1. sh-MKRN2-silenced CD34(+) cells had a significantly lower proliferation capacity and decreased levels of the early stem/progenitor subpopulation (CFU-GEMM) compared with control cultures. Over-expression of MKRN2 in K562 cells increased cell proliferation. Our results indicated possible roles of MKRN2 in normal and malignant hematopoiesis.	[Lee, King Yiu; Chan, Kathy Yuen Yee; Pak Cheung Ng; Li, Chi Kong; Kam Tong Leung; Li, Karen] Chinese Univ Hong Kong, Dept Paediat, Hong Kong, Hong Kong, Peoples R China; [Tsang, Kam Sze] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Chen, Yang Chao; Kung, Hsiang-fu] Chinese Univ Hong Kong, Ctr Emerging Infect Dis, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Li, K (corresponding author), Chinese Univ Hong Kong, Dept Paediat, Hong Kong, Hong Kong, Peoples R China.	lipang@cuhk.edu.hk	Leung, Kam Tong/I-8569-2017; Li, Chi-kong/J-8456-2013; Chan, Kathy/AAE-8538-2021; Chen, Yangchao/AAG-2127-2019	Leung, Kam Tong/0000-0002-7695-2513; Li, Chi-kong/0000-0002-2810-5758; Chan, Kathy/0000-0002-6501-9592; Chen, Yangchao/0000-0002-0249-3414	Research Grant Council of Hong Kong [470507, 2041293]	Research Grant Council of Hong Kong(Hong Kong Research Grants Council)	This project was supported by the Earmarked Grant 470507 and Direct Grant 2041293 of the Research Grant Council of Hong Kong to The Chinese University of Hong Kong. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YC, 2007, HEPATOLOGY, V46, P200, DOI 10.1002/hep.21668; Cheung WKC, 2010, BIOCHEM BIOPH RES CO, V394, P18, DOI 10.1016/j.bbrc.2010.02.041; Demidenko ZN, 2005, CANCER BIOL THER, V4, P484, DOI 10.4161/cbt.4.4.1702; Du ZW, 2001, BIOCHEM BIOPH RES CO, V282, P701, DOI 10.1006/bbrc.2001.4636; Gray TA, 2000, GENOMICS, V66, P76, DOI 10.1006/geno.2000.6199; Gray TA, 2001, GENOMICS, V77, P119, DOI 10.1006/geno.2001.6627; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; Ko A, 2012, JNCI-J NATL CANCER I, V104, P1660, DOI 10.1093/jnci/djs424; KRYSTAL GW, 1990, MOL CELL BIOL, V10, P4180, DOI 10.1128/MCB.10.8.4180; Lee KY, 2011, STEM CELLS DEV, V20, P31, DOI 10.1089/scd.2010.0196; Leung KT, 2011, BLOOD, V117, P1840, DOI 10.1182/blood-2010-04-281329; Li K, 2000, CELL TRANSPLANT, V9, P125, DOI 10.1177/096368970000900115; Mao M, 1998, P NATL ACAD SCI USA, V95, P8175, DOI 10.1073/pnas.95.14.8175; MUSZYNSKI KW, 1995, J EXP MED, V181, P2189, DOI 10.1084/jem.181.6.2189; Omwancha J, 2006, ENDOCRINE, V29, P363, DOI 10.1385/ENDO:29:2:363; Salvatico J, 2010, MOL CELL BIOCHEM, V342, P241, DOI 10.1007/s11010-010-0490-x; Stork PJS, 2005, BLOOD, V106, P2952, DOI 10.1182/blood-2005-03-1062; Yang PH, 2008, J BIOL CHEM, V283, P8486, DOI 10.1074/jbc.M704768200; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Yoshida Noriyuki, 2003, Hum Cell, V16, P65, DOI 10.1111/j.1749-0774.2003.tb00132.x; Zhang QH, 2000, GENOME RES, V10, P1546, DOI 10.1101/gr.140200	23	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92706	10.1371/journal.pone.0092706	http://dx.doi.org/10.1371/journal.pone.0092706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675897	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500034
J	Meersch, M; Schmidt, C; Van Aken, H; Martens, S; Rossaint, J; Singbartl, K; Gorlich, D; Kellum, JA; Zarbock, A				Meersch, Melanie; Schmidt, Christoph; Van Aken, Hugo; Martens, Sven; Rossaint, Jan; Singbartl, Kai; Goerlich, Dennis; Kellum, John A.; Zarbock, Alexander			Urinary TIMP-2 and IGFBP7 as Early Biomarkers of Acute Kidney Injury and Renal Recovery following Cardiac Surgery	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; CRITICALLY-ILL PATIENTS; GLOMERULAR-FILTRATION-RATE; CELL-CYCLE; CARDIOTHORACIC SURGERY; SERUM CREATININE; RISK-FACTORS; FAILURE; DIALYSIS; ASSOCIATION	Background: Difficulties in prediction and early identification of (acute kidney injury) AKI have hindered the ability to develop preventive and therapeutic measures for this syndrome. We tested the hypothesis that a urine test measuring insulin-like growth factor-binding protein 7 (IGFBP7) and tissue inhibitor of metalloproteinases-2 (TIMP-2), both inducers of G1 cell cycle arrest, a key mechanism implicated in acute kidney injury (AKI), could predict AKI in cardiac surgery patients. Methods: We studied 50 patients at high risk for AKI undergoing cardiac surgery with cardiopulmonary bypass (CPB). Serial urine samples were analyzed for [TIMP-2]*[IGFBP7] concentrations. The primary outcome measure was AKI as defined by international consensus criteria following surgery. Furthermore, we investigated whether urine [TIMP-2]*[IGFBP7] could predict renal recovery from AKI prior to hospital discharge. Results: 26 patients (52%) developed AKI. Diagnosis based on serum creatinine and/or oliguria did not occur until 1-3 days after CPB. In contrast, urine concentration of [TIMP-2]*[IGFBP7] rose from a mean of 0.49 (SE 0.24) at baseline to 1.51 (SE 0.57) 4 h after CPB in patients who developed AKI. The maximum urinary [TIMP-2]*[IGFBP7] concentration achieved in the first 24 hours following surgery (composite time point) demonstrated an area under the receiver-operating characteristic curve of 0.84. Sensitivity was 0.92, and specificity was 0.81 for a cutoff value of 0.50. The decline in urinary [TIMP-2]*[IGFBP7] values was the strongest predictor for renal recovery. Conclusions: Urinary [TIMP-2]*[IGFBP7] serves as a sensitive and specific biomarker to predict AKI early after cardiac surgery and to predict renal recovery.	[Meersch, Melanie; Schmidt, Christoph; Van Aken, Hugo; Rossaint, Jan; Zarbock, Alexander] Univ Munster, Dept Anesthesiol Intens Care & Pain Med, D-48149 Munster, Germany; [Martens, Sven] Univ Munster, Dept Cardiac Surg, Munster, Germany; [Singbartl, Kai] Penn State Coll Med, Dept Anesthesiol, Hershey, PA USA; [Goerlich, Dennis] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany; [Kellum, John A.] Univ Pittsburgh, CRISMA Ctr, Ctr Crit Care Nephrol, Dept Crit Care Med, Pittsburgh, PA 15260 USA	University of Munster; University of Munster; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Munster; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zarbock, A (corresponding author), Univ Munster, Dept Anesthesiol Intens Care & Pain Med, D-48149 Munster, Germany.	zarbock@uni-muenster.de	Kellum, John/AAP-3072-2020; Görlich, Dennis/C-8950-2012; Kellum, John A/HCH-2944-2022	Kellum, John/0000-0003-1995-2653; Görlich, Dennis/0000-0002-2574-9419; Kellum, John A/0000-0003-1995-2653	German Research Foundation [ZA428/6-1]	German Research Foundation(German Research Foundation (DFG))	The work was supported by the German Research Foundation (ZA428/6-1 to A.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bellomo R, 2004, INTENS CARE MED, V30, P33, DOI 10.1007/s00134-003-2078-3; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Chertow GM, 1998, AM J MED, V104, P343, DOI 10.1016/S0002-9343(98)00058-8; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Han WK, 2009, CLIN J AM SOC NEPHRO, V4, P873, DOI 10.2215/CJN.04810908; Kashani K, 2013, CRIT CARE, V17, DOI 10.1186/cc12503; Koyner JL, 2008, KIDNEY INT, V74, P1059, DOI 10.1038/ki.2008.341; Kundu S, 2011, EUR J EPIDEMIOL, V26, P261, DOI 10.1007/s10654-011-9567-4; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mangano CM, 1998, ANN INTERN MED, V128, P194, DOI 10.7326/0003-4819-128-3-199802010-00005; Manns B, 2003, CRIT CARE MED, V31, P449, DOI 10.1097/01.CCM.0000045182.90302.B3; Mehta RH, 2006, CIRCULATION, V114, P2208, DOI 10.1161/CIRCULATIONAHA.106.635573; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Melnikov VY, 2002, J CLIN INVEST, V110, P1083, DOI 10.1172/JCI200215623; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Murray Patrick T, 2002, Curr Opin Crit Care, V8, P519, DOI 10.1097/00075198-200212000-00007; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Price PM, 2009, KIDNEY INT, V76, P604, DOI 10.1038/ki.2009.224; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Smertka M, 2012, RENAL FAILURE, V34, P130, DOI 10.3109/0886022X.2011.623500; Srisawat N, 2011, KIDNEY INT, V80, P545, DOI 10.1038/ki.2011.160; Srisawat N, 2011, CLIN J AM SOC NEPHRO, V6, P1815, DOI 10.2215/CJN.11261210; Tang Ignatius Y, 2004, Best Pract Res Clin Anaesthesiol, V18, P91, DOI 10.1016/j.bpa.2003.09.006; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Wagener G, 2006, ANESTHESIOLOGY, V105, P485, DOI 10.1097/00000542-200609000-00011; Waikar SS, 2010, KIDNEY INT, V78, P486, DOI 10.1038/ki.2010.165; Wijeysundera DN, 2007, JAMA-J AM MED ASSOC, V297, P1801, DOI 10.1001/jama.297.16.1801; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214; Work Group Membership, 2012, KIDNEY INT S, V2, P2, DOI DOI 10.1038/KISUP.2012.7; Yang QH, 2009, J INFECTION, V58, P459, DOI 10.1016/j.jinf.2009.04.003; ZANARDO G, 1994, J THORAC CARDIOV SUR, V107, P1489, DOI 10.1016/S0022-5223(94)70429-5	40	265	283	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93460	10.1371/journal.pone.0093460	http://dx.doi.org/10.1371/journal.pone.0093460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675717	Green Accepted, Green Published, gold			2022-12-27	WOS:000333677500127
J	Xue, XB; Zou, LF; Ma, WX; Liu, ZY; Chen, GY				Xue, Xiao-bo; Zou, Li-fang; Ma, Wen-xiu; Liu, Zhi-yang; Chen, Gong-you			Identification of 17 HrpX-Regulated Proteins Including Two Novel Type III Effectors, XOC_3956 and XOC_1550, in Xanthomonas oryzae pv. oryzicola	PLOS ONE			English	Article							HYPERSENSITIVE RESPONSE; SECRETION SYSTEM; GENOME SEQUENCE; RALSTONIA-SOLANACEARUM; BACTERIAL-BLIGHT; FULL VIRULENCE; CAMPESTRIS; GENE; EXPRESSION; HOST	The function of some hypothetical proteins, possibly regulated by key hrp regulators, in the pathogenicity of phytopathogenic bacteria remains largely unknown. In the present study, in silicon microarray data demonstrated that the expression of 17 HrpX-regulated protein (Xrp) genes of X. oryzae pv. oryzicola (Xoc), which causes bacterial leaf streak in rice, were either positively or negatively regulated by HrpX or/and HrpG. Bioinformatics analysis demonstrated that five Xrps possess a putative type III secretion (T3S) signal in the first 50 N-terminal amino acids, six xrp genes contain a PIP-box-like sequence (TTCGB-N-X-TTCGB, 9 <= X <= 25) in the promoter regions, and two Xrps have both motifs. Twelve Xrps are widely conserved in Xanthomonas spp., whereas four are specific for X. oryzae (Xrp6) or Xoc (Xrp8, Xrp14 and Xrp17). In addition to the regulation by HrpG/HrpX, some of the 17 genes were also modulated by another hrp regulator HrpD6. Mutagenesis of these 17 genes indicated that five Xrps (Xrp1, Xrp2, Xrp5, Xrp8 and Xrp14) were required for full virulence and bacterial growth in planta. Immunoblotting assays and fusion with N-terminally truncated AvrXa10 indicated that Xrp3 and Xrp5 were secreted and translocated into rice cells through the type-III secretion system (T3S), suggesting they are novel T3S effectors. Our results suggest that Xoc exploits an orchestra of proteins that are regulated by HrpG, HrpX and HrpD6, and these proteins facilitate both infection and metabolism.	[Xue, Xiao-bo; Zou, Li-fang; Ma, Wen-xiu; Liu, Zhi-yang; Chen, Gong-you] Shanghai Jiao Tong Univ, Sch Agr & Biol, Key Lab Urban South, Minist Agr, Shanghai 200030, Peoples R China; [Zou, Li-fang; Chen, Gong-you] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China	Ministry of Agriculture & Rural Affairs; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, GY (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Key Lab Urban South, Minist Agr, Shanghai 200030, Peoples R China.	gyouchen@sjtu.edu.cn	CHEN, Gongyou/AAA-9694-2019	CHEN, Gongyou/0000-0003-1979-2880	State Key Basic Research and Development Project of China [20112CB114003]; Natural Science Foundation of China [31230059]; Special Fund for Agro-Scientific Research in the Public Interest of China [201303015]	State Key Basic Research and Development Project of China(State Key Development Program for Basic Research of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-Scientific Research in the Public Interest of China	This work was supported by the State Key Basic Research and Development Project of China (20112CB114003), the Natural Science Foundation of China (31230059), and the Special Fund for Agro-Scientific Research in the Public Interest of China (201303015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Alfano JR, 1997, J BACTERIOL, V179, P5655, DOI 10.1128/jb.179.18.5655-5662.1997; Axtell MJ, 2003, MOL MICROBIOL, V49, P1537, DOI 10.1046/j.1365-2958.2003.03666.x; Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; Bogdanove AJ, 2011, J BACTERIOL, V193, P5450, DOI 10.1128/JB.05262-11; Brito B, 1999, MOL MICROBIOL, V31, P237, DOI 10.1046/j.1365-2958.1999.01165.x; Buttner D, 2002, EMBO J, V21, P5313, DOI 10.1093/emboj/cdf536; Casper-Lindley C, 2002, P NATL ACAD SCI USA, V99, P8336, DOI 10.1073/pnas.122220299; Chao NX, 2008, MOL PLANT MICROBE IN, V21, P411, DOI 10.1094/MPMI-21-4-0411; Chen Gong-you, 2005, Chinese Journal of Rice Science, V19, P291; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cui YP, 2013, MOL PLANT PATHOL, V14, P678, DOI 10.1111/mpp.12039; Cunnac S, 2004, MOL MICROBIOL, V53, P115, DOI 10.1111/j.1365-2958.2004.04118.x; Furutani A, 2006, FEMS MICROBIOL LETT, V259, P133, DOI 10.1111/j.1574-6968.2006.00265.x; Furutani A, 2004, J BACTERIOL, V186, P1374, DOI 10.1128/JB.186.5.1374-1380.2004; Furutani A, 2009, MOL PLANT MICROBE IN, V22, P96, DOI 10.1094/MPMI-22-1-0096; Furutani Ayako, 2003, Journal of General Plant Pathology, V69, P271, DOI 10.1007/s10327-003-0042-2; Guo W, 2012, APPL ENVIRON MICROB, V78, P5672, DOI 10.1128/AEM.07997-11; Guo YP, 2011, MOL PLANT MICROBE IN, V24, P649, DOI 10.1094/MPMI-09-10-0209; Hilaire E, 2001, MOL PLANT MICROBE IN, V14, P1411, DOI 10.1094/MPMI.2001.14.12.1411; Hotson A, 2004, CURR OPIN PLANT BIOL, V7, P384, DOI 10.1016/j.pbi.2004.05.003; Hotson A, 2003, MOL MICROBIOL, V50, P377, DOI 10.1046/j.1365-2958.2003.03730.x; Huang DL, 2009, MOL PLANT MICROBE IN, V22, P321, DOI 10.1094/MPMI-22-3-0321; Jiang Jia, 2009, Wei Sheng Wu Xue Bao, V49, P1018; Jiang W, 2009, MOL PLANT MICROBE IN, V22, P1401, DOI 10.1094/MPMI-22-11-1401; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KAMDAR HV, 1993, J BACTERIOL, V175, P2017, DOI 10.1128/JB.175.7.2017-2025.1993; Kay S, 2009, CURR OPIN MICROBIOL, V12, P37, DOI 10.1016/j.mib.2008.12.006; Kim JG, 2009, PLANT CELL, V21, P1305, DOI 10.1105/tpc.108.063123; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; Li YR, 2011, MOL PLANT MICROBE IN, V24, P1086, DOI 10.1094/MPMI-09-10-0205; Li YR, 2011, APPL ENVIRON MICROB, V77, P3809, DOI 10.1128/AEM.02849-10; Lian HL, 2011, GENE DEV, V25, P1023, DOI 10.1101/gad.2025111; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Martin T., 1992, GUS protocols: using the GUS gene as a reporter of gene expression., P23; Mcnally RR, 2012, MOL PLANT PATHOL, V13, P160, DOI 10.1111/j.1364-3703.2011.00738.x; Mukaihara T, 2010, MOL PLANT MICROBE IN, V23, P251, DOI 10.1094/MPMI-23-3-0251; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; Noel L, 2002, J BACTERIOL, V184, P1340, DOI 10.1128/JB.184.5.1340-1348.2002; Ochiai H, 2005, JARQ-JPN AGR RES Q, V39, P275, DOI 10.6090/jarq.39.275; OKU T, 1995, DNA SEQUENCE, V5, P245, DOI 10.3109/10425179509030974; Ou S.H., 1985, RICE DIS IRRI; Pieretti I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-616; Qian GL, 2013, J PROTEOME RES, V12, P3327, DOI 10.1021/pr4001543; Robin GP, 2013, J PROTEOMICS; Roden J, 2004, MOL PLANT MICROBE IN, V17, P633, DOI 10.1094/MPMI.2004.17.6.633; Roden JA, 2004, P NATL ACAD SCI USA, V101, P16624, DOI 10.1073/pnas.0407383101; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Sambrook J., 2001, MOL CLONING LAB MANU; Schechter LM, 2006, MOL PLANT MICROBE IN, V19, P1180, DOI 10.1094/MPMI-19-1180; Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004; Scholze H, 2011, CURR OPIN MICROBIOL, V14, P47, DOI 10.1016/j.mib.2010.12.001; Seo YS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-99; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Shen YP, 2012, J INTEGR AGR, V11, P600, DOI 10.1016/S2095-3119(12)60047-1; Song CF, 2010, MOL PLANT MICROBE IN, V23, P893, DOI 10.1094/MPMI-23-7-0893; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Stushnoff C, 2010, J EXP BOT, V61, P1225, DOI 10.1093/jxb/erp394; Tampakaki AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/j.1462-5822.2004.00432.x; Thieme F, 2007, MOL PLANT MICROBE IN, V20, P1250, DOI 10.1094/MPMI-20-10-1250; Tsuge S, 2006, J BACTERIOL, V188, P4158, DOI 10.1128/JB.00006-06; Turner PE, 2004, GENETICS, V167, P9, DOI 10.1534/genetics.167.1.9; Venkatesh B, 2006, J BACTERIOL, V188, P3088, DOI 10.1128/JB.188.8.3088-3098.2006; Wang YinPeng, 2009, Acta Phytopathologica Sinica, V39, P392; Wei K, 2007, J BACTERIOL, V189, P2055, DOI 10.1128/JB.01331-06; Wengelnik K, 1996, J BACTERIOL, V178, P3462, DOI 10.1128/jb.178.12.3462-3469.1996; White FF, 2009, MOL PLANT PATHOL, V10, P749, DOI 10.1111/j.1364-3703.2009.00590.x; Xiao You-lun, 2007, Weishengwu Xuebao, V47, P396; Yamazaki A, 2008, J GEN PLANT PATHOL, V74, P138, DOI 10.1007/s10327-008-0075-7; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang SS, 2008, RES MICROBIOL, V159, P569, DOI 10.1016/j.resmic.2008.06.010; Zou LF, 2006, APPL ENVIRON MICROB, V72, P6212, DOI 10.1128/AEM.00511-06; Zou LF, 2011, AGR SCI CHINA, V10, P1139, DOI 10.1016/S1671-2927(11)60104-1	76	9	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93205	10.1371/journal.pone.0093205	http://dx.doi.org/10.1371/journal.pone.0093205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675748	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677500088
J	Zeng, P; Zhao, Y; Zhang, LW; Huang, SP; Chen, F				Zeng, Ping; Zhao, Yang; Zhang, Liwei; Huang, Shuiping; Chen, Feng			Rare Variants Detection with Kernel Machine Learning Based on Likelihood Ratio Test	PLOS ONE			English	Article							DISEASE ASSOCIATION; GENOMIC SIMILARITY; GENETIC PATHWAY; REGRESSION; COMMON; COMPONENTS; MODELS; SUSCEPTIBILITY; INFERENCE	This paper mainly utilizes likelihood-based tests to detect rare variants associated with a continuous phenotype under the framework of kernel machine learning. Both the likelihood ratio test (LRT) and the restricted likelihood ratio test (ReLRT) are investigated. The relationship between the kernel machine learning and the mixed effects model is discussed. By using the eigenvalue representation of LRT and ReLRT, their exact finite sample distributions are obtained in a simulation manner. Numerical studies are performed to evaluate the performance of the proposed approaches under the contexts of standard mixed effects model and kernel machine learning. The results have shown that the LRT and ReLRT can control the type I error correctly at the given alpha level. The LRT and ReLRT consistently outperform the SKAT, regardless of the sample size and the proportion of the negative causal rare variants, and suffer from fewer power reductions compared to the SKAT when both positive and negative effects of rare variants are present. The LRT and ReLRT performed under the context of kernel machine learning have slightly higher powers than those performed under the context of standard mixed effects model. We use the Genetic Analysis Workshop 17 exome sequencing SNP data as an illustrative example. Some interesting results are observed from the analysis. Finally, we give the discussion.	[Zeng, Ping; Zhao, Yang; Zhang, Liwei; Chen, Feng] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Zeng, Ping; Huang, Shuiping] Xuzhou Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Xuzhou, Jiangsu, Peoples R China	Nanjing Medical University; Xuzhou Medical University	Chen, F (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	fengchen@njmu.edu.cn	zhao, yang/GXF-4424-2022	Zeng, Ping/0000-0003-2710-3440; Chen, Feng/0000-0002-2699-7190	National Natural Science Foundation of China [81072389, 81373102]; Research Found for the Doctoral Program of Higher Education of China [20113234110002]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [10KJA330034]; College Philosophy and Social Science Foundation from Education Department of Jiangsu Province of China [2013SJB790059, 2013SJD790032]; Research Foundation from Xuzhou Medical College [2012KJ02]; Research and Innovation Project for College Graduates of Jiangsu Province of China [CXLX13_574]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Found for the Doctoral Program of Higher Education of China; Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); College Philosophy and Social Science Foundation from Education Department of Jiangsu Province of China; Research Foundation from Xuzhou Medical College; Research and Innovation Project for College Graduates of Jiangsu Province of China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Natural Science Foundation of China (No. 81072389, 81373102), Research Found for the Doctoral Program of Higher Education of China (No. 20113234110002), Key Grant of Natural Science Foundation of the Jiangsu Higher Education Institutions of China (No. 10KJA330034), College Philosophy and Social Science Foundation from Education Department of Jiangsu Province of China (No. 2013SJB790059, 2013SJD790032), Research Foundation from Xuzhou Medical College (No. 2012KJ02), Research and Innovation Project for College Graduates of Jiangsu Province of China (No. CXLX13_574), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy Laura, 2011, BMC Proc, V5 Suppl 9, pS2, DOI 10.1186/1753-6561-5-S9-S2; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Bacanu SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042530; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Bowes J, 2010, HUM GENET, V128, P627, DOI 10.1007/s00439-010-0889-1; Chen Z, 2003, BIOMETRICS, V59, P762, DOI 10.1111/j.0006-341X.2003.00089.x; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Claeskens G, 2004, J R STAT SOC B, V66, P909, DOI 10.1111/j.1467-9868.2004.05421.x; CORBEIL RR, 1976, TECHNOMETRICS, V18, P31, DOI 10.2307/1267913; Crainiceanu CM, 2004, J ROY STAT SOC B, V66, P165, DOI 10.1111/j.1467-9868.2004.00438.x; Cristianini N, 2000, INTRO SUPPORT VECTOR; Davies RB, 1980, J ROYAL STAT SOC C, V29, P323, DOI DOI 10.2307/2346911; Duchesne P, 2010, COMPUT STAT DATA AN, V54, P858, DOI 10.1016/j.csda.2009.11.025; Feng T, 2010, HUM GENET, V128, P269, DOI 10.1007/s00439-010-0849-9; Ghosh Saurabh, 2011, BMC Proc, V5 Suppl 9, pS1, DOI 10.1186/1753-6561-5-S9-S1; Gianola D, 2008, GENETICS, V178, P2289, DOI 10.1534/genetics.107.084285; Greven S, 2008, J COMPUT GRAPH STAT, V17, P870, DOI 10.1198/106186008X386599; Gudmundsson J, 2012, NAT GENET, V44, P1326, DOI 10.1038/ng.2437; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; HARVILLE DA, 1974, BIOMETRIKA, V61, P383, DOI 10.2307/2334370; Hofmann T, 2008, ANN STAT, V36, P1171, DOI 10.1214/009053607000000677; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; KIMELDORF G, 1971, J MATH ANAL APPL, V33, P82, DOI 10.1016/0022-247X(71)90184-3; Kuo BS, 1999, ECONOMET THEOR, V15, P24; Kwee LC, 2008, AM J HUM GENET, V82, P386, DOI 10.1016/j.ajhg.2007.10.010; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481; Lin XH, 1997, BIOMETRIKA, V84, P309, DOI 10.1093/biomet/84.2.309; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Liu D, 2007, BIOMETRICS, V63, P1079, DOI 10.1111/j.1541-0420.2007.00799.x; Liu DW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-292; Liu H, 2009, COMPUT STAT DATA AN, V53, P853, DOI 10.1016/j.csda.2008.11.025; Madsen B.E., 2009, PLOS GENET, V5; Mallick BK, 2005, J R STAT SOC B, V67, P219, DOI 10.1111/j.1467-9868.2005.00498.x; Masson E, 2008, HUM GENET, V123, P83, DOI 10.1007/s00439-007-0459-3; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Peng G, 2013, P NATL ACAD SCI USA, V110, P3985, DOI 10.1073/pnas.1222158110; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; R Core Team, 2021, R LANGUAGE ENV STAT; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schaid DJ, 2010, HUM HERED, V70, P109, DOI 10.1159/000312641; Schaid DJ, 2010, HUM HERED, V70, P132, DOI 10.1159/000312643; Scheipl F, 2008, COMPUT STAT DATA AN, V52, P3283, DOI 10.1016/j.csda.2007.10.022; Scholkopf B., 2001, LEARNING KERNELS; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Smith G, 2013, ANN CLIN BIOCHEM, V50, P83, DOI 10.1258/acb.2012.012103; STRAM DO, 1994, BIOMETRICS, V50, P1171, DOI 10.2307/2533455; Verbeke G, 2003, BIOMETRICS, V59, P254, DOI 10.1111/1541-0420.00032; Verbeke G, 2009, SPRINGER SER STAT, P1; Wahba G, 1999, ADVANCES IN KERNEL METHODS, P69; Wahba G., 1990, SPLINE MODELS OBSERV; Wu MC, 2013, GENET EPIDEMIOL, V37, P267, DOI 10.1002/gepi.21715; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yu L, 2013, HUM GENET, V132, P285, DOI 10.1007/s00439-012-1249-0; Zhan HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044173; Zuo LJ, 2013, J HUM GENET, V58, P178, DOI 10.1038/jhg.2012.153	69	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93355	10.1371/journal.pone.0093355	http://dx.doi.org/10.1371/journal.pone.0093355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675868	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500112
J	Zhao, YH; Yu, DD; Li, HD; Nie, P; Zhu, Y; Liu, SW; Zhu, M; Fang, B				Zhao, Yanhui; Yu, Dedong; Li, Handong; Nie, Ping; Zhu, Yun; Liu, Shengwen; Zhu, Min; Fang, Bing			Cyclin D1 Overexpression Is Associated with Poor Clinicopathological Outcome and Survival in Oral Squamous Cell Carcinoma in Asian Populations: Insights from a Meta-Analysis	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; MOLECULAR MARKERS; EXPRESSION; AMPLIFICATION; TONGUE; HEAD; NECK; P53; BIOMARKERS; CANCER	Background: The clinicopathological significance of cyclin D1 overexpression and prognosis of oral squamous cell carcinoma has not been fully quantified. We performed a comprehensive meta-analysis for evaluation of cyclin D1 overexpression in oral squamous cell carcinoma to determine the strength of this association. Methods: Using both medical subheadings and free terms, we searched PubMed, Embase and the Institute for Scientific Information Web of Science for all eligible studies published before Nov. 2013. We retrieved 1674 citations, determining that 15 met the selection criteria. We used the odds ratio (OR) and hazard ratio (HR) as the common measures of association to quantitatively determine the correlation between cyclin D1 overexpression and outcomes of oral cancer. We performed a meta-analysis and heterogeneity, sensitivity, and subgroup analyses to clarify and validate the pooled results. Results: The pooled results provided compelling evidence that cyclin D1 overexpression was significantly correlated with increased tumor size (OR = 1.617, 95% confidence interval [CI] = 1.046-2.498, p = 0.031), lymphoid node metastasis (OR = 2.035, 95% CI = 1.572-2.635, p<0.001), tumor differentiation (OR = 1.976, 95% CI = 1.363-2.866, p<0.001), and advancement of clinical stages (OR = 1.516, 95% CI = 1.140-2.015, p = 0.004), and adversely influenced overall survival of OSCC patients (HR = 1.897, 95% CI = 1.577-2.282, p<0.001). The strength of association varied in different oral cavity subsites. Conclusion: Our findings indicated that cyclin D1 expression correlates with detrimental clinicopathological outcome and poor prognosis in oral squamous cell carcinoma. Our results may be useful in the management of oral cancer.	[Zhao, Yanhui; Yu, Dedong; Nie, Ping; Zhu, Min; Fang, Bing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Stomatol,Shanghai Peoples Hosp 9, Dept Oral & Craniomaxillofacial Sci,Coll Stomatol, Shanghai 200030, Peoples R China; [Li, Handong] Sichuan Univ, West China Sch Publ Hlth, Dept Med Stat, Chengdu 610064, Sichuan, Peoples R China; [Zhu, Yun; Liu, Shengwen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Stomatol,Shanghai Peoples Hosp 9, Dept Oral & Maxillofacial Head & Neck Oncol,Coll, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Sichuan University; Shanghai Jiao Tong University	Zhu, M (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Stomatol,Shanghai Peoples Hosp 9, Dept Oral & Craniomaxillofacial Sci,Coll Stomatol, Shanghai 200030, Peoples R China.	zminnie@yahoo.com; fangbing@sjtu.edu.cn						Akervall JA, 1997, CANCER, V79, P380; Bova RJ, 1999, CLIN CANCER RES, V5, P2810; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; da Silva SD, 2011, ORAL ONCOL, V47, P783, DOI 10.1016/j.oraloncology.2011.07.004; Das SN, 2011, INDIAN J MED RES, V133, P381; de Vicente JC, 2002, ORAL ONCOL, V38, P301, DOI 10.1016/S1368-8375(01)00060-4; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DONALD A, 1987, STAT MED, V6, P491, DOI 10.1002/sim.4780060408; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Goto H, 2002, ORAL ONCOL, V38, P549, DOI 10.1016/S1368-8375(01)00121-X; Hanken H, 2014, CLIN ORAL INVEST, V18, P269, DOI 10.1007/s00784-013-0967-6; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang SF, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-40; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kudo Y, 2000, CLIN CANCER RES, V6, P916; Kuo MYP, 1999, J ORAL PATHOL MED, V28, P165; Lam KY, 2000, J ORAL PATHOL MED, V29, P167, DOI 10.1034/j.1600-0714.2000.290404.x; Masuda M, 1996, CANCER, V78, P390; Michalides RJAM, 1999, J CLIN PATHOL, V52, P555, DOI 10.1136/jcp.52.8.555; Mineta H, 2000, ORAL ONCOL, V36, P194, DOI 10.1016/S1368-8375(99)00078-0; Mishra R, 2009, ARCH ORAL BIOL, V54, P917, DOI 10.1016/j.archoralbio.2009.07.003; Miyamoto R, 2003, ORAL ONCOL, V39, P610, DOI 10.1016/S1368-8375(03)00048-4; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Neville BW, 2002, CA-CANCER J CLIN, V52, P195, DOI 10.3322/canjclin.52.4.195; Pestell RG, 1999, ENDOCR REV, V20, P501, DOI 10.1210/er.20.4.501; Rasamny JJ, 2012, OTOLARYNG HEAD NECK, V146, P923, DOI 10.1177/0194599811435052; Rousseau A, 2001, ORAL ONCOL, V37, P268, DOI 10.1016/S1368-8375(00)00114-7; Saawarn S, 2012, SCI WORLD J, DOI 10.1100/2012/978327; Salesiotis AN, 2000, CURR OPIN ONCOL, V12, P229, DOI 10.1097/00001622-200005000-00008; Scantlebury JB, 2013, HUM PATHOL, V44, P1672, DOI 10.1016/j.humpath.2013.01.021; Shah NG, 2009, HEAD NECK-J SCI SPEC, V31, P1544, DOI 10.1002/hed.21126; Shiraki M, 2005, MODERN PATHOL, V18, P1482, DOI 10.1038/modpathol.3800455; Tashiro E, 2007, CANCER SCI, V98, P629, DOI 10.1111/j.1349-7006.2007.00449.x; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Vora HH, 2003, J SURG ONCOL, V82, P34, DOI 10.1002/jso.10183; Wang Hengkun, 2006, Wuhan Daxue Xuebao (Yixue Ban), V27, P214; Xing Jin-Song, 2011, Hua Xi Kou Qiang Yi Xue Za Zhi, V29, P299; Xing JS, 2011, HUA XI KOU QIANG YI, V29, P301; Xing JS, 2011, HUA XI KOU QIANG YI, V29, P305; Xu J, 1998, CANCER-AM CANCER SOC, V83, P204, DOI 10.1002/(SICI)1097-0142(19980715)83:2<204::AID-CNCR2>3.0.CO;2-Q; Yun X, 2010, ONCOL LETT, V1, P437, DOI 10.3892/ol_00000077; Zhao J, 2012, DIS ESOPHAGUS, V25, P520, DOI 10.1111/j.1442-2050.2011.01278.x; [朱东望 Zhu Dongwang], 2003, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V30, P40	45	27	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93210	10.1371/journal.pone.0093210	http://dx.doi.org/10.1371/journal.pone.0093210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675814	gold, Green Submitted, Green Published			2022-12-27	WOS:000333677500091
J	Johnston, NN; Bradley, JE; Otter, KA				Johnston, Naira N.; Bradley, James E.; Otter, Ken A.			Increased Flight Altitudes among Migrating Golden Eagles Suggest Turbine Avoidance at a Rocky Mountain Wind Installation	PLOS ONE			English	Article							RED-TAILED HAWKS; BIRD MIGRATION; WEATHER; MORTALITY; BEHAVIOR; RISK; RAPTORS; HABITAT; FARMS; MODEL	Potential wind-energy development in the eastern Rocky Mountain foothills of British Columbia, Canada, raises concerns due to its overlap with a golden eagle (Aquila chrysaetos) migration corridor. The Dokie 1 Wind Energy Project is the first development in this area and stands as a model for other projects in the area because of regional consistency in topographic orientation and weather patterns. We visually tracked golden eagles over three fall migration seasons (2009-2011), one pre-and two post-construction, to document eagle flight behaviour in relation to a ridge-top wind energy development. We estimated three-dimensional positions of eagles in space as they migrated through our study site. Flight tracks were then incorporated into GIS to ascertain flight altitudes for eagles that flew over the ridge-top area (or turbine string). Individual flight paths were designated to a category of collision-risk based on flight altitude (e. g. flights within rotor-swept height; <= 150 m above ground) and wind speed (winds sufficient for the spinning of turbines; >6.8 km/h at ground level). Eagles were less likely to fly over the ridge-top area within rotor-swept height (risk zone) as wind speed increased, but were more likely to make such crosses under headwinds and tailwinds compared to western crosswinds. Most importantly, we observed a smaller proportion of flights within the risk zone at wind speeds sufficient for the spinning of turbines (higher-risk flights) during post-construction compared to pre-construction, suggesting that eagles showed detection and avoidance of turbines during migration.	[Johnston, Naira N.; Bradley, James E.; Otter, Ken A.] Univ No British Columbia, Prince George, BC V2L 5P2, Canada	University of Northern British Columbia	Johnston, NN (corresponding author), Univ No British Columbia, Prince George, BC V2L 5P2, Canada.	johnstn@alumni.unbc.ca			Natural Sciences and Research Engineering Council of Canada (NSERC) Industrial Postgraduate Scholarships program; NSERC Strategic Project Grant; Environment Canada; Stantec Consulting Ltd.; Dokie General Partnership	Natural Sciences and Research Engineering Council of Canada (NSERC) Industrial Postgraduate Scholarships program(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Strategic Project Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Environment Canada(CGIAR); Stantec Consulting Ltd.; Dokie General Partnership	Natural Sciences and Research Engineering Council of Canada (NSERC) Industrial Postgraduate Scholarships program: http://www.nserc-crsng.gc.ca/students-etudiants/pg-cs/ips-besii_eng.asp; NSERC Strategic Project Grant: http://www.nserc-crsng.gc.ca/professors-professeurs/rpp-pp/spg-sps_eng.asp; Environment Canada; and, through partnership through Stantec Consulting Ltd. and the Dokie General Partnership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1996, INTRO CATEGORICAL DA; Ainslie B, 2014, INT J BIOMETEOROL, V58, P17, DOI 10.1007/s00484-012-0620-0; Alerstam T, 1990, BIRD MIGRATION PHYSL, P331, DOI [DOI 10.1007/978-3-642-74542-3_22., 10.1007/978-3-642-74542-3_22]; Band W, 2007, BIRDS WIND FARMS RIS, P49; Barrios L, 2004, J APPL ECOL, V41, P72, DOI 10.1111/j.1365-2664.2004.00876.x; Barrios Luis, 2007, P229; Batschelet E, 1981, CIRCULAR STAT BIOL; De Lucas M, 2004, BIODIVERS CONSERV, V13, P395, DOI 10.1023/B:BIOC.0000006507.22024.93; de Lucas M, 2012, BIOL CONSERV, V147, P184, DOI 10.1016/j.biocon.2011.12.029; de Lucas Manuela, 2007, P219; Desholm M, 2005, BIOL LETTERS, V1, P296, DOI 10.1098/rsbl.2005.0336; Drewitt AL, 2008, ANN NY ACAD SCI, V1134, P233, DOI 10.1196/annals.1439.015; Drewitt AL, 2006, IBIS, V148, P29, DOI 10.1111/j.1474-919X.2006.00516.x; Ferrer M, 2012, J APPL ECOL, V49, P38, DOI 10.1111/j.1365-2664.2011.02054.x; Fox AD, 2006, IBIS, V148, P129, DOI 10.1111/j.1474-919X.2006.00510.x; Garvin JC, 2011, J APPL ECOL, V48, P199, DOI 10.1111/j.1365-2664.2010.01912.x; Goodale W, 2009, BRI200918; Harmata AR, 2000, AM MIDL NAT, V143, P30, DOI 10.1674/0003-0031(2000)143[0030:PRATOB]2.0.CO;2; Hoover SL, 2005, J WILDLIFE MANAGE, V69, P150, DOI 10.2193/0022-541X(2005)069<0150:BORHIA>2.0.CO;2; Hunt G, 1995, NRELSR50026092; Hunt G, 2002, 50002043F CAL EN COM; Johnson Gregory D., 2007, P241; Johnston NN, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00608-080212; Kerlinger P., 1989, Current Ornithology, V6, P109; Langston R.W.H., 2003, WIND FARMS BIRDS ANA; Lanzone MJ, 2012, BIOL LETTERS, V8, P710, DOI 10.1098/rsbl.2012.0359; Larsen JK, 2007, J APPL ECOL, V44, P516, DOI 10.1111/j.1365-2664.2007.01303.x; LIECHTI F, 1994, J THEOR BIOL, V170, P219, DOI 10.1006/jtbi.1994.1181; Liguori J., 2004, BIRDING, V36, P278; Mandel JT, 2011, ECOL APPL, V21, P2258, DOI 10.1890/10-1651.1; Maransky B, 1997, WILSON BULL, V109, P246; Martin GR, 2012, IBIS, V154, P626, DOI 10.1111/j.1474-919X.2012.01227.x; McIntyre CL, 2008, AUK, V125, P214, DOI 10.1525/auk.2008.125.1.214; McIsaac H. P., 2001, P NAT AV WIND POW PL, P59; Niles LJ, 1996, CONDOR, V98, P382, DOI 10.2307/1369156; Nygard T, 2010, BOU P CLIMATE CHANGE; Orloff S., 1992, WIND TURBINE EFFECTS; Pagel JE, 2013, J RAPTOR RES, V47, P311, DOI 10.3356/JRR-12-00019.1; Percival Steve, 2005, British Birds, V98, P194; Pomeroy A, 2009, 2009 WILDLIFE MONITO; RICHARDSON WJ, 1978, OIKOS, V30, P224, DOI 10.2307/3543482; Shamoun-Baranes J, 2003, BOUND-LAY METEOROL, V107, P673, DOI 10.1023/A:1022824008388; Sherrington Peter, 2003, Bird Trends, V9, P34; Smallwood KS, 2009, J WILDLIFE MANAGE, V73, P1082, DOI 10.2193/2008-555; Smallwood KS, 2004, DEV METHODS REDUCE B; Smallwood KS, 2009, CEC5002009065; Sparr Reto, 2000, Technical Soaring, V24, P49; Thelander Carl G., 2007, P25; Whiteman CD, 2000, MOUNTAIN METEROLOGY; Yates RE, 2001, J RAPTOR RES, V35, P81; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/; Zuur AF, 2009, MIXED EFFECTS MODELS, P264	52	27	27	4	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93030	10.1371/journal.pone.0093030	http://dx.doi.org/10.1371/journal.pone.0093030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671199	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677000103
J	Peng, J; Yang, H; Jiang, H; Lin, YX; Lu, CD; Xu, YW; Zeng, J				Peng, Jin; Yang, Hao; Jiang, Hua; Lin, Yi-xiao; Lu, Charles Damien; Xu, Ya-wei; Zeng, Jun			The Origin of Novel Avian Influenza A (H7N9) and Mutation Dynamics for Its Human-To-Human Transmissible Capacity	PLOS ONE			English	Article							ERROR CATASTROPHE; HUMAN INFECTION; VIRUS; RIBAVIRIN	In February 2013, H7N9 (A/H7N9/2013_China), a novel avian influenza virus, broke out in eastern China and caused human death. It is a global priority to discover its origin and the point in time at which it will become transmittable between humans. We present here an interdisciplinary method to track the origin of H7N9 virus in China and to establish an evolutionary dynamics model for its human-to-human transmission via mutations. After comparing influenza viruses from China since 1983, we established an A/H7N9/2013_China virus evolutionary phylogenetic tree and found that the human instances of virus infection were of avian origin and clustered into an independent line. Comparing hemagglutinin (HA) and neuraminidase (NA) gene sequences of A/H7N9/2013_China viruses with all human-to-human, avian, and swine influenza viruses in China in the past 30 years, we found that A/H7N9/2013_China viruses originated from Baer's Pochard H7N1 virus of Hu Nan Province 2010 (HA gene, EPI: 370846, similarity with H7N9 is 95.5%) and duck influenza viruses of Nanchang city 2000 (NA gene, EPI: 387555, similarity with H7N9 is 97%) through genetic re-assortment. HA and NA gene sequence comparison indicated that A/H7N9/2013_China virus was not similar to human-to-human transmittable influenza viruses. To simulate the evolution dynamics required for human-to-human transmission mutations of H7N9 virus, we employed the Markov model. The result of this calculation indicated that the virus would acquire properties for human-to-human transmission in 11.3 years (95% confidence interval (CI): 11.2-11.3, HA gene).	[Peng, Jin; Yang, Hao; Jiang, Hua; Lin, Yi-xiao; Lu, Charles Damien; Xu, Ya-wei; Zeng, Jun] Sichuan Acad Med Sci, Metabol & Multidisciplinary Lab Trauma Res, Inst Emergency & Disaster Med, Sichuan Prov Peoples Hosp,Dept Computat Math & Bi, Chengdu, Sichuan Provinc, Peoples R China; [Jiang, Hua; Zeng, Jun] Sichuan Acad Med Sci, Ctr Emergency Med, Sichuan Prov Peoples Hosp, Chengdu, Sichuan Provinc, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Jiang, H (corresponding author), Sichuan Acad Med Sci, Metabol & Multidisciplinary Lab Trauma Res, Inst Emergency & Disaster Med, Sichuan Prov Peoples Hosp,Dept Computat Math & Bi, Chengdu, Sichuan Provinc, Peoples R China.	cdjianghua@gmail.com; zengjun@medmail.com.cn	Jiang, Hua/ABE-5811-2021	Jiang, Hua/0000-0003-1465-0170	Sichuan Provincial Department of Science and Technology [2011SZ0139, 2011SZ0336, 2012SZ0181]; Chengdu Municipality Department of Science and Technology [12PPYB181SF-002]; Medical Research Grants of Sichuan Department of Health [100552, 100553, 110162]	Sichuan Provincial Department of Science and Technology; Chengdu Municipality Department of Science and Technology; Medical Research Grants of Sichuan Department of Health	This work was supported by the Sichuan Provincial Department of Science and Technology (Science and Technology Support Program, grants No.2011SZ0139, No.2011SZ0336, and No.2012SZ0181; http://www.scst.gov.cn/info/). This work was also supported by the Chengdu Municipality Department of Science and Technology (Grant No. 12PPYB181SF-002; http://www.cdst.gov.cn/). JZ and HJ are recipients of Medical Research Grants of Sichuan Department of Health (Grants No. 100552, No. 100553, and No. 110162; http://www.scwst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bull JJ, 2005, PLOS COMPUT BIOL, V1, P450, DOI 10.1371/journal.pcbi.0010061; Butler D, 2013, NATURE, V496, P145, DOI 10.1038/496145a; Cai B, 2012, ZHONG HUA JI ZHEN YI, V21, P887; Chang JT, 1996, MATH BIOSCI, V137, P51, DOI 10.1016/S0025-5564(96)00075-2; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Graci JD, 2002, VIROLOGY, V298, P175, DOI 10.1006/viro.2002.1487; Hayes DP, 2010, MED HYPOTHESES, V74, P831, DOI 10.1016/j.mehy.2009.12.002; Holmes EC, 2003, TRENDS MICROBIOL, V11, P543, DOI 10.1016/j.tim.2003.10.006; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Liu SL, 2011, WETLAND SCI MANAGEME, V7, P44; Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863; National Health and Family Planning Commission of China, 2013, EP INF H7N9 MAY 13; Norris J. R., 1998, MARKOV CHAINS; Potter CW, 2011, J INFECTION, V63, P252, DOI 10.1016/j.jinf.2011.04.013; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Takekawa JY, 2010, AVIAN DIS, V54, P466, DOI 10.1637/8914-043009-Reg.1; Wilks S, 2012, VACCINE, V30, P4369, DOI 10.1016/j.vaccine.2012.02.076; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yeung JWK, 2006, MED HYPOTHESES, V67, P1016, DOI 10.1016/j.mehy.2006.03.048; Zhao X, 1994, ZHE JIANG LIN YE KE, V5, P26; Zhao X. M., 2006, BIRD MIGRATION BIRD; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	24	20	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93094	10.1371/journal.pone.0093094	http://dx.doi.org/10.1371/journal.pone.0093094			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671138	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677000112
J	Comish, PB; Drumond, AL; Kinnell, HL; Anderson, RA; Matin, A; Meistrich, ML; Shetty, G				Comish, Paul B.; Drumond, Ana Luiza; Kinnell, Hazel L.; Anderson, Richard A.; Matin, Angabin; Meistrich, Marvin L.; Shetty, Gunapala			Fetal Cyclophosphamide Exposure Induces Testicular Cancer and Reduced Spermatogenesis and Ovarian Follicle Numbers in Mice	PLOS ONE			English	Article							CELL TUMOR SUSCEPTIBILITY; ANTI-MULLERIAN HORMONE; PRIMORDIAL GERM-CELLS; DNA-DAMAGE; MOUSE; CHEMOTHERAPY; RADIOSENSITIVITY; MALIGNANCIES; MECHANISMS; PREGNANCY	Exposure to radiation during fetal development induces testicular germ cell tumors (TGCT) and reduces spermatogenesis in mice. However, whether DNA damaging chemotherapeutic agents elicit these effects in mice remains unclear. Among such agents, cyclophosphamide (CP) is currently used to treat breast cancer in pregnant women, and the effects of fetal exposure to this drug manifested in the offspring must be better understood to offer such patients suitable counseling. The present study was designed to determine whether fetal exposure to CP induces testicular cancer and/or gonadal toxicity in 129 and in 129.MOLF congenic (L1) mice. Exposure to CP on embryonic days 10.5 and 11.5 dramatically increased TGCT incidence to 28% in offspring of 129 mice (control value, 2%) and to 80% in the male offspring of L1 (control value 33%). These increases are similar to those observed in both lines of mice by radiation. In utero exposure to CP also significantly reduced testis weights at 4 weeks of age to similar to 70% of control and induced atrophic seminiferous tubules in similar to 30% of the testes. When the in utero CP-exposed 129 mice reached adulthood, there were significant reductions in testicular and epididymal sperm counts to 62% and 70%, respectively, of controls. In female offspring, CP caused the loss of 77% of primordial follicles and increased follicle growth activation. The results indicate that i) DNA damage is a common mechanism leading to induction of testicular cancer, ii) increased induction of testis cancer by external agents is proportional to the spontaneous incidence due to inherent genetic susceptibility, and iii) children exposed to radiation or DNA damaging chemotherapeutic agents in utero may have increased risks of developing testis cancer and having reduced spermatogenic potential or diminished reproductive lifespan.	[Comish, Paul B.; Drumond, Ana Luiza; Meistrich, Marvin L.; Shetty, Gunapala] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Matin, Angabin] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Kinnell, Hazel L.; Anderson, Richard A.] Univ Edinburgh, MRC, Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Edinburgh	Shetty, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	sgunapal@mdanderson.org	Drumond-Bock, Ana Luiza/A-2152-2019	Drumond-Bock, Ana Luiza/0000-0003-3555-7741; Shetty, Gunapala/0000-0001-5786-0667	Florence M. Thomas Professorship in Cancer Research; Cancer Center Support Grant from the National Institutes of Health and Medical Reasearch Council [G1100357]; MRC [G1100357, G1002033, G1002118] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; Medical Research Council [G1002033, G1002118, G1100357] Funding Source: researchfish	Florence M. Thomas Professorship in Cancer Research; Cancer Center Support Grant from the National Institutes of Health and Medical Reasearch Council; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Florence M. Thomas Professorship in Cancer Research to MLM, Cancer Center Support Grant P30CA016672 from the National Institutes of Health and Medical Reasearch Council grant G1100357 to RAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Amant F, 2012, LANCET ONCOL, V13, P256, DOI 10.1016/S1470-2045(11)70363-1; Arora P, 2011, OBSTET GYNAECOL, V13, P67, DOI 10.1576/toag.13.2.67.27648; Aviles A, 2001, CLIN LYMPHOMA, V2, P173, DOI 10.3816/CLM.2001.n.023; BEAUMONT HM, 1960, INT J RADIAT BIOL RE, V2, P247, DOI 10.1080/09553006014550291; BEAUMONT HM, 1961, INT J RADIAT BIOL RE, V3, P59, DOI 10.1080/09553006114550071; BOFFETTA P, 1994, ACTA ONCOL, V33, P591, DOI 10.3109/02841869409121767; Brougham MFH, 2012, J CLIN ENDOCR METAB, V97, P2059, DOI 10.1210/jc.2011-3180; Cardonick E, 2010, AM J CLIN ONCOL-CANC, V33, P221, DOI 10.1097/COC.0b013e3181a44ca9; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; Chia VM, 2010, CANCER EPIDEM BIOMAR, V19, P1151, DOI 10.1158/1055-9965.EPI-10-0031; Chung CC, 2013, NAT GENET, V45, P680, DOI 10.1038/ng.2634; Da Silva-Buttkus P, 2009, P NATL ACAD SCI USA, V106, P456, DOI 10.1073/pnas.0810012106; Drumond AL, 2011, REPROD TOXICOL, V32, P395, DOI 10.1016/j.reprotox.2011.09.010; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Hahn KME, 2006, CANCER, V107, P1219, DOI 10.1002/cncr.22081; Heaney JD, 2008, CANCER RES, V68, P5193, DOI 10.1158/0008-5472.CAN-08-0779; HEMSWORTH BN, 1963, J REPROD FERTIL, V6, P229; HIRSHFIELD AN, 1994, BIOL REPROD, V50, P421, DOI 10.1095/biolreprod50.2.421; Howlader N, 2013, SEER CANC STAT REV 1; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Kerr JR, 2005, PHARMACOTHERAPY, V25, P438, DOI 10.1592/phco.25.3.438.59291; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; LU CC, 1979, CANCER RES, V39, P3575; McGlynn KA, 2009, CANCER RES, V69, P1901, DOI 10.1158/0008-5472.CAN-08-3935; Meistrich M.L., 1993, METHODS REPROD TOXIC, V3, P106; Mitchell RT, 2008, HUM REPROD, V23, P2755, DOI 10.1093/humrep/den295; Morgan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070117; PILLANS PI, 1989, CARCINOGENESIS, V10, P83, DOI 10.1093/carcin/10.1.83; PLOWCHALK DR, 1992, REPROD TOXICOL, V6, P411, DOI 10.1016/0890-6238(92)90004-D; Ray B, 2012, BRATISL MED J, V113, P637, DOI 10.4149/BLL_2012_144; Shah MN, 2007, INT J ANDROL, V30, P206, DOI 10.1111/j.1365-2605.2007.00795.x; Shetty G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032064; Siddik ZH, 2002, CANC HDB, P1295; Sievers S, 2005, GENE CHROMOSOME CANC, V44, P256, DOI 10.1002/gcc.20237; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; STEVENS LC, 1966, J NATL CANCER I, V37, P859; Surani MA, 2010, COLD SH Q B, V75, P211, DOI 10.1101/sqb.2010.75.010; Tang MS, 2011, MOL NUTR FOOD RES, V55, P1291, DOI 10.1002/mnfr.201100148; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Ustaalioglu BBO, 2010, INT J GYNECOL CANCER, V20, P698, DOI 10.1111/IGC.0b013e3181daaf3e; Van Calsteren K, 2010, GYNECOL ONCOL, V119, P594, DOI 10.1016/j.ygyno.2010.08.019; Van der Zwan YG, 2013, INT J DEV BIOL, V57, P299, DOI 10.1387/ijdb.130017ll; VERGOUWEN RPFA, 1995, RADIAT RES, V141, P66, DOI 10.2307/3579091; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; WATSON AR, 1985, BRIT MED J, V291, P1457, DOI 10.1136/bmj.291.6507.1457; Zhu R, 2007, MAMM GENOME, V18, P584, DOI 10.1007/s00335-007-9036-2	47	27	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93311	10.1371/journal.pone.0093311	http://dx.doi.org/10.1371/journal.pone.0093311			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691397	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100064
J	Hamada, K; Osaka, M; Yoshida, M				Hamada, Katsuhiko; Osaka, Mizuko; Yoshida, Masayuki			Cell Density Impacts Epigenetic Regulation of Cytokine-Induced E-Selectin Gene Expression in Vascular Endothelium	PLOS ONE			English	Article							NF-KAPPA-B; ADHESION MOLECULES; NITRIC-OXIDE; ACTIVATION; CHROMATIN; ATHEROSCLEROSIS; TRANSCRIPTION; RESOLUTION; PROMOTER; REQUIRES	Growing evidence suggests that the phenotype of endothelial cells during angiogenesis differs from that of quiescent endothelial cells, although little is known regarding the difference in the susceptibility to inflammation between both the conditions. Here, we assessed the inflammatory response in sparse and confluent endothelial cell monolayers. To obtain sparse and confluent monolayers, human umbilical vein endothelial cells were seeded at a density of 7.3x10(3) cells/cm(2) and 29.2x10(3) cells/cm(2), respectively, followed by culturing for 36 h and stimulation with tumor necrosis factor alpha. The levels of tumor necrosis factor alpha-induced E-selectin protein and mRNA expression were higher in the confluent monolayer than in the sparse monolayer. The phosphorylation of c-jun N-terminal kinase and p38 mitogen-activated protein kinase or nuclear factor-kappa B activation was not involved in this phenomenon. A chromatin immunoprecipitation assay of the E-selectin promoter using an anti-acetyl-histone H3 antibody showed that the E-selectin promoter was highly and specifically acetylated in the confluent monolayer after tumor necrosis factor alpha activation. Furthermore, chromatin accessibility real-time PCR showed that the chromatin accessibility at the E-selectin promoter was higher in the confluent monolayer than in the sparse monolayer. Our data suggest that the inflammatory response may change during blood vessel maturation via epigenetic mechanisms that affect the accessibility of chromatin.	[Hamada, Katsuhiko; Osaka, Mizuko; Yoshida, Masayuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Life Sci & Bioeth, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Yoshida, M (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Life Sci & Bioeth, Tokyo, Japan.	masa.vasc@tmd.ac.jp						Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Calao M, 2008, TRENDS BIOCHEM SCI, V33, P339, DOI 10.1016/j.tibs.2008.04.015; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cines DB, 1998, BLOOD, V91, P3527; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Edelstein LC, 2005, J BIOL CHEM, V280, P11192, DOI 10.1074/jbc.M412997200; Fish JE, 2010, J BIOL CHEM, V285, P810, DOI 10.1074/jbc.M109.067868; Fish JE, 2005, J BIOL CHEM, V280, P24824, DOI 10.1074/jbc.M502115200; Freire MO, 2013, PERIODONTOL 2000, V63, P149, DOI 10.1111/prd.12034; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Gerszten RE, 1996, CIRC RES, V79, P1205, DOI 10.1161/01.RES.79.6.1205; Helfrich I, 2011, MOL ONCOL, V5, P137, DOI 10.1016/j.molonc.2011.01.003; KASZUBSKA W, 1993, MOL CELL BIOL, V13, P7180, DOI 10.1128/MCB.13.11.7180; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Liebner S, 2006, ARTERIOSCL THROM VAS, V26, P1431, DOI 10.1161/01.ATV.0000218510.04541.5e; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Matouk CC, 2008, CIRC RES, V102, P873, DOI 10.1161/CIRCRESAHA.107.171025; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Mochizuki N, 2009, CIRC J, V73, P2183, DOI 10.1253/circj.CJ-09-0666; Napione L, 2012, BLOOD, V119, P5599, DOI 10.1182/blood-2011-11-390666; Orpana A, 1997, J CELL BIOCHEM, V64, P538; Pober JS, 2002, ARTHRITIS RES THER, V4, pS109, DOI 10.1186/ar576; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Rothballer A, 2013, CHROMOSOMA, V122, P415, DOI 10.1007/s00412-013-0417-x; WHITLEY MZ, 1994, MOL CELL BIOL, V14, P6464, DOI 10.1128/MCB.14.10.6464; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706	31	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e90502	10.1371/journal.pone.0090502	http://dx.doi.org/10.1371/journal.pone.0090502			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690766	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100011
J	Lexa, KW; Dolghih, E; Jacobson, MP				Lexa, Katrina W.; Dolghih, Elena; Jacobson, Matthew P.			A Structure-Based Model for Predicting Serum Albumin Binding	PLOS ONE			English	Article							PLASMA-PROTEIN BINDING; DRUG DISCOVERY; ATOMIC-STRUCTURE; DOCKING; LIGAND; SITES; CONFORMATIONS; FLEXIBILITY; AFFINITIES; METABOLISM	One of the many factors involved in determining the distribution and metabolism of a compound is the strength of its binding to human serum albumin. While experimental and QSAR approaches for determining binding to albumin exist, various factors limit their ability to provide accurate binding affinity for novel compounds. Thus, to complement the existing tools, we have developed a structure-based model of serum albumin binding. Our approach for predicting binding incorporated the inherent flexibility and promiscuity known to exist for albumin. We found that a weighted combination of the predicted logP and docking score most accurately distinguished between binders and nonbinders. This model was successfully used to predict serum albumin binding in a large test set of therapeutics that had experimental binding data.	[Lexa, Katrina W.; Dolghih, Elena; Jacobson, Matthew P.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lexa, KW (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	Katrina.lexa@ucsf.edu	Jacobson, Matthew/Y-5161-2018	Jacobson, Matthew/0000-0001-6262-655X	National Institutes of Health [AG021601, GM100619]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM100619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG021601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work has been supported by the National Institutes of Health (AG021601); www.nia.nih.gov. KWL also thanks the National Institutes of Health for funding (GM100619); www.nigms.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, QIKPROP VERS 3 3; [Anonymous], 2010, PRIMEX VERS 1 7; [Anonymous], 2010, PROT PREP WIZ; [Anonymous], 2010, LIGPREP VERS 2 4; [Anonymous], 2010, IND FIT; Ascenzi P, 2006, MINI-REV MED CHEM, V6, P483, DOI 10.2174/138955706776361448; Ascenzi P, 2010, BIOPHYS CHEM, V148, P16, DOI 10.1016/j.bpc.2010.03.001; Aureli L, 2005, J MED CHEM, V48, P2469, DOI 10.1021/jm049227l; Baur F, 2010, J MED CHEM, V53, P3675, DOI 10.1021/jm100068m; Beer J, 2009, AAPS J, V11, P1, DOI 10.1208/s12248-008-9072-1; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P38; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Bolli A, 2010, BIOCHEM BIOPH RES CO, V398, P444, DOI 10.1016/j.bbrc.2010.06.096; Bottegoni G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018845; Bottegoni G, 2009, J MED CHEM, V52, P397, DOI 10.1021/jm8009958; Brunton L., 2011, GOODMAN GILMANS PHAR; Campagna-Slater V, 2012, J CHEM INF MODEL, V52, P2471, DOI 10.1021/ci3003073; CARTER DC, 1990, SCIENCE, V249, P302, DOI 10.1126/science.2374930; Claussen H, 2001, J MOL BIOL, V308, P377, DOI 10.1006/jmbi.2001.4551; Colmenarejo G, 2001, J MED CHEM, V44, P4370, DOI 10.1021/jm010960b; CONN HL, 1961, J CLIN INVEST, V40, P509, DOI 10.1172/JCI104278; di Masi A, 2011, FEBS J, V278, P654, DOI 10.1111/j.1742-4658.2010.07986.x; Dunbar JB, 2013, J CHEM INF MODEL, V53, P1842, DOI [10.1021/ci400161J, 10.1021/ci4000486]; Durdagi S, 2011, J CHEM INF MODEL, V51, P463, DOI 10.1021/ci100409y; Ferreira RJ, 2012, J CHEM THEORY COMPUT, V8, P1853, DOI 10.1021/ct300083m; Fourches D, 2010, J CHEM INF MODEL, V50, P1189, DOI 10.1021/ci100176x; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Hall ML, 2013, J CHEM INF MODEL, V53, P907, DOI 10.1021/ci3006098; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Hein KL, 2010, J STRUCT BIOL, V171, P353, DOI 10.1016/j.jsb.2010.03.014; Howard ML, 2010, COMB CHEM HIGH T SCR, V13, P170, DOI 10.2174/138620710790596745; Huang SY, 2007, PROTEINS, V66, P399, DOI 10.1002/prot.21214; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kratochwil NA, 2002, BIOCHEM PHARMACOL, V64, P1355, DOI 10.1016/S0006-2952(02)01074-2; Kratz F, 2012, J CONTROL RELEASE, V161, P429, DOI 10.1016/j.jconrel.2011.11.028; Lexa KW, 2012, Q REV BIOPHYS, V45, P301, DOI 10.1017/S0033583512000066; Li HY, 2011, BIOPHARM DRUG DISPOS, V32, P333, DOI 10.1002/bdd.762; Li JN, 2011, J CHEM THEORY COMPUT, V7, P3829, DOI 10.1021/ct200462q; Liu XP, 2010, EUR J MED CHEM, V45, P4043, DOI 10.1016/j.ejmech.2010.05.063; Martin TM, 2012, J CHEM INF MODEL, V52, P2570, DOI 10.1021/ci300338w; Mitchell ML, 2010, BIOORG MED CHEM LETT, V20, P1589, DOI 10.1016/j.bmcl.2010.01.085; Mittal RR, 2009, J CHEM INF MODEL, V49, P1810, DOI 10.1021/ci900117m; Petitpas I, 2003, P NATL ACAD SCI USA, V100, P6440, DOI 10.1073/pnas.1137188100; Reichel A, 2009, CHEM BIODIVERS, V6, P2030, DOI 10.1002/cbdv.200900103; ROLAN PE, 1994, BRIT J CLIN PHARMACO, V37, P125, DOI 10.1111/j.1365-2125.1994.tb04251.x; Rueda M, 2010, J CHEM INF MODEL, V50, P186, DOI 10.1021/ci9003943; Ryan AJ, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-18; Schrodinger LLC, 2010, EP VERS 2 1; Simard JR, 2006, J MOL BIOL, V361, P336, DOI 10.1016/j.jmb.2006.06.028; Soskic M, 2007, BIOORGAN MED CHEM, V15, P4595, DOI 10.1016/j.bmc.2007.04.005; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Triballeau N, 2005, J MED CHEM, V48, P2534, DOI 10.1021/jm049092j; Tropsha A, 2010, MOL INFORM, V29, P476, DOI 10.1002/minf.201000061; Tyzack JD, 2013, J CHEM INF MODEL, V53, P1294, DOI 10.1021/ci400058s; Valko K, 2003, J PHARM SCI-US, V92, P2236, DOI 10.1002/jps.10494; Votano JR, 2006, J MED CHEM, V49, P7169, DOI 10.1021/jm051245v; Wardell M, 2002, BIOCHEM BIOPH RES CO, V291, P813, DOI 10.1006/bbrc.2002.6540; Warren GL, 2012, DRUG DISCOV TODAY, V17, P1270, DOI 10.1016/j.drudis.2012.06.011; Weaver S, 2008, J MOL GRAPH MODEL, V26, P1315, DOI 10.1016/j.jmgm.2008.01.002; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Yamaguchi S, 2010, J AM CHEM SOC, V132, P824, DOI 10.1021/ja908878n; Zhang FL, 2012, DRUG DISCOV TODAY, V17, P475, DOI 10.1016/j.drudis.2011.12.018; Zhang QY, 2009, J CHEM INF MODEL, V49, P1857, DOI 10.1021/ci900080f; Zsila F, 2011, BIOINFORMATICS, V27, P1806, DOI 10.1093/bioinformatics/btr284	69	46	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93323	10.1371/journal.pone.0093323	http://dx.doi.org/10.1371/journal.pone.0093323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691448	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100065
J	Li, BJ; Wang, L; Sun, ZH; Zhou, Y; Shao, DY; Zhao, J; Song, YN; Lv, JY; Dong, X; Liu, CH; Wang, P; Zhang, XY; Cui, RJ				Li, Bingjin; Wang, Liang; Sun, Zhihui; Zhou, Yang; Shao, Dongyuan; Zhao, Jing; Song, Yunong; Lv, Jiayin; Dong, Xue; Liu, Changhong; Wang, Pu; Zhang, Xingyi; Cui, Ranji			The Anticonvulsant Effects of SR 57227 on Pentylenetetrazole- Induced Seizure in Mice	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; C-FOS EXPRESSION; 5-HT3 RECEPTOR; RAT; ONDANSETRON; CITALOPRAM; SEROTONIN; MORPHINE	Recently, studies have shown that serotonin plays an important role in the control of seizure. However, the specific role of 5HT receptor subtypes is not yet well described, in particular that of the 5- HT3 receptor. The present study was aimed to investigate the role of 5 HT3 receptor on the pentylenetetrazole ( PTZ)- induced seizure in mice. Firstly, seizure latency was significantly prolonged by a 5 HT3 receptor agonist SR 57227 in a dose-dependent manner. Seizure score and mortality were also decreased by SR 57227 in PTZ- treated mice. Furthermore, these anticonvulsant effects of SR 57227 were inhibited by a 5- HT3 receptor antagonist ondansetron. However, ondansetron alone had no effect on seizure latency, seizure score or mortality at different doses. Immunohistochemical studies have also shown that c- Fos expression was significantly increased in hippocampus ( dentate gyrus, CA1, CA3 and CA4) of PTZ- treated mice. Furthermore, c- Fos expression was significantly inhibited by ondansetron in mice treated with PTZ and SR 57227. An ELISA study showed that SR 57227 attenuated the PTZinduced inhibitory effects of GABA levels in hippocampus and cortex, and the attenuated effects of SR 57227 were antagonized by ondansetron in hippocampus but not cortex. Our findings suggest that activation of 5-HT3 receptor by SR 57227, which plays an important role on the control of seizure induced by PTZ, may be related to GABA activity in hippocampus. Therefore, 5-HT3 receptor subtype is a potential target for the treatment of epilepsy.	[Li, Bingjin; Zhang, Xingyi; Cui, Ranji] Jilin Univ, Hosp 2, Changchun 130023, Peoples R China; [Li, Bingjin; Wang, Liang; Zhou, Yang; Shao, Dongyuan; Zhao, Jing; Song, Yunong; Dong, Xue; Liu, Changhong; Wang, Pu; Cui, Ranji] NE Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun, Peoples R China; [Sun, Zhihui] Jilin Univ, Hosp 1, Changchun 130023, Peoples R China; [Lv, Jiayin] China Japan Union Hosp, Changchun, Peoples R China	Jilin University; Northeast Normal University - China; Jilin University; Jilin University	Wang, L (corresponding author), Jilin Univ, Hosp 2, Changchun 130023, Peoples R China.	wangliangnenu@hotmail.com; xyzhang@jlu.edu.cn; cuiranji@hotmail.com	Wang, Liang/AAB-6335-2021; cui, ranji/AAV-6234-2021		Natural Science Foundation of China [31171123, 31300850, 81328011]; Program for New Century Excellent Talents in University [NCET-13-0715]; Jilin Provincial Department of Human Resources and Social Security Project [[2012]39]; Jilin Science and Technology Agency [20110726, 20140414039GH, 20130303095YY]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Jilin Provincial Department of Human Resources and Social Security Project; Jilin Science and Technology Agency	This work was supported by Natural Science Foundation of China (31171123; 31300850; 81328011). The project was supported by Program for New Century Excellent Talents in University (NCET-13-0715); Jilin Provincial Department of Human Resources and Social Security Project ([2012]39); and Jilin Science and Technology Agency funding (20110726; 20140414039GH; 20130303095YY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre V, 1998, EUR J NEUROSCI, V10, P2094, DOI 10.1046/j.1460-9568.1998.00223.x; BACHY A, 1993, EUR J PHARMACOL, V237, P299, DOI 10.1016/0014-2999(93)90282-M; Bagdy G, 2007, J NEUROCHEM, V100, P857, DOI 10.1111/j.1471-4159.2006.04277.x; Bahremand A, 2011, EPILEPSY BEHAV, V21, P122, DOI 10.1016/j.yebeh.2011.03.010; Chen CR, 2011, BRIT J PHARMACOL, V164, P1534, DOI 10.1111/j.1476-5381.2011.01456.x; Cui RJ, 2009, EUR J PHARMACOL, V609, P74, DOI 10.1016/j.ejphar.2008.12.051; Davis LL, 2000, J CLIN PSYCHOPHARM, V20, p1S, DOI 10.1097/00004714-200002001-00001; Erdtmann-Vourliotis M, 1998, BRAIN RES, V792, P299, DOI 10.1016/S0006-8993(98)00159-0; Fakhfouri G, 2012, DRUG DISCOV TODAY, V17, P741, DOI 10.1016/j.drudis.2012.02.009; Gholipour T, 2010, SEIZURE-EUR J EPILEP, V19, P17, DOI 10.1016/j.seizure.2009.10.006; Hirose S, 2000, EPILEPSY RES, V41, P191, DOI 10.1016/S0920-1211(00)00141-8; Jain S, 2012, HUM EXP TOXICOL, V31, P905, DOI 10.1177/0960327112436406; Li B, 2013, PROG NEUROPSYCHOPHAR, V48C, P199; Li BJ, 2013, J BIOCHEM MOL TOXIC, V27, P486, DOI 10.1002/jbt.21510; Li BJ, 2013, J PHARMACOL SCI, V123, P195, DOI 10.1254/jphs.13057SC; Li M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067060; Miraucourt LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029086; Morales M, 1997, J NEUROSCI, V17, P3157; Nichols RA, 1996, J NEUROCHEM, V67, P581; Payandemehr B, 2012, EPILEPSY RES, V101, P217, DOI 10.1016/j.eplepsyres.2012.04.004; PSARROPOULOU C, 1994, EPILEPSIA, V35, P12, DOI 10.1111/j.1528-1157.1994.tb02906.x; Puig MV, 2004, CEREB CORTEX, V14, P1365, DOI 10.1093/cercor/bhh097; Puthuran GJ, 2009, PHARMACOLOGYONLINE, V3, P463; Sharma A, 2001, ANN ONCOL, V12, P131, DOI 10.1023/A:1008394422101; Szyndler J, 2009, EPILEPSY BEHAV, V16, P216, DOI 10.1016/j.yebeh.2009.07.030; Walsh LA, 1999, J PHARMACOL EXP THER, V289, P1626; Watanabe K, 1998, EUR J PHARMACOL, V350, P181, DOI 10.1016/S0014-2999(98)00255-6; Watanabe Y, 2011, EPILEPSIA, V52, P140, DOI 10.1111/j.1528-1167.2010.02764.x; Ye JH, 1997, EUR J PHARMACOL, V337, P87, DOI 10.1016/S0014-2999(97)01279-X	29	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93158	10.1371/journal.pone.0093158	http://dx.doi.org/10.1371/journal.pone.0093158			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690630	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100049
J	Loison, E; Poirier-Beaudouin, B; Seffer, V; Paoletti, A; Abitbol, V; Tartour, E; Launay, O; Gougeon, ML				Loison, Emily; Poirier-Beaudouin, Beatrice; Seffer, Valerie; Paoletti, Audrey; Abitbol, Vered; Tartour, Eric; Launay, Odile; Gougeon, Marie-Lise			Suppression by Thimerosal of Ex- Vivo CD4(+) T Cell Response to Influenza Vaccine and Induction of Apoptosis in Primary Memory T Cells	PLOS ONE			English	Article							INTERFERON-GAMMA; FLOW-CYTOMETRY; CYTOCHROME-C; LIVING CELLS; EARLY EVENTS; ACTIVATION; PROTECTION; PATHWAYS; EXPOSURE; DEATH	Thimerosal is a preservative used widely in vaccine formulations to prevent bacterial and fungal contamination in multidose vials of vaccine. Thimerosal was included in the multidose non- adjuvanted pandemic 2009 H1N1 vaccine Panenza. In the context of the analysis of the ex-vivo T cell responses directed against influenza vaccine, we discovered the in vitro toxicity Panenza, due to its content in thimerosal. Because thimerosal may skew the immune response to vaccines, we investigated in detail the ex- vivo effects of thimerosal on the fate and functions of T cells in response to TCR ligation. We report that exvivo exposure of quiescent or TCR- activated primary human T cells to thimerosal induced a dose- dependent apoptotic cell death associated with depolarization of mitochondrial membrane, generation of reactive oxygen species, cytochrome c release from the mitochondria and caspase- 3 activation. Moreover, exposure to non- toxic concentrations of thimerosal induced cell cycle arrest in G0/G1 phase of TCR- activated T cells, and inhibition of the release of proinflammatory cytokines such as IFN gamma, IL- 1 beta, TNF alpha, IL- 2, as well as the chemokine MCP1. No shift towards Th2 or Th17 cells was detected. Overall these results underline the proapoptotic effect of thimerosal on primary human lymphocytes at concentrations 100 times less to those contained in the multidose vaccine, and they reveal the inhibitory effect of this preservative on T- cell proliferation and functions at nanomolar concentrations.	[Loison, Emily; Poirier-Beaudouin, Beatrice; Seffer, Valerie; Gougeon, Marie-Lise] Inst Pasteur, Antiviral Immun Biotherapy & Vaccine Unit, Paris, France; [Paoletti, Audrey] Inst Gustave Roussy, Inserm U1030, Villejuif, France; [Abitbol, Vered] Hop Cochin, AP HP, Dept Gastroenterol, F-75674 Paris, France; [Tartour, Eric] Univ Paris 05, PARCC, HEGP, Inserm U970, Paris, France; [Launay, Odile] Hop Cochin, AP HP, Ctr Invest Clin BT 505, F-75674 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Gougeon, ML (corresponding author), Inst Pasteur, Antiviral Immun Biotherapy & Vaccine Unit, Paris, France.	marie-lise.gougeon@pasteur.fr	tartour, eric/O-7957-2017	tartour, eric/0000-0002-7323-468X; paoletti, audrey/0000-0001-8979-385X	French Ministry of Health (Programme Hospitalier de Recherche Clinique (PHRC) National); ANRT (Agence Nationale de la Recherche et de la Technologie); Institut Pasteur; Crossject Company	French Ministry of Health (Programme Hospitalier de Recherche Clinique (PHRC) National); ANRT (Agence Nationale de la Recherche et de la Technologie)(French National Research Agency (ANR)); Institut Pasteur(European Commission); Crossject Company	This work was supported by grants from the French Ministry of Health (Programme Hospitalier de Recherche Clinique (PHRC) National), ANRT (Agence Nationale de la Recherche et de la Technologie) and Institut Pasteur. Crossject Company and ANRT provided the academic research/private research partnership to fund a CIFRE PhD fellowship to Emily Loison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2007, J LEUKOCYTE BIOL, V81, P474, DOI 10.1189/jlb.0706467; Ball LK, 2001, PEDIATRICS, V107, P1147, DOI 10.1542/peds.107.5.1147; Barile JP, 2012, J PEDIATR PSYCHOL, V37, P106, DOI 10.1093/jpepsy/jsr048; Baskin DS, 2003, TOXICOL SCI, V74, P361, DOI 10.1093/toxsci/kfg126; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Chatterjee Archana, 2010, Expert Rev Vaccines, V9, P497, DOI 10.1586/erv.10.36; Chauvat A, 2012, J IMMUNOL METHODS, V378, P81, DOI 10.1016/j.jim.2012.02.008; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cb.04.110188.001103; Cossarizza A, 2009, NAT PROTOC, V4, P1790, DOI 10.1038/nprot.2009.189; Dorea JG, 2013, J APPL TOXICOL, V33, P700, DOI 10.1002/jat.2855; Dussmann H, 2003, J BIOL CHEM, V278, P12645, DOI 10.1074/jbc.M210826200; Ferraro-Peyret C, 2002, J IMMUNOL, V169, P4805, DOI 10.4049/jimmunol.169.9.4805; Geier DA, 2007, J TOXICOL ENV HEAL B, V10, P575, DOI 10.1080/10937400701389875; Guzzi Gianpaolo, 2012, Interdiscip Toxicol, V5, P159, DOI 10.2478/v10102-012-0026-1; Humphrey ML, 2005, NEUROTOXICOLOGY, V26, P407, DOI 10.1016/j.neuro.2005.03.008; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Le Buanec H, 2011, P NATL ACAD SCI USA, V108, P18995, DOI 10.1073/pnas.1113301108; Lecoeur H, 1997, J IMMUNOL METHODS, V209, P111, DOI 10.1016/S0022-1759(97)00138-5; Lecoeur H, 2008, METHOD ENZYMOL, V442, P51, DOI 10.1016/S0076-6879(08)01403-1; Lee S, 2006, ENVIRON TOXICOL PHAR, V22, P194, DOI 10.1016/j.etap.2006.03.003; Li WX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049064; Liu SI, 2007, TOXICOL SCI, V100, P109, DOI 10.1093/toxsci/kfm205; Makani S, 2002, GENES IMMUN, V3, P270, DOI 10.1038/sj.gene.6363854; Masters SL, 2010, EMBO REP, V11, P640, DOI 10.1038/embor.2010.93; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; PETIT PX, 1995, J CELL BIOL, V130, P157, DOI 10.1083/jcb.130.1.157; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Seror C, 2011, J EXP MED, V208, P1823, DOI 10.1084/jem.20101805; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Tafani M, 2001, CANCER RES, V61, P2459; TORRESROCA JF, 1995, CELL DEATH DIFFER, V2, P309; Trompezinski S, 2008, TOXICOL APPL PHARM, V230, P397, DOI 10.1016/j.taap.2008.03.012; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Woo KJ, 2006, MOL CARCINOGEN, V45, P657, DOI 10.1002/mc.20202; Yel L, 2005, INT J MOL MED, V16, P971; Yole M, 2007, TOXICOLOGY, V231, P40, DOI 10.1016/j.tox.2006.11.062	40	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92705	10.1371/journal.pone.0092705	http://dx.doi.org/10.1371/journal.pone.0092705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690681	gold, Green Published, Green Submitted			2022-12-27	WOS:000334101100030
J	Merk, B; Rohde, U; Glivici-Cotruta, V; Litskevich, D; Scholl, S				Merk, Bruno; Rohde, Ulrich; Glivici-Cotruta, Varvara; Litskevich, Dzianis; Scholl, Susanne			On the Use of a Molten Salt Fast Reactor to Apply an Idealized Transmutation Scenario for the Nuclear Phase Out	PLOS ONE			English	Article								In the view of transmutation of transuranium ( TRU) elements, molten salt fast reactors (MSFRs) offer certain advantages compared to solid fuelled reactor types like sodium cooled fast reactors (SFRs). In the first part these advantages are discussed in comparison with the SFR technology, and the research challenges are analyzed. In the second part cycle studies for the MSFR are given for different configurations - a core with U-238 fertile, a fertile free core, and a core with Th-232 as fertile material. For all cases, the transmutation potential is determined and efficient transmutation performance for the case with thorium as a fertile material as well as for the fertile free case is demonstrated and the individual advantages are discussed. The time evolution of different important isotopes is analyzed. In the third part a strategy for the optimization of the transmutation efficiency is developed. The final aim is dictated by the phase out decision of the German government, which requests to put the focus on the determination of the maximal transmutation efficiency and on an as much as possible reduced leftover of transuranium elements at the end of the reactor life. This minimal leftover is achieved by a two step procedure of a first transmuter operation phase followed by a second deep burning phase. There the U-233, which is bred in the blanket of the core consisting of thorium containing salt, is used as feed. It is demonstrated, that transmutation rates up to more than 90% can be achieved for all transuranium isotopes, while the production of undesired high elements like californium is very limited. Additionally, the adaptations needed for the simulation of a MSFR, and the used tool HELIOS 1.10 is described.	[Merk, Bruno; Rohde, Ulrich; Glivici-Cotruta, Varvara; Litskevich, Dzianis; Scholl, Susanne] Helmholtz Zentrum Dresden Rossendorf, Inst Resource Ecol, Dept Reactor Safety, Dresden, Germany	Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR)	Merk, B (corresponding author), Helmholtz Zentrum Dresden Rossendorf, Inst Resource Ecol, Dept Reactor Safety, Dresden, Germany.	b.merk@hzdr.de		Litskevich, Dzianis/0000-0002-3207-3058				[Anonymous], 2012, OV; [Anonymous], 2011, MOLTEN SALT FAST REA; [Anonymous], 2003, HELIOS METH; Buiron L, 2009, GLOB 2009 PAR FRANC; Capelli E, 2013, EVOL WP2 WORKSH EVOL; Gauche F, 2012, INT WORKSH PREV MIT; Generation IV International Forum, 2009, ANN REP GEN 4 INF FO; Ingatiev V, 2007, ICAPP 2007 NIC FRANC; Ingatiev V, 2012, ICAPP 12 CHIC US JUN; Languille A., 1995, PROC VERSAILLES; MACPHERSON HG, 1985, NUCL SCI ENG, V90, P374, DOI 10.13182/NSE90-374; Mathieu L, 2009, NUCL SCI ENG, V161, P78, DOI 10.13182/NSE07-49; Mathieu L, 2005, P GLOBAL 2005 TSUK J; Merk B, 2011, ICAPP 12 CHIC US JUN; Merk B, 2008, ATOMWIRTSCHAFT, V6, P404; Merk B, 2006, 9 INF EXCH M P T NIM; Merk B, 2013, PLOS ONE UNPUB; Merk B, 2014, ANN NUCL ENERGY, V64, P441, DOI 10.1016/j.anucene.2013.07.014; Merk B, 2013, SCI TECHNOL NUCL INS, V2013, DOI 10.1155/2013/217548; Merk B, 2013, SCI TECHNOL NUCL INS, V2013, DOI 10.1155/2013/172518; Merk B, 2012, NUCL SCI ENG, V171, P136, DOI 10.13182/NSE10-58; Merk B, 2011, ANN NUCL ENERGY, V38, P2374, DOI 10.1016/j.anucene.2011.07.005; Merk B, 2011, ANN NUCL ENERGY, V38, P921, DOI 10.1016/j.anucene.2011.01.024; Merle-Lucotte E., 2011, P ICAPP 2011 NIC FRA; Merle-Lucotte E, 2009, P GLOB 2009 PAR FRAN; Rachamin R, 2013, ANN NUCL ENERGY, V55, P194, DOI 10.1016/j.anucene.2012.11.030; Renault C, 2010, 4 INPRO GIF INT M VI; Renault C, 2005, MOST FINAL REPORT; Salvatore M, 2004, 8 IEM P T LAS VEG US; Sauvage J. F., 2009, PHENIX 35 YEARS HIST; Schwenk-Ferrero A, 2013, SCI TECHNOL NUCL INS, V2013, DOI 10.1155/2013/293792; VILLARINO EA, 1992, NUCL SCI ENG, V112, P16, DOI 10.13182/NSE112-16; Wiese HW, 1998, J ALLOY COMPD, V271, P522, DOI 10.1016/S0925-8388(98)00141-8	33	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e92776	10.1371/journal.pone.0092776	http://dx.doi.org/10.1371/journal.pone.0092776			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690768	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100031
J	Abdoli, G; Bottai, M; Moradi, T				Abdoli, Gholamreza; Bottai, Matteo; Moradi, Tahereh			Cancer Mortality by Country of Birth, Sex, and Socioeconomic Position in Sweden, 1961-2009	PLOS ONE			English	Article							NEW-SOUTH-WALES; AFRICAN MIGRANTS; PROSTATE-CANCER; ASIAN MIGRANTS; CASE-FATALITY; SWEDISH-BORN; IMMIGRANTS; ENGLAND; WOMEN; RISK	In 2010, cancer deaths accounted for more than 15% of all deaths worldwide, and this fraction is estimated to rise in the coming years. Increased cancer mortality has been observed in immigrant populations, but a comprehensive analysis by country of birth has not been conducted. We followed all individuals living in Sweden between 1961 and 2009 (7,109,327 men and 6,958,714 women), and calculated crude cancer mortality rates and age-standardized rates (ASRs) using the world population for standardization. We observed a downward trend in all-site ASRs over the past two decades in men regardless of country of birth but no such trend was found in women. All-site cancer mortality increased with decreasing levels of education regardless of sex and country of birth (p for trend <0.001). We also compared cancer mortality rates among foreign-born (13.9%) and Sweden-born (86.1%) individuals and determined the effect of education level and sex estimated by mortality rate ratios (MRRs) using multivariable Poisson regression. All-site cancer mortality was slightly higher among foreign-born than Sweden-born men (MRR = 1.05, 95% confidence interval 1.04-1.07), but similar mortality risks was found among foreign-born and Sweden-born women. Men born in Angola, Laos, and Cambodia had the highest cancer mortality risk. Women born in all countries except Iceland, Denmark, and Mexico had a similar or smaller risk than women born in Sweden. Cancer-specific mortality analysis showed an increased risk for cervical and lung cancer in both sexes but a decreased risk for colon, breast, and prostate cancer mortality among foreign-born compared with Sweden-born individuals. Further studies are required to fully understand the causes of the observed inequalities in mortality across levels of education and countries of birth.	[Abdoli, Gholamreza; Moradi, Tahereh] Karolinska Inst, Inst Environm Med, Div Epidemiol, S-10401 Stockholm, Sweden; [Abdoli, Gholamreza] Kermanshah Univ Med Sci, Dept Biostat & Epidemiol, Kermanshah, Iran; [Bottai, Matteo] Karolinska Inst, Inst Environm Med, Biostat Unit, S-10401 Stockholm, Sweden; [Moradi, Tahereh] Healthcare Provis, Ctr Epidemiol & Social Med, Stockholm, Sweden	Karolinska Institutet; Kermanshah University of Medical Sciences; Karolinska Institutet	Abdoli, G (corresponding author), Karolinska Inst, Inst Environm Med, Div Epidemiol, S-10401 Stockholm, Sweden.	gholamreza.abdoli@ki.se	Abdoli, Gholamreza/B-5529-2018	Abdoli, Gholamreza/0000-0001-6972-4646	Kermanshah University of Medical Sciences, Kermanshah, Iran; department of environmental Medicine, Karolinska Institutet, Sweden	Kermanshah University of Medical Sciences, Kermanshah, Iran; department of environmental Medicine, Karolinska Institutet, Sweden	Gholamreza Abdoli doctoral studies are partially supported by The Kermanshah University of Medical Sciences, Kermanshah, Iran(http://www.kumc.ac.ir/home-en.html)and department of environmental Medicine, Karolinska Institutet, Sweden(URL:http://ki.se/ki/jsp/polopoly.jsp?d=1666&I=en). No additional external funding received for this study. "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azerkan F, 2012, INT J CANCER, V130, P937, DOI 10.1002/ijc.26084; BALZI D, 1995, CANCER CAUSE CONTROL, V6, P68, DOI 10.1007/BF00051682; Beiki O, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3086; Beiki O, 2009, INT J CANCER, V124, P1941, DOI 10.1002/ijc.24138; Borne Y, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-20; Bos V, 2004, INT J EPIDEMIOL, V33, P1112, DOI 10.1093/ije/dyh189; BOUCHARDY C, 1994, INT J CANCER, V58, P638, DOI 10.1002/ijc.2910580504; Bouchardy C, 1996, INT J EPIDEMIOL, V25, P5, DOI 10.1093/ije/25.1.5; BOUCHARDY C, 1995, CANCER CAUSE CONTROL, V6, P539, DOI 10.1007/BF00054163; Fernandez E, 1999, BRIT J CANCER, V79, P684, DOI 10.1038/sj.bjc.6690108; GEDDES M, 1991, CANCER CAUSE CONTROL, V2, P133, DOI 10.1007/BF00053133; GRULICH AE, 1992, BRIT J CANCER, V66, P905, DOI 10.1038/bjc.1992.383; Harding S, 2009, EUR J CANCER, V45, P2168, DOI 10.1016/j.ejca.2009.02.029; Ito S, 2008, EUR J PUBLIC HEALTH, V18, P466, DOI 10.1093/eurpub/ckn052; Johansson LA, 2009, J CLIN EPIDEMIOL, V62, P1202, DOI 10.1016/j.jclinepi.2009.01.010; KHLAT M, 1995, CANCER CAUSE CONTROL, V6, P525, DOI 10.1007/BF00054161; Kyobutungi C, 2006, EUR J CANCER, V42, P2577, DOI 10.1016/j.ejca.2006.03.032; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MALLIN K, 1988, INT J CANCER, V41, P670, DOI 10.1002/ijc.2910410506; MATOS EL, 1991, INT J CANCER, V49, P805, DOI 10.1002/ijc.2910490602; McCredie M, 1999, BRIT J CANCER, V79, P1277, DOI 10.1038/sj.bjc.6690205; Moradi Tahereh, 2006, Lakartidningen, V103, P137; Nasseri K, 2011, J IMMIGR MINOR HEALT, V13, P361, DOI 10.1007/s10903-009-9270-7; Ott JJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-110; Public health in Stockholm County, 2007, PUBL HLTH STOCKH CON; Puigpinos R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-35; Razum O, 1998, TROP MED INT HEALTH, V3, P297, DOI 10.1046/j.1365-3156.1998.00233.x; Regidor E, 2008, ANN EPIDEMIOL, V18, P605, DOI 10.1016/j.annepidem.2008.04.007; Ronellenfitsch U, 2009, EUR J GASTROEN HEPAT, V21, P319, DOI 10.1097/MEG.0b013e3283155220; ROSENWAIKE I, 1986, INT J EPIDEMIOL, V15, P30, DOI 10.1093/ije/15.1.30; ROSENWAIKE I, 1988, PUBLIC HEALTH REP, V103, P195; Seeff LC, 2003, CANCER DETECT PREV, V27, P203, DOI 10.1016/S0361-090X(03)00062-X; Singh GK, 2001, AM J PUBLIC HEALTH, V91, P392, DOI 10.2105/AJPH.91.3.392; Smith D, 1996, AUST NZ J PUBL HEAL, V20, P129, DOI 10.1111/j.1753-6405.1996.tb01806.x; Socialstyrelsen, 2010, CAUS DEATH SWED 2010; Spallek J, 2012, EUR J EPIDEMIOL, V27, P915, DOI 10.1007/s10654-012-9746-y; Statistics Sweden, 2006, HIST POP REG; Stirbu I, 2006, INT J CANCER, V119, P2665, DOI 10.1002/ijc.22200; SWERDLOW AJ, 1995, BRIT J CANCER, V72, P1312, DOI 10.1038/bjc.1995.507; SWERDLOW AJ, 1991, INT J EPIDEMIOL, V20, P13, DOI 10.1093/ije/20.1.13; Talback M, 2003, ACTA ONCOL, V42, P637, DOI 10.1080/02841860310013391; Torres-Cintron Mariela, 2012, Prev Chronic Dis, V9, pE15; United Nations Department of Economic and Social Affairs Population Division, 2009, TRENDS INT MIGR STOC; Uthman OA, 2013, J EPIDEMIOL IN PRESS, V67; WANG ZJ, 1989, INT J EPIDEMIOL, V18, P17, DOI 10.1093/ije/18.1.17; Weires M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-340; Wild SH, 2006, BRIT J CANCER, V94, P1079, DOI 10.1038/sj.bjc.6603031; Winkler V, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.9135; Winkler V, 2009, CANCER CAUSE CONTROL, V20, P1873, DOI 10.1007/s10552-009-9381-4; World Health Organization, CANCER; World Health Organization, 2022, CANCER; Yang D, 2012, EUR J PREV CARDIOL, V19, P1304, DOI 10.1177/1741826711425340	52	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93174	10.1371/journal.pone.0093174	http://dx.doi.org/10.1371/journal.pone.0093174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0TC	24682217	Green Published, Green Submitted, gold			2022-12-27	WOS:000333678100030
J	Dzhafarov, EN; Kujala, JV				Dzhafarov, Ehtibar N.; Kujala, Janne V.			Embedding Quantum into Classical: Contextualization vs Conditionalization	PLOS ONE			English	Article							HIDDEN-VARIABLES; SELECTIVITY; PROBABILITY; DISTANCE; EINSTEIN; ROSEN	We compare two approaches to embedding joint distributions of random variables recorded under different conditions (such as spins of entangled particles for different settings) into the framework of classical, Kolmogorovian probability theory. In the contextualization approach each random variable is "automatically'' labeled by all conditions under which it is recorded, and the random variables across a set of mutually exclusive conditions are probabilistically coupled (imposed a joint distribution upon). Analysis of all possible probabilistic couplings for a given set of random variables allows one to characterize various relations between their separate distributions (such as Bell-type inequalities or quantum-mechanical constraints). In the conditionalization approach one considers the conditions under which the random variables are recorded as if they were values of another random variable, so that the observed distributions are interpreted as conditional ones. This approach is uninformative with respect to relations between the distributions observed under different conditions because any set of such distributions is compatible with any distribution assigned to the conditions.	[Dzhafarov, Ehtibar N.] Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA; [Kujala, Janne V.] Univ Jyvaskyla, Dept Math Informat Technol, Jyvaskyla, Finland	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Jyvaskyla	Dzhafarov, EN (corresponding author), Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA.	ehtibar@purdue.edu			NSF [SES-1155956]; Direct For Social, Behav & Economic Scie [1155956] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by NSF grant SES-1155956 to ED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avis D, 2009, AIP CONF PROC, V1101, P294, DOI 10.1063/1.3109952; Badziag P, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.050401; Bell J. S., 1964, PHYSICS, V1, P195, DOI [10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; BELL JS, 1966, REV MOD PHYS, V38, P447, DOI 10.1103/RevModPhys.38.447; BOHM D, 1957, PHYS REV, V108, P1070, DOI 10.1103/PhysRev.108.1070; Cabello A, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.012113; Cabello A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.060402; Cereceda JL, 2000, FOUND PHYS LETT, V13, P427, DOI 10.1023/A:1007828731477; CIRELSON BS, 1980, LETT MATH PHYS, V4, P93, DOI 10.1007/BF00417500; CLAUSER JF, 1974, PHYS REV D, V10, P526, DOI 10.1103/PhysRevD.10.526; Dzhafarov Ehtibar N., 2012, Quantum Interaction. 6th International Symposium, QI 2012. Revised Selected Papers, P184, DOI 10.1007/978-3-642-35659-9_17; Dzhafarov E N, 2013, ARXIV13122239; Dzhafarov EN, 2013, P AM MATH SOC, V141, P3291, DOI 10.1090/S0002-9939-2013-11575-3; Dzhafarov EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061712; Dzhafarov EN, 2012, J MATH PSYCHOL, V56, P54, DOI 10.1016/j.jmp.2011.12.003; Dzhafarov EN, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00151; Dzhafarov EN, ADV COGN NEURODYN, VIV; Dzhafarov EN, FDN PHYS; Dzhafarov EN, LECT NOTES COMP SCI; FINE A, 1982, PHYS REV LETT, V48, P291, DOI 10.1103/PhysRevLett.48.291; Khrennikov A, 2009, FUND THEOR PHYS, V160, P3, DOI 10.1007/978-1-4020-9593-1_1; KOCHEN S, 1967, J MATH MECH, V17, P59; Kujala JV, 2008, J MATH PSYCHOL, V52, P128, DOI 10.1016/j.jmp.2008.01.008; LANDAU LJ, 1987, PHYS LETT A, V120, P54, DOI 10.1016/0375-9601(87)90075-2; Laudisa F, 1997, PHILOS SCI, V64, P478, DOI 10.1086/392562; Masanes L, 2006, PHYS REV A, V73, DOI [10.1103/PhysRevA.73.012112, 10.1103/PhysREvA.73.012112]; Thorisson Hermann, 2000, PROB APPL S	27	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92818	10.1371/journal.pone.0092818	http://dx.doi.org/10.1371/journal.pone.0092818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681665	Green Published, Green Submitted, gold			2022-12-27	WOS:000333678100017
J	McCormick, N; Lacaille, D; Bhole, V; Avina-Zubieta, JA				McCormick, Natalie; Lacaille, Diane; Bhole, Vidula; Avina-Zubieta, J. Antonio			Validity of Myocardial Infarction Diagnoses in Administrative Databases: A Systematic Review	PLOS ONE			English	Review							CORONARY-HEART-DISEASE; POSITIVE PREDICTIVE-VALUE; HOSPITAL DISCHARGE REGISTER; 1ST NATIONS POPULATION; CARDIOVASCULAR-DISEASE; RHEUMATOID-ARTHRITIS; LUPUS-ERYTHEMATOSUS; MORTALITY STATISTICS; EUROPEAN-SOCIETY; CODING ACCURACY	Background: Though administrative databases are increasingly being used for research related to myocardial infarction (MI), the validity of MI diagnoses in these databases has never been synthesized on a large scale. Objective: To conduct the first systematic review of studies reporting on the validity of diagnostic codes for identifying MI in administrative data. Methods: MEDLINE and EMBASE were searched (inception to November 2010) for studies: (a) Using administrative data to identify MI; or (b) Evaluating the validity of MI codes in administrative data; and (c) Reporting validation statistics (sensitivity, specificity, positive predictive value (PPV), negative predictive value, or Kappa scores) for MI, or data sufficient for their calculation. Additonal articles were located by handsearch (up to February 2011) of original papers. Data were extracted by two independent reviewers; article quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies tool. Results: Thirty studies published from 1984-2010 were included; most assessed codes from the International Classification of Diseases (ICD)-9 th revision. Sensitivity and specificity of hospitalization data for identifying MI in most [>= 50%] studies was >= 86%, and PPV in most studies was >= 93%. The PPV was higher in the more-recent studies, and lower when criteria that do not incorporate cardiac troponin levels (such as the MONICA) were employed as the gold standard. MI as a cause-of-death on death certificates also demonstrated lower accuracy, with maximum PPV of 60% (for definite MI). Conclusions: Hospitalization data has higher validity and hence can be used to identify MI, but the accuracy of MI as a cause-of-death on death certificates is suboptimal, and more studies are needed on the validity of ICD-10 codes. When using administrative data for research purposes, authors should recognize these factors and avoid using vital statistics data if hospitalization data is not available to confirm deaths from MI.	[McCormick, Natalie] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [McCormick, Natalie; Lacaille, Diane; Bhole, Vidula; Avina-Zubieta, J. Antonio] Arthrit Res Ctr Canada, Richmond, BC, Canada; [Lacaille, Diane; Bhole, Vidula; Avina-Zubieta, J. Antonio] Univ British Columbia, Dept Med, Div Rheumatol, Vancouver, BC, Canada; [Lacaille, Diane; Avina-Zubieta, J. Antonio] CANRAD Network, Cardiovasc Comm, Richmond, BC, Canada; EpiSolut Consultancy Serv, Thana, India	University of British Columbia; University of British Columbia	Avina-Zubieta, JA (corresponding author), Arthrit Res Ctr Canada, Richmond, BC, Canada.	azubieta@arthritisresearch.ca		McCormick, Natalie/0000-0002-4147-8348	Canadian Arthritis Network; Arthritis Society of Canada	Canadian Arthritis Network; Arthritis Society of Canada	This study was funded in part by the Canadian Arthritis Network (http://www.arthritisnetwork.ca). JAAZ held a salary award from the Canadian Arthritis Network and The Arthritis Society of Canada. He is currently the British Columbia Lupus Society Scholar. DL holds the Mary Pack Chair in Arthritis Research from UBC and The Arthritis Society of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainla T, 2006, SCAND J PUBLIC HEALT, V34, P327, DOI 10.1080/14034940500242019; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; [Anonymous], 1989, Can J Public Health, V80, P412; [Anonymous], 1992, Can J Cardiol, V8, P253; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Barber C, 2013, ARTHRIT CARE RES, V65, P1343, DOI 10.1002/acr.21959; Barchielli A, 2012, J EPIDEMIOL COMMUN H, V66, P462, DOI 10.1136/jech.2010.110908; Barnabe C, 2012, ARTHRIT CARE RES, V64, P1715, DOI 10.1002/acr.21743; Barnabe C, 2012, ARTHRIT CARE RES, V64, P138, DOI 10.1002/acr.20656; BEAGLEHOLE R, 1987, AUST NZ J MED, V17, P43, DOI 10.1111/j.1445-5994.1987.tb05048.x; Bernatsky S, 2007, RHEUMATOLOGY, V46, P1814, DOI 10.1093/rheumatology/kem233; Bernatsky S, 2011, RHEUMATOL INT, V31, P549, DOI 10.1007/s00296-010-1591-2; Bernatsky S, 2013, J RHEUMATOL, V40, P66, DOI 10.3899/jrheum.120835; BOYLE CA, 1995, AUST NZ J MED, V25, P316, DOI 10.1111/j.1445-5994.1995.tb01896.x; Chen GM, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-5; De Henauw S, 1998, J EPIDEMIOL COMMUN H, V52, P513, DOI 10.1136/jech.52.8.513; De Vera MA, 2010, ANN RHEUM DIS, V69, P1162, DOI 10.1136/ard.2009.122770; Fischer LM, 2004, AM J CARDIOL, V93, P198, DOI 10.1016/j.amjcard.2003.09.037; Gonzalez A, 2008, ANN RHEUM DIS, V67, P64, DOI 10.1136/ard.2006.059980; Hammar N, 2001, INT J EPIDEMIOL, V30, pS30, DOI 10.1093/ije/30.suppl_1.S30; Health statistics and informatics department World Health Organization, 2011, CAUS DEATH 2008 SUMM; Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314; Heisler CA, 2009, J AM COLL SURGEONS, V209, P119, DOI 10.1016/j.jamcollsurg.2009.03.017; Henderson T, 2006, MED CARE, V44, P1011, DOI 10.1097/01.mlr.0000228018.48783.34; Hudson M, 2013, J CLIN EPIDEMIOL, V66, P278, DOI 10.1016/j.jclinepi.2012.10.004; Humphries KH, 2000, J CLIN EPIDEMIOL, V53, P343, DOI 10.1016/S0895-4356(99)00188-2; Ingelsson E, 2005, EUR J HEART FAIL, V7, P787, DOI 10.1016/j.ejheart.2004.12.007; JACKSON R, 1988, NEW ZEAL MED J, V101, P658; Kavsak PA, 2006, AM HEART J, V152, P118, DOI 10.1016/j.ahj.2005.09.022; KENNEDY GT, 1984, AM J CARDIOL, V53, P1000, DOI 10.1016/0002-9149(84)90625-8; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Kontos MC, 2003, AM HEART J, V146, P446, DOI 10.1016/S0002-8703(03)00245-X; Kopec JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P929, DOI 10.1002/art.23827; Kramer MS, 1988, CLIN EPIDEMIOLOGY BI, P236; Kuo CF, 2013, RHEUMATOLOGY, V52, P111, DOI 10.1093/rheumatology/kes169; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733; Levy AR, 1999, CAN J CARDIOL, V15, P1277; LINDBLAD U, 1993, SCAND J SOC MED, V21, P3, DOI 10.1177/140349489302100102; LOWEL H, 1991, J CLIN EPIDEMIOL, V44, P249, DOI 10.1016/0895-4356(91)90036-9; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Mahonen M, 1997, EUR J EPIDEMIOL, V13, P403, DOI 10.1023/A:1007306110822; Mahonen M, 1999, J CLIN EPIDEMIOL, V52, P157, DOI 10.1016/S0895-4356(98)00145-0; McCarthy EP, 2000, MED CARE, V38, P868, DOI 10.1097/00005650-200008000-00010; Mensah GA, 2007, HEALTH AFFAIR, V26, P38, DOI 10.1377/hlthaff.26.1.38; Merry AHH, 2009, EUR J EPIDEMIOL, V24, P237, DOI 10.1007/s10654-009-9335-x; Office of Cardiovascular Diseases World Health Organization, 1999, MONICA MAN COR EV RE; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; PALOMAKI P, 1994, J CLIN EPIDEMIOL, V47, P659, DOI 10.1016/0895-4356(94)90213-5; Parikh NI, 2009, CIRCULATION, V119, P1203, DOI 10.1161/CIRCULATIONAHA.108.825364; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Pladevall M, 1996, INT J EPIDEMIOL, V25, P948, DOI 10.1093/ije/25.5.948; Rahman MM, 2013, ARTHRIT CARE RES, V65, P1951, DOI 10.1002/acr.22092; Rapola JM, 1997, EUR J EPIDEMIOL, V13, P133, DOI 10.1023/A:1007380408729; Rawson NSB, 1995, STAT MED, V14, P2627, DOI 10.1002/sim.4780142404; Roger VL, 2010, CIRCULATION, V121, P863, DOI 10.1161/CIRCULATIONAHA.109.897249; Rosamond WD, 2004, AM J EPIDEMIOL, V160, P1137, DOI 10.1093/aje/kwh341; Salomaa V, 2005, EUR HEART J, V26, P1719, DOI 10.1093/eurheartj/ehi185; Salomaa V, 2006, EUROPREVENT ANN C EU; Scherrer JF, 2010, AM HEART J, V159, P772, DOI 10.1016/j.ahj.2010.02.033; Soedamah-Muthu SS, 2006, DIABETES CARE, V29, P798, DOI 10.2337/diacare.29.04.06.dc05-1433; Solomon DH, 2006, ARTHRITIS RHEUM-US, V54, P3790, DOI 10.1002/art.22255; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; VANWALRAVEN C, 1990, CAN J CARDIOL, V6, P383; Varas-Lorenzo C, 2008, PHARMACOEPIDEM DR S, V17, P842, DOI 10.1002/pds.1619; Varas-Lorenzo C, 2007, ATHEROSCLEROSIS, V192, P376, DOI 10.1016/j.atherosclerosis.2006.05.019; Wahl PM, 2010, PHARMACOEPIDEM DR S, V19, P596, DOI 10.1002/pds.1924; Watson DJ, 2003, J RHEUMATOL, V30, P1196; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Widdifield J, 2013, ARTHRIT CARE RES, V65, P1490, DOI 10.1002/acr.21993	71	171	175	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92286	10.1371/journal.pone.0092286	http://dx.doi.org/10.1371/journal.pone.0092286			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682186	gold, Green Published, Green Submitted			2022-12-27	WOS:000333678100008
J	Diawara, MR; Hue, C; Wilder, SP; Venteclef, N; Aron-Wisnewsky, J; Scott, J; Clement, K; Gauguier, D; Calderari, S				Diawara, Malika R.; Hue, Christophe; Wilder, Steven P.; Venteclef, Nicolas; Aron-Wisnewsky, Judith; Scott, James; Clement, Karine; Gauguier, Dominique; Calderari, Sophie			Adaptive Expression of MicroRNA-125a in Adipose Tissue in Response to Obesity in Mice and Men	PLOS ONE			English	Article							INSULIN TARGET TISSUES; SPONTANEOUS RAT MODEL; 3T3-L1 ADIPOCYTES; GLUCOSE; RESISTANCE; CELLS; SENSITIVITY; METABOLISM; ACTIVATION; PROFILES	MicroRNAs are emerging as new mediators in the regulation of adipose tissue biology and the development of obesity. An important role of microRNA-125a has been suggested in the pathogenesis of insulin resistance (IR). Here, we characterized the function of microRNA-125a in adipose tissue in a context of experimentally-induced IR and obesity in mice and in obese patients. We showed time dependent overexpression of the microRNA in adipose tissue of BALB/c and C57BL/6J mice in response to high fat diet (HFD) feeding. MicroRNA-125a expression was downregulated in vitro in insulin resistant 3T3-L1 adipocytes and ex vivo in adipose tissue of obese patients. In vitro modulation of microRNA-125a expression in 3T3-L1 adipocytes did not affect glucose uptake. Gene set enrichment analysis (GSEA) identified significantly altered expression patterns of predicted microRNA-125a gene targets in transcriptomic datasets of adipose tissue from HFD-fed mice and obese patients. Among genes that contributed to global enrichment of altered expression of microRNA-125a targets, Thyrotroph embryonic factor (Tef), Mannan-binding lectin serine peptidase 1, Reticulon 2 and Ubiquitin-conjugating enzyme E2L3 were significantly differentially expressed in adipose tissue in these groups. We showed that Tef expression is reduced in adipose tissue of obese patients following gastric bypass surgery. Our findings indicate that microRNA-125a expression in adipose tissue adapts to IR and may play a role in the development of obesity in mice and obese subjects through uncoupled regulation of the expression of microRNA-125a and its targets.	[Diawara, Malika R.; Hue, Christophe; Venteclef, Nicolas; Aron-Wisnewsky, Judith; Clement, Karine; Gauguier, Dominique; Calderari, Sophie] Univ Paris 06, Cordeliers Res Ctr, INSERM, UMRS 872, Paris, France; [Diawara, Malika R.; Hue, Christophe; Venteclef, Nicolas; Aron-Wisnewsky, Judith; Clement, Karine; Gauguier, Dominique; Calderari, Sophie] Univ Paris 06, Pitie Salpetriere Hosp, ICAN, Inst Cardiometab & Nutr, Paris, France; [Wilder, Steven P.; Gauguier, Dominique] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Scott, James] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Oxford; Wellcome Centre for Human Genetics; Imperial College London	Calderari, S (corresponding author), Univ Paris 06, Cordeliers Res Ctr, INSERM, UMRS 872, Paris, France.	sophie.calderari@crc.jussieu.fr	Venteclef, Nicolas/K-8484-2017; ARON-WISNEWSKY, judith/AAH-7608-2020; Clément, karine/R-1120-2017; Gauguier, Dominique/G-2190-2016	Gauguier, Dominique/0000-0001-6156-9530; Wilder, Steven/0000-0001-8049-2559; Calderari, Sophie/0000-0002-9669-681X; Venteclef, Nicolas/0000-0002-6313-1214	Wellcome Functional Genomics Initiative BAIR (Biological Atlas of IR) [066786]; European Community [LSHG-CT-2006-037683]; Societe Francophone du Diabete; Institute of Cardiometabolism and Nutrition (ICAN) [ANR-10-IAHU-05]; Wellcome Senior Fellowship in Basic Biomedical Science [057733]; Ile de France region (CORDDIM); The Direction of Clinical Research (CRC) [PHRC 02076]; The Direction of Clinical Research (CRC) (CRC FIBROTA)	Wellcome Functional Genomics Initiative BAIR (Biological Atlas of IR); European Community(European Commission); Societe Francophone du Diabete; Institute of Cardiometabolism and Nutrition (ICAN); Wellcome Senior Fellowship in Basic Biomedical Science; Ile de France region (CORDDIM)(Region Ile-de-France); The Direction of Clinical Research (CRC); The Direction of Clinical Research (CRC) (CRC FIBROTA)	This work was supported by grants from the Wellcome Functional Genomics Initiative BAIR (Biological Atlas of IR) (066786), the European Community's Sixth Framework Programme under the grant agreement LSHG-CT-2006-037683 (FGENTCARD), the Societe Francophone du Diabete, the Institute of Cardiometabolism and Nutrition (ICAN, ANR-10-IAHU-05) and a Wellcome Senior Fellowship in Basic Biomedical Science (057733) to D. Gauguier. M. Diawara is supported by a PhD studentship from the Ile de France region (CORDDIM). The Direction of Clinical Research (CRC) promoted and supported clinical investigations (PHRC 02076 and CRC FIBROTA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bengestrate L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021305; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carrano AC, 2009, NATURE, V460, P396, DOI 10.1038/nature08130; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Dalmas E, 2011, AM J CLIN NUTR, V94, P450, DOI 10.3945/ajcn.111.013771; Dirksen C, 2012, DIABETOLOGIA, V55, P1890, DOI 10.1007/s00125-012-2556-7; Fearnside JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001668; Fernandez-Valverde SL, 2011, DIABETES, V60, P1825, DOI 10.2337/db11-0171; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Gachon F, 2011, P NATL ACAD SCI USA, V108, P4794, DOI 10.1073/pnas.1002862108; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Gunaratne PH, 2010, METHODS MOL BIOL, V667, P297, DOI 10.1007/978-1-60761-811-9_20; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Herrera BM, 2010, DIABETOLOGIA, V53, P1099, DOI 10.1007/s00125-010-1667-2; Herrera BM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-54; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ikemoto T, 2009, DIABETES, V58, P2802, DOI 10.2337/db09-0756; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Kallio P, 2009, INT J OBESITY, V33, P80, DOI 10.1038/ijo.2008.196; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Ling HY, 2009, CLIN EXP PHARMACOL P, V36, pe32, DOI 10.1111/j.1440-1681.2009.05207.x; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Megyeri M, 2009, J IMMUNOL, V183, P3409, DOI 10.4049/jimmunol.0900879; Nugent C, 2001, MOL ENDOCRINOL, V15, P1729, DOI 10.1210/me.15.10.1729; Oskowitz AZ, 2008, P NATL ACAD SCI USA, V105, P18372, DOI 10.1073/pnas.0809807105; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; PORTHA B, 1991, DIABETES, V40, P486, DOI 10.2337/diabetes.40.4.486; Potenza N, 2013, MOL GENET GENOMICS; Ross SA, 2000, BIOCHEM BIOPH RES CO, V273, P1033, DOI 10.1006/bbrc.2000.3082; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun YM, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-6; Thomson MJ, 1997, J BIOL CHEM, V272, P7759, DOI 10.1074/jbc.272.12.7759; Toye AA, 2007, DIABETOLOGIA, V50, P1867, DOI 10.1007/s00125-007-0738-5; West DB, 1998, AM J CLIN NUTR, V67, p505S, DOI 10.1093/ajcn/67.3.505S; Wilder SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-63	39	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e91375	10.1371/journal.pone.0091375	http://dx.doi.org/10.1371/journal.pone.0091375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675842	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677500014
J	Dubelman, S; Fischer, J; Zapata, F; Huizinga, K; Jiang, CJ; Uffman, J; Levine, S; Carson, D				Dubelman, Samuel; Fischer, Joshua; Zapata, Fatima; Huizinga, Kristin; Jiang, Changjian; Uffman, Joshua; Levine, Steven; Carson, David			Environmental Fate of Double-Stranded RNA in Agricultural Soils	PLOS ONE			English	Article							CRY1AB PROTEIN; DNA; DEGRADATION; PERSISTENCE; BIOASSAY; SEAWATER; CROPS	A laboratory soil degradation study was conducted to determine the biodegradation potential of a DvSnf7 dsRNA transcript derived from a Monsanto genetically modified (GM) maize product that confers resistance to corn rootworm (CRW; Diabrotica spp.). This study provides new information to improve the environmental assessment of dsRNAs that become pesticidal through an RNAi process. Three agricultural soils differing in their physicochemical characteristics were obtained from the U. S., Illinois (IL; silt loam), Missouri (MO; loamy sand) and North Dakota (ND; clay loam), and exposed to the target dsRNA by incorporating insect-protected maize biomass and purified (in vitro-transcribed) DvSnf7 RNA into soil. The GM and control (non-GM maize) materials were added to each soil and incubated at ca. 22 degrees C for 48 hours (h). Samples were collected at 12 time intervals during the incubation period, extracted, and analyzed using QuantiGene molecular analysis and insect bioassay methods. The DT50 (half-life) values for DvSnf7 RNA in IL, MO, and ND soils were 19, 28, and 15 h based on QuantiGene, and 18, 29, and 14 h based on insect bioassay, respectively. Furthermore, the DT90 (time to 90% degradation) values for DvSnf7 RNA in all three soils were <35 h. These results indicate that DvSnf7 RNA was degraded and biological activity was undetectable within approximately 2 days after application to soil, regardless of texture, pH, clay content and other soil differences. Furthermore, soil-incorporated DvSnf7 RNA was non-detectable in soil after 48 h, as measured by QuantiGene, at levels ranging more than two orders of magnitude (0.3, 1.5, 7.5 and 37.5 mu g RNA/g soil). Results from this study indicate that the DvSnf7 dsRNA is unlikely to persist or accumulate in the environment. Furthermore, the rapid degradation of DvSnf7 dsRNA provides a basis to define relevant exposure scenarios for future RNA-based agricultural products.	[Dubelman, Samuel; Fischer, Joshua; Zapata, Fatima; Huizinga, Kristin; Jiang, Changjian; Uffman, Joshua; Levine, Steven; Carson, David] Monsanto Co, Regulatory Div, St Louis, MO 63167 USA	Monsanto	Dubelman, S (corresponding author), Monsanto Co, Regulatory Div, St Louis, MO 63167 USA.	samuel.dubelman@monsanto.com			Monsanto Company	Monsanto Company	Monsanto Company funded this study. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Armstrong TA, 2013, J AGR FOOD CHEM, V61, P12557, DOI 10.1021/jf4031458; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Auer C, 2009, TRENDS BIOTECHNOL, V27, P644, DOI 10.1016/j.tibtech.2009.08.005; Badea EM, 2010, ROM BIOTECH LETT, V15, P55; Blum SAE, 1997, SYST APPL MICROBIOL, V20, P513, DOI 10.1016/S0723-2020(97)80021-5; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; CARSON DB, 1990, AM SOC TEST MATER, V1096, P48, DOI 10.1520/STP20098S; CRIPE CR, 1990, AM SOC TEST MATER, V1096, P29, DOI 10.1520/STP20097S; Dancer D, 2010, J FOOD PROTECT, V73, P2123, DOI 10.4315/0362-028X-73.11.2123; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DONEGAN KK, 1995, APPL SOIL ECOL, V2, P111, DOI 10.1016/0929-1393(94)00043-7; Dubelman S, 2005, ENVIRON ENTOMOL, V34, P915, DOI 10.1603/0046-225X-34.4.915; England LS, 1998, WORLD J MICROB BIOT, V14, P163, DOI 10.1023/A:1008865609698; England LS, 2003, RIV BIOL-BIOL FORUM, V96, P317; GLEDHILL WE, 1991, CHEMOSPHERE, V22, P873, DOI 10.1016/0045-6535(91)90245-9; GREAVES M P, 1970, Soil Biology and Biochemistry, V2, P257, DOI 10.1016/0038-0717(70)90032-5; GREEN PJ, 1994, ANNU REV PLANT PHYS, V45, P421, DOI 10.1146/annurev.pp.45.060194.002225; Gruber H, 2012, TRANSGENIC RES, V21, P77, DOI 10.1007/s11248-011-9509-7; Gulden RH, 2005, J AGR FOOD CHEM, V53, P5858, DOI 10.1021/jf0504667; Head G, 2002, ENVIRON ENTOMOL, V31, P30, DOI 10.1603/0046-225X-31.1.30; Herman RA, 2002, J AGR FOOD CHEM, V50, P7076, DOI 10.1021/jf025630u; Icoz I, 2008, SOIL BIOL BIOCHEM, V40, P559, DOI 10.1016/j.soilbio.2007.11.002; Iida T, 2006, CURR BIOL, V16, P1459, DOI 10.1016/j.cub.2006.05.061; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Keown H., 2004, New Zealand Natural Sciences, V29, P13; Levy-Booth DJ, 2008, J AGR FOOD CHEM, V56, P6339, DOI 10.1021/jf800767g; Levy-Booth DJ, 2007, SOIL BIOL BIOCHEM, V39, P2977, DOI 10.1016/j.soilbio.2007.06.020; Lundgren JG, 2013, BIOSCIENCE, V63, P657, DOI 10.1525/bio.2013.63.8.8; Miller SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047431; NOVITSKY JA, 1986, APPL ENVIRON MICROB, V52, P504, DOI 10.1128/AEM.52.3.504-509.1986; Palm CJ, 1996, CAN J MICROBIOL, V42, P1258, DOI 10.1139/m96-163; Pietramellara G, 2009, BIOL FERT SOILS, V45, P219, DOI 10.1007/s00374-008-0345-8; Pote J, 2005, CHEMOSPHERE, V61, P677, DOI 10.1016/j.chemosphere.2005.03.030; Ramaseshadri P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054270; Sims SR, 1996, ENVIRON ENTOMOL, V25, P659, DOI 10.1093/ee/25.3.659; Sims SR, 1997, J AGR FOOD CHEM, V45, P1502, DOI 10.1021/jf960647w; TSAI YL, 1995, APPL ENVIRON MICROB, V61, P363, DOI 10.1128/AEM.61.1.363-366.1995; US EPA, 1998, FED REGISTER; VANEWIJK PH, 1993, ECOTOX ENVIRON SAFE, V25, P25, DOI 10.1006/eesa.1993.1003	39	90	99	6	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93155	10.1371/journal.pone.0093155	http://dx.doi.org/10.1371/journal.pone.0093155			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676387	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677500084
J	Saitou, T; Kajiwara, K; Oneyama, C; Suzuki, T; Okada, M				Saitou, Takashi; Kajiwara, Kentaro; Oneyama, Chitose; Suzuki, Takashi; Okada, Masato			Roles of Raft-Anchored Adaptor Cbp/PAG1 in Spatial Regulation of c-Src Kinase	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASE; FOCAL ADHESION KINASE; FAMILY KINASES; SCAFFOLD PROTEINS; ACTIVATION; CSK; LYN; TRANSFORMATION; BINDING; CANCER	The tyrosine kinase c-Src is upregulated in numerous human cancers, implying a role for c-Src in cancer progression. Previously, we have shown that sequestration of activated c-Src into lipid rafts via a transmembrane adaptor, Cbp/PAG1, efficiently suppresses c-Src-induced cell transformation in Csk-deficient cells, suggesting that the transforming activity of c-Src is spatially regulated via Cbp in lipid rafts. To dissect the molecular mechanisms of the Cbp-mediated regulation of c-Src, a combined analysis was performed that included mathematical modeling and in vitro experiments in a c-Src-or Cbpinducible system. c-Src activity was first determined as a function of c-Src or Cbp levels, using focal adhesion kinase (FAK) as a crucial c-Src substrate. Based on these experimental data, two mathematical models were constructed, the sequestration model and the ternary model. The computational analysis showed that both models supported our proposal that raft localization of Cbp is crucial for the suppression of c-Src function, but the ternary model, which includes a ternary complex consisting of Cbp, c-Src, and FAK, also predicted that c-Src function is dependent on the lipid-raft volume. Experimental analysis revealed that c-Src activity is elevated when lipid rafts are disrupted and the ternary complex forms in non-raft membranes, indicating that the ternary model accurately represents the system. Moreover, the ternary model predicted that, if Cbp enhances the interaction between c-Src and FAK, Cbp could promote c-Src function when lipid rafts are disrupted. These findings underscore the crucial role of lipid rafts in the Cbp-mediated negative regulation of c-Src-transforming activity, and explain the positive role of Cbp in c-Src regulation under particular conditions where lipid rafts are perturbed.	[Saitou, Takashi] Ehime Univ, Grad Sch Med, Dept Mol Med Pathogenesis, Toon, Ehime, Japan; [Kajiwara, Kentaro; Oneyama, Chitose; Okada, Masato] Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Suita, Osaka 565, Japan; [Suzuki, Takashi] Osaka Univ, Grad Sch Engn Sci, Dept Syst Innovat, Div Math Sci, Toyonaka, Osaka 560, Japan; [Suzuki, Takashi] JST, CREST, Chiyoda Ku, Tokyo, Japan	Ehime University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Saitou, T (corresponding author), Ehime Univ, Grad Sch Med, Dept Mol Med Pathogenesis, Toon, Ehime, Japan.	t-saito@m.ehime-u.ac.jp; kajiwara@biken.osaka-u.ac.jp	Saitou, Takshi/AAF-2355-2019	Saitou, Takashi/0000-0003-0532-8112; Kajiwara, Kentaro/0000-0001-7574-4010	Japan Science Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST)	Japan Science Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST)	This work was supported by the Japan Science Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arold ST, 2011, CURR OPIN STRUC BIOL, V21, P808, DOI 10.1016/j.sbi.2011.09.008; Barua D, 2012, J IMMUNOL, V189, P646, DOI 10.4049/jimmunol.1102003; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Fuss H, 2008, BIOPHYS J, V94, P1995, DOI 10.1529/biophysj.107.115022; Fuss H, 2007, J COMPUT BIOL, V14, P1185, DOI 10.1089/cmb.2007.0095; Fuss H, 2006, BIOINFORMATICS, V22, pE158, DOI 10.1093/bioinformatics/btl201; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Ingley E, 2006, J BIOL CHEM, V281, P31920, DOI 10.1074/jbc.M602637200; Inoue K, 2009, GENE THER, V16, P1383, DOI 10.1038/gt.2009.105; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; Kaimachnikov NP, 2009, FEBS J, V276, P4102, DOI 10.1111/j.1742-4658.2009.07117.x; Kajiwara K, 2013, BIOCHEM J, V458, P81; Kanou T, 2011, MOL CANCER RES, V9, P103, DOI 10.1158/1541-7786.MCR-10-0340; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; OKADA M, 1991, J BIOL CHEM, V266, P24249; Okada M, 2012, INT J BIOL SCI, V8, P1385, DOI 10.7150/ijbs.5141; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Oneyama C, 2008, GENES CELLS, V13, P1, DOI 10.1111/j.1365-2443.2007.01145.x; Oneyama C, 2009, MOL CELL BIOL, V29, P6462, DOI 10.1128/MCB.00941-09; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Shima T, 2003, P NATL ACAD SCI USA, V100, P14897, DOI 10.1073/pnas.2432139100; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Solheim SA, 2008, FEBS J, V275, P4863, DOI 10.1111/j.1742-4658.2008.06626.x; Solheim SA, 2008, J BIOL CHEM, V283, P2773, DOI 10.1074/jbc.M705215200; Stites EC, 2007, SCIENCE, V318, P463, DOI 10.1126/science.1144642; Suzuki K, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.195362; Takeuchi S, 2000, J BIOL CHEM, V275, P29183, DOI 10.1074/jbc.C000326200; Tauzin S, 2008, BLOOD, V111, P2310, DOI 10.1182/blood-2007-05-090985; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Tomar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044041; Wang WQ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-49; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	50	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93470	10.1371/journal.pone.0093470	http://dx.doi.org/10.1371/journal.pone.0093470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675741	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677500128
J	Tamboli, IY; Heo, D; Rebeck, GW				Tamboli, Irfan Y.; Heo, Dongeun; Rebeck, G. William			Extracellular Proteolysis of Apolipoprotein E (apoE) by Secreted Serine Neuronal Protease	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; AMYLOID-BETA-PROTEIN; ALZHEIMERS-DISEASE; A-BETA; NEUTROPHIL SUPEROXIDE; BRAIN; INFLAMMATION; ALPHA-1-ANTICHYMOTRYPSIN; IDENTIFICATION; GLYCOSYLATION	Under normal conditions, brain apolipoprotein E (apoE) is secreted and lipidated by astrocytes, then taken up by neurons via receptor mediated endocytosis. Free apoE is either degraded in intraneuronal lysosomal compartments or released. Here we identified a novel way by which apoE undergoes proteolysis in the extracellular space via a secreted neuronal protease. We show that apoE is cleaved in neuronal conditioned media by a secreted serine protease. This apoE cleavage was inhibited by PMSF and alpha 1-antichymotrypsin, but not neuroserpin-1 or inhibitors of thrombin and cathepsin G, supporting its identity as a chymotrypsin like protease. In addition, apoE incubation with purified chymotrypsin produced a similar pattern of apoE fragments. Analysis of apoE fragments by mass spectrometry showed cleavages occuring at the C-terminal side of apoE tryptophan residues, further supporting our identification of cleavage by chymotrypsin like protease. Hippocampal neurons were more efficient in mediating this apoE cleavage than cortical neurons. Proteolysis of apoE4 generated higher levels of low molecular weight fragments compared to apoE3. Primary glial cultures released an inhibitor of this proteolytic activity. Together, these studies reveal novel mechanism by which apoE can be regulated and therefore could be useful in designing apoE directed AD therapeutic approaches.	[Tamboli, Irfan Y.; Heo, Dongeun; Rebeck, G. William] Georgetown Univ, Dept Neurosci, Washington, DC 20057 USA	Georgetown University	Rebeck, GW (corresponding author), Georgetown Univ, Dept Neurosci, Washington, DC 20057 USA.	gwr2@georgetown.edu	Rebeck, George William/J-2192-2012	Rebeck, George William/0000-0001-6276-248X	National Institute of Aging, Bethesda, MD, USA [R01 AG035379, P01 AG030128-01]; NATIONAL INSTITUTE ON AGING [P01AG030128, R01AG035379] Funding Source: NIH RePORTER	National Institute of Aging, Bethesda, MD, USA; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research was funded by two grants [R01 AG035379 -National Institute of Aging (Rebeck) P01 AG030128-01 -National Institute of Aging ( Rebeck)] from National Institute of Aging, Bethesda, MD 20892, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham CR, 2001, NEUROBIOL AGING, V22, P931, DOI 10.1016/S0197-4580(01)00302-5; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Aizawa Y, 1997, BRAIN RES, V768, P208, DOI 10.1016/S0006-8993(97)00640-9; Baker C, 2007, FRONT BIOSCI, V12, P2821, DOI 10.2741/2275; Belinson H, 2009, J ALZHEIMERS DIS, V17, P469, DOI 10.3233/JAD-2009-1065; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Cho HS, 2001, J NEUROPATH EXP NEUR, V60, P342, DOI 10.1093/jnen/60.4.342; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Czirr E, 2012, J CLIN INVEST, V122, P1156, DOI 10.1172/JCI58656; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Elliott DA, 2011, NEUROBIOL AGING, V32, P257, DOI 10.1016/j.neurobiolaging.2009.02.006; Ghosal K, 2013, NEURODEGENER DIS, V12, P51, DOI 10.1159/000341299; Gorodkiewicz E, 2011, MICROCHIM ACTA, V173, P407, DOI 10.1007/s00604-011-0569-4; GREGG RE, 1986, J CLIN INVEST, V78, P815, DOI 10.1172/JCI112645; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; Hawkes CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041636; Huang YD, 2004, J MOL NEUROSCI, V23, P189, DOI 10.1385/JMN:23:3:189; Hyman BT, 2000, ARCH NEUROL-CHICAGO, V57, P646, DOI 10.1001/archneur.57.5.646; Irizarry MC, 2000, ACTA NEUROPATHOL, V100, P451, DOI 10.1007/s004010000263; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Jones PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014586; Kanemaru K, 1996, NEUROBIOL AGING, V17, P767; KILPATRICK L, 1991, J IMMUNOL, V146, P2388; Kim J, 2012, J EXP MED, V209, P2149, DOI 10.1084/jem.20121274; Kim J, 2009, NEURON, V64, P632, DOI 10.1016/j.neuron.2009.11.013; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kline A, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt135; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Leduc Valerie, 2011, Int J Alzheimers Dis, V2011, P974361, DOI 10.4061/2011/974361; Lee CJ, 2011, BRIT J CLIN PHARMACO, V72, P581, DOI 10.1111/j.1365-2125.2011.03916.x; Lee Y, 2010, MOL CELL PROTEOMICS, V9, P1968, DOI 10.1074/mcp.M900430-MCP200; Licastro F, 1999, AM J PATHOL, V155, P869, DOI 10.1016/S0002-9440(10)65186-3; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Mahley RW, 2012, J MED CHEM, V55, P8997, DOI 10.1021/jm3008618; Mandrekar-Colucci S, 2010, CNS NEUROL DISORD-DR, V9, P156, DOI 10.2174/187152710791012071; Marques MA, 2004, J MOL NEUROSCI, V24, P73, DOI 10.1385/JMN:24:1:073; Masters CL, 1998, BRIT MED J, V316, P446, DOI 10.1136/bmj.316.7129.446; Minami SS, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-16; Miranda E, 2006, CELL MOL LIFE SCI, V63, P709, DOI 10.1007/s00018-005-5077-4; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; Nakamura T, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-35; Pocivavsek A, 2009, GLIA, V57, P444, DOI 10.1002/glia.20772; Porcellini E, 2008, CURR PHARM DESIGN, V14, P2659, DOI 10.2174/138161208786264151; Potter H, 2001, NEUROBIOL AGING, V22, P923, DOI 10.1016/S0197-4580(01)00308-6; REBECK GW, 1993, NEURON, V11, P575; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Sadowski MJ, 2006, P NATL ACAD SCI USA, V103, P18787, DOI 10.1073/pnas.0604011103; SCHUSTER MG, 1992, J BIOL CHEM, V267, P5056; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Shuvaev VV, 1999, BBA-MOL BASIS DIS, V1454, P296, DOI 10.1016/S0925-4439(99)00047-2; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Sullivan PM, 2011, NEUROBIOL AGING, V32, P791, DOI 10.1016/j.neurobiolaging.2009.05.011; Tai Leon M, 2011, Int J Alzheimers Dis, V2011, P810981, DOI 10.4061/2011/810981; Tamboli IY, 2008, J NEUROSCI, V28, P12097, DOI 10.1523/JNEUROSCI.2635-08.2008; Tanzi RE, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006296; Terwel D, 2011, J NEUROSCI, V31, P7049, DOI 10.1523/JNEUROSCI.6546-10.2011; Thal DR, 2005, ACTA NEUROPATHOL, V110, P459, DOI 10.1007/s00401-005-1053-1; Tokuda T, 2000, BIOCHEM J, V348, P359, DOI 10.1042/0264-6021:3480359; Tomomura A, 2002, NEUROSCI LETT, V317, P17, DOI 10.1016/S0304-3940(01)02409-0; Utter S, 2008, J NEUROPATH EXP NEUR, V67, P842, DOI 10.1097/NEN.0b013e3181836a71; Vance JE, 2010, BBA-MOL CELL BIOL L, V1801, P806, DOI 10.1016/j.bbalip.2010.02.007; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Vitek MP, 2012, NEURODEGENER DIS, V10, P122, DOI 10.1159/000334914; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; Weisgraber KH, 1996, FASEB J, V10, P1485, DOI 10.1096/fasebj.10.13.8940294; WERNETTEHAMMOND ME, 1989, J BIOL CHEM, V264, P9094; Wildsmith KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038013; WISNIEWSKI T, 1995, LANCET, V345, P956, DOI 10.1016/S0140-6736(95)90701-7; Yoshida S, 1999, INT J MOL MED, V3, P405; Zhou W, 2006, NEUROSCIENCE, V143, P689, DOI 10.1016/j.neuroscience.2006.08.019; Zhu YG, 2012, GLIA, V60, P559, DOI 10.1002/glia.22289; Zlokovic BV, 2013, JAMA NEUROL, V70, P440, DOI 10.1001/jamaneurol.2013.2152	77	26	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93120	10.1371/journal.pone.0093120	http://dx.doi.org/10.1371/journal.pone.0093120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675880	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677500074
J	Morris, RG; TenEyck, M; Barnes, JC; Kovandzic, TV				Morris, Robert G.; TenEyck, Michael; Barnes, J. C.; Kovandzic, Tomislav V.			The Effect of Medical Marijuana Laws on Crime: Evidence from State Panel Data, 1990-2006	PLOS ONE			English	Article							JUVENILE DETENTION CENTER; VIOLENT BEHAVIOR; DRUG-USE; USE LEAD; ALCOHOL; ASSOCIATION; AGGRESSION; CANNABIS; INVOLVEMENT; AMERICAN	Background: Debate has surrounded the legalization of marijuana for medical purposes for decades. Some have argued medical marijuana legalization (MML) poses a threat to public health and safety, perhaps also affecting crime rates. In recent years, some U.S. states have legalized marijuana for medical purposes, reigniting political and public interest in the impact of marijuana legalization on a range of outcomes. Methods: Relying on U.S. state panel data, we analyzed the association between state MML and state crime rates for all Part I offenses collected by the FBI. Findings: Results did not indicate a crime exacerbating effect of MML on any of the Part I offenses. Alternatively, state MML may be correlated with a reduction in homicide and assault rates, net of other covariates. Conclusions: These findings run counter to arguments suggesting the legalization of marijuana for medical purposes poses a danger to public health in terms of exposure to violent crime and property crimes.	[Morris, Robert G.; TenEyck, Michael; Barnes, J. C.; Kovandzic, Tomislav V.] Univ Texas Dallas, Program Criminol, Richardson, TX 75083 USA	University of Texas System; University of Texas Dallas	Morris, RG (corresponding author), Univ Texas Dallas, Program Criminol, Richardson, TX 75083 USA.	morris@utdallas.edu		Barnes, J.C./0000-0001-6932-5397				Allison PD, 2009, FIXED EFFECT REGRESS; Anderson DM, 2013, J LAW ECON, V56, P333, DOI 10.1086/668812; Arseneault L, 2000, ARCH GEN PSYCHIAT, V57, P979, DOI 10.1001/archpsyc.57.10.979; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Boden JM, 2012, DRUG ALCOHOL DEPEN, V122, P135, DOI 10.1016/j.drugalcdep.2011.09.023; Brady SS, 2008, J ADOLESCENT HEALTH, V43, P285, DOI 10.1016/j.jadohealth.2008.02.007; Bureau of Justice Statistics, 2008, DEATHS CUST REP PROG; Cleveland HH, 2008, DEV PSYCHOPATHOL, V20, P615, DOI 10.1017/S0954579408000308; DEMBO R, 1987, J PSYCHOACTIVE DRUGS, V19, P47, DOI 10.1080/02791072.1987.10472379; DEMBO R, 1987, J PSYCHOACTIVE DRUGS, V19, P361, DOI 10.1080/02791072.1987.10472424; DESIMONE J, 1998, E EC J, V0024; DiNardo J, 2001, J HEALTH ECON, V20, P991, DOI 10.1016/S0167-6296(01)00102-3; Freisthler B, 2013, AM J COMMUN PSYCHOL, V51, P278, DOI 10.1007/s10464-012-9542-6; Green KM, 2010, DRUG ALCOHOL DEPEN, V112, P117, DOI 10.1016/j.drugalcdep.2010.05.018; Harris AWF, 2010, AUST NZ J PSYCHIAT, V44, P85, DOI 10.3109/00048670903270423; Jacobs EA, 2004, PEDIATRICS, V113, P1825; Johnson Kevin, 2013, US TODAY; Kepple NJ, 2012, J STUD ALCOHOL DRUGS, V73, P523, DOI 10.15288/jsad.2012.73.523; Keyes KM, 2011, ADDICTION, V106, P1790, DOI 10.1111/j.1360-0443.2011.03485.x; KOVANDZIC TV, 2009, CRIMINOLOGY PUBLIC P, V0008; Levinthal C.F., 2008, DRUGS SOC CRIMINAL J; Monshouwer K, 2006, BRIT J PSYCHIAT, V188, P148, DOI 10.1192/bjp.188.2.148; Moore TM, 2005, AGGRESS VIOLENT BEH, V10, P171, DOI 10.1016/j.avb.2003.10.002; Niveau G, 2003, MED SCI LAW, V43, P115, DOI 10.1258/rsmmsl.43.2.115; O'Brien PK, 2013, DEVIANT BEHAV, V34, P423, DOI 10.1080/01639625.2012.735608; Ostrowsky MK, 2011, J DRUG EDUC, V41, P369, DOI 10.2190/DE.41.4.c; Pedersen W, 2010, ADDICTION, V105, P109, DOI 10.1111/j.1360-0443.2009.02719.x; Reingle JM, 2012, J INTERPERS VIOLENCE, V27, P1562, DOI 10.1177/0886260511425787; Scribner R, 1999, J STUD ALCOHOL, V60, P310, DOI 10.15288/jsa.1999.60.310; Swartout KM, 2010, J INTERPERS VIOLENCE, V25, P1716, DOI 10.1177/0886260509354586; Wooldridge JM, 2013, INTRO ECONOMETRICS M, V5th	31	64	64	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92816	10.1371/journal.pone.0092816	http://dx.doi.org/10.1371/journal.pone.0092816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24671103	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677000080
J	Burt, SA; Ojo-Fakunle, VTA; Woertman, J; Veldhuizen, EJA				Burt, Sara A.; Ojo-Fakunle, Victoria T. A.; Woertman, Jenifer; Veldhuizen, Edwin J. A.			The Natural Antimicrobial Carvacrol Inhibits Quorum Sensing in Chromobacterium violaceum and Reduces Bacterial Biofilm Formation at Sub-Lethal Concentrations	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; SUBINHIBITORY CONCENTRATIONS; LISTERIA-MONOCYTOGENES; STAINLESS-STEEL; ESSENTIAL OILS; TYPHIMURIUM; INACTIVATION; ANTIBIOTICS; POLYSTYRENE	The formation of biofilm by bacteria confers resistance to biocides and presents problems in medical and veterinary clinical settings. Here we report the effect of carvacrol, one of the major antimicrobial components of oregano oil, on the formation of biofilms and its activity on existing biofilms. Assays were carried out in polystyrene microplates to observe (a) the effect of 0-0.8 mM carvacrol on the formation of biofilms by selected bacterial pathogens over 24 h and (b) the effect of 0-8 mM carvacrol on the stability of pre-formed biofilms. Carvacrol was able to inhibit the formation of biofilms of Chromobacterium violaceum ATCC 12472, Salmonella enterica subsp. Typhimurium DT104, and Staphylococcus aureus 0074, while it showed no effect on formation of Pseudomonas aeruginosa (field isolate) biofilms. This inhibitory effect of carvacrol was observed at sub-lethal concentrations (<0.5 mM) where no effect was seen on total bacterial numbers, indicating that carvacrol's bactericidal effect was not causing the observed inhibition of biofilm formation. In contrast, carvacrol had (up to 8 mM) very little or no activity against existing biofilms of the bacteria described, showing that formation of the biofilm also confers protection against this compound. Since quorum sensing is an essential part of biofilm formation, the effect of carvacrol on quorum sensing of C. violaceum was also studied. Sub-MIC concentrations of carvacrol reduced expression of cviI (a gene coding for the N-acyl-L-homoserine lactone synthase), production of violacein (pigmentation) and chitinase activity (both regulated by quorum sensing) at concentrations coinciding with carvacrol's inhibiting effect on biofilm formation. These results indicate that carvacrol's activity in inhibition of biofilm formation may be related to the disruption of quorum sensing.	[Burt, Sara A.; Ojo-Fakunle, Victoria T. A.; Woertman, Jenifer] Univ Utrecht, Fac Vet Med, Vet Publ Hlth Div, Inst Risk Assessment Sci, Utrecht, Netherlands; [Veldhuizen, Edwin J. A.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University	Burt, SA (corresponding author), Univ Utrecht, Fac Vet Med, Vet Publ Hlth Div, Inst Risk Assessment Sci, Utrecht, Netherlands.	s.a.burt@uu.nl			Utrecht University, the Netherlands	Utrecht University, the Netherlands(Netherlands Government)	This study was funded by Utrecht University, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borges A, 2014, BIOFOULING, V30, P183, DOI 10.1080/08927014.2013.852542; Chernin LS, 1998, J BACTERIOL, V180, P4435, DOI 10.1128/JB.180.17.4435-4441.1998; Desai MA, 2012, J FOOD PROTECT, V75, P1332, DOI 10.4315/0362-028X.JFP-11-517; Gray KM, 2001, MICROBIOL-SGM, V147, P2379, DOI 10.1099/00221287-147-8-2379; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Inamuco J, 2012, VET MICROBIOL, V157, P200, DOI 10.1016/j.vetmic.2011.12.021; Knowles JR, 2005, APPL ENVIRON MICROB, V71, P797, DOI 10.1128/AEM.71.2.797-803.2005; Langeveld WT, 2014, CRIT REV MICROBIOL, V40, P76, DOI 10.3109/1040841X.2013.763219; Liu ZJ, 2013, FEMS MICROBIOL LETT, V341, P37, DOI 10.1111/1574-6968.12086; Molhoek EM, 2011, INT J ANTIMICROB AG, V37, P476, DOI 10.1016/j.ijantimicag.2010.12.020; Niu C, 2006, LETT APPL MICROBIOL, V43, P489, DOI 10.1111/j.1472-765X.2006.02001.x; Nostro A, 2007, J MED MICROBIOL, V56, P519, DOI 10.1099/jmm.0.46804-0; Nostro A, 2009, J MED MICROBIOL, V58, P791, DOI 10.1099/jmm.0.009274-0; Perez-Conesa D, 2006, J FOOD PROTECT, V69, P2947, DOI 10.4315/0362-028X-69.12.2947; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; Shapira R, 2007, MICROB DRUG RESIST, V13, P157, DOI 10.1089/mdr.2007.731; Singh BN, 2009, FOOD CHEM TOXICOL, V47, P778, DOI 10.1016/j.fct.2009.01.009; Soni KA, 2013, J FOOD PROTECT, V76, P205, DOI 10.4315/0362-028X.JFP-12-196; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Stauff DL, 2011, J BACTERIOL, V193, P3871, DOI 10.1128/JB.05125-11; van Alphen LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045343; Veldhuizen EJA, 2006, J AGR FOOD CHEM, V54, P1874, DOI 10.1021/jf052564y; Xue T, 2013, INT J ANTIMICROB AG, V41, P85, DOI 10.1016/j.ijantimicag.2012.08.016	23	155	165	2	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93414	10.1371/journal.pone.0093414	http://dx.doi.org/10.1371/journal.pone.0093414			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24691035	Green Published, gold			2022-12-27	WOS:000334101100078
J	Johansson, HM; Newman, DR; Sannes, PL				Johansson, Helena Morales; Newman, Donna R.; Sannes, Philip L.			Whole-Genome Analysis of Temporal Gene Expression during Early Transdifferentiation of Human Lung Alveolar Epithelial Type 2 Cells In Vitro	PLOS ONE			English	Article							KERATINOCYTE GROWTH-FACTOR; HUMAN PROTEIN ATLAS; II CELLS; EXTRACELLULAR-MATRIX; RAT LUNG; DIFFERENTIATION INVITRO; PULMONARY SURFACTANT; IMPROVED MAINTENANCE; BASEMENT-MEMBRANE; SODIUM-CHANNELS	It is generally accepted that the surfactant-producing pulmonary alveolar epithelial type II (AT2) cell acts as the progenitor of the type I (AT1) cell, but the regulatory mechanisms involved in this relationship remain the subject of active investigation. While previous studies have established a number of specific markers that are expressed during transdifferentiation from AT2 to AT1 cells, we hypothesized that additional, previously unrecognized, signaling pathways and relevant cellular functions are transcriptionally regulated at early stages of AT2 transition. In this study, a discovery-based gene expression profile analysis was undertaken of freshly isolated human AT2 (hAT2) cells grown on extracellular matrix (ECM) substrata known to either support (type I collagen) or retard (Matrigel) the early transdifferentiation process into hAT1-like cells over the first three days. Cell type-specific expression patterns analyzed by Illumina Human HT-12 BeadChip yielded over 300 genes that were up- or down-regulated. Candidate genes significantly induced or down-regulated during hAT2 transition to hAT1-like cells compared to non-transitioning hAT2 cells were identified. Major functional groups were also recognized, including those of signaling and cytoskeletal proteins as well as genes of unknown function. Expression of established signatures of hAT2 and hAT1 cells, such as surfactant proteins, caveolin-1, and channels and transporters, was confirmed. Selected novel genes further validated by qRT-PCR, protein expression analysis, and/or cellular localization included SPOCK2, PLEKHO1, SPRED1, RAB11FIP1, PTRF/CAVIN-1 and RAP1GAP. These results further demonstrate the utility of genome-wide analysis to identify relevant, novel cell type-specific signatures of early ECM-regulated alveolar epithelial transdifferentiation processes in vitro.	[Johansson, Helena Morales; Newman, Donna R.; Sannes, Philip L.] N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Dept Mol Biomed Sci, Raleigh, NC 27607 USA	University of North Carolina; North Carolina State University	Sannes, PL (corresponding author), N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Dept Mol Biomed Sci, Raleigh, NC 27607 USA.	plsannes@ncsu.edu			PHS [HL44497, HL95411, DK065988]; State of North Carolina; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044497, R03HL095411, R56HL044497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); State of North Carolina; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by: PHS grants HL44497, HL95411, DK065988 and the State of North Carolina. http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboulaich N, 2006, BIOCHEM BIOPH RES CO, V350, P657, DOI 10.1016/j.bbrc.2006.09.094; Aboulaich N, 2011, DIABETES, V60, P757, DOI 10.2337/db10-0744; ADAMSON IYR, 1975, LAB INVEST, V32, P736; ADAMSON IYR, 1992, ANAT EMBRYOL, V185, P275, DOI 10.1007/BF00211826; Adamson IYR, 1996, AM J PHYSIOL-LUNG C, V270, pL1017, DOI 10.1152/ajplung.1996.270.6.L1017; Ballard PL, 2010, AM J PHYSIOL-LUNG C, V299, pL36, DOI 10.1152/ajplung.00427.2009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borok Z, 1998, AM J RESP CELL MOL, V18, P554, DOI 10.1165/ajrcmb.18.4.2838; Borok Z, 1998, AM J PHYSIOL-LUNG C, V275, pL155, DOI 10.1152/ajplung.1998.275.1.L155; Buckley S, 1997, AM J PHYSIOL-LUNG C, V273, pL572, DOI 10.1152/ajplung.1997.273.3.L572; Campbell L, 1999, BIOCHEM BIOPH RES CO, V262, P744, DOI 10.1006/bbrc.1999.1280; Chen ZM, 2004, BIOCHEM BIOPH RES CO, V319, P774, DOI 10.1016/j.bbrc.2004.05.048; Comellas AP, 2010, J CELL SCI, V123, P1343, DOI 10.1242/jcs.066464; Deng W, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-29; Deterding RR, 1996, AM J PHYSIOL-LUNG C, V271, pL495, DOI 10.1152/ajplung.1996.271.4.L495; DETERDING RR, 1995, J CLIN INVEST, V95, P2963, DOI 10.1172/JCI118004; Dietl P, 1995, AM J PHYSIOL-LUNG C, V269, pL873, DOI 10.1152/ajplung.1995.269.6.L873; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Dobbs LG, 1997, AM J PHYSIOL-LUNG C, V273, pL347, DOI 10.1152/ajplung.1997.273.2.L347; Eaton DC, 2009, ANNU REV PHYSIOL, V71, P403, DOI 10.1146/annurev.physiol.010908.163250; EVANS MJ, 1975, EXP MOL PATHOL, V22, P142, DOI 10.1016/0014-4800(75)90059-3; Fujino N, 2012, AM J RESP CELL MOL, V46, P422, DOI 10.1165/rcmb.2011-0172OC; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Gonzalez R, 2005, AM J PHYSIOL-LUNG C, V288, pL179, DOI 10.1152/ajplung.00272.2004; Grau V, 2006, INT J BIOCHEM CELL B, V38, P279, DOI 10.1016/j.biocel.2005.09.010; Hadchouel A, 2011, AM J RESP CRIT CARE, V184, P1164, DOI 10.1164/rccm.201103-0548OC; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Herzog Erica L, 2008, Proc Am Thorac Soc, V5, P778, DOI 10.1513/pats.200803-028HR; Johnson MD, 2006, P NATL ACAD SCI USA, V103, P4964, DOI 10.1073/pnas.0600855103; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Kasper M, 1996, HISTOCHEM CELL BIOL, V106, P419; KASPER M, 1993, HISTOCHEMISTRY, V100, P65, DOI 10.1007/BF00268879; KAWADA H, 1988, BIOCHIM BIOPHYS ACTA, V972, P152, DOI 10.1016/0167-4889(88)90114-0; KAWADA H, 1990, AM J RESP CELL MOL, V3, P33, DOI 10.1165/ajrcmb/3.1.33; Kho AT, 2009, AM J RESP CELL MOL, V40, P47, DOI 10.1165/rcmb.2008-0048OC; KIKKAWA Y, 1983, LAB INVEST, V49, P122; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Lee IH, 2009, J BIOL CHEM, V284, P12663, DOI 10.1074/jbc.M809737200; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; MCCRAY PB, 1992, J CLIN INVEST, V90, P619, DOI 10.1172/JCI115901; McElroy MC, 2004, EUR RESPIR J, V24, P664, DOI 10.1183/09031936.04.00096003; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; MOORE KJ, 1992, GENOMICS, V12, P388, DOI 10.1016/0888-7543(92)90389-A; Nguyen NM, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-28; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Qiao R, 2008, AM J RESP CELL MOL, V38, P239, DOI 10.1165/rcmb.2007-0172OC; Ramirez MI, 2002, J HISTOCHEM CYTOCHEM, V50, P33, DOI 10.1177/002215540205000104; Rawlins EL, 2008, AM J PHYSIOL-LUNG C, V295, pL231, DOI 10.1152/ajplung.90209.2008; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Richter M, 2007, J NEUROSCI, V27, P14205, DOI 10.1523/JNEUROSCI.2746-07.2007; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; SANNES PL, 1984, J HISTOCHEM CYTOCHEM, V32, P827, DOI 10.1177/32.8.6747274; Schnepp A, 2005, J BIOL CHEM, V280, P11274, DOI 10.1074/jbc.M414276200; Schultess J, 2005, BLOOD, V105, P3185, DOI 10.1182/blood-2004-09-3605; Taipale J, 1997, FASEB J, V11, P51, DOI 10.1096/fasebj.11.1.9034166; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wang JR, 2007, AM J RESP CELL MOL, V36, P661, DOI 10.1165/rcmb.2006-0410OC; Wang YL, 2010, AM J PHYSIOL-LUNG C, V298, pL775, DOI 10.1152/ajplung.00327.2009; WOODCOCKMITCHELL J, 1989, AM REV RESPIR DIS, V139, P343, DOI 10.1164/ajrccm/139.2.343; Yu W, 2007, MOL BIOL CELL, V18, P1693, DOI 10.1091/mbc.E06-11-1052; Zhang HY, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-69	66	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93413	10.1371/journal.pone.0093413	http://dx.doi.org/10.1371/journal.pone.0093413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690998	Green Published, Green Submitted, gold			2022-12-27	WOS:000334101100077
J	Sakane, H; Horii, Y; Nogami, S; Kawano, Y; Kaneko-Kawano, T; Shirataki, H				Sakane, Hiroshi; Horii, Yukimi; Nogami, Satoru; Kawano, Yoji; Kaneko-Kawano, Takako; Shirataki, Hiromichi			alpha-Taxilin Interacts with Sorting Nexin 4 and Participates in the Recycling Pathway of Transferrin Receptor	PLOS ONE			English	Article							MEMBRANE-FUSION; EXPRESSION; PROTEIN; IDENTIFICATION; DEGRADATION; ENDOSOME; ENDOCYTOSIS; INTEGRINS; MUSCLES; COMPLEX	Membrane traffic plays a crucial role in delivering proteins and lipids to their intracellular destinations. We previously identified alpha-taxilin as a binding partner of the syntaxin family, which is involved in intracellular vesicle traffic. alpha-Taxilin is overexpressed in tumor tissues and interacts with polymerized tubulin, but the precise function of alpha-taxilin remains unclear. Receptor proteins on the plasma membrane are internalized, delivered to early endosomes and then either sorted to the lysosome for degradation or recycled back to the plasma membrane. In this study, we found that knockdown of alpha-taxilin induced the lysosomal degradation of transferrin receptor (TfnR), a well-known receptor which is generally recycled back to the plasma membrane after internalization, and impeded the recycling of transferrin. alpha-Taxilin was immunoprecipitated with sorting nexin 4 (SNX4), which is involved in the recycling of TfnR. Furthermore, knockdown of alpha-taxilin decreased the number and length of SNX4-positive tubular structures. We report for the first time that alpha-taxilin interacts with SNX4 and plays a role in the recycling pathway of TfnR.	[Sakane, Hiroshi; Horii, Yukimi; Nogami, Satoru; Kawano, Yoji; Kaneko-Kawano, Takako; Shirataki, Hiromichi] Dokkyo Med Univ, Grad Sch Med, Dept Mol & Cell Biol, Mibu, Tochigi, Japan	Dokkyo Medical University	Shirataki, H (corresponding author), Dokkyo Med Univ, Grad Sch Med, Dept Mol & Cell Biol, Mibu, Tochigi, Japan.	hiro-sh@dokkyomed.ac.jp	Nogami, Satoru/G-6061-2014; Kawano, Yoji/C-7484-2011	Nogami, Satoru/0000-0002-4517-0180; Kawano, Yoji/0000-0003-0687-2777	JSPS KAKENHI [23659403, 24790280]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grant number 23659403 to H. Shirataki and grant number 24790280 to H. Sakane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Fujimori KE, 2002, FEBS LETT, V529, P303, DOI 10.1016/S0014-5793(02)03386-0; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Horii Y, 2014, HISTOCHEM CELL BIOL, V141, P165, DOI 10.1007/s00418-013-1147-0; Horii Y, 2012, CELL STRUCT FUNCT, V37, P111, DOI 10.1247/csf.12002; Hunt SD, 2013, J CELL SCI, V126, P2493, DOI 10.1242/jcs.122317; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kikuchi A, 2009, TRENDS CELL BIOL, V19, P119, DOI 10.1016/j.tcb.2009.01.003; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Leprince C, 2003, J CELL SCI, V116, P1937, DOI 10.1242/jcs.00403; Mashidori T, 2011, BIOMED RES-TOKYO, V32, P103, DOI 10.2220/biomedres.32.103; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Nogami S, 2004, BIOCHEM BIOPH RES CO, V319, P936, DOI 10.1016/j.bbrc.2004.05.073; Nogami S, 2003, GENES CELLS, V8, P17, DOI 10.1046/j.1365-2443.2003.00612.x; Oba-Shinjo SM, 2005, MOL BRAIN RES, V140, P25, DOI 10.1016/j.molbrainres.2005.06.015; Ohtomo N, 2010, INT J ONCOL, V37, P1417, DOI 10.3892/ijo_00000793; Skanland SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005935; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Uyeda A, 2000, BIOCHEM BIOPH RES CO, V269, P564, DOI 10.1006/bbrc.2000.2330; van Kerkhof P, 2005, EMBO J, V24, P2851, DOI 10.1038/sj.emboj.7600756; van Weering JRT, 2012, TRAFFIC, V13, P94, DOI 10.1111/j.1600-0854.2011.01297.x; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Yoshida K, 2005, GENES CELLS, V10, P465, DOI 10.1111/j.1365-2443.2005.00848.x	32	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2014	9	4							e93509	10.1371/journal.pone.0093509	http://dx.doi.org/10.1371/journal.pone.0093509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6KM	24690921	Green Published, gold, Green Submitted			2022-12-27	WOS:000334101100094
J	Lamke, JP; Daniels, JK; Dorfel, D; Gaebler, M; Rahman, RA; Hummel, F; Erk, S; Walter, H				Lamke, Jan-Peter; Daniels, Judith K.; Doerfel, Denise; Gaebler, Michael; Rahman, Rasha Abdel; Hummel, Falk; Erk, Susanne; Walter, Henrik			The Impact of Stimulus Valence and Emotion Regulation on Sustained Brain Activation: Task-Rest Switching in Emotion	PLOS ONE			English	Article							DEFAULT MODE NETWORK; FUNCTIONAL CONNECTIVITY; FMRI DATA; STATE; AMYGDALA; RESPONSES; EXPERIENCE; ATTENTION; MIND	Task-rest interactions, defined as the modulation of brain activation during fixation periods depending on the preceding stimulation and experimental manipulation, have been described repeatedly for different cognitively demanding tasks in various regions across the brain. However, task-rest interactions in emotive paradigms have received considerably less attention. In this study, we therefore investigated task-rest interactions evoked by the induction and instructed regulation of negative emotion. Whole-brain, functional MRI data were acquired from 55 healthy participants. Two-level general linear model statistics were computed to test for differences between conditions, separately for stimulation and for fixation periods, as well as for interactions between stimulation and fixation (task-rest interactions). Results showed that the regulation of negative emotion led to reverse task-rest interactions (decreased activation during stimulation but increased activation during fixation) in the amygdala as well as in visual cortex regions and to concordant task-rest interactions (increased activation during both, stimulation and fixation) in the dorsolateral prefrontal cortex as well as in a number of brain regions at the intersection of the default mode and the dorsal attention networks. Thus, this first whole-brain investigation of task-rest interactions following the induction and regulation of negative emotion identified a widespread specific modulation of brain activation in regions subserving emotion generation and regulation as well as regions implicated in attention and default mode.	[Lamke, Jan-Peter; Daniels, Judith K.; Doerfel, Denise; Gaebler, Michael; Erk, Susanne; Walter, Henrik] Charite, Div Mind & Brain Res, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Lamke, Jan-Peter; Gaebler, Michael; Rahman, Rasha Abdel] Humboldt Univ, Dept Psychol, D-10099 Berlin, Germany; [Daniels, Judith K.] Univ Magdeburg, Clin Psychosomat Med & Psychotherapy, D-39106 Magdeburg, Germany; [Gaebler, Michael] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Rahman, Rasha Abdel; Walter, Henrik] Humboldt Univ, Berlin Sch Mind & Brain, D-10099 Berlin, Germany; [Hummel, Falk] Univ Bonn, Dept Psychiat & Psychotherapy, Div Med Psychol, Bonn, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Otto von Guericke University; Max Planck Society; Humboldt University of Berlin; University of Bonn	Daniels, JK (corresponding author), Charite, Div Mind & Brain Res, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany.	judith.daniels@charite.de; henrik.walter@charite.de	Dörfel, Denise/AAR-6523-2021; Walter, Henrik/O-2612-2013; Gaebler, Michael/C-1923-2014; Rahman, Rasha Abdel/J-4687-2015	Dörfel, Denise/0000-0002-5632-419X; Gaebler, Michael/0000-0002-4442-5778; Rahman, Rasha Abdel/0000-0002-8438-1570; Daniels, Judith/0000-0001-6304-2310; Walter, Henrik/0000-0002-9403-6121; Erk, Susanne/0000-0003-0961-3543	VW-foundation [II/84051]	VW-foundation(Volkswagen)	The work of Jan-Peter Lamke, Judith K. Daniels, and Michael Gaebler was supported by a VW-foundation grant (no. II/84051) to Henrik Walter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Anderson JS, 2011, BRAIN CONNECT, V1, P147, DOI 10.1089/brain.2011.0007; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J., 1997, CLIN MRI DEV MR, V7, P26; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bzdok D, 2012, HUMAN BRAIN MAPPING; COLLIGNON A, 1995, COMP IMAG VIS, V3, P263; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Daniels JK, 2013, PSYCHOL TRAUMA-US, V5, P142, DOI 10.1037/a0026946; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Eldaief MC, 2012, SOC COGN AFFECT NEUR, V7, P380, DOI 10.1093/scan/nsr003; Erk S, 2010, J NEUROSCI, V30, P15726, DOI 10.1523/JNEUROSCI.1856-10.2010; Eryilmaz H, 2011, NEUROIMAGE, V54, P2481, DOI 10.1016/j.neuroimage.2010.10.021; Evers EAT, 2012, BRAIN CONNECT, V2, P102, DOI 10.1089/brain.2011.0060; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Friston KJ, 2005, NEUROIMAGE, V24, P244, DOI 10.1016/j.neuroimage.2004.08.055; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Hamm AO, 1993, PSYCHOL RUNDSCHAU; Harrison BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001794; He BJ, 2013, J NEUROSCI, V33, P4672, DOI 10.1523/JNEUROSCI.2922-12.2013; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Koenigsberg HW, 2010, NEUROPSYCHOLOGIA, V48, P1813, DOI 10.1016/j.neuropsychologia.2010.03.002; Lang PJ, 2008, INT AFFECTIVE PICTUR; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Mcrae K, 2008, GROUP PROCESS INTERG, V11, P143, DOI 10.1177/1368430207088035; Mullinger KJ, 2013, P NATL ACAD SCI USA, V110, P13636, DOI 10.1073/pnas.1221287110; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nolen-Hoeksema S, 2012, ANNU REV CLIN PSYCHO, V8, P161, DOI 10.1146/annurev-clinpsy-032511-143109; Northoff G, 2010, TRENDS NEUROSCI, V33, P277, DOI 10.1016/j.tins.2010.02.006; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pitroda S, 2008, NEUROSCI LETT, V443, P72, DOI 10.1016/j.neulet.2008.07.050; Posner J, 2005, DEV PSYCHOPATHOL, V17, P715, DOI 10.1017/S0954579405050340; Pyka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007198; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Schardt DM, 2010, NEUROIMAGE, V53, P943, DOI 10.1016/j.neuroimage.2009.11.078; Schneider F, 2008, NEUROSCIENCE, V157, P120, DOI 10.1016/j.neuroscience.2008.08.014; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Tomasi D, 2011, CEREB CORTEX, V21, P2003, DOI 10.1093/cercor/bhq268; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Marle HJF, 2010, NEUROIMAGE, V53, P348, DOI 10.1016/j.neuroimage.2010.05.070; Veer IM, 2011, NEUROIMAGE, V57, P1534, DOI 10.1016/j.neuroimage.2011.05.074; Walter H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006726; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Zong XP, 2011, NEUROIMAGE, V57, P391, DOI 10.1016/j.neuroimage.2011.04.067	54	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93098	10.1371/journal.pone.0093098	http://dx.doi.org/10.1371/journal.pone.0093098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0TC	24682003	Green Published, gold			2022-12-27	WOS:000333678100024
J	Ma, JQ; Yao, MZ; Ma, CL; Wang, XC; Jin, JQ; Wang, XM; Chen, L				Ma, Jian-Qiang; Yao, Ming-Zhe; Ma, Chun-Lei; Wang, Xin-Chao; Jin, Ji-Qiang; Wang, Xue-Min; Chen, Liang			Construction of a SSR-Based Genetic Map and Identification of QTLs for Catechins Content in Tea Plant (Camellia sinensis)	PLOS ONE			English	Article							MARKER-ASSISTED SELECTION; QUANTITATIVE TRAIT LOCI; EXPRESSED SEQUENCE TAGS; MICROSATELLITE MARKERS; LINKAGE MAP; SEGREGATION DISTORTION; GREEN TEA; AFLP; TRANSFERABILITY; AMPLIFICATION	Catechins are the most important bioactive compounds in tea, and have been demonstrated to possess a wide variety of pharmacological activities. To characterize quantitative trait loci (QTLs) for catechins content in the tender shoots of tea plant, we constructed a moderately saturated genetic map using 406 simple sequence repeat (SSR) markers, based on a pseudo-testcross population of 183 individuals derived from an intraspecific cross of two Camellia sinensis varieties with diverse catechins composition. The map consisted of fifteen linkage groups (LGs), corresponding to the haploid chromosome number of tea plant (2n = 2x = 30). The total map length was 1,143.5 cM, with an average locus spacing of 2.9 cM. A total of 25 QTLs associated with catechins content were identified over two measurement years. Of these, nine stable QTLs were validated across years, and clustered into four main chromosome regions on LG03, LG11, LG12 and LG15. The population variability explained by each QTL was predominantly at moderate-to-high levels and ranged from 2.4% to 71.0%, with an average of 17.7%. The total number of QTL for each trait varied from four to eight, while the total population variability explained by all QTLs for a trait ranged between 38.4% and 79.7%. This is the first report on the identification of QTL for catechins content in tea plant. The results of this study provide a foundation for further cloning and functional characterization of catechin QTLs for utilization in improvement of tea plant.	[Ma, Jian-Qiang; Yao, Ming-Zhe; Ma, Chun-Lei; Wang, Xin-Chao; Jin, Ji-Qiang; Wang, Xue-Min; Chen, Liang] Chinese Acad Agr Sci TRICAAS, Natl Ctr Tea Improvement, Tea Res Inst, Key Lab Tea Plant Biol & Resources Utilizat,Minis, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS	Chen, L (corresponding author), Chinese Acad Agr Sci TRICAAS, Natl Ctr Tea Improvement, Tea Res Inst, Key Lab Tea Plant Biol & Resources Utilizat,Minis, Hangzhou, Zhejiang, Peoples R China.	liangchen@mail.tricaas.com	Wang, Xinchao/I-5745-2019; Chen, Liang/R-4438-2019; MINGZHE, YAO/AAH-7748-2021	Wang, Xinchao/0000-0002-5224-6286; Chen, Liang/0000-0002-7507-3947; 	Earmarked Fund for China Agriculture Research System [CARS-23]; Science and Technology Major Project for New Crop Varieties Breeding of Zhejiang Province [2012C12905-6]; National Natural Science Foundation of China [31170624, 31100504, 30901159]	Earmarked Fund for China Agriculture Research System; Science and Technology Major Project for New Crop Varieties Breeding of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported in part by the Earmarked Fund for China Agriculture Research System (CARS-23) to Liang Chen, the Science and Technology Major Project for New Crop Varieties Breeding of Zhejiang Province (2012C12905-6), National Natural Science Foundation of China (31170624, 31100504, 30901159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alheit KV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-380; [Anonymous], 2005, 145022 ISO; Bali S, 2013, MOL BREEDING, V32, P735, DOI 10.1007/s11032-013-9902-4; Barchi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043740; Basu A, 2007, NUTR REV, V65, P361, DOI 10.1111/j.1753-4887.2007.tb00314.x; Behrend A, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-64; Bradeen JM, 2001, GENOME, V44, P111, DOI 10.1139/gen-44-1-111; Charters YM, 1996, THEOR APPL GENET, V92, P442, DOI 10.1007/BF00223691; Chen X, 2010, GENETICS, V186, P1053, DOI 10.1534/genetics.110.120311; Chen ZY, 2010, CONSERV GENET, V11, P1163, DOI 10.1007/s10592-009-9908-y; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Ferreira A, 2006, GENET MOL BIOL, V29, P187, DOI 10.1590/S1415-47572006000100033; Foolad MR, 2012, CRIT REV PLANT SCI, V31, P93, DOI 10.1080/07352689.2011.616057; Freeman S, 2004, MOL ECOL NOTES, V4, P324, DOI 10.1111/j.1471-8286.2004.00682.x; Frenkel O, 2012, PLANT PATHOL, V61, P106, DOI 10.1111/j.1365-3059.2011.02502.x; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Gupta PK, 2000, EUPHYTICA, V113, P163, DOI 10.1023/A:1003910819967; Hackett CA, 2000, HEREDITY, V85, P346, DOI 10.1046/j.1365-2540.2000.00769.x; Hackett CA, 2003, HEREDITY, V90, P33, DOI 10.1038/sj.hdy.6800173; Hu CY, 2013, EUPHYTICA, V191, P141, DOI 10.1007/s10681-013-0908-0; Huang FuPing, 2006, Journal of Tea Science, V26, P171; Huang JianAn, 2005, Journal of Tea Science, V25, P7; Hung CY, 2008, CONSERV GENET, V9, P779, DOI 10.1007/s10592-007-9391-2; International Tea Committee, 2012, ANN B STAT 2012, P50; Isemura T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041304; Jin JiQiang, 2006, Journal of Tea Science, V26, P17; Kamunya SM, 2010, TREE GENET GENOMES, V6, P915, DOI 10.1007/s11295-010-0301-2; Kenis K, 2005, MOL BREEDING, V15, P205, DOI 10.1007/s11032-004-5592-2; Knott SA, 1997, THEOR APPL GENET, V94, P810, DOI 10.1007/s001220050482; Kumawat G, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-84; Li XH, 2011, THEOR APPL GENET, V123, P667, DOI 10.1007/s00122-011-1617-5; Ma JQ, 2012, SCI HORTIC-AMSTERDAM, V134, P167, DOI 10.1016/j.scienta.2011.10.029; Ma JQ, 2010, AM J BOT, V97, pE153, DOI 10.3732/ajb.1000376; Mano Y, 2005, PLANT BREEDING, V124, P432, DOI 10.1111/j.1439-0523.2005.01128.x; Miura K, 2011, TRENDS PLANT SCI, V16, P319, DOI 10.1016/j.tplants.2011.02.009; Ota S, 1999, BREED RES, V1, P16; Pang YZ, 2013, PLANT PHYSIOL, V161, P1103, DOI 10.1104/pp.112.212050; Petroli CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044684; Qin HD, 2008, THEOR APPL GENET, V117, P883, DOI 10.1007/s00122-008-0828-x; Rabbi I, 2012, THEOR APPL GENET, V125, P329, DOI 10.1007/s00122-012-1836-4; Saravanan M, 2005, PHYTOCHEMISTRY, V66, P561, DOI 10.1016/j.phytochem.2004.06.024; Schramm Laura, 2013, J Carcinog Mutagen, V4, P1000142; Sharma H, 2011, AM J BOT, V98, pE133, DOI 10.3732/ajb.1000525; Sharma RK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-53; Sibov ST, 2003, HEREDITAS, V139, P96, DOI 10.1111/j.1601-5223.2003.01666.x; Tanaka J., 2006, J REMOTE SENS SOC JP, V2006, P1, DOI [10.5979/cha.2006.1, DOI 10.5979/CHA.2006.1]; Tanaka JI, 1995, J JPN BREED, V45, P198; Taniguchi F, 2012, BREEDING SCI, V62, P263, DOI 10.1270/jsbbs.62.263; Taniguchi F, 2012, BREEDING SCI, V62, P186, DOI 10.1270/jsbbs.62.186; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tounekti T, 2013, CRIT REV PLANT SCI, V32, P192, DOI 10.1080/07352689.2012.747384; Van Ooijen J. W., 2006, JIONMAP 4 SOFTWARE C; van Ooijen JW, 2002, MAPQTL 4 0 SOFTWARE; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vogl C, 2000, GENETICS, V155, P1439; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Vuong QV, 2011, FOOD REV INT, V27, P227, DOI 10.1080/87559129.2011.563397; Wallace JG, 2014, HEREDITY, V112, P30, DOI 10.1038/hdy.2013.6; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Wang HF, 2000, TRENDS FOOD SCI TECH, V11, P152, DOI 10.1016/S0924-2244(00)00061-3; Wang XC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-415; Weinreb O, 2009, GENES NUTR, V4, P283, DOI 10.1007/s12263-009-0143-4; Wu HL, 2013, PLANT MOL BIOL REP, V31, P524, DOI 10.1007/s11105-012-0519-2; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yang JB, 2009, CONSERV GENET, V10, P1621, DOI 10.1007/s10592-009-9814-3; Yao MZ, 2012, TREE GENET GENOMES, V8, P205, DOI 10.1007/s11295-011-0433-z; Yin TM, 2004, THEOR APPL GENET, V109, P451, DOI 10.1007/s00122-004-1653-5; Yu ZN, 2003, BIOL BULL-US, V204, P327, DOI 10.2307/1543603; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394; Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006; Zhan HM, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-97; Zhao LP, 2008, CONSERV GENET, V9, P1327, DOI 10.1007/s10592-007-9476-y; Zhou YanHua, 2011, Scientia Silvae Sinicae, V47, P59	77	55	64	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93131	10.1371/journal.pone.0093131	http://dx.doi.org/10.1371/journal.pone.0093131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676054	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500078
J	Mancini, M; Lanzillo, R; Liuzzi, R; Di Donato, O; Ragucci, M; Monti, S; Salvatore, E; Morra, VB; Salvatore, M				Mancini, Marcello; Lanzillo, Roberta; Liuzzi, Raffaele; Di Donato, Orlando; Ragucci, Monica; Monti, Serena; Salvatore, Elena; Morra, Vincenzo Brescia; Salvatore, Marco			Internal Jugular Vein Blood Flow in Multiple Sclerosis Patients and Matched Controls	PLOS ONE			English	Article							CEREBROSPINAL VENOUS INSUFFICIENCY; PERFUSION; IMPAIRMENT; DISABILITY; ABNORMALITIES; LEUKOARAIOSIS; INCOMPETENCE; LESIONS; VALVE	The aim of the study was to investigate the Internal Jugular Veins dynamics using contrast enhanced ultrasonography in Multiple Sclerosis patients, clinically isolated syndrome patients and healthy controls. Contrast enhanced ultrasonography imaging of the Internal Jugular Vein was performed in fifty-eight patients with Multiple Sclerosis, seven clinically isolated syndrome patients and in thirteen healthy controls. Time-intensity curves were quantified using a semi-automated method and compared with clinical disease outcomes. Wash-out parameters were calculated and six Time-intensity curves shapes were created. Significantly reduction of wash-out rate in Internal Jugular Veins was detected in Multiple Sclerosis patients compared to healthy controls [22.2% (2.7%-65.9%) vs. 33.4% (16.2%-76.8%); P<0.005]. Internal Jugular Vein enhancement was heterogeneous in patients with Multiple Sclerosis and consisted of slow wash-out Time-intensity curves shapes, compared with almost only one type of Time-intensity curves shape in control subjects that correspond to fast enhancement and fast wash-out. The vein wash-in parameters were similar in Multiple Sclerosis group compared with controls. A significant correlation was found between Internal Jugular Vein wash-out and level of disability (R = -0.402, p<0.05). Contrast enhanced ultrasonography of the Internal Jugular Vein with time intensity curve analysis revealed alterations of cerebral venous outflow in Multiple Sclerosis patients, however mechanisms that determine this condition remains unclear.	[Mancini, Marcello; Liuzzi, Raffaele] IBB, Italian Natl Res Council CNR, Naples, Italy; [Mancini, Marcello; Ragucci, Monica] IRCCS, SDN Fdn, Inst Diagnost & Nucl Dev, Naples, Italy; [Lanzillo, Roberta; Morra, Vincenzo Brescia] Univ Naples Federico II, Sch Med, Dept Neurosci Reprod & Odontostomatol Sci, Naples, Italy; [Di Donato, Orlando; Salvatore, Elena; Salvatore, Marco] Univ Naples Federico II, Sch Med, Dept Adv Biomed Sci, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Istituto di Neuroscienze (IN-CNR); IRCCS Fondazione Pascale; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); University of Naples Federico II; University of Naples Federico II	Mancini, M (corresponding author), IBB, Italian Natl Res Council CNR, Naples, Italy.	marcello.mancini58@gmail.com	Liuzzi, Raffaele/AIC-0886-2022; Monti, Serena/C-1062-2015; Salvatore, Marco/K-8083-2016; Lanzillo, Roberta/AFA-8874-2022	Liuzzi, Raffaele/0000-0002-2350-6691; Monti, Serena/0000-0002-8777-7837; Salvatore, Marco/0000-0001-9734-7702; SALVATORE, Elena/0000-0003-1493-5133; Lanzillo, Roberta/0000-0001-6388-8180	Italian Ministry for Education University and Research in the framework of PRIN [2010XE5L2R_004]	Italian Ministry for Education University and Research in the framework of PRIN(Ministry of Education, Universities and Research (MIUR))	This work was supported by a research grant from the Italian Ministry for Education University and Research in the framework of PRIN (2010XE5L2R_004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN IV, 1981, NEUROPATH APPL NEURO, V7, P169, DOI 10.1111/j.1365-2990.1981.tb00087.x; Bateman GA, 2002, NEURORADIOLOGY, V44, P740, DOI 10.1007/s00234-002-0812-0; Beggs C, 2013, PHLEBOLOGY; Chung CP, 2011, ANN NEUROL, V69, P553, DOI 10.1002/ana.22276; Chung CP, 2010, MED HYPOTHESES, V75, P85, DOI 10.1016/j.mehy.2010.01.042; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dawson JW, 1916, EDINBURGH MED J, V17, DOI [10.1007/978-3-319-02735-7, DOI 10.1007/978-3-319-02735-7]; Delorme Stefan, 2006, Cancer Imaging, V6, P148, DOI 10.1102/1470-7330.2006.0023; Denislic M, 2013, PHLEBOLOGY, V28, P353, DOI 10.1258/phleb.2012.012065; Digre Kathleen B, 2002, Curr Pain Headache Rep, V6, P217, DOI 10.1007/s11916-002-0038-1; Doepp F, 2008, CEPHALALGIA, V28, P182, DOI 10.1111/j.1468-2982.2007.01484.x; Doepp F, 2008, J CLIN ULTRASOUND, V36, P480, DOI 10.1002/jcu.20470; Dolic K, 2012, AM J NEURORADIOL, V33, P16, DOI 10.3174/ajnr.A2877; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Frydrychowski AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048245; Gaitan MI, 2013, NEUROLOGY, V80, P145, DOI 10.1212/WNL.0b013e31827b916f; Garaci FG, 2012, RADIOLOGY, V265, P233, DOI 10.1148/radiol.12112245; Ge YL, 2005, AM J NEURORADIOL, V26, P1539; Ge YL, 2012, J CEREBR BLOOD F MET, V32, P403, DOI 10.1038/jcbfm.2011.191; Gianesini S, 2014, PHLEBOLOGY, V29, P632, DOI 10.1177/0268355513489549; Gosselink R, 1999, EUR RESPIR J, V13, P449, DOI 10.1183/09031936.99.13244999; Haacke EM, 2012, J VASC INTERV RADIOL, V23, P60, DOI 10.1016/j.jvir.2011.09.027; Haufschild T, 2001, J NEURO-OPHTHALMOL, V21, P37, DOI 10.1097/00041327-200103000-00011; Inglese M, 2008, J CEREBR BLOOD F MET, V28, P164, DOI 10.1038/sj.jcbfm.9600504; Inglese M, 2007, ARCH NEUROL-CHICAGO, V64, P196, DOI 10.1001/archneur.64.2.196; Jayaraman MV, 2012, AM J NEURORADIOL, V33, P1247, DOI 10.3174/ajnr.A2953; Kilsdonk ID, 2012, NEUROIMAG CLIN N AM, V22, P135, DOI 10.1016/j.nic.2012.02.010; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lanzillo R, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-20; Law M, 2004, RADIOLOGY, V231, P645, DOI 10.1148/radiol.2313030996; Mancini M, 2012, RADIOLOGY, V262, P947, DOI 10.1148/radiol.11111239; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Putnam TJ, 1937, ARCH NEURO PSYCHIATR, V38, P1, DOI 10.1001/archneurpsyc.1937.02260190011001; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Schaller B, 2004, BRAIN RES REV, V46, P243, DOI 10.1016/j.brainresrev.2004.04.005; Sinnecker T, 2013, MULT SCLER J, V19, P316, DOI 10.1177/1352458512451941; Sun X, 1998, Ann Nucl Med, V12, P89; Valdueza JM, 2000, LANCET, V355, P200; Varga AW, 2009, J NEUROL SCI, V282, P28, DOI 10.1016/j.jns.2008.12.036; Veroux P, 2013, J VASC INTERV RADIOL, V24, P1790, DOI 10.1016/j.jvir.2013.08.024; WAKEFIELD AJ, 1994, J CLIN PATHOL, V47, P129, DOI 10.1136/jcp.47.2.129; Weinstock-Guttman B, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-26; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zamboni P, 2012, J VASC SURG, V56, P677, DOI 10.1016/j.jvs.2012.01.074; Zamboni P, 2009, J NEUROL SCI, V282, P21, DOI 10.1016/j.jns.2008.11.027; Zivadinov R, 2011, NEUROLOGY, V77, P138, DOI 10.1212/WNL.0b013e318212a901	46	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92730	10.1371/journal.pone.0092730	http://dx.doi.org/10.1371/journal.pone.0092730			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675965	gold, Green Submitted, Green Published			2022-12-27	WOS:000333677500035
J	Pileggi, C; Manuti, B; Costantino, R; Bianco, A; Nobile, CGA; Pavia, M				Pileggi, Claudia; Manuti, Benedetto; Costantino, Rosa; Bianco, Aida; Nobile, Carmelo G. A.; Pavia, Maria			Quality of Care in One Italian Nursing Home Measured by ACOVE Process Indicators	PLOS ONE			English	Article							LONG-TERM-CARE; VULNERABLE ELDERS; COMMUNITY; PEOPLE	Objectives: To adapt the Assessing Care of Vulnerable Elders Quality Indicators (ACOVE QIs) for use in Italy, to assess the adherence to these indicators as reported in the medical records of residents in a nursing home (NH), to compare this adherence for general medical and geriatric conditions, and eventually, to identify the relationships between patients' characteristics and reported processes of care. Methods: Two physicians collected the data by reviewing medical records of all NH residents in the previous 5 years, for a period of one year. Patients aged <65 years were excluded. A total of 245 patients were reviewed during the study period. The ACOVE QIs set, developed for NH processes of care, was used to assess the quality of care. Multivariate analysis was performed to identify and to assess the role of patients' characteristics on quality of processes of care by several domains of care in general medical and geriatric conditions. Results: With the exception of diabetes management, quality of processes of care for general medical conditions approached adequate adherence. Care falls substantially short of acceptable levels for geriatric conditions (pressure ulcers, falls, dementia). On the contrary, the recommended interventions for urinary incontinence were commonly performed. Adherence to indicators varied for the different domains of care and was proven worse for the screening and prevention indicators both for geriatric and general medical conditions. Statistical analysis showed disparities in provision of appropriate processes of care associated with gender, age, co-morbidities, level of function and mobility, length of stay and modality of discharge by NHs. Conclusions: Adherence to recommended processes of care delivered in NH is inadequate. Substantial work lies ahead for the improvement of care. Efforts should focus particularly on management of geriatric conditions and on preventive healthcare.	[Pileggi, Claudia; Manuti, Benedetto; Costantino, Rosa; Bianco, Aida; Nobile, Carmelo G. A.; Pavia, Maria] Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy	Magna Graecia University of Catanzaro	Pavia, M (corresponding author), Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy.	pavia@unicz.it	PILEGGI, Claudia/AGU-6397-2022; Bianco, Aida/R-6612-2016	PILEGGI, Claudia/0000-0002-6288-5540; PAVIA, Maria/0000-0003-3879-1322; BIANCO, Aida/0000-0003-4674-0306; NOBILE, Carmelo Giuseppe Angelo/0000-0002-0762-513X	Italian Ministry of University and Research (MIUR/PRIN) [H8YFRE]	Italian Ministry of University and Research (MIUR/PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by the following Research Grants: Italian Ministry of University and Research (MIUR/PRIN-2008. Prot H8YFRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora VM, 2007, J AM GERIATR SOC, V55, P1705, DOI 10.1111/j.1532-5415.2007.01444.x; Askari M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028631; Bravo G, 2005, INT J QUAL HEALTH C, V17, P511, DOI 10.1093/intqhc/mzi064; Comondore VR, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2732; Donini LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055804; Fahey T, 2003, BRIT MED J, V326, P580, DOI 10.1136/bmj.326.7389.580; Flotta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048923; Garavaglia G, 2011, HEALTH CARE MANAG SC, V14, P22, DOI 10.1007/s10729-010-9139-2; Higashi T, 2007, NEW ENGL J MED, V356, P2496, DOI 10.1056/NEJMsa066253; Istituto Nazionale di Statistica, PRES RES SOC ASS; Kane RA, 1987, LONG TERM CARE PRINC; Levenson SA, 2009, J AM MED DIR ASSOC, V10, P597, DOI 10.1016/j.jamda.2009.08.012; MAHONEY F I, 1965, Md State Med J, V14, P61; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Min LC, 2005, J AM GERIATR SOC, V53, P1705, DOI 10.1111/j.1532-5415.2005.53520.x; Min LC, 2007, MED CARE, V45, P480, DOI 10.1097/MLR.0b013e318030fff9; Moro ML, 2007, INFECTION, V35, P250, DOI 10.1007/s15010-007-6200-2; Osservatorio nazionale sulla salute nelle regioni italiane, RAPP OSS 2012; Palmer MH, 2003, J AM GERIATR SOC, V51, P1810, DOI 10.1046/j.1532-5415.2003.51570.x; PARMELEE PA, 1995, J AM GERIATR SOC, V43, P130, DOI 10.1111/j.1532-5415.1995.tb06377.x; Pfeiffer E, 1975, J Long Term Care Adm, V3, P16; Saliba Debra, 2004, J Am Med Dir Assoc, V5, P297, DOI 10.1016/S1525-8610(04)70019-5; Saliba Debra, 2004, J Am Med Dir Assoc, V5, P310, DOI 10.1016/S1525-8610(04)70020-1; Schnelle JF, 2003, MED CARE, V41, P909, DOI 10.1097/00005650-200308000-00005; Shah SM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d912; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; StataCorp, 2009, STAT REL 11; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008; Wenger NS, 2001, ANN INTERN MED, V135, P642, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00002	29	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93064	10.1371/journal.pone.0093064	http://dx.doi.org/10.1371/journal.pone.0093064			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SW	24675745	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677500069
J	Vincent, AG; Sundqvist, MK; Wardle, DA; Giesler, R				Vincent, Andrea G.; Sundqvist, Maja K.; Wardle, David A.; Giesler, Reiner			Bioavailable Soil Phosphorus Decreases with Increasing Elevation in a Subarctic Tundra Landscape	PLOS ONE			English	Article							NITROGEN MINERALIZATION; HEDLEY FRACTIONATION; ORGANIC PHOSPHORUS; LITTER DECOMPOSITION; PHOSPHATE SORPTION; IRON ACCUMULATION; MOUNT KINABALU; BOREAL FORESTS; RAIN-FORESTS; ALUMINUM	Phosphorus (P) is an important macronutrient in arctic and subarctic tundra and its bioavailability is regulated by the mineralization of organic P. Temperature is likely to be an important control on P bioavailability, although effects may differ across contrasting plant communities with different soil properties. We used an elevational gradient in northern Sweden that included both heath and meadow vegetation types at all elevations to study the effects of temperature, soil P sorption capacity and oxalate-extractable aluminium (Al-ox) and iron (Fe-ox) on the concentration of different soil P fractions. We hypothesized that the concentration of labile P fractions would decrease with increasing elevation (and thus declining temperature), but would be lower in meadow than in heath, given that N to P ratios in meadow foliage are higher. As expected, labile P in the form of Resin-P declined sharply with elevation for both vegetation types. Meadow soils did not have lower concentrations of Resin-P than heath soils, but they did have 2-fold and 1.5-fold higher concentrations of NaOH-extractable organic P and Residual P, respectively. Further, meadow soils had 3-fold higher concentrations of Al-ox + Feox and a 20% higher P sorption index than did heath soils. Additionally, Resin-P expressed as a proportion of total soil P for the meadow was on average half that in the heath. Declining Resin-P concentrations with elevation were best explained by an associated 2.5-3.0 degrees C decline in temperature. In contrast, the lower P availability in meadow relative to heath soils may be associated with impaired organic P mineralization, as indicated by a higher accumulation of organic P and P sorption capacity. Our results indicate that predicted temperature increases in the arctic over the next century may influence P availability and biogeochemistry, with consequences for key ecosystem processes limited by P, such as primary productivity.	[Vincent, Andrea G.; Giesler, Reiner] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Vincent, Andrea G.; Sundqvist, Maja K.; Wardle, David A.] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden; [Giesler, Reiner] Umea Univ, Climate Impacts Res Ctr, Dept Ecol & Environm Sci, Umea, Sweden	Umea University; Swedish University of Agricultural Sciences; Umea University	Vincent, AG (corresponding author), Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden.	vincent.andrea@gmail.com	Sundqvist, Maja/C-6100-2015; Wardle, David A./F-6031-2011; Vincent, Andrea G./C-3989-2013	Sundqvist, Maja/0000-0001-5947-839X; Wardle, David A./0000-0002-0476-7335; Vincent, Andrea G./0000-0002-4301-0351	Wallenberg Scholars award; Centre for Environmental Research in Umea (CMF) [0632292]	Wallenberg Scholars award; Centre for Environmental Research in Umea (CMF)	This project was funded by a Wallenberg Scholars award to DAW (http://www.wallenberg.com/kaw/) and a grant from the Centre for Environmental Research in Umea (CMF) to DAW and RG (grant number 0632292; http://www8.umu.se/cmf/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achat DL, 2013, BIOGEOSCIENCES, V10, P733, DOI 10.5194/bg-10-733-2013; [Anonymous], 2005, ARCTIC CLIMATE IMPAC; BACHE BW, 1971, J SOIL SCI, V22, P289, DOI 10.1111/j.1365-2389.1971.tb01617.x; Binkley D, 2000, FOREST ECOL MANAG, V128, P241, DOI 10.1016/S0378-1127(99)00138-3; Bjork RG, 2007, PLANT SOIL, V294, P247, DOI 10.1007/s11104-007-9250-4; Brady NC., 1999, NATURE PROPERTIES SO; Bragazza L, 2013, NAT CLIM CHANGE, V3, P273, DOI [10.1038/nclimate1781, 10.1038/NCLIMATE1781]; Buurman P, 1996, MANUAL SOIL WATER AN; Celi L, 1999, SOIL SCI, V164, P574, DOI 10.1097/00010694-199908000-00005; Celi L., 2005, Organic phosphorus in the environment, P113, DOI 10.1079/9780851998220.0113; CHAPIN FS, 1978, OIKOS, V31, P189, DOI 10.2307/3543562; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Condron LM, 2011, J SOIL SEDIMENT, V11, P830, DOI 10.1007/s11368-011-0363-2; CROSS AF, 1995, GEODERMA, V64, P197, DOI 10.1016/0016-7061(94)00023-4; Dell'Olio LA, 2008, SOIL SCI, V173, P119, DOI [10.1097/ss.0b013e31815d8eb7, 10.1097/SS.0b013e31815d8eb7]; Dieter D, 2010, CATENA, V82, P118, DOI 10.1016/j.catena.2010.05.010; Eskelinen A, 2009, OECOLOGIA, V161, P113, DOI 10.1007/s00442-009-1362-5; Frossard E, 2000, J ENVIRON QUAL, V29, P15, DOI 10.2134/jeq2000.00472425002900010003x; Fukami T, 2005, P ROY SOC B-BIOL SCI, V272, P2105, DOI 10.1098/rspb.2005.3277; Gerke J, 2010, SOIL SCI, V175, P417, DOI 10.1097/SS.0b013e3181f1b4dd; GIBLIN AE, 1991, ECOL MONOGR, V61, P415, DOI 10.2307/2937049; Giesler R, 2005, SOIL SCI SOC AM J, V69, P77; Giesler R, 2004, ECOSYSTEMS, V7, P208, DOI 10.1007/s10021-003-0223-z; Giesler R, 2002, ECOSYSTEMS, V5, P300, DOI 10.1007/s10021-001-0073-5; Giesler R, 2012, BIOGEOCHEMISTRY, V108, P429, DOI 10.1007/s10533-011-9609-8; Girardin CAJ, 2013, GLOBAL BIOGEOCHEM CY, V27, P252, DOI 10.1029/2011GB004082; GUZMAN G, 1994, PLANT SOIL, V159, P219, DOI 10.1007/BF00009284; HEDLEY MJ, 1994, PLANT SOIL, V158, P53, DOI 10.1007/BF00007917; HEDLEY MJ, 1982, SOIL SCI SOC AM J, V46, P970, DOI 10.2136/sssaj1982.03615995004600050017x; Hoch G, 2012, GLOBAL ECOL BIOGEOGR, V21, P861, DOI 10.1111/j.1466-8238.2011.00731.x; Jansson M, 2008, ECOSYSTEMS, V11, P367, DOI 10.1007/s10021-008-9127-2; Jenny H, 1994, FACTORS SOIL FORMATI, P104; Johnson AH, 2003, OECOLOGIA, V135, P487, DOI 10.1007/s00442-002-1164-5; Jonasson S, 1999, ECOLOGY, V80, P1828, DOI 10.1890/0012-9658(1999)080[1828:RIMAPT]2.0.CO;2; JONASSON S, 1993, OECOLOGIA, V95, P179, DOI 10.1007/BF00323488; Kang J, 2009, SOIL SCI SOC AM J, V73, P360, DOI 10.2136/sssaj2008.0113; Kardol P, 2010, ECOLOGY, V91, P767, DOI 10.1890/09-0135.1; Karlsson J, 2005, GLOBAL CHANGE BIOL, V11, P710, DOI 10.1111/j.1365-2486.2005.00945.x; Kitayama K, 1998, ECOL RES, V13, P301, DOI 10.1046/j.1440-1703.1998.00264.x; Kitayama K, 2000, OECOLOGIA, V123, P342, DOI 10.1007/s004420051020; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kohler J, 2006, POLAR RES, V25, P91, DOI 10.1111/j.1751-8369.2006.tb00026.x; Lagerstrom A, 2009, BIOGEOCHEMISTRY, V95, P199, DOI 10.1007/s10533-009-9331-y; LITAOR MI, 1992, CATENA, V19, P1, DOI 10.1016/0341-8162(92)90013-2; LIU LX, 1992, CAN J SOIL SCI, V72, P159, DOI 10.4141/cjss92-015; MCBRIDE M, 1989, SOIL SCI SOC AM J, V53, P1668, DOI 10.2136/sssaj1989.03615995005300060009x; MCKEAGUE JA, 1966, CAN J SOIL SCI, V46, P13, DOI 10.4141/cjss66-003; Milbau A, 2013, NEW PHYTOL, V197, P1002, DOI 10.1111/nph.12054; Nadelhoffer KJ, 2002, PLANT SOIL, V242, P107, DOI 10.1023/A:1019646124768; Nieminen M, 1996, SCAND J FOREST RES, V11, P321, DOI 10.1080/02827589609382942; OGNALAGA M, 1994, SOIL SCI SOC AM J, V58, P332, DOI 10.2136/sssaj1994.03615995005800020011x; Quinn G.P., 2002, EXPT DESIGN DATA ANA; RICHARDSON CJ, 1985, SCIENCE, V228, P1424, DOI 10.1126/science.228.4706.1424; Rui YC, 2012, PLANT SOIL, V357, P73, DOI 10.1007/s11104-012-1132-8; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; SAGGAR S, 1990, FERT RES, V24, P173, DOI 10.1007/BF01073586; Salinas N, 2011, NEW PHYTOL, V189, P967, DOI 10.1111/j.1469-8137.2010.03521.x; Schimel JP, 2004, SOIL BIOL BIOCHEM, V36, P217, DOI 10.1016/j.soilbio.2003.09.008; Schmidt IK, 2002, PLANT SOIL, V242, P93, DOI 10.1023/A:1019642007929; SHAVER GR, 1995, ECOGRAPHY, V18, P259, DOI 10.1111/j.1600-0587.1995.tb00129.x; SIBBESEN E, 1978, PLANT SOIL, V50, P305, DOI 10.1007/BF02107180; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; STARK S, 2007, NUTR CYCLING TERREST, P309, DOI DOI 10.1007/978-3-540-68027-7_11; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Sundqvist MK, 2012, FUNCT ECOL, V26, P1090, DOI 10.1111/j.1365-2435.2012.02034.x; Sundqvist MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027056; Sundqvist MK, 2011, OIKOS, V120, P128, DOI 10.1111/j.1600-0706.2010.18811.x; Sundqvist MK, 2013, ANN REV ECO IN PRESS; SVEINBJORNSSON B, 1995, ARCTIC ALPINE RES, V27, P29, DOI 10.2307/1552065; Tiessen H., 1993, SOIL SAMPLING METHOD, P75, DOI [10.1201/9781420005271.ch25, DOI 10.1201/9781420005271.CH25]; Turner BL, 2004, SOIL BIOL BIOCHEM, V36, P815, DOI 10.1016/j.soilbio.2004.01.011; Vestergren J, 2012, ENVIRON SCI TECHNOL, V46, P3950, DOI 10.1021/es204016h; Vincent AG, 2013, PLANT SOIL, V367, P149, DOI 10.1007/s11104-013-1731-z; Vincent AG, 2012, BIOGEOCHEMISTRY, V108, P485, DOI 10.1007/s10533-011-9612-0; VITOUSEK PM, 1994, ECOLOGY, V75, P418, DOI 10.2307/1939545; VITOUSEK PM, 1988, OECOLOGIA, V77, P565, DOI 10.1007/BF00377275; Wallenstein MD, 2009, GLOBAL CHANGE BIOL, V15, P1631, DOI 10.1111/j.1365-2486.2008.01819.x; Wang SJ, 2009, SOIL BIOL BIOCHEM, V41, P891, DOI 10.1016/j.soilbio.2008.12.016; Wardle DA, 2008, OIKOS, V117, P93, DOI 10.1111/j.2007.0030-1299.16130.x; Weintraub MN, 2011, SOIL BIOL, V26, P295, DOI 10.1007/978-3-642-15271-9_12; Yang X, 2011, BIOGEOSCIENCES, V8, P2907, DOI 10.5194/bg-8-2907-2011; Zar J.H., 1996, BIOSTAT ANAL	82	39	44	7	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92942	10.1371/journal.pone.0092942	http://dx.doi.org/10.1371/journal.pone.0092942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676035	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677500058
J	Peano, C; Chiaramonte, F; Motta, S; Pietrelli, A; Jaillon, S; Rossi, E; Consolandi, C; Champion, OL; Michell, SL; Freddi, L; Falciola, L; Basilico, F; Garlanda, C; Mauri, P; De Bellis, G; Landini, P				Peano, Clelia; Chiaramonte, Fabrizio; Motta, Sara; Pietrelli, Alessandro; Jaillon, Sebastien; Rossi, Elio; Consolandi, Clarissa; Champion, Olivia L.; Michell, Stephen L.; Freddi, Luca; Falciola, Luigi; Basilico, Fabrizio; Garlanda, Cecilia; Mauri, Pierluigi; De Bellis, Gianluca; Landini, Paolo			Gene and Protein Expression in Response to Different Growth Temperatures and Oxygen Availability in Burkholderia thailandensis	PLOS ONE			English	Article							RNA DEGRADOSOME COMPOSITION; ESCHERICHIA-COLI; CAPSULAR POLYSACCHARIDE; VIRULENCE GENES; PSEUDOMALLEI; IDENTIFICATION; ADAPTATION; INFECTION; FLAGELLA; MALLEI	Burkholderia thailandensis, although normally avirulent for mammals, can infect macrophages in vitro and has occasionally been reported to cause pneumonia in humans. It is therefore used as a model organism for the human pathogen B. pseudomallei, to which it is closely related phylogenetically. We characterized the B. thailandensis clinical isolate CDC2721121 (BtCDC272) at the genome level and studied its response to environmental cues associated with human host colonization, namely, temperature and oxygen limitation. Effects of the different growth conditions on BtCDC272 were studied through whole genome transcription studies and analysis of proteins associated with the bacterial cell surface. We found that growth at 37 degrees C, compared to 28 degrees C, negatively affected cell motility and flagella production through a mechanism involving regulation of the flagellin-encoding fliC gene at the mRNA stability level. Growth in oxygen-limiting conditions, in contrast, stimulated various processes linked to virulence, such as lipopolysaccharide production and expression of genes encoding protein secretion systems. Consistent with these observations, BtCDC272 grown in oxygen limitation was more resistant to phagocytosis and strongly induced the production of inflammatory cytokines from murine macrophages. Our results suggest that, while temperature sensing is important for regulation of B. thailandensis cell motility, oxygen limitation has a deeper impact on its physiology and constitutes a crucial environmental signal for the production of virulence factors.	[Peano, Clelia; Motta, Sara; Pietrelli, Alessandro; Consolandi, Clarissa; Basilico, Fabrizio; Mauri, Pierluigi; De Bellis, Gianluca] CNR, Inst Biomed Technol, Milan, Italy; [Chiaramonte, Fabrizio; Rossi, Elio; Freddi, Luca; Landini, Paolo] Univ Milan, Dept Biosci, Milan, Italy; [Jaillon, Sebastien; Garlanda, Cecilia] Humanitas Clin & Res Ctr Inst, Milan, Italy; [Champion, Olivia L.; Michell, Stephen L.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Falciola, Luigi] Univ Milan, Dept Chem, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Milan; University of Exeter; University of Milan	Landini, P (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	paolo.landini@unimi.it	Freddi, Luca/ABG-1801-2020; Rossi, Elio/N-4802-2015; Pietrelli, Alessandro/J-4389-2016; Peano, Clelia/C-4015-2018; JAILLON, Sebastien/A-7537-2015; Mauri, Pietro Luigi/AAC-3095-2019; Garlanda, Cecilia/K-4601-2016; De Bellis, Gianluca/H-9725-2013; MOTTA, SARA/P-9635-2018; Landini, Paolo/B-7859-2017; Falciola, Luigi/Q-2256-2016	Rossi, Elio/0000-0002-2042-608X; Pietrelli, Alessandro/0000-0003-0241-8542; Peano, Clelia/0000-0001-7055-3629; JAILLON, Sebastien/0000-0002-5600-855X; Mauri, Pietro Luigi/0000-0003-4364-0393; Garlanda, Cecilia/0000-0002-1510-7703; De Bellis, Gianluca/0000-0002-1622-4477; MOTTA, SARA/0000-0001-8421-6287; Landini, Paolo/0000-0003-0999-426X; Falciola, Luigi/0000-0002-2031-239X; Freddi, Luca/0000-0002-3395-4113	Fondazione CARIPLO (Progetto Vaccini) [2009-3577]; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [FIRB RBLA039LSF]	Fondazione CARIPLO (Progetto Vaccini)(Fondazione Cariplo); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by Fondazione CARIPLO (Progetto Vaccini, contract number 2009-3577) and by Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (project FIRB RBLA039LSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; Braaten RO, 2000, AQUACULT ENG, V23, P295, DOI 10.1016/S0144-8609(00)00059-5; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Burtnick MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076767; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Chua KL, 2003, INFECT IMMUN, V71, P1622, DOI 10.1128/IAI.71.4.1622-1629.2003; Chuaygud T, 2008, T ROY SOC TROP MED H, V102, P140; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Comunian C, 2011, PROTEOMICS, V11, P2320, DOI 10.1002/pmic.201000479; CONDON C, 1995, MICROBIOL REV, V59, P623, DOI 10.1128/MMBR.59.4.623-645.1995; DeShazer D, 1997, J BACTERIOL, V179, P2116, DOI 10.1128/jb.179.7.2116-2125.1997; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fisher NA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-117; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Glass MB, 2006, J CLIN MICROBIOL, V44, P4601, DOI 10.1128/JCM.01585-06; Gualdi L, 2007, J BACTERIOL, V189, P8034, DOI 10.1128/JB.00900-07; Hamad MA, 2011, ANTIMICROB AGENTS CH, V55, P3313, DOI 10.1128/AAC.00953-10; Jensen PO, 2007, MICROBIOL-SGM, V153, P1329, DOI 10.1099/mic.0.2006/003863-0; Kamp HD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002153; Kim HS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-174; Lacqua A, 2006, APPL ENVIRON MICROB, V72, P956, DOI 10.1128/AEM.72.1.956-959.2006; Lertpatanasuwan N, 1999, CLIN INFECT DIS, V28, P927, DOI 10.1086/517253; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loferer H, 1997, MOL MICROBIOL, V26, P11, DOI 10.1046/j.1365-2958.1997.5231883.x; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; MASKELL JP, 1991, J MED MICROBIOL, V34, P253, DOI 10.1099/00222615-34-5-253; Mauri P, 2005, FASEB J, V19, P1125, DOI 10.1096/fj.04-3000fje; Mauri P, 2008, METHOD ENZYMOL, V447, P99, DOI 10.1016/S0076-6879(08)02206-4; Moalli F, 2010, BLOOD, V116, P5170, DOI 10.1182/blood-2009-12-258376; Nachin L, 2005, J BACTERIOL, V187, P6265, DOI 10.1128/JB.187.18.6265-6272.2005; O'Quinn AL, 2001, CELL MICROBIOL, V3, P381, DOI 10.1046/j.1462-5822.2001.00118.x; Ooi WF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003795; Palma CA, 2010, J AM CHEM SOC, V132, P17880, DOI 10.1021/ja107882e; Peano Clelia, 2013, Microb Inform Exp, V3, P1, DOI 10.1186/2042-5783-3-1; Pessi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072939; Pilatova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049745; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; Regonesi ME, 2006, BIOCHIMIE, V88, P151, DOI 10.1016/j.biochi.2005.07.012; Sass AM, 2013, ISME J, V7, P1568, DOI 10.1038/ismej.2013.36; Schell MA, 2011, J PROTEOME RES, V10, P2417, DOI 10.1021/pr1012398; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Sim BMQ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r89; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smith MD, 1997, INFECT IMMUN, V65, P4319, DOI 10.1128/IAI.65.10.4319-4321.1997; Soini J, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-30; Tomich M, 2002, INFECT IMMUN, V70, P1799, DOI 10.1128/IAI.70.4.1799-1806.2002; Wand ME, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-11; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Winsor GL, 2008, BIOINFORMATICS, V24, P2803, DOI 10.1093/bioinformatics/btn524; Yu YT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-46; Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6	54	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93009	10.1371/journal.pone.0093009	http://dx.doi.org/10.1371/journal.pone.0093009			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671187	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000100
J	Wang, ZK; Gao, JN; Song, HY; Wu, XM; Sun, Y; Qi, J; Yu, HY; Wang, ZG; Zhang, QQ				Wang, Zhongkai; Gao, Jinning; Song, Huayu; Wu, Xiaomeng; Sun, Yan; Qi, Jie; Yu, Haiyang; Wang, Zhigang; Zhang, Quanqi			Sexually Dimorphic Expression of vasa Isoforms in the Tongue Sole (Cynoglossus semilaevis)	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; GREEN FLUORESCENT PROTEIN; INITIATION-FACTOR 4A; GENOME-WIDE ANALYSIS; DEAD-BOX PROTEINS; TRANSLATION INITIATION; RNA HELICASE; DIFFERENTIAL EXPRESSION; CRYSTAL-STRUCTURE; HOMOLOG GENE	The vasa gene encodes an ATP-dependent RNA helicase of the DEAD box protein family that functions in a broad range of molecular events involving duplex RNA. In most species, the germline specific expression of vasa becomes a molecular marker widely used in the visualization and labeling of primordial germ cells (PGCs) and a tool in surrogate broodstock production through PGC transplantation. The vasa gene from tongue sole (Cynoglossus semilaevis) was characterized to promote the development of genetic breeding techniques in this species. Three C. semilaevis vasa transcripts were isolated, namely vas-l, vas-m, and vas-s. Quantitative real-time PCR results showed that C. semilaevis vasa transcripts were prevalently expressed in gonads, with very weak expression of vas-s in other tissues. Embryonic development expression profiles revealed the onset of zygotic transcription of vasa mRNAs and the maternal deposit of the three transcripts. The genetic ZW female juvenile fish was discriminated from genetic ZZ males by a pair of female specific primers. Only the expression of vas-s can be observed in both sexes during early gonadal differentiation. Before PGCs started mitosis, there was sexually dimorphic expression of vas-s with the ovary showing higher levels and downward trend. The results demonstrated the benefits of vasa as a germline specific marker for PGCs during embryonic development and gonadal differentiation. This study lays the groundwork for further application of C. semilaevis PGCs in fish breeding.	[Wang, Zhongkai; Gao, Jinning; Song, Huayu; Wu, Xiaomeng; Sun, Yan; Qi, Jie; Yu, Haiyang; Wang, Zhigang; Zhang, Quanqi] Ocean Univ China, Key Lab Marine Genet & Breeding MGB, Minist Educ, Coll Marine Life Sci, Qingdao, Peoples R China	Ocean University of China	Zhang, QQ (corresponding author), Ocean Univ China, Key Lab Marine Genet & Breeding MGB, Minist Educ, Coll Marine Life Sci, Qingdao, Peoples R China.	qzhang@ouc.edu.cn		wang, zhongkai/0000-0001-8909-7790	National High-Tech Research and Development Program [2012AA10A402]; National Natural Science Foundation of China [31172385]	National High-Tech Research and Development Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High-Tech Research and Development Program (2012AA10A402) and the National Natural Science Foundation of China (31172385). The URL is http://www.863.gov.cn and http://www.nsfc.gov.cn/Portal0/default152.htm, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Benz J, 1999, STRUCTURE, V7, P671, DOI 10.1016/S0969-2126(99)80088-4; Blazquez M, 2011, GEN COMP ENDOCR, V170, P322, DOI 10.1016/j.ygcen.2010.10.007; BLUM S, 1992, P NATL ACAD SCI USA, V89, P7664, DOI 10.1073/pnas.89.16.7664; Cao MX, 2012, COMP BIOCHEM PHYS A, V162, P163, DOI 10.1016/j.cbpa.2012.02.007; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Chen SL, 2014, NAT GENET, V46, P253, DOI 10.1038/ng.2890; Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272; Fairchild EA, 2007, J WORLD AQUACULT SOC, V38, P114, DOI 10.1111/j.1749-7345.2006.00079.x; Feng ZF, 2011, AQUACULTURE, V314, P202, DOI 10.1016/j.aquaculture.2011.02.017; Fujimura K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029477; Fujimura M, 2000, DEV GENES EVOL, V210, P64, DOI 10.1007/s004270050012; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Gao JN, 2013, GENE, V531, P411, DOI 10.1016/j.gene.2013.08.030; Gavis ER, 1996, DEVELOPMENT, V122, P2791; Gruidl ME, 1996, P NATL ACAD SCI USA, V93, P13837, DOI 10.1073/pnas.93.24.13837; Herpin A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-3; Ikenishi K, 2000, DEV GROWTH DIFFER, V42, P95; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Kobayashi T, 2003, FISH PHYSIOL BIOCHEM, V28, P479, DOI 10.1023/B:FISH.0000030634.37486.fa; Kobayashi T, 2002, MECH DEVELOP, V111, P167, DOI 10.1016/S0925-4773(01)00613-X; Kobayashi T, 2000, MECH DEVELOP, V99, P139, DOI 10.1016/S0925-4773(00)00464-0; Kobayashi T, 2007, MOL REPROD DEV, V74, P207, DOI 10.1002/mrd.20577; KOMIYA T, 1994, DEV BIOL, V162, P354, DOI 10.1006/dbio.1994.1093; Krovel AV, 2004, DEV BIOL, V271, P190, DOI 10.1016/j.ydbio.2004.04.004; Krovel AV, 2002, MECH DEVELOP, V116, P141, DOI 10.1016/S0925-4773(02)00154-5; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lin F, 2012, MOL REPROD DEV, V79, P803, DOI 10.1002/mrd.22120; [马学坤 MA Xuekun], 2006, [海洋水产研究, Marine Fisheries Research], V27, P55; Mallam AL, 2012, NATURE, V490, P121, DOI 10.1038/nature11402; Markussen FH, 1997, COLD SPRING HARB SYM, V62, P13; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; Mochizuki K, 2001, DEV GENES EVOL, V211, P299, DOI 10.1007/s004270100156; Nagasawa K, 2008, FISHERIES SCI, V75, P71; Okutsu T, 2006, P NATL ACAD SCI USA, V103, P2725, DOI 10.1073/pnas.0509218103; Olsen LC, 1997, MECH DEVELOP, V66, P95, DOI 10.1016/S0925-4773(97)00099-3; Pacchiarini T, 2013, REPROD FERT DEVELOP, V25, P646, DOI 10.1071/RD11240; PAUSE A, 1993, MOL CELL BIOL, V13, P6789, DOI 10.1128/MCB.13.11.6789; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Pugh GE, 1999, J MOL BIOL, V292, P771, DOI 10.1006/jmbi.1999.3112; Raghuveer K, 2010, COMP BIOCHEM PHYS A, V157, P79, DOI 10.1016/j.cbpa.2010.04.017; Rocak S, 2005, NUCLEIC ACIDS RES, V33, P999, DOI 10.1093/nar/gki244; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4; ROZEN F, 1989, MOL CELL BIOL, V9, P4061, DOI 10.1128/MCB.9.9.4061; Saito T, 2008, BIOL REPROD, V78, P159, DOI 10.1095/biolreprod.107.060038; Saito T, 2010, INT J DEV BIOL, V54, P1481, DOI 10.1387/ijdb.103111ts; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHUPBACH T, 1986, DEV BIOL, V113, P443, DOI 10.1016/0012-1606(86)90179-X; Schwer B, 2000, EMBO J, V19, P6582, DOI 10.1093/emboj/19.23.6582; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101; Shibata N, 1999, DEV BIOL, V206, P73, DOI 10.1006/dbio.1998.9130; Shinomiya A, 2000, DEV GROWTH DIFFER, V42, P317; Siddiqui NU, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r11; Takeuchi Y, 2003, BIOL REPROD, V69, P1142, DOI 10.1095/biolreprod.103.017624; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka M, 2001, P NATL ACAD SCI USA, V98, P2544, DOI 10.1073/pnas.041315498; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Thomsen S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r93; Tomancak P, 1998, DEVELOPMENT, V125, P1723; Tsunekawa N, 2000, DEVELOPMENT, V127, P2741; Vesterlund L, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-30; Wang XB, 2013, AQUACULTURE, V388, P49, DOI 10.1016/j.aquaculture.2013.01.024; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Wu XM, 2014, COMP BIOCHEM PHYS B, V167, P41, DOI 10.1016/j.cbpb.2013.06.004; Xu HY, 2005, DEV DYNAM, V233, P872, DOI 10.1002/dvdy.20410; Yang HX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064799, 10.1371/journal.pone.0064058]; Yang Q, 2007, MOL CELL, V28, P253, DOI 10.1016/j.molcel.2007.08.016; Yang QS, 2006, NAT STRUCT MOL BIOL, V13, P981, DOI 10.1038/nsmb1165; Yoon C, 1997, DEVELOPMENT, V124, P3157; Yoshizaki G, 2000, INT J DEV BIOL, V44, P323; Yoshizaki G, 2000, MOL REPROD DEV, V55, P364, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;364::AID-MRD2&gt;3.0.CO;2-8	75	6	8	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93380	10.1371/journal.pone.0093380	http://dx.doi.org/10.1371/journal.pone.0093380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671276	gold, Green Submitted, Green Published			2022-12-27	WOS:000333677000137
J	Zhang, B; Chen, SY; He, XY; Liu, WJ; Zhao, Q; Zhao, L; Tian, CJ				Zhang, Bin; Chen, Shengyun; He, Xingyuan; Liu, Wenjie; Zhao, Qian; Zhao, Lin; Tian, Chunjie			Responses of Soil Microbial Communities to Experimental Warming in Alpine Grasslands on the Qinghai-Tibet Plateau	PLOS ONE			English	Article							CLIMATE-CHANGE MANIPULATIONS; CARBON-CYCLE FEEDBACK; DYNAMICS; BACTERIA; FUNGI; MICROORGANISMS; TEMPERATURE; MOISTURE; LITTER; GROWTH	Global surface temperature is predicted to increase by at least 1.5 degrees C by the end of this century. However, the response of soil microbial communities to global warming is still poorly understood, especially in high-elevation grasslands. We therefore conducted an experiment on three types of alpine grasslands on the Qinghai-Tibet Plateau to study the effect of experimental warming on abundance and composition of soil microbial communities at 0-10 and 10-20 cm depths. Plots were passively warmed for 3 years using open-top chambers and compared to adjacent control plots at ambient temperature. Soil microbial communities were assessed using phospholipid fatty acid (PLFA) analysis. We found that 3 years of experimental warming consistently and significantly increased microbial biomass at the 0-10 cm soil depth of alpine swamp meadow (ASM) and alpine steppe (AS) grasslands, and at both the 0-10 and 10-20 cm soil depths of alpine meadow (AM) grasslands, due primarily to the changes in soil temperature, moisture, and plant coverage. Soil microbial community composition was also significantly affected by warming at the 0-10 cm soil depth of ASM and AM and at the 10-20 cm soil depth of AM. Warming significantly decreased the ratio of fungi to bacteria and thus induced a community shift towards bacteria at the 0-10 cm soil depth of ASM and AM. While the ratio of arbuscular mycorrhizal fungi to saprotrophic fungi (AMF/SF) was significantly decreased by warming at the 0-10 cm soil depth of ASM, it was increased at the 0-10 cm soil depth of AM. These results indicate that warming had a strong influence on soil microbial communities in the studied high-elevation grasslands and that the effect was dependent on grassland type.	[Zhang, Bin; He, Xingyuan; Tian, Chunjie] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China; [Chen, Shengyun; Liu, Wenjie; Zhao, Qian; Zhao, Lin] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, State Key Lab Cryospher Sci, Lanzhou, Peoples R China; [Zhao, Lin] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Observat & Res Stn Qinghai Tibet Plateau, Golmud, Peoples R China	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Tian, CJ (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China.	tiancj@iga.ac.cn	Zhang, Bangzhou/CAG-9625-2022; Cai, Guanjing/GZK-7070-2022; Zhao, Lin/M-9536-2018	Zhao, Lin/0000-0003-0245-8413	National Basic Research Program of China (973 program) [2013CBA01807]; Science Foundation of Chinese Academy of Sciences [KZZD-EW-TZ-16]; National Natural Science Foundation of China [Y4E1041001, 40901040]; Natural Science Foundation of Jilin Province [20130101080JC]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Science Foundation of Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province	This work was financially supported by the National Basic Research Program of China (973 program, 2013CBA01807, http://www.973.gov.cn/Default_3.aspx), the Science Foundation of Chinese Academy of Sciences (KZZD-EW-TZ-16, http://www.cas.cn/), the National Natural Science Foundation of China (Y4E1041001,40901040, http://www.nsfc.gov.cn/) and the Natural Science Foundation of Jilin Province (20130101080JC, http://kjt.jl.gov.cn/kjt/4/tindex.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CLIM CHANG 2013 PHYS; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Berg N, 2008, SOIL BIOL BIOCHEM, V40, P2686, DOI 10.1016/j.soilbio.2008.07.019; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; Brockett BFT, 2012, SOIL BIOL BIOCHEM, V44, P9, DOI 10.1016/j.soilbio.2011.09.003; [陈生云 Chen Shengyun], 2012, [冰川冻土, Journal of Glaciology and Geocryology], V34, P1142; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Crowther TW, 2012, ISME J, V6, P1992, DOI 10.1038/ismej.2012.53; Deslippe JR, 2012, FEMS MICROBIOL ECOL, V82, P303, DOI 10.1111/j.1574-6941.2012.01350.x; Eklof JS, 2012, ECOL LETT, V15, P864, DOI 10.1111/j.1461-0248.2012.01810.x; Frey SD, 2008, SOIL BIOL BIOCHEM, V40, P2904, DOI 10.1016/j.soilbio.2008.07.020; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Grimm NB, 2013, FRONT ECOL ENVIRON, V11, P474, DOI 10.1890/120282; Guo DL, 2012, INT J CLIMATOL, V32, P1775, DOI 10.1002/joc.2388; Haugwitz MS, 2014, PLANT SOIL, V374, P211, DOI 10.1007/s11104-013-1855-1; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Posada RH, 2012, FUNGAL BIOL-UK, V116, P747, DOI 10.1016/j.funbio.2012.04.003; Institute of Soil Sciences Chinese Academy of Sciences, 1978, PHYS CHEM AN METH SO, P7; IUSS Working Group WRB, 2006, WORLD REFERENCE BASE, V103; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Jackson RB, 2007, ECOLOGY, V88, P1343, DOI 10.1890/06-1882; KIEFT TL, 1994, APPL ENVIRON MICROB, V60, P3292, DOI 10.1128/AEM.60.9.3292-3299.1994; Klein JA, 2005, GLOBAL CHANGE BIOL, V11, P1440, DOI 10.1111/j.1365-2486.2005.00994.x; Liang C, 2012, APPL SOIL ECOL, V54, P24, DOI 10.1016/j.apsoil.2011.11.015; Liu WX, 2009, GLOBAL CHANGE BIOL, V15, P184, DOI 10.1111/j.1365-2486.2008.01728.x; Liu WJ, 2014, ENV RES LET IN PRESS; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Luo CY, 2010, GLOBAL CHANGE BIOL, V16, P1606, DOI 10.1111/j.1365-2486.2009.02026.x; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Margesin R, 2009, FEMS MICROBIOL ECOL, V67, P208, DOI 10.1111/j.1574-6941.2008.00620.x; Marion GM, 1997, GLOB CHANGE BIOL, V3, P20, DOI 10.1111/j.1365-2486.1997.gcb136.x; Mille-Lindblom C, 2006, OIKOS, V113, P233, DOI 10.1111/j.2006.0030-1299.14337.x; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; R Core Team, 2013, R LANG ENV STAT COMP; Rinnan R, 2007, GLOBAL CHANGE BIOL, V13, P28, DOI 10.1111/j.1365-2486.2006.01263.x; Rousk J, 2011, FEMS MICROBIOL ECOL, V78, P17, DOI 10.1111/j.1574-6941.2011.01106.x; Sheik CS, 2011, ISME J, V5, P1692, DOI 10.1038/ismej.2011.32; VESTAL JR, 1989, BIOSCIENCE, V39, P535, DOI 10.2307/1310976; Wen Z, 2014, ENVIRON EARTH SCI, V71, P1195, DOI 10.1007/s12665-013-2523-8; Wixon DL, 2013, SOIL BIOL BIOCHEM, V57, P769, DOI 10.1016/j.soilbio.2012.08.016; Yergeau E, 2012, ISME J, V6, P692, DOI 10.1038/ismej.2011.124; Yuan YL, 2014, FEMS MICROBIOL ECOL, V87, P121, DOI 10.1111/1574-6941.12197; Zhang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066184; Zhang B, 2012, SOIL TILL RES, V124, P153, DOI 10.1016/j.still.2012.05.011; Zhang NL, 2013, OECOLOGIA, V173, P1125, DOI 10.1007/s00442-013-2685-9; Zhang W, 2005, GLOBAL CHANGE BIOL, V11, P266, DOI 10.1111/j.1365-2486.2005.00902.x; Zhang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078616; Zhou JZ, 2012, NAT CLIM CHANGE, V2, P106, DOI 10.1038/NCLIMATE1331; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x	51	64	80	12	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103859	10.1371/journal.pone.0103859	http://dx.doi.org/10.1371/journal.pone.0103859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	24675867	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800091
J	Zhang, ZL; Wang, J; Chen, SF; Wei, ZY; Li, ZT; Zhao, SW; Lu, WJ				Zhang, Zili; Wang, Jian; Chen, Sifan; Wei, Zhaoyu; Li, Zhengtu; Zhao, Siwen; Lu, Wenju			Comparison of Vegetarian Diets and Omnivorous Diets on Plasma Level of HDL-c: A Meta-Analysis	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; SERUM-LIPIDS; RISK-FACTORS; METABOLIC SYNDROME; CHOLESTEROL; ASSOCIATION; CONSUMPTION; PREVENTION	Low plasma level of high density lipoprotein cholesterol (HDL-c) was an independent risk factor for cardio vascular disorder, and associated with poor outcomes in pulmonary arterial hypertension. To compare the effects of vegetarian diets and omnivorous diets on HDL-c in plasma, we identified cross-sectional and cohort studies related to HDL-c listed on PubMed and ISI Web of Knowledge as well as the corresponding references (until Nov, 2013). Twelve studies with a total of 4177 individuals were selected for meta-analysis. This meta-analysis indicates that vegetarian diets did not alter plasma HDL-c concentrations, as it wasn't initially expected by the authors [Standardized Mean Difference (SMD) = 0.02 mmol/l; 95% confidence interval (CI): -0.19 to 0.22 mmol/l]. In Asia and Latin America countries, no significant differences in HDL-c levels between vegetarians and omnivores were found (SMD = -0.09 mmol/l; 95% CI: -0.43 to 0.25 mmol/l). In Europe and North America countries, the plasma level of HDL-c was also not different between the two diets (SMD = 0.09 mmol/l; 95% CI: 2 0.19 to 0.36 mmol/l). In light of this meta-analysis, we conclude that there is no evidence that plasma HDL-c levels differs in vegetarians and omnivores, even after adjusting for cultural circumstances.	[Zhang, Zili; Wang, Jian; Li, Zhengtu; Lu, Wenju] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Chen, Sifan] Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, Guangzhou 510275, Guangdong, Peoples R China; [Wei, Zhaoyu] Guangzhou Med Univ, Dept Student Affairs, Guangzhou, Guangdong, Peoples R China; [Zhao, Siwen] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Sun Yat Sen University; Guangzhou Medical University; Guangzhou Medical University	Lu, WJ (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	wlu92@yahoo.com	Zhao, Qiongyi/B-4106-2014; Zhang, Zong Hong/N-9126-2013; Wray, Naomi/C-8639-2015; Bauer, Denis/C-3903-2009	Zhao, Qiongyi/0000-0002-6341-0416; Jhaveri, Dhanisha/0000-0002-5615-3546; Zhang, Zong Hong/0000-0002-8056-891X; Wray, Naomi/0000-0001-7421-3357; Edson, Janette/0000-0002-1864-0095; Bauer, Denis/0000-0001-8033-9810; Narayanan, Ramesh/0000-0001-8171-474X	NIH [R01-HL093020]; National Natural Science Foundation of China [81070043, 81173112, 81170052, 81220108001]; Guangdong Natural Science Foundation Team Grant [1035101200300000]; Guangzhou Department of Education Yangcheng Scholarship [10A058S, 12A001S]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093020] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation Team Grant; Guangzhou Department of Education Yangcheng Scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH (R01-HL093020), National Natural Science Foundation of China (81070043, 81173112, 81170052, 81220108001), Guangdong Natural Science Foundation Team Grant (1035101200300000), and Guangzhou Department of Education Yangcheng Scholarship (10A058S, 12A001S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander H, 1999, J AM COLL NUTR, V18, P127, DOI 10.1080/07315724.1999.10718840; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Assmann G, 1999, ARTERIOSCL THROM VAS, V19, P1819, DOI 10.1161/01.ATV.19.8.1819; Baer DJ, 2002, AM J CLIN NUTR, V75, P593, DOI 10.1093/ajcn/75.3.593; Barnard ND, 2000, AM J CARDIOL, V85, P969, DOI 10.1016/S0002-9149(99)00911-X; CASTELLI WP, 1977, CIRCULATION, V55, P767, DOI 10.1161/01.CIR.55.5.767; Chen CW, 2011, YONSEI MED J, V52, P13, DOI 10.3349/ymj.2011.52.1.13; CHOI SSY, 1994, J LIPID RES, V35, P848; Clarke R, 1997, BRIT MED J, V314, P112, DOI 10.1136/bmj.314.7074.112; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Craig WJ, 2009, J AM DIET ASSOC, V109, P1266, DOI 10.1016/j.jada.2009.05.027; De Biase SG, 2007, ARQ BRAS CARDIOL, V88, P35, DOI 10.1590/S0066-782X2007000100006; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Famodu AA, 1998, CLIN BIOCHEM, V31, P545, DOI 10.1016/S0009-9120(98)00067-8; Dourado KF, 2011, NUTR HOSP, V26, P959, DOI [10.3305/nh.2011.26.5.5108, 10.1590/S0212-16112011000500006]; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; HAMSTEN A, 1986, ATHEROSCLEROSIS, V60, P199, DOI 10.1016/0021-9150(86)90166-8; Harper CR, 1999, ARCH INTERN MED, V159, P1049, DOI 10.1001/archinte.159.10.1049; HELLER DA, 1993, NEW ENGL J MED, V328, P1150, DOI 10.1056/NEJM199304223281603; Heresi GA, 2010, AM J RESP CRIT CARE, V182, P661, DOI 10.1164/rccm.201001-0007OC; Hoffmann I, 2001, EUR J CLIN NUTR, V55, P887, DOI 10.1038/sj.ejcn.1601243; Kelley GA, 2012, CLIN NUTR, V31, P156, DOI 10.1016/j.clnu.2011.11.011; Krajcovicova-Kudlackova M, 2000, SCAND J CLIN LAB INV, V60, P657, DOI 10.1080/00365510050216385; Li D, 1999, EUR J CLIN NUTR, V53, P612, DOI 10.1038/sj.ejcn.1600817; Li D, 2001, CLIN SCI, V100, P25, DOI 10.1042/CS20000109; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; McCoy MG, 2002, J LIPID RES, V43, P921; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Teixeira RDMD, 2007, ARQ BRAS CARDIOL, V89, P237, DOI 10.1590/S0066-782X2007001600005; Papadaki A, 2008, PUBLIC HEALTH NUTR, V11, P1022, DOI 10.1017/S1368980007001498; PEKKANEN J, 1990, NEW ENGL J MED, V322, P1700, DOI 10.1056/NEJM199006143222403; Qin SC, 2000, J LIPID RES, V41, P269; Rader DJ, 1996, CURR OPIN LIPIDOL, V7, P117, DOI 10.1097/00041433-199606000-00002; Robinson F, 2002, J HUM NUTR DIET, V15, P323, DOI 10.1046/j.1365-277X.2002.00383.x; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rosengren A, 1997, EUR HEART J, V18, P754; SCOTT LW, 1994, ARCH INTERN MED, V154, P1261, DOI 10.1001/archinte.154.11.1261; SINCLAIR AJ, 1987, LIPIDS, V22, P523, DOI 10.1007/BF02540369; THOROGOOD M, 1987, BMJ-BRIT MED J, V295, P351, DOI 10.1136/bmj.295.6594.351; van der Gaag MS, 2001, J LIPID RES, V42, P2077; Vinagre JC, 2013, NUTR METAB CARDIOVAS, V23, P61, DOI 10.1016/j.numecd.2011.02.011; Vinagre JC, 2013, EUR J NUTR; WATTS GF, 1988, BMJ-BRIT MED J, V296, P235, DOI 10.1136/bmj.296.6617.235; Yoshikawa H, 1976, Rinsho Ketsueki, V17, P553; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295	46	34	38	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92609	10.1371/journal.pone.0092609	http://dx.doi.org/10.1371/journal.pone.0092609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	25119138	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000058
J	Okudela, K; Katayama, A; Woo, T; Mitsui, H; Suzuki, T; Tateishi, Y; Umeda, S; Tajiri, M; Masuda, M; Nagahara, N; Kitamura, H; Ohashi, K				Okudela, Koji; Katayama, Akira; Woo, Tetsukan; Mitsui, Hideaki; Suzuki, Takehisa; Tateishi, Yoko; Umeda, Shigeaki; Tajiri, Michihiko; Masuda, Munetaka; Nagahara, Noriyuki; Kitamura, Hitoshi; Ohashi, Kenichi			Proteome Analysis for Downstream Targets of Oncogenic KRAS - the Potential Participation of CLIC4 in Carcinogenesis in the Lung	PLOS ONE			English	Article							CHLORIDE CHANNEL PROTEIN; EMBRYONIC FIBROBLAST CELLS; H-RAS; K-RAS; BREAST-CANCER; EXPRESSION; TRANSFORMATION; MUTATIONS; THERAPY; ADENOCARCINOMAS	This study investigated the proteome modulated by oncogenic KRAS in immortalized airway epithelial cells. Chloride intracellular channel protein 4 (CLIC4), S100 proteins (S100A2 and S100A11), tropomyosin 2, cathepsin L1, integrins alpha 3, eukaryotic elongation factor 1, vimentin, and others were discriminated. We here focused on CLIC4 to investigate its potential involvement in carcinogenesis in the lung because previous studies suggested that some chloride channels and chloride channel regulators could function as tumor suppressors. CILC4 protein levels were reduced in some lung cancer cell lines. The restoration of CLIC4 in lung cancer cell lines in which CLIC4 expression was reduced attenuated their growth activity. The immunohistochemical expression of the CLIC4 protein was weaker in primary lung cancer cells than in non-tumorous airway epithelial cells and was occasionally undetectable in some tumors. CLIC4 protein levels were significantly lower in a subtype of mucinous ADC than in others, and were also significantly lower in KRAS-mutated ADC than in EGFR-mutated ADC. These results suggest that the alteration in CLIC4 could be involved in restrictedly the development of a specific fraction of lung adenocarcinomas. The potential benefit of the proteome modulated by oncogenic KRAS to lung cancer research has been demonstrated.	[Okudela, Koji; Mitsui, Hideaki; Suzuki, Takehisa; Tateishi, Yoko; Umeda, Shigeaki; Kitamura, Hitoshi; Ohashi, Kenichi] Yokohama City Univ, Grad Sch Med, Dept Pathol, Kanazawa Ku, Yokohama, Kanagawa 232, Japan; [Katayama, Akira] Nippon Med Univ, Dept Biochem Cell Biol, Bunkyo Ku, Tokyo, Japan; [Woo, Tetsukan; Masuda, Munetaka] Yokohama City Univ, Grad Sch Med, Dept Surgey, Kanazawa Ku, Yokohama, Kanagawa 232, Japan; [Tajiri, Michihiko] Kanagawa Prefectural Cardiovasc & Resp Ctr Hosp, Div Gen Thorac Surg, Kanazawa Ku, Yokohama, Kanagawa, Japan; [Nagahara, Noriyuki] Nippon Med Univ, Dept Enviromental Med, Bunkyo Ku, Tokyo, Japan	Yokohama City University; Yokohama City University; Kanagawa Cardiovascular & Respiratory Center	Okudela, K (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Pathol, Kanazawa Ku, 3-9 Future, Yokohama, Kanagawa 232, Japan.	kojixok@yokohama-cu.ac.jp	Amano, Tatsuya/E-7367-2010; Katayama, Naoki/O-2734-2018	Amano, Tatsuya/0000-0001-6576-3410; Katayama, Naoki/0000-0002-1136-442X; Naoe, Shoji/0000-0002-0605-4187	Japanese Ministry of Education, Culture, Sports, and Science (Tokyo Japan); Yokohama Medical Facility (Yokohama, Japan)	Japanese Ministry of Education, Culture, Sports, and Science (Tokyo Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yokohama Medical Facility (Yokohama, Japan)	This study was funded by The Japanese Ministry of Education, Culture, Sports, and Science (Tokyo Japan) and the Yokohama Medical Facility (Yokohama, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckley JR, 2004, J BIOL CHEM, V279, P41634, DOI 10.1074/jbc.M408334200; Bustin SA, 2001, DNA CELL BIOL, V20, P331, DOI 10.1089/10445490152122442; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Deshusses JMP, 2003, PROTEOMICS, V3, P1418, DOI 10.1002/pmic.200300492; Fernandez-Salas E, 2002, MOL CELL BIOL, V22, P3610, DOI 10.1128/MCB.22.11.3610-3620.2002; Ferreira L, 2012, ELECTROPHORESIS, V33, P1385, DOI 10.1002/elps.201100606; Finberg KE, 2007, J MOL DIAGN, V9, P320, DOI 10.2353/jmoldx.2007.060182; Gruber AD, 1999, CANCER RES, V59, P5488; Hoffman PC, 2002, LUNG CANCER-J IASLC, V38, P65, DOI 10.1016/S0169-5002(02)00144-7; Ikonomou G, 2012, J PROTEOMICS, V75, P5356, DOI 10.1016/j.jprot.2012.06.038; Ji H, 2008, ELECTROPHORESIS, V29, P2660, DOI 10.1002/elps.200800015; Jin BF, 2006, J PROTEOME RES, V5, P2815, DOI 10.1021/pr060283f; Kim S, 2008, PROTEOMICS, V8, P3082, DOI 10.1002/pmic.200800106; Li DF, 2006, PROTEIN PEPTIDE LETT, V13, P641, DOI 10.2174/092986606777145742; Maeshima A, 2002, VIRCHOWS ARCH, V440, P598, DOI 10.1007/s00428-002-0629-6; Marchetti A, 1996, J PATHOL, V179, P254, DOI 10.1002/(SICI)1096-9896(199607)179:3<254::AID-PATH589>3.0.CO;2-J; Mathias RA, 2009, J PROTEOME RES, V8, P2827, DOI 10.1021/pr8010974; Okudela K, 2010, PATHOL INT, V60, P651, DOI 10.1111/j.1440-1827.2010.02580.x; Okudela K, 2009, AM J PATHOL, V175, P2646, DOI 10.2353/ajpath.2009.080571; Okudela K, 2009, AM J PATHOL, V175, P867, DOI 10.2353/ajpath.2009.080489; Padmakumar VC, 2012, AM J PATHOL, V181, P74, DOI 10.1016/j.ajpath.2012.03.025; Park JW, 2006, PROTEOMICS, V6, P2433, DOI 10.1002/pmic.200500688; Park JW, 2006, PROTEOMICS, V6, P1175, DOI 10.1002/pmic.200500405; Proutski I, 2002, BIOCHEM BIOPH RES CO, V297, P317, DOI 10.1016/S0006-291X(02)02199-X; Rusch M, 2011, ANGEW CHEM INT EDIT, V50, P9838, DOI 10.1002/anie.201102967; Shiio Y, 2006, J BIOL CHEM, V281, P2750, DOI 10.1074/jbc.M509349200; Shukla A, 2013, ONCOGENE; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Sudhir PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020199; Suh KS, 2012, CARCINOGENESIS, V33, P986, DOI 10.1093/carcin/bgs115; Suh KS, 2005, J INVEST DERM SYMP P, V10, P105, DOI 10.1111/j.1087-0024.2005.200402.x; Suh KS, 2007, J CELL SCI, V120, P2631, DOI 10.1242/jcs.002741; Suh KS, 2007, CLIN CANCER RES, V13, P121, DOI 10.1158/1078-0432.CCR-06-1562; Travis WD., 2004, TRAVIS WB WHO CLASSI; Wang J, 2008, J PROTEOME RES, V7, P3879, DOI 10.1021/pr8001645; Woo T, 2009, LUNG CANCER, V65, P355, DOI 10.1016/j.lungcan.2008.11.020; Yao Q, 2009, ONCOL REP, V22, P541, DOI 10.3892/or_00000469; Yazawa T, 1999, J PATHOL, V187, P191, DOI 10.1002/(SICI)1096-9896(199901)187:2<191::AID-PATH206>3.0.CO;2-3; Zhan Xianquan, 2003, Pituitary, V6, P189, DOI 10.1023/B:PITU.0000023426.99808.40	39	49	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87193	10.1371/journal.pone.0087193	http://dx.doi.org/10.1371/journal.pone.0087193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24503901	Green Published, Green Submitted, gold			2022-12-27	WOS:000330631800020
J	Lin, H; Qu, YLW; Geng, ZX; Li, C; Wu, HP; Dong, N; Liu, ZG; Li, W				Lin, Hui; Qu, Yangluowa; Geng, Zhixin; Li, Cheng; Wu, Huping; Dong, Nuo; Liu, Zuguo; Li, Wei			Air Exposure Induced Characteristics of Dry Eye in Conjunctival Tissue Culture	PLOS ONE			English	Article							CORNEAL EPITHELIAL-CELLS; OCULAR SURFACE EPITHELIUM; FLOW-CYTOMETRIC ANALYSIS; MUCIN GENE-EXPRESSION; KERATOCONJUNCTIVITIS SICCA; SQUAMOUS METAPLASIA; LACRIMAL GLAND; MATRIX METALLOPROTEINASES; BENZALKONIUM CHLORIDE; INFLAMMATORY MARKERS	There are several animal models illustrating dry eye pathophysiology. Current study would like to establish an ex vivo tissue culture model for characterizing dry eye. Human conjunctival explants were cultured under airlift or submerged conditions for up to 2 weeks, and only airlifted conjunctival cultures underwent increased epithelial stratification. Starting on day 4, the suprabasal cells displayed decreased K19 expression whereas K10 keratin became evident in airlift group. Pax6 nuclear expression attenuated already at 2 days, while its perinuclear and cytoplasmic expression gradually increased. MUC5AC and MUC19 expression dramatically decreased whereas the full thickness MUC4 and MUC16 expression pattern disappeared soon after initiating the airlift condition. Real time PCR showed K16, K10 and MUC16 gene up-regulated while K19, MUC5AC, MUC19 and MUC4 down-regulated on day 8 and day 14. On day 2 was the appearance of apoptotic epithelial and stromal cells appeared. The Wnt signaling pathway was transiently activated from day 2 to day 10. The inflammatory mediators IL-1 beta, TNF-alpha, and MMP-9 were detected in the conditioned media after 6 to 8 days. In conclusion, airlifted conjunctival tissue cultures demonstrated Wnt signaling pathway activation, coupled with squamous metaplasia, mucin pattern alteration, apoptosis and upregulation of proinflammatory cytokine expression. These changes mimic the pathohistological alterations described in dry eye. This correspondence suggests that insight into the pathophysiology of dry eye may be aided through the use of airlifted conjunctival tissue cultures.	[Lin, Hui; Qu, Yangluowa; Geng, Zhixin; Li, Cheng; Liu, Zuguo; Li, Wei] Xiamen Univ, Inst Eye, Xiamen, Fujian, Peoples R China; [Geng, Zhixin; Wu, Huping; Dong, Nuo; Liu, Zuguo; Li, Wei] Xiamen Univ, Affiliated Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China; [Lin, Hui; Qu, Yangluowa; Li, Cheng; Liu, Zuguo; Li, Wei] Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University	Liu, ZG (corresponding author), Xiamen Univ, Inst Eye, Xiamen, Fujian, Peoples R China.	zuguoliu@xmu.edu.cn; wei1018@gmail.com	Li, Wei/P-8985-2015; Lin, Hui/N-6947-2018	Li, Wei/0000-0001-7458-2590; 	Chinese National Key Scientific Research Project [2013CB967003]; National Natural Science Foundation of China (NSFC) [81270977, 81000403, U1205025, 81270978]	Chinese National Key Scientific Research Project; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research described was supported in part by the grants from Chinese National Key Scientific Research Project (2013CB967003 [to WL]), the National Natural Science Foundation of China (NSFC, No. 81270977 [to WL], 81000403 [to HL], U1205025 [to ZL], 81270978 [to ZL]). The funders had no role in study design, data collection and analysis.	Acera A, 2008, OPHTHALMIC RES, V40, P315, DOI 10.1159/000150445; Afonso AA, 1999, INVEST OPHTH VIS SCI, V40, P2506; Barabino S, 2005, INVEST OPHTH VIS SCI, V46, P2766, DOI 10.1167/iovs.04-1326; Barabino S, 2004, INVEST OPHTH VIS SCI, V45, P1641, DOI 10.1167/iovs.03-1055; Brignole F, 2000, INVEST OPHTH VIS SCI, V41, P1356; Caffery B, 2008, MOL VIS, V14, P2547; Chen W, 2008, INVEST OPHTH VIS SCI, V49, P1386, DOI 10.1167/iovs.07-0744; Chen Y, 2004, AM J RESP CELL MOL, V30, P155, DOI 10.1165/rcmb.2003-0103OC; Chikama T, 2008, AM J PATHOL, V172, P638, DOI 10.2353/ajpath.2008.070897; Corrales RM, 2011, INVEST OPHTH VIS SCI, V52, P8363, DOI 10.1167/iovs.11-7655; Dogru M, 2008, ALLERGY, V63, P1324, DOI 10.1111/j.1398-9995.2008.01781.x; Dong N, 2009, INVEST OPHTHALMOL VI; Dursun D, 2002, INVEST OPHTH VIS SCI, V43, P632; Espana EM, 2003, INVEST OPHTH VIS SCI, V44, P5130, DOI 10.1167/iovs.03-0584; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fini ME, 1996, AM J PATHOL, V149, P1287; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Guo ZJ, 2000, EXP EYE RES, V71, P23, DOI 10.1006/exer.2000.0855; JESTER JV, 1989, INVEST OPHTH VIS SCI, V30, P936; Jones DT, 1998, ADV EXP MED BIOL, V438, P533; KASWAN R, 1994, ADV EXP MED BIOL, V350, P583; KASWAN RL, 1989, ARCH OPHTHALMOL-CHIC, V107, P1210, DOI 10.1001/archopht.1989.01070020276038; Kawakita T, 2008, J CELL MOL MED, V12, P1303, DOI 10.1111/j.1582-4934.2008.00297.x; Koroma BM, 1997, INVEST OPHTH VIS SCI, V38, P108; Li DQ, 2001, EXP EYE RES, V73, P449, DOI 10.1006/exer.2001.1054; Li W, 2008, J PATHOL, V214, P114, DOI 10.1002/path.2256; Li W, 2008, INVEST OPHTH VIS SCI, V49, P154, DOI 10.1167/iovs.07-0883; Li WM, 2003, DEVELOPMENT, V130, P6143, DOI 10.1242/dev.00820; Lin ZR, 2011, MOL VIS, V17, P257; LIU SH, 1987, INVEST OPHTH VIS SCI, V28, P270; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; Ma X, 2009, INVEST OPHTH VIS SCI, V50, P2716, DOI 10.1167/iovs.08-2139; Maas-Szabowski N, 2001, J INVEST DERMATOL, V116, P816, DOI 10.1046/j.1523-1747.2001.01349.x; Mantelli F, 2008, CURR OPIN ALLERGY CL, V8, P477, DOI 10.1097/ACI.0b013e32830e6b04; Marko CK, 2013, AM J PATHOL, V183, P35, DOI 10.1016/j.ajpath.2013.03.017; Miyoshi K, 2002, P NATL ACAD SCI USA, V99, P219, DOI 10.1073/pnas.012414099; Mukhopadhyay M, 2006, DEVELOPMENT, V133, P2149, DOI 10.1242/dev.02381; Murube J, 2003, EUR J OPHTHALMOL, V13, P115, DOI 10.1177/112067210301300201; Paulsen F, 2008, ANN ANAT, V190, P59, DOI 10.1016/j.aanat.2007.05.001; Pearton DJ, 2005, P NATL ACAD SCI USA, V102, P3714, DOI 10.1073/pnas.0500344102; Pflugfelder SC, 2005, AM J PATHOL, V166, P61, DOI 10.1016/S0002-9440(10)62232-8; Pisella PJ, 2000, OPHTHALMOLOGY, V107, P1841, DOI 10.1016/S0161-6420(00)00347-X; Pitz S, 2002, PROG RETIN EYE RES, V21, P241, DOI 10.1016/S1350-9462(01)00025-8; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; SCHERMER A, 1989, DIFFERENTIATION, V42, P103, DOI 10.1111/j.1432-0436.1989.tb00611.x; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Solomon A, 2001, INVEST OPHTH VIS SCI, V42, P2283; Song XJ, 2003, INVEST OPHTH VIS SCI, V44, P4223, DOI 10.1167/iovs.02-1319; Tei M, 2000, INVEST OPHTH VIS SCI, V41, P82; Tsubota K, 2003, EXP EYE RES, V76, P233, DOI 10.1016/S0014-4835(02)00279-8; Wang BE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002186; Xiong C, 2008, INVEST OPHTH VIS SCI, V49, P1850, DOI 10.1167/iovs.07-0720; Yeh S, 2003, INVEST OPHTH VIS SCI, V44, P124, DOI 10.1167/iovs.02-0581; Yu DF, 2008, EXP EYE RES, V86, P403, DOI 10.1016/j.exer.2007.11.013; 2007, OCUL SURF, V5, P93; 2007, OCUL SURF, V5, P179	56	25	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87368	10.1371/journal.pone.0087368	http://dx.doi.org/10.1371/journal.pone.0087368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24671174	Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900100
J	You, ZQ; Chen, MX; Yang, S; Zhou, ZK; Qin, P				You, Zhiqi; Chen, Mingxi; Yang, Sen; Zhou, Zongkui; Qin, Ping			Childhood Adversity, Recent Life Stressors and Suicidal Behavior in Chinese College Students	PLOS ONE			English	Article							EVENTS; ABUSE; RISK; ADOLESCENCE; IDEATION; GENDER; WOMEN	Background: Although the independent effects of childhood adversities and of recent negative events on suicidality have been well-documented, the combinative role of childhood and recent adversities on risk for suicidality is still underexplored, especially in the context of Chinese culture and in consideration of specific types of negative events. Method: 5989 students, randomly sampled from six universities in central China, completed the online survey for this study. Suicidal behavior, life adversity during childhood and stressful events in recent school life were assessed with designed questionnaires. Results: Students experiencing recent stressful life events more often reported an experience of life adversity during childhood. While recent stressful life events and childhood life adversity both were associated with an increased risk for suicidal behavior, the two exposures presented conjunctively and acted interactively to increase the risk. There was noticeable variation of effects associated with specific childhood life adversities, and sexual abuse, poor parental relationship, divorce of parents and loss of a parent were among the adversities associated with the highest increased risk. Recent conflicts with classmates, poor school performance and rupture of romantic relationships were the recent school life stressors associated with the highest increased risk. Conclusions: Childhood adversity and recent school life stressors had a combinative role in predicting suicidality of young people studying in Chinese colleges. Unhappy family life during childhood and recent interpersonal conflicts in school were the most important predictors of suicidality in this population.	[You, Zhiqi; Chen, Mingxi; Yang, Sen; Zhou, Zongkui] Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Peoples R China; [You, Zhiqi; Chen, Mingxi; Yang, Sen; Zhou, Zongkui] Cent China Normal Univ, Sch Psychol, Wuhan, Peoples R China; [Qin, Ping] Univ Aarhus, Natl Ctr Register Based Res, Aarhus, Denmark; [Qin, Ping] Univ Oslo, Natl Ctr Suicide Res & Prevent, Inst Clin Med, Oslo, Norway	Central China Normal University; Aarhus University; University of Oslo	Zhou, ZK (corresponding author), Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Peoples R China.	zhouzk@mail.ccnu.edu.cn	; Park, Cheol-Young/C-6690-2018	You, Zhiqi/0000-0002-2140-5870; Park, Cheol-Young/0000-0002-9415-9965; Yang, Soo Jin/0000-0001-7892-7648	Key Project of International Cooperation from the Chinese Ministry of Science and Technology [2010DFA31790]; Major Program of National Social Science Foundation of P.R. China [11ZD151]; Excellent doctoral dissertation cultivation grant from Central China Normal University [2013YBZD05]	Key Project of International Cooperation from the Chinese Ministry of Science and Technology; Major Program of National Social Science Foundation of P.R. China; Excellent doctoral dissertation cultivation grant from Central China Normal University	This work was funded by Key Project of International Cooperation from the Chinese Ministry of Science and Technology [project number: 2010DFA31790], Major Program of National Social Science Foundation of P.R. China [project number: 11&ZD151] and Excellent doctoral dissertation cultivation grant from Central China Normal University [project number: 2013YBZD05]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman BP, 2004, DEV PSYCHOL, V40, P367, DOI 10.1037/0012-1649.40.3.367; Bedi S, 2011, SUICIDE LIFE-THREAT, V41, P406, DOI 10.1111/j.1943-278X.2011.00040.x; Buchmann AF, 2012, PRAX KINDERPSYCHOL K, V61, P32, DOI 10.13109/prkk.2012.61.1.32; Cupina D, 2009, AUSTRALAS PSYCHIATRY, V17, P233, DOI 10.1080/10398560802680746; Frederick J, 2008, CHILD FAM SOC WORK, V13, P300, DOI 10.1111/j.1365-2206.2008.00554.x; Galera C, 2008, ACTA PSYCHIAT SCAND, V118, P480, DOI 10.1111/j.1600-0447.2008.01262.x; Grover KE, 2009, J CLIN PSYCHOL, V65, P1281, DOI 10.1002/jclp.20632; Hawton K, 2001, PSYCHOL MED, V31, P827, DOI 10.1017/S0033291701003993; Hawton K, 2000, BRIT J PSYCHIAT, V177, P484, DOI 10.1192/bjp.177.6.484; HILL EM, 1994, ETHOL SOCIOBIOL, V15, P323, DOI 10.1016/0162-3095(94)90006-X; Vazquez JJ, 2010, J COMMUNITY APPL SOC, V20, P288, DOI 10.1002/casp.1036; Kleiman EM, 2012, J AFFECT DISORDERS, V143, P236, DOI 10.1016/j.jad.2012.05.014; Kwok SYCL, 2011, NURS RES, V60, P422, DOI 10.1097/NNR.0b013e31823585d6; Moscicki Eve K., 1994, Annals of Epidemiology, V4, P152; Pedersen NL, 2010, EUR PSYCHIAT, V25, P264, DOI 10.1016/j.eurpsy.2009.12.008; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Pompili M, 2009, J HEADACHE PAIN, V10, P283, DOI 10.1007/s10194-009-0134-2; Sarchiapone A, 2009, EUR PSYCHIAT, V24, P57, DOI 10.1016/j.eurpsy.2008.07.005; Sfoggia A, 2008, CRISIS, V29, P154, DOI 10.1027/0227-5910.29.3.154; Singh S, 2012, ASIAN J PSYCHIATR, V5, P154, DOI 10.1016/j.ajp.2012.02.024; Skopp NA, 2011, J SOC CLIN PSYCHOL, V30, P361, DOI 10.1521/jscp.2011.30.4.361; Spokas M, 2009, J TRAUMA STRESS, V22, P467, DOI 10.1002/jts.20438; Sundin M, 2011, SUBST USE MISUSE, V46, P1690, DOI 10.3109/10826084.2011.605414; Tang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017977; Van Heeringen K, 2000, CRISIS, V21, p192a, DOI [10.1201/b12215-7, DOI 10.1201/B12215-7]; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Violato C., 2004, INDIVID DIFFER RES, V2, P162; Wang YQ, 2012, PSYCHIAT ANN, V42, P101, DOI 10.3928/00485713-20120217-07; Yen S, 2009, ACTA PSYCHIAT SCAND, V120, P222, DOI 10.1111/j.1600-0447.2009.01366.x; Zhang J, 2006, DEATH STUD, V30, P259, DOI 10.1080/07481180500493443; Zhang J, 2012, J AFFECT DISORDERS, V140, P161, DOI 10.1016/j.jad.2012.01.010	31	37	39	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e86672	10.1371/journal.pone.0086672	http://dx.doi.org/10.1371/journal.pone.0086672			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0TC	25133775	Green Published, gold, Green Submitted			2022-12-27	WOS:000333678100001
J	Zhang, BZ; Cai, GJ; Wang, HT; Li, D; Yang, XJ; An, XL; Zheng, XW; Tian, Y; Zheng, W; Zheng, TL				Zhang, Bangzhou; Cai, Guanjing; Wang, Haitao; Li, Dong; Yang, Xujun; An, Xinli; Zheng, Xiaowei; Tian, Yun; Zheng, Wei; Zheng, Tianling			Streptomyces alboflavus RPS and Its Novel and High Algicidal Activity against Harmful Algal Bloom Species Phaeocystis globosa	PLOS ONE			English	Article							TOXIC DINOFLAGELLATE; MICROCYSTIS-AERUGINOSA; POPULATION-DYNAMICS; MARINE; BACTERIUM; IDENTIFICATION; CYANOBACTERIA; ACTINOMYCETE; MECHANISMS; COMPOUND	Phaeocystis globosa blooms have frequently occurred along coastal waters and exerted serious impacts on ecological environments by releasing toxic hemolytic substances, forming nuisance foam, and causing oxygen depletion. An actinomycete strain RPS with high algicidal activity against P. globosa was isolated and identified as Streptomyces alboflavus, based on morphology, physiological and biochemical characteristics, and 16S rDNA sequence analysis. RPS lysed 95% of P. globosa within 48 h by releasing an extracellular active substance into the growth medium. The activity of RPS supernatant was sensitive to temperature at and above 50 degrees C and insensitive to pH from 3 to 11. The molecular weight of the active substance was between 100 Da and 1000 Da, and approximately 90% of it was extracted by ethyl acetate. It was presumed that the active component efficiently inhibited the movement of P. globosa, caused the flagella to fall off the algae, and finally lysed the algal cells. RPS showed a wide target range against harmful algae. S. alboflavus RPS with high algicidal activity and such novel features of temperature and pH sensitivity, low molecular weight, algicidal process, and target range possesses great potential in the biological control of P. globosa blooms.	[Zheng, Wei] Xiamen Univ, Sch Life Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China; Xiamen Univ, Sch Life Sci, Key Lab, Minist Educ, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University	Zheng, W (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China.	jedi@xmu.edu.cn; microzh@xmu.edu.cn	Zhang, Bangzhou/CAG-9625-2022; Cai, Guanjing/GZK-7070-2022; Zhao, Lin/M-9536-2018	Zhao, Lin/0000-0003-0245-8413	National Natural Science Foundation of China [40930847, 41376119]; Public Science and Technology Research Funds Projects of Ocean [201305016]; Special Fund for Ph.D. Programs in the University [20120121130001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Science and Technology Research Funds Projects of Ocean; Special Fund for Ph.D. Programs in the University	This work was supported by the National Natural Science Foundation of China (40930847, 41376119) (http://www.nsfc.gov.cn/publish/portal0/default.htm), the Public Science and Technology Research Funds Projects of Ocean (201305016) (http://www.soa.gov.cn/), and the Special Fund for Ph.D. Programs in the University (20120121130001) (http://www.cutech.edu.cn/cn/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actinomycete Classification Group of CAS, 1975, MAN STREPT ID, P13; Amin SA, 2012, MICROBIOL MOL BIOL R, V76, P667, DOI 10.1128/MMBR.00007-12; Anderson DM, 2012, ANNU REV MAR SCI, V4, P143, DOI 10.1146/annurev-marine-120308-081121; Anderson DM, 2009, OCEAN COAST MANAGE, V52, P342, DOI 10.1016/j.ocecoaman.2009.04.006; Arnoux P, 2009, PLANT CELL, V21, P2036, DOI 10.1105/tpc.109.068007; Bai SJJ, 2011, CURR MICROBIOL, V62, P1774, DOI 10.1007/s00284-011-9927-z; Banin E, 2001, APPL ENVIRON MICROB, V67, P1536, DOI 10.1128/AEM.67.4.1536-1541.2001; Baudoux AC, 2005, VIROLOGY, V341, P80, DOI 10.1016/j.virol.2005.07.002; Blauw AN, 2010, J MARINE SYST, V83, P115, DOI 10.1016/j.jmarsys.2010.05.003; Cai WW, 2011, APPL ENVIRON MICROB, V77, P7837, DOI 10.1128/AEM.05783-11; Choi HJ, 2005, BIOL CONTROL, V33, P335, DOI 10.1016/j.biocontrol.2005.03.007; Hai DN, 2010, J MARINE SYST, V83, P253, DOI 10.1016/j.jmarsys.2010.04.015; Fei XG, 2004, HYDROBIOLOGIA, V512, P145, DOI 10.1023/B:HYDR.0000020320.68331.ce; Gumbo RJ, 2008, AFR J BIOTECHNOL, V7, P4765; Guo ZY, 2009, J ANTIBIOT, V62, P201, DOI 10.1038/ja.2009.15; Jeong HJ, 2008, HARMFUL ALGAE, V7, P368, DOI 10.1016/j.hal.2007.12.004; Jessup DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004550; Kodama M, 2006, ECOL STU AN, V189, P243, DOI 10.1007/978-3-540-32210-8_19; Kodani S, 2002, J APPL PHYCOL, V14, P109, DOI 10.1023/A:1019533414018; Kong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057654; Lamy D, 2009, AQUAT MICROB ECOL, V58, P95, DOI 10.3354/ame01359; Lee SO, 2000, APPL ENVIRON MICROB, V66, P4334, DOI 10.1128/AEM.66.10.4334-4339.2000; Lee SW, 2013, J HAZARD MATER, V263, P20, DOI 10.1016/j.jhazmat.2013.08.017; Lee YJ, 2008, HARMFUL ALGAE, V7, P154, DOI 10.1016/j.hal.2007.06.004; Li FM, 2005, APPL ENVIRON MICROB, V71, P6545, DOI 10.1128/AEM.71.11.6545-6553.2005; Li L, 2013, ENVIRON SCI TECHNOL, V47, P4555, DOI 10.1021/es305234d; Li PN, 2011, ENVIRON SCI TECHNOL, V45, P4521, DOI 10.1021/es200057g; LISS PS, 1994, J MARINE SYST, V5, P41, DOI 10.1016/0924-7963(94)90015-9; Manset KJV, 2013, J ENVIRON SCI MANAG, P11; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; Mayali X, 2002, HARMFUL ALGAE, V1, P277, DOI 10.1016/S1568-9883(02)00032-X; Meuser D, 1999, FEBS LETT, V462, P447, DOI 10.1016/S0014-5793(99)01579-3; Monchy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039924; Nakashima T, 2006, AQUAT MICROB ECOL, V45, P255, DOI 10.3354/ame045255; Nayak BB, 2000, WORLD J MICROB BIOT, V16, P99, DOI 10.1023/A:1008934406780; Ni LX, 2012, CHEMOSPHERE, V88, P1051, DOI 10.1016/j.chemosphere.2012.05.009; Nishitarumizu S, 2011, FISHERIES SCI, P1; Orton JH, 1923, NATURE, V111, P773, DOI 10.1038/111773a0; Ozaki K, 2008, CHEMOSPHERE, V71, P1531, DOI 10.1016/j.chemosphere.2007.11.052; Paul C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021032; Peng XC, 2005, J INTEGR PLANT BIOL, V47, P165, DOI 10.1111/j.1744-7909.2005.00039.x; Peperzak L, 2008, J SEA RES, V60, P220, DOI 10.1016/j.seares.2008.06.001; Qi YZ, 2004, HYDROBIOLOGIA, V512, P209, DOI 10.1023/B:HYDR.0000020329.06666.8c; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Schoemann V, 2005, J SEA RES, V53, P43, DOI 10.1016/j.seares.2004.01.008; Seong Kyeong Ah, 2011, Ocean Science Journal, V46, P105, DOI 10.1007/s12601-011-0010-2; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Skerratt JH, 2002, MAR ECOL PROG SER, V244, P1, DOI 10.3354/meps244001; Su RQ, 2007, HARMFUL ALGAE, V6, P799, DOI 10.1016/j.hal.2007.04.004; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Wang BX, 2010, LETT APPL MICROBIOL, V51, P552, DOI 10.1111/j.1472-765X.2010.02936.x; Wang BX, 2012, HARMFUL ALGAE, V13, P83, DOI 10.1016/j.hal.2011.10.006; Wang XL, 2005, HARMFUL ALGAE, V4, P433, DOI 10.1016/j.hal.2004.06.001; Yamamoto Y, 1998, J APPL PHYCOL, V10, P391, DOI 10.1023/A:1008077414808; Yan Rong-jun, 2011, Huanjing Kexue, V32, P225; Yang CY, 2012, HARMFUL ALGAE, V20, P132, DOI 10.1016/j.hal.2012.09.002; Yoshikawa K, 2000, APPL ENVIRON MICROB, V66, P718, DOI 10.1128/AEM.66.2.718-722.2000; Zhang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063018; Zhang SJ, 2012, ENVIRON SCI TECHNOL, V46, P8764, DOI 10.1021/es301000m; Zheng XW, 2013, APPL MICROBIOL BIOT, V97, P9207, DOI 10.1007/s00253-012-4617-8; Zhou LH, 2007, HARMFUL ALGAE, V6, P354, DOI 10.1016/j.hal.2006.10.002	62	64	80	12	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92907	10.1371/journal.pone.0092907	http://dx.doi.org/10.1371/journal.pone.0092907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675867	gold, Green Submitted, Green Published			2022-12-27	WOS:000333677500054
J	Peng, Z; Wang, CX; Fang, EH; Lu, XM; Wang, GB; Tong, Q				Peng, Zhao; Wang, Chenxiao; Fang, Erhu; Lu, Xiaoming; Wang, Guobin; Tong, Qiang			Co-Delivery of Doxorubicin and SATB1 shRNA by Thermosensitive Magnetic Cationic Liposomes for Gastric Cancer Therapy	PLOS ONE			English	Article							OVERCOME DRUG-RESISTANCE; IN-VITRO; TEMPERATURE; GENE; RNA; ADENOCARCINOMA; NANOPARTICLES; EXPRESSION; RELEASE; CELLS	In previous a study, we had developed a novel thermosensitive magnetic delivery system based on liposomes. This study aimed to evaluate the efficiency of this system for the co-delivery of both drugs and genes to the same cell and its antitumor effects on gastric cancer. Doxorubicin (DOX) and SATB1 shRNA vector were loaded into the co-delivery system, and in vitro DOX thermosensitive release activity, targeted gene silencing efficiency, targeted cellular uptake, in vitro cytotoxicity, as well as in vivo anti-tumor activity were determined. The results showed that this co-delivery system had desirable targeted delivery efficacy, DOX thermosensitive release and SATB1 gene silencing. Moreover, the co-delivery of DOX and SATB1 shRNA exhibited enhanced activity to inhibit gastric cancer cell growth in vitro and in vivo, compared to single delivery. In conclusion, the novel thermosensitive magnetic drug and gene co-delivery system has promising application in combined chemotherapy and gene therapy for gastric cancer.	[Peng, Zhao; Wang, Chenxiao; Fang, Erhu; Lu, Xiaoming; Wang, Guobin; Tong, Qiang] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Wang, GB (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	guobinwang1954@gmail.com; qiangtong@hust.edu.cn	Li, Yilin/AAW-9533-2021		National Natural Science Foundation of China [81172186]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81172186). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Alberts SR, 2003, ANN ONCOL, V14, P31, DOI 10.1093/annonc/mdg726; Alexiou C, 2000, CANCER RES, V60, P6641; Chen J, 2013, DRUG DEV IND PHARM, V39, P197, DOI 10.3109/03639045.2012.668912; Chen YC, 2010, J BIOL CHEM, V285, P22639, DOI 10.1074/jbc.M110.125906; Cheng C, 2010, APMIS, V118, P855, DOI 10.1111/j.1600-0463.2010.02673.x; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GABER MH, 1995, PHARMACEUT RES, V12, P1407, DOI 10.1023/A:1016206631006; Heger Z, 2013, INT J MOL SCI, V14, P21629, DOI 10.3390/ijms141121629; Huang B, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-8; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Juergen S, 2012, FUNDAMENTALS APPL CO, P291; Kohwi-Shigematsu T, 2013, SEMIN CANCER BIOL, V23, P72, DOI 10.1016/j.semcancer.2012.06.009; Kono K, 2004, METHODS ENZYMOL, V387, P73; Li Wei, 2011, Zhonghua Wei Chang Wai Ke Za Zhi, V14, P432; Liu CX, 2013, BIOMATERIALS, V34, P2547, DOI 10.1016/j.biomaterials.2012.12.038; Lu XM, 2010, ONCOL REP, V24, P981, DOI 10.3892/or_00000945; Mir R, 2012, CURR DRUG TARGETS, V13, P1603, DOI 10.2174/138945012803530008; Mykhaylyk O, 2010, METHODS MOL BIOL, V605, P487, DOI 10.1007/978-1-60327-360-2_34; Park SC, 2013, GUT LIVER, V7, P385, DOI 10.5009/gnl.2013.7.4.385; Patani N, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-18; Pradhan P, 2010, J CONTROL RELEASE, V142, P108, DOI 10.1016/j.jconrel.2009.10.002; Pradhan P, 2010, METHODS MOL BIOL, V605, P279, DOI 10.1007/978-1-60327-360-2_19; Shen JA, 2012, BIOMATERIALS, V33, P8613, DOI 10.1016/j.biomaterials.2012.08.007; Shim G, 2011, J CONTROL RELEASE, V155, P60, DOI 10.1016/j.jconrel.2010.10.017; Skeel R, 2011, HDB CANC CHEMOTHERAP; Stebbing J, 2002, CANCER TREAT REV, V28, P121, DOI 10.1053/ctrv.2002.0262; Ta T, 2013, J CONTROL RELEASE, V169, P112, DOI 10.1016/j.jconrel.2013.03.036; Takahashi Tsunehiro, 2013, Cancers (Basel), V5, P48, DOI 10.3390/cancers5010048; Torchilin Vladimir P, 2010, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-00477-3_1; Wang CM, 2011, BIOCHEM BIOPH RES CO, V410, P537, DOI 10.1016/j.bbrc.2011.06.019; Xiao YL, 2012, NANOSCALE, V4, P7185, DOI 10.1039/c2nr31853a; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047902; Zhao F, 2014, BIOMATERIALS, V35, P1050, DOI 10.1016/j.biomaterials.2013.10.044; Zheng XL, 2009, INT J PHARMACEUT, V366, P211, DOI 10.1016/j.ijpharm.2008.09.019; Zhou Lai-Yong, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P534; Zhu XD, 2010, ONCOL LETT, V1, P407, DOI 10.3892/ol_00000071	39	136	146	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92924	10.1371/journal.pone.0092924	http://dx.doi.org/10.1371/journal.pone.0092924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24416238	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677500056
J	Hu, YS; Young, AJ; Ehli, EA; Nowotny, D; Davies, PS; Droke, EA; Soundy, TJ; Davies, GE				Hu, Yueshan; Young, Alan J.; Ehli, Erik A.; Nowotny, Dustin; Davies, Paige S.; Droke, Elizabeth A.; Soundy, Timothy J.; Davies, Gareth E.			Metformin and Berberine Prevent Olanzapine-Induced Weight Gain in Rats	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MESSENGER-RNA EXPRESSION; FATTY LIVER-DISEASE; DOUBLE-BLIND; BODY-WEIGHT; INSULIN-RESISTANCE; METABOLIC SYNDROME; SCHIZOPHRENIA; CLOZAPINE; GLUCOSE	Olanzapine is a first line medication for the treatment of schizophrenia, but it is also one of the atypical antipsychotics carrying the highest risk of weight gain. Metformin was reported to produce significant attenuation of antipsychotic-induced weight gain in patients, while the study of preventing olanzapine-induced weight gain in an animal model is absent. Berberine, an herbal alkaloid, was shown in our previous studies to prevent fat accumulation in vitro and in vivo. Utilizing a well-replicated rat model of olanzapine-induced weight gain, here we demonstrated that two weeks of metformin or berberine treatment significantly prevented the olanzapine-induced weight gain and white fat accumulation. Neither metformin nor berberine treatment demonstrated a significant inhibition of olanzapine-increased food intake. But interestingly, a significant loss of brown adipose tissue caused by olanzapine treatment was prevented by the addition of metformin or berberine. Our gene expression analysis also demonstrated that the weight gain prevention efficacy of metformin or berberine treatment was associated with changes in the expression of multiple key genes controlling energy expenditure. This study not only demonstrates a significant preventive efficacy of metformin and berberine treatment on olanzapine-induced weight gain in rats, but also suggests a potential mechanism of action for preventing olanzapine-reduced energy expenditure.	[Hu, Yueshan; Ehli, Erik A.; Nowotny, Dustin; Davies, Paige S.; Davies, Gareth E.] Avera McKennan Hosp, Avera Inst Human Genet, Sioux Falls, SD 57117 USA; [Hu, Yueshan; Ehli, Erik A.; Nowotny, Dustin; Davies, Paige S.; Davies, Gareth E.] Univ Hlth Ctr, Sioux Falls, SD USA; [Hu, Yueshan; Ehli, Erik A.; Soundy, Timothy J.; Davies, Gareth E.] Univ S Dakota, Dept Psychiat, Sanford Sch Med, Sioux Falls, SD USA; [Young, Alan J.] S Dakota State Univ, Dept Vet & Biomed Sci, Coll Agr & Biol Sci, Brookings, SD 57007 USA; [Droke, Elizabeth A.] S Dakota State Univ, Dept Hlth & Nutr Sci, Coll Educ & Human Sci, Brookings, SD 57007 USA; [Davies, Gareth E.] S Dakota State Univ, Coll Pharm, Dept Pharm Practice, Brookings, SD 57007 USA	University of South Dakota; South Dakota State University; South Dakota State University; South Dakota State University	Hu, YS (corresponding author), Avera McKennan Hosp, Avera Inst Human Genet, Sioux Falls, SD 57117 USA.	Yueshan.Hu@avera.org		Xiang, Zou/0000-0003-3925-0296	Avera Research Institute	Avera Research Institute	Avera Research Institute sponsored this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaugh VL, 2006, OBESITY, V14, P36, DOI 10.1038/oby.2006.6; Blouin M, 2008, OBESITY, V16, P1780, DOI 10.1038/oby.2008.277; Boyda HN, 2014, PROG NEURO-PSYCHOPH, V48, P170, DOI 10.1016/j.pnpbp.2013.10.006; Boyda HN, 2012, J PSYCHIATR NEUROSCI, V37, P407, DOI 10.1503/jpn.110140; Case M, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-72; Chen CH, 2008, PROG NEURO-PSYCHOPH, V32, P925, DOI 10.1016/j.pnpbp.2007.11.013; Citrome L, 2011, CLIN DRUG INVEST, V31, P455, DOI 10.2165/11589060-000000000-00000; D'Agostino G, 2007, J PHARMACOL EXP THER, V322, P1137, DOI 10.1124/jpet.107.123265; De Hert MA, 2006, SCHIZOPHR RES, V83, P87, DOI 10.1016/j.schres.2005.12.855; Hert M, 2012, NAT REV ENDOCRINOL, V8, P114, DOI 10.1038/nrendo.2011.156; Dessalle K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050878; Faulkner G, 2006, CAN J PSYCHIAT, V51, P502, DOI 10.1177/070674370605100805; Fell MJ, 2007, PSYCHOPHARMACOLOGY, V194, P221, DOI 10.1007/s00213-007-0833-9; Feng S, 2012, NEUROENDOCRINOL LETT, V33, P493; Gilles M, 2010, CLIN NEUROPHARMACOL, V33, P248, DOI 10.1097/WNF.0b013e3181f0ec33; Goudie AJ, 2002, J PSYCHOPHARMACOL, V16, P291, DOI 10.1177/026988110201600402; Haupt DW, 2006, EUR NEUROPSYCHOPHARM, V16, pS149, DOI 10.1016/j.euroneuro.2006.06.003; Hu Y, 2012, PHARMACOGENOMICS J, V12, P372, DOI 10.1038/tpj.2011.24; Hu Y, 2009, PHYTOMEDICINE, V16, P864, DOI 10.1016/j.phymed.2009.03.002; Hu YS, 2012, PHYTOMEDICINE, V19, P861, DOI 10.1016/j.phymed.2012.05.009; Hu YS, 2010, PHYTOTHER RES, V24, P1831, DOI 10.1002/ptr.3204; Hu YS, 2010, FITOTERAPIA, V81, P358, DOI 10.1016/j.fitote.2009.10.010; Hu YS, 2010, FITOTERAPIA, V81, P259, DOI 10.1016/j.fitote.2009.09.012; Ikegami M, 2013, EUR J PHARM; Jarskog LF, 2007, ANNU REV MED, V58, P49, DOI 10.1146/annurev.med.58.060904.084114; Jassim G, 2012, PSYCHOPHARMACOLOGY, V219, P783, DOI 10.1007/s00213-011-2397-y; Kluge M, 2007, J CLIN PSYCHOPHARM, V27, P662, DOI 10.1097/jcp.0b013e31815a8872; Kreuzer P, 2012, NERVENARZT, V83, P630, DOI 10.1007/s00115-011-3310-y; Kudoh A, 2004, ANESTH ANALG, V98, P111, DOI 10.1213/01.ANE.0000093313.16711.5E; Kulkarni SK, 2010, PHYTOTHER RES, V24, P317, DOI 10.1002/ptr.2968; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; Lee MS, 2011, J NUTR, V141, P1947, DOI 10.3945/jn.111.146050; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Liebig M, 2010, OBESITY, V18, P1952, DOI 10.1038/oby.2010.17; Lindenmayer JP, 2003, AM J PSYCHIAT, V160, P290, DOI 10.1176/appi.ajp.160.2.290; Maayan L, 2010, NEUROPSYCHOPHARMACOL, V35, P1520, DOI 10.1038/npp.2010.21; Makino T, 2009, BIOL PHARM BULL, V32, P1741, DOI 10.1248/bpb.32.1741; de Morentin PBM, 2012, DIABETES, V61, P807, DOI 10.2337/db11-1079; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; Muench J, 2010, AM FAM PHYSICIAN, V81, P617; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Newcomer JW, 2006, CAN J PSYCHIAT, V51, P480, DOI 10.1177/070674370605100803; Newcomer JW, 2004, CLIN THER, V26, P1936, DOI 10.1016/j.clinthera.2004.12.003; Oh JE, 2012, EXP MOL MED, V44, P545, DOI 10.3858/emm.2012.44.9.062; Praharaj SK, 2011, BRIT J CLIN PHARMACO, V71, P377, DOI 10.1111/j.1365-2125.2010.03783.x; Russo GL, 2013, BIOCHEM PHARMACOL, V86, P339, DOI 10.1016/j.bcp.2013.05.023; Saddichha S, 2008, SCHIZOPHR RES, V101, P266, DOI 10.1016/j.schres.2008.01.004; Schreiner A, 2012, J CLIN PSYCHOPHARM, V32, P449, DOI 10.1097/JCP.0b013e31825cccad; Sejima E, 2011, CELL MOL NEUROBIOL, V31, P985, DOI 10.1007/s10571-011-9663-8; Shirzadi AA, 2006, HARVARD REV PSYCHIAT, V14, P152, DOI 10.1080/10673220600748486; Skrede S, 2012, INT J NEUROPSYCHOPH, V15, P163, DOI 10.1017/S1461145711001271; Smith G. C., 2011, Archives of Physiology and Biochemistry, V117, P241, DOI 10.3109/13813455.2011.576681; Stefanidis A, 2009, OBESITY, V17, P16, DOI 10.1038/oby.2008.468; Thakore JH, 2004, BRIT J PSYCHIAT, V184, pS76, DOI 10.1192/bjp.184.47.s76; Toalson Patrick, 2004, Prim Care Companion J Clin Psychiatry, V6, P152; Tschoner A, 2007, INT J CLIN PRACT, V61, P1356, DOI 10.1111/j.1742-1241.2007.01416.x; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Vuddanda PR, 2010, EXPERT OPIN INV DRUG, V19, P1297, DOI 10.1517/13543784.2010.517745; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wang YW, 2011, METABOLISM, V60, P298, DOI 10.1016/j.metabol.2010.02.005; Wu RR, 2008, AM J PSYCHIAT, V165, P352, DOI 10.1176/appi.ajp.2007.07010079; Xing LJ, 2011, EUR J PHARMACOL, V668, P467, DOI 10.1016/j.ejphar.2011.07.036; Yang QH, 2011, CHIN J INTEGR MED, V17, P205, DOI 10.1007/s11655-011-0668-4; Zhang M, 2012, MOL CELL ENDOCRINOL, V363, P122, DOI 10.1016/j.mce.2012.08.006; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhang YF, 2008, J CLIN ENDOCR METAB, V93, P2559, DOI 10.1210/jc.2007-2404	66	150	161	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93310	10.1371/journal.pone.0093310	http://dx.doi.org/10.1371/journal.pone.0093310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24676355	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600170
J	Peng, Z; Zhu, Y; Wang, QQ; Gao, J; Li, YL; Li, YY; Ge, S; Shen, L				Peng, Zhi; Zhu, Yan; Wang, Qianqian; Gao, Jing; Li, Yilin; Li, Yanyan; Ge, Sai; Shen, Lin			Prognostic Significance of MET Amplification and Expression in Gastric Cancer: A Systematic Review with Meta-Analysis	PLOS ONE			English	Review							HEPATOCYTE GROWTH-FACTOR; C-MET; FACTOR-RECEPTOR; POOR-PROGNOSIS; E-CADHERIN; GENE; OVEREXPRESSION; MARKER; CARCINOMA; P53	Background and Aims: MET, the hepatocyte growth factor receptor, is a receptor tyrosine kinase overexpressed and activated in a subset of gastric cancer. Several studies investigated the relationship between MET amplification and expression with the clinical outcome in patients with gastric cancer, but yielded conflicting results. We performed a systematic review and meta-analysis to determine the influence of MET amplification and expression on prognosis in gastric cancer. Methods: MEDLINE and EMBASE were searched for studies that explored the association between MET amplification and expression with survival in patients with gastric cancer up to 1 April, 2013. Data of individual hazard ratios (HRs) and 95% confidence intervals (CIs) for meta-analyses were extracted from the publications and combined in pooled HRs. Results: Fourteen studies involving 2,258 patients with gastric cancer were included. It was suggested that MET overexpression had an unfavorable impact on survival of patients with gastric cancer, with HRs (95% CIs) of 2.57 (95% CI: 1.97-3.35) overall, 2.82 (95% CI: 1.86-4.27) among studies using amplification for measure scale of MET and 2.42 (95% CI: 1.66-3.54) for expression. The magnitude of association was reduced whereas remained statistically significant in high quality studies or in larger sample size studies and corresponding HRs were 2.18(1.76, 2.70) and 2.35(1.93, 2.87), respectively, without significant heterogeneity. Conclusion: The findings from present study indicated that higher MET gene amplification and expression in gastric cancer was an indicator of poor prognosis.	[Peng, Zhi; Zhu, Yan; Gao, Jing; Li, Yilin; Li, Yanyan; Ge, Sai; Shen, Lin] Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol,Key Lab Carcinogenesi, Beijing 100871, Peoples R China; [Wang, Qianqian] Peking Univ, Clin Med Coll 4, Beijing Jishuitan Hosp, Dept Epidemiol, Beijing 100871, Peoples R China	Peking University; Peking University	Shen, L (corresponding author), Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol,Key Lab Carcinogenesi, Beijing 100871, Peoples R China.	lin100@medmail.com.cn	Li, Yilin/AAW-9533-2021		National Natural Science Foundation of China [81172110]; National High Technology Research and Development Program [2006AA 02A 402-B02, 2012AA 02A 504]; China Postdoctoral Scientific Fund [2013M530494]; Beijing Municipal Science & Technology Commission Program "Exploring the utilization of molecular markers in the individual treatment of gastric cancer based on the clinical research cohort''	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program(National High Technology Research and Development Program of China); China Postdoctoral Scientific Fund; Beijing Municipal Science & Technology Commission Program "Exploring the utilization of molecular markers in the individual treatment of gastric cancer based on the clinical research cohort''	This work was supported by National Natural Science Foundation of China (No. 81172110), National High Technology Research and Development Program (No. 2006AA 02A 402-B02, 2012AA 02A 504), China Postdoctoral Scientific Fund (2013M530494) and Beijing Municipal Science & Technology Commission Program "Exploring the utilization of molecular markers in the individual treatment of gastric cancer based on the clinical research cohort''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya H, 2010, INVEST CLIN, V51, P369; Asaoka Y, 2011, EXPERT OPIN INV DRUG, V20, P595, DOI 10.1517/13543784.2011.566863; Bamias A, 2010, CANCER CHEMOTH PHARM, V65, P1009, DOI 10.1007/s00280-010-1256-6; Bang YJ, 2010, LANCET, V376, P1302; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Catenacci DVT, 2011, CANCER BIOL THER, V12, P9, DOI 10.4161/cbt.12.1.15747; de Graeff P, 2009, BRIT J CANCER, V101, P149, DOI 10.1038/sj.bjc.6605112; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Drebber U, 2008, ONCOL REP, V19, P1477; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Ge SH, 2011, CHINESE J CANCER RES, V23, P153, DOI 10.1007/s11670-011-0153-9; Gooden MJM, 2011, BRIT J CANCER, V105, P93, DOI 10.1038/bjc.2011.189; Graziano F, 2011, J CLIN ONCOL, V29, P4789, DOI 10.1200/JCO.2011.36.7706; Hayes DF, 1996, JNCI-J NATL CANCER I, V88, P1456, DOI 10.1093/jnci/88.20.1456; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang TJ, 2001, ACTA ONCOL, V40, P638; Janjigian YY, 2011, CANCER EPIDEM BIOMAR, V20, P1021, DOI 10.1158/1055-9965.EPI-10-1080; Jatoi Ismail, 2010, Curr Probl Surg, V47, P750, DOI 10.1067/j.cpsurg.2010.06.002; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kubicka S, 2002, DIGEST DIS SCI, V47, P114, DOI 10.1023/A:1013275706401; KUNIYASU H, 1992, BIOCHEM BIOPH RES CO, V189, P227, DOI 10.1016/0006-291X(92)91548-5; Lee HE, 2012, BRIT J CANCER, V107, P325, DOI 10.1038/bjc.2012.237; Lee J, 2011, ONCOL REP, V25, P1517, DOI 10.3892/or.2011.1219; Lennerz JK, 2011, J CLIN ONCOL, V29, P4803, DOI 10.1200/JCO.2011.35.4928; Li Y, 2012, J SURG ONCOL, V106, P304, DOI 10.1002/jso.23008; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Meert AP, 2002, EUR RESPIR J, V20, P975, DOI 10.1183/09031936.02.00296502; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nakajima M, 1999, CANCER, V85, P1894; Oldenhuis CNAM, 2008, EUR J CANCER, V44, P946, DOI 10.1016/j.ejca.2008.03.006; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; Shi J, 2012, INT J MOL SCI, V13, P4714, DOI 10.3390/ijms13044714; Sierra J Rafael, 2011, Ther Adv Med Oncol, V3, pS21, DOI 10.1177/1758834011422557; Smith RA, 2011, BRIT J CANCER, V104, P1440, DOI 10.1038/bjc.2011.110; Taniguchi K, 1998, CANCER, V82, P2112, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2112::AID-CNCR5>3.3.CO;2-U; Toiyama Y, 2012, INT J CANCER, V130, P2912, DOI 10.1002/ijc.26330; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Tsugawa K, 1998, ONCOLOGY-BASEL, V55, P475, DOI 10.1159/000011898; Wu H, 2009, CONSERV GENET RESOUR, V1, P1, DOI 10.1007/s12686-009-9000-4; Yonemura Y, 1996, INT J ONCOL, V8, P555; Yonemura Y, 1997, ONCOL REP, V4, P743; Zhao J, 2011, HISTOL HISTOPATHOL, V26, P1111, DOI 10.14670/HH-26.1111; Zhuang X, 2000, Zhonghua Bing Li Xue Za Zhi, V29, P409	44	136	146	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84502	10.1371/journal.pone.0084502	http://dx.doi.org/10.1371/journal.pone.0084502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416238	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500132
J	Hu, Y; Zhu, Q; Tang, LL				Hu, Yu; Zhu, Qin; Tang, Lili			MiR-99a Antitumor Activity in Human Breast Cancer Cells through Targeting of mTOR Expression	PLOS ONE			English	Article							DOWN-REGULATION; HEPATOCELLULAR-CARCINOMA; LUNG-CANCER; S6 KINASE; MICRORNA; PATHWAY; GROWTH; AKT; TRANSLATION; APOPTOSIS	MicroRNAs (miRNAs) play an important role in human tumorigenesis as oncogenes or tumor suppressors. miR-99a has been reported as a tumor suppressor gene in various cancers in humans. However, only limited information about the function of miR-99a in human breast cancers is available. Here we investigated the expression of miR-99a in breast cancer tissue specimens and its antitumor activity in breast cancer cells. We initially identified that the expression of miR-99a was significantly reduced in four breast cancer cell lines. More importantly, we found downregulation of miR-99a in breast cancer specimens from ten different patients. We then analyzed the mechanism of miR-99a in inhibiting tumorigenesis. Cell-based assays that showed overexpression of miR-99a not only reduced breast cancer cell viability by inducing accumulation of cells at sub-G1 phase and cell apoptosis, but also inhibited tumorigenicity in vivo. As a critical miR-99a target, we have shown that the function of mammalian target of rapamycin (mTOR) was greatly inhibited by miR-99a-based Luciferase report assay; overexpression of miR-99a reduced the expression of mTOR and its downstream phosphorylated proteins (p-4E-BP1 and p-S6K1). Similar to restoring miR-99a expression, mTOR downregulation suppressed cell viability and increased cell apoptosis, whereas restoration of mTOR expression significantly reversed the inhibitory effects of miR-99a on the mTOR/p-4E-BP1/p-S6K1 signal pathway and the miR-99a antitumor activity. In clinical specimens and cell lines, mTOR was commonly overexpressed and its protein levels were statistically inversely correlated with miR-99a expression. Taken together, these results have demonstrated that miR-99a antitumor activity is achieved by targeting the mTOR/p-4E-BP1/p-S6K1 pathway in human breast cancer cells. This study suggests a potential therapeutic strategy to effectively control breast cancer development.	[Hu, Yu; Tang, Lili] Cent S Univ, Xiangya Hosp, Dept Breast Surg, Changsha, Hunan, Peoples R China; [Zhu, Qin] Cent S Univ, Xiangya Hosp, Dept Gen Surg, Changsha, Hunan, Peoples R China	Central South University; Central South University	Tang, LL (corresponding author), Cent S Univ, Xiangya Hosp, Dept Breast Surg, Changsha, Hunan, Peoples R China.	lilitangxy@126.com		Xiang, Zou/0000-0003-3925-0296				Bose S, 2006, MODERN PATHOL, V19, P238, DOI 10.1038/modpathol.3800525; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen ZJ, 2012, ORAL ONCOL, V48, P686, DOI 10.1016/j.oraloncology.2012.02.020; Cui L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-546; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Ekman S, 2012, J THORAC ONCOL, V7, P947, DOI 10.1097/JTO.0b013e31825581bd; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Grabinski N, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-85; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Heinonen H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-348; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; Jastrzebski K, 2007, GROWTH FACTORS, V25, P209, DOI 10.1080/08977190701779101; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Kajstura M, 2007, CYTOM PART A, V71A, P125, DOI 10.1002/cyto.a.20357; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kremer CL, 2006, PROSTATE, V66, P1203, DOI 10.1002/pros.20410; Li D, 2011, J BIOL CHEM, V286, P36677, DOI 10.1074/jbc.M111.270561; Li M, 2012, ONCOL LETT, V4, P1213, DOI 10.3892/ol.2012.930; Li XH, 2011, MOL CANCER RES, V9, P824, DOI 10.1158/1541-7786.MCR-10-0529; Lin HJ, 2005, BRIT J CANCER, V93, P1372, DOI 10.1038/sj.bjc.6602862; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martelli AM, 2009, EXPERT OPIN INV DRUG, V18, P1333, DOI 10.1517/14728220903136775; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Mueller AC, 2013, ONCOGENE, V32, P1164, DOI 10.1038/onc.2012.131; Nagayama K, 2007, GENE CHROMOSOME CANC, V46, P1000, DOI 10.1002/gcc.20485; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Noh WC, 2004, CLIN CANCER RES, V10, P1013, DOI 10.1158/1078-0432.CCR-03-0043; Oberg AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020465; Oneyama C, 2011, ONCOGENE, V30, P3489, DOI 10.1038/onc.2011.63; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; Rojo F, 2007, CLIN CANCER RES, V13, P81, DOI 10.1158/1078-0432.CCR-06-1560; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Soni A, 2008, MOL CANCER THER, V7, P1782, DOI 10.1158/1535-7163.MCT-07-2357; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Sun J, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0411-9; TELFORD WG, 1992, CYTOMETRY, V13, P137, DOI 10.1002/cyto.990130205; Turcatel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031032; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang BY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047053; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Zhou J, 2010, MOL MED REP, V3, P387, DOI 10.3892/mmr_00000269	45	150	161	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92099	10.1371/journal.pone.0092099	http://dx.doi.org/10.1371/journal.pone.0092099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24676355	Green Submitted, gold, Green Published			2022-12-27	WOS:000333254100111
J	Liu, N; Lin, ZF; Guan, LL; Gaughan, G; Lin, GZ				Liu, Nan; Lin, Zhifang; Guan, Lanlan; Gaughan, Gerald; Lin, Guizhu			Antioxidant Enzymes Regulate Reactive Oxygen Species during Pod Elongation in Pisum sativum and Brassica chinensis	PLOS ONE			English	Article							HYDROXYL RADICALS; HYDROGEN-PEROXIDE; CELL-WALL; ROOT; SUPEROXIDE; GROWTH; LEAVES; H2O2	Previous research has focused on the involvement of reactive oxygen species (ROS) in cell wall loosening and cell extension in plant vegetative growth, but few studies have investigated ROS functions specifically in plant reproductive organs. In this study, ROS levels and antioxidant enzyme activities were assessed in Pisum sativum and Brassica chinensis pods at five developmental stages. In juvenile pods, the high levels of O-2(-) and OH indicates that they had functions in cell wall loosening and cell elongation. In later developmental stages, high levels of. OH were also related to increases in cell wall thickness in lignified tissues. Throughout pod development, most of the O-2(-) was detected on plasma membranes of parenchyma cells and outer epidermis cells of the mesocarp, while most of the H2O2 was detected on plasma membranes of most cells throughout the mesocarp. This suggests that these sites are presumably the locations of ROS generation. The antioxidant enzymes superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT) apparently contributed to ROS accumulation in pod wall tissues. Furthermore, specifically SOD and POD were found to be associated with pod growth through the regulation of ROS generation and transformation. Throughout pod development, O-2(-) decreases were associated with increased SOD activity, while changes in H2O2 accumulation were associated with changes in CAT and POD activities. Additionally, high POD activity may contribute to the generation of. OH in the early development of pods. It is concluded that the ROS are produced in different sites of plasma membranes with the regulation of antioxidant enzymes, and that substantial ROS generation and accumulation are evident in cell elongation and cell wall loosening in pod wall cells.	[Liu, Nan; Lin, Zhifang; Guan, Lanlan; Lin, Guizhu] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Gaughan, Gerald] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lin, ZF (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	linzhif@scbg.ac.cn	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	China Scholarship Council [201204910138]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The current study was supported by China Scholarship Council (No. 201204910138, http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; BARRETO JC, 1994, LIFE SCI, V56, pPL89, DOI 10.1016/0024-3205(94)00925-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Derbyshire P, 2007, J EXP BOT, V58, P2079, DOI 10.1093/jxb/erm074; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; GILBERT DL, 1981, OXYGEN LIVING PROCES; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Ivakov A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00439; Ivanchenko MG, 2013, ANN BOT, DOI [10.1093/aob/mct181, DOI 10.1093/A0B/MCT181]; Johnansen DA, 1940, PLANT MICROTECHNIQUE; Kranner I, 2010, J PLANT PHYSIOL, V167, P805, DOI 10.1016/j.jplph.2010.01.019; Kukavica B, 2009, PLANT CELL PHYSIOL, V50, P304, DOI 10.1093/pcp/pcn199; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu N, 2013, J PLANT GROWTH REGUL, V32, P83, DOI 10.1007/s00344-012-9278-4; Liu N, 2010, ECOTOX ENVIRON SAFE, V73, P1238, DOI 10.1016/j.ecoenv.2010.06.017; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; Perl RT., 2002, OXIDATIVE STRESS PLA, P1; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Barcelo AR, 2009, SIGNAL COMMUN PLANTS, P73, DOI 10.1007/978-3-642-00390-5_5; Schopfer P, 2006, BIOFACTORS, V28, P73, DOI 10.1002/biof.5520280202; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Yang XF, 2001, ANALYST, V126, P928, DOI 10.1039/b100085n; ZENG S-X, 1991, Acta Phytophysiologica Sinica, V17, P177; [张玲玲 ZHANG LingLing], 2006, [生态学报, Acta Ecologica Sinica], V26, P1330, DOI 10.1016/S1872-2032(06)60025-5	32	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87588	10.1371/journal.pone.0087588	http://dx.doi.org/10.1371/journal.pone.0087588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24671213	Green Published, gold, Green Submitted			2022-12-27	WOS:000330631800048
J	Hobbelen, PHF; Paveley, ND; van den Bosch, F				Hobbelen, Peter H. F.; Paveley, Neil D.; van den Bosch, Frank			The Emergence of Resistance to Fungicides	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; MYCOSPHAERELLA-GRAMINICOLA; PESTICIDE RESISTANCE; SPRAY HETEROGENEITY; SEPTORIA-TRITICI; SELECTION; MIXTURES; PATHOGEN; MODEL; POPULATIONS	Many studies exist about the selection phase of fungicide resistance evolution, where a resistant strain is present in a pathogen population and is differentially selected for by the application of fungicides. The emergence phase of the evolution of fungicide resistance - where the resistant strain is not present in the population and has to arise through mutation and subsequently invade the population - has not been studied to date. Here, we derive a model which describes the emergence of resistance in pathogen populations of crops. There are several important examples where a single mutation, affecting binding of a fungicide with the target protein, shifts the sensitivity phenotype of the resistant strain to such an extent that it cannot be controlled effectively('qualitative' or 'single-step' resistance). The model was parameterized for this scenario for Mycosphaerella graminicola on winter wheat and used to evaluate the effect of fungicide dose rate on the time to emergence of resistance for a range of mutation probabilities, fitness costs of resistance and sensitivity levels of the resistant strain. We also evaluated the usefulness of mixing two fungicides of differing modes of action for delaying the emergence of resistance. The results suggest that it is unlikely that a resistant strain will already have emerged when a fungicide with a new mode of action is introduced. Hence, 'anti-emergence' strategies should be identified and implemented. For all simulated scenarios, the median emergence time of a resistant strain was affected little by changing the dose rate applied, within the range of doses typically used on commercial crops. Mixing a single-site acting fungicide with a multi-site acting fungicide delayed the emergence of resistance to the single-site component. Combining the findings with previous work on the selection phase will enable us to develop more efficient anti-resistance strategies.	[Hobbelen, Peter H. F.; van den Bosch, Frank] Rothamsted Res, Harpenden, Herts, England; [Paveley, Neil D.] ADAS UK Ltd, Malton, N Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	van den Bosch, F (corresponding author), Rothamsted Res, Harpenden, Herts, England.	frank.vandenbosch@rothamsted.ac.uk	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Biological and Biotechnological Research Council of the United Kingdom; Department for Environment, Food and Rural Affairs of the United Kingdom [PS2712]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Biological and Biotechnological Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives support from the Biological and Biotechnological Research Council of the United Kingdom. Part of this research was funded by the Department for Environment, Food and Rural Affairs of the United Kingdom (project number PS2712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch CPD, 1997, J APPL ECOL, V34, P1032, DOI 10.2307/2405292; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Carnegie SF, 2008, POTATO RES, V51, P113, DOI 10.1007/s11540-008-9094-1; DOSTER MA, 1990, PHYTOPATHOLOGY, V80, P1190, DOI 10.1094/Phyto-80-1190; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Grabski C., 1985, BRIT CROP PROT C MON, V31, P315; Grimmer M, 2011, RESISTANCE 2011, P94; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Hall RJ, 2007, B MATH BIOL, V69, P525, DOI 10.1007/s11538-006-9139-z; Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006; HOARE FA, 1986, PLANT PATHOL, V35, P506, DOI 10.1111/j.1365-3059.1986.tb02048.x; Hobbelen PHF, 2013, PHYTOPATHOLOGY, V103, P690, DOI 10.1094/PHYTO-06-12-0142-R; Hobbelen PHF, 2011, PHYTOPATHOLOGY, V101, P1224, DOI 10.1094/PHYTO-10-10-0290; Hobbelen PHF, 2011, PLANT PATHOL, V60, P304, DOI 10.1111/j.1365-3059.2010.02380.x; Horsten JAHM, 1979, THESIS WAGENINGEN U; HUNTER T, 1987, ANN APPL BIOL, V110, P515, DOI 10.1111/j.1744-7348.1987.tb04169.x; Iwasa Y, 2004, J THEOR BIOL, V226, P205, DOI 10.1016/j.jtbi.2003.08.014; JOSEPOVITS G, 1989, CROP PROT, V8, P106, DOI 10.1016/0261-2194(89)90084-7; Kang JM, 2006, FASEB J, V20, P2476, DOI 10.1096/fj.06-6209com; LaMondia J. A., 2001, Journal of Environmental Horticulture, V19, P51; Mavroeidi VI, 2006, PLANT PATHOL, V55, P715, DOI 10.1111/j.1365-3059.2006.01441.x; McCartney C, 2007, CROP PROT, V26, P1272, DOI 10.1016/j.cropro.2006.10.027; Metcalfe RJ, 2000, PLANT PATHOL, V49, P546, DOI 10.1046/j.1365-3059.2000.00486.x; MILGROOM MG, 1990, PHYTOPATHOLOGY, V80, P410, DOI 10.1094/Phyto-80-410; Parnell S, 2006, PHYTOPATHOLOGY, V96, P549, DOI 10.1094/PHYTO-96-0549; Parnell S, 2005, PHYTOPATHOLOGY, V95, P632, DOI 10.1094/PHYTO-95-0632; Paveley ND, 2011, HGCA WHEAT DIS MANAG; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; SANDERS PL, 1985, PLANT DIS, V69, P939; SANOAMUANG N, 1995, MYCOL RES, V99, P677, DOI 10.1016/S0953-7562(09)80527-3; Serra MC, 2007, THEOR POPUL BIOL, V72, P167, DOI 10.1016/j.tpb.2007.01.005; Serra MC, 2006, J APPL PROBAB, V43, P296, DOI 10.1239/jap/1143936262; Shaw MW, 2000, PHYTOPATHOLOGY, V90, P333, DOI 10.1094/PHYTO.2000.90.4.333; SHAW MW, 1993, CROP PROT, V12, P120, DOI 10.1016/0261-2194(93)90138-9; Tenaillon O, 2004, TRENDS MICROBIOL, V12, P264, DOI 10.1016/j.tim.2004.04.002; Thornley JHM., 1990, PLANT CROP MODELLING; Thygesen K, 2009, EUR J PLANT PATHOL, V123, P435, DOI 10.1007/s10658-008-9381-3; Turechek WW, 2004, PLANT HLTH PROG; VALI RJ, 1992, PLANT DIS, V76, P919, DOI 10.1094/PD-76-0919; van den Bosch F, 2011, PLANT PATHOL, V60, P597, DOI 10.1111/j.1365-3059.2011.02439.x; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; WAGGONER PE, 1987, PHYTOPATHOLOGY, V77, P393; Zhang CQ, 2008, ANN APPL BIOL, V153, P205, DOI 10.1111/j.1744-7348.2008.00248.x	48	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91910	10.1371/journal.pone.0091910	http://dx.doi.org/10.1371/journal.pone.0091910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24671213	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300044
J	da Silva, VCP; Bertin, A; Blin, A; Germain, JF; Bernardi, D; Rignol, G; Botton, M; Malausa, T				Pacheco da Silva, Vitor C.; Bertin, Aline; Blin, Aurelie; Germain, Jean-Francois; Bernardi, Daniel; Rignol, Guylene; Botton, Marcos; Malausa, Thibaut			Molecular and Morphological Identification of Mealybug Species (Hemiptera: Pseudococcidae) in Brazilian Vineyards	PLOS ONE			English	Article							FERRISIA FULLAWAY HEMIPTERA; SCALE INSECTS HEMIPTERA; EXPORT GRAPE PRODUCTION; MULTIPLEX PCR; PEST; PHYLOGENY; MARKERS	Mealybugs (Hemiptera: Pseudococcidae) are pests constraining the international trade of Brazilian table grapes. They damage grapes by transmitting viruses and toxins, causing defoliation, chlorosis, and vigor losses and favoring the development of sooty mold. Difficulties in mealybug identification remain an obstacle to the adequate management of these pests. In this study, our primary aim was to identify the principal mealybug species infesting the major table grape-producing regions in Brazil, by morphological and molecular characterization. Our secondary aim was to develop a rapid identification kit based on species-specific Polymerase Chain Reactions, to facilitate the routine identification of the most common pest species. We surveyed 40 sites infested with mealybugs and identified 17 species: Dysmicoccus brevipes (Cockerell), Dysmicoccus sylvarum Williams and Granara de Willink, Dysmicoccus texensis (Tinsley), Ferrisia cristinae Kaydan and Gullan, Ferrisia meridionalis Williams, Ferrisia terani Williams and Granara de Willink, Phenacoccus baccharidis Williams, Phenacoccus parvus Morrison, Phenacoccus solenopsis Tinsley, Planococcus citri (Risso), Pseudococcus viburni (Signoret), Pseudococcus cryptus Hempel, four taxa closely related each of to Pseudococcus viburni, Pseudococcus sociabilis Hambleton, Pseudococcus maritimus (Ehrhorn) and Pseudococcus meridionalis Prado, and one specimen from the genus Pseudococcus Westwood. The PCR method developed effectively identified five mealybug species of economic interest on grape in Brazil: D. brevipes, Pl. citri, Ps. viburni, Ph. solenopsis and Planococcus ficus (Signoret). Nevertheless, it is not possible to assure that this procedure is reliable for taxa that have not been sampled already and might be very closely related to the target species.	[Pacheco da Silva, Vitor C.; Botton, Marcos] Embrapa Uva & Vinho, Bento Goncalves, Brazil; [Bertin, Aline; Bernardi, Daniel] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Blin, Aurelie; Rignol, Guylene; Malausa, Thibaut] INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, F-06903 Sophia Antipolis, France; [Germain, Jean-Francois] ANSES, Lab Sante Vegetaux, Unite Entomol & Plantes Invas, Montferrier Sur Lez, France	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Malausa, T (corresponding author), INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, BP 167, F-06903 Sophia Antipolis, France.	tmalausa@sophia.inra.fr	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	European Union [265865, 269196, 324475]; French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS) [1001001]; Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	European Union(European Commission); French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS); Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union Seventh Framework Programme FP7-KBBE #265865 "PURE'', FP7-IRSES #269196 "IPRABIO'' and FP7-IAPP #324475 "COLBICS'' and by the French grants Agropolis Fondation (http://www.agropolis-fondation.fr/) (RTRA - Montpellier, BIOFIS project number 1001001) and 'Bibliotheque du Vivant'. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Ben-Dov Y, 2012, SCALENET DATABASE SC; Bertin S, 2010, PHYTOPARASITICA, V38, P401, DOI 10.1007/s12600-010-0109-5; Beuning LL, 1999, J ECON ENTOMOL, V92, P463, DOI 10.1093/jee/92.2.463; Camargo UA, 2011, REV BRAS FRUTIC, V33, P144, DOI 10.1590/S0100-29452011000500017; Cavalieri V, 2008, ZOOTAXA, P65, DOI 10.11646/zootaxa.1816.1.6; Charles J. G., 2006, New Zealand Plant Protection, V59, P330; Charles JG, 2011, BIOCONTROL, V56, P155, DOI 10.1007/s10526-010-9322-x; Correa L. R. B., 2005, Laranja, V26, P265; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; Correa M, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2926.1.2; Santa-Cecilia LVC, 2009, ACTA SCI-AGRON, V31, P13, DOI 10.4025/actasciagron.v31i1.6603; Culik Mark Paul, 2007, Biota Neotrop., V7, P61, DOI 10.1590/S1676-06032007000300006; Culik MP, 2005, ZOOTAXA, P1; Daane KM, 2008, CALIF AGR, V62, P167, DOI 10.3733/ca.v062n04p167; Daane Kent M., 2012, P271; Daane KM, 2011, ENVIRON ENTOMOL, V40, P1595, DOI 10.1603/EN11075; Granara De Willink María Cristina, 2007, Rev. Soc. Entomol. Argent., V66, P29; Demontis MA, 2007, J APPL ENTOMOL, V131, P59, DOI 10.1111/j.1439-0418.2006.01126.x; Foldi Imre, 2005, Nouvelle Revue d'Entomologie, V22, P305; GARAU R, 1995, VITIS, V34, P67; Gimpel William F. Jr, 1996, Contributions on Entomology International, V2, P1; Golino D. A., 2002, California Agriculture, V56, P196, DOI 10.3733/ca.v056n06p196; Gonzalez R. H., 2004, Revista Fruticola, V25, P41; Gullan PJ, 2010, SYST ENTOMOL, V35, P329, DOI 10.1111/j.1365-3113.2009.00513.x; Gullan PJ, 2003, ANN ENTOMOL SOC AM, V96, P723, DOI 10.1603/0013-8746(2003)096[0723:ANPSOT]2.0.CO;2; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kaydan MB, 2012, ZOOTAXA, P1; Kuniyuki Hugo, 2006, Summa phytopathol., V32, P151, DOI 10.1590/S0100-54052006000200009; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Martelli G P, 2002, Arch Virol, V147, P2039, DOI 10.1007/s007050200048; Mello LMR, 2013, VITICULTURA BRASILEI; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Morandi Filho WJ, 2008, ARQ I BIOL-SAO PAULO, V76, P427; Morse GE, 2006, SYST ENTOMOL, V31, P338, DOI 10.1111/j.1365-3113.2005.00316.x; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Saccaggi DL, 2008, B ENTOMOL RES, V98, P27, DOI 10.1017/S000748530700538X; SANTA-CECÍLIA LENIRA V.C., 2002, Neotrop. entomol., V31, P333, DOI 10.1590/S1519-566X2002000200024; Selwyn B, 2007, J AGRAR CHANGE, V7, P526, DOI 10.1111/j.1471-0366.2007.00155.x; Selwyn B, 2010, J AGRAR CHANGE, V10, P537, DOI 10.1111/j.1471-0366.2009.00245.x; Souza B., 2008, Coffee Science, V3, P104; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Villard P, 2013, MOL ECOL RESOUR, V13, P755, DOI 10.1111/1755-0998.12116; Walton V. M., 2004, South African Journal of Enology and Viticulture, V25, P54; Walton VM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.4701; Willians DJ, 1992, MEALYBUGS CENTRAL S; Yokogawa T, 2009, GENES GENET SYST, V84, P57, DOI 10.1266/ggs.84.57	50	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103267	10.1371/journal.pone.0103267	http://dx.doi.org/10.1371/journal.pone.0103267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	24671213	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992600050
J	Ramos, JE; Pecl, GT; Moltschaniwskyj, NA; Strugnell, JM; Leon, RI; Semmens, JM				Ramos, Jorge E.; Pecl, Gretta T.; Moltschaniwskyj, Natalie A.; Strugnell, Jan M.; Leon, Rafael I.; Semmens, Jayson M.			Body Size, Growth and Life Span: Implications for the Polewards Range Shift of Octopus tetricus in South-Eastern Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMON OCTOPUS; REPRODUCTIVE-CYCLE; UPWELLING SYSTEM; VULGARIS; SQUID; EVOLUTIONARY; ECOLOGY; AGE; TEMPERATURE	Understanding the response of any species to climate change can be challenging. However, in short-lived species the faster turnover of generations may facilitate the examination of responses associated with longer-term environmental change. Octopus tetricus, a commercially important species, has undergone a recent polewards range shift in the coastal waters of south-eastern Australia, thought to be associated with the southerly extension of the warm East Australian Current. At the cooler temperatures of a polewards distribution limit, growth of a species could be slower, potentially leading to a bigger body size and resulting in a slower population turnover, affecting population viability at the extreme of the distribution. Growth rates, body size, and life span of O. tetricus were examined at the leading edge of a polewards range shift in Tasmanian waters (40 degrees S and 147 degrees E) throughout 2011. Octopus tetricus had a relatively small body size and short lifespan of approximately 11 months that, despite cooler temperatures, would allow a high rate of population turnover and may facilitate the population increase necessary for successful establishment in the new extended area of the range. Temperature, food availability and gender appear to influence growth rate. Individuals that hatched during cooler and more productive conditions, but grew during warming conditions, exhibited faster growth rates and reached smaller body sizes than individuals that hatched into warmer waters but grew during cooling conditions. This study suggests that fast growth, small body size and associated rapid population turnover may facilitate the range shift of O. tetricus into Tasmanian waters.	[Ramos, Jorge E.; Pecl, Gretta T.; Leon, Rafael I.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Moltschaniwskyj, Natalie A.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia; [Strugnell, Jan M.] La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia	University of Tasmania; University of Newcastle; La Trobe University	Ramos, JE (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	jeramos@utas.edu.au	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Consejo Nacional de Ciencia y Tecnologia of Mexico [308672]; University of Tasmania; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Tasmania; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J. Ramos was awarded the scholarship 308672 by Consejo Nacional de Ciencia y Tecnologia of Mexico, a Tasmania Graduate Research scholarship from the University of Tasmania and a Bookend Lynchpin Ocean Scholarship 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amundsen PA, 2012, BIOL INVASIONS, V14, P1501, DOI 10.1007/s10530-012-0175-3; Anderson RC, 2008, MAR ECOL PROG SER, V371, P199, DOI 10.3354/meps07649; Arenas M, 2012, MOL BIOL EVOL, V29, P207, DOI 10.1093/molbev/msr187; Arkhipkin AI, 2005, MAR FRESHWATER RES, V56, P371, DOI 10.1071/MF04274; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Calosi P, 2013, INTEGR COMP BIOL, V53, P660, DOI 10.1093/icb/ict041; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Canali E, 2011, MAR ECOL PROG SER, V441, P141, DOI 10.3354/meps09399; Carrasco JF, 2006, AQUAC RES, V37, P1601, DOI 10.1111/j.1365-2109.2006.01594.x; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1105, DOI 10.1098/rstb.1996.0096; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dia M.A., 1988, THESIS U W BRITTANY THESIS U W BRITTANY; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; Edgar G, 2000, AUSTR MARINE LIFE PL; Engel Katharina, 2011, Communicative & Integrative Biology, V4, P247, DOI 10.4161/cib.4.3.14885; Forsythe J.W., 1987, P135; FORSYTHE JW, 1988, MAR BIOL, V98, P369, DOI 10.1007/BF00391113; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Fox J., 2019, R COMPANION APPL REG, V.; Fulton EA, 2011, ICES J MAR SCI, V68, P1329, DOI 10.1093/icesjms/fsr032; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hanlon RT, 1996, CEPHALOPOD BEHAV; Harrington JJ, 2006, FISH RES, V77, P10, DOI 10.1016/j.fishres.2005.09.003; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Herwig JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043679; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Jackson GD, 2004, MAR FRESHWATER RES, V55, P357, DOI 10.1071/MF03152; Jackson GD, 2003, MAR BIOL, V142, P925, DOI 10.1007/s00227-002-1005-4; Jackson GD, 2001, MAR ECOL PROG SER, V218, P167, DOI 10.3354/meps218167; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Katsanevakis S, 2006, ICES J MAR SCI, V63, P151, DOI 10.1016/j.icesjms.2005.07.004; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leporati SC, 2008, MAR ECOL PROG SER, V367, P213, DOI 10.3354/meps07558; Leporati SC, 2008, MAR BIOL, V155, P375, DOI 10.1007/s00227-008-1033-9; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; Lourenco S, 2012, FISH RES, V127, P116, DOI 10.1016/j.fishres.2012.04.006; Mangold K., 1983, P335; Mangold K., 1987, P157; Mather JA, 2012, CURR ZOOL, V58, P597, DOI 10.1093/czoolo/58.4.597; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Moreno A, 2012, J MAR BIOL ASSOC UK, V92, P1619, DOI 10.1017/S0025315411002141; Norman M.D., 2000, GUIDE SQUID CUTTLEFI; Okei N, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P468; Oosthuizen A, 2003, J MAR BIOL ASSOC UK, V83, P535, DOI 10.1017/S0025315403007458h; Otero J, 2008, MAR ECOL PROG SER, V362, P181, DOI 10.3354/meps07437; Otero J, 2007, FISH RES, V85, P122, DOI 10.1016/j.fishres.2007.01.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Pecl GT, 2004, MAR FRESHWATER RES, V55, P387, DOI 10.1071/MF03153; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; R Core Team, 2021, R LANGUAGE ENV STAT; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosas C, 2008, AQUACULTURE, V275, P291, DOI 10.1016/j.aquaculture.2008.01.015; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Scandol J, 2008, STATUS FISHERIES RES, P193; Schwarz R, 2010, FISH RES, V106, P177, DOI 10.1016/j.fishres.2010.06.008; Semmens J, 2011, J EXP BIOL, V214, P2799, DOI 10.1242/jeb.051631; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Spiess A, 2013, QPCR MODELLING ANAL; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tasmania Wild Fisheries Management Branch Tasmania Department of Primary Industries and Water, 2009, SACL FISH MAN PLAN R; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; VILLANUEVA R, 1992, J EXP MAR BIOL ECOL, V159, P157, DOI 10.1016/0022-0981(92)90034-8; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wolf BM, 1997, J SHELLFISH RES, V16, P533	85	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103480	10.1371/journal.pone.0103480	http://dx.doi.org/10.1371/journal.pone.0103480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	24671213	Green Accepted, Green Published, gold			2022-12-27	WOS:000339812700029
J	Wu, KL; Zeng, SJ; Lin, DI; da Silva, JAT; Bu, ZY; Zhang, JX; Duan, J				Wu, Kunlin; Zeng, Songjun; Lin, Danni; da Silva, Jaime A. Teixeira; Bu, Zhaoyang; Zhang, Jianxia; Duan, Ju			In Vitro Propagation and Reintroduction of the Endangered Renanthera imschootiana Rolfe	PLOS ONE			English	Article							ASYMBIOTIC SEED-GERMINATION; CALCIUM HYPOCHLORITE; ESTABLISHMENT; REGENERATION; GROWTH; ORCHID	Renanthera imschootiana Rolfe is an endangered tropical epiphytic orchid that is threatened with extinction due to over-collection and the loss of suitable habitats. In vitro propagation is a useful way to mass produce plants for re-establishment in the wild and for commercial propagation. Seeds collected 150 days after pollination (DAP) were the optimum stage for in vitro culture. Seed germination reached 93.1% on quarter-strength MS (i.e., MS containing a quarter of macro-and micronutrients) medium containing 0.5 mg l(-1) a-naphthaleneacetic acid (NAA), 20% coconut water (CW), 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 1.0 g l(-1) activated charcoal (AC). Quarter-strength MS medium supplemented with 1.0 mg l(-1) BA, 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 20% CW was suitable for the sub-culture of protocorm-like bodies (PLBs) in which the PLB proliferation ratio was 2.88. Quarter-strength MS medium containing 1.0 mg l(-1) NAA, 1.0 g l(-1) peptone, 100 g l(-1) banana homogenate (BH), and 1.0 g l(-1) AC was suitable for plantlet formation and 95.67% of plantlets developed from PLBs within 60 days of culture. Hyponex N016 medium supplemented with 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 20 g l(-1) sucrose, 150 g l(-1) BH, and 1.0 g l(-1) AC was suitable for the in vitro growth of plantlets about 2-cm in height. Plantlets 3-cm in height or taller were transplanted to Chilean sphagnum moss, and 95% of plantlets survived after 60 days in a greenhouse. Three hundred transplanted of seedlings 360-days old were reintroduced into three natural habitats. Highest percentage survival (79.67%) was observed in Yuanjiang Nature Reserve two years after reintroduction, followed by Huolu Mountain forest park (71.33%). This protocol is an efficient means for the large-scale propagation and in vitro and in vivo germplasm conservation of R. imschootiana.	[Wu, Kunlin; Zeng, Songjun; Lin, Danni; Zhang, Jianxia] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Duan, Ju] Chinese Acad Sci, South China Bot Garden, Key Lab S China Agr Plant Mol Anal & Gene Improve, Guangzhou, Guangdong, Peoples R China; [da Silva, Jaime A. Teixeira] Kagawa Ken, Takamatsu, Kagawa, Japan; [Bu, Zhaoyang] Guangxi Acad Agr Sci, Flower Res Inst, Nanning 150931, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Guangxi Academy of Agricultural Sciences	Zeng, SJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	zengsongjun@scib.ac.cn; yangnv@126.com	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [211026]; Guangzhou Key Technology Research and Development Program [Y233051001]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Guangzhou Key Technology Research and Development Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a fund of the Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (No. 211026), and the Guangzhou Key Technology Research and Development Program (Y233051001). Songjun Zeng received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd J., 1995, HDB BOT GARDENS REIN; [Anonymous], 2014, WORLD CHECKLIST SELE; Arditti J., 1993, MICROPROPAGATION ORC; Arditti J, 1982, ORCHID BIOL REV PERS, P352; Chu Chin-Chang, 1994, Lindleyana, V9, P153; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; da Silva JAT, 2006, PLANT CELL TISS ORG, V84, P135, DOI 10.1007/s11240-005-9003-0; da Silva JAT, 2005, PROPAG ORNAM PLANTS, V5, P129; DASILVA JAT, 2012, ASIAN AUSTRALASIAN J, V6, P121; DeMarie E., 1991, HORTSCIENCE, V26, P272; Dix L., 1982, PLANT CELL TISSUE OR, V12, P39; Ernst R., 1975, American Orchid Society Bulletin, V44, P12; Ernst R., 1974, American Orchid Society Bulletin, V43, P35; Goh C. J., 1982, Orchid Review, V90, P295; GOH CJ, 1990, SCI HORTIC-AMSTERDAM, V44, P315, DOI 10.1016/0304-4238(90)90132-X; HARVAIS G, 1973, CAN J BOT, V51, P327, DOI 10.1139/b73-040; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; Kauth P.J., 2008, FLORICULTURE ORNAMEN, P375; Kishor R, 2009, EUPHYTICA, V165, P247, DOI 10.1007/s10681-008-9755-9; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Lee YI, 2006, ANN BOT-LONDON, V98, P1311, DOI 10.1093/aob/mcl222; Lin DL, 2008, J FOOD DRUG ANAL, V16, P1; Lo SF, 2004, IN VITRO CELL DEV-PL, V40, P528, DOI 10.1079/IVP2004571; McNaughton S.J., 1989, P109; Miyoshi K, 1998, PHYSIOL PLANTARUM, V102, P481, DOI 10.1034/j.1399-3054.1998.1020401.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mweetwa AM, 2008, SCI HORTIC-AMSTERDAM, V117, P257, DOI 10.1016/j.scienta.2008.03.035; NAGASHIMA T, 1982, J JPN SOC HORTIC SCI, V51, P94, DOI 10.2503/jjshs.51.94; PIERIK RLM, 1988, SCI HORTIC-AMSTERDAM, V34, P139, DOI 10.1016/0304-4238(88)90084-2; Raghavan V., 1977, CRC HDB SERIES NUTR, P361; Ren H, 2012, ORYX, V46, P391, DOI 10.1017/S0030605311000615; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; SEENI S, 1992, PLANT CELL TISS ORG, V29, P167, DOI 10.1007/BF00034349; Seeni S, 2000, PLANT CELL TISS ORG, V61, P1, DOI 10.1023/A:1006444614657; Teixeira da Silva J., 2013, FLORIC ORNAM BIOTECH, V7, P1, DOI DOI 10.1016/0168-1656(90)90117-T; Thomale H., 1954, ORCHIDEEN, P62; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; Tsi Z. H., 1999, FLORA REIPUBLICAE PO, V19, P291; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; van der Kinderen G., 1987, LINDLEYANA, V2, P84; VANWAES JM, 1986, PHYSIOL PLANTARUM, V66, P435, DOI 10.1111/j.1399-3054.1986.tb05947.x; Vyas S, 2009, SCI HORTIC-AMSTERDAM, V121, P32, DOI 10.1016/j.scienta.2009.01.012; Wu KL, 2012, SCI HORTIC-AMSTERDAM, V135, P194, DOI 10.1016/j.scienta.2011.11.028; Wu KunLin, 2010, Acta Horticulturae Sinica, V37, P685; Wu Z.Y., 2009, FLORA CHINA, V25; YAM T W, 1990, Lindleyana, V5, P256; Yong JWH, 2009, MOLECULES, V14, P5144, DOI 10.3390/molecules14125144; Zeng SJ, 2015, CRIT REV BIOTECHNOL, V35, P279; Zeng SJ, 2011, HORTSCIENCE, V46, P460, DOI 10.21273/HORTSCI.46.3.460; Zeng SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P198, DOI 10.1016/j.scienta.2012.02.026	51	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110033	10.1371/journal.pone.0110033	http://dx.doi.org/10.1371/journal.pone.0110033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	24671213	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100017
